PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stoll, SW; Stuart, PE; Swindell, WR; Tsoi, LC; Li, B; Gandarillas, A; Lambert, S; Johnston, A; Nair, RP; Elder, JT				Stoll, S. W.; Stuart, P. E.; Swindell, W. R.; Tsoi, L. C.; Li, B.; Gandarillas, A.; Lambert, S.; Johnston, A.; Nair, R. P.; Elder, J. T.			The EGF receptor ligand amphiregulin controls cell division via FoxM1	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CONFIDENCE-INTERVALS; GENE-EXPRESSION; HUMAN KERATINOCYTES; SQUAMOUS-CELL; MICE LACKING; DIFFERENTIATION; CANCER; KINASE; ACTIVATION	Epidermal growth factor receptor (EGFR) is central to epithelial cell physiology, and deregulated EGFR signaling has an important role in a variety of human carcinomas. Here we show that silencing of the EGF-related factor amphiregulin (AREG) markedly inhibits the expansion of human keratinocytes through mitotic failure and accumulation of cells with >= 4n DNA content. RNA-sequencing-based transcriptome analysis revealed that tetracycline-mediated AREG silencing significantly altered the expression of 2331 genes, 623 of which were not normalized by treatment with EGF. Interestingly, genes irreversibly upregulated by suppression of AREG overlapped with genes involved in keratinocyte differentiation. Moreover, a significant proportion of the irreversibly downregulated genes featured upstream binding sites recognized by forkhead box protein M1 (FoxM1), a key transcription factor in the control of mitosis that is widely dysregulated in cancer. The downregulation of FoxM1 and its target genes preceded mitotic arrest. Constitutive expression of FoxM1 in AREG knockdown cells normalized cell proliferation, reduced the number of cells with >= 4n DNA content and rescued expression of FoxM1 target genes. These results demonstrate that AREG controls G2/M progression and cytokinesis in keratinocytes via activation of a FoxM1-dependent transcriptional program, suggesting new avenues for treatment of epithelial cancer.	[Stoll, S. W.; Stuart, P. E.; Swindell, W. R.; Lambert, S.; Johnston, A.; Nair, R. P.; Elder, J. T.] Univ Michigan, Dept Dermatol, 7415 Med Sci Bldg 1,1301 East Catherine, Ann Arbor, MI 48109 USA; [Tsoi, L. C.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Li, B.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gandarillas, A.] Fdn Inst Invest Marques de Valdecilla IDIVAL, Cell Cycle Stem Cell Fate & Canc Lab, Santander, Spain; [Elder, J. T.] Ann Arbor Vet Affairs Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Hospital Universitario Marques de Valdecilla (HUMV)	Stoll, SW (corresponding author), Univ Michigan, Dept Dermatol, 7415 Med Sci Bldg 1,1301 East Catherine, Ann Arbor, MI 48109 USA.	sstoll@umich.edu		Tsoi, Lam Cheung/0000-0003-1627-5722	National Institute for Arthritis, Musculoskeletal and Skin Disease (NIAMS), National Institutes of Health (NIH) [K01 AR050462, R03 AR049420, K01 AR064765, R01 AR052889]; Instituto de Salud Carlos III (Spain, ISCIII-FIS/FEDER) [PI11/02070]; Babcock Foundation Endowment; Ann Arbor Veterans Affairs Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052889, R03AR049420, K01AR050462] Funding Source: NIH RePORTER	National Institute for Arthritis, Musculoskeletal and Skin Disease (NIAMS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Instituto de Salud Carlos III (Spain, ISCIII-FIS/FEDER); Babcock Foundation Endowment; Ann Arbor Veterans Affairs Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Mahdu Prasad for assistance with RNA-seq assays and Dr James Rheinwald (Harvard Medical School, Boston, MA) for providing the N/TERT-2G keratinocyte cell line. This work was in part supported by the National Institute for Arthritis, Musculoskeletal and Skin Disease (NIAMS), National Institutes of Health (NIH award K01 AR050462 and R03 AR049420 to SWS, K01 AR064765 to AJ and R01 AR052889 to JTE) and Instituto de Salud Carlos III (Spain, ISCIII-FIS/FEDER, PI11/02070, to AG). AJ is supported by a Babcock Foundation Endowment. JTE is supported by the Ann Arbor Veterans Affairs Hospital.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BOONSTRA J, 1985, EXP CELL RES, V161, P421, DOI 10.1016/0014-4827(85)90098-9; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fontanini G, 1998, CLIN CANCER RES, V4, P241; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Gandarillas A, 2014, EXP DERMATOL, V23, P87, DOI 10.1111/exd.12287; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jean GW, 2008, PHARMACOTHERAPY, V28, P742, DOI 10.1592/phco.28.6.742; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Jost M, 1999, J INVEST DERMATOL, V112, P443, DOI 10.1046/j.1523-1747.1999.00543.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kansra S, 2004, MOL BIOL CELL, V15, P4299, DOI 10.1091/mbc.E04-03-0233; Kansra S, 2005, MOL PHARMACOL, V67, P1145, DOI 10.1124/mol.104.004689; Kong XY, 2013, CANCER RES, V73, P3987, DOI 10.1158/0008-5472.CAN-12-3859; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Mascia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005773; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Maxwell SE, 2004, DESIGNING EXPT ANAL, P868; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Okabe H, 2001, CANCER RES, V61, P2129; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rittie L, 2007, AM J PATHOL, V170, P2089, DOI 10.2353/ajpath.2007.060537; Robertson ED, 2012, J CELL SCI, V125, P3320, DOI 10.1242/jcs.095125; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schelfhout VRJ, 2002, J PATHOL, V198, P523, DOI 10.1002/path.1240; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sternlicht MD, 2008, J MAMMARY GLAND BIOL, V13, P181, DOI 10.1007/s10911-008-9084-6; Stoll S, 1997, J CLIN INVEST, V100, P1271, DOI 10.1172/JCI119641; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Stoll SW, 2010, J INVEST DERMATOL, V130, P295, DOI 10.1038/jid.2009.211; Stoll SW, 1998, ONCOGENE, V16, P1493, DOI 10.1038/sj.onc.1201657; Stoll SW, 2015, J INVEST DERMA UNPUB; Swindell WR, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-27; Swindell WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079253; Swindell WR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01215; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Teh MT, 2002, CANCER RES, V62, P4773; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tinhofer I, 2011, CLIN CANCER RES, V17, P5197, DOI 10.1158/1078-0432.CCR-10-3338; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang HX, 2010, CARCINOGENESIS, V31, P1132, DOI 10.1093/carcin/bgq058; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yoshida T, 2010, BIOCHEM PHARMACOL, V80, P613, DOI 10.1016/j.bcp.2010.05.014; Yu G, 2015, R PACKAGE VERSION 1	80	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2075	2086		10.1038/onc.2015.269	http://dx.doi.org/10.1038/onc.2015.269			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26234682	Green Accepted			2022-12-26	WOS:000374505600007
J	Normant, V; Beaudoin, J; Labbe, S				Normant, Vincent; Beaudoin, Jude; Labbe, Simon			An Antisense RNA-mediated Mechanism Eliminates a Meiosis-specific Copper-regulated Transcript in Mitotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER GENE-EXPRESSION; BINDING FACTOR PHP4; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SELECTIVE ELIMINATION; SPORULATING CELLS; CONVERGENT GENES; IRON-DEFICIENCY; S. POMBE; POLYMERASE	Sense and antisense transcripts produced from convergent gene pairs could interfere with the expression of either partner gene. In Schizosaccharomyces pombe, we found that the iss1(+) gene produces two transcript isoforms, including a long antisense mRNA that is complementary to the meiotic cum1(+) sense transcript, inhibiting cum1(+) expression in vegetative cells. Inhibition of cum1(+) transcription was not at the level of its initiation because fusion of the cum1(+) promoter to the lacZ gene showed that activation of the reporter gene occurs in response to low copper conditions. Further analysis showed that the transcription factor Cuf1 and conserved copper-signaling elements (CuSEs) are required for induction of cum1(+)-lacZ transcription under copper deficiency. Insertion of a multipartite polyadenylation signal immediately downstream of iss1(+) led to the exclusive production of a shorter iss1(+) mRNA isoform, thereby allowing accumulation of cum1(+) sense mRNA in copper-limited vegetative cells. This finding suggested that the long iss1(+) antisense mRNA could pair with cum1(+) sense mRNA, thereby producing double-stranded RNA molecules that could induce RNAi. We consistently found that mutant strains for RNAi (dcr1 Delta, ago1 Delta, rdp1 Delta, and clr4 Delta) are defective in selectively eliminating cum1(+) sense transcript in the G(1) phase of the cell cycle. Taken together, these results describe the first example of a copper-regulated meiotic gene repressed by an antisense transcription mechanism in vegetative cells.	[Normant, Vincent; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Canadian Institutes of Health Research Grant [MOP-114986]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-114986 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Aranda A, 1999, MOL CELL BIOL, V19, P1251; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2013, EUKARYOT CELL, V12, P575, DOI 10.1128/EC.00019-13; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chen HM, 2011, CURR OPIN MICROBIOL, V14, P655, DOI 10.1016/j.mib.2011.09.010; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Gullerova M, 2011, GENE DEV, V25, P556, DOI 10.1101/gad.618611; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Moldon A, 2009, NAT STRUCT MOL BIOL, V16, P350, DOI 10.1038/nsmb0409-350; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Plante S, 2014, J BIOL CHEM, V289, P10168, DOI 10.1074/jbc.M113.543678; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Singleton TL, 2002, EUKARYOT CELL, V1, P44, DOI 10.1128/EC.01.1.44-55.2002; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Suzuki S, 2013, FUNGAL GENET BIOL, V56, P42, DOI 10.1016/j.fgb.2013.04.008; Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2013, NUCLEIC ACIDS RES, V41, P9680, DOI 10.1093/nar/gkt763; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014	50	2	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22622	22637		10.1074/jbc.M115.674556	http://dx.doi.org/10.1074/jbc.M115.674556			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26229103	hybrid, Green Published			2022-12-26	WOS:000361171500028
J	Speare, R; Mendez, D; Judd, J; Reid, S; Tzipori, S; Massey, PD				Speare, Rick; Mendez, Diana; Judd, Jenni; Reid, Simon; Tzipori, Saul; Massey, Peter D.			Willingness to Consult a Veterinarian on Physician's Advice for Zoonotic Diseases: A Formal Role for Veterinarians in Medicine?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NEW-SOUTH-WALES; PRIMARY-CARE; HEALTH; AUSTRALIA; BRUCELLOSIS; LEPTOSPIROSIS; ZOONOSES; OUTBREAK; RISK	Physicians appear to find zoonotic diseases a challenge and consider that this topic belongs more to the veterinary profession. However, veterinarians have no formal role in clinical medicine. Data were collected as part of the Queensland Social Survey 2014 to determine the willingness of the public, if diagnosed with a zoonotic disease, to consult a veterinarian on the advice of a physician. Self-reported willingness to consult with a veterinarian at the respondent's own expense was 79.8% (95% CI: 81.96%-77.46%) (976/1223). If the cost was funded by Medicare, the Australian public health insurance scheme, 90.7% (95% CI: 92.18%-88.92%) (1109/1223) would be willing to consult a veterinarian. Therefore, a large majority of Australian residents would be willing to consult with a veterinarian on the advice of their physician if they had a zoonotic disease. Does this indicate a possible new role for veterinarians under Clinical One Health?	[Speare, Rick] Trop Hlth Solut, Townsville, Qld, Australia; [Speare, Rick; Mendez, Diana] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Judd, Jenni] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia; [Reid, Simon] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Boston, MA 02111 USA; [Massey, Peter D.] Hunter New England Populat Hlth, Tamworth, NSW, Australia	James Cook University; James Cook University; University of Queensland; Tufts University	Speare, R (corresponding author), Trop Hlth Solut, Townsville, Qld, Australia.	rickspeare@gmail.com	Massey, Peter/AAZ-8001-2021; Massey, Peter/AAD-6176-2022; Reid, Simon/E-9884-2011	Massey, Peter/0000-0001-7194-1914; Reid, Simon/0000-0002-6103-4429; Speare, Rick/0000-0002-9993-1213	Tropical Health Solutions (THS); THS [AUD9500]	Tropical Health Solutions (THS); THS	This study was funded by a private company, Tropical Health Solutions (THS), owned by four people including the lead author, Rick Speare. The funder provided support in the form of salary for the author (RS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of RS are articulated in the 'author contributions' section. THS paid for the cost of the CATI survey (AUD9500) done by CQ University and paid the publication fee for the article.	[Anonymous], 2014, VET REC, V175, P394, DOI 10.1136/vr.g6175; [Anonymous], 2010, VET REC, V167, P638, DOI 10.1136/vr.c5436; [Anonymous], 2013, EMERG INFECT DIS, DOI [10.3201/eid1912.130265, DOI 10.3201/EID1912.130265]; Australian Bureau of Statistics, 2012, 2011 CENS POP HOUS 2; Australian Government Department of Health, 2014, MED BEN SCHED ALL HL; Baker MG, 2007, EPIDEMIOL INFECT, V135, P76, DOI 10.1017/S0950268806006534; Barrett MA, 2015, ECOHEALTH, V12, P212, DOI 10.1007/s10393-014-0964-5; Benetato MA, 2011, JAVMA-J AM VET MED A, V238, P31, DOI 10.2460/javma.238.1.31; Bordier M, 2013, ANIM HEALTH RES REV, V14, P40, DOI 10.1017/S1466252313000017; Cant RP, 2011, AUST HEALTH REV, V35, P468, DOI 10.1071/AH10938; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589; Eales KM, 2010, AM J TROP MED HYG, V83, P876, DOI 10.4269/ajtmh.2010.10-0237; Ellis R, 2014, AM FAM PHYSICIAN, V90, P239; Grant S, 1999, EMERG INFECT DIS, V5, P159, DOI 10.3201/eid0501.990121; Grimmer-Somers K, 2008, AUST FAM PHYSICIAN, V37, P774; Grimmer-Somers K, 2010, AUST HEALTH REV, V34, P18, DOI 10.1071/AH09619; Heath TJ, 2008, AUST VET J, V86, P283, DOI 10.1111/j.1751-0813.2008.00314.x; Hill WA, 2012, JAVMA-J AM VET MED A, V240, P1432, DOI 10.2460/javma.240.12.1432; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Kahn Laura H, 2007, Vet Ital, V43, P5; Kaplan B, 2011, VET ITAL, V47, P129; Khabbaz RF, 2014, LANCET, V384, P53, DOI 10.1016/S0140-6736(14)60890-4; Lappin MR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-26; Lindahl C, 2013, J AGROMEDICINE, V18, P274, DOI 10.1080/1059924X.2013.796906; Lipton BA, 2008, JAVMA-J AM VET MED A, V233, P1242, DOI 10.2460/javma.233.8.1242; Massey PD, 2011, RURAL REMOTE HEALTH, V11; Mochizuki T, 2015, J DERMATOL, V42, P232, DOI 10.1111/1346-8138.12813; Mughini-Gras L, 2014, EPIDEMIOL INFECT, V142, P1172, DOI 10.1017/S0950268813001817; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; O'Toole J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-71; Population Research Laboratory, 2014, FIN TECHN SAMPL REP; Reid SM, 2012, AVIAN DIS, V56, P1062, DOI 10.1637/10178-041012-Reg.1; Ridoutt C, 2014, AUST VET J, V92, P343, DOI 10.1111/avj.12203; Tiplady CM, 2012, AUST VET J, V90, P48, DOI 10.1111/j.1751-0813.2011.00843.x; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; von Matthiessen PW, 2003, AIDS, V17, P1404, DOI 10.1097/00002030-200306130-00021; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Woldemeskel M., 2013, Open Journal of Veterinary Medicine, V3, P213	39	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0131406	10.1371/journal.pone.0131406	http://dx.doi.org/10.1371/journal.pone.0131406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237399	Green Published, gold, Green Accepted			2022-12-26	WOS:000358942400006
J	Kumar, H; Wacklin, P; Nakphaichit, M; Loyttyniemi, E; Chowdhury, S; Shouche, Y; Matto, J; Isolauri, E; Salminen, S				Kumar, Himanshu; Wacklin, Pirjo; Nakphaichit, Massalin; Loyttyniemi, Eliisa; Chowdhury, Somak; Shouche, Yogesh; Matto, Jaana; Isolauri, Erika; Salminen, Seppo			Secretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy	PLOS ONE			English	Article							GUT MICROBIOTA; BLOOD-GROUP; WEIGHT; WOMEN; GENOTYPE; DISEASE	During pregnancy there are significant changes in gut microbiota composition and activity. The impact of secretor status as determined by genotyping FUT2 (fucosyltransferase 2) gene was taken as one of the confounding factors associated with faecal microbiota changes during pregnancy. In this prospective study, we followed women during pregnancy (total = 123 of which secretors = 108, non-secretors = 15) and characterised their gut microbiota by quantitative polymerase chain reaction (qPCR), Fluorescence In situ Hybridisation (FISH), Denaturing Gradient Gel Electrophoresis (DGGE) and pyrosequencing. qPCR revealed that C. coccoides group counts decreased significantly in non-secretors in comparison to secretors (p = 0.02). Similar tendency was found by FISH analysis in Clostridium histolyticum and Lactobacillus-Enterococcus groups between the secretor and the non-secretor pregnant women. DGGE analysis showed significant decrease in richness of Clostridium sp. between secretor and non-secretor mothers during pregnancy. Pyrosequencing based analysis at phyla level showed that there is greater increase in Actinobacteria in secretors in comparison to non-secretors, whereas Proteobacteria showed more increase in non-secretors. Change in relative abundance of Clostridiaceae family from first to third trimester were significantly associated with secretor status of pregnant women (p = 0.05). Polyphasic approach for microbiota analysis points out that the host secretor status (FUT2 genotype) affects the gut microbiota during pregnancy. This may lead to altered infant gut microbiota colonization.	[Kumar, Himanshu; Salminen, Seppo] Univ Turku, Funt Foods Forum, FIN-20520 Turku, Finland; [Wacklin, Pirjo; Matto, Jaana] Finnish Red Cross Blood Serv, Helsinki, Finland; [Nakphaichit, Massalin] Kasetsart Univ, Fac Agroind, Bangkok 10900, Thailand; [Loyttyniemi, Eliisa] Univ Turku, Fac Med, Dept Stat, FIN-20520 Turku, Finland; [Chowdhury, Somak; Shouche, Yogesh] Natl Ctr Cell Sci, Microbial Culture Collect, Pune 411007, Maharashtra, India; [Isolauri, Erika] Univ Turku, Dept Paediat, FIN-20520 Turku, Finland	University of Turku; Kasetsart University; University of Turku; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); University of Turku	Kumar, H (corresponding author), Univ Turku, Funt Foods Forum, FIN-20520 Turku, Finland.	kumhim@utu.fi	kumar, Himanshu/ABE-7982-2020; Nakphaichit, Massalin/HDR-7404-2022	kumar, Himanshu/0000-0002-9749-8620; Nakphaichit, Massalin/0000-0002-1277-9299	TEKES - Finnish Funding Agency for Innovation [40052/11]; Academy of Finland [255736]	TEKES - Finnish Funding Agency for Innovation; Academy of Finland(Academy of Finland)	This study was funded by TEKES - Finnish Funding Agency for Innovation (40052/11) and Academy of Finland (255736).	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Biondi C, 1999, ANN CLIN BIOCHEM, V36, P391, DOI 10.1177/000456329903600314; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Endo A, 2014, ANAEROBE, V28, P149, DOI 10.1016/j.anaerobe.2014.06.006; Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lee HA, 2013, J EPIDEMIOL, V23, P371, DOI 10.2188/jea.JE20120219; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Prince AL, 2014, SEMIN REPROD MED, V32, P14, DOI 10.1055/s-0033-1361818; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Team RC, 2012, R LANG ENV STAT COMP; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09	24	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134623	10.1371/journal.pone.0134623	http://dx.doi.org/10.1371/journal.pone.0134623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231005	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400141
J	Polanski, A; Marczyk, M; Pietrowska, M; Widlak, P; Polanska, J				Polanski, Andrzej; Marczyk, Michal; Pietrowska, Monika; Widlak, Piotr; Polanska, Joanna			Signal Partitioning Algorithm for Highly Efficient Gaussian Mixture Modeling in Mass Spectrometry	PLOS ONE			English	Article							IMPROVED PEAK DETECTION; LASER-DESORPTION/IONIZATION; FEATURE-EXTRACTION; EM ALGORITHM; QUANTIFICATION; SPECTRA; PATTERN; LIKELIHOOD; ALIGNMENT; VALUES	Mixture - modeling of mass spectra is an approach with many potential applications including peak detection and quantification, smoothing, de-noising, feature extraction and spectral signal compression. However, existing algorithms do not allow for automated analyses of whole spectra. Therefore, despite highlighting potential advantages of mixture modeling of mass spectra of peptide/protein mixtures and some preliminary results presented in several papers, the mixture modeling approach was so far not developed to the stage enabling systematic comparisons with existing software packages for proteomic mass spectra analyses. In this paper we present an efficient algorithm for Gaussian mixture modeling of proteomic mass spectra of different types (e.g., MALDI-ToF profiling, MALDI-IMS). The main idea is automated partitioning of protein mass spectral signal into fragments. The obtained fragments are separately decomposed into Gaussian mixture models. The parameters of the mixture models of fragments are then aggregated to form the mixture model of the whole spectrum. We compare the elaborated algorithm to existing algorithms for peak detection and we demonstrate improvements of peak detection efficiency obtained by using Gaussian mixture modeling. We also show applications of the elaborated algorithm to real proteomic datasets of low and high resolution.	[Polanski, Andrzej] Silesian Tech Univ, Inst Informat, Gliwice, Poland; [Marczyk, Michal; Polanska, Joanna] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland; [Pietrowska, Monika; Widlak, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland; [Pietrowska, Monika; Widlak, Piotr] Inst Oncol, Gliwice, Poland	Silesian University of Technology; Silesian University of Technology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Polanska, J (corresponding author), Silesian Tech Univ, Inst Automat Control, Gliwice, Poland.	joanna.polanska@polsl.pl	Marczyk, Michal/C-2556-2016; Polański, Andrzej/H-5323-2016; Widlak, Piotr/AAL-8075-2021; Polanska, Joanna/H-4513-2013	Marczyk, Michal/0000-0003-2508-5736; Polański, Andrzej/0000-0002-1793-9546; Widlak, Piotr/0000-0001-5099-4726; Polanska, Joanna/0000-0001-8004-9864; Pietrowska, Monika/0000-0001-9317-7822	National Science Centre [UMO-2013/08/M/ST6/00924, UMO-2011/01/B/ST6/06868]; National Centre for Research and Development [POIG.02.03.01-24-099/13]	National Science Centre(National Science Centre, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland)	This paper was partially financially supported by the following grants funded by the National Science Centre (www.ncn.gov.pl): UMO-2013/08/M/ST6/00924 to JP and UMO-2011/01/B/ST6/06868 to AP, and by the National Centre for Research and Development (http://www.ncbir.pl): POIG.02.03.01-24-099/13 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Biernacki C, 2004, STAT COMPUT, V14, P267, DOI 10.1023/B:STCO.0000035306.77434.31; Biernacki C, 2003, COMPUT STAT DATA AN, V41, P561, DOI 10.1016/S0167-9473(02)00163-9; Coombes KR, 2005, CANCER INFORM, V1, P41; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; de Noo ME, 2006, EUR J CANCER, V42, P1068, DOI 10.1016/j.ejca.2005.12.023; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dijkstra M, 2006, PROTEOMICS, V6, P5106, DOI 10.1002/pmic.200600181; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Du P, 2007, BIOINFORMATICS, V23, P1394, DOI 10.1093/bioinformatics/btm083; Emanuele VA, 2009, PROTEOMICS, V9, P1754, DOI 10.1002/pmic.200701171; Falkner JA, 2007, J AM SOC MASS SPECTR, V18, P850, DOI 10.1016/j.jasms.2007.01.010; Gillette MA, 2005, J PROTEOME RES, V4, P1143, DOI 10.1021/pr0500962; Henson R., 2005, ENCY GENETICS GENOMI, V4, P105; Karlis D, 2003, COMPUT STAT DATA AN, V41, P577, DOI 10.1016/S0167-9473(02)00177-9; Karpievitch YV, 2007, BIOINFORMATICS, V23, P264, DOI 10.1093/bioinformatics/btl583; Kempka M, 2004, RAPID COMMUN MASS SP, V18, P1208, DOI 10.1002/rcm.1467; Lange Eva, 2006, Pac Symp Biocomput, P243, DOI 10.1142/9789812701626_0023; Leptos KC, 2006, PROTEOMICS, V6, P1770, DOI 10.1002/pmic.200500201; Li X, 2005, STAT BIOL HEALTH, P91; Mantini D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-101; McLachlan G., 2000, WILEY SER PROB STAT; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Murray KK, 2013, PURE APPL CHEM, V85, P1515, DOI 10.1351/PAC-REC-06-04-06; Noy K, 2007, BIOINFORMATICS, V23, P2528, DOI 10.1093/bioinformatics/btm385; Pelikan R, 2010, IEEE ACM T COMPUT BI, V7, P126, DOI 10.1109/TCBB.2008.31; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Polanska J, 2012, EXPERT SYST, V29, P216, DOI 10.1111/j.1468-0394.2011.00582.x; Polanski A, 2013, STUDIA INFORM, V34, P1; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Spainhour JCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111016; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Tuszynski J, CAMASSCLASS PROCESSI; Wang Y, 2008, BIOINFORMATICS, V24, pI407, DOI 10.1093/bioinformatics/btn143; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449	39	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134256	10.1371/journal.pone.0134256	http://dx.doi.org/10.1371/journal.pone.0134256			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230717	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400094
J	Arfmann-Knubel, S; Struck, B; Genrich, G; Helm, O; Sipos, B; Sebens, S; Schafer, H				Arfmann-Knuebel, Sarah; Struck, Birte; Genrich, Geeske; Helm, Ole; Sipos, Bence; Sebens, Susanne; Schaefer, Heiner			The Crosstalk between Nrf2 and TGF-beta 1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN EXPRESSION; CANCER-CELLS; TRANSCRIPTION FACTOR; PROTEASOME ACTIVITY; KEAP1-NRF2 PATHWAY; SIGNALING PATHWAY; OXIDATIVE STRESS; CARCINOMA-CELLS; EMERGING ROLE	Nrf2 and TGF-beta 1 both affect tumorigenesis in a dual fashion, either by preventing carcinogen induced carcinogenesis and suppressing tumor growth, respectively, or by conferring cytoprotection and invasiveness to tumor cells during malignant transformation. Given the involvement of Nrf2 and TGF-beta 1 in the adaptation of epithelial cells to persistent inflammatory stress, e.g. of the pancreatic duct epithelium during chronic pancreatitis, a crosstalk between Nrf2 and TGF-beta 1 can be envisaged. By using premalignant human pancreatic duct cells (HPDE) and the pancreatic ductal adenocarcinoma cell line Colo357, we could show that Nrf2 and TGF-beta 1 independently but additively conferred an invasive phenotype to HPDE cells, whereas acting synergistically in Colo357 cells. This was accompanied by differential regulation of EMT markers like vimentin, Slug, L1CAM and E-cadherin. Nrf2 activation suppressed E-cadherin expression through an as yet unidentified ARE related site in the E-cadherin promoter, attenuated TGF-beta 1 induced Smad2/3-activity and enhanced JNK-signaling. In Colo357 cells, TGF-beta 1 itself was capable of inducing Nrf2 whereas in HPDE cells TGF-beta 1 per-se did not affect Nrf2 activity, but enhanced Nrf2 induction by tBHQ. In Colo357, but not in HPDE cells, the effects of TGF-beta 1 on invasion were sensitive to Nrf2 knock-down. In both cell lines, E-cadherin re-expression inhibited the proinvasive effect of Nrf2. Thus, the increased invasion of both cell lines relates to the Nrf2-dependent downregulation of E-cadherin expression. In line, immunohistochemistry analysis of human pancreatic intraepithelial neoplasias in pancreatic tissues from chronic pancreatitis patients revealed strong Nrf2 activity already in premalignant epithelial duct cells, accompanied by partial loss of E-cadherin expression. Our findings indicate that Nrf2 and TGF-beta 1 both contribute to malignant transformation through distinct EMT related mechanisms accounting for an invasive phenotype. Provided a crosstalk between both pathways, Nrf2 and TGF-beta 1 mutually promote their tumorigenic potential, a condition manifesting already at an early stage during inflammation induced carcinogenesis of the pancreas.	[Arfmann-Knuebel, Sarah; Struck, Birte; Schaefer, Heiner] Dept Internal Med 1, Lab Mol Gastroenterol, D-24105 Kiel, Germany; [Genrich, Geeske; Helm, Ole; Sebens, Susanne] CAU Kiel, Inst Expt Med, Grp Inflammatory Carcinogenesis, D-24105 Kiel, Germany; [Sipos, Bence] Univ Tubingen Hosp, Dept Pathol & Neuropathol, D-72076 Tubingen, Germany	University of Kiel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schafer, H (corresponding author), Dept Internal Med 1, Lab Mol Gastroenterol, UKSH Campus Kiel,Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Schäfer, Heiner/C-1055-2011	Schafer, Heiner/0000-0001-6936-9090	Medical Faculty at the Kiel University; DFG-Cluster of Excellence "Inflammation at Interfaces"	Medical Faculty at the Kiel University; DFG-Cluster of Excellence "Inflammation at Interfaces"(German Research Foundation (DFG))	This study was funded by the Medical Faculty at the Kiel University (to BS) and the DFG-Cluster of Excellence "Inflammation at Interfaces" (SS & HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Birnbaum DJ, 2012, CELL CYCLE, V11, P683, DOI 10.4161/cc.11.4.19130; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; Dai JL, 1998, CANCER RES, V58, P4592; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Duong HQ, 2014, INT J ONCOL, V44, P959, DOI 10.3892/ijo.2013.2229; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Goebel L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1000083; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Helm O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094357; Hilbig A, 2011, CURR PHARM BIOTECHNO, V12, P2158, DOI 10.2174/138920111798808356; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji XJ, 2014, INT J CANCER, V135, P574, DOI 10.1002/ijc.28699; Joo YE, 2002, PANCREATOLOGY, V2, P129, DOI 10.1159/000055903; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kim WD, 2012, J CELL SCI, V125, P1284, DOI 10.1242/jcs.095422; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pan H, 2013, WORLD NEUROSURG, V80, P363, DOI 10.1016/j.wneu.2011.06.063; PIGNATELLI M, 1994, J PATHOL, V174, P243, DOI 10.1002/path.1711740403; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shen H, 2014, DIS ESOPHAGUS, V27, P685, DOI 10.1111/dote.12124; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Soini Y, 2014, PATHOL RES PRACT, V210, P35, DOI 10.1016/j.prp.2013.10.001; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; VEZERIDIS MP, 1990, J SURG RES, V48, P51, DOI 10.1016/0022-4804(90)90145-R; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Zhang LM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-66; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001	66	36	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132978	10.1371/journal.pone.0132978	http://dx.doi.org/10.1371/journal.pone.0132978			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226105	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700013
J	Das, A; Holmes, TC; Sheeba, V				Das, Antara; Holmes, Todd C.; Sheeba, Vasu			dTRPA1 Modulates Afternoon Peak of Activity of Fruit Flies Drosophila melanogaster	PLOS ONE			English	Article							CIRCADIAN CLOCK; TEMPERATURE ENTRAINMENT; SEMINATURAL CONDITIONS; PACEMAKER NEURONS; LIGHT; CRYPTOCHROME; CHANNEL; BEHAVIOR; RHYTHMS; SENSOR	Daily rhythms in Drosophila under semi-natural conditions (or SN) have received much recent attention. One of the striking differences in the behaviour of wild type flies under SN is the presence of an additional peak of activity in the middle of the day. This is referred to as the afternoon peak (A-peak) and is absent under standard laboratory regimes using gated light and temperature cues. Although previous reports identified the physical factors that contribute towards the A-peak there is no evidence for underlying molecular mechanisms or pathways that control A-peak. We report that the A-peak is mediated by thermo-sensitive dTRPA1 (drosophila Transient Receptor Potential-A1) ion channels as this peak is absent in dTRPA1 null mutants. Further, when natural cycles of light and temperature are simulated in the lab, we find that the amplitude of the A-peak is dTRPA1-dependent. Although a few circadian neurons express dTRPA1, we show that modulation of A-peak is primarily influenced by non-CRY dTRPA1 expressing neurons. Hence, we propose that A-peak of activity observed under SN is a temperature sensitive response in flies that is elicited through dTRPA1 receptor signalling.	[Das, Antara; Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560064, Karnataka, India; [Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Neurosci Unit, Bangalore 560064, Karnataka, India; [Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); University of California System; University of California Irvine	Sheeba, V (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, PB 6436,Jakkur Post, Bangalore 560064, Karnataka, India.	sheeba@jncasr.ac.in	Das, Antara/AAW-9674-2021	Das, Antara/0000-0002-9593-8856; Vasu, Sheeba/0000-0003-2924-7130; Holmes, Todd/0000-0001-8152-8832	Ramanujan Fellowship (Department of Science and Technology, India); Council of Scientific and Industrial Research (India) fellowship; National Institute of Health [R01s NS046750, GM102965, GM107405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102965, R01GM107405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	Ramanujan Fellowship (Department of Science and Technology, India); Council of Scientific and Industrial Research (India) fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Ramanujan Fellowship (Department of Science and Technology, India) to VS; Council of Scientific and Industrial Research (India) fellowship to AD; and National Institute of Health R01s NS046750, GM102965, and GM107405 to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hamasaka Y, 2010, GENES CELLS, V15, P1240, DOI 10.1111/j.1365-2443.2010.01456.x; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Prabhakaran PM, 2014, J COMP PHYSL A; Prabhakaran PM, 2013, J EXP BIOL, V216, P4691, DOI 10.1242/jeb.092270; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tang X, 2013, J NEUROSCI, V33, P894, DOI 10.1523/JNEUROSCI.1894-12.2013; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii T, 2015, J NEUROSCI, V35, P6131, DOI 10.1523/JNEUROSCI.0070-15.2015; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134213	10.1371/journal.pone.0134213	http://dx.doi.org/10.1371/journal.pone.0134213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226013	Green Published, gold			2022-12-26	WOS:000358837700062
J	Jayachandran, D; Lainez-Aguirre, J; Rundell, A; Vik, T; Hannemann, R; Reklaitis, G; Ramkrishna, D				Jayachandran, Devaraj; Lainez-Aguirre, Jose; Rundell, Ann; Vik, Terry; Hannemann, Robert; Reklaitis, Gintaras; Ramkrishna, Doraiswami			Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; THIOPURINE METHYLTRANSFERASE; MAINTENANCE THERAPY; MERCAPTOPURINE METABOLISM; PREDICTIVE CONTROL; 6-MERCAPTOPURINE; RISK; PHARMACOKINETICS; PHARMACOGENETICS; MEDICINE	6-Mercaptopurine (6-MP) is one of the key drugs in the treatment of many pediatric cancers, auto immune diseases and inflammatory bowel disease. 6-MP is a prodrug, converted to an active metabolite 6-thioguanine nucleotide (6-TGN) through enzymatic reaction involving thiopurine methyltransferase (TPMT). Pharmacogenomic variation observed in the TPMT enzyme produces a significant variation in drug response among the patient population. Despite 6-MP's widespread use and observed variation in treatment response, efforts at quantitative optimization of dose regimens for individual patients are limited. In addition, research efforts devoted on pharmacogenomics to predict clinical responses are proving far from ideal. In this work, we present a Bayesian population modeling approach to develop a pharmacological model for 6-MP metabolism in humans. In the face of scarcity of data in clinical settings, a global sensitivity analysis based model reduction approach is used to minimize the parameter space. For accurate estimation of sensitive parameters, robust optimal experimental design based on D-optimality criteria was exploited. With the patient-specific model, a model predictive control algorithm is used to optimize the dose scheduling with the objective of maintaining the 6-TGN concentration within its therapeutic window. More importantly, for the first time, we show how the incorporation of information from different levels of biological chain-of response (i.e. gene expression-enzyme phenotype-drug phenotype) plays a critical role in determining the uncertainty in predicting therapeutic target. The model and the control approach can be utilized in the clinical setting to individualize 6-MP dosing based on the patient's ability to metabolize the drug instead of the traditional standard-dose-for-all approach.	[Jayachandran, Devaraj; Lainez-Aguirre, Jose; Hannemann, Robert; Reklaitis, Gintaras; Ramkrishna, Doraiswami] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Rundell, Ann; Hannemann, Robert] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Vik, Terry] James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; James Whitcomb Riley Hospital Children	Ramkrishna, D (corresponding author), Purdue Univ, Sch Chem Engn, 480 Stadium Mall Way, W Lafayette, IN 47907 USA.	ramkrish@purdue.edu	Vik, Terry Allan/AAG-9422-2019; Reklaitis, Gintaras/AAJ-5106-2020	Vik, Terry Allan/0000-0002-9883-0568; 	Walther Cancer Institute;  [NSF-CBET-0941302]	Walther Cancer Institute; 	Funded by Walther Cancer Institute (http://www.walther.org/) and NSF-CBET-0941302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, ACTA PAEDIATR, V87, P108, DOI 10.1080/08035259850158001; [Anonymous], 2008, R LANGUAGE ENV STAT; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; Armstrong L, 2011, ALIMENT PHARM THER, V34, P1106, DOI 10.1111/j.1365-2036.2011.04848.x; Belaiche J, 2001, SCAND J GASTROENTERO, V36, P71, DOI 10.1080/00365520150218084; Bishop C. M, 2006, PATTERN RECOGNITION; Blau G, 2008, COMPUT CHEM ENG, V32, P971, DOI 10.1016/j.compchemeng.2007.04.008; Campo PJ, ROBUST MODEL PREDICT; Chan K., 2000, SENSITIVITY ANAL; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Chessells JM, 1997, BRIT J HAEMATOL, V98, P945, DOI 10.1046/j.1365-2141.1997.3113127.x; Cortese DA, 2007, CLIN PHARMACOL THER, V82, P491, DOI 10.1038/sj.clpt.6100390; Davies Stella M, 2006, Hematology Am Soc Hematol Educ Program, P111; Derijks LJJ, 2004, THER DRUG MONIT, V26, P311, DOI 10.1097/00007691-200406000-00016; Estlin EJ, 2000, BRIT J HAEMATOL, V110, P29, DOI 10.1046/j.1365-2141.2000.02028.x; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fransson M., 2007, STATISTICS, V2009; Gearry RB, 2005, INTERN MED J, V35, P580, DOI 10.1111/j.1445-5994.2005.00904.x; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P826, DOI 10.1111/j.1365-2125.2008.03281.x; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hood E, 2003, ENVIRON HEALTH PERSP, V111, pA580, DOI 10.1289/ehp.111-a580; Jayachandran D, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.6; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; Lainez JM, 2011, PHARM BASED DESIGN I; Lainez JM, 2013, PHARMACOTHERAPY J HU; Lainez-Aguirre JM, 2012, TECHNOMETRI IN PRESS; Lainez-Aguirre JM, 2013, AICHE J, V59, P3296, DOI 10.1002/aic.14100; Langreth, 1999, Oncologist, V4, P426; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LENNARD L, 1987, CLIN PHARMACOL THER, V41, P18, DOI 10.1038/clpt.1987.4; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1993, BRIT J CLIN PHARMACO, V36, P277, DOI 10.1111/j.1365-2125.1993.tb00365.x; LENNARD L, 1989, J CLIN ONCOL, V7, P1816, DOI 10.1200/JCO.1989.7.12.1816; Lennard L, 1990, J CLIN ONCOL, V8, P567; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Noble SL, 2010, J THEOR BIOL, V264, P990, DOI 10.1016/j.jtbi.2010.01.031; Rosenthal RE, 2011, GAMS USERS GUIDE; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; SCHMIEGELOW K, 1995, J CLIN ONCOL, V13, P345, DOI 10.1200/JCO.1995.13.2.345; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Shastry BS, 2006, PHARMACOGENOMICS J, V6, P16, DOI 10.1038/sj.tpj.6500338; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Xu J, 2010, DEATHS FINAL DATA 20	48	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133244	10.1371/journal.pone.0133244	http://dx.doi.org/10.1371/journal.pone.0133244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226448	gold, Green Published			2022-12-26	WOS:000358837700016
J	Penedos, A; Johnson, AL; Strong, E; Goldman, AS; Carballo, JA; Cha, RS				Penedos, Ana; Johnson, Anthony L.; Strong, Emily; Goldman, Alastair S.; Carballo, Jesus A.; Cha, Rita S.			Essential and Checkpoint Functions of Budding Yeast ATM and ATR during Meiotic Prophase Are Facilitated by Differential Phosphorylation of a Meiotic Adaptor Protein, Hop1	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; FHA DOMAIN; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; INTERHOMOLOG RECOMBINATION; SQ/TQ CLUSTER; MEIOSIS; MEK1; KINASE; HOMOLOG	A hallmark of the conserved ATM/ATR signalling is its ability to mediate a wide range of functions utilizing only a limited number of adaptors and effector kinases. During meiosis, Tel1 and Mec1, the budding yeast ATM and ATR, respectively, rely on a meiotic adaptor protein Hop1, a 53BP1/Rad9 functional analog, and its associated kinase Mek1, a CHK2/Rad53-paralog, to mediate multiple functions: control of the formation and repair of programmed meiotic DNA double strand breaks, enforcement of inter-homolog bias, regulation of meiotic progression, and implementation of checkpoint responses. Here, we present evidence that the multi-functionality of the Tel1/Mec1-to-Hop1/Mek1 signalling depends on stepwise activation of Mek1 that is mediated by Tel1/Mec1 phosphorylation of two specific residues within Hop1: phosphorylation at the threonine 318 (T318) ensures the transient basal level Mek1 activation required for viable spore formation during unperturbed meiosis. Phosphorylation at the serine 298 (S298) promotes stable Hop1-Mek1 interaction on chromosomes following the initial phospho-T318 mediated Mek1 recruitment. In the absence of Dmc1, the phospho-S298 also promotes Mek1 hyper-activation necessary for implementing meiotic checkpoint arrest. Taking these observations together, we propose that the Hop1 phospho-T318 and phospho-S298 constitute key components of the Tel1/Mec1-based meiotic recombination surveillance (MRS) network and facilitate effective coupling of meiotic recombination and progression during both unperturbed and challenged meiosis.	[Carballo, Jesus A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Penedos, Ana; Johnson, Anthony L.] Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, London NW7 1AA, England; [Cha, Rita S.] Bangor Univ, North West Canc Res Fund Inst, Sch Med Sci, Bangor LL57 2UW, Gwynedd, Wales; [Strong, Emily; Goldman, Alastair S.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sussex; MRC National Institute for Medical Research; Bangor University; University of Sheffield	Carballo, JA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	J.A.Carballo@sussex.ac.uk	; Carballo, Jesus/K-9899-2014	Goldman, Alastair/0000-0002-0516-3197; Krishnan, Emily/0000-0003-3443-6104; Carballo, Jesus/0000-0003-2259-3743; Penedos, Ana/0000-0002-1933-0726	MRC [U1175.01.005.00005.01]; MRC centre grant [G0801130]; Medical Research Council [G0801130] Funding Source: researchfish; MRC [G0801130] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research was partly funded by the MRC program grant U1175.01.005.00005.01 from RSC and by the MRC centre grant G0801130 from JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta I, 2011, MOL BIOL CELL, V22, P3478, DOI 10.1091/mbc.E11-06-0482; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argunhan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065875; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Cartagena-Lirola H, 2008, MOL CELL BIOL, V28, P4480, DOI 10.1128/MCB.00375-08; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lo YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085687; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shinohara M, 1997, GENETICS, V147, P1545; Tougan T, 2010, CELL CYCLE, V9, P4688, DOI 10.4161/cc.9.23.14050; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Wu HY, 2010, CURR BIOL, V20, P1707, DOI 10.1016/j.cub.2010.09.016; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134297	10.1371/journal.pone.0134297	http://dx.doi.org/10.1371/journal.pone.0134297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225562	Green Published, Green Accepted, gold			2022-12-26	WOS:000358837700069
J	Liem, PH; Morimoto, N; Mahara, A; Jinno, C; Shima, K; Ogino, S; Sakamoto, M; Kakudo, N; Inoie, M; Kusumoto, K; Fujisato, T; Suzuki, S; Yamaoka, T				Pham Hieu Liem; Morimoto, Naoki; Mahara, Atsushi; Jinno, Chizuru; Shima, Koji; Ogino, Shuichi; Sakamoto, Michiharu; Kakudo, Natsuko; Inoie, Masukazu; Kusumoto, Kenji; Fujisato, Toshia; Suzuki, Shigehiko; Yamaoka, Tetsuji			Preparation of Inactivated Human Skin Using High Hydrostatic Pressurization for Full-Thickness Skin Reconstruction	PLOS ONE			English	Article							PRESSURE; BONE; DECELLULARIZATION; CELLS	We have reported that high-hydrostatic-pressure (HHP) technology is safe and useful for producing various kinds of decellularized tissue. However, the preparation of decellularized or inactivated skin using HHP has not been reported. The objective of this study was thus to prepare inactivated skin from human skin using HHP, and to explore the appropriate conditions of pressurization to inactivate skin that can be used for skin reconstruction. Human skin samples of 8 mm in diameter were packed in bags filled with normal saline solution (NSS) or distilled water (DW), and then pressurized at 0, 100, 150, 200 and 1000 MPa for 10 minutes. The viability of skin after HHP was evaluated using WST-8 assay. Outgrowth cells from pressurized skin and the viability of pressurized skin after cultivation for 14 days were also evaluated. The pressurized skin was subjected to histological evaluation using hematoxylin and eosin staining, scanning electron microscopy (SEM), immunohistochemical staining of type IV collagen for the basement membrane of epidermis and capillaries, and immunohistochemical staining of von Willebrand factor (vWF) for capillaries. Then, human cultured epidermis (CE) was applied on the pressurized skin and implanted into the subcutis of nude mice; specimens were subsequently obtained 14 days after implantation. Skin samples pressurized at more than 200 MPa were inactivated in both NSS and DW. The basement membrane and capillaries remained intact in all groups according to histological and immunohistological evaluations, and collagen fibers showed no apparent damage by SEM. CE took on skin pressurized at 150 and 200 MPa after implantation, whereas it did not take on skin pressurized at 1000 MPa. These results indicate that human skin could be inactivated after pressurization at more than 200 MPa, but skin pressurized at 1000 MPa had some damage to the dermis that prevented the taking of CE. Therefore, pressurization at 200 MPa is optimal for preparing inactivated skin that can be used for skin reconstruction.	[Pham Hieu Liem; Jinno, Chizuru; Ogino, Shuichi; Sakamoto, Michiharu; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan; [Morimoto, Naoki; Kakudo, Natsuko; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan; [Mahara, Atsushi; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Shima, Koji; Fujisato, Toshia] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan; [Inoie, Masukazu] Japan Tissue Engn Co Ltd, Gamagori, Japan; [Pham Hieu Liem] Pham Ngoc Thach Univ Med, Dept Plast & Aesthet Surg, Ho Chi Minh City, Vietnam	Kyoto University; Kansai Medical University; National Cerebral & Cardiovascular Center - Japan; Osaka Institute of Technology	Morimoto, N (corresponding author), Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan.	morimotn@hirakata.kmu.ac.jp	Mahara, Atsushi/AAG-1301-2022; Mahara, Atsushi/AES-9161-2022	FUJISATO, Toshia/0000-0002-7206-093X; Inoie, Masukazu/0000-0002-8101-170X; Kakudo, Natsuko/0000-0001-9785-1490; Morimoto, Naoki/0000-0002-0712-3172; Ogino, Shuichi/0000-0003-1063-5272	Japan Society for Promotion of Science (JSPS) KAKENHI [24659782]; Japan Science and Technology Agency(JST); Japan Tissue Engineering Co., Ltd	Japan Society for Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(JST)(Japan Science & Technology Agency (JST)); Japan Tissue Engineering Co., Ltd	This study was supported partially by Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number 24659782 (https://kaken.nii.ac.jp/d/p/24659782.en.html) and by the Adaptable and Seamless Technology transfer Program through target driven R & D from Japan Science and Technology Agency(JST)(http://www.jst.go.jp/a-step/kadai/h24-2fs.html). NM TY TF received those findings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Japan Tissue Engineering Co., Ltd provided support in the form of salaries for authors MI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Arneja Jugpal S, 2009, Plast Reconstr Surg, V124, p1e, DOI 10.1097/PRS.0b013e3181ab11be; Cardone F, 2006, BBA-PROTEINS PROTEOM, V1764, P558, DOI 10.1016/j.bbapap.2006.01.022; CASTILLA EE, 1981, BRIT J DERMATOL, V104, P307, DOI 10.1111/j.1365-2133.1981.tb00954.x; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Diehl P, 2005, INT J MOL MED, V16, P285; Diehl P, 2008, ANTICANCER RES, V28, P3877; Follonier S, 2012, APPL MICROBIOL BIOT, V93, P1805, DOI 10.1007/s00253-011-3854-6; Fujisato T, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P83, DOI 10.1007/4-431-27378-6_7; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mahara A, 2015, BIOMATERIALS, V58, P54, DOI 10.1016/j.biomaterials.2015.04.031; Mahara A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379607; Morimoto N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/587247; Naal FD, 2008, J BIOMED MATER RES B, V87B, P19, DOI 10.1002/jbm.b.31059; Nicoletti G, 2015, J TISSUE ENG REGEN M, V9, P460, DOI 10.1002/term.1939; Liem PH, 2013, J ARTIF ORGANS, V16, P332, DOI 10.1007/s10047-013-0708-2; Philandrianos C, 2012, BURNS, V38, P820, DOI 10.1016/j.burns.2012.02.008; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001; Schauwecker J, 2006, ANTICANCER RES, V26, P85; Schauwecker J, 2011, ANTICANCER RES, V31, P1235; Schiestl C, 2010, J PLAST RECONSTR AES, V63, P610, DOI 10.1016/j.bjps.2009.01.050; Schneider J, 2009, BURNS, V35, P51, DOI 10.1016/j.burns.2008.07.018; Suzuki S, 2013, J PLAST RECONSTR AES, V66, pE229, DOI 10.1016/j.bjps.2013.03.018; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Yamaguchi T, 2008, CELL MOL BIOL LETT, V13, P49, DOI 10.2478/s11658-007-0034-x	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133979	10.1371/journal.pone.0133979	http://dx.doi.org/10.1371/journal.pone.0133979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226373	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700045
J	Wilkerson, RC; Linton, YM; Fonseca, DM; Schultz, TR; Price, DC; Strickman, DA				Wilkerson, Richard C.; Linton, Yvonne-Marie; Fonseca, Dina M.; Schultz, Ted R.; Price, Dana C.; Strickman, Daniel A.			Making Mosquito Taxonomy Useful: A Stable Classification of Tribe Aedini that Balances Utility with Current Knowledge of Evolutionary Relationships	PLOS ONE			English	Article							RIFT-VALLEY FEVER; EASTERN EQUINE ENCEPHALITIS; ALLIED TAXA DIPTERA; PHYLOGENETIC-RELATIONSHIPS; YELLOW-FEVER; ARBOVIRUS SURVEILLANCE; WUCHERERIA-BANCROFTI; MORPHOLOGICAL DATA; SYNOPTIC CATALOG; GENERIC RANK	The tribe Aedini (Family Culicidae) contains approximately one-quarter of the known species of mosquitoes, including vectors of deadly or debilitating disease agents. This tribe contains the genus Aedes, which is one of the three most familiar genera of mosquitoes. During the past decade, Aedini has been the focus of a series of extensive morphology-based phylogenetic studies published by Reinert, Harbach, and Kitching (RH&K). Those authors created 74 new, elevated or resurrected genera from what had been the single genus Aedes, almost tripling the number of genera in the entire family Culicidae. The proposed classification is based on subjective assessments of the "number and nature of the characters that support the branches" subtending particular monophyletic groups in the results of cladistic analyses of a large set of morphological characters of representative species. To gauge the stability of RH&K's generic groupings we reanalyzed their data with unweighted parsimony jackknife and maximum-parsimony analyses, with and without ordering 14 of the characters as in RH&K. We found that their phylogeny was largely weakly supported and their taxonomic rankings failed priority and other useful taxon-naming criteria. Consequently, we propose simplified aedine generic designations that 1) restore a classification system that is useful for the operational community; 2) enhance the ability of taxonomists to accurately place new species into genera; 3) maintain the progress toward a natural classification based on monophyletic groups of species; and 4) correct the current classification system that is subject to instability as new species are described and existing species more thoroughly defined. We do not challenge the phylogenetic hypotheses generated by the above-mentioned series of morphological studies. However, we reduce the ranks of the genera and subgenera of RH&K to subgenera or informal species groups, respectively, to preserve stability as new data become available.	[Wilkerson, Richard C.; Linton, Yvonne-Marie; Schultz, Ted R.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Linton, Yvonne-Marie] Smithsonian Inst, Museum Support Ctr, Walter Reed Biosystemat Unit, Suitland, MD USA; [Linton, Yvonne-Marie] Walter Reed Army Inst Res, Dept Entomol, Silver Spring, MD USA; [Linton, Yvonne-Marie] Uniformed Serv Univ Hlth Sci, Fac Preventat Med & Biometr, Bethesda, MD 20814 USA; [Fonseca, Dina M.; Price, Dana C.] Rutgers State Univ, Dept Entomol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Strickman, Daniel A.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA; Rutgers State University New Brunswick; Bill & Melinda Gates Foundation	Wilkerson, RC (corresponding author), Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, NHB 169, Washington, DC 20560 USA.	wilkersonr@si.edu	Fonseca, Dina/HHS-1320-2022; Linton, Yvonne/AAG-2353-2019; Linton, Yvonne-Marie/AAW-3992-2021; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	Direct For Biological Sciences [0949689, 1456964] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		ANDREADIS TG, 1994, J AM MOSQUITO CONTR, V10, P556; Andreadis TG, 1998, J MED ENTOMOL, V35, P296, DOI 10.1093/jmedent/35.3.296; Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669; [Anonymous], 2005, J MED ENTOMOL, V42, P511; Armstrong PM, 2010, EMERG INFECT DIS, V16, P1869, DOI 10.3201/eid1612.100640; ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1; ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI and II; Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Black WC, 2004, J AM MOSQUITO CONTR, V20, P215; Carpenter S. J., 1955, MOSQUITOES N AM N ME; CDC, 2015, ARB CAT; Centers for Disease Control and Prevention (CDC), 2012, MOSQ SPEC WHICH W NI; Clements A., 2012, BIOL MOSQUITOES, V3; Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2; Darsie RF, 2005, IDENTIFICATION GEOGR, Vxiv; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Edwards FW, 1932, GENERA INSESTORUM DI; Ergunay K, 2013, VECTOR-BORNE ZOONOT, V13, P744, DOI 10.1089/vbz.2012.1288; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; GAFFIGAN T V, 1985, Mosquito Systematics, V17, P52; GARGAN TP, 1988, AM J TROP MED HYG, V38, P440, DOI 10.4269/ajtmh.1988.38.440; GERMAIN M, 1980, AM J TROP MED HYG, V29, P929, DOI 10.4269/ajtmh.1980.29.929; Gjelsvik A, 1981, THEORY THIN WALLED B, DOI DOI 10.1115/1.3162198; Glaubrechet M, 2010, EVOLUTION ACTION CAS; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; GORDON SW, 1992, AM J TROP MED HYG, V47, P742, DOI 10.4269/ajtmh.1992.47.742; GOULD DJ, 1982, MOSQ NEWS, V42, P560; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hennig W., 1981, INSECT PHYLOGENY; Huang Y.-M., 1990, Contributions of the American Entomological Institute, V26, P3; HUANG YM, 1986, J MED ENTOMOL, V23, P196, DOI 10.1093/jmedent/23.2.196; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; HURLBUT HS, 1956, AM J TROP MED HYG, V5, P76, DOI 10.4269/ajtmh.1956.5.76; HARINASUTA C., 1970, Southeast Asian Journal of Tropical Medicine and Public Health, V1, P233; Iyengar MOT, 1954, 66 S PAC COMM, P52; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Kluge AG, 1997, CLADISTICS, V13, P81, DOI 10.1111/j.1096-0031.1997.tb00242.x; Knight K. L., 1978, CATALOG MOSQUITOES S; Kumar A, 1998, INSECT MOL BIOL, V7, P367, DOI 10.1046/j.1365-2583.1998.740367.x; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160; Marcondes CB, 2007, TRENDS PARASITOL, V23, P302, DOI 10.1016/j.pt.2007.04.011; Marks EN, 1947, U QUEENSLAND PAPERS, V2, P1; McIntosh B M, 1972, J S Afr Vet Med Assoc, V43, P391; MCINTOSH BM, 1980, S AFR MED J, V58, P127; McIntosh BM, 1971, J ENTOMOL SOC S AFR, P319; Miller BR, 1997, INSECT MOL BIOL, V6, P105, DOI 10.1111/j.1365-2583.1997.tb00078.x; MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6; Mitchell CJ, 1998, J MED ENTOMOL, V35, P573, DOI 10.1093/jmedent/35.4.573; Niebylski ML, 1992, MMWR-MORBID MORTAL W, V41, P121; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318; Polaszek A, 2006, TRENDS PARASITOL, V22, P8, DOI 10.1016/j.pt.2005.11.003; Polaszek A, 2007, TRENDS PARASITOL, V23, P303, DOI 10.1016/j.pt.2007.04.010; REINERT J F, 1982, Mosquito Systematics, V14, P101; Reinert J. F., 1990, Contributions of the American Entomological Institute, V26, P1; Reinert J.F., 1987, MOSQ SYST, V18, P307; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P57; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Reinert JF, 1979, MOSQ SYST, V11, P144; Reinert JF, 2008, ZOOL J LINN SOC-LOND, V153, P29, DOI 10.1111/j.1096-3642.2008.00382.x; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Reinert John F., 1999, Contributions of the American Entomological Institute, V31, P1; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; RODANICHE ED, 1963, AM J TROP MED HYG, V12, P924; Savage HM, 2005, J MED ENTOMOL, V42, P923, DOI 10.1603/0022-2585(2005)042[0923:COMITA]2.0.CO;2; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Stone A., 1971, Proceedings of the Entomological Society of Washington, V73, P180; STONE A, 1970, P ENTOMOL SOC WASH, V72, P137; STONE A, 1967, P ENTOMOL SOC WASH, V69, P197; Stone A., 1959, SYNOPTIC CATALOG MOS; Stone A., 1977, CATALOG MOSQUITOES W; STONE ALAN, 1963, PROC ENTOMOL SOC WASHINGTON, V65, P117; STONE ALAN, 1961, PROC ENT SOC WASHINGTON, V63, P29; SUGURI S, 1985, JPN J EXP MED, V55, P61; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TANAKA K, 1979, CONTRIB AM ENTOMOL I, V16, P987; Tao San-ju, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P322; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turrell MJ, 2005, J MED ENTOMOL, V25, P262, DOI [10.1093/jmedent/25.4.262, DOI 10.1093/JMEDENT/25.4.262]; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170; Wang Gang, 2012, PLoS ONE, V7, pe47051, DOI 10.1371/journal.pone.0047051; Wang ZS, 2009, CHINA PUB HLTH, V25, P769, DOI 10.3321/j.issn:1001-0580.2009.07.001; WARD R A, 1984, Mosquito Systematics, V16, P227; Ward Ronald A., 1992, Mosquito Systematics, V24, P177; WELLINGS FM, 1972, AM J TROP MED HYG, V21, P201, DOI 10.4269/ajtmh.1972.21.201; Wiley E. O., 2011, PHYLOGENETIC SYSTEMA; WILEY EO, 1979, SYST ZOOL, V28, P308; Wood D.M., 1989, Agriculture Canada Monograph, P1333; Wozniak A, 2001, J AM MOSQUITO CONTR, V17, P73	104	180	209	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133602	10.1371/journal.pone.0133602	http://dx.doi.org/10.1371/journal.pone.0133602			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226613	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700027
J	Kolan, SS; Lejon, K; Holm, CK; Sulniute, R; Lundberg, P; Matozaki, T; Oldenborg, PA				Kolan, Shrikant Shantilal; Lejon, Kristina; Holm, Cecilia Koskinen; Sulniute, Rima; Lundberg, Pernilla; Matozaki, Takashi; Oldenborg, Per-Arne			Non-Hematopoietic and Hematopoietic SIRP alpha Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen	PLOS ONE			English	Article							HOMEOSTASIS; RESPONSES; RECEPTOR; NICHES; CD47; SELF	B lymphocyte development occurs in the bone marrow, while final differentiation and maturation can occur in both the bone marrow and the spleen. Here we provide evidence that signal regulatory protein a (SIRP alpha), an Ig-superfamily ITIM-receptor expressed by myeloid but not by lymphoid cells, is involved in regulating B cell maturation. Lack of SIRP alpha signaling in adult SIRP alpha-mutant mice resulted in a reduced maturation of B cells in the bone marrow, evident by reduced numbers of semi-mature IgD(+)vertical bar IgM(hi) follicular type-II (F-II) and mature IgD(+)vertical bar IgM(lo) follicular type-I (F-I) B cells, as well as reduced blood B cell numbers. In addition, lack of SIRP alpha signaling also impaired follicular B cell maturation in the spleen. Maturing BM or splenic B cells of SIRP alpha-mutant mice were found to express higher levels of the pro-apoptotic protein BIM and apoptosis was increased among these B cells. Bone marrow reconstitution experiments revealed that the B cell maturation defect in bone marrow and blood was due to lack of SIRP alpha signaling in non-hematopoietic cells, while hematopoietic SIRP alpha signaling was important for follicular B cell maturation in the spleen. Adding on to our previous findings of a stromal cell defect in SIRP alpha-mutant mice was the finding that gene expression of receptor activator of nuclear factor-kappa B ligand (RANKL) was significantly lower in cultured bone marrow stromal cells of SIRP alpha mutant mice. These data suggest a novel and opposite contribution of SIRP alpha signaling within non-hematopoietic and hematopoietic cells, respectively, to maintain B cell maturation and to prevent apoptosis in the bone marrow and spleen of adult mice.	[Kolan, Shrikant Shantilal; Oldenborg, Per-Arne] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Lejon, Kristina] Umea Univ, Immunol Sect, Dept Clin Microbiol, Umea, Sweden; [Holm, Cecilia Koskinen; Sulniute, Rima; Lundberg, Pernilla] Umea Univ, Dept Odontol, Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan	Umea University; Umea University; Umea University; Kobe University	Oldenborg, PA (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	per-arne.oldenborg@umu.se			Swedish Research Council [20122702]; King Gustaf V 80-Year Foundation [FAI2013-0090]; Grants-in-Aid for Scientific Research [26291022] Funding Source: KAKEN	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V 80-Year Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Swedish Research Council (20122702; PAO) http://www.vr.se; The King Gustaf V 80-Year Foundation (FAI2013-0090; PAO) http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond. 4.11deaee4147afe3f46050da.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Ceredig R, 2012, SEMIN IMMUNOL, V24, P159, DOI 10.1016/j.smim.2012.02.004; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; den Haan JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00201; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gaudin E, 2004, IMMUNOL REV, V197, P102, DOI 10.1111/j.0105-2896.2004.0095.x; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jorgensen TN, 2007, J IMMUNOL, V179, P3417, DOI 10.4049/jimmunol.179.6.3417; Koskinen C, 2013, J BIOL CHEM, V288, P29333, DOI 10.1074/jbc.M113.494591; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Patton DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088771; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, IMMUNOL CELL BIOL, V87, P16, DOI 10.1038/icb.2008.89; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sato-Hashimoto M, 2011, J IMMUNOL, V187, P291, DOI 10.4049/jimmunol.1100528; Stenberg A, 2014, J INNATE IMMUN, V6, P553, DOI 10.1159/000357820; Tischner D, 2010, Cell Death Dis, V1, pe48, DOI 10.1038/cddis.2010.27; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Yun TJ, 1998, J IMMUNOL, V161, P6113; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134113	10.1371/journal.pone.0134113	http://dx.doi.org/10.1371/journal.pone.0134113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222253	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800105
J	Mogen, AB; Chen, F; Ahn, SJ; Burne, RA; Wang, D; Rice, KC				Mogen, Austin B.; Chen, Fu; Ahn, Sang-Joon; Burne, Robert A.; Wang, Dong; Rice, Kelly C.			Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms	PLOS ONE			English	Article							SALIVA-COATED HYDROXYAPATITE; QUORUM-SENSING MOLECULE; DENTAL-CARIES; CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; TARGETED DELIVERY; DRUG-DELIVERY; GLUCOSYLTRANSFERASE ACTIVITY; TT-FARNESOL; IN-VITRO	Streptococcus mutans is the primary causative agent of dental caries, one of the most prevalent diseases in the United States. Previously published studies have shown that Pluronic-based tooth-binding micelles carrying hydrophobic antimicrobials are extremely effective at inhibiting S. mutans biofilm growth on hydroxyapatite (HA). Interestingly, these studies also demonstrated that non-binding micelles (NBM) carrying antimicrobial also had an inhibitory effect, leading to the hypothesis that the Pluronic micelles themselves may interact with the biofilm. To explore this potential interaction, three different S. mutans strains were each grown as biofilm in tissue culture plates, either untreated or supplemented with NBM alone (P85), NBM containing farnesol (P85F), or farnesol alone (F). In each tested S. mutans strain, biomass was significantly decreased (SNK test, p < 0.05) in the P85F and F biofilms relative to untreated biofilms. Furthermore, the P85F biofilms formed large towers containing dead cells that were not observed in the other treatment conditions. Tower formation appeared to be specific to formulated farnesol, as this phenomenon was not observed in S. mutans biofilms grown with NBM containing triclosan. Parallel CFU/ml determinations revealed that biofilm growth in the presence of P85F resulted in a 3-log reduction in viability, whereas F decreased viability by less than 1-log. Wild-type biofilms grown in the absence of sucrose or gtfBC mutant biofilms grown in the presence of sucrose did not form towers. However, increased cell killing with P85F was still observed, suggesting that cell killing is independent of tower formation. Finally, repeated treatment of pre-formed biofilms with P85F was able to elicit a 2-log reduction in viability, whereas parallel treatment with F alone only reduced viability by 0.5-log. Collectively, these results suggest that Pluronics-formulated farnesol induces alterations in biofilm architecture, presumably via interaction with the sucrose-dependent biofilm matrix, and may be a viable treatment option in the prevention and treatment of pathogenic plaque biofilms.	[Mogen, Austin B.; Rice, Kelly C.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Chen, Fu; Wang, Dong] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Ahn, Sang-Joon; Burne, Robert A.] Univ Florida, Dept Oral Biol, Coll Dent, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; State University System of Florida; University of Florida	Rice, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	kcrice@ufl.edu		Burne, Robert/0000-0002-4234-0316	University of Florida-University Scholars undergraduate research fellowship; National Institutes of Health [R03 DE019179, R01 DE13239]; "Proof of Concept" grant award from University of Nebraska Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019179] Funding Source: NIH RePORTER	University of Florida-University Scholars undergraduate research fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Proof of Concept" grant award from University of Nebraska Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by University of Florida-University Scholars undergraduate research fellowship (http://scholars.ufl.edu/) to ABM, and in part by National Institutes of Health grants R03 DE019179 (KCR), R01 DE13239 (RAB), and a "Proof of Concept" grant award from University of Nebraska Foundation (https://nufoundation.org/unmc) (DW).	AOKI H, 1986, INFECT IMMUN, V53, P587, DOI 10.1128/IAI.53.3.587-594.1986; ARENDS J, 1986, J DENT RES, V65, P2, DOI 10.1177/00220345860650010201; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Cerca Nuno, 2012, BMC Res Notes, V5, P244, DOI 10.1186/1756-0500-5-244; Chen F, 2013, PHARM RES-DORDR, V30, P2808, DOI 10.1007/s11095-013-1105-5; Chen F, 2010, PHARM RES-DORDR, V27, P2356, DOI 10.1007/s11095-010-0119-5; Chen F, 2009, ANTIMICROB AGENTS CH, V53, P4898, DOI 10.1128/AAC.00387-09; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Decanis Nadege, 2011, Open Microbiol J, V5, P119, DOI 10.2174/1874285801105010119; Edwards BJ, 2008, LANCET ONCOL, V9, P1166, DOI 10.1016/S1470-2045(08)70305-X; Edwards BJ, 2008, J AM DENT ASSOC, V139, P1674, DOI 10.14219/jada.archive.2008.0110; EMILSON CG, 1994, J DENT RES, V73, P682, DOI 10.1177/00220345940730031401; FITZGERALD R J, 1960, J Am Dent Assoc, V61, P9; Gomes F, 2011, CURR MICROBIOL, V63, P354, DOI 10.1007/s00284-011-9984-3; Gomes F, 2011, AM J MED SCI, V341, P191, DOI 10.1097/MAJ.0b013e3181fcf138; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; HAMADA S, 1984, J DENT RES, V63, P407, DOI 10.1177/00220345840630031001; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Horev B, 2015, ACS NANO, V9, P2390, DOI 10.1021/nn507170s; Horn T, 2004, TOXICOLOGIST, V78, P15; Horn TL, 2005, CHEM-BIOL INTERACT, V152, P79, DOI 10.1016/j.cbi.2005.02.006; Housley L, 2009, FEMS MICROBIOL LETT, V293, P148, DOI 10.1111/j.1574-6968.2009.01528.x; Hu ZY, 2008, J BIOMED MATER RES A, V85A, P797, DOI 10.1002/jbm.a.31615; Inoue Y, 2004, FEMS MICROBIOL LETT, V237, P325, DOI 10.1016/j.femsle.2004.06.049; Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006; Jabra-Rizk MA, 2006, FEMS YEAST RES, V6, P1063, DOI 10.1111/j.1567-1364.2006.00121.x; Jagdale SC, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/804616; Jeon JG, 2011, INT J ORAL SCI, V3, P98, DOI 10.4248/IJOS11038; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Kim JY, 2013, BIOMATERIALS, V34, P1170, DOI 10.1016/j.biomaterials.2012.09.047; Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376; Koo H, 2002, ANTIMICROB AGENTS CH, V46, P1302, DOI 10.1128/AAC.46.5.1302-1309.2002; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2002, ORAL MICROBIOL IMMUN, V17, P337, DOI 10.1034/j.1399-302X.2002.170602.x; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kozlov MY, 2000, MACROMOLECULES, V33, P3305, DOI 10.1021/ma991634x; Langford ML, 2009, FUTURE MICROBIOL, V4, P1353, DOI [10.2217/fmb.09.98, 10.2217/FMB.09.98]; Lapczynski A, 2008, FOOD CHEM TOXICOL, V46, pS149, DOI 10.1016/j.fct.2008.06.046; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Li XR, 2009, J DRUG TARGET, V17, P739, DOI 10.3109/10611860903062062; LI YH, 1994, J DENT RES, V73, P1615, DOI 10.1177/00220345940730100601; LITTLE WA, 1979, ANTIMICROB AGENTS CH, V15, P440, DOI 10.1128/AAC.15.3.440; Liu J, 2013, FEMS MICROBIOL LETT, V340, P11, DOI 10.1111/1574-6968.12066; Liu JS, 2014, INT J NANOMED, V9, P3923, DOI 10.2147/IJN.S62263; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; MURCHISON HH, 1986, INFECT IMMUN, V54, P273, DOI 10.1128/IAI.54.2.273-282.1986; Nguyen PTM, 2005, ORAL MICROBIOL IMMUN, V20, P93, DOI 10.1111/j.1399-302X.2004.00197.x; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Olson ME, 2002, CAN J VET RES, V66, P86; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; PUCCI MJ, 1987, INFECT IMMUN, V55, P2176, DOI 10.1128/IAI.55.9.2176-2182.1987; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; SHAW JH, 1987, NEW ENGL J MED, V317, P996, DOI 10.1056/NEJM198710153171605; Shen S, 2004, J DENT, V32, P667, DOI 10.1016/j.jdent.2004.07.002; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Tang Zi-sheng, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P266; TANZER JM, 1995, J DENT RES, V74, P1536, DOI 10.1177/00220345950740090601; Tatman D, 2002, CANCER LETT, V175, P129, DOI 10.1016/S0304-3835(01)00723-6; Tavano L, 2013, LANGMUIR, V29, P12638, DOI 10.1021/la4021383; Twetman S, 2004, CARIES RES, V38, P223, DOI 10.1159/000077758; Unnanuntana A, 2009, J BONE JOINT SURG AM, V91A, P2683, DOI 10.2106/JBJS.H.01699; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; VaccaSmith AM, 1996, ARCH ORAL BIOL, V41, P291, DOI 10.1016/0003-9969(95)00129-8; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Zhou Q, 2011, J PHYS CHEM B, V115, P12662, DOI 10.1021/jp207951e; Zhu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028830	73	16	16	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133886	10.1371/journal.pone.0133886	http://dx.doi.org/10.1371/journal.pone.0133886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222384	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800076
J	Sahu, BD; Kumar, JM; Sistla, R				Sahu, Bidya Dhar; Kumar, Jerald Mahesh; Sistla, Ramakrishna			Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-kappa B Pathways	PLOS ONE			English	Article							INDUCED RENAL INJURY; INDUCED NEPHROTOXICITY; SCUTELLARIA-BAICALENSIS; OXIDATIVE STRESS; PROTEIN-KINASE; CELL-DEATH; INHIBITION; PROTECTION; NRF2; INFLAMMATION	Acute renal failure is a serious complication of the anticancer drug cisplatin. The potential role of baicalein, a naturally occurring bioflavonoid on cisplatin-induced renal injury is unknown. Here, we assessed the effect of baicalein against a murine model of cisplatin-induced acute renal failure and investigated the underlying possible mechanisms. Renal function, kidney histology, inflammation, oxidative stress, renal mitochondrial function, proteins involved in apoptosis, nuclear translocation of Nrf2 and effects on intracellular signaling pathways such as MAPKs, and NF-kappa B were assessed. Pretreatment with baicalein ameliorated the cisplatin-induced renal oxidative stress, apoptosis and inflammation and improved kidney injury and function. Baicalein inhibited the cisplatin-induced expression of iNOS, TNF-alpha, IL-6 and mononuclear cell infiltration and concealed redox-sensitive transcription factor NF-kappa B activation via reduced DNA-binding activity, I kappa B alpha phosphorylation and p65 nuclear translocation in kidneys. Further studies demonstrated baicalein markedly attenuated cisplatin-induced p38 MAPK, ERK1/2 and JNK phosphorylation in kidneys. Baicalein also restored the renal antioxidants and increased the amount of total and nuclear accumulation of Nrf2 and downstream target protein, HO-1 in kidneys. Moreover, baicalein preserved mitochondrial respiratory enzyme activities and inhibited cisplatin-induced apoptosis by suppressing p53 expression, Bax/Bcl-2 imbalance, cytochrome c release and activation of caspase-9, caspase-3 and PARP. Our findings suggest that baicalein ameliorates cisplatin-induced renal damage through up-regulation of antioxidant defense mechanisms and down regulation of the MAPKs and NF-kappa B signaling pathways.	[Sahu, Bidya Dhar; Sistla, Ramakrishna] CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad 500007, Andhra Pradesh, India; [Kumar, Jerald Mahesh] CSIR Ctr Cellular & Mol Biol CCMB, Anim House Facil, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sistla, R (corresponding author), CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad 500007, Andhra Pradesh, India.	sistla@iict.res.in			CSIR project 'SMiLE' [CSC 0111]; CSIR, India	CSIR project 'SMiLE'; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by a research grant from CSIR project 'SMiLE' (CSC 0111). Senior Research Fellowship to BDS from CSIR, India, is gratefully acknowledged.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Ahad A, 2014, BIOCHIMIE, V106, P101, DOI 10.1016/j.biochi.2014.08.006; Akmal Y, 2011, J AM COLL SURGEONS, pS136; Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Chao JI, 2007, MOL CANCER THER, V6, P3039, DOI 10.1158/1535-7163.MCT-07-0281; Chen HJ, 2014, CANCER LETT, V354, P5, DOI 10.1016/j.canlet.2014.08.003; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Francescato HDC, 2007, NEPHROL DIAL TRANSPL, V22, P2138, DOI 10.1093/ndt/gfm144; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Khan MAH, 2013, FASEB J, V27, P2946, DOI 10.1096/fj.12-218040; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Lee EK, 2011, FREE RADICAL RES, V45, P507, DOI 10.3109/10715762.2011.555479; Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Moon JH, 2013, FOOD CHEM TOXICOL, V62, P159, DOI 10.1016/j.fct.2013.08.039; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nozaki Y, 2011, AM J PHYSIOL-RENAL, V301, pF1098, DOI 10.1152/ajprenal.00193.2011; Oh GS, 2014, KIDNEY INT, V85, P547, DOI 10.1038/ki.2013.330; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Pan H, 2009, AM J PHYSIOL-RENAL, V296, pF496, DOI 10.1152/ajprenal.90443.2008; Park HM, 2008, BIOCHEM PHARMACOL, V76, P597, DOI 10.1016/j.bcp.2008.06.021; Piao XL, 2008, FOOD CHEM TOXICOL, V46, P1576, DOI 10.1016/j.fct.2007.12.023; Qin S, 2014, ARCH BIOCHEM BIOPHYS, V559, P53, DOI 10.1016/j.abb.2014.03.011; Rajasundari A, 2011, LAB INVEST, V91, P1717, DOI 10.1038/labinvest.2011.126; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tsai CL, 2014, J ETHNOPHARMACOL, V153, P197, DOI 10.1016/j.jep.2014.02.010; Wang YW, 2014, MOL MED REP, V10, P515, DOI 10.3892/mmr.2014.2157; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Xin WY, 2014, CURR OPIN COMPLEMENT, V1; Xing J, 2006, ASIAN J PHARMACODYN, V6, P29, DOI DOI 10.1016/J.LFS.2005.04.072; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yeh JH, 2010, INT J PHARMACOL, V6, P81; Zhang ZJ, 2012, J AGR FOOD CHEM, V60, P8171, DOI 10.1021/jf301511m; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zirak MR, 2014, EUR J PHARMACOL, V738, P222, DOI 10.1016/j.ejphar.2014.05.050	55	105	113	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134139	10.1371/journal.pone.0134139	http://dx.doi.org/10.1371/journal.pone.0134139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222683	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800109
J	Sanchez-Diaz, I; Rosales-Bravo, F; Reyes-Taboada, JL; Covarrubias, AA; Narvaez-Padilla, V; Reynaud, E				Sanchez-Diaz, Ivan; Rosales-Bravo, Fernando; Luis Reyes-Taboada, Jose; Covarrubias, Alejandra A.; Narvaez-Padilla, Veronica; Reynaud, Enrique			The Esg Gene Is Involved in Nicotine Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							EXPRESSION; RECEPTOR; COCAINE; FAMILY; CELLS; GERM	In humans, there is a strong correlation between sensitivity to substances of abuse and addiction risk. This differential tolerance to drugs has a strong genetic component. The identification of human genetic factors that alter drug tolerance has been a difficult task. For this reason and taking advantage of the fact that Drosophila responds similarly to humans to many drugs, and that genetically it has a high degree of homology (sharing at least 70% of genes known to be involved in human genetic diseases), we looked for genes in Drosophila that altered their nicotine sensitivity. We developed an instantaneous nicotine vaporization technique that exposed flies in a reproducible way. The amount of nicotine sufficient to "knock out" half of control flies for 30 minutes was determined and this parameter was defined as Half Recovery Time (HRT). Two fly lines, L4 and L70, whose HRT was significantly longer than control's were identified. The L4 insertion is a loss of function allele of the transcriptional factor escargot (esg), whereas L70 insertion causes miss-expression of the microRNA cluster miR-310-311-312-313 (miR-310(c)). In this work, we demonstrate that esg loss of function induces nicotine sensitivity possibly by altering development of sensory organs and neurons in the medial section of the thoracoabdominal ganglion. The ectopic expression of the miR-310(c) also induces nicotine sensitivity by lowering Esg levels thus disrupting sensory organs and possibly to the modulation of other miR-310(c) targets.	[Sanchez-Diaz, Ivan; Reynaud, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Rosales-Bravo, Fernando; Narvaez-Padilla, Veronica] Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Cuernavaca 62209, Morelos, Mexico; [Luis Reyes-Taboada, Jose; Covarrubias, Alejandra A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62210, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Reynaud, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Ave Univ 2001,Apartado Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	enrique@ibt.unam.mx	Reyes, Jose/D-7331-2013	Narvaez Padilla, Veronica/0000-0002-3484-1612	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [131685, 481914, 255052]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN203611, IN204214]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico), (http://www.conacyt.mx/), (grant no. 131685 to ER), scholarship no. 481914 to Fernando Rosales, and scholarship no. 255052 to Ivan Sanchez. Universidad Nacional Autonoma de Mexico; Direccion General de asuntos del Personal Academico. Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (http://dgapa.unam.mx/html/papiit/papit.html), grant no. IN203611 and IN204214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Hartl M, 2011, J NEUROSCI, V31, P15660, DOI 10.1523/JNEUROSCI.2592-11.2011; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Heberlein U, 2009, NEUROPHARMACOLOGY, V56, P97, DOI 10.1016/j.neuropharm.2008.07.023; Hersberger M, 1996, MUTAT RES-ENVIR MUTA, V361, P165, DOI 10.1016/S0165-1161(96)90251-4; Huang AM, 2009, COLD SPRING HARB PRO, V2009; Korzelius J, 2014, EMBO J, V289, P29261; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Lai SL, 2012, DEV CELL, V23, P849, DOI 10.1016/j.devcel.2012.09.007; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Pancratov R, 2013, DEVELOPMENT, V140, P2904, DOI 10.1242/dev.092817; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Streit A, 2002, INT J DEV BIOL, V46, P159; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Tang TA, 2010, P NATL ACAD SCI USA, V107, P12935, DOI 10.1073/pnas.1007591107; Tarazona S., 2011, EMBNET J, V17, P18, DOI [10.14806/ej.17.B.265, DOI 10.14806/EJ.17.B.265]; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Velazquez-Marrero C, 2014, J BIOL CHEM, V289, P29261, DOI 10.1074/jbc.M114.604306; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	35	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133956	10.1371/journal.pone.0133956	http://dx.doi.org/10.1371/journal.pone.0133956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222315	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800085
J	Thangamani, S; Younis, W; Seleem, MN				Thangamani, Shankar; Younis, Waleed; Seleem, Mohamed N.			Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens	PLOS ONE			English	Article							INTRACELLULAR STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; INHIBITION; VANCOMYCIN; MECHANISM; GENES; ANTIMICROBIALS; COMBINATION; EXPRESSION; BACTERIA	Without a doubt, our current antimicrobials are losing the battle in the fight against newly-emerged multidrug-resistant pathogens. There is a pressing, unmet need for novel antimicrobials and novel approaches to develop them; however, it is becoming increasingly difficult and costly to develop new antimicrobials. One strategy to reduce the time and cost associated with antimicrobial innovation is drug repurposing, which is to find new applications outside the scope of the original medical indication of the drug. Ebselen, an organoselenium clinical molecule, possesses potent antimicrobial activity against clinical multidrug-resistant Gram-positive pathogens, including Staphylococcus, Streptococcus, and Enterococcus, but not against Gram-negative pathogens. Moreover, the activity of ebselen against Gram-positive pathogens exceeded those activities determined for vancomycin and linezolid, drugs of choice for treatment of Enterococcus and Staphylococcus infections. The minimum inhibitory concentrations of ebselen at which 90% of clinical isolates of Enterococcus and Staphylococcus were inhibited (MIC90) were found to be 0.5 and 0.25 mg/L, respectively. Ebselen showed significant clearance of intracellular methicillin-resistant S. aureus (MRSA) in comparison to vancomycin and linezolid. We demonstrated that ebselen inhibits the bacterial translation process without affecting mitochondrial biogenesis. Additionally, ebselen was found to exhibit excellent activity in vivo in a Caenorhabditis elegans MRSA-infected whole animal model. Finally, ebselen showed synergistic activities with conventional antimicrobials against MRSA. Taken together, our results demonstrate that ebselen, with its potent antimicrobial activity and safety profiles, can be potentially used to treat multidrug resistant Gram-positive bacterial infections alone or in combination with other antibiotics and should be further clinically evaluated.	[Thangamani, Shankar; Younis, Waleed; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Younis, Wlaeed/AAA-1743-2022	Seleem, Mohamed/0000-0003-0939-0458; Younis, Wlaeed/0000-0001-5572-0142	NIAID/NIH [HHSN272200700055C]	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract #HHSN272200700055C and BEI resources, NIAID, NIH for providing bacterial strains used in this study.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Alajlouni RA, 2013, NUCLEIC ACID THER, V23, P363, DOI 10.1089/nat.2013.0426; Appelbaum PC, 2007, CLIN INFECT DIS, V45, pS165, DOI 10.1086/519474; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; CLSI, 2007, M7A7 CLSI; Cohen DJ, 2012, ANN SURG ONCOL, V19, P478, DOI 10.1245/s10434-011-1940-8; Cruciani M, 1996, J ANTIMICROB CHEMOTH, V38, P865; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Diep BA, 2013, J INFECT DIS, V208, P75, DOI 10.1093/infdis/jit129; Diep BA, 2012, CURR THER RES CLIN E, V73, P86, DOI 10.1016/j.curtheres.2012.04.002; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003; Ellington JK, 2003, J BONE JOINT SURG BR, V85B, P918, DOI 10.1302/0301-620X.85B6.13509; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gerson SL, 2002, ANTIMICROB AGENTS CH, V46, P2723, DOI 10.1128/AAC.46.8.2723-2726.2002; Huang VH, 2005, ANTIMICROB AGENTS CH, V49, P302, DOI 10.1128/AAC.49.1.302-308.2005; Karau MJ, 2012, ANTIMICROB AGENTS CH, V56, P5401, DOI 10.1128/AAC.01080-12; Kuter DJ, 2001, PHARMACOTHERAPY, V21, P1010, DOI 10.1592/phco.21.11.1010.34517; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; MANYAN DR, 1972, J LAB CLIN MED, V79, P137; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Mohammad H, 2014, J ANTIBIOTICS; Nakae T, 1991, Kitasato Arch Exp Med, V64, P115; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; Otto MP, 2013, J ANTIMICROB CHEMOTH, V68, P1524, DOI 10.1093/jac/dkt073; Parashar S, 1972, J Postgrad Med, V18, P90; Peltola H, 2009, CLIN INFECT DIS, V49, P993, DOI 10.1086/605541; Rajamuthiah R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124595; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Seleem MN, 2009, ANTIMICROB AGENTS CH, V53, P4270, DOI 10.1128/AAC.00815-09; Seleem MN, 2009, FEMS MICROBIOL LETT, V294, P24, DOI 10.1111/j.1574-6968.2009.01530.x; Seral C, 2003, ANTIMICROB AGENTS CH, V47, P2283, DOI 10.1128/AAC.47.7.2283-2292.2003; Skripkin E, 2008, ANTIMICROB AGENTS CH, V52, P3550, DOI 10.1128/AAC.01193-07; Soofi MA, 2012, ANTIMICROB AGENTS CH, V56, P6407, DOI 10.1128/AAC.01437-12; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Thangamani S, 2015, CURRENT PHARM DESIGN; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; Yan K, 2006, ANTIMICROB AGENTS CH, V50, P3875, DOI 10.1128/AAC.00184-06; Younis W, 2015, CURRENT PHARM DESIGN; YUNIS AA, 1973, SEMIN HEMATOL, V10, P225	48	45	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133877	10.1371/journal.pone.0133877	http://dx.doi.org/10.1371/journal.pone.0133877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222252	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800075
J	Zhu, W; Castro, NJ; Cheng, XQ; Keidar, M; Zhang, LG				Zhu, Wei; Castro, Nathan J.; Cheng, Xiaoqian; Keidar, Michael; Zhang, Lijie Grace			Cold Atmospheric Plasma Modified Electrospun Scaffolds with Embedded Microspheres for Improved Cartilage Regeneration	PLOS ONE			English	Article							SURFACE MODIFICATION; TISSUE; BONE; DIFFERENTIATION; NANOFIBERS; BLENDS	Articular cartilage is prone to degeneration and possesses extremely poor self-healing capacity due to inherent low cell density and the absence of a vasculature network. Tissue engineered cartilage scaffolds show promise for cartilage repair. However, there still remains a lack of ideal biomimetic tissue scaffolds which effectively stimulate cartilage regeneration with appropriate functional properties. Therefore, the objective of this study is to develop a novel biomimetic and bioactive electrospun cartilage substitute by integrating cold atmospheric plasma (CAP) treatment with sustained growth factor delivery microspheres. Specifically, CAP was applied to a poly(e-caprolactone) electrospun scaffold with homogeneously distributed bioactive factors (transforming growth factor-beta 1 and bovine serum albumin) loaded poly(lactic-co-glycolic) acid microspheres. We have shown that CAP treatment renders electrospun scaffolds more hydrophilic thus facilitating vitronectin adsorption. More importantly, our results demonstrate, for the first time, CAP and microspheres can synergistically enhance stem cell growth as well as improve chondrogenic differentiation of human marrow-derived mesenchymal stem cells (such as increased glycosaminoglycan, type II collagen, and total collagen production). Furthermore, CAP can substantially enhance 3D cell infiltration (over two-fold increase in infiltration depth after 1 day of culture) in the scaffolds. By integrating CAP, sustained bioactive factor loaded microspheres, and electrospinning, we have fabricated a promising bioactive scaffold for cartilage regeneration.	[Zhu, Wei; Castro, Nathan J.; Cheng, Xiaoqian; Keidar, Michael; Zhang, Lijie Grace] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA; [Zhang, Lijie Grace] George Washington Univ, Dept Med, Washington, DC USA	George Washington University; George Washington University	Zhang, LG (corresponding author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.	lgzhang@gwu.edu	Castro, Nathan/F-9421-2015	Castro, Nathan/0000-0002-2526-3849; Zhang, Lijie Grace/0000-0003-3009-045X; Cheng, Xiaoqian/0000-0002-2544-4260	NIH National Center for Advancing Translational Sciences [UL1TR000075]; NIH Director's New Innovator Award [DP2EB020549]; George Washington Institute for Biomedical Engineering	NIH National Center for Advancing Translational Sciences; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington Institute for Biomedical Engineering	This work was supported by Award Number UL1TR000075 from the NIH National Center for Advancing Translational Sciences, NIH Director's New Innovator Award DP2EB020549, and the George Washington Institute for Biomedical Engineering.	Adam C, 1998, CLIN BIOMECH, V13, P1, DOI 10.1016/S0268-0033(97)85881-0; Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017; Chan CM, 1996, SURF SCI REP, V24, P3; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Cheng XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098652; Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805; Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s; Dolci LS, 2014, PLASMA PROCESS POLYM, V11, P203, DOI 10.1002/ppap.201300104; Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031; Ghasemi-Mobarakeh L, 2007, TISSUE ENG, V13, P916; Holmes B, 2016, CARBON, V97, P1, DOI 10.1016/j.carbon.2014.12.035; Holmes B, 2012, TISSUE ENG PART B-RE, V18, P478, DOI [10.1089/ten.teb.2012.0096, 10.1089/ten.TEB.2012.0096]; Holmes B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365102; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101; Li YF, 2012, PLASMA PROCESS POLYM, V9, P585, DOI 10.1002/ppap.201100090; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Matsiko A, 2013, MATERIALS, V6, P637, DOI 10.3390/ma6020637; Moffa M, 2013, SOFT MATTER, V9, P5529, DOI 10.1039/c3sm50328c; Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Ratovitski EA, 2014, PLASMA PROCESS POLYM, V11, P1128, DOI 10.1002/ppap.201400071; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Toh WS, 2014, STEM CELL REV REP, V10, P686, DOI 10.1007/s12015-014-9526-z; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang MA, 2014, TISSUE ENG PT A, V20, P1060, DOI [10.1089/ten.tea.2013.0235, 10.1089/ten.TEA.2013.0235]; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1, DOI 10.1615/CritRevBiomedEng.v37.i1-2.10; Zheng R, 2014, BIOMATERIALS, V35, P152, DOI 10.1016/j.biomaterials.2013.09.082; Zhu W, 2015, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2014.12.001, DOI 10.1016/J.NAN0.2014.12.001]; Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/NNM.14.36, 10.2217/nnm.14.36]	43	25	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134729	10.1371/journal.pone.0134729	http://dx.doi.org/10.1371/journal.pone.0134729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222527	Green Published, gold			2022-12-26	WOS:000358836800157
J	Vaughn, LS; Bragg, DC; Sharma, N; Camargos, S; Cardoso, F; Patel, RC				Vaughn, Lauren S.; Bragg, D. Cristopher; Sharma, Nutan; Camargos, Sarah; Cardoso, Francisco; Patel, Rekha C.			Altered Activation of Protein Kinase PKR and Enhanced Apoptosis in Dystonia Cells Carrying a Mutation in PKR Activator Protein PACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING DOMAIN; 16 ACUTE ONSET; CELLULAR ACTIVATOR; STRESS; DYT16; IDENTIFICATION; TRBP; RAX; PHOSPHORYLATION; ASSOCIATION	PACT is a stress-modulated activator of the interferon-induced double-stranded RNA-activated protein kinase (PKR). Stress-induced phosphorylation of PACT is essential for PACT's association with PKR leading to PKR activation. PKR activation leads to phosphorylation of translation initiation factor eIF2 alpha inhibition of protein synthesis and apoptosis. A recessively inherited form of early-onset dystonia DYT16 has been recently identified to arise due to a homozygous missense mutation P222L in PACT. To examine if the mutant P222L protein alters the stress-response pathway, we examined the ability of mutant P222L to interact with and activate PKR. Our results indicate that the substitution mutant P222L activates PKR more robustly and for longer duration albeit with slower kinetics in response to the endoplasmic reticulum stress. In addition, the affinity of PACT-PACT and PACT-PKR interactions is enhanced in dystonia patient lymphoblasts, thereby leading to intensified PKR activation and enhanced cellular death. P222L mutation also changes the affinity of PACT-TRBP interaction after cellular stress, thereby offering a mechanism for the delayed PKR activation in response to stress. Our results demonstrate the impact of a dystonia-causing substitution mutation on stress-induced cellular apoptosis.	[Vaughn, Lauren S.; Patel, Rekha C.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Bragg, D. Cristopher; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Camargos, Sarah; Cardoso, Francisco] Univ Fed Minas Gerais, Dept Internal Med, BR-31270901 Belo Horizonte, MG, Brazil	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Harvard University; Massachusetts General Hospital; Universidade Federal de Minas Gerais	Patel, RC (corresponding author), Univ S Carolina, Dept Biol Sci, 700 Sumter St, Columbia, SC 29208 USA.	patelr@biol.sc.edu	Bragg, D. Cristopher/AGT-6759-2022; CAMARGOS, SARAH/Y-4071-2019; CAMARGOS, SARAH T/O-4670-2014; Patel, Rekha/M-7123-2015	CAMARGOS, SARAH/0000-0001-9829-6783; CAMARGOS, SARAH T/0000-0001-9829-6783; Patel, Rekha/0000-0001-9434-4880; Vaughn, Lauren/0000-0003-2282-6738	Dystonia Medical Research Foundation; National Institutes of Health (NINDS) [P50NS037409]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409] Funding Source: NIH RePORTER	Dystonia Medical Research Foundation; National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Dystonia Medical Research Foundation grant (to R. P.). The work was also supported by National Institutes of Health Grant P50NS037409 (NINDS; to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguiar PD, 2015, MOVEMENT DISORD, V30, P877, DOI 10.1002/mds.26175; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Brashear A, 2013, MOVEMENT DISORD, V28, P1939, DOI 10.1002/mds.25774; Bressman SB, 2007, PARKINSONISM RELAT D, V13, pS347, DOI 10.1016/S1353-8020(08)70029-4; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Camargos S, 2012, J NEUROL NEUROSUR PS, V83, P1012, DOI 10.1136/jnnp-2012-302841; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Geyer HL, 2006, LANCET NEUROL, V5, P780, DOI 10.1016/S1474-4422(06)70547-6; Gordon KL, 2011, NEUROCHEM RES, V36, P452, DOI 10.1007/s11064-010-0363-4; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Heyam A, 2015, WIRES RNA, V6, P271, DOI 10.1002/wrna.1272; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Klein C, 2008, LANCET NEUROL, V7, P192, DOI 10.1016/S1474-4422(08)70023-1; Lemmon ME, 2013, MOVEMENT DISORD, V28, P1937, DOI 10.1002/mds.25703; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Paquet C, 2012, BRAIN PATHOL, V22, P219, DOI 10.1111/j.1750-3639.2011.00520.x; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; PATEL RC, 1992, J BIOL CHEM, V267, P7671; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Seibler P, 2008, LANCET NEUROL, V7, P380, DOI 10.1016/S1474-4422(08)70075-9; Singh M, 2012, J CELL BIOCHEM, V113, P2754, DOI 10.1002/jcb.24152; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Singh M, 2009, J MOL BIOL, V385, P457, DOI 10.1016/j.jmb.2008.10.068; Stoessl AJ, 2014, LANCET, V384, P532, DOI 10.1016/S0140-6736(14)60041-6; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; Thompson ML, 2014, DIS MODEL MECH, V7, P233, DOI 10.1242/dmm.013615; Vaughn LS, 2014, GENE, V536, P90, DOI 10.1016/j.gene.2013.11.074; Xiao JF, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0462-8; Yong Yue, 2014, Front Biol (Beijing), V9, P382; Zech M, 2014, MOVEMENT DISORD, V29, P1504, DOI 10.1002/mds.25981	50	36	38	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22543	22557		10.1074/jbc.M115.669408	http://dx.doi.org/10.1074/jbc.M115.669408			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231208	hybrid, Green Published			2022-12-26	WOS:000361171500021
J	Mauceri, D; Hagenston, AM; Schramm, K; Weiss, U; Bading, H				Mauceri, Daniela; Hagenston, Anna M.; Schramm, Kathrin; Weiss, Ursula; Bading, Hilmar			Nuclear Calcium Buffering Capacity Shapes Neuronal Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; SYNAPTIC ACTIVITY; HISTONE DEACETYLASES; NMDA RECEPTORS; CELL-DEATH; PHOSPHORYLATION; BRAIN; ACTIVATION; REPRESSION; EXPRESSION	Calcium-binding proteins (CaBPs) such as parvalbumin are part of the cellular calcium buffering system that determines intracellular calcium diffusion and influences the spatiotemporal dynamics of calcium signals. In neurons, CaBPs are primarily localized to the cytosol and function, for example, in nerve terminals in short-term synaptic plasticity. However, CaBPs are also expressed in the cell nucleus, suggesting that they modulate nuclear calcium signals, which are key regulators of neuronal gene expression. Here we show that the calcium buffering capacity of the cell nucleus in mouse hippocampal neurons regulates neuronal architecture by modulating the expression levels of VEGFD and the complement factor C1q-c, two nuclear calcium-regulated genes that control dendrite geometry and spine density, respectively. Increasing the levels of nuclear calcium buffers by means of expression of a nuclearly targeted form of parvalbumin fused to mCherry (PV. NLS-mC) led to a reduction in VEGFD expression and, as a result, to a decrease in total dendritic length and complexity. In contrast, mRNA levels of the synapse pruning factor C1q-c were increased in neurons expressing PV. NLS-mC, causing a reduction in the density and size of dendritic spines. Our results establish a close link between nuclear calcium buffering capacity and the transcription of genes that determine neuronal structure. They suggest that the development of cognitive deficits observed in neurological conditions associated with CaBP deregulation may reflect the loss of necessary structural features of dendrites and spines.	[Mauceri, Daniela; Hagenston, Anna M.; Schramm, Kathrin; Weiss, Ursula; Bading, Hilmar] Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633	ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 636]; Excellence Cluster CellNetworks at Heidelberg University; German Ministry of Education and Research [01GQ1003A]	ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster CellNetworks at Heidelberg University; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by an ERC Advanced Grant (to H. B.), by Sonderforschungsbereich 636 of the Deutsche Forschungsgemeinschaft, by the Excellence Cluster CellNetworks at Heidelberg University, and by German Ministry of Education and Research Grant 01GQ1003A. The authors declare that they have no conflicts of interest with the contents of this article.	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Dickstein DL, 2013, NEUROSCIENCE, V251, P21, DOI 10.1016/j.neuroscience.2012.09.077; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; Kasischke K, 2001, ACTA NEUROPATHOL, V101, P483; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Pegoraro S, 2010, J CELL PHYSIOL, V222, P713, DOI 10.1002/jcp.21998; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Riascos D, 2011, ACTA NEUROPATHOL, V122, P565, DOI 10.1007/s00401-011-0865-4; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; SHOLL DA, 1953, J ANAT, V87, P387; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	51	19	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23039	23049		10.1074/jbc.M115.654962	http://dx.doi.org/10.1074/jbc.M115.654962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26231212	Green Published, hybrid			2022-12-26	WOS:000361685500018
J	Wu, TP; Liang, FW; Huang, YL; Chen, LH; Lu, TH				Wu, Tung-Pi; Liang, Fu-Wen; Huang, Ya-Li; Chen, Lea-Hua; Lu, Tsung-Hsueh			Maternal Mortality in Taiwan: A Nationwide Data Linkage Study	PLOS ONE			English	Article							PREGNANCY-RELATED DEATHS; UNITED-STATES	Background To examine the changes in the maternal mortality ratio (MMR) and causes of maternal death in Taiwan based on nationwide linked data sets. Methods We linked four population-based data sets (birth registration, birth notification, National Health Insurance inpatient claims, and cause of death mortality data) to identify maternal deaths for 2004-2011. Subsequently, we calculated the MMR (deaths per 100,000 live births) and the proportion of direct and indirect causes of maternal death by maternal age and year. Findings Based on the linked data sets, we identified 236 maternal death cases, of which only 102 were reported in officially published mortality data, with an underreporting rate of 57% [(236-102) x 100 / 236]. The age-adjusted MMR was 18.4 in 2004-2005 and decreased to 12.5 in 2008-2009; however, the MMR leveled off at 12.6 in 2010-2011. The MMR increased from 5.2 in 2008-2009 to 7.1 in 2010-2011 for patients aged 15-29 years. Women aged 15-29 years had relatively lower proportion in dying from direct causes (amniotic fluid embolism and obstetric hemorrhage) compared with their counterpart older women. Conclusions Approximately two-thirds of maternal deaths were not reported in officially published mortality data. Routine surveillance of maternal mortality by using enhanced methods is necessary to monitor the health status of reproductive-age women. Furthermore, a comprehensive maternal death review is necessary to explore the preventability of these maternal deaths.	[Wu, Tung-Pi] Sin Lau Christian Hosp, Dept Obstet & Gynecol, Tainan, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, NCKU Res Ctr Hlth Data, Tainan 70101, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Dept Publ Hlth, Tainan 70101, Taiwan; [Huang, Ya-Li] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan; [Chen, Lea-Hua] Minist Hlth & Welf, Dept Stat, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Huang, YL (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.	ylhuang@tmu.edu.tw		Liang, Fu-Wen/0000-0002-3396-037X	Sin-Lau Christian Hospital [SLH-102-03]; Ministry of Health and Welfare [MOHW103-TDU-M-211-000016]; Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project	Sin-Lau Christian Hospital; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project	This study was financially supported by Sin-Lau Christian Hospital (SLH-102-03), the Ministry of Health and Welfare (MOHW103-TDU-M-211-000016), and the Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project.	Amarin Z, 2010, INT J GYNECOL OBSTET, V111, P152, DOI 10.1016/j.ijgo.2010.05.016; Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; BOUVIERCOLLE MH, 1991, INT J EPIDEMIOL, V20, P717, DOI 10.1093/ije/20.3.717; Buescher Paul A, 2002, N C Med J, V63, P76; Callaghan WM, 2014, AM J OBSTET GYNECOL, V211, P581, DOI 10.1016/j.ajog.2014.07.041; Center of Intellegency Agency of the United States, WORLD FACTBOOK; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Department of Household Registration Ministry of Internal AffairsTaiwan, TABL 11 NUMB BIRTH A; Directorate General of Budget Accounting and Statistics Executive Yuan Taiwan, NAT ACC STAT TABL; Gissler M, 1997, ACTA OBSTET GYN SCAN, V76, P651, DOI 10.3109/00016349709024605; Gissler M, 2007, EUR J OBSTET GYN R B, V133, P179, DOI 10.1016/j.ejogrb.2006.08.013; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Hsieh WS, 2011, J WOMENS HEALTH, V20, P1083, DOI 10.1089/jwh.2011.2809; Kao SY, 1997, ACTA OBSTET GYN SCAN, V76, P629, DOI 10.3109/00016349709024602; Karimian-Teherani D, 2002, ACTA OBSTET GYN SCAN, V81, P323; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; MacKay AP, 2011, OBSTET GYNECOL, V118, P104, DOI 10.1097/AOG.0b013e31821fd49d; McCaw-Binns AM, 2015, INT J GYNECOL OBSTET, V128, P62, DOI 10.1016/j.ijgo.2014.07.023; Ministry of Health and Welfare,Taiwan, TABL 11 NUMB DEATHS; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; OECD, 2014, NAT INC PER CAP OECD; Pallin DJ, 2002, AM J PUBLIC HEALTH, V92, P1319, DOI 10.2105/AJPH.92.8.1319; Schuitemaker N, 1997, OBSTET GYNECOL, V90, P78, DOI 10.1016/S0029-7844(97)00128-2; Turner Linda A, 2002, Chronic Dis Can, V23, P22; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Wu TP, 2015, TAIWAN J OB IN PRESS	27	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0132547	10.1371/journal.pone.0132547	http://dx.doi.org/10.1371/journal.pone.0132547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237411	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400007
J	Bu, CF; Zhang, KK; Zhang, CY; Wu, SF				Bu, Chongfeng; Zhang, Kankan; Zhang, Chunyun; Wu, Shufang			Key Factors Influencing Rapid Development of Potentially Dune-Stabilizing Moss-Dominated Crusts	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; MICROBIOTIC CRUSTS; NEGEV-DESERT; CULTURE; RECOVERY	Biological soil crusts (BSCs) are a widespread photosynthetic ground cover in arid and semiarid areas. They have many positive ecological functions, such as increasing soil stability, and reducing water and wind erosion. Using artificial technology to achieve the rapid development of BSCs is expected to become a low-cost and highly beneficial ecological restoration measure. In the present study, typical moss-dominated crusts in a region characterized by mobile dunes (Mu Us Sandland, China) were collected, and a 40-day cultivation experiment was performed to investigate key factors, including watering frequency, light intensity and a nutrient addition, which affect the rapid development of moss crusts and their optimal combination. The results demonstrated that watering frequency and illumination had a significant positive effect (P=0.049, three-factor ANOVA) and a highly significant, complicated effect (P=0.000, three-factor ANOVA), respectively, on the plant density of bryophytes, and a highly significant positive effect on the chlorophyll a and exopolysaccharide contents (P=0.000, P=0.000; P=0.000, P=0.000; one-way ANOVA). Knop nutrient solution did not have a significant positive but rather negative effect on the promotion of moss-dominated crust development (P=0.270, three-factor ANOVA). Moss-dominated crusts treated with the combination of moderate-intensity light (6,000 lx) + high watering frequency (1 watering/2 days) - Knop had the highest moss plant densities, while the treatment with high-intensity light (12,000 lx) + high watering frequency (1 watering/2 days) + Knop nutrient solution had higher chlorophyll a contents than that under other treatments. It is entirely feasible to achieve the rapid development of moss crusts under laboratory conditions by regulating key factors and creating the right environment. Future applications may seek to use cultured bryophytes to control erosion in vulnerable areas with urgent needs.	[Bu, Chongfeng; Zhang, Kankan; Zhang, Chunyun; Wu, Shufang] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Bu, Chongfeng] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Bu, Chongfeng] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Wu, Shufang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Bu, CF (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China.	buchongfeng@163.com; wsfjs@163.com			National Natural Science Foundation of China [41071192, 40701096]; Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [K318009902-1405]; West Light Foundation of Chinese Academy of Science [2014-91]; Chinese Universities Scientific Fund [2014YQ006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau; West Light Foundation of Chinese Academy of Science(Chinese Academy of Sciences); Chinese Universities Scientific Fund	The National Natural Science Foundation of China (grant nos. 41071192 & 40701096), the Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (K318009902-1405), the West Light Foundation of Chinese Academy of Science (No. 2014-91) and the Chinese Universities Scientific Fund (grant no. 2014YQ006) provided funding for this research.	Ahmed MGU, 2010, KOREAN J HORTIC SCI, V28, P108; [Anonymous], 2003, BIOLOGICAL SOIL CRUS, DOI DOI 10.1007/978-3-642-56475-8; Asthana AK, 2011, NATL ACAD SCI LETT, V34, P23; BELNAP J, 1993, GREAT BASIN NAT, V53, P89; Belnap J., 2001, BIOL SOIL CRUSTS STR; Belnap J, 2000, BIOL FERT SOILS, V35, P128; Belnap J., 2003, BIOL SOIL CRUSTS STR, P3; BROTHERSON JD, 1983, J RANGE MANAGE, V36, P579, DOI 10.2307/3898344; Chen Yan-qin, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P586; Chen YY, 2009, ANN BOT FENN, V46, P516, DOI 10.5735/085.046.0604; DeFalco LA, 2001, PLANT SOIL, V234, P1, DOI 10.1023/A:1010323001006; Duckett JG, 2004, J BRYOL, V26, P3, DOI 10.1179/037366803235001742; Elmarsdottir A, 2003, J APPL ECOL, V40, P815, DOI 10.1046/j.1365-2664.2003.00848.x; George DB, 2003, ARID LAND RES MANAG, V17, P113, DOI 10.1080/15324980301588; Gretarsdottir J, 2004, RESTOR ECOL, V12, P268, DOI 10.1111/j.1061-2971.2004.00371.x; Guo Yi-rui, 2008, Huanjing Kexue, V29, P1027; Harper KT, 2001, J ARID ENVIRON, V47, P347, DOI 10.1006/jare.2000.0713; Harris ESJ, 2008, BRYOLOGIST, V111, P169, DOI 10.1639/0007-2745(2008)111[169:ETUAFC]2.0.CO;2; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; [赵允格 Zhao Yunge], 2010, [生态学报, Acta Ecologica Sinica], V30, P4668; Kidron J, 2008, GEOMORPHOLOGY, V100, P444, DOI 10.1016/j.geomorph.2008.01.012; Kidron GJ, 2014, J HYDROL, V509, P398, DOI 10.1016/j.jhydrol.2013.11.041; Kidron GJ, 2010, CATENA, V82, P92, DOI 10.1016/j.catena.2010.05.006; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P1594, DOI 10.1002/esp.1843; Kidron GJ, 2000, GEOMORPHOLOGY, V36, P1, DOI 10.1016/S0169-555X(00)00043-X; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Marsh J, 2006, CAN J BOT, V84, P717, DOI [10.1139/b06-026, 10.1139/B06-026]; Mikano Road Joint-Stock Company, 2004, Patent No. [CN1522562A, 1522562A]; Nehira K, 1964, B BIOL SOC HIROSHIMA, V31, P15; Prasse R, 2000, PLANT ECOL, V150, P65, DOI 10.1023/A:1026593429455; Qiao FL, 2002, DETERMINATION ANAL T; Stark LR, 2011, J ARID ENVIRON, V75, P457, DOI 10.1016/j.jaridenv.2010.12.015; Wang S. D., 2001, J DESERT RES, V21, P244; [徐杰 Xu Jie], 2005, [生态学报, Acta Ecologica Sinica], V25, P1247; Xu SJ, 2008, ENVIRON ENG SCI, V25, P1129, DOI 10.1089/ees.2006.0272; Yang JZ, 2010, THESIS NW AGR FOREST; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zaady E, 2014, AEOLIAN RES, V13, P81, DOI 10.1016/j.aeolia.2014.04.002; [张元明 Zhang Yuanming], 2002, [生态学报, Acta Ecologica Sinica], V22, P1129; 胡春香, 2003, [自然科学进展, Progress in Natural Science], V13, P791	40	12	15	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134447	10.1371/journal.pone.0134447	http://dx.doi.org/10.1371/journal.pone.0134447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230324	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400122
J	Bu, SC; Kuijer, R; van der Worp, RJ; Li, XR; Hooymans, JMM; Los, LI				Bu, Shao Chong; Kuijer, Roel; van der Worp, Roelofje J.; Li, Xiao Rong; Hooymans, Johanna M. M.; Los, Leonoor I.			The Ultrastructural Localization of Type II, IV, and VI Collagens at the Vitreoretinal Interface	PLOS ONE			English	Article							RABBIT VITREOUS BODY; BASEMENT-MEMBRANE COMPONENT; AGE-DEPENDENT CHANGES; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; LIMITING MEMBRANE; VASCULAR REMNANTS; HUMAN PLACENTA; HUMAN-EYE; IN-VITRO	Background The vitreoretinal interface is the border of the cortical vitreous and the inner surface of the retina. The adhesion of the cortical vitreous to the ILM, namely vitreoretinal adhesion, involves a series of complex molecular adhesion mechanisms and has been considered as an important pathogenic factor in many vitreoretinal diseases. The presence of type VI collagen at the vitreoretinal interface and its possible interaction with collagens and glycoproteins indicates that type VI collagen may contribute to the vitreoretinal adhesion. Purpose To clarify the ultrastructural location of type VI collagen and its relationship to type II and IV collagens at the vitreoretinal interface. Methods The ultrastructural localization of type II, IV and VI collagens in the adult human vitreoretinal interface of five donor eyes was evaluated by transmission electron microscopy using immunogold labeling. Results In the pre-equatorial region, we observed densely packed vitreous lamellae with a partly intraretinal course containing type II and VI collagens, reticular structures containing type IV and VI collagens and a thin inner limiting membrane (ILM) containing type IV and VI collagens in a linear distribution pattern. From the anterior to the posterior retina, the linear pattern of type IV and VI collagen labeling gradually became more diffusely present throughout the entire thickness of the ILM. Conclusions The presence of type VI collagen in vitreous lamellae penetrating the ILM into the superficial retina suggests that type VI collagen may be involved in the organization of vitreous fibers into lamellae and in the adhesion of the vitreous fibers to the retina. The close relation of type VI to type IV collagen in the ILM suggests that type VI collagen is an important collagen type in the ILM. The topographic variations of type IV and VI collagens in the different regions of the ILM suggest a regional heterogeneity of the ILM. The reticular labeling pattern of type IV and VI collagens observed in the anterior vitreous are highly similar to labeling patterns of blood vessel walls. In the anterior vitreous, they may represent remnants of the regressed embryonic hyaloid blood vessel system. Their presence is in support of the theory on interactive remodeling of the developing vitreous as opposed to the main stream theory of displacement and compression of the primary by the secondary vitreous.	[Bu, Shao Chong; van der Worp, Roelofje J.; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Kuijer, Roel] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Bu, Shao Chong; Kuijer, Roel; van der Worp, Roelofje J.; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands; [Bu, Shao Chong; Li, Xiao Rong] Tianjin Med Univ, Hosp Eye, Tianjin 300384, Peoples R China	University of Groningen; University of Groningen; University of Groningen; Tianjin Medical University	Los, LI (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	l.i.los@umcg.nl	Kuijer, Roel/A-6690-2015	Kuijer, Roel/0000-0002-7637-4944; Bu, Shaochong/0000-0002-9060-7361	"Stichting Blindenhulp" of the Netherlands	"Stichting Blindenhulp" of the Netherlands	The study was financially supported by "Stichting Blindenhulp" of the Netherlands.	Aumailley M, 2000, J CELL SCI, V113, P259; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Bai XY, 2009, MATRIX BIOL, V28, P194, DOI 10.1016/j.matbio.2009.02.004; Barishak Y R, 1992, Dev Ophthalmol, V24, P1; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bishop P, 1996, GRAEF ARCH CLIN EXP, V234, P710, DOI 10.1007/BF00292358; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BREM RB, 1994, INVEST OPHTH VIS SCI, V35, P3466; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; DESJARDINS M, 1989, J HISTOCHEM CYTOCHEM, V37, P885, DOI 10.1177/37.6.2723404; FOOS RY, 1972, INVEST OPHTH VISUAL, V11, P801; Gandorfer A, 2009, RETINA-J RET VIT DIS, V29, P1097, DOI 10.1097/IAE.0b013e3181aa8fb1; GLOOR BP, 1975, T OPHTHAL SOC UK, V95, P387; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P1000, DOI 10.1167/iovs.04-1185; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; IIDA K, 1994, J ELECTRON MICROSC, V43, P367; Kagemann L, 2006, AM J OPHTHALMOL, V142, P862, DOI 10.1016/j.ajo.2006.05.059; Kampik Anselm, 2012, Retina, V32 Suppl 2, pS194, DOI 10.1097/IAE.0b013e31825bc20a; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KIELTY CM, 1992, J CELL BIOL, V118, P979, DOI 10.1083/jcb.118.4.979; KISHI S, 1986, INT OPHTHALMOL, V9, P253, DOI 10.1007/BF00137539; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kritzenberger M, 2011, HISTOPATHOLOGY, V58, P953, DOI 10.1111/j.1365-2559.2011.03820.x; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kuppermann BD, 2005, AM J OPHTHALMOL, V140, P585, DOI 10.1016/j.ajo.2005.06.022; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Los LI, 1999, EXP EYE RES, V69, P343, DOI 10.1006/exer.1999.0708; Los LI, 2000, EXP EYE RES, V71, P153, DOI 10.1006/exer.2000.0865; Los LI, 2000, EXP EYE RES, V71, P143, DOI 10.1006/exer.2000.0864; LosI LI, 1997, DEV AGE RELATED REMO; MARSHALL GE, 1992, INVEST OPHTH VIS SCI, V33, P2546; Oliveira LB, 2001, RETINA-J RET VIT DIS, V21, P324, DOI 10.1097/00006982-200108000-00005; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Ponsioen TL, 2008, MOL VIS, V14, P652; Ponsioen TL, 2010, PROG RETIN EYE RES, V29, P580, DOI 10.1016/j.preteyeres.2010.07.001; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Russell Stephen R, 2012, Retina, V32 Suppl 2, pS181, DOI 10.1097/IAE.0b013e31825bf014; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9; SANNES PL, 1984, J HISTOCHEM CYTOCHEM, V32, P827, DOI 10.1177/32.8.6747274; Sasaki T, 1998, EXP CELL RES, V238, P70, DOI 10.1006/excr.1997.3837; Savige J, 2010, INVEST OPHTH VIS SCI, V51, P1621, DOI 10.1167/iovs.08-3323; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Sebag J, 1989, VITREOUS STRUCTURE F, pxi; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P356, DOI 10.1136/bjophthalmol-2013-304219; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Tezel TH, 1998, RETINA-J RET VIT DIS, V18, P7; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Vergleichende A. J., 1927, UNTERSUCHUNGEN BAU E, P183; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Wang J, 2003, INVEST OPHTH VIS SCI, V44, P1793, DOI 10.1167/iovs.02-0802; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Yanoff M, 2004, OPHTHALMOLOGY, pxxii; ZHU D, 1994, J HISTOCHEM CYTOCHEM, V42, P577, DOI 10.1177/42.5.8157929	63	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134325	10.1371/journal.pone.0134325	http://dx.doi.org/10.1371/journal.pone.0134325			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230410	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400101
J	Edmunds, LR; Sharma, L; Wang, H; Kang, A; d'Souza, S; Lu, J; McLaughlin, M; Dolezal, JM; Gao, XL; Weintraub, ST; Ding, Y; Zeng, XM; Yates, N; Prochownik, EV				Edmunds, Lia R.; Sharma, Lokendra; Wang, Huabo; Kang, Audry; d'Souza, Sonia; Lu, Jie; McLaughlin, Michael; Dolezal, James M.; Gao, Xiaoli; Weintraub, Susan T.; Ding, Ying; Zeng, Xuemei; Yates, Nathan; Prochownik, Edward V.			c-Myc and AMPK Control Cellular Energy Levels by Cooperatively Regulating Mitochondrial Structure and Function	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GREEN FLUORESCENT PROTEIN; OXYGEN-FREE RADICALS; COMPLEX I DEFICIENCY; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE ACTIVITY; GENE-EXPRESSION; MESSENGER-RNA; TUMOR-CELLS; TRANSCRIPTION	The c-Myc (Myc) oncoprotein and AMP-activated protein kinase (AMPK) regulate glycolysis and oxidative phosphorylation (Oxphos) although often for different purposes. Because Myc over-expression depletes ATP with the resultant activation of AMPK, we explored the potential co-dependency of and cross-talk between these proteins by comparing the consequences of acute Myc induction in ampk+/+ (WT) and ampk-/- (KO) murine embryo fibroblasts (MEFs). KO MEFs showed a higher basal rate of glycolysis than WT MEFs and an appropriate increase in response to activation of a Myc-estrogen receptor (MycER) fusion protein. However, KO MEFs had a diminished ability to increase Oxphos, mitochondrial mass and reactive oxygen species in response to MycER activation. Other differences between WT and KO MEFs, either in the basal state or following MycER induction, included abnormalities in electron transport chain function, levels of TCA cycle-related oxidoreductases and cytoplasmic and mitochondrial redox states. Transcriptional profiling of pathways pertinent to glycolysis, Oxphos and mitochondrial structure and function also uncovered significant differences between WT and KO MEFs and their response to MycER activation. Finally, an unbiased mass-spectrometry (MS)-based survey capable of quantifying similar to 40% of all mitochondrial proteins, showed about 15% of them to be AMPK- and/or Myc-dependent in their steady state. Significant differences in the activities of the rate-limiting enzymes pyruvate kinase and pyruvate dehydrogenase, which dictate pyruvate and acetyl coenzyme A abundance, were also differentially responsive to Myc and AMPK and could account for some of the differences in basal metabolite levels that were also detected by MS. Thus, Myc and AMPK are highly co-dependent and appear to engage in significant cross-talk across numerous pathways which support metabolic and ATP-generating functions.	[Edmunds, Lia R.; Sharma, Lokendra; Wang, Huabo; d'Souza, Sonia; Lu, Jie; Prochownik, Edward V.] UPMC, Sect Hematol Oncol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Edmunds, Lia R.; Kang, Audry; McLaughlin, Michael; Dolezal, James M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Gao, Xiaoli; Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Ding, Ying] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Zeng, Xuemei; Yates, Nathan] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Hillman Canc Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Sect Hematol Oncol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.	procev@chp.edu		Dolezal, James/0000-0002-6788-7203; Ding, Ying/0000-0003-1352-1000	Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; RO1 grant [CA174713]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; RO1 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a pre-doctoral fellowship award to LRE from the Children's Hospital of Pittsburgh of UPMC Research Advisory Committee and by RO1 grant CA174713 to EVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alaynick WA, 2008, MITOCHONDRION, V8, P329, DOI 10.1016/j.mito.2008.02.001; Attie AD, 2003, NAT GENET, V34, P244, DOI 10.1038/ng0703-244; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cao Zhenbo, 2007, V44, P295; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Edmunds LR, 2014, J BIOL CHEM, V289, P25382, DOI 10.1074/jbc.M114.580662; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Graves JA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037699, DOI 10.1371/J0URNAL.P0NE.0037699]; Hann SR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014399; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Janssen-Heininger YMW, 2013, J CELL BIOCHEM, V114, P1962, DOI 10.1002/jcb.24551; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jiang K, 2006, PLANT PHYSIOL, V141, P397, DOI 10.1104/pp.106.078246; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kuehl WM, 2012, BLOOD, V120, P2351, DOI 10.1182/blood-2012-08-445262; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li FengZhen, 2005, Journal of Triticeae Crops, V25, P14; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Matalon O, 2014, CURR OPIN STRUC BIOL, V26, P113, DOI 10.1016/j.sbi.2014.06.001; Meng FY, 2007, J AM SOC MASS SPECTR, V18, P226, DOI 10.1016/j.jasms.2006.09.014; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miedel MT, 2014, METHODS, V68, P536, DOI 10.1016/j.ymeth.2014.04.019; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miranda-Vizuete A, 2000, ANTIOXID REDOX SIGN, V2, P801, DOI 10.1089/ars.2000.2.4-801; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Paredes RM, 2014, INT J NEUROPSYCHOPH, V17, P1139, DOI 10.1017/S1461145714000157; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Petrich AM, 2014, CANCER-AM CANCER SOC, V120, P3884, DOI 10.1002/cncr.28899; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Roussel MF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014308; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Semenza G L, 2001, Novartis Found Symp, V240, P251; Shirwany NA, 2014, FRONT BIOSCI-LANDMRK, V19, P447, DOI 10.2741/4218; Sid B, 2013, BIOCHEM PHARMACOL, V86, P200, DOI 10.1016/j.bcp.2013.05.007; Sodir NM, 2011, ONCOTARGET, V2, P1307; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Yakubovskaya E, 2014, NUCLEIC ACIDS RES, V42, P4100, DOI 10.1093/nar/gkt1360; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Zeng XM, 2011, J THORAC ONCOL, V6, P725, DOI 10.1097/JTO.0b013e31820c312e; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437; Zhou JZ, 2015, ONCOGENE, V34, P1831, DOI 10.1038/onc.2014.113	110	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134049	10.1371/journal.pone.0134049	http://dx.doi.org/10.1371/journal.pone.0134049			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230505	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000358838400069
J	Liu, ZB; Benard, O; Syeda, MM; Schuster, VL; Chi, YL				Liu, Zhongbo; Benard, Outhiriaradjou; Syeda, Mahrukh M.; Schuster, Victor L.; Chi, Yuling			Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats	PLOS ONE			English	Article							IN-VITRO; KERATINOCYTE PROLIFERATION; ENDOTHELIAL DYSFUNCTION; CD34-POSITIVE CELLS; FOOT ULCERS; BLOOD-FLOW; EXPRESSION; MODEL; ANGIOGENESIS; LIMB	Peripheral ischemia, resulting from diminished arterial flow and defective local vascularization, is one of the main causes of impaired wound healing in diabetes. Vasodilatory prostaglandins (PGs), including PGE(2) and PGI(2), regulate blood flow in peripheral tissues. PGs also stimulate angiogenesis by inducing vascular endothelial growth factor. However, PG levels are reduced in diabetes mainly due to enhanced degradation. We hypothesized that inhibition of the prostaglandin transporter (PGT) (SLCO2A1), which mediates the degradation of PGs, would increase blood flow and stimulate vascularization, thereby mitigating peripheral ischemia and accelerating wound healing in diabetes. Here we report that inhibiting PGT with intravenously injected PGT inhibitor, T26A, increased blood flow in ischemic hind limbs created in non-diabetic rats and streptozotocin induced diabetic rats. Systemic, or combined with topical, T26A accelerated closure of cutaneous wounds. Immunohistochemical examination revealed that inhibition of PGT enhanced vascularization (marked by larger numbers of vessels formed by CD34+ cells), and accelerated re-epithelialization of cutaneous wounds. In cultured primary human bone marrow CD34+ cells and human epidermal keratinocytes (HEKs) either inhibiting or silencing PGT increased migration in both cell lines. Thus PGT directly regulates mobilization of endothelial progenitor cells (EPCs) and HEKs, which could contribute to PGT-mediated vascularization and re-epithelialization. At the molecular level, systemic inhibition of PGT raised circulating PGE(2). Taken together, our data demonstrate that PGT modulates arterial blood flow, mobilization of EPCs and HEKs, and vascularization and epithelialization in wound healing by regulating vasodilatory and pro-angiogenic PGs.	[Liu, Zhongbo; Benard, Outhiriaradjou; Syeda, Mahrukh M.; Schuster, Victor L.; Chi, Yuling] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Schuster, Victor L.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, YL (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	yuling.chi@einstein.yu.edu	Liu, Zhongbo/U-3004-2017; Syeda, Mahrukh M/AAD-1927-2019	Syeda, Mahrukh M/0000-0002-4081-2068	American Heart Association [0735066N]; American Diabetes Association [1-11-JF-06]; National Institute of Diabetes and Digestive and Kidney Diseases [DK49688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049688, P30DK041296] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by 0735066N, American Heart Association, http://www.heart.org/HEARTORG/, to YC; 1-11-JF-06, American Diabetes Association, http://www.diabetes.org/, to YC; and DK49688, The National Institute of Diabetes and Digestive and Kidney Diseases, http://www.niddk.nih. gov/Pages/default.aspx, to VLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh N, 2007, WOUND REPAIR REGEN, V15, P809, DOI 10.1111/j.1524-475X.2007.00312.x; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Bitto A, 2008, J VASC SURG, V48, P1292, DOI 10.1016/j.jvs.2008.06.041; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARTER J, 1986, COMP BIOCHEM PHYS C, V83, P401, DOI 10.1016/0742-8413(86)90143-X; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Chi YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131735; Chi YL, 2011, J PHARMACOL EXP THER, V339, P633, DOI 10.1124/jpet.111.181354; Conconi MT, 1996, ANN ANAT, V178, P229, DOI 10.1016/S0940-9602(96)80055-0; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; Dick F, 2008, CIRCULATION, V118, P1920, DOI 10.1161/CIRCULATIONAHA.108.787754; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Frykberg RG, 2002, AM FAM PHYSICIAN, V66, P1655; Guerci B, 2001, DIABETES METAB, V27, P436; Hishinuma T, 1999, PROSTAG OTH LIPID M, V58, P263, DOI 10.1016/S0090-6980(99)00029-5; Hishinuma T, 1996, PROSTAG LEUKOTR ESS, V54, P445, DOI 10.1016/S0952-3278(96)90029-0; Hogikyan RV, 1998, J CLIN ENDOCR METAB, V83, P1946, DOI 10.1210/jc.83.6.1946; HOLZER P, 1995, BRIT J PHARMACOL, V116, P2365, DOI 10.1111/j.1476-5381.1995.tb15081.x; JARABAK J, 1979, PROSTAGLANDINS, V18, P241, DOI 10.1016/0090-6980(79)90109-6; Kampfer H, 2005, DIABETES, V54, P1543, DOI 10.2337/diabetes.54.5.1543; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; KOLLER A, 1990, CIRC RES, V67, P529, DOI 10.1161/01.RES.67.2.529; Lee CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017867; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Matsumura S, 2015, J DERMATOL SCI, V78, P215, DOI 10.1016/j.jdermsci.2015.02.021; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; PERICO N, 1992, DIABETES, V41, P533, DOI 10.2337/diabetes.41.4.533; Rissanen TT, 2001, EUR J CLIN INVEST, V31, P651, DOI 10.1046/j.1365-2362.2001.00864.x; Ritz U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097369; Schanzer Andres, 2010, Curr Treat Options Cardiovasc Med, V12, P214, DOI 10.1007/s11936-010-0076-7; Sheikh AQ, 2014, AM J PHYSL CELL PHYS; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Silvestre JS, 2014, ARTERIOSCLER THROMB; Sima AAF, 1996, J CLIN INVEST, V97, P1900, DOI 10.1172/JCI118621; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Spinella F, 2004, J BIOL CHEM, V279, P46700, DOI 10.1074/jbc.M408584200; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Szerafin T, 2006, CIRC RES, V99, pE12, DOI 10.1161/01.RES.0000241051.83067.62; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; WEEKS JR, 1972, ANNU REV PHARMACOLOG, V12, P317, DOI 10.1146/annurev.pa.12.040172.001533; Wentzel P, 1999, DIABETES, V48, P813, DOI 10.2337/diabetes.48.4.813; Wu ZW, 2014, J DERMATOL SCI, V75, P16, DOI 10.1016/j.jdermsci.2014.03.004; Yang Z, 2009, VASC PHARMACOL, V51, P268, DOI 10.1016/j.vph.2009.07.001	48	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133615	10.1371/journal.pone.0133615	http://dx.doi.org/10.1371/journal.pone.0133615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230411	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400046
J	Nardone, V; Cistrone, L; Di Salvo, I; Ariano, A; Migliozzi, A; Allegrini, C; Ancillotto, L; Fulco, A; Russo, D				Nardone, Valentina; Cistrone, Luca; Di Salvo, Ivy; Ariano, Alessandro; Migliozzi, Antonello; Allegrini, Claudia; Ancillotto, Leonardo; Fulco, Antonio; Russo, Danilo			How to Be a Male at Different Elevations: Ecology of Intra-Sexual Segregation in the Trawling Bat Myotis daubentonii	PLOS ONE			English	Article							LONG-FINGERED BAT; HABITAT SELECTION; TEMPERATE BATS; DAILY TORPOR; FEMALE; ECHOLOCATION; PATTERNS; VESPERTILIONIDAE; THERMOREGULATION; HETEROTHERMY	Intra-sexual segregation is a form of social segregation widespread among vertebrates. In the bat Myotis daubentonii, males are disproportionately abundant at higher elevations, while females are restricted to lower altitude. Intra-male segregation is also known to occur yet its ecological and behavioural determinants are unclear. We studied male segregation along a river in Central Italy where we tested the following predictions: 1. Upstream (> 1000 m a.s.l.) males will rely on scarcer prey; 2. To deal with this limitation and exploit a cooler roosting environment, they will employ more prolonged and deeper torpor than downstream (< 900 m a.s.l.) males; 3. Body condition will be better in downstream males as they forage in more productive areas; 4. To cope with less predictable foraging opportunities, upstream males will use more habitat types. Consistent with our predictions, we found that prey were less common at higher altitudes, where bats exhibited prolonged and deeper torpor. Body condition was better in downstream males than in upstream males but not in all summer months. This result reflected a decrease in downstream males' body condition over the season, perhaps due to the energy costs of reduced opportunities to use torpor and/or intraspecific competition. Downstream males mainly foraged over selected riparian vegetation whereas upstream males used a greater variety of habitats. One controversial issue is whether upstream males are excluded from lower elevations by resident bats. We tested this by translocating 10 upstream males to a downstream roost: eight returned to the high elevation site in 1-2 nights, two persisted at low altitude but did not roost with resident bats. These results are consistent with the idea of segregation due to competition. Living at high altitude allows for more effective heterothermy and may thus be not detrimental for survival, but by staying at lower altitude males increase proximity to females and potentially benefit from summer mating opportunities.	[Nardone, Valentina; Di Salvo, Ivy; Ariano, Alessandro; Allegrini, Claudia; Ancillotto, Leonardo; Fulco, Antonio; Russo, Danilo] Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Wildlife Res Unit, Naples, Italy; [Cistrone, Luca] Forestry & Conservat, Cassino, Italy; [Migliozzi, Antonello] Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Naples, Italy; [Allegrini, Claudia; Ancillotto, Leonardo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Russo, Danilo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Naples Federico II; University of Naples Federico II; Sapienza University Rome; University of Bristol	Russo, D (corresponding author), Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Wildlife Res Unit, Naples, Italy.	danrusso@unina.it		Migliozzi, Antonello/0000-0001-9799-2939; Russo, Danilo/0000-0002-1934-7130				AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Almenar David, 2009, Endangered Species Research, V8, P69, DOI 10.3354/esr00183; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Altringham JD, 1997, BIOL CONSERVATION DA; Altringham John D., 2005, P280; Ancillotto L, 2014, NATURWISSENSCHAFTEN, V101, P221, DOI 10.1007/s00114-014-1146-6; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; Anthony E. L. P., 1988, ECOLOGICAL BEHAV MET, P1; August TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112225; Becker NI, 2013, PHYSIOL BIOCHEM ZOOL, V86, P361, DOI 10.1086/670527; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Delettre YR, 2000, FRESHWATER BIOL, V44, P399, DOI 10.1046/j.1365-2427.2000.00578.x; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Dietz M, 2006, ACTA CHIROPTEROL, V8, P403, DOI 10.3161/1733-5329(2006)8[403:SSDPOF]2.0.CO;2; Dietz M, 2011, FOLIA ZOOL, V60, P5; Encarnacao JA, 2010, CAN J ZOOL, V88, P1192, DOI 10.1139/Z10-085; Encarnacao JA, 2005, MAMMAL REV, V35, P285, DOI 10.1111/j.1365-2907.2005.00066.x; Encarnacao JA, 2004, MAMMALIA, V68, P291, DOI 10.1515/mamm.2004.028; Encarnacao JA, 2012, J THERM BIOL, V37, P564, DOI 10.1016/j.jtherbio.2012.07.002; Encarnacao JA, 2012, CONSERV GENET, V13, P1433, DOI 10.1007/s10592-012-0375-5; Encarnacao JA, 2012, J ETHOL, V30, P271, DOI 10.1007/s10164-011-0323-8; Erickson JL, 2003, NORTHWEST SCI, V77, P126; GEIST V, 1978, Z SAUGETIERKD, V43, P223; Griffin DR, 1958, LISTENING DARK; Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; Holland RA, 2007, BEHAVIOUR, V144, P1053, DOI 10.1163/156853907781871842; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; Kriner E, 2014, MAMM BIOL, DOI [DOI 10.1016/J.MAMBI0.2014.10.005, 10.1016/j.mambio.2014.10.005]; Kunz T.H., 1988, P191; Leuzinger Yves, 1994, Mitteilungen der Naturforschenden Gesellschaft Schaffhausen, V39, P135; Lintott PR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140200; McGuire LP, 2013, BIOL REV, V88, P767, DOI 10.1111/brv.12024; Park KJ, 1999, J ZOOL, V248, P419; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Parsons KN, 2003, ANIM CONSERV, V6, P283, DOI 10.1017/S1367943003003342; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Racey P.A., 1988, P31; RAE JG, 1989, OHIO J SCI, V89, P5; Rebelo Hugo, 2009, Endangered Species Research, V8, P61, DOI 10.3354/esr00100; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Russo D, 2002, MAMMALIA, V66, P543, DOI 10.1515/mamm.2002.66.4.543; Russo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048144; Russo D, 2011, MAMM BIOL, V76, P701, DOI 10.1016/j.mambio.2010.11.007; Rydell J, 1999, FUNCT ECOL, V13, P247, DOI 10.1046/j.1365-2435.1999.00304.x; SAETHER O A, 1979, Holarctic Ecology, V2, P65; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Suba J, 2011, HYSTRIX, V22, P179, DOI 10.4404/Hystrix-22.1-4516; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; Turbill C, 2006, J COMP PHYSIOL B, V176, P165, DOI 10.1007/s00360-005-0038-7; Turbill C, 2003, PHYSIOL BIOCHEM ZOOL, V76, P868, DOI 10.1086/378915; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Venturi F, 1982, ENCICLOPEDIA SCI ZOO, V2, P101; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Walker IR, 2006, QUATERNARY SCI REV, V25, P1911, DOI 10.1016/j.quascirev.2006.01.014; Wang L.C.H., 1989, Advances in Comparative and Environmental Physiology, V4, P361; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; White G.C., 1990, ANAL WILDLIFE RADIO; Willis C., 2006, FUNCTIONAL EVOLUTION, P38; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Willis CKR, 2005, CAN J ZOOL, V83, P871, DOI 10.1139/Z05-074; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y; Zabala J, 2007, ANN ZOOL FENN, V44, P249	73	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134573	10.1371/journal.pone.0134573	http://dx.doi.org/10.1371/journal.pone.0134573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230548	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400136
J	Udomsinprasert, W; Poovorawan, Y; Chongsrisawat, V; Vejchapipat, P; Zhan, D; Honsawek, S				Udomsinprasert, Wanvisa; Poovorawan, Yong; Chongsrisawat, Voranush; Vejchapipat, Paisarn; Zhan, Dong; Honsawek, Sittisak			Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia	PLOS ONE			English	Article							LIVER-DISEASES; AGE; POLYMORPHISM; INSTABILITY; CIRRHOSIS; BIOLOGY; CELLS	Objective The purpose of this study was to investigate the association of telomere length in peripheral blood leukocytes with the severity of biliary atresia (BA). Methods One hundred and fourteen BA patients and 114 age-matched healthy controls were enrolled. Relative telomere length (RTL) was assessed using a quantitative real-time polymerase chain reaction. Multivariate regression analysis was used to estimate RTL as an independent risk factor of BA. Receiver operating characteristic curve analysis was used to calculate the accuracy of biomarkers in the prediction of liver cirrhosis. Results BA patients had significantly shorter telomeres than healthy controls (p < 0.0001). The RTL in BA patients with jaundice was considerably lower than that of patients without jaundice (p = 0.005). Moreover, RTL was markedly shorter in patients with cirrhosis (F4), as compared to patients with mild fibrosis (F2) and non-fibrosis (F0-F1, p < 0.0001). Logistic regression analysis indicated that short RTL was associated with a higher risk of liver cirrhosis in BA. Tertile analysis showed a dose-response effect for this association (p trend < 0.0001). Additionally, RTL in BA children revealed a negative correlation with age (r = -0.50, p < 0.001). We noted an association between reduction of RTL and liver stiffness scores, adjusted for age and gender (b = -0.01, p < 0.0001). Short RTL can be employed to distinguish cirrhosis patients from non-cirrhosis patients (AUC = 0.78). Further analysis showed a linear correlation between leukocyte RTL and liver RTL in BA patients (r = 0.83, p < 0.001). Conclusion The findings of this study provide evidence that telomere shortening is associated with an elevated risk of liver cirrhosis in BA.	[Udomsinprasert, Wanvisa; Honsawek, Sittisak] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Biochem,Fac Med, Bangkok 10330, Thailand; [Poovorawan, Yong; Chongsrisawat, Voranush] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Ctr Excellence Clin Virol,Dept Pediat,Fac Med, Bangkok 10330, Thailand; [Vejchapipat, Paisarn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Surg,Fac Med, Bangkok 10330, Thailand	Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Thai Red Cross Society	Honsawek, S (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Biochem,Fac Med, Bangkok 10330, Thailand.	Sittisak.H@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; Udomsinprasert, Wanvisa/0000-0002-1132-7442	Thailand Research Fund [RSA5880019]; 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship	Thailand Research Fund(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship	This research has been supported by grants from the Thailand Research Fund (RSA5880019) and the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship to WU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Boardman LA, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; De Meyer T, 2008, FRONT BIOSCI-LANDMRK, V13, P2960, DOI 10.2741/2901; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Honsawek S, 2013, CLIN BIOCHEM, V46, P214, DOI 10.1016/j.clinbiochem.2012.11.013; Invernizzi P, 2014, DIGEST LIVER DIS, V46, P363, DOI 10.1016/j.dld.2013.11.008; Kaewkiattiyot S, 2011, HEPATOL RES, V41, P1249, DOI 10.1111/j.1872-034X.2011.00870.x; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; Sasaki H, 2014, PEDIATR SURG INT, V30, P871, DOI 10.1007/s00383-014-3552-4; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Udomsinprasert W, 2012, WORLD J PEDIATR, V8, P328, DOI 10.1007/s12519-012-0377-x; Urabe Y, 1996, LIVER, V16, P293; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134689	10.1371/journal.pone.0134689	http://dx.doi.org/10.1371/journal.pone.0134689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230851	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400150
J	Bedore, J; Martyn, AC; Li, AKC; Dolinar, EA; McDonald, IS; Coupland, SG; Prado, VF; Prado, MA; Hill, KA				Bedore, Jake; Martyn, Amanda C.; Li, Anson K. C.; Dolinar, Eric A.; McDonald, Ian S.; Coupland, Stuart G.; Prado, Vania F.; Prado, Marco A.; Hill, Kathleen A.			Whole-Retina Reduced Electrophysiological Activity in Mice Bearing Retina-Specific Deletion of Vesicular Acetylcholine Transporter	PLOS ONE			English	Article							AFFINITY CHOLINE TRANSPORTER; RETINOTOPIC MAP REFINEMENT; OSCILLATORY POTENTIALS; NEUROTRANSMITTER REGULATION; LEADING-EDGE; INNER RETINA; SILICONE OIL; ALPHA-WAVE; B-WAVE; A-WAVE	Background Despite rigorous characterization of the role of acetylcholine in retinal development, long-term effects of its absence as a neurotransmitter are unknown. One of the unanswered questions is how acetylcholine contributes to the functional capacity of mature retinal circuits. The current study investigates the effects of disrupting cholinergic signalling in mice, through deletion of vesicular acetylcholine transporter (VAChT) in the developing retina, pigmented epithelium, optic nerve and optic stalk, on electrophysiology and structure of the mature retina. Methods & Results A combination of electroretinography, optical coherence tomography imaging and histological evaluation assessed retinal integrity in mice bearing retina-targeted (embryonic day 12.5) deletion of VAChT (VAChT(Six3-Cre-flox/flox)) and littermate controls at 5 and 12 months of age. VAChT(Six3-Cre-flox/flox) mice did not show any gross changes in nuclear layer cellularity or synaptic layer thickness. However, VAChT(Six3-Cre-flox/flox) mice showed reduced electrophysiological response of the retina to light stimulus under scotopic conditions at 5 and 12 months of age, including reduced a-wave, b-wave, and oscillatory potential (OP) amplitudes and decreased OP peak power and total energy. Reduced a-wave amplitude was proportional to the reduction in b-wave amplitude and not associated with altered a-wave 10%-90% rise time or inner and outer segment thicknesses. Significance This study used a novel genetic model in the first examination of function and structure of the mature mouse retina with disruption of cholinergic signalling. Reduced amplitude across the electroretinogram wave form does not suggest dysfunction in specific retinal cell types and could reflect underlying changes in the retinal and/or extraretinal microenvironment. Our findings suggest that release of acetylcholine by VAChT is essential for the normal electrophysiological response of the mature mouse retina.	[Bedore, Jake; Li, Anson K. C.; Dolinar, Eric A.; McDonald, Ian S.; Hill, Kathleen A.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Martyn, Amanda C.; Prado, Vania F.; Prado, Marco A.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Mol Med, London, ON N6A 5B7, Canada; [Coupland, Stuart G.] Univ Ottawa, Ottawa Eye Inst, Ophthalmol Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute	Hill, KA (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	khill22@uwo.ca	Bedore, Jake/E-8011-2015; Prado, Marco Antonio Maximo/K-7638-2013; Prado, Vania Ferreira/K-7630-2013	Bedore, Jake/0000-0003-2152-6792; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Prado, Vania Ferreira/0000-0003-4994-6393; Hill, Kathleen/0000-0002-7788-5105	National Sciences and Engineering Research Council [R3511A12, NSERC402524-2013 RGPIN]; Canadian Institutes of Health Research [MOP-126000, MOP-89910]; Canadian Foundation for Innovation [X3551A11]; Plunkett Foundation	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Plunkett Foundation	This work was supported by the following funding sources: National Sciences and Engineering Research Council (grants R3511A12 to KAH and NSERC402524-2013 RGPIN to VFP) as well as the Canadian Institutes of Health Research (MOP-126000 to MAP; MOP-89910 to VFP, Canadian Foundation for Innovation (grant X3551A11 to KAH) and Plunkett Foundation (to KAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSERC website: www.nserc-crsng.gc.ca/index_eng.asp, CIHR website: http://www.cihr-irsc.gc.ca/e/193.html, (CFI) website: http://www.innovation.ca/, Plunkett Foundation website: http://www.fleetwoodcountrycruizein.com/plunkett_foundation/ plunkett_foundation.html.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bytyqi AH, 2004, EUR J NEUROSCI, V20, P2953, DOI 10.1111/j.1460-9568.2004.03753.x; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Erickson JD, 2000, FASEB J, V14, P2450, DOI 10.1096/fj.00-0206rev; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; HOOD DC, 1993, VISION RES, V33, P1605, DOI 10.1016/0042-6989(93)90027-T; HOOD DC, 1993, VISUAL NEUROSCI, V10, P857, DOI 10.1017/S0952523800006076; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Koulen P, 1997, NEUROREPORT, V8, P2845, DOI 10.1097/00001756-199709080-00008; Laliberte AM, 2011, EXP EYE RES, V93, P833, DOI 10.1016/j.exer.2011.09.017; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEREDITH TA, 1985, BRIT J OPHTHALMOL, V69, P254, DOI 10.1136/bjo.69.4.254; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Pardue MT, 2014, DOC OPHTHALMOL, V128, P77, DOI 10.1007/s10633-013-9424-8; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Robson JG, 2014, PROG RETIN EYE RES, V39, P1, DOI 10.1016/j.preteyeres.2013.12.003; Shatz CJ, 1996, J PHYSIOLOGY-PARIS, V90, P141, DOI 10.1016/S0928-4257(97)81413-1; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; THALER A, 1986, DOC OPHTHALMOL, V62, P41, DOI 10.1007/BF00140545; Tsui E, 2011, INVEST OPHTH VIS SCI, V52, P3539, DOI 10.1167/iovs.10-6399; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; VANDERTORREN K, 1988, DOC OPHTHALMOL, V69, P153, DOI 10.1007/BF00153696; VANNORREN D, 1979, VISION RES, V19, P1433, DOI 10.1016/0042-6989(79)90219-0; Vistamehr S, 2004, VISUAL NEUROSCI, V21, P23, DOI 10.1017/S0952523804041033; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; WONG ROL, 1995, J NEUROSCI, V15, P2696; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Xu HP, 2015, DEV NEUROBIOL, V75, P621, DOI 10.1002/dneu.22288; Yamada ES, 2003, J COMP NEUROL, V461, P76, DOI 10.1002/cne.10672	63	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133989	10.1371/journal.pone.0133989	http://dx.doi.org/10.1371/journal.pone.0133989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226617	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700047
J	Genc, B; Lagrimas, AKB; Kuru, P; Hess, R; Tu, MW; Menichella, DM; Miller, RJ; Paller, AS; Oezdinler, PH				Genc, Baris; Lagrimas, Amiko Krisa Bunag; Kuru, Pinar; Hess, Robert; Tu, Michael William; Menichella, Daniela Maria; Miller, Richard J.; Paller, Amy S.; Oezdinler, P. Hande			Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-PRODUCT 9.5; SMALL-FIBER NEUROPATHY; PERIPHERAL-NERVE REGENERATION; CARBOXYL-TERMINAL HYDROLASE; TRANSGENIC MICE; CUTANEOUS INNERVATION; MYSTACIAL PAD; MOUSE MODEL; IN-VIVO	Visualization of peripheral nervous system axons and cell bodies is important to understand their development, target recognition, and integration into complex circuitries. Numerous studies have used protein gene product (PGP) 9.5 [a.k.a. ubiquitin carboxy-terminal hydrolase L1 (UCHL1)] expression as a marker to label sensory neurons and their axons. Enhanced green fluorescent protein (eGFP) expression, under the control of UCHL1 promoter, is stable and long lasting in the UCHL1-eGFP reporter line. In addition to the genetic labeling of corticospinal motor neurons in the motor cortex and degeneration-resistant spinal motor neurons in the spinal cord, here we report that neurons of the peripheral nervous system are also fluorescently labeled in the UCHL1-eGFP reporter line. eGFP expression is turned on at embryonic ages and lasts through adulthood, allowing detailed studies of cell bodies, axons and target innervation patterns of all sensory neurons in vivo. In addition, visualization of both the sensory and the motor neurons in the same animal offers many advantages. In this report, we used UCHL1-eGFP reporter line in two different disease paradigms: diabetes and motor neuron disease. eGFP expression in sensory axons helped determine changes in epidermal nerve fiber density in a high-fat diet induced diabetes model. Our findings corroborate previous studies, and suggest that more than five months is required for significant skin denervation. Crossing UCHL1-eGFP with hSOD1(G93A) mice generated hSOD1(G93A)-UeGFP reporter line of amyotrophic lateral sclerosis, and revealed sensory nervous system defects, especially towards disease end-stage. Our studies not only emphasize the complexity of the disease in ALS, but also reveal that UCHL1-eGFP reporter line would be a valuable tool to visualize and study various aspects of sensory nervous system development and degeneration in the context of numerous diseases.	[Genc, Baris; Lagrimas, Amiko Krisa Bunag; Kuru, Pinar; Hess, Robert; Tu, Michael William; Menichella, Daniela Maria; Oezdinler, P. Hande] Northwestern Univ, Davee Dept Neurol & Clin Neurol Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Miller, Richard J.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Miller, Richard J.; Paller, Amy S.; Oezdinler, P. Hande] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Skin Dis Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Oezdinler, P. Hande] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Oezdinler, PH (corresponding author), Northwestern Univ, Davee Dept Neurol & Clin Neurol Sci, Feinberg Sch Med, Chicago, IL 60611 USA.	ozdinler@northwestern.edu	Bektaşoğlu, Pınar Kuru/K-8612-2013	Bektaşoğlu, Pınar Kuru/0000-0001-9889-9955; Paller, Amy/0000-0001-6187-6549	Les Turner ALS Foundation; Wenske Foundation; National Institute of Health [RO1NS085161-01, R21NS085750]; National Institute of Health Mechanisms of Aging and Dementia training grant [5T32AG020506-09]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085750, R01NS085161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	Les Turner ALS Foundation; Wenske Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Mechanisms of Aging and Dementia training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by grants from Les Turner ALS Foundation (PHO), Wenske Foundation (PHO), National Institute of Health RO1NS085161-01 and R21NS085750 (PHO), and National Institute of Health Mechanisms of Aging and Dementia training grant 5T32AG020506-09 (BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bannerman PG, 2007, J NEUROL SCI, V260, P23, DOI 10.1016/j.jns.2007.03.020; BRADLEY WG, 1983, ANN NEUROL, V14, P267, DOI 10.1002/ana.410140304; CALZADA B, 1994, ANN ANAT, V176, P437, DOI 10.1016/S0940-9602(11)80473-5; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Dacci P, 2010, GLIA, V58, P2005, DOI 10.1002/glia.21069; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2005, NEUROBIOL DIS, V19, P293, DOI 10.1016/j.nbd.2005.01.008; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo YS, 2009, EXP MOL MED, V41, P140, DOI 10.3858/emm.2009.41.3.017; Hammad M, 2007, NEUROLOGY, V69, P2236, DOI 10.1212/01.wnl.0000286948.99150.16; HEADS T, 1991, ACTA NEUROPATHOL, V82, P316, DOI 10.1007/BF00308818; Hsieh ST, 2000, J NEUROPATH EXP NEUR, V59, P297, DOI 10.1093/jnen/59.4.297; Isaacs JD, 2007, J NEUROL NEUROSUR PS, V78, P750, DOI 10.1136/jnnp.2006.098798; Jackman A, 2000, J COMP NEUROL, V418, P281; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; KARANTH SS, 1991, AM J ANAT, V191, P369, DOI 10.1002/aja.1001910404; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; Kent C, 1991, Brain Res Dev Brain Res, V58, P147; Kon Y, 1999, MOL REPROD DEV, V54, P333, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;333::AID-MRD3&gt;3.0.CO;2-8; KRAMMER HJ, 1993, ANN ANAT, V175, P321, DOI 10.1016/S0940-9602(11)80029-4; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Luigetti M, 2012, NEUROL SCI, V33, P1095, DOI 10.1007/s10072-011-0909-5; McLenachan S, 2008, TRANSGENIC RES, V17, P1103, DOI 10.1007/s11248-008-9210-7; Mellgren SI, 2013, HAND CLINIC, V115, P171, DOI 10.1016/B978-0-444-52902-2.00010-2; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pan CL, 2001, NEUROREPORT, V12, P787, DOI 10.1097/00001756-200103260-00034; Pan YA, 2003, J NEUROSCI, V23, P11479; Phillips RJ, 2004, J NEUROSCI METH, V133, P99, DOI 10.1016/j.jneumeth.2003.10.004; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; PROPERZI G, 1993, J PATHOL, V169, P269, DOI 10.1002/path.1711690215; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; RICE FL, 1993, J COMP NEUROL, V337, P366, DOI 10.1002/cne.903370303; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sidebotham EL, 2001, PEDIATR SURG INT, V17, P304, DOI 10.1007/s003830100599; Stucky CL, 1999, J NEUROSCI, V19, P6497; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; TOHGI H, 1977, ACTA NEUROPATHOL, V38, P95, DOI 10.1007/BF00688554; Truini A, 2015, J NEUROL, V262, P1014, DOI 10.1007/s00415-015-7672-0; Verdu E, 1997, EXP NEUROL, V146, P187, DOI 10.1006/exnr.1997.6517; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Wang XQ, 2014, J INVEST DERMATOL, V134, P1446, DOI 10.1038/jid.2013.532; Webb CM, 2012, VET PATHOL, V49, P727, DOI 10.1177/0300985811414033; Weis J, 2011, NEUROLOGY, V76, P2024, DOI 10.1212/WNL.0b013e31821e553a; Wiese CB, 2013, GENESIS, V51, P852, DOI 10.1002/dvg.22716; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Xu LL, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/305205; Yan Y, 2011, EXP NEUROL, V232, P7, DOI 10.1016/j.expneurol.2011.06.013; Yasvoina MV, 2013, J NEUROSCI, V33, P7890, DOI 10.1523/JNEUROSCI.2787-12.2013	65	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132815	10.1371/journal.pone.0132815	http://dx.doi.org/10.1371/journal.pone.0132815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222784	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800030
J	Yu, L; Yan, XM; Ye, CL; Zhao, HY; Chen, XY; Hu, F; Li, HX				Yu, Li; Yan, Xiaomei; Ye, Chenglong; Zhao, Haiyan; Chen, Xiaoyun; Hu, Feng; Li, Huixin			Bacterial Respiration and Growth Rates Affect the Feeding Preferences, Brood Size and Lifespan of Caenorhabditis elegans	PLOS ONE			English	Article							CARBON-DIOXIDE AVOIDANCE; COMMUNITY STRUCTURE; SOIL NEMATODES; BEHAVIOR; REPRODUCTION; EXTENSION; CEPHALOBIDAE; RESPONSES; SIGNALS; FOOD	Bacteria serve as live food and nutrients for bacterial-feeding nematodes (BFNs) in soils, and influence nematodes behavior and physiology through their metabolism. Five bacterial taxa (Bacillus amyloliquefaciens JX1, Variovorax sp. JX14, Bacillus megaterium JX15, Pseudomonas fluorescens Y1 and Escherichia coli OP50) and the typical BFN Caenorhabditis elegans were selected to study the effects of bacterial respiration and growth rates on the feeding preferences, brood size and lifespan of nematodes. P. fluorescens Y1 and E. coli OP50 were found to be more active, with high respiration and rapid growth, whereas B. amyloliquefaciens JX1 and B. megaterium JX15 were inactive. The nematode C. elegans preferred active P. fluorescens Y1 and E. coli OP50 obviously. Furthermore, worms that fed on these two active bacteria produced more offspring but had shorter lifespan, while inactive and less preferred bacteria had increased nematodes lifespan and decreased the brood size. Based on these results, we propose that the bacterial activity may influence the behavior and life traits of C. elegans in the following ways: (1) active bacteria reproduce rapidly and emit high levels of CO2 attracting C. elegans; (2) these active bacteria use more resources in the nematodes' gut to sustain their survival and reproduction, thereby reducing the worm's lifespan; (3) inactive bacteria may provide less food for worms than active bacteria, thus increasing nematodes lifespan but decreasing their fertility. Nematodes generally require a balance between their preferred foods and beneficial foods, only preferred food may not be beneficial for nematodes.	[Yu, Li; Yan, Xiaomei; Ye, Chenglong; Chen, Xiaoyun; Hu, Feng; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China; [Zhao, Haiyan] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China.	huixinli@njau.edu.cn	Li, huixin/H-5573-2011		National Natural Science Foundation of China [41271270]; Foundation of Graduate Creative Program of Jiangsu Province [CXLX13 277]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Graduate Creative Program of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (Grant No. 41271270), the Foundation of Graduate Creative Program of Jiangsu Province (Grant No. CXLX13 277) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Bjornlund L, 2006, BIOL FERT SOILS, V43, P1, DOI 10.1007/s00374-005-0052-7; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bonkowski M, 2000, APPL SOIL ECOL, V14, P37, DOI 10.1016/S0929-1393(99)00047-5; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; Djigal D, 2004, PLANT SOIL, V262, P33, DOI 10.1023/B:PLSO.0000037022.16822.75; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Gallagher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059865; Garigan D, 2002, GENETICS, V161, P1101; Gomez F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-300; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Li HuiXin, 2001, Pedosphere, V11, P57; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Newsham KK, 2004, EUR J SOIL BIOL, V40, P1, DOI 10.1016/j.ejsobi.2004.01.004; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Rankin CH, 2006, CURR BIOL, V16, pR89, DOI 10.1016/j.cub.2006.01.025; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Salinas KA, 2007, PEDOBIOLOGIA, V51, P55, DOI 10.1016/j.pedobi.2006.12.003; Schlotz N, 2014, FEMS MICROBIOL ECOL, V90, P467, DOI 10.1111/1574-6941.12407; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Smith EM, 2003, AQUAT MICROB ECOL, V30, P251, DOI 10.3354/ame030251; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tan K, 2014, BEHAV ECOL SOCIOBIOL, V68, P13, DOI 10.1007/s00265-013-1617-3; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; Venette RC, 1998, SOIL BIOL BIOCHEM, V30, P949, DOI 10.1016/S0038-0717(97)00176-4; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	54	23	25	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134401	10.1371/journal.pone.0134401	http://dx.doi.org/10.1371/journal.pone.0134401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222828	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800140
J	Wu, XZ; Gowda, NM; Gowda, DC				Wu, Xianzhu; Gowda, Nagaraj M.; Gowda, D. Channe			Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM; PARASITES; ALPHA; DNA; ERYTHROCYTES; PHAGOCYTOSIS; GENERATION; EXPRESSION; HEMOZOIN; VACCINE	Inflammatory cytokines produced at the early stages of malaria infection contribute to shaping protective immunity and pathophysiology. To gain mechanistic insight into these processes, it is important to understand the cellular origin of cytokines because both cytokine input and cytokine-producing cells play key roles. Here, we determined cytokine responses by monocytes, macrophages, and dendritic cells (DCs) to purified Plasmodium falciparum and Plasmodium berghei ANKA, and by spleen macrophages and DCs from Plasmodium yoelii 17NXL-infected and P. berghei ANKA-infected mice. The results demonstrate that monocytes and macrophages do not produce inflammatory cytokines to malaria parasites and that DCs are the primary source early in infection, and DC subsets differentially produce cytokines. Importantly, blocking of phagosomal acidification by inhibiting vacuolar-type H+-ATPase enabled macrophages to elicit cytokine responses. Because cytokine responses to malaria parasites are mediated primarily through endosomal Toll-like receptors, our data indicate that the inability of macrophages to produce cytokines is due to the phagosomal acidification that disrupts endosomal ligand-receptor engagement. Macrophages efficiently produced cytokines to LPS upon simultaneously internalizing parasites and to heat-killed Escherichia coli, demonstrating that phagosomal acidification affects endosomal receptor-mediated, but not cell surface receptor-mediated, recognition of Toll-like receptor agonists. Enabling monocytes/macrophages to elicit immune responses to parasites by blocking endosomal acidification can be a novel strategy for the effective development of protective immunity to malaria. The results have important implications for enhancing the efficacy of a whole parasite-based malaria vaccine and for designing strategies for the development of protective immunity to pathogens that induce immune responses primarily through endosomal receptors.	[Wu, Xianzhu; Gowda, Nagaraj M.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108	National Institutes of Health from NIAID [R01 AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139, R01AI104844] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI41139 from NIAID. The authors declare that they have no conflicts of interest with the contents of this article.	Antonelli LRV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004393; Baccarella A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-354; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; DENT G, 1994, AM J RESP CELL MOL, V10, P565, DOI 10.1165/ajrcmb.10.5.8179921; Doxsee CL, 2003, J IMMUNOL, V171, P1156, DOI 10.4049/jimmunol.171.3.1156; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Good MF, 2011, TRENDS PARASITOL, V27, P335, DOI 10.1016/j.pt.2011.03.003; Gowda NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077604; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Haque A, 2014, J CLIN INVEST, V124, P2483, DOI 10.1172/JCI70698; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Marwick JA, 2008, BIOCHEM BIOPH RES CO, V377, P797, DOI 10.1016/j.bbrc.2008.10.065; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stout-Delgado HW, 2007, J IMMUNOL, V179, P6561, DOI 10.4049/jimmunol.179.10.6561; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Targett GAT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-362; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urban BC, 2005, CURR TOP MICROBIOL, V297, P25; Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	53	17	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23135	23147		10.1074/jbc.M115.671065	http://dx.doi.org/10.1074/jbc.M115.671065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240140	Green Published, hybrid			2022-12-26	WOS:000361685500025
J	Lin, YF; Chen, G; Fu, Z; Ma, L; Li, WR				Lin, Yifan; Chen, Gui; Fu, Zhen; Ma, Lian; Li, Weiran			Cone-Beam Computed Tomography Assessment of Lower Facial Asymmetry in Unilateral Cleft Lip and Palate and Non-Cleft Patients with Class III Skeletal Relationship	PLOS ONE			English	Article							TEMPOROMANDIBULAR-JOINT; MANDIBULAR ASYMMETRY; CRANIOFACIAL MORPHOLOGY; CEPHALOMETRIC RADIOGRAPHY; CONDYLAR POSITION; NORMAL OCCLUSION; DIVISION 1; INDIVIDUALS; ACCURACY; CHILDREN	Introduction To evaluate, using cone-beam computed tomography (CBCT), both the condylar-fossa relationships and the mandibular and condylar asymmetries between unilateral cleft lip and palate (UCLP) patients and non-cleft patients with class III skeletal relationship, and to investigate the factors of asymmetry contributing to chin deviation. Methods The UCLP and non-cleft groups consisted of 30 and 40 subjects, respectively, in mixed dentition with class III skeletal relationships. Condylar-fossa relationships and the dimensional and positional asymmetries of the condyles and mandibles were examined using CBCT. Intra-group differences were compared between two sides in both groups using a paired t-test. Furthermore, correlations between each measurement and chin deviation were assessed. Results It was observed that 90% of UCLP and 67.5% of non-cleft subjects had both condyles centered, and no significant asymmetry was found. The axial angle and the condylar center distances to the midsagittal plane were significantly greater on the cleft side than on the non-cleft side (P=0.001 and P=0.028, respectively) and were positively correlated with chin deviation in the UCLP group. Except for a larger gonial angle on the cleft side, the two groups presented with consistent asymmetries showing shorter mandibular bodies and total mandibular lengths on the cleft (deviated) side. The average chin deviation was 1.63 mm to the cleft side, and the average absolute chin deviation was significantly greater in the UCLP group than in the non-cleft group (P=0.037). Conclusion Compared with non-cleft subjects with similar class III skeletal relationships, the subjects with UCLP showed more severe lower facial asymmetry. The subjects with UCLP presented with more asymmetrical positions and rotations of the condyles on axial slices, which were positively correlated with chin deviation.	[Lin, Yifan; Chen, Gui; Fu, Zhen; Li, Weiran] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Ma, Lian] Peking Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Surg, Beijing 100871, Peoples R China	Peking University; Peking University	Li, WR (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	weiranli2003@163.com	Li, weiran/R-6769-2019	Lin, Yifan/0000-0002-2614-9159				Abad-Santamaria L, 2014, IRISH J MED SCI, V183, P357, DOI 10.1007/s11845-013-1020-0; Baccetti T., 2005, SEMIN ORTHOD, V11, P119, DOI DOI 10.1053/J.S0D0.2005.04.005; BERGERSEN EO, 1980, ANGLE ORTHOD, V50, P230; BISHARA SE, 1974, INT J ORAL MAXILLOF, V3, P65, DOI 10.1016/S0300-9785(74)80081-5; Celikoglu M, 2013, AM J ORTHOD DENTOFAC, V144, P691, DOI 10.1016/j.ajodo.2013.07.009; Choi YK, 2013, KOREAN J ORTHOD, V43, P113, DOI 10.4041/kjod.2013.43.3.113; Dahlberg G, 1940, STAT METHODS MED BIO; Damstra J, 2012, CLIN ORAL INVEST, V16, P285, DOI 10.1007/s00784-011-0512-4; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Dogan S, 2006, BRIT J ORAL MAX SURG, V44, P28, DOI 10.1016/j.bjoms.2005.07.023; Vitral RWF, 2011, AM J ORTHOD DENTOFAC, V140, P18, DOI 10.1016/j.ajodo.2009.07.030; Fraga MR, 2013, MED SCI MONITOR, V19, P903, DOI 10.12659/MSM.889528; Haraguchi S, 2002, ANGLE ORTHOD, V72, P28; Hassan B, 2009, EUR J ORTHODONT, V31, P129, DOI 10.1093/ejo/cjn088; Hilgers ML, 2005, AM J ORTHOD DENTOFAC, V128, P803, DOI 10.1016/j.ajodo.2005.08.034; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Hwang HS, 2006, AM J ORTHOD DENTOFAC, V130, P779, DOI 10.1016/j.ajodo.2005.02.021; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; Jena AK, 2011, ANGLE ORTHOD, V81, P872, DOI 10.2319/110610-646.1; Kamelchuk LS, 1996, CRANIO, V14, P23, DOI 10.1080/08869634.1996.11745945; Kim KS, 2013, KOREAN J ORTHOD, V43, P168, DOI 10.4041/kjod.2013.43.4.168; Kokich VG, 2010, AM J ORTHOD DENTOFAC, V137, pS16, DOI 10.1016/j.ajodo.2010.02.014; Kurt G, 2010, EUR J ORTHODONT, V32, P19, DOI 10.1093/ejo/cjp063; Kwon TG, 2006, INT J ORAL MAX SURG, V35, P43, DOI 10.1016/j.ijom.2005.04.006; Kyrkanides S, 2000, CLEFT PALATE-CRAN J, V37, P556, DOI 10.1597/1545-1569(2000)037<0556:CBAFSA>2.0.CO;2; KYRKANIDES S, 1995, CLEFT PALATE-CRAN J, V32, P428, DOI 10.1597/1545-1569(1995)032<0428:SAOTNC>2.3.CO;2; Lagravere MO, 2008, AM J ORTHOD DENTOFAC, V134, P112, DOI 10.1016/j.ajodo.2006.08.024; Laspos CP, 1997, CLEFT PALATE-CRAN J, V34, P410, DOI 10.1597/1545-1569(1997)034<0410:MAINAU>2.3.CO;2; Laspos CP, 1997, CLEFT PALATE-CRAN J, V34, P232, DOI 10.1597/1545-1569(1997)034<0232:MAMAII>2.3.CO;2; MARS M, 1992, CLEFT PALATE-CRAN J, V29, P405, DOI 10.1597/1545-1569(1992)029<0405:ASCISO>2.3.CO;2; Michiels G, 1994, Int J Adult Orthodon Orthognath Surg, V9, P95; MOLSTED K, 1990, CLEFT PALATE J, V27, P184, DOI 10.1597/1545-1569(1990)027<0184:AOTMIC>2.3.CO;2; Ozturk Y, 1996, CLEFT PALATE-CRAN J, V33, P32, DOI 10.1597/1545-1569_1996_033_0032_eocmic_2.3.co_2; PIRTTINIEMI PM, 1994, AM J ORTHOD DENTOFAC, V106, P191, DOI 10.1016/S0889-5406(94)70038-9; PULLINGER A, 1986, ORAL SURG ORAL MED O, V62, P719, DOI 10.1016/0030-4220(86)90270-7; Rodrigues AF, 2009, AM J ORTHOD DENTOFAC, V136, P199, DOI 10.1016/j.ajodo.2007.07.033; Ross R B, 1987, Cleft Palate J, V24, P5; Ross RB, 1987, CLEFT PALATE J, V24, P24; Ross RB, 1987, CLEFT PALATE J, V24, P71; Severt T R, 1997, Int J Adult Orthodon Orthognath Surg, V12, P171; Shetye PR, 2006, ANGLE ORTHOD, V76, P810, DOI 10.2319/032505-121; SMAHEL Z, 1986, CLEFT PALATE J, V23, P225; Smahel Z, 1998, CLEFT PALATE-CRAN J, V35, P240, DOI 10.1597/1545-1569(1998)035<0240:CICDDT>2.3.CO;2; Sukovic P, 2003, Orthod Craniofac Res, V6 Suppl 1, P31, DOI 10.1034/j.1600-0544.2003.259.x; Suri S, 2008, AM J ORTHOD DENTOFAC, V134, P418, DOI 10.1016/j.ajodo.2006.09.065; Trpkova B, 2003, AM J ORTHOD DENTOFAC, V123, P512, DOI 10.1016/S0889-5406(02)57034-7; Veli I, 2011, KOREAN J ORTHOD, V41, P431, DOI 10.4041/kjod.2011.41.6.431; Vitral RWF, 2002, AM J ORTHOD DENTOFAC, V121, P369, DOI 10.1067/mod.2002.121664	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0130235	10.1371/journal.pone.0130235	http://dx.doi.org/10.1371/journal.pone.0130235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237311	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400005
J	Odhiambo, JA; Norton, U; Ashilenje, D; Omondi, EC; Norton, JB				Odhiambo, Judith A.; Norton, Urszula; Ashilenje, Dennis; Omondi, Emmanuel C.; Norton, Jay B.			Weed Dynamics during Transition to Conservation Agriculture in Western Kenya Maize Production	PLOS ONE			English	Article							SMALLHOLDER FARMERS; TILLAGE; YIELD; MANAGEMENT; ADOPTION; ECOLOGY; GROWTH; CROP	Weed competition is a significant problem in maize (Zea mays, L.) production in Sub-Saharan Africa. Better understanding of weed management and costs in maize inter-cropped with beans (Phaseolus vulgaris, L.) during transition to conservation agricultural systems is needed. Changes in weed population and maize growth were assessed for a period of three years at Bungoma where crops are grown twice per year and at Trans-Nzoia where crops are grown once per year. Treatments included three tillage practices: minimum (MT), no-till (NT) and conventional (CT) applied to three cropping systems: continuous maize/bean intercropping (TYPICAL), maize/bean intercropping with relayed mucuna after bean harvest (RELAY) and maize, bean and mucuna planted in a strip intercropping arrangement (STRIP). Herbicides were used in NT, shallow hand hoeing and herbicides were used in MT and deep hoeing with no herbicides were used in CT. Weed and maize performance in the maize phase of each cropping system were assessed at both locations and costs of weed control were estimated at Manor House only. Weed density of grass and forb species declined significantly under MT and NT at Manor House and of grass species only at Mabanga. The greatest declines of more than 50% were observed as early as within one year of the transition to MT and NT in STRIP and TYPICAL cropping systems at Manor House. Transitioning to conservation based systems resulted in a decline of four out of five most dominant weed species. At the same time, no negative impact of MT or NT on maize growth was observed. Corresponding costs of weed management were reduced by $148.40 ha(-1) in MT and $149.60 ha(-1) in NT compared with CT. In conclusion, farmers can benefit from effective and less expensive weed management alternatives early in the process of transitioning to reduced tillage operations.	[Odhiambo, Judith A.; Norton, Urszula] Univ Wyoming, Dept Plant Sci, Dept 3354, Laramie, WY 82071 USA; [Norton, Urszula] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Ashilenje, Dennis] Manor House Agr Ctr, Kitale 30200, Kenya; [Omondi, Emmanuel C.; Norton, Jay B.] Dept 3354, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Norton, U (corresponding author), Univ Wyoming, Dept Plant Sci, Dept 3354, 1000 E Univ Ave, Laramie, WY 82071 USA.	unorton@uwyo.edu	Norton, Urszula/AAX-6303-2021	Omondi, Emmanuel/0000-0002-3870-0809	United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP) [EPP-A-00-04-00013-00]; Schlumberger Foundation Faculty for the Future Fellowship	United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP)(United States Agency for International Development (USAID)); Schlumberger Foundation Faculty for the Future Fellowship(Schlumberger)	This research was funded by the United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP) grant number EPP-A-00-04-00013-00 and a Schlumberger Foundation Faculty for the Future Fellowship. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins S. H. M., 2012, Agriculture and Biology Journal of North America, V3, P25, DOI 10.5251/abjna.2012.3.1.25.30; Andersson JA, 2014, AGR ECOSYST ENVIRON, V187, P116, DOI 10.1016/j.agee.2013.08.008; Baudron F, 2012, J DEV STUD, V48, P393, DOI 10.1080/00220388.2011.587509; Carsky RJ, 2001, SUSTAINING SOIL FERT, V58, P111, DOI 10.2136/SSSASPECPUB58.CH6; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan BS, 2010, WEED RES, V50, P553, DOI 10.1111/j.1365-3180.2010.00807.x; Chikoye D., 2007, 16 INT PLANT PROTECT, P652; Corbeels M, 2014, AGR ECOSYST ENVIRON, V187, P155, DOI 10.1016/j.agee.2013.10.011; Dixit PN, 2011, EXP AGR, V47, P317, DOI 10.1017/S0014479710000773; Giller KE, 2011, FIELD CROP RES, V124, P468, DOI 10.1016/j.fcr.2011.04.010; Gopal R, 2010, TECHNICAL B INT MAIZ; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; HALL MR, 1992, WEED SCI, V40, P441, DOI 10.1017/S0043174500051882; Ikuenobe CE, 2003, WEED RES, V43, P199, DOI 10.1046/j.1365-3180.2003.00334.x; Islam MR, 2011, CROP PASTURE SCI, V62, P374, DOI 10.1071/CP10244; Jaetzold R, 2005, FARM MANAGEMENT HDB, V2; Jordan-Meille L, 2004, PLANT SOIL, V265, P75, DOI 10.1007/s11104-005-0695-z; Kabamba H., 2009, Journal of Animal and Plant Sciences (JAPS), V3, P205; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mandumbu R., 2012, Archives of Phytopathology and Plant Protection, V45, P2165, DOI 10.1080/03235408.2012.722842; Mashingaidze N, 2012, SOIL TILL RES, V124, P102, DOI 10.1016/j.still.2012.05.008; Mokhtarpour H., 2010, Communications in Biometry and Crop Science, V5, P19; Mugalavai EM, 2008, AGR FOREST METEOROL, V148, P1123, DOI 10.1016/j.agrformet.2008.02.013; Ndakidemi PA, 2006, AFR J BIOTECHNOL, V5, P2526; Ngome AFE, 2011, J AGR RURAL DEV TROP, V112, P1; Ngwira AR, 2013, RENEW AGR FOOD SYST, V28, P350, DOI 10.1017/S1742170512000257; Nyamangara J, 2014, AGR ECOSYST ENVIRON, V187, P146, DOI 10.1016/j.agee.2013.10.005; Odhiambo A., 2014, INT J PLANT SOIL SCI, V5, P127, DOI 10.9734/IJPSS/2015/14476; Odhiambo J. A., 2011, Archives of Phytopathology and Plant Protection, V44, P158, DOI 10.1080/03235400902952194; Pannell DJ, 2014, AGR ECOSYST ENVIRON, V187, P52, DOI 10.1016/j.agee.2013.10.014; R Core Team, 2021, R LANGUAGE ENV STAT; Riemens MM, 2007, WEED RES, V47, P442, DOI 10.1111/j.1365-3180.2007.00582.x; Rugare J.T., 2013, GLOB ADV RES J AGR S, V2, P231; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Thierfelder C, 2010, J CROP IMPROV, V24, P113, DOI 10.1080/15427520903558484; WRUCKE MA, 1985, WEED SCI, V33, P853, DOI 10.1017/S0043174500083491	37	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133976	10.1371/journal.pone.0133976	http://dx.doi.org/10.1371/journal.pone.0133976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237404	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400013
J	Choi, HJ; Song, JM; Bondy, BJ; Compans, RW; Kang, SM; Prausnitz, MR				Choi, Hyo-Jick; Song, Jae-Min; Bondy, Brian J.; Compans, Richard W.; Kang, Sang-Moo; Prausnitz, Mark R.			Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles	PLOS ONE			English	Article							ESCHERICHIA-COLI; A VIRUS; WATER PERMEABILITY; BILAYER THICKNESS; MOLECULAR-BIOLOGY; PROTEIN FUNCTION; LIPID-MEMBRANES; MATRIX PROTEIN; DELIVERY; VESICLES	Enveloped virus vaccines can be damaged by high osmotic strength solutions, such as those used to protect the vaccine antigen during drying, which contain high concentrations of sugars. We therefore studied shrinkage and activity loss of whole inactivated influenza virus in hyperosmotic solutions and used those findings to improve vaccine coating of microneedle patches for influenza vaccination. Using stopped-flow light scattering analysis, we found that the virus underwent an initial shrinkage on the order of 10% by volume within 5 s upon exposure to a hyperosmotic stress difference of 217 milliosmolarity. During this shrinkage, the virus envelope had very low osmotic water permeability (1-6x10(-4) cm s(-1)) and high Arrhenius activation energy (E-a = 15.0 kcal mol(-1)), indicating that the water molecules diffused through the viral lipid membranes. After a quasi-stable state of approximately 20 s to 2 min, depending on the species and hypertonic osmotic strength difference of disaccharides, there was a second phase of viral shrinkage. At the highest osmotic strengths, this led to an undulating light scattering profile that appeared to be related to perturbation of the viral envelope resulting in loss of virus activity, as determined by in vitro hemagglutination measurements and in vivo immunogenicity studies in mice. Addition of carboxymethyl cellulose effectively prevented vaccine activity loss in vitro and in vivo, believed to be due to increasing the viscosity of concentrated sugar solution and thereby reducing osmotic stress during coating of microneedles. These results suggest that hyperosmotic solutions can cause biphasic shrinkage of whole inactivated influenza virus which can damage vaccine activity at high osmotic strength and that addition of a viscosity enhancer to the vaccine coating solution can prevent osmotically driven damage and thereby enable preparation of stable microneedle coating formulations for vaccination.	[Choi, Hyo-Jick; Bondy, Brian J.; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Choi, Hyo-Jick] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Song, Jae-Min] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea; [Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kang, Sang-Moo] Georgia Inst Technol, Ctr Inflammat Immun, Atlanta, GA 30332 USA; [Kang, Sang-Moo] Georgia Inst Technol, Infect & Dept Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Alberta; Sungshin Women's University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Prausnitz, MR (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	prausnitz@gatech.edu		Choi, Hyo-Jick/0000-0001-8233-5864; Prausnitz, Mark/0000-0002-9076-8448	National Institutes of Health (NIH) [EB006369, EB012495, AI0680003, AI105170, AI093772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R01AI093772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012495, R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was financially supported by National Institutes of Health (NIH) grants EB006369 and EB012495 (M.R.P.) and AI0680003 (R.W.C.), and AI105170 and AI093772 (S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BARNHART ER, 1975, VIROLOGY, V66, P563, DOI 10.1016/0042-6822(75)90228-7; BAYER ME, 1967, J BACTERIOL, V93, P1104, DOI 10.1128/JB.93.3.1104-1112.1967; Biebl R, 2009, J MAR BIOL ASSOC UK, V31, P307; BITTMAN R, 1976, BIOCHIM BIOPHYS ACTA, V433, P63, DOI 10.1016/0005-2736(76)90178-4; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; CASS A, 1967, J GEN PHYSIOL, V50, P1765, DOI 10.1085/jgp.50.6.1765; Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026; Choi HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066316; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; CITOVSKY V, 1985, J BIOL CHEM, V260, P2072; COCKING EC, 1972, ANN REV PLANT PHYSIO, V23, P29, DOI 10.1146/annurev.pp.23.060172.000333; COLWELL WM, 1975, AVIAN DIS, V19, P781, DOI 10.2307/1589191; CORTESE JD, 1989, P NATL ACAD SCI USA, V86, P5773, DOI 10.1073/pnas.86.15.5773; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; CROWE LM, 1986, BIOCHIM BIOPHYS ACTA, V861, P131, DOI 10.1016/0005-2736(86)90411-6; DUWE HP, 1989, ANGEW MAKROMOL CHEM, V166, P1, DOI 10.1002/apmc.1989.051660101; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; FETTIPLACE R, 1980, PHYSIOL REV, V60, P510, DOI 10.1152/physrev.1980.60.2.510; FUJIYOSHI Y, 1994, EMBO J, V13, P318, DOI 10.1002/j.1460-2075.1994.tb06264.x; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Hackl W, 1998, PHYS REV LETT, V80, P1786, DOI 10.1103/PhysRevLett.80.1786; Helfer E, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021904; HELLEBUST JA, 1976, ANNU REV PLANT PHYS, V27, P485, DOI 10.1146/annurev.pp.27.060176.002413; HENDRY BM, 1978, BIOCHIM BIOPHYS ACTA, V513, P106, DOI 10.1016/0005-2736(78)90116-5; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Knaysi G, 1951, BACTERIAL PHYSL, P62; Kommareddy S, 2012, J PHARM SCI-US, V101, P1021, DOI 10.1002/jps.23019; Kunitz M, 1926, J GEN PHYSIOL, V9, P715, DOI 10.1085/jgp.9.6.715; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LATIMER P, 1972, BIOPHYS J, V12, P764, DOI 10.1016/S0006-3495(72)86120-4; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Lodish H, 2000, MOL CELL BIOL, V4th, P633; Loeb J, 1921, J GEN PHYSIOL, V4, P97, DOI 10.1085/jgp.4.1.97; LUCY JA, 1986, FEBS LETT, V199, P1, DOI 10.1016/0014-5793(86)81213-3; Pettis RJ, 2012, THER DELIV, V3, P357, DOI 10.4155/TDE.12.13; Powl AM, 2007, CURR TOP MEMBR, V58, P151, DOI 10.1016/S1063-5823(06)58006-8; PRITZEN C, 1988, BIOSCIENCE REP, V8, P55, DOI 10.1007/BF01128972; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Saluja V, 2010, J CONTROL RELEASE, V144, P127, DOI 10.1016/j.jconrel.2010.02.025; Scala AR, 1956, REVERSIBLE EFFECT HY, P289; SCHEIE PO, 1969, J BACTERIOL, V98, P335, DOI 10.1128/JB.98.2.335-340.1969; SCHULZE IT, 1972, VIROLOGY, V47, P181, DOI 10.1016/0042-6822(72)90251-6; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Sherman JM, 1934, J BACTERIOL, V27, P341, DOI 10.1128/JB.27.4.341-348.1934; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Stauch O, 2002, BIOMACROMOLECULES, V3, P324, DOI 10.1021/bm015613y; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; TOLSKAYA EA, 1966, VIROLOGY, V29, P613, DOI 10.1016/0042-6822(66)90285-6; Viallat A, 2004, BIOPHYS J, V86, P2179, DOI 10.1016/S0006-3495(04)74277-0; Vrdoljak A, 2012, J CONTROL RELEASE, V159, P34, DOI 10.1016/j.jconrel.2011.12.026; WAITE MRF, 1968, J VIROL, V2, P759, DOI 10.1128/JVI.2.7.759-760.1968; Wong YL, 2007, P NATL ACAD SCI USA, V104, P2591, DOI 10.1073/pnas.0611430104	72	18	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134431	10.1371/journal.pone.0134431	http://dx.doi.org/10.1371/journal.pone.0134431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230936	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400118
J	de Sousa, DL; Lima, RA; Zanin, IC; Klein, MI; Janal, MN; Duarte, S				de Sousa, Denise Lins; Lima, Ramille Araujo; Zanin, Iriana Carla; Klein, Marlise I.; Janal, Malvin N.; Duarte, Simone			Effect of Twice-Daily Blue Light Treatment on Matrix-Rich Biofilm Development	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-MUTANS; VISIBLE-LIGHT; IN-VITRO; PORPHYROMONAS-GINGIVALIS; EXOPOLYSACCHARIDE MATRIX; PHOTODYNAMIC THERAPY; HYDROGEN-PEROXIDE; SUCROSE; STARCH	Background The use of blue light has been proposed as a direct means of affecting local bacterial infections, however the use of blue light without a photosensitizer to prevent the biofilm development has not yet been explored. The aim of this study was to determine how the twice-daily treatment with blue light affects the development and composition of a matrix-rich biofilm. Methodology/Principal Findings Biofilms of Streptococcus mutans UA159 were formed on saliva-coated hydroxyapatite discs for 5 days. The biofilms were exposed twice-daily to non-coherent blue light (Luma-Care; 420 nm) without a photosensitizer. The distance between the light and the sample was 1.0 cm; energy density of 72 J cm(-2); and exposure time of 12 min 56 s. Positive and negative controls were twice-daily 0.12% chlorhexidine (CHX) and 0.89% NaCl, respectively. Biofilms were analyzed for bacterial viability, dry-weight, and extra (EPS-insoluble and soluble) and intracellular (IPS) polysaccharides. Variable pressure scanning electron microscopy and confocal scanning laser microscopy were used to check biofilm morphology and bacterial viability, respectively. When biofilms were exposed to twice-daily blue light, EPS-insoluble was reduced significantly more than in either control group (CHX and 0.89% NaCl). Bacterial viability and dry weight were also reduced relative to the negative control (0.89% NaCl) when the biofilms were treated with twice-daily blue light. Different morphology was also visible when the biofilms were treated with blue light. Conclusions Twice-daily treatment with blue light without a photosensitizer is a promising mechanism for the inhibition of matrix-rich biofilm development.	[de Sousa, Denise Lins; Lima, Ramille Araujo; Zanin, Iriana Carla] Univ Fed Ceara, Dept Dent Clin, Sch Pharm Dent & Nursing, Fortaleza, Ceara, Brazil; [Klein, Marlise I.] State Univ Sao Paulo, Dept Biomat, Araraquara, SP, Brazil; [Janal, Malvin N.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Duarte, Simone] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA	Universidade Federal do Ceara; Universidade Estadual Paulista; New York University; New York University	Duarte, S (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	sduarte@nyu.edu	Lima, Ramille/AAK-9378-2021; Duarte, Simone/Y-2496-2019; Klein, Marlise Inêz/A-2550-2014; Janal, Malvin/AAA-2036-2020	Lima, Ramille/0000-0001-5764-7081; Duarte, Simone/0000-0002-4744-4026; Klein, Marlise Inêz/0000-0002-7916-1557; 	CAPES Foundation [Process 18494-12-9, 7715-13-7]	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by CAPES Foundation from whom the first and second authors received a scholarship (Process 18494-12-9 and 7715-13-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Araujo NC, 2012, PHOTOMED LASER SURG, V30, P393, DOI 10.1089/pho.2011.3195; Bonomi HR, 2012, P NATL ACAD SCI USA, V109, P12135, DOI 10.1073/pnas.1121292109; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 1999, CARIES RES, V33, P1, DOI 10.1159/000016489; Bumah VV, 2013, PHOTOMED LASER SURG, V31, P547, DOI 10.1089/pho.2012.3461; Chebath-Taub D, 2012, J PHOTOCH PHOTOBIO B, V116, P75, DOI 10.1016/j.jphotobiol.2012.08.004; Dai TH, 2013, PHOTOMED LASER SURG, V31, P531, DOI 10.1089/pho.2012.3365; Dai TH, 2013, ANTIMICROB AGENTS CH, V57, P1238, DOI 10.1128/AAC.01652-12; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; DIPERSIO JR, 1974, INFECT IMMUN, V10, P597, DOI 10.1128/IAI.10.3.597-604.1974; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Duarte S, 2008, ORAL MICROBIOL IMMUN, V23, P206, DOI 10.1111/j.1399-302X.2007.00412.x; Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Duarte S, 2006, ARCH ORAL BIOL, V51, P15, DOI 10.1016/j.archoralbio.2005.06.002; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feuerstein O, 2006, J ANTIMICROB CHEMOTH, V57, P872, DOI 10.1093/jac/dkl070; Feuerstein O, 2005, PHOTOCHEM PHOTOBIOL, V81, P1186, DOI 10.1562/2005-04-06-RA-477; Feuerstein O, 2004, PHOTOCHEM PHOTOBIOL, V80, P412, DOI 10.1562/0031-8655(2004)080<0412:PEOVLO>2.0.CO;2; Feuerstein O, 2012, Adv Dent Res, V24, P103, DOI 10.1177/0022034512449469; Fontana CR, 2009, J PERIODONTAL RES, V44, P751, DOI 10.1111/j.1600-0765.2008.01187.x; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; HAMBLIN MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI DOI 10.1039/B311900A; HERLES S, 1994, J DENT RES, V73, P1748, DOI 10.1177/00220345940730111101; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Kim S, 2013, PHOTOMED LASER SURG, V31, P554, DOI 10.1089/pho.2012.3343; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Paschoal M., 2013, LASER MED SCI, P1; Paschoal MA, 2014, PHOTOMED LASER SURG, V32, P175, DOI 10.1089/pho.2013.3656; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Song HH, 2013, J PERIODONTAL IMPLAN, V43, P72, DOI 10.5051/jpis.2013.43.2.72; Steinberg D, 2008, ANTIMICROB AGENTS CH, V52, P2626, DOI 10.1128/AAC.01666-07; TAN KL, 1991, CLIN PERINATOL, V18, P423, DOI 10.1016/S0095-5108(18)30506-2; Teixeira AH, 2012, CARIES RES, V46, P549, DOI 10.1159/000341190; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Weber K, 2014, FEMS MICROBIOL LETT, V350, P175, DOI 10.1111/1574-6968.12334; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Yoshida A, 2013, J PHOTOCH PHOTOBIO B, V129, P1, DOI 10.1016/j.jphotobiol.2013.09.003; Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232; ZERO DT, 1986, ARCH ORAL BIOL, V31, P229, DOI 10.1016/0003-9969(86)90054-3	46	29	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131941	10.1371/journal.pone.0131941	http://dx.doi.org/10.1371/journal.pone.0131941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230333	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400012
J	Sakamoto, T; Nishiyama, Y; Ikeda, A; Takahashi, H; Hyodo, S; Kagawa, N; Sakamoto, H				Sakamoto, Tatsuya; Nishiyama, Yudai; Ikeda, Aoi; Takahashi, Hideya; Hyodo, Susumu; Kagawa, Nao; Sakamoto, Hirotaka			Neurohypophysial Hormones Regulate Amphibious Behaviour in the Mudskipper Goby	PLOS ONE			English	Article							BREAM SPARUS-AURATA; RAPID MORPHOLOGICAL OSCILLATION; ESOPHAGEAL SPHINCTER MUSCLE; FLOUNDER PLATICHTHYS-FLESUS; DISTINCT PREOPTIC REGIONS; AFRICAN CICHLID FISH; ARGININE-VASOTOCIN; PERIOPHTHALMUS-MODESTUS; SEA BREAM; SOCIAL-BEHAVIOR	The neurohypophysial hormones, arginine vasotocin and isotocin, regulate both hydromineral balance and social behaviors in fish. In the amphibious mudskipper, Periophthalmus modestus, we previously found arginine-vasotocin-specific regulation of aggressive behavior, including migration of the submissive subordinate into water. This migration also implies the need for adaptation to dehydration. Here, we examined the effects of arginine vasotocin and isotocin administration on the amphibious behavior of individual mudskippers in vivo. The mudskippers remained in the water for an increased period of time after 1-8 h of intracerebroventricular (ICV) injection with 500 pg/g arginine vasotocin or isotocin. The 'frequency of migration' was decreased after ICV injection of arginine vasotocin or isotocin, reflecting a tendency to remain in the water. ICV injections of isotocin receptor antagonist with arginine vasotocin or isotocin inhibited all of these hormonal effects. In animals kept out of water, mRNA expression of brain arginine vasotocin and isotocin precursors increased 3- and 1.5-fold, respectively. Given the relatively wide distribution of arginine vasotocin fibres throughout the mudskipper brain, induction of arginine vasotocin and isotocin under terrestrial conditions may be involved also in the preference for an aquatic habitat as ligands for brain isotocin receptors.	[Sakamoto, Tatsuya; Nishiyama, Yudai; Ikeda, Aoi; Takahashi, Hideya; Sakamoto, Hirotaka] Okayama Univ, Fac Sci, Ushimado Marine Inst, Ushimado, Setouchi 7014303, Japan; [Hyodo, Susumu] Univ Tokyo, Atmosphere & Ocean Res Inst, Physiol Lab, Kashiwa, Chiba 2778564, Japan; [Kagawa, Nao] Kinki Univ, Fac Sci & Technol, Dept Life Sci, Higashiosaka, Osaka 5778502, Japan	Okayama University; University of Tokyo; Kindai University (Kinki University)	Sakamoto, T (corresponding author), Okayama Univ, Fac Sci, Ushimado Marine Inst, Ushimado, Setouchi 7014303, Japan.	ryu@uml.okayama-u.ac.jp	Sakamoto, Hirotaka/AAE-3720-2021	Sakamoto, Hirotaka/0000-0002-6224-4591; Hyodo, Susumu/0000-0001-8146-2386	Japan Society for the Promotion of Science (JSPS) [19570057, 22570065]; Grants-in-Aid for Scientific Research [26291065, 26650110] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Japan Society for the Promotion of Science (JSPS): (http://www.jsps.go.jp/), 19570057 and 22570065 to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HE, 2012, HORM BEHAV, V61, P283, DOI 10.1016/j.yhbeh.2011.10.007; Martos-Sitcha JA, 2015, COMP BIOCHEM PHYS A, V182, P93, DOI 10.1016/j.cbpa.2014.12.027; Backstrom T, 2009, PHYSIOL BEHAV, V96, P470, DOI 10.1016/j.physbeh.2008.11.013; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Clayton D. A., 1993, OCEANOGRAPHY MARINE; DEMSKI LS, 1971, J COMP NEUROL, V143, P1, DOI 10.1002/cne.901430102; Fitts DA, 2005, PHYSIOL BEHAV, V86, P573, DOI 10.1016/j.physbeh.2005.08.027; Fitts DA, 2003, AM J PHYSIOL-REG I, V285, pR1331, DOI 10.1152/ajpregu.00254.2003; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2004, HORM BEHAV, V45, P136, DOI 10.1016/j.yhbeh.2003.08.006; Goodson JL, 2000, NATURE, V403, P769, DOI 10.1038/35001581; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; HAUSMANN H, 1995, FEBS LETT, V370, P227, DOI 10.1016/0014-5793(95)00832-T; HOLMQVIST BI, 1995, J CHEM NEUROANAT, V8, P125, DOI 10.1016/0891-0618(94)00041-Q; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; HYODO S, 1991, J COMP PHYSIOL B, V161, P549, DOI 10.1007/BF00260744; Kagawa N, 2013, J FISH BIOL, V82, P354, DOI 10.1111/j.1095-8649.2012.03490.x; Kagawa N, 2013, GEN COMP ENDOCR, V194, P257, DOI 10.1016/j.ygcen.2013.09.023; Kleszczynska A, 2006, COMP BIOCHEM PHYS A, V145, P268, DOI 10.1016/j.cbpa.2006.06.037; Kline RJ, 2011, J CHEM NEUROANAT, V42, P72, DOI 10.1016/j.jchemneu.2011.06.005; Konno N, 2010, PEPTIDES, V31, P1273, DOI 10.1016/j.peptides.2010.04.014; Konno N, 2010, ENDOCRINOLOGY, V151, P1089, DOI 10.1210/en.2009-1070; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; LEE CGL, 1987, COMP BIOCHEM PHYS A, V87, P1009, DOI 10.1016/0300-9629(87)90028-4; Lee HJ, 2005, J EXP BIOL, V208, P169, DOI 10.1242/jeb.01361; Lema SC, 2015, J NEUROENDOCRINOL, V27, P142, DOI 10.1111/jne.12239; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2014, INTEGR COMP BIOL, V54, P850, DOI 10.1093/icb/icu019; Lema SC, 2010, MOL CELL ENDOCRINOL, V321, P215, DOI 10.1016/j.mce.2010.02.015; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; Martos-Sitcha JA, 2014, GEN COMP ENDOCR, V197, P5, DOI 10.1016/j.ygcen.2013.11.026; Martos-Sitcha JA, 2015, J EXP BIOL, V218, P684, DOI 10.1242/jeb.114546; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Mancera JM, 2008, COMP BIOCHEM PHYS A, V149, P92, DOI 10.1016/j.cbpa.2007.10.016; Motohashi E, 2009, COMP BIOCHEM PHYS A, V154, P353, DOI 10.1016/j.cbpa.2009.07.003; Mukuda T, 2005, J EXP ZOOL PART A, V303A, P366, DOI 10.1002/jez.a.134; Nobata S, 2011, AM J PHYSIOL-REG I, V300, P1569, DOI 10.1152/ajpregu.00056.2011; Ojima D, 2010, GEN COMP ENDOCR, V168, P82, DOI 10.1016/j.ygcen.2010.04.007; Ojima D, 2009, COMP BIOCHEM PHYS A, V152, P293, DOI 10.1016/j.cbpa.2008.06.037; Sakamoto T, 2000, J EXP ZOOL, V286, P666, DOI 10.1002/(SICI)1097-010X(20000501)286:6<666::AID-JEZ14>3.0.CO;2-G; Sakamoto T, 2002, J COMP PHYSIOL B, V172, P447, DOI 10.1007/s00360-002-0274-z; Sakamoto T, 2002, J COMP PHYSIOL B, V172, P435, DOI 10.1007/s00360-002-0272-1; Sakamoto T, 2005, J MOL ENDOCRINOL, V34, P825, DOI 10.1677/jme.1.01768; Sakamoto T, 2011, PHYSIOL BEHAV, V104, P923, DOI 10.1016/j.physbeh.2011.06.002; Sakihara T, 2007, J COMP PHYSIOL B, V177, P927, DOI 10.1007/s00360-007-0191-2; Salek SJ, 2002, BEHAV BRAIN RES, V133, P177, DOI 10.1016/S0166-4328(02)00003-7; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Singh V, 2009, GEN COMP ENDOCR, V162, P172, DOI 10.1016/j.ygcen.2009.03.016; Takahashi H, 2006, J COMP PHYSIOL B, V176, P463, DOI 10.1007/s00360-006-0067-x; Takahashi H, 2006, LIFE SCI, V79, P1873, DOI 10.1016/j.lfs.2006.06.021; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Tsukada T, 2007, J EXP BIOL, V210, P3970, DOI 10.1242/jeb.010645; Warne J, 2002, EXPTL BIOL REV, P83; Warne JM, 2000, GEN COMP ENDOCR, V119, P77, DOI 10.1006/gcen.2000.7495; Warne JM, 2001, GEN COMP ENDOCR, V122, P312, DOI 10.1006/gcen.2001.7644; Watanabe Y, 2007, J COMP PHYSIOL B, V177, P867, DOI 10.1007/s00360-007-0184-1; Yamaguchi Y, 2012, GEN COMP ENDOCR, V178, P519, DOI 10.1016/j.ygcen.2012.07.008	60	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134605	10.1371/journal.pone.0134605	http://dx.doi.org/10.1371/journal.pone.0134605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230718	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400138
J	Szentagotai-Tatar, A; Chis, A; Vulturar, R; Dobrean, A; Candea, DM; Miu, AC				Szentagotai-Tatar, Aurora; Chis, Adina; Vulturar, Romana; Dobrean, Anca; Candea, Diana Mirela; Miu, Andrei C.			Shame and Guilt-Proneness in Adolescents: Gene-Environment Interactions	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; SELF-CONSCIOUS EMOTIONS; EARLY-LIFE STRESS; COGNITIVE VULNERABILITY; NEUROTROPHIC FACTOR; DEPRESSION; SEROTONIN; CHILDHOOD; 5-HTTLPR; EVENTS	Rooted in people's preoccupation with how they are perceived and evaluated, shame and guilt are self-conscious emotions that play adaptive roles in social behavior, but can also contribute to psychopathology when dysregulated. Shame and guilt-proneness develop during childhood and adolescence, and are influenced by genetic and environmental factors that are little known to date. This study investigated the effects of early traumatic events and functional polymorphisms in the brain-derived neurotrophic factor (BDNF) gene and the serotonin transporter gene promoter (5-HTTLPR) on shame and guilt in adolescents. A sample of N = 271 healthy adolescents between 14 and 17 years of age filled in measures of early traumatic events and proneness to shame and guilt, and were genotyped for the BDNF Val66Met and 5-HTTLPR polymorphisms. Results of moderator analyses indicated that trauma intensity was positively associated with guilt-proneness only in carriers of the low-expressing Met allele of BDNF Val66Met. This is the first study that identifies a gene-environment interaction that significantly contributes to guilt proneness in adolescents, with potential implications for developmental psychopathology.	[Szentagotai-Tatar, Aurora; Dobrean, Anca; Candea, Diana Mirela] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania; [Chis, Adina; Vulturar, Romana] Iuliu Hatieganu Univ Med & Pharm, Dept Cell & Mol Biol, Cluj Napoca, Romania; [Miu, Andrei C.] Univ Babes Bolyai, Dept Psychol, Cognit Neurosci Lab, R-3400 Cluj Napoca, Cluj, Romania	Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy; Babes Bolyai University from Cluj	Szentagotai-Tatar, A (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania.	auraszentagotai@psychology.ro	Vulturar, Romana C/C-5345-2011; Nechita, Diana/AAB-5024-2021; Dobrean, Anca/AAN-5464-2020; Tatar, Aurora Szentagotai/C-4045-2012; Miu, Andrei C./C-5184-2011; Vulturar, Romana/AAA-8604-2019; Dobrean, Anca/K-6562-2013	Vulturar, Romana C/0000-0003-2476-9706; Nechita, Diana/0000-0002-0750-8953; Miu, Andrei C./0000-0002-6459-5010; Chis, Adina/0000-0002-1651-0860; Dobrean, Anca/0000-0001-6089-1018	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045, PN-II-RU-PD-2012-3-0501]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by grants from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro/), grants number PNII-ID-PCCE-2011-2-0045 (ACM) and PN-II-RU-PD-2012-3-0501 (AC). Although the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, provided finding for the collection of data and the manuscript preparation, they had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	Aiken L. S., 1991, MULTIPLE REGRESSION; ANDREWS B, 1995, J ABNORM PSYCHOL, V104, P277, DOI 10.1037/0021-843X.104.2.277; Andrews B, 2000, J ABNORM PSYCHOL, V109, P69, DOI 10.1037/0021-843X.109.1.69; Belden AC, 2015, JAMA PSYCHIAT, V72, P40, DOI 10.1001/jamapsychiatry.2014.1604; Bennett DS, 2010, CHILD MALTREATMENT, V15, P305, DOI 10.1177/1077559510379634; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briggs-Gowan MJ, 2010, J CHILD PSYCHOL PSYC, V51, P1132, DOI 10.1111/j.1469-7610.2010.02256.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Carnuta M, 2015, PSYCHONEUROENDOCRINO, V51, P176, DOI 10.1016/j.psyneuen.2014.09.026; Carver CS, 2011, J AFFECT DISORDERS, V132, P89, DOI 10.1016/j.jad.2011.02.001; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Claesson K, 2002, CLIN PSYCHOL PSYCHOT, V9, P277, DOI 10.1002/cpp.331; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Hooge IE, 2007, COGNITION EMOTION, V21, P1025, DOI 10.1080/02699930600980874; de Hooge IE, 2010, COGNITION EMOTION, V24, P111, DOI 10.1080/02699930802584466; Donatelli J.L., 2007, J CHILD FAM STUD, V16, DOI [10.1007/s10826-006-9130-1, DOI 10.1007/S10826-006-9130-1]; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feiring C, 2002, DEV PSYCHOL, V38, P79, DOI 10.1037//0012-1649.38.1.79; Feiring Candice, 2002, Child Maltreat, V7, P26, DOI 10.1177/1077559502007001003; Ferguson TJ, 2000, GENET SOC GEN PSYCH, V126, P319; Fletcher KE, 2011, J CHILD ADOLESCENT T, V4, P339, DOI DOI 10.1080/19361521.2011.623146; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gavazzi IG, 2011, EUR J DEV PSYCHOL, V8, P311, DOI 10.1080/17405629.2010.491303; Hayden EP, 2008, J AFFECT DISORDERS, V107, P227, DOI 10.1016/j.jad.2007.07.028; Hayden EP, 2013, DEV PSYCHOPATHOL, V25, P587, DOI 10.1017/S0954579413000035; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOGLUND CL, 1995, J FAM VIOLENCE, V10, P141, DOI 10.1007/BF02110597; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Lagattuta K. H., 2007, SELF CONSCIOUS EMOTI, P91; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Leary MR, 2004, PSYCHOL INQ, V15, P129; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lester KJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.33; Lester KJ, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-4; Lewis H., 1971, SHAME GUILT NEUROSIS; Lewis M., 2007, SELF CONSCIOUS EMOTI, P134; Lickel B, 2014, EMOTION, V14, P1049, DOI 10.1037/a0038235; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Luby J, 2009, J CHILD PSYCHOL PSYC, V50, P1156, DOI 10.1111/j.1469-7610.2009.02077.x; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mills RSL, 2015, CHILD PSYCHIAT HUM D, V46, P194, DOI 10.1007/s10578-013-0416-4; Mills RSL, 2005, DEV REV, V25, P26, DOI 10.1016/j.dr.2004.08.001; Miu AC, 2013, EMOTION, V13, P1012, DOI 10.1037/a0033383; Mongillo EA, 2009, J ABNORM CHILD PSYCH, V37, P455, DOI 10.1007/s10802-008-9283-z; Muris P, 2014, CLIN CHILD FAM PSYCH, V17, P19, DOI 10.1007/s10567-013-0137-z; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Olthof T, 2004, COGNITION EMOTION, V18, P383, DOI 10.1080/02699930341000077; Orth U, 2010, J PERS SOC PSYCHOL, V99, P1061, DOI 10.1037/a0021342; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Rakow A, 2012, J FAM PSYCHOL, V25, P147; Rakow A, 2009, J CHILD FAM STUD, V18, P367, DOI 10.1007/s10826-008-9239-5; Rankin JL, 2004, J RES ADOLESCENCE, V14, P1, DOI 10.1111/j.1532-7795.2004.01401001.x; Roberts W, 2014, CAN J BEHAV SCI, V46, P465, DOI 10.1037/a0035057; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roos S, 2014, DEV PSYCHOL, V50, P941, DOI 10.1037/a0033904; Rutter M, 1997, DEV PSYCHOPATHOL, V9, P335, DOI 10.1017/S0954579497002083; Scherer KR, 2009, EUR J PERSONALITY, V23, P265, DOI 10.1002/per.714; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharpley CF, 2014, BEHAV BRAIN RES, V273, P89, DOI 10.1016/j.bbr.2014.07.030; Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020; Sheikh HI, 2010, PSYCHIAT GENET, V20, P109, DOI 10.1097/YPG.0b013e32833a2038; Smyth JM, 2008, J AM COLL HEALTH, V57, P69, DOI 10.3200/JACH.57.1.69-76; Somerville LH, 2013, PSYCHOL SCI, V24, P1554, DOI 10.1177/0956797613475633; Stuewig J, 2005, CHILD MALTREATMENT, V10, P324, DOI 10.1177/1077559505279308; Stuewig J, 2015, CHILD PSYCHIAT HUM D, V46, P217, DOI 10.1007/s10578-014-0467-1; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Tangney J. P., 1991, TEST SELF CONSCIOUS; Tangney J.P., 2003, SHAME GUILT; Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tilghman-Osborne C, 2012, J ABNORM CHILD PSYCH, V40, P607, DOI 10.1007/s10802-011-9591-6; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Vulturar R, 2012, PSYCHOPHYSIOLOGY, V49, P1412, DOI 10.1111/j.1469-8986.2012.01445.x; Webb M, 2007, CHILD ABUSE NEGLECT, V31, P1143, DOI 10.1016/j.chiabu.2007.09.003; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; West SG, 1996, J PERS, V64, P1, DOI 10.1111/j.1467-6494.1996.tb00813.x; Westenberg PM, 2004, J CHILD PSYCHOL PSYC, V45, P481; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Zahn-Waxler Carolyn, 1995, P143	100	11	12	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134716	10.1371/journal.pone.0134716	http://dx.doi.org/10.1371/journal.pone.0134716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230319	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400155
J	Tsai, CF; Lee, YT; Lee, WJ; Hwang, JP; Wang, SJ; Fuh, JL				Tsai, Chia-Fen; Lee, Yao-Tung; Lee, Wei-Ju; Hwang, Jen-Ping; Wang, Shuu-Jiun; Fuh, Jong-Ling			Depression of Family Caregivers Is Associated with Disagreements on Life-Sustaining Preferences for Treating Patients with Dementia	PLOS ONE			English	Article							DECISION-MAKING; CARE; CONCORDANCE; AGREEMENT; ATTITUDES; VERSION; BURDEN; STATE	Background Family caregivers may not agree with patients with dementia regarding attitudes toward end-of-life preferences, and the effects of this type of disagreement are not well understood. This study sought to identify such a disagreement and its predictors. Methods A cross-sectional sample of 84 family caregivers and patients with dementia was recruited from memory clinics. We used the Mini-Mental State Examination, Neuropsychiatric Inventory, Clinical Dementia Rating, and Katz index of independence in activities of daily living to assess patient symptoms, functions, and severity of dementia. Caregivers completed questionnaires on perceived patient end-of-life care preferences, caregiver end-of-life care preferences for patients, Zarit Burden Interview (ZBI), Center for Epidemiological Studies-Depression Scale (CES-D), and knowledge of clinical complications of advanced dementia. Results The self-disclosure rates of patient preferences were 34.5% for tube feeding, 39.3% for cardiopulmonary resuscitation, and 45.2% for mechanical ventilation. For patients who had disclosed preferences, the disagreement rate between them and their caregivers was 48.3% for tube feeding, 48.5% for cardiopulmonary resuscitation, and 60.3% for mechanical ventilation. Caregiver depression (i.e., CES-D >= 16) was associated with disagreements on cardiopulmonary resuscitation (adjusted odds ratio (aOR) = 6.6, 95% CI = 1.4-31.1, P = 0.01) and mechanical ventilation (aOR = 14, 95% CI = 2.2-87.2, P = 0.005) preferences. Conclusion The preferences of end-of-life issues differed greatly between dementia patients and their caregivers. Depression in caregivers is associated with such discrepancy.	[Tsai, Chia-Fen; Hwang, Jen-Ping] Vet Gen Hosp, Neurol Inst, Dept Psychiat, Taipei, Taiwan; [Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Tsai, Chia-Fen] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Wei-Ju] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Chia-Fen; Lee, Wei-Ju; Hwang, Jen-Ping; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Lee, Wei-Ju] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lee, Yao-Tung] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital	Fuh, JL (corresponding author), 201 Sec 2,Shipai Rd, Taipei 112, Taiwan.	jlfuh@vghtpe.gov.tw		Lee, Wei-Ju/0000-0002-3720-4539	Ministry of Science and Technology of Taiwan [NSC 101-2314-B-075-037-MY2, 101-2314-B-075A-013, 102-2321-B-010-030]; Taipei Veterans General Hospital [V103E9-006, V103E3-005, V103C-083]; Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 102-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-075-037-MY2, 101-2314-B-075A-013, 102-2321-B-010-030), Taipei Veterans General Hospital (V103E9-006, V103E3-005, V103C-083), Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877; Bambauer Kara Zivin, 2007, Am J Hosp Palliat Care, V24, P185; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Borum ML, 2000, J AM GERIATR SOC, V48, pS194, DOI 10.1111/j.1532-5415.2000.tb03132.x; Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuh JL, 2001, INT PSYCHOGERIATR, V13, P121, DOI 10.1017/S1041610201007517; Jennings B, 2003, HASTINGS CENT REP, V33, pS24; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Ko KT, 2008, AM J GERIAT PSYCHIAT, V16, P513, DOI 10.1097/JGP.0b013e318167ae5b; Kwok T, 2007, J ADV NURS, V58, P256, DOI 10.1111/j.1365-2648.2007.04230.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meuser TM, 2001, GERONTOLOGIST, V41, P658, DOI 10.1093/geront/41.5.658; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Mitchell Susan L, 2009, N Engl J Med, V361, P1529, DOI 10.1056/NEJMoa0902234; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reamy AM, 2013, GERONTOLOGIST, V53, P293, DOI 10.1093/geront/gns078; Rurup ML, 2006, PATIENT EDUC COUNS, V61, P372, DOI 10.1016/j.pec.2005.04.016; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Siminoff LA, 2006, PSYCHO-ONCOLOGY, V15, P528, DOI 10.1002/pon.989; Speice J, 2000, PSYCHO-ONCOL, V9, P101, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<101::AID-PON435>3.0.CO;2-D; Swails P., 2009, DEMENTIA, V8, P117; Tang ST, 2005, J PAIN SYMPTOM MANAG, V30, P510, DOI 10.1016/j.jpainsymman.2005.05.019; Winter L, 2007, SOC SCI MED, V65, P1695, DOI 10.1016/j.socscimed.2007.06.012; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252	34	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133711	10.1371/journal.pone.0133711	http://dx.doi.org/10.1371/journal.pone.0133711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230958	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400052
J	Fahlgren, A; Bratengeier, C; Gelmi, A; Semeins, CM; Klein-Nulend, J; Jager, EWH; Bakker, AD				Fahlgren, Anna; Bratengeier, Cornelia; Gelmi, Amy; Semeins, Cornelis M.; Klein-Nulend, Jenneke; Jager, Edwin W. H.; Bakker, Astrid D.			Biocompatibility of Polypyrrole with Human Primary Osteoblasts and the Effect of Dopants	PLOS ONE			English	Article							CHONDROITIN SULFATE; CONDUCTING POLYMERS; SURFACE; EXPRESSION; ELECTROCHEMISTRY; DIFFERENTIATION; NANOPARTICLES; OSTEOCALCIN; INHIBITION; TOPOGRAPHY	Polypyrrole (PPy) is a conducting polymer that enables controlled drug release upon electrical stimulation. We characterized the biocompatibility of PPy with human primary osteoblasts, and the effect of dopants. We investigated the biocompatibility of PPy comprising various dopants, i.e. p-toluene sulfonate (PPy-pTS), chondroitin sulfate (PPy-CS), or dodecylbenzenesulfonate (PPy-DBS), with human primary osteoblasts. PPy-DBS showed the roughest appearance of all surfaces tested, and its wettability was similar to the gold-coated control. The average number of attached cells was 45% higher on PPy-DBS than on PPyCS or PPy-pTS, although gene expression of the proliferation marker Ki-67 was similar in osteoblasts on all surfaces tested. Osteoblasts seeded on PPy-DBS or gold showed similar vinculin attachment points, vinculin area per cell area, actin filament structure, and Feret's diameter, while cells seeded on PPY-CS or PPY-pTS showed disturbed focal adhesions and were enlarged with disorganized actin filaments. Osteoblasts grown on PPy-DBS or gold showed enhanced alkaline phosphatase activity and osteocalcin gene expression, but reduced osteopontin gene expression compared to cells grown on PPy-pTS and PPy-CS. In conclusion, PPy doped with DBS showed excellent biocompatibility, which resulted in maintaining focal adhesions, cell morphology, cell number, alkaline phosphatase activity, and osteocalcin gene expression. Taken together, conducting polymers doped with DBS are well tolerated by osteoblasts. Our results could provide a basis for the development of novel orthopedic or dental implants with controlled release of antibiotics and pharmaceutics that fight infections or focally enhance bone formation in a tightly controlled manner.	[Fahlgren, Anna; Bratengeier, Cornelia] Linkoping Univ, Div Orthopaed, Dept Clin & Expt Med, Linkoping, Sweden; [Gelmi, Amy; Jager, Edwin W. H.] Linkoping Univ, Dept Phys Chem & Biol, Biosensors & Bioelect Ctr, Linkoping, Sweden; [Semeins, Cornelis M.; Klein-Nulend, Jenneke; Bakker, Astrid D.] ACTA Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [Semeins, Cornelis M.; Klein-Nulend, Jenneke; Bakker, Astrid D.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Linkoping University; Linkoping University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Fahlgren, A (corresponding author), Linkoping Univ, Div Orthopaed, Dept Clin & Expt Med, Linkoping, Sweden.	anna.fahlgren@liu.se	Jager, Edwin/F-1481-2013; Bakker, Astrid Diana/AAD-1286-2019	Jager, Edwin/0000-0002-2071-7768; Gelmi, Amy/0000-0003-1636-6448; Bratengeier, Cornelia/0000-0001-9302-0710; Fahlgren, Anna/0000-0002-0299-1763	VINNOVA [2012-04409]; Vetenskapradet [521-2013-2593]; Linkoping Initiative in Life Science Technologies (LIST)	VINNOVA(Vinnova); Vetenskapradet; Linkoping Initiative in Life Science Technologies (LIST)	This work was supported by VINNOVA (2012-04409, http://www.vinnova.se/sv/), Vetenskapradet (521-2013-2593, http://www.vr.se/), and Linkoping Initiative in Life Science Technologies (LIST) (https://www.liu.se/forskning/list?l = en&sc = true). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi J, 2012, BONE, V50, P1148, DOI 10.1016/j.bone.2012.02.001; Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141; Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015; Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024; Chen JC, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029551; Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014; Davies John E, 2003, J Dent Educ, V67, P932; Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124; Gelmi A, 2014, J MATER CHEM B, V2, P3860, DOI 10.1039/c4tb00142g; Gelmi A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2084165; Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085; HEINZE J, 1991, SYNTHETIC MET, V43, P2805, DOI 10.1016/0379-6779(91)91183-B; Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x; Hennig S, 2007, PAGANZ 07 POP APPR G; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Hojo H, 2015, REGEN THER, V1, P57, DOI 10.1016/j.reth.2014.10.002; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kapustin AN, 2011, ARTERIOSCL THROM VAS, V31, P2169, DOI 10.1161/ATVBAHA.111.233601; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Liu WF, 2012, CARDIOVASC RES, V95, P215, DOI 10.1093/cvr/cvs168; Marra M, 2012, BIOTECHNOL ADV, V30, P302, DOI 10.1016/j.biotechadv.2011.06.018; Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Pecchi E, 2012, OSTEOARTHR CARTILAGE, V20, P127, DOI 10.1016/j.joca.2011.12.002; Santos A, 2011, CALCIFIED TISSUE INT, V89, P318, DOI 10.1007/s00223-011-9521-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101; Stoddart MJ., 2011, METHODS MOL BIOL; Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j; Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053; TOURILLON G, 1983, J PHYS CHEM-US, V87, P2289, DOI 10.1021/j100236a010; Tsai SW, 2010, J BIOMED MATER RES A, V93A, P115, DOI 10.1002/jbm.a.32502; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; WARREN LF, 1987, J ELECTROCHEM SOC, V134, P101, DOI 10.1149/1.2100383; Yue C, 2015, J BIOMED MATER RES A, P1; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796; Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011	44	47	49	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134023	10.1371/journal.pone.0134023	http://dx.doi.org/10.1371/journal.pone.0134023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225862	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700051
J	Northover, C; Thapar, A; Langley, K; van Goozen, SHM				Northover, Clare; Thapar, Anita; Langley, Kate; van Goozen, Stephanie H. M.			Pain Sensitivity in Adolescent Males with Attention-Deficit/Hyperactivity Disorder: Testing for Associations with Conduct Disorder and Callous and Unemotional Traits	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PSYCHOPATHIC TRAITS; TOLERANCE; AGGRESSION; VALIDATION; CHILDREN; BEHAVIOR; ANXIETY; VIOLENT; EMPATHY	Background Reduced processing and experience of aversive emotional cues is a common component of theories on the development and persistence of aggression and antisocial behaviour. Yet physical pain, arguably the most basic aversive cue, has attracted comparatively little attention. Methods This study measured pain sensitivity and physiological response to painful stimuli (skin conductance level, SCL) in adolescent boys with Attention-Deficit/Hyperactivity Disorder (ADHD; n = 183), who are at high risk for antisocial behaviour. We compared boys with ADHD with and without a comorbid diagnosis of Conduct Disorder (CD) on pain sensitivity, and examined patterns of association between pain measures, on the one hand, and problem severity and callous and unemotional (CU) traits, on the other. Results Boys with comorbid CD exhibited a higher pain threshold and tolerance than boys with ADHD alone, but the groups did not differ in physiology at the time the pain threshold and tolerance were reported. Regression analyses showed that ADHD problem severity positively predicted pain sensitivity, whereas levels of CU traits negatively predicted pain sensitivity. Conclusions These findings on physical pain processing extend evidence of impairments in aversive cue processing among those at risk of antisocial behaviour. The study highlights the importance of considering comorbidity and heterogeneity of disorders when developing interventions. The current findings could be used to identify subgroups within those with ADHD who might be less responsive to interventions that use corrective feedback to obtain behaviour change.	[Northover, Clare; Langley, Kate; van Goozen, Stephanie H. M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Thapar, Anita; Langley, Kate] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	van Goozen, SHM (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	vangoozens@cardiff.ac.uk	Thapar, Anita/AAH-5555-2020	Thapar, Anita/0000-0002-3689-737X; Langley, Kate/0000-0002-2033-2657	UK Medical Research Council [G1000632]; MRC [G1000632] Funding Source: UKRI; Medical Research Council [MR/L010305/1, G1000632] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research has been supported by a grant (G1000632) from the UK Medical Research Council awarded to A Thapar, SHM van Goozen, and K Langley. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andershed H., 2002, PSYCHOPATHS CURRENT, P131, DOI DOI 10.1037/T07576-000; Andershed H, 2007, ASSESSMENT, V14, P144, DOI 10.1177/1073191106298286; Baker E, 2013, PSYCHOL SCI, V24, P1051, DOI 10.1177/0956797612465198; BERKOWITZ L, 1993, MOTIV EMOTION, V17, P277, DOI 10.1007/BF00992223; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Blair J., 2005, PSYCHOPATH EMOTION B; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Caes L, 2012, J PAIN, V13, P467, DOI 10.1016/j.jpain.2012.02.003; Cheng YW, 2012, DEV PSYCHOPATHOL, V24, P623, DOI 10.1017/S095457941200020X; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decety J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00489; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; Fairchild G, 2010, BIOL PSYCHIAT, V68, P272, DOI 10.1016/j.biopsych.2010.02.019; Fairchild G, 2009, J CHILD PSYCHOL PSYC, V50, P627, DOI 10.1111/j.1469-7610.2008.02020.x; FEDORA O, 1993, J CLIN PSYCHOL, V49, P326, DOI 10.1002/1097-4679(199305)49:3<326::AID-JCLP2270490304>3.0.CO;2-5; Franklin JC, 2011, PSYCHIAT RES, V189, P362, DOI 10.1016/j.psychres.2011.08.001; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Garofalo John P, 2006, Pain Pract, V6, P186, DOI 10.1111/j.1533-2500.2006.00084.x; Geuter S, 2014, PAIN, V155, P994, DOI 10.1016/j.pain.2014.02.005; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; HAIER RJ, 1984, PERS INDIV DIFFER, V5, P293, DOI 10.1016/0191-8869(84)90068-0; HARE R D, 1970, Journal of Abnormal Psychology, V76, P370, DOI 10.1037/h0030276; HARE RD, 1968, J ABNORM PSYCHOL, V73, P268, DOI 10.1037/h0025872; Hawes DJ, 2014, CLIN CHILD FAM PSYCH, V17, P248, DOI 10.1007/s10567-014-0167-1; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Johnson Malcolm H, 2005, Curr Pain Headache Rep, V9, P90, DOI 10.1007/s11916-005-0044-1; Kessler RC, 2009, PSYCHOL MED, V39, P137, DOI 10.1017/S0033291708003309; Lahey BB, 2012, J CHILD PSYCHOL PSYC, V53, P536, DOI 10.1111/j.1469-7610.2011.02509.x; Lamm C., J COGN NEUROSCI, V19, P42; Lykken D.T., 1995, ANTISOCIAL PERSONALI, DOI DOI 10.4324/9780203763551; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Miller JD, 2014, J ABNORM PSYCHOL, V123, P205, DOI 10.1037/a0035072; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Niel KA, 2007, PSYCHOL REP, V101, P141, DOI 10.2466/PR0.101.1.141-144; Parush S, 1997, DEV MED CHILD NEUROL, V39, P464, DOI 10.1111/j.1469-8749.1997.tb07466.x; Raine A, 1996, ANN NY ACAD SCI, V794, P46, DOI 10.1111/j.1749-6632.1996.tb32508.x; Raine A., 1997, PSYCHOPATHOLOGY CRIM; Reidy DE, 2009, AGGRESSIVE BEHAV, V35, P422, DOI 10.1002/ab.20315; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Scherder EJA, 2008, EUR J PAEDIATR NEURO, V12, P461, DOI 10.1016/j.ejpn.2007.11.004; Seguin JR, 1996, J CHILD PSYCHOL PSYC, V37, P823, DOI 10.1111/j.1469-7610.1996.tb01478.x; Stray LL, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-18; Syngelaki EM, 2013, DEVELOPMENTAL SCI, V16, P84, DOI 10.1111/j.1467-7687.2012.01191.x; Thapar A, 2006, MOL PSYCHIATR, V11, P714, DOI 10.1038/sj.mp.4001831; Thompson T, 2008, PAIN, V134, P187, DOI 10.1016/j.pain.2007.04.018; Treister R, 2015, PAIN PRACT, V15, P4, DOI 10.1111/papr.12129; Treister R, 2012, PAIN, V153, P1807, DOI 10.1016/j.pain.2012.04.008; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; van Goozen SHM, 2004, J CHILD PSYCHOL PSYC, V45, P884; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; Vendruscolo LF, 2004, BRAIN RES, V1030, P277, DOI 10.1016/j.brainres.2004.10.016; Viding E, 2007, BRIT J PSYCHIAT, V190, pS33, DOI 10.1192/bjp.190.5.s33; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Younger J, 2009, CURR PAIN HEADACHE R, V13, P39, DOI 10.1007/s11916-009-0009-x	61	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134417	10.1371/journal.pone.0134417	http://dx.doi.org/10.1371/journal.pone.0134417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225935	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000358837700092
J	Orobaton, N; Abegunde, D; Shoretire, K; Abdulazeez, J; Fapohunda, B; Lamiri, G; Maishanu, A; Ganiyu, A; Ndifon, E; Gwamzhi, R; Osborne-Smith, M				Orobaton, Nosakhare; Abegunde, Dele; Shoretire, Kamil; Abdulazeez, Jumare; Fapohunda, Bolaji; Lamiri, Goli; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon; Osborne-Smith, Matthew			A Report of At-Scale Distribution of Chlorhexidine Digluconate 7.1% Gel for Newborn Cord Care to 36,404 Newborns in Sokoto State, Nigeria: Initial Lessons Learned	PLOS ONE			English	Article								Background With an annual estimated 276,000 neonatal deaths, Nigeria has the second highest of any country in the world. Global progress in accelerating neonatal deaths is hinged to scaled-up interventions in Nigeria. We used routine data of chlorhexidine digluconate 7.1% gel utilized by 36,404 newborns delivered by 36,370 mothers, to study lessons associated with atscale distribution in Sokoto State, North West Nigeria. Methods and Findings Under state government leadership, a community-based distribution system overseen by 244 ward development committees and over 3,440 community-based health volunteers and community drug keepers, was activated to deliver two locally stored medicines to women when labor commenced. Newborns and their mothers were tracked through 28 days and 42 days respectively, including verbal autopsy results. 36,404 or 26.3% of expected newborns received the gel from April 2013 to December 2013 throughout all 244 wards in the State. 99.97% of newborns survived past 28 days. There were 124 pre-verified neonatal deaths reported. Upon verification using verbal autopsy procedures, 76 deaths were stillborn and 48 were previously live births. Among the previous 48 live births, the main causes of death were sepsis (40%), asphyxia (29%) and prematurity (8%). Underuse of logistics management information by government in procurement decisions and not accounting for differences in LGA population sizes during commodity distribution, severely limited program scalability. Conclusions Enhancements in the predictable availability and supply of chlorhexidine digluconate 7.1% gel to communities through better, evidence-based logistics management by the state public sector will most likely dramatically increase program scalability. Infections as a cause of mortality in babies delivered in home settings may be much higher than previously conceived. In tandem with high prevalence of stillborn deaths, delivery, interventions designed to increase mothers' timely and regular use of quality antenatal care, and increased facility-based based delivery, need urgent attention. We call for accelerated investments in community health volunteer programs and the requisite community measurement systems to better track coverage. We also advocate for the development, refinement and use of routine community-based verbal autopsies to track newborn and maternal survival.	[Orobaton, Nosakhare; Abegunde, Dele; Shoretire, Kamil; Abdulazeez, Jumare; Fapohunda, Bolaji; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon] United States Agcy Int Dev, Targeted States High Impact Project, Sokoto, Nigeria; [Shoretire, Kamil] Jhpiego, Baltimore, MD USA; [Orobaton, Nosakhare; Abegunde, Dele; Abdulazeez, Jumare; Fapohunda, Bolaji; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon] John Snow Inc, Res & Training Inst, Boston, MA USA; [Lamiri, Goli] European Union Support Immunizat Governance Niger, EU SIGN Project, Abuja, Nigeria; [Osborne-Smith, Matthew] Partners Hlth, Boston, MA USA	Jhpiego; Partners Healthcare System	Orobaton, N (corresponding author), United States Agcy Int Dev, Targeted States High Impact Project, Sokoto, Nigeria.	norobaton@jsi.com						Chlorhexidine Navi Care Program JSI Research & Training Institute I, CHLORH NEP PUBL PRIV; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Federal Republic of Nigeria, 2013, COUNTR IMPL PLAN PRI; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; JSI Research & Training Institute I, 2013, INTR CHLORH NEP; Lawn JE, 2004, LANCET, V364, P2020, DOI 10.1016/S0140-6736(04)17511-9; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Maron D.F., 2013, SCI AM, V309; Nasir SG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001687; National Population Commission (NPC) [Nigeria] ICF International, 2014, NIG DEM HLTH SURV 20; National Population Commission (NPC) Sokoto State Nigeria, 2013, POP DAT EXP BIRTH LG; Olatunji Alabi, 2014, GLOBAL HLTH ACTION, P23368; Olatunji Alabi, 2014, INT J EPIDEMIOL, P1; Shah R, 2010, J HEALTH POPUL NUTR, V28, P610; Sokoto State Government Nigeria, 2015, GEN INF SOK STAT GOV; Sokpo Emmanuel, PRIMARY HLTH CARE ON; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Development Programme Nigeria GoTFRo, 2007, NIG DELT PIL LOC DEV; USAID/Targeted States High Impact Project (TSHIP), 2014, ANN REPORT; Walsh, 2006, ROLE TRADITIONAL RUL; WHO, 2014, WHO TECH REP SER, V985, P1; World Bank, 2010, IMPR PRIM HLTH CAR D, P90; World Health Organization, 2012, SEL US ESS MED REP W, Vxiv; World Health Organization, 2013, US ESS MED REP 19 WH; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134040	10.1371/journal.pone.0134040	http://dx.doi.org/10.1371/journal.pone.0134040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226017	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700052
J	Choudhury, D; Das Talukdar, A; Choudhury, MD; Maurya, AP; Paul, D; Chanda, DD; Chakravorty, A; Bhattacharjee, A				Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta; Maurya, Anand Prakash; Paul, Deepjyoti; Chanda, Debadatta Dhar; Chakravorty, Atanu; Bhattacharjee, Amitabha			Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; EXPRESSION; MECHANISMS; EMERGENCE; OPERON	Carbapenem resistance presents severe threat to the treatment of multidrug resistant Pseudomonas aeruginosa infections. The study was undertaken to investigate the role of efflux pumps in conferring meropenem resistance and effect of single dose exposure of meropenem on transcription level of mexA gene in clinical isolates of P. aeruginosa from a tertiary referral hospital of India. Further, in this investigation an effort was made to assess whether different components of MexAB-OprM operon expresses in the same manner and the extent of contributions of those components in meropenem resistance in its natural host (P. aeruginosa) and in a heterologous host (E. coli). Out of 83 meropenem nonsusceptible isolates, 22 isolates were found to possess efflux pump activity phenotypically. Modified hodge test and multiplex PCR confirmed the absence of carbapenemase genes in those isolates. All of them were of multidrug resistant phenotype and were resistant to all the carbepenem drug tested. MexAB-OprM efflux pump was found to be overexpressed in all the study isolates. It could be observed that single dose exposure meropenem could give rise to trivial increase in transcription of mexA gene. Different constructs of MexAB-OprM (mexR-mexA-mexB-OprM; mexA-mexB-OprM; mexA-mexB) could be expressed in both its natural (P. aeruginosa PAO1) and heterologous host (E. coli JM107) but transcription level of mexA gene varied in both the hosts before and after single dose exposure of meropenem. Different components of the operon failed to enhance meropenem resistance in E. coli JM107 and P. aeruginosa PAO1. This study could prove that MexAB-OprM efflux pump can significantly contribute to meropenem resistance in hospital isolates of P. aeruginosa where an acquired resistant mechanism is absent. Thus, equal importance should be given for diagnosis of intrinsic resistance mechanism so as to minimize treatment failure. As meropenem could not enhance mexA transcriptions significantly, there might be a possibility that the increase in expression of efflux pump genes does not mediated by single antibiotic but rather by a combination of antipseudomonal drugs which are used during treatments. Early detection of efflux genes will help in selection of proper therapeutic options.	[Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Maurya, Anand Prakash; Paul, Deepjyoti; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, Assam, India; [Chanda, Debadatta Dhar; Chakravorty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, Assam, India	Assam University; Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, Assam, India.	ab0404@gmail.com	Choudhury, Manabendra/AAP-1817-2021	Paul, Deepjyoti/0000-0002-6078-9408; Dutta Choudhury, Manabendra/0000-0002-9472-0572; Talukdar, Anupam Das/0000-0001-8916-2791; Maurya, Anand Prakash/0000-0001-5231-8174	DBT-NER twining Department of Biotechnology (DBT) government of India [BCIL/NER-BPMC/2014-203]; Assam University Institutional Biotech Hub Department of Biotechnology (DBT) government of India [BT/04/NE/2009]; University Grants Commission Basic Scientific Research (UGC-BSR) scheme	DBT-NER twining Department of Biotechnology (DBT) government of India; Assam University Institutional Biotech Hub Department of Biotechnology (DBT) government of India; University Grants Commission Basic Scientific Research (UGC-BSR) scheme	This research was funded by DBT-NER twining (BCIL/NER-BPMC/2014-203) Department of Biotechnology (DBT) government of India (www.dbtindia.gov.in): AB Assam University Institutional Biotech Hub (BT/04/NE/2009) Department of Biotechnology (DBT) government of India (www.dbtindia.gov.in): MDC. Debarati Choudhury received a junior research fellowship under University Grants Commission Basic Scientific Research (UGC-BSR) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrain L, 2013, RND EFFLUX PUMPS P A, P26; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Kolayli F, 2004, J MED MICROBIOL, V53, P915, DOI 10.1099/jmm.0.45692-0; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Poole K, 1996, ANTIMICROB AGENTS CH, V40, P2021, DOI 10.1128/AAC.40.9.2021; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Riou M, 2010, ECCMID 10 13 APR VIE, pP780; Saito K, 2001, FEMS MICROBIOL LETT, V195, P23, DOI 10.1016/S0378-1097(00)00539-5; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Srikumar R, 1998, ANTIMICROB AGENTS CH, V42, P65, DOI 10.1128/AAC.42.1.65; Tomas M, 2010, ANTIMICROB AGENTS CH, V54, P2219, DOI 10.1128/AAC.00816-09; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	23	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133842	10.1371/journal.pone.0133842	http://dx.doi.org/10.1371/journal.pone.0133842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221722	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800071
J	Dominguez-Martinez, E; Parise, E; Strandvall, T; Reid, VM				Dominguez-Martinez, Estefania; Parise, Eugenio; Strandvall, Tommy; Reid, Vincent M.			The Fixation Distance to the Stimulus Influences ERP Quality: An EEG and Eye Tracking N400 Study	PLOS ONE			English	Article							AVERAGE REFERENCE; MODULATION; ACTIVATION; ATTENTION; COMPONENT; INFANT; FOVEAL	In a typical visual Event Related Potential (ERP) study, the stimulus is presented centrally on the screen. Normally an ERP response will be measured provided that the participant directs their gaze towards the stimulus. The aim of this study was to assess how the N400 component of an ERP was affected when the stimulus was presented in the foveal, parafoveal or peripheral vision of the participant's visual field. Utilizing stimuli that have previously produced an N400 response to action incongruities, the same stimuli sequences were presented at 0 degrees, 4 degrees, 8 degrees and 12 degrees of visual angle from a fixation location. In addition to the EEG data, eye tracking data were recorded to act as a fixation control method and to allow for eye artifact detection. The results show a significant N400 effect in the right parietotemporal electrodes within the 0 degrees visual angle condition. For the other conditions, the N400 effect was reduced (4 degrees) or not present (8 degrees and 12 degrees). Our results suggest that the disappearance of the N400 effect with eccentricity is due to the fixation distance to the stimulus. However, variables like attentional allocation could have also had an impact on the results. This study highlights the importance of presenting a stimulus within the foveal vision of the participant in order to maximize ERP effects related to higher order cognitive processes.	[Dominguez-Martinez, Estefania; Parise, Eugenio; Reid, Vincent M.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Dominguez-Martinez, Estefania; Strandvall, Tommy] Tobii AB, Danderyd, Sweden	Lancaster University	Dominguez-Martinez, E (corresponding author), Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England.	e.dominguezmartinez@lancaster.ac.uk	Parise, Eugenio/ABC-3974-2021; Parise, Eugenio/ABD-9940-2021	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370; Reid, Vincent/0000-0002-2774-6975	Marie Curie FP7-PEOPLE / Initial Training Network of the European Union [ACT 289404]; Economic and Social Research Council [ES/L008955/1]; Tobii Technology AB; ESRC [ES/L008955/1] Funding Source: UKRI	Marie Curie FP7-PEOPLE / Initial Training Network of the European Union; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Tobii Technology AB; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Marie Curie FP7-PEOPLE / Initial Training Network of the European Union (ACT 289404) and the Economic and Social Research Council [ES/L008955/1]. Tobii Technology AB also provided support in the form of salaries for authors EDM and TS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amoruso L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00057; ANTES JR, 1981, PSYCHOL RES-PSYCH FO, V43, P277, DOI 10.1007/BF00308452; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; Bonifacci P, 2008, COGN PROCESS, V9, P127, DOI 10.1007/s10339-007-0198-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Cristescu TC, 2008, J COGNITIVE NEUROSCI, V20, P787, DOI 10.1162/jocn.2008.20503; DeHaan M., 2007, INFANT EEG EVENT REL; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Duchowski A., 2007, EYE TRACKING METHODO; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Hoehl S, 2008, DEVELOPMENTAL SCI, V11, P10, DOI 10.1111/j.1467-7687.2007.00643.x; Hoehl S, 2012, DEV NEUROPSYCHOL, V37, P187, DOI 10.1080/87565641.2011.627958; Holmqvist K., 2011, EYE TRACKING COMPREH; Hoormann J, 1998, BEHAV RES METH INS C, V30, P103, DOI 10.3758/BF03209420; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Karatekin C, 2007, J EXP CHILD PSYCHOL, V96, P107, DOI 10.1016/j.jecp.2006.05.005; Kleiner M, 2007, PERC 36 ECVP S14; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 1995, INTRO EVENT RELATED; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MCCARTHY G, 1993, ELECTROEN CLIN NEURO, V88, P210, DOI 10.1016/0168-5597(93)90005-A; Olsen A, 2012, P S EYE TRACKING RES, P317, DOI [DOI 10.1145/2168556.2168625, 10.1145/2168556.2168625]; Olsen A., 2012, TOBII I VT FIXATION, V21, P4; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1981, J EXP PSYCHOL HUMAN, V7, P167, DOI 10.1037/0096-1523.7.1.167; Reid VM, 2009, DEV PSYCHOL, V45, P620, DOI 10.1037/a0015209; Rugg M., 1995, ELECTROPHYSIOLOGY MI; Sanocki T, 1997, PSYCHOL SCI, V8, P374, DOI 10.1111/j.1467-9280.1997.tb00428.x; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003	43	7	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134339	10.1371/journal.pone.0134339	http://dx.doi.org/10.1371/journal.pone.0134339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222059	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000358836800133
J	Nakiyingi, L; Nonyane, BAS; Ssengooba, W; Kirenga, BJ; Nakanjako, D; Lubega, G; Byakika-Kibwika, P; Joloba, ML; Ellner, JJ; Dorman, SE; Mayanja-Kizza, H; Manabe, YC				Nakiyingi, Lydia; Nonyane, Bareng A. S.; Ssengooba, Willy; Kirenga, Bruce J.; Nakanjako, Damalie; Lubega, Gloria; Byakika-Kibwika, Pauline; Joloba, Moses L.; Ellner, Jerry J.; Dorman, Susan E.; Mayanja-Kizza, Harriet; Manabe, Yukari C.			Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ALGORITHM; SETTINGS; PREVALENCE; MORTALITY; PERFORMANCE; COUNTRIES; ACCURACY; AREA	Background The existing World Health Organization diagnostic algorithms for smear-negative TB perform poorly in HIV-infected individuals. New TB diagnostics such as urine TB lipoarabinomannan (LAM) could improve the accuracy and reduce delays in TB diagnosis in HIV-infected smear-negative presumptive TB. We sought to determine predictors for MTB culture-positivity among these patients. Methods This study was nested into a prospective evaluation of HIV-infected outpatients and inpatients clinically suspected to have TB who were screened by smear-microscopy on two spot sputum samples. Data on socio-demographics, clinical symptoms, antiretroviral therapy, CXR, CD4 count, mycobacterial sputum and blood cultures and TB-LAM were collected. Logistic regression and conditional inference tree analysis were used to determine the most predictive indicators for MTB culture-positivity. Results Of the 418 smear-negative participants [female, 64%; median age (IQR) 32 (28-39) years, median CD4 106 (IQR 22-298) cells/mm(3)], 96/418 (23%) were sputum and/or blood culture-positive for Mycobacterium tuberculosis (MTB) complex. Abnormal CXR (aOR 3.68, 95% CI 1.76-7.71, p=0.001) and positive urine TB-LAM (aOR 6.21, 95% CI 3.14-12.27, p<0.001) were significantly associated with MTB culture-positivity. Previous TB treatment (aOR 0.41, 95% CI 0.17-0.99, p=0.049) reduced the likelihood of a positive MTB culture. A conditional inference tree analysis showed that positive urine TB-LAM and abnormal CXR were the most predictive indicators of MTB culture-positivity. A combination of urine TB-LAM test and CXR had sensitivity and specificity of 50% and 86.1% respectively overall, and 70.8% and 84.1% respectively among those with CD4<100 cells/mm(3). Conclusions A positive urine TB-LAM test and an abnormal CXR significantly predict MTB culture-positivity among smear-negative HIV-infected presumptive TB patients while previous TB treatment reduces the likelihood of a positive MTB culture. Validation studies to assess the performance of diagnostic algorithms that include urine TB-LAM in the diagnosis of smear-negative TB in HIV-infected individuals are warranted.	[Nakiyingi, Lydia; Nakanjako, Damalie; Lubega, Gloria; Byakika-Kibwika, Pauline; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nakiyingi, Lydia; Nakanjako, Damalie; Byakika-Kibwika, Pauline; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Nonyane, Bareng A. S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Ssengooba, Willy; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Dorman, Susan E.; Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Ellner, Jerry J.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02215 USA	Makerere University; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Johns Hopkins University; Boston Medical Center; Boston University	Nakiyingi, L (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	lydikiyingi@yahoo.com	Ssengooba, Willy/AAG-1202-2020; Mayanja-Kizza, Harriet/AAM-5372-2020; Ssengooba, Willy/ABE-2168-2020; Nonyane, Bareng A.S./AAC-8118-2020; Nakiyingi, Lydia/ABG-7669-2020	Ssengooba, Willy/0000-0002-1643-110X; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Ssengooba, Willy/0000-0002-1643-110X; Nonyane, Bareng A.S./0000-0001-5633-7487; Nakiyingi, Lydia/0000-0001-7263-3198; Joloba, Moses/0000-0002-0334-9983; Nakanjako, Damalie/0000-0002-0935-2112; Kirenga, Bruce/0000-0002-2023-2840	Medical Education for Equitable Services to All Ugandans (MESAU); Medical Education Partnership Initiative (MEPI) grant from the Office of Global AIDS Coordinator [5R24TW008886]; U. S. Department of Health and Human Services, Health Resources and Services Administration; National Institutes of Health; federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under "TB Clinical Diagnostics Research Consortium" [HHSN2722000900050C]; Johns Hopkins University Center for AIDS Research (National Institute of Allergy and Infectious Diseases) [1P30AI094189]; FOGARTY INTERNATIONAL CENTER [R24TW008886, D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K24AI104830] Funding Source: NIH RePORTER	Medical Education for Equitable Services to All Ugandans (MESAU); Medical Education Partnership Initiative (MEPI) grant from the Office of Global AIDS Coordinator; U. S. Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under "TB Clinical Diagnostics Research Consortium"; Johns Hopkins University Center for AIDS Research (National Institute of Allergy and Infectious Diseases); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	LN is a PhD candidate funded by Medical Education for Equitable Services to All Ugandans (MESAU), a Medical Education Partnership Initiative (MEPI) grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. The study project was funded with federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract #HHSN2722000900050C, "TB Clinical Diagnostics Research Consortium." Additional support to YCM was by the Johns Hopkins University Center for AIDS Research (Grant Number 1P30AI094189 from the National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo ST, 2012, TROP MED INT HEALTH, V17, P884, DOI 10.1111/j.1365-3156.2012.03003.x; [Anonymous], 2012, INFECTIOUS DISEASES; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Bah B, 2002, INT J TUBERC LUNG D, V6, P592; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Banda H, 2000, INT J TUBERC LUNG D, V4, P968; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Li XX, 2013, CHINESE MED J-PEKING, V126, P3662, DOI 10.3760/cma.j.issn.0366-6999.20122778; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Nakiyingi L, 2013, AFR HEALTH SCI, V13, P522, DOI 10.4314/ahs.v13i2.46; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Nakiyingi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074023; Nakiyingi Lydia, 2012, BMC Res Notes, V5, P487, DOI 10.1186/1756-0500-5-487; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; Orikiriza P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118191; Padmapriyadarsini C, 2013, JAIDS-J ACQ IMM DEF, V63, P331, DOI 10.1097/QAI.0b013e31829341af; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; Tafuma TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088654; Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Trauner A, 2014, DRUGS, V74, P1063, DOI 10.1007/s40265-014-0248-y; van't Hoog AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082786; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440; World Health Organisation, 2007, WHO HTM HIV 2007 01	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133756	10.1371/journal.pone.0133756	http://dx.doi.org/10.1371/journal.pone.0133756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222142	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800064
J	Wolf, RM; Steele, KE; Peterson, LA; Magnuson, TH; Schweitzer, MA; Wong, GW				Wolf, Risa M.; Steele, Kimberley E.; Peterson, Leigh A.; Magnuson, Thomas H.; Schweitzer, Michael A.; Wong, G. William			Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; UNITED-STATES; ADIPONECTIN; ADIPOKINE; TISSUE; GLUCOSE; PATTERNS; FAMILY; MICE	Purpose C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that lowers blood glucose levels, reduces liver triglyceride synthesis, and is protective against hepatic steatosis in diet-induced obese mouse models. We hypothesized that higher circulating serum levels of CTRP3 would be associated with a lean body mass index (BMI) and a more favorable metabolic profile in humans. The aim of this study was to investigate CTRP3 levels in lean individuals compared to obese individuals. Methods This was a cross-sectional study of obese (n=44) and lean control patients (n=60). Fasting metabolic parameters were measured in all patients and serum CTRP3 levels were measured by ELISA. Results BMI of the lean group was 21.9 +/- 0.2 kg/m(2) and obese group was 45.2 +/- 1.1 kg/m(2). We found significantly lower circulating levels of CTRP3 in obese individuals (405 +/- 8.3 vs. 436 +/- 6.7ng/mL, p=0.004) compared to the lean group. Serum CTRP3 levels were inversely correlated with BMI (p=0.001), and triglycerides (p<0.001), and significantly associated with gender (p<0.01), ethnicity (p=0.05), HDL-cholesterol (p<0.01), and adiponectin (p<0.01). We found BMI (p<0.01), gender (p< 0.01), and ethnicity (p<0.05) to be significant predictors of CTRP3 levels when controlling for age in multiple regression analysis. Conclusions CTRP3 is a beneficial adipokine whose circulating levels are significantly lower in obese individuals. Obesity causes dysregulation in adipokine production, including the down-regulation of CTRP3. Lower CTRP3 levels may contribute to the pathophysiology of metabolic disorders associated with obesity. Optimizing CTRP3 levels through novel therapies may improve obesity and its comorbidities.	[Wolf, Risa M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Steele, Kimberley E.; Peterson, Leigh A.; Magnuson, Thomas H.; Schweitzer, Michael A.] Johns Hopkins Ctr Bariatr Surg, Dept Surg, Baltimore, MD 21205 USA; [Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Wolf, Risa M.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wolf, RM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	RWolf@jhu.edu	Frame, Leigh A./L-3104-2016	Frame, Leigh A./0000-0002-1475-2778; Wong, G. William/0000-0002-5286-6506	NIDDK [DK007751]; Pediatric Endocrine Society Research Fellowship Award; Endocrine Society Endocrine Scholars Award; NIH [DK084171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, T32DK007751] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pediatric Endocrine Society Research Fellowship Award; Endocrine Society Endocrine Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R. M. W. was supported by a T32 training grant from NIDDK (DK007751), the Pediatric Endocrine Society Research Fellowship Award, and the Endocrine Society Endocrine Scholars Award. G. W. W. was supported by an NIH RO1 grant (DK084171). These funding sources played no role in the study design, collection, analysis, and interpretation of data, the writing of the manuscript and the decision to submit the manuscript for publication.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azrad M, 2013, ENDOCRINE, V43, P586, DOI 10.1007/s12020-012-9797-6; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Choi KM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-14; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hulver MW, 2004, METABOLISM, V53, P1, DOI 10.1016/j.metabol.2003.07.002; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Li XB, 2015, FOOD AGR IMMUNOL, V26, P109, DOI 10.1080/09540105.2013.873390; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Wei Z, 2014, AM J PHYSL IN PRESS; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Ye RS, 2014, ELIFE, V3, DOI 10.7554/eLife.03851; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744	40	59	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133955	10.1371/journal.pone.0133955	http://dx.doi.org/10.1371/journal.pone.0133955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222183	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800084
J	Subbaiah, VK; Zhang, Y; Rajagopalan, D; Abdullah, LN; Yeo-Teh, NSL; Tomaic, V; Banks, L; Myers, MP; Chow, EK; Jha, S				Subbaiah, V. K.; Zhang, Y.; Rajagopalan, D.; Abdullah, L. N.; Yeo-Teh, N. S. L.; Tomaic, V.; Banks, L.; Myers, M. P.; Chow, E. K.; Jha, S.			E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; HISTONE ACETYLTRANSFERASE; EDD; ACETYLATION; PROTEIN; GENE; DEGRADATION; INHIBITION; CHROMATIN; COMPLEX	Tat-interacting protein of 60 kDa (TIP60) is an essential lysine acetyltransferase implicated in transcription, DNA damage response and apoptosis. TIP60 protein expression is reduced in cancers. In cervical cancers, human papillomavirus (HPV) E6 oncogene targets cellular p53, Bak and some of the PDZ domain-containing proteins for proteasome-mediated degradation through E6AP ligase. Recently, E6 oncogene from high-risk and low-risk categories was also shown to target TIP60. However, the molecular mechanisms and whether destabilization of TIP60 contributes to HPV E6-mediated transformation remain unanswered. Our proteomic analyses revealed EDD1 (E3 identified by differential display), an E3 ligase generally overexpressed in cancers as a novel interacting partner of TIP60. By investigating protein turnover and ubiquitination assays, we show that EDD1 negatively regulates TIP60's stability through the proteasome pathway. Strikingly, HPV E6 uses this function of EDD1 to destabilize TIP60. Colony-formation assays and soft agar assays show that gain of function of TIP60 or depletion of EDD1 in HPV-positive cervical cancer cells significantly inhibits cell growth in vitro. This phenotype is strongly supported by the in-vivo studies where re-activation of TIP60 in cervical cancer cells dramatically reduces tumor formation. In summary, we have discovered a novel ligase through which E6 destabilizes TIP60. Currently, in the absence of an effective therapeutic vaccine for malignant cervical cancers, cervical cancer still remains to be a major disease burden. Hence, our studies implying a distinct tumor suppressor role for TIP60 in cervical cancers show that reactivation of TIP60 could be of therapeutic value.	[Subbaiah, V. K.; Zhang, Y.; Rajagopalan, D.; Abdullah, L. N.; Yeo-Teh, N. S. L.; Chow, E. K.; Jha, S.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Rajagopalan, D.; Jha, S.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Yeo-Teh, N. S. L.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Tomaic, V.; Banks, L.; Myers, M. P.] Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy; [Chow, E. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; International Center for Genetic Engineering & Biotechnology (ICGEB); National University of Singapore	Jha, S (corresponding author), Ctr Translat Med, 14 Med Dr,MD6-13-02J, Singapore 117599, Singapore.	csisjha@nus.edu.sg	, Subbaiah/AAB-9747-2021; Jha, Sudhakar/B-2308-2009; Jha, Sudhakar/S-3550-2019	Jha, Sudhakar/0000-0002-5093-4843; Yeo-Teh, Nicole/0000-0002-9153-9663; Krishna, Vanitha/0000-0002-0444-531X; Chow, Edward/0000-0002-3075-1898	National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative to the Cancer Science Institute of Singapore [R-713-006-014-271]; National Medical Research Council (NMRC) [CBRG-NIG BNIG11nov001]; Ministry of Education Academic Research Fund (MOE AcRF); National Research Foundation Cancer Science Institute of Singapore RCE Main Grant; National Medical Research Council (NMRC CBRG-NIG) [BNIG12nov017]	National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centers of Excellence initiative to the Cancer Science Institute of Singapore(Ministry of Education, Singapore); National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Ministry of Education Academic Research Fund (MOE AcRF); National Research Foundation Cancer Science Institute of Singapore RCE Main Grant(National Research Foundation, Singapore); National Medical Research Council (NMRC CBRG-NIG)(National Medical Research Council, Singapore)	We thank the members of the Jha laboratory for helpful discussion and comments. We thank Drs Neerja Karnani (Singapore Institute for Clinical Science, A*STAR), Daniel G Tenen (Cancer Science Institute of Singapore) and Yoshiaki Ito (Cancer Science Institute of Singapore) for their comments on the manuscript. We thank Drs Shojiro Kitajima for soft agar assays, Amit Kumar Pandey for real-time PCR and Tan Boon Toh for tumor quantification analysis. SJ was supported by grants from the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative to the Cancer Science Institute of Singapore (R-713-006-014-271), National Medical Research Council (NMRC CBRG-NIG BNIG11nov001) and Ministry of Education Academic Research Fund (MOE AcRF Tier 1 T1-2012 Oct-04). EKC was supported by grants from the National Research Foundation Cancer Science Institute of Singapore RCE Main Grant, National Medical Research Council (NMRC CBRG-NIG BNIG12nov017) and Ministry of Education Academic Research Fund (MOE AcRF Tier 1 T1-2012 Oct-11).	Alpsoy A, 2014, BIOMED PHARMACOTHER, V68, P351, DOI 10.1016/j.biopha.2013.09.007; Awasthi S, 2005, MOL CELL BIOL, V25, P6178, DOI 10.1128/MCB.25.14.6178-6198.2005; Bradley A, 2014, CARCINOGENESIS, V35, P1100, DOI 10.1093/carcin/bgt489; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chou SW, 2009, ANTIMICROB AGENTS CH, V53, P81, DOI 10.1128/AAC.01177-08; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gupta A, 2013, ONCOGENE, V32, P5017, DOI 10.1038/onc.2012.534; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lee MT, 2013, J BIOL CHEM, V288, P25038, DOI 10.1074/jbc.M113.476952; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Mahajan MA, 2014, MOL CELL ENDOCRINOL, V382, P159, DOI 10.1016/j.mce.2013.09.021; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mori Y, 2002, CANCER RES, V62, P3641; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Reitsma JM, 2011, CELL HOST MICROBE, V9, P103, DOI 10.1016/j.chom.2011.01.006; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sho T, 2011, BBA-MOL CELL RES, V1813, P1245, DOI 10.1016/j.bbamcr.2011.03.018; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Subbaiah VK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002543; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Tomaic V, 2011, J VIROL, V85, P3120, DOI 10.1128/JVI.02004-10; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Zheng H, 2013, MOL CELL, V50, P699, DOI 10.1016/j.molcel.2013.04.013	46	37	40	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2062	2074		10.1038/onc.2015.268	http://dx.doi.org/10.1038/onc.2015.268			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26234678				2022-12-26	WOS:000374505600006
J	Clark, AL; Naya, FJ				Clark, Amanda L.; Naya, Francisco J.			MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; MYOCARDIAL-INFARCTION; HEART DEVELOPMENT; TFAP2B MUTATIONS; CELL-CYCLE; GENE; IDENTIFICATION; EXPRESSION; DEFECTS; PROTEIN	Understanding cell cycle regulation in postmitotic cardiomyocytes may lead to new therapeutic approaches to regenerate damaged cardiac tissue. We have demonstrated previously that microRNAs encoded by the Gtl2-Dio3 noncoding RNA locus function downstream of the MEF2A transcription factor in skeletal muscle regeneration. We have also reported expression of these miRNAs in the heart. Here we investigated the role of two Gtl2-Dio3 miRNAs, miR-410 and miR-495, in cardiac muscle. Overexpression of miR-410 and miR-495 robustly stimulated cardiomyocyte DNA synthesis and proliferation. Interestingly, unlike our findings in skeletal muscle, these miRNAs did not modulate the activity of the WNT signaling pathway. Instead, these miRNAs targeted Cited2, a coactivator required for proper cardiac development. Consistent with miR-410 and miR-495 overexpression, siRNA knockdown of Cited2 in neonatal cardiomyocytes resulted in robust proliferation. This phenotype was associated with reduced expression of Cdkn1c/p57/ Kip2, a cell cycle inhibitor, and increased expression of VEGFA, a growth factor with proliferation-promoting effects. Therefore, miR-410 and miR-495 are among a growing number of miRNAs that have the ability to potently stimulate neonatal cardiomyocyte proliferation.	[Clark, Amanda L.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			NHLBI, National Institutes of Health [HL73304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL73304 (to F. J. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Chu HY, 2014, TUMOR BIOL, V35, P3487, DOI 10.1007/s13277-013-1460-1; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; EDELHOFF S, 1993, GENOMICS, V17, P93, DOI 10.1006/geno.1993.1288; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Feng T, 2015, CLIN SCI, V128, P761, DOI 10.1042/CS20140606; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Janssen R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00171; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Kobayashi Y, 2005, HYPERTENS RES, V28, P229, DOI 10.1291/hypres.28.229; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu D, 2015, THROMB RES, V135, P146, DOI 10.1016/j.thromres.2014.10.027; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Mani A, 2005, P NATL ACAD SCI USA, V102, P2975, DOI 10.1073/pnas.0409852102; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Otte C, 2010, J CLIN ENDOCR METAB, V95, P2885, DOI 10.1210/jc.2009-2251; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Takakura S, 2001, INT J ONCOL, V18, P817; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Tian Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010841; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057; Zhao D, 2015, MOL CELL BIOCHEM, V400, P87, DOI 10.1007/s11010-014-2265-2; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	58	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23162	23172		10.1074/jbc.M115.672659	http://dx.doi.org/10.1074/jbc.M115.672659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240138	Green Published, hybrid			2022-12-26	WOS:000361685500027
J	Callaway, CW; Elmer, J; Guyette, FX; Molyneaux, BJ; Anderson, KB; Empey, PE; Gerstel, SJ; Holquist, K; Repine, MJ; Rittenberger, JC				Callaway, Clifton W.; Elmer, Jonathan; Guyette, Francis X.; Molyneaux, Bradley J.; Anderson, Kacey B.; Empey, Philip E.; Gerstel, Stacy J.; Holquist, Kate; Repine, Melissa J.; Rittenberger, Jon C.			Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PERCUTANEOUS CORONARY INTERVENTION; TARGETED TEMPERATURE MANAGEMENT; RANDOMIZED CLINICAL-TRIAL; 4-DEGREES-C NORMAL SALINE; AGITATION-SEDATION SCALE; HOSPITAL CARDIAC-ARREST; HEALTHY-VOLUNTEERS; INTENSIVE-CARE; ADDITIVELY REDUCE	Background and Purpose Reducing body temperature can prolong tolerance to ischemic injury such as stroke or myocardial infarction, but is difficult and uncomfortable in awake patients because of shivering. We tested the efficacy and safety of the alpha-2-adrenergic agonist dexmedetomidine for suppressing shivering induced by a rapid infusion of cold intravenous fluids. Methods Ten subjects received a rapid intravenous infusion of two liters of cold (4 degrees C) isotonic saline on two separate test days, and we measured their core body temperature, shivering, hemodynamics and sedation for two hours. On one test day, fluid infusion was preceded by placebo infusion. On the other test day, fluid infusion was preceded by 1.0 mu g/kg bolus of dexmedetomidine over 10 minutes. Results All ten subjects experienced shivering on placebo days, with shivering beginning at a mean (SD) temperature of 36.6 (0.3)degrees C. The mean lowest temperature after placebo was 36.0 (0.3)degrees C (range 35.7-36.5 degrees C). Only 3/10 subjects shivered on dexmedetomidine days, and the mean lowest temperature was 35.7 (0.4)degrees C (range 35.0-36.3 degrees C). Temperature remained below 36 degrees C for the full two hours in 6/10 subjects. After dexmedetomidine, subjects had moderate sedation and a mean 26 (13) mmHg reduction in blood pressure that resolved within 90 minutes. Heart rate declined a mean 23 (11) bpm after both placebo and dexmedetomidine. Dexmedetomidine produced no respiratory depression. Conclusion Dexmedetomidine decreases shivering in normal volunteers. This effect is associated with decreased systolic blood pressure and sedation, but no respiratory depression.	[Callaway, Clifton W.; Elmer, Jonathan; Guyette, Francis X.; Gerstel, Stacy J.; Holquist, Kate; Repine, Melissa J.; Rittenberger, Jon C.] Univ Pittsburgh, Appl Physiol Lab, Dept Emergency Med, Pittsburgh, PA 15260 USA; [Elmer, Jonathan; Molyneaux, Bradley J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Anderson, Kacey B.; Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rittenberger, JC (corresponding author), Univ Pittsburgh, Appl Physiol Lab, Dept Emergency Med, Pittsburgh, PA 15260 USA.	rittjc@upmc.edu	Empey, Philip/L-9604-2019; , Francis/AAE-1586-2022	Empey, Philip/0000-0001-7474-2339; 	Pittsburgh Emergency Medicine Foundation; National Heart, Lung and Blood Institute - NHLBI [5K12HL109068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER	Pittsburgh Emergency Medicine Foundation; National Heart, Lung and Blood Institute - NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Pittsburgh Emergency Medicine Foundation (www.pemf.net) (JCR), and National Heart, Lung and Blood Institute - NHLBI 5K12HL109068 (http://www.nhlbi.nih.gov/research/training/emergency-med-k12) (JE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; De Wolf AM, 2001, ANESTH ANALG, V93, P1205, DOI 10.1097/00000539-200111000-00031; Dewhirst Elisabeth, 2011, J Pediatr Pharmacol Ther, V16, P113, DOI 10.5863/1551-6776-16.2.113; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; DYCK JB, 1993, ANESTHESIOLOGY, V78, P813, DOI 10.1097/00000542-199305000-00002; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Holliday SF, 2014, SCI WORLD J, DOI 10.1155/2014/805013; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Hostler D, 2009, APPL PHYSIOL NUTR ME, V34, P582, DOI 10.1139/H09-011; Iirola T, 2011, CRIT CARE, V15, DOI 10.1186/cc10518; Jakob SM, 2014, BRIT J ANAESTH, V112, P581, DOI 10.1093/bja/aeu032; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kimberger O, 2007, CRIT CARE, V11, DOI 10.1186/cc5709; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Komatsu R, 2006, BRIT J ANAESTH, V96, P732, DOI 10.1093/bja/ael101; Kurz A, 1997, ANESTHESIOLOGY, V86, P1046, DOI 10.1097/00000542-199705000-00007; Lenhardt R, 2009, ANESTHESIOLOGY, V111, P110, DOI 10.1097/ALN.0b013e3181a979a3; Li WJ, 2009, J PHARMACEUT BIOMED, V50, P897, DOI 10.1016/j.jpba.2009.06.012; Liu Y, 2013, CASE REP MED, V2013, DOI 10.1155/2013/358182; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Lyden Patrick D, 2005, J Stroke Cerebrovasc Dis, V14, P107, DOI 10.1016/j.jstrokecerebrovasdis.2005.01.001; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Madden CJ, 2013, J NEUROSCI, V33, P2017, DOI 10.1523/JNEUROSCI.4701-12.2013; MCCLEARY P, 1982, NEUROPHARMACOLOGY, V21, P1337, DOI 10.1016/0028-3908(82)90143-5; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; Paris A, 2005, ANESTH ANALG, V100, P102, DOI 10.1213/01.ANE.0000139355.86522.D1; Richards JR, 2015, DRUG ALCOHOL DEPEN, V150, P1, DOI 10.1016/j.drugalcdep.2015.01.040; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rincon F, 2014, INT J STROKE, V9, P646, DOI 10.1111/ijs.12220; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Takada K, 2002, ANESTHESIOLOGY, V96, P1420, DOI 10.1097/00000542-200206000-00022; Talke P, 1997, ANESTHESIOLOGY, V87, P835, DOI 10.1097/00000542-199710000-00017; Valitalo PA, 2013, CLIN DRUG INVEST, V33, P579, DOI 10.1007/s40261-013-0101-1; Venn RM, 2002, BRIT J ANAESTH, V88, P669, DOI 10.1093/bja/88.5.669	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0129709	10.1371/journal.pone.0129709	http://dx.doi.org/10.1371/journal.pone.0129709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237219	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400004
J	Espinar, MJ; Miranda, IM; Costa-de-Oliveira, S; Rocha, R; Rodrigues, AG; Pina-Vaz, C				Espinar, Maria Jose; Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Rocha, Rita; Rodrigues, Acacio G.; Pina-Vaz, Cidalia			Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum beta-Lactamases: Risk Factors and Molecular Epidemiology	PLOS ONE			English	Article							AMPLIFIED POLYMORPHIC DNA; INTENSIVE-CARE-UNIT; CTX-M ENZYMES; RENAL-TRANSPLANTATION; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; RECIPIENTS; COMMUNITY; RECURRENT; BACTEREMIA	Urinary tract infection (UTI) is a common complication after kidney transplantation, often associated to graft loss and increased healthcare costs. Kidney transplant patients (KTPs) are particularly susceptible to infection by Enterobacteriaceae-producing extended-spectrum beta-lactamases (ESBLs). A retrospective case-control study was conducted to identify independent risk factors for ESBL-producing Escherichia coli and Klebsiella pneumoniae in non-hospitalized KTPs with UTI. Forty-nine patients suffering from UTI by ESBL-producing bacteria (ESBL-P) as case group and the same number of patients with UTI by ESBL negative (ESBL-N) as control-group were compared. Clinical data, renal function parameters during UTI episodes, UTI recurrence and relapsing rate, as well as risk factors for recurrence, molecular characterization of isolates and the respective antimicrobial susceptibility profile were evaluated. Diabetes mellitus (p <0.007), previous antibiotic prophylaxis (p=0.017) or therapy (p<0.001), previous UTI (p=0.01), relapsing infection (p=0.019) and patients with delayed graft function after transplant (p=0.001) represented risk factors for infection by ESBL positive Enterobacteriaceae in KTPs. Interestingly, the period of time between data of transplantation and data of UTI was shorter in case of ESBL-P case-group (28.8 months) compared with ESBL-N control-group (50.9 months). ESBL-producing bacteria exhibited higher resistance to fluoroquinolones (p=0.002), trimethoprim-sulfamethoxazole (p<0.001) and gentamicin (p<0.001). Molecular analysis showed that bla(CTX-M) was the most common ESBL encoding gene (65.3%), although in 55.1% of the cases more than one ESBL gene was found. In 29.4% of K. pneumoniae isolates, three bla-genes (bla(CTX-M)-bla(TEM)-bla(SHV)) were simultaneously detected. Low estimated glomerular filtration rate (p=0.009) was found to be risk factor for UTI recurrence. Over 60% of recurrent UTI episodes were caused by genetically similar strains. UTI by ESBL-producing	[Espinar, Maria Jose; Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Rocha, Rita; Rodrigues, Acacio G.; Pina-Vaz, Cidalia] Univ Porto, Fac Med, Dept Microbiol, P-4100 Oporto, Portugal; [Espinar, Maria Jose; Rodrigues, Acacio G.; Pina-Vaz, Cidalia] Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal; [Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Pina-Vaz, Cidalia] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Pina-Vaz, C (corresponding author), Univ Porto, Fac Med, Dept Microbiol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cpinavaz@yahoo.com	Pina-Vaz, Cidália/K-1835-2013; Miranda, Isabel M./B-2017-2009; Oliveira, Sofia/K-2156-2013; Rodrigues, Acacio G/K-1467-2013; Rocha, Rita/M-9564-2013	Pina-Vaz, Cidália/0000-0003-4936-1301; Miranda, Isabel M./0000-0003-4839-1613; Oliveira, Sofia/0000-0003-2899-6615; Rodrigues, Acacio G/0000-0003-4246-5212; Rocha, Rita/0000-0003-1193-8320				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Ariza-Heredia EJ, 2013, ANN TRANSPL, V18, P195, DOI 10.12659/AOT.883901; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Bodro M, 2015, AM J TRANSPLANT, V15, P1021, DOI 10.1111/ajt.13075; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; BRADFORD PA, 1995, ANTIMICROB AGENTS CH, V39, P899, DOI 10.1128/AAC.39.4.899; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; CLSI, 2011, M100S20 CLSI, P172; Coque TM, 2008, EURO SURVEILL, V13; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P297, DOI 10.1093/jac/dkq463; EISEN D, 1995, J CLIN MICROBIOL, V33, P713, DOI 10.1128/JCM.33.3.713-717.1995; Espinar MJ, 2011, J MED MICROBIOL, V60, P756, DOI 10.1099/jmm.0.024075-0; Goyal A, 2009, INDIAN J MED RES, V129, P695; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2013, AM J KIDNEY DIS, V61, P686, DOI 10.1053/j.ajkd.2013.03.003; Lim JH, 2013, TRANSPL P, V45, P1584, DOI 10.1016/j.transproceed.2012.12.011; Linares L, 2008, AM J TRANSPLANT, V8, P1000, DOI 10.1111/j.1600-6143.2008.02197.x; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lucet JC, 1996, CLIN INFECT DIS, V22, P430, DOI 10.1093/clinids/22.3.430; Machado E, 2007, J ANTIMICROB CHEMOTH, V60, P1370, DOI 10.1093/jac/dkm381; Mendonca N, 2007, ANTIMICROB AGENTS CH, V51, P1946, DOI 10.1128/AAC.01412-06; Mitra Subhashis, 2011, Curr Infect Dis Rep, V13, P579, DOI 10.1007/s11908-011-0210-z; Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pinheiro HS, 2010, TRANSPL P, V42, P486, DOI 10.1016/j.transproceed.2010.02.002; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pournaras S, 2004, J ANTIMICROB CHEMOTH, V54, P574, DOI 10.1093/jac/dkh323; Ramadas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091289; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Vidal E, 2012, TRANSPL INFECT DIS, V14, P595, DOI 10.1111/j.1399-3062.2012.00744.x; WONG NACS, 1994, EPIDEMIOL INFECT, V113, P445, DOI 10.1017/S095026880006845X; Wu SW, 2013, J FORMOS MED ASSOC, V112, P138, DOI 10.1016/j.jfma.2012.01.010	40	42	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134737	10.1371/journal.pone.0134737	http://dx.doi.org/10.1371/journal.pone.0134737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237422	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942400036
J	Abramczuk, E; Stepinska, J; Hryniewiecki, T				Abramczuk, Elzbieta; Stepinska, Janina; Hryniewiecki, Tomasz			Twenty-Year Experience in the Diagnosis and Treatment of Infective Endocarditis	PLOS ONE			English	Article							PROSTHETIC VALVE ENDOCARDITIS; LONG-TERM PROGNOSIS; CLINICAL-FEATURES; RISK-FACTORS; EPIDEMIOLOGY; REPLACEMENT; 10-YEAR; SURGERY; CULTURE; MICROBIOLOGY	Aims The aim of this study was to compare the etiology, clinical course, selected diagnostic methods and efficacy of the treatment used in patients with infective endocarditis (IE) in the nineteen eighties and nineties. Material and Methods The study group comprised 300 patients with infective endocarditis hospitalized in the Institute of Cardiology in Warsaw in the following years: from 1982 to 1987 (150 patients: 75 successive patients with IE on the prosthetic valve and 75 successive patients with IE on the native valve), as well as from 1990 to 2003 (150 patients: 75 successive patients with IE on the prosthetic valve and 75 successive patients with IE on the native valve). Results In the nineties, immunological symptoms, embolism formation and progressive heart failure were diagnosed decidedly more frequently. Early prosthetic valve endocarditis (PVE) (up to 60 days after operation) occurred significantly more frequently in the eighties. The quantity of negative blood cultures in PVE has not decreased, it is still observed in over 20% of cases. For 20 years the etiology of PVE has remained the same, the dominant pathogen remains Staphylococcus. The frequency of PVE caused by Streptococci has markedly reduced. In both the decades analyzed the etiology of native valve endocarditis (NVE) was similar. In the eighties Streptococcus was predominant. In successive years the number of infections caused by Staphylococci was the same as that caused by Streptococci. Conclusions The incidence of early PVE decreased in the nineties. More patients were treated surgically with lesser peri-operative mortality. A lower incidence of infective endocarditis on prosthetic valves caused by streptococci may signify better prophylaxis against infective endocarditis. Infective endocarditis with sterile blood cultures continues to occur frequently.	[Abramczuk, Elzbieta; Stepinska, Janina; Hryniewiecki, Tomasz] Inst Cardiol, Warsaw, Poland	Institute of Cardiology - Poland	Abramczuk, E (corresponding author), Inst Cardiol, Warsaw, Poland.	e.abramczuk@ikard.pl						Ako J, 2003, CIRC J, V67, P3, DOI 10.1253/circj.67.3; Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; Bayer A, AM J MED, V96, P211; Castillo JC, 2000, HEART, V83, P525, DOI 10.1136/heart.83.5.525; Castillo JC, 2004, AM J CARDIOL, V93, P1185, DOI 10.1016/j.amjcard.2004.01.056; Castillo JC, 2002, AM J CARDIOL, V90, P1266, DOI 10.1016/S0002-9149(02)02851-5; Cecchi E, 2015, INT J CARDIOL, V190, P151, DOI 10.1016/j.ijcard.2015.04.123; Choussat R, 1999, EUR HEART J, V20, P232, DOI 10.1053/euhj.1998.1240; DELAHAYE F, 1995, EUR HEART J, V16, P48, DOI 10.1093/eurheartj/16.suppl_B.48; Delay D, 2000, ANN THORAC SURG, V70, P1219, DOI 10.1016/S0003-4975(00)01887-7; Dunne B, 2014, HEART LUNG CIRC, V23, P628, DOI 10.1016/j.hlc.2014.02.010; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Fefer P, 2002, EUR J CLIN MICROBIOL, V21, P432, DOI 10.1007/s10096-002-0740-2; FOWLER VG, 1994, CURR OPIN CARDIOL, V9, P389, DOI 10.1097/00001573-199405000-00018; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Hryniewiecki T, 2002, J HEART VALVE DIS, V11, P870; IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223; Karchmer AW, 1992, INFECT ENDOCARDITIS, P225; KAY JH, 1961, NEW ENGL J MED, V264, P907, DOI 10.1056/NEJM196105042641804; KUYVENHOVEN JP, 1994, EUR J CARDIO-THORAC, V8, P420, DOI 10.1016/1010-7940(94)90083-3; Lamas CC, 1998, HEART, V79, P442, DOI 10.1136/hrt.79.5.442; Lytle BW, 1996, J THORAC CARDIOV SUR, V111, P198, DOI 10.1016/S0022-5223(96)70417-8; Mangoni ED, 2003, AM HEART J, V146, P311, DOI 10.1016/S0002-8703(02)94802-7; Marks DJB, 2015, QJM-INT J MED, V108, P219, DOI 10.1093/qjmed/hcu188; Morris AJ, 2003, CLIN INFECT DIS, V36, P697, DOI 10.1086/367842; Murtagh B, 2003, CURR OPIN CARDIOL, V18, P106, DOI 10.1097/00001573-200303000-00006; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; NISSEN H, 1992, EUR HEART J, V13, P872, DOI 10.1093/oxfordjournals.eurheartj.a060285; Pansini S, 1997, J HEART VALVE DIS, V6, P84; Pant S, 2015, J AM COLL CARDIOL, V65, P2070, DOI 10.1016/j.jacc.2015.03.518; Poesen K, 2014, ACTA CLIN BELG, V69, P183, DOI 10.1179/0001551214Z.00000000046; Prendergast BD, 2002, BRIT MED J, V325, P845, DOI 10.1136/bmj.325.7369.845; Raoult D, 1999, ANN INTERN MED, V131, P144, DOI 10.7326/0003-4819-131-2-199907200-00012; Renzulli A, 2000, EUR J CARDIO-THORAC, V17, P228, DOI 10.1016/S1010-7940(00)00342-0; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sexton Daniel J., 2003, Cardiology Clinics, V21, P273, DOI 10.1016/S0733-8651(03)00031-6; Thalme A, 1996, SCAND J INFECT DIS, V28, P407, DOI 10.3109/00365549609037928; TORNOS P, 1992, CHEST, V101, P37, DOI 10.1378/chest.101.1.37; Tornos P, 1995, EUR HEART J, V16, P1686; Tunkel A.R., 1992, INFECT ENDOCARDITIS, P85; Vlessis AA, 1996, ANN THORAC SURG, V61, P1217, DOI 10.1016/0003-4975(96)00029-X; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WALLACE AG, 1965, CIRCULATION, V31, P450, DOI 10.1161/01.CIR.31.3.450; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Watkin RW, 2003, J INFECTION, V47, P1, DOI 10.1016/S0163-4453(03)00003-3; Yankah AC, 2002, EUR J CARDIO-THORAC, V21, P260, DOI 10.1016/S1010-7940(01)01084-3	48	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134021	10.1371/journal.pone.0134021	http://dx.doi.org/10.1371/journal.pone.0134021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230402	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400068
J	Eikmeyer, FG; Heinl, S; Marx, H; Puhler, A; Grabherr, R; Schluter, A				Eikmeyer, Felix Gregor; Heinl, Stefan; Marx, Hans; Puehler, Alfred; Grabherr, Reingard; Schlueter, Andreas			Identification of Oxygen-Responsive Transcripts in the Silage Inoculant Lactobacillus buchneri CD034 by RNA Sequencing	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; AEROBIC STABILITY; PYRUVATE OXIDASE; GENE-EXPRESSION; GRASS-SILAGE; ACETIC-ACID; GROWTH; PLANTARUM; PHASE; STRESS	The Lactobacillus buchneri CD034 strain, known to improve the ensiling process of green fodder and the quality of the silage itself was transcriptionally analyzed by sequencing of transcriptomes isolated under anaerobic vs. aerobic conditions. L. buchneri CD034 was first cultivated under anaerobic conditions and then shifted to aerobic conditions by aeration with 21% oxygen. Cultivations already showed that oxygen was consumed by L. buchneri CD034 after aeration of the culture while growth of L. buchneri CD034 was still observed. RNA sequencing data revealed that irrespective of the oxygen status of the culture, the most abundantly transcribed genes are required for basic cell functions such as protein biosynthesis, energy metabolism and lactic acid fermentation. Under aerobic conditions, 283 genes were found to be transcriptionally up-regulated while 198 genes were found to be down-regulated (p-value < 0.01). Up-regulated genes i.a. play a role in oxygen consumption via oxidation of pyruvate or lactate (pox, lctO). Additionally, genes encoding proteins required for decomposition of reactive oxygen species (ROS) such as glutathione reductase or NADH peroxidase were also found to be up-regulated. Genes related to pH homeostasis and redox potential balance were found to be down-regulated under aerobic conditions. Overall, genes required for lactic acid fermentation were hardly affected by the growth conditions applied. Genes identified to be differentially transcribed depending on the aeration status of the culture are suggested to specify the favorable performance of the strain in silage formation.	[Eikmeyer, Felix Gregor; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Heinl, Stefan; Grabherr, Reingard] Univ Nat Resources & Life Sci, CD Lab Genet Engn Lact Acid Bacteria, Vienna, Austria; [Marx, Hans] Univ Nat Resources & Life Sci, CD Lab Biotechnol Glycerol, Vienna, Austria; [Heinl, Stefan; Marx, Hans; Grabherr, Reingard] Univ Nat Resources & Life Sci, Dept Biotechnol, BOKU VIBT, Vienna, Austria	University of Bielefeld; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Schluter, A (corresponding author), Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany.	aschluet@cebitec.uni-bielefeld.de		Schluter, Andreas/0000-0003-4830-310X; Marx, Hans/0000-0002-0451-1719; Grabherr, Reingard/0000-0002-4501-927X; Puhler, Alfred/0000-0003-4723-2960	CLIB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia; Bielefeld University; Deutsche Forschungsgemeinschaft	CLIB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia; Bielefeld University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by CLIB Graduate Cluster 'Industrial Biotechnology' (www.graduatecluster.net), cofinanced by the Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia (www.wissenschaft.nrw.de) and Bielefeld University (www.uni-bielefeld.de), without grant number SH HM RG: Christian Doppler Forschungsgesellschaft (www.cdg.ac.at), without grant number FGE SH HM AP RG AS: Funding of the Article Processing Charge by the Deutsche Forschungsgemeinschaft (www.dfg.de) and the Open Access Publication Fund of Bielefeld University, without grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Arena ME, 2008, J APPL MICROBIOL, V105, P158, DOI 10.1111/j.1365-2672.2008.03725.x; Azcarate-Peril MA, 2009, J DAIRY SCI, V92, P870, DOI 10.3168/jds.2008-1457; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrangou R, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P77; BOBILLO M, 1991, Food Microbiology (London), V8, P153, DOI 10.1016/0740-0020(91)90008-P; Burge SW, 2012, NUCL ACIDS RES, DOI 101093/nar/gks1005; Cesselin B, 2011, FOOD MICROBIOL FOOD, P111, DOI 10.1007/978-0-387-92771-8_6; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; CONDON S, 1987, FEMS MICROBIOL LETT, V46, P269, DOI 10.1111/j.1574-6968.1987.tb02465.x; Danner H, 2003, APPL ENVIRON MICROB, V69, P562, DOI 10.1128/AEM.69.1.562-567.2003; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Driehuis F, 2001, GRASS FORAGE SCI, V56, P330, DOI 10.1046/j.1365-2494.2001.00282.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eikmeyer FG, 2013, J BIOTECHNOL, V167, P334, DOI 10.1016/j.jbiotec.2013.07.021; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Heinl S, 2012, J BIOTECHNOL, V161, P153, DOI 10.1016/j.jbiotec.2012.03.007; Heinl S, 2011, PLASMID, V66, P159, DOI 10.1016/j.plasmid.2011.08.002; Hertel C, 1998, APPL ENVIRON MICROB, V64, P1359; Hertzberger R, 2014, APPL ENVIRON MICROB, V80, P2229, DOI 10.1128/AEM.04272-13; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Holzer M, 2003, TRENDS BIOTECHNOL, V21, P282, DOI 10.1016/S0167-7799(03)00106-9; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Ishak N, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-47; Khudyakov JI, 2012, P NATL ACAD SCI USA, V109, pE2173, DOI 10.1073/pnas.1112750109; Kim JH, 2009, MICROBIOL-SGM, V155, P1351, DOI 10.1099/mic.0.024653-0; Kleinschmit DH, 2006, J DAIRY SCI, V89, P4005, DOI 10.3168/jds.S0022-0302(06)72444-4; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, DETAILS FOR LACTOBAC; [LGC Standards American Type Culture Collection (ATCC)], LACT BUCHN HENN BERG; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Pahlow G., 2003, SILAGE SCI TECHNOL, V42, P31, DOI [DOI 10.2134/AGRONMONOGR42.C2, 10.]; Pieterse B, 2006, J MICROBIOL METH, V64, P207, DOI 10.1016/j.mimet.2005.04.035; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Schwientek P, 2013, J BIOTECHNOL, V167, P166, DOI 10.1016/j.jbiotec.2012.10.019; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Suarez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076170; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Woolford M.K., 1998, MICROBIOLOGY FERMENT, P73, DOI [10.1007/978-1-4613-0309-1_3, DOI 10.1007/978-1-4613-0309-1_3]; Wu R, 2009, MOL CELL PROTEOMICS, V8, P2321, DOI 10.1074/mcp.M800483-MCP200; Zeng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060465; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	55	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134149	10.1371/journal.pone.0134149	http://dx.doi.org/10.1371/journal.pone.0134149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230316	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400078
J	Helbig, AK; Stockl, D; Heier, M; Ladwig, KH; Meisinger, C				Helbig, A. Katharina; Stoeckl, Doris; Heier, Margit; Ladwig, Karl-Heinz; Meisinger, Christa			Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CAUSE-SPECIFIC MORTALITY; GERMAN HEALTH INTERVIEW; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; RISK-FACTOR; GENERAL-POPULATION; SEVERITY INDEX; QUALITY INDEX; HEART-DISEASE	Objective To examine the relationship between symptoms of insomnia and sleep duration and incident total (non-fatal plus fatal) strokes, non-fatal strokes, and fatal strokes in a large cohort of men and women from the general population in Germany. Methods In four population-based MONICA (monitoring trends and determinants in cardiovascular disease)/KORA (Cooperative Health Research in the Region of Augsburg) surveys conducted between 1984 and 2001, 17,604 men and women (aged 25 to 74 years) were asked about issues like sleep, health behavior, and medical history. In subsequent surveys and mortality follow-ups, incident stroke cases (cerebral hemorrhage, ischemic stroke, transient ischemic attack, unknown stroke type) were gathered prospectively until 2009. Sex-specific hazard ratios (HR) and their 95% confidence intervals (CI) were estimated using sequential Cox proportional hazards regression models. Results During a mean follow-up of 14 years, 917 strokes (710 non-fatal strokes and 207 fatal strokes) were observed. Trouble falling asleep and difficulty staying asleep were not significantly related to any incident stroke outcome in either sex in the multivariable models. Among men, the HR for the association between short (<= 5 hours) and long (>= 10 hours) daily sleep duration and total strokes were 1.44 (95% CI: 1.01-2.06) and 1.63 (95% CI: 1.16-2.29), after adjustment for basic confounding variables. As for non-fatal strokes and fatal strokes, in the analyses adjusted for age, survey, education, physical activity, alcohol consumption, smoking habits, body mass index, hypertension, diabetes, and dyslipidemia, the increased risks persisted, albeit somewhat attenuated, but no longer remained significant. Among women, in the multivariable analyses the quantity of sleep was also not related to any stroke outcome. Conclusion In the present study, symptoms of insomnia and exceptional sleep duration were not significantly predictive of incident total strokes, non-fatal strokes, and fatal strokes in either sex.	[Helbig, A. Katharina; Stoeckl, Doris; Heier, Margit; Ladwig, Karl-Heinz; Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Ladwig, Karl-Heinz] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Helbig, AK (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.	Katharina.Helbig@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Ladwig, Karl-Heinz/B-5351-2014	Ladwig, Karl-Heinz/0000-0003-0710-1720; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research, and Technology; state of Bavaria	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education, Science, Research, and Technology; state of Bavaria	The KORA (Cooperative Research in the Region of Augsburg) research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research, and Technology and by the state of Bavaria.	Aggarwal S, 2013, CLIN CARDIOL, V36, P671, DOI 10.1002/clc.22160; Aldabal Laila, 2011, Open Respir Med J, V5, P31, DOI 10.2174/1874306401105010031; Allison P, 2010, SURVIVAL ANAL USING; Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Amagai Y, 2004, J EPIDEMIOL, V14, P124, DOI 10.2188/jea.14.124; Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Birbaumer N., 2010, BIOL PSYCHOL, DOI [10.1007/978-3-540-95938-0, DOI 10.1007/978-3-540-95938-0]; BLIWISE DL, 1994, J CLIN EPIDEMIOL, V47, P35, DOI 10.1016/0895-4356(94)90031-0; Blomstrand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005173; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cai H, 2015, SLEEP, V38, P529, DOI 10.5665/sleep.4564; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chalmers J, 1999, J HYPERTENS, V17, P151; Chang JJ, 2012, J RURAL HEALTH, V28, P268, DOI 10.1111/j.1748-0361.2011.00398.x; Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; COX DR, 1972, J R STAT SOC B, V34, P187; Ellis JG, 2014, SLEEP, V37, P97, DOI 10.5665/sleep.3316; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Epstein JF, 2001, PUBLIC OPIN QUART, V65, P529, DOI 10.1086/323577; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; German Society for General Medicine and Family Medicine (DEGAM), 2012, STROK DEGAM GUID NUM; Gillum RF, 2001, INT J OBESITY, V25, P628, DOI 10.1038/sj.ijo.0801590; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grandner MA, 2007, SLEEP MED REV, V11, P341, DOI 10.1016/j.smrv.2007.03.010; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Green MJ, 2012, SLEEP, V35, P815, DOI 10.5665/sleep.1882; Hamazaki Y, 2011, SCAND J WORK ENV HEA, V37, P411, DOI 10.5271/sjweh.3168; Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017; Icks A, 2009, DIABETOLOGIA, V52, P1836, DOI 10.1007/s00125-009-1434-4; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jackowska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047292; Kakizaki M, 2013, J SLEEP RES, V22, P209, DOI 10.1111/j.1365-2869.2012.01053.x; Kim Y, 2013, PREV MED, V57, P377, DOI 10.1016/j.ypmed.2013.06.017; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Ladwig KH, 2004, ANN EPIDEMIOL, V14, P332, DOI 10.1016/j.annepidem.2003.09.003; Larsson SC, 2015, NEUROLOGY; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leng Y, 2015, NEUROLOGY, V84, P1072, DOI 10.1212/WNL.0000000000001371; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magee CA, 2012, J SLEEP RES, V21, P441, DOI 10.1111/j.1365-2869.2011.00993.x; Mallampalli MP, 2014, J WOMENS HEALTH, V23, P553, DOI 10.1089/jwh.2014.4816; Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2005, DIABETOLOGIA, V48, P235, DOI 10.1007/s00125-004-1634-x; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Michal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104324; Morin CM, 2014, SLEEP, V37, P319, DOI 10.5665/sleep.3406; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Morphy H, 2007, SLEEP, V30, P274; Palma JA, 2013, SLEEP MED, V14, P229, DOI 10.1016/j.sleep.2012.11.019; Pan A, 2014, STROKE; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patyar S, 2015, J STROKE CEREBROVASC, V24, P905, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.038; Phillips CL, 2013, NAT SCI SLEEP, V5, P43, DOI 10.2147/NSS.S34841; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Robert Koch-Institut, 2005, USITC PUBL, V27; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Schlack R, 2013, BUNDESGESUNDHEITSBLA, V56, P740, DOI 10.1007/s00103-013-1689-2; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Tikk K, 2014, STROKE, V45, P2041, DOI 10.1161/STROKEAHA.114.005025; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; UN, 2013, WORLD POP AG 2013; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; von dem Knesebeck O, 1998, SUBJECTIVE HLTH ELDE; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; von Zerssen D, 1976, PSYCHOMANUAL MAIN PA; Westerlund A, 2013, EUR J EPIDEMIOL, V28, P463, DOI 10.1007/s10654-013-9802-2; WRIGHT BM, 1970, LANCET, V1, P337; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675	94	32	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134480	10.1371/journal.pone.0134480	http://dx.doi.org/10.1371/journal.pone.0134480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230576	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400125
J	Kana, J; Tahovska, K; Kopacek, J; Santruckova, H				Kana, Jiri; Tahovska, Karolina; Kopacek, Jiri; Santruckova, Hana			Excess of Organic Carbon in Mountain Spruce Forest Soils after Bark Beetle Outbreak Altered Microbial N Transformations and Mitigated N-Saturation	PLOS ONE			English	Article							GROSS NITROGEN MINERALIZATION; BOHEMIAN FOREST; NATURAL DISTURBANCES; PLESNE LAKE; NITRATE; NITRIFICATION; DYNAMICS; BIOMASS; FUNGI; IMMOBILIZATION	Mountain forests in National park Bohemian Forest (Czech Republic) were affected by bark beetle attack and windthrows in 2004-2008, followed by an extensive tree dieback. We evaluated changes in the biochemistry of the uppermost soil horizons with the emphasis on carbon (C) and nitrogen (N) cycling in a near-natural spruce (Picea abies) mountain forest after the forest dieback, and compared it with an undisturbed control plot of similar age, climate, elevation, deposition, N-saturation level, and land use history. We hypothesised that the high litter input after forest dieback at the disturbed plot and its consequent decomposition might influence the availability of C for microorganisms, and consequently, N transformations in the soil. The concentrations of dissolved organic C (DOC) and N (DON) in soil water extracts rapidly increased at the disturbed plot for 3 yeas and then continually decreased. Net ammonification exhibited a similar trend as DOC and DON, indicating elevated mineralization. Despite the high ammonium concentrations found after the forest dieback (an increase from 0.5 mmol kg(-1) to 2-3 mmol kg(-1)), net nitrification was stable and low during these 3 years. After the DOC depletion and decrease in microbial biomass 5 years after the forest dieback, net nitrification started to rise, and nitrate concentrations increased from 0.2-1 mmol kg(-1) to 2-3 mmol kg(-1). Our results emphasize the key role of the availability of organic C in microbial N transformations, which probably promoted microbial heterotrophic activity at the expense of slow-growing nitrifiers.	[Kana, Jiri; Kopacek, Jiri] CAS, Inst Hydrobiol, Vvi, Biol Ctr, Ceske Budejovice, Czech Republic; [Kana, Jiri; Tahovska, Karolina; Santruckova, Hana] Univ South Bohemia Ceske Budejovice, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kana, J (corresponding author), CAS, Inst Hydrobiol, Vvi, Biol Ctr, Ceske Budejovice, Czech Republic.	jiri.kana@centrum.cz	Kaňa, Jiří/C-4277-2014; Santruckova, Hana/D-7365-2016; Kopacek, Jiri/A-7373-2014; Tahovska, Karolina/A-7248-2012; Tahovská, Karolina/AAI-3219-2021	Santruckova, Hana/0000-0001-9947-5687; Kopacek, Jiri/0000-0002-4409-4032; Tahovska, Karolina/0000-0003-4499-9533; Tahovská, Karolina/0000-0003-4499-9533; Kana, Jiri/0000-0003-3596-4742	Czech Science Foundation [P504/12/1218]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation, project number P504/12/1218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, SOIL MICROBIOLOGY BI; Beggs KMH, 2011, ENVIRON SCI TECHNOL, V45, P5717, DOI 10.1021/es1042436; Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Berg B., 2006, ADV ECOLOGICAL RES, V38; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Byrd KB, 2000, CAN J BOT, V78, P149, DOI 10.1139/cjb-78-2-149; DAVIDSON EA, 1992, ECOLOGY, V73, P1148, DOI 10.2307/1940665; Ekstrom SM, 2011, ENVIRON SCI TECHNOL, V45, P4733, DOI 10.1021/es104126f; Evans CD, 2006, ECOSYSTEMS, V9, P453, DOI 10.1007/s10021-006-0051-z; Evans CD, 2012, GLOBAL CHANGE BIOL, V18, P3317, DOI 10.1111/j.1365-2486.2012.02794.x; Ferrenberg S, 2014, FRONT MICROB, P5, DOI [10.3389/fmicb.204.00681, DOI 10.3389/FMICB.204.00681]; Fisher R. F., 2000, ECOLOGY MANAGEMENT F, DOI DOI 10.1002/9781118422342; Griffin JM, 2012, OECOLOGIA, V170, P551, DOI 10.1007/s00442-012-2323-y; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Hogberg MN, 2007, BIOL FERT SOILS, V44, P363, DOI 10.1007/s00374-007-0215-9; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Huber C, 2005, J ENVIRON QUAL, V34, P1772, DOI 10.2134/jeq2004.0210; Huber C., 2004, WATER AIR SOIL POLL, V4, P391, DOI DOI 10.1023/B:WAF0.0000028367.69158.8D; Kana J, 2013, BIOGEOCHEMISTRY, V113, P369, DOI 10.1007/s10533-012-9765-5; Karlberg B., 1983, FOCUS, V6, P14; Kauffman SJ, 2003, BIOGEOCHEMISTRY, V63, P23, DOI 10.1023/A:1023335002926; Kop&aacute;cek J, 2013, SILVA GABRETA, V19, P105; Kopacek J, 2001, HYDROL EARTH SYST SC, V5, P391, DOI 10.5194/hess-5-391-2001; Kopacek J, 2001, COMMUN SOIL SCI PLAN, V32, P1431, DOI 10.1081/CSS-100104203; Kopacek J, 2015, BOREAL ENVIRON RES, V20, P305; Kopacek J, 2013, BIOGEOCHEMISTRY, V115, P33, DOI 10.1007/s10533-013-9892-7; Kopacek J, 2010, BOREAL ENVIRON RES, V15, P413; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; McHale MR, 2007, BIOGEOCHEMISTRY, V84, P311, DOI 10.1007/s10533-007-9124-0; Mikkelson KM, 2013, BIOGEOCHEMISTRY, V115, P1, DOI 10.1007/s10533-013-9875-8; Mikkelson KM, 2013, NAT CLIM CHANGE, V3, P218, DOI [10.1038/NCLIMATE1724, 10.1038/nclimate1724]; Morehouse K, 2008, FOREST ECOL MANAG, V255, P2698, DOI 10.1016/j.foreco.2008.01.050; Olsson BA, 1996, FOREST ECOL MANAG, V84, P135, DOI 10.1016/0378-1127(96)03730-9; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Porebska G, 2008, SCI TOTAL ENVIRON, V399, P105, DOI 10.1016/j.scitotenv.2008.03.029; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Santruckova H., 2001, SILVA GABRETA, V7, P79; Santruckova H, 2006, BIOLOGIA, V61, pS499, DOI 10.2478/s11756-007-0073-9; Santruckova H, 2009, BIOL FERT SOILS, V45, P395, DOI 10.1007/s00374-008-0349-4; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SHAW A, 1988, INTRO USE FLOW INJEC; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Strauss EA, 2002, FRESHWATER BIOL, V47, P65, DOI 10.1046/j.1365-2427.2002.00776.x; Stursova M, 2014, ISME J, V8, P1920, DOI 10.1038/ismej.2014.37; Svoboda M, 2006, BIOLOGIA, V61, pS509, DOI 10.2478/s11756-007-0074-8; Svoboda M, 2006, BIOLOGIA, V61, pS523, DOI 10.2478/s11756-007-0075-7; Svoboda M, 2012, J VEG SCI, V23, P86, DOI 10.1111/j.1654-1103.2011.01329.x; Tahovska K, 2013, SOIL BIOL BIOCHEM, V59, P58, DOI 10.1016/j.soilbio.2012.12.015; Tahovska K, 2010, BOREAL ENVIRON RES, V15, P553; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tejnecky V, 2013, SCI TOTAL ENVIRON, V442, P165, DOI 10.1016/j.scitotenv.2012.10.053; TUREK J, 2014, SILVA GABRETA, V20, P1; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P689, DOI 10.1016/0038-0717(87)90050-2; Vesely Josef, 1993, Journal of Paleolimnology, V8, P211; Vrba J, 2003, SCI TOTAL ENVIRON, V310, P73, DOI 10.1016/S0048-9697(02)00624-1; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Zimmermann L, 2000, SILVA GABRETA, V4, P51	62	28	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134165	10.1371/journal.pone.0134165	http://dx.doi.org/10.1371/journal.pone.0134165			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230678	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400083
J	Araujo, IR; Ferrari, TCA; Teixeira-Carvalho, A; Campi-Azevedo, AC; Rodrigues, LV; Guimaraes, MH; Barros, TLS; Gelape, CL; Sousa, GR; Nunes, MCP				Araujo, Izabella Rodrigues; Abreu Ferrari, Teresa Cristina; Teixeira-Carvalho, Andrea; Campi-Azevedo, Ana Carolina; Rodrigues, Luan Vieira; Guimaraes Junior, Milton Henriques; Souza Barros, Thais Lins; Gelape, Claudio Leo; Sousa, Giovane Rodrigo; Pereira Nunes, Maria Carmo			Cytokine Signature in Infective Endocarditis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; MONONUCLEAR-CELLS; FACTOR-ALPHA; TNF-ALPHA; PROFILE; INTERLEUKIN-10; DIAGNOSIS; FAMILY	Infective endocarditis (IE) is a severe disease with high mortality rate. Cytokines participate in its pathogenesis and may contribute to early diagnosis improving the outcome. This study aimed to evaluate the cytokine profile in IE. Serum concentrations of interleukin (IL)-1 beta, IL-6, IL-8, IL-10, IL-12 and tumor necrosis factor (TNF)-alpha were measured by cytometric bead array (CBA) at diagnosis in 81 IE patients, and compared with 34 healthy subjects and 30 patients with non-IE infections, matched to the IE patients by age and gender. Mean age of the IE patients was 47 +/- 17 years (range, 15-80 years), and 40 (50%) were male. The IE patients had significantly higher serum concentrations of IL-1 beta, IL-6, IL-8, IL-10 and TNF-alpha as compared to the healthy individuals. The median levels of IL-1 beta, TNF-alpha and IL-12 were higher in the IE than in the non-IE infections group. TNF-alpha and IL-12 levels were higher in staphylococcal IE than in the non-staphylococcal IE subgroup. There was a higher proportion of both low IL-10 producers and high producers of IL-1 beta, TNF-alpha and IL-12 in the staphylococcal IE than in the non-staphylococcal IE subgroup. This study reinforces a relationship between the expression of proinflammatory cytokines, especially IL-1 beta, IL-12 and TNF-alpha, and the pathogenesis of IE. A lower production of IL-10 and impairment in cytokine network may reflect the severity of IE and may be useful for risk stratification.	[Araujo, Izabella Rodrigues; Abreu Ferrari, Teresa Cristina; Rodrigues, Luan Vieira; Guimaraes Junior, Milton Henriques; Souza Barros, Thais Lins; Sousa, Giovane Rodrigo; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil; [Teixeira-Carvalho, Andrea; Campi-Azevedo, Ana Carolina] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Gelape, Claudio Leo] Univ Fed Minas Gerais, Fac Med, Dept Cirurgia, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Sousa, Giovane R./H-6102-2016; Nunes, Maria Carmo/AAV-5185-2020; Campi-Azevedo, Ana Carolina/ABE-8321-2021; Ferrari, Teresa C. A./D-5530-2014; Gelape, Claudio Leo/J-5834-2018	Sousa, Giovane R./0000-0003-0085-3882; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Ferrari, Teresa C. A./0000-0001-9459-2294; Gelape, Claudio Leo/0000-0002-8287-0733				Alter P, 2002, AM J CARDIOL, V89, P1400, DOI 10.1016/S0002-9149(02)02353-6; Bustamante J, 2011, REV ESP CARDIOL, V64, P1056, DOI [10.1016/j.recesp.2011.02.024, 10.1016/j.rec.2011.02.027]; Capo C, 1999, CLIN EXP IMMUNOL, V115, P120; Capo C, 1996, INFECT IMMUN, V64, P1638, DOI 10.1128/IAI.64.5.1638-1642.1996; Capo C, 1996, INFECT IMMUN, V64, P4143, DOI 10.1128/IAI.64.10.4143-4147.1996; Chen R, 1999, CLIN CHEM, V45, P1693; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Gouriet F, 2006, CLIN VACCINE IMMUNOL, V13, P301, DOI 10.1128/CVI.13.2.301.2006; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; HEINLE S, 1994, AM J CARDIOL, V74, P799, DOI 10.1016/0002-9149(94)90438-3; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282; Jiang YL, 1999, INFECT IMMUN, V67, P2125, DOI 10.1128/IAI.67.5.2125-2130.1999; Kang BY, 2006, CURR MED CHEM, V13, P1149, DOI 10.2174/092986706776360879; Kelso A, 1998, IMMUNOL CELL BIOL, V76, P300, DOI 10.1046/j.1440-1711.1998.00757.x; KERN WV, 1993, INFECT IMMUN, V61, P5413, DOI 10.1128/IAI.61.12.5413-5416.1993; LI L, 1994, J IMMUNOL, V153, P3967; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Nunes MCP AI, 2013, ADV INFECT DIS, V3, P115; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Nunes MCP, 2010, INT J INFECT DIS, V14, pE394, DOI 10.1016/j.ijid.2009.06.024; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Rawczynska-Englert I, 2000, J HEART VALVE DIS, V9, P705; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tarnok A, 2003, CLIN CHEM, V49, P1000, DOI 10.1373/49.6.1000; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; TUNKEL AR, 1992, NEW ENGL J MED, V326, P1215, DOI 10.1056/NEJM199204303261809; Watkin RW, 2007, J INFECTION, V55, P220, DOI 10.1016/j.jinf.2007.05.174; Weinstock M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110151	32	20	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133631	10.1371/journal.pone.0133631	http://dx.doi.org/10.1371/journal.pone.0133631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225421	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700028
J	Bukowczan, J; Warzecha, Z; Ceranowicz, P; Kusnierz-Cabala, B; Tomaszewska, R				Bukowczan, Jakub; Warzecha, Zygmunt; Ceranowicz, Piotr; Kusnierz-Cabala, Beata; Tomaszewska, Romana			Obestatin Accelerates the Recovery in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats	PLOS ONE			English	Article							GHRELIN GENE-PRODUCTS; GROWTH-HORMONE; NITRIC-OXIDE; SECRETION; MICROCIRCULATION; RECEPTOR; INJURY; GUT; INTERLEUKIN-1; REGENERATION	Objective Several previous studies have shown that obestatin exhibits protective and regenerative effects in some organs including the stomach, kidney, and the brain. In the pancreas, pretreatment with obestatin inhibits the development of cerulein-induced acute pancreatitis, and promotes survival of pancreatic beta cells and human islets. However, no studies investigated the effect of obestatin administration following the onset of experimental acute pancreatitis. Aim The aim of this study was to evaluate the impact of obestatin therapy in the course of ischemia/reperfusion-induced pancreatitis. Moreover, we tested the influence of ischemia/reperfusion-induced acute pancreatitis and administration of obestatin on daily food intake and pancreatic exocrine secretion. Methods Acute pancreatitis was induced by pancreatic ischemia followed by reperfusion of the pancreas. Obestatin (8nmol/kg/dose) was administered intraperitoneally twice a day, starting 24 hours after the beginning of reperfusion. The effect of obestatin in the course of necrotizing pancreatitis was assessed between 2 and 14 days, and included histological, functional, and biochemical analyses. Secretory studies were performed on the third day after sham-operation or induction of acute pancreatitis in conscious rats equipped with chronic pancreatic fistula. Results Treatment with obestatin ameliorated morphological signs of pancreatic damage including edema, vacuolization of acinar cells, hemorrhages, acinar necrosis, and leukocyte infiltration of the gland, and led to earlier pancreatic regeneration. Structural changes were accompanied by biochemical and functional improvements manifested by accelerated normalization of interleukin-1 beta level and activity of myeloperoxidase and lipase, attenuation of the decrease in pancreatic DNA synthesis, and by an improvement of pancreatic blood flow. Induction of acute pancreatitis by pancreatic ischemia followed by reperfusion significantly decreased daily food intake and pancreatic exocrine secretion. Administration of obestatin at doses used was without significant effect with regard to daily food intake or pancreatic exocrine secretion in sham-operated rats, as well as in rats with acute pancreatitis. On the other hand, obestatin abolished a statistical significance of difference in food intake between animals with AP and control animals without pancreatic fistula and induction of AP. Conclusion Treatment with the exogenous obestatin reduces severity of ischemia/reperfusion-induced acute pancreatitis and accelerates recovery in this disease. The involved mechanisms are likely to be multifactorial, and are mediated, at least in part, by anti-inflammatory properties of obestatin.	[Bukowczan, Jakub] Northumbria NHS Fdn Trust, Dept Endocrinol & Diabet Mellitus, North Shields, Tyne & Wear, England; [Warzecha, Zygmunt; Ceranowicz, Piotr] Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland; [Kusnierz-Cabala, Beata] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Tomaszewska, Romana] Jagiellonian Univ, Dept Pathol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bukowczan, J (corresponding author), Northumbria NHS Fdn Trust, Dept Endocrinol & Diabet Mellitus, Rake Lane, North Shields, Tyne & Wear, England.	jakubbukowczan@gmail.com	Warzecha, Zygmunt/AAZ-2744-2020	Kusnierz-Cabala, Beata/0000-0001-8639-5688				Andican G, 2005, WORLD J GASTROENTERO, V11, P2340, DOI 10.3748/wjg.v11.i15.2340; Baragli I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064374; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bukowczan J, 2015, CURR PHARM DESIGN, V21, P2284, DOI 10.2174/1381612821666150105152553; Bukowczan J, 2015, EUR J PHARMACOL, V760, P113, DOI 10.1016/j.ejphar.2015.04.016; Ceranowicz D, 2010, J PHYSIOL PHARMACOL, V61, P599; Ceranowicz P, 2015, J PHYSIOL PHARMACOL, V66, P11; Ceranowicz P, 2009, J PHYSIOL PHARMACOL, V60, P95; Ceranowicz P, 2008, J PHYSIOL PHARMACOL, V59, P103; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chooklin S, 2009, HEPATOB PANCREAT DIS, V8, P627; Cuthbertson CM, 2006, BRIT J SURG, V93, P518, DOI 10.1002/bjs.5316; Dembinski A, 2004, J PHYSIOL PHARMACOL, V55, P811; Dembinski A, 2003, J PHYSIOL PHARMACOL, V54, P561; Dembinski A, 2001, J PHYSIOL PHARMACOL, V52, P221; Dembinski A, 2008, EUR J PHARMACOL, V591, P284, DOI 10.1016/j.ejphar.2008.06.059; Dembinski A, 2006, GROWTH HORM IGF RES, V16, P348, DOI 10.1016/j.ghir.2006.09.003; Dembinski A, 2011, MED SCI MONITOR, V17, pBR196, DOI 10.12659/MSM.881897; DINARELLO CA, 1991, BLOOD, V77, P1627; EVANDER A, 1982, DIGESTION, V24, P159, DOI 10.1159/000198792; Fabre A, 2014, J PEDIATR GASTR NUTR, V58, pE41, DOI [10.1097/MPG.0000000000000287, 10.1097/MPG.0000000000000307]; Fares A, 2013, J POSTGRAD MED, V59, P203, DOI 10.4103/0022-3859.118039; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; Gesmundo I, 2013, IUBMB LIFE, V65, P976, DOI 10.1002/iub.1226; GILES KW, 1965, NATURE, V206, P93, DOI 10.1038/206093a0; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Hammer HF, 2014, WIEN MED WOCHENSCHR, V164, P57, DOI 10.1007/s10354-013-0260-y; Hartwig W, 1999, J APPL PHYSIOL, V87, P743, DOI 10.1152/jappl.1999.87.2.743; Hernandez-Barbachano E, 2006, PANCREAS, V32, P335, DOI 10.1097/01.mpa.0000220856.47754.c4; Jeyarajah R, 2014, CURR PROB SURG, V51, P370, DOI 10.1067/j.cpsurg.2014.07.002; Kapica M, 2007, J PHYSIOL PHARMACOL, V58, P123; Kingsnorth A, 1997, GUT, V40, P1; Koc M, 2014, PEPTIDES, V60, P23, DOI 10.1016/j.peptides.2014.07.019; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; KONTUREK SJ, 1994, INT J PANCREATOL, V15, P19; Lacquaniti A, 2011, ANN NUTR METAB, V59, P193, DOI 10.1159/000334106; Li JB, 2011, ENDOCRINE, V39, P205, DOI 10.1007/s12020-011-9453-6; Mendez-Bailon M, 2015, PANCREATOLOGY, V15, P64, DOI 10.1016/j.pan.2014.11.004; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; NIEDERAU C, 1990, GASTROENTEROLOGY, V99, P1120, DOI 10.1016/0016-5085(90)90633-C; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; Plusczyk T, 2003, AM J PHYSIOL-GASTR L, V285, pG145, DOI 10.1152/ajpgi.00181.2002; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; Schanaider A, 2014, CLIN EXP MED; Schaser KD, 2005, AM J TRANSPLANT, V5, P341, DOI 10.1111/j.1600-6143.2004.00663.x; Tomaszewska Romana, 2000, Polish Journal of Pathology, V51, P179; Trovato L, 2014, FRONT HORM RES, V42, P175, DOI 10.1159/000358346; von Dobschuetz E, 2004, AM J PHYSIOL-GASTR L, V286, pG791, DOI 10.1152/ajpgi.00407.2003; Warzecha Z, 2011, J PHYSIOL PHARMACOL, V62, P207; Warzecha Z, 2010, J PHYSIOL PHARMACOL, V61, P419; Warzecha Z, 2001, EUR J PHARMACOL, V430, P113, DOI 10.1016/S0014-2999(01)01352-8; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	54	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134380	10.1371/journal.pone.0134380	http://dx.doi.org/10.1371/journal.pone.0134380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226277	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700084
J	Kim, YW; Yun, SJ; Jeong, P; Kim, SK; Kim, SY; Yan, C; Seo, SP; Lee, SK; Kim, J; Kim, WJ				Kim, Young-Won; Yun, Seok Joong; Jeong, Phildu; Kim, Seon-Kyu; Kim, Seon-Young; Yan, Chunri; Seo, Sung Phil; Lee, Sang Keun; Kim, Jayoung; Kim, Wun-Jae			The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; URINARY-BLADDER; BREAST-CANCER; EXPRESSION; AXL; MIGRATION; TUMOR; OVEREXPRESSION	Previous studies have shown that c-MET is overexpressed in cases of aggressive bladder cancer (BCa). Identification of crosstalk between c-MET and other RTKs such as AXL and PDGFR suggest that c-MET network genes (c-MET-AXL-PDGFR) may be clinically relevant to BCa. Here, we examine whether expression of c-MET network genes can be used to identify BCa patients at increased risk of developing aggressive disease. In vitro analysis, c-MET knockdown suppressed cell proliferation, invasion, and migration, and increased sensitivity to cisplatin-induced apoptosis. In addition, c-MET network gene (c-MET, AXL, and PDGFR) expression allowed discrimination of BCa tissues from normal control tissues and appeared to predict poor disease progression in non-muscle invasive BCa patients and poor overall survival in muscle invasive BCa patients. These results suggest that c-MET network gene expression is a novel prognostic marker for predicting which BCa patients have an increased risk of developing aggressive disease. These genes might be a useful marker for co-targeting therapy, and are expected to play an important role in improving both response to treatment and survival of BCa patients.	[Kim, Young-Won; Yun, Seok Joong; Jeong, Phildu; Yan, Chunri; Seo, Sung Phil; Lee, Sang Keun; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Chongju, South Korea; [Kim, Seon-Kyu; Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea; [Kim, Jayoung] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Jayoung] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Kim, Jayoung] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Harvard Medical School; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kim, WJ (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Urol, Chongju, South Korea.	Jayoung.Kim@cshs.org; wjkim@chungbuk.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A1A09006983]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01008753]; NIH NCATS UCLA CTSI [UL1TR000124]; Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; IMAGINE NO IC Research Program Award;  [R01DK100974];  [U01 DK103260];  [U24 DK097154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100974, U24DK097154, U01DK082316, U01DK103260] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NIH NCATS UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; IMAGINE NO IC Research Program Award; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; http://www.msip.go.kr/web/main/main. do) (No. NRF-2014R1A2A1A09006983) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (http://www.moe.go.kr/main.do) (2012R1A1A4A01008753). Also, this work was partly supported by the R01DK100974; U01 DK103260; U24 DK097154; NIH NCATS UCLA CTSI UL1TR000124; a Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; an IMAGINE NO IC Research Program Award (to JK). JK is an American Urological Association Foundation Research Scholar and a Harvard Medical School Eleanor and Miles Shore Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena S, 2007, P NATL ACAD SCI USA, V104, P11412, DOI 10.1073/pnas.0703205104; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Comperat E, 2008, J UROLOGY, V179, P868, DOI 10.1016/j.juro.2007.10.079; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Fudge K, 1996, PROSTATE, V29, P282; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hofner T, 2013, J UROLOGY, V190, P2263, DOI 10.1016/j.juro.2013.06.053; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Miyata Y, 2009, HUM PATHOL, V40, P496, DOI 10.1016/j.humpath.2008.09.011; NGUYEN PL, 1994, AM J CLIN PATHOL, V101, P166, DOI 10.1093/ajcp/101.2.166; Noon AR, 2013, NAT REV UROL, V10, P67, DOI 10.1038/nrurol.2012.252; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Remon J, 2014, CANCER TREAT REV, V40, P93, DOI 10.1016/j.ctrv.2013.06.002; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Tsai YS, 2012, ADV UROL, V2012, DOI 10.1155/2012/181964; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Xu X, 2013, MOL CELLS, V36, P62, DOI 10.1007/s10059-013-0044-7; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139	30	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134552	10.1371/journal.pone.0134552	http://dx.doi.org/10.1371/journal.pone.0134552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225770	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700110
J	Stadlbauer, S; Rios, P; Ohmori, K; Suzuki, K; Kohn, M				Stadlbauer, Sven; Rios, Pablo; Ohmori, Ken; Suzuki, Keisuke; Koehn, Maja			Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating Liver	PLOS ONE			English	Article							CATECHIN-CLASS POLYPHENOLS; CELL-CYCLE ARREST; GREEN TEA; SYNTHETIC STRATEGY; (-)-EPIGALLOCATECHIN GALLATE; CANCER-CELLS; METASTASIS; INHIBITION; PROANTHOCYANIDINS; EPIGALLOCATECHIN-3-GALLATE	Natural polyphenols like oligomeric catechins (procyanidins) derived from green tea and herbal medicines are interesting compounds for pharmaceutical research due to their ability to protect against carcinogenesis in animal models. It is nevertheless still unclear how intracellular pathways are modulated by polyphenols. Monomeric polyphenols were shown to affect the activity of some protein phosphatases (PPs). The three phosphatases of regenerating liver (PRLs) are close relatives and promising therapeutic targets in cancer. In the present study we show that several procyanidins inhibit the activity of all three members of the PRL family in the low micromolar range, whereas monomeric epicatechins show weak inhibitory activity. Increasing the number of catechin units in procyanidins to more than three does not further enhance the potency. Remarkably, the tested procyanidins showed selectivity in vitro when compared to other PPs, and over 10-fold selectivity toward PRL-1 over PRL-2 and PRL-3. As PRL overexpression induces cell migration compared to control cells, the effect of procyanidins on this phenotype was studied. Treatment with procyanidin C2 led to a decrease in cell migration of PRL-1- and PRL-3-overexpressing cells, suggesting the compound-dependent inhibition of PRL-promoted cell migration. Treatment with procyanidin B3 led to selective suppression of PRL-1 overexpressing cells, thereby corroborating the selectivity toward PRL-1-over PRL-3 in vitro. Together, our results show that procyanidins negatively affect PRL activity, suggesting that PRLs could be targets in the polypharmacology of natural polyphenols. Furthermore, they are interesting candidates for the development of PRL-1 inhibitors due to their low cellular toxicity and the selectivity within the PRL family.	[Stadlbauer, Sven; Rios, Pablo; Koehn, Maja] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Ohmori, Ken; Suzuki, Keisuke] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	European Molecular Biology Laboratory (EMBL); Tokyo Institute of Technology	Stadlbauer, S (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	sven.stadlbauer@web.de; koehn@embl.de	Köhn, Maja/G-5131-2012	Köhn, Maja/0000-0001-8142-3504; Ohmori, Ken/0000-0002-8498-0821	Alexander von Humboldt-Foundation [1135581]; German Science Foundation (DFG) [KO 4013/1-1]; Japan Society for the Promotion of Science (JSPS); EMBL Protein Expression and Purification Core Facility; EMBL Chemical Biology Core Facility; EMBL Flow Cytometry Core laboratory	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBL Protein Expression and Purification Core Facility; EMBL Chemical Biology Core Facility; EMBL Flow Cytometry Core laboratory	S. Stadlbauer thanks the Alexander von Humboldt-Foundation for a return fellowship (1135581). M.K. thanks the German Science Foundation (DFG) for support within the Emmy Noether program (KO 4013/1-1). This work was supported by a Grant-in-Aid for Specially Promoted Research (No. 23000006) from the Japan Society for the Promotion of Science (JSPS). The authors acknowledge the support of the EMBL Protein Expression and Purification Core Facility, the EMBL Chemical Biology Core Facility, and the EMBL Flow Cytometry Core laboratory.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Dennis EG, 2012, TETRAHEDRON, V68, P340, DOI 10.1016/j.tet.2011.10.039; Deziel BA, 2010, J CELL BIOCHEM, V111, P742, DOI 10.1002/jcb.22761; Ferreira D, 2011, PLANTA MED, V77, P1071, DOI 10.1055/s-0030-1270908; Fujii W, 2013, TETRAHEDRON, V69, P3543, DOI 10.1016/j.tet.2013.02.087; Gopalakrishnan A, 2006, ARCH PHARM RES, V29, P633, DOI 10.1007/BF02968247; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Hara Y., 2001, GREEN TEA HLTH BENEF; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; He Tai-ping, 2010, Zhong Yao Cai, V33, P771; Hemmersbach S, 2013, J AGR FOOD CHEM, V61, P7932, DOI 10.1021/jf402019f; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Ito Y, 2014, ANGEW CHEM INT EDIT, V53, P10129, DOI 10.1002/anie.201405600; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kiss A, 2013, FEBS J, V280, P612, DOI 10.1111/j.1742-4658.2012.08498.x; Kozikowski AP, 2003, J ORG CHEM, V68, P1641, DOI 10.1021/jo020393f; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Li X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003203; Liu YX, 2008, J ORG CHEM, V73, P4625, DOI 10.1021/jo8005649; Lu JW, 2012, CLIN TRANSL ONCOL, V14, P287, DOI 10.1007/s12094-012-0797-z; Ma JF, 2011, BIOCHEM BIOPH RES CO, V407, P98, DOI 10.1016/j.bbrc.2011.02.116; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Meyer C, 2014, ACS CHEM BIOL, V9, P769, DOI 10.1021/cb400903u; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; Ohmori K, 2004, P NATL ACAD SCI USA, V101, P12002, DOI 10.1073/pnas.0401651101; Ohmori K, 2011, ANGEW CHEM INT EDIT, V50, P4862, DOI 10.1002/anie.201007473; Ohmori K, 2011, CHEM REC, V11, P252, DOI 10.1002/tcr.201100026; Ohmori K, 2010, ORG BIOMOL CHEM, V8, P2693, DOI 10.1039/c003464a; Ohmori K, 2009, CHEM LETT, V38, P934, DOI 10.1246/cl.2009.934; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Siddiqui IA, 2011, FASEB J, V25, P1198, DOI 10.1096/fj.10-167924; Singh AP, 2009, PHYTOTHER RES, V23, P1066, DOI 10.1002/ptr.2667; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sotoud H, 2013, J BIOMOL SCREEN, V18, P899, DOI 10.1177/1087057113486000; Stadlbauer S, 2012, CHEM COMMUN, V48, P8425, DOI 10.1039/c2cc33704e; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Verstraeten SV, 2015, FOOD FUNCT, V6, P32, DOI [10.1039/c4fo00647j, 10.1039/C4FO00647J]; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wegner Adam M., 2007, V365, P61; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	50	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134336	10.1371/journal.pone.0134336	http://dx.doi.org/10.1371/journal.pone.0134336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226290	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700074
J	Wagner, K; Groger, M; McCook, O; Scheuerle, A; Asfar, P; Stahl, B; Huber-Lang, M; Ignatius, A; Jung, B; Duechs, M; Moller, P; Georgieff, M; Calzia, E; Radermacher, P; Wagner, F				Wagner, Katja; Groeger, Michael; McCook, Oscar; Scheuerle, Angelika; Asfar, Pierre; Stahl, Bettina; Huber-Lang, Markus; Ignatius, Anita; Jung, Birgit; Duechs, Matthias; Moeller, Peter; Georgieff, Michael; Calzia, Enrico; Radermacher, Peter; Wagner, Florian			Blunt Chest Trauma in Mice after Cigarette Smoke-Exposure: Effects of Mechanical Ventilation with 100% O-2	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED LUNG INJURY; HEMORRHAGIC-SHOCK; SYSTEMIC INFLAMMATION; ALVEOLAR MACROPHAGES; MURINE MODEL; MOUSE MODEL; HYPEROXIA; OXYGEN; INHIBITION	Cigarette smoking (CS) aggravates post-traumatic acute lung injury and increases ventilator-induced lung injury due to more severe tissue inflammation and apoptosis. Hyper-inflammation after chest trauma is due to the physical damage, the drop in alveolar PO2, and the consecutive hypoxemia and tissue hypoxia. Therefore, we tested the hypotheses that 1) CS exposure prior to blunt chest trauma causes more severe post-traumatic inflammation and thereby aggravates lung injury, and that 2) hyperoxia may attenuate this effect. Immediately after blast wave-induced blunt chest trauma, mice (n=32) with or without 3-4 weeks of CS exposure underwent 4 hours of pressure-controlled, thoraco-pulmonary compliance-titrated, lung-protective mechanical ventilation with air or 100% O-2. Hemodynamics, lung mechanics, gas exchange, and acid-base status were measured together with blood and tissue cytokine and chemokine concentrations, heme oxygenase-1 (HO-1), activated caspase-3, and hypoxia-inducible factor 1-alpha (HIF-1 alpha) expression, nuclear factor-kappa B (NF-kappa B) activation, nitrotyrosine formation, purinergic receptor 2X(4) (P2XR(4)) and 2X(7) (P2XR(7)) expression, and histological scoring. CS exposure prior to chest trauma lead to higher pulmonary compliance and lower PaO2 and Horovitz-index, associated with increased tissue IL-18 and blood MCP-1 concentrations, a 2-4-fold higher inflammatory cell infiltration, and more pronounced alveolar membrane thickening. This effect coincided with increased activated caspase-3, nitrotyrosine, P2XR(4), and P2XR(7) expression, NF-kappa B activation, and reduced HIF-1 alpha expression. Hyperoxia did not further affect lung mechanics, gas exchange, pulmonary and systemic cytokine and chemokine concentrations, or histological scoring, except for some patchy alveolar edema in CS exposed mice. However, hyperoxia attenuated tissue HIF-1 alpha, nitrotyrosine, P2XR(7), and P2XR(4) expression, while it increased HO-1 formation in CS exposed mice. Overall, CS exposure aggravated post-traumatic inflammation, nitrosative stress and thereby organ dysfunction and injury; short-term, lung-protective, hyperoxic mechanical ventilation have no major beneficial effect despite attenuation of nitrosative stress, possibly due to compensation of by regional alveolar hypoxia and/or consecutive hypoxemia, resulting in down-regulation of HIF-1 alpha expression.	[Wagner, Katja; Groeger, Michael; McCook, Oscar; Stahl, Bettina; Calzia, Enrico; Radermacher, Peter; Wagner, Florian] Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany; [Wagner, Katja; Georgieff, Michael; Wagner, Florian] Univ Ulm Klinikum, Anasthesiol Klin, Ulm, Germany; [Scheuerle, Angelika; Moeller, Peter] Univ Ulm Klinikum, Inst Pathol, Ulm, Germany; [Asfar, Pierre] Univ Angers, Dept Reanimat Med & Med Hyperbare, Ctr Hosp Univ,CNRS UMR 6214,INSERM U1083, Lab HIFIH,UPRES EA 3859,PRES UNAM,IFR 132, Angers, France; [Huber-Lang, Markus] Univ Ulm Klinikum, Klin Unfall Hand Plast & Wiederherstellungschirur, Ulm, Germany; [Ignatius, Anita] Univ Ulm Klinikum, Inst Unfallchirurg Forsch & Biomech, Ulm, Germany; [Jung, Birgit; Duechs, Matthias] Boehringer Ingelheim Pharma GmbH & Co KG, Abt Resp Dis Res, Biberach, Germany	Ulm University; Ulm University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Ulm University; Ulm University; Boehringer Ingelheim	Radermacher, P (corresponding author), Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany.	peter.radermacher@uni-ulm.de	Ignatius, Anita/M-6012-2013; van Griensven, Martijn/F-5808-2012; McCook, Oscar/AAF-1647-2020; Huber-Lang, Markus/AAJ-2209-2020; Asfar, Pierre/K-1402-2015	Ignatius, Anita/0000-0002-4782-1979; van Griensven, Martijn/0000-0001-5104-9881; McCook, Oscar/0000-0001-7879-7695; 	Deutsche Forschungsgemeinschaft [Klinische Forschergruppe 200, DFG RA 396/9-2]; Ministry of Science, Research and the Arts of Baden-Wurttemberg [Az:32-729.55-0/239-5/32-7533.-6-10/15/1]; Boehringer Ingelheim Pharma GmbH Co. KG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Science, Research and the Arts of Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Supported by a grant of the Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 200 "Die Entzundungsantwort nach muskuloskelettalem Trauma"; DFG RA 396/9-2) and a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (Az:32-729.55-0/239-5/32-7533.-6-10/15/1) to P.R. (Boehringer Ingelheim Ulm University BioCenter). The Deutsche Forschungsgemeinschaft had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors B.J. and M.D., but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of B.J. and M.D. are articulated in the "author contributions" section.	Albaiceta GM, 2008, J TRAUMA, V64, P470, DOI 10.1097/TA.0b013e31814931ac; Barth E, 2008, CRIT CARE MED, V36, P495, DOI 10.1097/01.CCM.0B013E318161FC45; Bitterman H, 1996, AM J PHYSIOL-HEART C, V271, pH203, DOI 10.1152/ajpheart.1996.271.1.H203; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Calvert JW, 2006, J APPL PHYSIOL, V101, P853, DOI 10.1152/japplphysiol.00268.2006; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V165, P61, DOI 10.1016/j.resp.2008.10.006; Chao J, 2011, AM J RESP CELL MOL, V45, P53, DOI 10.1165/rcmb.2010-0264OC; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; DANTZKER DR, 1975, J APPL PHYSIOL, V38, P886, DOI 10.1152/jappl.1975.38.5.886; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Efrati S, 2008, NEPHROL DIAL TRANSPL, V23, P2213, DOI 10.1093/ndt/gfn093; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fisarkova B, 2004, PHYSIOL RES, V53, P487; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Geldmacher H, 2008, DEUT MED WOCHENSCHR, V133, P2609, DOI 10.1055/s-0028-1105858; Geraghty P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00267; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; Gould NS, 2010, AM J RESP CRIT CARE, V182, P1114, DOI 10.1164/rccm.201003-0442OC; Guan SP, 2013, BRIT J PHARMACOL, V168, P1707, DOI 10.1111/bph.12054; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Hauser B, 2009, CRIT CARE MED, V37, P2465, DOI 10.1097/CCM.0b013e3181aee8ad; Hirsch J, 2014, CRIT CARE, V18, DOI 10.1186/cc13795; Hoth JJ, 2009, SHOCK, V31, P376, DOI 10.1097/SHK.0b013e3181862279; Hou LC, 2009, SHOCK, V32, P451, DOI 10.1097/SHK.0b013e31819c391a; Hsieh SJ, 2014, CRIT CARE MED, V42, P2058, DOI 10.1097/CCM.0000000000000418; Jiang H, 2012, ACTA PHARMACOL SIN, V33, P635, DOI 10.1038/aps.2012.5; Jiang H, 2010, ACTA BIOCH BIOPH SIN, V42, P483, DOI 10.1093/abbs/gmq041; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kawano A, 2012, BIOCHEM BIOPH RES CO, V420, P102, DOI 10.1016/j.bbrc.2012.02.122; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kotani N, 1999, ANESTHESIOLOGY, V91, P1823, DOI 10.1097/00000542-199912000-00037; Lee SH, 2014, CLIN BIOCHEM, V47, P552, DOI 10.1016/j.clinbiochem.2014.01.012; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Madjdpour C, 2003, AM J PHYSIOL-LUNG C, V284, pL360, DOI 10.1152/ajplung.00158.2002; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McGrath-Morrow SA, 2011, AM J RESP CELL MOL, V45, P610, DOI 10.1165/rcmb.2010-0259OC; Meier J, 2004, SHOCK, V22, P240, DOI 10.1097/01.shk.0000131192.02909.4c; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Muller-Redetzky HC, 2014, CRIT CARE, V18, DOI 10.1186/cc13830; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; Ohata Y, 2011, CIRC J, V75, P945, DOI 10.1253/circj.CJ-09-0575; Papandrinopoulou D, 2012, PULM MED, V2012, DOI 10.1155/2012/542769; Park JW, 2013, EUR J PHARMACOL, V706, P76, DOI 10.1016/j.ejphar.2013.02.049; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Schmidt E P, 2010, J Cell Death, V3, P41; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Sukhotnik I, 2009, CRIT CARE MED, V37, P1054, DOI 10.1097/CCM.0b013e31819d0f5c; Suresh MV, 2014, CRIT CARE MED, V42, pE642, DOI 10.1097/CCM.0000000000000488; Thakur VS, 2014, TOXICOL LETT, V230, P322, DOI 10.1016/j.toxlet.2014.03.006; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Uematsu S, 2013, CRIT CARE MED, V41, P151, DOI 10.1097/CCM.0b013e318267606f; Vlaar APJ, 2010, INTENS CARE MED, V36, P879, DOI 10.1007/s00134-010-1802-z; Vlahos R, 2006, PULM PHARMACOL THER, V19, P12, DOI 10.1016/j.pupt.2005.02.006; Vuichard D, 2005, CLIN EXP IMMUNOL, V141, P248, DOI 10.1111/j.1365-2249.2005.02835.x; Wagner F, 2011, J TRAUMA, V71, P1659, DOI 10.1097/TA.0b013e318228842e; Wagner F, 2011, SHOCK, V35, P396, DOI 10.1097/SHK.0b013e3181ffff0e; Wagner K, 2013, INTENS CARE MED EXP, V1, DOI 10.1186/2197-425X-1-2; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Waisman D, 2012, SHOCK, V37, P95, DOI 10.1097/SHK.0b013e3182356fc3; Weinhold K, 2010, CELL MOL LIFE SCI, V67, P2631, DOI 10.1007/s00018-010-0355-1; Wilson MR, 2012, CRIT CARE MED, V40, P2850, DOI 10.1097/CCM.0b013e31825b91ef; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910	79	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132810	10.1371/journal.pone.0132810	http://dx.doi.org/10.1371/journal.pone.0132810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225825	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700011
J	Amaral, SV; Forte, T; Ramalho-Santos, J; da Cruz, MTG				Amaral, Sara Varela; Forte, Teresa; Ramalho-Santos, Joao; Teresa Girao da Cruz, M.			I Want More and Better Cells! - An Outreach Project about Stem Cells and Its Impact on the General Population	PLOS ONE			English	Article							SCIENCE COMMUNICATION; PUBLIC SUPPORT	Although science and technology impact every aspect of modern societies, there is still an extensive gap between science and society, which impairs the full exercise of citizenship. In the particular case of biomedical research increased investment should be accompanied by parallel efforts in terms of public information and engagement. We have carried out a project involving the production and evaluation of educational contents focused on stem cells - illustrated newspaper chronicles, radio interviews, a comic book, and animated videos - and monitored their impact on the Portuguese population. The study of the outreach materials in a heterogeneous sample of the population suggests that they are valuable tools to disseminate scientific messages, and that this is especially true for the comic-book format. Furthermore, the data showed that clear and stimulating outreach materials, that are able to teach new concepts and to promote critical thinking, increase engagement in science at different levels, depending on the depth of the concepts involved. Additionally, these materials can influence political, social and personal attitudes toward science. These results, together with the importance attributed to scientific research in stem cells by the population sampled, validates the diffusion of such materials as a significant contribution towards an overall public understanding and engagement in contemporary science, and this strategy should thus be considered in future projects. Regardless, stringent quality control must be implemented in order to efficiently communicate accurate scientific developments, and the public stimulated in terms of finding additional sources of reliable information.	[Amaral, Sara Varela; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Amaral, Sara Varela; Ramalho-Santos, Joao; Teresa Girao da Cruz, M.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal; [Forte, Teresa] Univ Coimbra, Fac Psychol & Educ Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	da Cruz, MTG (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal.	mtgirao@cnc.uc.pt	Amaral, Sara/AAX-8956-2021; da Cruz, Maria Teresa Girão/D-8576-2011; Ramalho-Santos, João/F-8641-2012; Santos, João/HHZ-5595-2022	da Cruz, Maria Teresa Girão/0000-0003-2625-2567; Ramalho-Santos, João/0000-0002-1172-4018; Forte, Teresa/0000-0003-3817-7410; Varela Amaral, Sara/0000-0001-9514-4696				Allen S, 2009, FRAMEWORK EVALUATING; [Anonymous], 2013, HOP HYP SCOTT STEM C; [Anonymous], 2013, WHAT ARE STEM CELLS; Barros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096672; Bauer M.W., 2014, MODERN PORTUGAL ITS; Besley JC, 2015, J RES SCI TEACH, V52, P199, DOI 10.1002/tea.21186; Bodmer W., 1985, PUBLIC UNDERST SCI; Burns TW, 2003, PUBLIC UNDERST SCI, V12, P183, DOI 10.1177/09636625030122004; Cambridge Science Festival, 2014, CAMBR SCI FEST; Carvalho AS, 2013, EUR J HUM GENET, V21, P591, DOI 10.1038/ejhg.2012.232; Dench S, 2000, LEARNING LATER LIFE; Dire&ccedil;&atilde;ao-Geral de Estat&iacute;sticas de Educa&ccedil;&atilde;o eCi&ecirc;ncia, 2014, PROD CIENT PORT 1990; DURANT JR, 1989, NATURE, V340, P11, DOI 10.1038/340011a0; EC, 2002, SCI SOC ACT PLAN; European-Commission, 2007, PUBL ENG SCI REP SCI; European-Commission, 2008, FLASH EUR 239 YOUNG; European-Commission, 2009, MASIS REP CHALL FUT; European-Commission, 2010, SPEC EUR 340 SCI TEC; European-Commission, 2013, EUR 79 2 RESP RES IN; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; Greco P, 2003, J SCI COMMUNICATION; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Irwin A, 2001, PUBLIC UNDERST SCI, V10, P1, DOI 10.1088/0963-6625/10/1/301; Kemp E, 2015, EMBO REP, V16, P7, DOI 10.15252/embr.201439398; Kim A, 2004, EDUC GERONTOL, V30, P441, DOI 10.1080/03601270490445069; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Leao MJ, 2012, EMBO REP, V13, P954, DOI 10.1038/embor.2012.151; Lee O, 1997, J RES SCI TEACH, V34, P219; Liu H, 2009, PUBLIC UNDERST SCI, V18, P704, DOI 10.1177/0963662508097625; Macleod K, 2012, HOPE HYPE STORY STEM; NIH, 2001, STEM CELLS SCI PROGR; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; Nisbet MC, 2005, INT J PUBLIC OPIN R, V17, P90, DOI 10.1093/ijpor/edh058; Obliger JL, 2008, ED NET GENERATION; Pestana M. H., 2014, ANALISE DADOS CIENCI, V6; Pinto B, 2013, PUBLIC UNDERST SCI, V0, P1; Ramalho-Santos J, 2013, CELULAS ESTAMINAIS Q; Ramalho-Santos J, 2013, UMA AVENTURA ESTAMIN; Redey S, 2006, SCI PUBLIC DIMENSION, P75; Semir V, 2012, TOOLKIT IMPACT ASSES; Sutton M, 2007, S AFR J SCI, V9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakeford T, 2004, DEMOCRATISING TECHNO	44	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133753	10.1371/journal.pone.0133753	http://dx.doi.org/10.1371/journal.pone.0133753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222053	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800063
J	Chiodini, RJ; Dowd, SE; Chamberlin, WM; Galandiuk, S; Davis, B; Glassing, A				Chiodini, Rodrick J.; Dowd, Scot E.; Chamberlin, William M.; Galandiuk, Susan; Davis, Brian; Glassing, Angela			Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum	PLOS ONE			English	Article							BILOPHILA-WADSWORTHIA; RUMEN	Since Crohn's disease is a transmural disease, we hypothesized that examination of deep submucosal tissues directly involved in the inflammatory disease process may provide unique insights into bacterial populations transgressing intestinal barriers and bacterial populations more representative of the causes and agents of the disease. We performed deep 16s microbiota sequencing on isolated ilea mucosal and submucosal tissues on 20 patients with Crohn's disease and 15 non-inflammatory bowel disease controls with a depth of coverage averaging 81,500 sequences in each of the 70 DNA samples yielding an overall resolution down to 0.0001% of the bacterial population. Of the 4,802,328 total sequences generated, 98.9% or 4,749,183 sequences aligned with the Kingdom Bacteria that clustered into 8545 unique sequences with <3% divergence or operational taxonomic units enabling the identification of 401 genera and 698 tentative bacterial species. There were significant differences in all taxonomic levels between the submucosal microbiota in Crohn's disease compared to controls, including organisms of the Order Desulfovibrionales that were present within the submucosal tissues of most Crohn's disease patients but absent in the control group. A variety of organisms of the Phylum Firmicutes were increased in the subjacent submucosa as compared to the parallel mucosal tissue including Ruminococcus spp., Oscillospira spp., Pseudobutyrivibrio spp., and Tumebacillus spp. In addition, Propionibacterium spp. and Cloacibacterium spp. were increased as well as large increases in Proteobacteria including Parasutterella spp. and Methylobacterium spp. This is the first study to examine the microbial populations within submucosal tissues of patients with Crohn's disease and to compare microbial communities found deep within the submucosal tissues with those present on mucosal surfaces. Our data demonstrate the existence of a distinct submucosal microbiome and ecosystem that is not well reflected in the mucosa and/or downstream fecal material.	[Chiodini, Rodrick J.; Chamberlin, William M.] St Vincent Healthcare, Sisters Charity Leavenworth Hlth Syst, Billings, MT 59101 USA; [Chiodini, Rodrick J.; Glassing, Angela] Montana State Univ, Dept Biol & Phys Sci, Billings, MT USA; [Dowd, Scot E.] Mr DNA Mol Res Lab, Shallowater, TX USA; [Galandiuk, Susan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Davis, Brian] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Paul L Foster Sch Med, El Paso, TX USA	Montana State University System; Montana State University Billings; Montana State University Bozeman; University of Louisville; Texas Tech University System; Texas Tech University	Chiodini, RJ (corresponding author), St Vincent Healthcare, Sisters Charity Leavenworth Hlth Syst, Billings, MT 59101 USA.	rodrick.chiodini@msubillings.edu	Davis, Brian/T-5148-2019; Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	Broad Medical Research Program (BMRP-CCFA Proposal) [335929 IBD-0381]; State of Montana, Montana Department of Commerce Biomedical Research Grant [14-51-BMR-002]; St. Vincent Healthcare; Montana State University-Billings	Broad Medical Research Program (BMRP-CCFA Proposal); State of Montana, Montana Department of Commerce Biomedical Research Grant; St. Vincent Healthcare; Montana State University-Billings	Supported in part by grants from the Broad Medical Research Program (BMRP-CCFA Proposal No. 335929 IBD-0381) (http://www.ccfa.org/science-and-professionals/broad/); State of Montana, Montana Department of Commerce Biomedical Research Grant (14-51-BMR-002) (http://commerce.mt.gov/); St. Vincent Healthcare (http://www.svh-mt.org/); and Montana State University-Billings (http://www.msubillings.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Ballester JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062107; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BARON EJ, 1992, J CLIN MICROBIOL, V30, P1882, DOI 10.1128/JCM.30.7.1882-1884.1992; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Chiodini RJ, 2013, J CLIN GASTROENTEROL, V47, P612, DOI 10.1097/MCG.0b013e31827b4f94; D'Argenio V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/325340; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gutierrez A, 2014, GUT, V63, P272, DOI 10.1136/gutjnl-2012-303557; Haag LM, 2014, BEST PRACT RES CL GA, V28, P399, DOI 10.1016/j.bpg.2014.04.001; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Liu JZ, 2014, BEST PRACT RES CL GA, V28, P373, DOI 10.1016/j.bpg.2014.04.009; Martinez-Medina Margarita, 2014, World J Gastrointest Pathophysiol, V5, P213, DOI 10.4291/wjgp.v5.i3.213; McInnes P, 2010, HUMAN MICROBIOME PRO; McOrist AL, 2001, J CLIN MICROBIOL, V39, P1577, DOI 10.1128/JCM.39.4.1577-1579.2001; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Williams WL, 2010, J DAIRY SCI, V93, P4735, DOI 10.3168/jds.2009-2920; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129; Winter SE, 2014, CELL MICROBIOL, V16, P179, DOI 10.1111/cmi.12245	29	92	94	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134382	10.1371/journal.pone.0134382	http://dx.doi.org/10.1371/journal.pone.0134382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222621	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800138
J	Gariboldi, MC; Tunez, JI; Dejean, CB; Failla, M; Vitullo, AD; Negri, MF; Cappozzo, HL				Constanza Gariboldi, Maria; Ignacio Tunez, Juan; Beatriz Dejean, Cristina; Failla, Mauricio; Daniel Vitullo, Alfredo; Fernanda Negri, Maria; Luis Cappozzo, Humberto			Population Genetics of Franciscana Dolphins (Pontoporia blainvillei): Introducing a New Population from the Southern Edge of Their Distribution	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; TIME DEPENDENCY; NORTH-ATLANTIC; MITOCHONDRIAL; DIFFERENTIATION; CONSERVATION; WHALES; GROWTH; FLOW	Due to anthropogenic factors, the franciscana dolphin, Pontoporia blainvillei, is the most threatened small cetacean on the Atlantic coast of South America. Four Franciscana Management Areas have been proposed: Espiritu Santo to Rio de Janeiro (FMA I), Sao Paulo to Santa Catarina (FMA II), Rio Grande do Sul to Uruguay (FMA III), and Argentina (FMA IV). Further genetic studies distinguished additional populations within these FMAs. We analyzed the population structure, phylogeography, and demographic history in the southernmost portion of the species range. From the analysis of mitochondrial DNA control region sequences, 5 novel haplotypes were found, totalizing 60 haplotypes for the entire distribution range. The haplotype network did not show an apparent phylogeographical signal for the southern FMAs. Two populations were identified: Monte Hermoso (MH) and Necochea (NC)+Claromeco (CL)+Rio Negro (RN). The low levels of genetic variability, the relative constant size over time, and the low levels of gene flow may indicate that MH has been colonized by a few maternal lineages and became isolated from geographically close populations. The apparent increase in NC+CL+RN size would be consistent with the higher genetic variability found, since genetic diversity is generally higher in older and expanding populations. Additionally, RN may have experienced a recent split from CL and NC; current high levels of gene flow may be occurring between the latter ones. FMA IV would comprise four franciscana dolphin populations: Samborombon West+Samborombon South, Cabo San Antonio+Buenos Aires East, NC+CL+Buenos Aires Southwest+RN and MH. Results achieved in this study need to be taken into account in order to ensure the long-term survival of the species.	[Constanza Gariboldi, Maria; Beatriz Dejean, Cristina; Daniel Vitullo, Alfredo; Luis Cappozzo, Humberto] Univ Maimonides, CEBBAD, Buenos Aires, DF, Argentina; [Constanza Gariboldi, Maria; Ignacio Tunez, Juan; Daniel Vitullo, Alfredo; Fernanda Negri, Maria; Luis Cappozzo, Humberto] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Ignacio Tunez, Juan] Univ Nacl Lujan, Dept Ciencias Basicas, Grp Estud Ecol Mamiferos, Lujan, Argentina; [Beatriz Dejean, Cristina] Univ Buenos Aires, Fac Filosofia & Letras, ICA, Secc Antropol Biol, Buenos Aires, DF, Argentina; [Beatriz Dejean, Cristina; Luis Cappozzo, Humberto] Univ Maimonides, Fdn Azara, Buenos Aires, DF, Argentina; [Failla, Mauricio] Fdn Cethus, Buenos Aires, DF, Argentina; [Fernanda Negri, Maria; Luis Cappozzo, Humberto] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecol Comportamiento & Mamiferos Marinos, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; University of Buenos Aires; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Gariboldi, MC (corresponding author), Univ Maimonides, CEBBAD, Buenos Aires, DF, Argentina.	gariboldi.constanza@maimonides.edu	Vitullo, Alfredo/F-9744-2015; Dejean, Cristina/AAM-1408-2021	Vitullo, Alfredo/0000-0002-4833-5147; 	Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; Whale and Dolphin Conservation	Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; Whale and Dolphin Conservation	Funding was provided by Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; and Whale and Dolphin Conservation.	Adams LD, 2006, MAR BIOL, V148, P671, DOI 10.1007/s00227-005-0094-2; [Anonymous], 2010, LATIN AM J AQUAT MAM, DOI DOI 10.5597/lajam00155; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Bordino P, 2013, ENDANGER SPECIES RES, V21, P1, DOI 10.3354/esr00503; Bordino P, 2002, MAR MAMMAL SCI, V18, P833, DOI 10.1111/j.1748-7692.2002.tb01076.x; Bordino P, 2008, INT WHAL COMM SCI CO; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Cappozzo Humberto L., 2007, Latin American Journal of Aquatic Mammals, V6, P127; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen L, 2010, MAR BIOL, V157, P1453, DOI 10.1007/s00227-010-1420-x; Costa-Urrutia P, 2012, J HERED, V103, P92, DOI 10.1093/jhered/esr103; Crespo EA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P466; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; Crespo Enrique Alberto, 1994, Reports of the International Whaling Commission Special Issue, V15, P269; Cunha HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085633; Di Beneditto Ana Paula Madeira, 2003, Latin American Journal of Aquatic Mammals, V2, P79; DIZON AE, 1992, CONSERV BIOL, V6, P24, DOI 10.1046/j.1523-1739.1992.610024.x; Donovan GP, 1995, REPORT INT WHALING C, P378; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Failla M., 2004, 56 ANN M SCI COMM IN; Failla Mauricio, 2012, Marine Biodiversity Records, V5, pe102, DOI 10.1017/S1755267212000875; Negri MF, 2012, BRAZ J OCEANOGR, V60, P149, DOI 10.1590/S1679-87592012000200005; Frankham R, 2010, INTRO CONSERVATION G; Franklin I.R., 1980, CONSERVATION BIOL EV; Fu YX, 1997, GENETICS, V147, P915; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; King TL, 1999, MOL ECOL, V8, pS1, DOI 10.1046/j.1365-294X.1999.00893.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mardulyn P, 2012, MOL ECOL, V21, P3385, DOI 10.1111/j.1365-294X.2012.05622.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Negri MF, 2011, THESIS U BUENOS AIRE; Nielsen R, 2001, GENETICS, V158, P885; OCorryCrowe GM, 1997, MOL ECOL, V6, P955, DOI 10.1046/j.1365-294X.1997.00267.x; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Paso Viola MN, 2014, THESIS U BUENOS AIRE; Pinedo M.C., 1989, Biology and Conservation of the River Dolphins, VNo. 3, P46; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reeves R, 2012, DATABASE IUCN RED LI; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Rousset F, 1997, GENETICS, V145, P1219; Sambrook J., 1989, MOLECULAR CLONING A; Schneider S, 1999, GENETICS, V152, P1079; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Secchi ER, 2010, WILDL PROT DESTR EXT, P323; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi ER, 1998, CAN J ZOOL, V76, P1622, DOI 10.1139/cjz-76-9-1622; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; TAJIMA F, 1989, GENETICS, V123, P585; Valsecchi E., 2003, Journal of Cetacean Research and Management, V5, P69; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wells RS, 2013, MAR MAMMAL SCI, V29, pE520, DOI 10.1111/mms.12010; Xu LJ, 2010, J HERED, V101, P562, DOI 10.1093/jhered/esq039	78	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132854	10.1371/journal.pone.0132854	http://dx.doi.org/10.1371/journal.pone.0132854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221960	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800032
J	Grover, P; Shi, HB; Baumgartner, M; Camacho, CJ; Smithgall, TE				Grover, Prerna; Shi, Haibin; Baumgartner, Matthew; Camacho, Carlos J.; Smithgall, Thomas E.			Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function	PLOS ONE			English	Article							C-ABL; BCR-ABL; FAMILY KINASES; DYNAMIC REGULATION; AUTOINHIBITION; MECHANISMS; LIGAND; AMBER	The ABL protein-tyrosine kinase regulates intracellular signaling pathways controlling diverse cellular processes and contributes to several forms of cancer. The kinase activity of ABL is repressed by intramolecular interactions involving its regulatory Ncap, SH3 and SH2 domains. Small molecules that allosterically regulate ABL kinase activity through its noncatalytic domains may represent selective probes of ABL function. Here we report a screening assay for chemical modulators of ABL kinase activity that target the regulatory interaction of the SH3 domain with the SH2-kinase linker. This fluorescence polarization (FP) assay is based on a purified recombinant ABL protein consisting of the N-cap, SH3 and SH2 domains plus the SH2-kinase linker (N32L protein) and a short fluorescein-labeled probe peptide that binds to the SH3 domain. In assay development experiments, we found that the probe peptide binds to the recombinant ABL N32L protein in vitro, producing a robust FP signal that can be competed with an excess of unlabeled peptide. The FP signal is not observed with control N32L proteins bearing either an inactivating mutation in the SH3 domain or enhanced SH3: linker interaction. A pilot screen of 1200 FDA-approved drugs identified four compounds that specifically reduced the FP signal by at least three standard deviations from the untreated controls. Secondary assays showed that one of these hit compounds, the antithrombotic drug dipyridamole, enhances ABL kinase activity in vitro to a greater extent than the previously described ABL agonist, DPH. Docking studies predicted that this compound binds to a pocket formed at the interface of the SH3 domain and the linker, suggesting that it activates ABL by disrupting this regulatory interaction. These results show that screening assays based on the non-catalytic domains of ABL can identify allosteric small molecule regulators of kinase function, providing a new approach to selective drug discovery for this important kinase system.	[Grover, Prerna; Shi, Haibin; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Baumgartner, Matthew; Camacho, Carlos J.] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Baumgartner, Matthew/0000-0002-1279-9038	National Institutes of Health [CA185702, GM097082]; Commonwealth of Pennsylvania Department of Health Grant [SAP 4100062224]; National Science Foundation [CNS1229064]; NATIONAL CANCER INSTITUTE [R21CA185702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania Department of Health Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA185702 (to T.E.S.) and GM097082 (C.J.C.) as well as Commonwealth of Pennsylvania Department of Health Grant SAP 4100062224 (C.J.C.). Computational resources were supported by National Science Foundation Grant CNS1229064 (C.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Balakumar P, 2014, PHARMACOL RES, V87, P144, DOI 10.1016/j.phrs.2014.05.008; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Case DA, 2014, AMBER 14; Champ PC, 2007, NUCLEIC ACIDS RES, V35, pW556, DOI 10.1093/nar/gkm326; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Chen SG, 2008, BIOCHEMISTRY-US, V47, P5795, DOI 10.1021/bi800446b; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Dragiev P, 2012, BIOINFORMATICS, V28, P1775, DOI 10.1093/bioinformatics/bts262; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Engen JR, 2013, INT REV PHYS CHEM, V32, P96, DOI 10.1080/0144235X.2012.751175; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Jason-Moller L., 2006, CURR PROTOC PROTEIN, P1, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45, 10.1002/0471142301.ps1914s45]; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Moroco JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105629; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Shun TY, 2011, J BIOMOL SCREEN, V16, P1, DOI 10.1177/1087057110389039; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133590	10.1371/journal.pone.0133590	http://dx.doi.org/10.1371/journal.pone.0133590			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222440	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358836800056
J	Ali, M; Daze, KD; Strongin, DE; Rothbart, SB; Rincon-Arano, H; Allen, HF; Li, J; Strahl, BD; Hof, F; Kutateladze, TG				Ali, Muzaffar; Daze, Kevin D.; Strongin, Daniel E.; Rothbart, Scott B.; Rincon-Arano, Hector; Allen, Hillary F.; Li, Janessa; Strahl, Brian D.; Hof, Fraser; Kutateladze, Tatiana G.			Molecular Insights into Inhibition of the Methylated Histone-Plant Homeodomain Complexes by Calixarenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE BINDING; CHROMATIN-BINDING; EPIGENETIC MARKS; GENE REPRESSION; DNA METHYLATION; DRUG DISCOVERY; H3; RECOGNITION; DOMAIN	Plant homeodomain (PHD) finger-containing proteins are implicated in fundamental biological processes, including transcriptional activation and repression, DNA damage repair, cell differentiation, and survival. The PHD finger functions as an epigenetic reader that binds to posttranslationally modified or unmodified histone H3 tails, recruiting catalytic writers and erasers and other components of the epigenetic machinery to chromatin. Despite the critical role of the histone-PHD interaction in normal and pathological processes, selective inhibitors of this association have not been well developed. Here we demonstrate that macrocyclic calixarenes can disrupt binding of PHD fingers to methylated lysine 4 of histone H3 in vitro and in vivo. The inhibitory activity relies on differences in binding affinities of the PHD fingers for H3K4me and the methylation state of the histone ligand, whereas the composition of the aromatic H3K4me-binding site of the PHD fingers appears to have no effect. Our approach provides a novel tool for studying the biological roles of methyllysine readers in epigenetic signaling.	[Ali, Muzaffar; Allen, Hillary F.; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Daze, Kevin D.; Li, Janessa; Hof, Fraser] Univ Victoria, Dept Chem, Victoria, BC V8W 3V6, Canada; [Strongin, Daniel E.; Rincon-Arano, Hector] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Victoria; Fred Hutchinson Cancer Center; Van Andel Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kutateladze, TG (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	fhof@uvic.ca; tatiana.kutateladze@ucdenver.edu	Regan, Clinton/E-6250-2012; Strahl, Brian D/C-7601-2012	Kutateladze, Tatiana/0000-0001-7375-6990; Hof, Fraser/0000-0003-4658-9132; Strahl, Brian D/0000-0002-4947-6259	National Institutes of Health [GM101664, GM100907, CA181343]; W. M. Keck Foundation; Prostate Cancer Canada; WestCoast Ride to Live; Prostate Cancer Foundation of British Columbia; NATIONAL CANCER INSTITUTE [K99CA181343, R00CA181343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100907, R01GM101664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Prostate Cancer Canada; WestCoast Ride to Live; Prostate Cancer Foundation of British Columbia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grants GM101664 and GM100907 (to T. G. K.) and CA181343 (to S. B. R.). This work was also supported by grants from the W. M. Keck Foundation (to B. D. S.) and from Prostate Cancer Canada (to F. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by WestCoast Ride to Live and the Prostate Cancer Foundation of British Columbia.	Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Allen HF, 2014, BIOCHEM J, V459, P505, DOI 10.1042/BJ20140145; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Beaver JE, 2015, ORG BIOMOL CHEM, V13, P3220, DOI 10.1039/c4ob02231a; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Chang PY, 2010, J MOL BIOL, V400, P137, DOI 10.1016/j.jmb.2010.05.005; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Daze KD, 2012, ORG LETT, V14, P1512, DOI 10.1021/ol300243b; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Florea M, 2012, CHEM-EUR J, V18, P3521, DOI 10.1002/chem.201103397; Gamal-Eldin MA, 2013, ORG BIOMOL CHEM, V11, P488, DOI 10.1039/c2ob27007b; Gao C, 2011, J AM CHEM SOC, V133, P5357, DOI 10.1021/ja110432e; Ghale G, 2014, ANGEW CHEM INT EDIT, V53, P2762, DOI 10.1002/anie.201309583; He FH, 2010, STRUCTURE, V18, P1127, DOI 10.1016/j.str.2010.06.012; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; James LI, 2013, J AM CHEM SOC, V135, P6450, DOI 10.1021/ja307907p; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu YL, 2014, PHARMACOL THERAPEUT, V143, P275, DOI 10.1016/j.pharmthera.2014.03.007; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Martos V, 2009, P NATL ACAD SCI USA, V106, P10482, DOI 10.1073/pnas.0813396106; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McGovern RE, 2015, CHEM SCI, V6, P442, DOI 10.1039/c4sc02383h; McGovern RE, 2012, NAT CHEM, V4, P527, DOI [10.1038/nchem.1342, 10.1038/NCHEM.1342]; Miller TCR, 2014, ACS CHEM BIOL, V9, P2864, DOI 10.1021/cb500585s; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pinkin NK, 2014, ORG BIOMOL CHEM, V12, P7059, DOI 10.1039/c4ob01249f; Ren CY, 2015, CHEM BIOL, V22, P161, DOI 10.1016/j.chembiol.2014.11.021; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Wagner EK, 2012, BIOCHEMISTRY-US, V51, P8293, DOI 10.1021/bi3009278; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	46	22	22	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22919	22930		10.1074/jbc.M115.669333	http://dx.doi.org/10.1074/jbc.M115.669333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229108	Green Published, hybrid			2022-12-26	WOS:000361685500005
J	Pozhidaeva, AK; Mohni, KN; Dhe-Paganon, S; Arrowsmith, CH; Weller, SK; Korzhnev, DM; Bezsonova, I				Pozhidaeva, Alexandra K.; Mohni, Kareem N.; Dhe-Paganon, Sirano; Arrowsmith, Cheryl H.; Weller, Sandra K.; Korzhnev, Dmitry M.; Bezsonova, Irina			Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; REGULATORY PROTEIN; P53 STABILIZATION; P53-MDM2 PATHWAY; CHEMICAL-SHIFTS; E3 LIGASE; USP7; HAUSP; USP7/HAUSP; DOMAIN	Human ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme that prevents protein degradation by removing polyubiquitin chains from its substrates. It regulates the stability of a number of human transcription factors and tumor suppressors and plays a critical role in the development of several types of cancer, including prostate and small cell lung cancer. In addition, human USP7 is targeted by several viruses of the Herpesviridae family and is required for effective herpesvirus infection. The USP7 C-terminal region (C-USP7) contains five ubiquitin-like domains (UBL1-5) that interact with several USP7 substrates. Although structures of the USP7 C terminus bound to its substrates could provide vital information for understanding USP7 substrate specificity, no such data has been available to date. In this work we have demonstrated that the USP7 ubiquitin-like domains can be studied in isolation by solution NMR spectroscopy, and we have determined the structure of the UBL1 domain. Furthermore, we have employed NMR and viral plaque assays to probe the interaction between the C-USP7 and HSV-1 immediate-early protein ICP0 (infected cell protein 0), which is essential for efficient lytic infection and virus reactivation from latency. We have shown that depletion of the USP7 in HFF-1 cells negatively affects the efficiency of HSV-1 lytic infection. We have also found that USP7 directly binds ICP0 via its C-terminal UBL1-2 domains and mapped the USP7-binding site for ICP0. Therefore, this study represents a first step toward understanding the molecular mechanism of C-USP7 specificity toward its substrates and may provide the basis for future development of novel antiviral and anticancer therapies.	[Pozhidaeva, Alexandra K.; Weller, Sandra K.; Korzhnev, Dmitry M.; Bezsonova, Irina] Univ Connecticut Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Mohni, Kareem N.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Connecticut; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; University of Toronto; Structural Genomics Consortium	Bezsonova, I (corresponding author), Univ Connecticut Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	bezsonova@uchc.edu	; Weller, Sandra/N-3979-2013	Pozhidaeva, Alexandra/0000-0001-8602-1790; Arrowsmith, Cheryl/0000-0002-4971-3250; Weller, Sandra/0000-0002-4519-6276	Charles H. Hood Foundation; State of Connecticut Department of Public Health Biomedical Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021747] Funding Source: NIH RePORTER	Charles H. Hood Foundation; State of Connecticut Department of Public Health Biomedical Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Charles H. Hood Foundation child health research award and a State of Connecticut Department of Public Health Biomedical Research Grant (to I. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2013, J GEN VIROL, V94, P465, DOI 10.1099/vir.0.048900-0; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cheng CY, 2013, J VIROL, V87, P6232, DOI 10.1128/JVI.00384-13; Ching W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EVERETT RD, 1993, J MOL BIOL, V234, P1038, DOI 10.1006/jmbi.1993.1657; Everett RD, 1999, J VIROL, V73, P417, DOI 10.1128/JVI.73.1.417-426.1999; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Goddard D., 2008, SPARKY 3; Grishaev A, 2005, PROTEINS, V61, P36, DOI 10.1002/prot.20457; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Keller R, 2004, THESIS ETH ZURICH; Kessler BM, 2007, J PROTEOME RES, V6, P4163, DOI 10.1021/pr0702161; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Mohni KN, 2010, J VIROL, V84, P12152, DOI 10.1128/JVI.01643-10; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wrigley JD, 2011, CELL BIOCHEM BIOPHYS, V60, P99, DOI 10.1007/s12013-011-9186-4; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	58	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22907	22918		10.1074/jbc.M115.664805	http://dx.doi.org/10.1074/jbc.M115.664805			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224631	Green Published, hybrid			2022-12-26	WOS:000361685500004
J	Christofzik, D; Schwendicke, F; Florke, C; Hartl, A; Dorfer, C; Grossner-Schreiber, B				Christofzik, David; Schwendicke, Falk; Floerke, Christian; Haertl, Alexander; Doerfer, Christof; Groessner-Schreiber, Birte			In Vitro Comparison of Raypex 6 and Endopilot Using a Novel, Computer-Aided Measurement System, for Determining the Working Length	PLOS ONE			English	Article							ELECTRONIC APEX LOCATORS; ROOT-CANAL INSTRUMENTATION; VIVO ACCURACY; APICAL LIMIT; RATIO METHOD; OBTURATION; ZX; PROPEX	Introduction Experimental evaluation of endometric devices usually relies on visual, subjective detection of the apical constriction to determine the accuracy of measurements. The aim of the present study was to analyze the accuracy of measurements of Raypex 6 and EndoPilot using a novel, objective image-analysis system. Methods Onehundred and twenty teeth were randomized and allocated to three groups: After coronal flaring, either Raypex 6 or EndoPilot were used to determine the endodontic working length during instrumentation using manual files (RPM and EPM group respectively). In addition, EndoPilot was used for continuous, automatic measurement during rotating instrumentation (EPA group). If the working length had been reached according to endometric results, the files were fixed in place. Tooth and file were then embedded and prepared for analysis. Subsequently, the distance between the tip of the file and the apical constriction (D-AC) or the apical foramen (D-AF) was calculated using trigonometric analysis and the position of the file relative to AC and AF was analyzed. Results Both inter-and intra-examiner-reliability of the trigonometric analysis were nearly perfect (ICC = 0.999, p<0.001). D-AC was not significantly different between groups (p>0.05, t-test). D-AF was significantly decreased when EPA had been used compared to EPM (p<0.05, Exact-test). EPA resulted in files being positioned beyond AF significantly more often than the other two methods (p<0.01). Conclusions All methods allowed reliable detection of AC. However, EPA significantly increased the risk of overpreparation. Objective, digital assessment based on image analysis was suitable to compare the accuracy of different endometric devices.	[Christofzik, David; Floerke, Christian; Doerfer, Christof; Groessner-Schreiber, Birte] Univ Kiel, Clin Conservat Dent & Periodontol, Sch Dent Med, Kiel, Germany; [Schwendicke, Falk] Charite, Dept Operat & Prevent Dent, Charite Ctr 3, D-13353 Berlin, Germany; [Haertl, Alexander] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA	University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Miami	Christofzik, D (corresponding author), Univ Kiel, Clin Conservat Dent & Periodontol, Sch Dent Med, Kiel, Germany.	david.christofzik@uksh.de	Doerfer, Christof/E-4041-2010	Doerfer, Christof/0000-0002-2508-8075; Schwendicke, Falk/0000-0003-1223-1669				Bergenholtz G, 1979, J Endod, V5, P310, DOI 10.1016/S0099-2399(79)80080-1; Chugal NM, 2003, ORAL SURG ORAL MED O, V96, P81, DOI 10.1016/S1079-2104(02)91703-8; Dunlap CA, 1998, J ENDODONT, V24, P48, DOI 10.1016/S0099-2399(98)80214-8; Ebrahim Aqeel Khalil, 2007, Aust Endod J, V33, P7, DOI 10.1111/j.1747-4477.2007.00049.x; ElAyouti A, 2001, J ENDODONT, V27, P49, DOI 10.1097/00004770-200101000-00018; ERIKSEN HM, 1991, ENDOD DENT TRAUMATOL, V7, P189; GREEN D., 1956, ORAL SURG ORAL MED AND ORAL PATHOL, V9, P1224, DOI 10.1016/0030-4220(56)90192-X; GREEN D., 1960, ORAL SURG ORAL MED AND ORAL PATHOL, V13, P728, DOI 10.1016/0030-4220(60)90373-X; Hellwig E., 2009, EINFUHRUNG ZAHNERHAL; Hoer D, 2004, INT ENDOD J, V37, P125, DOI 10.1111/j.0143-2885.2004.00764.x; Hor D, 2005, INT ENDOD J, V38, P855, DOI 10.1111/j.1365-2591.2005.01004.x; HUANG L, 1987, J ENDODONT, V13, P60, DOI 10.1016/S0099-2399(87)80156-5; KATZ A, 1991, ORAL SURG ORAL MED O, V72, P238, DOI 10.1016/0030-4220(91)90169-D; KELLER ME, 1991, J ENDODONT, V17, P271, DOI 10.1016/S0099-2399(06)81865-0; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; KOBAYASHI C, 1994, J ENDODONT, V20, P111, DOI 10.1016/S0099-2399(06)80053-1; Lauper R, 1996, J ENDODONT, V22, P260, DOI 10.1016/S0099-2399(06)80145-7; Liang YH, 2012, CLIN ORAL INVEST, V16, P1619, DOI 10.1007/s00784-011-0671-3; Marending M, 2012, INT ENDOD J, V45, P169, DOI 10.1111/j.1365-2591.2011.01967.x; Markula-Liegau A., 1996, THESIS ERLANGEN; Moura-Netto C, 2013, BRAZ ORAL RES, V27, P26, DOI 10.1590/S1806-83242012005000029; Mull J Paras, 2012, J Conserv Dent, V15, P178, DOI 10.4103/0972-0707.94585; NAIR PNR, 1987, J ENDODONT, V13, P29, DOI 10.1016/S0099-2399(87)80089-4; Pagavino G, 1998, J ENDODONT, V24, P438, DOI 10.1016/S0099-2399(98)80029-0; Plotino G, 2006, INT ENDOD J, V39, P408, DOI 10.1111/j.1365-2591.2006.01095.x; Ricucci D, 1998, INT ENDOD J, V31, P384; Ricucci D, 1998, INT ENDOD J, V31, P394; Schaeffer MA, 2005, J ENDODONT, V31, P271, DOI 10.1097/01.don.0000140585.52178.78; Schlumbohm G, 2008, INVENTORVERFAHREN ZU; Schlumbohm G, 2012, INVENTORVERFAHREN ZU; Somma F, 2012, INT ENDOD J, V45, P552, DOI 10.1111/j.1365-2591.2011.02010.x; Stavileci M, 2013, MED SCI MONIT BASIC, V19, P163, DOI 10.12659/MSMBR.889350	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134383	10.1371/journal.pone.0134383	http://dx.doi.org/10.1371/journal.pone.0134383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237310	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400026
J	Kanda, E; Muneyuki, T; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Suwa, Kaname; Nakajima, Kei			Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; RICH RED WINE; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; RENAL DYSFUNCTION; JAPANESE ADULTS; UNITED-STATES; RISK-FACTORS; DISEASE; CONSUMPTION	Background Although lifestyle is associated with metabolic syndrome and cardiovascular diseases, there has been no sufficient evidence of lifestyles on incident chronic kidney disease (CKD). The purpose of this prospective cohort study is to investigate the effects of lifestyles on kidney function in healthy people. Methods A total of 7473 healthy people were enrolled in this Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. Data on alcohol consumption, exercise frequency, and sleep duration were collected. The outcome event was incident CKD or decrease in estimated glomerular filtration rate (eGFR) by >25% in 3 years. Results Subjects were classified into four groups according to body mass index and gender. Mean +/- standard deviation of age was 38.8+/-10.5 years; eGFR, 78.1+/-15.2 ml/min/1.73m(2). In the male groups, multivariate logistic regression models showed that the outcome events were associated with a small amount of alcohol consumed (20 to 140g of alcohol/week) (ref. more than 140g of alcohol/week); non-obese male, adjusted odds ratio 1.366 (95% confidence interval, 1.086, 1.718); obese male (body mass index >= 25), 1.634 (1.160, 2.302); and with frequent exercise (twice a week or more) (ref. no exercise); non-obese male, 1.417 (1.144, 1.754); obese male, 1.842 (1.317, 2.577). Sleep duration was not associated with the outcome events. Conclusion These findings suggest that, regardless of obesity, a small amount of alcohol consumed and high exercise frequency were associated with the increased risk of loss of kidney function in the male groups.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Saitama Citizens Med Ctr, Saitama, Japan; [Muneyuki, Toshitaka] Funabashi City Rehabil Hosp, Dept Rehabil, Funabashi, Chiba, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Saitama, Japan; [Nakajima, Kei] Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, Sakado, Saitama 35002, Japan; [Nakajima, Kei] Kuki Gen Hosp, Dept Metab, Kuki, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Josai University	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Matsuo, Keitaro/H-6758-2019; Nakajima, Kei/AAF-2801-2019	Matsuo, Keitaro/0000-0003-1761-6314; Nakajima, Kei/0000-0002-1788-3896	Saitama Health Promotion Corporation	Saitama Health Promotion Corporation	Saitama Health Promotion Corporation provided support in the form of salaries for one author [KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Cheungpasitporn W, 2015, QJM-INT J MED, V108, P539, DOI 10.1093/qjmed/hcu247; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365, DOI 10.1152/ajprenal.2001.280.3.F365; Eidemak I, 1997, NEPHRON, V75, P36, DOI 10.1159/000189497; Emanuele MA, 2001, ALCOHOL RES HEALTH, V25, P282; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; Estruch R, 2011, NUTR METAB CARDIOVAS, V21, P46, DOI 10.1016/j.numecd.2009.07.006; Femia R, 2006, ARTERIOSCL THROM VAS, V26, P1607, DOI 10.1161/01.ATV.0000222929.99098.1f; Ferreira MP, 2008, J AM DIET ASSOC, V108, P1668, DOI 10.1016/j.jada.2008.07.011; GAVALER JS, 1993, ALCOHOL CLIN EXP RES, V17, P786, DOI 10.1111/j.1530-0277.1993.tb00842.x; GAVALER JS, 1992, ALCOHOL CLIN EXP RES, V16, P87, DOI 10.1111/j.1530-0277.1992.tb00642.x; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Knight EL, 2003, NEPHROL DIAL TRANSPL, V18, P1549, DOI 10.1093/ndt/gfg228; Komura Hiroshi, 2013, BMC Res Notes, V6, P463, DOI 10.1186/1756-0500-6-463; Leehey DJ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-62; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Menon V, 2010, NEPHROL DIAL TRANSPL, V25, P3301, DOI 10.1093/ndt/gfq188; Middlekauff HR, 1997, CIRC RES, V80, P62, DOI 10.1161/01.RES.80.1.62; Muneyuki T, 2013, OPEN J ENDOCRINE MET, V3; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Plantinga L, 2011, AM J KIDNEY DIS, V58, P554, DOI 10.1053/j.ajkd.2011.05.024; Ricardo AC, 2013, CLIN J AM SOC NEPHRO, V8, P602, DOI 10.2215/CJN.00600112; Rodrigo R, 2004, NEPHROL DIAL TRANSPL, V19, P2237, DOI 10.1093/ndt/gfh369; Rodrigo R, 2002, LIFE SCI, V71, P2881, DOI 10.1016/S0024-3205(02)02140-9; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tokashiki K, 2009, CLIN EXP NEPHROL, V13, P55, DOI 10.1007/s10157-008-0085-y; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Verzola D, 2009, BIOCHEM BIOPH RES CO, V387, P531, DOI 10.1016/j.bbrc.2009.07.056; White SL, 2009, NEPHROL DIAL TRANSPL, V24, P2464, DOI 10.1093/ndt/gfp114; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134937	10.1371/journal.pone.0134937	http://dx.doi.org/10.1371/journal.pone.0134937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237314	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942400040
J	Lu, QS; Li, JP; Senkowski, C; Tang, ZQ; Wang, JH; Huang, TH; Wang, X; Terry, K; Brower, S; Glasgow, W; Chen, HB; Jiang, SW				Lu, Qinsheng; Li, Jinping; Senkowski, Christopher; Tang, Zuoqing; Wang, Jianhao; Huang, Tianhe; Wang, Xue; Terry, Karen; Brower, Steven; Glasgow, Wayne; Chen, Haibin; Jiang, Shi-Wen			Promoter Hypermethylation and Decreased Expression of Syncytin-1 in Pancreatic Adenocarcinomas	PLOS ONE			English	Article							TROPHOBLAST CELL-FUSION; HERV-W FAMILY; ENDOGENOUS RETROVIRUSES; ENDOMETRIAL CARCINOMA; BEWO CELLS; CANCER; METHYLATION; GENES; APOPTOSIS; HYPOMETHYLATION	Syncytin-1 is a member of human endogenous retroviral W gene family (HERVW1). Known to be expressed in human placental trophoblast, syncytin-1 protein mediates the fusion of cytotrophoblasts for the formation of syncytiotrophoblasts, the terminally differentiated form of trophoblast lineage. In addition, in vitro studies indicate that syncytin-1 possessed nonfusogenic functions such as those for immune suppression, cell cycle regulation and anti-apoptotic activities. Overexpression of syncytin-1 has been observed in various malignant tissues including breast, endometrial and ovarian cancers. It was reported that syncytin-1 gene expression is associated with dynamic changes of DNA hypomethylation in the 5' LTR. In this study, applying the real-time PCR, Western blot analysis and immunohistochemistry methods, we demonstrate a constitutive expression of syncytin-1 in normal pancreas tissues as well as normal tissues adjacent to cancer lesions. Moreover, a reduced expression is found in the pancreatic adenocarcinoma tissues. The expression levels of syncytin-1 are not correlated with the stage, historical grade and gender, but inversely correlated with patients' age. Furthermore, COBRA and bisulfite sequencing results indicated that the lower expression of syncytin-1 is correlated with the hypermethylation of two CpG dinucleotides in the 5' LTR of syncytin-1 gene. The nonfusogenic function of syncytin-1 in normal pancreas as well as its role(s) in the pathogenesis and progression of pancreatic cancers remains to be investigated. Identification of the two CpG dinucleotides around transcription start site as key epigenetic elements has provided valuable information for further studies on the epigenetic regulation of syncytin-1 in pancreatic cancer cells.	[Lu, Qinsheng; Chen, Haibin] Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China; [Lu, Qinsheng; Li, Jinping; Huang, Tianhe; Wang, Xue; Glasgow, Wayne; Jiang, Shi-Wen] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA; [Senkowski, Christopher; Terry, Karen] Mem Hlth Univ Med Ctr, Curtis & Elizabeth Anderson Canc Inst, Dept Surg, Savannah, GA 31404 USA; [Tang, Zuoqing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Wang, Jianhao] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Jiangsu, Peoples R China; [Brower, Steven] Beth Israel Deaconess Med Ctr, Dept Surg & Surg Oncol, New York, NY 10003 USA; [Jiang, Shi-Wen] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou 325027, Peoples R China; [Li, Jinping; Jiang, Shi-Wen] Mem Hlth Univ Med Ctr, Dept Obstet & Gynecol, Savannah, GA 31404 USA	Shantou University; Mercer University; Capital Medical University; Changzhou University; Harvard University; Beth Israel Deaconess Medical Center; Wenzhou Medical University	Chen, HB (corresponding author), Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China.	chenhb@stu.edu.cn; Jiang_S@mercer.edu	Huang, Tianhe/U-8565-2017	Huang, Tianhe/0000-0002-2737-4016	Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program; ACI Excellence through Discovery Laboratory Research Fund; ACI/MUSM Profession Development Fund; Distinguished Cancer Scholar Program of Georgia Research Alliance; Georgia Research Alliance; Collaborative Research Fund of Shantou University Medical College; Mercer University Seed Grant; Beijing Natural Science Foundation [7142026]; Mercer University Seed Grant and Start-up Fund	Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program; ACI Excellence through Discovery Laboratory Research Fund; ACI/MUSM Profession Development Fund; Distinguished Cancer Scholar Program of Georgia Research Alliance; Georgia Research Alliance; Collaborative Research Fund of Shantou University Medical College; Mercer University Seed Grant; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Mercer University Seed Grant and Start-up Fund	This study is supported by Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program (Li, J.; Jiang, S.-W; Brower. S.); The ACI Excellence through Discovery Laboratory Research Fund (Li, J.; Jiang, S.-W; Brower, S.; Glasgow, W.); ACI/MUSM Profession Development Fund (Li J.; Jiang, S.-W.); Distinguished Cancer Scholar Program of Georgia Research Alliance (Jiang, S.-W); Research Award from Georgia Research Alliance (Jiang, S.-W.); Collaborative Research Fund of Shantou University Medical College (Jiang, S.-W.; Chen, H.); Mercer University Seed Grant (Li, J.; Jiang, S.-W.); Beijing Natural Science Foundation 7142026 (Tang, Z.; Jiang, S.-W.); and Mercer University Seed Grant and Start-up Fund (Li, J.; Jiang, S.-W).	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonnaud B, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-57; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fukushige S, 2014, CANCER LETT, V342, P231, DOI 10.1016/j.canlet.2012.03.022; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Huang Q, 2014, CELL MOL LIFE SCI, V71, P3151, DOI 10.1007/s00018-013-1533-8; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Knerr I, 2008, J CELL BIOCHEM, V105, P766, DOI 10.1002/jcb.21874; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Muniraj T, 2013, DM-DIS MON, V59, P368, DOI 10.1016/j.disamonth.2013.08.001; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Piperi Christina, 2008, J Biomol Tech, V19, P281; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; SAKAI T, 1991, AM J HUM GENET, V48, P880; Shiroma T, 2001, J HUM GENET, V46, P619, DOI 10.1007/s100380170012; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Strissel PL, 2008, INT J CANCER, V123, P2871, DOI 10.1002/ijc.23900; Strissel PL, 2012, ONCOTARGET, V3, P1204; Sun Y, 2010, LEUKEMIA RES, V34, P1195, DOI 10.1016/j.leukres.2010.03.016; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Trejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yi JM, 2004, ZOOL SCI, V21, P649, DOI 10.2108/zsj.21.649; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhou HY, 2014, CURR PHARM DESIGN, V20, P1786, DOI 10.2174/13816128113199990540; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134412	10.1371/journal.pone.0134412	http://dx.doi.org/10.1371/journal.pone.0134412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230721	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400116
J	Melling, N; Harutyunyan, L; Hube-Magg, C; Kluth, M; Simon, R; Lebok, P; Minner, S; Tsourlakis, MC; Koop, C; Graefen, M; Adam, M; Haese, A; Wittmer, C; Steurer, S; Izbicki, J; Sauter, G; Wilczak, W; Schlomm, T; Krech, T				Melling, Nathaniel; Harutyunyan, Levon; Hube-Magg, Claudia; Kluth, Martina; Simon, Ronald; Lebok, Patrick; Minner, Sarah; Tsourlakis, Maria Christina; Koop, Christina; Graefen, Markus; Adam, Meike; Haese, Alexander; Wittmer, Corinna; Steurer, Stefan; Izbicki, Jakob; Sauter, Guido; Wilczak, Waldemar; Schlomm, Thorsten; Krech, Till			High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; TUMOR-SUPPRESSOR GENES; EARLY PSA RECURRENCE; DELETION; REARRANGEMENT; FUSION; PTEN; CENTROSOME; LOCALIZES; LANDSCAPE	Hook microtubule-tethering protein 3 (HOOK3) is an adaptor protein for microtubule-dependent intracellular vesicle and protein trafficking. In order to assess the role of HOOK3 in prostate cancer we analyzed HOOK3 expression by immunohistochemistry on a TMA containing more than 12,400 prostate cancers. Results were compared to tumor phenotype and PSA recurrence as well as aberrations possibly defining relevant molecular subtypes such as ERG status and deletions of 3p13, 5q21, 6q15 and PTEN. HOOK3 immunostaining was negative in normal luminal cells of prostate epithelium, whereas 53.3% of 10,572 interpretable cancers showed HOOK3 expression, which was considered low in 36.4% and high in 16.9% of cases. High-level HOOK3 expression was linked to advanced tumor stage, high Gleason score, high proliferation index, positive lymph node stage, and PSA recurrence (p<0.0001 each). The prognostic role of HOOK3 expression was independent of established clinico-pathological parameters both in preoperative and postoperative settings. Comparisons with molecular features were performed to draw conclusions on the potential function of HOOK3 in the prostate. A strong association with all examined deletions is consistent with a role of HOOK3 for maintaining genomic integrity by contributing to proper centrosome assembly. Finding HOOK3 expression in 74% of ERG positive but in only 38% of ERG negative cancers (p<0.0001) further suggests functional interactions between these genes. In conclusion, the results of our study identify HOOK3 as a strong candidate prognostic marker with a possible role in maintaining genomic integrity in prostate cancer, which may have potential for inclusion into clinical routine assays.	[Melling, Nathaniel; Harutyunyan, Levon; Hube-Magg, Claudia; Kluth, Martina; Simon, Ronald; Lebok, Patrick; Minner, Sarah; Tsourlakis, Maria Christina; Koop, Christina; Wittmer, Corinna; Steurer, Stefan; Sauter, Guido; Wilczak, Waldemar; Krech, Till] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Melling, Nathaniel; Izbicki, Jakob] Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept & Clin, Hamburg, Germany; [Graefen, Markus; Adam, Meike; Haese, Alexander; Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Sect Translat Prostate Canc Res, Dept Urol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany.	r.simon@uke.de		Schlomm, Thorsten/0000-0001-9557-4653				Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Becker-Santos DD, 2012, CARCINOGENESIS, V33, P2558, DOI 10.1093/carcin/bgs285; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Ciampi R, 2007, ENDOCR-RELAT CANCER, V14, P445, DOI 10.1677/ERC-07-0039; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kluth M, 2013, MODERN PATHOL, V26, P975, DOI 10.1038/modpathol.2012.236; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kramer H, 1999, GENETICS, V151, P675; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; Mao XY, 2011, AM J CANCER RES, V1, P604; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Schlomm T, 2008, UROLOGE, V47, P1193, DOI 10.1007/s00120-008-1834-y; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Toma MI, 2010, ANAL QUANT CYTOL, V32, P1; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134614	10.1371/journal.pone.0134614	http://dx.doi.org/10.1371/journal.pone.0134614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230842	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400139
J	Jain, N; Bhargava, A; Rathi, M; Dilip, RV; Panwar, J				Jain, Navin; Bhargava, Arpit; Rathi, Mohit; Dilip, R. Venkataramana; Panwar, Jitendra			Removal of Protein Capping Enhances the Antibacterial Efficiency of Biosynthesized Silver Nanoparticles	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; MECHANISM; TOXICITY; IONS; SURFACTANTS; NANOSILVER; POLYMERS; BACTERIA; RELEASE	The present study demonstrates an economical and environmental affable approach for the synthesis of "protein-capped" silver nanoparticles in aqueous solvent system. A variety of standard techniques viz. UV-visible spectroscopy, transmission electron microscopy (TEM), energy dispersive spectroscopy (EDS) and X-ray diffraction (XRD) measurements were employed to characterize the shape, size and composition of nanoparticles. The synthesized nanoparticles were found to be homogenous, spherical, mono-dispersed and covered with multi-layered protein shell. In order to prepare bare silver nanoparticles, the protein shell was removed from biogenic nanoparticles as confirmed by UV-visible spectroscopy, FTIR and photoluminescence analysis. Subsequently, the antibacterial efficacy of protein-capped and bare silver nanoparticles was compared by bacterial growth rate and minimum inhibitory concentration assay. The results revealed that bare nanoparticles were more effective as compared to the protein-capped silver nanoparticles with varying antibacterial potential against the tested Gram positive and negative bacterial species. Mechanistic studies based on ROS generation and membrane damage suggested that protein-capped and bare silver nanoparticles demonstrate distinct mode of action. These findings were strengthened by the TEM imaging along with silver ion release measurements using inductively coupled plasma atomic emission spectroscopy (ICP-AES). In conclusion, our results illustrate that presence of protein shell on silver nanoparticles can decrease their bactericidal effects. These findings open new avenues for surface modifications of nanoparticles to modulate and enhance their functional properties.	[Jain, Navin; Bhargava, Arpit; Rathi, Mohit; Dilip, R. Venkataramana; Panwar, Jitendra] Birla Inst Technol & Sci, Dept Biol Sci, Ctr Biotechnol, Pilani 333031, Rajasthan, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Panwar, J (corresponding author), Birla Inst Technol & Sci, Dept Biol Sci, Ctr Biotechnol, Pilani 333031, Rajasthan, India.	drjitendrapanwar@yahoo.co.in		Jain, Navin/0000-0002-8207-2491	University Grant Commission, Government of India [42-185/2013(SR)]	University Grant Commission, Government of India(University Grants Commission, India)	This research work was financially supported by University Grant Commission (www.ugc.ac.in), Government of India under Major Project Scheme [F. No. 42-185/2013(SR)].	Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Amato E, 2011, LANGMUIR, V27, P9165, DOI 10.1021/la201200r; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Bartlomiejczyk T, 2013, ANN AGR ENV MED, V20, P48; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett DW, 2006, OSTOMY WOUND MANAG, V52, P34; Buege J A, 1978, Methods Enzymol, V52, P302; Calzolai L, 2010, NANO LETT, V10, P3101, DOI 10.1021/nl101746v; Chang QY, 2007, LANGMUIR, V23, P11197, DOI 10.1021/la701006r; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5; de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780; Dimkpa CO, 2011, J HAZARD MATER, V188, P428, DOI 10.1016/j.jhazmat.2011.01.118; FALES FW, 1951, J BIOL CHEM, V193, P113; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; HOCHMAN A, 1991, BIOCHIM BIOPHYS ACTA, V1077, P299, DOI 10.1016/0167-4838(91)90544-A; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Jain N, 2013, APPL MICROBIOL BIOT, V97, P859, DOI 10.1007/s00253-012-3934-2; Jain N, 2011, NANOSCALE, V3, P635, DOI 10.1039/c0nr00656d; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134; Lu WT, 2010, CHEM PHYS LETT, V487, P92, DOI 10.1016/j.cplett.2010.01.027; Lu XM, 2009, ANNU REV PHYS CHEM, V60, P167, DOI 10.1146/annurev.physchem.040808.090434; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Mijnendonckx K, 2013, BIOMETALS, V26, P609, DOI 10.1007/s10534-013-9645-z; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pradeep T, 2009, THIN SOLID FILMS, V517, P6441, DOI 10.1016/j.tsf.2009.03.195; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Rico CM, 2013, ENVIRON SCI TECHNOL, V47, P5635, DOI 10.1021/es401032m; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Shaligram NS, 2009, PROCESS BIOCHEM, V44, P939, DOI 10.1016/j.procbio.2009.04.009; Shankar SS, 2003, J MATER CHEM, V13, P1822, DOI 10.1039/b303808b; Sheehy K, 2015, J COLLOID INTERF SCI, V443, P56, DOI 10.1016/j.jcis.2014.11.074; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Somasundaran P, 2004, J COSMET SCI, V55, pS1; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Suchomel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119202; Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x; Vigneshwaran N, 2006, COLLOID SURFACE B, V53, P55, DOI 10.1016/j.colsurfb.2006.07.014; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	62	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134337	10.1371/journal.pone.0134337	http://dx.doi.org/10.1371/journal.pone.0134337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226385	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700075
J	Nakanishi, N; Camara, AC; Yuan, DC; Gold, DA; Jacobs, DK				Nakanishi, Nagayasu; Camara, Anthony C.; Yuan, David C.; Gold, David A.; Jacobs, David K.			Gene Expression Data from the Moon Jelly, Aurelia, Provide Insights into the Evolution of the Combinatorial Code Controlling Animal Sense Organ Development	PLOS ONE			English	Article							EYES ABSENT; PAX-6-EYA-DACH NETWORK; CRANIAL PLACODES; PAX GENES; CONSERVATION; SPECIFICATION; PATTERNS; FAMILIES; MEDUSAE; SYSTEM	In Bilateria, Pax6, Six, Eya and Dach families of transcription factors underlie the development and evolution of morphologically and phyletically distinct eyes, including the compound eyes in Drosophila and the camera-type eyes in vertebrates, indicating that bilaterian eyes evolved under the strong influence of ancestral developmental gene regulation. However the conservation in eye developmental genetics deeper in the Eumetazoa, and the origin of the conserved gene regulatory apparatus controlling eye development remain unclear due to limited comparative developmental data from Cnidaria. Here we show in the eye-bearing scyphozoan cnidarian Aurelia that the ectodermal photosensory domain of the developing medusa sensory structure known as the rhopalium expresses sine oculis (so)/six1/2 and eyes absent/eya, but not optix/six3/6 or pax (A&B). In addition, the so and eya co-expression domain encompasses the region of active cell proliferation, neurogenesis, and mechanoreceptor development in rhopalia. Consistent with the role of so and eya in rhopalial development, developmental transcriptome data across Aurelia life cycle stages show upregulation of so and eya, but not optix or pax (A&B), during medusa formation. Moreover, pax6 and dach are absent in the Aurelia genome, and thus are not required for eye development in Aurelia. Our data are consistent with so and eya, but not optix, pax or dach, having conserved functions in sensory structure specification across Eumetazoa. The lability of developmental components including Pax genes relative to so-eya is consistent with a model of sense organ development and evolution that involved the lineage specific modification of a combinatorial code that specifies animal sense organs.	[Nakanishi, Nagayasu; Camara, Anthony C.; Yuan, David C.; Gold, David A.; Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles	Jacobs, DK (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90089 USA.	djacobs@ucla.edu	Gold, David/I-5398-2012	Gold, David/0000-0003-0135-4022	UCLA Edwin W. Pauley fellowship; NIH Genomic Analysis and Interpretation Training Grant [T32HG002536]; NASA Astrobiology Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	UCLA Edwin W. Pauley fellowship; NIH Genomic Analysis and Interpretation Training Grant; NASA Astrobiology Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the UCLA Edwin W. Pauley fellowship (to N.N.), NIH Genomic Analysis and Interpretation Training Grant T32HG002536 (to D.A.G.), and a NASA Astrobiology Institute Grant (to DKJ). https://astrobiology.nasa.gov/nai/ in http://www.complex-life.org/.	Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Bebenek IG, 2004, DEV GENES EVOL, V214, P342, DOI 10.1007/s00427-004-0407-3; Blumer MJF, 1995, ZOOMORPHOLOGY, V115, P221, DOI 10.1007/BF00393802; Brekhman V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1320-z; Carl M, 2002, DEVELOPMENT, V129, P4057; Darwin C., 1859, PRESERVATION FAVOURE, Vix; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Donner AL, 2004, INT J DEV BIOL, V48, P743, DOI 10.1387/ijdb.041877ad; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Graziussi DF, 2012, J EXP ZOOL PART B, V318B, P257, DOI 10.1002/jez.b.22442; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hernandez-Nicaise M.-L., 1991, P359; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; HORRIDGE A, 1956, Q J MICROSC SCI, V97, P59; HORRIDGE GA, 1959, J EXP BIOL, V36, P72; Horstmann E, 1934, PFLUG ARCH GES PHYS, V234, P406, DOI 10.1007/BF01766923; Hoshiyama D, 1998, J MOL EVOL, V47, P640, DOI 10.1007/PL00006421; Hroudova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036420; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Jacobs DK, 2007, INTEGR COMP BIOL, V47, P712, DOI 10.1093/icb/icm094; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mackie GO., 1971, SAL ACT 1 S INT ZOOF, P269; Martin-Duran JM, 2012, DEV GENES EVOL, V222, P45, DOI 10.1007/s00427-012-0389-5; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Nakanishi N, 2010, EVOL DEV, V12, P404, DOI 10.1111/j.1525-142X.2010.00427.x; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Passano L.M., 1973, Publications Seto Mar Biol Lab, V20, P615; PASSANO LM, 1965, AM ZOOL, V5, P465; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schafer E.A., 1878, PHILOS T ROY SOC LON, V169, P563; Schlosser G, 2008, DEV BIOL, V320, P199, DOI 10.1016/j.ydbio.2008.05.523; Schlosser G, 2007, INTEGR COMP BIOL, V47, P343, DOI 10.1093/icb/icm031; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schmich J, 1998, CELL TISSUE RES, V294, P169, DOI 10.1007/s004410051167; Schroth W, 2005, MAR BIOTECHNOL, V7, P449, DOI 10.1007/s10126-004-4095-9; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Steinmetz PRH, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-14; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; TAKASU N, 1984, ZOOL SCI, V1, P367; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; von Salvini-Plawen L., 1977, Evolutionary Biology (New York), V10, P207; Wallberg A, 2004, CLADISTICS, V20, P558, DOI 10.1111/j.1096-0031.2004.00041.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu PX, 1997, DEVELOPMENT, V124, P219; Yamasu T., 1973, Publications Seto Mar Biol Lab, V20, P757; Yoshida M., 1980, P343; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8	66	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132544	10.1371/journal.pone.0132544	http://dx.doi.org/10.1371/journal.pone.0132544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225420	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700008
J	Dan, XJ; King, BR; Doyon, JL; Chan, P				Dan, Xiaojuan; King, Bradley R.; Doyon, Julien; Chan, Piu			Motor Sequence Learning and Consolidation in Unilateral De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							REACTION-TIME-TASK; BASAL GANGLIA; MEMORY CONSOLIDATION; VISUOMOTOR SEQUENCE; FUNCTIONAL MRI; FRONTAL LOBES; OLDER-ADULTS; SLEEP; STRIATUM; SKILL	Previous research investigating motor sequence learning (MSL) and consolidation in patients with Parkinson's disease (PD) has predominantly included heterogeneous participant samples with early and advanced disease stages; thus, little is known about the onset of potential behavioral impairments. We employed a multisession MSL paradigm to investigate whether behavioral deficits in learning and consolidation appear immediately after or prior to the detection of clinical symptoms in the tested (left) hand. Specifically, our patient sample was limited to recently diagnosed patients with pure unilateral PD. The left hand symptomatic (LH-S) patients provided an assessment of performance following the onset of clinical symptoms in the tested hand. Conversely, right hand affected (left hand asymptomatic, LH-A) patients served to investigate whether MSL impairments appear before symptoms in the tested hand. LH-S patients demonstrated impaired learning during the initial training session and both LH-S and LH-A patients demonstrated decreased performance compared to controls during the next-day retest. Critically, the impairments in later learning stages in the LH-A patients were evident even before the appearance of traditional clinical symptoms in the tested hand. Results may be explained by the progression of disease-related alterations in relevant corticostriatal networks.	[Dan, Xiaojuan; Chan, Piu] Capital Med Univ, Dept Neurobiol & Neurol, Beijing Key Lab Parkinsons Dis, Xuanwu Hosp,Key Lab,Minist Educ Neurodegenerat Di, Beijing, Peoples R China; [King, Bradley R.; Doyon, Julien] Univ Montreal, Dept Psychol, Funct Neuroimaging Unit, Montreal, PQ H3C 3J7, Canada; [Chan, Piu] Parkinsons Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Universite de Montreal	Chan, P (corresponding author), Capital Med Univ, Dept Neurobiol & Neurol, Beijing Key Lab Parkinsons Dis, Xuanwu Hosp,Key Lab,Minist Educ Neurodegenerat Di, Beijing, Peoples R China.	pbchan90@gmail.com	King, Bradley/U-1820-2018; Chan, Piu/I-4580-2016	King, Bradley/0000-0002-3010-8755; Chan, Piu/0000-0003-1346-881X	Ministry of Science and Technology of China [2012AA02A514]; National Basic Research Development Program of China [2011CB504101]; Ministry of Health [201002011]; Beijing High Standard Health Human Resource Cultural Program in Health System [2009e1e12]; European Commission - ERA Net Neuron [26659]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Development Program of China(National Basic Research Program of China); Ministry of Health; Beijing High Standard Health Human Resource Cultural Program in Health System; European Commission - ERA Net Neuron(European CommissionEuropean Commission Joint Research Centre); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The study was supported by grants from the Ministry of Science and Technology of China (2012AA02A514), the National Basic Research Development Program of China (2011CB504101), Ministry of Health (201002011), Beijing High Standard Health Human Resource Cultural Program in Health System (2009e1e12) awarded to P.C. as well as the European Commission - ERA Net Neuron (Identifying #26659) awarded to J.D. Postdoctoral fellowship support for author B.R.K. was provided by the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino R, 2004, MOVEMENT DISORD, V19, P1285, DOI 10.1002/mds.20247; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brown RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006683; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Deroost N, 2006, NEUROPSYCHOLOGIA, V44, P1653, DOI 10.1016/j.neuropsychologia.2006.03.021; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2008, CURR OPIN NEUROL, V21, P478, DOI 10.1097/WCO.0b013e328304b6a3; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fogel SM, 2014, HUM BRAIN MAPP, V35, P3625, DOI 10.1002/hbm.22426; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Helmuth LL, 2000, NEUROPSYCHOLOGIA, V38, P1443, DOI 10.1016/S0028-3932(00)00059-2; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kwak Y, 2013, J MOTOR BEHAV, V45, P423, DOI 10.1080/00222895.2013.817380; Kwak Y, 2012, BEHAV BRAIN RES, V230, P116, DOI 10.1016/j.bbr.2012.02.006; Kwak Y, 2010, J NEUROPHYSIOL, V103, P942, DOI 10.1152/jn.00197.2009; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Marek KL, 1996, NEUROLOGY, V46, P231, DOI 10.1212/WNL.46.1.231; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; MARSDEN CD, 1994, BRAIN, V117, P877, DOI 10.1093/brain/117.4.877; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; NAHMIAS C, 1985, J NEUROL SCI, V69, P223, DOI 10.1016/0022-510X(85)90135-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Ruitenberg MFL, 2015, CORTEX, V65, P102, DOI 10.1016/j.cortex.2015.01.005; Schwarz J, 2000, ARCH NEUROL-CHICAGO, V57, P205, DOI 10.1001/archneur.57.2.205; Seidler RD, 2007, BRAIN RES, V1137, P104, DOI 10.1016/j.brainres.2006.12.057; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Smith J, 2001, BRAIN COGNITION, V45, P378, DOI 10.1006/brcg.2001.1286; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; Stephan MA, 2011, BRAIN COGNITION, V75, P135, DOI 10.1016/j.bandc.2010.10.015; Terpening Z, 2013, J SLEEP RES, V22, P398, DOI 10.1111/jsr.12028; Tessa C, 2013, PARKINSONISM RELAT D, V19, P265, DOI 10.1016/j.parkreldis.2012.07.018; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Williams JR, 2012, NEUROLOGY, V78, P998, DOI 10.1212/WNL.0b013e31824d587f; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	56	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134291	10.1371/journal.pone.0134291	http://dx.doi.org/10.1371/journal.pone.0134291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222151	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800124
J	Drummond, H; Rodriguez, C				Drummond, Hugh; Rodriguez, Cristina			Viability of Booby Offspring is Maximized by Having One Young Parent and One Old Parent	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; PATERNAL AGE; DIFFERENTIAL ALLOCATION; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; MATERNAL AGE; GOOD GENES; FEMALE; SENESCENCE; QUALITY	It is widely expected that the quality of offspring will vary with the age of their parents and that this variation should influence animals' choice of mates. However, theoretical predictions for age effects are contradictory and, to our knowledge, we do not know for any wild animal how the quality of offspring is affected by both parents' ages across their lifespans, or whether mothers' and fathers' ages interact. We tackled this question using long-term data on a highly philopatric, insular population of the blue-footed booby (Sula nebouxii). In this species extra-pair paternity is most common in pairs of two young parents or two old parents, implying that these age combinations might prejudice offspring quality. Analysis of the viability of 3,361 offspring of parents up to 21 years old revealed that fledglings with two young parents or two old parents were least likely to become breeders, whereas fledglings with one young parent and one old parent were most likely to do so. For young parents of either sex, offspring viability increased with age of the other parent; for very old parents, it decreased. These effects could be mediated by parents flexibly modifying their investment in offspring in response to their own and their partners 'ages, but evidence for this was lacking. In 5,343 breeding attempts, although mothers' and fathers' ages independently affected four heavily care-dependent breeding traits at the clutch and nestling stages, their interaction did not affect any trait. The effects of parental age combinations on viability could also be mediated by genes: fledglings with one young parent and one old parent could benefit from greater heterozygosity or better genes.	[Drummond, Hugh; Rodriguez, Cristina] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolutiva, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Drummond, H (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolutiva, Mexico City 04510, DF, Mexico.	hugh@unam.mx			Consejo Nacional de Ciencia y Tecnologia [4722-N9407, C01-47599, D112-903581, PCCNCNA-031528, 31973-H, 34500V, 104313]; Universidad Nacional Autonoma de Mexico (PAPIIT) [IN211491, IN-200702-3, IN206610-3, IN205313]; National Geographic Society	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); National Geographic Society(National Geographic Society)	Finance was provided by the Consejo Nacional de Ciencia y Tecnologia (4722-N9407, C01-47599, D112-903581, PCCNCNA-031528, 31973-H, 34500V, 104313), the Universidad Nacional Autonoma de Mexico (PAPIIT, IN211491, IN-200702-3, IN206610-3, IN205313) and the National Geographic Society (1992, 1996).	Balbontin J, 2007, J ANIM ECOL, V76, P915, DOI 10.1111/j.1365-2656.2007.01269.x; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Beck CW, 2000, EVOL ECOL RES, V2, P107; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Bille C, 2005, EPIDEMIOLOGY, V16, P311, DOI 10.1097/01.ede.0000158745.84019.c2; Bluhm CK, 2004, ANIM BEHAV, V68, P985, DOI 10.1016/j.anbehav.2004.01.012; Bogdanova MI, 2006, FUNCT ECOL, V20, P132, DOI 10.1111/j.1365-2435.2006.01088.x; Bouwhuis S, 2010, J EVOLUTION BIOL, V23, P636, DOI 10.1111/j.1420-9101.2009.01929.x; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Carmichael AN, 2000, J MOL EVOL, V50, P443, DOI 10.1007/s002390010046; Cichon M, 2003, OECOLOGIA, V134, P78, DOI 10.1007/s00442-002-1099-x; Crawley M.J., 2007, R BOOK; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Descamps S, 2008, OIKOS, V117, P1406, DOI 10.1111/j.0030-1299.2008.16545.x; Drummond H, 2003, AM NAT, V161, P794, DOI 10.1086/375170; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; ELLNER S, 1994, AM NAT, V143, P403, DOI 10.1086/285610; Ellner S, 1996, THEOR POPUL BIOL, V50, P31, DOI 10.1006/tpbi.1996.0022; Fisch H, 2003, J UROLOGY, V169, P2275, DOI 10.1097/01.ju.0000067958.36077.d8; Forstmeier W, 2014, TRENDS ECOL EVOL, V29, P456, DOI 10.1016/j.tree.2014.05.005; Fuerst-Waltl B, 2004, J DAIRY SCI, V87, P2293, DOI 10.3168/jds.S0022-0302(04)70050-8; Garcia-Palomares S, 2009, BIOL REPROD, V80, P337, DOI 10.1095/biolreprod.108.072066; Gonzalez-Solis J, 2004, J ORNITHOL, V145, P129, DOI 10.1007/s10336-004-0023-z; Green RF, 2010, ANN EPIDEMIOL, V20, P241, DOI 10.1016/j.annepidem.2009.10.009; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Harris WE, 2009, PHILOS T R SOC B, V364, P1039, DOI 10.1098/rstb.2008.0299; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Hegyi G, 2006, BEHAV ECOL SOCIOBIOL, V60, P672, DOI 10.1007/s00265-006-0211-3; Johnson SL, 2012, BIOESSAYS, V34, P609, DOI 10.1002/bies.201100157; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Kim SY, 2007, BEHAV ECOL, V18, P1132, DOI 10.1093/beheco/arm091; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Krishna MS, 2012, ZOOL STUD, V51, P72; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004; MANNING JT, 1985, J THEOR BIOL, V116, P349, DOI 10.1016/S0022-5193(85)80273-3; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; Michl G, 2005, BEHAV ECOL, V16, P383, DOI 10.1093/beheco/ari002; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moore PJ, 2003, P ROY SOC B-BIOL SCI, V270, pS192, DOI 10.1098/rsbl.2003.0051; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Nikola T, 2004, EVOL ECOL, V18, P187, DOI 10.1023/B:EVEC.0000021090.51851.bd; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Osorio-Beristain M, 1998, BEHAV ECOL SOCIOBIOL, V43, P307, DOI 10.1007/s002650050496; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Postma M, 2013, POLAR BIOL, V36, P719, DOI 10.1007/s00300-013-1298-4; Preston BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7146; Price DK, 1998, BEHAV GENET, V28, P395, DOI 10.1023/A:1021677804038; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos AG, 2014, BEHAV ECOL SOCIOBIOL, V68, P1603, DOI 10.1007/s00265-014-1769-9; Ratikainen II, 2010, BEHAV ECOL, V21, P195, DOI 10.1093/beheco/arp168; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Richard M, 2005, MOL ECOL, V14, P3147, DOI 10.1111/j.1365-294X.2005.02662.x; Saino N, 2002, J ANIM ECOL, V71, P309, DOI 10.1046/j.1365-2656.2002.00600.x; Sanchez-Macouzet O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2843; Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Serre V, 1998, FERTIL STERIL, V70, P625, DOI 10.1016/S0015-0282(98)00259-3; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Skaug H, 2011, GEN LINEAR MIXED MOD, pr143; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Torres R, 2011, PLOS ONE, V6, P11, DOI [10.1371/journal.pone.0027245, DOI 10.1371/J0URNAL.P0NE.0027245]; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; Velando A, 2011, J EVOLUTION BIOL, V24, P693, DOI 10.1111/j.1420-9101.2010.02201.x; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; Wang MH, 2000, NATURE, V407, P469, DOI 10.1038/35035156; WILK MB, 1968, BIOMETRIKA, V55, P1	80	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133213	10.1371/journal.pone.0133213	http://dx.doi.org/10.1371/journal.pone.0133213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221951	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800042
J	Fellman, JB; Hood, E; Dryer, W; Pyare, S				Fellman, Jason B.; Hood, Eran; Dryer, William; Pyare, Sanjay			Stream Physical Characteristics Impact Habitat Quality for Pacific Salmon in Two Temperate Coastal Watersheds	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; GLACIER COVERAGE; CLIMATE-CHANGE; TEMPORAL VARIABILITY; BRITISH-COLUMBIA; THERMAL REGIME; OXYGEN; RIVER; TROUT; FLOW	Climate warming is likely to cause both indirect and direct impacts on the biophysical properties of stream ecosystems especially in regions that support societally important fish species such as Pacific salmon. We studied the seasonal variability and interaction between stream temperature and DO in a low-gradient, forested stream and a glacial-fed stream in coastal southeast Alaska to assess how these key physical parameters impact freshwater habitat quality for salmon. We also use multiple regression analysis to evaluate how discharge and air temperature influence the seasonal patterns in stream temperature and DO. Mean daily stream temperature ranged from 1.1 to 16.4 degrees C in non-glacial Peterson Creek but only 1.0 to 8.8 degrees C in glacial-fed Cowee Creek, reflecting the strong moderating influence glacier meltwater had on stream temperature. Peterson Creek had mean daily DO concentrations ranging from 3.8 to 14.1mg L-1 suggesting future climate changes could result in an even greater depletion in DO. Mean daily stream temperature strongly controlled mean daily DO in both Peterson ( R-2 = 0.82, P<0.01) and Cowee Creek ( R-2=0.93, P<0.01). However, DO in Peterson Creek was mildly related to stream temperature ( R-2=0.15, P<0.01) and strongly influenced by discharge ( R-2=0.46, P<0.01) on days when stream temperature exceeded 10 degrees C. Moreover, Peterson Creek had DO values that were particularly low (<5.0 mg L-1) on days when discharge was low but also when spawning salmon were abundant. Our results demonstrate the complexity of stream temperature and DO regimes in coastal temperate watersheds and highlight the need for watershed managers to move towards multi-factor risk assessment of potential habitat quality for salmon rather than single factor assessments alone.	[Fellman, Jason B.; Hood, Eran; Dryer, William; Pyare, Sanjay] Univ Alaska Southeast, Environm Sci & Geog Program, Juneau, AK 99801 USA	University of Alaska System; University of Alaska Southeastern	Fellman, JB (corresponding author), Univ Alaska Southeast, Environm Sci & Geog Program, Juneau, AK 99801 USA.	jbfellman@uas.alaska.edu			Department of Interior Alaska Climate Science Center; U. S. National Science Foundation [OIA-1208927]; Office of Integrative Activities [1208927] Funding Source: National Science Foundation	Department of Interior Alaska Climate Science Center; U. S. National Science Foundation(National Science Foundation (NSF)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the Department of Interior Alaska Climate Science Center and the U. S. National Science Foundation (#OIA-1208927).	ALABASTER JS, 1989, J FISH BIOL, V34, P331, DOI 10.1111/j.1095-8649.1989.tb03315.x; Arendt A, 2009, J CLIMATE, V22, P4117, DOI 10.1175/2009JCLI2784.1; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Armstrong JB, 2013, ECOLOGY, V94, P2066, DOI 10.1890/12-1200.1; Bacon PJ, 2005, J ANIM ECOL, V74, P1, DOI 10.1111/j.1365-2656.2004.00875.x; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Blaen PJ, 2013, HYDROL PROCESS, V27, P2958, DOI 10.1002/hyp.9431; Brabets T, 2001, 014109 US GEOL SURV, P24; Brett J. R., 1971, INTEGR COMP BIOL, V11, P99, DOI [DOI 10.1093/ICB/11.1.99, 10.1093/ICB/11.1.99]; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carter K., 2005, EFFECTS DISSOLVED OX; Connolly NM, 2004, J N AM BENTHOL SOC, V23, P251, DOI 10.1899/0887-3593(2004)023&lt;0251:EOLDOO&gt;2.0.CO;2; DAVIS GERALD E., 1963, TRANS AMER FISH SOC, V92, P111, DOI 10.1577/1548-8659(1963)92[111:TIOOCO]2.0.CO;2; Dewson ZS, 2007, J N AM BENTHOL SOC, V26, P401, DOI 10.1899/06-110.1; Dorava JM, 2000, HYDROL PROCESS, V14, P3149, DOI 10.1002/1099-1085(200011/12)14:16/17<3149::AID-HYP139>3.3.CO;2-P; Dugdale SJ, 2013, REMOTE SENS ENVIRON, V136, P358, DOI 10.1016/j.rse.2013.05.018; EATON JG, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AFISFE>2.0.CO;2; Fellman JB, 2014, ECOSYSTEMS, V17, P1014, DOI 10.1007/s10021-014-9777-1; Fellman JB, 2014, HYDROL PROCESS, V28, P2062, DOI 10.1002/hyp.9742; Fleming SW, 2005, J HYDRAUL ENG-ASCE, V131, P615, DOI 10.1061/(ASCE)0733-9429(2005)131:7(615); FOUNTAIN AG, 1985, WATER RESOUR RES, V21, P579, DOI 10.1029/WR021i004p00579; Geist DR, 2006, T AM FISH SOC, V135, P1462, DOI 10.1577/T05-294.1; Graeber D, 2013, HYDROBIOLOGIA, V717, P147, DOI 10.1007/s10750-013-1570-1; HALUPKA KC, 2002, PNW468 USDA FOR SERV; Hannah DM, 2005, J HYDROL, V308, P18, DOI 10.1016/j.jhydrol.2004.10.018; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Holtgrieve GW, 2011, ECOLOGY, V92, P373, DOI 10.1890/09-1694.1; Hood E, 2007, LIMNOL OCEANOGR, V52, P1580, DOI 10.4319/lo.2007.52.4.1580; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Hrachowitz M, 2010, HYDROL PROCESS, V24, P3374, DOI 10.1002/hyp.7756; Imholt C, 2013, RIVER RES APPL, V29, P403, DOI 10.1002/rra.1608; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Kelleher C, 2012, HYDROL PROCESS, V26, P771, DOI 10.1002/hyp.8186; KNAPP G, 2007, GREAT SALMON RUN COM; Krider LA, 2013, J AM WATER RESOUR AS, V49, P896, DOI 10.1111/jawr.12046; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Levi PS, 2013, ECOSYSTEMS, V16, P269, DOI 10.1007/s10021-012-9613-4; Lightfoot G, 2008, SCHO0808BOLVEP ENV A, P42; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Lisi PJ, 2014, GEOPHYS RES IN PRESS; Mark BG, 2007, ENVIRON SCI TECHNOL, V41, P6955, DOI 10.1021/es071099d; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; Mauger S, 2011, 1101 COOK INL; McAfee SA, 2014, HYDROL PROCESS, V28, P3930, DOI 10.1002/hyp.9934; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Mitchell NL, 2005, LIMNOL OCEANOGR, V50, P217, DOI 10.4319/lo.2005.50.1.0217; Moore R. D., 2006, Canadian Water Resources Journal, V31, P41; Moore RD, 2013, CAN WATER RESOUR J, V38, P135, DOI 10.1080/07011784.2013.794992; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Nelitz MA, 2007, N AM J FISH MANAGE, V27, P405, DOI 10.1577/M05-146.1; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Radic V, 2011, NAT GEOSCI, V4, P91, DOI [10.1038/ngeo1052, 10.1038/NGEO1052]; REYNOLDS WW, 1974, COPEIA, P747; Richards J, 2012, HYDROL PROCESS, V26, P2687, DOI 10.1002/hyp.8360; Richards J, 2011, HYDROL PROCESS, V25, P4154, DOI 10.1002/hyp.8343; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Rietti-Shati M, 2000, CHEM GEOL, V166, P341, DOI 10.1016/S0009-2541(99)00233-8; Ruggerone GT, 2000, J FISH BIOL, V56, P1013, DOI 10.1111/j.1095-8649.2000.tb00889.x; Sear DA, 2014, HYDROL PROCESS, V28, P86, DOI 10.1002/hyp.9565; Sergeant CJ, 2015, RIVER RES APPL, V31, P602, DOI 10.1002/rra.2767; Shanley C, 2015, CLIMATE CHA IN PRESS; Shanley CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104799; SPOOR WA, 1990, J FISH BIOL, V36, P363, DOI 10.1111/j.1095-8649.1990.tb05616.x; Stahl K, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005956; Stahl K, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR005022; Sullivan K., 2000, ANAL EFFECTS TEMPERA; Trepanier S, 1996, J FISH BIOL, V48, P925, DOI 10.1111/j.1095-8649.1996.tb01487.x; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Whited DC, 2007, ECOLOGY, V88, P940, DOI 10.1890/05-1149; WHITMORE CECIL M., 1960, TRANS AMER FISH SOC, V89, P17, DOI 10.1577/1548-8659(1960)89[17:AROSAC]2.0.CO;2	73	23	35	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132652	10.1371/journal.pone.0132652	http://dx.doi.org/10.1371/journal.pone.0132652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222506	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800027
J	Koehn, D; Meyer, KJ; Syed, NA; Anderson, MG				Koehn, Demelza; Meyer, Kacie J.; Syed, Nasreen A.; Anderson, Michael G.			Ketamine/Xylazine-Induced Corneal Damage in Mice	PLOS ONE			English	Article							BAND KERATOPATHY; MOUSE MODELS; KETAMINE; XYLAZINE; RATS; SUSCEPTIBILITY; ANESTHESIA; THICKNESS; CATARACT; GLAUCOMA	Purpose We have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity. The purpose of this study was to establish the clinical and histological features of this deleterious side effect, its sensitivity with respect to age and anesthesia protocol, and approaches for avoiding it. Methods Young C57BL/6J, C57BLKS/J, and SJL/J mice were treated with permutations of anesthesia protocols and compared using slit-lamp exams, optical coherence tomography, histologic analyses, and telemetric measurements of body temperature. Results Ketamine/xylazine induces corneal damage in mice with a variable frequency. Among 12 experimental cohorts, corneal damage associated with ketamine/xylazine was observed in 9 of them. Despite various treatments to avoid corneal dehydration during anesthesia, the frequency of corneas experiencing damage among responding cohorts was 42% (26% inclusive of all cohorts), which is significantly greater than the natural prevalence (5%). The damage was consistent with band keratopathy. It appeared as a white or gray horizontal band located proximal to the pupil and was positive for subepithelial calcium deposition with von Kossa stain. Conclusions The sum of our clinical and histological observations is consistent with ketamine/xylazine-induced band keratopathy in mice. This finding is relevant for mouse studies involving the eye and/or vision-dependent behavioral assays, which would both be prone to artifact without appreciation of the damage caused by ketamine/xylazine anesthesia. Use of yohimbine is suggested as a practical means of avoiding this complication.	[Koehn, Demelza; Meyer, Kacie J.; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Syed, Nasreen A.; Anderson, Michael G.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Syed, Nasreen A.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Anderson, Michael G.] Iowa City VA Hlth Care Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Anderson, MG (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	michael-g-anderson@uiowa.edu	Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105; Syed, Nasreen/0000-0002-7192-0774	National Institutes of Health [EY021436, EY017673, EY018825]; NATIONAL EYE INSTITUTE [R01EY017673, R01EY018825, F32EY021436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the following: National Institutes of Health EY021436 (to DK) (http://www.nih.gov/) and National Institutes of Health EY017673 and EY018825 (to MGA) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Bartsch U, 2013, INVEST OPHTH VIS SCI, V54, P6952, DOI 10.1167/iovs.13-12945; Bergman S A, 1999, Anesth Prog, V46, P10; Bhutta AT, 2007, SEMIN PERINATOL, V31, P303, DOI 10.1053/j.semperi.2007.07.005; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Dolansky G, 2008, PAED CHILD HEALT-CAN, V13, P307, DOI 10.1093/pch/13.4.307; Dursun I, 2011, ALCOHOL CLIN EXP RES, V35, P2063, DOI 10.1111/j.1530-0277.2011.01557.x; Eagle RC., 2011, EYE PATHOLOGY ATLAS; Fario QA, 2004, OPHTHALMOLOGY; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x; GUILLET R, 1988, INVEST OPHTH VIS SCI, V29, P949; HOFFMAN RW, 1983, ARTHRITIS RHEUM, V26, P645, DOI 10.1002/art.1780260511; Islam MS, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/149452; Jhanji V, 2011, CURR OPIN OPHTHALMOL, V22, P283, DOI 10.1097/ICU.0b013e3283477d36; Jones NP, 2013, UVEITIS; Lively GD, 2010, PHYSIOL GENOMICS, V42, P281, DOI 10.1152/physiolgenomics.00140.2009; Lively GD, 2010, INVEST OPHTH VIS SCI, V51, P160, DOI 10.1167/iovs.09-3429; Mao M, 2011, INVEST OPHTH VIS SCI, V52, P2679, DOI 10.1167/iovs.10-5993; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; O'Connor G R, 1972, Trans Am Ophthalmol Soc, V70, P58; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Qiu YG, 2014, CURR EYE RES, V39, P365, DOI 10.3109/02713683.2013.845224; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Son AI, 2013, MOL VIS, V19, P254; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Starte JM, 2012, CORNEA, V31, P572, DOI 10.1097/ICO.0b013e31823f8af4; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tita B, 2001, OPHTHALMIC RES, V33, P345, DOI 10.1159/000055692; Turner PV, 2005, COMPARATIVE MED, V55, P175; Wood D, 2011, BJU INT, V107, P1881, DOI 10.1111/j.1464-410X.2010.10031.x; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	37	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132804	10.1371/journal.pone.0132804	http://dx.doi.org/10.1371/journal.pone.0132804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222692	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800029
J	Paiva, RJO; Brites, RS; Machado, RB				Oliveira Paiva, Rodrigo Jose; Brites, Ricardo Seixas; Machado, Ricardo Bomfim			The Role of Protected Areas in the Avoidance of Anthropogenic Conversion in a High Pressure Region: A Matching Method Analysis in the Core Region of the Brazilian Cerrado	PLOS ONE			English	Article							LAND-USE; AVOIDED DEFORESTATION; CONSERVATION; BIODIVERSITY; LOCATION; HISTORY; RESERVE; IMPACT; GOVERNANCE; VEGETATION	Global efforts to avoid anthropogenic conversion of natural habitat rely heavily on the establishment of protected areas. Studies that evaluate the effectiveness of these areas with a focus on preserving the natural habitat define effectiveness as a measure of the influence of protected areas on total avoided conversion. Changes in the estimated effectiveness are related to local and regional differences, evaluation methods, restriction categories that include the protected areas, and other characteristics. The overall objective of this study was to evaluate the effectiveness of protected areas to prevent the advance of the conversion of natural areas in the core region of the Brazil's Cerrado Biome, taking into account the influence of the restriction degree, governmental sphere, time since the establishment of the protected area units, and the size of the area on the performance of protected areas. The evaluation was conducted using matching methods and took into account the following two fundamental issues: control of statistical biases caused by the influence of covariates on the likelihood of anthropogenic conversion and the non-randomness of the allocation of protected areas throughout the territory (spatial correlation effect) and the control of statistical bias caused by the influence of auto-correlation and leakage effect. Using a sample design that is not based on ways to control these biases may result in outcomes that underestimate or overestimate the effectiveness of those units. The matching method accounted for a bias reduction in 94-99% of the estimation of the average effect of protected areas on anthropogenic conversion and allowed us to obtain results with a reduced influence of the auto-correlation and leakage effects. Most protected areas had a positive influence on the maintenance of natural habitats, although wide variation in this effectiveness was dependent on the type, restriction, governmental sphere, size and age group of the unit.	[Oliveira Paiva, Rodrigo Jose; Brites, Ricardo Seixas] Univ Brasilia, Inst Geociencias, Programa Posgrad Geociencias Aplicadas, Brasilia, DF, Brazil; [Machado, Ricardo Bomfim] Univ Brasilia, Dept Zool, Programa Posgrad Zool, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Paiva, RJO (corresponding author), Univ Brasilia, Inst Geociencias, Programa Posgrad Geociencias Aplicadas, Brasilia, DF, Brazil.	drigojbio@gmail.com	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Brites, Ricardo/0000-0002-8471-8823	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RBM received a research grant from CNPq (http://www.cnpq.br/).	Abbot JIO, 1999, J APPL ECOL, V36, P422, DOI 10.1046/j.1365-2664.1999.00413.x; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Angelsen A., 2009, REALISING REDD NATL; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Beltran J., 2000, BEST PRACT PROTECT A, V4; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Brandon K., 1998, PARKS PERIL PEOPLE P; Brasil, 2007, INFORME NACL AREAS P; Bray D. B., 2008, Ecology and Society, V13, P56; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Carranza T, 2014, CONSERV LETT, V7, P216, DOI 10.1111/conl.12049; CBD, 2010, C PART CONV BIOL DIV; Chape S., 2009, BIOSCIENCE, V59, P623; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; CSR/IBAMA, 2013, PROJ MON DESM BIOM B; Diniz Filho J.A.F., 2009, OECOLOGIA BRAS, V13, P470, DOI DOI 10.4257/0EC0.2009.1303.05; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Evans Sterling, 1999, GREEN REPUBLIC CONSE; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; FELFILI J. M., 2005, CERRADO ECOLOGIA BIO; Ferraro PJ, 2007, PROTECTED AREAS AVOI; Ferreira L.G, 2008, ENCRUZILHAD SOCIOAMB; Ferreira ME, 2009, REV BRASILEIRA CARTO, V61, P37; FUNAI, 2013, MAP TERR IND BRAS; Gangl M., 2004, RBOUNDS STATA MODULE; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; IBGE, 2013, IBGE SER HIST EST PO; INCRA, 2013, MAP TERR QUIL INCRA; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, MAP BIOM BRAS; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Leverington F, 2010, MANAGEMENT EFFECTIVE; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Machado A. B. M., 2008, RED BOOK BRAZILIAN F; MARGULES CR, 1988, BIOL CONSERV, V43, P63, DOI 10.1016/0006-3207(88)90078-X; Martinelli G, 2013, LIVRO VERMALHO FLORA; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Mistry J., 2000, WORLD SAVANNAS ECOLO; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; MMA, 2013, MAP UN CONS MMA; MMA, 2010, 4 MMA CONV BIOL DIV; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; NELSON A, 2009, PROTECTED AREA EFFEC; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nelson GC, 2013, LAND ECON, V77, P187; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Pauchard A, 2002, NAT AREA J, V22, P318; Pelkey NW, 2000, BIOL CONSERV, V94, P297, DOI 10.1016/S0006-3207(99)00195-0; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; R Core Team, 2019, R LANG ENV STAT COMP; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; Rocha G.F., 2012, REV BRAS CARTOGR, V63, P341; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Rylands AB, 2005, CONSERV BIOL, V19, P612, DOI 10.1111/j.1523-1739.2005.00711.x; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Siqueira Marinez Ferreira de, 2003, Biota Neotrop., V3, P1, DOI 10.1590/S1676-06032003000200005; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; UNEP, 2004, US EC INSTR ENV POL; UNEP/CBD, 1992, CONV BIOL DIV, P1; Walter BMT, 2008, CERRADO ECOLOGIA FLO, V1, P21; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wu JJ, 2000, AM J AGR ECON, V82, P979, DOI 10.1111/0002-9092.00096; Wunder S, 2008, MOVING AHEAD REDD IS; Yanai AM, 2012, FOREST ECOL MANAG, V282, P78, DOI 10.1016/j.foreco.2012.06.029; Yoshii K, 2000, ENV MONITORING PROCE	92	17	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132582	10.1371/journal.pone.0132582	http://dx.doi.org/10.1371/journal.pone.0132582			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222140	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800024
J	Pan, PY; Marrs, J; Ryan, TA				Pan, Ping-Yue; Marrs, Julia; Ryan, Timothy A.			Vesicular Glutamate Transporter 1 Orchestrates Recruitment of Other Synaptic Vesicle Cargo Proteins during Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTOSIS; RETRIEVAL; SYNAPTOPHYSIN; EXOCYTOSIS	A long standing question in synaptic physiology is how neurotransmitter-filled vesicles are rebuilt after exocytosis. Among the first steps in this process is the endocytic retrieval of the transmembrane proteins that are enriched in synaptic vesicles (SVs). At least six types of transmembrane proteins must be recovered, but the rules for how this multiple cargo selection is accomplished are poorly understood. Among these SV cargos is the vesicular glutamate transporter (vGlut). We show here that vGlut1 has a strong influence on the kinetics of retrieval of half of the known SV cargos and that specifically impairing the endocytosis of vGlut1 in turn slows down other SV cargos, demonstrating that cargo retrieval is a collective cargo-driven process. Finally, we demonstrate that different cargos can be retrieved in the same synapse with different kinetics, suggesting that additional post-endocytic sorting steps likely occur in the nerve terminal.	[Pan, Ping-Yue; Marrs, Julia; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Pan, Pingyue/0000-0002-2805-6810; Ryan, Timothy/0000-0003-2533-9548	NINDS, National Institutes of Health [NS036942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942, R37NS036942] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant NS036942 (to T. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Armbruster M, 2011, NAT NEUROSCI, V14, P824, DOI 10.1038/nn.2828; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Koch M, 2012, BBA-MOL CELL BIOL L, V1821, P1114, DOI 10.1016/j.bbalip.2012.02.008; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Willox AK, 2012, CURR BIOL, V22, P1435, DOI 10.1016/j.cub.2012.05.048; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	27	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22593	22601		10.1074/jbc.M115.651711	http://dx.doi.org/10.1074/jbc.M115.651711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224632	Green Published, hybrid			2022-12-26	WOS:000361171500025
J	Giaimo, S; Baudisch, A				Giaimo, Stefano; Baudisch, Annette			The Effect of Post-Reproductive Lifespan on the Fixation Probability of Beneficial Mutations	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SURVIVAL PROBABILITY; MUTANT-GENE; LONGEVITY; FECUNDITY; HISTORY	Post-reproductive lifespan is a common trait among mammals and is usually considered to be neutral; i.e. with no influence on population dynamics. Here, we explore the role of post-reproductive lifespan in the fixation probability of beneficial genetic variation. We compare two separate, stationary populations living in a constant environment that are equivalent except for the average time their respective members spend in the post-reproductive stage of life. Using a recently derived approximation, we show that fixation of a beneficial mutation is more likely in the population with greater post-reproductive longevity. This finding is surprising, as the population with more prolonged post-reproductive lifespan has smaller effective size and the classic population-genetic model would suggest that decreasing effective size reduces fixation chances of beneficial mutations. Yet, as we explain, in the age-structured case, when effective size gets smaller because of longer post-reproductive lifespan but census size is kept equal, a beneficial mutation has a higher likelihood to get fixed because it finds itself at higher initial frequency.	[Giaimo, Stefano; Baudisch, Annette] Max Planck Inst Demog Res, Max Planck Res Grp, Modeling Evolut Aging, Rostock, Germany	Max Planck Society	Giaimo, S (corresponding author), Max Planck Inst Demog Res, Max Planck Res Grp, Modeling Evolut Aging, Rostock, Germany.	giaimo@demogr.mpg.de	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X	Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research	Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research	This research was funded by the Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research.	Araki H, 2007, MOL ECOL, V16, P953, DOI 10.1111/j.1365-294X.2006.03206.x; ATHREYA KB, 1993, J MATH BIOL, V32, P45, DOI 10.1007/BF00160373; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Engen S, 2005, GENETICS, V170, P941, DOI 10.1534/genetics.104.028233; Engen S, 2005, MATH BIOSCI, V195, P210, DOI 10.1016/j.mbs.2005.02.003; ESHEL I, 1984, J MATH BIOL, V19, P201, DOI 10.1007/BF00277746; Felsenstein J, 1971, INBREEDING VARIANCE, V68, P581; Fisher RA, 1930, GENETICAL THEORY NAT; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hawks J, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P9, DOI 10.1007/978-1-4020-6424-1_1; HOPPE FM, 1992, J MATH BIOL, V30, P567, DOI 10.1007/BF00948891; JORDE PE, 1995, GENETICS, V139, P1077; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Kim PS, 2012, P ROY SOC B-BIOL SCI, V279, P4880, DOI 10.1098/rspb.2012.1751; KIMURA M, 1962, GENETICS, V47, P713; Lande R., 2003, OXFORD SERIES ECOLOG; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nunney L, 1996, BIOL J LINN SOC, V59, P411, DOI 10.1111/j.1095-8312.1996.tb01474.x; NUNNEY L, 1991, P ROY SOC B-BIOL SCI, V246, P71, DOI 10.1098/rspb.1991.0126; ORIVE ME, 1993, THEOR POPUL BIOL, V44, P316, DOI 10.1006/tpbi.1993.1031; Vindenes Y, 2010, EVOLUTION, V64, P1063, DOI 10.1111/j.1558-5646.2009.00868.x; Wright S, 1931, GENETICS, V16, P0097	28	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133820	10.1371/journal.pone.0133820	http://dx.doi.org/10.1371/journal.pone.0133820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230256	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400055
J	King, BA; Parra, C; Li, YM; Helton, KJ; Qaddoumi, I; Wilson, MW; Ogg, RJ				King, Benjamin A.; Parra, Carlos; Li, Yimei; Helton, Kathleen J.; Qaddoumi, Ibrahim; Wilson, Matthew W.; Ogg, Robert J.			Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma	PLOS ONE			English	Article							BILATERAL RETINOBLASTOMA; TEMPORAL EXPRESSION; RETINAL DEVELOPMENT; R PACKAGE; CELL; ORIGIN; ANGIOGENESIS; TOPOGRAPHY; DISEASE; OPSINS	Purpose To accurately map the retinal area covered by tumor in a prospectively enrolled cohort of children diagnosed with retinoblastoma. Methods Orbital MRI in 106 consecutive retinoblastoma patients (44 bilateral) was analyzed. For MRI-visible tumors, the polar angle and angle of eccentricity of points defining tumor perimeter on the retina were determined by triangulation from images in three orthogonal planes. The centroid of the mapped area was calculated to approximate tumor origin, and the location and cumulative tumor burden were analyzed in relation to mutation type (germline vs. somatic), tumor area, and patient age at diagnosis. Location of small tumors undetected by MRI was approximated with fundoscopic images. Results Mapping was successful for 129 tumors in 91 eyes from 67 patients (39 bilateral, 43 germline mutation). Cumulative tumor burden was highest within the macula and posterior pole and was asymmetrically higher within the inferonasal periphery. Tumor incidence was lowest in the superotemporal periphery. Tumor location varied with age at diagnosis in a complex pattern. Tumor location was concentrated in the macula and superonasal periphery in patients <5.6 months, in the inferotemporal quadrant of the posterior pole in patients 5.6-8.8 months, in the inferonasal quadrant in patients 8.8-13.2 months, and in the nasal and superotemporal periphery in patients >13.2 months. The distribution of MRI-invisible tumors was consistent with the asymmetry of mapped tumors. Conclusions MRI-based mapping revealed a previously unrecognized pattern of retinoblastoma localization that evolves with age at diagnosis. The structured spatiotemporal distribution of tumors may provide valuable clues about cellular or molecular events associated with tumorigenesis in the developing retina.	[King, Benjamin A.; Wilson, Matthew W.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Hamilton Eye Inst, Memphis, TN 38163 USA; [King, Benjamin A.; Parra, Carlos; Helton, Kathleen J.; Ogg, Robert J.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Parra, Carlos] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Li, Yimei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Qaddoumi, Ibrahim] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wilson, Matthew W.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Memphis; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ogg, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Radiol Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	Robert.ogg@stjude.org	Qaddoumi, Ibrahim/N-8101-2018		NIH Grant [HD049888]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received support from an NIH Grant (HD049888) and an Unrestricted Grant from the Research to Prevent Blindness.	Abramson DH, 1998, ACTA OPHTHALMOL SCAN, V76, P334, DOI 10.1034/j.1600-0420.1998.760316.x; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1324, DOI 10.1001/archopht.122.9.1324; Abramson DH, 1996, RETINA-J RET VIT DIS, V16, P232, DOI 10.1097/00006982-199616030-00009; Agostinelli C, 2017, R PACKAGE CIRCULAR C; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Anand-Apte B, 2010, ENCY EYE, P9; Arean C, 2010, ARCH OPHTHALMOL-CHIC, V128, P223, DOI 10.1001/archophthalmol.2009.386; Baddeley A, 2005, J R STAT SOC B, V67, P617, DOI 10.1111/j.1467-9868.2005.00519.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2011, STAT SCI, V26, P613, DOI 10.1214/11-STS367; Bai SW, 2011, INVEST OPHTH VIS SCI, V52, P4560, DOI 10.1167/iovs.10-5487; Barb SM, 2011, INVEST OPHTH VIS SCI, V52, P2619, DOI 10.1167/iovs.10-5600; BOGENMANN E, 1988, SCIENCE, V240, P76, DOI 10.1126/science.2451289; Brinkert AW, 1998, OPHTHALMIC GENET, V19, P63, DOI 10.1076/opge.19.2.63.2320; BUCKLEY EG, 1992, J PEDIATR OPHTHALMOL, V29, P103; Bumsted K, 1997, J COMP NEUROL, V378, P117; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Eklund Aron, 2013, BEE SWARM PLOT ALTER; Hall LS, 1999, J AAPOS, V3, P138, DOI 10.1016/S1091-8531(99)70058-3; Hatterer E, 2011, NEUROSCI RES, V70, P172, DOI 10.1016/j.neures.2011.02.008; HOLBEK S, 1989, ACTA OPHTHALMOL, V67, P560; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lees Jonathan M., 2013, GEOMAP TOPOGRAPHIC G; Lemon J., 2006, R R NEWS; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Linn Murphree A, 2005, Ophthalmol Clin North Am, V18, P41; Little MP, 2012, INT J CANCER, V130, P631, DOI 10.1002/ijc.26039; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Marback EF, 2003, BRIT J OPHTHALMOL, V87, P1224, DOI 10.1136/bjo.87.10.1224; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MUNIER FL, 1994, OPHTHALMIC GENET, V15, P101, DOI 10.3109/13816819409057835; Peters MA, 2002, DEV BIOL, V251, P59, DOI 10.1006/dbio.2002.0791; Pilhofer A, 2013, J STAT SOFTW, V53, P1; Pinheiro J., NLME LINEAR NONLINEA; PROVIS JM, 1985, J COMP NEUROL, V233, P429, DOI 10.1002/cne.902330403; R Core Team, 2018, R LANGUAGE ENV STAT; RICKMAN DW, 1995, VISUAL NEUROSCI, V12, P215, DOI 10.1017/S0952523800007896; Rodriguez-Galindo Carlos, 2007, Curr Treat Options Neurol, V9, P294, DOI 10.1007/s11940-007-0015-4; Rootman DB, 2013, BRIT J OPHTHALMOL, V97, P59, DOI 10.1136/bjophthalmol-2012-302133; RUBENFELD M, 1986, OPHTHALMOLOGY, V93, P1016; Snyder J., 1987, MAP PROJECT WORKING, P191; Urbanek S., 2013, IPLOTS IPLOTS INTERA; Urbanek Simon, 2012, R GRAPHICS DEVICE US; VANEY DI, 1985, PROC R SOC SER B-BIO, V224, P475, DOI 10.1098/rspb.1985.0045; Xiao M, 2000, J COMP NEUROL, V425, P545; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132932	10.1371/journal.pone.0132932	http://dx.doi.org/10.1371/journal.pone.0132932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230335	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400023
J	Mainassara, HB; Lagare, A; Tempia, S; Sidiki, A; Issaka, B; Sidikou, BA; Oukem-Boyer, OOM				Mainassara, Halima Boubacar; Lagare, Adamou; Tempia, Stefano; Sidiki, Ali; Issaka, Bassira; Sidikou, Bibata Abdou; Oukem-Boyer, Odile Ouwe Missi			Influenza Sentinel Surveillance among Patients with Influenza-Like-Illness and Severe Acute Respiratory Illness within the Framework of the National Reference Laboratory, Niger, 2009-2013	PLOS ONE			English	Article							VIRUS SUBTYPE H1N1; SYNCYTIAL VIRUS; EPIDEMIOLOGY; CIRCULATION; COUNTRIES; MORTALITY; AFRICA	Background Little is known about the epidemiology of influenza in Africa, including Niger. We documented the epidemiology of seasonal and pandemic influenza among outpatients with influenza-like-illness (ILI) and inpatients with severe acute respiratory illness (SARI) presenting at selected sentinel sites in Niger from April 2009 through April 2013. Methods Patients meeting the ILI or the SARI case definitions and presenting at the outpatient or inpatient departments of selected sentinel sites were enrolled. Epidemiological data and nasopharyngeal swabs were collected. The respiratory samples were tested by real-time reverse transcription polymerase chain reaction. Results From April 2009 to April 2013, laboratory results were obtained from 1176 ILI and 952 SARI cases, of which 146 (12%) and 54 (6%) tested positive for influenza virus, respectively. The influenza positivity rate was highest in the 5-14 year age-group (32/130; 24% among ILI patients and 6/61; 10% among SARI patients) followed by the 1-4 year age-group (69/438; 16% among ILI patients and 32/333; 9% among SARI patients). Of the 200 influenza positive cases 104 (52%) were A(H1N1)pdm09, 62 (31%) were A(H3N2) and 34 (17%) were B. Influenza viruses were detected predominantly from November to April with peak viral activity observed in February. Conclusions The Niger sentinel surveillance system allowed to monitor the circulation of seasonal influenza as well as the introduction and spread of influenza A(H1N1)pdm09 in the country. Continuous influenza surveillance is needed to better understand the epidemiology of seasonal influenza and monitor the emergence of influenza strains with pandemic potential.	[Mainassara, Halima Boubacar; Lagare, Adamou; Sidiki, Ali; Issaka, Bassira; Sidikou, Bibata Abdou; Oukem-Boyer, Odile Ouwe Missi] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger; [Tempia, Stefano] Ctr Res Dis Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Res Dis Prevent, Influenza Div, Pretoria, South Africa		Mainassara, HB (corresponding author), Ctr Rech Med & Sanitaire CERMES, Niamey, Niger.	halima@cermes.org; adamsyn03@gmail.com			National Ministry of Public Health; Division International of Pasteur Institute of Paris; Sanofi-Pasteur; Direction de la Cooperation Internationale of Monaco	National Ministry of Public Health; Division International of Pasteur Institute of Paris; Sanofi-Pasteur; Direction de la Cooperation Internationale of Monaco	The World Health Organization and CDC Atlanta afforded reagents, rRT-PCR machine and technical support. Financial support was obtained from the National Ministry of Public Health, the Division International of Pasteur Institute of Paris, Sanofi-Pasteur and the Direction de la Cooperation Internationale of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2012, J INFECT DIS, V206, pS94, DOI 10.1093/infdis/jis547; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Bonney JHK, 2012, J INFECT DIS, V206, pS108, DOI 10.1093/infdis/jis577; Dalhatu IT, 2009, J INFECT DIS S1, V206, pS121; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Nzussouo NT, 2012, J INFECT DIS, V206, pS101, DOI 10.1093/infdis/jis572; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; World Health Organization, INFL OVERV; World Health Organization, WHO GLOB INFL; World Health Organization, FLUNET; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	17	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133178	10.1371/journal.pone.0133178	http://dx.doi.org/10.1371/journal.pone.0133178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230666	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400027
J	Tepper, N; Shlomi, T				Tepper, Naama; Shlomi, Tomer			Efficient Modeling of MS/MS Data for Metabolic Flux Analysis	PLOS ONE			English	Article							BIDIRECTIONAL REACTION STEPS; MASS-SPECTROMETRY; NETWORKS; FRAMEWORK; EMU	Metabolic flux analysis (MFA) is a widely used method for quantifying intracellular metabolic fluxes. It works by feeding cells with isotopic labeled nutrients, measuring metabolite isotopic labeling, and computationally interpreting the measured labeling data to estimate flux. Tandem mass-spectrometry (MS/MS) has been shown to be useful for MFA, providing positional isotopic labeling data. Specifically, MS/MS enables the measurement of a metabolite tandem mass-isotopomer distribution, representing the abundance in which certain parent and product fragments of a metabolite have different number of labeled atoms. However, a major limitation in using MFA with MS/MS data is the lack of a computationally efficient method for simulating such isotopic labeling data. Here, we describe the tandemer approach for efficiently computing metabolite tandem mass-isotopomer distributions in a metabolic network, given an estimation of metabolic fluxes. This approach can be used by MFA to find optimal metabolic fluxes, whose induced metabolite labeling patterns match tandem mass-isotopomer distributions measured by MS/MS. The tandemer approach is applied to simulate MS/MS data in a small-scale metabolic network model of mammalian methionine metabolism and in a large-scale metabolic network model of E. coli. It is shown to significantly improve the running time by between two to three orders of magnitude compared to the state-of-the-art, cumomers approach. We expect the tandemer approach to promote broader usage of MS/MS technology in metabolic flux analysis. Implementation is freely available at www.cs.technion.ac.il/similar to tomersh/methods.html	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il						Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004; Choi J, 2012, ANAL CHEM, V84, P4628, DOI 10.1021/ac300611n; Choi J, 2011, METAB ENG, V13, P225, DOI 10.1016/j.ymben.2010.11.006; Jeffrey FMH, 2002, ANAL BIOCHEM, V300, P192, DOI 10.1006/abio.2001.5457; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; KAHN AB, 1962, COMMUN ACM, V5, P558, DOI 10.1145/368996.369025; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; Rantanen A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-266; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schellenberger J, 2012, BMC SYSTEMS BIOL, V6; Shlomi T, 2014, ANAL CHEM; Sillers R, 2009, BIOTECHNOL BIOENG, V102, P38, DOI 10.1002/bit.22058; Srour O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-129; Tepper N, 2013, BIOINFORMATICS, V29, P3045, DOI 10.1093/bioinformatics/btt516; Weitzel M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-315; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2002, GENET ENG P, V24, P215; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P118, DOI 10.1002/(SICI)1097-0290(19970705)55:1<118::AID-BIT13>3.0.CO;2-I; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	24	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130213	10.1371/journal.pone.0130213	http://dx.doi.org/10.1371/journal.pone.0130213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230524	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400004
J	Bejaoui, M; Pantazi, E; De Luca, V; Panisello, A; Folch-Puy, E; Hotter, G; Capasso, C; Supuran, CT; Rossello-Catafau, J				Bejaoui, Mohamed; Pantazi, Eirini; De Luca, Viviana; Panisello, Arnau; Folch-Puy, Emma; Hotter, Georgina; Capasso, Clemente; Supuran, Claudiu T.; Rossello-Catafau, Joan			Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OF-WISCONSIN SOLUTION; RAT-LIVER; IGL-1 SOLUTION; THERAPEUTIC APPLICATIONS; STEATOTIC LIVERS; PRESERVATION; KINASE; TRANSPLANTATION; INHIBITORS	Carbonic anhydrases (CAs) are ubiquitous metalloenzymes that catalyze the reversible hydration of carbon dioxide to bicarbonate and a proton. CAs are involved in numerous physiological and pathological processes, including acid-base homeostasis, electrolyte balance, oxygen delivery to tissues and nitric oxide generation. Given that these processes are found to be dysregulated during ischemia reperfusion injury (IRI), and taking into account the high vulnerability of steatotic livers to preservation injury, we hypothesized a new role for CA as a pharmacological agent able to protect against ischemic damage. Two different aspects of the role of CA II in fatty liver grafts preservation were evaluated: 1) the effect of its addition to Institut Georges Lopez (IGL-1) storage solution after cold ischemia; 2) and after 24h of cold storage followed by two hours of normothermic ex-vivo perfusion. In all cases, liver injury, CA II protein concentration, CA II mRNA levels and CA II activity were determined. In case of the ex-vivo perfusion, we further assessed liver function (bile production, bromosulfophthalein clearance) and Western blot analysis of phosphorylated adenosine monophosphate activated protein kinase (AMPK), mitogen activated protein kinases family (MAPKs) and endoplasmic reticulum stress (ERS) parameters (GRP78, PERK, IRE, eIF2 alpha and ATF6). We found that CA II was downregulated after cold ischemia. The addition of bovine CA II to IGL-1 preservation solution efficiently protected steatotic liver against cold IRI. In the case of reperfusion, CA II protection was associated with better function, AMPK activation and the prevention of ERS and MAPKs activation. Interestingly, CA II supplementation was not associated with enhanced CO2 hydration. The results suggest that CA II modulation may be a promising target for fatty liver graft preservation.	[Bejaoui, Mohamed; Pantazi, Eirini; Panisello, Arnau; Folch-Puy, Emma; Hotter, Georgina; Rossello-Catafau, Joan] IDIBAPS, Spanish Natl Res Council IIBB CSIC, Inst Biomed Res Barcelona, Dept Expt Pathol, Barcelona, Spain; [De Luca, Viviana; Capasso, Clemente] CNR, Inst Biosci & Bioresources IBBR, Naples, Italy; [Supuran, Claudiu T.] Univ Florence, Neurofarba Dept, Florence, Italy; [Rossello-Catafau, Joan] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Florence; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Rossello-Catafau, J (corresponding author), IDIBAPS, Spanish Natl Res Council IIBB CSIC, Inst Biomed Res Barcelona, Dept Expt Pathol, Barcelona, Spain.	jrcbam@iibb.csic.es	Mohamed, Bejaoui/AAJ-2952-2020; Puy, Emma Folch/AAX-5558-2020; Capasso, Clemente/P-3522-2016; Hotter, Georgina/R-1156-2018; De Luca, Viviana/Q-2911-2016; Folch Puy, Emma/Q-3157-2017	Mohamed, Bejaoui/0000-0003-1075-6170; Puy, Emma Folch/0000-0002-6277-9027; Capasso, Clemente/0000-0003-3314-2411; Folch Puy, Emma/0000-0002-6277-9027; DE LUCA, Viviana/0000-0003-3406-833X	Fondo de Investigaciones Sanitarias [PI12/00519]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	EP is a fellowship-holder of the "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (2012FI_B00382), Generalitat de Catalunya, Barcelona, Catalonia, Spain. This work was supported by the "Fondo de Investigaciones Sanitarias" (PI12/00519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamand R, 2009, AM J PHYSIOL-HEART C, V297, pH2068, DOI 10.1152/ajpheart.00525.2009; Alchera E, 2008, HEPATOLOGY, V48, P230, DOI 10.1002/hep.22249; Anderson CD, 2011, LIVER TRANSPLANT, V17, P189, DOI 10.1002/lt.22220; Bejaoui M, 2015, WORLD J GASTROENTERO, V21, P396, DOI 10.3748/wjg.v21.i2.396; Ben Abdennebi H, 1998, TRANSPLANT INT, V11, P223, DOI 10.1007/s001470050132; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Ben Mosbah I, 2007, LIVER TRANSPLANT, V13, P410, DOI 10.1002/lt.21059; Ben Mosbah I, 2006, LIVER TRANSPLANT, V12, P1215, DOI 10.1002/lt.20788; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Chirica LC, 1997, EUR J BIOCHEM, V244, P755, DOI 10.1111/j.1432-1033.1997.00755.x; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Deschenes M, 2013, LIVER TRANSPLANT, V19, pS6, DOI 10.1002/lt.23746; Guan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Hao Mao-Lin, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P48; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Mosbah IB, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.12; Noh MR, 2015, BBA-MOL BASIS DIS, V1852, P1895, DOI 10.1016/j.bbadis.2015.06.004; Papanikolaou V, 2002, LIVER TRANSPLANT, V8, P1028, DOI 10.1053/jlts.2002.36243; Saidi Reza F, 2013, Int J Organ Transplant Med, V4, P46; Scozzafava A, 2013, EXPERT OPIN THER PAT, V23, P725, DOI 10.1517/13543776.2013.790957; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FUTURE MED CHEM, V3, P1165, DOI [10.4155/fmc.11.69, 10.4155/FMC.11.69]; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Yoshinari D, 2001, TRANSPLANTATION, V72, P22, DOI 10.1097/00007890-200107150-00007; Zaouali MA, 2010, TRANSPL P, V42, P159, DOI 10.1016/j.transproceed.2009.12.035; Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051; Zaouali MA, 2010, WORLD J GASTROENTERO, V16, P5693, DOI 10.3748/wjg.v16.i45.5693	34	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134499	10.1371/journal.pone.0134499	http://dx.doi.org/10.1371/journal.pone.0134499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225852	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700101
J	Czembor, E; Stepien, L; Waskiewicz, A				Czembor, Elzbieta; Stepien, Lukasz; Waskiewicz, Agnieszka			Effect of Environmental Factors on Fusarium Species and Associated Mycotoxins in Maize Grain Grown in Poland	PLOS ONE			English	Article							FUMONISIN B-1 PRODUCTION; EAR ROT RESISTANCE; F-PROLIFERATUM; NATURAL OCCURRENCE; WATER ACTIVITY; HEAD BLIGHT; WHEAT; VERTICILLIOIDES; CONTAMINATION; INFECTION	Maize is one of the most important crops and Poland is the fifth largest producing country in Europe. Diseases caused by Fusarium spp. can affect the yield and grain quality of maize because of contamination with numerous mycotoxins produced by these fungi. The present study was performed to identify the prevailing Fusarium species and the environmental factors affecting their frequencies and the contamination of grain with the main mycotoxins deoxynivalenol (DON), zearalenone (ZON) and fumonisin B1 (FB1). Thirty kernel samples were collected in three locations in 2011 and in seven locations in 2012 from three hybrids. On average, 25.24% kernels were colonized by Fusarium spp. (424 strains were isolated). Fusarium verticillioides and F. temperatum were the most prevalent species, F. subglutinans, F. proliferatum and F. graminearum were in minor abundance. In total, 272 isolates of F. verticillioides and 81 isolates of F. temperatum were identified. Fusarium temperatum frequency ranged from 1.70% to 28.57% and differences between locations were significant. Fumonisin B1 was found in all tested samples. DON was found in 66.67% and ZON in 43.33% of samples. Rainfall amount positively affected F. temperatum and F. subglutinans frequency in opposite to mean temperatures in July. On the other hand, relationships between frequency of these species and historical data from 1950-2000 for annual temperature range were negative in contrast to the coldest quarter temperatures.	[Czembor, Elzbieta] Plant Breeding & Acclimatizat Inst NRI, Grasses & Legumes Dept, Radzikow, Poland; [Stepien, Lukasz] Polish Acad Sci, Inst Plant Genet, Dept Pathogen Genet & Plant Resistance, Poznan, Poland; [Waskiewicz, Agnieszka] Poznan Univ Life Sci, Dept Chem, Poznan, Poland	Institute of Plant Breeding & Acclimatization; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Poznan University of Life Sciences	Czembor, E (corresponding author), Plant Breeding & Acclimatizat Inst NRI, Grasses & Legumes Dept, Radzikow, Poland.	e.czembor@ihar.edu.pl	Stepien, Lukasz/G-2322-2012	Stepien, Lukasz/0000-0001-9740-9520; Czembor, Elzbieta/0000-0002-3021-3053; , Agnieszka/0000-0003-4113-1595	Polish Ministry of Agriculture and Rural Development [HORzg 8421/1]; Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland	Polish Ministry of Agriculture and Rural Development; Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland	This work was supported by the Polish Ministry of Agriculture and Rural Development (project HORzg 8421/1 "Plant improvement for sustainable agroecosystems, high-quality food and crop production for non-food purposes) and Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguin O, 2014, PLANT PATHOL, V63, P946, DOI 10.1111/ppa.12151; Arino A, 2007, J FOOD PROTECT, V70, P151, DOI 10.4315/0362-028X-70.1.151; Bakan B, 2002, J AGR FOOD CHEM, V50, P728, DOI 10.1021/jf0108258; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Berek L, 2001, TOXICOL IN VITRO, V15, P25, DOI 10.1016/S0887-2333(00)00055-2; Blandino M, 2009, WORLD MYCOTOXIN J, V2, P409, DOI 10.3920/WMJ2008.1098; Blandino M, 2008, C PLANT PATHOLOGY J; Blaszczyk L, 2004, CELL MOL BIOL LETT, V9, P869; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Boutigny AL, 2012, PLANT PATHOL, V61, P522, DOI 10.1111/j.1365-3059.2011.02544.x; Butron A, 2006, J AGR FOOD CHEM, V54, P6113, DOI 10.1021/jf0611163; Cao A, 2013, INT J FOOD MICROBIOL, V164, P15, DOI 10.1016/j.ijfoodmicro.2013.03.012; Chelkowski J, 1987, Mycotoxin Res, V3, P111, DOI 10.1007/BF03191997; Chelkowski J, 2012, WORLD MYCOTOXIN J, V5, P133, DOI 10.3920/WMJ2011.1304; Chelkowski J., 1989, Fusarium: mycotoxins, taxonomy and pathogenicity., P53; COOK RJ, 1976, PHYTOPATHOLOGY, V66, P193, DOI 10.1094/Phyto-66-193; Covarelli L, 2011, FOOD CHEM TOXICOL, V49, P2365, DOI 10.1016/j.fct.2011.06.047; Czembor E, 2014, PLANT DIS, V98, P1001, DOI 10.1094/PDIS-11-13-1184-PDN; Czembor E, 2013, B IHAR, V270, P55; Doohan FM, 2003, EUR J PLANT PATHOL, V109, P755, DOI 10.1023/A:1026090626994; Dorn B, 2011, J APPL MICROBIOL, V111, P693, DOI 10.1111/j.1365-2672.2011.05091.x; Dorn B, 2009, EUR J PLANT PATHOL, V125, P51, DOI 10.1007/s10658-009-9457-8; Duncan KE, 2010, MOL PLANT MICROBE IN, V23, P6, DOI 10.1094/MPMI-23-1-0006; Eckard S, 2011, TOXINS, V3, P949, DOI 10.3390/toxins3080949; Golinski P, 2010, FOOD ADDIT CONTAM A, V27, P1015, DOI 10.1080/19440041003702208; Gortz A, 2004, CEREAL RES COMMUN, V36, P617; Jurado M, 2006, Mycotoxin Res, V22, P87, DOI 10.1007/BF02956769; Krska R, 1996, J AGR FOOD CHEM, V44, P3665, DOI 10.1021/jf960064m; LEBARS J, 1994, J AOAC INT, V77, P517; Lemmens-Gruber R, 2000, MYCOPATHOLOGIA, V149, P5, DOI 10.1023/A:1007293812007; LESLIE JF, 1995, CAN J BOT, V73, pS282, DOI 10.1139/b95-258; Leslie JF, 2006, FUSARIUM LAB MANUAL; Lew H, 1991, Mycotoxin Res, V7 Suppl 1, P71, DOI 10.1007/BF03192189; Loffler M, 2010, THEOR APPL GENET, V120, P1053, DOI 10.1007/s00122-009-1233-9; Logrieco A, 2002, EUR J PLANT PATHOL, V108, P597, DOI 10.1023/A:1020679029993; Marin S, 1996, CAN J MICROBIOL, V42, P1045, DOI 10.1139/m96-134; Marin S, 1999, INT J FOOD MICROBIOL, V51, P159, DOI 10.1016/S0168-1605(99)00115-4; Meissle M, 2010, J APPL ENTOMOL, V134, P357, DOI 10.1111/j.1439-0418.2009.01491.x; Milevoj L, 1997, CEREAL RES COMMUN, V25, P603; Miller JD, 2001, ENVIRON HEALTH PERSP, V109, P321, DOI 10.2307/3435025; Mule G, 2004, EUR J PLANT PATHOL, V110, P495, DOI 10.1023/B:EJPP.0000032389.84048.71; Munkvold GP, 1997, PHYTOPATHOLOGY, V87, P1071, DOI [10.1094/PHYTO.1997.87.10.1071, 10.1094/PHYTO.1997.87.2.209]; Munkvold GP, 2003, EUR J PLANT PATHOL, V109, P705, DOI 10.1023/A:1026078324268; Munkvold GP, 2003, ANNU REV PHYTOPATHOL, V41, P99, DOI 10.1146/annurev.phyto.41.052002.095510; MUNOZ L, 1990, J AGR FOOD CHEM, V38, P1004, DOI 10.1021/jf00094a019; Nedelnik J., 2000, 6 EUR FUS SEM 11 16, P111; Oldenburg E, 2005, Mycotoxin Res, V21, P105, DOI 10.1007/BF02954430; Perkowski J, 1997, CEREAL RES COMMUN, V25, P379; Presello DA, 2011, EUPHYTICA, V178, P23, DOI 10.1007/s10681-010-0255-3; Presello DA, 2005, EUPHYTICA, V143, P1, DOI 10.1007/s10681-005-6149-0; Ramirez ML, 2006, EUR J PLANT PATHOL, V115, P139, DOI 10.1007/s10658-006-0009-1; Reid LM, 1999, PHYTOPATHOLOGY, V89, P1028, DOI 10.1094/PHYTO.1999.89.11.1028; Robertson LA, 2006, CROP SCI, V46, P353, DOI 10.2135/cropsci2005.0139; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Samapundo S, 2005, J FOOD PROTECT, V68, P1054, DOI 10.4315/0362-028X-68.5.1054; Scauflaire J, 2012, FUNGAL BIOL-UK, V116, P1073, DOI 10.1016/j.funbio.2012.07.011; Scauflaire J, 2012, EUR J PLANT PATHOL, V133, P911, DOI 10.1007/s10658-012-9958-8; Scauflaire J, 2011, MYCOLOGIA, V103, P586, DOI 10.3852/10-135; Stepien L, 2004, CELL MOL BIOL LETT, V9, P819; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Stepien L, 2012, J APPL GENET, V53, P227, DOI 10.1007/s13353-012-0085-1; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomczak M, 2002, EUR J PLANT PATHOL, V108, P625, DOI 10.1023/A:1020639315880; Torres MR, 2003, INT J FOOD MICROBIOL, V81, P185, DOI 10.1016/S0168-1605(02)00226-X; Velluti A, 2000, INT J FOOD MICROBIOL, V59, P59, DOI 10.1016/S0168-1605(00)00289-0; Vigier B, 1997, CAN J PLANT PATHOL, V19, P60, DOI 10.1080/07060669709500574; Voss K A, 2006, Mycotoxin Res, V22, P61, DOI 10.1007/BF02954559; Waskiewicz A, 2013, FOOD ADDIT CONTAM A, V30, P1332, DOI 10.1080/19440049.2013.796095; Waskiewicz A, 2013, TOXINS, V5, P488, DOI 10.3390/toxins5030488; Waskiewicz A, 2012, ARH HIG RADA TOKSIKO, V63, P437, DOI 10.2478/10004-1254-63-2012-2230; Zhang X, 2014, ANN APPL BIOL, V164, P384, DOI 10.1111/aab.12107; Zijlstra C, 2011, PEST MANAG SCI, V67, P616, DOI 10.1002/ps.2134	73	57	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133644	10.1371/journal.pone.0133644	http://dx.doi.org/10.1371/journal.pone.0133644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225823	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700031
J	Ko, BK; Choi, S; Cui, LG; Lee, YH; Hwang, IS; Kim, KT; Shim, H; Lee, JS				Ko, Bong-Kook; Choi, Soyoung; Cui, Lei Guang; Lee, Young-Ha; Hwang, In-Sik; Kim, Kyu-Tae; Shim, Hyunbo; Lee, Jong-Seo			Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TRASTUZUMAB; COMBINATION; PERTUZUMAB; HER2; HUMANIZATION; INHIBITION; RESIDUES; SURVIVAL	Anti-HER2 murine monoclonal antibody 1E11 has strong and synergistic anti-tumor activity in HER2-overexpressing gastric cancer cells when used in combination with trastuzumab. We presently optimized this antibody for human therapeutics. First, the complementarity determining regions (CDRs) of the murine antibody were grafted onto human germline immunoglobulin variable genes. No difference in affinity and biological activity was observed between chimeric 1E11 (ch1E11) and humanized 1E11 (hz1E11). Next, affinity maturation of hz1E11 was performed by the randomization of CDR-L3 and H3 residues followed by stringent biopanning selection. Milder selection pressure favored the selection of more diverse clones, whereas higher selection stringency resulted in the convergence of the panning output to a smaller number of clones with improved affinity. Clone 1A12 had four amino acid substitutions in CDR-L3, and showed a 10-fold increase in affinity compared to the parental clone and increased potency in an in vitro anti-proliferative activity assay with HER2-overepxressing gastric cancer cells. Clone 1A12 inhibited tumor growth of NCI-N87 xenograft model with similar efficacy to trastuzumab alone, and the combination treatment of 1A12 and trastuzumab completely removed the established tumors. These results suggest that humanized and affinity matured monoclonal antibody 1A12 is a highly optimized molecule for future therapeutic development against HER2-positive tumors.	[Ko, Bong-Kook; Choi, Soyoung; Cui, Lei Guang; Lee, Young-Ha; Hwang, In-Sik; Kim, Kyu-Tae; Lee, Jong-Seo] AbClon Inc, Therapeut Antibody Res Ctr, Seoul, South Korea; [Shim, Hyunbo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea; [Shim, Hyunbo] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Kim, KT (corresponding author), AbClon Inc, Therapeut Antibody Res Ctr, Seoul, South Korea.	ktkim@abclon.com; hshim@ewha.ac.kr		Ko, Bong-Kook/0000-0002-8688-3179	AbClon Inc.; National Research Foundation of Korea (NRF) [NRF-2013M3A6A4044991]	AbClon Inc.; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by AbClon Inc., and by National Research Foundation of Korea (NRF) grant to HS for Medicinal Bioconvergence Research Center (NRF-2013M3A6A4044991). The commercial funder (AbClon Inc.) provided support in the form of salaries for authors (BKK, SC, LGC, YHL, ISH, KTK, and JSL) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Andris-Widhopf J, 2001, PHAGE DISPLAY LAB MA; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Garcia I, 2003, ANN SURG ONCOL, V10, P234, DOI 10.1245/ASO.2003.05.010; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kamat V, 2008, CANCER BIOL THER, V7, P726, DOI 10.4161/cbt.7.5.6097; Kawa S, 2011, MABS-AUSTIN, V3, P479, DOI 10.4161/mabs.3.5.17228; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Ko BK, 2015, MOL ONCOL, V9, P398, DOI 10.1016/j.molonc.2014.09.007; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang AL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-20	36	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134600	10.1371/journal.pone.0134600	http://dx.doi.org/10.1371/journal.pone.0134600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225765	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700120
J	Valenzano, MC; DiGuilio, K; Mercado, J; Teter, M; To, J; Ferraro, B; Mixson, B; Manley, I; Baker, V; Moore, BA; Wertheimer, J; Mullin, JM				Valenzano, Mary Carmen; DiGuilio, Katherine; Mercado, Joanna; Teter, Mimi; To, Julie; Ferraro, Brendan; Mixson, Brittany; Manley, Isabel; Baker, Valerissa; Moore, Beverley A.; Wertheimer, Joshua; Mullin, James M.			Remodeling of Tight Junctions and Enhancement of Barrier Integrity of the CACO-2 Intestinal Epithelial Cell Layer by Micronutrients	PLOS ONE			English	Article							ZINC SUPPLEMENTATION; IN-VITRO; BUTYRATE; PERMEABILITY; EXPRESSION; QUERCETIN; ACTIVATION; OCCLUDIN; MONOLAYERS; CLAUDIN-4	The micronutrients zinc, quercetin, butyrate, indole and berberine were evaluated for their ability to induce remodeling of epithelial tight junctions (TJs) and enhance barrier integrity in the CACO-2 gastrointestinal epithelial cell culture model. All five of these chemically very diverse micronutrients increased transepithelial electrical resistance (R-t) significantly, but only berberine also improved barrier integrity to the non-electrolyte D-mannitol. Increases of Rt as much as 200% of untreated controls were observed. Each of the five micronutrients also induced unique, signature-like changes in TJ protein composition, suggesting multiple pathways (and TJ arrangements) by which TJ barrier function can be enhanced. Decreases in abundance by as much as 90% were observed for claudin-2, and increases of over 300% could be seen for claudins -5 and -7. The exact effects of the micronutrients on barrier integrity and TJ protein composition were found to be highly dependent on the degree of differentiation of the cell layer at the time it was exposed to the micronutrient. The substratum to which the epithelial layer adheres was also found to regulate the response of the cell layer to the micronutrient. The implications of these findings for therapeutically decreasing morbidity in Inflammatory Bowel Disease are discussed.	[Valenzano, Mary Carmen; DiGuilio, Katherine; Mercado, Joanna; Mixson, Brittany; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Mullin, James M.] Lankenau Med Ctr, Div Gastroenterol, Wynnewood, PA 19096 USA; [Teter, Mimi; To, Julie; Ferraro, Brendan; Manley, Isabel; Baker, Valerissa] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Moore, Beverley A.; Wertheimer, Joshua] Janssen Res & Dev LLC, Spring House, PA 19477 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Lankenau Medical Center; Drexel University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA 19096 USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530	Sharpe Strumia Foundation; Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority	Sharpe Strumia Foundation; Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority	This project was financed by grants from the Sharpe Strumia Foundation and from the Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority.	Amasheh M, 2008, J NUTR, V138, P1067, DOI 10.1093/jn/138.6.1067; Amasheh M, 2012, ANN NY ACAD SCI, V1258, P100, DOI 10.1111/j.1749-6632.2012.06609.x; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bzik VA, 2012, J PHARM PHARMACOL, V64, P644, DOI 10.1111/j.2042-7158.2011.01441.x; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Carr G, 2010, J MEMBRANE BIOL, V237, P115, DOI 10.1007/s00232-010-9312-z; Carrasco-Pozo C, 2013, J AGR FOOD CHEM, V61, P5291, DOI 10.1021/jf400150p; Chuenkitiyanon S, 2010, INT J TOXICOL, V29, P418, DOI 10.1177/1091581810366487; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; Gu LL, 2009, FITOTERAPIA, V80, P241, DOI 10.1016/j.fitote.2009.02.005; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mercado J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078775; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; PETERSON MD, 1992, J CELL SCI, V102, P581; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Rodriguez P, 1996, GUT, V39, P416, DOI 10.1136/gut.39.3.416; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080604; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Tan S, 2002, INT J CANCER, V98, P523, DOI 10.1002/ijc.10236; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	46	86	88	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133926	10.1371/journal.pone.0133926	http://dx.doi.org/10.1371/journal.pone.0133926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226276	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700044
J	Beckenkamp, A; Willig, JB; Santana, DB; Nascimento, J; Paccez, JD; Zerbini, LF; Bruno, AN; Pilger, DA; Wink, MR; Buffon, A				Beckenkamp, Aline; Willig, Julia Biz; Santana, Danielle Bertodo; Nascimento, Jessica; Paccez, Juliano Domiraci; Zerbini, Luiz Fernando; Bruno, Alessandra Nejar; Pilger, Diogo Andre; Wink, Marcia Rosangela; Buffon, Andreia			Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; PROSTATE-CANCER CELLS; OVARIAN-CARCINOMA; MALIGNANT PHENOTYPE; HUMAN-LYMPHOCYTES; CD26; BINDING; ACTIVATION; SERUM; CHEMOKINE	Dipeptidyl peptidase IV (DPPIV/CD26) is a transmembrane glycoprotein that inactivates or degrades some bioactive peptides and chemokines. For this reason, it regulates cell proliferation, migration and adhesion, showing its role in cancer processes. This enzyme is found mainly anchored onto the cell membrane, although it also has a soluble form, an enzymatically active isoform. In the present study, we investigated DPPIV/CD26 activity and expression in cervical cancer cell lines (SiHa, HeLa and C33A) and non-tumorigenic HaCaT cells. The effect of the DPPIV/CD26 inhibitor (sitagliptin phosphate) on cell migration and adhesion was also evaluated. Cervical cancer cells and keratinocytes exhibited DPPIV/CD26 enzymatic activity both membrane-bound and in soluble form. DPPIV/CD26 expression was observed in HaCaT, SiHa and C33A, while in HeLa cells it was almost undetectable. We observed higher migratory capacity of HeLa, when compared to SiHa. But in the presence of sitagliptin SiHa showed an increase in migration, indicating that, at least in part, cell migration is regulated by DPPIV/CD26 activity. Furthermore, in the presence of sitagliptin phosphate, SiHa and HeLa cells exhibited a significant reduction in adhesion. However this mechanism seems to be mediated independent of DPPIV/CD26. This study demonstrates, for the first time, the activity and expression of DPPIV/CD26 in cervical cancer cells and the effect of sitagliptin phosphate on cell migration and adhesion.	[Beckenkamp, Aline; Willig, Julia Biz; Santana, Danielle Bertodo; Nascimento, Jessica; Pilger, Diogo Andre; Buffon, Andreia] Fed Univ Rio Grande do Sul UFRGS, Fac Pharm, Pharmaceut Sci Grad Program, Porto Alegre, RS, Brazil; [Paccez, Juliano Domiraci; Zerbini, Luiz Fernando] Canc Genom Grp, ICGEB, Cape Town, South Africa; [Bruno, Alessandra Nejar] Fed Inst Educ Sci & Technol, Porto Alegre, RS, Brazil; [Wink, Marcia Rosangela] Fed Univ Hlth Sci Porto Alegre, Cell Biol Lab, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; Instituto Federal do Rio Grande do Sul (IFRS)	Buffon, A (corresponding author), Fed Univ Rio Grande do Sul UFRGS, Fac Pharm, Pharmaceut Sci Grad Program, Porto Alegre, RS, Brazil.	andreia.buffon@ufrgs.br	Paccez, Juliano/K-8560-2012; Zerbini, Luiz/B-7720-2015; Pilger, Diogo/S-5299-2019; Beckenkamp, Aline/L-9540-2015	Paccez, Juliano/0000-0002-1086-4588; Zerbini, Luiz/0000-0003-0736-9508; Pilger, Diogo/0000-0002-6773-6480; Beckenkamp, Aline/0000-0003-4227-7844	Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Auxilio Recem-Doutor 0902665]; Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES) [071/2013 - 15819]; Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil); CAPES-Brazil; ICGEB	Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ICGEB(Department of Biotechnology (DBT) India)	This work was supported by grants from Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, Auxilio Recem-Doutor 0902665), Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES, Edital no 071/2013 - 15819). A. Beckenkamp was a recipient of fellowships from Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) and CAPES-Brazil, and J. Paccez was a recipient of postdoctoral fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; BAUVOIS B, 1988, BIOCHEM J, V252, P723, DOI 10.1042/bj2520723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buffon A, 2007, LIFE SCI, V80, P950, DOI 10.1016/j.lfs.2006.11.024; Busek P, 2012, INT J BIOCHEM CELL B, V44, P738, DOI 10.1016/j.biocel.2012.01.011; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cordero OJ, 2011, WORLD J CLIN ONCOL, V2, P245, DOI 10.5306/wjco.v2.i6.245; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cro L, 2009, HEMATOL ONCOL, V27, P140, DOI 10.1002/hon.888; De Andrade CFCG, 2009, J ENZYM INHIB MED CH, V24, P708, DOI 10.1080/14756360802334800; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; de Cremoux P, 2009, INT J CANCER, V124, P778, DOI 10.1002/ijc.24075; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Dong RP, 1997, J IMMUNOL, V159, P6070; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Eric-Nikolic A, 2011, IMMUNOBIOLOGY, V216, P942, DOI 10.1016/j.imbio.2011.01.005; Gonzalez-Gronow M, 2001, BIOCHEM J, V355, P397, DOI 10.1042/0264-6021:3550397; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Goscinski MA, 2008, APMIS, V116, P823, DOI 10.1111/j.1600-0463.2008.01029.x; HANSKI C, 1988, EXP CELL RES, V178, P64, DOI 10.1016/0014-4827(88)90378-3; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrera C, 2001, J BIOL CHEM, V276, P19532, DOI 10.1074/jbc.M004586200; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Iwaki-Egawa S, 1998, J BIOCHEM, V124, P428, DOI 10.1093/oxfordjournals.jbchem.a022130; Kajiyama H, 2003, CANCER RES, V63, P2278; Kajiyama H, 2002, CANCER RES, V62, P2753; Kajiyama H, 2006, ANN NY ACAD SCI, V1086, P233, DOI 10.1196/annals.1377.007; Kikkawa F, 2005, BBA-PROTEINS PROTEOM, V1751, P45, DOI 10.1016/j.bbapap.2004.09.028; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lambeir AM, 1997, BBA-PROTEIN STRUCT M, V1340, P215, DOI 10.1016/S0167-4838(97)00045-9; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; Matic IZ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-48; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Rama CH, 2008, REV SAUDE PUBL, V42, P123, DOI 10.1590/S0034-89102008000100016; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; Wang Aiying, 2012, BMC Pharmacology, V12, P2, DOI 10.1186/1471-2210-12-2; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wesley UV, 1999, J EXP MED, V190, P311, DOI 10.1084/jem.190.3.311; Wesley UV, 2004, INT J CANCER, V109, P855, DOI 10.1002/ijc.20091; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zagouri F, 2012, GYNECOL ONCOL, V126, P291, DOI 10.1016/j.ygyno.2012.04.007; Zanoni TB, 2014, TOXICOL LETT, V227, P139, DOI 10.1016/j.toxlet.2014.03.007; Zerbini LF, 2003, CANCER RES, V63, P2206	51	28	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134305	10.1371/journal.pone.0134305	http://dx.doi.org/10.1371/journal.pone.0134305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222679	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800128
J	Mentzel, CMJ; Anthon, C; Jacobsen, MJ; Karlskov-Mortensen, P; Bruun, CS; Jorgensen, CB; Gorodkin, J; Cirera, S; Fredholm, M				Mentzel, Caroline M. Junker; Anthon, Christian; Jacobsen, Mette J.; Karlskov-Mortensen, Peter; Bruun, Camilla S.; Jorgensen, Claus B.; Gorodkin, Jan; Cirera, Susanna; Fredholm, Merete			Gender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese Pigs	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE; INSULIN-RESISTANCE; GENE-EXPRESSION; ACCUMULATION; FAT; INFORMATION; MUSCLE; MIRNA; PCR; MEN	Obesity is a complex condition that increases the risk of life threatening diseases such as cardiovascular disease and diabetes. Studying the gene regulation of obesity is important for understanding the molecular mechanisms behind the obesity derived diseases and may lead to better intervention and treatment plans. MicroRNAs (miRNAs) are short non-coding RNAs regulating target mRNA by binding to their 3'UTR. They are involved in numerous biological processes and diseases, including obesity. In this study we use a mixed breed pig model designed for obesity studies to investigate differentially expressed miRNAs in subcutaneous adipose tissue by RNA sequencing (RNAseq). Both male and female pigs are included to explore gender differences. The RNAseq study shows that the most highly expressed miRNAs are in accordance with comparable studies in pigs and humans. A total of six miRNAs are differentially expressed in subcutaneous adipose tissue between the lean and obese group of pigs, and in addition gender specific significant differential expression is observed for a number of miRNAs. The differentially expressed miRNAs have been verified using qPCR. The results of these studies in general confirm the trends found by RNAseq. Mir-9 and mir-124a are significantly differentially expressed with large fold changes in subcutaneous adipose tissue between lean and obese pigs. Mir-9 is more highly expressed in the obese pigs with a fold change of 10 and a p-value <0.001. Mir-124a is more highly expressed in the obese pigs with a fold change of 114 and a p-value <0.001. In addition, mir-124a is significantly higher expressed in abdominal adipose tissue in male pigs with a fold change of 119 and a p-value <0.05. Both miRNAs are also significantly higher expressed in the liver of obese male pigs where mir-124a has a fold change of 12 and mir-9 has a fold change of 1.6, both with p-values <0.05.	[Mentzel, Caroline M. Junker; Jacobsen, Mette J.; Karlskov-Mortensen, Peter; Bruun, Camilla S.; Jorgensen, Claus B.; Cirera, Susanna; Fredholm, Merete] Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Anim Genet, Frederiksberg, Denmark; [Mentzel, Caroline M. Junker; Anthon, Christian; Gorodkin, Jan; Fredholm, Merete] Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Ctr Non Coding RNA Technol & Hlth Computat Biol &, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen	Fredholm, M (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Anim Genet, Frederiksberg, Denmark.	mf@sund.ku.dk	Cirera, Susanna/K-8540-2017; Jorgensen, Claus B./GXH-7925-2022; Mentzel, Caroline/AAX-1577-2021; Karlskov-Mortensen, Peter/C-3030-2013	Jorgensen, Claus B./0000-0003-4749-5306; Mentzel, Caroline/0000-0003-4688-7367; Karlskov-Mortensen, Peter/0000-0002-2491-2763; Cirera, Susanna/0000-0001-8105-1579; Jacobsen, Mette Juul/0000-0001-9264-7554; Fredholm, Merete/0000-0002-3563-7648; Anthon, Christian/0000-0002-4336-1688; Gorodkin, Jan/0000-0001-5823-4000	Ministry for Science and Technology; Danish Independent Research Council [DFF - 1335-00127]; Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies)	Ministry for Science and Technology; Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies)	The project was supported by a grant from the Ministry for Science and Technology to the "UNIK Project for Food Fitness and Pharma for Health", by the Danish Independent Research Council (DFF - 1335-00127), and by the Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies). Innovation Fund Denmark (CMJM, MF, JG) and Danish Center for Scientific Computing (DCSC, DeIC) (JG).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Bruun CS, 2013, LUNG, V191, P669, DOI 10.1007/s00408-013-9504-2; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082; Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7; Cirera Susanna, 2013, BMC Res Notes, V6, P472, DOI 10.1186/1756-0500-6-472; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haukeland JW, 2008, SCAND J GASTROENTERO, V43, P1241, DOI 10.1080/00365520802158614; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kogelman Lisette J. A., 2013, Frontiers in Genetics, V4, P29, DOI 10.3389/fgene.2013.00029; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MA J, 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0080041; Martin M, 2011, CUTADAPT REMOVES ADA; MERSMANN HJ, 1984, GROWTH, V48, P321; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stockl S, 2013, CELL PHYSIOL BIOCHEM, V31, P703, DOI 10.1159/000350089; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445	69	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131650	10.1371/journal.pone.0131650	http://dx.doi.org/10.1371/journal.pone.0131650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222688	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800018
J	Morita, H; Obata, K; Abe, C; Shiba, D; Shirakawa, M; Kudo, T; Takahashi, S				Morita, Hironobu; Obata, Koji; Abe, Chikara; Shiba, Dai; Shirakawa, Masaki; Kudo, Takashi; Takahashi, Satoru			Feasibility of a Short-Arm Centrifuge for Mouse Hypergravity Experiments	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; RATS; ISS	To elucidate the pure impact of microgravity on small mammals despite uncontrolled factors that exist in the International Space Station, it is necessary to construct a 1 g environment in space. The Japan Aerospace Exploration Agency has developed a novel mouse habitat cage unit that can be installed in the Cell Biology Experiment Facility in the Kibo module of the International Space Station. The Cell Biology Experiment Facility has a short-arm centrifuge to produce artificial 1 g gravity in space for mouse experiments. However, the gravitational gradient formed inside the rearing cage is larger when the radius of gyration is shorter; this may have some impact on mice. Accordingly, biological responses to hypergravity induced by a short-arm centrifuge were examined and compared with those induced by a long-arm centrifuge. Hypergravity induced a significant Fos expression in the central nervous system, a suppression of body mass growth, an acute and transient reduction in food intake, and impaired vestibulomotor coordination. There was no difference in these responses between mice raised in a short-arm centrifuge and those in a long-arm centrifuge. These results demonstrate the feasibility of using a short-arm centrifuge for mouse experiments.	[Morita, Hironobu; Obata, Koji; Abe, Chikara] Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan; [Morita, Hironobu; Kudo, Takashi; Takahashi, Satoru] Japan Aerosp Explorat Agcy, Mouse Epigenet Project, ISS Kibo Expt, Tsukuba, Ibaraki, Japan; [Shiba, Dai; Shirakawa, Masaki] Japan Aerosp Explorat Agcy, JEM Utilizat Ctr, Human Spaceflight Technol Directorate, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	Gifu University; Japan Aerospace Exploration Agency (JAXA); Japan Aerospace Exploration Agency (JAXA); University of Tsukuba; University of Tsukuba	Morita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan.	zunzunmorita@gmail.com	Abe, Chikara/V-6174-2019	Abe, Chikara/0000-0003-3856-7494; Kudo, Takashi/0000-0001-5477-7235; Shiba, Dai/0000-0003-3808-5428	Japan Society for the Promotion of Science [24590298]; Japan Aerospace Exploration Agency [13YPTK-013584, 14YPTK-000980, 14YPTK005512]; Grants-in-Aid for Scientific Research [15K21745] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HM: Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24590298) http://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HM: Short arm centrifuge project commissioned from Japan Aerospace Exploration Agency (13YPTK-013584 and 14YPTK-000980) http://iss.jaxa.jp/kiboexp/participation/application/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ST: Prioritized research selected for life science from Japan Aerospace Exploration Agency (14YPTK005512) http://iss.jaxa.jp/kiboexp/participation/application/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2008, AM J PHYSIOL-REG I, V295, pR173, DOI 10.1152/ajpregu.00120.2008; Abe C, 2007, EXP BRAIN RES, V181, P639, DOI 10.1007/s00221-007-0961-9; Abe C, 2013, J APPL PHYSIOL, V115, P1082, DOI 10.1152/japplphysiol.00285.2013; Abe C, 2011, NEUROSCI LETT, V502, P138, DOI 10.1016/j.neulet.2011.06.041; Abe C, 2010, J APPL PHYSIOL, V109, P1635, DOI 10.1152/japplphysiol.00515.2010; Albi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048518; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Brinckmann E, 2002, ADV SPACE RES, V30, P809, DOI 10.1016/S0273-1177(02)00401-5; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Hallil A, 2010, RADIAT PROT DOSIM, V138, P295, DOI 10.1093/rpd/ncp265; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Mazars C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091814; Reitz G, 2005, RADIAT PROT DOSIM, V116, P374, DOI 10.1093/rpd/nci262; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sasa M, 2001, Biol Sci Space, V15, P371, DOI 10.2187/bss.15.371; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001; Walton KD, 2005, J PHYSIOL-LONDON, V565, P593, DOI 10.1113/jphysiol.2004.074385; Yamaguchi N, 2014, MICROBES ENVIRON, V29, P250, DOI 10.1264/jsme2.ME14031; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119	21	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133981	10.1371/journal.pone.0133981	http://dx.doi.org/10.1371/journal.pone.0133981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221724	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800091
J	Buiten, MS; de Bie, MK; Rotmans, JI; Dekker, FW; van Buren, M; Rabelink, TJ; Cobbaert, CM; Schalij, MJ; van der Laarse, A; Jukema, JW				Buiten, Maurits S.; de Bie, Mihyly K.; Rotmans, Joris I.; Dekker, Friedo W.; van Buren, Marjolijn; Rabelink, Ton J.; Cobbaert, Christa M.; Schalij, Martin J.; van der Laarse, Arnoud; Jukema, J. Wouter			Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease	PLOS ONE			English	Article							HIGH-SENSITIVITY ASSAY; CHRONIC KIDNEY-DISEASE; MYOCARDIAL-INFARCTION; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; ASYMPTOMATIC PATIENTS; PROGNOSTIC VALUE; ASSOCIATION; AUTOANTIBODIES; METAANALYSIS	Background Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients. Methods Troponin levels were measured using 5th generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis. Results We included 154 consecutive patients, 68+/-7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99th percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006). Conclusion In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients.	[Buiten, Maurits S.; de Bie, Mihyly K.; Schalij, Martin J.; van der Laarse, Arnoud; Jukema, J. Wouter] Leiden Univ, Med Ctr LUMC, Dept Cardiol, Leiden, Netherlands; [Rotmans, Joris I.; Rabelink, Ton J.] LUMC, Dept Nephrol, Leiden, Netherlands; [Dekker, Friedo W.] LUMC, Dept Clin Epidemiol, Leiden, Netherlands; [van Buren, Marjolijn] HAGA, Dept Nephrol, The Hague, Netherlands; [Cobbaert, Christa M.; van der Laarse, Arnoud] LUMC, Dept Clin Chem & Lab Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Jukema, JW (corresponding author), Leiden Univ, Med Ctr LUMC, Dept Cardiol, Leiden, Netherlands.	j.w.jukema@lumc.nl	Rabelink, Ton J./A-5316-2008; Rotmans, Joris I./G-8866-2014; Jukema, J. Wouter/ABD-6503-2021; Dekker, Friedo W/B-6452-2011	Rabelink, Ton J./0000-0001-6780-5186; Rotmans, Joris I./0000-0001-9682-6234; Jukema, J. Wouter/0000-0002-3246-8359; Dekker, Friedo W/0000-0002-2433-2494; van Buren, Marjolijn/0000-0002-1822-6863; Cobbaert, Christa/0000-0003-3565-1404	Boston Scientific (Natick, Massachusetts, USA); Medtronic (Minneapolis, Minnesota, USA); Biotronik (Berlin, Germany)	Boston Scientific (Natick, Massachusetts, USA); Medtronic (Minneapolis, Minnesota, USA)(Medtronic); Biotronik (Berlin, Germany)	The department of Cardiology in the LUMC received unrestricted grants from Boston Scientific (Natick, Massachusetts, USA) and Medtronic (Minneapolis, Minnesota, USA). The ICD-2 study is supported by an unrestricted educational research grant from Biotronik (Berlin, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, CIRCULATION, V23, P2014, DOI DOI 10.1161/CIR.0000000000000133; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Artunc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047610; Basit M, 2007, AM J CLIN PATHOL, V128, P164, DOI 10.1309/LR7FC0LUGLHT8X6J; Cardinaels EPM, 2013, CLIN CHEM, V59, P1083, DOI 10.1373/clinchem.2012.200543; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; Cobbaert CM, 2014, INT J CARDIOL, V172, pE3, DOI 10.1016/j.ijcard.2013.12.141; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Coudrey L, 1998, ARCH INTERN MED, V158, P1173, DOI 10.1001/archinte.158.11.1173; de Bie MK, 2008, CURR MED RES OPIN, V24, P2151, DOI 10.1185/03007990802237343; de Bie MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067936; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Eriksson S, 2005, CLIN CHEM, V51, P839, DOI 10.1373/clinchem.2004.040063; Eriksson S, 2005, NEW ENGL J MED, V352, P98, DOI 10.1056/NEJM200501063520123; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Franekova J, 2015, CLIN CHIM ACTA, V446, P128, DOI 10.1016/j.cca.2015.03.046; Gaze DC, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000108; Gillis JM, 2013, CLIN CHEM, V59, P442, DOI 10.1373/clinchem.2012.192211; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Hayashi T, 2008, NEPHROL DIAL TRANSPL, V23, P2936, DOI 10.1093/ndt/gfn181; Jacobs LH, 2009, ANN CLIN BIOCHEM, V46, P283, DOI 10.1258/acb.2009.008197; Jung HH, 2004, NEPHROL DIAL TRANSPL, V19, P3117, DOI 10.1093/ndt/gfh488; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Krintus M, 2014, CLIN CHEM LAB MED, V52, P1657, DOI 10.1515/cclm-2014-0107; Kumar N, 2011, NEPHROL DIAL TRANSPL, V26, P665, DOI 10.1093/ndt/gfq442; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lowbeer C, 1999, NEPHROL DIAL TRANSPL, V14, P1948, DOI 10.1093/ndt/14.8.1948; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; Mallamaci F, 2002, KIDNEY INT, V62, P1884, DOI 10.1046/j.1523-1755.2002.00641.x; Michos ED, 2014, ANN INTERN MED, V161, P491, DOI 10.7326/M14-0743; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Moore JK, 2013, CLIN TOXICOL, V51, P532, DOI 10.3109/15563650.2013.816853; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ungerer JPJ, 2012, CLIN CHEM, V58, P274, DOI 10.1373/clinchem.2011.175059; Wang AYM, 2012, SEMIN DIALYSIS, V25, P388, DOI 10.1111/j.1525-139X.2012.01099.x; Wayand D, 2000, CLIN CHEM, V46, P1345; Wong SL, 2014, CAN J CARDIOL, V30, DOI 10.1016/j.cjca.2014.03.037; Wu AHB, 1998, CLIN CHEM, V44, P1198; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Ziebig R, 2003, CLIN CHEM, V49, P1191, DOI 10.1373/49.7.1191	42	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134245	10.1371/journal.pone.0134245	http://dx.doi.org/10.1371/journal.pone.0134245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237313	gold, Green Submitted, Green Published			2022-12-26	WOS:000358942400019
J	Kaeidi, A; Azizi, H; Javan, M; Soleimani, SMA; Fathollahi, Y; Semnanian, S				Kaeidi, Ayat; Azizi, Hossein; Javan, Mohammad; Soleimani, S. Mohammad Ahmadi; Fathollahi, Yaghoub; Semnanian, Saeed			Direct Facilitatory Role of Paragigantocellularis Neurons in Opiate Withdrawal-Induced Hyperactivity of Rat Locus Coeruleus Neurons: An In Vitro Study	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; NUCLEUS PARAGIGANTOCELLULARIS; CHRONIC MORPHINE; CERULEUS NEURONS; HORSERADISH-PEROXIDASE; POTASSIUM CHANNELS; INDUCED ACTIVATION; DEPENDENT RATS; BRAIN-SLICES; SINGLE-UNIT	Studies have shown that following opiate withdrawal, the spontaneous discharge rate of locus coeruleus (LC) neurons remarkably increases. Combination of intrinsic mechanisms with extrinsic excitatory modulations mediates the withdrawal-induced hyperactivity of LC neurons. The nucleus paragigantocellularis (PGi) provides the main excitatory inputs to LC and plays a pivotal role in opiate withdrawal. In the present study the direct facilitatory role of PGi on opiate withdrawal-induced hyperactivity of LC neurons was investigated using a newly developed brain slice, containing both LC and PGi. HRP retrograde neuronal tracing was used to verify the existence of both LC and PGi neurons in the developed slice. The spontaneous discharge rate (SDR), resting membrane potential (RMP) and spontaneous excitatory post-synaptic currents (sEPSCs) were recorded in LC neurons using whole cell patch clamp recording. Results showed that the net SDR and the net RMP of LC neurons in slices containing both LC and PGi neurons are significantly higher than slices lacking intact (uncut) PGi inputs. Also, the frequency of sEPSCs in those LC neurons receiving PGi inputs significantly increased compared to the slices containing no intact PGi inputs. Altogether, our results propose that increase in PGi-mediated excitatory transmission might facilitate the opiate withdrawal-induced hyperactivity of LC neurons.	[Kaeidi, Ayat; Azizi, Hossein; Javan, Mohammad; Soleimani, S. Mohammad Ahmadi; Fathollahi, Yaghoub; Semnanian, Saeed] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran	Tarbiat Modares University	Semnanian, S (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, POB 14115-331, Tehran, Iran.	ssemnan@modares.ac.ir	Kaeidi, Ayat/O-3477-2017; Soleimani, Seyed Mohammad Ahmadi/M-4154-2018; Azizi, Hossein/AAG-1330-2019; fathollahi, yaghoub/C-1670-2010; Javan, Mohammad/C-6758-2008	Kaeidi, Ayat/0000-0002-3292-2603; Azizi, Hossein/0000-0001-8489-0861; Javan, Mohammad/0000-0003-2045-6171; fathollahi, yghoub/0000-0002-3695-4805; Ahmadi Soleimani, Seyed Mohammad/0000-0003-3288-945X	Iran National Science Foundation (INSF); Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	This study was supported by grants from the Iran National Science Foundation (INSF) and Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, NATURE, V276, P186, DOI 10.1038/276186a0; AGHAJANIAN GK, 1994, BRAIN RES, V636, P126, DOI 10.1016/0006-8993(94)90186-4; AKAOKA H, 1991, J NEUROSCI, V11, P3830; ANDRADE R, 1983, EUR J PHARMACOL, V91, P161, DOI 10.1016/0014-2999(83)90461-2; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; AstonJones G, 1997, BRAIN RES, V765, P331, DOI 10.1016/S0006-8993(97)00682-3; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Bell JA, 1998, BRAIN RES, V788, P237, DOI 10.1016/S0006-8993(98)00003-1; Cao JL, 2010, P NATL ACAD SCI USA, V107, P17011, DOI 10.1073/pnas.1010077107; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; ENNIS M, 1988, J NEUROSCI, V8, P3644; GUITART X, 1990, J NEUROSCI, V10, P2649; GUITART X, 1989, J NEUROSCI, V9, P4371; Haghparast A, 1998, BRAIN RES, V814, P71, DOI 10.1016/S0006-8993(98)01029-4; Ivanov A, 2001, J NEUROPHYSIOL, V85, P2388, DOI 10.1152/jn.2001.85.6.2388; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; KRISTENSSON K, 1971, BRAIN RES, V32, P399, DOI 10.1016/0006-8993(71)90332-5; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LAVAIL JH, 1974, J COMP NEUROL, V157, P303, DOI 10.1002/cne.901570304; MATSUOKA I, 1994, EUR J PHARM-MOLEC PH, V268, P215, DOI 10.1016/0922-4106(94)90191-0; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Mesulam M, 1982, TRACING NEURAL CONNE, P1; NESTLER EJ, 1989, BRAIN RES, V476, P230, DOI 10.1016/0006-8993(89)91243-2; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; RASMUSSEN K, 1989, BRAIN RES, V505, P346, DOI 10.1016/0006-8993(89)91466-2; Rasmussen K, 1996, NEUROPSYCHOPHARMACOL, V15, P497, DOI 10.1016/S0893-133X(96)00094-2; Saiepour MH, 2001, EUR J PHARMACOL, V411, P85, DOI 10.1016/S0014-2999(00)00862-1; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; TUNG CS, 1990, ACTA PHYSIOL SCAND, V138, P581, DOI 10.1111/j.1748-1716.1990.tb08888.x; Van Bockstaele EJ, 2010, BRAIN RES, V1314, P162, DOI 10.1016/j.brainres.2009.09.036; van der Want JJL, 1997, BRAIN RES PROTOC, V1, P269, DOI 10.1016/S1385-299X(96)00042-6; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zhu H, 2010, EUR J PHARMACOL, V636, P65, DOI 10.1016/j.ejphar.2010.03.033	39	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134873	10.1371/journal.pone.0134873	http://dx.doi.org/10.1371/journal.pone.0134873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230639	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400181
J	Kayvanpour, E; Mansi, T; Sedaghat-Hamedani, F; Amr, A; Neumann, D; Georgescu, B; Seegerer, P; Kamen, A; Haas, J; Frese, KS; Irawati, M; Wirsz, E; King, V; Buss, S; Mereles, D; Zitron, E; Keller, A; Katus, HA; Comaniciu, D; Meder, B				Kayvanpour, Elham; Mansi, Tommaso; Sedaghat-Hamedani, Farbod; Amr, Ali; Neumann, Dominik; Georgescu, Bogdan; Seegerer, Philipp; Kamen, Ali; Haas, Jan; Frese, Karen S.; Irawati, Maria; Wirsz, Emil; King, Vanessa; Buss, Sebastian; Mereles, Derliz; Zitron, Edgar; Keller, Andreas; Katus, Hugo A.; Comaniciu, Dorin; Meder, Benjamin			Towards Personalized Cardiology: Multi-Scale Modeling of the Failing Heart	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; ELECTROMECHANICAL MODEL; 12-LEAD ECG; PREDICTION; FRAMEWORK; ELECTROPHYSIOLOGY; UNCERTAINTY; MECHANICS; FAILURE; CRT	Background Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quality of life of HF patients remain poor. This is in part due to insufficient patient stratification and lack of individualized therapy planning, resulting in less effective treatments and a significant number of non-responders. Methods and Results State-of-the-art clinical phenotyping was acquired, including magnetic resonance imaging (MRI) and biomarker assessment. An individualized, multi-scale model of heart function covering cardiac anatomy, electrophysiology, biomechanics and hemodynamics was estimated using a robust framework. The model was computed on n=46 HF patients, showing for the first time that advanced multi-scale models can be fitted consistently on large cohorts. Novel multi-scale parameters derived from the model of all cases were analyzed and compared against clinical parameters, cardiac imaging, lab tests and survival scores to evaluate the explicative power of the model and its potential for better patient stratification. Model validation was pursued by comparing clinical parameters that were not used in the fitting process against model parameters. Conclusion This paper illustrates how advanced multi-scale models can complement cardiovascular imaging and how they could be applied in patient care. Based on obtained results, it becomes conceivable that, after thorough validation, such heart failure models could be applied for patient management and therapy planning in the future, as we illustrate in one patient of our cohort who received CRT-D implantation.	[Kayvanpour, Elham; Sedaghat-Hamedani, Farbod; Amr, Ali; Haas, Jan; Frese, Karen S.; Irawati, Maria; Buss, Sebastian; Mereles, Derliz; Zitron, Edgar; Katus, Hugo A.; Meder, Benjamin] Heidelberg Univ, Dept Med 3, Heidelberg, Germany; [Kayvanpour, Elham; Sedaghat-Hamedani, Farbod; Amr, Ali; Haas, Jan; Frese, Karen S.; Katus, Hugo A.; Meder, Benjamin] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany; [Mansi, Tommaso; Neumann, Dominik; Georgescu, Bogdan; Seegerer, Philipp; Kamen, Ali; Comaniciu, Dorin] Siemens Corp, Corp Technol, Imaging & Comp Vis, Princeton, NJ USA; [Wirsz, Emil] Siemens AG, Corp Technol, Erlangen, Germany; [King, Vanessa] Siemens Corp, Corp Technol, Sensor Technol, Princeton, NJ USA; [Keller, Andreas] Biomarker Discovery Ctr Heidelberg, Heidelberg, Germany; [Keller, Andreas] Univ Saarland, Dept Human Genet, Homburg, Germany; [Katus, Hugo A.; Meder, Benjamin] Klaus Tschira Inst Computat Cardiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Siemens AG; Siemens AG; Siemens Germany; Siemens AG; Saarland University	Meder, B (corresponding author), Heidelberg Univ, Dept Med 3, Heidelberg, Germany.	Benjamin.Meder@med.uni-heidelberg.de	Seegerer, Philipp/AAE-3706-2020; Keller, Andreas/ABB-6412-2021	Seegerer, Philipp/0000-0002-4707-7991; Keller, Andreas/0000-0002-5361-0895; Comaniciu, Dorin/0000-0002-5238-8647; Mereles, Derliz/0000-0001-9601-7103	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); European Union [GA 306031]	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work has been supported by the DZHK (German Centre for Cardiovascular Research), by the BMBF (German Ministry of Education and Research), and by the European Union FP7 (BestAgeing, GA 306031). This work was in part conducted within an industry supported project (Siemens AG, Siemens Research Project). Siemens provided support in the form of salaries for authors TM, DN, BG, PS, AK, EW, VK and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Allard J, 2007, STUD HEALTH TECHNOL, V125, P13; ARTS T, 1979, ANN BIOMED ENG, V7, P299, DOI 10.1007/BF02364118; Ashikaga H, 2013, HEART RHYTHM, V10, P1109, DOI 10.1016/j.hrthm.2013.04.015; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Campbell SG, 2011, J R SOC INTERFACE, V8, P1550, DOI 10.1098/rsif.2011.0184; Comas O, 2008, LECT NOTES COMPUT SC, V5104, P28, DOI 10.1007/978-3-540-70521-5_4; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Dye C., 2013, RESEARCH FOR UNIVERS; Georgescu B RS, 2013, MICCAI WORKSHOP2013; Guetter C, 2011, I S BIOMED IMAGING, P590, DOI 10.1109/ISBI.2011.5872476; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Huntjens PR, 2014, EUROPACE, V16, P62, DOI 10.1093/europace/euu231; Kerckhoffs RCP, 2008, PROG BIOPHYS MOL BIO, V97, P543, DOI 10.1016/j.pbiomolbio.2008.02.024; Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7; Konukoglu E, 2011, PROG BIOPHYS MOL BIO, V107, P134, DOI 10.1016/j.pbiomolbio.2011.07.002; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; Kuijpers NHL, 2012, J CARDIOVASC TRANSL, V5, P159, DOI 10.1007/s12265-012-9346-y; Land S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0076; Lecoq G, 2005, EUR HEART J, V26, P1094, DOI 10.1093/eurheartj/ehi146; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Mansi T, 2010, APPLICATION TO TETRA; Marchesseau S, 2013, MED IMAGE ANAL, V17, P816, DOI 10.1016/j.media.2013.04.012; Marchesseau S, 2013, BIOMECH MODEL MECHAN, V12, P815, DOI 10.1007/s10237-012-0446-z; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mollema SA, 2007, AM J CARDIOL, V100, P1665, DOI 10.1016/j.amjcard.2007.06.071; Neumann D, 2014, I S BIOMED IMAGING, P935, DOI 10.1109/ISBI.2014.6868025; Neumann D, 2014, LECT NOTES COMPUT SC, V8674, P9, DOI 10.1007/978-3-319-10470-6_2; Ng J, 2012, J AM COLL CARDIOL, V60, P423, DOI 10.1016/j.jacc.2012.03.029; Niederer SA, 2008, PROG BIOPHYS MOL BIO, V96, P90, DOI 10.1016/j.pbiomolbio.2007.08.001; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; Nordsletten DA, 2011, PROG BIOPHYS MOL BIO, V104, P77, DOI 10.1016/j.pbiomolbio.2009.11.001; Potse M, 2014, EUROPACE EUROPEAN PA, V16, piv56, DOI [10.1093/europace/euu257, DOI 10.1093/EUR0PACE/EUU257]; Powell MJD, 2006, NONCON OPTIM ITS APP, V83, P255; Rapaka S, 2012, LECT NOTES COMPUT SC, V7511, P33, DOI 10.1007/978-3-642-33418-4_5; Relan J, 2011, INTERFACE FOCUS, V1, P396, DOI 10.1098/rsfs.2010.0041; Seegerer P, 2015, LECT NOTES COMPUT SC, V8896, P204, DOI 10.1007/978-3-319-14678-2_21; Segers P, 2008, JOURNAL OF ENGINEERI, V222, P417; Sermesant A, 2006, IEEE T MED IMAGING, V25, P612, DOI 10.1109/TMI.2006.872746; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; Sermesant Maxime, 2008, Heart Fail Clin, V4, P289, DOI 10.1016/j.hfc.2008.02.014; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tobon-Gomez C, 2013, MED BIOL ENG COMPUT, V51, P1235, DOI 10.1007/s11517-013-1044-7; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Wallman M, 2014, MED IMAGE ANAL, V18, P228, DOI 10.1016/j.media.2013.10.006; Xi JH, 2013, MED IMAGE ANAL, V17, P133, DOI 10.1016/j.media.2012.08.001; Zettinig O, 2014, MED IMAGE ANAL, V18, P1361, DOI 10.1016/j.media.2014.04.011; Zettinig O, 2013, LECT NOTES COMPUT SC, V7945, P249, DOI 10.1007/978-3-642-38899-6_30; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zhou LF, 2014, CIRC-ARRHYTHMIA ELEC, V7, P143, DOI 10.1161/CIRCEP.113.000600	56	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134869	10.1371/journal.pone.0134869	http://dx.doi.org/10.1371/journal.pone.0134869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230546	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400180
J	Albert, J; Rooman, M				Albert, Jaroslav; Rooman, Marianne			Is the Cell Nucleus a Necessary Component in Precise Temporal Patterning?	PLOS ONE			English	Article							IMPORTIN-ALPHA; NOISE-REDUCTION; TRANSPORT; DELAY; RNA; MECHANISM; RATES	One of the functions of the cell nucleus is to help regulate gene expression by controlling molecular traffic across the nuclear envelope. Here we investigate, via stochastic simulation, what effects, if any, does segregation of a system into the nuclear and cytoplasmic compartments have on the stochastic properties of a motif with a negative feedback. One of the effects of the nuclear barrier is to delay the nuclear protein concentration, allowing it to behave in a switch-like manner. We found that this delay, defined as the time for the nuclear protein concentration to reach a certain threshold, has an extremely narrow distribution. To show this, we considered two models. In the first one, the proteins could diffuse freely from cytoplasm to nucleus (simple model); and in the second one, the proteins required assistance from a special class of proteins called importins. For each model, we generated fifty parameter sets, chosen such that the temporal profiles they effectuated were very similar, and whose average threshold time was approximately 150 minutes. The standard deviation of the threshold times computed over one hundred realizations were found to be between 1.8 and 7.16 minutes across both models. To see whether a genetic motif in a prokaryotic cell can achieve this degree of precision, we also simulated five variations on the coherent feed-forward motif (CFFM), three of which contained a negative feedback. We found that the performance of these motifs was nowhere near as impressive as the one found in the eukaryotic cell; the best standard deviation was 6.6 minutes. We argue that the significance of these results, the fact and necessity of spatio-temporal precision in the developmental stages of eukaryotes, and the absence of such a precision in prokaryotes, all suggest that the nucleus has evolved, in part, under the selective pressure to achieve highly predictable phenotypes.	[Albert, Jaroslav; Rooman, Marianne] Univ Libre Bruxelles, BioModeling BioInformat & BioProc, Brussels, Belgium; [Albert, Jaroslav] Vrije Univ Brussel, Appl Phys Res Grp, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Albert, J (corresponding author), Univ Libre Bruxelles, BioModeling BioInformat & BioProc, Brussels, Belgium.	jalbert@ulb.ac.be			Belgian Fund for Scientific Research (FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office [IAP P7-35]; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research programme "Applied Physics and Systems Biology"	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research programme "Applied Physics and Systems Biology"	JA was supported by Belgian Fund for Scientific Research (FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office, under grant IAP P7-35 (www.belspo.be); and Onderzoeksraad of the Vrije Universiteit Brussel (www.vub.ac.be) through the strategic research programme "Applied Physics and Systems Biology."	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bel G, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016003; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eldar A, 2010, NATURE REV, V467; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Ghim CM, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-94; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Joshi A, 2012, FEBS J, V279, P3501, DOI 10.1111/j.1742-4658.2012.08571.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komorowski M, 2013, BIOPHYS J, V104, P1783, DOI 10.1016/j.bpj.2013.02.027; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mather W, 2014, SYNCHRONIZATION DEGR, V113; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Okada N, 2008, J CELL MOL MED, V12, P1863, DOI 10.1111/j.1582-4934.2008.00437.x; Pilpel Y, 2011, METHODS MOL BIOL, V759, P407, DOI 10.1007/978-1-61779-173-4_23; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rooman M, 2014, J THEOR BIOL, V354, P113, DOI 10.1016/j.jtbi.2014.03.007; Sturrock M, J MATH BIOL; Sturrock M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0988; Sturrock M, 2012, B MATH BIOL, V74, P1531, DOI 10.1007/s11538-012-9725-1; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Terry J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016980, DOI 10.1371/JOURNAL.PONE.0016980]; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; You P, 2013, IN VITRO CELL DEV-AN, V49, P346, DOI 10.1007/s11626-013-9599-z; Zavala E, 2014, BIOPHYS J, V106, P467, DOI 10.1016/j.bpj.2013.12.010; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134239	10.1371/journal.pone.0134239	http://dx.doi.org/10.1371/journal.pone.0134239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226505	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700066
J	Sciascia, QL; Pacheco, D; McCoard, SA				Sciascia, Quentin L.; Pacheco, David; McCoard, Susan A.			Administration of Exogenous Growth Hormone Is Associated with Changes in Plasma and Intracellular Mammary Amino Acid Profiles and Abundance of the Mammary Gland Amino Acid Transporter SLC3A2 in Mid-Lactation Dairy Cows	PLOS ONE			English	Article							RECOMBINANT BOVINE SOMATOTROPIN; REAL-TIME PCR; STATISTICAL-ANALYSIS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; MILK-PRODUCTION; LATE LACTATION; NITRIC-OXIDE; METABOLISM; TISSUE	The objectives of this study were to (1) identify changes in plasma and mammary intracellular amino acid (AA) profiles in dairy cows treated with growth hormone (GH), and (2) evaluate the expression of mammary gland genes involved in the transport of AA identified in (1). Eight non-pregnant (n = 4 per group) lactating dairy cows were treated with a single subcutaneous injection of either a slow-release formulation of commercially available GH (Lactotropin 500 mg) or physiological saline solution. Six days after treatment, cows were milked and blood collected from the jugular vein for the analysis of free AA in the plasma. Cows were euthanized and mammary tissue harvested. Treatment with GH increased milk, protein, fat and lactose yields, with no effect on dry matter intake. Plasma concentrations of lysine and group I AA decreased significantly, and arginine, methionine, tyrosine and arginine-family AA tended to decrease in GH-treated cows. Concentrations of intracellular glycine, serine and glutamate increased significantly, with a trend for decreased arginine observed in the mammary gland of GH-treated cows. A trend for increased concentrations of intracellular total AA, NEAA and arginine-family AA were observed in the mammary gland of GH-treated cows. Variance in the concentration of plasma methionine, tyrosine, valine, alanine, ornithine, BCAA, EAA was significantly different between treatments. Variance in the concentration of intracellular lysine, valine, glutamine, EAA and group II was significantly different between treatments. AA changes were associated with increased mRNA abundance of the mammary gland AA transporter SLC3A2. We propose that these changes occur to support increased milk protein and fatty acid production in the mammary gland of GH-treated cows via potential mTOR pathway signaling.	[Sciascia, Quentin L.] Leibniz Inst Farm Anim Biol FBN, Dept Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Pacheco, David; McCoard, Susan A.] AgRes Grasslands, Anim Nutr & Hlth Grp, Palmerston North 4442, New Zealand	Forschungsinstitut fur Nutztierbiologie (FBN); AgResearch - New Zealand	Pacheco, D (corresponding author), AgRes Grasslands, Anim Nutr & Hlth Grp, Private Bag 11008, Palmerston North 4442, New Zealand.	David.Pacheco@agresearch.co.nz	Pacheco, David/I-2362-2013	Pacheco, David/0000-0002-9307-9197; mccoard, susan/0000-0002-4806-0323	Ministry of Business, Innovation, and Employment [CX10X0702]; AgResearch Capability Fund	Ministry of Business, Innovation, and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); AgResearch Capability Fund	The data presented and discussed was obtained with financial support from the Ministry of Business, Innovation, and Employment (funding number: CX10X0702) and the AgResearch Capability Fund (Maori PhD fellowship for Q Sciascia). The animal trial, from which the tissues used in this experiment were derived, was conducted as part of a Joint Venture between AgResearch Limited New Zealand and Primary Industries Research Victoria, Australia. The funders provided support in the form of salaries for authors SAM & DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aleman G, 2009, METABOLISM, V58, P594, DOI 10.1016/j.metabol.2008.12.003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appuhamy JADRN, 2012, J NUTR, V142, P484, DOI 10.3945/jn.111.152595; BAUMRUCKER CR, 1985, J DAIRY SCI, V68, P2436, DOI 10.3168/jds.S0022-0302(85)81119-X; Bequette BJ, 1998, J DAIRY SCI, V81, P2540, DOI 10.3168/jds.S0022-0302(98)70147-X; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; BLACK AL, 1955, BIOCHIM BIOPHYS ACTA, V17, P346, DOI 10.1016/0006-3002(55)90382-6; BURTON JL, 1994, CAN J ANIM SCI, V74, P167, DOI 10.4141/cjas94-027; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiofalo V, 1999, SMALL RUMINANT RES, V34, P119, DOI 10.1016/S0921-4488(99)00061-9; DISENHAUS C, 1995, SMALL RUMINANT RES, V15, P139, DOI 10.1016/0921-4488(94)00019-4; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Hanigan MD, 2002, J THEOR BIOL, V217, P311, DOI 10.1006/jtbi.2002.3037; HANIGAN MD, 1992, J DAIRY SCI, V75, P161, DOI 10.3168/jds.S0022-0302(92)77750-9; Hayashi AA, 2009, J DAIRY SCI, V92, P1889, DOI 10.3168/jds.2008-1334; Lacasse P, 1996, J DAIRY SCI, V79, P1369, DOI 10.3168/jds.S0022-0302(96)76494-9; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Littell RC, 1998, J ANIM SCI, V76, P1216; Mabjeesh SJ, 2000, J DAIRY SCI, V83, P996, DOI 10.3168/jds.S0022-0302(00)74964-2; MCDOWELL GH, 1987, AUST J BIOL SCI, V40, P295, DOI 10.1071/BI9870295; MEPHAM TB, 1982, J DAIRY SCI, V65, P287, DOI 10.3168/jds.S0022-0302(82)82191-7; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pacheco D, 2010, EFFECT GROWTH HORMON; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; PEEL CJ, 1983, J DAIRY SCI, V66, P776, DOI 10.3168/jds.S0022-0302(83)81857-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sallam SMA, 2005, SMALL RUMINANT RES, V56, P165, DOI 10.1016/j.smallrumres.2004.06.010; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sciascia Q, 2013, J DAIRY SCI, V96, P2327, DOI 10.3168/jds.2012-6267; Shennan DB, 1997, P NUTR SOC, V56, P177, DOI 10.1079/PNS19970020; van der Linden DS, 2013, J ANIM SCI, V91, P644, DOI 10.2527/jas.2012-5629; Wright TC, 2006, J DAIRY SCI, V89, P2552, DOI 10.3168/jds.S0022-0302(06)72331-1; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	37	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134323	10.1371/journal.pone.0134323	http://dx.doi.org/10.1371/journal.pone.0134323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226162	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700073
J	Wang, XP; Lei, F; Du, F; Chai, YS; Jiang, JF; Wang, YG; Yu, X; Yan, XJ; Xing, DM; Du, LJ				Wang, Xin-Pei; Lei, Fan; Du, Feng; Chai, Yu-Shuang; Jiang, Jing-Fei; Wang, Yu-Gang; Yu, Xuan; Yan, Xiao-Jin; Xing, Dong-Ming; Du, Li-Jun			Protection of Gastrointestinal Mucosa from Acute Heavy Alcohol Consumption: The Effect of Berberine and Its Correlation with TLR2, 4/IL1 beta-TNF alpha Signaling	PLOS ONE			English	Article							TIGHT JUNCTION BARRIER; NECROSIS-FACTOR-ALPHA; CEREBRAL-ISCHEMIA; EPITHELIAL-CELLS; TNF-ALPHA; ETHANOL; ACTIVATION; EXPRESSION; OCCLUDIN; COLITIS	The purpose of the present study is to confirm the protective effect of berberine (BBR) on gastrointestinal injury caused by acute heavy alcohol exposure, an effect that has not been reported previously. Our research details how BBR protects against gastrointestinal injuries from acute alcohol exposure using both in vivo and in vitro experiments. Acute high alcohol concentrations lead to obvious damage to the gastrointestinal mucosa, resulting in necrosis of the intestinal mucosa. Oral administration of BBR was able to significantly reduce this alcohol-induced damage, inhibit increases of alcohol-induced TNF alpha and IL-1 beta expression in gastrointestinal mucosa as well as their upstream signals TLR2 and TLR4, and regulate cytokines that modulate tight junctions. Alcohol consumption is a popular human social behavior worldwide, and the present study reports a comprehensive mechanism by which BBR protects against gastrointestinal injuries from alcohol stress, providing people with a novel application of BBR.	[Wang, Xin-Pei; Chai, Yu-Shuang; Jiang, Jing-Fei; Yu, Xuan; Yan, Xiao-Jin; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Lei, Fan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Wang, Yu-Gang] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Tsinghua University; Tsinghua University; Tulane University; University of Texas System; UTMD Anderson Cancer Center	Du, LJ (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Sch Life Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn		Wang, Xinpei/0000-0002-1219-3423; Yu, Xuan/0000-0001-6826-7260	National Natural Science Foundation of China [90713043, 30973896, 30801523, 81073092]; National S& T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2012ZX09102-201-008, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S& T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (90713043, 30973896, 30801523 and 81073092) and the National S& T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2012ZX09102-201-008 and 2011ZX09101-002-11). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Anderson P, 2014, ALCOHOL ALCOHOLISM, V49, P531, DOI 10.1093/alcalc/agu043; Bailey KL, 2010, ALCOHOL CLIN EXP RES, V34, P51, DOI 10.1111/j.1530-0277.2009.01065.x; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Cicero AF, 2009, CLIN LIPIDOL, V4, P553, DOI 10.2217/CLP.09.41; Coltart C, 2011, LANCET, V378, P1215, DOI 10.1016/S0140-6736(11)61461-X; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gmel G, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-24; HALLEUX C, 1991, IN VITRO CELL DEV B, V27, P293; Heberlein A, 2014, ALCOHOL, V48, P671, DOI 10.1016/j.alcohol.2014.08.003; Hong JS, 2012, J NEUROSCI RES, V90, P489, DOI 10.1002/jnr.22756; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee CH, 2007, PHARMACOL RES, V56, P193, DOI 10.1016/j.phrs.2007.06.003; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Lehnert M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/283756; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Liu LZ, 2010, MOL CELL ENDOCRINOL, V317, P148, DOI 10.1016/j.mce.2009.12.027; Liu MY, 2003, ALCOHOL, V30, P61, DOI 10.1016/S0741-8329(03)00094-6; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Markov A G, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P1043; Morrow CMK, 2010, PHILOS T R SOC B, V365, P1679, DOI 10.1098/rstb.2010.0025; Murthy KNC, 2012, EUR J PHARMACOL, V688, P14, DOI 10.1016/j.ejphar.2012.05.004; Nagatake T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090638; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Pandey SC, 2012, BRIT J PHARMACOL, V165, P1316, DOI 10.1111/j.1476-5381.2011.01695.x; Pang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-55; Pascual M, 2011, BRAIN BEHAV IMMUN, V25, pS80, DOI 10.1016/j.bbi.2011.02.012; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Pedersen SL, 2013, ALCOHOL CLIN EXP RES, V37, P1056, DOI 10.1111/acer.12068; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Serretti A, 2006, NEUROSCI LETT, V406, P107, DOI 10.1016/j.neulet.2006.07.003; Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761; Soellner R, 2014, J PUBLIC HEALTH-HEID, V22, P57, DOI 10.1007/s10389-013-0593-4; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tamai H, 2000, ALCOHOL CLIN EXP RES, V24, P390, DOI 10.1111/j.1530-0277.2000.tb04629.x; Ueyama Takashi, 2001, Acta Anatomica Nipponica, V76, P435; Wang Y, 2014, MOL MED REP, V9, P2352, DOI 10.3892/mmr.2014.2126; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yazir Y, 2012, ALCOHOL, V46, P649, DOI 10.1016/j.alcohol.2012.06.003; Yuki T, 2011, J IMMUNOL, V187, P3230, DOI 10.4049/jimmunol.1100058; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	59	15	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134044	10.1371/journal.pone.0134044	http://dx.doi.org/10.1371/journal.pone.0134044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226164	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700053
J	Boudreau, PD; Monroe, EA; Mehrotra, S; Desfor, S; Korobeynikov, A; Sherman, DH; Murray, TF; Gerwick, L; Dorrestein, PC; Gerwick, WH				Boudreau, Paul D.; Monroe, Emily A.; Mehrotra, Suneet; Desfor, Shane; Korobeynikov, Anton; Sherman, David H.; Murray, Thomas F.; Gerwick, Lena; Dorrestein, Pieter C.; Gerwick, William H.			Expanding the Described Metabolome of the Marine Cyanobacterium Moorea producens JHB through Orthogonal Natural Products Workflows	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; MOLECULAR NETWORKING; HECTOCHLORIN; DEREPLICATION; FUNDAMENTALS; HALOGENATION; DOMAINS; GENOMES; REAGENT; POTENT	Moorea producens JHB, a Jamaican strain of tropical filamentous marine cyanobacteria, has been extensively studied by traditional natural products techniques. These previous bioassay and structure guided isolations led to the discovery of two exciting classes of natural products, hectochlorin (1) and jamaicamides A (2) and B (3). In the current study, mass spectrometry-based 'molecular networking' was used to visualize the metabolome of Moorea producens JHB, and both guided and enhanced the isolation workflow, revealing additional metabolites in these compound classes. Further, we developed additional insight into the metabolic capabilities of this strain by genome sequencing analysis, which subsequently led to the isolation of a compound unrelated to the jamaicamide and hectochlorin families. Another approach involved stimulation of the biosynthesis of a minor jamaicamide metabolite by cultivation in modified media, and provided insights about the underlying biosynthetic machinery as well as preliminary structure-activity information within this structure class. This study demonstrated that these orthogonal approaches are complementary and enrich secondary metabolomic coverage even in an extensively studied bacterial strain.	[Boudreau, Paul D.; Desfor, Shane; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Monroe, Emily A.] William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA; [Mehrotra, Suneet; Murray, Thomas F.] Creighton Univ, Dept Pharmacol, Sch Med, Omaha, NE 68178 USA; [Desfor, Shane] Calif State Univ San Marcos, Dept Biol, San Marcos, CA 92078 USA; [Korobeynikov, Anton] Russian Acad Sci, St Petersburg Acad Univ, Algorithm Biol Lab, St Petersburg 194021, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Dept Math & Mech, St Petersburg 194021, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Ctr Algorithm Biotechnol, St Petersburg 194021, Russia; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Creighton University; California State University System; California State University San Marcos; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Saint Petersburg State University; Saint Petersburg State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Gerwick, WH (corresponding author), Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	wgerwick@ucsd.edu	Korobeynikov, Anton/D-3555-2009; Dorrestein, Pieter/ABF-2930-2020	Korobeynikov, Anton/0000-0002-2937-9259; 	National Institutes of Health [NS053398, CA100851, CA108874, GM107550]; Russian Science Foundation [14-50-069]; Russian Science Foundation [14-50-00069] Funding Source: Russian Science Foundation; NATIONAL CANCER INSTITUTE [R01CA100851, P30CA023100, R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS053398 (to WHG and TFM), National Institutes of Health grant CA100851 (to WHG), National Institutes of Health grant CA108874 (to WHG, LG, and DHS), National Institutes of Health grant GM107550 (to WHG, LG, and PCD), and Russian Science Foundation grant 14-50-069 (to AK).	Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bruland KW, 1983, CHEM OCEANOGR, P172; BUTLER A, 1993, CHEM REV, V93, P1937, DOI 10.1021/cr00021a014; Cao ZY, 2008, J PHARMACOL EXP THER, V326, P604, DOI 10.1124/jpet.108.138230; Cao ZY, 2011, J PHARMACOL EXP THER, V336, P197, DOI 10.1124/jpet.110.171850; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Dalisay DS, 2009, J NAT PROD, V72, P732, DOI 10.1021/np8007649; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P1537, DOI 10.1021/bi052333k; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Esquenazi E, 2011, P NATL ACAD SCI USA, V108, P5226, DOI 10.1073/pnas.1012813108; Fenn JB, 2003, ANGEW CHEM INT EDIT, V42, P3871, DOI 10.1002/anie.200300605; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Fujimori DG, 2007, CURR OPIN CHEM BIOL, V11, P553, DOI 10.1016/j.cbpa.2007.08.002; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gao S, 2011, J COMPUT BIOL, V18, P1681, DOI 10.1089/cmb.2011.0170; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Hayes R, 2014, J CHROMATOGR A, V1357, P36, DOI 10.1016/j.chroma.2014.05.010; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Jabba SV, 2010, J PHARMACOL EXP THER, V332, P698, DOI 10.1124/jpet.109.161802; Jensen PR, 2014, J IND MICROBIOL BIOT, V41, P203, DOI 10.1007/s10295-013-1353-8; Johnson TA, 2010, J NAT PROD, V73, P359, DOI 10.1021/np900565a; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Kupce E, 2003, J MAGN RESON, V162, P300, DOI 10.1016/S1090-7807(02)00196-9; Link B, 2015, CUSTOMER RELATIONS L; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Marquez BL, 2002, J NAT PROD, V65, P866, DOI 10.1021/np0106283; Mevers E, 2011, J NAT PROD, V74, P928, DOI 10.1021/np200077f; Miller B, 2014, J NAT PROD, V77, P92, DOI 10.1021/np400727r; Molinski TF, 2010, NAT PROD REP, V27, P321, DOI 10.1039/b920545b; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Nunnery JK, 2012, J ORG CHEM, V77, P4198, DOI 10.1021/jo300160e; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Ramaswamy AV, 2007, J NAT PROD, V70, P1977, DOI 10.1021/np0704250; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sundberg RJ, 2007, ADVANCED ORGANIC CHE, V300, P1018; Suntornchashwej S, 2005, J NAT PROD, V68, P951, DOI 10.1021/np0500124; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	50	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133297	10.1371/journal.pone.0133297	http://dx.doi.org/10.1371/journal.pone.0133297			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222584	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800048
J	Bradesi, S; Karagiannides, I; Bakirtzi, K; Joshi, SM; Koukos, G; Iliopoulos, D; Pothoulakis, C; Mayer, EA				Bradesi, Sylvie; Karagiannides, Iordanes; Bakirtzi, Kyriaki; Joshi, Swapna Mahurkar; Koukos, Georgios; Iliopoulos, Dimitrios; Pothoulakis, Charalabos; Mayer, Emeran A.			Identification of Spinal Cord MicroRNA and Gene Signatures in a Model of Chronic Stress-Induced Visceral Hyperalgesia in Rat	PLOS ONE			English	Article							NEUROPATHIC PAIN; MESSENGER-RNA; IN-VITRO; INTERLEUKIN-6; ACTIVATION; EXPOSURE; MAINTENANCE; MICROGLIA; CYTOKINES; RESPONSES	Introduction Animal studies have shown that stress could induce epigenetic and transcriptomic alterations essential in determining the balance between adaptive or maladaptive responses to stress. We tested the hypothesis that chronic stress in rats deregulates coding and noncoding gene expression in the spinal cord, which may underline neuroinflammation and nociceptive changes previously observed in this model. Methods Male Wistar rats were exposed to daily stress or handled, for 10 days. At day 11, lumbar spinal segments were collected and processed for mRNA/miRNA isolation followed by expression profiling using Agilent SurePrint Rat Exon and Rat miRNA Microarray platforms. Differentially expressed gene lists were generated using the dChip program. Microarrays were analyzed using the Ingenuity Pathways Analysis (IPA) tool from Ingenuity Systems. Multiple methods were used for the analysis of miRNA-mRNA functional modules. Quantitative real time RT-PCR for Interleukin 6 signal transducer (gp130), the Signal Transducer And Activator Of Transcription 3 (STAT3), glial fibrillary acidic protein and mir-17-5p were performed to confirm levels of expression. Results Gene network analysis revealed that stress deregulated different inflammatory (IL-6, JAK/STAT, TNF) and metabolic (PI3K/AKT) signaling pathways. MicroRNA array analysis revealed a signature of 39 deregulated microRNAs in stressed rats. MicroRNA-gene network analysis showed that microRNAs are regulators of two gene networks relevant to inflammatory processes. Specifically, our analysis of miRNA-mRNA functional modules identified miR-17-5p as an important regulator in our model. We verified miR-17-5p increased expression in stress using qPCR and in situ hybridization. In addition, we observed changes in the expression of gp130 and STAT3 (involved in intracellular signaling cascades in response to gp130 activation), both predicted targets for miR-17-5p. A modulatory role of spinal mir17-5p in the modulation of visceral sensitivity was confirmed in vivo. Conclusion Using an integrative high throughput approach, our findings suggest a link between miR-17-5p increased expression and gp130/STAT3 activation providing new insight into the possible mechanisms mediating the effect of chronic stress on neuroinflammation in the spinal cord.	[Bradesi, Sylvie; Karagiannides, Iordanes; Joshi, Swapna Mahurkar; Pothoulakis, Charalabos; Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Oppenheimer Family Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Karagiannides, Iordanes; Bakirtzi, Kyriaki] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Inflammatory Bowel Dis Ctr & Neuroendocrine Assay, Los Angeles, CA 90095 USA; [Joshi, Swapna Mahurkar; Koukos, Georgios; Iliopoulos, Dimitrios; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Syst Biomed, Los Angeles, CA 90095 USA; [Bradesi, Sylvie] Vet Adm, CURE Ctr, Greater Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bradesi, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Oppenheimer Family Ctr Neurobiol Stress, Los Angeles, CA 90095 USA.	sbradesi@ucla.edu	Koukos, Georgios/B-1544-2009; Iliopoulos, Dimitrios/AAE-9106-2019	Koukos, Georgios/0000-0002-9470-0651; 	National Institute of Health [5 R01 DA026597]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026597] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health 5 R01 DA026597 SB, http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Biala YN, 2011, HIPPOCAMPUS, V21, P1114, DOI 10.1002/hipo.20825; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bradesi S, 2010, NEUROGASTROENT MOTIL, V22, P499, DOI 10.1111/j.1365-2982.2010.01491.x; Bradesi S, 2011, AM J PHYSIOL-GASTR L, V301, pG580, DOI 10.1152/ajpgi.00182.2011; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Brummett BH, 2012, BIOL PSYCHOL, V89, P94, DOI 10.1016/j.biopsycho.2011.09.013; Bryan K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1318; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Frank MG, 2014, PSYCHONEUROENDOCRINO, V40, P191, DOI 10.1016/j.psyneuen.2013.11.006; Girotti M, 2013, PSYCHONEUROENDOCRINO, V38, P1158, DOI 10.1016/j.psyneuen.2012.11.004; Golovatscka V, 2012, NEUROIMMUNOMODULAT, V19, P367, DOI 10.1159/000342092; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Larauche M, 2012, WORLD J GASTROENTERO, V18, P225, DOI 10.3748/wjg.v18.i3.225; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu PY, 2012, GASTROENTEROLOGY, V142, P165, DOI 10.1053/j.gastro.2011.09.041; Malan-Muller S, 2013, MOL NEUROBIOL, V47, P726, DOI 10.1007/s12035-012-8374-6; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Nekovarova T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00099; Quarta S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-73; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Song DD, 2014, AM J PHYSL GASTROINT; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Tenorio G, 2013, PAIN, V154, P71, DOI 10.1016/j.pain.2012.09.008; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Zannas A.S., 2013, NEUROSCIENCE; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	31	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130938	10.1371/journal.pone.0130938	http://dx.doi.org/10.1371/journal.pone.0130938			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222740	gold, Green Published			2022-12-26	WOS:000358836800009
J	Malfait, B; Staes, F; de Vries, A; Smeets, A; Hawken, M; Robinson, MA; Vanrenterghem, J; Verschueren, S				Malfait, Bart; Staes, Filip; de Vries, Aijse; Smeets, Annemie; Hawken, Malcolm; Robinson, Mark A.; Vanrenterghem, Jos; Verschueren, Sabine			Dynamic Neuromuscular Control of the Lower Limbs in Response to Unexpected Single-Planar versus Multi-Planar Support Perturbations in Young, Active Adults	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURIES; POSTURAL RESPONSES; JOINT STABILITY; VIDEO ANALYSIS; TEAM HANDBALL; KNEE AXIS; ANTERIOR; FEMALE; RISK; BASKETBALL	Purpose An anterior cruciate ligament (ACL) injury involves a multi-planar injury mechanism. Nevertheless, unexpected multi-planar perturbations have not been used to screen athletes in the context of ACL injury prevention yet could reveal those more at risk. The objective of this study was to compare neuromuscular responses to multi-planar (MPP) and single-planar perturbations (SPP) during a stepping-down task. These results might serve as a basis for future implementation of external perturbations in ACL injury screening programs. Methods Thirteen young adults performed a single leg stepping-down task in eight conditions (four MPP and four SPP with a specified amplitude and velocity). The amplitudes of vastus lateralis (VL), vastus medialis (VM), hamstrings lateralis (HL), hamstrings medialis (HM) EMG activity, medio-lateral and anterior-posterior centre of mass (COM) displacements, the peak knee flexion and abduction angles were compared between conditions using an one-way ANOVA. Number of stepping responses were monitored during all conditions. Results Significantly greater muscle activity levels were found in response to the more challenging MPP and SPP compared to the less challenging conditions (p < 0.05). No differences in neuromuscular activity were found between the MPP conditions and their equivalents in the SPP. Eighteen stepping responses were monitored in the SPP versus nine in the MPP indicating that the overall neuromuscular control was even more challenged during the SPP which was supported by greater COM displacements in the SPP. Conclusion The more intense MPP and SPP evoked different neuromuscular responses resulting in greater muscle activity levels compared to small perturbations. Based on the results of COM displacements and based on the amount of stepping responses, dynamic neuromuscular control of the knee joint appeared less challenged during the MPP. Therefore, future work should investigate extensively if other neuromuscular differences (i.e. co-activation patterns and kinetics) exist between MPP and SPP. In addition, future work should examine the influence on the neuromuscular control of the magnitude of the perturbations and the magnitude of stepping height and stepping distance.	[Malfait, Bart; Staes, Filip; de Vries, Aijse; Smeets, Annemie; Verschueren, Sabine] Katholieke Univ Leuven, Musculoskeletal Rehabil Res Grp, Dept Rehabil Sci & Physiotherapy, Fac Kinesiol & Rehabil Sci, Leuven, Belgium; [Hawken, Malcolm; Robinson, Mark A.; Vanrenterghem, Jos] Liverpool John Moores Univ, Fac Sci, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	KU Leuven; Liverpool John Moores University	Verschueren, S (corresponding author), Katholieke Univ Leuven, Musculoskeletal Rehabil Res Grp, Dept Rehabil Sci & Physiotherapy, Fac Kinesiol & Rehabil Sci, Leuven, Belgium.	sabine.verschueren@faber.kuleuven.be	Verschueren, Sabine/K-4213-2015; Smeets, Annemie/ACW-6678-2022; Robinson, Mark A./H-7108-2019	Verschueren, Sabine/0000-0003-2592-494X; Smeets, Annemie/0000-0003-4569-8652; Robinson, Mark A./0000-0002-5627-492X; Staes, Filip/0000-0002-1569-6333; Vanrenterghem, Jos/0000-0002-1682-8430				Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Benoit DL, 2003, GAIT POSTURE, V18, P56, DOI 10.1016/S0966-6362(02)00194-7; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; BEYNNON B, 1992, INT ORTHOP, V16, P1; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Brown LA, 2001, GAIT POSTURE, V14, P256, DOI 10.1016/S0966-6362(01)00131-X; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259, DOI 10.2106/00004623-198062020-00013; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Chen CL, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-50; Chen CL, 2013, GAIT POSTURE, V37, P296, DOI 10.1016/j.gaitpost.2012.07.007; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Fauth ML, 2010, J STRENGTH COND RES, V24, P1131, DOI 10.1519/JSC.0b013e3181cc2353; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 2011, EXERC SPORT SCI REV, V39, P161, DOI 10.1097/JES.0b013e3182297439; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Landry SC, 2007, AM J SPORT MED, V35, P1888, DOI 10.1177/0363546507300823; Lees A, 2007, MED ENG PHYS, V29, P629, DOI 10.1016/j.medengphy.2006.06.004; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Malanga GA, 2003, ARCH PHYS MED REHAB, V84, P592, DOI 10.1053/apmr.2003.50026; Malfait B, 2014, MED SCI SPORT EXER, V46, P678, DOI 10.1249/MSS.0000000000000170; Markolf KL, 1995, J ORTHOPAED RES, V13, P930, DOI 10.1002/jor.1100130618; Myer GD, 2005, J ELECTROMYOGR KINES, V15, P181, DOI 10.1016/j.jelekin.2004.08.006; Myer GD, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-39; Oliveira AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059029; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Quatman CE, 2010, SPORTS MED, V40, P729, DOI 10.2165/11534950-000000000-00000; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Stensrud S, 2011, BRIT J SPORT MED, V45, P589, DOI 10.1136/bjsm.2010.078287; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Szturm T, 1998, J VESTIBUL RES-EQUIL, V8, P381, DOI 10.1016/S0957-4271(97)00087-6; Vanrenterghem J, 2012, J BIOMECH, V45, P2444, DOI 10.1016/j.jbiomech.2012.06.029; Wikstrom EA, 2006, SPORTS MED, V36, P393, DOI 10.2165/00007256-200636050-00003; Zebis MK, 2009, AM J SPORT MED, V37, P1967, DOI 10.1177/0363546509335000	46	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133147	10.1371/journal.pone.0133147	http://dx.doi.org/10.1371/journal.pone.0133147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222790	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358836800040
J	Saski, CA; Bhattacharjee, R; Scheffler, BE; Asiedu, R				Saski, Christopher A.; Bhattacharjee, Ranjana; Scheffler, Brian E.; Asiedu, Robert			Genomic Resources for Water Yam (Dioscorea alata L.): Analyses of EST-Sequences, De Novo Sequencing and GBS Libraries	PLOS ONE			English	Article							MILLET SETARIA-ITALICA; MICROSATELLITE MARKERS; DNA; GENERATION; RESISTANCE; ALIGNMENT	The reducing cost and rapid progress in next-generation sequencing techniques coupled with high performance computational approaches have resulted in large-scale discovery of advanced genomic resources in several model and non-model plant species. Yam (Dioscorea spp.) is a major food and cash crop in many countries but research efforts have been limited to understand the genetics and generate genomic information for the crop. The availability of a large number of genomic resources including genome-wide molecular markers will accelerate the breeding efforts and application of genomic selection in yams. In the present study, several methods including expressed sequence tags (EST)-sequencing, de novo sequencing, and genotyping-by-sequencing (GBS) profiles on two yam (Dioscorea alata L.) genotypes (TDa 95/00328 and TDa 95-310) was performed to generate genomic resources for use in its improvement programs. This includes a comprehensive set of EST-SSRs, genomic SSRs, whole genome SNPs, and reduced representation SNPs. A total of 1,152 EST-SSRs were developed from >40,000 EST-sequences generated from the two genotypes. A set of 388 EST-SSRs were validated as polymorphic showing a polymorphism rate of 34% when tested on two diverse parents targeted for anthracnose disease. In addition, approximately 40X de novo whole genome sequence coverage was generated for each of the two genotypes, and a total of 18,584 and 15,952 genomic SSRs were identified for TDa 95/00328 and TDa 95-310, respectively. A custom made pipeline resulted in the selection of 573 genomic SSRs common across the two genotypes, of which only eight failed, 478 being polymorphic and 62 monomorphic indicating a polymorphic rate of 83.5%. Additionally, 288,505 high quality SNPs were also identified between these two genotypes. Genotyping by sequencing reads on these two genotypes also revealed 36,790 overlapping SNP positions that are distributed throughout the genome. Our efforts in using different approaches in generating genomic resources provides a non-biased glimpse into the publicly available EST-sequences, yam genome, and GBS profiles with affirmation that the genomic complexity can be methodically unraveled and constitute a critical foundation for future studies in linkage mapping, germplasm analysis, and predictive breeding.	[Saski, Christopher A.] Clemson Univ, Genom & Computat Biol Lab, Inst Translat Genom, Clemson, SC USA; [Bhattacharjee, Ranjana; Asiedu, Robert] Int Inst Trop Agr, Biosci Ctr, Ibadan, Nigeria; [Scheffler, Brian E.] USDA ARS, Genom & Bioinformat Res Unit, Stoneville, MS 38776 USA	Clemson University; CGIAR; International Institute of Tropical Agriculture (IITA); United States Department of Agriculture (USDA)	Bhattacharjee, R (corresponding author), Int Inst Trop Agr, Biosci Ctr, PMB 5320, Ibadan, Nigeria.	r.bhattacharjee@cgiar.org	Asiedu, Robert/AAV-6512-2021; Bhattacharjee, Ranjana/AAN-1979-2020	Asiedu, Robert/0000-0001-8943-2376; Scheffler, Brian/0000-0003-1968-8952	USAID-Linkage grant through the International Institute of Tropical Agriculture; ARS [ARS-0425248] Funding Source: Federal RePORTER	USAID-Linkage grant through the International Institute of Tropical Agriculture(United States Agency for International Development (USAID)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	RB thanks USAID-Linkage grant awarded through the International Institute of Tropical Agriculture for sponsoring the research. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Brunner I, 2001, MOL ECOL, V10, P2079, DOI 10.1046/j.1365-294X.2001.01325.x; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Chen YC, 2011, PLOS ONE, V8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Hochu I, 2006, MOL ECOL NOTES, V6, P137, DOI 10.1111/j.1471-8286.2005.01166.x; Lambel S, 2014, THEOR APPL GENET, V127, P2105, DOI 10.1007/s00122-014-2363-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mignouna HD, 2002, THEOR APPL GENET, V105, P716, DOI 10.1007/s00122-002-0911-7; Mignouna HD, 2001, THEOR APPL GENET, V103, P52, DOI 10.1007/s001220000531; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Narina SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-100; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Petro D, 2011, EUPHYTICA, V179, P405, DOI 10.1007/s10681-010-0338-1; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tabbasam N, 2014, PLANT SYST EVOL, V300, P559, DOI 10.1007/s00606-013-0891-x; Tostain S, 2006, MOL ECOL NOTES, V6, P173, DOI 10.1111/j.1471-8286.2005.01182.x; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Waldbieser GC, 2003, BIOTECHNIQUES, V35, P976, DOI 10.2144/03355st05; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhao H, 2015, SCI REPORTS, V5, P1	32	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134031	10.1371/journal.pone.0134031	http://dx.doi.org/10.1371/journal.pone.0134031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222616	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800098
J	Tesli, M; Kauppi, K; Bettella, F; Brandt, CL; Kaufmann, T; Espeseth, T; Mattingsdal, M; Agartz, I; Melle, I; Djurovic, S; Westlye, LT; Andreassen, OA				Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Mattingsdal, Morten; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.			Altered Brain Activation during Emotional Face Processing in Relation to Both Diagnosis and Polygenic Risk of Bipolar Disorder	PLOS ONE			English	Article							PREFRONTAL CORTEX; SCHIZOPHRENIA; AMYGDALA; FMRI; ASSOCIATIONS; METAANALYSIS; RELIABILITY; NETWORKS; CHILDREN; SCALE	Objectives Bipolar disorder (BD) is a highly heritable disorder with polygenic inheritance. Among the most consistent findings from functional magnetic imaging (fMRI) studies are limbic hyper-activation and dorsal hypoactivation. However, the relation between reported brain functional abnormalities and underlying genetic risk remains elusive. This is the first cross-sectional study applying a whole-brain explorative approach to investigate potential influence of BD case-control status and polygenic risk on brain activation. Methods A BD polygenic risk score (PGRS) was estimated from the Psychiatric Genomics Consortium BD case-control study, and assigned to each individual in our independent sample (N=85 BD cases and 121 healthy controls (HC)), all of whom participated in an fMRI emotional faces matching paradigm. Potential differences in BOLD response across diagnostic groups were explored at whole-brain level in addition to amygdala as a region of interest. Putative effects of BD PGRS on brain activation were also investigated. Results At whole-brain level, BD cases presented with significantly lower cuneus/precuneus activation than HC during negative face processing (Z-threshold=2.3 as cluster-level correction). The PGRS was associated positively with increased right inferior frontal gyrus (rIFG) activation during negative face processing. For amygdala activation, there were no correlations with diagnostic status or PGRS. Conclusions These findings are in line with previous reports of reduced precuneus and altered rIFG activation in BD. While these results demonstrate the ability of PGRS to reveal underlying genetic risk of altered brain activation in BD, the lack of convergence of effects at diagnostic and PGRS level suggests that this relation is a complex one.	[Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Mattingsdal, Morten; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Espeseth, Thomas; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Mattingsdal, Morten] Sorlandet Hosp HF, Kristiansand, Norway; [Agartz, Ingrid] Karolinska Hosp & Inst, HUBIN Project, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Div Med Genet, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Diakonhjemmet Hospital; University of Oslo	Tesli, M (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway.	m.s.tesli@medisin.uio.no	Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020; Kaufmann, Tobias/M-8972-2017; Mattingsdal, Morten/Q-9367-2016	Melle, Ingrid S/0000-0002-9783-548X; Kaufmann, Tobias/0000-0002-4003-1018; Mattingsdal, Morten/0000-0003-4440-0324; Westlye, Lars T./0000-0001-8644-956X; Djurovic, Srdjan/0000-0002-8140-8061; Agartz, Ingrid/0000-0002-9839-5391; Kauppi, Karolina/0000-0003-4908-341X	Research Council of Norway [223273]; South East Health Authority [2013-123]; KG Jebsen Foundation	Research Council of Norway(Research Council of Norway); South East Health Authority; KG Jebsen Foundation	This work was supported by the Research Council of Norway (#223273), South East Health Authority (#2013-123), and KG Jebsen Foundation.	Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Brandt CL, 2014, BRIT J PSYCHIAT, V204, P290, DOI 10.1192/bjp.bp.113.129254; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carre JM, 2012, SOC COGN AFFECT NEUR, V7, P213, DOI 10.1093/scan/nsq101; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Engh JA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-71; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Hajek T, 2013, J PSYCHIATR RES, V47, P1955, DOI 10.1016/j.jpsychires.2013.08.015; Hajek T, 2013, BIOL PSYCHIAT, V73, P144, DOI 10.1016/j.biopsych.2012.06.015; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Haxby JV, 2006, NAT NEUROSCI, V9, P1084, DOI 10.1038/nn0906-1084; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Heinrich A, 2013, BIPOLAR DISORD, V15, P440, DOI 10.1111/bdi.12068; Houenou Josselin, 2012, Front Biosci (Elite Ed), V4, P593; Jogia J, 2011, MOL PSYCHIATR, V16, P1070, DOI 10.1038/mp.2011.49; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Meda SA, 2014, P NATL ACAD SCI USA, V111, pE2066, DOI 10.1073/pnas.1313093111; Ousdal OT, 2012, TWIN RES HUM GENET, V15, P273, DOI 10.1017/thg.2012.5; Pavuluri MN, 2009, J AM ACAD CHILD PSY, V48, P308, DOI 10.1097/CHI.0b013e3181948fc7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Rich BA, 2008, DEV PSYCHOPATHOL, V20, P529, DOI 10.1017/S0954579408000266; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Tesli M, 2014, ACTA PSYCHIAT SCAND, V130, P311, DOI 10.1111/acps.12307; Tesli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056970; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wegbreit E, 2014, JAMA PSYCHIAT, V71, P926, DOI 10.1001/jamapsychiatry.2014.660; Wessa M, 2010, MOL PSYCHIATR, V15, P1126, DOI 10.1038/mp.2009.103; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; Whalley HC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.60; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	42	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134202	10.1371/journal.pone.0134202	http://dx.doi.org/10.1371/journal.pone.0134202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222050	Green Published, gold			2022-12-26	WOS:000358836800113
J	Singh, S; Michalska, K; Bigelow, L; Endres, M; Kharel, MK; Babnigg, G; Yennamalli, RM; Bingman, CA; Joachimiak, A; Thorson, JS; Phillips, GN				Singh, Shanteri; Michalska, Karolina; Bigelow, Lance; Endres, Michael; Kharel, Madan K.; Babnigg, Gyorgy; Yennamalli, Ragothaman M.; Bingman, Craig A.; Joachimiak, Andrzej; Thorson, Jon S.; Phillips, George N., Jr.			Structural Characterization of CalS8, a TDP-alpha-D-Glucose Dehydrogenase Involved in Calicheamicin Aminodideoxypentose Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES VIRIDOCHROMOGENES TU57; UDP-GLUCURONIC ACID; ESCHERICHIA-COLI; GENE-CLUSTER; MOLECULAR-REPLACEMENT; POLYMYXIN RESISTANCE; PURIFICATION; CLONING; INHIBITION; PROTEINS	Classical UDP-glucose 6-dehydrogenases (UGDHs; EC 1.1.1.22) catalyze the conversion of UDP-alpha-D-glucose (UDPGlc) to the key metabolic precursor UDP-alpha-D-glucuronic acid (UDP-GlcA) and display specificity for UDP-Glc. The fundamental biochemical and structural study of the UGDH homolog CalS8 encoded by the calicheamicin biosynthetic gene is reported and represents one of the first studies of a UGDH homolog involved in secondary metabolism. The corresponding biochemical characterization of CalS8 reveals CalS8 as one of the first characterized base-permissive UGDH homologs with a > 15-fold preference for TDP-Glc over UDP-Glc. The corresponding structure elucidations of apo-CalS8 and the CalS8.substrate .cofactor ternary complex (at 2.47 and 1.95 angstrom resolution, respectively) highlight a notably high degree of conservation between CalS8 and classical UGDHs where structural divergence within the intersubunit loop structure likely contributes to the CalS8 base permissivity. As such, this study begins to provide a putative blueprint for base specificity among sugar nucleotide-dependent dehydrogenases and, in conjunction with prior studies on the base specificity of the calicheamicin aminopentosyltransferase CalG4, provides growing support for the calicheamicin aminopentose pathway as a TDP-sugar-dependent process.	[Singh, Shanteri; Thorson, Jon S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY 40536 USA; [Michalska, Karolina; Bigelow, Lance; Endres, Michael; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Michalska, Karolina; Bigelow, Lance; Endres, Michael; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Kharel, Madan K.] Univ Maryland Eastern Shore, Sch Pharm, Princess Anne, MD 21853 USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Yennamalli, Ragothaman M.; Phillips, George N., Jr.] Rice Univ, Dept Chem, Dept Biosci, Houston, TX 77005 USA	University of Kentucky; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland Eastern Shore; University of Wisconsin System; University of Wisconsin Madison; Rice University	Thorson, JS (corresponding author), Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY 40536 USA.	jsthorson@uky.edu; georgep@rice.edu	Yennamalli, Ragothaman/M-7870-2017; Thorson, Jon S/L-3696-2013	Yennamalli, Ragothaman/0000-0002-3327-1582; Thorson, Jon S/0000-0002-7148-0721; Joachimiak, Andrzej/0000-0003-2535-6209; Singh, Shanteri/0000-0003-0960-4794	U. S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CANCER INSTITUTE [R01CA084374] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098248, U54GM094585] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Structural Biology Center beamlines was supported by the U. S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. The Life Sciences Collaborative Access Team (LS-CAT) has been supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bililign T, 2002, CHEMBIOCHEM, V3, P1143, DOI 10.1002/1439-7633(20021104)3:11<1143::AID-CBIC1143>3.0.CO;2-W; Bricogne G., 2011, BUSTER VERSION 2 10; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chang A, 2011, P NATL ACAD SCI USA, V108, P17649, DOI 10.1073/pnas.1108484108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DiMaio F, 2013, ACTA CRYSTALLOGR D, V69, P2202, DOI 10.1107/S0907444913023305; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2012, J BIOL CHEM, V287, P2119, DOI 10.1074/jbc.M111.313015; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Elshahawi SI, 2015, CHEM SOC REV, V44, P7591, DOI 10.1039/c4cs00426d; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fontaine T, 2009, CARBOHYD RES, V344, P1960, DOI 10.1016/j.carres.2009.07.012; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Granja AT, 2007, APPL MICROBIOL BIOT, V76, P1319, DOI 10.1007/s00253-007-1112-8; Guillemette C, 2003, PHARMACOGENOMICS J, V3, P136, DOI 10.1038/sj.tpj.6500171; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; Hung RJ, 2007, J BIOL CHEM, V282, P17738, DOI 10.1074/jbc.M701824200; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Kadirvelraj R, 2014, BIOCHEMISTRY-US, V53, P8043, DOI 10.1021/bi500594x; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; Mainprize IL, 2013, J BIOL CHEM, V288, P23064, DOI 10.1074/jbc.M113.486613; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Peltier-Pain P, 2015, CHEMBIOCHEM, V16, P2141, DOI 10.1002/cbic.201500365; PEROZICH J, 1995, ADV EXP MED BIOL, V372, P79; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rajakannan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025226; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rocha J, 2011, J BACTERIOL, V193, P3978, DOI 10.1128/JB.01076-10; Rocha J, 2010, ACTA CRYSTALLOGR F, V66, P69, DOI 10.1107/S174430910904929X; Sakuraba H, 2012, ACTA CRYSTALLOGR F, V68, P1003, DOI 10.1107/S1744309112030667; SCHILLER JG, 1973, BIOCHIM BIOPHYS ACTA, V293, P1, DOI 10.1016/0005-2744(73)90369-0; Simkhada D, 2009, APPL MICROBIOL BIOT, V83, P885, DOI 10.1007/s00253-009-1941-8; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; US PATENT, 2003, Patent No. 20030143666; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang CS, 2008, CHEM BIOL, V15, P842, DOI 10.1016/j.chembiol.2008.06.011; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	63	1	1	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26249	26258		10.1074/jbc.M115.673459	http://dx.doi.org/10.1074/jbc.M115.673459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26240141	hybrid, Green Published			2022-12-26	WOS:000363527300041
J	Munoz-Escobar, J; Matta-Camacho, E; Kozlov, G; Gehring, K				Munoz-Escobar, Juliana; Matta-Camacho, Edna; Kozlov, Guennadi; Gehring, Kalle			The MLLE Domain of the Ubiquitin Ligase UBR5 Binds to Its Catalytic Domain to Regulate Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A)-BINDING PROTEIN; HYPERPLASTIC-DISCS; STRUCTURAL BASIS; INHIBITS TELOMERASE; EDD; RECOGNITION; PABC; GENE; IDENTIFICATION; AUTOINHIBITION	E3 ubiquitin ligases catalyze the transfer of ubiquitin from an E2-conjugating enzyme to a substrate. UBR5, homologous to the E6APC terminus (HECT)-type E3 ligase, mediates the ubiquitination of proteins involved in translation regulation, DNA damage response, and gluconeogenesis. In addition, UBR5 functions in a ligase-independent manner by prompting protein/protein interactions without ubiquitination of the binding partner. Despite recent functional studies, the mechanisms involved in substrate recognition and selective ubiquitination of its binding partners remain elusive. The C terminus of UBR5 harbors the HECT catalytic domain and an adjacent MLLE domain. MLLE domains mediate protein/protein interactions through the binding of a conserved peptide motif, termed PAM2. Here, we characterize the binding properties of the UBR5 MLLE domain to PAM2 peptides from Paip1 and GW182. The crystal structure with a Paip1 PAM2 peptide reveals the network of hydrophobic and ionic interactions that drive binding. In addition, we identify a novel interaction of the MLLE domain with the adjacent HECT domain mediated by a PAM2-like sequence. Our results confirm the role of the MLLE domain of UBR5 in substrate recruitment and suggest a potential role in regulating UBR5 ligase activity.	[Munoz-Escobar, Juliana; Matta-Camacho, Edna; Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS) was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bethard JR, 2011, J PROTEOMICS, V75, P603, DOI 10.1016/j.jprot.2011.08.023; Bradley A, 2014, CARCINOGENESIS, V35, P1100, DOI 10.1093/carcin/bgt489; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cojocaru M, 2011, J BIOL CHEM, V286, P5012, DOI 10.1074/jbc.M110.176628; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	50	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22841	22850		10.1074/jbc.M115.672246	http://dx.doi.org/10.1074/jbc.M115.672246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224628	Green Published, hybrid			2022-12-26	WOS:000361171500046
J	Caserta, E; Liu, LC; Grundy, FJ; Henkin, TM				Caserta, Enrico; Liu, Liang-Chun; Grundy, Frank J.; Henkin, Tina M.			Codon-Anticodon Recognition in the Bacillus subtilis glyQS T Box Riboswitch RNA-DEPENDENT CODON SELECTION OUTSIDE THE RIBOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITERMINATION IN-VITRO; AMINOACYL-TRANSFER-RNA; COGNATE TRANSFER-RNA; MESSENGER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; E-SITE; CRYSTAL-STRUCTURE; READING FRAME; P-SITE	Many amino acid-related genes in Gram-positive bacteria are regulated by the T box riboswitch. The leader RNA of genes in the T box family controls the expression of downstream genes by monitoring the aminoacylation status of the cognate tRNA. Previous studies identified a three-nucleotide codon, termed the "Specifier Sequence," in the riboswitch that corresponds to the amino acid identity of the downstream genes. Pairing of the Specifier Sequence with the anticodon of the cognate tRNA is the primary determinant of specific tRNA recognition. This interaction mimics codon-anticodon pairing in translation but occurs in the absence of the ribosome. The goal of the current study was to determine the effect of a full range of mismatches for comparison with codon recognition in translation. Mutations were individually introduced into the Specifier Sequence of the glyQS leader RNA and tRNA(Gly) anticodon to test the effect of all possible pairing combinations on tRNA binding affinity and antitermination efficiency. The functional role of the conserved purine 3' of the Specifier Sequence was also verified in this study. We found that substitutions at the Specifier Sequence resulted in reduced binding, the magnitude of which correlates well with the predicted stability of the RNA-RNA pairing. However, the tolerance for specific mismatches in antitermination was generally different from that during decoding, which reveals a unique tRNA recognition pattern in the T box antitermination system.	[Henkin, Tina M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henkin, TM (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	henkin.3@osu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM047823]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM047823. The authors declare that they have no conflict of interest with the contents of this article.	Ashraf SS, 1999, RNA, V5, P1191, DOI 10.1017/S1355838299990933; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; BOREN T, 1993, J MOL BIOL, V230, P739, DOI 10.1006/jmbi.1993.1196; Bucklin DJ, 2005, J MOL BIOL, V345, P39, DOI 10.1016/j.jmb.2004.10.037; Chang AT, 2013, FEBS LETT, V587, P3495, DOI 10.1016/j.febslet.2013.09.003; CURRAN JF, 1987, SCIENCE, V238, P1545, DOI 10.1126/science.3685992; CURRAN JF, 1993, NUCLEIC ACIDS RES, V21, P1837, DOI 10.1093/nar/21.8.1837; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Daviter T, 2006, BIOCHIMIE, V88, P1001, DOI 10.1016/j.biochi.2006.04.013; ELLIOTT MS, 1984, J BIOL CHEM, V259, P2407; Gallant J, 2004, J MOL BIOL, V342, P713, DOI 10.1016/j.jmb.2004.07.030; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; GROSJEAN HJ, 1978, P NATL ACAD SCI USA, V75, P610, DOI 10.1073/pnas.75.2.610; GRUNDY FJ, 1994, J BACTERIOL, V176, P4518, DOI 10.1128/JB.176.15.4518-4526.1994; Grundy FJ, 2005, J MOL BIOL, V346, P73, DOI 10.1016/j.jmb.2004.11.051; Grundy FJ, 1997, J BACTERIOL, V179, P2587, DOI 10.1128/jb.179.8.2587-2594.1997; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Hansen TM, 2003, EMBO REP, V4, P499, DOI 10.1038/sj.embor.embor825; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Lim VI, 2005, J MOL BIOL, V351, P470, DOI 10.1016/j.jmb.2005.06.019; Lim VI, 2001, RNA, V7, P942, DOI 10.1017/S135583820100214X; LIM VI, 1995, J MOL BIOL, V252, P277, DOI 10.1006/jmbi.1995.0494; LUSTIG F, 1989, P NATL ACAD SCI USA, V86, P6873, DOI 10.1073/pnas.86.18.6873; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; MIZUNO H, 1978, NUCLEIC ACIDS RES, V5, P4451, DOI 10.1093/nar/5.11.4451; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; NEGRE D, 1986, BIOCHEMISTRY-US, V25, P6391, DOI 10.1021/bi00369a008; Nelson AR, 2006, RNA, V12, P1254, DOI 10.1261/rna.29906; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; O'Connor M, 2001, RNA, V7, P969, DOI 10.1017/S1355838201010184; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PARKER J, 1978, P NATL ACAD SCI USA, V75, P1091, DOI 10.1073/pnas.75.3.1091; Putzer H, 2002, NUCLEIC ACIDS RES, V30, P3026, DOI 10.1093/nar/gkf415; Qin D, 2007, RNA, V13, P2348, DOI 10.1261/rna.715307; RAFTERY LA, 1987, EMBO J, V6, P1499, DOI 10.1002/j.1460-2075.1987.tb02392.x; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rollins SM, 1997, MOL MICROBIOL, V25, P411, DOI 10.1046/j.1365-2958.1997.4851839.x; Sanbonmatsu KY, 2003, J MOL BIOL, V328, P33, DOI 10.1016/S0022-2836(03)00236-5; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Sponer J, 2004, J AM CHEM SOC, V126, P10142, DOI 10.1021/ja048436s; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Takai K, 1999, BIOCHEM BIOPH RES CO, V257, P662, DOI 10.1006/bbrc.1999.0538; Takai K, 2006, J THEOR BIOL, V242, P564, DOI 10.1016/j.jtbi.2006.04.009; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Wang JC, 2011, J MOL BIOL, V408, P99, DOI 10.1016/j.jmb.2011.02.014; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yousef MR, 2005, J MOL BIOL, V349, P273, DOI 10.1016/j.jmb.2005.03.061; Yousef MR, 2003, RNA, V9, P1148, DOI 10.1261/rna.5540203; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440	75	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23336	23347		10.1074/jbc.M115.673236	http://dx.doi.org/10.1074/jbc.M115.673236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229106	Green Published, hybrid			2022-12-26	WOS:000361685500040
J	Bevilacqua, CB; Basu, S; Pereira, A; Tseng, TM; Zimmer, PD; Burgos, NR				Bevilacqua, Caroline Borges; Basu, Supratim; Pereira, Andy; Tseng, Te-Ming; Zimmer, Paulo Dejalma; Burgos, Nilda Roma			Analysis of Stress-Responsive Gene Expression in Cultivated and Weedy Rice Differing in Cold Stress Tolerance	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENOME-WIDE ANALYSIS; HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; LOW-TEMPERATURE; INDICA RICE; GLUTAMATE-DEHYDROGENASE; SUBMERGENCE TOLERANCE; ASCORBATE PEROXIDASE; MOLECULAR RESPONSES	Rice (Oryza sativa L.) cultivars show impairment of growth in response to environmental stresses such as cold at the early seedling stage. Locally adapted weedy rice is able to survive under adverse environmental conditions, and can emerge in fields from greater soil depth. Cold-tolerant weedy rice can be a good genetic source for developing cold-tolerant, weed-competitive rice cultivars. An in-depth analysis is presented here of diverse indica and japonica rice genotypes, mostly weedy rice, for cold stress response to provide an understanding of different stress adaptive mechanisms towards improvement of the rice crop performance in the field. We have tested a collection of weedy rice genotypes to: 1) classify the subspecies (ssp.) grouping (japonica or indica) of 21 accessions; 2) evaluate their sensitivity to cold stress; and 3) analyze the expression of stress-responsive genes under cold stress and a combination of cold and depth stress. Seeds were germinated at 25 degrees C at 1.5- and 10-cm sowing depth for 10d. Seedlings were then exposed to cold stress at 10 degrees C for 6, 24 and 96h, and the expression of cold-, anoxia-, and submergence-inducible genes was analyzed. Control plants were seeded at 1.5cm depth and kept at 25 degrees C. The analysis revealed that cold stress signaling in indica genotypes is more complex than that of japonica as it operates via both the CBF-dependent and CBF-independent pathways, implicated through induction of transcription factors including OsNAC2, OsMYB46 and OsF-BOX28. When plants were exposed to cold + sowing depth stress, a complex signaling network was induced that involved cross talk between stresses mediated by CBF-dependent and CBF-independent pathways to circumvent the detrimental effects of stresses. The experiments revealed the importance of the CBF regulon for tolerance to both stresses in japonica and indica ssp. The mechanisms for cold tolerance differed among weedy indica genotypes and also between weedy indica and cultivated japonica ssp. as indicated by the up/downregulation of various stress-responsive pathways identified from gene expression analysis. The cold-stress response is described in relation to the stress signaling pathways, showing complex adaptive mechanisms in different genotypes.	[Bevilacqua, Caroline Borges; Zimmer, Paulo Dejalma] Univ Fed Pelotas, Capao Do Leao, RS, Brazil; [Basu, Supratim; Pereira, Andy; Tseng, Te-Ming; Burgos, Nilda Roma] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Universidade Federal de Pelotas; University of Arkansas System; University of Arkansas Fayetteville	Burgos, NR (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	nburgos@uark.edu	Tseng, Te-Ming/AAJ-5860-2021; Pereira, Andy/AAF-4781-2020	Pereira, Andy/0000-0003-1378-4273; Tseng, Te-Ming Paul/0000-0002-8102-8149	National Research Initiative (NRI), United States of America [2009-35320-05036]; National Science Foundation (NSF), United States of America [DBI-0922747]; CNPq, Brasil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Research Initiative (NRI), United States of America; National Science Foundation (NSF), United States of America(National Science Foundation (NSF)); CNPq, Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by The National Research Initiative (NRI), United States of America, Grant #2009-35320-05036: NRB, The National Science Foundation (NSF), United States of America, Grant #DBI-0922747: AP and CNPq, Brasil: PDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2012, PLANT CELL PHYSIOL, V53, P1445, DOI 10.1093/pcp/pcs089; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Baek JS, 2012, RICE, V5, DOI 10.1186/1939-8433-5-21; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Basu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/706890; BECK E, 1989, ANNU REV PLANT PHYS, V40, P95, DOI 10.1146/annurev.pp.40.060189.000523; BOARD JE, 1980, AGRON J, V72, P483, DOI 10.2134/agronj1980.00021962007200030019x; Bosetti F, 2012, BREEDING SCI, V62, P209, DOI 10.1270/jsbbs.62.209; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; CHRISTIE PJ, 1991, PLANT PHYSIOL, V95, P699, DOI 10.1104/pp.95.3.699; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cruz Renata Pereira da, 2004, Sci. agric. (Piracicaba, Braz.), V61, P1, DOI 10.1590/S0103-90162004000100001; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DOLFERUS R, 1994, PLANT PHYSIOL, V105, P1075, DOI 10.1104/pp.105.4.1075; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dubois M, 2013, PLANT PHYSIOL, V162, P319, DOI 10.1104/pp.113.216341; DUMAS B, 1993, CR ACAD SCI III-VIE, V316, P793; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Ganguly M, 2012, PLANT SIGNAL BEHAV, V7, P502, DOI 10.4161/psb.19646; Gealy DR, 2013, PLANT SOIL, V370, P277, DOI 10.1007/s11104-013-1587-2; Gealy DR, 2000, WEED TECHNOL, V14, P406, DOI 10.1614/0890-037X(2000)014[0406:EORROS]2.0.CO;2; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gregorio G.B., 1997, IRRI DISCUSSION PAPE, P1; Gross BL, 2009, NEW PHYTOL, V184, P842, DOI 10.1111/j.1469-8137.2009.02957.x; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Herbek JH, 1988, SOYBEAN PRODUCTION; Himmelbach A, 2010, PLANT CELL, V22, P937, DOI 10.1105/tpc.109.067934; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang J, 2000, PLANTA, V211, P467, DOI 10.1007/s004250000311; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jacobs BC, 1999, J AGRON CROP SCI, V182, P79, DOI 10.1046/j.1439-037x.1999.00259.x; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Karki S, 2013, RICE, V6, DOI 10.1186/1939-8433-6-28; Kaw R. N., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P593; Kim WC, 2014, PLANT MOL BIOL, V85, P589, DOI 10.1007/s11103-014-0205-x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar RG, 2000, PLANT SCI, V156, P23, DOI 10.1016/S0168-9452(00)00224-7; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Levitt J., 1980, RESPONSES PLANTS ENV, V1, P496; Lim CJ, 2007, BIOCHEM BIOPH RES CO, V362, P431, DOI 10.1016/j.bbrc.2007.08.007; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Lourenco T, 2013, PLANT MOL BIOL, V83, P351, DOI 10.1007/s11103-013-0092-6; Mackill DJ, 1997, CROP SCI, V37, P1340, DOI 10.2135/cropsci1997.0011183X003700040051x; Malone Gaspar, 2007, Rev. bras. sementes, V29, P61, DOI 10.1590/S0101-31222007000100009; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Moons A, 1997, PLANT CELL, V9, P2243, DOI 10.1105/tpc.9.12.2243; Mori M, 2011, BREEDING SCI, V61, P61, DOI 10.1270/jsbbs.61.61; Nahar K., 2009, BOT RES INT, V2, P295, DOI DOI 10.1142/S1793536909000047; Nakamura C, 2012, TROPICAL AGR RES EXT, V14, P25; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Pegoraro C, 2013, THEOR EXP PLANT PHYS, V25, P261, DOI 10.1590/S2197-00252013000400004; da Cruz RP, 2006, GENET MOL BIOL, V29, P314, DOI 10.1590/S1415-47572006000200020; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Roychoudhury A, 2008, PLANT CELL REP, V27, P1395, DOI 10.1007/s00299-008-0556-3; Roychoudhury A, 2009, ACTA PHYSIOL PLANT, V31, P915, DOI 10.1007/s11738-009-0305-4; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Satake T., 1976, CLIMATE AND RICE, P281; Sato A, 2006, J AM SOC HORTIC SCI, V131, P185, DOI 10.21273/JASHS.131.2.185; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi JL, 2012, MOL BREEDING, V29, P743, DOI 10.1007/s11032-011-9587-5; Shimono H, 2005, AGRON J, V97, P1524, DOI 10.2134/agronj2005.0043; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Shivrain VK, 2009, WEED SCI, V57, P94, DOI 10.1614/WS-08-112.1; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Soltani A, 2002, SEED SCI TECHNOL, V30, P51; SOUZA P. R., 1990, LAVOURA ARROZEIRA, V43, P9; Srivastava A.K., 2006, ENG PRINCIPLES AGR M, V2nd; Steffens B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00685; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Sthapit BR, 1998, CROP SCI, V38, P660, DOI 10.2135/cropsci1998.0011183X003800030007x; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yu SM, 1996, PLANT MOL BIOL, V30, P1277, DOI 10.1007/BF00019558; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang JA, 2011, PLANT PHYSIOL BIOCH, V49, P33, DOI 10.1016/j.plaphy.2010.09.014; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	105	28	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132100	10.1371/journal.pone.0132100	http://dx.doi.org/10.1371/journal.pone.0132100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230579	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400015
J	Cao, QQ; Wang, RQ; Zhang, HJ; Ge, XL; Liu, J				Cao, Qingqing; Wang, Renqing; Zhang, Haijie; Ge, Xiuli; Liu, Jian			Distribution of Organic Carbon in the Sediments of Xinxue River and the Xinxue River Constructed Wetland, China	PLOS ONE			English	Article							FRESH-WATER WETLANDS; LIGHT-FRACTION; GLOBAL DISTRIBUTION; METHANE EMISSION; HEAVY-FRACTION; MATTER; NITROGEN; MINERALIZATION; VEGETATION; LABILE	Wetland ecosystems are represented as a significant reservoir of organic carbon and play an important role in mitigating the greenhouse effect. In order to compare the compositions and distribution of organic carbon in constructed and natural river wetlands, sediments from the Xinxue River Constructed Wetland and the Xinxue River, China, were sampled at two depths (0-15 cm and 15-25 cm) in both upstream and downstream locations. Three types of organic carbon were determined: light fraction organic carbon, heavy fraction organic carbon, and dissolved organic carbon. The results show that variations in light fraction organic carbon are significantly larger between upstream and downstream locations than they are between the two wetland types; however, the opposite trend is observed for the dissolved organic carbon. There are no significant differences in the distribution of heavy fraction organic carbon between the discrete variables (e.g., between the two depths, the two locations, or the two wetland types). However, there are significant cross-variable differences; for example, the distribution patterns of heavy fraction organic carbon between wetland types and depths, and between wetland types and locations. Correlation analysis reveals that light fraction organic carbon is positively associated with light fraction nitrogen in both wetlands, while heavy fraction organic carbon is associated with both heavy fraction nitrogen and the moisture content in the constructed wetland. The results of this study demonstrate that the constructed wetland, which has a relatively low background value of heavy fraction organic carbon, is gradually accumulating organic carbon of different types, with the level of accumulation dependent on the balance between carbon accumulation and carbon decomposition. In contrast, the river wetland has relatively stable levels of organic carbon.	[Cao, Qingqing; Wang, Renqing; Zhang, Haijie; Liu, Jian] Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China; [Wang, Renqing] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Ge, Xiuli] Qilu Univ Technol, Sch Environm Sci & Engn, Jinan 250353, Peoples R China	Shandong University; Shandong University; Qilu University of Technology	Liu, J (corresponding author), Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China.	ecology@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	National Water Special Project [2012ZX07203-004]; National Natural Science Foundation of China [31200426, 31400356]	National Water Special Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by "National Water Special Project" (No. 2012ZX07203-004) and "National Natural Science Foundation of China" (No. 31200426; No. 31400356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; [Anonymous], 2007, US FOREST CARBON CLI; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; BOONE RD, 1994, SOIL BIOL BIOCHEM, V26, P1459, DOI 10.1016/0038-0717(94)90085-X; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Braskerud BC, 2001, J ENVIRON QUAL, V30, P1447, DOI 10.2134/jeq2001.3041447x; Brevik EC, 2004, CATENA, V57, P221, DOI 10.1016/j.catena.2003.12.001; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; CHIOU CT, 1986, ENVIRON SCI TECHNOL, V20, P502, DOI 10.1021/es00147a010; Clay GD, 2009, J HYDROL, V367, P41, DOI 10.1016/j.jhydrol.2008.12.022; Compton JE, 2002, SOIL BIOL BIOCHEM, V34, P933, DOI 10.1016/S0038-0717(02)00025-1; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Furukawa K, 1997, ESTUAR COAST SHELF S, V44, P301, DOI 10.1006/ecss.1996.0120; Gosselink J.G., 2000, WETLANDS; Gregorich EG, 1996, SOIL SCI, V161, P680, DOI 10.1097/00010694-199610000-00005; Haynes RJ, 2000, SOIL BIOL BIOCHEM, V32, P211, DOI 10.1016/S0038-0717(99)00148-0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Hui Y., 2009, WSEAS ISAA, V6, P1790; Jastrow J. D., 1997, SOIL PROCESSES CARBO; Jin XB, 2008, BIOL FERT SOILS, V44, P997, DOI 10.1007/s00374-008-0310-6; Jokic A, 2003, GEOCHIM COSMOCHIM AC, V67, P2585, DOI 10.1016/S0016-7037(03)00101-7; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; KADLEC RH, 1990, J HYDRAUL ENG-ASCE, V116, P691, DOI 10.1061/(ASCE)0733-9429(1990)116:5(691); Kansiime Frank, 2007, Wetlands Ecology and Management, V15, P443, DOI 10.1007/s11273-007-9043-9; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Robertson MM, 2004, GEOFORUM, V35, P361, DOI 10.1016/j.geoforum.2003.06.002; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Sakadevan K, 1998, WATER RES, V32, P393, DOI 10.1016/S0043-1354(97)00271-6; Schuyt KD, 2005, ECOL ECON, V53, P177, DOI 10.1016/j.ecolecon.2004.08.003; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sohi SP, 2001, SOIL SCI SOC AM J, V65, P1121, DOI 10.2136/sssaj2001.6541121x; SOLLINS P, 1984, SOIL BIOL BIOCHEM, V16, P31, DOI 10.1016/0038-0717(84)90122-6; Tan Z, 2007, SOIL TILL RES, V92, P53, DOI 10.1016/j.still.2006.01.003; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Tiner R.W., 1999, WETLAND INDICATORS G; Waldrop MP, 2006, ECOSYSTEMS, V9, P921, DOI 10.1007/s10021-004-0149-0; WESTRICH JT, 1984, LIMNOL OCEANOGR, V29, P236, DOI 10.4319/lo.1984.29.2.0236; Whiting GJ, 2001, TELLUS B, V53, P521, DOI 10.1034/j.1600-0889.2001.530501.x; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; YAVITT JB, 1987, BIOGEOCHEMISTRY, V4, P141, DOI 10.1007/BF02180152; Zhang DQ, 2009, ECOL ENG, V35, P1367, DOI 10.1016/j.ecoleng.2009.07.007; [张建 ZHANG Jian], 2008, [中国给水排水, China Water & Wastewater], V24, P49; ZHANG W.J, 2005, ENV SCI, V26, P56, DOI DOI 10.1007/s10971-005-6694-y; [张文菊 Zhang Wenju], 2004, [地球科学进展, Advance in Earth Sciences], V19, P558	55	15	15	9	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134713	10.1371/journal.pone.0134713	http://dx.doi.org/10.1371/journal.pone.0134713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230255	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400154
J	Gong, XQ; Yang, JE; Tang, JM; Gu, C; Huang, LJ; Zheng, Y; Liang, HQ; Wang, M; Wu, CC; Chen, Y; Zhang, MY; Yu, ZJ; Mao, QG				Gong, Xianqiong; Yang, Jiaen; Tang, Jinmo; Gu, Chong; Huang, Lijian; Zheng, Ying; Liang, Huiqing; Wang, Min; Wu, Chuncheng; Chen, Yue; Zhang, Manying; Yu, Zhijian; Mao, Qianguo			A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B	PLOS ONE			English	Article							PERSISTENTLY NORMAL ALT; ASIAN-AMERICANS; VIRUS INFECTION; CUTOFF VALUES; CARRIERS; DNA; DISEASE; UPDATE; PHASE; HBEAG	To understand the mechanisms underlying the discordance between normal serum alanine aminotransferase (ALT) levels and significant alterations in liver histology of chronic hepatitis B virus (HBV) infection with persistent normal ALT (PNALT) or minimally elevated ALT. A total of 300 treatment-naive chronic HBV-infected patients with PNALT (ALT <= upper limit of normal [ULN, 40 U/ml]) or minimally elevated ALT (1-2xULN) were retrospectively enrolled. All patients underwent liver biopsy and histological changes were analyzed along with biochemical and HBV markers. Among 300 participants, 177 were HBeAg-positive and 123 HBeAg-negative. Significant histologic abnormalities were found in 42.9% (76/177) and 52.8% (65/123) of HBeAg-positive and HBeAg-negative patients, respectively. Significant fibrosis, which is a marker of prior injury, was more frequently detected than significant necroinflammation (suggesting active liver injury) in both HBeAg-positive and -negative groups, suggesting that liver injury occurred intermittently in our cohort. No significant differences were noticed in the percentage of patients with severe fibrosis between HBeAg-positive and negative phases or between ages 30 and 40 and over 40, suggesting that the fibrosis was possibly carried over from an early phase. Finally, lowering ALT ULN (30 U/L for men, 19 U/L for women) alone was not adequate to increase the sensitivity of ALT detection of liver injury. However, the study was limited to a small sample size of 13 HBeAg-positive patients with ALT in the revised normal range. We detected significant liver pathology in almost 50% of chronic HBV infected patients with PNALT (ALT <= 40 U/ml) or minimally elevated ALT. We postulated that small-scale intermittent liver injury was possibly responsible for the discordance between normal serum ALT and significant liver changes in our cohort.	[Gong, Xianqiong; Yang, Jiaen; Tang, Jinmo; Gu, Chong; Huang, Lijian; Zheng, Ying; Liang, Huiqing; Wang, Min; Wu, Chuncheng; Chen, Yue; Zhang, Manying; Mao, Qianguo] Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China; [Yu, Zhijian] Shenzhen Nanshan Hosp, Shenzhen Key Lab Endogenous Infect, Shenzhen, Guangdong, Peoples R China		Mao, QG (corresponding author), Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China.	maoqg1962@163.com			Xiamen Science and Technology program [3502Z20134022]; Youth Foundation of Health Department of Fujian Province [2013-2-96]; Medical Innovation Project of Fujian Province [2014-CXB-45]; Shenzhen Scientific. Research Program of the People's Republic of China [JCYJ20130402151227167]	Xiamen Science and Technology program; Youth Foundation of Health Department of Fujian Province; Medical Innovation Project of Fujian Province; Shenzhen Scientific. Research Program of the People's Republic of China	This work was supported by grants from Xiamen Science and Technology program (No. 3502Z20134022), Youth Foundation of Health Department of Fujian Province (No. 2013-2-96), Medical Innovation Project of Fujian Province (No. 2014-CXB-45), and Shenzhen Scientific. Research Program of the People's Republic of China (No. JCYJ20130402151227167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahtab M, 2011, DIGESTION, V83, P60, DOI 10.1159/000319758; Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Assy N, 2009, WORLD J GASTROENTERO, V15, P3025, DOI 10.3748/wjg.15.3025; Bertoletti A, 2015, CELL MOL IMMUNOL, V12, P258, DOI 10.1038/cmi.2014.79; Chen EQ, 2010, DIGEST DIS SCI, V55, P432, DOI 10.1007/s10620-009-0724-5; Gui HL, 2010, J VIRAL HEPATITIS, V17, P44, DOI 10.1111/j.1365-2893.2010.01270.x; Hsu YN, 2014, DIGEST DIS SCI, V59, P865, DOI 10.1007/s10620-014-3054-1; Ijaz B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-86; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liao BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078672; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Nguyen MH, 2009, AM J GASTROENTEROL, V104, P2206, DOI 10.1038/ajg.2009.248; Ocama Ponsiano, 2005, Am J Med, V118, P1413, DOI 10.1016/j.amjmed.2005.06.021; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080585; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	24	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134532	10.1371/journal.pone.0134532	http://dx.doi.org/10.1371/journal.pone.0134532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230094	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400131
J	Kakigi, C; Kasuga, T; Wang, SY; Singh, K; Hiratsuka, Y; Murakami, A; Lin, SC				Kakigi, Caitlin; Kasuga, Toshimitsu; Wang, Sophia Y.; Singh, Kuldev; Hiratsuka, Yoshimune; Murakami, Akira; Lin, Shan C.			Hypothyroidism and Glaucoma in The United States	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ASSOCIATION; POPULATION; VALIDITY; RISK	Purpose To investigate the association between hypothyroidism and glaucomatous disease. Methods This cross-sectional study included all subjects above the age of 40 years from two nationwide surveys: the 2008 National Health Interview Survey (NHIS) as well as the 2007 and 2008 National Health and Nutrition Examination Survey (NHANES). The presence or absence of glaucoma, thyroid disease and other demographic and health-related information including comorbidities was ascertained via interview. Blood samples were collected from NHANES subjects and analyzed for thyrotropin (TSH). Results A total of 13,599 and 3,839 NHIS and NHANES participants respectively were analyzed to assess for a possible relationship between self-reported glaucoma, and self-reported hypothyroidism as well as self-reported thyroid disease. The unadjusted odds ratio (OR) for NHIS showed a significant association between self-reported glaucoma and self-reported hypothyroidism (OR 1.46, 95% confidence interval [CI] 1.07-1.99). Multivariate logistic regression analysis adjusted for age, gender, race, comorbidities, and health-related behavior, however, showed no association between self-reported glaucoma and hypothyroidism or thyroid disease in both surveys (OR 1.60, 95% CI 0.87-2.95 for NHIS; OR 1.05, 95% CI 0.59-1.88 for NHANES). Conclusion A previously reported association between hypothyroidism and glaucomatous disease was not confirmed in two large U.S. health survey populations. While such an association was noted in the univariate analysis for the NHIS survey, such a relationship was not found in the multivariate analysis after adjustment for potential confounding variables.	[Kakigi, Caitlin; Kasuga, Toshimitsu; Wang, Sophia Y.; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Kasuga, Toshimitsu; Hiratsuka, Yoshimune; Murakami, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Singh, Kuldev] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Juntendo University; Stanford University	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	LinS@vision.ucsf.edu		Wang, Sophia/0000-0003-0916-9403	NIH-NEI - Core Grant for Vision Research [EY002162]; That Man May See, Inc; Research to prevent Blindness; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	NIH-NEI - Core Grant for Vision Research; That Man May See, Inc; Research to prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH-NEI EY002162 - Core Grant for Vision Research; That Man May See, Inc (http://thatmanmaysee.org/); and Research to prevent Blindness.(http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles Carenini B, 1997, ACTA OPHTHALMOL SC S, P47; Brix TH, 2001, THYROID, V11, P769, DOI 10.1089/10507250152484619; Calissendorff J, 2011, BRIT J OPHTHALMOL, V95, P592, DOI 10.1136/bjo.2010.195032; Centanni M, 1997, EUR J ENDOCRINOL, V136, P595, DOI 10.1530/eje.0.1360595; Cross JM, 2008, BRIT J OPHTHALMOL, V92, P1503, DOI 10.1136/bjo.2008.147165; Gillow JT, 1997, EYE, V11, P113, DOI 10.1038/eye.1997.22; Hertel G, 1920, KLIN MONBL AUGENHEIL, V64, P390; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Karadimas P, 2001, AM J OPHTHALMOL, V131, P126, DOI 10.1016/S0002-9394(00)00724-8; Kim M, 2012, JPN J OPHTHALMOL, V56, P324, DOI 10.1007/s10384-012-0153-4; Lee a J, 2004, EYE, V18, P600; Lin HC, 2010, OPHTHALMOLOGY, V117, P1960, DOI 10.1016/j.ophtha.2010.02.005; McDaniel D, 1996, J Am Optom Assoc, V67, P109; Motsko SP, 2008, OPHTHALMOLOGY, V115, P1581, DOI 10.1016/j.ophtha.2008.01.016; Munoz-Negrete FJ, 2000, OPHTHALMOLOGICA, V214, P347, DOI 10.1159/000027518; Patty L, 2012, OPHTHALMOLOGY, V119, P1725, DOI 10.1016/j.ophtha.2012.02.029; RITCH R, 1994, OPHTHALMOLOGY, V101, P623; SMITH KD, 1992, CAN J OPHTHALMOL, V27, P345; SMITH KD, 1993, OPHTHALMOLOGY, V100, P1580; SMITH KD, 1992, CAN J OPHTHALMOL, V27, P341	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133688	10.1371/journal.pone.0133688	http://dx.doi.org/10.1371/journal.pone.0133688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230664	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400049
J	Kawalec, M; Boratynska-Jasinska, A; Beresewicz, M; Dymkowska, D; Zablocki, K; Zablocka, B				Kawalec, Maria; Boratynska-Jasinska, Anna; Beresewicz, Malgorzata; Dymkowska, Dorota; Zablocki, Krzysztof; Zablocka, Barbara			Mitofusin 2 Deficiency Affects Energy Metabolism and Mitochondrial Biogenesis in MEF Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; REAL-TIME; MFN2; GENE; EXPRESSION; DNA; MUTATION	Mitofusin 2 (Mfn2), mitochondrial outer membrane protein which is involved in rearrangement of these organelles, was first described in pathology of hypertension and diabetes, and more recently much attention is paid to its functions in Charcot-Marie-Tooth type 2A neuropathy (CMT2A). Here, cellular energy metabolism was investigated in mouse embryonic fibroblasts (MEF) differing in the presence of the Mfn2 gene; control (MEFwt) and with Mfn2 gene depleted MEFMfn2-/-. These two cell lines were compared in terms of various parameters characterizing mitochondrial bioenergetics. Here, we have shown that relative rate of proliferation of MEFMfn2-/- cells versus control fibroblasts depend on serum supplementation of the growth media. Moreover, MEFMfn2-/- cells exhibited significantly increased respiration rate in comparison to MEFwt, regardless of serum supplementation of the medium. This effect was correlated with increased level of mitochondrial markers (TOM20 and NAO) as well as mitochondrial transcription factor A (TFAM) and peroxisome proliferator- activated receptor gamma coactivator 1-alpha (PGC-1 alpha) protein levels and unchanged total ATP content. Interestingly, mitochondrial DNA content in MEFMfn2-/- cells was not reduced. Fundamentally, these results are in contrast to a commonly accepted belief that mitofusin 2 deficiency inevitably results in debilitation of mitochondrial energy metabolism. However, we suggest a balance between negative metabolic consequences of mitofusin 2 deficiency and adaptive processes exemplified by increased level of PGC-1 alpha and TFAM transcription factor which prevent an excessive depletion of mtDNA and severe impairment of cell metabolism.	[Kawalec, Maria; Boratynska-Jasinska, Anna; Beresewicz, Malgorzata; Zablocka, Barbara] PAS, Mol Biol Unit, Mossakowski Med Res Ctr, Warsaw, Poland; [Dymkowska, Dorota; Zablocki, Krzysztof] PAS, Dept Biochem, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Zablocki, K (corresponding author), PAS, Dept Biochem, Nencki Inst Expt Biol, Warsaw, Poland.	k.zablocki@nencki.gov.pl	Boratyńska-Jasińska, Anna/AAQ-9352-2021; Beresewicz Haller, Malgorzata/AAG-2147-2020; Dymkowska, Dorota/AAB-5193-2021; Zablocki, Krzysztof/R-4181-2016	Beresewicz Haller, Malgorzata/0000-0002-2204-5184; Dymkowska, Dorota/0000-0003-4798-4062; Zablocka, Barbara/0000-0003-3116-7295; Boratynska-Jasinska, Anna/0000-0003-1337-3175; Zablocki, Krzysztof/0000-0002-9987-1257	Narodowe Centrum Nauki grant [NN402474640]	Narodowe Centrum Nauki grant(National Science Centre, Poland)	This work was supported by Narodowe Centrum Nauki grant number NN402474640. BioTech Poland Sp. z o.o. provided the access to the xCELLigence RTCA DP Instrument.	[Anonymous], [No title captured]; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ding YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121328; Dorn GW, 2013, CIRC J, V77, P1370, DOI 10.1253/circj.CJ-13-0453; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KunzSchughart LA, 1997, AM J PHYSIOL-CELL PH, V273, pC1487, DOI 10.1152/ajpcell.1997.273.5.C1487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Moniri MR, 2015, CYTOTECHNOLOGY, V67, P379, DOI 10.1007/s10616-014-9692-5; Myers MB, 2009, BIOTECHNIQUES, V47, P867, DOI 10.2144/000113222; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Segales J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1208, DOI 10.1152/ajpendo.00546.2012; Son MJ, 2015, CELL DEATH DIFFER, V22, P1957, DOI 10.1038/cdd.2015.43; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4; Yan LJ, 2009, ANAL BIOCHEM, V389, P143, DOI 10.1016/j.ab.2009.03.043; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	34	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134162	10.1371/journal.pone.0134162	http://dx.doi.org/10.1371/journal.pone.0134162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230519	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400081
J	Zhang, LY; Guo, SH; Wu, B				Zhang, Lingyan; Guo, Shuhai; Wu, Bo			The Source, Spatial Distribution and Risk Assessment of Heavy Metals in Soil from the Pearl River Delta Based on the National Multi-Purpose Regional Geochemical Survey	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; CONTAMINATION; MERCURY; MULTIVARIATE; SEDIMENTS; POLLUTION; ELEMENTS; TREND; CHINA	The data on the heavy metal content at different soil depths derived from a multi-purpose regional geochemical survey in the Pearl River Delta (PRD) were analyzed using ArcGIS 10.0. By comparing their spatial distributions and areas, the sources of heavy metals (Cd, Hg, As and Pb) were quantitatively identified and explored. Netted measuring points at 25 x25 km were set over the entire PRD according to the geochemical maps. Based on the calculation data obtained from different soil depths, the concentrations of As and Cd in a large area of the PRD exceeded the National Second-class Standard. The spatial disparity of the geometric centers in the surface soil and deep soil showed that As in the surface soil mainly came from parent materials, while Cd had high consistency in different soil profiles because of deposition in the soil forming process. The migration of Cd also resulted in a considerable ecological risk to the Beijiang and Xijiang River watershed. The potential ecological risk index followed the order Cd >= Hg > Pb > As. According to the sources, the distribution trends and the characteristics of heavy metals in the soil from the perspective of the whole area, the Cd pollution should be repaired, especially in the upper reaches of the Xijiang and Beijiang watershed to prevent risk explosion while the pollution of Hg and Pb should be controlled in areas with intense human activity, and supervision during production should be strengthened to maintain the ecological balance of As.	[Zhang, Lingyan; Guo, Shuhai; Wu, Bo] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Zhang, Lingyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guo, SH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.	shuhaiguo@iae.ac.cn			Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard [201511082-05]; Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale [KFJ-EW-STS-013]	Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard; Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale	Author SHG receives the following funding: (1) the Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard (No. 201511082-05), (2) Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale (KFJ-EW-STS-013).	Ahn JS, 2005, ENVIRON GEOCHEM HLTH, V27, P147, DOI 10.1007/s10653-005-0121-8; Bai JM, 2014, ENVIRON MONIT ASSESS, V186, P8051, DOI 10.1007/s10661-014-4050-9; Bian Y, 2014, J APPL GEOPHYS, V107, P36, DOI 10.1016/j.jappgeo.2014.05.003; Biasioli M, 2012, CHEMOSPHERE, V88, P1241, DOI 10.1016/j.chemosphere.2012.03.081; Blundell A, 2009, EARTH-SCI REV, V95, P158, DOI 10.1016/j.earscirev.2009.05.001; Boruvka L, 2005, GEODERMA, V128, P289, DOI 10.1016/j.geoderma.2005.04.010; CHEN JS, 1991, WATER AIR SOIL POLL, V57-8, P699, DOI 10.1007/BF00282934; Chen LG, 2012, CHEMOSPHERE, V88, P612, DOI 10.1016/j.chemosphere.2012.03.041; [成杭新 Cheng Hangxin], 2005, [第四纪研究, Quaternary Sciences], V25, P285; China Geological Survey, 2005, CRIT NAT MULT REG GE; China National Environmental Monitoring Centre, 1990, SOIL EL BACKGR VAL C; Dou M, 2013, ENVIRON MONIT ASSESS, V185, P7501, DOI 10.1007/s10661-013-3115-5; Duan DD, 2014, CHEMOSPHERE, V103, P35, DOI 10.1016/j.chemosphere.2013.11.011; Fialova H, 2006, J APPL GEOPHYS, V59, P273, DOI 10.1016/j.jappgeo.2005.10.006; Godin P, 1986, THESIS I NATL AGRONO; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hou EQ, 2014, FORESTS, V5, P885, DOI 10.3390/f5050885; Li M, 2014, J GEOCHEM EXPLOR, V139, P21, DOI 10.1016/j.gexplo.2013.06.002; Li RZ, 2010, CHINESE GEOGR SCI, V20, P9, DOI 10.1007/s11769-010-0009-0; Lin CJ, 1999, ATMOS ENVIRON, V33, P2067, DOI 10.1016/S1352-2310(98)00387-2; Lindberg S, 2007, AMBIO, V36, P19, DOI 10.1579/0044-7447(2007)36[19:ASOPAU]2.0.CO;2; Liu HY, 2005, SCI TOTAL ENVIRON, V339, P153, DOI 10.1016/j.scitotenv.2004.07.030; Lowers HA, 2007, GEOCHIM COSMOCHIM AC, V71, P2699, DOI 10.1016/j.gca.2007.03.022; Lu AX, 2012, SCI TOTAL ENVIRON, V425, P66, DOI 10.1016/j.scitotenv.2012.03.003; Martin JAR, 2006, ENVIRON POLLUT, V144, P1001, DOI 10.1016/j.envpol.2006.01.045; Roussel C, 2000, J ENVIRON QUAL, V29, P182, DOI 10.2134/jeq2000.00472425002900010023x; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; Tian HZ, 2010, ATMOS CHEM PHYS, V10, P11905, DOI 10.5194/acp-10-11905-2010; Wang Y, 2014, J GEOCHEM EXPLOR, V138, P72, DOI 10.1016/j.gexplo.2013.12.012; Xi XH, 2011, MULTIPURPOSE REGIONA; Yu H, 2014, J GEOCHEM EXPLOR, V146, P136, DOI 10.1016/j.gexplo.2014.08.010; Yu JB, 2002, CHINESE GEOGR SCI, V12, P268, DOI 10.1007/s11769-002-0013-0; Zheng JY, 2011, SCI TOTAL ENVIRON, V412, P214, DOI 10.1016/j.scitotenv.2011.10.024	35	16	18	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132040	10.1371/journal.pone.0132040	http://dx.doi.org/10.1371/journal.pone.0132040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230506	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400014
J	Bach, DR; Furl, N; Barnes, G; Dolan, RJ				Bach, Dominik R.; Furl, Nicholas; Barnes, Gareth; Dolan, Raymond J.			Sustained Magnetic Responses in Temporal Cortex Reflect Instantaneous Significance of Approaching and Receding Sounds	PLOS ONE			English	Article							LOOMING SIGNALS; MULTISENSORY INTEGRATION; AUDITORY-CORTEX; RHESUS-MONKEYS; HUMAN AMYGDALA; PERCEPTION; ARRIVAL; BRAIN; TIME; MODALITY	Rising sound intensity often signals an approaching sound source and can serve as a powerful warning cue, eliciting phasic attention, perception biases and emotional responses. How the evaluation of approaching sounds unfolds over time remains elusive. Here, we capitalised on the temporal resolution of magnetoencephalograpy (MEG) to investigate in humans a dynamic encoding of perceiving approaching and receding sounds. We compared magnetic responses to intensity envelopes of complex sounds to those of white noise sounds, in which intensity change is not perceived as approaching. Sustained magnetic fields over temporal sensors tracked intensity change in complex sounds in an approximately linear fashion, an effect not seen for intensity change in white noise sounds, or for overall intensity. Hence, these fields are likely to track approach/recession, but not the apparent ( instantaneous) distance of the sound source, or its intensity as such. As a likely source of this activity, the bilateral inferior temporal gyrus and right temporo-parietal junction emerged. Our results indicate that discrete temporal cortical areas parametrically encode behavioural significance in moving sound sources where the signal unfolded in a manner reminiscent of evidence accumulation. This may help an understanding of how acoustic percepts are evaluated as behaviourally relevant, where our results highlight a crucial role of cortical areas.	[Bach, Dominik R.; Furl, Nicholas; Barnes, Gareth; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Bach, Dominik R.] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Furl, Nicholas] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England	University of London; University College London; University of Zurich; University of Cambridge	Bach, DR (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	dominik.bach@uzh.ch	Barnes, Gareth/ABB-7650-2020; Bach, Dominik R/B-4302-2019	Barnes, Gareth/0000-0002-5396-7712; Bach, Dominik R/0000-0003-3717-2036; furl, nicholas/0000-0003-2488-1343	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Swiss National Science Foundation [PA117384]; Medical Research Council [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [RJD, Senior Investigator Award 098362/Z/12/Z], the Swiss National Science Foundation [DRB, Advanced Postdoctoral Mobility Fellowship PA117384], and the Medical Research Council [GB, Partnership Grant MR/K005464/1]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [091593/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 1999, J NEUROSCI, V19, P2681; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Clarke SE, 2013, P NATL ACAD SCI USA, V110, P13624, DOI 10.1073/pnas.1306428110; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; EDWORTHY J, 1991, HUM FACTORS, V33, P205, DOI 10.1177/001872089103300206; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gordon MS, 2013, ATTEN PERCEPT PSYCHO, V75, P738, DOI 10.3758/s13414-013-0424-2; Gordon MS, 2005, PERCEPT PSYCHOPHYS, V67, P580, DOI 10.3758/BF03193516; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2009, J EXP PSYCHOL HUMAN, V35, P225, DOI 10.1037/a0013159; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Sutherland CAM, 2014, COGNITION, V132, P312, DOI 10.1016/j.cognition.2014.04.011; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Tyll S, 2013, NEUROIMAGE, V65, P13, DOI 10.1016/j.neuroimage.2012.09.056; Uppenkamp S, 2014, HEARING RES, V307, P65, DOI 10.1016/j.heares.2013.08.005; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134060	10.1371/journal.pone.0134060	http://dx.doi.org/10.1371/journal.pone.0134060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226395	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358837700055
J	Chukwuma, VU; Hicar, MD; Chen, XM; Nicholas, KJ; Joyner, A; Kalams, SA; Landucci, G; Forthal, DN; Spearman, PW; Crowe, JE				Chukwuma, Valentine U.; Hicar, Mark D.; Chen, Xuemin; Nicholas, Katherine J.; Joyner, Amanda; Kalams, Spyros A.; Landucci, Gary; Forthal, Donald N.; Spearman, Paul W.; Crowe, James E., Jr.			Association of V(H)4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCLONAL-ANTIBODIES; MATRIX PROTEIN; B-CELLS; MEMBRANE-BINDING; STRUCTURAL BASIS; IGG ANTIBODIES; LIFE-CYCLE; P17; PARTICLES	The human antibody response against HIV-1 infection recognizes diverse antigenic subunits of the virion, and includes a high level of antibodies to the Gag protein. We report here the isolation and characterization of a subset of Gag-specific human monoclonal antibodies (mAbs) that were prevalent in the antibody repertoire of an HIV-infected individual. Several lineages of Gag-specifc mAbs were encoded by a single antibody heavy chain variable region, V(H)4-59, and a representative antibody from this group designated mAb 3E4 recognized a linear epitope on the globular head of the p17 subunit of Gag. We found no evidence that mAb 3E4 exhibited any function in laboratory studies aimed at elucidating the immunologic activity, including assays for neutralization, Ab-dependent cell-mediated virus inhibition, or enhanced T cell reactivity caused by Gag-3E4 complexes. The findings suggest this immunodominant epitope in Gag protein, which is associated with V(H)4-59 germline gene usage, may induce a high level of B cells that encode binding but non-functional antibodies that occupy significant repertoire space following HIV infection. The studies define an additional specific molecular mechanism in the immune distraction activity of the HIV virion.	[Chukwuma, Valentine U.; Nicholas, Katherine J.; Joyner, Amanda; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Hicar, Mark D.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Kalams, Spyros A.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Microbiol & Immunol, Nashville, TN 37235 USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Microbiol, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Immunol, Atlanta, GA USA; [Spearman, Paul W.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); University of California System; University of California Irvine	Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIAID, NIH [U01 AI-078407, P30 AI-054999]; Vanderbilt-Meharry Center for AIDS Research [P30 AI-054999]; Emory Center for AIDS Research [P30-AI50409]; Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research; NIH [K08 AI 083078]; IDSA ERF; Wyeth Vaccines Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125119, U01AI078407, P30AI054999, K08AI083078, R01AI084834, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111027] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vanderbilt-Meharry Center for AIDS Research; Emory Center for AIDS Research; Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDSA ERF; Wyeth Vaccines Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by U01 AI-078407 (NIAID, NIH), P30 AI-054999 (NIAID, NIH; the Vanderbilt-Meharry Center for AIDS Research), and P30-AI50409 (Emory Center for AIDS Research). MDH was supported by a Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research and NIH K08 AI 083078, and portions of this work were performed as the Young Investigator Award recipient of the IDSA ERF and NFID sponsored by Wyeth Vaccines Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; CHARGELEGUE D, 1995, CLIN EXP IMMUNOL, V99, P175, DOI 10.1111/j.1365-2249.1995.tb05529.x; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; FERNS RB, 1989, AIDS, V3, P829, DOI 10.1097/00002030-198912000-00008; Finn JA, 2013, CURR OPIN IMMUNOL, V25, P613, DOI 10.1016/j.coi.2013.09.010; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jalaguier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028314; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kageyama S, 1996, ACTA VIROL, V40, P195; Li S, 2010, NEW MICROBIOL, V33, P13; Nicholas KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084185; NIEDRIG M, 1988, J GEN VIROL, V69, P2109, DOI 10.1099/0022-1317-69-8-2109; Ota A, 1998, HYBRIDOMA, V17, P73, DOI 10.1089/hyb.1998.17.73; PAPSIDERO LD, 1989, J VIROL, V63, P267, DOI 10.1128/JVI.63.1.267-272.1989; Perez M, 2010, BRIT J DERMATOL, V162, P611, DOI 10.1111/j.1365-2133.2009.09576.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; SHANG F, 1991, J VIROL, V65, P4798, DOI 10.1128/JVI.65.9.4798-4804.1991; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Truong C, 1997, J MED VIROL, V51, P145, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;145::AID-JMV2&gt;3.0.CO;2-6; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; YU XF, 1992, J VIROL, V66, P5667, DOI 10.1128/JVI.66.9.5667-5670.1992	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133509	10.1371/journal.pone.0133509	http://dx.doi.org/10.1371/journal.pone.0133509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226263	Green Published, gold			2022-12-26	WOS:000358837700024
J	Ni, F; Kondrashkina, E; Wang, QH				Ni, Fengyun; Kondrashkina, Elena; Wang, Qinghua			Structural and Functional Studies of Influenza Virus A/H6 Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; WILD AQUATIC BIRDS; A VIRUS; HUMAN INFECTION; HUMAN H1; SPECIFICITY; ORIGIN; H6; DETERMINANTS; PREFERENCES	In June 2013, the first human infection by avian influenza A(H6N1) virus was reported in Taiwan. This incident raised the concern for possible human epidemics and pandemics from H6 viruses. In this study, we performed structural and functional investigation on the hemagglutinin (HA) proteins of the human-infecting A/Taiwan/2/2013(H6N1) (TW H6) virus and an avian A/chicken/Guangdong/S1311/2010(H6N6) (GD H6) virus that transmitted efficiently in guinea pigs. Our results revealed that in the presence of HA(1) Q226, the triad of HA(1) S137, E190 and G228 in GD H6 HA allows the binding to both avian-and human-like receptors with a slight preference for avian receptors. Its conservation among the majority of H6 HAs provides an explanation for the broader host range of this subtype. Furthermore, the triad of N137, V190 and S228 in TW H6 HA may alleviate the requirement for a hydrophobic residue at HA(1) 226 of H2 and H3 HAs when binding to human-like receptors. Consequently, TW H6 HA has a slight preference for human receptors, thus may represent an intermediate towards a complete human adaptation. Importantly, the triad observed in TW H6 HA is detected in 74% H6 viruses isolated from Taiwan in the past 14 years, suggesting an elevated threat of H6 viruses from this region to human health. The novel roles of the triad at HA(1) 137, 190 and 228 of H6 HA in binding to receptors revealed here may also be used by other HA subtypes to achieve human adaptation, which needs to be further tested in laboratory and closely monitored in field surveillance.	[Ni, Fengyun; Wang, Qinghua] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kondrashkina, Elena] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL USA	Baylor College of Medicine; Northwestern University	Wang, QH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	qinghuaw@bcm.edu			National Institutes of Health [R01-AI067839]; Gillson-Longenbaugh Foundation; Welch Foundation [Q-1826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gillson-Longenbaugh Foundation; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	QW acknowledges support from the National Institutes of Health (R01-AI067839), the Gillson-Longenbaugh Foundation, and The Welch Foundation (Q-1826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bottcher-Friebertshauser E, 2014, CURR TOP MICROBIOL, V385, P3, DOI 10.1007/82_2014_384; Byrd-Leotis L, 2014, P NATL ACAD SCI USA, V111, pE2241, DOI 10.1073/pnas.1323162111; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng KH, 2014, ARCH VIROL, V159, P2275, DOI 10.1007/s00705-014-2058-7; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; He JL, 2015, VIRUS RES, V197, P101, DOI 10.1016/j.virusres.2014.12.010; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kayali G, 2010, ZOONOSES PUBLIC HLTH, V57, P265, DOI 10.1111/j.1863-2378.2009.01231.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Qi L, 2014, MBIO, V5, DOI 10.1128/mBio.02116-14; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Shi WF, 2013, PROTEIN CELL, V4, P846, DOI 10.1007/s13238-013-3083-0; Shi Y, 2014, NAT REV MICROBIOL, V12, P822, DOI 10.1038/nrmicro3362; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tzarum N, 2015, CELL HOST MICROBE, V17, P369, DOI 10.1016/j.chom.2015.02.005; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wang F., 2015, EMBO J; Wang GJ, 2014, J VIROL, V88, P3953, DOI 10.1128/JVI.03292-13; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Xiong XL, 2014, CURR TOP MICROBIOL, V385, P63, DOI 10.1007/82_2014_423; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Yang H, 2015, J VIROL, V89, P4612, DOI 10.1128/JVI.03456-14; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479; Zhang GH, 2011, INFECT GENET EVOL, V11, P1174, DOI 10.1016/j.meegid.2011.02.023; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	63	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134576	10.1371/journal.pone.0134576	http://dx.doi.org/10.1371/journal.pone.0134576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226046	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700112
J	Pedro, SLS; Alves, JMP; Barreto, AS; Lima, AOD				Sao Pedro, Simone Lima; Pereira Alves, Joao Marcelo; Barreto, Andre Silva; de Souza Lima, Andre Oliveira			Evidence of Positive Selection of Aquaporins Genes from Pontoporia blainvillei during the Evolutionary Process of Cetaceans	PLOS ONE			English	Article							AMINO-ACID SITES; PHYLOGENETIC ANALYSIS; WATER CHANNEL; SWISS-MODEL; KIDNEY; EXPRESSION; MEMBRANE; CLONING; OSMOREGULATION; COMPLEXES	Background Marine mammals are well adapted to their hyperosmotic environment. Several morphological and physiological adaptations for water conservation and salt excretion are known to be present in cetaceans, being responsible for regulating salt balance. However, most previous studies have focused on the unique renal physiology of marine mammals, but the molecular bases of these mechanisms remain poorly explored. Many genes have been identified to be involved in osmotic regulation, including the aquaporins. Considering that aquaporin genes were potentially subject to strong selective pressure, the aim of this study was to analyze the molecular evolution of seven aquaporin genes (AQP1, AQP2, AQP3, AQP4, AQP6, AQP7, and AQP9) comparing the lineages of cetaceans and terrestrial mammals. Results Our results demonstrated strong positive selection in cetacean-specific lineages acting only in the gene for AQP2 (amino acids 23, 83, 107,179, 180, 181, 182), whereas no selection was observed in terrestrial mammalian lineages. We also analyzed the changes in the 3D structure of the aquaporin 2 protein. Signs of strong positive selection in AQP2 sites 179, 180, 181, and 182 were unexpectedly identified only in the baiji lineage, which was the only river dolphin examined in this study. Positive selection in aquaporins AQP1 (45), AQP4 (74), AQP7 (342, 343, 356) was detected in cetaceans and artiodactyls, suggesting that these events are not related to maintaining water and electrolyte homeostasis in seawater. Conclusions Our results suggest that the AQP2 gene might reflect different selective pressures in maintaining water balance in cetaceans, contributing to the passage from the terrestrial environment to the aquatic. Further studies are necessary, especially those including other freshwater dolphins, who exhibit osmoregulatory mechanisms different from those of marine cetaceans for the same essential task of maintaining serum electrolyte balance.	[Sao Pedro, Simone Lima; de Souza Lima, Andre Oliveira] Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Genet Mol Lab, Itajai, SC, Brazil; [Pereira Alves, Joao Marcelo] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil; [de Souza Lima, Andre Oliveira] Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Lab Informat Biodiversidade & Geomat, Itajai, SC, Brazil	Universidade do Vale do Itajai; Universidade de Sao Paulo; Universidade do Vale do Itajai	Lima, AOD (corresponding author), Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Genet Mol Lab, Itajai, SC, Brazil.	andreolima@gmail.com	Alves, Joao M.P./G-8927-2011; Barreto, A. S./A-7707-2010; Lima, Andre O S/J-3626-2014	Alves, Joao M.P./0000-0001-5914-2087; Barreto, A. S./0000-0002-6606-0028; Lima, Andre O S/0000-0003-2261-2801	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) [563337/2010-9, 565062/2010-7]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil) [8588/2011-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil) [2013/14622-3]; Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil) [563337/2010-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, http://www.cnpq.br/) - Grant Process 563337/2010-9; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, http://www.cnpq.br/) - Grant Process 565062/2010-7; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil, http://www.fapesc.sc.gov.br/) - Grant Process 8588/2011-0; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil,http://www.fapesp.br/) - Grant Process 2013/14622-3 - JMPA support; Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil, http://www.capes.gov.br/) - Grant-Process 563337/2010-9 - SLSP support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BESTER M N, 1975, Madoqua Series II, V4, P69; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cauet E, 2005, J CHEM THEORY COMPUT, V1, P472, DOI 10.1021/ct049875k; Cohen E, 2012, ORNITHOL HERPETOL S, VS1, P1, DOI DOI 10.4172/2161-0983.S1-001; Costa DP, 2002, ENCY MARINE MAMMALS, P801; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; GRAUR D, 1985, J MOL EVOL, V22, P53, DOI 10.1007/BF02105805; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo A, 2014, ZOOLOGICAL STUDIES, V53, P1; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HUI CA, 1981, PHYSIOL ZOOL, V54, P430, DOI 10.1086/physzool.54.4.30155836; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Kovacs, 2006, MARINE MAMMALS EVOLU, P312, DOI [10.1016/B978-012088552-7/50013-8, DOI 10.1016/B978-012088552-7/50013-8]; Maluf NSR, 1998, ANAT RECORD, V250, P34; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Reeves R. R., 2012, PONTOPORIA BLAINVILL; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Secchi E.R., 2012, IUCN RED LIST THREAT; SECCHI ER, 2002, LATIN AM J AQUATIC M, V1, P11; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki M, 2008, J COMP PHYSIOL B, V178, P149, DOI 10.1007/s00360-007-0204-1; Vahedi-Faridi A, 2013, MICROSCOPY-JPN, V62, P95, DOI 10.1093/jmicro/dfs091; VARDY PH, 1981, J MORPHOL, V167, P13, DOI 10.1002/jmor.1051670103; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Xu Shixia, 2013, BMC Evolutionary Biology, V13, P1; Yamamoto T, 1998, KIDNEY INT, V54, P1041, DOI 10.1046/j.1523-1755.1998.00123.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134516	10.1371/journal.pone.0134516	http://dx.doi.org/10.1371/journal.pone.0134516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226365	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700105
J	Yoo, SW; Guevara, P; Jeong, Y; Yoo, K; Shin, JS; Mangin, JF; Seong, JK				Yoo, Sang Wook; Guevara, Pamela; Jeong, Yong; Yoo, Kwangsun; Shin, Joseph S.; Mangin, Jean-Francois; Seong, Joon-Kyung			An Example-Based Multi-Atlas Approach to Automatic Labeling of White Matter Tracts	PLOS ONE			English	Article							FIBER TRACTOGRAPHY; DIFFUSION MRI; SEGMENTATION; TRACKING; BRAIN	We present an example-based multi-atlas approach for classifying white matter (WM) tracts into anatomic bundles. Our approach exploits expert-provided example data to automatically classify the WM tracts of a subject. Multiple atlases are constructed to model the example data from multiple subjects in order to reflect the individual variability of bundle shapes and trajectories over subjects. For each example subject, an atlas is maintained to allow the example data of a subject to be added or deleted flexibly. A voting scheme is proposed to facilitate the multi-atlas exploitation of example data. For conceptual simplicity, we adopt the same metrics in both example data construction and WM tract labeling. Due to the huge number of WM tracts in a subject, it is time-consuming to label each WM tract individually. Thus, the WM tracts are grouped according to their shape similarity, and WM tracts within each group are labeled simultaneously. To further enhance the computational efficiency, we implemented our approach on the graphics processing unit (GPU). Through nested cross-validation we demonstrated that our approach yielded high classification performance. The average sensitivities for bundles in the left and right hemispheres were 89.5% and 91.0%, respectively, and their average false discovery rates were 14.9% and 14.2%, respectively.	[Yoo, Sang Wook; Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Yoo, Sang Wook; Shin, Joseph S.] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea; [Guevara, Pamela] CEA, I2BM, Gif Sur Yvette, France; [Guevara, Pamela; Mangin, Jean-Francois] Inst Federat Rech 49, Gif Sur Yvette, France; [Guevara, Pamela; Mangin, Jean-Francois] Univ Concepcion, Concepcion, Chile; [Jeong, Yong; Yoo, Kwangsun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Shin, Joseph S.] Handong Global Univ, Pohang, South Korea	Korea University; Korea Advanced Institute of Science & Technology (KAIST); CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidad de Concepcion; Korea Advanced Institute of Science & Technology (KAIST); Handong Global University	Seong, JK (corresponding author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.	jkseong@korea.ac.kr	Yoo, Kwangsun/F-1408-2014; Mangin, Jean-Francois/AAI-8983-2020; Guevara, Pamela/B-2300-2019; Jeong, Yong/C-1677-2011; Guevara, Pamela/AAZ-6221-2021; Shin, Sung Yong/C-1955-2011	Yoo, Kwangsun/0000-0002-5213-4575; Guevara, Pamela/0000-0001-9988-400X; Jeong, Yong/0000-0002-5907-3787; Guevara, Pamela/0000-0001-9988-400X; Yoo, Sang Wook/0000-0002-5404-4397	National Research Foundation of Korea (NRF) [NRF-2012R1A1B3004157]; Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea 567 [HI14C2768]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government (MSIP) [B0101-15-247]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea 567; Institute for Information & communications Technology Promotion(IITP) grant - Korea government (MSIP)	This work was partially supported by the National Research Foundation of Korea (NRF) (No. NRF-2012R1A1B3004157), a grant of the Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea 567 (grant number: HI14C2768), and by Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government (MSIP) (No. B0101-15-247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazin PL, 2011, NEUROIMAGE, V58, P458, DOI 10.1016/j.neuroimage.2011.06.020; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dodero L, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00087; Duda R.O., 2006, PATTERN CLASSIFICATI; Fowlkes C, 2004, IEEE T PATTERN ANAL, V26, P214, DOI 10.1109/TPAMI.2004.1262185; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Goh A, 2009, LECT NOTES COMPUT SC, V5761, P877, DOI 10.1007/978-3-642-04268-3_108; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Goodlett CB, 2009, NEUROIMAGE, V45, pS133, DOI 10.1016/j.neuroimage.2008.10.060; Guevara P, 2012, NEUROIMAGE, V61, P1083, DOI 10.1016/j.neuroimage.2012.02.071; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Guevara P, 2009, MICCAI 2009 WORKSH D; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jin Y, 2014, NEUROIMAGE, V100, P75, DOI 10.1016/j.neuroimage.2014.04.048; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Labra N, 2014, IEEE ENG MED BIO, P2376, DOI 10.1109/EMBC.2014.6944099; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nvidia, 2022, CUD 11 2; O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2012, NEUROIMAGE, V60, P456, DOI 10.1016/j.neuroimage.2011.11.014; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; Perrin M, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/368406; Poupon C., 2006, P 12 ANN M ORG HUM B; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Santos-Pereira CM, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P291; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tunc B, 2014, NEUROIMAGE, V102, P596, DOI 10.1016/j.neuroimage.2014.08.021; Visser E, 2011, NEUROIMAGE, V54, P303, DOI 10.1016/j.neuroimage.2010.07.038; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang Q, 2013, HUM BRAIN MAPP, V34, P2089, DOI 10.1002/hbm.22051; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050; Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004; Wu X, 2012, MAGN RESON IMAGING, V30, P485, DOI 10.1016/j.mri.2011.12.017; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	57	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133337	10.1371/journal.pone.0133337	http://dx.doi.org/10.1371/journal.pone.0133337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225419	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700018
J	Ishihara, Y; Takemoto, T; Itoh, K; Ishida, A; Yamazaki, T				Ishihara, Yasuhiro; Takemoto, Takuya; Itoh, Kouichi; Ishida, Atsuhiko; Yamazaki, Takeshi			Dual Role of Superoxide Dismutase 2 Induced in Activated Microglia OXIDATIVE STRESS TOLERANCE AND CONVERGENCE OF INFLAMMATORY RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; NADPH OXIDASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL ROS; INTERFERON-GAMMA; REDOX REGULATION; NEURONAL INJURY; GENE-EXPRESSION	Microglia are activated quickly in response to external pathogens or cell debris and clear these substances via the inflammatory response. However, excessive activation of microglia can be harmful to host cells due to the increased production of reactive oxygen species and proinflammatory cytokines. Superoxide dismutase 2 (SOD2) is reportedly induced under various inflammatory conditions in the central nervous system. We herein demonstrated that activated microglia strongly express SOD2 and examined the role of SOD2, focusing on regulation of the microglial activity and the susceptibility of microglia to oxidative stress. When rat primary microglia were treated with LPS, poly(I:C), peptidoglycan, or CpG oligodeoxynucleotide, respectively, the mRNA and protein levels of SOD2 largely increased. However, an increased expression of SOD2 was not detected in the primary neurons or astrocytes, indicating that SOD2 is specifically induced in microglia under inflammatory conditions. The activated microglia showed high tolerance to oxidative stress, whereas SOD2 knockdown conferred vulnerability to oxidative stress. Interestingly, the production of proinflammatory cytokines was increased in the activated microglia treated with SOD2 siRNA compared with that observed in the control siRNA-treated cells. Pretreatment with NADPH oxidase inhibitors, diphenylene iodonium and apocynin, decreased in not only reactive oxygen species generation but also the proinflammatory cytokine expression. Notably, SOD2 knockdown largely potentiated the nuclear factor kappa B activity in the activated microglia. Taken together, increased SOD2 conferred tolerance to oxidative stress in the microglia and decreased proinflammatory cytokine production by attenuating the nuclear factor kappa B activity. Therefore, SOD2 might regulate neuroinflammation by controlling the microglial activities.	[Ishihara, Yasuhiro] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Lab Mol Brain Sci, Higashihiroshima 7398521, Japan; [Itoh, Kouichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Brain Sci, Sanuki, Kagawa 7692193, Japan	Hiroshima University; Tokushima Bunri University	Ishihara, Y (corresponding author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, Lab Mol Brain Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.	ishiyasu@hiroshima-u.ac.jp	Ishihara, Yasuhiro/U-6511-2017	Ishihara, Yasuhiro/0000-0001-9751-7660	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26740024, 30291149, 22310041]; Fujii Foundation; Hiroshima University Education and Research Support Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujii Foundation; Hiroshima University Education and Research Support Foundation	This work was supported in part by KAKENHI Grants 26740024, 30291149, and 22310041 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. I., K. I., and T. Y.); a grant from the Fujii Foundation (to Y. I.); and a grant from the Hiroshima University Education and Research Support Foundation (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Borrello S, 1997, ARCH BIOCHEM BIOPHYS, V348, P289, DOI 10.1006/abbi.1997.0355; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chen X, 2009, FREE RADICAL BIO MED, V46, P1204, DOI 10.1016/j.freeradbiomed.2009.01.027; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; DECHATELET LR, 1975, J CLIN INVEST, V55, P714, DOI 10.1172/JCI107981; Egger T, 2003, BIOCHEM J, V370, P459, DOI 10.1042/BJ20021358; Fullerton JM, 2010, BIPOLAR DISORD, V12, P550, DOI 10.1111/j.1399-5618.2010.00834.x; Galecki P, 2010, PSYCHIAT RES, V179, P43, DOI 10.1016/j.psychres.2009.06.016; Godbout JP, 2004, J NEUROIMMUNOL, V149, P101, DOI 10.1016/j.jneuroim.2003.12.017; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hu ZQ, 2014, TOXICOL APPL PHARM, V276, P95, DOI 10.1016/j.taap.2014.01.020; Ishihara Y, 2006, TOXICOL APPL PHARM, V214, P109, DOI 10.1016/j.taap.2005.12.003; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Ishihara Y, 2014, LIFE SCI, V99, P24, DOI 10.1016/j.lfs.2014.01.061; Ishihara Y, 2012, NEUROCHEM INT, V60, P782, DOI 10.1016/j.neuint.2012.03.004; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; ITOH K, 1992, BRAIN RES, V580, P233, DOI 10.1016/0006-8993(92)90949-A; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kairisalo M, 2007, BIOCHEM BIOPH RES CO, V364, P138, DOI 10.1016/j.bbrc.2007.09.115; Kaneko M, 2004, BIOL PHARM BULL, V27, P1202, DOI 10.1248/bpb.27.1202; Kaneko YS, 2012, CLIN EXP PHARMACOL P, V39, P599, DOI 10.1111/j.1440-1681.2012.05716.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiningham KK, 2008, FREE RADICAL BIO MED, V44, P1610, DOI 10.1016/j.freeradbiomed.2008.01.015; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Kramer BC, 2002, NEUROSCIENCE, V114, P361, DOI 10.1016/S0306-4522(02)00310-X; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Li YK, 2001, J NEUROSCI RES, V66, P163, DOI 10.1002/jnr.1208; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Sugaya K, 1998, MOL BRAIN RES, V58, P1, DOI 10.1016/S0169-328X(97)00365-3; Sugaya K, 1997, NEUROREPORT, V8, P3547, DOI 10.1097/00001756-199711100-00026; Takemoto T, 2015, ENVIRON TOXICOL PHAR, V40, P199, DOI 10.1016/j.etap.2015.06.010; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wang VC, 2010, CLIN BIOCHEM, V43, P979, DOI 10.1016/j.clinbiochem.2010.05.009; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Warner BB, 1996, AM J PHYSIOL-LUNG C, V271, pL150, DOI 10.1152/ajplung.1996.271.1.L150; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	56	60	63	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22805	22817		10.1074/jbc.M115.659151	http://dx.doi.org/10.1074/jbc.M115.659151			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231211	Green Published, hybrid			2022-12-26	WOS:000361171500043
J	Hu, CY; Yu, CF; Liu, YH; Hou, XH; Liu, XY; Hu, YF; Jin, CW				Hu, Cuiyun; Yu, Caifang; Liu, Yanhua; Hou, Xianhui; Liu, Xiaoyun; Hu, Yunfei; Jin, Changwen			A Hybrid Mechanism for the Synechocystis Arsenate Reductase Revealed by Structural Snapshots during Arsenate Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; AUREUS PLASMID PI258; BACILLUS-SUBTILIS; PCC 6803; NOE ASSIGNMENT; PROTEIN; CYANOBACTERIUM; DETOXIFICATION; PHOSPHATASES; RESISTANCE	Evolution of enzymes plays a crucial role in obtaining new biological functions for all life forms. Arsenate reductases (ArsC) are several families of arsenic detoxification enzymes that reduce arsenate to arsenite, which can subsequently be extruded from cells by specific transporters. Among these, the Synechocystis ArsC (SynArsC) is structurally homologous to the well characterized thioredoxin (Trx)-coupled ArsC family but requires the glutaredoxin (Grx) system for its reactivation, therefore classified as a unique Trx/Grx-hybrid family. The detailed catalytic mechanism of SynArsC is unclear and how the "hybrid" mechanism evolved remains enigmatic. Herein, we report the molecular mechanism of SynArsC by biochemical and structural studies. Our work demonstrates that arsenate reduction is carried out via an intramolecular thiol-disulfide cascade similar to the Trx-coupled family, whereas the enzyme reactivation step is diverted to the coupling of the glutathione-Grx pathway due to the local structural difference. The current results support the hypothesis that SynArsC is likely a molecular fossil representing an intermediate stage during the evolution of the Trx-coupled ArsC family from the low molecular weight protein phosphotyrosine phosphatase (LMW-PT Pase) family.	[Hu, Cuiyun; Yu, Caifang; Liu, Yanhua; Hou, Xianhui; Liu, Xiaoyun; Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Cuiyun; Yu, Caifang; Hou, Xianhui; Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022		National Natural Science Foundation of China [31170681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 31170681 from the National Natural Science Foundation of China (to C. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett MS, 2001, P NATL ACAD SCI USA, V98, P13577, DOI 10.1073/pnas.241397198; Bohari Y, 2002, J ENVIRON MONITOR, V4, P596, DOI 10.1039/b203988p; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Demel S, 2004, PROTEIN SCI, V13, P2330, DOI 10.1110/ps.04787204; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo XR, 2005, J BIOL CHEM, V280, P39601, DOI 10.1074/jbc.M508132200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu M, 2014, J PROTEOMICS, V109, P16, DOI 10.1016/j.jprot.2014.06.017; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; Kim SG, 2012, BBA-PROTEINS PROTEOM, V1824, P392, DOI [10.1016/j.bbapap.2011.10.012, 10.1016/j.bbapap.2011.11.012]; Li RH, 2003, J BACTERIOL, V185, P6780, DOI 10.1128/JB.185.23.6780-6789.2003; Li Y, 2007, J BIOL CHEM, V282, P11078, DOI 10.1074/jbc.M700970200; Lopez-Maury L, 2009, J BACTERIOL, V191, P3534, DOI 10.1128/JB.01798-08; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Messens J, 2002, J BIOL INORG CHEM, V7, P146, DOI 10.1007/s007750100282; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Slejkovec Z, 1999, TALANTA, V49, P619, DOI 10.1016/S0039-9140(99)00048-X; Suginaka K, 1999, BIOSCI BIOTECH BIOCH, V63, P1112, DOI 10.1271/bbb.63.1112; Yu CF, 2011, BIOMOL NMR ASSIGN, V5, P85, DOI 10.1007/s12104-010-9273-2; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843	38	5	6	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22262	22273		10.1074/jbc.M115.659896	http://dx.doi.org/10.1074/jbc.M115.659896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26224634	Green Published, hybrid			2022-12-26	WOS:000360968500042
J	Knight, D; Iliadi, KG; Iliadi, N; Wilk, R; Hu, J; Krause, HM; Taylor, P; Moran, MF; Boulianne, GL				Knight, David; Iliadi, Konstantin G.; Iliadi, Natalia; Wilk, Ronit; Hu, Jack; Krause, Henry M.; Taylor, Paul; Moran, Michael F.; Boulianne, Gabrielle L.			Distinct Regulation of Transmitter Release at the Drosophila NMJ by Different Isoforms of nemy	PLOS ONE			English	Article							LARVAL NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; VESICLE POOLS; OCTOPAMINE; MUTANT; NEUROPEPTIDE; MEMORY; MELANOGASTER; DOPAMINE; PLASTICITY	Synaptic transmission is highly plastic and subject to regulation by a wide variety of neuromodulators and neuropeptides. In the present study, we have examined the role of isoforms of the cytochrome b561 homologue called no extended memory (nemy) in regulation of synaptic strength and plasticity at the neuromuscular junction (NMJ) of third instar larvae in Drosophila. Specifically, we generated two independent excisions of nemy that differentially affect the expression of nemy isoforms. We show that the nemy(45) excision, which specifically reduces the expression of the longest splice form of nemy, leads to an increase in stimulus evoked transmitter release and altered synaptic plasticity at the NMJ. Conversely, the nemy(26.2) excision, which appears to reduce the expression of all splice forms except the longest splice isoform, shows a reduction in stimulus evoked transmitter release, and enhanced synaptic plasticity. We further show that nemy45 mutants have reduced levels of amidated peptides similar to that observed in peptidyl-glycine hydryoxylating mono-oxygenase (PHM) mutants. In contrast, nemy26.2 mutants show no defects in peptide amidation but rather display a decrease in Tyramine beta hydroxylase activity (T beta H). Taken together, these results show non-redundant roles for the different nemy isoforms and shed light on the complex regulation of neuromodulators.	[Knight, David; Iliadi, Konstantin G.; Boulianne, Gabrielle L.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada; [Moran, Michael F.; Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Hu, Jack; Krause, Henry M.] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Taylor, Paul; Moran, Michael F.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Boulianne, GL (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada.	gboul@sickkids.ca	Knight, David/U-4162-2017; Moran, Michael/GYD-3631-2022	Krause, Henry/0000-0002-6182-7074	Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research (FRN) [14143]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (FRN)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to GLB from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research (FRN#14143). GLB is the recipient of a Tier I Canada Research Chair in Molecular and Developmental Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Bousquet-Moore D, 2010, J NEUROSCI RES, V88, P2535, DOI 10.1002/jnr.22404; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Curran KP, 2012, INVERTEBR NEUROSCI, V12, P81, DOI 10.1007/s10158-012-0140-y; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Dunn TW, 2005, PEPTIDES, V26, P269, DOI 10.1016/j.peptides.2004.09.010; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; FLEMING PJ, 1991, AM J CLIN NUTR, V54, pS1173, DOI 10.1093/ajcn/54.6.1173s; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hess CR, 2008, J BIOL CHEM, V283, P3042, DOI 10.1074/jbc.M705911200; Hewes RS, 1998, J NEUROSCI, V18, P7138; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Kamyshev NG, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-9; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Klose MK, 2010, J NEUROSCI, V30, P14724, DOI 10.1523/JNEUROSCI.3612-10.2010; Knight D, 2007, DEV NEUROBIOL, V67, P1598, DOI 10.1002/dneu.20532; Knight D, 2010, J NEUROSCI, V30, P5047, DOI 10.1523/JNEUROSCI.6241-09.2010; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Koon AC, 2012, J NEUROSCI, V32, P6312, DOI 10.1523/JNEUROSCI.6517-11.2012; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Kuromi H, 2003, J NEUROCYTOL, V32, P551, DOI 10.1023/B:NEUR.0000020610.13554.3c; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Lee MG, 2011, NEUROREPORT, V22, P609, DOI 10.1097/WNR.0b013e3283495a6e; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Park D, 2011, CURR BIOL, V21, P1515, DOI 10.1016/j.cub.2011.08.015; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Saito TH, 2010, J NEUROPHYSIOL, V104, P3518, DOI 10.1152/jn.01027.2009; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Taghert PH, 1999, MICROSC RES TECHNIQ, V45, P80, DOI 10.1002/(SICI)1097-0029(19990415)45:2<80::AID-JEMT3>3.0.CO;2-X; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Vautrin J, 2003, SYNAPSE, V47, P184, DOI 10.1002/syn.10161; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wilk R., 2010, SITU HYBRIDIZATION F; Wu CL, 2013, CURR BIOL, V23, P2346, DOI 10.1016/j.cub.2013.09.056; Wu Wen-Hui, 2012, Exp Neurobiol, V21, P101, DOI 10.5607/en.2012.21.3.101; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0132548	10.1371/journal.pone.0132548	http://dx.doi.org/10.1371/journal.pone.0132548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237434	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400008
J	Sheft, S; Shafiro, V; Wang, E; Barnes, LL; Shah, RC				Sheft, Stanley; Shafiro, Valeriy; Wang, Emily; Barnes, Lisa L.; Shah, Raj C.			Relationship between Auditory and Cognitive Abilities in Older Adults	PLOS ONE			English	Article							IN-NOISE PERCEPTION; HEARING-LOSS; ALZHEIMERS-DISEASE; WORKING-MEMORY; SHORT-TERM; INDIVIDUAL-DIFFERENCES; AFRICAN-AMERICANS; SPEECH-PERCEPTION; COMPLEX SPAN; RISK-FACTORS	Objective The objective was to evaluate the association of peripheral and central hearing abilities with cognitive function in older adults. Methods Recruited from epidemiological studies of aging and cognition at the Rush Alzheimer's Disease Center, participants were a community-dwelling cohort of older adults (range 63-98 years) without diagnosis of dementia. The cohort contained roughly equal numbers of Black (n=61) and White (n=63) subjects with groups similar in terms of age, gender, and years of education. Auditory abilities were measured with pure-tone audiometry, speech-in-noise perception, and discrimination thresholds for both static and dynamic spectral patterns. Cognitive performance was evaluated with a 12-test battery assessing episodic, semantic, and working memory, perceptual speed, and visuospatial abilities. Results Among the auditory measures, only the static and dynamic spectral-pattern discrimination thresholds were associated with cognitive performance in a regression model that included the demographic covariates race, age, gender, and years of education. Subsequent analysis indicated substantial shared variance among the covariates race and both measures of spectral-pattern discrimination in accounting for cognitive performance. Among cognitive measures, working memory and visuospatial abilities showed the strongest interrelationship to spectral-pattern discrimination performance. Conclusions For a cohort of older adults without diagnosis of dementia, neither hearing thresholds nor speech-in-noise ability showed significant association with a summary measure of global cognition. In contrast, the two auditory metrics of spectral-pattern discrimination ability significantly contributed to a regression model prediction of cognitive performance, demonstrating association of central auditory ability to cognitive status using auditory metrics that avoided the confounding effect of speech materials.	[Sheft, Stanley; Shafiro, Valeriy; Wang, Emily] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA; [Barnes, Lisa L.; Shah, Raj C.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University	Sheft, S (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA.	ssheft@gmail.com	Shah, Raj/AAS-2210-2021	Shah, Raj/0000-0001-9706-9730; Wang, Emily/0000-0001-6020-6228; Shafiro, Valeriy/0000-0002-5722-748X	National Institute on Deafness and Other Communication Disorders [R15DC011916]; National Institute on Aging [R01AG022018, R01AG017917, P30AG010161]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG022018, R01AG017917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC011916] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R15DC011916 from the National Institute on Deafness and Other Communication Disorders, www.nidcd.nih.gov, to SS; R01AG022018 from the National Institute on Aging, www.nia.nih.gov, to LLB; R01AG017917 from the National Institute on Aging, www.nia.nih.gov, to Rush Alzheimer's Disease Center; P30AG010161 from the National Institute on Aging, www.nia.nih.gov, to Rush Alzheimer's Disease Center; and the Illinois Department of Public Health, www.idphgrants.com, to Rush Alzheimer's Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; [Anonymous], 1994, ASSESSMENT CLIN MANU; Anstey KJ, 2003, J EXP PSYCHOL GEN, V132, P470, DOI 10.1037/0096-3445.132.3.470; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barnes LL, 2012, J INT NEUROPSYCH SOC, V18, P856, DOI 10.1017/S1355617712000628; Barnes LL, 2014, HEALTH AFFAIR, V33, P580, DOI 10.1377/hlthaff.2013.1353; Barnes LL, 2011, J GERONTOL B-PSYCHOL, V66, P354, DOI 10.1093/geronb/gbr016; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Besser J, 2012, J SPEECH LANG HEAR R, V55, P194, DOI 10.1044/1092-4388(2011/11-0008); Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; CHABA, 1988, J ACOUST SOC AM, V83, P859, DOI [DOI 10.1121/1.395965, 10.1121/1.395965]; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Etymotic Research, 2001, QUICK SPEECH IN NOIS; Fogerty D, 2010, J ACOUST SOC AM, V127, P2509, DOI 10.1121/1.3316291; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fostick Leah, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P175, DOI 10.1515/jbcpp-2013-0048; Fullgrabe C, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00347; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Gatehouse Stuart, 2003, Int J Audiol, V42 Suppl 1, pS77, DOI 10.3109/14992020309074648; GATES GA, 1995, ARCH NEUROL-CHICAGO, V52, P626, DOI 10.1001/archneur.1995.00540300108020; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Gates GA, 2011, ARCH OTOLARYNGOL, V137, P390, DOI 10.1001/archoto.2011.28; Gates GA, 2010, COGN BEHAV NEUROL, V23, P218, DOI 10.1097/WNN.0b013e3181d748d7; GENNIS V, 1991, ARCH INTERN MED, V151, P2259, DOI 10.1001/archinte.151.11.2259; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Gussekloo J, 2005, AM J GERIAT PSYCHIAT, V13, P781, DOI 10.1176/appi.ajgp.13.9.781; Hofer SM, 2003, PSYCHOL AGING, V18, P285, DOI 10.1037/0882-7974.18.2.285; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Humes LE, 2010, SPRINGER HANDB AUDIT, V34, P211, DOI 10.1007/978-1-4419-0993-0_8; Humes LE, 2002, J ACOUST SOC AM, V112, P1112, DOI 10.1121/1.1499132; Idrizbegovic E, 2011, AGE AGEING, V40, P249, DOI 10.1093/ageing/afq168; Iliadou Vassiliki, 2003, Ann Gen Hosp Psychiatry, V2, P12, DOI 10.1186/1475-2832-2-12; KURYLO DD, 1993, NEUROLOGY, V43, P1893, DOI 10.1212/WNL.43.10.1893; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nimon K., 2010, MULTIPLE LINEAR REGR, V36, P10, DOI DOI 10.2106/JBJS.M.00521; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Pratt SR, 2009, J SPEECH LANG HEAR R, V52, P973, DOI 10.1044/1092-4388(2009/08-0026); RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Raven JC., 1992, MANUAL RAVENS PROGR; Redick TS, 2013, PSYCHON B REV, V20, P1102, DOI 10.3758/s13423-013-0453-9; Ronnberg J, 2011, J SPEECH LANG HEAR R, V54, P705, DOI 10.1044/1092-4388(2010/09-0088); Schneider BA, 2011, AUDIOL RES, V1, P34, DOI 10.4081/audiores.2011.e10; Schneider BA, 2002, CAN J EXP PSYCHOL, V56, P139, DOI 10.1037/h0087392; Schoof T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00307; Sheft S., 2012, SPEECH PERCEPTION AU, P481; Smith A., 1982, SYMBOL DIGIT MODALIT; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STROUSE AL, 1995, EAR HEARING, V16, P230, DOI 10.1097/00003446-199504000-00010; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; VANROOIJ JCGM, 1992, J ACOUST SOC AM, V91, P1028, DOI 10.1121/1.402628; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179	65	19	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134330	10.1371/journal.pone.0134330	http://dx.doi.org/10.1371/journal.pone.0134330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237423	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942400022
J	Penna, M; Moreno-Gomez, FN				Penna, Mario; Moreno-Gomez, Felipe N.			Contrasting Propagation of Natural Calls of Two Anuran Species from the South American Temperate Forest	PLOS ONE			English	Article							EVOKED VOCAL RESPONSES; ADVERTISEMENT CALLS; SOUND-TRANSMISSION; FROG; HABITAT; NOISE; SONG; EVOLUTION; COMMUNICATION; SEGREGATION	The acoustic adaptation hypothesis predicts that sound communication signals have an optimal relationship with animals' native environments. However, species sharing a habitat produce signals stratified in the spectral domain and exhibit different temporal patterns resulting in acoustic niche partitioning. The diversity generated is likely to affect differently the characteristics of propagating signals. We recorded at various distances from the sound source calls of the frogs Eupsophus calcaratus and E. emiliopugini in the austral temperate forest where they communicate and breed syntopically. The calls of E. calcaratus have higher frequency components and lower amplitude relative to calls of E. emiliopugini, and the acoustic active space for the signals of E. calcaratus is restricted relative to E. emiliopugini. The signals of both species experience similar attenuation patterns, but calls of E. calcaratus are affected by spectral degradation to a larger extent, with linear decreases in spectral cross-correlation and in the amplitude ratio between the first two harmonics. The calls of E. emiliopugini are affected by temporal degradation as a linear decrease in amplitude modulation depth of their pulsed structure. Further studies are needed to assess the relative importance of selective and phylogenetic factors on the divergent propagation patterns reported.	[Penna, Mario; Moreno-Gomez, Felipe N.] Univ Chile, Fac Med, Inst Biomed Sci, Program Physiol & Biophys, Santiago, Chile	Universidad de Chile	Penna, M (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Program Physiol & Biophys, Independencia 838000, Santiago, Chile.	mpenna@med.uchile.cl	Moreno-Gómez, Felipe N/N-7148-2014; Moreno-Gómez, Felipe N./Q-5072-2019	Moreno-Gómez, Felipe N/0000-0001-5715-309X; Moreno-Gómez, Felipe N./0000-0001-5715-309X	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110939]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by Proyecto 1110939 Fondo Nacional de Desarrollo Cientifico y Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D.M., 2010, LME4 MIXED EFFECTS M; Boncoraglio G, 2007, FUNCT ECOL, V21, P134, DOI 10.1111/j.1365-2435.2006.01207.x; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bradbury Jack W., 1998, pi; BRENOWITZ EA, 1986, BRAIN BEHAV EVOLUT, V28, P32, DOI 10.1159/000118690; BROWN CH, 1984, Z TIERPSYCHOL, V65, P273; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Correa C, 2006, REV CHIL HIST NAT, V79, P435, DOI 10.4067/S0716-078X2006000400003; Couldridge VCK, 2004, J EXP BIOL, V207, P2777, DOI 10.1242/jeb.01092; EMBLETON TFW, 1976, J ACOUST SOC AM, V59, P267, DOI 10.1121/1.380882; Erdtmann LK, 2013, ETHOL ECOL EVOL, V25, P1, DOI 10.1080/03949370.2012.744356; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; FORREST TG, 1994, AM ZOOL, V34, P644; Garcia-Rutledge EJ, 2001, HERPETOLOGICA, V57, P104; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gingras B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-134; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Kuczynski MC, 2010, J EXP BIOL, V213, P2840, DOI 10.1242/jeb.044628; Luther D, 2009, BEHAV ECOL, V20, P864, DOI 10.1093/beheco/arp074; Malone JH, 2014, EVOLUTION, V68, P1306, DOI 10.1111/evo.12366; Moreno-Gomez FN, 2013, BIOL J LINN SOC, V110, P814, DOI 10.1111/bij.12156; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Mouterde SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102842; Parris KM, 2002, ECOL MODEL, V156, P213, DOI 10.1016/S0304-3800(02)00170-9; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Penna M, 2006, J ACOUST SOC AM, V119, P1227, DOI 10.1121/1.2149769; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2005, HERPETOLOGICA, V61, P1, DOI 10.1655/04-21; Penna M, 2004, J ACOUST SOC AM, V116, P1254, DOI 10.1121/1.1768257; Penna M, 1999, BEHAV ECOL SOCIOBIOL, V47, P94, DOI 10.1007/s002650050654; Penna M, 1996, ANIM BEHAV, V51, P255, DOI 10.1006/anbe.1996.0026; PENNA M, 1990, J HERPETOL, V24, P23, DOI 10.2307/1564285; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Penna M, 2007, ETHOLOGY, V113, P313, DOI 10.1111/j.1439-0310.2007.01339.x; Penna M, 2014, J COMP PHYSIOL A, V200, P171, DOI 10.1007/s00359-013-0875-x; Penna M, 2013, J COMP PHYSIOL A, V199, P723, DOI 10.1007/s00359-013-0831-9; Penna M, 2012, J ACOUST SOC AM, V132, P4025, DOI 10.1121/1.4763982; PIERCY JE, 1977, J ACOUST SOC AM, V61, P1403, DOI 10.1121/1.381455; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2010, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; ROBISSON P, 1991, BEHAVIOUR, V119, P302, DOI 10.1163/156853991X00490; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 1998, SPR HDB AUD, V10, P63; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt AKD, 2013, BEHAV ECOL, V24, P470, DOI 10.1093/beheco/ars187; SHY E, 1983, BEHAV ECOL SOCIOBIOL, V12, P71, DOI 10.1007/BF00296935; SORJONEN J, 1986, BEHAVIOUR, V98, P274, DOI 10.1163/156853986X01008; Sueur J, 2003, NATURWISSENSCHAFTEN, V90, P322, DOI 10.1007/s00114-003-0432-5; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Zaveri M, 1988, ACOUSTIC NOISE MEASU; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	54	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134498	10.1371/journal.pone.0134498	http://dx.doi.org/10.1371/journal.pone.0134498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230852	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400128
J	Pompey, JM; Foda, B; Singh, U				Pompey, Justine M.; Foda, Bardees; Singh, Upinder			A Single RNaseIII Domain Protein from Entamoeba histolytica Has dsRNA Cleavage Activity and Can Help Mediate RNAi Gene Silencing in a Heterologous System	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TRYPANOSOMA-BRUCEI; INTERFERENCE PATHWAYS; PROTOZOAN PARASITE; C-ELEGANS; DICER; DISTINCT; BINDING; ROLES; RIBONUCLEASE	Dicer enzymes process double-stranded RNA (dsRNA) into small RNAs that target gene silencing through the RNA interference (RNAi) pathway. Dicer enzymes are complex, multidomain RNaseIII proteins, however structural minimalism of this protein has recently emerged in parasitic and fungal systems. The most minimal Dicer, Saccharomyces castellii Dicer1, has a single RNaseIII domain and two double stranded RNA binding domains. In the protozoan parasite Entamoeba histolytica 27nt small RNAs are abundant and mediate silencing, yet no canonical Dicer enzyme has been identified. Although EhRNaseIII does not exhibit robust dsRNA cleavage in vitro, it can process dsRNA in the RNAi-negative background of Saccharomyces cerevisiae, and in conjunction with S. castellii Argonaute1 can partially reconstitute the RNAi pathway. Thus, although EhRNaseIII lacks the domain architecture of canonical or minimal Dicer enzymes, it has dsRNA processing activity that contributes to gene silencing via RNAi. Our data advance the understanding of small RNA biogenesis in Entamoeba as well as broaden the spectrum of non-canonical Dicer enzymes that contribute to the RNAi pathway.	[Pompey, Justine M.; Singh, Upinder] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Foda, Bardees; Singh, Upinder] Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA; [Foda, Bardees] Natl Res Ctr, Mol Genet & Enzymol Dept, Dokki, Egypt	Stanford University; Stanford University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Singh, U (corresponding author), Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA.	usingh@stanford.edu	Foda, Bardees/B-2182-2019	Foda, Bardees/0000-0001-8869-3697; Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [AI53724, AI085178, T32 AI07328]; American Society for Microbiology Watkins Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053724, R21AI085178, T32AI007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Microbiology Watkins Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI53724 to US, AI085178 to US, and T32 AI07328 to JMP) and American Society for Microbiology Watkins Fellowship to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Astromskas E, 2007, YEAST, V24, P499, DOI 10.1002/yea.1488; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; GUNZL A, 1995, J BIOL CHEM, V270, P17287, DOI 10.1074/jbc.270.29.17287; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kohrer K., 1991, METHOD ENZYMOL, V194, P398, DOI DOI 10.1016/0076-6879(91)94030-G; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MacFarlane RC, 2007, EUKARYOT CELL, V6, P2139, DOI 10.1128/EC.00174-07; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morf L, 2013, NUCLEIC ACIDS RESEAR, V9, P2013; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Parrish S, 2001, RNA, V7, P1397; Patrick KL, 2009, P NATL ACAD SCI USA, V106, P17933, DOI 10.1073/pnas.0907766106; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Shi HF, 2006, RNA, V12, P2063, DOI 10.1261/rna.246906; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Suk K, 2011, NUCLEIC ACIDS RES, V39, pE43, DOI 10.1093/nar/gkq1321; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang HB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-53; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219; Zhang HP, 2008, STAT INTERFACE, V1, P1	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133740	10.1371/journal.pone.0133740	http://dx.doi.org/10.1371/journal.pone.0133740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230096	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400054
J	Gurt, I; Artsi, H; Cohen-Kfir, E; Hamdani, G; Ben-Shalom, G; Feinstein, B; El-Haj, M; Dresner-Pollak, R				Gurt, Irina; Artsi, Hanna; Cohen-Kfir, Einav; Hamdani, Gilad; Ben-Shalom, Gal; Feinstein, Ben; El-Haj, Madi; Dresner-Pollak, Rivka			The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE ACTIVATION; BETA-CATENIN; DIFFERENTIATION; RESVERATROL; MICE; TRANSCRIPTION; ACETYLATION; MECHANISM; SRT1720	Increased osteoclast-mediated bone resorption is characteristic of osteoporosis, malignant bone disease and inflammatory arthritis. Targeted deletion of Sirtuin1 (Sirt1), a key player in aging and metabolism, in osteoclasts results in increased osteoclast-mediated bone resorption in vivo, making it a potential novel therapeutic target to block bone resorption. Sirt1 activating compounds (STACs) were generated and were investigated in animal disease models and in humans however their mechanism of action was a source of controversy. We studied the effect of SRT2183 and SRT3025 on osteoclastogenesis in bonemarrow derived macrophages (BMMs) in vitro, and discovered that these STACs inhibit RANKL-induced osteoclast differentiation, fusion and resorptive capacity without affecting osteoclast survival. SRT2183 and SRT3025 activated AMPK, increased Sirt1 expression and decreased RelA/p65 lysine310 acetylation, critical for NF-kappa B activation, and an established Sirt1 target. However, inhibition of osteoclastogenesis by these STACs was also observed in BMMs derived from sirt1 knock out (sirt1(-/-)) mice lacking the Sirt1 protein, in which neither AMPK nor RelA/p65 lysine 310 acetylation was affected, confirming that these effects require Sirt1, but suggesting that Sirt1 is not essential for inhibition of osteoclastogenesis by these STACs under these conditions. In sirt1 null osteoclasts treated with SRT2183 or SRT3025 Sirt3 was found to be down-regulated. Our findings suggest that SRT2183 and SRT3025 activate Sirt1 and inhibit RANKL-induced osteoclastogenesis in vitro however under conditions of Sirt1 deficiency can affect Sirt3. As aging is associated with reduced Sirt1 level and activity, the influence of STACs on Sirt3 needs to be investigated in vivo in animal and human disease models of aging and osteoporosis.	[Gurt, Irina; Artsi, Hanna; Cohen-Kfir, Einav; Hamdani, Gilad; Ben-Shalom, Gal; Dresner-Pollak, Rivka] Hadassah Hebrew Univ Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Feinstein, Ben] Hebrew Univ Jerusalem, Einstein Inst Math, Jerusalem, Israel; [El-Haj, Madi] Hadassah Hebrew Univ Med Ctr, Dept Orthoped, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Dresner-Pollak, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel.	rivkap@hadassah.org.il			Israel Science Foundation [842/10]; Ministry of Health, Israel [3_3926]; Hadassah Women Organization research fund Joint Research Fund of Hadassah; Hebrew University	Israel Science Foundation(Israel Science Foundation); Ministry of Health, Israel; Hadassah Women Organization research fund Joint Research Fund of Hadassah; Hebrew University	The Israel Science Foundation Grant 842/10 (http://www.isf.org.il/english), The Chief Scientist, Ministry of Health, Israel, Grant 3_3926 (http://www.old.health.gov.il/english/Pages_E/default.asp?maincat=12&catId=20&PageId=79) Hadassah Women Organization research fund Joint Research Fund of Hadassah and the Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Deng FY, 2008, PROTEOMICS, V8, P4259, DOI 10.1002/pmic.200700480; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Nguyen GTT, 2013, ACTA CRYSTALLOGR D, V69, P1423, DOI 10.1107/S0907444913015448; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Huber JL, 2010, FUTURE MED CHEM, V2, P1751, DOI 10.4155/FMC.10.257; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang H, 2013, J BIOL CHEM, V288, P12187, DOI 10.1074/jbc.M112.430389; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; National Institute of Mental Health, 2011, PHAS 1B STUD ASS SAF; National Institute of Mental Health, 2011, U VIRG STUD HLTH MAL; National Institute of Mental Health, 2009, CLIN STUD ASS SAF TO; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	47	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134391	10.1371/journal.pone.0134391	http://dx.doi.org/10.1371/journal.pone.0134391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226624	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700087
J	Shorter, JR; Geisz, M; Ozsoy, E; Magwire, MM; Carbone, MA; Mackay, TFC				Shorter, John R.; Geisz, Matthew; Ozsoy, Ergi; Magwire, Michael M.; Carbone, Mary Anna; Mackay, Trudy F. C.			The Effects of Royal Jelly on Fitness Traits and Gene Expression in Drosophila melanogaster	PLOS ONE			English	Article							TRADE-OFF; LIFE-SPAN; LONGEVITY; HONEYBEES; FECUNDITY; GENOMICS; SIZE	Royal Jelly (RJ) is a product made by honey bee workers and is required for queen differentiation and accompanying changes in queen body size, development time, lifespan and reproductive output relative to workers. Previous studies have reported similar changes in Drosophila melanogaster in response to RJ. Here, we quantified viability, development time, body size, productivity, lifespan and genome wide transcript abundance of D. melanogaster reared on standard culture medium supplemented with increasing concentrations of RJ. We found that lower concentrations of RJ do induce significant differences in body size in both sexes; higher concentrations reduce size, increase mortality, shorten lifespan and reduce productivity. Increased concentrations of RJ also consistently lengthened development time in both sexes. RJ is associated with changes in expression of 1,581 probe sets assessed using Affymetrix Drosophila 2.0 microarrays, which were enriched for genes associated with metabolism and amino acid degradation. The transcriptional changes are consistent with alterations in cellular processes to cope with excess nutrients provided by RJ, including biosynthesis and detoxification, which might contribute to accelerated senescence and reduced lifespan.	[Shorter, John R.; Geisz, Matthew; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Shorter, John R.; Magwire, Michael M.; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Shorter, John R.; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Ozsoy, Ergi] Hacettepe Univ, Dept Biol, Ankara, Turkey	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Hacettepe University	Shorter, JR (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	john_shorter@ncsu.edu		shorter, john/0000-0003-4732-5526	National Institutes of Health [R01 GM45146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM45146 to TFCM.	Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Azab KS, 2011, N AM J MED SCI, V3, P268, DOI 10.4297/najms.2011.3268; Chen SL, 2002, BEE WORLD, V83, P69, DOI 10.1080/0005772X.2002.11099543; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Djawdan M, 1996, PHYSIOL ZOOL, V69, P1176, DOI 10.1086/physzool.69.5.30164252; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; European-Food-Safety-Authority, 2011, EFSA J, P2083; Guo H, 2007, J NUTR SCI VITAMINOL, V53, P345, DOI 10.3177/jnsv.53.345; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Honda Y, 2011, PLOS ONE, V6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kayashima Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2107, DOI 10.1271/bbb.120496; Kohguchi M, 2004, FOOD SCI TECHNOL RES, V10, P420, DOI 10.3136/fstr.10.420; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; MANGEL M, 1994, BEHAV ECOL, V5, P412, DOI 10.1093/beheco/5.4.412; Miyatake T, 1997, HEREDITY, V78, P93, DOI 10.1038/hdy.1997.11; Morita H, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-77; Nakaya M, 2007, BIOSCI BIOTECH BIOCH, V71, P253, DOI 10.1271/bbb.60453; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Park HM, 2012, J MED FOOD, V15, P568, DOI 10.1089/jmf.2011.1888; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; R Core Team, 2012, R LANG ENV STAT COMP; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHI Y, 2012, PLOS ONE, V7; Spannhoff A, 2011, EMBO REP, V12, P238, DOI 10.1038/embor.2011.9; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhao FY, 2013, EUR FOOD RES TECHNOL, V236, P799, DOI 10.1007/s00217-013-1939-4; Zheng HQ, 2011, APIDOLOGIE, V42, P39, DOI 10.1051/apido/2010033	46	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134612	10.1371/journal.pone.0134612	http://dx.doi.org/10.1371/journal.pone.0134612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226016	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700122
J	Wiezik, M; Svitok, M; Wiezikova, A; Dovciak, M				Wiezik, Michal; Svitok, Marek; Wiezikova, Adela; Dovciak, Martin			Identifying Shifts in Leaf-Litter Ant Assemblages (Hymenoptera: Formicidae) across Ecosystem Boundaries Using Multiple Sampling Methods	PLOS ONE			English	Article							PITFALL TRAPS; SPECIES RICHNESS; HABITAT COMPLEXITY; FOREST SUCCESSION; PLANT DIVERSITY; 4 DECADES; COMMUNITIES; VEGETATION; TEMPERATE; PATTERNS	Global or regional environmental changes in climate or land use have been increasingly implied in shifts in boundaries (ecotones) between adjacent ecosystems such as beech or oak-dominated forests and forest-steppe ecotones that frequently co-occur near the southern range limits of deciduous forest biome in Europe. Yet, our ability to detect changes in biological communities across these ecosystems, or to understand their environmental drivers, can be hampered when different sampling methods are required to characterize biological communities of the adjacent but ecologically different ecosystems. Ants (Hymenoptera: Formicidae) have been shown to be particularly sensitive to changes in temperature and vegetation and they require different sampling methods in closed vs. open habitats. We compared ant assemblages of closed-forests (beech-or oak-dominated) and open forest-steppe habitats in southwestern Carpathians using methods for closed-forest (litter sifting) and open habitats (pitfall trapping), and developed an integrated sampling approach to characterize changes in ant assemblages across these adjacent ecosystems. Using both methods, we collected 5,328 individual ant workers from 28 species. Neither method represented ant communities completely, but pitfall trapping accounted for more species (24) than litter sifting (16). Although pitfall trapping characterized differences in species richness and composition among the ecosystems better, with beech forest being most species poor and ecotone most species rich, litter sifting was more successful in identifying characteristic litter-dwelling species in oak-dominated forest. The integrated sampling approach using both methods yielded more accurate characterization of species richness and composition, and particularly so in species-rich forest-steppe habitat where the combined sample identified significantly higher number of species compared to either of the two methods on their own. Thus, an integrated sampling approach should be used to fully characterize changes in ant assemblages across ecosystem boundaries, or with vegetation change over time, and particularly so in species-rich habitats such as forest-steppe ecotones.	[Wiezik, Michal] Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Appl Ecol, Zvolen, Slovakia; [Svitok, Marek; Wiezikova, Adela] Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Biol & Gen Ecol, Zvolen, Slovakia; [Svitok, Marek] Eawag Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Dovciak, Martin] SUNY Syracuse, Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Technical University Zvolen; Technical University Zvolen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Wiezik, M (corresponding author), Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Appl Ecol, Zvolen, Slovakia.	wiezik@tuzvo.sk	Wieziková, Adela/CAH-2427-2022; Svitok, Marek/A-4843-2013	Wieziková, Adela/0000-0003-4848-5177; Svitok, Marek/0000-0003-2710-8102	Slovak Grant Agency for Science (VEGA) [1/0186/14, 2/0052/15]	Slovak Grant Agency for Science (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	The study was co-funded by research grants no. 1/0186/14 and 2/0052/15 of the Slovak Grant Agency for Science (VEGA).	ADIS J, 1979, ZOOL ANZ, V202, P177; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Andersen Alan N., 2000, P25; ANDERSEN AN, 1991, AUST J ECOL, V16, P273, DOI 10.1111/j.1442-9993.1991.tb01054.x; Andersen AN, 2004, FRONT ECOL ENVIRON, V2, P291; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; [Anonymous], 2006, 92006 EEA; [Anonymous], 2014, R LANG ENV STAT COMP; Arnan X, 2014, J ANIM ECOL, V83, P1398, DOI 10.1111/1365-2656.12227; Bestelmeyer Brandon T., 2000, P122; Bouget C., 2009, FOREST INSECT STUDIE; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Calixto AA, 2007, SOUTHWEST ENTOMOL, V32, P87, DOI 10.3958/0147-1724-32.2.87; Canty A., 2015, BOOT BOOTSTRAP R S P; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chen YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116113; CZECHOWSKI W, 1990, Fragmenta Faunistica (Warsaw), V34, P133; Dahms Henriette, 2005, Myrmecologische Nachrichten, V7, P9; Dauber J, 2005, BASIC APPL ECOL, V6, P83, DOI 10.1016/j.baae.2004.09.011; Dekoninck W, 2008, EUR J ENTOMOL, V105, P681, DOI 10.14411/eje.2008.092; Dekoninck W, 2010, RESTOR ECOL, V18, P681, DOI 10.1111/j.1526-100X.2008.00499.x; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dovciak M, 2005, ECOL MONOGR, V75, P363, DOI 10.1890/03-0802; Dovciak M, 2014, NEW FOREST, V45, P733, DOI 10.1007/s11056-014-9419-7; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Fox J., 2019, R COMPANION APPL REG, V.; Franklin K, 2012, BIOL CONSERV, V148, P96, DOI 10.1016/j.biocon.2012.01.045; Frelich LE, 2012, PHILOS T R SOC B, V367, P2955, DOI 10.1098/rstb.2012.0235; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Gomez C, 2003, BIODIVERS CONSERV, V12, P2135, DOI 10.1023/A:1024142415454; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; GREENSLA.PJ, 1973, INSECT SOC, V20, P343, DOI 10.1007/BF02226087; GREENSLADE PJM, 1977, INSECT SOC, V24, P163, DOI 10.1007/BF02227169; Groc S, 2014, MYRMECOL NEWS, V19, P43; Holecova M, 2012, BIODIVERSITY SOIL MI; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hrvol J, 2009, BIOLOGIA, V64, P605, DOI 10.2478/s11756-009-0091-x; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; King JR, 2005, ENVIRON ENTOMOL, V34, P1566, DOI 10.1603/0046-225X-34.6.1566; Korpel S, 1989, VIRGIN FORESTS SLOVA; Krell FT, 2005, PEDOBIOLOGIA, V49, P175, DOI 10.1016/j.pedobi.2004.10.005; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Majer J. D., 1996, P MUSEUM VICTORIA, V56, P323; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mette T, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00115.1; Oksanen J., 2019, VEGAN COMMUNITY ECOL; OLSON DM, 1991, BIOTROPICA, V23, P166, DOI 10.2307/2388302; Ottonetti L, 2006, RESTOR ECOL, V14, P60, DOI 10.1111/j.1526-100X.2006.00105.x; Palladini JD, 2007, FOREST ECOL MANAG, V242, P619, DOI 10.1016/j.foreco.2007.01.074; Pekar S, 2002, PEDOBIOLOGIA, V46, P539, DOI 10.1078/0031-4056-00158; Pinheiro J, 2015, NLME LINEAR NONLINEA; Quinn GP, 2003, EXPT DESIGN DATA ANA; Resasco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088029; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; Sabu TK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9801; Saniga M, 2014, IFOREST, V7, P324, DOI 10.3832/ifor0996-007; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Sorensen Th, 1948, K DANSKE VIDENSK SEL, V5, P1, DOI DOI 10.3109/00016924809131205; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Tausan I, 2013, BRUKENTHAL ACTA MUSE, V8, P461; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Wallwork J A, 1970, ECOLOGY SOIL ANIMALS; Wang CL, 2001, ENVIRON ENTOMOL, V30, P842, DOI 10.1603/0046-225X-30.5.842; Wiezik M, 2013, BIODIVERS CONSERV, V22, P2305, DOI 10.1007/s10531-013-0446-z; Wiezik M, 2011, TUEXENIA, P301	77	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134502	10.1371/journal.pone.0134502	http://dx.doi.org/10.1371/journal.pone.0134502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226140	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700103
J	Wu, Y; Ji, GJ; Zang, YF; Liao, W; Jin, Z; Liu, YL; Li, K; Zeng, YW; Fang, F				Wu, Yun; Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei; Jin, Zhen; Liu, Ya-Li; Li, Ke; Zeng, Ya-Wei; Fang, Fang			Local Activity and Causal Connectivity in Children with Benign Epilepsy with Centrotemporal Spikes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CHILDHOOD EPILEPSY; FUNCTIONAL CONNECTIVITY; ROLANDIC EPILEPSY; BASAL GANGLIA; LANGUAGE; NETWORK; FMRI; ATTENTION; DISORDER	The aim of the current study was to localize the epileptic focus and characterize its causal relation with other brain regions, to understand the cognitive deficits in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Resting-state functional magnetic resonance imaging (fMRI) was performed in 37 children with BECTS and 25 children matched for age, sex and educational achievement. We identified the potential epileptogenic zone (EZ) by comparing the amplitude of low frequency fluctuation (ALFF) of spontaneous blood oxygenation level dependent fMRI signals between the groups. Granger causality analysis was applied to explore the causal effect between EZ and the whole brain. Compared with controls, children with BECTS had significantly increased ALFF in the right postcentral gyrus and bilateral calcarine, and decreased ALFF in the left anterior cingulate cortex, bilateral putaman/caudate, and left cerebellum. ALFF values in the putaman/caudate were positively correlated with verbal IQ scores in patients. The ALFF values in cerebellum and performance IQ scores were negatively correlated in patients. These results suggest that ALFF disturbances in the putaman/caudate and cerebellum play an important role in BECTS cognitive dysfunction. Compared with controls, the patients showed increased driving effect from the EZ to the right medial frontal cortex and posterior cingulate cortex and decreased causal effects from the EZ to left inferior frontal gyrus. The causal effect of the left inferior frontal gyrus negatively correlated with disease duration, which suggests a relation between the epileptiform activity and language impairment. All together, these findings provide additional insight into the neurophysiological mechanisms of epilepitogenisis and cognitive dysfunction associated with BECTS.	[Wu, Yun; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Ji, Gong-Jun] Anhui Med Univ, Dept Med Psychol, Lab Cognit Neuropsychol, Hefei, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Jin, Zhen; Liu, Ya-Li; Li, Ke; Zeng, Ya-Wei] Peoples Liberat Army, Hosp 306, fMRI Ctr, Beijing, Peoples R China	Capital Medical University; Anhui Medical University; Hangzhou Normal University; Hangzhou Normal University	Wu, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China.	brain136@126.com; 13910150389@163.com		JI, Gong-Jun/0000-0002-7073-5534	Natural Science Foundation of China [81341041, 81401400, 81471653]; National Key Basic Research Program of China (973 Program) [2012CB720704]; 'Qian Jiang Distinguished Professor' program	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); 'Qian Jiang Distinguished Professor' program	This work was supported by the Natural Science Foundation of China (Grant no. 81341041) to YW, National Key Basic Research Program of China (973 Program) 2012CB720704 to ZJ, Natural Science Foundation of China (Grant nos. 81401400 to GJ and 81471653 to WL), and the 'Qian Jiang Distinguished Professor' program to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Archer JS, 2003, EPILEPSIA, V44, P200, DOI 10.1046/j.1528-1157.2003.02502.x; Bedoin N, 2012, EPILEPSY BEHAV, V25, P81, DOI 10.1016/j.yebeh.2012.05.025; Bedoin N, 2011, EPILEPSY BEHAV, V21, P42, DOI 10.1016/j.yebeh.2011.02.026; Bennett-Back O, 2011, PEDIATR NEUROL, V44, P187, DOI 10.1016/j.pediatrneurol.2010.10.003; Berg AT, 1999, EPILEPSIA, V40, P439, DOI 10.1111/j.1528-1157.1999.tb00738.x; Besseling RMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083568; Besseling RMH, 2013, EPILEPSY RES, V107, P253, DOI 10.1016/j.eplepsyres.2013.10.008; Besseling RMH, 2013, NEUROIMAGE-CLIN, V2, P239, DOI 10.1016/j.nicl.2013.01.004; Boor R, 2007, CLIN NEUROPHYSIOL, V118, P901, DOI 10.1016/j.clinph.2006.11.272; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cadotte AJ, 2009, IEEE T NEUR SYS REH, V17, P214, DOI 10.1109/TNSRE.2008.2006220; Cerminara C, 2010, EPILEPSY BEHAV, V19, P69, DOI 10.1016/j.yebeh.2010.07.008; Chan SH, 2013, BRAIN LANG, V125, P283, DOI 10.1016/j.bandl.2011.11.005; Chen G, 2009, P INT SOC MAG RESON, V17; Clarke T, 2007, EPILEPSIA, V48, P2258; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deltour L, 2007, EPILEPTIC DISORD, V9, P424; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044847, 10.1371/journal.pone.0028196]; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; Jenison RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109689; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Kay BP, 2013, EPILEPSIA, V54, P461, DOI 10.1111/epi.12057; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim EH, 2014, EPILEPSY BEHAV, V37, P54, DOI 10.1016/j.yebeh.2014.05.030; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Lengler U, 2007, EPILEPSY RES, V75, P29, DOI 10.1016/j.eplepsyres.2007.03.016; Lin JJ, 2012, EPILEPSIA, V53, P677, DOI 10.1111/j.1528-1167.2012.03422.x; Liu XJ, 2012, NEUROSCI LETT, V507, P1, DOI 10.1016/j.neulet.2011.10.016; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Lv ZX, 2014, EPILEPSY BEHAV, V35, P64, DOI 10.1016/j.yebeh.2014.04.001; Masterton RAJ, 2010, NEUROIMAGE, V51, P252, DOI 10.1016/j.neuroimage.2010.01.109; McGill ML, 2012, EPILEPSY BEHAV, V23, P353, DOI 10.1016/j.yebeh.2012.01.013; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Monjauze C, 2011, EPILEPSIA, V52, pE79, DOI 10.1111/j.1528-1167.2011.03105.x; Nadine O, 2014, EPILEPSY BEHAV, V33, P12, DOI 10.1016/j.yebeh.2014.01.008; Newman LA, 2015, J PHYSIOL-PARIS, V109, P95, DOI 10.1016/j.jphysparis.2014.06.004; Northcott E, 2007, EPILEPSY RES, V75, P57, DOI 10.1016/j.eplepsyres.2007.04.004; Overvliet GM, 2011, J NEUROL SCI, V304, P71, DOI 10.1016/j.jns.2011.02.009; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Panayiotopoulos CP, 2008, BRAIN, V131, P2264, DOI 10.1093/brain/awn162; Pinton F, 2006, EPILEPTIC DISORD, V8, P11; Rektor I, 2013, BRAIN TOPOGR, V26, P355, DOI 10.1007/s10548-012-0272-8; Rektor I, 2012, EPILEPSY BEHAV, V25, P56, DOI 10.1016/j.yebeh.2012.04.125; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riva D, 2007, EPILEPSY BEHAV, V10, P278, DOI 10.1016/j.yebeh.2006.12.003; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sanchez-Carpintero R, 2003, EPILEPSIA, V44, P1340, DOI 10.1046/j.1528-1157.2003.16403.x; Seghier ML, 2010, CEREB CORTEX, V20, P570, DOI 10.1093/cercor/bhp123; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Staden U, 1998, NEUROPEDIATRICS, V29, P242, DOI 10.1055/s-2007-973569; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Tang YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/960395; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Vaessen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090068; Volkl-Kernstock S, 2006, EPILEPSY RES, V72, P39, DOI 10.1016/j.eplepsyres.2006.07.004; Woodward KE, 2014, BRAIN CONNECT, V4, P91, DOI 10.1089/brain.2013.0178; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	74	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134361	10.1371/journal.pone.0134361	http://dx.doi.org/10.1371/journal.pone.0134361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225427	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700078
J	Haran, J; Roques, A; Bernard, A; Robinet, C; Roux, G				Haran, Julien; Roques, Alain; Bernard, Alexis; Robinet, Christelle; Roux, Geraldine			Altitudinal Barrier to the Spread of an Invasive Species: Could the Pyrenean Chain Slow the Natural Spread of the Pinewood Nematode?	PLOS ONE			English	Article							MONOCHAMUS-GALLOPROVINCIALIS COLEOPTERA; POSTGLACIAL RE-COLONIZATION; WILT DISEASE; BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; GENETIC DIFFERENTIATION; ADMIXTURE PROPORTIONS; PROCESSIONARY MOTH; DNA PHYLOGEOGRAPHY; COMPUTER-PROGRAM	Mountain ranges may delimit the distribution of native species as well as constitute potential barriers to the spread of invasive species. The invasive pinewood nematode, Bursaphelenchus xylophilus, is a severe forest pest inducing pine wilt disease. It is vectored in Europe by a native long-horned beetle, Monochamus galloprovincialis. This study explored the potential of the Pyrenean chain to slow or prevent the natural spread of nematode-infested beetles from the Iberian Peninsula, where the nematode is established and is expanding its range, towards France and the rest of Europe. An analysis of the genetic structure and migration patterns of the beetle populations throughout the Pyrenean mountain range was combined with a spread model simulating the potential movements of nematode-infested beetles across it. The central part of the Pyrenees, which corresponds to the highest elevation zone, was shown to prevent gene flow between the French and Spanish populations of M. galloprovincialis on each side of the mountains. Conversely, strong admixture was detected between populations located on both sides of low elevation hills, and especially at the east and west extremities of the mountain range. Simulations of the spread of nematode-infested beetles under various thresholds of beetle survival and pine wilt disease expression gave results consistent with the variation in genetic make-up, suggesting that western and eastern hillsides may represent corridors favoring natural spread of the nematode from the Iberian Peninsula to France. Simulations also showed that temperature rise due to climate change may significantly reduce the extent of the barrier formed by highest elevations. Our results support the hypothesis that the Pyrenean chain represents a partial barrier to the natural spread of nematode-infested beetles. These results, which have to be considered together with potential human-assisted long-distance spread of the nematode, highlight priority zones for future pest monitoring and management programs. More generally, such an integrated approach could be used to assess the role of mountain chains in the potential spread of other invasive pests.	[Haran, Julien; Roques, Alain; Bernard, Alexis; Robinet, Christelle; Roux, Geraldine] INRA, Zool Forestiere UR633, F-45075 Orleans, France; [Haran, Julien; Roux, Geraldine] Univ Orleans, Orleans, France	INRAE; Universite de Orleans	Haran, J (corresponding author), INRA, Zool Forestiere UR633, F-45075 Orleans, France.	julien.haran@orleans.inra.fr		Robinet, Christelle/0000-0002-4933-4656; Roux, Geraldine/0000-0002-1116-2799	European project REPHRAME (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy) [KBBE.2010.1.4-09]; French Ministry of Research and Education	European project REPHRAME (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy); French Ministry of Research and Education	This work was funded by the European project REPHRAME KBBE.2010.1.4-09 (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy). First author was funded by the French Ministry of Research and Education.	[Anonymous], 2008, PINE WILT DISEASE; [Anonymous], 2013, 6 DREAL MID SECR GEN; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bergdalh DR, 1988, J NEMATOL, V20, P206; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Brasier C.M., 1987, POPULATIONS PLANT PA, P213; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chikhi L, 2001, GENETICS, V158, P1347; Choi SK, 2011, ANN ENTOMOL SOC AM, V104, P816, DOI 10.1603/AN11012; Choisy M, 2004, MOL ECOL, V13, P955, DOI 10.1111/j.1365-294X.2004.02107.x; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Cooper SJB, 1993, INSECT MOL BIOL, V4, P49; Cornuet JM, 1999, GENETICS, V153, P1989; David G, 2014, J APPL ENTOMOL, V138, P566, DOI 10.1111/jen.12110; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eschen R, 2014, DIVERS DISTRIB, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gruffudd H., 2013, Berichte aus dem Julius Kuhn-Institut, P82; Haran J, 2014, CONSERV GENET RESOUR, V6, P975, DOI 10.1007/s12686-014-0262-0; HELLRIGL K G, 1971, Redia, V52, P367; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joger U, 2007, ZOOL ANZ, V246, P293, DOI 10.1016/j.jcz.2007.09.002; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Koutroumpa FA, 2013, BIOL J LINN SOC, V109, P354, DOI 10.1111/bij.12042; Langella O, 2001, MOL ECOL NOTES, V1, P357, DOI 10.1046/j.1471-8278.2001.00099.x; LINIT MJ, 1988, J NEMATOL, V20, P227; Lopez Sergio, 2012, Psyche (Cambridge), V2012, P1; Lopez-Moreno JI, 2008, INT J CLIMATOL, V28, P1535, DOI 10.1002/joc.1645; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Luchi N, 2011, FOREST PATHOL, V41, P270, DOI 10.1111/j.1439-0329.2010.00670.x; MAMIYA Y, 1988, J NEMATOL, V20, P219; Mas H., 2013, Berichte aus dem Julius Kuhn-Institut, P22; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Naves P, 2009, J PEST SCI, V82, P1, DOI 10.1007/s10340-008-0210-4; Naves PM, 2007, ENTOMOL FENNICA, V18, P193; Naves PM, 2006, ENTOMOL EXP APPL, V120, P99, DOI 10.1111/j.1570-7458.2006.00430.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Potter C, 2011, PHILOS T R SOC B, V366, P1966, DOI 10.1098/rstb.2010.0395; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Robinet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043366; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roques A, 2014, CLIMATE CHA IN PRESS; Roques Alain, 2010, BioRisk, V4, P1; Rousselet J, 2010, J BIOGEOGR, V37, P1478, DOI 10.1111/j.1365-2699.2010.02289.x; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schrey NM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11001; Schroeder T., 2009, Bulletin OEPP, V39, P179, DOI 10.1111/j.1365-2338.2009.02287.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shigesada N., 1997, OXFORD SERIES ECOLOG; Shoda-Kagaya E, 2007, B ENTOMOL RES, V97, P167, DOI 10.1017/S000748530700483X; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TABERLET P, 1994, EVOLUTION, V48, P623, DOI 10.1111/j.1558-5646.1994.tb01349.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Takasu Fugo, 2000, Biological Invasions, V2, P141, DOI 10.1023/A:1010048725497; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Troltzsch K, 2009, FOREST ECOL MANAG, V257, P294, DOI 10.1016/j.foreco.2008.09.012; Vincent B, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007083; Wallin Henrik, 2013, Norwegian Journal of Entomology, V60, P11; WALLIS GP, 1989, EVOLUTION, V43, P88, DOI 10.1111/j.1558-5646.1989.tb04209.x; Wiens JA, 2000, ECOLOGICAL CONSEQUEN, P9; Yamamura K, 2003, POPUL ECOL, V45, P149, DOI 10.1007/s10144-003-0152-x; Yoshimura A, 1999, ECOLOGY, V80, P1691, DOI 10.2307/176557; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zhao B.G., 2008, PINE WILT DISEASE, P18	92	17	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134126	10.1371/journal.pone.0134126	http://dx.doi.org/10.1371/journal.pone.0134126			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222551	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800108
J	Stoltenburg, R; Schubert, T; Strehlitz, B				Stoltenburg, Regina; Schubert, Thomas; Strehlitz, Beate			In vitro Selection and Interaction Studies of a DNA Aptamer Targeting Protein A	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STRUCTURAL BASIS; BINDING-SITE; IGG-BINDING; AFFINITY; IDENTIFICATION; LIGANDS; SELEX; RECOGNITION; MOLECULES	A new DNA aptamer targeting Protein A is presented. The aptamer was selected by use of the FluMag-SELEX procedure. The SELEX technology (Systematic Evolution of Ligands by EXponential enrichment) is widely applied as an in vitro selection and amplification method to generate target-specific aptamers and exists in various modified variants. FluMag-SELEX is one of them and is characterized by the use of magnetic beads for target immobilization and fluorescently labeled oligonucleotides for monitoring the aptamer selection progress. Structural investigations and sequence truncation experiments of the selected aptamer for Protein A led to the conclusion, that a stem-loop structure at its 5'-end including the 5'-primer binding site is essential for aptamer-target binding. Extensive interaction analyses between aptamer and Protein A were performed by methods like surface plasmon resonance, MicroScale Thermophoresis and bead-based binding assays using fluorescence measurements. The binding of the aptamer to its target was thus investigated in assays with immobilization of one of the binding partners each, and with both binding partners in solution. Affinity constants were determined in the low micromolar to submicromolar range, increasing to the nanomolar range under the assumption of avidity. Protein A provides more than one binding site for the aptamer, which may overlap with the known binding sites for immunoglobulins. The aptamer binds specifically to both native and recombinant Protein A, but not to other immunoglobulin-binding proteins like Protein G and L. Cross specificity to other proteins was not found. The application of the aptamer is directed to Protein A detection or affinity purification. Moreover, whole cells of Staphylococcus aureus, presenting Protein A on the cell surface, could also be bound by the aptamer.	[Stoltenburg, Regina] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Schubert, Thomas] 2bind GmbH, Regensburg, Germany; [Strehlitz, Beate] UFZ Helmholtz Ctr Environm Res, Dept Environm & Biotechnol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Stoltenburg, R (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany.	regina.stoltenburg@ufz.de	Strehlitz, Beate/H-3054-2019; Stoltenburg, Regina/D-5482-2015	Strehlitz, Beate/0000-0002-3211-0584; Stoltenburg, Regina/0000-0001-5361-6632; Schubert, Thomas/0000-0002-9709-3287	Federal Ministry of Education and Research (BMBF), Germany [02WM1027, 02WM1165]; 2bind GmbH; UFZ	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); 2bind GmbH; UFZ(Helmholtz Association)	This work was integrated in the joint project "International Water Research Alliance Saxony-IWAS" and was funded by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/en/index.php), Germany (02WM1027, 02WM1165). 2bind GmbH and UFZ provided support in the form of salaries for authors TS and BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1989, J BIOL CHEM, V264, P19740; AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Baumstummler A, 2014, LETT APPL MICROBIOL, V59, P422, DOI 10.1111/lam.12295; Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; BJORCK L, 1988, J IMMUNOL, V140, P1194; Boyacioglu O, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.37; BOYLE MDP, 1998, ENCY IMMUNOLOGY, P323; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01863; Cheung YW, 2013, P NATL ACAD SCI USA, V110, P15967, DOI 10.1073/pnas.1309538110; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; Daniel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075419; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Friedman AD, 2015, BIOMATERIALS, V36, P110, DOI 10.1016/j.biomaterials.2014.08.046; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Han SR, 2014, ANN MICROBIOL, V64, P883, DOI 10.1007/s13213-013-0720-z; Hasegawa H, 2008, SENSORS-BASEL, V8, P1090, DOI 10.3390/s8021090; Heilkenbrinker A, 2015, ANAL CHEM, V87, P677, DOI 10.1021/ac5034819; IBRAHIM S, 1993, SCAND J IMMUNOL, V38, P368, DOI 10.1111/j.1365-3083.1993.tb01739.x; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KASTERN W, 1992, J BIOL CHEM, V267, P12820; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maeng JS, 2012, J NANOSCI NANOTECHNO, V12, P5138, DOI 10.1166/jnn.2012.6369; Mallikaratchy PR, 2011, NUCLEIC ACIDS RES, V39, P2458, DOI 10.1093/nar/gkq996; Moon J, 2015, SENSORS-BASEL, V15, P8884, DOI 10.3390/s150408884; Paniel N, 2013, METHODS, V64, P229, DOI 10.1016/j.ymeth.2013.07.001; Peyret N., 2000, THESIS; Radom F, 2013, BIOTECHNOL ADV, V31, P1260, DOI 10.1016/j.biotechadv.2013.04.007; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Ruigrok VJB, 2012, CHEMBIOCHEM, V13, P829, DOI 10.1002/cbic.201100774; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sorum M, 2013, PATHOG DIS, V67, P19, DOI 10.1111/2049-632X.12017; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Strehlitz B, 2011, Germany patent, P1, Patent No. [DE 102011006610, 102011006610]; Szeitner Z, 2014, J PHARMACEUT BIOMED, V101, P58, DOI 10.1016/j.jpba.2014.04.018; Tothova P, 2014, BIOCHEMISTRY-US, V53, P7013, DOI 10.1021/bi500773c; Tucker WO, 2012, CURR PHARM DESIGN, V18, P2014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turek Diane, 2013, World J Transl Med, V2, P67; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	51	53	5	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134403	10.1371/journal.pone.0134403	http://dx.doi.org/10.1371/journal.pone.0134403			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221730	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800141
J	Zhang, DL; Zhang, ZD; Li, JM; Chang, YB; Du, QJ; Pan, TH				Zhang, Dalong; Zhang, Zhongdian; Li, Jianming; Chang, Yibo; Du, Qingjie; Pan, Tonghua			Regulation of Vapor Pressure Deficit by Greenhouse Micro-Fog Systems Improved Growth and Productivity of Tomato via Enhancing Photosynthesis during Summer Season	PLOS ONE			English	Article							STOMATAL SIZE; FOGGING SYSTEMS; AIR HUMIDITY; WATER STATUS; LEAF-AREA; CONDUCTANCE; DENSITY; TEMPERATURE; TRANSPIRATION; ACCLIMATION	The role of a proposed micro-fog system in regulating greenhouse environments and enhancing tomato (Solanum lycopersicum L.) productivity during summer season was studied. Experiments were carried out in a multi-span glass greenhouse, which was divided into two identical compartments involving different environments: (1) without environment control and (2) with a micro-fog system operating when the air vapor pressure deficit (VPD) of greenhouse was higher than 0.5 KPa. The micro-fog system effectively alleviated heat stress and evaporative demand in the greenhouse during summer season. The physiologically favourable environment maintained by micro-fog treatment significantly enhanced elongation of leaf and stem, which contributed to a substantial elevation of final leaf area and shoot biomass. These improvements in physiological and morphological traits resulted in around 12.3% increase of marketable tomato yield per plant. Relative growth rate (RGR) of micro-fog treatment was also significantly higher than control plants, which was mainly determined by the substantial elevation in net assimilation rate (NAR), and to a lesser extent caused by leaf area ratio (LAR). Measurement of leaf gas exchange parameters also demonstrated that micro-fog treatment significantly enhanced leaf photosynthesis capacity. Taken together, manipulation of VPD in greenhouses by micro-fog systems effectively enhanced tomato growth and productivity via improving photosynthesis during summer season.	[Zhang, Dalong; Zhang, Zhongdian; Li, Jianming; Chang, Yibo; Du, Qingjie; Pan, Tonghua] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Li, JM (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	lijianming66@163.com			National Science Foundation of China [31471916]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China 31471916.	Abdel-Ghany AM, 2006, BIOSYST ENG, V94, P97, DOI 10.1016/j.biosystemseng.2006.02.008; APHALO PJ, 1991, PLANT CELL ENVIRON, V14, P127, DOI 10.1111/j.1365-3040.1991.tb01379.x; Arbel A, 2003, BIOSYST ENG, V84, P45, DOI 10.1016/S1537-5110(02)00216-7; Arbel A, 1999, J AGR ENG RES, V72, P129, DOI 10.1006/jaer.1998.0351; Athanasiou K, 2010, PLANT PHYSIOL, V152, P366, DOI 10.1104/pp.109.149351; BAKKER JC, 1991, SCI HORTIC-AMSTERDAM, V48, P205, DOI 10.1016/0304-4238(91)90128-L; Bunce JA, 1997, PLANT CELL ENVIRON, V20, P131, DOI 10.1046/j.1365-3040.1997.d01-3.x; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Codarin S, 2006, SCI HORTIC-AMSTERDAM, V108, P303, DOI 10.1016/j.scienta.2006.01.036; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Kaiser H, 2009, PLANT CELL ENVIRON, V32, P1091, DOI 10.1111/j.1365-3040.2009.01990.x; Katsoulas N, 2009, SCI HORTIC-AMSTERDAM, V123, P90, DOI 10.1016/j.scienta.2009.08.004; Katsoulas N, 2001, AGR FOREST METEOROL, V106, P233, DOI 10.1016/S0168-1923(00)00211-2; KOCH GW, 1994, TREE PHYSIOL, V14, P347, DOI 10.1093/treephys/14.4.347; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Lawson T, 2014, PLANT PHYSIOL, V164, P1556, DOI 10.1104/pp.114.237107; Li S, 2006, ACTA HORTIC, P393, DOI 10.17660/ActaHortic.2006.719.44; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Max JFJ, 2009, SCI HORTIC-AMSTERDAM, V122, P179, DOI 10.1016/j.scienta.2009.05.007; MIRANDA V, 1981, NEW PHYTOL, V88, P595, DOI 10.1111/j.1469-8137.1981.tb01735.x; Mortensen LM, 2000, SCI HORTIC-AMSTERDAM, V86, P299, DOI 10.1016/S0304-4238(00)00155-2; Muraoka H, 2000, PLANT CELL ENVIRON, V23, P235, DOI 10.1046/j.1365-3040.2000.00547.x; Nejad AR, 2008, J EXP BOT, V59, P289, DOI 10.1093/jxb/erm308; Ohyama K, 2008, ACTA HORTIC, P321, DOI 10.17660/ActaHortic.2008.797.45; Patane C, 2010, AGR WATER MANAGE, V97, P131, DOI 10.1016/j.agwat.2009.08.021; RADOGLOU KM, 1990, ANN BOT-LONDON, V65, P617, DOI 10.1093/oxfordjournals.aob.a087978; Schymanski SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054231; [沈明卫 Shen Mingwei], 2003, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V34, P65; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Teitel M, 2010, BIOSYST ENG, V106, P166, DOI 10.1016/j.biosystemseng.2010.03.007; Toida H, 2006, BIOSYST ENG, V93, P205, DOI 10.1016/j.biosystemseng.2005.11.003; Torre S, 2003, J AM SOC HORTIC SCI, V128, P598, DOI 10.21273/JASHS.128.4.0598; Tucci MLS, 2010, PHOTOSYNTHETICA, V48, P421, DOI 10.1007/s11099-010-0055-y; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Yamori W., 2013, J PLANT BIOCH PHYSL, V1, P113, DOI DOI 10.4172/2329-9029.1000113; Yamori W, 2011, PLANT J, V68, P966, DOI 10.1111/j.1365-313X.2011.04747.x; Zhang Jie, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P193; Zhang YJ, 2013, PLANT CELL ENVIRON, V36, P149, DOI 10.1111/j.1365-3040.2012.02563.x; Zhao Y, 2001, J AGR ENG RES, V78, P431, DOI 10.1006/jaer.2000.0649	42	34	38	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133919	10.1371/journal.pone.0133919	http://dx.doi.org/10.1371/journal.pone.0133919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221726	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800081
J	Rodriguez, AC; Yu, SH; Li, B; Zegzouti, H; Kohler, JJ				Rodriguez, Andrea C.; Yu, Seok-Ho; Li, Bin; Zegzouti, Hicham; Kohler, Jennifer J.			Enhanced Transfer of a Photocross-linking N-Acetylglucosamine (GlcNAc) Analog by an O-GlcNAc Transferase Mutant with Converted Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED PROTEINS; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; CHEMICAL REPORTERS; LINKED GLCNAC; GLYCOSYLATION; NUCLEAR; GLCNACYLATION; PHOSPHORYLATION; COACTIVATOR	O-Linked beta-N-acetylglucosamine (O-GlcNAc) is a post-translational modification of proteins in multicellular organisms. O-GlcNAc modification is catalyzed by the O-GlcNAc transferase (OGT), which transfers N-acetylglucosamine (GlcNAc) from the nucleotide sugar donor UDP-GlcNAc to serine or threonine residues of protein substrates. Recently, we reported a novel metabolic labeling method to introduce the diazirine photocross-linking functional group onto O-GlcNAc residues in mammalian cells. In this method, cells are engineered to produce diazirine-modified UDP-GlcNAc (UDP-GlcNDAz), and the diazirine-modified GlcNAc analog (GlcNDAz) is transferred to substrate proteins by endogenous OGT, producing O-GlcNDAz. O-GlcNDAz-modified proteins can be covalently cross-linked to their binding partners, providing information about O-GlcNAc-dependent interactions. The utility of the method was demonstrated by cross-linking highly O-GlcNAc-modified nucleoporins to proteins involved in nuclear transport. For practical application of this method to a broader range of O-GlcNAc-modified proteins, efficient O-GlcNDAz production is critical. Here we examined the ability of OGT to transfer GlcNDAz and found that the wild-type enzyme (wtOGT) prefers the natural substrate, UDP-GlcNAc, over the unnatural UDP-GlcNDAz. This competition limits O-GlcNDAz production in cells and the extent of O-GlcNDAz-dependent cross-linking. Here we identified an OGT mutant, OGT(C917A), that efficiently transfers GlcNDAz and, surprisingly, has altered substrate specificity, preferring to transfer GlcNDAz rather than GlcNAc to protein substrates. We confirmed the reversed substrate preference by determining the Michaelis-Menten parameters describing the activity of wtOGT and OGT(C917A) with both UDP-GlcNAc and UDP-GlcNDAz. Use of OGT(C917A) enhances O-GlcNDAz production, yielding improved cross-linking of O-GlcNDAz-modified molecules both in vitro and in cells.	[Rodriguez, Andrea C.; Yu, Seok-Ho; Li, Bin; Kohler, Jennifer J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Zegzouti, Hicham] Promega Corp, Madison, WI 53711 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Promega Corporation	Kohler, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jennifer.kohler@utsouthwestern.edu	Kohler, Jennifer J./B-6589-2009; rodriguez, andrea/GRO-4054-2022; Regan, Clinton/E-6250-2012	Kohler, Jennifer J./0000-0001-5373-3329; Yu, Seok-Ho/0000-0002-8372-1094; Zegzouti, Hicham/0000-0002-0989-6195	National Institutes of Health [R01GM090271, T32GM007062]; Welch Foundation [I-1686]; Graduate Programs Initiative from University of Texas System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090271, T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Graduate Programs Initiative from University of Texas System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM090271. This work was also supported by Welch Foundation Grant I-1686. H. Z. is an employee of Promega Corp., which sells the UDP-Glo (TM) glycosyltransferase assay. The remaining authors declare that they have no conflicts of interest with the contents of this article.; Supported by training grants from the National Institutes of Health (Grant T32GM007062) and the Graduate Programs Initiative from the University of Texas System.	Bateman LA, 2013, CHEM COMMUN, V49, P4328, DOI 10.1039/c2cc37963e; Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HART GW, 1995, ADV EXP MED BIOL, V376, P115; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Leavy TM, 2007, BIOORG MED CHEM LETT, V17, P3851, DOI 10.1016/j.bmcl.2007.05.008; Lim K, 2010, BIOCHEM BIOPH RES CO, V393, P314, DOI 10.1016/j.bbrc.2010.01.128; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Mizuguchi-Hata C, 2013, BBA-MOL CELL RES, V1833, P2682, DOI 10.1016/j.bbamcr.2013.06.008; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Rodriguez AC, 2014, MEDCHEMCOMM, V5, P1227, DOI 10.1039/c4md00164h; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yu SH, 2012, P NATL ACAD SCI USA, V109, P4834, DOI 10.1073/pnas.1114356109; Zaro BW, 2011, P NATL ACAD SCI USA, V108, P8146, DOI 10.1073/pnas.1102458108; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	34	22	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22638	22648		10.1074/jbc.M115.667006	http://dx.doi.org/10.1074/jbc.M115.667006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240142	Green Published, hybrid			2022-12-26	WOS:000361171500029
J	Devieux, JG; Saxena, A; Rosenberg, R; Klausner, JD; Jean-Gilles, M; Madhivanan, P; Gaston, S; Rubens, M; Theodore, H; Deschamps, MM; Koenig, SP; Pape, JW				Devieux, Jessy G.; Saxena, Anshul; Rosenberg, Rhonda; Klausner, Jeffrey D.; Jean-Gilles, Michele; Madhivanan, Purnima; Gaston, Stephanie; Rubens, Muni; Theodore, Harry; Deschamps, Marie-Marcelle; Koenig, Serena P.; Pape, Jean William			Knowledge, Attitudes, Practices and Beliefs about Medical Male Circumcision (MMC) among a Sample of Health Care Providers in Haiti	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; PROSTATE-CANCER; ACCEPTABILITY; HIV/AIDS; MEN; INFECTION; IMPLEMENTATION; TRANSMISSION; PROTECTION	Background Haiti has the highest number of people living with HIV infection in the Caribbean/Latin America region. Medical male circumcision (MMC) has been recommended to help prevent the spread of HIV. We sought to assess knowledge, attitudes, practices and beliefs about MMC among a sample of health care providers in Haiti. Methods A convenience sample of 153 health care providers at the GHESKIO Centers in Haiti responded to an exploratory survey that collected information on several topics relevant to health providers about MMC. Descriptive statistics were calculated for the responses and multivariable logistic regression was conducted to determine opinions of health care providers about the best age to perform MMC on males. Bayesian network analysis and sensitivity analysis were done to identify the minimum level of change required to increase the acceptability of performing MMC at age less than 1 year. Results The sample consisted of medical doctors (31.0%), nurses (49.0%), and other health care professionals (20.0%). Approximately 76% showed willingness to offer MMC services if they received training. Seventy-six percent believed that their male patients would accept circumcision, and 59% believed infancy was the best age for MMC. More than 90% of participants said that MMC would reduce STIs. Physicians and nurses who were willing to offer MMC if provided with adequate training were 2.5 (1.15-5.71) times as likely to choose the best age to perform MMC as less than one year. Finally, if the joint probability of choosing "the best age to perform MMC" as one year or older and having the mistaken belief that "MMC prevents HIV entirely" is reduced by 63% then the probability of finding that performing MMC at less than one year acceptable to health care providers is increased by 35%. Conclusion Participants demonstrated high levels of knowledge and positive attitudes towards MMC. Although this study suggests that circumcision is acceptable among certain health providers in Haiti, studies with larger and more representative samples are needed to confirm this finding.	[Devieux, Jessy G.; Saxena, Anshul; Rosenberg, Rhonda; Jean-Gilles, Michele; Madhivanan, Purnima; Rubens, Muni] Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Gaston, Stephanie; Theodore, Harry; Deschamps, Marie-Marcelle; Pape, Jean William] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	State University System of Florida; Florida International University; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Cornell University	Devieux, JG (corresponding author), Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA.	devieuxj@fiu.edu	Madhivanan, Purnima/AAH-4849-2019; Rubens, Muni/J-3503-2019	Madhivanan, Purnima/0000-0001-7818-3394; Rubens, Muni/0000-0003-1812-9753	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R21 HD076685]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD076685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, U01AI069421] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant Number R21 HD076685 to Dr. Jessy Devieux. This grant supported a percentage of Time and Effort for Drs. Devieux, Rosenberg, Klausner, Jean-Gilles, Madhivanan, Mr. Saxena and Ms. Gaston. The other authors did not have current funding sources for this study.	Albero G, 2012, SEX TRANSM DIS, V39, P104, DOI 10.1097/OLQ.0b013e3182387abd; American Academy of Pediatrics Task Force On Circumcision, 2012, PEDIATRICS, V130, P585, DOI DOI 10.1542/PEDS.2012-1989; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2014, 21 C RETR OPP INF CR, P501; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bektas HA, 2007, AIDS CARE, V19, P888, DOI 10.1080/09540120701203352; Bicer S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.26258; Brito MO, 2010, AIDS CARE, V22, P1530, DOI 10.1080/09540121.2010.484455; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Carbery B, 2012, AIDS EDUC PREV, V24, P377, DOI 10.1521/aeap.2012.24.4.377; Carvalho J. E. S., 2014, SEXUAL RISK BEHAV AD, P1; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Colin JM, 2014, CULTURAL CLIN CARE H; Ferlay J., 2015, INT J CANCER, V136, pE359; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2539, DOI 10.1001/jama.2008.752; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Holschneider SOM, 2003, J ADOLESCENT HEALTH, V33, P31, DOI 10.1016/S1054-139X(02)00418-4; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; Klausner JD, 2013, SEX TRANSM DIS, V40, P526, DOI 10.1097/01.OLQ.0000431046.28649.23; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Mavhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082911; MITACEK EJ, 1986, INT J CANCER, V38, P9, DOI 10.1002/ijc.2910380103; Morris Brian J, 2014, ISRN Urol, V2014, P684706, DOI 10.1155/2014/684706; Morris BJ, 2014, CUAJ-CAN UROL ASSOC, V8, P396, DOI 10.5489/cuaj.2490; Morris BJ, 2014, J MED ETHICS, V40, P463, DOI 10.1136/medethics-2013-101614; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Morris BJ, 2012, ASIAN J ANDROL, V14, P661, DOI 10.1038/aja.2012.47; Morris BJ, 2012, AIDS CARE, V24, P1565, DOI 10.1080/09540121.2012.661836; Morris BJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-20; Pearl J., 2011, BAYESIAN NETWORKS; Peltzer K, 2008, AFR J TRADIT COMPLEM, V5, P346; Perchal P, 2011, INT AIDS SOC C IT RO; Phillips AA, 2007, CANCER INVEST, V25, P476, DOI 10.1080/07357900701359841; Qian H-Z, 2014, 21 C RETR OPP INF CR, P505; Ramkissoon A, 2011, 6 IAS C; Sawires SR, 2007, LANCET, V369, P708, DOI 10.1016/S0140-6736(07)60323-7; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Starzyk EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115891; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; UNAIDS, 2013, HIV AIDS EST HAIT; Wamai RG, 2015, GLOB PUBLIC HEALTH, V10, P639, DOI 10.1080/17441692.2014.989532; Wamai RG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-49; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO, 2007, GLOB PREV MAL CIRC; World Health Organization, 2012, VOL MED MAL CIRC HIV; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Wright JL, 2012, CANCER-AM CANCER SOC, V118, P4437, DOI 10.1002/cncr.26653; Wynn A, 2010, RAPID SCALE UP HIGH; Zetola N, 2012, SEX TRANSM DIS, V39, P114, DOI 10.1097/OLQ.0b013e318242b4f3	55	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134667	10.1371/journal.pone.0134667	http://dx.doi.org/10.1371/journal.pone.0134667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237217	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942400032
J	Enarson, PM; Gie, RP; Mwansambo, CC; Chalira, AE; Lufesi, NN; Maganga, ER; Enarson, DA; Cameron, NA; Graham, SM				Enarson, Penelope M.; Gie, Robert P.; Mwansambo, Charles C.; Chalira, Alfred E.; Lufesi, Norman N.; Maganga, Ellubey R.; Enarson, Donald A.; Cameron, Neil A.; Graham, Stephen M.			Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; TUBERCULOSIS PATIENTS; CHILDHOOD PNEUMONIA; REDUCES MORTALITY; NATIONAL CAUSES; ILL CHILDREN; COTRIMOXAZOLE; ETIOLOGY; IMPACT; CARE	Objective To investigate recognised co-morbidities and clinical management associated with inpatient pneumonia mortality in Malawian district hospitals. Methods Prospective cohort study, of patient records, carried out in Malawi between 1st October 2000 and 30th June 2003. The study included all children aged 0-59 months admitted to the paediatric wards in sixteen district hospitals throughout Malawi with severe and very severe pneumonia. We compared individual factors between those that survived (n = 14 076) and those that died (n = 1 633). Results From logistic regression analysis, predictors of death in hospital, adjusted for age, sex and severity grade included comorbid conditions of meningitis (OR = 2.49, 95% CI 1.50-4.15), malnutrition (OR = 2.37, 95% CI 1.94-2.88) and severe anaemia (OR = 1.41, 95% CI 1.03-1.92). Requiring supplementary oxygen (OR = 2.16, 95% CI 1.85-2.51) and intravenous fluids (OR = 3.02, 95% CI 2.13-4.28) were associated with death while blood transfusion was no longer significant (OR = 1.10, 95% CI 0.77-1.57) when the model included severe anaemia. Conclusions This study identified a number of challenges to improve outcome for Malawian infants and children hospitalised with pneumonia. These included improved assessment of co-morbidities and more rigorous application of standard case management.	[Enarson, Penelope M.; Enarson, Donald A.; Graham, Stephen M.] Int Union TB & Lung Dis, Paris, France; [Enarson, Penelope M.; Gie, Robert P.; Enarson, Donald A.] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [Gie, Robert P.] Univ Stellenbosch, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Mwansambo, Charles C.; Chalira, Alfred E.; Lufesi, Norman N.] Minist Hlth, Lilongwe, Malawi; [Maganga, Ellubey R.] UNICEF Malawi, Lilongwe, Malawi; [Cameron, Neil A.] Univ Stellenbosch, Div Community Hlth, Dept Interdisciplinary Sci, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Graham, Stephen M.] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Stellenbosch University; Stellenbosch University; Stellenbosch University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Enarson, PM (corresponding author), Int Union TB & Lung Dis, Paris, France.	pennyenarson@theunion.org		Graham, Stephen/0000-0003-3525-2294	MoH of Malawi; Bill and Melinda Gates Foundation [413]	MoH of Malawi; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The CLHP was primarly funded by the MoH of Malawi, who contributed 69% of the running costs comprising facilities and human resources that are part of the existing health system. The Bill and Melinda Gates Foundation funded the remaining 31% of the costs, 21% of which was investment and 79% operating costs. The Bill & Melinda Gates Foundation grant ID#: 413 http://www.gatesfoundation.org/Pages/home.aspx). The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Duke T, 2006, J TROP PEDIATRICS, V52, P1, DOI 10.1093/tropej/fmk006; Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Enarson PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102955; Enarson PM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000137; Enarson Penny M, 2010, Expert Rev Respir Med, V4, P211, DOI 10.1586/ers.10.14; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Fenn B, 2005, INT J EPIDEMIOL, V34, P368, DOI 10.1093/ije/dyh335; Government of Malawi, 2011, CLIN MAN HIV CHILDR; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Graham SM, 2011, PEDIATR INFECT DIS J, V30, P33, DOI 10.1097/INF.0b013e3181fcabe4; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliwa JN, 2015, LANCET RESP MED, V3, P235, DOI 10.1016/S2213-2600(15)00028-4; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schumacher RF, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.073; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Swann O, 2014, PEDIATR INFECT DIS J, V33, P560, DOI 10.1097/INF.0000000000000210; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	34	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133365	10.1371/journal.pone.0133365	http://dx.doi.org/10.1371/journal.pone.0133365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237222	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400011
J	Ghosh, A; Marquez-Lago, TT				Ghosh, Atiyo; Marquez-Lago, Tatiana T.			Simulating Stochastic Reaction-Diffusion Systems on and within Moving Boundaries	PLOS ONE			English	Article								Chemical reactions inside cells are generally considered to happen within fixed-size compartments. However, cells and their compartments are highly dynamic. Thus, such stringent geometrical assumptions may not reflect biophysical reality, and can highly bias conclusions from simulation studies. In this work, we present an intuitive algorithm for particle-based diffusion in and on moving boundaries, for both point particles and spherical particles. We first benchmark our proposed stochastic method against solutions of partial differential equations in appropriate scenarios, and further demonstrate that moving boundaries can give rise to super-diffusive motion as well as time-inhomogeneous reaction rates. Finally, we conduct a numerical experiment representing photobleaching of diffusing fluorescent proteins in dividing Saccharomyces cerevisiae cells to demonstrate that moving boundaries might cause important effects neglected in previously published studies of cell compartmentalization.	[Ghosh, Atiyo; Marquez-Lago, Tatiana T.] Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Marquez-Lago, TT (corresponding author), Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan.	tatiana.marquezlago@gmail.com		Ghosh, Atiyo/0000-0003-1606-8520	Okinawa Institute of Science and Technology	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	This work was supported by core funding from the Okinawa Institute of Science and Technology given to TML (Integrative Systems Biology Unit).	Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Boettcher B, 2012, J CELL BIOL, V197, P921, DOI 10.1083/jcb.201112117; Burrage K, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P43, DOI 10.1007/978-1-4419-6766-4_2; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Donev A, 2010, J COMPUT PHYS, V229, P3214, DOI 10.1016/j.jcp.2009.12.038; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Isaacson SA, 2009, SIAM J APPL MATH, V70, P77, DOI 10.1137/070705039; Leier A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3634003; Li B. Q., 2006, CO FL SO ME, V578, DOI 10.1007/1-84628-205-5; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Macklin P, 2008, J SCI COMPUT, V35, P266, DOI 10.1007/s10915-008-9190-z; Marquez-Lago TT, 2012, IET SYST BIOL, V6, P134, DOI 10.1049/iet-syb.2011.0049; Notelaers K, 2012, BBA-BIOMEMBRANES, V1818, P3131, DOI 10.1016/j.bbamem.2012.08.010; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716; Zavala E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003725	18	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133401	10.1371/journal.pone.0133401	http://dx.doi.org/10.1371/journal.pone.0133401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230406	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400035
J	Goldhammer, JE; Marhefka, GD; Daskalakis, C; Berguson, MW; Bowen, JE; Diehl, JT; Sun, JZ				Goldhammer, Jordan E.; Marhefka, Gregary D.; Daskalakis, Constantine; Berguson, Mark W.; Bowen, John E.; Diehl, James T.; Sun, Jianzhong			The Effect of Aspirin on Bleeding and Transfusion in Contemporary Cardiac Surgery	PLOS ONE			English	Article							ARTERY-BYPASS-SURGERY; VEIN GRAFT PATENCY; ANTIPLATELET THERAPY; BLOOD-LOSS; CORONARY; OUTCOMES; GUIDELINE; MORTALITY; SOCIETY; TRIAL	Objective Despite evidence that preoperative aspirin improves outcomes in cardiac surgery, recommendations for aspirin use are inconsistent due to aspirin's anti-platelet effect and concern for bleeding. The purpose of this study was to investigate preoperative aspirin use and its effect on bleeding and transfusion in cardiac surgery. Methods This retrospective study involved consecutive patients (n=1571) who underwent CABG, valve, or combined CABG and valve surgery at a single center between March 2007 and July 2012. Of all patients, 728 met the inclusion criteria and were divided into two groups: those using (n=603) or not using (n=125) aspirin within 5 days of surgery. Data were collected on chest tube drainage, re-operation for bleeding, and transfusion of red blood cells (RBCs), fresh frozen plasma (FFP), and platelets. Results No significant difference was observed between the two groups in chest tube drainage or re-operation for bleeding. An increase in patients transfused with RBCs was observed in the aspirin group (61.9 vs 51.2%, adjusted OR 1.77, p=0.027); however, among those transfused RBCs, no significant difference in mean units transfused or massive transfusion was observed. No significant difference was seen in transfusion requirement of FFP or platelets. Conclusions In patients undergoing CABG, valve, or combined CABG/valve surgery, preoperative aspirin, within 5 days of surgery, was associated with an increased probability of receiving an RBC transfusion. Preoperative aspirin was not associated with an increase in chest tube drainage, re-operation for bleeding complications, or transfusion of FFP or platelets.	[Goldhammer, Jordan E.; Berguson, Mark W.; Sun, Jianzhong] Thomas Jefferson Univ, Dept Anesthesiol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Marhefka, Gregary D.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Med, Div Cardiol, Philadelphia, PA 19107 USA; [Daskalakis, Constantine] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Div Biostat, Philadelphia, PA 19107 USA; [Bowen, John E.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Diehl, James T.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Surg, Div Cardiothorac Surg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Goldhammer, JE (corresponding author), Thomas Jefferson Univ, Dept Anesthesiol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	jordan.goldhammer@jefferson.edu						Al-Atassi T, 2012, CIRCULATION, V126, pS239, DOI 10.1161/CIRCULATIONAHA.111.084772; Biancari F, 2012, EUR J CARDIO-THORAC, V41, P50, DOI 10.1016/j.ejcts.2011.04.023; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030094; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub4; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; GOLDMAN S, 1991, CIRCULATION, V84, P520, DOI 10.1161/01.CIR.84.2.520; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Hillis LD, 2011, CIRCULATION, V124, P2610, DOI 10.1161/CIR.0b013e31823b5fee; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P404, DOI 10.1016/1010-7940(94)90081-7; Karthik S, 2004, ANN THORAC SURG, V78, P527, DOI 10.1016/j.athoracsur.2004.02.088; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Maxwell MJ, 2006, CONTIN ED ANAESTH CR, V6, P225, DOI DOI 10.1093/BJACEACCP/MKL053; Ngaage DL, 2010, EUR J CARDIO-THORAC, V37, P1375, DOI 10.1016/j.ejcts.2009.11.055; Ravn HB, 2011, J CARDIOTHOR VASC AN, V25, P36, DOI 10.1053/j.jvca.2010.05.006; SETHI GK, 1990, J AM COLL CARDIOL, V15, P15, DOI 10.1016/0735-1097(90)90168-O; Sun JC, 2010, CIRCULATION, V122, P2680; Weightman WM, 2002, J CARDIOTHOR VASC AN, V16, P54, DOI 10.1053/jcan.2002.29674; Yao LN, 2015, ANN SURG, V261, P207, DOI 10.1097/SLA.0000000000000641	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134670	10.1371/journal.pone.0134670	http://dx.doi.org/10.1371/journal.pone.0134670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230605	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400147
J	Rong, XF; Ji, YH; Fang, YW; Jiang, YX; Lu, Y				Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi			Long-Term Visual Outcomes of Secondary Intraocular Lens Implantation in Children with Congenital Cataracts	PLOS ONE			English	Article							INFANT APHAKIA TREATMENT; SURGERY; PERIOD; COMPLICATIONS; STRABISMUS; GLAUCOMA; ACUITY; CORTEX; AGE; EYE	Aim The aim of this study was to evaluate the long-term visual outcomes and factors affecting visual results in children undergoing secondary intraocular lens (IOL) implantation following primary congenital cataract extraction. Methods Children with congenital cataracts who underwent secondary IOL implantation for aphakia at the Eye and ENT Hospital of Fudan University between January 1, 2001, and December 31, 2007, were retrospectively reviewed. One eye was randomly selected in children with bilateral cataracts. Laterality, type of cataract (total or partial opacity), sex, age at primary and secondary surgeries, visual axis opacity (VAO), compliance with amblyopia therapy, postoperative ocular complications, refractive error, ocular alignment, and best corrected visual acuity (BCVA) at last follow-up were recorded; potential factors that might have affected the visual results were evaluated. Results Seventy-six bilateral and 34 unilateral congenital cataract cases were analyzed; the mean ages of the children were 12.70 +/- 5.06 and 12.50 +/- 2.71 years at final follow-up, the mean follow-up periods from IOL implantation were 94.93 +/- 24.22 and 109.09 +/- 18.89 months, and the mean BCVA (Log MAR) values were 0.51 +/- 0.37 and 1.05 +/- 0.46, respectively. Final BCVA after secondary IOL implantation was significantly associated with laterality, type of cataract, age at primary cataract extraction, compliance with amblyopia therapy, and refractive correction after surgery. No significant associations were found between BCVA and sex, age at secondary IOL implantation, VAO, or other ocular complications. The most common ocular complications were VAO and elevated intraocular pressure after surgery. There were no other complications, with the exception of one eye with IOL dislocation. Conclusions The results indicate that the important determinants of long-term visual outcomes in children with congenital cataracts undergoing secondary IOL implantation are laterality, cataract type, age at initial cataract extraction, compliance with amblyopia therapy, and refractive error.	[Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China; [Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University	Lu, Y (corresponding author), Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	luyiox@163.com			National Natural Science Foundation of China [81300806, 81300745]; Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program [SHDC12012104]; Key-Collabotative Project of Health Bureau of Pudong New Area [PW2011D-7]; Program of Science and Technology Commission of Shanghai Municipality [124119a9900]; Youth Foundation Project of Shanghai Municipal Health Bureau [20124y041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program; Key-Collabotative Project of Health Bureau of Pudong New Area; Program of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Youth Foundation Project of Shanghai Municipal Health Bureau	This study was supported by grants from the National Natural Science Foundation of China (No. 81300806 and 81300745), the Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program (No. SHDC12012104), Key-Collabotative Project of Health Bureau of Pudong New Area (No. PW2011D-7), Program of Science and Technology Commission of Shanghai Municipality (No. 124119a9900) and the Youth Foundation Project of Shanghai Municipal Health Bureau (20124y041). The funding organizations had no role in designing or conducting this research.	Alagaratnam J, 2002, EYE, V16, P557, DOI 10.1038/sj.eye.6700149; Basti S, 1996, OPHTHALMOLOGY, V103, P713; Birch EE, 2012, J AAPOS, V16, P156, DOI 10.1016/j.jaapos.2011.11.007; Borisovsky G, 2013, GRAEF ARCH CLIN EXP, V251, P2205, DOI 10.1007/s00417-013-2327-2; Bothun ED, 2013, OPHTHALMOLOGY, V120, P1227, DOI 10.1016/j.ophtha.2012.11.039; BRADFORD GM, 1994, AM J OPHTHALMOL, V117, P58, DOI 10.1016/S0002-9394(14)73015-6; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Drews-Botsch CD, 2012, INVEST OPHTH VIS SCI, V53, P3368, DOI 10.1167/iovs.11-8457; ELSTON JS, 1992, BRIT J OPHTHALMOL, V76, P327, DOI 10.1136/bjo.76.6.327; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Horton JC, 1997, J NEUROSCI, V17, P3684; Kim DH, 2012, ACTA OPHTHALMOL, V90, P231, DOI 10.1111/j.1755-3768.2010.01872.x; Lambert SR, 2014, JAMA OPHTHALMOL, V132, P676, DOI 10.1001/jamaophthalmol.2014.531; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Lambert SR, 2006, J AAPOS, V10, P30, DOI 10.1016/j.jaapos.2005.10.002; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Lee SJ, 2014, INT J OPHTHALMOL-CHI, V7, P522, DOI 10.3980/j.issn.2222-3959.2014.03.25; LORENZ B, 1991, GRAEF ARCH CLIN EXP, V229, P123, DOI 10.1007/BF00170543; Magli A, 2013, GRAEF ARCH CLIN EXP, V251, P309, DOI 10.1007/s00417-012-1979-7; Nihalani BR, 2011, J AAPOS, V15, P435, DOI 10.1016/j.jaapos.2011.05.019; PARKS MM, 1993, OPHTHALMOLOGY, V100, P826; Plager DA, 2011, OPHTHALMOLOGY, V118, P2330, DOI 10.1016/j.ophtha.2011.06.017; Sjostrand J, 2011, ACTA OPHTHALMOL, V89, P30, DOI 10.1111/j.1755-3768.2009.01618.x; Tatham A, 2010, EYE, V24, P1366, DOI 10.1038/eye.2010.46; Vaegan Taylor D, 1979, T OPHTHAL SOC UK, V99, P432; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wilson ME, 1996, OPHTHALMOLOGY, V103, P1719, DOI 10.1016/S0161-6420(96)30436-3	27	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134864	10.1371/journal.pone.0134864	http://dx.doi.org/10.1371/journal.pone.0134864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230501	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400179
J	Ye, JQ; Gaur, M; Zhang, Y; Sievers, RE; Woods, BJ; Aurigui, J; Bernstein, HS; Yeghiazarians, Y				Ye, Jianqin; Gaur, Meenakshi; Zhang, Yan; Sievers, Richard E.; Woods, Brandon J.; Aurigui, Julian; Bernstein, Harold S.; Yeghiazarians, Yerem			Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RAT HEARTS; TRANSPLANTATION; CARDIOMYOCYTES; THERAPY; PROTECTION; INJECTION; CYTOKINES; REPAIR	Background We previously reported the generation of a reporter line of human embryonic stem cells (hESCs) with enhanced green fluorescent protein (eGFP) expression driven by the alpha-myosin heavy chain (alpha MHC) promoter. The GFP(+)/alpha MHC+ cells derived from this cell line behave as multipotent, human myocardial precursors (hMPs) in vitro. In this study, we evaluated the therapeutic effects of GFP(+)/alpha MHC+ cells isolated from the reporter line in a mouse model of myocardial infarction (MI). Methods MI was generated in immunodeficient mice. hMPs were injected into murine infarcted hearts under ultrasound guidance at 3 days post-MI. Human fetal skin fibroblasts (hFFs) were injected as control. Cardiac function was evaluated by echocardiography. Infarct size, angiogenesis, apoptosis, cell fate, and teratoma formation were analyzed by immunohistochemical staining. Results Compared with control, hMPs resulted in improvement of cardiac function post-MI with smaller infarct size, induced endogenous angiogenesis, and reduced apoptosis of host cardiomyocytes at the peri-infarct zone at 28 days post-MI. Conclusion Intramyocardial injection of hMPs improved cardiac function post-MI. The engraftment rate of these cells in the myocardium post-MI was low, suggesting that the majority of effect occurs via paracrine mechanisms.	[Ye, Jianqin; Gaur, Meenakshi; Zhang, Yan; Sievers, Richard E.; Woods, Brandon J.; Yeghiazarians, Yerem] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Aurigui, Julian; Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yeghiazarians, Y (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	yeghiaza@medicine.ucsf.edu	ye, jian/GQH-3702-2022		California Institute of Regenerative Medicine [RC1-00104-1]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by a grant from the California Institute of Regenerative Medicine to HSB and YY (RC1-00104-1).	Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bernstein H. S., 2010, J VIS EXP; Bernstein HS, 2012, REGEN MED, V7, P697, DOI [10.2217/RME.12.46, 10.2217/rme.12.46]; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Sui RQ, 2011, STEM CELL REV REP, V7, P172, DOI 10.1007/s12015-010-9131-8; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z; van Laake LW, 2009, STEM CELL RES, V3, P106, DOI 10.1016/j.scr.2009.05.004; Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301; Ye JQ, 2014, J CARDIOVASC PHARM, V63, P85, DOI 10.1097/FJC.0b013e318299ebc0; Ye JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030329; Yeghiazarians Y, 2012, CYTOTHERAPY, V14, P223, DOI 10.3109/14653249.2011.623690; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131123	10.1371/journal.pone.0131123	http://dx.doi.org/10.1371/journal.pone.0131123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230835	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400007
J	Zhao, JN; Zhang, XX; He, XC; Yang, GR; Zhang, XQ; Li, HC				Zhao, Jiang-nan; Zhang, Xian-xin; He, Xiao-chun; Yang, Guo-ru; Zhang, Xiao-qi; Li, Huai-chen			The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INFECTIONS; MANAGEMENT; CIRRHOSIS; ALBUMIN	Objective The relationship between extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant Gram-negative bacilli (MDR-GNB) is unclear. Identification of the relationship between XDR-TB and MDR-GNB would have important implications for patient care. Methods We conducted a retrospective study reviewing the records of patients admitted with a confirmed pulmonary TB from 2011 to 2014. To identify the relationship between XDR-TB and MDR-GNB, univariable comparison and multivariable logistic regression were performed. Results Among 2962 pulmonary TB patients, 45(1.5%) patients had a diagnosis of XDR-TB. A total of 165 MDR-GNB strains were detected in 143 (4.8%) pulmonary TB patients. XDR-TB patients had a significantly higher occurrence of MDR-GNB than non-XDR-TB patients (24.4% vs. 4.5%; P<0.001). Age (OR 1.02, 95% CI 1.01-1.03), hypoalbuminemia (OR 1.48, 95% CI 1.18-1.85), chronic renal failure (OR 6.67, 95% CI 1.42-31.47), chronic hepatic insufficiency (OR 1.99, 95% CI 1.15-3.43), presence of XDR-TB (OR 6.56, 95% CI 1.61-26.69), and duration of TB diagnostic delay (OR 1.01, 95% CI 1.00-1.02) were the independent risk factors for MDR-GNB infection. Conclusions Patients with XDR-TB have a significantly higher risk of being affected by MDR-GNB pathogen. The underlying mechanism association warrant further studies.	[Zhao, Jiang-nan; He, Xiao-chun; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China; [Zhang, Xian-xin] Shandong Prov Chest Hosp, Dept Resp Med, Jinan, Peoples R China; [Yang, Guo-ru] Chest Specially Hosp Weifang, Dept Resp Med, Weifang, Peoples R China; [Zhang, Xiao-qi] Chest Specially Hosp Weifang, Dept TB Med, Weifang, Peoples R China	Shandong University; Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China.	zjn911016@126.com			Science and technology development plan of Shandong Province [2009GG10002054]	Science and technology development plan of Shandong Province	This work was supported by Science and technology development plan of Shandong Province (Grant Number: 2009GG10002054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P430; [Anonymous], 2009, GUID SURV DRUG RES T; Arruda EAG, 1999, INFECT CONT HOSP EP, V20, P620, DOI 10.1086/501683; Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Chang KC, 2013, RESPIROLOGY, V18, P8, DOI 10.1111/j.1440-1843.2012.02257.x; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; D'Agata EMC, 2004, INFECT CONT HOSP EP, V25, P842, DOI 10.1086/502306; Daley CL, 2014, CLIN INFECT DIS, V59, P1064, DOI 10.1093/cid/ciu578; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; Jalan R, 2013, J HEPATOL, V59, P918, DOI 10.1016/j.jhep.2013.08.001; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Kim HR, 2011, J HOSP INFECT, V77, P134, DOI 10.1016/j.jhin.2010.07.004; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lai CC, 2011, J ANTIMICROB CHEMOTH, V66, P1374, DOI 10.1093/jac/dkr103; Lam E, 2014, EMERG INFECT DIS, V20, P400, DOI 10.3201/eid2003.130951; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pop-Vicas AE, 2005, CLIN INFECT DIS, V40, P1792, DOI 10.1086/430314; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Siege JD, 2006, MANAGEMENT MULTIDRUG; Simonsen GS, 2004, B WORLD HEALTH ORGAN, V82, P928; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Wong SSY, 2007, PERITON DIALYSIS INT, V27, pS272; World Health Organization, 2014, GLOB TUB REP; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134998	10.1371/journal.pone.0134998	http://dx.doi.org/10.1371/journal.pone.0134998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230499	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400190
J	de Souza, LM; Le Guen, V; Cerqueira-Silva, CBM; Silva, CC; Mantello, CC; Conson, ARO; Vianna, JPG; Zucchi, MI; Scaloppi, EJ; Fialho, JD; de Moraes, MLT; Goncalves, PD; de Souza, AP				de Souza, Livia Moura; Le Guen, Vincent; Moreno Cerqueira-Silva, Carlos Bernardo; Silva, Carla Cristina; Mantello, Camila Campos; Oliveira Conson, Andre Ricardo; Gomes Vianna, Joao Paulo; Zucchi, Maria Imaculada; Scaloppi Junior, Erivaldo Jose; Fialho, Josefino de Freitas; Teixeira de Moraes, Mario Luis; Goncalves, Paulo de Souza; de Souza, Anete Pereira			Genetic Diversity Strategy for the Management and Use of Rubber Genetic Resources: More than 1,000 Wild and Cultivated Accessions in a 100-Genotype Core Collection	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; IDENTIFICATION; CONSERVATION; POPULATIONS; INFERENCE; PROGRAM; MARKERS	The rubber tree [Hevea brasiliensis (Willd. ex Adr. de Juss.) Muell. Arg.] is the only plant species worldwide that is cultivated for the commercial production of natural rubber. This study describes the genetic diversity of the Hevea spp. complex that is available in the main ex situ collections of South America, including Amazonian populations that have never been previously described. Genetic data were analyzed to determine the genetic structure of the wild populations, quantify the allelic diversity and suggest the composition of a core collection to capture the maximum genetic diversity within a minimal sample size. A total of 1,117 accessions were genotyped with 13 microsatellite markers. We identified a total of 408 alleles, 319 of which were shared between groups and 89 that were private in different groups of accessions. In a population structure and principal component analysis, the level of clustering reflected a primary division into the following two subgroups: cluster 1, which consisted of varieties from the advanced breeding germplasm that originated from the Wickham and Mato Grosso accessions; and cluster 2, which consisted of the wild germplasm from the Acre, Amazonas, Para and Rondonia populations and Hevea spp. The analyses revealed a high frequency of gene flow between the groups, with the genetic differentiation coefficient (GST) estimated to be 0.018. Additionally, no distinct separation among the H. brasiliensis accessions and the other species from Amazonas was observed. A core collection of 99 accessions was identified that captured the maximum genetic diversity. Rubber tree breeders can effectively utilize this core collection for cultivar improvement. Furthermore, such a core collection could provide resources for forming an association panel to evaluate traits with agronomic and commercial importance. Our study generated a molecular database that should facilitate the management of the Hevea germplasm and its use for subsequent genetic and genomic breeding.	[de Souza, Livia Moura; Moreno Cerqueira-Silva, Carlos Bernardo; Silva, Carla Cristina; Mantello, Camila Campos; Oliveira Conson, Andre Ricardo; Gomes Vianna, Joao Paulo; de Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil; [Le Guen, Vincent] UMR AGAP, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, Herault, France; [Moreno Cerqueira-Silva, Carlos Bernardo] State Univ Southwest Bahia UESB, Dept Exact & Nat Sci, Lab Appl Mol Genet, Itapetinga, BA, Brazil; [Gomes Vianna, Joao Paulo; Zucchi, Maria Imaculada] Agencia Paulista Tecnol Agronegocios, Polo Reg Noroeste Paulista, Votuporanga, SP, Brazil; [Fialho, Josefino de Freitas] Embrapa Cerrados EMBRAPA, Planaltina, DF, Brazil; [Teixeira de Moraes, Mario Luis] Univ Estadual Paulista, UNESP, Fac Engn Ilha Solteira, Dept Fitotecnia, Ilha Solteira, SP, Brazil; [Scaloppi Junior, Erivaldo Jose; Goncalves, Paulo de Souza] Rubber Res Adv Ctr CAPSA, Agron Inst IAC, Votuporanga, SP, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; CIRAD; Universite de Montpellier; Universidade Estadual do Sudoeste da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	Conson, Andre Ricardo Olivei RO/Q-1916-2018; Le Guen, Vincent/I-2229-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Zucchi, Maria Imaculada/D-2637-2012; Viana, João Paulo JPGV Gomes/K-1178-2012; Conson, Andre Ricardo Oliveira/O-1609-2019; DE SOUZA, ANETE PEREIRA/B-8663-2012	Conson, Andre Ricardo Olivei RO/0000-0002-8131-7127; Zucchi, Maria Imaculada/0000-0002-4863-1843; Zucchi, Maria Imaculada/0000-0002-4863-1843; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604; Conson, Andre Ricardo Oliveira/0000-0002-8131-7127; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Scaloppi Junior, Erivaldo Jose/0000-0002-8050-2187; Campos Mantello, Camila/0000-0002-9716-0400; Da Silva, Carla/0000-0003-4779-0014	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50392-1, 2012/50491-8, 2011/50188-0, 2009/52975-0, 2012/05473-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478701/2012-8, 402954/2012-2]; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2007/50392-1; 2012/50491-8) for financial support and scholarships to CCM (2011/50188-0), CCS (2009/52975-0), and LMS (2012/05473-1), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support (478701/2012-8; 402954/2012-2) and research fellowships to APS and PSG, and the Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) for financial support (Computational Biology Program and CAPES-Agropolis Program) and a graduate scholarship to AROC.	[Anonymous], 2014, J BIOL AGR HEALTHC, V4, P132; Balas FC, 2014, TREE GENET GENOMES, V10, P703, DOI 10.1007/s11295-014-0715-3; BALDWIN JT, 1947, J HERED, V38, P54, DOI 10.1093/oxfordjournals.jhered.a105691; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; BESSE P, 1994, THEOR APPL GENET, V88, P199, DOI 10.1007/BF00225898; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Clement-Demange A., 1998, Symposium on natural rubber (Hevea brasiliensis). Volume 1. General, soils and fertilization, and breeding and selection sessions, Ho Chi Minh City, Vietnam, 14-15 October 1997., P71; Clement-Demange Andre, 2001, P455; Cochard B, 2009, TREE GENET GENOMES, V5, P493, DOI 10.1007/s11295-009-0203-3; Cubry P, 2013, GENET RESOUR CROP EV, V60, P483, DOI 10.1007/s10722-012-9851-5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Falush D, 2003, GENETICS, V164, P1567; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Goncalves PS, 1981, EXPEDICAO INT AMAZON; Graudal L., 1999, DFSC SERIES TECHNICA; Greene SL, 1996, CROP SCI, V36, P1398, DOI 10.2135/cropsci1996.0011183X003600050051x; Gross BL, 2012, J AM SOC HORTIC SCI, V137, P333, DOI 10.21273/JASHS.137.5.333; Halle F, 1974, AMAZONIE BRESILIENNE; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lam LV, 2009, MOL BIOTECHNOL, V42, P292, DOI 10.1007/s12033-009-9159-7; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Le Guen V, 2009, TREE GENET GENOMES, V5, P673, DOI 10.1007/s11295-009-0218-9; Lekawipat N., 2003, Journal of Rubber Research, V6, P36; Lins ACR, 1981, REPORT ACRE TEAM JOI, P24; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Marcano M, 2007, THEOR APPL GENET, V114, P877, DOI 10.1007/s00122-006-0486-9; Paiva J, 1994, SILVAE GENET, V43, P306; Paiva J, 1981, COLETA MAT SEXUADO A; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pires JM, 2002, TAXONOMIA FITOGEOGRA; Pritchard JK, 2000, GENETICS, V155, P945; Priyadarshan PM, 2003, GENET RESOUR CROP EV, V50, P101, DOI 10.1023/A:1022972320696; Rands R.D., 1955, PROGR REPORT COOPERA; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saha T, 2005, PLANT BREEDING, V124, P86, DOI 10.1111/j.1439-0523.2004.01053.x; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seguin Marc, 2003, P277; Seibert RJ, 1948, MISSOURI BOT GARD SA, V35, P61; Shan F, 2007, GENET RESOUR CROP EV, V54, P519, DOI 10.1007/s10722-006-0008-2; Souza LM, 2009, CONSERV GENET RESOUR, V1, P75, DOI 10.1007/s12686-009-9018-7; Van Helten VM, 1918, ARCH RUBBERCULT NED, V2, P87; van Treuren R, 2010, GENET RESOUR CROP EV, V57, P853, DOI 10.1007/s10722-009-9525-0; Yeang HY, 1999, ANN BOT-LONDON, V84, P681, DOI 10.1006/anbo.1999.0959; Zhang DP, 2009, TREE GENET GENOMES, V5, P1, DOI 10.1007/s11295-008-0163-z	47	17	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134607	10.1371/journal.pone.0134607	http://dx.doi.org/10.1371/journal.pone.0134607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225861	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700121
J	Garcia, S; Petrini, K; Rubin, GS; Da Cruz, L; Nardini, M				Garcia, Sara; Petrini, Karin; Rubin, Gary S.; Da Cruz, Lyndon; Nardini, Marko			Visual and Non-Visual Navigation in Blind Patients with a Retinal Prosthesis	PLOS ONE			English	Article							PATH-INTEGRATION; OCCIPITAL CORTEX; TACTILE ACUITY; SPACE; INFORMATION; COGNITION; ABILITY; HUMANS	Human adults with normal vision can combine visual landmark and non-visual self-motion cues to improve their navigational precision. Here we asked whether blind individuals treated with a retinal prosthesis could also benefit from using the resultant new visual signal together with non-visual information when navigating. Four patients (blind for 15-52 years) implanted with the Argus II retinal prosthesis (Second Sight Medical Products Inc. Sylmar, CA), and five age-matched and six younger controls, participated. Participants completed a path reproduction and a triangle completion navigation task, using either an indirect visual landmark and non-visual self-motion cues or non-visual self-motion cues only. Control participants wore goggles that approximated the field of view and the resolution of the Argus II prosthesis. In both tasks, control participants showed better precision when navigating with reduced vision, compared to without vision. Patients, however, did not show similar improvements when navigating with the prosthesis in the path reproduction task, but two patients did show improvements in the triangle completion task. Additionally, all patients showed greater precision than controls in both tasks when navigating without vision. These results indicate that the Argus II retinal prosthesis may not provide sufficiently reliable visual information to improve the precision of patients on tasks, for which they have learnt to rely on non-visual senses.	[Garcia, Sara; Petrini, Karin; Rubin, Gary S.; Da Cruz, Lyndon; Nardini, Marko] UCL, Inst Ophthalmol, London, England; [Petrini, Karin] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Rubin, Gary S.; Da Cruz, Lyndon] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Rubin, Gary S.; Da Cruz, Lyndon] UCL Inst Ophthalmol, London, England; [Da Cruz, Lyndon] Moorfields Eye Hosp NHS Fdn Trust, Vitreoretinal Serv, London, England; [Nardini, Marko] Univ Durham, Dept Psychol, Durham DH1 3LE, England	University of London; University College London; University of Bath; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Durham University	Garcia, S (corresponding author), UCL, Inst Ophthalmol, London, England.	sara.garcia.12@ucl.ac.uk	Nardini, Marko/C-1905-2008	Nardini, Marko/0000-0001-6614-7775; Garcia, Sara/0000-0001-6254-6015; Petrini, Karin/0000-0001-5354-5600	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; University College London	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; University College London(General Electric)	This work was supported by the James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program, and the NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London.	Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; Bates SL, 2014, NEUROBIOL AGING, V35, P2761, DOI 10.1016/j.neurobiolaging.2014.04.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Fornos AP, 2012, INVEST OPHTH VIS SCI, V53, P2720, DOI 10.1167/iovs.11-9344; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; GALLISTEL CR, 1990, COGNITION, V37, P1, DOI 10.1016/0010-0277(90)90016-D; Goldreich D, 2003, J NEUROSCI, V23, P3439; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Kalia AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072170; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrini K, 2014, J VISION, V14, P1345, DOI [10.1167/14.10.1345, DOI 10.1167/14.10.1345]; Petrini K, 2014, DEVELOPMENTAL SCI, V17, P376, DOI 10.1111/desc.12127; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P16, DOI 10.1016/j.neubiorev.2012.11.017; Ptito M, 2008, EXP BRAIN RES, V184, P193, DOI 10.1007/s00221-007-1091-0; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; Verboven S, 2005, CHEMOMETR INTELL LAB, V75, P127, DOI 10.1016/j.chemolab.2004.06.003; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315	32	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134369	10.1371/journal.pone.0134369	http://dx.doi.org/10.1371/journal.pone.0134369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225762	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358837700080
J	McCabe, MS; Cormican, P; Keogh, K; O'Connor, A; O'Hara, E; Palladino, RA; Kenny, DA; Waters, SM				McCabe, Matthew Sean; Cormican, Paul; Keogh, Kate; O'Connor, Aaron; O'Hara, Eoin; Alejandro Palladino, Rafael; Kenny, David Anthony; Waters, Sinead Mary			Illumina MiSeq Phylogenetic Amplicon Sequencing Shows a Large Reduction of an Uncharacterised Succinivibrionaceae and an Increase of the Methanobrevibacter gottschalkii Clade in Feed Restricted Cattle	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; METHANE EMISSIONS; SP-NOV; RUMEN; PROPIONATE; COMMUNITY; DISCOVERY; DIGESTION; ECOSYSTEM; GENOMES	Periodic feed restriction is used in cattle production to reduce feed costs. When normal feed levels are resumed, cattle catch up to a normal weight by an acceleration of normal growth rate, known as compensatory growth, which is not yet fully understood. Illumina Miseq Phylogenetic marker amplicon sequencing of DNA extracted from rumen contents of 55 bulls showed that restriction of feed (70% concentrate, 30% grass silage) for 125 days, to levels that caused a 60% reduction of growth rate, resulted in a large increase of relative abundance of Methanobrevibacter gottschalkii clade (designated as OTU-M7), and a large reduction of an uncharacterised Succinivibrionaceae species (designated as OTU-S3004). There was a strong negative Spearman correlation (rho = -0.72, P = <1x10(-20)) between relative abundances of OTU-3004 and OTU-M7 in the liquid rumen fraction. There was also a significant increase in acetate:propionate ratio (A:P) in feed restricted animals that showed a negative Spearman correlation (rho = -0.69, P = <1x10(-20)) with the relative abundance of OTU-S3004 in the rumen liquid fraction but not the solid fraction, and a strong positive Spearman correlation with OTU-M7 in the rumen liquid (rho = 0.74, P = <1x10(-20)) and solid (rho = 0.69, P = <1x10(-20)) fractions. Reduced A:P ratios in the rumen are associated with increased feed efficiency and reduced production of methane which has a global warming potential (GWP 100 years) of 28. Succinivibrionaceae growth in the rumen was previously suggested to reduce methane emissions as some members of this family utilise hydrogen, which is also utilised by methanogens for methanogenesis, to generate succinate which is converted to propionate. Relative abundance of OTU-S3004 showed a positive Spearman correlation with propionate (rho = 0.41, P = <0.01) but not acetate in the liquid rumen fraction.	[McCabe, Matthew Sean; Cormican, Paul; Keogh, Kate; O'Hara, Eoin; Kenny, David Anthony; Waters, Sinead Mary] Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, County Meath, Ireland; [O'Connor, Aaron] Univ Coll Dublin, Coll Life Sci, UCD Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Alejandro Palladino, Rafael] Univ Buenos Aires, Dept Anim Prod, Buenos Aires, DF, Argentina	Teagasc; University College Dublin; University of Buenos Aires	McCabe, MS (corresponding author), Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, County Meath, Ireland.	matthew.mccabe@teagasc.ie	Keogh, Kate/AAY-2455-2020; Kenny, David/B-1653-2013	Keogh, Kate/0000-0001-8338-5177; Kenny, David/0000-0001-9204-098X	Science Foundation Ireland [SFI 09/RFP/GEN2447]; Teagasc Walsh Fellowship Funding (Teagasc project) [RMIS 6341]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Teagasc Walsh Fellowship Funding (Teagasc project)	This study was supported by the Science Foundation Ireland (http://www.sfi.ie) (Contract number SFI 09/RFP/GEN2447-awarded to SMW) and Teagasc Walsh Fellowship Funding (www.teagasc.ie) (Teagasc project RMIS 6341-awarded to SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MIN 17 STAT SOFTW; [Anonymous], 2015, PLOS ONE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BLACKBURN TH, 1963, APPL MICROBIOL, V11, P132, DOI 10.1128/AEM.11.2.132-135.1963; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; BROTZ PG, 1987, J MICROBIOL METH, V6, P139, DOI 10.1016/0167-7012(87)90009-1; CALDWELL DR, 1966, APPL MICROBIOL, V14, P794, DOI 10.1128/AEM.14.5.794-801.1966; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christophersen CT, 2008, J ANIM SCI, V86, P384, DOI 10.2527/jas.2007-0373; Creevey CJ, 2014, MICROB BIOTECHNOL, V7, P467, DOI 10.1111/1751-7915.12141; Czerkawski J. W., 1986, INTRO RUMEN STUDIES; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DINIUS DA, 1976, J ANIM SCI, V42, P229, DOI 10.2527/jas1976.421229x; Dworkin M, 2006, PROKARYOTES, V3, P419; Evans JD, 1997, APPL ENVIRON MICROB, V63, P4853, DOI 10.1128/AEM.63.12.4853-4858.1997; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; GALYEAN ML, 1991, PHYSIOLOGICAL ASPECTS OF DIGESTION AND METABOLISM IN RUMINANTS, P483; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hippe H, 1999, INT J SYST BACTERIOL, V49, P779, DOI 10.1099/00207713-49-2-779; Hogg BW, 1991, GROWTH REGULATION FA; HUNGATE RE, 1966, RUMEN ITS MICROBES; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Keogh K, 2014, P WORLD C GEN APPL L; Keogh K, 2014, EFFECT FEED RESTRICT, P89; Keogh K, 2012, P AGR RES FOR TULL, P44; Kim M, 2011, FOLIA MICROBIOL, V56, P453, DOI 10.1007/s12223-011-0066-5; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LEAHY SC, 2010, PLOS ONE, V5; Lee PC, 1999, ENZYME MICROB TECH, V24, P549, DOI 10.1016/S0141-0229(98)00156-2; Li MJ, 2012, VET MICROBIOL, V155, P72, DOI 10.1016/j.vetmic.2011.08.007; MEISKE JC, 1958, J ANIM SCI, V17, P774, DOI 10.2527/jas1958.173774x; Michalet-Doreau B, 2001, ANIM RES, V50, P451, DOI 10.1051/animres:2001107; O'Shea E, 2014, P AGR RES FOR TULL, P148; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pope PB, 2011, SCIENCE, V333, P646, DOI 10.1126/science.1205760; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; R Core Team, 2012, R LANG ENV STAT COMP; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Reti KL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-8; RUSSELL JB, 1981, J DAIRY SCI, V64, P1153, DOI 10.3168/jds.S0022-0302(81)82694-X; SCHEIFINGER CC, 1973, APPL MICROBIOL, V26, P789, DOI 10.1128/AEM.26.5.789-795.1973; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARNER ACI, 1962, J GEN MICROBIOL, V28, P129, DOI 10.1099/00221287-28-1-129; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang S, 2013, J ANIM SCI, V91, P1696, DOI 10.2527/jas.2012-5774	56	57	60	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133234	10.1371/journal.pone.0133234	http://dx.doi.org/10.1371/journal.pone.0133234			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226343	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700015
J	Bordoy, AE; Chatterjee, A				Bordoy, Antoni E.; Chatterjee, Anushree			Cis-Antisense Transcription Gives Rise to Tunable Genetic Switch Behavior: A Mathematical Modeling Approach	PLOS ONE			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; MESSENGER-RNA; BIDIRECTIONAL PROMOTERS; STAPHYLOCOCCUS-AUREUS; BACTERIOPHAGE 186; VIRULENCE GENE; EXPRESSION; INTERFERENCE; OPERON	Antisense transcription has been extensively recognized as a regulatory mechanism for gene expression across all kingdoms of life. Despite the broad importance and extensive experimental determination of cis-antisense transcription, relatively little is known about its role in controlling cellular switching responses. Growing evidence suggests the presence of non-coding cis-antisense RNAs that regulate gene expression via antisense interaction. Recent studies also indicate the role of transcriptional interference in regulating expression of neighboring genes due to traffic of RNA polymerases from adjacent promoter regions. Previous models investigate these mechanisms independently, however, little is understood about how cells utilize coupling of these mechanisms in advantageous ways that could also be used to design novel synthetic genetic devices. Here, we present a mathematical modeling framework for antisense transcription that combines the effects of both transcriptional interference and cis-antisense regulation. We demonstrate the tunability of transcriptional interference through various parameters, and that coupling of transcriptional interference with cis-antisense RNA interaction gives rise to hypersensitive switches in expression of both antisense genes. When implementing additional positive and negative feed-back loops from proteins encoded by these genes, the system response acquires a bistable behavior. Our model shows that combining these multiple-levels of regulation allows fine-tuning of system parameters to give rise to a highly tunable output, ranging from a simple-first order response to biologically complex higher-order response such as tunable bistable switch. We identify important parameters affecting the cellular switch response in order to provide the design principles for tunable gene expression using antisense transcription. This presents an important insight into functional role of antisense transcription and its importance towards design of synthetic biological switches.	[Bordoy, Antoni E.; Chatterjee, Anushree] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Chatterjee, Anushree] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chatterjee, A (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	chatterjee@colorado.edu	Bordoy, Antoni E./AAI-1705-2019	Bordoy, Antoni E./0000-0002-1165-542X	William M. Keck Foundation; Balsells Foundation; University of Colorado	William M. Keck Foundation(W.M. Keck Foundation); Balsells Foundation; University of Colorado	This work was supported by William M. Keck Foundation and University of Colorado start-up funds to AC. AEB was supported by Balsells Graduate fellowship from Balsells Foundation and University of Colorado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021974; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Crampton N, 2006, NUCLEIC ACIDS RES, V34, P5416, DOI 10.1093/nar/gkl668; Dodd IB, 2007, J MOL BIOL, V369, P1200, DOI 10.1016/j.jmb.2007.04.041; Dodd IB, 2002, MOL MICROBIOL, V45, P697, DOI 10.1046/j.1365-2958.2002.03038.x; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Trevino-Quintanilla LG, 2013, CURR GENOMICS, V14, P378, DOI 10.2174/1389202911314060007; Giangrossi M, 2010, NUCLEIC ACIDS RES, V38, P3362, DOI 10.1093/nar/gkq025; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Gottesman S, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A003798; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Licht A, 2011, MICROBIOL-SGM, V157, P1000, DOI 10.1099/mic.0.047209-0; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mason E, 2013, MOL MICROBIOL, V90, P716, DOI 10.1111/mmi.12394; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Monti L, 2009, INT J ONCOL, V34, P1099, DOI 10.3892/ijo_00000237; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murchland I, 2014, J BIOL CHEM, V289, P32094, DOI 10.1074/jbc.M114.608026; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Peterson EJR, 2014, NUCLEIC ACIDS RES, V42, P11291, DOI 10.1093/nar/gku777; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Record M. T., 1996, ESCHERICHIA COLI RNA; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Stork M, 2007, J BACTERIOL, V189, P3479, DOI 10.1128/JB.00619-06; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Xu J, 2000, J BACTERIOL, V182, P3165, DOI 10.1128/JB.182.11.3165-3174.2000; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Xue ZH, 2014, NATURE, V514, P650, DOI 10.1038/nature13671; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	94	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133873	10.1371/journal.pone.0133873	http://dx.doi.org/10.1371/journal.pone.0133873			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222133	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800074
J	Boumans, MLLM; Krings, M; Wagner, H				Boumans, Mark L. L. M.; Krings, Markus; Wagner, Hermann			Muscular Arrangement and Muscle Attachment Sites in the Cervical Region of the American Barn Owl (Tyto furcata pratincola)	PLOS ONE			English	Article							ANTERIOR PRESACRAL REGION; SPLENIUS-CAPITIS; HEAD MOVEMENTS; NECK; ANATOMY; COLUMN; MORPHOLOGY; HOMOLOGIES; DIAPSIDA; BEHAVIOR	Owls have the largest head rotation capability amongst vertebrates. Anatomical knowledge of the cervical region is needed to understand the mechanics of these extreme head movements. While data on the morphology of the cervical vertebrae of the barn owl have been provided, this study is aimed to provide an extensive description of the muscle arrangement and the attachment sites of the muscles on the owl's head-neck region. The major cervical muscles were identified by gross dissection of cadavers of the American barn owl (Tyto furcata pratincola), and their origin, courses, and insertion were traced. In the head-neck region nine superficial larger cervical muscles of the craniocervical, dorsal and ventral subsystems were selected for analysis, and the muscle attachment sites were illustrated in digital models of the skull and cervical vertebrae of the same species as well as visualised in a two-dimensional sketch. In addition, fibre orientation and lengths of the muscles and the nature (fleshy or tendinous) of the attachment sites were determined. Myological data from this study were combined with osteological data of the same species. This improved the anatomical description of the cervical region of this species. The myological description provided in this study is to our best knowledge the most detailed documentation of the cervical muscles in a strigiform species presented so far. Our results show useful information for researchers in the field of functional anatomy, biomechanical modelling and for evolutionary and comparative studies.	[Boumans, Mark L. L. M.; Krings, Markus; Wagner, Hermann] Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany	RWTH Aachen University	Wagner, H (corresponding author), Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany.	wagner@bio2.rwth-aachen.de			RWTH Aachen University	RWTH Aachen University	The research was funded by RWTH Aachen University.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Baumel J.J, 1993, HDB AVIAN ANATOMY NO; Boas J.E.V., 1929, K DANSK VIDENSK SELS, V9, P101; BOCK W J, 1972, Anatomischer Anzeiger, V130, P222; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Brause C, 2009, IBIS, V151, P633, DOI 10.1111/j.1474-919X.2009.00947.x; Burk C.M., 1893, MYOLOGY PIGEON COLUM; BURTON P J K, 1974, Bulletin of the British Museum (Natural History) Zoology, V27, P1; BURTON PJK, 1971, IBIS, V113, P19, DOI 10.1111/j.1474-919X.1971.tb05120.x; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; de Kok-Mercado F, 2013, SCIENCE, V339, P514; Desselberger H, 1930, J F ORNITHOL, P86; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fisher HI, 1955, MYOLOGY WHOOPING CRA; FRITSCH E, 1988, IBIS, V130, P124, DOI 10.1111/j.1474-919X.1988.tb00962.x; GANS C, 1991, J BIOMECH, V24, P53, DOI 10.1016/0021-9290(91)90377-Y; Ghetie VCS., 1976, ANATOMICAL ATLAS DOM; HOYTE DAN, 1966, AM J PHYS ANTHROPOL, V24, P205, DOI 10.1002/ajpa.1330240209; JENNI L, 1981, Journal fuer Ornithologie, V122, P37, DOI 10.1007/BF01643442; Kaupp BF, 1918, ANATOMY DOMESTIC FOW; Krings M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091653; KURODA NAGAHISA, 1962, MISC REPTS YAMASHINA S INST ORNITHOL AND ZOOL, V3, P189; LANDOLT R, 1985, NETH J ZOOL, V35, P611; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; MASINO T, 1993, J NEUROSCI, V13, P351; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Palmgren P, 1949, ORNITHOLOGIE ALS BIO, P192; Proctor NS, 1993, MANUAL ORNITHOLOGY; Shufeldt R.W., 1890, MYOLOGY RAVEN CORVUS; Snively E, 2014, J ZOOL, V292, P290, DOI 10.1111/jzo.12109; Snively E, 2007, ZOOL J LINN SOC-LOND, V151, P759, DOI 10.1111/j.1096-3642.2007.00334.x; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Taylor MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078214; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Virchow H, 1926, UEBER BEWEGUNGSMOGLI, P38; Wedel Mathew J., 2002, Paleobios, V22, P1; ZUSI R L, 1985, Records of the Australian Museum, V37, P229; ZUSI R L, 1984, Smithsonian Contributions to Zoology, P1; Zusi R.L., 1969, OSTEOLOGY MYOLOGY HE; Zusi RL., 1962, STRUCTURAL ADAPTATIO; Zweers G., 1994, P201; ZWEERS GA, 1987, ACTA MORPHOL NEER SC, V25, P131	49	6	7	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134272	10.1371/journal.pone.0134272	http://dx.doi.org/10.1371/journal.pone.0134272			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222908	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800120
J	de Oliveira, JT; Ribeiro, C; Barros, R; Gomes, C; de Matos, AJ; Reis, CA; Rutteman, GR; Gartner, F				de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; de Matos, Augusto J.; Reis, Celso A.; Rutteman, Gerard R.; Gaertner, Fatima			Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; PROSTATE-CANCER; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; EPITHELIAL-CELLS; MUC1; PHOSPHORYLATION; ANGIOGENESIS; PATHWAY; MICROENVIRONMENT	The tumor microenvironment encompasses several stressful conditions for cancer cells such as hypoxia, oxidative stress and pH alterations. Galectin-3, a well-studied member of the beta-galactoside-binding animal family of lectins has been implicated in multiple steps of metastasis as cell-cell and cell-ECM adhesion, promotion of angiogenesis, cell proliferation and resistance to apoptosis. However, both its aberrantly up-and down-regulated expression was observed in several types of cancer. Thus, the mechanisms that regulate galectin-3 expression in neoplastic settings are not clear. In order to demonstrate the putative role of hypoxia in regulating galectin-3 expression in canine mammary tumors (CMT), in vitro and in vivo studies were performed. In malignant CMT cells, hypoxia was observed to induce expression of galectin-3, a phenomenon that was almost completely prevented by catalase treatment of CMT-U27 cells. Increased galectin-3 expression was confirmed at the mRNA level. Under hypoxic conditions the expression of galectin-3 shifts from a predominant nuclear location to cytoplasmic and membrane expressions. In in vivo studies, galectin-3 was overexpressed in hypoxic areas of primary tumors and well-established metastases. Tumor hypoxia thus up-regulates the expression of galectin-3, which may in turn increase tumor aggressiveness.	[de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Oporto, Portugal; [de Oliveira, Joana T.; de Matos, Augusto J.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [de Oliveira, Joana T.] Lusophone Univ Humanities & Technol, Fac Vet Med, Lisbon, Portugal; [de Matos, Augusto J.] Univ Porto, Food & Agrarian Sci & Technol Inst ICETA, Anim Sci & Study Cent CECA, P-4100 Oporto, Portugal; [Rutteman, Gerard R.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Rutteman, Gerard R.] Specialist Vet Ctr De Wagenrenk, Utrecht, Netherlands	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Lusofona University; Universidade de Lisboa; Universidade do Porto; Utrecht University	de Oliveira, JT (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	joanao@ipatimup.pt	Gomes, Catarina/CAJ-5505-2022; Gomes, Catarina/AAU-4636-2020; Gomes, Catarina/AAC-3325-2021; Gartner, Maria de Fatima/A-3530-2010; Barros, Rita/C-1072-2012; Ribeiro, Ana Claudia/E-6906-2015; Reis, Celso/B-9969-2008	Gomes, Catarina/0000-0002-0352-6783; Gartner, Maria de Fatima/0000-0002-5302-0086; Barros, Rita/0000-0002-1667-7329; Ribeiro, Ana Claudia/0000-0002-1723-5055; Reis, Celso/0000-0002-0286-6639	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology [PTDC/CVT/117610/2010, SFRH/ BPD/ 68276/ 2010, SFRH/ BPD/ / 201]	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) do Quadro Comunitario de Apoio III" and Project grant no. PTDC/CVT/117610/2010. RB (SFRH/ BPD/ 68276/ 2010) and CG (SFRH/ BPD/ / 201) acknowledge the Portuguese Foundation for Science and Technology. Institute of Molecular Pathology and Immunology is an Associate Laboratory of the Portuguese Ministry of Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2007, BIOCHEM BIOPH RES CO, V358, P241, DOI 10.1016/j.bbrc.2007.04.114; Al-Salam S, 2013, INT J CLIN EXP PATHO, V6, P853; Andre S, 2007, FEBS J, V274, P3233, DOI 10.1111/j.1742-4658.2007.05851.x; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Baba A.I, 2007, COMP ONCOLOGY 2; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Rego MJBD, 2013, MED MOL MORPHOL, V46, P92, DOI 10.1007/s00795-013-0013-4; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N; Choi YK, 2004, J COMP PATHOL, V131, P242, DOI 10.1016/j.jcpa.2004.02.002; de Oliveira JT, 2010, GLYCOBIOLOGY, V20, P1341, DOI 10.1093/glycob/cwq103; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; DEO JT, 2014, ANTICANCER RES, V34, P2211; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Ellerhorst J, 1999, UROL RES, V27, P362, DOI 10.1007/s002400050164; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Gartner F, 2013, GALECTINS POTENTIAL; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hashimoto K, 2011, NAGOYA J MED SCI, V73, P15; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Hockel M, 1996, CANCER RES, V56, P4509; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Kitamoto S, 2013, ONCOGENE, V32, P4614, DOI 10.1038/onc.2012.478; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Le Mercier M, 2008, TOXICOL APPL PHARM, V229, P172, DOI 10.1016/j.taap.2008.01.009; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lukyanov P, 2005, BIOCHEM BIOPH RES CO, V338, P1031, DOI 10.1016/j.bbrc.2005.10.033; LYNG H, 1992, CANCER RES, V52, P584; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Malagolini N, 2009, GLYCOBIOLOGY, V19, P172, DOI 10.1093/glycob/cwn122; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2504, DOI 10.4161/cc.10.15.16585; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Mengwasser J, 2002, GLYCOBIOLOGY, V12, P129, DOI 10.1093/glycob/12.2.129; Montero AJ, 2012, BREAST CANCER RES TR, V132, P747, DOI 10.1007/s10549-011-1919-y; Nakahara S, 2007, CANCER METAST REV, V26, P605, DOI 10.1007/s10555-007-9095-6; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliveira JTd, 2012, DYNAMIC TUNING GALEC; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Reis CA, 1998, INT J CANCER, V79, P402, DOI 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Sanjuan X, 1997, GASTROENTEROLOGY, V113, P1906, DOI 10.1016/S0016-5085(97)70010-6; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Snyder SA, 2008, VET COMP ONCOL, V6, P213, DOI 10.1111/j.1476-5829.2008.00163.x; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05	67	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134458	10.1371/journal.pone.0134458	http://dx.doi.org/10.1371/journal.pone.0134458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222311	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800145
J	Deliyanti, D; Zhang, Y; Khong, F; Berka, DR; Stapleton, DI; Kelly, DJ; Wilkinson-Berka, JL				Deliyanti, Devy; Zhang, Yuan; Khong, Fay; Berka, David R.; Stapleton, David I.; Kelly, Darren J.; Wilkinson-Berka, Jennifer L.			FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; GLYCATION END-PRODUCTS; RETINAL NEOVASCULARIZATION; ADHESION MOLECULE-1; VITREOUS FLUID; (MREN-2)27 RAT; HEART-FAILURE; EXPRESSION; TRANILAST; INHIBITION	Diabetic retinopathy features inflammation as well as injury to glial cells and the microvasculature, which are influenced by hypertension and overactivity of the renin-angiotensin system. FT011 is an anti-inflammatory and anti-fibrotic agent that has been reported to attenuate organ damage in diabetic rats with cardiomyopathy and nephropathy. However, the potential therapeutic utility of FT011 for diabetic retinopathy has not been evaluated. We hypothesized that FT011 would attenuate retinopathy in diabetic Ren-2 rats, which exhibit hypertension due to an overactive extra-renal renin-angiotensin system. Diabetic rats were studied for 8 and 32 weeks and received intravitreal injections of FT011 (50 mu M) or vehicle (0.9% NaCl). Comparisons were to age-matched controls. In the 8-week study, retinal inflammation was examined by quantitating vascular leukocyte adherence, microglial/macrophage density and the expression of inflammatory mediators. Macroglial Muller cells which exhibit a pro-inflammatory and pro-angiogenic phenotype in diabetes, were evaluated in the 8-week study as well as in culture following exposure to hyperglycaemia and FT011 (10, 30, 100 mu M) for 72 hours. In the 32-week study, severe retinal vasculopathy was examined by quantitating acellular capillaries and extracellular matrix proteins. In diabetic rats, FT011 reduced retinal leukostasis, microglial density and mRNA levels of intercellular adhesion molecule-1 (ICAM-1). In Muller cells, FT011 reduced diabetes-induced gliosis and vascular endothelial growth factor (VEGF) immunolabeling and the hyperglycaemic-induced increase in ICAM-1, monocyte chemoattractant protein-1, CCL20, cytokine-induced neutrophil chemoattractant-1, VEGF and IL-6. Late intervention with FT011 reduced acellular capillaries and the elevated mRNA levels of collagen IV and fibronectin in diabetic rats. In conclusion, the protective effects of FT011 in cardiorenal disease extend to key elements of diabetic retinopathy and highlight its potential as a treatment approach.	[Deliyanti, Devy; Berka, David R.; Wilkinson-Berka, Jennifer L.] Monash Univ, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia; [Zhang, Yuan; Khong, Fay; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Stapleton, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Monash University; St Vincent's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Wilkinson-Berka, JL (corresponding author), Monash Univ, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia.	jennifer.wilkinson-berka@monash.edu	Deliyanti, Devy/I-1562-2014; Wilkinson-Berka, Jennifer/D-4232-2011	Deliyanti, Devy/0000-0002-0390-3454; Kelly, Darren/0000-0003-4850-3929; Wilkinson-Berka, Jennifer/0000-0003-3512-4030	National Health and Medical Research Council of Australia; Peggy and Lesley Cranbourne Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peggy and Lesley Cranbourne Foundation	National Health and Medical Research Council of Australia provided a Senior Research Fellowship to JWB. The study was partially supported by a Peggy and Lesley Cranbourne Foundation grant to DIS.	Adachi T, 2010, INVEST OPHTH VIS SCI, V51, P3954, DOI 10.1167/iovs.09-4161; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Batenburg WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100954; Berka JLW, 2009, CIRC RES, V104, P124, DOI 10.1161/CIRCRESAHA.108.176008; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; Connelly KA, 2007, CARDIOVASC RES, V76, P280, DOI 10.1016/j.cardiores.2007.06.022; Curtis TM, 2004, DIABETES-METAB RES, V20, P28, DOI 10.1002/dmrr.431; DANSER AHJ, 1989, J CLIN ENDOCR METAB, V68, P160, DOI 10.1210/jcem-68-1-160; Deliyanti D, 2014, ARTERIOSCL THROM VAS, V34, P2033, DOI 10.1161/ATVBAHA.114.303792; FRANKEN AAM, 1988, J HYPERTENS, V6, pS461, DOI 10.1097/00004872-198812040-00145; Gao Hua, 2003, Trans Am Ophthalmol Soc, V101, P183; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; He J, 2015, BLOCKADE VASCULAR EN, V2015; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kelly DJ, 1998, KIDNEY INT, V54, P343, DOI 10.1046/j.1523-1755.1998.00019.x; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Lange CAK, 2011, AM J OPHTHALMOL, V152, P406, DOI 10.1016/j.ajo.2011.02.014; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; McCarthy CA, 2013, CLIN EXP PHARMACOL P, V40, P571, DOI 10.1111/1440-1681.12099; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Mifsud S, 2003, NEPHRON PHYSIOL, V95, P83, DOI DOI 10.1159/000074845.PMID:14694265; Miller AG, 2010, DIABETES, V59, P3208, DOI 10.2337/db10-0552; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Moravski CJ, 2003, AM J PATHOL, V162, P151, DOI 10.1016/S0002-9440(10)63806-0; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Phipps JA, 2007, INVEST OPHTH VIS SCI, V48, P927, DOI 10.1167/iovs.06-0892; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Stitt A, 2002, DIABETES, V51, P2826, DOI 10.2337/diabetes.51.9.2826; Takehana Y, 1999, INVEST OPHTH VIS SCI, V40, P459; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Wilkinson-Berka JL, 2012, PEPTIDES, V36, P142, DOI 10.1016/j.peptides.2012.04.008; Wilkinson-Berka JL, 2007, AM J HYPERTENS, V20, P423, DOI 10.1016/j.amjhyper.2006.09.018; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6; Zammit SC, 2009, BIOORG MED CHEM LETT, V19, P7003, DOI 10.1016/j.bmcl.2009.09.120; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang WB, 2011, IMMUNOTHERAPY-UK, V3, P609, DOI [10.2217/imt.11.24, 10.2217/IMT.11.24]; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134392	10.1371/journal.pone.0134392	http://dx.doi.org/10.1371/journal.pone.0134392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222724	Green Published, gold			2022-12-26	WOS:000358836800139
J	Frakes, RA; Belden, RC; Wood, BE; James, FE				Frakes, Robert A.; Belden, Robert C.; Wood, Barry E.; James, Frederick E.			Landscape Analysis of Adult Florida Panther Habitat	PLOS ONE			English	Article							PUMAS PUMA-CONCOLOR; SELECTION; CONSERVATION; FORESTS; WINTER; EDGE; SIZE	Historically occurring throughout the southeastern United States, the Florida panther is now restricted to less than 5% of its historic range in one breeding population located in southern Florida. Using radio-telemetry data from 87 prime-aged (>= 3 years old) adult panthers (35 males and 52 females) during the period 2004 through 2013 (28,720 radio-locations), we analyzed the characteristics of the occupied area and used those attributes in a random forest model to develop a predictive distribution map for resident breeding panthers in southern Florida. Using 10-fold cross validation, the model was 87.5 % accurate in predicting presence or absence of panthers in the 16,678 km(2) study area. Analysis of variable importance indicated that the amount of forests and forest edge, hydrology, and human population density were the most important factors determining presence or absence of panthers. Sensitivity analysis showed that the presence of human populations, roads, and agriculture (other than pasture) had strong negative effects on the probability of panther presence. Forest cover and forest edge had strong positive effects. The median model-predicted probability of presence for panther home ranges was 0.81 (0.82 for females and 0.74 for males). The model identified 5579 km(2) of suitable breeding habitat remaining in southern Florida; 1399 km(2) (25%) of this habitat is in non-protected private ownership. Because there is less panther habitat remaining than previously thought, we recommend that all remaining breeding habitat in south Florida should be maintained, and the current panther range should be expanded into south-central Florida. This model should be useful for evaluating the impacts of future development projects, in prioritizing areas for panther conservation, and in evaluating the potential impacts of sea-level rise and changes in hydrology.	[Frakes, Robert A.; Belden, Robert C.; Wood, Barry E.] US Fish & Wildlife Serv, South Florida Ecol Serv Off, Vero Beach, FL 32960 USA; [James, Frederick E.] Everglades Natl Pk, Natl Pk Serv, South Florida Nat Resources Ctr, Homestead, FL USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior	Frakes, RA (corresponding author), US Fish & Wildlife Serv, South Florida Ecol Serv Off, 1339 20th St, Vero Beach, FL 32960 USA.	frakesr@comcast.net						BELDEN RC, 1988, J WILDLIFE MANAGE, V52, P660, DOI 10.2307/3800927; Benson JF, 2008, J WILDLIFE MANAGE, V72, P405, DOI 10.2193/2007-264; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Comiskey EJ, 2002, CONSERV ECOL, V6; Cox JJ, 2006, J WILDLIFE MANAGE, V70, P1778, DOI 10.2193/0022-541X(2006)70[1778:FPHUNA]2.0.CO;2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dalrymple George H., 1996, Bulletin of the Florida Museum of Natural History, V39, P173; Dees CS, 2001, J WILDLIFE MANAGE, V65, P141, DOI 10.2307/3803287; Duever M. J., 1986, BIG CYPRESS NATL PRE; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fish U. S. and Wildlife Service, 2008, FLOR PANTH REC PLAN; Florida Fish and Wildlife Conservation Commission, 2014, ANN REP RES MAN FLOR; Franklin J, 2009, MAPPING SPECIES DIST; Holmes BR, 2006, WILDLIFE BIOL, V12, P201, DOI 10.2981/0909-6396(2006)12[201:UOOEAF]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones Jr FK, 1965, FLORIDA GAME FRESH W; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Labisky R.G., 1995, POPULATION DYNAMICS; Land ED, 2008, J WILDLIFE MANAGE, V72, P633, DOI 10.2193/2007-136; Laundre JW, 2007, AM MIDL NAT, V157, P221, DOI 10.1674/0003-0031(2007)157[221:IOEHOS]2.0.CO;2; Laundre JW, 2003, WILDLIFE BIOL, V9, P123, DOI 10.2981/wlb.2003.034; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Maehr David S., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P310; MAEHR DS, 1995, CONSERV BIOL, V9, P1008, DOI 10.1111/j.1523-1739.2005.00286.x-i1; MAEHR DS, 2002, CLEAN TECHNOL ENVIR, V3, P398, DOI DOI 10.1007/S10098-001-0129-4; McBride RT, 2012, SYNOPTIC SURVE UNPUB; Milborrow S., 2015, PLOT MODELS RESPONSE; Onorato DP, 2011, ANIM CONSERV, V14, P196, DOI 10.1111/j.1469-1795.2010.00415.x; Quigley Howard, 2010, P59; Riley SJ, 2001, ENVIRON MANAGE, V28, P317, DOI 10.1007/s0026702503; Schwab AC, 2006, THESIS U S FLORIDA; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Severinghaus CW, 1969, DEER N AM, P57; South Florida Natural Resources Center, DATAFOREVER DAT; South Florida Water Management District, 2009, FLOR LAND US COV CLA; South Florida Water Management District, DBHYDRO ENV DAT; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Thatcher CA, 2009, J MAMMAL, V90, P918, DOI 10.1644/08-MAMM-A-219.1; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; U. S. Army Corps of Engineers, SW FLOR FEAS STUD SW; U. S. Census Bureau, 2011, TIGER LIN SHAP FLOR; U. S. Geological Survey, HIGH ACC EL DAT PROJ; US Fish and Wildlife Service, S FLOR EC SERV OFF H	43	13	14	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133044	10.1371/journal.pone.0133044	http://dx.doi.org/10.1371/journal.pone.0133044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222526	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800037
J	Song, MG; Ryoo, IG; Choi, HY; Choi, BH; Kim, ST; Heo, TH; Lee, JY; Park, PH; Kwak, MK				Song, Min-gu; Ryoo, In-geun; Choi, Hye-young; Choi, Bo-hyun; Kim, Sang-Tae; Heo, Tae-Hwe; Lee, Joo Young; Park, Pil-Hoon; Kwak, Mi-Kyoung			NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; CELLULAR STRESS; PHORBOL ESTER; ACTIVATION; PHOSPHORYLATION; MECHANISMS	Blood monocytes are recruited to injured tissue sites and differentiate into macrophages, which protect against pathogens and repair damaged tissues. Reactive oxygen species (ROS) are known to be an important contributor to monocytes' differentiation and macrophages' function. NF-E2-related factor 2 (NRF2), a transcription factor regulating cellular redox homeostasis, is known to be a critical modulator of inflammatory responses. We herein investigated the role of NRF2 in macrophage differentiation using the human monocytic U937 cell line and phorbol-12-myristate-13-acetate (PMA). In U937 cells with NRF2 silencing, PMA-stimulated cell adherence was significantly facilitated when compared to control U937 cells. Both transcript and protein levels for pro-inflammatory cytokines, including interleukine-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) were highly elevated in PMA-stimulated NRF2-silenced U937 compared to the control. In addition, PMA-inducible secretion of monocyte chemotactic protein 1 (MCP-1) was significantly high in NRF2-silenced U937. As an underlying mechanism, we showed that NRF2-knockdown U937 retained high levels of cellular ROS and endoplasmic reticulum (ER) stress markers expression; and subsequently, PMA-stimulated levels of Ca2+ and PKC alpha were greater in NRF2-knockdown U937 cells, which caused enhanced nuclear accumulation of nuclear factor-kappa B (NF kappa B) p50 and extracellular signal-regulated kinase (ERK)-1/2 phosphorylation. Whereas the treatment of NRF2-silenced U937 cells with pharmacological inhibitors of NF kappa B or ERK1/2 largely blocked PMA-induced IL-1 beta and IL-6 expression, indicating that these pathways are associated with cell differentiation. Taken together, our results suggest that the NRF2 system functions to suppress PMA-stimulated U937 cell differentiation into pro-inflammatory macrophages and provide evidence that the ROS-PKC alpha-ERK-NF kappa B axis is involved in PMA-facilitated differentiation of NRF2-silenced U937 cells.	[Song, Min-gu; Park, Pil-Hoon] Yeungnam Univ, Coll Pharm, Gyongsan 712749, Gyeongsangbuk D, South Korea; [Ryoo, In-geun; Choi, Hye-young; Choi, Bo-hyun; Heo, Tae-Hwe; Lee, Joo Young; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea; [Kim, Sang-Tae] Seoul Natl Univ, Bundang Hosp, Songnam 463707, Gyeonggi Do, South Korea	Yeungnam University; Catholic University of Korea; Seoul National University (SNU)	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr			National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013R1A2A2A01015497]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This study was financially supported by the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A2A2A01015497).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Bobilev I, 2011, CANCER BIOL THER, V11, P317, DOI 10.4161/cbt.11.3.14098; Bocci V, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00004; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; CAVENDER DE, 1991, J LEUKOCYTE BIOL, V49, P566, DOI 10.1002/jlb.49.6.566; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Chen HM, 2013, CELL BIOL INT, V37, P1215, DOI 10.1002/cbin.10156; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Choi BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107158; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Fan HC, 2014, BIOCHEM PHARMACOL, V88, P139, DOI 10.1016/j.bcp.2014.01.006; Garcia A, 1999, EXP HEMATOL, V27, P353, DOI 10.1016/S0301-472X(98)00038-1; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Jung KA, 2015, MOL PHARMACOL, V87, P465, DOI 10.1124/mol.114.096065; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kuhn AM, 2011, FREE RADICAL BIO MED, V50, P1382, DOI 10.1016/j.freeradbiomed.2011.02.036; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Martinon F, 2012, MICROBES INFECT, V14, P1293, DOI 10.1016/j.micinf.2012.07.005; Naldini A, 1998, J CELL PHYSIOL, V177, P76, DOI 10.1002/(SICI)1097-4652(199810)177:1<76::AID-JCP8>3.0.CO;2-B; Otte A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-20; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; PEDRINACI S, 1990, INT J CANCER, V45, P294, DOI 10.1002/ijc.2910450215; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Ruotsalainen AK, 2013, CARDIOVASC RES, V98, P107, DOI 10.1093/cvr/cvt008; Ryoo IG, 2015, ARCH PHARM RES, V38, P272, DOI 10.1007/s12272-014-0380-y; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Song JW, 2013, TOX RESEARCH, V29, P235, DOI 10.5487/TR.2013.29.4.235; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; VANROOZENDAAL KEP, 1990, EXP CELL RES, V190, P137, DOI 10.1016/0014-4827(90)90155-4; Zhang GL, 2014, ACTA BIOCH BIOPH SIN, V46, P540, DOI 10.1093/abbs/gmu042; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	57	27	27	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134235	10.1371/journal.pone.0134235	http://dx.doi.org/10.1371/journal.pone.0134235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222138	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800114
J	Xie, JG; Yang, ZX; Liang, LL				Xie, Jianguang; Yang, Zhaoxu; Liang, Leilei			Investigation of Low Heat Accumulation Asphalt Mixture and Its Impact on Urban Heat Environment	PLOS ONE			English	Article								This study is focused on investigating the effectiveness of low heat accumulation asphalt mixture and its impact on the urban heat environment. Infrared radiation experiments showed that the temperature of the asphalt mixture decreased with the increase in far-infrared radiant material. The results also revealed that, compared to asphalt with 0% far-infrared radiant content, the asphalt material with a certain ratio of far-infrared radiation material had higher stability at high and low temperatures as well as good water absorption capacity. The Marshall stability of the specimen mixed with 6% far-infrared radiant was higher by 12.2% and had a residual stability of up to 98.9%. Moreover, the low-temperature splitting tensile strength of the asphalt mixture with 6% far-infrared radiation material increased by 21.3%. The friction coefficient of the asphalt mixtures with 6% and 12% far-infrared radiation material increased by 17.7% and 26.9%, respectively.	[Xie, Jianguang; Yang, Zhaoxu; Liang, Leilei] Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Xie, JG (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China.	xiejg@nuaa.edu.cn			National Natural Science Foundation of China [51078183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 51078183).	Brown E.R., 1993, 935 NCAT; Chen JA, 1997, HIGHWAYS, V12, P18; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Chiu CT, 2007, CONSTR BUILD MATER, V21, P1027, DOI 10.1016/j.conbuildmat.2006.02.005; Fan WX, 2002, COAST ENV, V8, P12; Gibbons CJ, 1996, J AM PLAN ASS, V62, P243; Hao P., 1997, J CHONGQING JIAOTONG, V16, P80; Ibrahim MA, 2006, J CONSTR BUILD MAT, V20, P982; Maurice GE, 1999, APPR MILL 1999 APA N; Moghadas NF, 2010, J CONSTR BUILD MAT, V24, P1158; National Standards of the People's Republic of China, 2004, F402004 JTG NAT STAN; National Standards of the People's Republic of China, 2000, JTJ0522000 NAT STAND; Ni BS, 2009, COMMUN SCI TECHNOL H, V32, P22; Ren R, 2008, J INNER MONGOLIA AGR, V29, P144; Sarah B, 1998, PROFESSIONAL ROOFING; Shen J, 2005, URBAN ROADS BRIDGES, V9, P43; Wang JY, 2010, J HIGHW CONSTR MAINT, V224, P175; Wu JB, 2011, THEOR APPL CLIMATOL, V103, P489, DOI 10.1007/s00704-010-0323-6; Yang Wen-juan, 2008, Journal of Highway and Transportation Research and Development, V25, P147; Zhang DL, 2000, HIGHWAY, V5, P63; Zhang X, 2006, J JINLING I TECHNOL, V2, P69; Zhou LW, 2005, THESIS HEBEI U TECHN	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133829	10.1371/journal.pone.0133829	http://dx.doi.org/10.1371/journal.pone.0133829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222762	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800069
J	Liu, YB; Huang, XG; He, X; Zhou, YQ; Jiang, XG; Chen-Kiang, S; Jaffrey, SR; Xu, GQ				Liu, Yaobin; Huang, Xiangao; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Chen-Kiang, Selina; Jaffrey, Samie R.; Xu, Guoqiang			A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function	FASEB JOURNAL			English	Article						cullin RING ligase; multiple myeloma; lenalidomide; pomalidomide	RING E3 LIGASE; LENALIDOMIDE; PROTEIN; DEGRADATION; AUTOUBIQUITINATION; IDENTIFICATION; EXPRESSION; CHANNEL; ARCHITECTURE; SURVIVAL	The immunomodulatory drug (IMiD) thalidomide and its structural analogs lenalidomide and pomalidomide are highly effective in treating clinical indications. Thalidomide binds to cereblon (CRBN), a substrate receptor of the cullin-4 really interesting new gene (RING) E3 ligase complex. Here, we examine the effect of thalidomide and its analogs on CRBN ubiquitination and its functions in human cell lines. We find that the ubiquitin modification of CRBN includes K48-linked polyubiquitin chains and that thalidomide blocks the formation of CRBN-ubiquitin conjugates. Furthermore, we show that ubiquitinated CRBN is targeted for proteasomal degradation. Treatment of human myeloma cell lines such as MM1.S, OPM2, and U266 with thalidomide (100 mu M) and its structural analog lenalidomide (10 mu M) results in stabilization of CRBN and elevation of CRBN protein levels. This in turn leads to the reduced level of CRBN target proteins and enhances the sensitivity of human multiple myeloma cells to IMiDs. Our results reveal a novel mechanism by which thalidomide and its analogs modulate the CRBN function in cells. Through inhibition of CRBN ubiquitination, thalidomide and its analogs allow CRBN to accumulate, leading to the increased cullin-4 RING E3 ligase-mediated degradation of target proteins.	[Liu, Yaobin; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou, Jiangsu, Peoples R China; [Liu, Yaobin; He, Xian; Zhou, Yanqing; Jiang, Xiaogang; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Huang, Xiangao; Chen-Kiang, Selina] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Soochow University - China; Soochow University - China; Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu; gux2002@suda.edu.cn		Jaffrey, Samie/0000-0003-3615-6958; Xu, Guoqiang/0000-0002-4753-4769	National Basic Research Program of China [2012CB947602]; National Natural Science Foundation of China [31270874]; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions; U.S. National Institutes of Health (NIH) National Institute of Mental Health [MH086128]; U.S. NIH National Cancer Institute [R01 CA188794]; NATIONAL CANCER INSTITUTE [R01CA188794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086128] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions; U.S. National Institutes of Health (NIH) National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Pengbo Zhou (Weill Medical College, Cornell University, New York, NY, USA) for kindly providing Cul4A and DN-Cul4A plasmids. This work was supported by the National Basic Research Program of China (973 Program, 2012CB947602), the National Natural Science Foundation of China (31270874), Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (to G.X.), U.S. National Institutes of Health (NIH) National Institute of Mental Health (MH086128; to S.R.J.), and U.S. NIH National Cancer Institute (R01 CA188794; to S.C.-K.).	Aizawa M, 2011, NEUROSCI RES, V69, P343, DOI 10.1016/j.neures.2010.12.019; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Broyl A, 2013, BLOOD, V121, P624, DOI 10.1182/blood-2012-06-438101; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Christian MS, 2007, BIRTH DEFECTS RES B, V80, P188, DOI 10.1002/bdrb.20115; Diaz-Rodriguez E, 2016, LEUKEMIA LYMPHOMA, V57, P167, DOI 10.3109/10428194.2015.1037752; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Higgins JJ, 2010, J NEUROGENET, V24, P18, DOI 10.3109/01677060903567849; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lai ZH, 2002, P NATL ACAD SCI USA, V99, P14734, DOI 10.1073/pnas.212428599; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sui YY, 2015, BIOCHEM BIOPH RES CO, V461, P653, DOI 10.1016/j.bbrc.2015.04.085; Suppiah R, 2006, CLIN LYMPHOMA MYELOM, V6, P301, DOI 10.3816/CLM.2006.n.004; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063; Zou YD, 2013, LEUKEMIA LYMPHOMA, V54, P2219, DOI 10.3109/10428194.2013.774393	35	31	32	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4829	4839		10.1096/fj.15-274050	http://dx.doi.org/10.1096/fj.15-274050			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26231201	Green Published			2022-12-26	WOS:000365523600010
J	Li, DY; Zhang, P; Li, F; Chi, LQ; Zhu, DY; Zhang, QY; Chi, LL				Li, Daoyuan; Zhang, Ping; Li, Fei; Chi, Lequan; Zhu, Deyu; Zhang, Qunye; Chi, Lianli			Recognition of N-Glycoforms in Human Chorionic Gonadotropin by Monoclonal Antibodies and Their Interaction Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERGLYCOSYLATED HCG; BIOLOGICAL FUNCTIONS; GLYCOSYLATION; BETA; PREGNANCY; DIAGNOSIS; PROTEINS; EPITOPES; CORE	The glycosylation of human chorionic gonadotropin (hCG) plays an important role in reproductive tumors. Detecting hCG N-glycosylation alteration may significantly improve the diagnostic accuracy and sensitivity of related cancers. However, developing an immunoassay directly against the N-linked oligosaccharides is unlikely because of the heterogeneity and low immunogenicity of carbohydrates. Here, we report a hydrogen/deuterium exchange and MS approach to investigate the effect of N-glycosylation on the binding of antibodies against different hCG glycoforms. Hyperglycosylated hCG was purified from the urine of invasive mole patients, and the structure of its N-linked oligosaccharides was confirmed to be more branched by MS. The binding kinetics of the anti-hCG antibodies MCA329 and MCA1024 against hCG and hyperglycosylated hCG were compared using biolayer interferometry. The binding affinity of MCA1024 changed significantly in response to the alteration of hCG N-linked oligosaccharides. Hydrogen/deuterium exchange-MS reveals that the peptide beta 65-83 of the hCG beta subunit is the epitope for MCA1024. Site-specific N-glycosylation analysis suggests that N-linked oligosaccharides at Asn-13 and Asn-30 on the beta subunit affect the binding affinity of MCA1024. These results prove that some antibodies are sensitive to the structural change of N-linked oligosaccharides, whereas others are not affected by N-glycosylation. It is promising to improve glycoprotein biomarker-based cancer diagnostics by developing combined immunoassays that can determine the level of protein and measure the degree of N-glycosylation simultaneously.	[Li, Daoyuan; Li, Fei; Chi, Lianli] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Li, Daoyuan; Zhu, Deyu; Chi, Lianli] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Ping] Shandong Univ, Hosp 2, Dept Obstet & Gynecol, Jinan 250033, Peoples R China; [Chi, Lequan] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Zhang, Qunye] Shandong Univ, Cent Res Lab, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res,Hosp 2, Jinan 250100, Peoples R China; [Zhang, Qunye] Shandong Univ, Qilu Hosp, Minist Publ Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Shandong University; Shandong University	Zhang, QY (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Peoples R China.	wz.zhangqy@sdu.edu.cn; lianlichi@sdu.edu.cn	Chi, Lianli/B-9149-2015	Chi, Lianli/0000-0003-1126-1022	National Basic Research Program of China [2012CB822102]; National High Technology Research and Development Program of China [2012AA021504]; National Natural Science Foundation of China [21472115, 31000367, 91439111]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China Grant 2012CB822102, the National High Technology Research and Development Program of China Grant 2012AA021504, and the National Natural Science Foundation of China Grants 21472115, 31000367, and 91439111. The authors declare that they have no conflicts of interest with the contents of this article.	AJDUKIEWICZ AB, 1993, CANCER LETT, V74, P43, DOI 10.1016/0304-3835(93)90042-8; Bai X, 2015, ANAL BIOANAL CHEM, V407, P1857, DOI 10.1007/s00216-014-8439-7; Barh D, 2014, CANCER BIOMARKERS: MINIMAL AND NONINVASIVE EARLY DIAGNOSIS AND PROGNOSIS, P1, DOI 10.1201/b16389; BERGER P, 1993, J CLIN ENDOCR METAB, V77, P347, DOI 10.1210/jc.77.2.347; Berger P, 2002, TUMOR BIOL, V23, P1, DOI 10.1159/000048686; Birken S, 1999, ENDOCRINE, V10, P137, DOI 10.1385/ENDO:10:2:137; Birken S, 2005, TUMOR BIOL, V26, P131, DOI 10.1159/000086484; Birken S, 2003, MOL CELL ENDOCRINOL, V204, P21, DOI 10.1016/S0303-7207(03)00153-9; Cole LA, 2007, MOL CELL ENDOCRINOL, V260, P228, DOI 10.1016/j.mce.2006.03.047; Cole LA, 2012, MOL CELL ENDOCRINOL, V349, P232, DOI 10.1016/j.mce.2011.10.029; Cole LA, 2012, CLIN CHIM ACTA, V413, P48, DOI 10.1016/j.cca.2011.09.037; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; de Medeiros SF, 2009, HUM REPROD UPDATE, V15, P69, DOI 10.1093/humupd/dmn036; Durand G, 2000, CLIN CHEM, V46, P795; Elliott MM, 1997, ENDOCRINE, V7, P15, DOI 10.1007/BF02778058; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Ford PJ, 2013, J Cancer Policy, V1, pE2, DOI 10.1016/j.jcpo.2013.04.002; Gam LH, 2005, INT J BIOL SCI, V1, P103; Gilgunn S, 2013, NAT REV UROL, V10, P99, DOI 10.1038/nrurol.2012.258; Heuvers ME, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-77; Jackson AM, 1996, J REPROD IMMUNOL, V31, P21, DOI 10.1016/0165-0378(96)00978-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LUSTBADER JW, 1989, BIOCHEMISTRY-US, V28, P9239, DOI 10.1021/bi00450a001; Pan S., 2011, MOL CELL PROTEOMICS, V10; Stenman UH, 2004, CLIN BIOCHEM, V37, P549, DOI 10.1016/j.clinbiochem.2004.05.008; Toll H, 2006, ELECTROPHORESIS, V27, P2734, DOI 10.1002/elps.200600022; Tuccillo FM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/742831; Valmu L, 2006, GLYCOBIOLOGY, V16, P1207, DOI 10.1093/glycob/cwl034; Vashist SK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04407; Weinans MJN, 2000, PRENATAL DIAG, V20, P976, DOI 10.1002/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922	34	7	7	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22715	22723		10.1074/jbc.M115.657072	http://dx.doi.org/10.1074/jbc.M115.657072			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240146	Green Published, hybrid			2022-12-26	WOS:000361171500035
J	Chen, SC; Chen, CF; Huang, JC; Lee, MY; Chen, JH; Chang, JM; Hwang, SJ; Chen, HC				Chen, Szu-Chia; Chen, Chien-Fu; Huang, Jiun-Chi; Lee, Mei-Yueh; Chen, Jui-Hsin; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; STAGE RENAL-DISEASE; BLOOD-PRESSURE INDEX; SPECTRAL-ANALYSIS; ARTERIOVENOUS-FISTULA; ENDOTHELIAL FUNCTION; DIABETIC-PATIENTS; RISK; MORTALITY; FAILURE	Peripheral artery disease (PAD) and low heart rate variability (HRV) are highly prevalent in hemodialysis patients, and both are associated with increased cardiovascular morbidity and mortality. This study aims to examine the suggested relationship between PAD and HRV, and the relationship of parameters before and after hemodialysis. This study enrolled 161 maintenance hemodialysis patients. PAD was defined as ABI < 0.9 in either leg. HRV was performed to assess changes before and after hemodialysis. The change in HRV (Delta HRV) was defined as post-hemodialysis HRV minus pre-hemodialysis HRV. Patients' clinical parameters were collected from the dialysis records. All HRV parameters except high frequency (HF) % were lower in patients with PAD than patients without PAD, though not achieving significant level. In patients without PAD, HF (P = 0.013), low frequency (LF) % (P = 0.028) and LF/HF (P = 0.034) were significantly elevated after hemodialysis, whereas no significant HRV parameters change was noted in patients with PAD. Serum intact parathyroid hormone was independently associated with Delta HF (beta = -0.970, P = 0.032) and Delta LF% (beta = -12.609, P = 0.049). Uric acid level (beta = -0.154, P = 0.027) was negatively associated with Delta LF/HF in patients without PAD. Our results demonstrated that some of the HRV parameters were significantly increased after hemodialysis in patients without PAD, but not in patients with PAD, reflecting a state of impaired sympatho-vagal equilibrium. Severity of secondary hyperparathyroidism and hyperuricemia contributed to lesser HRV parameters increase after hemodialysis in patients without PAD.	[Chen, Szu-Chia; Huang, Jiun-Chi; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Chien-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Neurol, Kaohsiung, Taiwan; [Lee, Mei-Yueh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Lee, Mei-Yueh; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Jui-Hsin] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Chang, JM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan.	jemich@kmu.edu.tw	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung [kmhk-103-001]	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung	The research presented in this article is supported by the grant from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-103-001), Kaohsiung Medical University, Kaohsiung, and the statistical work by the Department of Research Education and Training at Kaohsiung Municipal Hsiao-Kang Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 1998, DIABETES CARE, V21, P1173, DOI 10.2337/diacare.21.7.1173; Barnas MGW, 1999, J AM SOC NEPHROL, V10, P2577; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Boaz M, 2005, CLIN NEPHROL, V63, P98; Brown MD, 2005, MICROCIRCULATION, V12, P373, DOI 10.1080/10739680590934817; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Camm AJ, 1996, CIRCULATION, V93, P1043; Canani LH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-54; Chen CJ, 2009, CLIN NEUROPHYSIOL, V120, P348, DOI 10.1016/j.clinph.2008.10.155; Chen SC, 2009, CLIN NEPHROL, V72, P501; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chen SC, 2009, CLIN J AM SOC NEPHRO, V4, P128, DOI 10.2215/CJN.03080608; Daugirdas JT, 2001, AM J KIDNEY DIS, V38, pS11, DOI 10.1053/ajkd.2001.28090; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Dumaine RL, 2009, AM HEART J, V158, P141, DOI 10.1016/j.ahj.2009.05.011; Eggers PW, 1999, KIDNEY INT, V56, P1524, DOI 10.1046/j.1523-1755.1999.00668.x; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; FOUAD FM, 1984, AM J PHYSIOL, V246, pH838, DOI 10.1152/ajpheart.1984.246.6.H838; Fukuta H, 2003, NEPHROL DIAL TRANSPL, V18, P318, DOI 10.1093/ndt/18.2.318; Goernig M, 2008, PACE, V31, P858, DOI 10.1111/j.1540-8159.2008.01100.x; Gotch FA, 2001, SEMIN DIALYSIS, V14, P252, DOI 10.1046/j.1525-139X.2001.00064.x; Grandaliano G, 2003, KIDNEY INT, V64, P715, DOI 10.1046/j.1523-1755.2003.00120.x; Grandi NC, 2011, HEART, V97, P1215, DOI 10.1136/hrt.2011.223529; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; KLEIGER RE, 1991, AM J CARDIOL, V68, P626, DOI 10.1016/0002-9149(91)90355-O; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Li X, 2011, CLIN AUTON RES, V21, P143, DOI 10.1007/s10286-010-0112-4; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; Longenecker JC, 2009, MED PRIN PRACT, V18, P85, DOI 10.1159/000189804; MOLGAARD H, 1991, AM J CARDIOL, V68, P777, DOI 10.1016/0002-9149(91)90653-3; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Oikawa K, 2009, INT J CARDIOL, V131, P370, DOI 10.1016/j.ijcard.2007.10.033; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Polak G, 2004, AUTON NEUROSCI-BASIC, V115, P94, DOI 10.1016/j.autneu.2004.08.002; Rajagopalan S, 2006, CIRCULATION, V114, P1914, DOI 10.1161/CIRCULATIONAHA.105.607390; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Tejera E, 2012, HYPERTENS PREGNANCY, V31, P59, DOI 10.3109/10641955.2010.544802; Tong YQ, 2007, AM J NEPHROL, V27, P63, DOI 10.1159/000099013; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhang J, 2013, CLIN J AM SOC NEPHRO, V8, P1378, DOI 10.2215/CJN.10381012; Zitt E, 2008, KIDNEY BLOOD PRESS R, V31, P217, DOI 10.1159/000141926	46	36	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0120459	10.1371/journal.pone.0120459	http://dx.doi.org/10.1371/journal.pone.0120459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237669	gold, Green Submitted, Green Published			2022-12-26	WOS:000358942400001
J	Kang, S; Kim, HS; Han, I				Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu			Unplanned Excision of Extremity Soft Tissue Sarcoma in Korea: A Nationwide Study Based on a Claims Registry	PLOS ONE			English	Article							LYMPH-NODE EVALUATION; RESIDUAL DISEASE; HOSPITAL TYPE; HEALTH; SYSTEM; IMPACT	Unplanned excision of extremity soft tissue sarcoma (STS) is common and has detrimental effects not only on patients' oncologic outcomes but also on functional and economic issues. However, no study has analyzed a nationwide population-based database. To estimate the incidence and treatment pattern of unplanned excision in extremity STS in the Korean population, a nationwide epidemiologic study was performed using the Korean Health Insurance Review and Assessment Service database, a centralized nationwide healthcare claims registry of Korea that covers the entire Korean population. Among 1,517 patients with extremity STS in the 4-year study period, 553 (36.5%) underwent unplanned excision (unplanned group). About 80% of unplanned excisions were performed in tertiary or general hospitals. Of the unplanned group, 240 (43.4%) underwent re-excision with or without radiation therapy and/or chemotherapy, and 51 (9.2%) did not undergo re-excision but were treated with radiation therapy and/or chemotherapy; whereas, 262 (47.4%) did not undergo any further treatment following unplanned excision. This study is the first nationwide population-based study on the unplanned excision of extremity STS. The results may have implications in establishing preventive or therapeutic measures to reduce the burden of unplanned excision of extremity STS.	[Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea; [Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu] Seoul Natl Univ, Canc Hosp, Musculoskeletal Tumor Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Han, I (corresponding author), Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea.	hik19@snu.ac.kr		HAN, ILKYU/0000-0001-9841-3775				Bauer HCF, 2001, ACTA ORTHOP SCAND, V72, P150, DOI 10.1080/000164701317323408; Bilimoria KY, 2008, ARCH SURG-CHICAGO, V143, P671, DOI 10.1001/archsurg.143.7.671; BORING CC, 1993, CA-CANCER J CLIN, V43, P7, DOI 10.3322/canjclin.43.1.7; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Davis AM, 1997, J SURG ONCOL, V66, P81, DOI 10.1002/(SICI)1096-9098(199710)66:2<81::AID-JSO2>3.0.CO;2-H; Demetri GD, 2010, J NATL COMPR CANC NE, V8, P630, DOI 10.6004/jnccn.2010.0049; Dudeja V, 2012, ANN SURG ONCOL, V19, P365, DOI 10.1245/s10434-011-1973-z; Fletcher CD., 2002, WHO CLASSIFICATION T; GIULIANO AE, 1985, J CLIN ONCOL, V3, P1344, DOI 10.1200/JCO.1985.3.10.1344; Gong HS, 2009, J BONE JOINT SURG AM, V91A, P2376, DOI 10.2106/JBJS.H.01871; Health Insurance Review and Assessment Service, 2013, HLTH INS STAT YB; Hsieh MC, 2012, CANCER-AM CANCER SOC, V118, P1675, DOI 10.1002/cncr.26473; Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230; Kang S, 2015, CANCER RES TREAT; Kang S, 2013, UNPLANNED EXCISION S; Kang S, 2013, SURG ONCOL, V22, pE17, DOI 10.1016/j.suronc.2013.02.006; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim HS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-205; Kim JY, 2005, STRATEGIES ENHANCE U; Kim YB, 2008, INT J RADIAT ONCOL, V70, P139, DOI 10.1016/j.ijrobp.2007.05.067; Lewis JJ, 2000, ANN SURG, V231, P655, DOI 10.1097/00000658-200005000-00005; Mankin HJ, 1996, J BONE JOINT SURG AM, V78A, P656, DOI 10.2106/00004623-199605000-00004; MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P1121, DOI 10.2106/00004623-198264080-00002; Maretty-Nielsen K, 2014, ACTA ONCOL, V53, P1188, DOI 10.3109/0284186X.2014.888494; Maretty-Nielsen Katja, 2013, Clin Epidemiol, V5, P45, DOI 10.2147/CLEP.S41835; NICE, 2005, REF GUID SUSP CANC, V27, P43; Noria S, 1996, J BONE JOINT SURG AM, V78A, P650, DOI 10.2106/00004623-199605000-00003; Park B, 2002, STRATEGIES IMPROVE V; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Park YT, 2012, HEALTHC INFORM RES, V18, P215, DOI 10.4258/hir.2012.18.3.215; ROSS JA, 1993, CANCER, V72, P486, DOI 10.1002/1097-0142(19930715)72:2<486::AID-CNCR2820720226>3.0.CO;2-R; Trovik Clement S., 2001, Acta Orthopaedica Scandinavica, V72, P1, DOI 10.1080/000164701753740096	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134354	10.1371/journal.pone.0134354	http://dx.doi.org/10.1371/journal.pone.0134354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237049	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400024
J	Li, DH; Shi, W; Munroe, TA; Gong, L; Kong, XY				Li, Dong-He; Shi, Wei; Munroe, Thomas A.; Gong, Li; Kong, Xiao-Yu			Concerted Evolution of Duplicate Control Regions in the Mitochondria of Species of the Flatfish Family Bothidae (Teleostei: Pleuronectiformes)	PLOS ONE			English	Article							DNA-SEQUENCE; GENOME; REPLICATION; SNAKE; REARRANGEMENTS; PLATYSTERNON; MITOGENOME; PHYLOGENY; ORIGINS; TURTLE	Mitogenomes of flatfishes (Pleuronectiformes) exhibit the greatest diversity of gene rearrangements in teleostean fishes. Duplicate control regions (CRs) have been found in the mito-genomes of two flatfishes, Samariscus latus (Samaridae) and Laeops lanceolata (Bothidae), which is rare in teleosts. It has been reported that duplicate CRs have evolved in a concerted fashion in fishes and other animals, however, whether concerted evo-lution exists in flatfishes remains unknown. In this study, based on five newly sequenced and six previously reported mitogenomes of lefteye flounders in the Bothidae, we explored whether duplicate CRs and concerted evolution exist in these species. Results based on the present study and previous reports show that four out of eleven bothid species examined have duplicate CRs of their mitogenomes. The core regions of the duplicate CRs of mitogenomes in the same species have identical, or nearly identical, sequences when compared to each other. This pattern fits the typical characteristics of concerted evolution. Additionally, phylogenetic and ancestral state reconstruction analysis also provided evidence to support the hypothesis that duplicate CRs evolved concertedly. The core region of concerted evolution is situated at the conserved domains of the CR of the mitogenome from the termination associated sequences (TASs) to the conserved sequence blocks (CSBs). Commonly, this region is con-sidered to regulate mitochondrial replication and transcription. Thus, we hypothesize that the cause of concerted evolution of the duplicate CRs in the mtDNAs of these four bothids may be related to some function of the conserved sequences of the CRs during mitochondrial rep-lication and transcription. We hope our results will provide fresh insight into the molecular mechanisms related to replication and evolution of mitogenomes.	[Li, Dong-He; Shi, Wei; Gong, Li; Kong, Xiao-Yu] Chinese Acad Sci, Key Lab Trop Marine Bio resources & Ecol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Shi, Wei; Gong, Li; Kong, Xiao-Yu] Chinese Acad Sci, Guangdong Prov Key Lab Appl Marine Biol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Shi, Wei; Gong, Li] South China Sea Bioresource Exploitat & Utilizat, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Gong, Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Munroe, Thomas A.] NOAA, Natl Systemat Lab NMFS, Smithsonian Inst NHB, Washington, DC 20013 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Shi, W (corresponding author), Chinese Acad Sci, Key Lab Trop Marine Bio resources & Ecol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China.	shiwei@scsio.ac.cn; xykong@scsio.ac.cn	Gong, lI/ABE-4558-2021		Natural Science Foundation of China [31471979, 41206134, 30870283]; Science and Technology Planning Project of Guangdong Province, China [2014B030301064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported by the Natural Science Foundation of China (grant numbers 31471979, 41206134, 30870283) and Science and Technology Planning Project of Guangdong Province, China (2014B030301064).	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Betancur R, 2014, MOL PHYLOGENET EVOL, V73, P18, DOI 10.1016/j.ympev.2014.01.006; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710; Campbell MA, 2014, GENE, V551, P176, DOI 10.1016/j.gene.2014.08.053; Campbell MA, 2014, MOL PHYLOGENET EVOL, V75, P149, DOI 10.1016/j.ympev.2014.02.011; Campbell MA, 2013, MOL PHYLOGENET EVOL, V69, P664, DOI 10.1016/j.ympev.2013.07.011; CHAPLEAU F, 1993, B MAR SCI, V52, P516; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Dubey B, 2012, MOL BIOL REP, V39, P7403, DOI 10.1007/s11033-012-1572-5; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fonseca MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106654; Gong L, 2016, MITOCHONDRIAL DNA A, V27, P3089, DOI 10.3109/19401736.2014.1003922; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Kumazawa Y, 1998, GENETICS, V150, P313; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; Li S.-Z., 1995, FAUNA SINICA OSTEICH; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; Ogoh K, 2007, MOL BIOL EVOL, V24, P74, DOI 10.1093/molbev/msl132; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parham JF, 2006, MOL PHYLOGENET EVOL, V38, P50, DOI 10.1016/j.ympev.2005.07.015; Peng QL, 2006, GENE, V380, P14, DOI 10.1016/j.gene.2006.04.001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schirtzinger EE, 2012, MOL PHYLOGENET EVOL, V64, P342, DOI 10.1016/j.ympev.2012.04.009; Schwarzhans, 1999, COMP MORPHOLOGICAL T; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; Shi W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-352; Shi W, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-173; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134580	10.1371/journal.pone.0134580	http://dx.doi.org/10.1371/journal.pone.0134580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237419	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400029
J	Belichenko, PV; Kleschevnikov, AM; Becker, A; Wagner, GE; Lysenko, LV; Yu, YE; Mobley, WC				Belichenko, Pavel V.; Kleschevnikov, Alexander M.; Becker, Ann; Wagner, Grant E.; Lysenko, Larisa V.; Yu, Y. Eugene; Mobley, William C.			Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues	PLOS ONE			English	Article							TS65DN MOUSE MODEL; LONG-TERM POTENTIATION; OBSESSIVE-COMPULSIVE DISORDER; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; WORKING-MEMORY; CRITICAL REGION; OBJECT RECOGNITION; ANIMAL-MODEL; YOUNG-ADULTS	Down syndrome (DS), trisomy for chromosome 21, is the most common genetic cause of intellectual disability. The genomic regions on human chromosome 21 (HSA21) are syntenically conserved with regions on mouse chromosomes 10, 16, and 17 (Mmu10, Mmu16, and Mmu17). Recently, we created a genetic model of DS which carries engineered duplications of all three mouse syntenic regions homologous to HSA21. This 'triple trisomic' or TTS model thus represents the most complete and accurate murine model currently available for experimental studies of genotype-phenotype relationships in DS. Here we extended our initial studies of TTS mice. Locomotor activity, stereotypic and repetitive behavior, anxiety, working memory, long-term memory, and synaptic plasticity in the dentate gyrus were examined in the TTS and wild-type (WT) control mice. Changes in locomotor activity were most remarkable for a significant increase in ambulatory time and a reduction in average velocity of TTS mice. No changes were detected in repetitive and stereotypic behavior and in measures of anxiety. Working memory showed no changes when tested in Y-maze, but deficiency in a more challenging T-maze test was detected. Furthermore, long-term object recognition memory was significantly reduced in the TTS mice. These changes were accompanied by deficient long-term potentiation in the dentate gyrus, which was restored to the WT levels following blockade of GABAA receptors with picrotoxin (100 mu M). TTS mice thus demonstrated a number of phenotypes characteristic of DS and may serve as a new standard by which to evaluate and direct findings in other less complete models of DS.	[Belichenko, Pavel V.; Kleschevnikov, Alexander M.; Becker, Ann; Wagner, Grant E.; Lysenko, Larisa V.; Mobley, William C.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Yu, Y. Eugene] Roswell Pk Canc Inst, Genet Program, Buffalo, NY 14263 USA; [Yu, Y. Eugene] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of California System; University of California San Diego; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Kleschevnikov, AM (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	akleschevnikov@ucsd.edu	Lysenko, Larisa/ABF-2485-2020; Lysenko, Larisa/C-1802-2014	Lysenko, Larisa/0000-0002-0861-2904	National Institute of Health [R01NS066072, R01HL091519]; Hillblom Foundation; LuMind Foundation; Cure Alzheimer's Fund; Jerome Lejeune Foundation; Down Syndrome Research and Treatment Center at the University of California, San Diego; Children's Guild Foundation; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066072] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; LuMind Foundation; Cure Alzheimer's Fund; Jerome Lejeune Foundation; Down Syndrome Research and Treatment Center at the University of California, San Diego; Children's Guild Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Health, grants R01NS066072 (WCM and EY); R01HL091519 (EY); The L.L. Hillblom Foundation (WCM); The LuMind Foundation (PVB, WCM, AMK); The Cure Alzheimer's Fund (AMK); The Jerome Lejeune Foundation (AMK); The Down Syndrome Research and Treatment Center at the University of California, San Diego (PVB, AMK); The Children's Guild Foundation (EY).	Aldridge K, 2007, AM J MED GENET A, V143A, P1060, DOI 10.1002/ajmg.a.31721; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Azkona G, 2010, GENES BRAIN BEHAV, V9, P160, DOI 10.1111/j.1601-183X.2009.00538.x; Baddeley A, 2007, J INTELL DISABIL RES, V51, P925, DOI 10.1111/j.1365-2788.2007.00979.x; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Capone G, 2006, AM J MED GENET C, V142C, P158, DOI 10.1002/ajmg.c.30097; Carlesimo GA, 1997, NEUROPSYCHOLOGIA, V35, P71, DOI 10.1016/S0028-3932(96)00055-3; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; CRONK CE, 1978, PEDIATRICS, V61, P564; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; De S, 2010, CURR OPIN CELL BIOL, V22, P326, DOI 10.1016/j.ceb.2010.04.004; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deitz SL, 2011, GENETICS, V189, P1487, DOI 10.1534/genetics.111.131391; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; Demas GE, 1998, BEHAV BRAIN RES, V90, P199, DOI 10.1016/S0166-4328(97)00116-2; Di Filippo M, 2010, BIOL PSYCHIAT, V67, P666, DOI 10.1016/j.biopsych.2009.08.018; Dierssen M, 2001, PHYSIOL BEHAV, V73, P859, DOI 10.1016/S0031-9384(01)00523-6; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; DOUGLASS HM, 1995, J AM ACAD CHILD PSY, V34, P1424, DOI 10.1097/00004583-199511000-00008; Driscoll LL, 2004, BEHAV NEUROSCI, V118, P1196, DOI 10.1037/0735-7044.118.6.1196; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Ekstein S, 2011, J CHILD NEUROL, V26, P1290, DOI 10.1177/0883073811405201; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Evans DW, 2000, CHILD DEV, V71, P288, DOI 10.1111/1467-8624.00144; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Fernandez F, 2007, NEUROSCI LETT, V421, P137, DOI 10.1016/j.neulet.2007.04.075; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fuchs C, 2012, LAB INVEST, V92, P1648, DOI 10.1038/labinvest.2012.117; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Galdzicki Z, 2003, GENES BRAIN BEHAV, V2, P167, DOI 10.1034/j.1601-183X.2003.00024.x; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Gardiner K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-244; Gathercole SE, 2006, J CHILD PSYCHOL PSYC, V47, P4, DOI 10.1111/j.1469-7610.2005.01446.x; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Haw CM, 1996, MOVEMENT DISORD, V11, P395, DOI 10.1002/mds.870110408; Haydar TF, 1996, J NEUROSCI, V16, P6175; HOLTZMAN DM, 1992, EMBO J, V11, P619, DOI 10.1002/j.1460-2075.1992.tb05094.x; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Jarrold C, 1999, Downs Syndr Res Pract, V6, P61, DOI 10.3104/reviews.97; Kaur G, 2014, J NEUROSCI, V34, P5099, DOI 10.1523/JNEUROSCI.5338-13.2014; Kerins Gerard, 2008, Downs Syndr Res Pract, V12, P141, DOI 10.3104/reports.2009; Kleschevnikov AM, 2012, PROG BRAIN RES, V197, P199, DOI 10.1016/B978-0-444-54299-1.00010-8; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; LACEYCASEM ML, 1994, CRIT REV NEUROBIOL, V8, P293; Lalo E, 2005, NEUROPHYSIOL CLIN, V35, P81, DOI 10.1016/j.neucli.2005.03.002; Lana-Elola E, 2011, DIS MODEL MECH, V4, P586, DOI 10.1242/dmm.008078; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P397, DOI 10.1080/09297040902740652; LAUTESLAGER PEM, 1995, MED SPORT SCI, V40, P75; LEJEUNE J., 1959, ARCH FRANC PEDIATRIE, V16, P962; Levkovitz Y, 1999, J NEUROSCI, V19, P10977, DOI 10.1523/JNEUROSCI.19-24-10977.1999; Liu CH, 2011, DEV NEUROSCI-BASEL, V33, P404, DOI 10.1159/000329422; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Lysenko LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114521; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; Mouton-Liger F, 2014, NEUROBIOL DIS, V63, P92, DOI 10.1016/j.nbd.2013.11.016; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Olson LE, 2011, AM J MED GENET A, V155A, P2436, DOI 10.1002/ajmg.a.34203; Pereira PL, 2009, HUM MOL GENET, V18, P4756, DOI 10.1093/hmg/ddp438; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; Potier MC, 2014, CNS NEUROL DISORD-DR, V13, P8, DOI 10.2174/18715273113126660185; PRASHER VP, 1995, J AUTISM DEV DISORD, V25, P453, DOI 10.1007/BF02179379; Pritchard MA, 1999, J NEURAL TRANSM-SUPP, P293; Rachidi M, 2007, NEUROSCI RES, V59, P349, DOI 10.1016/j.neures.2007.08.007; de Asua DR, 2014, RES DEV DISABIL, V35, P2942, DOI 10.1016/j.ridd.2014.07.038; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Rueda N, 2010, J ALZHEIMERS DIS, V21, P277, DOI 10.3233/JAD-2010-100240; Ruparelia A, 2013, DEV DISABIL RES REV, V18, P43, DOI 10.1002/ddrr.1127; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Sahun I, 2014, GENETICS, V197, P899, DOI 10.1534/genetics.114.165241; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith GK, 2014, HIPPOCAMPUS, V24, P354, DOI 10.1002/hipo.22229; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Turner CA, 2001, BEHAV GENET, V31, P393, DOI 10.1023/A:1012226603255; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0; Whitney KN, 2012, BEHAV BRAIN RES, V232, P202, DOI 10.1016/j.bbr.2012.03.042; Woods-Kettelberger A, 1997, Expert Opin Investig Drugs, V6, P1369, DOI 10.1517/13543784.6.10.1369; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Zhang L, 2014, HUM MOL GENET, V23, P578, DOI 10.1093/hmg/ddt446; Zhang L, 2012, BIOENGINEERED, V3, P8, DOI 10.4161/bbug.3.1.17696; Zohar AH, 1999, CHILD ADOL PSYCH CL, V8, P445	118	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134861	10.1371/journal.pone.0134861	http://dx.doi.org/10.1371/journal.pone.0134861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230397	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400178
J	Briner, AE; Lugli, GA; Milani, C; Duranti, S; Turroni, F; Gueimonde, M; Margolles, A; van Sinderen, D; Ventura, M; Barrangou, R				Briner, Alexandra E.; Lugli, Gabriele Andrea; Milani, Christian; Duranti, Sabrina; Turroni, Francesca; Gueimonde, Miguel; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco; Barrangou, Rodolphe			Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium	PLOS ONE			English	Article							COMPARATIVE GENOMICS; ACQUIRED-RESISTANCE; RNA; EVOLUTION; CLASSIFICATION; ENDONUCLEASE; SEQUENCES; LOCI	CRISPR-Cas systems constitute adaptive immune systems for antiviral defense in bacteria. We investigated the occurrence and diversity of CRISPR-Cas systems in 48 Bifidobacterium genomes to gain insights into the diversity and co-evolution of CRISPR-Cas systems within the genus and investigate CRISPR spacer content. We identified the elements necessary for the successful targeting and inference of foreign DNA in select Type II CRISPR-Cas systems, including the tracrRNA and target PAM sequence. Bifidobacterium species have a very high frequency of CRISPR-Cas occurrence (77%, 37 of 48). We found that many Bifidobacterium species have unusually large and diverse CRISPR-Cas systems that contain spacer sequences showing homology to foreign genetic elements like prophages. A large number of CRISPR spacers in bifidobacteria show perfect homology to prophage sequences harbored in the chromosomes of other species of Bifidobacterium, including some spacers that self-target the chromosome. A correlation was observed between strains that lacked CRISPR-Cas systems and the number of times prophages in that chromosome were targeted by other CRISPR spacers. The presence of prophage-targeting CRISPR spacers and prophage content may shed light on evolutionary processes and strain divergence. Finally, elements of Type II CRISPR-Cas systems, including the tracrRNA and crRNAs, set the stage for the development of genome editing and genetic engineering tools.	[Briner, Alexandra E.; Barrangou, Rodolphe] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Lugli, Gabriele Andrea; Milani, Christian; Duranti, Sabrina; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogenom, I-43100 Parma, Italy; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gueimonde, Miguel; Margolles, Abelardo] Spanish Natl Res Council IPLA CSIC, Dairy Res Inst Asturias, Villaviciosa, Asturias, Spain	University of North Carolina; North Carolina State University; University of Parma; University College Cork; University College Cork; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Barrangou, R (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu	Van Sinderen, Douwe/A-6778-2015; Gueimonde, Miguel/A-2106-2008; Turroni, Francesca/K-9660-2016; Lugli, Gabriele Andrea/AAV-5150-2021; Duranti, Sabrina/AAI-7916-2020; Barrangou, Rodolphe/I-2878-2014; Lugli, Gabriele Andrea/GRX-2617-2022; Margolles, Abelardo/H-3871-2012; ventura, marco/M-8230-2015; Milani, Christian/ABA-8160-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Gueimonde, Miguel/0000-0002-0192-901X; Turroni, Francesca/0000-0001-5363-0231; Lugli, Gabriele Andrea/0000-0002-3024-0537; Duranti, Sabrina/0000-0002-7724-5669; Barrangou, Rodolphe/0000-0002-0648-3504; Lugli, Gabriele Andrea/0000-0002-3024-0537; Margolles, Abelardo/0000-0003-2278-1816; Milani, Christian/0000-0002-5062-3164; Crawley, Alexandra/0000-0002-3970-9506	North Carolina State University; GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [SFI/12/RC/2273]	North Carolina State University; GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This study was supported by startup funds from North Carolina State University. The authors thank GenProbio srl for financial support of the Laboratory of Probiogenomics. DvS is a member of the Alimentary pharmabiotic Centre funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant number SFI/12/RC/2273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Duranti S, 2015, ENV MICROBI IN PRESS; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas Giedrius, 2012, Proc Natl Acad Sci U S A, V109, pE2579; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Lugli GA, 2014, APPL ENVIRON MICROB, V80, P6383, DOI 10.1128/AEM.02004-14; Mahony J, 2015, CURR OPIN BIOTECH, V32, P8, DOI [10.1016/j.copbio.2014.09.006, 10.1016/j.copbio.2014.09.00]; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Ventura M, 2005, APPL ENVIRON MICROB, V71, P8692, DOI 10.1128/AEM.71.12.8692-8705.2005; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Ventura M, 2010, ANTON LEEUW INT J G, V98, P39, DOI 10.1007/s10482-010-9426-4; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	45	51	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133661	10.1371/journal.pone.0133661	http://dx.doi.org/10.1371/journal.pone.0133661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230606	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400048
J	Fan, XL; Jin, T; Zhao, SC; Liu, CY; Han, JM; Jiang, XM; Jiang, YF				Fan, Xueli; Jin, Tao; Zhao, Songchen; Liu, Caiyun; Han, Jinming; Jiang, Xinmei; Jiang, Yanfang			Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; B-CELLS; EXPRESSION; FOLLICLES; DISEASE; CCR7; ASSOCIATION; ANTIBODIES; CHEMOKINES; ROLES	Objective This study is aimed at examining the potential roles of circulating memory T follicular helper (Tfh) cells in patients with multiple sclerosis (MS). Methods The numbers of different subsets of circulating memory Tfh cells in 25 patients with relapsed MS before and after treatment as well as 14 healthy controls (HC) were examined by flow cytometry. The levels of plasma IL-21 in all patients and cerebrospinal fluid (CSF) IL-21 in some MS patients and controls with non-inflammatory neuronal diseases (NND) were measured by ELISA. Results In comparison with that in the HC, the numbers of circulating CD3+CD4+CXCR5+CD45RA-, ICOS+, CCR7+ and CCR7+ ICOS+ memory Tfh cells and the levels of plasma IL-21 significantly increased in MS patients, but significantly decreased in the patients with complete remission (CR). The levels of CSF IL-21 were significantly higher in the MS patients than that in the NND patients. The numbers of CCR7+ICOS+ memory Tfh cells were positively correlated with the EDSS scores, the levels of plasma and CSF IL-21, IgG, MBP-Ab or MOG-Ab. Conclusions Our findings indicated that circulating memory Tfh cells, especially CCR7+ICOS+ memory Tfh cells, may be associated with the relapse of MS and may serve as a new therapeutic target.	[Fan, Xueli; Jin, Tao; Liu, Caiyun; Han, Jinming; Jiang, Xinmei] Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China; [Zhao, Songchen; Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Jilin University; Jilin University; Jilin University	Jiang, XM (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China.	1115764585@qq.com; yanfangjiang@hotmail.com	Han, Jinming/R-6607-2019	Han, Jinming/0000-0002-6084-3275; Liu, Caiyun/0000-0002-3724-5840	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR060268] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cardona AE, 2008, J LEUKOCYTE BIOL, V84, P587, DOI 10.1189/jlb.1107763; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Krumbholz M, 2014, SEMIN IMMUNOPATHOL, V36, P339, DOI 10.1007/s00281-014-0424-x; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Li YJ, 2015, J NEUROIMMUNOL, V278, P239, DOI 10.1016/j.jneuroim.2014.11.011; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ray A, 2011, J NEUROIMMUNOL, V230, P1, DOI 10.1016/j.jneuroim.2010.10.037; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sellebjerg F, 2005, EUR J NEUROL, V12, P939, DOI 10.1111/j.1468-1331.2005.01352.x; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Tellier J, 2013, CELL MOL LIFE SCI, V70, P4771, DOI 10.1007/s00018-013-1420-3; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; Vojdani A, 2003, J INTERN MED, V254, P363, DOI 10.1046/j.1365-2796.2003.01203.x; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955	38	8	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134523	10.1371/journal.pone.0134523	http://dx.doi.org/10.1371/journal.pone.0134523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231034	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400130
J	Farace, C; Oliver, JA; Melguizo, C; Alvarez, P; Bandiera, P; Rama, AR; Malaguarnera, G; Ortiz, R; Madeddu, R; Prados, J				Farace, Cristiano; Oliver, Jaime Antonio; Melguizo, Consolacion; Alvarez, Pablo; Bandiera, Pasquale; Rama, Ana Rosa; Malaguarnera, Giulia; Ortiz, Raul; Madeddu, Roberto; Prados, Jose			Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NUCLEAR LOCALIZED DECORIN; GENE-EXPRESSION PROFILE; EXTRACELLULAR-MATRIX; TUMOR MICROENVIRONMENT; DEVELOPMENTAL BIOLOGY; ADJUVANT TEMOZOLOMIDE; GROWTH-FACTORS; ORAL-CANCER; IDENTIFICATION	The presence of cancer stem cells (CSCs) or tumor-initiating cells can lead to cancer recurrence in a permissive cell-microenvironment interplay, promoting invasion in glioblastoma (GBM) and neuroblastoma (NB). Extracellular matrix (ECM) small leucine-rich proteoglycans (SLRPs) play multiple roles in tissue homeostasis by remodeling the extracellular matrix (ECM) components and modulating intracellular signaling pathways. Due to their pan-inhibitory properties against receptor tyrosine kinases (RTKs), SLRPs are reported to exert anticancer effects in vitro and in vivo. However, their roles seem to be tissue-specific and they are also involved in cancer cell migration and drug resistance, paving the way to complex different scenarios. The aim of this study was to determine whether the SLRPs decorin (DCN) and lumican (LUM) are recruited in cell plasticity and microenvironmental adaptation of differentiated cancer cells induced towards stem-like phenotype. Floating neurospheres were generated by applying CSC enrichment medium (neural stem cell serum-free medium, NSC SFM) to the established SF-268 and SK-N-SH cancer cell lines, cellular models of GBM and NB, respectively. In both models, the time-dependent synergistic activation of DCN and LUM was observed. The highest DCN and LUM mRNA/protein expression was detected after cell exposure to NSC SFM for 8/12 days, considering these cells as SLRP-expressing (SLRP+) CSC-like. Ultrastructural imaging showed the cellular heterogeneity of both the GBM and NB neurospheres and identified the inner living cells. Parental cell lines of both GBM and NB grew only in soft agar + NSC SFM, whereas the secondary neurospheres (originated from SLRP+ t(8) CSC-like) showed lower proliferation rates than primary neurospheres. Interestingly, the SLRP+ CSC-like from the GBM and NB neurospheres were resistant to temozolomide (TMZ) at concentrations >750 mu M. Our results suggest that GBM and NB CSC-like promote the activation of huge quantities of SLRP in response to CSC enrichment, simultaneously acquiring TMZ resistance, cellular heterogeneity, and a quiescent phenotype, suggesting a novel pivotal role for SLRP in drug resistance and cell plasticity of CSC-like, allowing cell survival and ECM/niche modulation potential.	[Farace, Cristiano; Bandiera, Pasquale; Madeddu, Roberto] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Oliver, Jaime Antonio; Melguizo, Consolacion; Alvarez, Pablo; Rama, Ana Rosa; Ortiz, Raul; Prados, Jose] Inst Biopathol & Regenerat Med IBIMER, Granada, Spain; [Melguizo, Consolacion; Prados, Jose] Univ Granada, Dept Anat & Embryol, Granada, Spain; [Melguizo, Consolacion; Alvarez, Pablo; Rama, Ana Rosa; Ortiz, Raul; Prados, Jose] SAS Univ Granada, Biosanitary Inst Granada ibs Granada, Granada, Spain; [Rama, Ana Rosa; Ortiz, Raul] Univ Jaen, Dept Hlth Sci, Jaen, Spain; [Malaguarnera, Giulia] Univ Catania, Res Ctr Great Senescence, Catania, Italy; [Madeddu, Roberto] Natl Inst Biostruct & Biosyst INBB, Rome, Italy	University of Sassari; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidad de Jaen; University of Catania	Farace, C (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	cfarace@uniss.it; rmadeddu@uniss.it	Bandiera, Pasquale/F-4276-2017; Ballesteros, Ana Rosa Rama/AAG-7976-2020; Madeddu, Roberto/J-4206-2014; Prados, Jose/J-7116-2017; Melguizo, Consolación/E-9842-2016; ORTIZ, RAUL/GOH-0599-2022; Ortiz Quesada, Raúl/J-7256-2017; Malaguarnera, Giulia/ABD-4968-2020	Bandiera, Pasquale/0000-0002-0589-4539; Ballesteros, Ana Rosa Rama/0000-0002-3698-2013; Prados, Jose/0000-0003-4303-7746; Melguizo, Consolación/0000-0003-3990-806X; Ortiz Quesada, Raúl/0000-0001-8409-5235; Malaguarnera, Giulia/0000-0003-3655-4307; Madeddu, Roberto/0000-0002-2016-0357; FARACE, Cristiano/0000-0002-6534-0087	Fundacio la Marato TV3 [111431]	Fundacio la Marato TV3	This study was supported by Fundacio la Marato TV3, Project no 111431.	Asara Y, 2013, INT J MOL SCI, V14, P16600, DOI 10.3390/ijms140816600; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Bleau AM, 2014, HISTOL HISTOPATHOL, V29, P1499, DOI 10.14670/HH-29.1499; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Dil N, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-11; Dil N, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-44; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; El Behi M, 2013, EMBO MOL MED, V5, P1835, DOI 10.1002/emmm.201302655; Engel S, 1999, J NEUROIMMUNOL, V99, P13, DOI 10.1016/S0165-5728(99)00062-4; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galli Rossella, 2013, Methods Mol Biol, V986, P267, DOI 10.1007/978-1-62703-311-4_17; Gammon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062493; Gutenberg A, 2013, ACTA NEUROCHIR, V155, P429, DOI 10.1007/s00701-012-1583-y; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hua YQ, 2012, CANCER-AM CANCER SOC, V118, P5140, DOI 10.1002/cncr.27496; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kasamatsu A, 2015, BIOCHEM BIOPH RES CO, V457, P71, DOI 10.1016/j.bbrc.2014.12.093; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leygue E, 1998, CANCER RES, V58, P1348; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuda Y, 2008, INT J ONCOL, V33, P1177, DOI 10.3892/ijo_00000107; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naito Z, 2002, INT J ONCOL, V20, P943; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Oe T, 2005, J NEUROCHEM, V94, P1264, DOI 10.1111/j.1471-4159.2005.03273.x; Oike T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078943; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Persano L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.153; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pope WB, 2012, AM J NEURORADIOL, V33, P1059, DOI 10.3174/ajnr.A2917; Prindull G, 2004, BLOOD, V103, P2892, DOI 10.1182/blood-2003-08-2807; Puglisi MA, 2013, WORLD J GASTROENTERO, V19, P2997, DOI 10.3748/wjg.v19.i20.2997; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Qiu ZK, 2014, CHIN J CANCER, V33, DOI 10.5732/cjc.012.10236; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sailer MHM, 2013, J CELL SCI, V126, P3533, DOI 10.1242/jcs.125757; Santra M, 2006, J CEREBR BLOOD F MET, V26, P1311, DOI 10.1038/sj.jcbfm.9600285; Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Seya T, 2006, ONCOL REP, V16, P1225; Shekhani MT, 2013, AM J STEM CELLS, V2, P52; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Van Bockstal Mieke, 2014, Oncoscience, V1, P634; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yang ZX, 2013, HEPATO-GASTROENTEROL, V60, P349, DOI 10.5754/hge12642; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zagris N, 2011, INT J DEV BIOL, V55, P633, DOI 10.1387/ijdb.113321nz	84	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134111	10.1371/journal.pone.0134111	http://dx.doi.org/10.1371/journal.pone.0134111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230845	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400073
J	Gracia, E; Ortego, J; Godoy, JA; Perez-Garcia, JM; Blanco, G; Delgado, MD; Penteriani, V; Almodovar, I; Botella, F; Sanchez-Zapata, JA				Gracia, Eva; Ortego, Joaquin; Antonio Godoy, Jose; Manuel Perez-Garcia, Juan; Blanco, Guillermo; Delgado, Maria del Mar; Penteriani, Vincenzo; Almodovar, Irene; Botella, Francisco; Antonio Sanchez-Zapata, Jose			Genetic Signatures of Demographic Changes in an Avian Top Predator during the Last Century: Bottlenecks and Expansions of the Eurasian Eagle Owl in the Iberian Peninsula	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; POPULATION-STRUCTURE; BUBO-BUBO; MICROSATELLITE MARKERS; BREEDING PERFORMANCE; NATAL PHILOPATRY; RANGE EXPANSION; SIZE; DIVERSITY; FRAGMENTATION	The study of the demographic history of species can help to understand the negative impact of recent population declines in organisms of conservation concern. Here, we use neutral molecular markers to explore the genetic consequences of the recent population decline and posterior recovery of the Eurasian eagle owl (Bubo bubo) in the Iberian Peninsula. During the last century, the species was the object of extermination programs, suffering direct persecution by hunters until the 70's. Moreover, during the last decades the eagle owl was severely impacted by increased mortality due to electrocution and the decline of its main prey species, the European rabbit (Oryctolagus cuniculus). In recent times, the decrease of direct persecution and the implementation of some conservation schemes have allowed the species' demographic recovery. Yet, it remains unknown to which extent the past population decline and the later expansion have influenced the current species' pattern of genetic diversity. We used eight microsatellite markers to genotype 235 eagle owls from ten Spanish subpopulations and analyse the presence of genetic signatures attributable to the recent population fluctuations experienced by the species. We found moderate levels of differentiation among the studied subpopulations and Bayesian analyses revealed the existence of three genetic clusters that grouped subpopulations from central, south-western and southeastern Spain. The observed genetic structure could have resulted from recent human-induced population fragmentation, a patchy distribution of prey populations and/or the philopatric behaviour and habitat selection of the species. We detected an old population bottleneck, which occurred approximately 10,000 years ago, and significant signatures of recent demographic expansions. However, we did not find genetic signatures for a recent bottleneck, which may indicate that population declines were not severe enough to leave detectable signals on the species genetic makeup or that such signals have been eroded by the rapid demographic recovery experienced by the species in recent years.	[Gracia, Eva; Manuel Perez-Garcia, Juan; Almodovar, Irene; Botella, Francisco; Antonio Sanchez-Zapata, Jose] Miguel Hernandez Univ, Dept Appl Biol, Ecol Area, Elche, Spain; [Ortego, Joaquin] CSIC UCLM JCCM, Hunting Resources Res Inst, Genet & Cultural Biodivers Grp, Ciudad Real, Spain; [Ortego, Joaquin; Antonio Godoy, Jose] CSIC, Donana Biol Stn, Dept Integrat Ecol, E-41080 Seville, Spain; [Blanco, Guillermo] CSIC, Natl Museum Nat Hist, Dept Evolutionary Ecol, Madrid, Spain; [Delgado, Maria del Mar] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Delgado, Maria del Mar; Penteriani, Vincenzo] Univ Oviedo, UO CSIC PA, UMIB, Res Unit Biodivers, Mieres, Spain; [Penteriani, Vincenzo] CSIC, Donana Biol Stn, Dept Conservat Biol, E-41080 Seville, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gracia, E (corresponding author), Miguel Hernandez Univ, Dept Appl Biol, Ecol Area, Elche, Spain.	egracia@umh.es	Graciá, Eva/H-2270-2015; Godoy, José Antonio/B-9288-2008; Sanchez-Zapata, Jose Antonio/H-1413-2015; Botella, Francisco/F-7626-2011; Ortego, Joaquin/F-4936-2010; Botella, Francisco/P-7790-2019; Blanco, Guillermo/L-3170-2014; Pérez-García, Juan Manuel/A-7037-2012	Graciá, Eva/0000-0003-0790-163X; Godoy, José Antonio/0000-0001-7502-9471; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Botella, Francisco/0000-0002-1877-5360; Ortego, Joaquin/0000-0003-2709-429X; Botella, Francisco/0000-0002-1877-5360; Blanco, Guillermo/0000-0001-5742-4929; Pérez-García, Juan Manuel/0000-0002-1191-0187	Consejeria de Medio Ambiente, of the Junta de Andalucia [700/2005/M/00]; Conselleria de Medio Ambiente of the Generalitat Valenciana	Consejeria de Medio Ambiente, of the Junta de Andalucia(Junta de Andalucia); Conselleria de Medio Ambiente of the Generalitat Valenciana	Consejeria de Medio Ambiente, of the Junta de Andalucia, financially supported the study in the Donana area (research project no. 700/2005/M/00). Conselleria de Medio Ambiente of the Generalitat Valenciana partially funded the field work during 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allendorf F. W., 2012, CONSERV GENET; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; Beaumont MA, 1999, GENETICS, V153, P2013; Blanco JC, 1998, MAMIFEROS ESPANA; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Carr D, 2007, J WILDLIFE MANAGE, V71, P1853, DOI 10.2193/2006-274; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Cornuet JM, 1996, GENETICS, V144, P2001; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Delgado MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077557; Delgado MD, 2010, J ANIM ECOL, V79, P620, DOI 10.1111/j.1365-2656.2009.01655.x; Delgado MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2851; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; DONAZAR JA, 1990, J ORNITHOL, V131, P439, DOI 10.1007/BF01639820; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Fernandez-de-Simon J, 2014, ACTA OECOL, V60, P1, DOI 10.1016/j.actao.2014.06.006; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gonzalez J.L., 1980, Boletin de la Estacion Central de Ecologia, V9, P63; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Herrlinger E., 1973, BONNER ZOOLOGICAL MO, V4; HIRONS G J M, 1985, Journal of Zoology Series B, V1, P21; Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025; Hsu YC, 2003, MOL ECOL NOTES, V3, P595, DOI 10.1046/j.1471-8286.2003.00523.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Isaksson M, 2002, MOL ECOL NOTES, V2, P91, DOI 10.1046/j.1471-8286.2002.00156.x; Leon-Ortega M, 2014, ARDEOLA, V61, P45, DOI 10.13157/arla.61.1.2014.45; Perez-Garcia J, 2010, J RAPTOR RES, V44, P161, DOI 10.3356/JRR-09-30.1; Martinez JA, 2001, J ORNITHOL, V142, P204, DOI 10.1007/BF01651788; Martinez JA, 2003, ATLAS AVES REPRODUCT; Martinez JA, 2006, BIRD CONSERV INT, V16, P265, DOI 10.1017/S0959270906000402; Martinez-Abrain A, 2009, ANIM CONSERV, V12, P204, DOI 10.1111/j.1469-1795.2009.00239.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; McEachern MB, 2011, CONSERV GENET, V12, P285, DOI 10.1007/s10592-010-0139-z; Mendez M, 2014, EVOL APPL, V7, P506, DOI 10.1111/eva.12154; Mikkola H., 1983, P1; Mira S, 2013, IBIS, V155, P485, DOI 10.1111/ibi.12065; Mock KE, 2004, CONSERV GENET, V5, P631, DOI 10.1007/s10592-004-1849-x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Moleon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022851; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Moleon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002307; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Niethammer G., 1964, Falke, V11, P189; Omote K, 2012, ZOOL SCI, V29, P299, DOI 10.2108/zsj.29.299; Ortego J, 2007, ORNIS FENNICA, V84, P78; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2011, ECOGRAPHY, V34, P729, DOI 10.1111/j.1600-0587.2010.06773.x; Perez-Garcia JM, 2012, BIRD STUDY, V59, P22, DOI 10.1080/00063657.2011.613111; Perez-Garcia JM, 2011, BIRD CONSERV INT, V21, P296, DOI 10.1017/S0959270911000062; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2011, AM MIDL NAT, V166, P415, DOI 10.1674/0003-0031-166.2.415; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Selas V, 1997, ORNIS FENNICA, V74, P113; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Storz JF, 2002, EVOLUTION, V56, P154; Thode AB, 2002, MOL ECOL NOTES, V2, P446, DOI 10.1046/j.1471-8286.2002.00267.x; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venturas M, 2013, PLANT ECOL, V214, P317, DOI 10.1007/s11258-013-0170-5; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; Wang JL, 1998, HEREDITY, V81, P174, DOI 10.1046/j.1365-2540.1998.00390.x; White C.M., 1994, NEW WORLD VULTURES G; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wright S, 1943, GENETICS, V28, P114; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099	88	7	7	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133954	10.1371/journal.pone.0133954	http://dx.doi.org/10.1371/journal.pone.0133954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230922	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400063
J	Guzman-Silva, A; de Lara, LGV; Torres-Jacome, J; Vargaz-Guadarrama, A; Flores-Flores, M; Said, EP; Lagunas-Martinez, A; Mendoza-Milla, C; Tanzi, F; Moccia, F; Berra-Romani, R				Guzman-Silva, Alejandro; Vazquez de Lara, Luis G.; Torres-Jacome, Julin; Vargaz-Guadarrama, Ajelet; Flores-Flores, Marycruz; Pezzat Said, Elias; Lagunas-Martinez, Alfredo; Mendoza-Milla, Criselda; Tanzi, Franco; Moccia, Francesco; Berra-Romani, Roberto			Lung Beractant Increases Free Cytosolic Levels of Ca2+ in Human Lung Fibroblasts	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PULMONARY SURFACTANT; INOSITOL TRISPHOSPHATE; CALCIUM OSCILLATIONS; CHANNELS; STORE; RELEASE; CONSEQUENCES; PATHOGENESIS; NEUTROPHILS	Beractant, a natural surfactant, induces an antifibrogenic phenotype and apoptosis in normal human lung fibroblasts (NHLF). As intracellular Ca2+ signalling has been related to programmed cell death, we aimed to assess the effect of beractant on intracellular Ca2+ concentration ([Ca2+](i)) in NHLF in vitro. Cultured NHLF were loaded with Fura-2 AM(3 mu M) and Ca2+ signals were recorded by microfluorimetric techniques. Beractant causes a concentration-dependent increase in [Ca2+] i with a EC50 of 0.82 mu g/ml. The application of beractant, at a concentration of 500 mu g/ml, which has been shown to exert an apoptotic effect in human fibroblasts, elicited different patterns of Ca2+ signals in NHLF: a) a single Ca2+ spike which could be followed by b) Ca2+ oscillations, c) a sustained Ca2+ plateau or d) a sustained plateau overlapped by Ca2+ oscillations. The amplitude and pattern of Ca2+ transients evoked by beractant were dependent on the resting [Ca2+](i). Pharmacological manipulation revealed that beractant activates a Ca2+ signal through Ca2+ release from intracellular stores mediated by phospholipase C beta (PLC beta), Ca2+ release from inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and Ca2+ influx via a store-operated pathway. Moreover, beractant-induced Ca2+ release was abolished by preventing membrane depolarization upon removal of extracellular Na+ and Ca2+. Finally, the inhibition of store-operated channels prevented beractant-induced NHLF apoptosis and downregulation of alpha(1)(I) procollagen expression. Therefore, beractant utilizes SOCE to exert its pro-apoptotic and antifibrinogenic effect on NHLF.	[Guzman-Silva, Alejandro; Vargaz-Guadarrama, Ajelet; Flores-Flores, Marycruz; Berra-Romani, Roberto] Benemerita Univ Autonoma Puebla, Sch Med, Dept Biomed, Puebla, Puebla, Mexico; [Vazquez de Lara, Luis G.; Pezzat Said, Elias] Benemerita Univ Autonoma Puebla, Sch Med, Expt Med Lab, Puebla, Puebla, Mexico; [Torres-Jacome, Julin] Benemerita Univ Autonoma Puebla, Inst Physiol, Puebla, Puebla, Mexico; [Lagunas-Martinez, Alfredo] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Mendoza-Milla, Criselda] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Tanzi, Franco; Moccia, Francesco] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Lab Gen Physiol, I-27100 Pavia, Italy	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Salud Publica; University of Pavia	Berra-Romani, R (corresponding author), Benemerita Univ Autonoma Puebla, Sch Med, Dept Biomed, Puebla, Puebla, Mexico.	rberra001@hotmail.com	Berra-Romani, Roberto/R-6894-2018; Vargaz Guadarrama, Verónica Ajelet/AAF-3913-2021; Moccia, Francesco/AAX-6447-2020; torres, julian/ABB-9917-2020; MENDOZA-MILLA, CRISELDA/AAC-5311-2020	Berra-Romani, Roberto/0000-0003-4884-0925; Vargaz Guadarrama, Verónica Ajelet/0000-0001-8616-429X; Moccia, Francesco/0000-0003-0010-0098; MENDOZA-MILLA, CRISELDA/0000-0003-0304-2313; Guzman, Alejandro/0000-0001-5449-5553; Torres-Jacome, Julian/0000-0002-8575-2839; Flores Flores, Marycruz/0000-0001-6975-5645	Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico [BERR-SAL11-I]	Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico	This work was supported by Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico, Grant No. BERR-SAL11-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Akella A, 2013, INDIAN J EXP BIOL, V51, P5; Almirza WHM, 2012, CELL CALCIUM, V51, P12, DOI 10.1016/j.ceca.2011.10.001; AMBLER SK, 1988, J BIOL CHEM, V263, P1952; Berra-Romani R, 2008, CELL CALCIUM, V44, P298, DOI 10.1016/j.ceca.2007.12.007; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Berra-Romani R, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S40; Berra-Romani R, 2012, J VASC RES, V49, P65, DOI 10.1159/000329618; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berroneau Matthieu, 2012, Bulletin de la Societe Herpetologique de France, P1; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; Boston ME, 2004, EXP BIOL MED, V229, P99, DOI 10.1177/153537020422900112; BYRON KL, 1989, J BIOL CHEM, V264, P18234; Castro R, 2008, INFLAMM RES, V57, P489, DOI 10.1007/s00011-008-6214-y; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chacon-Cruz E, 2000, PEDIATR RES, V47, P405, DOI 10.1203/00006450-200003000-00020; Chen JB, 2010, J CELL PHYSIOL, V223, P68, DOI 10.1002/jcp.22010; De Lara LV, 2000, AM J PHYSIOL-LUNG C, V279, pL950, DOI 10.1152/ajplung.2000.279.5.L950; Diambra L, 2009, CHAOS, V19, DOI 10.1063/1.3147425; Dragoni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091099; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Guerreiro Serge, 2011, Handb Exp Pharmacol, P135, DOI 10.1007/978-3-642-13443-2_5; Gurung IS, 2008, BRIT J PHARMACOL, V154, P882, DOI 10.1038/bjp.2008.97; Harari S, 2010, ALLERGY, V65, P537, DOI 10.1111/j.1398-9995.2009.02305.x; Ishida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086410; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Mahaut-Smith MP, 1999, J PHYSIOL-LONDON, V515, P385, DOI 10.1111/j.1469-7793.1999.385ac.x; Misquitta CM, 2005, BIOCHEM J, V388, P291, DOI 10.1042/BJ20041568; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Moccia F, 2003, J CELL PHYSIOL, V194, P139, DOI 10.1002/jcp.10198; Moccia F, 2014, ANTI-CANCER AGENT ME, V14, P296, DOI 10.2174/18715206113139990315; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Mukherjee S, 2013, INT J BIOCHEM CELL B, V45, P1516, DOI 10.1016/j.biocel.2013.04.018; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Oelberg DG, 2000, MOL GENET METAB, V70, P295, DOI 10.1006/mgme.2000.3022; Ong HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047146; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Potenza DM, 2014, CELL CALCIUM, V56, P225, DOI 10.1016/j.ceca.2014.07.010; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shuttleworth TJ, 1996, BIOCHEM J, V313, P815, DOI 10.1042/bj3130815; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Thomassen MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL159, DOI 10.1152/ajplung.1996.270.1.L159; Thurley K, 2012, BBA-GEN SUBJECTS, V1820, P1185, DOI 10.1016/j.bbagen.2011.10.007; TOESCU EC, 1993, J BIOL CHEM, V268, P18654; Tzouvelekis A, 2015, THER CLIN RISK MANAG, V11, P359, DOI 10.2147/TCRM.S69716; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134564	10.1371/journal.pone.0134564	http://dx.doi.org/10.1371/journal.pone.0134564			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230503	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400135
J	Hammerl, EE; Baier, MA; Reinhard, KJ				Hammerl, Emily E.; Baier, Melissa A.; Reinhard, Karl J.			Agave Chewing and Dental Wear: Evidence from Quids	PLOS ONE			English	Article							RIO ZAPE; PHYTOLITHS; DIET; MICROWEAR; DURANGO; REGION; CAVE	Agave quid chewing is examined as a potential contributing behavior to hunter-gatherer dental wear. It has previously been hypothesized that the contribution of Agave quid chewing to dental wear would be observed in communities wherever phytolith-rich desert succulents were part of subsistence. Previous analysis of coprolites from a prehistoric agricultural site, La Cueva de los Muertos Chiquitos in Durango, Mexico, showed that Agave was a consistent part of a diverse diet. Therefore, quids recovered at this site ought to be useful materials to test the hypothesis that dental wear was related to desert succulent consumption. The quids recovered from the site were found to be largely derived from chewing Agave. In this study, the quids were found to be especially rich in phytoliths, and analysis of dental casts made from impressions left in the quids revealed flat wear and dental attrition similar to that of Agave-reliant hunter-gatherers. Based on evidence obtained from the analysis of quids, taken in combination with results from previous studies, it is determined that Agave quid chewing was a likely contributing factor to dental wear in this population. As such, our method provides an additional avenue of dental research in areas where quids are present.	[Hammerl, Emily E.] Univ Nebraska, Dept Anthropol, Lincoln, NE 68588 USA; [Hammerl, Emily E.] Univ Nebraska, Forens Sci Program, Lincoln, NE USA; [Baier, Melissa A.] Natl Pk Serv, Buffalo Natl River, Harrison, AR USA; [Reinhard, Karl J.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; University of Nebraska System; University of Nebraska Lincoln	Hammerl, EE (corresponding author), Univ Nebraska, Dept Anthropol, Lincoln, NE 68588 USA.	ehammerl2@unl.edu	Reinhard, Karl/AAT-7881-2020		Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln	Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln	This work was supported by the Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bell WH, 1944, AM ANTIQUITY, V10, P150, DOI 10.2307/275111; BROOKS RH, 1962, AM ANTIQUITY, V27, P356, DOI 10.2307/277801; Bryant Jr VM, 2008, PAPERS NATURAL RESOU, V19; Byers D, 1967, PREHISTORY TEHUACAN, V1; Callen E.O., 1967, PREHISTORY TEHUACAN, VVolume 1, P261; Castetter EF, 1935, U NM B 266 ETHNOBOTA, V1; Danielson DR, 1998, AM J PHYS ANTHROPOL, V107, P297, DOI 10.1002/(SICI)1096-8644(199811)107:3<297::AID-AJPA6>3.0.CO;2-M; Fish S. K., 1985, Desert Plants, V7, P107; Fish S.K., 1990, ARCHAEOLOGY REGIONS, P189; Fish Suzanne K., 1992, MARANA COMMUNITY HOH, P73; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; HARTNADY P, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P267; Holt B, 1993, PHYTOLITHARIEN NEWSL, V7; Jimenez FA, 2012, J PARASITOL, V98, P304, DOI 10.1645/GE-2915.1; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; MARKS M, 1988, PLAINS ANTHROPOL, V33, P75; Meade T, 1994, DIETARY ANAL COPROLI; Middleton W., 1993, PHYTOLITHARIEN NEWSL, V7, P8; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Pearson OM, 2014, J HUMAN EVOLUTION; Reed Alan D., 1978, Southwestern Lore, V44, P1; Reinhard K, 2001, BRIT ARCHAEOL REP IN, VS934, P113; Reinhard K. J, 2002, BILBY RES CTR OCCASI, V1, P135; Reinhard KJ, 2012, CURR ANTHROPOL, V53, P506, DOI 10.1086/665923; Reinhard KJ, 2005, J ARCHAEOL SCI, V32, P981, DOI 10.1016/j.jas.2005.01.014; Reinhard KJ, 1989, TEXAS ARKANSAS ARCHA, P93; Robson J, 1986, GUILA NAQUITZ ARCHAI; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schmidt CW, 2001, AM J PHYS ANTHROPOL, V114, P139, DOI 10.1002/1096-8644(200102)114:2&lt;139::AID-AJPA1013&gt;3.0.CO;2-9; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Smith CE, 1967, PREHISTORY TEHUACAN, V1; Turner C, 1967, REPORTS U CALIF ARCH, V70, P1; TURPIN SA, 1986, PLAINS ANTHROPOL, V31, P295	37	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133710	10.1371/journal.pone.0133710	http://dx.doi.org/10.1371/journal.pone.0133710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230855	Green Published, gold			2022-12-26	WOS:000358838400051
J	Kang, JY; Lim, SJ; Kwon, O; Lee, SG; Kim, HH; Oh, DB				Kang, Ji-Yeon; Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Kim, Ha Hyung; Oh, Doo-Byoung			Enhanced Bacterial alpha(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate	PLOS ONE			English	Article							PHOTOBACTERIUM-DAMSELA ALPHA-2,6-SIALYLTRANSFERASE; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; N-GLYCAN ANALYSIS; SIALYLTRANSFERASE; CELLS	Bacterial alpha(2,6)-sialyltransferases (STs) from Photobacterium damsela, Photobacterium sp. JT-ISH-224, and P. leiognathi JT-SHIZ-145 were recombinantly expressed in Escherichia coli and their ST activities were compared directly using a galactosylated bi-antennary N-glycan as an acceptor substrate. In all ST reactions, there was an increase of sialylated glycans at shorter reaction times and later a decrease in prolonged reactions, which is related with the inherent sialidase activities of bacterial STs. These sialidase activities are greatly increased by free cytidine monophosphate (CMP) generated from a donor substrate CMP-N-acetylneuraminic acid (CMP-Neu5Ac) during the ST reactions. The decrease of sialylated glycans in prolonged ST reaction was prevented through an inhibition of sialidase activity by simple treatment of alkaline phosphatase (AP), which dephosphorylates CMP to cytidine. Through supplemental additions of AP and CMP-Neu5Ac to the reaction using the recombinant alpha(2,6)-ST from P. leiognathi JT-SHIZ-145 (P145-ST), the content of bi-sialylated N-glycan increased up to similar to 98% without any decrease in prolonged reactions. This optimized P145-ST reaction was applied successfully for alpha(2,6)-sialylation of asialofetuin, and this resulted in a large increase in the populations of multi-sialylated N-glycans compared with the reaction without addition of AP and CMP-Neu5Ac. These results suggest that the optimized reaction using the recombinant P145-ST readily expressed from E. coli has a promise for economic glycan synthesis and glyco-conjugate remodeling.	[Kang, Ji-Yeon; Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Oh, Doo-Byoung] KRIBB, Synth Biol & Bioengn Res Ctr, Taejon, South Korea; [Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Oh, Doo-Byoung] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon, South Korea; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University	Oh, DB (corresponding author), KRIBB, Synth Biol & Bioengn Res Ctr, Taejon, South Korea.	dboh@kribb.re.kr	Lee, Seung-Goo/AAR-9823-2021; Lee, Seung-Goo/AAS-1613-2021	Lee, Seung-Goo/0000-0003-4539-9812; Oh, Doo-Byoung/0000-0002-4432-0941	Ministry of Trade, Industry Energy [10048311]; National Research Foundation of Korea [NRF-2013M3A9B6075888]; Next-Generation BioGreen 21 Program of the Rural Development Administration [PJ011078]; Intelligent Synthetic Biology Center of Global Frontier Project in Republic of Korea [2011-0031944]	Ministry of Trade, Industry Energy; National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program of the Rural Development Administration; Intelligent Synthetic Biology Center of Global Frontier Project in Republic of Korea	This work was supported by the grants from the Ministry of Trade, Industry & Energy [10048311], the National Research Foundation of Korea [NRF-2013M3A9B6075888], the Next-Generation BioGreen 21 Program of the Rural Development Administration [PJ011078], and the Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944] in Republic of Korea.	Air GM, 2014, CURR OPIN VIROL, V7, P128, DOI 10.1016/j.coviro.2014.06.004; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Cheng JS, 2010, GLYCOBIOLOGY, V20, P260, DOI 10.1093/glycob/cwp172; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kim HG, 2003, BIOCHEM BIOPH RES CO, V305, P488, DOI 10.1016/S0006-291X(03)00795-2; Lee KJ, 2015, J BIOCHEM, V157, P35, DOI 10.1093/jb/mvu051; Lee KJ, 2013, GLYCOCONJUGATE J, V30, P537, DOI 10.1007/s10719-012-9453-7; Lee SG, 2002, BIOTECHNOL BIOENG, V80, P516, DOI 10.1002/bit.10398; Mine T, 2010, GLYCOBIOLOGY, V20, P158, DOI 10.1093/glycob/cwp157; Mun JY, 2013, ANAL CHEM, V85, P7462, DOI 10.1021/ac401431u; Sun MC, 2008, BIOTECHNOL LETT, V30, P671, DOI 10.1007/s10529-007-9588-y; Tsai TI, 2013, J AM CHEM SOC, V135, P14831, DOI 10.1021/ja4075584; Tsukamoto H, 2008, J BIOCHEM, V143, P187, DOI 10.1093/jb/mvm208; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yamamoto T, 2007, GLYCOBIOLOGY, V17, P1167, DOI 10.1093/glycob/cwm086	18	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133739	10.1371/journal.pone.0133739	http://dx.doi.org/10.1371/journal.pone.0133739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231036	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400053
J	Possati-Resende, JC; Fregnani, JHTG; Kerr, LM; Mauad, EC; Longatto, A; Scapulatempo-Neto, C				Possati-Resende, Julio C.; Fregnani, Jose H. T. G.; Kerr, Ligia M.; Mauad, Edmundo C.; Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam			The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL	PLOS ONE			English	Article							HYBRID CAPTURE 2; RISK HUMAN-PAPILLOMAVIRUS; ATYPICAL SQUAMOUS-CELLS; COBAS 4800 HPV; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; PERFORMANCE; COLPOSCOPY; TRIAGE; TECHNOLOGIES	The objective of this study was to compare the accuracies of double staining for p16/Ki-67 and the molecular test for high-risk HPV (hr-HPV) to identify high-grade cervical intraepithelial neoplasia (CIN2/CIN3) in women with cervical cytology of atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL). Data were collected from 201 women who underwent cervical cytology screening in the Barretos Cancer Hospital and their results were categorized as ASC-US (n= 96) or LSIL (n=105). All patients underwent colposcopy with or without cervical biopsy for diagnosis of CIN2/CIN3. The hr-HPV test (Cobas 4800 test) and immunocytochemistry were performed to detect biomarkers p16/Ki-67 (CINtec PLUS test). Two samples (1 ASC-US/1 LSIL) were excluded from the analysis due to inconclusive results of the histologic examination. There were 8 cases of CIN2/CIN3 among 95 women with ASC-US (8.4%), and 23 cases of CIN2/CIN3 among 104 women with LSIL (22.1%). In the group of women with ASC-US, the sensitivity and specificity in diagnosing CIN2/CIN3 were 87.5% and 79.5% for the HPV test and 62.5% and 93.1% for p16/Ki-67. Among women with LSIL, the sensitivity and specificity in the diagnosis of CIN2/CIN3 were 87% and 34.7% for the HPV test and 69.6% and 75.3% for immunocytochemistry. Superior performance was observed for p16/Ki-67 double staining, especially among women under 30 for whom the test had an area under the ROC curve of 0.762 (p<0.001). Both p16/Ki-67 double staining and the hr-HPV DNA test had similar performance in predicting high-grade cervical intraepithelial neoplasia among women with ASC-US. The best performance was observed in women aged >30 years. In younger women (<= 30 years) with LSIL, p16/Ki-67 had greater accuracy in identifying precursor lesions. Among women > 30 years diagnosed with LSIL, the two methods showed similar performance.	[Possati-Resende, Julio C.; Mauad, Edmundo C.] Barretos Canc Hosp, Canc Prevent Dept, Barretos, SP, Brazil; [Fregnani, Jose H. T. G.] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil; [Kerr, Ligia M.; Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil; [Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Ctr Mol Oncol, Barretos, SP, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 14, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo	Possati-Resende, JC (corresponding author), Barretos Canc Hosp, Canc Prevent Dept, Barretos, SP, Brazil.	julio.possati@uol.com.br	longatto-filho, adhemar/D-7039-2013; Fregnani, José H/H-4238-2012; Filho, Adhemar Longatto/A-2889-2016; Longatto-Filho, Adhemar/N-3397-2019; Possati-Resende, Julio Cesar/C-8575-2016	longatto-filho, adhemar/0000-0002-5779-9752; Fregnani, José H/0000-0002-5235-6469; Longatto-Filho, Adhemar/0000-0002-5779-9752; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Possati-Resende, Julio Cesar/0000-0002-7869-3885				Allen K, 2002, RISK MANAGEMENT CYTO; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; Brown CA, 2012, J ONCOL, V2012, DOI 10.1155/2012/289315; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2012, VACCINE, V30, pF107, DOI 10.1016/j.vaccine.2012.05.088; de Oliveira CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-357; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Edgerton N, 2013, DIAGN CYTOPATHOL, V41, P35, DOI 10.1002/dc.21757; Kisser A, 2015, BJOG-INT J OBSTET GY, V122, P64, DOI 10.1111/1471-0528.13076; Lapierre SG, 2012, J CLIN MICROBIOL, V50, P1240, DOI 10.1128/JCM.06656-11; Loghavi S, 2013, DIAGN CYTOPATHOL, V41, P582, DOI 10.1002/dc.22900; Lonky NM, 1999, AM J OBSTET GYNECOL, V181, P560, DOI 10.1016/S0002-9378(99)70493-X; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Sankaranarayanan R, 1988, IARC SCI PUBLICATION, V15; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Waldstrom M, 2013, CANCER CYTOPATHOL, V121, P136, DOI 10.1002/cncy.21233; Walker JL, 2006, AM J OBSTET GYNECOL, V195, P341, DOI 10.1016/j.ajog.2006.02.047; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; White C, 2013, J CLIN MICROBIOL, V51, P3415, DOI 10.1128/JCM.01949-13; Wong AA, 2012, J CLIN MICROBIOL, V50, P25, DOI 10.1128/JCM.05400-11; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	29	35	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134445	10.1371/journal.pone.0134445	http://dx.doi.org/10.1371/journal.pone.0134445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230097	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400120
J	Zhang, M; Wang, LH; Guo, R; Liang, S; Jiang, XF; Zhang, M; Li, B				Zhang, Miao; Wang, Lihua; Guo, Rui; Liang, Sheng; Jiang, Xufeng; Zhang, Min; Li, Biao			Molecular In Vivo Imaging Using a Noninvasive Cardiac-Specific MLC-2v Promoter Driven Dual-Gene Recombinant Lentivirus Monitoring System	PLOS ONE			English	Article							MUSCLE-SPECIFIC EXPRESSION; REPORTER GENE; SYMPORTER; MOUSE	Background Our study aimed to demonstrate the feasibility of using the sodium/iodide symporter (NIS) to monitor vascular endothelial growth factor (VEGF(165)) expression in vivo. Methods We constructed a recombinant lentivirus plasmid with the MLC-2v promoter driving the sodium/iodide symporter (NIS) reporter gene linked to the VEGF(165) gene. Expression of NIS and VEGF gene were identified by Western blot. On days 2 and 54, Tc-99m-MIBI imaging was used to evaluate changes in myocardial ischemia. Noninvasive I-125 micro-SPECT/CT imaging was used to assess the expression of NIS reporter gene dynamically over the next 2 months. Results Western blot analysis showed that both NIS and VEGF(165) were highly expressed in rat cardiomyoblast H9C2 cells transduced with Lenti-MLC-2v-NIS-VEGF(165). I-125 micro-SPECT/CT reporter imaging showed higher uptake in mouse myocardium transduced with Lenti-MLC-2v-VEGF(165)-IRES-NIS. NIS expression peaked on day 1 after transduction followed by a progressive decline to negligible levels by day 21. On day 1, mean I-125 activity value in group 1 was higher than that in group 2 (P<0.05). The mean I-125 activity value in group 3 was statically lower than that in group 1 and 2 (P<0.01). On day 60, I-125 uptakes in test and positive control groups became very low, and no significant differences in the mean I-125 activity values were detected between group 1 and group 2 (P = 0.531 > 0.05). In group 1 (test group), Tc-99m-MIBI SPECT/CT revealed improvements in perfusion and wall thickening in the apical anterior wall. Mean IOD values of NIS and CD34 were significantly higher in group 1 than group 3 (P<0.05). Our study proved mean I-125 uptake was significantly correlated with mean IOD value of NIS and CD34 (P<0.05). Conclusion This study demonstrates the feasibility of using the NIS gene to monitor VEGF(165) expression in a mouse myocardial ischemia model.	[Zhang, Miao; Wang, Lihua; Guo, Rui; Jiang, Xufeng; Zhang, Min; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Xin Hua Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn			National Natural Science Foundation of China [NSFC 30900375]; Shanghai Outstanding Academic Leaders Project [11XD1403700]; China National leading clinical discipline project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project; China National leading clinical discipline project	This work was funded by National Natural Science Foundation of China (NSFC 30900375, http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700, http://www.stcsm.gov.cn/) and China National leading clinical discipline project.	Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Guo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102011; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kang JH, 2005, J NUCL MED, V46, P479; Lee KH, 2005, J NUCL MED, V46, P652; LEE KJ, 1992, J BIOL CHEM, V267, P15875; LEE KJ, 1994, MOL CELL BIOL, V14, P1220, DOI 10.1128/MCB.14.2.1220; Lei Han, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P232; Miyagawa M, 2005, CARDIOVASC RES, V65, P195, DOI 10.1016/j.cardiores.2004.10.001; Patrick PS, 2014, P NATL ACAD SCI USA, V111, P415, DOI 10.1073/pnas.1319000111; Perin EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022949; Rao VP, 2007, TRANSPLANTATION, V84, P1662, DOI 10.1097/01.tp.0000295932.26883.ba; Ricci D, 2008, EUR J CARDIO-THORAC, V33, P32, DOI 10.1016/j.ejcts.2007.09.033; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Su H, 2004, P NATL ACAD SCI USA, V101, P16280, DOI 10.1073/pnas.0407449101; Vadysirisack DD, 2006, J NUCL MED, V47, P182; Velazquez EJ, 2012, CIRC-CARDIOVASC IMAG, V5, P271, DOI 10.1161/CIRCIMAGING.111.964650; Wu JC, 2004, CIRCULATION, V110, P685, DOI 10.1161/01.CIR.0000138153.02213.22; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092326	23	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133952	10.1371/journal.pone.0133952	http://dx.doi.org/10.1371/journal.pone.0133952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230833	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400062
J	Zhao, YQ; Zhou, M; Gao, Y; Liu, HY; Yang, WY; Yue, JH; Chen, DK				Zhao, Yanqing; Zhou, Ming; Gao, Yang; Liu, Heyuan; Yang, Wenyu; Yue, Jinhua; Chen, Dekun			Shifted T Helper Cell Polarization in a Murine Staphylococcus aureus Mastitis Model	PLOS ONE			English	Article							BOVINE MAMMARY-GLAND; ANTIMICROBIAL SUSCEPTIBILITY; BACTERIAL CAUSES; RISK-FACTORS; DAIRY FARMS; IMMUNITY; PREVALENCE; COWS; CYTOKINES; IL-17	Mastitis, one of the most costly diseases in dairy ruminants, is an inflammation of the mammary gland caused by pathogenic infection. The mechanisms of adaptive immunity against pathogens in mastitis have not been fully elucidated. To investigate T helper cell-mediated adaptive immune responses, we established a mastitis model by challenge with an inoculum of 4 x 10(6) colony-forming units of Staphylococcus aureus in the mammary gland of lactating mice, followed by quantification of bacterial burden and histological analysis. The development of mastitis was accompanied by a significant increase in both Th17 and Th1 cells in the mammary gland. Moreover, the relative expression of genes encoding cytokines and transcription factors involved in the differentiation and function of these T helper cells, including Il17, Rorc, Tgfb, Il1b, Il23, Ifng, Tbx21, and Il12, was greatly elevated in the infected mammary gland. IL-17 is essential for neutrophil recruitment to infected mammary gland via CXC chemokines, whereas the excessive IL-17 production contributes to tissue damage in mastitis. In addition, a shift in T helper cell polarization toward Th2 and Treg cells was observed 5 days post-infection, and the mRNA expression of the anti-inflammatory cytokine Il10 was markedly increased at day 7 post-infection. These results indicate that immune clearance of Staphylococcus aureus in mastitis is facilitated by the enrichment of Th17, Th1 and Th2 cells in the mammary gland mediated by pro-inflammatory cytokine production, which is tightly regulated by Treg cells and the anti-inflammatory cytokine IL-10.	[Zhao, Yanqing; Zhou, Ming; Gao, Yang; Liu, Heyuan; Yang, Wenyu; Yue, Jinhua; Chen, Dekun] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Chen, DK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	chendekun163@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20120204110031]; Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China [2013KTZB02-02-03]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China	This study was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120204110031, http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm) and Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China (Grant No. 2013KTZB02-02-03, http://www.shaanxi.gov.cn/0/xxgk/1/2/4/430/1374/1396/1412/39702.htm). DKC received the funding, who conceived and designed theexperiments and contributed to the writing of the manuscript.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Alluwaimi AM, 2004, RES VET SCI, V77, P211, DOI 10.1016/j.rvsc.2004.04.006; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Barlow J, 2011, J MAMMARY GLAND BIOL, V16, P383, DOI 10.1007/s10911-011-9235-z; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Bharathan M, 2011, J MAMMARY GLAND BIOL, V16, P409, DOI 10.1007/s10911-011-9233-1; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Contreras A, 2007, SMALL RUMINANT RES, V68, P145, DOI 10.1016/j.smallrumres.2006.09.011; Darling AR, 2014, CLIN IMMUNOL, V150, P153, DOI 10.1016/j.clim.2013.11.010; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Green M, 2013, VET REC, V173, P517, DOI 10.1136/vr.f7029; Haftu R, 2012, TROP ANIM HEALTH PRO, V44, P1765, DOI 10.1007/s11250-012-0135-z; HASEGAWA T, 1993, J VET MED SCI, V55, P169, DOI 10.1292/jvms.55.169; Hogeveen H, 2011, P 50 ANN M NAT MAST; Jing XQ, 2012, J ANIM VET ADV, V11, P475; Jing XQ, 2012, ASIAN J ANIM VET ADV, V7, P1266, DOI 10.3923/ajava.2012.1266.1278; Kurebayashi Y, 2013, GENES CELLS, V18, P247, DOI 10.1111/gtc.12039; Marogna G, 2012, SMALL RUMINANT RES, V102, P74, DOI 10.1016/j.smallrumres.2011.08.013; Nagahata H, 2011, J VET MED SCI, V73, P885, DOI 10.1292/jvms.10-0379; Niteesh Kumar, 2013, International Journal of Herbal Medicine, V1, P1; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Pereira UP, 2011, VET MICROBIOL, V148, P117, DOI 10.1016/j.vetmic.2010.10.003; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Regassa A, 2013, TROP ANIM HEALTH PRO, V45, P1589, DOI 10.1007/s11250-013-0403-6; Rivas AL, 2000, CAN J VET RES, V64, P232; Slight SR, 2013, AM J PATHOL, V183, P1397, DOI 10.1016/j.ajpath.2013.07.008; Soltys J, 1999, INFECT IMMUN, V67, P6293; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Sordillo LM, 2011, J MAMMARY GLAND BIOL, V16, P271, DOI 10.1007/s10911-011-9239-8; Srinivasan P, 2013, Pak J Biol Sci, V16, P1776, DOI 10.3923/pjbs.2013.1776.1780; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Wenz JR, 2010, J DAIRY SCI, V93, P2458, DOI 10.3168/jds.2009-2819; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Wilson CR, 2013, CAN VET J, V54, P292; Zeryehun T, 2013, J ANIM PLANT SCI, V23, P50; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13	43	23	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134797	10.1371/journal.pone.0134797	http://dx.doi.org/10.1371/journal.pone.0134797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230498	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400168
J	Marzagalli, M; Casati, L; Moretti, RM; Marelli, MM; Limonta, P				Marzagalli, Monica; Casati, Lavinia; Moretti, Roberta M.; Marelli, Marina Montagnani; Limonta, Patrizia			Estrogen Receptor beta Agonists Differentially Affect the Growth of Human Melanoma Cell Lines	PLOS ONE			English	Article							BREAST-CANCER CELLS; ER-BETA; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; DNA METHYLATION; GENE-EXPRESSION; PROLIFERATION; ISOFORMS; BIOLOGY; ALPHA	Background Cutaneous melanoma is an aggressive malignancy; its incidence is increasing worldwide and its prognosis remains poor. Clinical observations indicate that estrogen receptor beta (ER beta) is expressed in melanoma tissues and its expression decreases with tumor progression, suggesting its tumor suppressive function. These experiments were performed to investigate the effects of ER beta activation on melanoma cell growth. Methods and Results Protein expression was analyzed by Western blot and immunofluorescence assays. Cell proliferation was assessed by counting the cells by hemocytometer. ER beta transcriptional activity was evaluated by gene reporter assay. Global DNA methylation was analyzed by restriction enzyme assay and ER beta isoforms were identified by qRT-PCR. We demonstrated that ER beta is expressed in a panel of human melanoma cell lines (BLM, WM115, A375, WM1552). In BLM (NRAS-mutant) cells, ER beta agonists significantly and specifically inhibited cell proliferation. ER beta activation triggered its cytoplasmic-to-nuclear translocation and transcriptional activity. Moreover, the antiproliferative activity of ER beta agonists was associated with an altered expression of G1-S transition-related proteins. In these cells, global DNA was found to be hypomethylated when compared to normal melanocytes; this DNA hypomethylation status was reverted by ER beta activation. ER beta agonists also decreased the proliferation of WM115 (BRAF V600D-mutant) cells, while they failed to reduce the growth of A375 and WM1552 (BRAF V600E-mutant) cells. Finally, we could observe that ER beta isoforms are expressed at different levels in the various cell lines. Specific oncogenic mutations or differential expression of receptor isoforms might be responsible for the different responses of cell lines to ER beta agonists. Conclusions Our results demonstrate that ER beta is expressed in melanoma cell lines and that ER beta agonists differentially regulate the proliferation of these cells. These data confirm the notion that melanoma is a heterogeneous tumor and that genetic profiling is mandatory for the development of effective personalized therapeutic approaches for melanoma patients.	[Marzagalli, Monica; Moretti, Roberta M.; Marelli, Marina Montagnani; Limonta, Patrizia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Casati, Lavinia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Milan; University of Milan	Limonta, P (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	patrizia.limonta@unimi.it	Moretti, Roberta Manuela/G-7514-2012; Marzagalli, Monica/AAS-2938-2020; marelli, marina montagnani/G-7521-2012	Moretti, Roberta Manuela/0000-0001-6456-5869; marelli, marina montagnani/0000-0002-3739-6278; Casati, Lavinia/0000-0001-9044-6767; Marzagalli, Monica/0000-0001-7684-606X	Fondazione Banca del Monte di Lombardia; PRIN-MIUR [NFEB9L_004]	Fondazione Banca del Monte di Lombardia; PRIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Funding was provided by Fondazione Banca del Monte di Lombardia 2012, http://www.fbml.it/ (P.L., L.C., R.M.M., M.M.M.); PRIN-MIUR 2010-20112010, NFEB9L_004, http://prin.miur.it/ (P.L., R.M.M., M.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Besaratinia A, 2014, J MOL CELL BIOL, V6, P356, DOI 10.1093/jmcb/mju027; Bilal I, 2014, WORLD J CLIN ONCOL, V5, P705, DOI 10.5306/wjco.v5.i4.705; Calabrese EJ, 2013, ENVIRON POLLUT, V182, P452, DOI 10.1016/j.envpol.2013.07.046; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Casati L, 2014, CELL ADHES MIGR, V8, P595, DOI 10.4161/19336918.2014.972785; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chaudhary SC, 2014, CANCER PREV RES, V7, P186, DOI 10.1158/1940-6207.CAPR-13-0276; Chen J, 2014, RECHARGEABLE SENSOR NETWORKS: TECHNOLOGY, THEORY, AND: APPLICATION: INTRODUCING ENERGY HARVESTING TO SENSOR NETWORKS, P1, DOI 10.1142/8911; Ciucci A, 2014, GYNECOL ONCOL, V132, P351, DOI 10.1016/j.ygyno.2013.12.027; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; de Giorgi V, 2013, BRIT J DERMATOL, V168, P513, DOI 10.1111/bjd.12056; De Giorgi V, 2011, EXPERT REV ANTICANC, V11, P739, DOI [10.1586/ERA.11.42, 10.1586/era.11.42]; de Giorgi V, 2009, ARCH DERMATOL, V145, P30, DOI 10.1001/archdermatol.2008.537; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Docquier A, 2013, MOL ENDOCRINOL, V27, P1429, DOI 10.1210/me.2012-1351; Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Ecsedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096612; Ecsedi SI, 2013, INT J CLIN EXP PATHO, V6, P2943; Ekedahl H, 2013, BRIT J DERMATOL, V169, P1049, DOI 10.1111/bjd.12504; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Hapangama DK, 2015, HUM REPROD UPDATE, V21, P174, DOI 10.1093/humupd/dmu053; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heinzerling L, 2013, BRIT J CANCER, V108, P2164, DOI 10.1038/bjc.2013.143; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Leung AM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00110; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2012, STEROIDS, V77, P727, DOI 10.1016/j.steroids.2012.03.008; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Lewies A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00215; Liu XW, 2014, CELL CYCLE, V13, DOI [10.4161/cc.26971, 10.4161/cc.28607]; Liu XY, 2015, MOL MED REP, V11, P1516, DOI 10.3892/mmr.2014.2811; Liu ZG, 2013, ENDOCRINE, V44, P517, DOI 10.1007/s12020-013-9916-z; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Manente AG, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.32; Martini PGV, 2000, MOL CELL BIOL, V20, P6224, DOI 10.1128/MCB.20.17.6224-6232.2000; Marzioni M, 2012, DIGEST LIVER DIS, V44, P134, DOI 10.1016/j.dld.2011.06.014; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Moore JT, 1998, BIOCHEM BIOPH RES CO, V247, P75, DOI 10.1006/bbrc.1998.8738; Moretti RM, 2002, J CLIN ENDOCR METAB, V87, P3791, DOI 10.1210/jc.87.8.3791; Moretti RM, 2010, ENDOCRINOLOGY, V151, P4643, DOI 10.1210/en.2010-0163; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; Nair HB, 2011, STEROIDS, V76, P792, DOI 10.1016/j.steroids.2011.02.038; Nakamura Y, 2013, PROSTATE, V73, P590, DOI 10.1002/pros.22599; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pasquali S, 2014, CANCER TREAT REV, V40, P893, DOI 10.1016/j.ctrv.2014.06.008; Piccolella M, 2014, PHARMACOL RES, V79, P13, DOI 10.1016/j.phrs.2013.10.002; Pinton G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-227; Pinton G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014110; Ramsey TL, 2004, ENDOCRINOLOGY, V145, P149, DOI 10.1210/en.2003-1043; Rizza P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3619; Ruddy SC, 2014, MOL CANCER THER, V13, P1882, DOI 10.1158/1535-7163.MCT-13-1066; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmidt AN, 2006, EXP DERMATOL, V15, P971, DOI 10.1111/j.1600-0625.2006.00502.x; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Voskoboynik M, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/307059; Vujic I, 2015, ONCOTARGET, V6, P969, DOI 10.18632/oncotarget.2824; Wang J, 2015, BREAST CANCER RES TR, V152, P255, DOI 10.1007/s10549-015-3467-3; Warner M, 2010, BIOCHEM BIOPH RES CO, V396, P63, DOI 10.1016/j.bbrc.2010.02.144; Wu ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089806; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yakimchuk K, 2014, BLOOD, V123, P2054, DOI 10.1182/blood-2013-07-517292; Yang GS, 2007, CHINESE MED J-PEKING, V120, P1611, DOI 10.1097/00029330-200709020-00012; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; Zhou JH, 2014, AM J DERMATOPATH, V36, P74, DOI 10.1097/DAD.0b013e3182914c64	81	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134396	10.1371/journal.pone.0134396	http://dx.doi.org/10.1371/journal.pone.0134396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225426	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700088
J	Calderon-Gierszal, EL; Prins, GS				Calderon-Gierszal, Esther L.; Prins, Gail S.			Directed Differentiation of Human Embryonic Stem Cells into Prostate Organoids In Vitro and its Perturbation by Low-Dose Bisphenol A Exposure	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; HOMEOBOX GENE; ESTROGENS; CANCER; GLAND; CARCINOGENESIS; DISEASE; URINARY; TISSUE	Studies using rodent and adult human prostate stem-progenitor cell models suggest that developmental exposure to the endocrine disruptor Bisphenol-A (BPA) can predispose to prostate carcinogenesis with aging. Unknown at present is whether the embryonic human prostate is equally susceptible to BPA during its natural developmental window. To address this unmet need, we herein report the construction of a pioneer in vitro human prostate developmental model to study the effects of BPA. The directed differentiation of human embryonic stem cells (hESC) into prostatic organoids in a spatial system was accomplished with precise temporal control of growth factors and steroids. Activin-induced definitive endoderm was driven to prostate specification by combined exposure to WNT10B and FGF10. Matrigel culture for 20-30 days in medium containing R-Spondin-1, Noggin, EGF, retinoic acid and testosterone was sufficient for mature prostate organoid development. Immunofluorescence and gene expression analysis confirmed that organoids exhibited cytodifferentiation and functional properties of the human prostate. Exposure to 1 nM or 10 nM BPA throughout differentiation culture disturbed early morphogenesis in a dose-dependent manner with 1 nM BPA increasing and 10 nM BPA reducing the number of branched structures formed. While differentiation of branched structures to mature organoids seemed largely unaffected by BPA exposure, the stem-like cell population increased, appearing as focal stem cell nests that have not properly entered lineage commitment rather than the rare isolated stem cells found in normally differentiated structures. These findings provide the first direct evidence that low-dose BPA exposure targets hESC and perturbs morphogenesis as the embryonic cells differentiate towards human prostate organoids, suggesting that the developing human prostate may be susceptible to disruption by in utero BPA exposures.	[Prins, Gail S.] Univ Illinois, Dept Urol, Coll Med, Chicago, IL 60607 USA; Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prins, GS (corresponding author), Univ Illinois, Dept Urol, Coll Med, Chicago, IL 60607 USA.	gprins@uic.edu			National Institutes of Health [R01-ES015584, RC2-ES018758, ES022071]; Michael Reese Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA172220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022071, RC2ES018758, R01ES015584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Reese Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01-ES015584, RC2-ES018758 and ES022071, and the Michael Reese Research and Education Foundation to GSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik I, 2005, CANCER RES, V65, P358; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Biemann R, 2014, OBESITY FACTS, V7, P48, DOI 10.1159/000358913; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Callan AC, 2013, INT J HYG ENVIR HEAL, V216, P641, DOI 10.1016/j.ijheh.2012.10.002; Chen M, 2009, ENDOCRINOLOGY, V150, P251, DOI 10.1210/en.2008-0044; COLBORN T, 1995, ENVIRON HEALTH PERSP, V103, P135, DOI 10.2307/3432522; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Edlow AG, 2012, REPROD TOXICOL, V34, P1, DOI 10.1016/j.reprotox.2012.03.009; Fenichel P, 2012, HUM REPROD, V27, P983, DOI 10.1093/humrep/der451; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Ho SM, 2015, EXPOSURE OF HUMAN PR; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Keil KP, 2012, DIFFERENTIATION, V84, P232, DOI 10.1016/j.diff.2012.07.005; Kim HG, 1999, HISTOL HISTOPATHOL, V14, P1175, DOI 10.14670/HH-14.1175; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kuruto-Niwa R, 2007, CHEMOSPHERE, V66, P1160, DOI 10.1016/j.chemosphere.2006.06.073; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Margel D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000311; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; McPherson SJ, 2001, ENDOCRINOLOGY, V142, P2458, DOI 10.1210/en.142.6.2458; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; Moad M, 2013, EUR UROL, V64, P753, DOI 10.1016/j.eururo.2013.03.054; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nahar MS, 2013, J BIOCHEM MOL TOXIC, V27, P116, DOI 10.1002/jbt.21459; Okada M, 2008, BIOMED RES-TOKYO, V29, P163, DOI 10.2220/biomedres.29.163; Ouji Y, 2013, BIOCHEM BIOPH RES CO, V438, P493, DOI 10.1016/j.bbrc.2013.07.108; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins GS, 2006, ANN NY ACAD SCI, V1089, P1, DOI 10.1196/annals.1386.009; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; Prins GS, 2014, ENDOCRINOLOGY; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sajiki J, 2003, CHEMOSPHERE, V51, P55, DOI 10.1016/S0045-6535(02)00789-0; Santos FCA, 2006, BIOL REPROD, V75, P370, DOI 10.1095/biolreprod.106.051789; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tang WY, 2012, ENDOCRINOLOGY, V153, P42, DOI 10.1210/en.2011-1308; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-25; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vrooman LA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004949; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109; Watson CS, 2007, MOL CELL ENDOCRINOL, V274, P1, DOI 10.1016/j.mce.2007.05.011; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Yang LQ, 2013, TOXICOL LETT, V218, P187, DOI 10.1016/j.toxlet.2013.01.026; Zaviacic M, 2000, HISTOL HISTOPATHOL, V15, P131, DOI 10.14670/HH-15.131; Zhao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064503	68	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133238	10.1371/journal.pone.0133238	http://dx.doi.org/10.1371/journal.pone.0133238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222054	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800043
J	Mizunoya, W; Miyahara, H; Okamoto, S; Akahoshi, M; Suzuki, T; Do, MKQ; Ohtsubo, H; Komiya, Y; Lan, M; Waga, T; Iwata, A; Nakazato, K; Ikeuchi, Y; Anderson, JE; Tatsumi, R				Mizunoya, Wataru; Miyahara, Hideo; Okamoto, Shinpei; Akahoshi, Mariko; Suzuki, Takahiro; Do, Mai-Khoi Q.; Ohtsubo, Hideaki; Komiya, Yusuke; Lan, Mu; Waga, Toshiaki; Iwata, Akira; Nakazato, Koichi; Ikeuchi, Yoshihide; Anderson, Judy E.; Tatsumi, Ryuichi			Improvement of Endurance Based on Muscle Fiber-Type Composition by Treatment with Dietary Apple Polyphenols in Rats	PLOS ONE			English	Article							CHEMOREPELLENT SEMAPHORIN 3A; ACTIVATED RECEPTOR-DELTA; HEAVY-CHAIN ISOFORMS; SKELETAL-MUSCLE; SATELLITE CELLS; SLOW MUSCLES; WISTAR RATS; EXPRESSION; MICE; DIFFERENTIATION	A recent study demonstrated a positive effect of apple polyphenol (APP) intake on muscle endurance of young-adult animals. While an enhancement of lipid metabolism may be responsible, in part, for the improvement, the contributing mechanisms still need clarification. Here we show that an 8-week intake of 5% (w/w) APP in the diet, up-regulates two features related to fiber type: the ratio of myosin heavy chain (MyHC) type IIx/IIb and myoglobin protein expression in plantaris muscle of 9-week-old male Fischer F344 rats compared to pair-fed controls (P < 0.05). Results were demonstrated by our SDS-PAGE system specialized for MyHC isoform separation and western blotting of whole muscles. Animal-growth profiles (food intake, body-weight gain, and internal-organ weights) did not differ between the control and 5% APP-fed animals (n = 9/group). Findings may account for the increase in fatigue resistance of lower hind limb muscles, as evidenced by a slower decline in the maximum isometric planter-flexion torque generated by a 100-s train of electrical stimulation of the tibial nerve. Additionally, the fatigue resistance was lower after 8 weeks of a 0.5% APP diet than after 5% APP, supporting an APP-dose dependency of the shift in fiber-type composition. Therefore, the present study highlights a promising contribution of dietary APP intake to increasing endurance based on fiber-type composition in rat muscle. Results may help in developing a novel strategy for application in animal sciences, and human sports and age-related health sciences.	[Mizunoya, Wataru; Miyahara, Hideo; Okamoto, Shinpei; Akahoshi, Mariko; Suzuki, Takahiro; Do, Mai-Khoi Q.; Ohtsubo, Hideaki; Komiya, Yusuke; Lan, Mu; Ikeuchi, Yoshihide; Tatsumi, Ryuichi] Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Hakozaki, Fukuoka, Japan; [Waga, Toshiaki] Asahi Brewery Co Ltd, Fundamental Res Lab, Moriya, Ibaraki, Japan; [Iwata, Akira] Osaka Prefecture Univ, Fac Comprehens Rehabil, Dept Phys Therapy, Habikino, Osaka, Japan; [Nakazato, Koichi] Nippon Sport Sci Univ, Grad Sch Hlth & Sport Sci, Dept Exercise Physiol, Fukasawa, Tokyo, Japan; [Anderson, Judy E.] Univ Manitoba, Fac Sci, Dept Biol Sci, Winnipeg, MB, Canada	Kyushu University; Asahi Group Holdings Ltd.; Osaka Metropolitan University; Nippon Sport Science University; University of Manitoba	Tatsumi, R (corresponding author), Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Hakozaki, Fukuoka, Japan.	rtatsumi@agr.kyushu-u.ac.jp	Mizunoya, Wataru/W-1674-2019	Mizunoya, Wataru/0000-0002-2258-1964; Komiya, Yusuke/0000-0003-3225-2491; Iwata, Akira/0000-0002-5002-2553	Japan Society for the Promotion of Science (JSPS) [20658067, 23658242, 19380152, 22380145, 25292164, 24248045]; JSPS [26712023, 22580136]; Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; Asahi Breweries, Ltd.; Grants-in-Aid for Scientific Research [26450390] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Asahi Breweries, Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Challenging Exploratory Research 20658067, 23658242, Scientific Research (B) 19380152, 22380145, 25292164 and Scientific Research (A) 24248045 from the Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/j-grantsinaid/index.html; http://www.jsps.go.jp/j-inv/index.html) (all to RT) and by Grants-in-Aid for Young Scientists (A) 26712023 and Scientific Research (C) 22580136 from JSPS (http://www.jsps.go.jp/j-grantsinaid/index. html; http://www.jsps.go.jp/j-inv/index.html) (to WM). The research was also supported by funds from a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) (to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Asahi Breweries, Ltd. provided support in the form of a salary for author TW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abe T, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/907565; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bhat KPL, 2001, ANTIOXID REDOX SIGN, V3, P1041, DOI 10.1089/152308601317203567; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P399, DOI 10.1113/jphysiol.1960.sp006394; Buller AJ, 1958, J PHYSL, V143, P23, DOI [10.1113/jphysiol.1958.sp1958143suppltoc, DOI 10.1113/JPHYSI0L.1958.SP1958143SUPPLT0C]; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Do MKQ, 2012, ANIM SCI J, V83, P712, DOI 10.1111/j.1740-0929.2012.01057.x; Do MKQ, 2011, AM J PHYSIOL-CELL PH, V301, pC1270, DOI 10.1152/ajpcell.00257.2011; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Iwata A, 2010, MUSCLE NERVE, V41, P694, DOI 10.1002/mus.21567; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Kanda T, 1998, BIOSCI BIOTECH BIOCH, V62, P1284, DOI 10.1271/bbb.62.1284; Kang YK, 2011, MEAT SCI, V89, P384, DOI 10.1016/j.meatsci.2011.04.019; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Khan M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-177; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085636; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mukai R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045048; Mukai R, 2010, J NAT PROD, V73, P1708, DOI 10.1021/np100240y; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nakazato K, 2007, MED SCI SPORT EXER, V39, P934, DOI 10.1249/mss.0b013e31803df4bc; Nakazato K, 2006, EXP ANIM TOKYO, V55, P383, DOI 10.1538/expanim.55.383; Nakazato K, 2010, MOL NUTR FOOD RES, V54, P364, DOI 10.1002/mnfr.200900145; Sakaguchi S, 2014, INT J BIOCHEM CELL B, V54, P272, DOI 10.1016/j.biocel.2014.05.032; SALMONS S, 1969, J PHYSIOL-LONDON, V201, P535, DOI 10.1113/jphysiol.1969.sp008771; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sato Y, 2013, ANIM SCI J, V84, P185, DOI 10.1111/asj.12014; Sawano S, 2014, ANIM SCI J, V85, P994, DOI 10.1111/asj.12264; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; Shono Jun-ichi, 2013, Anim Sci J, V84, P744, DOI 10.1111/asj.12105; STRETER FA, 1973, NATURE-NEW BIOL, V241, P17, DOI 10.1038/newbio241017a0; Suzuki T, 2013, EMBO WORKSHOP ON SEM; Suzuki T, 2014, FASEB SCIENCE RESEAR; Suzuki T, 2013, INT J BIOCHEM CELL B, V45, P476, DOI 10.1016/j.biocel.2012.10.003; Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V297, pC238, DOI 10.1152/ajpcell.00161.2009; Wang YX, 2005, PLOS BIOL, V3, P177, DOI 10.1371/journal.pbio.0030061	46	23	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134303	10.1371/journal.pone.0134303	http://dx.doi.org/10.1371/journal.pone.0134303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222548	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800127
J	Rompikuntal, PK; Vdovikova, S; Duperthuy, M; Johnson, TL; Ahlund, M; Lundmark, R; Oscarsson, J; Sandkvist, M; Uhlin, BE; Wai, SN				Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Johnson, Tanya L.; Ahlund, Monika; Lundmark, Richard; Oscarsson, Jan; Sandkvist, Maria; Uhlin, Bernt Eric; Wai, Sun Nyunt			Outer Membrane Vesicle-Mediated Export of Processed PrtV Protease from Vibrio cholerae	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; POLYCYSTIC KIDNEY-DISEASE; SP STRAIN O-7; ESCHERICHIA-COLI; II SECRETION; METALLOPROTEASE PRTV; VIRULENCE FACTORS; MARINE BACTERIUM; SUICIDE VECTOR; CLYA CYTOTOXIN	Background Outer membrane vesicles (OMVs) are known to release from almost all Gram-negative bacteria during normal growth. OMVs carry different biologically active toxins and enzymes into the surrounding environment. We suggest that OMVs may therefore be able to transport bacterial proteases into the target host cells. We present here an analysis of the Vibrio cholerae OMV-associated protease PrtV. Methodology/Principal Findings In this study, we demonstrated that PrtV was secreted from the wild type V. cholerae strain C6706 via the type II secretion system in association with OMVs. By immunoblotting and electron microscopic analysis using immunogold labeling, the association of PrtV with OMVs was examined. We demonstrated that OMV-associated PrtV was biologically active by showing altered morphology and detachment of cells when the human ileocecum carcinoma (HCT8) cells were treated with OMVs from the wild type V. cholerae strain C6706 whereas cells treated with OMVs from the prtV isogenic mutant showed no morphological changes. Furthermore, OMV-associated PrtV protease showed a contribution to bacterial resistance towards the antimicrobial peptide LL-37. Conclusion/Significance Our findings suggest that OMVs released from V. cholerae can deliver a processed, biologically active form of PrtV that contributes to bacterial interactions with target host cells.	[Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Uhlin, Bernt Eric; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Lundmark, Richard; Uhlin, Bernt Eric; Wai, Sun Nyunt] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Johnson, Tanya L.; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Ahlund, Monika; Lundmark, Richard] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Oscarsson, Jan] Umea Univ, Dept Odontol, Oral Microbiol, S-90187 Umea, Sweden	Umea University; Umea University; University of Michigan System; University of Michigan; Umea University; Umea University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	sun.nyunt.wai@umu.se	Duperthuy, Marylise/AFO-2793-2022; Uhlin, Bernt Eric/AAO-6292-2021	Duperthuy, Marylise/0000-0002-9226-9343; Uhlin, Bernt Eric/0000-0002-2991-8072; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council [2014-4401, 2013-2392, 2010-3031, 2012-4638, 353-2010-7074, 349-2007-8673]; Umea University; NIH [R01AI49294]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049294] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SNW was supported by the Swedish Research Council project grants 2014-4401 (VR-NT) and 2013-2392 (VR-MH). BEU was supported by the Swedish Research Council project grants 2010-3031 (VR-MH) and 2012-4638 (VR-NT). The Laboratory for Molecular Infection Medicine Sweden (MIMS) is supported by Umea University and the Swedish Research Council (353-2010-7074). This work was performed as part of the Umea Centre for Microbial Research (UCMR) Linnaeus Program supported by Umea University and the Swedish Research Council (349-2007-8673). Funding website: URL: http://www.vr.se. MS was supported by NIH (R01AI49294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Bielig H, 2011, GUT MICROBES, V2, P274, DOI 10.4161/gmic.2.5.18091; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chatterjee S, 1998, J BACTERIOL, V180, P901, DOI 10.1128/JB.180.4.901-908.1998; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Edwin A, 2013, FEBS OPEN BIO, V3, P263, DOI 10.1016/j.fob.2013.06.003; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elluri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106731; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jochumsen N, 2011, MICROBIOL-SGM, V157, P2647, DOI 10.1099/mic.0.049445-0; Johansson J, 2000, CELL, V102, P475, DOI 10.1016/S0092-8674(00)00052-0; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Kaparakis-Liaskos M., 2015, NAT REV IMMUNOL; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kateb B, 2010, METHODS MOL BIOL, V651, P307, DOI 10.1007/978-1-60761-786-0_18; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lehner T, 2000, EUR J IMMUNOL, V30, P2245, DOI 10.1002/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7; Levin BR, 1996, CURR BIOL, V6, P1389, DOI 10.1016/S0960-9822(96)00738-5; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Medina A, 2010, WOUND REPAIR REGEN, V18, P245, DOI 10.1111/j.1524-475X.2010.00580.x; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyamoto K, 2002, BIOSCI BIOTECH BIOCH, V66, P416, DOI 10.1271/bbb.66.416; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nordin JZ, 2015, NANOMEDICINE; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Premjani V, 2014, FEMS MICROBIOL LETT, V355, P185, DOI 10.1111/1574-6968.12463; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Sorensen Ole E., 2008, V15, P61, DOI 10.1159/000136315; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uhlin B.E., 2014, PATHOGENIC ESCHERICH, P161; Vaitkevicius K, 2008, FEBS J, V275, P3167, DOI 10.1111/j.1742-4658.2008.06470.x; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Vanhove AS, 2015, ENVIRON MICROBIOL, V17, P1152, DOI 10.1111/1462-2920.12535; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	65	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134098	10.1371/journal.pone.0134098	http://dx.doi.org/10.1371/journal.pone.0134098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222047	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800103
J	Saw, LE; Lim, FKS; Carrasco, LR				Saw, Le E.; Lim, Felix K. S.; Carrasco, Luis R.			The Relationship between Natural Park Usage and Happiness Does Not Hold in a Tropical City-State	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GREEN SPACE; LIFE EVENTS; URBAN HEAT; HEALTH; ENVIRONMENTS; STRESS; PREFERENCE; ASSOCIATIONS; SATISFACTION	Previous studies have shown that contact with urban green spaces can produce positive effects on people's stress, health and well-being levels. However, much of this research has been conducted in the temperate regions of Europe or North America. Additionally, most studies have only compared the effects of urban and natural areas on health and wellbeing, but not made a finer distinction between different types of urban green spaces. We tested the relationship between well-being and the access or use of different types of green spaces among young adults in Singapore, a tropical city-state. The results showed that extraversion and emotional stability increased subjective well-being, positive affect and life satisfaction and decreased stress and negative affect. In addition, we found that level of physical activity increased positive affect and health problems increased negative affect. Neither access to green spaces nor the use of green spaces in Singapore significantly affected the well-being metrics considered, contradicting findings in the temperate regions of the world. We hypothesize that the differences in temperature and humidity and the higher greenery and biodiversity levels outside parks in Singapore could explain this phenomenon. Our results thus question the universality of the relationship between well-being and park usage and highlight the need for more research into the multifaceted effects of green spaces on well-being in the tropics.	[Saw, Le E.; Lim, Felix K. S.; Carrasco, Luis R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsctlr@nus.edu.sg	Carrasco, Luis R/H-8017-2012	Carrasco, Luis R/0000-0002-2894-1473; Lim, Felix/0000-0003-1227-460X	Tier 2 grant from the Ministry of Education of Singapore [WBS R154000574112]	Tier 2 grant from the Ministry of Education of Singapore(Ministry of Education, Singapore)	LRC and FKSL received funding from: Tier 2 grant from the Ministry of Education of Singapore, WBS R154000574112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews F. M., 1976, SOCIAL INDICATORS OF; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Barton K, 2015, MUMIN; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BOP Consulting, 2014, WORLD CITIES CULTURE; Burnham K. P., 2002, MODEL SELECTION AND; Carballeira M, 2014, PSYECOLOGY, V1, P371; CLARK LA, 1988, J PERS SOC PSYCHOL, V54, P296, DOI 10.1037/0022-3514.54.2.296; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Cummins RA, 2003, SOC INDIC RES, V64, P225, DOI 10.1023/A:1024712527648; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fan YL, 2011, HEALTH PLACE, V17, P1202, DOI 10.1016/j.healthplace.2011.08.008; Faris REL, 1939, MENTAL DISORDERS IN; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gerdtham U.-G., 2001, J SOC EC, V30, P553, DOI [10.1016/S1053-5357(01)00118-4, DOI 10.1016/S1053-5357(01)00118-4]; Giles-Corti B, 2003, AM J PUBLIC HEALTH, V93, P1583, DOI 10.2105/AJPH.93.9.1583; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grahn Patrik, 2003, Urban Forestry & Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019; Grahn P, 2010, LANDSCAPE URBAN PLAN, V94, P264, DOI 10.1016/j.landurbplan.2009.10.012; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Hall P, 2000, URBAN FUTURE 21 A GL; Hamer M, 2009, BRIT J SPORT MED, V43, P1111, DOI 10.1136/bjsm.2008.046243; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Haslam N, 2009, PERS INDIV DIFFER, V46, P40, DOI 10.1016/j.paid.2008.09.001; HOLM S, 1979, SCAND J STAT, V6, P65; Hong Kong Bird Watching Society, 2015, LIST OF HK BIRDS 201; Kaplan R, 1989, THE EXPERIENCE OF NA; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; KAPLAN S, 1972, PERCEPT PSYCHOPHYS, V12, P354, DOI 10.3758/BF03207221; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Lafortezza R, 2009, URBAN FOR URBAN GREE, V8, P97, DOI 10.1016/j.ufug.2009.02.003; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McKenzie K, 2013, J AFFECT DISORDERS, V150, P1019, DOI 10.1016/j.jad.2013.05.032; Mitchell R, 2013, SOC SCI MED, V91, P130, DOI 10.1016/j.socscimed.2012.04.012; MOORE EO, 1981, J ENVIRON SYST, V11, P17, DOI 10.2190/KM50-WH2K-K2D1-DM69; National Parks Board, 2015, WILDLIFE IN SINGAPOR; National Parks Board, 2010, 4TH NATIONAL REPORT; Nordh H, 2009, URBAN FOR URBAN GREE, V8, P225, DOI 10.1016/j.ufug.2009.06.003; Oliveira S, 2011, BUILD ENVIRON, V46, P2186, DOI 10.1016/j.buildenv.2011.04.034; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Rasciute S, 2010, KYKLOS, V63, P256, DOI 10.1111/j.1467-6435.2010.00472.x; Romans S, 2011, SOC PSYCH PSYCH EPID, V46, P567, DOI 10.1007/s00127-010-0222-2; The New York State Ornithological Association Inc, 2014, CHECKLIST OF THE BIR; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; TOTALS BL, 2015, CHANGES, V157, P186; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; ULRICH R S, 1992, P93; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; UN/DESA, 2014, WORLD URB PROSP 2014; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Watson D, 1997, EXTRAVERSION AND ITS; West MJ, 1986, LANDSCAPE VIEWS AND; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; White R, 1998, ENVIRONMENT AND MENTAL HEALTH, P175; Wilson E.O., 1984, P1; Wilson Edward O., 2007, pXIII; Wong KoonKwai, 2009, Managing Leisure, V14, P125, DOI 10.1080/13606710902752653; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008	71	42	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133781	10.1371/journal.pone.0133781	http://dx.doi.org/10.1371/journal.pone.0133781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222280	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800065
J	Schwen, LO; Schenk, A; Kreutz, C; Timmer, J; Rodriguez, MMB; Kuepfer, L; Preusser, T				Schwen, Lars Ole; Schenk, Arne; Kreutz, Clemens; Timmer, Jens; Rodriguez, Maria Matilde Bartolome; Kuepfer, Lars; Preusser, Tobias			Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations	PLOS ONE			English	Article							PULSATILE INSULIN-SECRETION; LOCALIZED ADJOINT METHODS; IN-VIVO EXTRAPOLATION; DRUG-METABOLIZING-ENZYMES; ARTERIAL BUFFER RESPONSE; PERFUSED-RAT-LIVER; BLOOD-FLOW; NONALCOHOLIC STEATOHEPATITIS; CYTOCHROME-P450 EXPRESSION; 1ST-PASS ELIMINATION	The mammalian liver plays a key role for metabolism and detoxification of xenobiotics in the body. The corresponding biochemical processes are typically subject to spatial variations at different length scales. Zonal enzyme expression along sinusoids leads to zonated metabolization already in the healthy state. Pathological states of the liver may involve liver cells affected in a zonated manner or heterogeneously across the whole organ. This spatial heterogeneity, however, cannot be described by most computational models which usually consider the liver as a homogeneous, well-stirred organ. The goal of this article is to present a methodology to extend whole-body pharmacokinetics models by a detailed liver model, combining different modeling approaches from the literature. This approach results in an integrated four-scale model, from single cells via sinusoids and the organ to the whole organism, capable of mechanistically representing metabolization inhomogeneity in livers at different spatial scales. Moreover, the model shows circulatory mixing effects due to a delayed recirculation through the surrounding organism. To show that this approach is generally applicable for different physiological processes, we show three applications as proofs of concept, covering a range of species, compounds, and diseased states: clearance of midazolam in steatotic human livers, clearance of caffeine in mouse livers regenerating from necrosis, and a parameter study on the impact of different cell entities on insulin uptake in mouse livers. The examples illustrate how variations only discernible at the local scale influence substance distribution in the plasma at the whole-body level. In particular, our results show that simultaneously considering variations at all relevant spatial scales may be necessary to understand their impact on observations at the organism scale.	[Schwen, Lars Ole; Preusser, Tobias] Fraunhofer MEVIS, Bremen, Germany; [Schenk, Arne; Kuepfer, Lars] Bayer Technol Serv, Computat Syst Biol, Leverkusen, Germany; [Schenk, Arne] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Kreutz, Clemens; Timmer, Jens] Univ Freiburg, Inst Phys, Freiburg Ctr Data Anal & Modeling FDM, D-79106 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Rodriguez, Maria Matilde Bartolome] Univ Freiburg, Med Ctr, Clin Internal Med Mol Biol 2, D-79106 Freiburg, Germany; [Kuepfer, Lars] Rhein Westfal TH Aachen, Inst Appl Microbiol, Aachen, Germany; [Preusser, Tobias] Jacobs Univ Bremen, D-28759 Bremen, Germany	Bayer AG; RWTH Aachen University; University of Freiburg; University of Freiburg; University of Freiburg; RWTH Aachen University; Jacobs University	Schwen, LO (corresponding author), Fraunhofer MEVIS, Bremen, Germany.	ole.schwen@mevis.fraunhofer.de	Schwen, Lars Ole/AAI-8048-2020; Kuepfer, Lars/F-5795-2012; Kreutz, Clemens/ABC-9732-2020; Kuepfer, Lars/AAD-5884-2022	Schwen, Lars Ole/0000-0003-0195-9603; Kreutz, Clemens/0000-0002-8796-5766; Kuepfer, Lars/0000-0002-8741-7786	German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver [0315769, 0315747, 0315766]; Bayer Technology Services	German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver(Federal Ministry of Education & Research (BMBF)); Bayer Technology Services	This work was supported by the German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver (http://www.virtual-liver.de/), grant numbers 0315769 (LOS, TP), 0315747 (AS, LK), and 0315766 (CK, JT, MMBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer Technology Services provided support in the form of salaries for authors AS and LK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abu-Zahra TN, 2000, DRUG METAB DISPOS, V28, P807; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Anissimov YG, 2002, J PHARMACOKINET PHAR, V29, P131, DOI 10.1023/A:1019703607647; [Anonymous], 2010, TRANSPORT PHENOMENA; [Anonymous], 2011, THESIS; ATKINSON AJ, 1979, ANNU REV PHARMACOL, V19, P105, DOI 10.1146/annurev.pa.19.040179.000541; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; BASS L, 1978, J THEOR BIOL, V72, P161, DOI 10.1016/0022-5193(78)90023-1; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bessems M, 2006, LAB ANIM-UK, V40, P236, DOI 10.1258/002367706777611460; Binning P, 2002, ADV WATER RESOUR, V25, P147, DOI 10.1016/S0309-1708(01)00051-3; Bjorkman S, 2005, BRIT J CLIN PHARMACO, V59, P691, DOI 10.1111/j.1365-2125.2004.02225.x; Bois FY, 2010, TOXICOLOGY, V278, P256, DOI 10.1016/j.tox.2010.06.007; BORNER W, 1964, ARCH KREISLAUFFORSCH, V43, P221, DOI 10.1007/BF02120035; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Brill MJE, 2014, CLIN PHARMACOKINET, V53, P931, DOI 10.1007/s40262-014-0166-x; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Buters JTM, 1996, PHARMACOGENETICS, V6, P291, DOI 10.1097/00008571-199608000-00002; Cabrera M., 2012, INTRAVITAL, V1, P107, DOI DOI 10.4161/INTV.23423; Capitan V, 2012, EUR RADIOL, V22, P2161, DOI 10.1007/s00330-012-2468-4; CELIA MA, 1990, ADV WATER RESOUR, V13, P187, DOI 10.1016/0309-1708(90)90041-2; Chow ECY, 2013, CURR DRUG METAB, V14, P57; Cohen S. D., 1996, Computers in Physics, V10, P138; Couinaud C., 1957, LE FOIE ETUDES ANATO; Debbaut C, 2014, COMPUT METHOD BIOMEC, V17, P1295, DOI 10.1080/10255842.2012.744399; Drasdo D, 2014, ARCH TOXICOL, V88, P2071, DOI 10.1007/s00204-014-1384-6; Eipel C, 2010, WORLD J GASTROENTERO, V16, P6046, DOI 10.3748/wjg.v16.i48.6046; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Ewing RE, 2001, J COMPUT APPL MATH, V128, P423, DOI 10.1016/S0377-0427(00)00522-7; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Fasel JHD, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.120803; FEHLBERG E, 1970, COMPUTING, V6, P61, DOI 10.1007/BF02241732; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; FORKER EL, 1978, AM J PHYSIOL, V235, pE648, DOI 10.1152/ajpendo.1978.235.6.E648; Francque S, 2010, LIVER INT, V30, P365, DOI 10.1111/j.1478-3231.2009.02136.x; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Galassi M, 2013, GNU SCIENTIFIC LIBRA; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P382, DOI [10.1309/EY72F1EN0XCB1KXX, 10.1309/EY72F1EN9XCB1KXX]; GORES GJ, 1986, HEPATOLOGY, V6, P511, DOI 10.1002/hep.1840060331; Gross ES, 1999, J HYDRAUL ENG-ASCE, V125, P32, DOI 10.1061/(ASCE)0733-9429(1999)125:1(32); Gupta SC, 2006, FLUID MECHANICS AND; Hairer E, 1996, SOLVING ORDINARY DIF, V14; HAUSSINGER D, 1985, J HEPATOL, V1, P3, DOI 10.1016/S0168-8278(85)80063-5; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43, DOI 10.1111/j.1365-2125.1983.tb02270.x; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Holzhutter HG, COMMUNICATION; Homeyer A, 2013, COMPUT MED IMAG GRAP, V37, P313, DOI 10.1016/j.compmedimag.2013.05.002; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Ierapetritou MG, 2009, CTS-CLIN TRANSL SCI, V2, P228, DOI 10.1111/j.1752-8062.2009.00092.x; Ijaz S, 2003, MICROCIRCULATION, V10, P447, DOI 10.1038/sj.mn.7800206; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Karcaaltincaba M, 2007, EUR J RADIOL, V61, P33, DOI 10.1016/j.ejrad.2006.11.005; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; KOO A, 1975, Q J EXP PHYSIOL CMS, V60, P261, DOI 10.1113/expphysiol.1975.sp002320; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; KREJCIE TC, 1994, J PHARMACOL EXP THER, V269, P609; Kreutz C, 2011, THESIS; Kuepfer L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.70; Kuntz E, 2008, HEPATOLOGY TEXTBOOK; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; Lautt WW, 2007, HEPATOL RES, V37, P891, DOI 10.1111/j.1872-034X.2007.00148.x; Li P, 2011, DRUG METAB DISPOS, V39, P571, DOI 10.1124/dmd.110.036806; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Lippert J, 2012, CPT-PHARMACOMET SYST, V1, DOI [10.1038/psp.2012.14, 10.1038/psp.2012.22]; Lonardo A, 2005, ALIMENT PHARM THER, V22, P64, DOI 10.1111/j.1365-2036.2005.02600.x; Maharaj AR, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.45; MAHARAJ B, 1986, LANCET, V1, P523; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Matveyenko AV, 2008, AM J PHYSIOL-ENDOC M, V295, pE569, DOI 10.1152/ajpendo.90335.2008; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Meyer M, 2012, DRUG METAB DISPOS, V40, P892, DOI 10.1124/dmd.111.043174; MILLER DL, 1979, GASTROENTEROLOGY, V76, P965; Miners JO, 1996, GEN PHARMACOL-VASC S, V27, P245, DOI 10.1016/0306-3623(95)02014-4; MISBIN RI, 1976, AM J PHYSIOL, V230, P171, DOI 10.1152/ajplegacy.1976.230.1.171; Muller M, 2009, BILDVERARBEITUNG MED, P36, DOI DOI 10.1007/978-3-540-93860-6_8; Neubauer T, 2005, ADV WATER RESOUR, V28, P1292, DOI 10.1016/j.advwatres.2005.04.010; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; Oyama T, 2007, FRONT BIOSCI-LANDMRK, V12, P2299, DOI 10.2741/2232; PALSSON BO, 1984, J THEOR BIOL, V111, P273, DOI 10.1016/S0022-5193(84)80211-8; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; Pang KS, 2007, AAPS J, V9, pE268, DOI 10.1208/aapsj0902030; Pang KS, 2010, J PHARMACOKINET PHAR, V37, P591, DOI 10.1007/s10928-010-9185-x; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; POND SM, 1984, CLIN PHARMACOKINET, V9, P1, DOI 10.2165/00003088-198409010-00001; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Press WH, 1992, NUMERICAL RECIPIES I; Puhl G, 2003, TRANSPLANTATION, V75, P756, DOI 10.1097/01.TP.0000056634.18191.1A; Rani HP, 2006, J BIOMECH, V39, P551, DOI 10.1016/j.jbiomech.2004.11.029; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Ricken T, 2014, BIOMECH MODEL MECHAN, P1; Rostami-Hodjegan A, 2012, CLIN PHARMACOL THER, V92, P50, DOI 10.1038/clpt.2012.65; Rumpf AG, 2011, QUOCMESH SOFTWARE LI; Russell TF, 2002, ADV WATER RESOUR, V25, P1215, DOI 10.1016/S0309-1708(02)00104-5; SAVILLE BA, 1992, DRUG METAB REV, V24, P49, DOI 10.3109/03602539208996290; Schaller S, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.40; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schreiner W., 2001, COMMENTS THEOR BIOL, P103; Schwen LO, 2015, J THEOR BIOL, V365, P289, DOI 10.1016/j.jtbi.2014.10.026; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Schwen LO, 2015, ZONATED QUANTIFICATI; Schwen LO, 2014, PRESENTATION AT VPH; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Selle D, 2002, IEEE T MED IMAGING, V21, P1344, DOI 10.1109/TMI.2002.801166; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shestopaloff YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099836; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; TANAKA E, 1994, PHARMACOL TOXICOL, V75, P150, DOI 10.1111/j.1600-0773.1994.tb00338.x; Tanaka T, 2003, J VASC INTERV RADIOL, V14, P63, DOI 10.1097/01.RVI.0000052292.26939.59; Teutsch HF, 1999, HEPATOLOGY, V29, P494, DOI 10.1002/hep.510290243; Thiel C, 2015, J PHARM SCI-US, V104, P191, DOI 10.1002/jps.24214; Thummel KE, 1996, CLIN PHARMACOL THER, V59, P491, DOI 10.1016/S0009-9236(96)90177-0; Upton RN, 2004, BRIT J ANAESTH, V92, P475, DOI 10.1093/bja/aeh089; Vag JE, 1996, ADV WATER RESOUR, V19, P297, DOI 10.1016/0309-1708(96)00006-1; VAUPEL P, 1989, CANCER RES, V49, P6449; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; WANG H, 1995, IMA J NUMER ANAL, V15, P405, DOI 10.1093/imanum/15.3.405; Wang H, 1998, NUMER METH PART D E, V14, P739, DOI 10.1002/(SICI)1098-2426(199811)14:6<739::AID-NUM3>3.0.CO;2-R; Wang H, 1999, J COMPUT PHYS, V152, P120, DOI 10.1006/jcph.1999.6239; Wang H, 2001, SIAM J NUMER ANAL, V38, P1846, DOI 10.1137/S0036142999362389; Webborn PJH, 2007, XENOBIOTICA, V37, P1090, DOI 10.3109/00498250701557266; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Weiss M, 2011, EUR J PHARM SCI, V44, P359, DOI 10.1016/j.ejps.2011.08.018; WILKINSON GR, 1987, PHARMACOL REV, V39, P1; Willmann Stefan, 2003, Biosilico, V1, P121, DOI 10.1016/S1478-5382(03)02342-4; Willmann S, 2012, J PHARM PHARMACOL, V64, P997, DOI 10.1111/j.2042-7158.2012.01534.x; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115; Yoon YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068600; Younes A, 2008, COMMUN NUMER METH EN, V24, P897, DOI 10.1002/cnm.996	148	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133653	10.1371/journal.pone.0133653	http://dx.doi.org/10.1371/journal.pone.0133653			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222615	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800058
J	Vogelaar, CF; Konig, B; Krafft, S; Estrada, V; Brazda, N; Ziegler, B; Faissner, A; Muller, HW				Vogelaar, Christina Francisca; Koenig, Brigitte; Krafft, Stefanie; Estrada, Veronica; Brazda, Nicole; Ziegler, Brigida; Faissner, Andreas; Mueller, Hans Werner			Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In Vivo	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; CENTRAL-NERVOUS-SYSTEM; AXON GROWTH; GLIAL SCAR; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; NEURITE OUTGROWTH; IRON CHELATORS; UP-REGULATION	Lesion-induced scarring is a major impediment for regeneration of injured axons in the central nervous system (CNS). The collagen-rich glial-fibrous scar contains numerous axon growth inhibitory factors forming a regeneration-barrier for axons. We demonstrated previously that the combination of the iron chelator 2,2'-bipyridine-5,5'-decarboxylic acid (BPYDCA) and 8-Br-cyclic AMP (cAMP) inhibits scar formation and collagen deposition, leading to enhanced axon regeneration and partial functional recovery after spinal cord injury. While BPY-DCA is not a clinical drug, the clinically approved iron chelator deferoxamine mesylate (DFO) may be a suitable alternative for anti-scarring treatment (AST). In order to prove the scar-suppressing efficacy of DFO we modified a recently published in vitro model for CNS scarring. The model comprises a co-culture system of cerebral astrocytes and meningeal fibroblasts, which form scar-like clusters when stimulated with transforming growth factor-beta (TGF-beta). We studied the mechanisms of TGF-beta-induced CNS scarring and compared the efficiency of different putative pharmacological scar-reducing treatments, including BPY-DCA, DFO and cAMP as well as combinations thereof. We observed modulation of TGF-beta-induced scarring at the level of fibroblast proliferation and contraction as well as specific changes in the expression of extracellular matrix molecules and axon growth inhibitory proteins. The individual and combinatorial pharmacological treatments had distinct effects on the cellular and molecular aspects of in vitro scarring. DFO could be identified as a putative anti-scarring treatment for CNS trauma. We subsequently validated this by local application of DFO to a dorsal hemisection in the rat thoracic spinal cord. DFO treatment led to significant reduction of scarring, slightly increased regeneration of corticospinal tract as well as ascending CGRP-positive axons and moderately improved locomotion. We conclude that the in vitro model for CNS scarring is suitable for efficient pre-screening and identification of putative scar-suppressing agents prior to in vivo application and validation, thus saving costs, time and laboratory animals.	[Vogelaar, Christina Francisca; Koenig, Brigitte; Krafft, Stefanie; Estrada, Veronica; Brazda, Nicole; Ziegler, Brigida; Mueller, Hans Werner] Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, Dusseldorf, Germany; [Vogelaar, Christina Francisca] Johannes Gutenberg Univ Mainz, Inst Microanat & Neurobiol, D-55122 Mainz, Germany; [Faissner, Andreas] Ruhr Univ Bochum, Inst Cellular Morphol & Mol Neurobiol, Bochum, Germany	Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz; Ruhr University Bochum	Vogelaar, CF (corresponding author), Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, Dusseldorf, Germany.	Tineke.vogelaar@unimedizin-mainz.de	Vogelaar, Christina/AAA-8484-2021; Faissner, Andreas/A-5314-2008	Vogelaar, Christina/0000-0002-9683-7336; Faissner, Andreas/0000-0002-2211-8259	Research Committee University of Dusseldorf [Az.:52/08]; Deutsche Forschungsgemeinschaft [SFB 590, TP C2]; European Cooperation in Science and Technology (ECMNET); DFG-Research Training Group 1033	Research Committee University of Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology (ECMNET); DFG-Research Training Group 1033	Research Committee University of Dusseldorf (Az.:52/08): http://www.medizin.hhu.de/dekanat/gremien-und-kommissionen/kommissionen/forschungskommission.html, Deutsche Forschungsgemeinschaft (SFB 590, TP C2) http://www.biologie.hhu.de/forschung-biologie/sfb/sfb-590.html, European Cooperation in Science and Technology (ECMNET) http://www.cost.eu/COST_Actions/bmbs/Actions/BM1001, DFG-Research Training Group 1033 http://www.grk1033.hhu.de/.	Adcock KH, 2004, EUR J NEUROSCI, V20, P1425, DOI 10.1111/j.1460-9568.2004.03573.x; Asher RA, 2000, J NEUROSCI, V20, P2427; AZZI G, 1990, MATRIX, V9, P479, DOI 10.1016/S0934-8832(11)80017-X; Bahr M, 1996, J NEUROBIOL, V30, P281, DOI 10.1002/(SICI)1097-4695(199606)30:2<281::AID-NEU9>3.0.CO;2-1; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beerepoot LV, 1996, CANCER RES, V56, P3747; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deller T, 1997, NEUROSCIENCE, V81, P829, DOI 10.1016/S0306-4522(97)00194-2; Dobbertin A, 2010, EXP NEUROL, V225, P60, DOI 10.1016/j.expneurol.2010.04.019; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FAISSNER A, 1990, J NEUROCHEM, V54, P1004, DOI 10.1111/j.1471-4159.1990.tb02350.x; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grimpe B, 2004, J NEUROSCI, V24, P1393, DOI 10.1523/JNEUROSCI.4986-03.2004; Guth L, 1999, ANN NY ACAD SCI, V890, P366, DOI 10.1111/j.1749-6632.1999.tb08017.x; HALES NJ, 1993, J MED CHEM, V36, P3853, DOI 10.1021/jm00076a014; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Heck N, 2003, GLIA, V41, P382, DOI 10.1002/glia.10184; Heck N, 2007, MOL CELL NEUROSCI, V36, P71, DOI 10.1016/j.mcn.2007.06.002; Howland MA, 1996, J TOXICOL-CLIN TOXIC, V34, P491, DOI 10.3109/15563659609028006; Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; IMAI Y, 1994, ENDOCR J, V41, P645, DOI 10.1507/endocrj.41.645; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; JUNGHANS U, 1995, EUR J NEUROSCI, V7, P2341, DOI 10.1111/j.1460-9568.1995.tb00655.x; Kappler J, 1997, EUR J NEUROSCI, V9, P306, DOI 10.1111/j.1460-9568.1997.tb01401.x; Kicic A, 2001, CANCER, V92, P3093, DOI 10.1002/1097-0142(20011215)92:12<3093::AID-CNCR10107>3.0.CO;2-B; Kimura-Kuroda J, 2010, MOL CELL NEUROSCI, V43, P177, DOI 10.1016/j.mcn.2009.10.008; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kohta M, 2009, NEUROSCI RES, V65, P393, DOI 10.1016/j.neures.2009.08.017; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Koops A, 1996, MOL BRAIN RES, V41, P65, DOI 10.1016/0169-328X(96)00067-8; Kozlov AK, 2014, P NATL ACAD SCI USA, V111, P3591, DOI 10.1073/pnas.1401459111; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lankhorst AJ, 1999, J NEUROTRAUM, V16, P323, DOI 10.1089/neu.1999.16.323; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; McTigue DM, 2000, EXP NEUROL, V163, P220, DOI 10.1006/exnr.2000.7372; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; OBRIEN MF, 1994, SPINE, V19, P2321, DOI 10.1097/00007632-199410150-00012; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Park SM, 2008, CELL PROLIFERAT, V41, P248, DOI 10.1111/j.1365-2184.2008.00514.x; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rathore KI, 2012, GLIA, V60, P738, DOI 10.1002/glia.22303; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Samuni Y, 1999, CANCER RES, V59, P405; Schira J, 2012, BRAIN, V135, P431, DOI 10.1093/brain/awr222; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; SCHMALENBACH C, 1993, J CHEM NEUROANAT, V6, P229, DOI 10.1016/0891-0618(93)90044-5; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; SHELLSWELL GB, 1979, FEBS LETT, V106, P305, DOI 10.1016/0014-5793(79)80520-7; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Takeuchi M, 2012, NEUROREPORT, V23, P712, DOI 10.1097/WNR.0b013e3283567196; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; TSCHANK G, 1987, BIOCHEM J, V248, P625, DOI 10.1042/bj2480625; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Vogelaar CF, 2004, NEUROSCIENCE, V125, P645, DOI 10.1016/j.neuroscience.2004.02.006; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang XH, 2009, J CLIN NEUROSCI, V16, P818, DOI 10.1016/j.jocn.2008.09.014; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721	86	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134371	10.1371/journal.pone.0134371	http://dx.doi.org/10.1371/journal.pone.0134371			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222542	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800137
J	Jiang, L; Tam, BM; Ying, GX; Wu, S; Hauswirth, WW; Frederick, JM; Moritz, OL; Baehr, W				Jiang, Li; Tam, Beatrice M.; Ying, Guoxing; Wu, Sen; Hauswirth, William W.; Frederick, Jeanne M.; Moritz, Orson L.; Baehr, Wolfgang			Kinesin family 17 (osmotic avoidance abnormal-3) is dispensable for photoreceptor morphology and function	FASEB JOURNAL			English	Article						anterograde intraflagellar transport; kinesin-2 truncation mutants; photoreceptor degeneration; rhodopsin trafficking	SENSORY CILIA; MOTOR PROTEIN; CHEMOSENSORY NEURONS; RHODOPSIN TRANSPORT; IFT-PARTICLES; KIF17; CONE; AUTOINHIBITION; ARCHITECTURE; TRAFFICKING	In Caenorhabditis elegans, homodimeric [kinesin family (KIF) 17, osmotic avoidance abnormal-3 (OSM-3)] and heterotrimeric (KIF3) kinesin-2 motors are required to establish sensory cilia by intraflagellar transport (IFT) where KIF3 and KIF17 cooperate to build the axoneme core and KIF17 builds the distal segments. However, the function of KIF17 in vertebrates is unresolved. We expressed full-length and motorless KIF17 constructs in mouse rod photoreceptors using adeno-associated virus in Xenopus laevis rod photoreceptors using a transgene and in ciliated IMCD3 cells. We found that tagged KIF17 localized along the rod outer segment axoneme when expressed in mouse and X. laevis photoreceptors, whereas KIF3A was restricted to the proximal axoneme. Motorless KIF3A and KIF17 mutants caused photoreceptor degeneration, likely through dominant negative effects on IFT. KIF17 mutant lacking the motor domain translocated to nuclei after exposure of a C-terminal nuclear localization signal. Germ-line deletion of Kif17 in mouse did not affect photoreceptor function. A rod-specific Kif3/Kif17 double knockout mouse demonstrated that KIF17 and KIF3 do not act synergistically and did not prevent rhodopsin trafficking to rod outer segments. In summary, the nematode model of KIF3/KIF17 cooperation apparently does not apply to mouse photoreceptors in which the photosensory cilium is built exclusively by KIF3.	[Jiang, Li; Ying, Guoxing; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Tam, Beatrice M.; Moritz, Orson L.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Wu, Sen] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of British Columbia; China Agricultural University; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah	Jiang, L (corresponding author), Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu			U.S. National Institutes of Health [EY08123, EY019298]; National Eye Institute [EY014800-039003]; Canadian Institutes of Health Research [MOP-64400]; Foundation Fighting Blindness (Toronto, ON, Canada); Research to Prevent Blindness (New York, NY, USA); Research to Prevent Blindness; Nelson Trust Award; NATIONAL EYE INSTITUTE [P30EY014800, R01EY008123, R01EY019298] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness (Toronto, ON, Canada); Research to Prevent Blindness (New York, NY, USA)(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Nelson Trust Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health Grants EY08123, EY019298 (to W.B.), EY014800-039003 (National Eye Institute core grant to the Department of Ophthalmology, University of Utah), and Canadian Institutes of Health Research MOP-64400, as well as the Foundation Fighting Blindness (Toronto, ON, Canada) (to O.M.) and unrestricted grants to the Department of Ophthalmology, University of Utah, from Research to Prevent Blindness (New York, NY, USA). W.B. is a recipient of a Research to Prevent Blindness Senior Investigator and a Nelson Trust Award.	Audas TE, 2012, CELL CYCLE, V11, P2059, DOI 10.4161/cc.20140; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Bader JR, 2012, VISION RES, V75, P37, DOI 10.1016/j.visres.2012.10.009; Besharse JC., 1990, CILIARY FLAGELLAR ME, P389; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Deretic D, 2012, VISION RES, V75, P5, DOI 10.1016/j.visres.2012.07.015; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Imanishi M, 2006, J CELL BIOL, V174, P931, DOI 10.1083/jcb.200605179; Inglis P. N., 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.126.2; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, METHOD CELL BIOL, V93, P219, DOI 10.1016/S0091-679X(08)93012-0; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Karan S, 2011, VISION RES, V51, P2304, DOI 10.1016/j.visres.2011.09.001; Kayadjanian N, 2007, MOL CELL NEUROSCI, V34, P219, DOI 10.1016/j.mcn.2006.11.001; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Malicki J, 2012, VISION RES, V75, P33, DOI 10.1016/j.visres.2012.10.008; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Moritz OL, 2002, TRANSGENIC RES, V11, P315, DOI 10.1023/A:1015612022976; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Ye F, 2013, ELIFE, V2, DOI 10.7554/eLife.00654; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	46	32	32	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4866	4880		10.1096/fj.15-275677	http://dx.doi.org/10.1096/fj.15-275677			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26229057	Green Published			2022-12-26	WOS:000365523600013
J	Funk, MA; Marsh, ENG; Drennan, CL				Funk, Michael A.; Marsh, E. Neil G.; Drennan, Catherine L.			Substrate-bound Structures of Benzylsuccinate Synthase Reveal How Toluene Is Activated in Anaerobic Hydrocarbon Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; THAUERA-AROMATICA; DENITRIFYING BACTERIUM; P-CYMENE; MECHANISM; OXIDATION; ENZYME; FUMARATE; METABOLISM; ALKANES	Various bacteria perform anaerobic degradation of small hydrocarbons as a source of energy and cellular carbon. To activate non-reactive hydrocarbons such as toluene, enzymes conjugate these molecules to fumarate in a radical-catalyzed, C-C bond-forming reaction. We have determined x-ray crystal structures of the glycyl radical enzyme that catalyzes the addition of toluene to fumarate, benzylsuccinate synthase (BSS), in two oligomeric states with fumarate alone or with both substrates. We find that fumarate is secured at the bottom of a long active site cavity with toluene bound directly above it. The two substrates adopt orientations that appear ideal for radical-mediated C-C bond formation; the methyl group of toluene is positioned between fumarate and a cysteine that forms a thiyl radical during catalysis, which is in turn adjacent to the glycine that serves as a radical storage residue. Toluene is held in place by fumarate on one face and tight packing by hydrophobic residues on the other face and sides. These hydrophobic residues appear to become ordered, thus encapsulating toluene, only in the presence of BSS beta, a small protein subunit that forms a tight complex with BSS beta, the catalytic subunit. Enzymes related to BSS are able to metabolize a wide range of hydrocarbons through attachment to fumarate. Using our structures as a guide, we have constructed homology models of several of these "X-succinate synthases" and determined conservation patterns that will be useful in understanding the basis for catalysis and specificity in this family of enzymes.	[Funk, Michael A.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Chem & Biol Chem, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Marsh, Neil/G-7553-2016	Marsh, Neil/0000-0003-1713-1683	Department of Energy Geosciences [DE-FG02-92ER14244]; Department of Energy Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	Department of Energy Geosciences(United States Department of Energy (DOE)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at Beamline X26A, National Synchrotron Light Source, Brookhaven National Laboratory. Beamline X26A is supported by the Department of Energy Geosciences (DE-FG02-92ER14244 to the University of Chicago Center for Advanced Radiation Sources). The National Synchrotron Light Source is supported by the Department of Energy Office of Basic Energy Sciences under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annweiler E, 2000, APPL ENVIRON MICROB, V66, P5329, DOI 10.1128/AEM.66.12.5329-5333.2000; ATLAS RM, 1992, ADV MICROB ECOL, V12, P287; Beasley KK, 2012, ENVIRON SCI TECHNOL, V46, P8244, DOI 10.1021/es3009503; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Bhandare R, 2006, BIOCHEM BIOPH RES CO, V346, P992, DOI 10.1016/j.bbrc.2006.05.199; Bharadwaj VS, 2015, PHYS CHEM CHEM PHYS, V17, P4054, DOI 10.1039/c4cp04317k; Biegert T, 1996, EUR J BIOCHEM, V238, P661, DOI 10.1111/j.1432-1033.1996.0661w.x; Callaghan AV, 2008, BIOCHEM BIOPH RES CO, V366, P142, DOI 10.1016/j.bbrc.2007.11.094; Coschigano PW, 2002, FEMS MICROBIOL LETT, V217, P37, DOI 10.1016/S0378-1097(02)01051-0; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Grundmann O, 2008, ENVIRON MICROBIOL, V10, P376, DOI 10.1111/j.1462-2920.2007.01458.x; Harms G, 1999, ARCH MICROBIOL, V172, P303, DOI 10.1007/s002030050784; Hilberg M., 2012, THESIS PHILIPPS U MA; Himo F, 2005, BBA-BIOENERGETICS, V1707, P24, DOI 10.1016/j.bbabio.2004.04.006; Kniemeyer O, 2007, NATURE, V449, P898, DOI 10.1038/nature06200; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lehtio L, 2004, PROTEIN ENG DES SEL, V17, P545, DOI 10.1093/protein/gzh059; Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x; Leuthner B, 2000, J BACTERIOL, V182, P272, DOI 10.1128/JB.182.2.272-277.2000; Li L, 2006, BIOCHEMISTRY-US, V45, P13932, DOI 10.1021/bi061117o; Li L, 2006, J AM CHEM SOC, V128, P16056, DOI 10.1021/ja067329q; Li L, 2009, BIOCHEMISTRY-US, V48, P1284, DOI 10.1021/bi801766g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller JA, 2001, J BACTERIOL, V183, P752, DOI 10.1128/JB.183.2.752-757.2001; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ocean Studies and Marine Board, 2003, OIL SEA, P89; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiao CH, 2005, J AM CHEM SOC, V127, P8608, DOI 10.1021/ja051972f; Selesi D, 2010, J BACTERIOL, V192, P295, DOI 10.1128/JB.00874-09; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Spormann AM, 2000, BIODEGRADATION, V11, P85, DOI 10.1023/A:1011122631799; Strijkstra A, 2014, APPL ENVIRON MICROB, V80, P7592, DOI 10.1128/AEM.02385-14; Verfurth K, 2004, ARCH MICROBIOL, V181, P155, DOI 10.1007/s00203-003-0642-4; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wohlbrand L, 2013, ENVIRON MICROBIOL, V15, P1334, DOI 10.1111/j.1462-2920.2012.02885.x	43	21	21	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22398	22408		10.1074/jbc.M115.670737	http://dx.doi.org/10.1074/jbc.M115.670737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224635	Green Published, hybrid			2022-12-26	WOS:000361171500007
J	Yang, H; Luo, P; Wang, J; Mou, CX; Mo, L; Wang, ZY; Fu, Y; Lin, HH; Yang, YP; Bhatta, LD				Yang, Hao; Luo, Peng; Wang, Jun; Mou, Chengxiang; Mo, Li; Wang, Zhiyuan; Fu, Yao; Lin, Honghui; Yang, Yongping; Bhatta, Laxmi Dutt			Ecosystem Evapotranspiration as a Response to Climate and Vegetation Coverage Changes in Northwest Yunnan, China	PLOS ONE			English	Article							SURFACE-ENERGY-BALANCE; WATER YIELD; DROUGHT; FOREST; BIODIVERSITY; IMPACTS; TEMPERATURE; CATCHMENT; PRECIPITATION; CONSERVATION	Climate and human-driven changes play an important role in regional droughts. Northwest Yunnan Province is a key region for biodiversity conservation in China, and it has experienced severe droughts since the beginning of this century; however, the extent of the contributions from climate and human-driven changes remains unclear. We calculated the ecosystem evapotranspiration (ET) and water yield (WY) of northwest Yunnan Province, China from 2001 to 2013 using meteorological and remote sensing observation data and a Surface Energy Balance System(SEBS) model. Multivariate regression analyses were used to differentiate the contribution of climate and vegetation coverage to ET. The results showed that the annual average vegetation coverage significantly increased over time with a mean of 0.69 in spite of the precipitation fluctuation. Afforestation/reforestation and other management efforts attributed to vegetation coverage increase in NW Yunnan. Both ET and WY considerably fluctuated with the climate factors, which ranged from 623.29 mm to 893.8 mm and -51.88 mm to 384.40 mm over the time period. Spatially, ET in the southeast of NW Yunnan (mainly in Lijiang) increased significantly, which was in line with the spatial trend of vegetation coverage. Multivariate linear regression analysis indicated that climatic factors accounted for 85.18% of the ET variation, while vegetation coverage explained 14.82%. On the other hand, precipitation accounted for 67.5% of the WY. We conclude that the continuous droughts in northwest Yunnan were primarily climatically driven; however, man-made land cover and vegetation changes also increased the vulnerability of local populations to drought. Because of the high proportion of the water yield consumed for subsistence and poor infrastructure for water management, local populations have been highly vulnerable to climate drought conditions. We suggest that conservation of native vegetation and development of water-conserving agricultural practices should be implemented as adaptive strategies to mitigate climate change.	[Yang, Hao; Luo, Peng; Wang, Jun; Mou, Chengxiang; Mo, Li] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Peoples R China; [Yang, Hao; Wang, Jun; Lin, Honghui] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Luo, Peng] Chinese Acad Sci, Ecol Restorat & Biodivers Conservat Key Lab Sichu, Chengdu Inst Biol, Chengdu, Peoples R China; [Wang, Jun; Mou, Chengxiang; Mo, Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhiyuan] Yunnan Acad Agr Sci, Kunming, Peoples R China; [Fu, Yao; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China; [Bhatta, Laxmi Dutt] Int Ctr Integrated Mt Dev, Kathmandu, Nepal	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan Academy of Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Luo, P (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Peoples R China.	luopeng@cib.ac.cn			National Natural Science Foundation of China [31170432]; Basic Study Project of Science & Technology Ministry [2012FY110300]; International Center for Integrated Mountain Development (HICAP); CEPF Project of Shan Shui Conservation Center [201204003]; John D. and Catherine T. MacArthur foundation [104115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Study Project of Science & Technology Ministry; International Center for Integrated Mountain Development (HICAP); CEPF Project of Shan Shui Conservation Center; John D. and Catherine T. MacArthur foundation	This research was funded by the National Natural Science Foundation of China (31170432), the Basic Study Project of Science & Technology Ministry (2012FY110300), the International Center for Integrated Mountain Development (HICAP), the CEPF Project of Shan Shui Conservation Center (201204003), and the John D. and Catherine T. MacArthur foundation (104115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaier F, 2012, HYDROL EARTH SYST SC, V16, P1833, DOI 10.5194/hess-16-1833-2012; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2007, J IRRIG DRAIN ENG, V133, P380, DOI 10.1061/(ASCE)0733-9437(2007)133:4(380); Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Belal AA, 2014, ARAB J GEOSCI, V7, P35, DOI 10.1007/s12517-012-0707-2; Berrang-Ford L, 2011, GLOBAL ENVIRON CHANG, V21, P25, DOI 10.1016/j.gloenvcha.2010.09.012; Brandt JS, 2013, BIOL CONSERV, V158, P116, DOI 10.1016/j.biocon.2012.07.026; Brandt JS, 2012, REMOTE SENS ENVIRON, V121, P358, DOI 10.1016/j.rse.2012.02.010; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Cai GY, 2011, IFIP ADV INF COMM TE, V345, P243; Cao Gong-xiang, 2013, Yingyong Shengtai Xuebao, V24, P2089; Chen F, 2014, RANGELAND J, V36, P185, DOI 10.1071/RJ13098; Chen MP, 2015, CLIMATIC CHANGE, V128, P367, DOI 10.1007/s10584-014-1163-7; Chen X, 2014, ATMOS CHEM PHYS, V14, P13097, DOI 10.5194/acp-14-13097-2014; Cook BI, 2009, P NATL ACAD SCI USA, V106, P4997, DOI 10.1073/pnas.0810200106; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Delworth TL, 2014, NAT GEOSCI, V7, P583, DOI 10.1038/NGEO2201; Du H, 2014, RESOURCES ENV YANGTZ, V23, P715; Elhag M, 2011, WATER RESOUR MANAG, V25, P2731, DOI 10.1007/s11269-011-9835-9; Frayer J, 2014, FORESTS, V5, P3257, DOI 10.3390/f5123257; Frayer J, 2014, LAND USE POLICY, V36, P248, DOI 10.1016/j.landusepol.2013.08.005; Fu CB, 2003, GLOBAL PLANET CHANGE, V37, P219, DOI 10.1016/S0921-8181(02)00207-2; Fu GB, 2009, CLIMATIC CHANGE, V97, P193, DOI 10.1007/s10584-009-9579-1; Gitay H, 2002, CLIMATE CHANGE BIODI; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Houghton RA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001970; Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849; Jing X, 2011, MATH COMPUT MODEL, V54, P1079, DOI 10.1016/j.mcm.2010.11.038; Li S, 2013, HYDROL PROCESS, V27, P3981, DOI 10.1002/hyp.9541; Li Z., 2015, SPATIAL TEMPORAL VAR, P61; Li ZX, 2011, QUATERN INT, V236, P127, DOI 10.1016/j.quaint.2010.05.017; Licata JA, 2008, FOREST ECOL MANAG, V255, P753, DOI 10.1016/j.foreco.2007.09.061; [刘建刚 Liu Jiangang], 2011, [防灾减灾工程学报, Journal of Disaster Prevention and Mitigation Engineering], V31, P196; Liu LY, 2009, ENVIRON MONIT ASSESS, V153, P339, DOI 10.1007/s10661-008-0360-0; Liu ML, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003687; Liu Y, 2013, HYDROL EARTH SYST SC, V17, P4957, DOI 10.5194/hess-17-4957-2013; Lu JM, 2012, SCI CHINA EARTH SCI, V55, P98, DOI 10.1007/s11430-011-4348-1; Lu Z, 2011, MUNICH PERSONAL REPE, P1; Lyon B, 2005, J AM WATER RESOUR AS, V41, P1457, DOI 10.1111/j.1752-1688.2005.tb03812.x; Ma W, 2011, HYDROL EARTH SYST SC, V15, P1403, DOI 10.5194/hess-15-1403-2011; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Melick D, 2006, MT RES DEV, V26, P292, DOI 10.1659/0276-4741(2006)26[292:ELBAAM]2.0.CO;2; Morell V, 2008, SCIENCE, V320, P1442, DOI 10.1126/science.320.5882.1442; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Qin TL, 2014, J APPL MATH, DOI 10.1155/2014/673485; Qiu J, 2010, NATURE, V465, P142, DOI 10.1038/465142a; Quality and Technical Supervision Bureau of Yunnan Province, 2013, DB53T1862013 QUAL TE; Rosenberg NJ, 1999, CLIMATIC CHANGE, V42, P677, DOI 10.1023/A:1005424003553; Scoot DF, 2000, REANALYSIS S AFRICAN; State Forestry Administration of the People's Republic of China, 2009, 7 NAT FOR RES INV RE; Statistic Bureau of Yunnan Province, 2001, YUNN STAT YB; Stone R, 2010, SCIENCE, V327, P1311, DOI 10.1126/science.327.5971.1311; Su YF, 2012, REG ENVIRON CHANGE, V12, P855, DOI 10.1007/s10113-012-0304-7; Su Z, 2003, INT GEOSCI REMOTE SE, P1166; Su Z, 2002, HYDROL EARTH SYST SC, V6, P85, DOI 10.5194/hess-6-85-2002; Su Z, 2001, ADV EARTH OBSERVATIO, V01-02, P91; Sun G, 2005, J HYDROL, V308, P258, DOI 10.1016/j.jhydrol.2004.11.021; Tan ZH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050006; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Wang Y, 2007, SCI TECHNOLOGY DALI, V2, P9; Wang ZX, 2010, J ENVIRON DEV, V19, P28, DOI 10.1177/1070496509338838; Water Resources Department of Yunnan Province, 2001, YUNN PROV WAT RES B; Weiss M, 2009, ECOL SOC, V14; Weyerhaeuser H, 2005, AGR SYST, V85, P234, DOI 10.1016/j.agsy.2005.06.008; World Meteorological Organization, 1976, 449 WORLD MET ORG, P6; Wu BF, 2004, INT GEOSCI REMOTE SE, P4352; Wu H, 2013, GREENPEACE, V1, P56; Xu JC, 2004, BIODIVERS CONSERV, V13, P959, DOI 10.1023/B:BIOC.0000014464.80847.02; Xu X, 2012, HYDROL EARTH SYST SC, V16, P43, DOI 10.5194/hess-16-43-2012; Yang DW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006948; Yang JW., 2002, FOR RESOUR MANAG, V3, P61; Yang XF, 2009, ECOL SOC, V14; Yang YM, 2004, BIODIVERS CONSERV, V13, P813, DOI 10.1023/B:BIOC.0000011728.46362.3c; Yin H, 2013, J ARID METEOROL, V31, P182, DOI DOI 10.11755/J.ISSN.1006-7639(2013)-01-0182; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang JL, 2014, INT J APPL EARTH OBS, V31, P25, DOI 10.1016/j.jag.2014.01.006; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang W. J., 2012, ENV SKEPT CRIT, V1, P34; [张远东 Zhang Yuandong], 2011, [生态学报, Acta Ecologica Sinica], V31, P7601; Zhao CH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/295856	80	17	21	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134795	10.1371/journal.pone.0134795	http://dx.doi.org/10.1371/journal.pone.0134795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237220	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400039
J	Jiang, YH; Jiang, P; Yang, JL; Ma, DF; Lin, HQ; Su, WG; Wang, Z; Li, X				Jiang, Yue-Hua; Jiang, Ping; Yang, Jin-long; Ma, Du-Fang; Lin, Hai-Qing; Su, Wen-ge; Wang, Zhen; Li, Xiao			Cardiac Dysregulation and Myocardial Injury in a 6-Hydroxydopamine-Induced Rat Model of Sympathetic Denervation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RENAL DENERVATION; AUTONOMIC DENERVATION; TYROSINE-HYDROXYLASE; ARTERIAL-PRESSURE; DIABETIC-RATS; NERVE; VAGAL; ELECTROCARDIOGRAM; MODULATION	Background Cardiac sympathetic denervation is found in various cardiac pathologies; however, its relationship with myocardial injury has not been thoroughly investigated. Methods Twenty-four rats were assigned to the normal control group (NC), sympathectomy control group (SC), and a sympathectomy plus mecobalamin group (SM). Sympathectomy was induced by injection of 6-OHDA, after which, the destruction and distribution of sympathetic and vagal nerve in the left ventricle (LV) myocardial tissue were determined by immunofluorescence and ELISA. Heart rate variability (HRV), ECG and echocardiography, and assays for myocardial enzymes in serum before and after sympathectomy were examined. Morphologic changes in the LV by HE staining and transmission electron microscope were used to estimate levels of myocardial injury and concentrations of inflammatory cytokines were used to reflect the inflammatory reaction. Results Injection of 6-OHDA decreased NE (933.1 +/- 179 ng/L for SC vs. 3418.1 +/- 443.6 ng/L for NC, P < 0.01) and increased NGF (479.4 +/- 56.5 ng/mL for SC vs. 315.85 +/- 28.6 ng/mL for NC, P < 0.01) concentrations. TH expression was reduced, while ChAT expression showed no change. Sympathectomy caused decreased HRV and abnormal ECG and echocardiography results, and histopathologic examinations showed myocardial injury and increased collagen deposition as well as inflammatory cell infiltration in the cardiac tissue of rats in the SC and SM groups. However, all pathologic changes in the SM group were less severe compared to those in the SC group. Conclusions Chemical sympathectomy with administration of 6-OHDA caused dysregulation of the cardiac autonomic nervous system and myocardial injuries. Mecobalamin alleviated inflammatory and myocardial damage by protecting myocardial sympathetic nerves.	[Jiang, Yue-Hua; Yang, Jin-long; Lin, Hai-Qing; Su, Wen-ge; Wang, Zhen; Li, Xiao] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Shandong, Peoples R China; [Jiang, Ping; Ma, Du-Fang] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Li, X (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Shandong, Peoples R China.	ljy6617@163.com		Yang, Jinlong/0000-0002-5355-1493; Jiang, Yue-Hua/0000-0003-0156-0715	Chinese national natural science foundation [81072962]; Shan Dong Province "Taishan Scholar" Construction Project [2012-55]	Chinese national natural science foundation(National Natural Science Foundation of China (NSFC)); Shan Dong Province "Taishan Scholar" Construction Project	This work was funded by Chinese national natural science foundation #81072962 and Shan Dong Province "Taishan Scholar" Construction Project Awards #2012-55.	AKTAS M, 1993, VET RES COMMUN, V17, P353, DOI 10.1007/BF01839386; Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Aubert AE, 1999, COMPUT METH PROG BIO, V60, P197, DOI 10.1016/S0169-2607(99)00017-6; Boettger S, 2006, CLIN NEUROPHYSIOL, V117, P2715, DOI 10.1016/j.clinph.2006.08.009; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; BOTTING JH, 1983, BRIT J PHARMACOL, V79, P265, DOI 10.1111/j.1476-5381.1983.tb10520.x; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Camm AJ, 1996, CIRCULATION, V93, P1043; DiBona GF, 2004, AM J PHYSIOL-RENAL, V286, pF1209, DOI 10.1152/ajprenal.00010.2004; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Facoetti A, 2006, EUR J HISTOCHEM, V50, P133; Franco LG, 2009, ACTA CIR BRAS, V24, P36, DOI 10.1590/S0102-86502009000100008; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Hage FG, 2011, CIRC-CARDIOVASC IMAG, V4, P79, DOI 10.1161/CIRCIMAGING.111.963967; Herring N, 2015, EXP PHYSIOL, V100, P354, DOI 10.1113/expphysiol.2014.080184; Herring N, 2012, J MOL CELL CARDIOL, V52, P667, DOI 10.1016/j.yjmcc.2011.11.016; HILL R, 1960, BRIT J EXP PATHOL, V41, P633; Jacob F, 2003, AM J PHYSIOL-HEART C, V284, pH2302, DOI 10.1152/ajpheart.01029.2002; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; Joers V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035371; KANAKIS SJ, 1985, DEV BRAIN RES, V20, P197, DOI 10.1016/0165-3806(85)90106-3; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Kawamura M, 1999, NEUROCHEM RES, V24, P25, DOI 10.1023/A:1020919828028; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; KLINE RL, 1980, CAN J PHYSIOL PHARM, V58, P1384, DOI 10.1139/y80-209; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; KOIZUMI K, 1982, P NATL ACAD SCI-BIOL, V79, P2116, DOI 10.1073/pnas.79.6.2116; Kong X, 2014, J RENIN-ANGIO-ALDO S, V15, P259, DOI 10.1177/1470320313489061; KORSCHING S, 1985, J NEUROSCI, V5, P1058; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LAVALLEE M, 1985, CIRC RES, V57, P383, DOI 10.1161/01.RES.57.3.383; Levick SP, 2010, HYPERTENSION, V55, P270, DOI 10.1161/HYPERTENSIONAHA.109.142042; Li W, 2004, AM J PHYSIOL-HEART C, V286, pH2229, DOI 10.1152/ajpheart.00768.2003; Lurie K G, 1988, Am J Cardiovasc Pathol, V2, P181; Mabe AM, 2009, CARDIOVASC RES, V82, P93, DOI 10.1093/cvr/cvp029; Machado CRS, 2000, HUM PATHOL, V31, P3, DOI 10.1016/S0046-8177(00)80191-4; Mizukami H, 2011, EUR J CLIN INVEST, V41, P442, DOI 10.1111/j.1365-2362.2010.02430.x; Nazari A, 2013, J BIOPHOTONICS, V6, P171, DOI 10.1002/jbio.201200012; NORMANN SJ, 1961, CIRC RES, V9, P282, DOI 10.1161/01.RES.9.2.282; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Picklo MJ, 1997, J AUTONOM NERV SYST, V62, P111, DOI 10.1016/S0165-1838(96)00121-X; Piya MK, 2011, METABOLISM, V60, P1115, DOI 10.1016/j.metabol.2010.12.004; Roach D, 2004, J AM COLL CARDIOL, V43, P2271, DOI 10.1016/j.jacc.2004.01.050; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Salman IM, 2010, INDIAN J MED RES, V131, P76; SAMBHI MP, 1960, CIRC RES, V8, P129, DOI 10.1161/01.RES.8.1.129; Schneider R, 2010, HISTOL HISTOPATHOL, V25, P1581, DOI 10.14670/HH-25.1581; SONOBE M, 1988, HORM METAB RES, V20, P717, DOI 10.1055/s-2007-1010925; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Sun Yu, 2005, Acta Neurol Taiwan, V14, P48; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Utsunomiya K, 1998, EUR J NUCL MED, V25, P1643, DOI 10.1007/s002590050343; XQ S, 1989, EXPT ZOOLOGY MED; YANOWITZ F, 1966, CIRC RES, V18, P416, DOI 10.1161/01.RES.18.4.416; Zulfiqar U, 2010, AM J CARDIOL, V105, P1181, DOI 10.1016/j.amjcard.2009.12.022	59	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133971	10.1371/journal.pone.0133971	http://dx.doi.org/10.1371/journal.pone.0133971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230083	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400065
J	Kowalska, A; Palyga, I; Gasior-Perczak, D; Walczyk, A; Trybek, T; Sluszniak, A; Mezyk, R; Gozdz, S				Kowalska, Aldona; Palyga, Iwona; Gasior-Perczak, Danuta; Walczyk, Agnieszka; Trybek, Tomasz; Sluszniak, Anna; Mezyk, Ryszard; Gozdz, Stanislaw			The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer	PLOS ONE			English	Article							LOW-RISK PATIENTS; SERUM THYROGLOBULIN; HUMAN THYROTROPIN; RADIOIODINE ABLATION; HORMONE WITHDRAWAL; REMNANT ABLATION; CARCINOMA; MANAGEMENT; DIAGNOSIS; RHTSH	Background The treatment of differentiated thyroid cancer (DTC) ends in full recovery in 80% of cases. However, in 20% of cases local recurrences or distant metastases are observed, for this reason DTC patients are under life-long follow-up. The most sensitive marker for recurrence is stimulated thyroglobulin (Tg) which, together with neck ultrasound (US), enables correct diagnosis in nearly all cases of the active disease. For many years the only known stimulation was a 4-5 week withdrawal from the L-T4 therapy (THW). For the last couple of years stimulation with the use of recombinant human TSH (rhTSH) has been available. This method of stimulation may have a significant influence in obtaining the Tg level. However, it is important to determine the cut-off level for rhTSH-stimulated Tg (rhTSH/Tg). Materials and Methods This is a retrospective analysis of consecutive patients from one facility who have qualified over a period of two years for repeated radioiodine therapy (RIA). In our facility the ablation effectiveness evaluation is always carried out with the use of rhTSH, with the repeated therapy following THW. Such a procedure enables two Tg measurements in the same patient after both types of stimulation within 4-5 weeks. The obtained values were compared, cutoff levels in THW conditions were used (2.0 ng/ml for patients in remission and 10.0 ng/ml for patients with an active disease). In order to determine the cut-off level for rhTSH/Tg, regression analysis and ROC curves were used. Results In 63 patients the Tg measurement of both methods of stimulation were obtained. It was observed that there was a high correlation between rhTSH/Tg and THW/Tg. However, the rhTSH/Tg level was significantly lower than THW/Tg. The rhTSH/Tg cut-off levels which corresponded to the 2.0 ng/ml and 10.0 ng/ml limits for THW/Tg were calculated and the values were 0.6 ng/ml and 2.3 ng/ml respectively. Conclusions The method of stimulation has a significant impact on the obtained Tg concentrations. The assumed THW/Tg cut off levels must not be transferred to rhTSH/Tg.	[Kowalska, Aldona; Palyga, Iwona; Gasior-Perczak, Danuta; Walczyk, Agnieszka; Trybek, Tomasz; Mezyk, Ryszard] Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland; [Sluszniak, Anna] Holycross Canc Ctr, Lab Tumor Markers, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Clin Oncol, Kielce, Poland		Kowalska, A (corresponding author), Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland.	aldonako@onkol.kielce.pl	Kielce, SCO/O-6702-2016; Gąsior-Perczak, Danuta/AAM-2668-2020; Walczyk, Agnieszka/ABC-3334-2020; Gozdz, Stanislaw/D-3300-2013	Gąsior-Perczak, Danuta/0000-0003-0936-4890; Palyga, Iwona/0000-0001-5333-6112; Gozdz, Stanislaw/0000-0001-6902-3807; KOWALSKA, ALDONA/0000-0001-5647-5898; Walczyk, Agnieszka/0000-0002-5083-659X	Holycross Cancer Centre	Holycross Cancer Centre	The study was funded by Holycross Cancer Centre.	Aschebrook-Kilfoy B, 2011, THYROID, V21, P125, DOI 10.1089/thy.2010.0021; Barbaro D, 2006, NUCL MED COMMUN, V27, P627, DOI 10.1097/00006231-200608000-00005; Chianelli M, 2009, EUR J ENDOCRINOL, V160, P431, DOI 10.1530/EJE-08-0669; David A, 2005, THYROID, V15, P267, DOI 10.1089/thy.2005.15.267; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; Haugen BR, 2002, THYROID, V12, P37, DOI 10.1089/105072502753451959; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mazzaferri EL, 2002, J CLIN ENDOCR METAB, V87, P1490, DOI 10.1210/jc.87.4.1490; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Nakabashi CCD, 2014, EUR THYROID J, V3, P43, DOI 10.1159/000360077; Pacini F, 2003, J CLIN ENDOCR METAB, V88, P3668, DOI 10.1210/jc.2002-021925; Pacini F, 2001, J CLIN ENDOCR METAB, V86, P5686, DOI 10.1210/jc.86.12.5686; PACINI F, 1980, CLIN ENDOCRINOL, V13, P107, DOI 10.1111/j.1365-2265.1980.tb01030.x; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Schlumberger M, 2003, THYROID TUMORS, P163; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Taieb D, 2009, CLIN ENDOCRINOL, V71, P115, DOI 10.1111/j.1365-2265.2008.03424.x; Torlontano M, 2003, EUR J ENDOCRINOL, V148, P19, DOI 10.1530/eje.0.1480019; Wojciechowska U, 2014, CANCER IN POLAND IN	24	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133852	10.1371/journal.pone.0133852	http://dx.doi.org/10.1371/journal.pone.0133852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230494	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400058
J	Roerdink, M; Daffertshofer, A; Marmelat, V; Beek, PJ				Roerdink, Melvyn; Daffertshofer, Andreas; Marmelat, Vivien; Beek, Peter J.			How to Sync to the Beat of a Persistent Fractal Metronome without Falling Off the Treadmill?	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; TO-STRIDE FLUCTUATIONS; HUMAN GAIT; NONLINEAR DYNAMICS; HUMAN LOCOMOTION; HUMAN WALKING; VARIABILITY; INTERVAL; DISEASE; COMPLEXITY	In rehabilitation, rhythmic acoustic cues are often used to improve gait. However, stride-time fluctuations become anti-persistent with such pacing, thereby deviating from the characteristic persistent long-range correlations in stride times of self-paced walking healthy adults. Recent studies therefore experimented with metronomes with persistence in interbeat intervals and successfully evoked persistent stride-time fluctuations. The objective of this study was to examine how participants couple their gait to a persistent metronome, evoking persistently longer or shorter stride times over multiple consecutive strides, without wandering off the treadmill. Twelve healthy participants walked on a treadmill in self-paced, isochronously paced and non-isochronously paced conditions, the latter with anti-persistent, uncorrelated and persistent correlations in interbeat intervals. Stride-to-stride fluctuations of stride times, stride lengths and stride speeds were assessed with detrended fluctuation analysis, in conjunction with an examination of the coupling between stride times and stride lengths. Stride-speed fluctuations were anti-persistent for all conditions. Stride-time and stride-length fluctuations were persistent for self-paced walking and anti-persistent for isochronous pacing. Both stride times and stride lengths changed from anti-persistence to persistence over the four non-isochronous metronome conditions, accompanied by an increasingly stronger coupling between these gait parameters, with peak values for the persistent metronomes. These results revealed that participants were able to follow the beat of a persistent metronome without falling off the treadmill by strongly coupling stride-length fluctuations to the stride-time fluctuations elicited by persistent metronomes, so as to prevent large positional displacements along the treadmill. For self-paced walking, in contrast, this coupling was very weak. In combination, these results challenge the premise that persistent metronomes in gait rehabilitation would evoke stride-to-stride dynamics reminiscent of self-paced walking healthy adults. Future studies are recommended to include an analysis of the interrelation between stride times and stride lengths in addition to the correlational structure of either one in isolation.	[Roerdink, Melvyn; Daffertshofer, Andreas; Beek, Peter J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Marmelat, Vivien] Univ Montpellier, Movement Hlth Lab, Euromov, F-34059 Montpellier, France	Vrije Universiteit Amsterdam; Universite de Montpellier	Roerdink, M (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Fac Behav & Movement Sci, Amsterdam, Netherlands.	m.roerdink@vu.nl		Daffertshofer, Andreas/0000-0001-9107-3552; Beek, Peter/0000-0002-0917-8548; Roerdink, Melvyn/0000-0002-8534-1124	Netherlands Organisation for Scientific Research (NWO) [400-08-127]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Andreas Daffertshofer received financial support from the Netherlands Organisation for Scientific Research (NWO grant #400-08-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank PJM, 2011, EXP BRAIN RES, V209, P159, DOI 10.1007/s00221-010-2531-9; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dutta S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00274; Glass L., 1988, CLOCK CHAOS RHYTHMS; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Hunt N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05879; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Kantz H., 2004, NONLINEAR TIME SERIE; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; Mazaheri M, 2014, GAIT POSTURE, V40, P182, DOI 10.1016/j.gaitpost.2014.03.183; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Peper CE, 2012, GAIT POSTURE, V36, P378, DOI 10.1016/j.gaitpost.2012.03.032; Pierrynowski MR, 2005, GAIT POSTURE, V22, P46, DOI 10.1016/j.gaitpost.2004.06.007; Rhea CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106755; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Roerdink M, 2008, J BIOMECH, V41, P2628, DOI 10.1016/j.jbiomech.2008.06.023; Roerdink M, 2014, MED BIOL ENG COMPUT, V52, P963, DOI 10.1007/s11517-014-1195-1; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Schaefer A, 2014, J NEUROSCI METH, V222, P118, DOI 10.1016/j.jneumeth.2013.10.017; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00230; Terrier P, 2012, HUM MOVEMENT SCI, V31, P1585, DOI 10.1016/j.humov.2012.05.004; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176; van Orden G., 2009, HDB PHILOS SCI, V10, P639, DOI DOI 10.1016/B978-0-444-52076-0.50022-5	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134148	10.1371/journal.pone.0134148	http://dx.doi.org/10.1371/journal.pone.0134148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230254	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400077
J	Sampangi, S; Kassianos, AJ; Wang, XJ; Beagley, KW; Klein, T; Afrin, S; Healy, H; Wilkinson, R				Sampangi, Sandeep; Kassianos, Andrew J.; Wang, Xiangju; Beagley, Kenneth W.; Klein, Travis; Afrin, Sadia; Healy, Helen; Wilkinson, Ray			The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function	PLOS ONE			English	Article							TUBULAR CELLS; EXPRESSION; GLOMERULONEPHRITIS; RECRUITMENT; INHIBITION; RESPONSES; RECEPTOR; SUBSETS; DISEASE; ACID	Proximal tubule epithelial cells (PTEC) of the kidney line the proximal tubule downstream of the glomerulus and play a major role in the re-absorption of small molecular weight proteins that may pass through the glomerular filtration process. In the perturbed disease state PTEC also contribute to the inflammatory disease process via both positive and negative mechanisms via the production of inflammatory cytokines which chemo-attract leukocytes and the subsequent down-modulation of these cells to prevent uncontrolled inflammatory responses. It is well established that dendritic cells are responsible for the initiation and direction of adaptive immune responses. Both resident and infiltrating dendritic cells are localised within the tubulointerstitium of the renal cortex, in close apposition to PTEC, in inflammatory disease states. We previously demonstrated that inflammatory PTEC are able to modulate autologous human dendritic cell phenotype and functional responses. Here we extend these findings to characterise the mechanisms of this PTEC immune-modulation using primary human PTEC and autologous monocyte-derived dendritic cells (MoDC) as the model system. We demonstrate that PTEC express three inhibitory molecules: (i) cell surface PD-L1 that induces MoDC expression of PD-L1; (ii) intracellular IDO that maintains the expression of MoDC CD14, drives the expression of CD80, PD-L1 and IL-10 by MoDC and inhibits T cell stimulatory capacity; and (iii) soluble HLA-G (sHLA-G) that inhibits HLA-DR and induces IL-10 expression by MoDC. Collectively the results demonstrate that primary human PTEC are able to modulate autologous DC phenotype and function via multiple complex pathways. Further dissection of these pathways is essential to target therapeutic strategies in the treatment of inflammatory kidney disorders.	[Sampangi, Sandeep; Kassianos, Andrew J.; Wang, Xiangju; Afrin, Sadia; Healy, Helen; Wilkinson, Ray] Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia; [Kassianos, Andrew J.; Wang, Xiangju; Healy, Helen; Wilkinson, Ray] Royal Brisbane & Womens Hosp, Dept Renal Med, Brisbane, Qld, Australia; [Sampangi, Sandeep; Beagley, Kenneth W.; Klein, Travis; Afrin, Sadia; Wilkinson, Ray] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Wilkinson, Ray] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); University of Queensland	Wilkinson, R (corresponding author), Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia.	ray.wilkinson@qimr.edu.au	Beagley, Kenneth/J-1129-2012; Healy, Helen/G-2686-2010; Kassianos, Andrew/I-6767-2015; Klein, Travis/J-1117-2012	Beagley, Kenneth/0000-0003-3112-6557; Healy, Helen/0000-0003-4342-5300; Kassianos, Andrew/0000-0002-0994-3588; Klein, Travis/0000-0002-6669-7766; Afrin, Sadia/0000-0003-0501-2847	Pathology Queensland; Kidney Research Foundation; Royal Brisbane and Women's Hospital Foundation	Pathology Queensland; Kidney Research Foundation; Royal Brisbane and Women's Hospital Foundation	Funding was provided by Pathology Queensland to RW and AK, Kidney Research Foundation to SS, and Royal Brisbane and Women's Hospital Foundation to RW and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Carosella ED, 2011, CELL MOL LIFE SCI, V68, P337, DOI 10.1007/s00018-010-0577-2; Chen YW, 2006, NEPHRON EXP NEPHROL, V102, pE81, DOI 10.1159/000089686; Crispim JCO, 2008, TRANSPL IMMUNOL, V18, P361, DOI 10.1016/j.trim.2007.10.010; Ding HL, 2005, CLIN IMMUNOL, V115, P184, DOI 10.1016/j.clim.2005.01.005; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fiore N, 2008, MOL IMMUNOL, V45, P259, DOI 10.1016/j.molimm.2007.04.029; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glynne PA, 1999, KIDNEY INT, V55, P2573, DOI 10.1046/j.1523-1755.1999.00456.x; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Heyliger SO, 1999, LIFE SCI, V64, P1177, DOI 10.1016/S0024-3205(99)00049-1; Hou WP, 2009, CLIN EXP IMMUNOL, V156, P363, DOI 10.1111/j.1365-2249.2009.03902.x; Kassianos AJ, 2015, KIDNEY INT, V87, P1153, DOI 10.1038/ki.2014.407; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Kassianos AJ, 2013, NEPHROL DIAL TRANSPL, V28, P303, DOI 10.1093/ndt/gfs136; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Mohib K, 2008, AM J PHYSIOL-RENAL, V295, pF226, DOI 10.1152/ajprenal.00567.2007; Morita T, 2001, ANN CLIN BIOCHEM, V38, P242, DOI 10.1258/0004563011900461; Rebmann V, 2009, HUM IMMUNOL, V70, P995, DOI 10.1016/j.humimm.2009.07.016; Sampangi S, 2015, NEPHROL DIA IN PRESS; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; Shalamanova L, 2007, AM J PHYSIOL-RENAL, V292, pF1846, DOI 10.1152/ajprenal.00265.2006; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Wilkinson R, 2011, NEPHROL DIAL TRANSPL, V26, P1483, DOI 10.1093/ndt/gfq677	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134688	10.1371/journal.pone.0134688	http://dx.doi.org/10.1371/journal.pone.0134688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230727	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400149
J	Azarbaijani, BA; Sheikhi, M; Oskam, IC; Nurmio, M; Laine, T; Tinkanen, H; Makinen, S; Tanbo, TG; Hovatta, O; Jahnukainen, K				Azarbaijani, Babak Asadi; Sheikhi, Mona; Oskam, Irma C.; Nurmio, Mirja; Laine, Tiina; Tinkanen, Helena; Makinen, Sirpa; Tanbo, Tom G.; Hovatta, Outi; Jahnukainen, Kirsi			Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro	PLOS ONE			English	Article							CHILDHOOD-CANCER SURVIVOR; PRIMORDIAL FOLLICLES; FERTILITY PRESERVATION; DEVELOPMENTAL COMPETENCE; PHYSIOLOGICAL FUNCTIONS; FEMALE REPRODUCTION; MOUSE OOCYTES; CYCLOPHOSPHAMIDE; CONTAMINATION; VITRIFICATION	Background Cryopreservation of ovarian tissue has been widely accepted as an option for fertility preservation among cancer patients. Some patients are exposed to chemotherapy prior to ovarian tissue cryopreservation. Consequently, assessment of the developmental capacity of human ovarian tissue after chemotherapy is of primary importance. Materials In order to study the impact of previous chemotherapy on in vitro development and viability of ovarian follicles, quality control samples from 34 female cancer patients at median age of 15 years (range 1-35), cryopreserved for fertility preservation before (n = 14) or after (n = 20) initiation of chemotherapy, were thawed and cultured for 7 days. The morphology and developmental stages of ovarian follicles were studied by light microscopy before and after culture. Possible associations between follicular densities, age and exposure to alkylating agents, expressed as cyclophosphamide equivalent dose (CED) were tested. Results Exposure to chemotherapy significantly impaired the survival and development of ovarian follicles in culture. After seven days, significantly higher densities of intermediary, primary and secondary follicles and lower densities of atretic follicles was detected in the samples collected before chemotherapy. Increasing dose of alkylating agents was identified by multivariate linear regression analysis as an independent predictor of a higher density of atretic follicles, whereas increasing age of the patient predicted a better outcome with less follicle atresia and a higher density of maturing follicles. Conclusion This study provides quantitative in vitro evidence of the impact of chemotherapy on developmental capacity of cryopreserved human ovarian tissue. The results indicate that fertility preservation should be carried out, if possible, before initiation of alkylating agents in order to guarantee better in vitro survival of ovarian follicles. In addition, ovarian samples from younger girls show lower viability and fewer developing follicles in culture.	[Azarbaijani, Babak Asadi; Tanbo, Tom G.] Oslo Univ Hosp, Women & Childrens Div, Rikshosp, Oslo, Norway; [Azarbaijani, Babak Asadi; Tanbo, Tom G.] Univ Oslo, Oslo, Norway; [Sheikhi, Mona; Hovatta, Outi] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynecol, Stockholm, Sweden; [Sheikhi, Mona] Stockholm IVF, Stockholm, Sweden; [Oskam, Irma C.] Univ Oslo, Fac Vet Med & Biosci, Oslo, Norway; [Nurmio, Mirja] Univ Turku, Dept Physiol & Pediat, Turku, Finland; [Laine, Tiina; Jahnukainen, Kirsi] Univ Helsinki, Cent Hosp, Dept Pediat, Helsinki, Finland; [Laine, Tiina; Jahnukainen, Kirsi] Univ Helsinki, Div Obstet & Gynecol, Helsinki, Finland; [Tinkanen, Helena] Tampere Univ, Cent Hosp, SF-33520 Tampere, Finland; [Makinen, Sirpa] Family Federat Finland, Fertil Clin, Helsinki, Finland; [Jahnukainen, Kirsi] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Jahnukainen, Kirsi] Univ Hosp, Stockholm, Sweden	University of Oslo; National Hospital Norway; University of Oslo; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Family Federation of Finland; Karolinska Institutet	Azarbaijani, BA (corresponding author), Oslo Univ Hosp, Women & Childrens Div, Rikshosp, Oslo, Norway.	basad@ous-hf.no		Nurmio, Mirja/0000-0002-3278-639X	Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; Swedish Childhood Cancer Foundation; Finnish Cancer Society; Finnish Pediatric Research Foundation; Paulo Foundation; Vare Foundation for Pediatric Cancer Research; Academy of Finland; Swedish Research Council; ALF Stockholm County; Karolinska Institute	Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; Swedish Childhood Cancer Foundation(European Commission); Finnish Cancer Society; Finnish Pediatric Research Foundation; Paulo Foundation; Vare Foundation for Pediatric Cancer Research; Academy of Finland(Academy of Finland); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Stockholm County; Karolinska Institute(Karolinska Institutet)	This research was supported by grants from the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; the Swedish Childhood Cancer Foundation; the Finnish Cancer Society; the Finnish Pediatric Research Foundation; the Paulo Foundation; the Vare Foundation for Pediatric Cancer Research; the Academy of Finland; The Swedish Research Council; ALF Stockholm County and the Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Carlsson IB, 2006, REPRODUCTION, V131, P641, DOI 10.1530/rep.1.00868; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Gougeon A, 1989, Acta Eur Fertil, V20, P185; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; HAIEMEDER C, 1993, INT J RADIAT ONCOL, V25, P419, DOI 10.1016/0360-3016(93)90062-Z; HALES BF, 1982, CANCER RES, V42, P3016; Hovatta O, 1996, HUM REPROD, V11, P1268; Jadoul P, 2010, HUM REPROD UPDATE, V16, P617, DOI 10.1093/humupd/dmq010; Jahnukainen K, 2013, LEUKEMIA, V27, P1183, DOI 10.1038/leu.2012.279; Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; Lass A, 1997, HUM REPROD, V12, P294, DOI 10.1093/humrep/12.2.294; McDermott EM, 1996, ANN RHEUM DIS, V55, P224, DOI 10.1136/ard.55.4.224; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Newton H, 1996, HUM REPROD, V11, P1487; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Oktay K, 2009, PEDIATR BLOOD CANCER, V53, P267, DOI 10.1002/pbc.22003; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Oktem O, 2007, CANCER-AM CANCER SOC, V110, P2222, DOI 10.1002/cncr.23071; Oskam IC, 2010, FERTIL STERIL, V93, P2764, DOI 10.1016/j.fertnstert.2010.02.003; Perez GI, 2000, BIOL REPROD, V63, P1358, DOI 10.1095/biolreprod63.5.1358; Rosendahl M, 2013, J ASSIST REPROD GEN, V30, P11, DOI 10.1007/s10815-012-9912-x; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016/j.fertnstert.2009.02.043; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Schmidt KT, 2013, REPROD BIOMED ONLINE, V26, P272, DOI 10.1016/j.rbmo.2012.12.001; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Scott JE, 2004, REPROD BIOMED ONLINE, V9, P287, DOI 10.1016/S1472-6483(10)62143-8; Sheikhi M, 2013, FERTIL STERIL, V100, P170, DOI 10.1016/j.fertnstert.2013.03.018; Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243; Tao T, 2008, J ASSIST REPROD GEN, V25, P287, DOI 10.1007/s10815-008-9236-z; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133985	10.1371/journal.pone.0133985	http://dx.doi.org/10.1371/journal.pone.0133985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226487	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700046
J	Mahata, B; Biswas, S; Rayman, P; Chahlavi, A; Ko, J; Bhattacharjee, A; Li, YT; Li, YT; Das, T; Sa, G; Raychaudhuri, B; Vogelbaum, MA; Tannenbaum, C; Finke, JH; Biswas, K				Mahata, Barun; Biswas, Soumika; Rayman, Patricia; Chahlavi, Ali; Ko, Jennifer; Bhattacharjee, Ashish; Li, Yu-Teh; Li, Yuntao; Das, Tanya; Sa, Gaurisankar; Raychaudhuri, Baisakhi; Vogelbaum, Michael A.; Tannenbaum, Charles; Finke, James H.; Biswas, Kaushik			GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway	PLOS ONE			English	Article							PRIMARY INTRACRANIAL TUMORS; CARCINOMA PATIENTS; HUMAN GLIOMAS; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; LYMPHOCYTES; CANCER; BRAIN; GLIOBLASTOMAS; MECHANISMS	Previously we demonstrated that human glioblastoma cell lines induce apoptosis in peripheral blood T cells through partial involvement of secreted gangliosides. Here we show that GBM-derived gangliosides induce apoptosis through involvement of the TNF receptor and activation of the caspase cascade. Culturing T lymphocytes with GBM cell line derived gangliosides (10-20 mu g/ml) demonstrated increased ROS production as early as 18 hrs as indicated by increased uptake of the dye H(2)DCFDA while western blotting demonstrated mitochondrial damage as evident by cleavage of Bid to t-Bid and by the release of cytochrome-c into the cytosol. Within 48-72 hrs apoptosis was evident by nuclear blebbing, trypan blue positivity and annexinV/7AAD staining. GBM-ganglioside induced activation of the effector caspase-3 along with both initiator caspases (-9 and -8) in T cells while both the caspase-8 and -9 inhibitors were equally effective in blocking apoptosis (60% protection) confirming the role of caspases in the apoptotic process. Ganglioside-induced T cell apoptosis did not involve production of TNF-alpha since anti-human TNF alpha antibody was unable to protect T cells from nuclear blebbing and subsequent cell death. However, confocal microscopy demonstrated co-localization of GM2 ganglioside with the TNF receptor and co-immunoprecipitation experiments showed recruitment of death domains FADD and TRADD with the TNF receptor post ganglioside treatment, suggesting direct interaction of gangliosides with the TNF receptor. Further confirmation of the interaction between GM2 and TNFR1 was obtained from confocal microscopy data with wild type and TNFR1 KO (TALEN mediated) Jurkat cells, which clearly demonstrated co-localization of GM2 and TNFR1 in the wild type cells but not in the TNFR1 KO clones. Thus, GBM-ganglioside can mediate T cell apoptosis by interacting with the TNF receptor followed by activation of both the extrinsic and the intrinsic pathway of caspases.	[Mahata, Barun; Das, Tanya; Sa, Gaurisankar; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata, India; [Biswas, Soumika; Rayman, Patricia; Li, Yuntao; Das, Tanya; Sa, Gaurisankar; Tannenbaum, Charles; Finke, James H.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Chahlavi, Ali] St Vincents Med Ctr, Spine & Brain Inst, Jacksonville, FL USA; [Ko, Jennifer] Cleveland Clin, Inst Pathol, Cleveland, OH 44106 USA; [Bhattacharjee, Ashish] Natl Inst Technol, Dept Biotechnol, Durgapur, India; [Li, Yu-Teh] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; [Raychaudhuri, Baisakhi; Vogelbaum, Michael A.] Cleveland Clin, Neurol Inst, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA	Department of Science & Technology (India); Bose Institute; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institute of Technology (NIT System); National Institute of Technology Durgapur; Tulane University; Cleveland Clinic Foundation	Biswas, K (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	kaushik@jcbose.ac.in	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515; Mahata, Barun/0000-0002-1614-0791	Bose Institute; Frank Rudy Fund for Cancer Research;  [R01-CA116255]; NATIONAL CANCER INSTITUTE [R01CA116255] Funding Source: NIH RePORTER	Bose Institute(Department of Science & Technology (India)); Frank Rudy Fund for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by internal funding from the Bose Institute (K Biswas), the Frank Rudy Fund for Cancer Research (JH Finke), and by R01-CA116255 (JH Finke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avradopoulos K, 1997, ANN SURG ONCOL, V4, P184, DOI 10.1007/BF02303803; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; BODMER S, 1989, J IMMUNOL, V143, P3222; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Coussens LM, 2008, CURR OPIN GENET DEV, V18, P1, DOI 10.1016/j.gde.2008.04.001; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Didenko VV, 2002, J NEUROSURG, V96, P580, DOI 10.3171/jns.2002.96.3.0580; Dix AR, 1999, J NEUROIMMUNOL, V100, P216, DOI 10.1016/S0165-5728(99)00203-9; DUMONTET C, 1994, CANCER IMMUNOL IMMUN, V38, P311, DOI 10.1007/BF01525509; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; ELLIOTT LH, 1984, J IMMUNOL, V132, P1208; Finke J, 1999, IMMUNOL TODAY, V20, P158, DOI 10.1016/S0167-5699(98)01435-2; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Finke JH, 2004, UROLOGE A, V43, pS131, DOI 10.1007/s00120-004-0600-z; FONTANA A, 1991, CIBA F SYMP, V157, P232; Gastman BR, 2000, BLOOD, V95, P2015, DOI 10.1182/blood.V95.6.2015; Gastman BR, 1999, CANCER RES, V59, P5356; Haymaker C, 2012, ONCOIMMUNOLOGY, V1, P735, DOI 10.4161/onci.20823; Heitger A, 1996, BBA-LIPID LIPID MET, V1303, P161, DOI 10.1016/0005-2760(96)00091-4; HISHII M, 1995, NEUROSURGERY, V37, P1160, DOI 10.1227/00006123-199512000-00016; Irani DN, 1996, J IMMUNOL, V157, P4333; Julien T, 2000, SURG NEUROL, V53, P360, DOI 10.1016/S0090-3019(00)00178-6; KIKUCHI K, 1983, J NEUROSURG, V59, P790, DOI 10.3171/jns.1983.59.5.0790; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kudo D, 2003, CANCER RES, V63, P1676; KUPPNER MC, 1989, J NEUROSURG, V71, P211, DOI 10.3171/jns.1989.71.2.0211; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mahata B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09048; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; McKallip R, 1999, J IMMUNOL, V163, P3718; Morford LA, 1999, J NEUROSURG, V91, P935, DOI 10.3171/jns.1999.91.6.0935; NAKAMURA O, 1991, ACTA NEUROCHIR, V109, P34, DOI 10.1007/BF01405694; PALMA L, 1978, J NEUROSURG, V49, P854, DOI 10.3171/jns.1978.49.6.0854; Ravindranath MH, 2004, BIOCHEM BIOPH RES CO, V324, P154, DOI 10.1016/j.bbrc.2004.09.029; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Retter MW, 2005, CANCER RES, V65, P6425, DOI 10.1158/0008-5472.CAN-05-0300; ROSZMAN TL, 1982, CANCER, V50, P1273, DOI 10.1002/1097-0142(19821001)50:7<1273::AID-CNCR2820500709>3.0.CO;2-5; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; TSUCHIDA T, 1987, J NATL CANCER I, V78, P55, DOI 10.1093/jnci/78.1.55; Uzzo RG, 1999, CLIN CANCER RES, V5, P1219; Wagener R, 1999, ACTA NEUROCHIR, V141, P1339, DOI 10.1007/s007010050439; Walker DG, 2006, J NEUROIMMUNOL, V175, P59, DOI 10.1016/j.jneuroim.2006.03.006; Walker PR, 2003, BRAIN RES REV, V42, P97, DOI 10.1016/S0165-0173(03)00141-3; Whiteside TL, 1998, CANCER IMMUNOL IMMUN, V46, P175, DOI 10.1007/s002620050476; Whiteside TL., 2009, ORAL ONCOL S, VS1368-8375	53	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134425	10.1371/journal.pone.0134425	http://dx.doi.org/10.1371/journal.pone.0134425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226135	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700093
J	Panzer, K; Yilmaz, P; Weiss, M; Reich, L; Richter, M; Wiese, J; Schmaljohann, R; Labes, A; Imhoff, JF; Glockner, FO; Reich, M				Panzer, Katrin; Yilmaz, Pelin; Weiss, Michael; Reich, Lothar; Richter, Michael; Wiese, Jutta; Schmaljohann, Rolf; Labes, Antje; Imhoff, Johannes F.; Gloeckner, Frank Oliver; Reich, Marlis			Identification of Habitat-Specific Biomes of Aquatic Fungal Communities Using a Comprehensive Nearly Full-Length 18S rRNA Dataset Enriched with Contextual Data	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; ORGANIC-CARBON DOC; MARINE FUNGI; DEEP-SEA; EUKARYOTIC COMMUNITY; MICROBIAL EUKARYOTES; LEAF-LITTER; DIVERSITY; SEDIMENTS; ECOSYSTEM	Molecular diversity surveys have demonstrated that aquatic fungi are highly diverse, and that they play fundamental ecological roles in aquatic systems. Unfortunately, comparative studies of aquatic fungal communities are few and far between, due to the scarcity of adequate datasets. We combined all publicly available fungal 18S ribosomal RNA (rRNA) gene sequences with new sequence data from a marine fungi culture collection. We further enriched this dataset by adding validated contextual data. Specifically, we included data on the habitat type of the samples assigning fungal taxa to ten different habitat categories. This dataset has been created with the intention to serve as a valuable reference dataset for aquatic fungi including a phylogenetic reference tree. The combined data enabled us to infer fungal community patterns in aquatic systems. Pairwise habitat comparisons showed significant phylogenetic differences, indicating that habitat strongly affects fungal community structure. Fungal taxonomic composition differed considerably even on phylum and class level. Freshwater fungal assemblage was most different from all other habitat types and was dominated by basal fungal lineages. For most communities, phylogenetic signals indicated clustering of sequences suggesting that environmental factors were the main drivers of fungal community structure, rather than species competition. Thus, the diversification process of aquatic fungi must be highly clade specific in some cases. The combined data enabled us to infer fungal community patterns in aquatic systems. Pairwise habitat comparisons showed significant phylogenetic differences, indicating that habitat strongly affects fungal community structure. Fungal taxonomic composition differed considerably even on phylum and class level. Freshwater fungal assemblage was most different from all other habitat types and was dominated by basal fungal lineages. For most communities, phylogenetic signals indicated clustering of sequences suggesting that environmental factors were the main drivers of fungal community structure, rather than species competition. Thus, the diversification process of aquatic fungi must be highly clade specific in some cases.	[Panzer, Katrin; Reich, Marlis] Univ Bremen, Mol Ecol, FB2, D-28359 Bremen, Germany; [Panzer, Katrin; Gloeckner, Frank Oliver] Jacobs Univ Bremen gGmbH, Dept Life Sci & Chem, D-28759 Bremen, Germany; [Yilmaz, Pelin; Richter, Michael; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, D-28359 Bremen, Germany; [Weiss, Michael] Univ Tubingen, Dept Biol, D-72076 Tubingen, Germany; [Reich, Lothar] Potsdam Transfer, D-14482 Potsdam, Germany; [Wiese, Jutta; Schmaljohann, Rolf; Labes, Antje; Imhoff, Johannes F.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Marine Microbiol, D-24105 Kiel, Germany	University of Bremen; Jacobs University; Max Planck Society; Eberhard Karls University of Tubingen; University of Potsdam; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Reich, M (corresponding author), Univ Bremen, Mol Ecol, FB2, Leobener Str 2, D-28359 Bremen, Germany.	reich@uni-bremen.de	Labes, Antje/AGK-3198-2022; Imhoff, Johannes F./AAB-8765-2022; Weiß, Michael/F-6206-2012; Reich, Marlis/AAC-4604-2021; Wiese, Jutta/B-9076-2012; Imhoff, Johannes F./D-2515-2010	Labes, Antje/0000-0002-4807-3378; Imhoff, Johannes F./0000-0001-8789-0728; Weiß, Michael/0000-0002-4869-9186; Reich, Marlis/0000-0001-7537-5809; Imhoff, Johannes F./0000-0001-8789-0728; Yilmaz, Pelin/0000-0003-4724-323X	University of Bremen, Germany; German Research Foundation (DFG)	University of Bremen, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the University of Bremen, Germany (http://www.uni-bremen.de/). Sanger sequencing partly supported by the German Research Foundation (DFG) (http://www.dfg.de/en/) Cluster of Excellence "Inflammation at Interfaces" and "Future Ocean".	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; [Anonymous], 2015, PRACTICAL GUIDE SYSM, DOI [10.1016/c2013-0-14457-1, DOI 10.1016/C2013-0-14457-1, DOI 10.1016/C2013-0-10998-1]; Arfi Y, 2012, FUNGAL ECOL, V5, P282, DOI 10.1016/j.funeco.2011.09.004; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Avramidis P, 2013, FRESEN ENVIRON BULL, V22, P1628; Bachy C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00106; BALDY V, 1995, OIKOS, V74, P93, DOI 10.2307/3545678; Barr DJS, 2001, MYCOTA, V7, P93; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chukanhom Kanit, 2004, Mycoscience, V45, P42, DOI 10.1007/s10267-003-0153-9; Danger M, 2013, FUNGAL ECOL, V6, P453, DOI 10.1016/j.funeco.2013.05.007; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goh TK, 1996, J IND MICROBIOL BIOT, V17, P328, DOI 10.1007/BF01574764; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x; Gutierrez MH, 2011, MAR BIOL, V158, P205, DOI 10.1007/s00227-010-1552-z; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hedges JI, 1999, AM J SCI, V299, P529, DOI 10.2475/ajs.299.7-9.529; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jobard M, 2010, AQUAT SCI, V72, P255, DOI 10.1007/s00027-010-0133-z; Jones EBG, 2012, MAR FRESHW BOTANY; Jones EBG, 2012, MAR FRESHW BOTANY, P49; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Jones EBG, 1971, METHOD MICROBIOL, P731; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kagami M, 2012, MICROB ECOL, V63, P358, DOI 10.1007/s00248-011-9913-9; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lefevre E, 2012, AQUAT MICROB ECOL, V67, P91, DOI 10.3354/ame01592; Livermore JA, 2013, ENVIRON MICROBIOL, V15, P2333, DOI 10.1111/1462-2920.12106; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magnes M, 1991, BIBL MYCOL, V991, P1, DOI DOI 10.1007/S13225-015-0331-Z; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; MONK KA, 1990, BIOTROPICA, V22, P16, DOI 10.2307/2388715; Morshed A, 2013, IEEE INT CONF TRUST, P1907, DOI 10.1109/TrustCom.2013.279; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Nakagiri A, 2012, MAR FRESHW BOTANY, P501; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Ohm R.A., 2012, PLOS PATHOGENS, V8; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Otto S, 1998, PROG OCEANOGR, V42, P127, DOI 10.1016/S0079-6611(98)00031-7; Panno L, 2013, NEW BIOTECHNOL, V30, P685, DOI 10.1016/j.nbt.2013.01.010; Panzer K., 2015, DRYAD DIGITAL REPOSI; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raghukumar C, 2012, BIOL MARINE FUNGI; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shearer CA, 2007, BIODIVERS CONSERV, V16, P49, DOI 10.1007/s10531-006-9120-z; Singh P, 2011, MICROB ECOL, V61, P507, DOI 10.1007/s00248-010-9765-8; Sowerby A, 2010, EUR J SOIL SCI, V61, P697, DOI 10.1111/j.1365-2389.2010.01276.x; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Sridhar KR, 2012, MAR FRESHW BOTANY, P475; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Takishita K, 2007, EXTREMOPHILES, V11, P563, DOI 10.1007/s00792-007-0068-z; Team RDC, 2019, R LANG ENV STAT COMP; Tian F, 2009, POLAR BIOL, V32, P93, DOI 10.1007/s00300-008-0509-x; Velmurugan N, 2012, MAR FRESHW BOTANY, P441; Wang X., 2014, PLOS ONE, V9; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Yuen TK, 1999, MICROB ECOL, V37, P257, DOI 10.1007/s002489900151; Zuccaro A, 2003, MYCOL RES, V107, P1451, DOI 10.1017/S0953756203008657	98	44	45	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134377	10.1371/journal.pone.0134377	http://dx.doi.org/10.1371/journal.pone.0134377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226014	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700082
J	Tian, SY				Tian, Suyan			Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm	PLOS ONE			English	Article							RNA-SEQ; CLASSIFICATION; EXPRESSION; REGULARIZATION; PROFILES; NETWORK	The existence of fundamental differences between lung adenocarcinoma (AC) and squamous cell carcinoma (SCC) in their underlying mechanisms motivated us to postulate that specific genes might exist relevant to prognosis of each histology subtype. To test on this research hypothesis, we previously proposed a simple Cox-regression model based feature selection algorithm and identified successfully some subtype-specific prognostic genes when applying this method to real-world data. In this article, we continue our effort on identification of subtype-specific prognostic genes for AC and SCC, and propose a novel embedded feature selection method by extending Threshold Gradient Descent Regularization (TGDR) algorithm and minimizing on a corresponding negative partial likelihood function. Using real-world datasets and simulated ones, we show these two proposed methods have comparable performance whereas the new proposal is superior in terms of model parsimony. Our analysis provides some evidence on the existence of such subtype-specific prognostic genes, more investigation is warranted.	Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Jilin, Peoples R China	Jilin University	Tian, SY (corresponding author), Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Jilin, Peoples R China.	stian@rockefeller.edu	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	Natural Science Foundation of China [31401123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (No 31401123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-hamo R, 2013, SYST BIOMED, V1, P83, DOI DOI 10.4161/sysb.25983; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman JH, 2004, TECHNICAL REPORT; Guo Nancy Lan, 2011, International Journal of Computational Biology and Drug Design, V4, P19, DOI 10.1504/IJCBDD.2011.038655; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2007, BIOINFORMATICS, V23, P466, DOI 10.1093/bioinformatics/btl632; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Mramor M, 2007, BIOINFORMATICS, V23, P2147, DOI 10.1093/bioinformatics/btm312; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Shi XJ, 2014, BRIEF BIOINFORM, V15, P671, DOI 10.1093/bib/bbt044; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tarca AL, 2013, SYST BIOMED, V1, P1; Tian S., 2013, SYST BIOMED, V1, P278, DOI [10.4161/sysb.25979, DOI 10.4161/SYSB.25979]; Tian SY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0051-z; Tian SY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-97; Vaporciyan A, 2010, 78 CANC LUNG HOLLAND; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Zhang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110052; Zhao Q, 2014, BRIEF BIOINFORM, V16; Zhao SD, 2014, BIOINFORMATICS, V30, P3062, DOI 10.1093/bioinformatics/btu488; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134630	10.1371/journal.pone.0134630	http://dx.doi.org/10.1371/journal.pone.0134630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226392	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700125
J	Harini, K; Sowdhamini, R				Harini, K.; Sowdhamini, Ramanathan			Computational Approaches for Decoding Select Odorant-Olfactory Receptor Interactions Using Mini-Virtual Screening	PLOS ONE			English	Article							AUTOMATED DOCKING; MOLECULAR-BASIS; EXPRESSION; PROTEINS; MODEL; DISCRIMINATION; IDENTIFICATION; SPECIFICITY; SIMILARITY; ALDEHYDES	Olfactory receptors (ORs) belong to the class A G-Protein Coupled Receptor superfamily of proteins. Unlike G-Protein Coupled Receptors, ORs exhibit a combinatorial response to odors/ligands. ORs display an affinity towards a range of odor molecules rather than binding to a specific set of ligands and conversely a single odorant molecule may bind to a number of olfactory receptors with varying affinities. The diversity in odor recognition is linked to the highly variable transmembrane domains of these receptors. The purpose of this study is to decode the odor-olfactory receptor interactions using in silico docking studies. In this study, a ligand (odor molecules) dataset of 125 molecules was used to carry out in silico docking using the GLIDE docking tool (SCHRODINGER Inc Pvt LTD). Previous studies, with smaller datasets of ligands, have shown that orthologous olfactory receptors respond to similarly-tuned ligands, but are dramatically different in their efficacy and potency. Ligand docking results were applied on homologous pairs (with varying sequence identity) of ORs from human and mouse genomes and ligand binding residues and the ligand profile differed among such related olfactory receptor sequences. This study revealed that homologous sequences with high sequence identity need not bind to the same/ similar ligand with a given affinity. A ligand profile has been obtained for each of the 20 receptors in this analysis which will be useful for expression and mutation studies on these receptors.	[Harini, K.; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore, Karnataka, India.	mini@ncbs.res.in			Indo-Japan Department of Biotechnology Grant [BT/IC/Japan (BI)/01/2010]	Indo-Japan Department of Biotechnology Grant	KH was funded by Indo-Japan Department of Biotechnology Grant (BT/IC/Japan (BI)/01/2010).	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brodin M, 2009, CHEM SENSES, V34, P625, DOI 10.1093/chemse/bjp044; CAIN WS, 1974, ANN NY ACAD SCI, V237, P427, DOI 10.1111/j.1749-6632.1974.tb49876.x; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cometto-Muniz JE, 2010, CHEM SENSES, V35, P289, DOI 10.1093/chemse/bjq018; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Floriano WB, 2000, P NATL ACAD SCI USA, V97, P10712, DOI 10.1073/pnas.97.20.10712; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Gromiha MM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S1; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Harini K, 2012, BIOINFORM BIOL INSIG, V6, P33, DOI 10.4137/BBI.S8990; Harini K, 2012, J MOL BIOCHEM, P1; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; KOSHLAND DE, 1963, SCIENCE, V142, P1533, DOI 10.1126/science.142.3599.1533; Krautwurst D, 2008, CHEM BIODIVERS, V5, P842, DOI 10.1002/cbdv.200890099; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kurland MD, 2010, BIOCHEMISTRY-US, V49, P6302, DOI 10.1021/bi100976w; Lai Peter C., 2012, Frontiers in Genetics, V3, P61, DOI 10.3389/fgene.2012.00061; Madala PK, 2012, J CHEM INF MODEL, V52, P1401, DOI 10.1021/ci2005498; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Mathew D, 2013, P NATL ACAD SCI USA, V110, pE2134, DOI 10.1073/pnas.1306976110; Meier R, 2010, J CHEM INF MODEL, V50, P879, DOI 10.1021/ci900467x; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagarathnam B, 2014, BIOINFORM BIOL INSIG, V8, P147, DOI 10.4137/BBI.S14858; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Singer MS, 2000, CHEM SENSES, V25, P155, DOI 10.1093/chemse/25.2.155; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Topin J, 2014, CHEM-EUR J, V20, P10227, DOI 10.1002/chem.201402486; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	70	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131077	10.1371/journal.pone.0131077	http://dx.doi.org/10.1371/journal.pone.0131077			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221959	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800012
J	Spotswood, EN; Bartolome, JW; Allen-Diaz, B				Spotswood, Erica N.; Bartolome, James W.; Allen-Diaz, Barbara			Hotspots of Community Change: Temporal Dynamics Are Spatially Variable in Understory Plant Composition of a California Oak Woodland	PLOS ONE			English	Article							BETA DIVERSITY; CLIMATE-CHANGE; VARIABILITY; HETEROGENEITY; BIODIVERSITY; STABILITY; RESPONSES; PATTERNS; DRIVERS; PRODUCTIVITY	Community response to external drivers such climate and disturbance can lead to fluctuations in community composition, or to directional change. Temporal dynamics can be influenced by a combination of drivers operating at multiple spatial scales, including external landscape scale drivers, local abiotic conditions, and local species pools. We hypothesized that spatial variation in these factors can create heterogeneity in temporal dynamics within landscapes. We used understory plant species composition from an 11 year dataset from a California oak woodland to compare plots where disturbance was experimentally manipulated with the removal of livestock grazing and a prescribed burn. We quantified three properties of temporal variation: compositional change (reflecting the appearance and disappearance of species), temporal fluctuation, and directional change. Directional change was related most strongly to disturbance type, and was highest at plots where grazing was removed during the study. Temporal fluctuations, compositional change, and directional change were all related to intrinsic abiotic factors, suggesting that some locations are more responsive to external drivers than others. Temporal fluctuations and compositional change were linked to local functional composition, indicating that environmental filters can create subsets of the local species pool that do not respond in the same way to external drivers. Temporal dynamics are often assumed to be relatively static at the landscape scale, provided disturbance and climate are continuous. This study shows that local and landscape scale factors jointly influence temporal dynamics creating hotspots that are particularly responsive to climate and disturbance. Thus, adequate predictions of response to disturbance or to changing climate will only be achieved by considering how factors at multiple spatial scales influence community resilience and recovery.	[Spotswood, Erica N.; Bartolome, James W.; Allen-Diaz, Barbara] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Allen-Diaz, Barbara] Univ Calif, Dept Agr & Nat Resources, Oakland, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Spotswood, EN (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	espots@berkeley.edu			Integrated Hardwood Management Program; University of California Department of Agriculture and Natural Resources	Integrated Hardwood Management Program; University of California Department of Agriculture and Natural Resources(University of California System)	This project was funded primarily through the Integrated Hardwood Management Program which is a program with the University of California Department of Agriculture and Natural Resources (http://ucanr.edu/sites/oak_range/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Adler PB, 2008, AM NAT, V172, pE186, DOI 10.1086/591678; Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bartolome JW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P367; BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; Beckman NG, 2013, BIOTROPICA, V45, P666, DOI 10.1111/btp.12071; Bretz F., 2011, MULTIPLE COMPARISONS; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Collins SL, 2015, AM NAT, V185, pE30, DOI 10.1086/679315; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; D'Antonio C, 2000, ECOLOGY RESTORATION; Elmendorf SC, 2011, ECOLOGY, V92, P602, DOI 10.1890/10-0535.1; Fernandez-Going BM, 2012, ECOLOGY, V93, P2104, DOI 10.1890/11-2003.1; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gaertner M, 2012, RESTOR ECOL, P265, DOI [10.1002/9781118223130.CH20, DOI 10.1002/9781118223130.CH20]; Gea-Izquierdo G, 2007, APPL VEG SCI, V10, P343, DOI 10.1111/j.1654-109X.2007.tb00433.x; George M, 2001, ANR PUBLICATION; Geroy IJ, 2011, HYDROL PROCESS, V25, P3836, DOI 10.1002/hyp.8281; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; Hallett LM, 2014, ECOLOGY, V95, P1693, DOI 10.1890/13-0895.1; He NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026506; HEADY HAROLD F., 1959, JOUR RANGE MANAGEMENT, V12, P180, DOI 10.2307/3894848; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jackson RD, 2002, PLANT ECOL, V162, P49, DOI 10.1023/A:1020363603900; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lewis D, 2000, J HYDROL, V240, P106, DOI 10.1016/S0022-1694(00)00337-1; Mariotte P, 2013, BASIC APPL ECOL, V14, P217, DOI 10.1016/j.baae.2013.02.003; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Morecroft MD, 2012, J APPL ECOL, V49, P547, DOI [10.1111/j.1365-2664.2012.02136.x, 10.1111/j.1365-2664.2012.02147.x]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; R Core Team, 2018, R LANG ENV STAT COMP; Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841; Stahlheber KA, 2013, BIOL CONSERV, V157, P300, DOI 10.1016/j.biocon.2012.09.008; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Troeh F.R., 1993, SOILS SOIL FERTILITY, VFifth edition; VANDERMAAREL E, 1993, J VEG SCI, V4, P179, DOI 10.2307/3236103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; White EP, 2010, PHILOS T R SOC B, V365, P3633, DOI 10.1098/rstb.2010.0280; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yoshioka PM, 2008, MAR ECOL PROG SER, V368, P309, DOI 10.3354/meps07728; Zuur Alain F., 2009, P1	66	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133501	10.1371/journal.pone.0133501	http://dx.doi.org/10.1371/journal.pone.0133501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222069	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800053
J	Uddin, GMN; Larsen, MH; Barco, L; Phu, TM; Dalsgaard, A				Uddin, Gazi Md. Noor; Larsen, Marianne Halberg; Barco, Lisa; Tran Minh Phu; Dalsgaard, Anders			Clonal Occurrence of Salmonella Weltevreden in Cultured Shrimp in the Mekong Delta, Vietnam	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; IMPORTED FOODS; SEROVARS; SEAFOOD; HUMANS; FISH; PREVALENCE; PROTOCOLS; PULSENET	This study investigated the occurrence, serovar and antimicrobial resistance of Salmonella spp. in shrimp samples from intensive and extensive farms located in three different provinces in the Mekong Delta, Vietnam. Shrimp from 11 of the 48 farms all contained S. Weltevreden, except for one farm yielding S. Agona, with no difference in Salmonella occurrence between the two production systems. Pulsed field gel electrophoresis (PFGE) of S. Weltevreden showed closely related XbaI pulse types, suggesting a clonal relationship despite the farms and shrimp samples being epidemiologically unrelated. S. Weltevreden was susceptible to most antimicrobials tested, with a few strains being resistant to florfenicol, chloramphenicol, sulfamethoxazole or trimethoprim. Future studies of the ecology of S. Weltevreden should establish if this serovar may survive better and even multiply in warm-water shrimp farm environments compared to other Salmonella serovars.	[Uddin, Gazi Md. Noor; Larsen, Marianne Halberg; Dalsgaard, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Barco, Lisa] Ist Zooprofilatt Sperimentale Venezie, World Org Anim Hlth OIE, Natl Reference Lab Salmonella, Padua, Italy; [Tran Minh Phu] Can Tho Univ, Coll Aquaculture & Fisheries, Can Tho City, Vietnam	University of Copenhagen; IZS delle Venezie; Can Tho University	Dalsgaard, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark.	adal@sund.ku.dk	; Barco, Lisa/K-2284-2016	Larsen, Marianne Halberg/0000-0001-6242-6937; Tran, Minh Phu/0000-0002-2521-0667; Barco, Lisa/0000-0002-6247-248X	University of Copenhagen; EU [222889]	University of Copenhagen; EU(European Commission)	This study was funded by the University of Copenhagen through a PhD fellowship to G.M.N. Uddin. The work presented is also part of and supported by the EU funded project "Sustaining Ethical Aquaculture Trade" (SEAT project no 222889: www.seatglobal.eu).	AABO S, 1993, MOL CELL PROBE, V7, P171, DOI 10.1006/mcpr.1993.1026; Aarestrup FM, 2003, J ANTIMICROB CHEMOTH, V52, P715, DOI 10.1093/jac/dkg426; Amagliani G, 2012, FOOD RES INT, V45, P780, DOI 10.1016/j.foodres.2011.06.022; [Anonymous], 2007, ANIMAL FECES AND IN; Arcangioli MA, 1999, FEMS MICROBIOL LETT, V174, P327, DOI 10.1016/S0378-1097(99)00161-5; Asai Y, 2008, J FOOD PROTECT, V71, P1460, DOI 10.4315/0362-028X-71.7.1460; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Center for Disease Control and Prevention, 2014, DRINKING WATER; Clinical and Laboratory Standard Institute, 2012, CLSI DOCUMENT M100 S; Clinical and Laboratory Standard Institute, 2008, CLSI DOCUMENT M31A3; Food and Agriculture Organization of the United Nations, 2010, FAO EXPERT WORKSHOP; Heinitz ML, 2000, J FOOD PROTECT, V63, P579, DOI 10.4315/0362-028X-63.5.579; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Joseph B, 2001, INT J FOOD MICROBIOL, V64, P367, DOI 10.1016/S0168-1605(00)00466-9; Koonse B, 2005, J FOOD PROTECT, V68, P2527, DOI 10.4315/0362-028X-68.12.2527; Kumar R, 2009, J APPL MICROBIOL, V106, P515, DOI 10.1111/j.1365-2672.2008.04020.x; Kumar R, 2008, LETT APPL MICROBIOL, V46, P221, DOI 10.1111/j.1472-765X.2007.02286.x; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P2089, DOI 10.1128/AEM.70.4.2089-2097.2004; Nesse LL, 2005, EPIDEMIOL INFECT, V133, P53, DOI 10.1017/S0950268804003279; Ogasawara N, 2008, J VET MED SCI, V70, P1159, DOI 10.1292/jvms.70.1159; Pal A, 2009, FOOD MICROBIOL, V26, P317, DOI 10.1016/j.fm.2008.12.003; Parente L. S., 2011, Brazilian Journal of Veterinary Research and Animal Science, V48, P46; Phan LT, 2011, SEAT DELIVERABLE; Phan TT, 2005, J FOOD PROTECT, V68, P1077, DOI 10.4315/0362-028X-68.5.1077; Ponce E, 2008, FOOD MICROBIOL, V25, P29, DOI 10.1016/j.fm.2007.09.001; Rahimi E., 2013, Comparative Clinical Pathology, V22, P59, DOI 10.1007/s00580-011-1368-3; Ribeiro RV, 2010, LETT APPL MICROBIOL, V51, P611, DOI 10.1111/j.1472-765X.2010.02946.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Simental L, 2008, APPL ENVIRON MICROB, V74, P5918, DOI 10.1128/AEM.01139-08; de Carvalho FCT, 2009, REV CIENC AGRON, V40, P549; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2011, THE DANISH INTEGRATE, P67; Thong KL, 2002, J CLIN MICROBIOL, V40, P2498, DOI 10.1128/JCM.40.7.2498-2503.2002; Vo ATT, 2006, VET MICROBIOL, V113, P153, DOI 10.1016/j.vetmic.2005.10.034; Weill F, 2007, WHO COLLAB ORATING C; Yam WC, 2000, WATER RES, V34, P51, DOI 10.1016/S0043-1354(99)00105-0; Yasin Rohani M., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P457; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhao SH, 2003, INT J FOOD MICROBIOL, V84, P87, DOI 10.1016/S0168-1605(02)00402-6	40	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134252	10.1371/journal.pone.0134252	http://dx.doi.org/10.1371/journal.pone.0134252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222547	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800117
J	Phatak, P; Byrnes, KA; Mansour, D; Liu, L; Cao, S; Li, R; Rao, JN; Turner, DJ; Wang, JY; Donahue, JM				Phatak, P.; Byrnes, K. A.; Mansour, D.; Liu, L.; Cao, S.; Li, R.; Rao, J. N.; Turner, D. J.; Wang, J-Y; Donahue, J. M.			Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1	ONCOGENE			English	Article							MESSENGER-RNA; DOWN-REGULATION; EXPRESSION; MICRORNAS; APOPTOSIS	Based on its marked overexpression in multiple malignancies and its roles in promoting cell survival and proliferation, survivin is an attractive candidate for targeted therapy. Toward this end, a detailed understanding of the mechanisms regulating survivin expression in different cancer cells will be critical. We have previously shown that the RNA-binding protein (RBP) CUG-BP1 is overexpressed in esophageal cancer cells and post-transcriptionally regulates survivin in these cells. The objective of this study was to investigate the role of microRNAs (miRs) in regulating survivin expression in esophageal cancer cells. Using miR expression profiling analysis, we found that miR-214-3p is one of the most markedly downregulated miRs in two esophageal squamous cancer cell lines compared with esophageal epithelial cells. Interestingly, using miR target prediction programs, both survivin and CUG-BP1 mRNA were found to contain potential binding sites for miR-214-3p. Forced expression of miR-214-3p in esophageal cancer cells leads to a decrease in the mRNA and protein levels of both survivin and CUG-BP1. This effect is due to decreased mRNA stability of both targets. By contrast, silencing miR-214-3p in esophageal epithelial cells leads to an increase in both survivin and CUG-BP1 mRNA and protein. To determine whether the observed effect of miR-214-3p on survivin expression was direct, mediated through CUG-BP1, or both, binding studies utilizing biotin pull-down assays and heterologous luciferase reporter constructs were performed. These demonstrated that the mRNA of survivin and CUG-BP1 each contain two functional miR-214-3p-binding sites as confirmed by mutational analysis. Finally, forced expression of miR-214-3p enhances the sensitivity of esophageal cancer cells to cisplatin-induced apoptosis. This effect is abrogated with rescue expression of survivin or CUG-BP1. These findings suggest that miR-214-3p acts as a tumor suppressor and that its downregulation contributes to chemoresistance in esophageal cancer cells by targeting both survivin and CUG-BP1.	[Phatak, P.; Byrnes, K. A.; Mansour, D.; Liu, L.; Cao, S.; Li, R.; Rao, J. N.; Turner, D. J.; Wang, J-Y; Donahue, J. M.] Univ Maryland, Sch Med, Dept Surg, Cell Biol Grp, 29 South Greene St,Suite 504, Baltimore, MD 21201 USA; [Phatak, P.; Byrnes, K. A.; Mansour, D.; Liu, L.; Cao, S.; Li, R.; Rao, J. N.; Turner, D. J.; Wang, J-Y; Donahue, J. M.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Wang, J-Y] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore	Donahue, JM (corresponding author), Univ Maryland, Sch Med, Dept Surg, Cell Biol Grp, 29 South Greene St,Suite 504, Baltimore, MD 21201 USA.	jdonahue@smail.umaryland.edu			Department of Veterans Affairs, USA; National Institutes of Health [DK-57819, DK-61972, DK-68491]; Department of Surgery, University of Maryland School of Medicine; NATIONAL CANCER INSTITUTE [T32CA154274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068491, R01DK061972, R01DK057819] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000713, I01BX000113, I01BX000332] Funding Source: NIH RePORTER	Department of Veterans Affairs, USA(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery, University of Maryland School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, USA (Merit Review Grants to JNR, DJT and J-YW; VA Career Development Award to JMD); the National Institutes of Health (grant numbers DK-57819, DK-61972 and DK-68491 to J-YW) and departmental funds from the Department of Surgery, University of Maryland School of Medicine (to JMD). The authors also acknowledge Dr Karthika Natarajan, Dr Xi Yang and Ratnakar Potla for their technical assistance as well as Dr Anne W Hamburger for assistance in preparation of the manuscript.	Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Cao WG, 2013, TUMOR BIOL, V34, P963, DOI 10.1007/s13277-012-0632-8; Chang E, 2010, J THORAC CARDIOV SUR, V140, P225, DOI 10.1016/j.jtcvs.2009.11.038; Chang ET, 2012, BIOCHEM J, V446, P113, DOI 10.1042/BJ20120112; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Choi YE, 2014, ELIFE, V3, DOI 10.7554/eLife.02445; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cui YH, 2012, MOL BIOL CELL, V23, P151, DOI 10.1091/mbc.E11-05-0456; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Donahue JM, 2011, BIOCHEM J, V437, P89, DOI 10.1042/BJ20110028; Duan Q, 2012, PLOS ONE, V7, P1; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Huang SD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-51; Jangpatarapongsa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045971; Kato J, 2001, INT J CANCER, V95, P92; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Shen ZS, 2012, MED ONCOL, V29, P2473, DOI 10.1007/s12032-011-0156-x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Talwar S, 2013, RNA BIOL, V10, P277, DOI 10.4161/rna.23315; Vallbohmer D, 2008, PHARMACOGENOMICS, V9, P681, DOI 10.2217/14622416.9.6.681; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang W, 2013, CELL BIOCHEM FUNCT, V31, P82, DOI 10.1002/cbf.2863; Xu D, 2013, MOL MED REP, V8, P379, DOI 10.3892/mmr.2013.1504; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]	33	70	76	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2087	2097		10.1038/onc.2015.271	http://dx.doi.org/10.1038/onc.2015.271			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26234674	Green Accepted			2022-12-26	WOS:000374505600008
J	Wang, RS; Chen, SY; Liu, YC; Diao, SY; Xue, YQ; You, XQ; Park, EA; Liao, FF				Wang, Ruishan; Chen, Shaoya; Liu, Yingchun; Diao, Shiyong; Xue, Yueqiang; You, Xiaoqing; Park, Edwards A.; Liao, Francesca-Fang			All-trans-retinoic Acid Reduces BACE1 Expression under Inflammatory Conditions via Modulation of Nuclear Factor kappa B (NF kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIONAL MEMORY DEFICIT; TUMOR-NECROSIS-FACTOR; VITAMIN-A-DEFICIENCY; ALZHEIMERS-DISEASE; AMYLOID-BETA; DIFFERENTIAL REGULATION; THERAPEUTIC STRATEGY; PROMOTER ACTIVITY; RECEPTORS; INHIBITION	Insulin resistance and neuroinflammation have emerged as two likely key contributors in the pathogenesis of Alzheimer disease (AD), especially in those sporadic AD cases compromised by diabetes or cardiovascular disease. Amyloid-beta (A beta) deposition and its associated inflammatory response are hallmarks in sporadic AD brains. Elevated expression and activity of beta-secretase 1 (BACE1), the rate-limiting enzyme responsible for the beta-cleavage of amyloid precursor proteins to A beta peptides, are also observed in sporadic AD brains. Previous studies have suggested that there is therapeutic potential for retinoic acid in treating neurodegeneration based on decreased A beta. Here we discovered that BACE1 expression is elevated in the brains of both Tg2576 transgenic mice and mice on high fat diets. These conditions are associated with a neuroinflammatory response. We found that administration of all-trans-retinoic acid (atRA) down-regulated the expression of BACE1 in the brains of Tg2576 mice and in mice fed a high fat diet. Moreover, in LPS-treated mice and cultured neurons, BACE1 expression was repressed by the addition of atRA, correlating with the anti-inflammatory efficacy of atRA. Mutations of the NF kappa B binding site in BACE1 promoter abolished the suppressive effect of atRA. Furthermore, atRA disrupted LPS-induced nuclear translocation of NF kappa B and its binding to BACE1 promoter as well as promoting the recruitment of the corepressor NCoR. Our findings indicate that atRA represses BACE1 gene expression under inflammatory conditions via the modulation of NF kappa B signaling.	[Wang, Ruishan; Chen, Shaoya; Liu, Yingchun; Diao, Shiyong; Xue, Yueqiang; Park, Edwards A.; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Park, Edwards A.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA; [You, Xiaoqing] Fujian Med Univ, Div Cell Biol & Genet, Fuzhou 350004, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Fujian Medical University	Wang, RS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	rwang11@uthsc.edu; fliao@uthsc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 AG031893, R21 AG041934, R21NS083908]; Alzheimer Association [IIRG-11-204030]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031893, R01AG049772, R21AG041934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AG031893 and R21 AG041934 (to F. -F. L.) and R21NS083908 (to F. -F. L. and E. A. P.), and by Alzheimer Association Grant IIRG-11-204030 (to F. -F. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Austenaa LM, 2009, J NUTR BIOCHEM, V20, P726, DOI 10.1016/j.jnutbio.2008.07.002; Austenaa LMI, 2004, FASEB J, V18, P1255, DOI 10.1096/fj.03-1098fje; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Benkoussa M, 2002, MOL CELL BIOL, V22, P4522, DOI 10.1128/MCB.22.13.4522-4534.2002; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Culpan D, 2009, NEUROBIOL AGING, V30, P1052, DOI 10.1016/j.neurobiolaging.2007.10.014; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Dutta A, 2010, CELL ADHES MIGR, V4, P409, DOI 10.4161/cam.4.3.11682; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Espinosa-Oliva Ana M, 2013, Methods Mol Biol, V1041, P295, DOI 10.1007/978-1-62703-520-0_26; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Guglielmotto M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.026; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hong K, 2014, IMMUNOL LETT, V162, P34, DOI 10.1016/j.imlet.2014.06.011; Janardhan KS, 2006, HISTOL HISTOPATHOL, V21, P687, DOI 10.14670/HH-21.687; Jimenez-Jimenez FJ, 1999, EUR J NEUROL, V6, P495, DOI 10.1046/j.1468-1331.1999.640495.x; Kampmann E, 2008, J NEUROCHEM, V106, P320, DOI 10.1111/j.1471-4159.2008.05395.x; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kirchmeyer M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2569; Koryakina A, 2009, FEBS J, V276, P2645, DOI 10.1111/j.1742-4658.2009.06992.x; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; Lee HP, 2009, EXPERT REV NEUROTHER, V9, P1615, DOI 10.1586/ERN.09.86; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lerner AJ, 2012, BIOFACTORS, V38, P84, DOI 10.1002/biof.196; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Malaspina A, 2008, J NEUROCHEM, V104, P584, DOI 10.1111/j.1471-4159.2007.05071.x; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; MEHTA K, 1994, J LEUKOCYTE BIOL, V55, P336, DOI 10.1002/jlb.55.3.336; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; Ono K, 2012, GERIATR GERONTOL INT, V12, P180, DOI 10.1111/j.1447-0594.2011.00786.x; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schmidt CK, 2003, ANAL BIOCHEM, V315, P36, DOI 10.1016/S0003-2697(02)00662-0; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Valero J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00083; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; ZITNIK RJ, 1994, J IMMUNOL, V152, P1419	63	54	60	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22532	22542		10.1074/jbc.M115.662908	http://dx.doi.org/10.1074/jbc.M115.662908			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26240147	hybrid, Green Published			2022-12-26	WOS:000361171500020
J	Abraham, BG; Sarkisyan, KS; Mishin, AS; Santala, V; Tkachenko, NV; Karp, M				Abraham, Bobin George; Sarkisyan, Karen S.; Mishin, Alexander S.; Santala, Ville; Tkachenko, Nikolai V.; Karp, Matti			Fluorescent Protein Based FRET Pairs with Improved Dynamic Range for Fluorescence Lifetime Measurements	PLOS ONE			English	Article							ENERGY-TRANSFER; IMAGING MICROSCOPY; FORSTER DISTANCES; MONOMERIC RED; SENSOR; CELLS; ENVIRONMENT; EXCITATION	Fluorescence Resonance Energy Transfer (FRET) using fluorescent protein variants is widely used to study biochemical processes in living cells. FRET detection by fluorescence lifetime measurements is the most direct and robust method to measure FRET. The traditional cyan-yellow fluorescent protein based FRET pairs are getting replaced by green-red fluorescent protein variants. The green-red pair enables excitation at a longer wavelength which reduces cellular autofluorescence and phototoxicity while monitoring FRET. Despite the advances in FRET based sensors, the low FRET efficiency and dynamic range still complicates their use in cell biology and high throughput screening. In this paper, we utilized the higher lifetime of NowGFP and screened red fluorescent protein variants to develop FRET pairs with high dynamic range and FRET efficiency. The FRET variations were analyzed by proteolytic activity and detected by steady-state and time-resolved measurements. Based on the results, NowGFP-tdTomato and NowGFP-mRuby2 have shown high potentials as FRET pairs with large fluorescence lifetime dynamic range. The in vitro measurements revealed that the NowGFP-tdTomato has the highest Forster radius for any fluorescent protein based FRET pairs yet used in biological studies. The developed FRET pairs will be useful for designing FRET based sensors and studies employing Fluorescence Lifetime Imaging Microscopy (FLIM).	[Abraham, Bobin George; Santala, Ville; Tkachenko, Nikolai V.; Karp, Matti] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland; [Sarkisyan, Karen S.; Mishin, Alexander S.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Tampere University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Abraham, BG (corresponding author), Tampere Univ Technol, Dept Chem & Bioengn, POB 541, FIN-33101 Tampere, Finland.	bobin.georgeabraham@tut.fi	Abraham, Bobin George/AAX-2600-2020; Mishin, Alexander/L-9420-2014; Sarkisyan, Karen S/M-6821-2015; Sarkisyan, Karen/AAA-5784-2021; Karp, Matti/G-4227-2014; Tkachenko, Nikolai V./G-4232-2014	Mishin, Alexander/0000-0002-4935-7030; Sarkisyan, Karen S/0000-0002-5375-6341; Sarkisyan, Karen/0000-0002-5375-6341; Karp, Matti/0000-0001-6686-4416; Tkachenko, Nikolai V./0000-0002-8504-2335; George Abraham, Bobin/0000-0002-1373-4244; Santala, Ville/0000-0002-9084-931X	BGA; Finnish Cultural Foundation (Suomen Kulttuurirahasto); Russian Foundation for Basic Research [13-04-01878-A]	BGA; Finnish Cultural Foundation (Suomen Kulttuurirahasto)(Finnish Cultural Foundation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	LASKEMO graduate school is acknowledged for financial support by BGA. MK acknowledges the sabbatical year funding from Finnish Cultural Foundation (Suomen Kulttuurirahasto). KSS and ASM are supported by Russian Foundation for Basic Research (grant 13-04-01878-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BG, 2014, ANAL BIOANAL CHEM, V406, P7195, DOI 10.1007/s00216-014-8165-1; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Bayle V, 2008, PLANT PHYSIOL, V148, P51, DOI 10.1104/pp.108.117358; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Chang CW, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3257254; Chen YE, 2004, MICROSC RES TECHNIQ, V63, P72, DOI 10.1002/jemt.10430; Dewitt S, 2009, J CELL BIOL, V184, P197, DOI 10.1083/jcb.200806047; Eisenstein M, 2006, NAT METHODS, V3, P647, DOI 10.1038/nmeth0806-647; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hink MA, 2003, J FLUORESC, V13, P185, DOI 10.1023/A:1022947411788; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; McGinty J, 2009, LAB TECH BIOCHEM MOL, V33, P133, DOI 10.1016/S0075-7535(08)00004-1; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Piatkevich KD, 2011, METHOD CELL BIOL, V102, P431, DOI 10.1016/B978-0-12-374912-3.00017-1; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Pliss A, 2012, ACS CHEM BIOL, V7, P1385, DOI 10.1021/cb300065w; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sarkisyan KS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00608; Sarkisyan KS, BIOPHYSICAL IN PRESS; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Suhling K, 2014, FLUORESCENCE LIFETIM, P23; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Dongen EMWM, 2007, J AM CHEM SOC, V129, P3494, DOI 10.1021/ja069105d; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Veselov AA, 2012, ANAL BIOANAL CHEM, V402, P1149, DOI 10.1007/s00216-011-5564-4; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	46	21	21	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134436	10.1371/journal.pone.0134436	http://dx.doi.org/10.1371/journal.pone.0134436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237400	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400027
J	Roybal, KT; Mace, EM; Clark, DJ; Leard, AD; Herman, A; Verkade, P; Orange, JS; Wulfing, C				Roybal, Kole T.; Mace, Emily M.; Clark, Danielle J.; Leard, Alan D.; Herman, Andrew; Verkade, Paul; Orange, Jordan S.; Wuelfing, Christoph			Modest Interference with Actin Dynamics in Primary T Cell Activation by Antigen Presenting Cells Preferentially Affects Lamellal Signaling	PLOS ONE			English	Article							KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; SPATIOTEMPORAL ORGANIZATION; RETROGRADE FLOW; CDC42 ACTIVITY; CALCIUM-ENTRY; RECEPTOR; CYTOSKELETON; POLYMERIZATION; COSTIMULATION	Dynamic subcellular distributions of signaling system components are critical regulators of cellular signal transduction through their control of molecular interactions. Understanding how signaling activity depends on such distributions and the cellular structures driving them is required for comprehensive insight into signal transduction. In the activation of primary murine T cells by antigen presenting cells (APC) signaling intermediates associate with various subcellular structures, prominently a transient, wide, and actin-associated lamellum extending from an interdigitated T cell: APC interface several micrometers into the T cell. While actin dynamics are well established as general regulators of cellular organization, their role in controlling signaling organization in primary T cell: APC couples and the specific cellular structures driving it is unresolved. Using modest interference with actin dynamics with a low concentration of Jasplakinolide as corroborated by costimulation blockade we show that T cell actin preferentially controls lamellal signaling localization and activity leading downstream to calcium signaling. Lamellal localization repeatedly related to efficient T cell function. This suggests that the transient lamellal actin matrix regulates T cell signaling associations that facilitate T cell activation.	[Roybal, Kole T.; Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Mace, Emily M.; Orange, Jordan S.] Univ Penn, Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Clark, Danielle J.; Herman, Andrew; Wuelfing, Christoph] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Leard, Alan D.; Verkade, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bristol; University of Bristol; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wulfing, C (corresponding author), UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.	Christoph.Wuelfing@bristol.co.uk	Verkade, Paul/N-7240-2014	Verkade, Paul/0000-0002-2497-1026; Wuelfing, Christoph/0000-0002-6156-9861; Mace, Emily/0000-0003-0226-7393; orange, jordan/0000-0001-7117-7725	National Institutes of Health (NIH) Ruth L. Kirschstein research service award [2T32AI005284-32]; NIH [A1-97981]; NSF [1121793]; BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein research service award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) Ruth L. Kirschstein research service award (2T32AI005284-32) to K. R. and NIH (A1-97981) and NSF (1121793) funding to C. W.	Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133231	10.1371/journal.pone.0133231	http://dx.doi.org/10.1371/journal.pone.0133231			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237588	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942400009
J	Zavallo, D; Debat, HJ; Conti, G; Manacorda, CA; Rodriguez, MC; Asurmendi, S				Zavallo, Diego; Julio Debat, Humberto; Conti, Gabriela; Augusto Manacorda, Carlos; Cecilia Rodriguez, Maria; Asurmendi, Sebastian			Differential mRNA Accumulation upon Early Arabidopsis thaliana Infection with ORMV and TMV-Cg Is Associated with Distinct Endogenous Small RNAs Level	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ABIOTIC STRESS RESPONSES; TRANS-ACTING SIRNAS; DNA-METHYLATION; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORKS; PLANT DEVELOPMENT; TARGET GENES; MICRORNAS; EXPRESSION	Small RNAs (sRNAs) play important roles in plant development and host-pathogen interactions. Several studies have highlighted the relationship between viral infections, endogenous sRNA accumulation and transcriptional changes associated with symptoms. However, few studies have described a global analysis of endogenous sRNAs by comparing related viruses at early stages of infection, especially before viral accumulation reaches systemic tissues. An sRNA high-throughput sequencing of Arabidopsis thaliana leaf samples infected either with Oilseed rape mosaic virus (ORMV) or crucifer-infecting Tobacco mosaic virus (TMV-Cg) with slightly different symptomatology at two early stages of infection (2 and 4dpi) was performed. At early stages, both viral infections strongly alter the patterns of several types of endogenous sRNA species in distal tissues with no virus accumulation suggesting a systemic signaling process foregoing to virus spread. A correlation between sRNAs derived from protein coding genes and the associated mRNA transcripts was also detected, indicating that an unknown recursive mechanism is involved in a regulatory circuit encompassing this sRNA/mRNA equilibrium. This work represents the initial step in uncovering how differential accumulation of endogenous sRNAs contributes to explain the massive alteration of the transcriptome associated with plant-virus interactions.	[Zavallo, Diego; Conti, Gabriela; Augusto Manacorda, Carlos; Cecilia Rodriguez, Maria; Asurmendi, Sebastian] CICVyA INTA, Inst Biotecnol, Hurlingham, Buenos Aires, Argentina; [Zavallo, Diego; Conti, Gabriela; Cecilia Rodriguez, Maria; Asurmendi, Sebastian] Consejo Nacl Invest Cient ficas Tecn CONICET, Buenos Aires, DF, Argentina; [Julio Debat, Humberto] Ctr Invest Agropecuarias CIAP, Inst Patol Vegetal IPAVE, INTA, Cordoba, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Asurmendi, S (corresponding author), CICVyA INTA, Inst Biotecnol, Hurlingham, Buenos Aires, Argentina.	asurmendi.sebastian@inta.gob.ar	Debat, Humberto Julio/GXF-9011-2022; Debat, Humberto/Y-6380-2019; Asurmendi, Sebastian/AAJ-1400-2021	Debat, Humberto/0000-0003-3056-3739; Zavallo, Diego/0000-0002-9021-2175; Asurmendi, Sebastian/0000-0001-9516-5948; Conti, Gabriela/0000-0003-4221-3760	Instituto Nacional de Tecnologia Agropecuaria (INTA) [PE 1131022]; ANPCyT PICT [2011-939]	Instituto Nacional de Tecnologia Agropecuaria (INTA); ANPCyT PICT(ANPCyT)	This work was supported by the Instituto Nacional de Tecnologia Agropecuaria (INTA) [PE 1131022] and by ANPCyT PICT 2011-939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Manacorda CA, 2013, MOL PLANT MICROBE IN, V26, P1486, DOI 10.1094/MPMI-07-13-0190-R; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bazzini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028466; Bazzini AA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-152; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Debat HJ, 2014, PLANT MOL BIOL REP, V32, P1257, DOI 10.1007/s11105-014-0727-z; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Duplan V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00042; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; German-Retana S, 2008, MOL PLANT PATHOL, V9, P127, DOI [10.1111/j.1364-3703.2007.00451.x, 10.1111/J.1364-3703.2007.00451.X]; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Guo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116175; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hu QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019549; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1046/j.1365-313X.2003.01869.x; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; LEISNER SM, 1993, PLANT CELL, V5, P191, DOI 10.1105/tpc.5.2.191; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang G, 2010, PLANT SIGNAL BEHAV, V5, P1257, DOI 10.4161/psb.5.10.12608; Lin KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011928; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lopez-Gomollon S, 2012, PLANTA, V236, P1875, DOI 10.1007/s00425-012-1734-7; Mansilla C, 2009, MOL PLANT PATHOL, V10, P59, DOI 10.1111/j.1364-3703.2008.00506.x; Martinez G, 2014, NUCLEIC ACIDS RES, V42, P1553, DOI 10.1093/nar/gkt968; Miozzi L, 2013, VIRUS RES, V178, P287, DOI 10.1016/j.virusres.2013.09.029; Mitter N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076276; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Palukaitis P, 2013, CURR OPIN PLANT BIOL, V16, P513, DOI 10.1016/j.pbi.2013.06.004; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Seguin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088513; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Thatcher SR, 2015, PLANT CELL ENVIRON, V38, P188, DOI 10.1111/pce.12393; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149	72	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134719	10.1371/journal.pone.0134719	http://dx.doi.org/10.1371/journal.pone.0134719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237414	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400035
J	Choi, YJ; Thines, M				Choi, Young-Joon; Thines, Marco			Host Jumps and Radiation, Not Co-Divergence Drives Diversification of Obligate Pathogens. A Case Study in Downy Mildews and Asteraceae	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; EVOLUTION; HISTORY; GENERA; HYALOPERONOSPORA; RECONSTRUCTION; COSPECIATION; ASSOCIATIONS; COPHYLOGENY; COEVOLUTION	Even though the microevolution of plant hosts and pathogens has been intensely studied, knowledge regarding macro-evolutionary patterns is limited. Having the highest species diversity and host-specificity among Oomycetes, downy mildews are a useful a model for investigating long-term host-pathogen coevolution. We show that phylogenies of Bremia and Asteraceae are significantly congruent. The accepted hypothesis is that pathogens have diverged contemporarily with their hosts. But maximum clade age estimation and sequence divergence comparison reveal that congruence is not due to long-term coevolution but rather due to host-shift driven speciation (pseudo-cospeciation). This pattern results from parasite radiation in related hosts, long after radiation and speciation of the hosts. As large host shifts free pathogens from hosts with effector triggered immunity subsequent radiation and diversification in related hosts with similar innate immunity may follow, resulting in a pattern mimicking true co-divergence, which is probably limited to the terminal nodes in many pathogen groups.	[Choi, Young-Joon; Thines, Marco] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Fac Biosci, D-60438 Frankfurt, Germany; [Choi, Young-Joon; Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Integrat Fungal Res Cluster IPF, D-60325 Frankfurt, Germany; [Thines, Marco] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN)	Choi, YJ (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Fac Biosci, D-60438 Frankfurt, Germany.	youngjoon.choi@senckenberg.de; marco.thines@senckenberg.de			Alexander von Humboldt foundation; LOEWE excellence program of the German state of Hessen; Biodiversity and Climate Research Centre (BiK-F)	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); LOEWE excellence program of the German state of Hessen; Biodiversity and Climate Research Centre (BiK-F)	YJC was supported by a fellowship from the Alexander von Humboldt foundation (http://www.humboldt-foundation.de/web/home.html). This work was supported by the LOEWE excellence program of the German state of Hessen, in the framework of the Integrative Fungal Research Cluster (IPF) and the Biodiversity and Climate Research Centre (BiK-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Barreda VD, 2012, ANN BOT-LONDON, V109, P127, DOI 10.1093/aob/mcr240; Choi YJ, 2015, MOL ECOL RESOUR, V15, P1275, DOI 10.1111/1755-0998.12398; Choi YJ, 2011, ORG DIVERS EVOL, V11, P193, DOI 10.1007/s13127-011-0043-5; Choi YJ, 2011, FUNGAL BIOL-UK, V115, P102, DOI 10.1016/j.funbio.2010.10.010; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Desprez-Loustau ML, 2011, MYCOSCIENCE, V52, P165, DOI 10.1007/s10267-010-0100-5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fahrenholz H, 1913, ZOOL ANZ, V41, P371; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; Gaumann E., 1919, MITT NAT FORSCH GES, V1918, P45; GAUMANN E, 1918, BOT ZENTRALBLATT S, V35, P395; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Goker M., 2004, Mycological Progress, V3, P83, DOI 10.1007/s11557-006-0079-7; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Hirose S, 2005, MYCOL RES, V109, P912, DOI 10.1017/S0953756205003527; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Jackson AP, 2004, EVOLUTION, V58, P1909, DOI 10.1111/j.0014-3820.2004.tb00479.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kilian N., 2009, SYSTEMATICS EVOLUTIO; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Matari NH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-101; Matsuda S, 2003, MOL PHYLOGENET EVOL, V27, P314, DOI 10.1016/S1055-7903(02)00401-3; McLeish MJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-1; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Merkle D, 2005, THEOR BIOSCI, V123, P277, DOI 10.1016/j.thbio.2005.01.003; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Navarro E, 2003, PLANT SOIL, V254, P207, DOI 10.1023/A:1024978409187; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rambaut A., 2002, TREEANNOTATOR VERSIO; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Runge F, 2012, PLANT DIS, V96, P55, DOI 10.1094/PDIS-01-11-0035; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Swofford D., 2002, PAUP 4 0 B10 PHYLOGE; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thines M, 2010, EUR J PLANT PATHOL, V128, P81, DOI 10.1007/s10658-010-9632-y; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Voglmayr H, 2004, MYCOL RES, V108, P1011, DOI 10.1017/S0953756204000954; Voglmayr H, 2008, MYCOL RES, V112, P487, DOI 10.1016/j.mycres.2007.10.009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Zhang JW, 2011, TAXON, V60, P15, DOI 10.1002/tax.601003	67	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133655	10.1371/journal.pone.0133655	http://dx.doi.org/10.1371/journal.pone.0133655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230508	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400047
J	Flores-Hernandez, S; Saturno-Hernandez, PJ; Reyes-Morales, H; Barrientos-Gutierrez, T; Villalpando, S; Hernandez-Avila, M				Flores-Hernandez, Sergio; Saturno-Hernandez, Pedro J.; Reyes-Morales, Hortensia; Barrientos-Gutierrez, Tonatiuh; Villalpando, Salvador; Hernandez-Avila, Mauricio			Quality of Diabetes Care: The Challenges of an Increasing Epidemic in Mexico. Results from Two National Health Surveys (2006 and 2012)	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; OF-CARE; CARDIOVASCULAR-DISEASE; TYPE-2; MANAGEMENT; MELLITUS; COMPLICATIONS; IMPROVEMENT; PREVENTION; COUNTRIES	Background The quality of diabetes care remains suboptimal according to numerous studies assessing the achievement of quality indicators for diabetes care in various healthcare settings. We report about global and specific quality indicators for diabetes care and their association to glycemic control at the population level in two national health surveys in Mexico. Methods We conducted a cross-sectional analysis of the 2006 and 2012 National Health Surveys in Mexico. We examined quality of care for 2,965 and 4,483 adults (>= 20 years) with diagnosed type 2 diabetes using fourteen simple and two composite indicators derived from self-reported information. In a subsample for both surveys, glycated hemoglobin (HbA1c) was measured at the time of the interview. We obtained survey weight-adjusted estimators using multiple regression models (logistic and linear) with combined data files, including survey year as covariate to assess change. Results Global quality of care in 2012 was 40.8%, with a relative improvement of 11.7% between 2006 and 2012. Detections of cardiovascular disease risk factors (dyslipidemia and hypertension) were the indicators with the highest improvement, while non-pharmaceutical treatment and diabetic foot exams showed minor changes. We found a significant association between the quality of the process of diabetes care and glycemic control (OR 2.53, 95% CI 1.63-3.94). Age more than 65 years old, the type of health subsystem, gender (males), and high socio-economic status were also significantly associated to glycemic control. Conclusions Quality diabetes care and glycemic control improved and are significantly associated. However, according to international standards, the current situation remains suboptimal. A more holistic approach is needed, with an emphasis on improving quality in outpatient care.	[Flores-Hernandez, Sergio] Ctr Invest Evaluac & Encuestas, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Saturno-Hernandez, Pedro J.] Inst Nacl Salud Publ, Direcc Ctr Invest Evaluac & Encuestas, Cuernavaca, Morelos, Mexico; [Reyes-Morales, Hortensia] Hosp Infantil Mexico Dr Federico Gomez, Direcc Invest, Mexico City, DF, Mexico; [Barrientos-Gutierrez, Tonatiuh] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Villalpando, Salvador] Inst Nacl Salud Publ, Ctr Invest Salud & Nutr, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Inst Nacl Salud Publ, Direcc Gen, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Hospital Infantil de Mexico Federico Gomez; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Flores-Hernandez, S (corresponding author), Ctr Invest Evaluac & Encuestas, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.	sergio.flores@insp.mx	Villalpando, Salvador/AAS-3874-2021	Villalpando, Salvador/0000-0001-6429-3816; Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], GBD PROF MEX GLOB BU; [Anonymous], 2013, INF EL FED C UN SIT; Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Bruno Graziella, 2012, Diabetes Care, V35, pe64; Buenas Pr&aacute;cticas en la Seguridad Social, 2012, PROGR MAN INT DIAB E; Carter JS, 2000, ARCH INTERN MED, V160, P3471, DOI 10.1001/archinte.160.22.3471; Centers for Disease Control and Prevention, 2012, DIAB REP CARD 2012; Hernandez-Romieu AC, 2011, SALUD PUBLICA MEXICO, V53, P34, DOI 10.1590/S0036-36342011000100006; Cordova-Villalobos JA, 2008, SALUD PUBLICA MEXICO, V50, P419, DOI 10.1590/s0036-36342008000500015; Diabetes UK, CAR CON CAMP STAT NA; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Gagliardino J J, 2001, Rev Panam Salud Publica, V10, P309, DOI 10.1590/S1020-49892001001100003; Gakidou E, 2011, B WORLD HEALTH ORGAN, V89, P172, DOI 10.2471/BLT.10.080820; Gil-Velazquez Luisa Estela, 2013, Rev Med Inst Mex Seguro Soc, V51, P58; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2006, IDF DIAB ATL 2; International Diabetes Federation, 2011, GLOB DIAB PLAN 2011; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2014, IDF DIABETES ATLAS U; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Jimenez-Corona A, 2013, SALUD PUBLICA MEXICO, V55, pS137, DOI 10.21149/spm.v55s2.5109; Kontopantelis E, 2015, DIABETOLOGIA, V58, P505, DOI 10.1007/s00125-014-3473-8; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Lee S, 2007, 2007 CAL HLTH INT SU; Mannucci E, 2013, DIABETES CARE, V36, pS259, DOI 10.2337/dcS13-2018; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; National Center for Quality Assurance, 2013, 20135155 NAT CTR QUA, P51; National Institute for Clinical Excellence, MAN TYP 2 DIAB NIC C; Olaiz-Fernandez G, 2006, ENCUESTA NACL SALUD; Olaiz-Fernandez G, 2007, SALUD PUBLICA MEXICO, V49, pS331, DOI 10.1590/S0036-36342007000900004; Ortiz-Dominguez ME, 2011, SALUD PUBLICA MEXICO, V53, pS436, DOI 10.1590/S0036-36342011001000007; Perez-Cuevas R, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-50; Reeves D, 2007, MED CARE, V45, P489, DOI 10.1097/MLR.0b013e31803bb479; Reyes-Morales H, 2009, FAM MED, V41, P277; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Saluwe A., 2013, HLTH GLANC OECD IND, DOI [DOI 10.1787/HEALTH_GLANCE-2013-EN, 10.1787/health_glance-2013-en]; Sattar N, 2012, DIABETES OBES METAB, P1, DOI [10.1111/dom.12018, DOI 10.1111/D0M.12018]; Saturno PJ, 2004, REV CALIDAD ASISTENC, V19, P407, DOI DOI 10.1016/S1134-282X(04)77732-5; Saturno PJ, 2008, METODOS HERRAMIENTAS; Secretar&iacute;a de salud, GUIAS PRACT CLIN DIA; Secretar&iacute;a de Salud, 2007, DIABETES MELLITUS; Shaw J., 2012, DIABETES SILENT PAND; Sistema Nacional de Informaci&oacute;n en Salud, EST TEM DEF; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Villarreal H&eacute;ctor J, 2015, HLTH POLICY PLANNING, P1, DOI [10.1093/heapol/czv015, DOI 10.1093/HEAP0L/CZV015]; Wandurraga EA, 2014, REV ASOCIACION LATIN, V4, P106	55	34	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133958	10.1371/journal.pone.0133958	http://dx.doi.org/10.1371/journal.pone.0133958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230991	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400064
J	Kondo, M; Yamato, M; Takagi, R; Namiki, H; Okano, T				Kondo, Makoto; Yamato, Masayuki; Takagi, Ryo; Namiki, Hideo; Okano, Teruo			Membrane-Permeable Calpain Inhibitors Promote Rat Oral Mucosal Epithelial Cell Proliferation by Inhibiting IL-1 alpha Signaling	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; HUMAN KERATINOCYTES; ACTIVATING FACTOR; GROWTH; EXPRESSION; INVITRO; SHEETS; ENZYME	To standardise regenerative medicine using cultured cells, the use of serum-free, chemically defined media will be necessary. We have reported that IL-1 alpha inhibits the growth of epithelial cells in culture and that recombinant IL-1 receptor antagonist (IL-1RA) significantly promotes epithelial cell growth in no feeder layer condition. In this study, we examined inhibitors of calpain, a cysteine proteinase that plays crucial roles in various cellular functions, including IL-1 alpha maturation and secretion. The culturing of epithelial cells in serum-free media supplemented with a membrane-permeable calpain inhibitor significantly promoted growth while suppressing IL-1 alpha maturation and secretion. By contrast, non-membrane-permeable calpain inhibitor treatment did not have these effects. Interestingly, immunoblotting analysis revealed that immature, untruncated, IL-1 alpha expression was also downregulated by cell-permeable calpain inhibitor treatment, and the difference in IL-1 alpha gene expression increased from day 2 to day 6. Although IL-1RA has been reported to promote epithelial cell growth, we detected no synergistic promotion of epithelial cell growth using a calpain inhibitor and IL-1RA. These findings indicate that calpain inhibitors promote epithelial cell proliferation by inhibiting IL-1 alpha maturation at an early phase of epithelial cell culture and by suppressing the positive feedback-mediated amplification of IL-1 alpha signalling.	[Kondo, Makoto; Yamato, Masayuki; Takagi, Ryo; Okano, Teruo] Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Kondo, Makoto; Namiki, Hideo] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Tokyo Women's Medical University; Waseda University	Yamato, M (corresponding author), Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamato.masayuki@twmu.ac.jp	Kondo, Makoto/AAE-2471-2019	Kondo, Makoto/0000-0002-5978-0043; Okano, Teruo/0000-0002-4470-9842	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the MEXT; Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" from MEXT [K08]; JSPS from the Japanese Society for the Promotion of Science [DC1: 22-3791]	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the MEXT; Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" from MEXT; JSPS from the Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to TO); the Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" (K08) from MEXT (to MY) (http://www.jsps.go.jp/j-globalcoe/05_kyoten_k.html); and JSPS research fellowship (DC1: 22-3791) from the Japanese Society for the Promotion of Science (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bygrave FL, 1996, CELL CALCIUM, V19, P547, DOI 10.1016/S0143-4160(96)90064-0; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; DELUCA M, 1990, TRANSPLANTATION, V50, P454, DOI 10.1097/00007890-199009000-00019; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hata K, 1996, Hum Cell, V9, P91; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Kondo M, 2014, J BIOMED MATER RES A, V102, P1829, DOI 10.1002/jbm.a.34849; Kondo M, 2013, BIOMATERIALS, V34, P121, DOI 10.1016/j.biomaterials.2012.09.036; KUPPER TS, 1986, J EXP MED, V164, P2095, DOI 10.1084/jem.164.6.2095; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; LUGER TA, 1981, J IMMUNOL, V127, P1493; MULLERGLAUSER W, 1983, ARCH ORAL BIOL, V28, P765, DOI 10.1016/0003-9969(83)90113-9; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohki T, 2012, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2012.04.050, DOI 10.1053/J.GASTR0.2012.04.050]; PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2; PILLAI S, 1989, J CLIN INVEST, V83, P816, DOI 10.1172/JCI113963; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Seitz CS, 2000, CANCER RES, V60, P4085; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Sultana T, 2003, INT J ANDROL, V26, P37, DOI 10.1046/j.1365-2605.2003.00386.x; Tsai CY, 1997, J CRANIO MAXILL SURG, V25, P4, DOI 10.1016/S1010-5182(97)80017-0; UEDA M, 1995, ANN PLAS SURG, V35, P498, DOI 10.1097/00000637-199511000-00009; WATANABE N, 1994, CYTOKINE, V6, P597, DOI 10.1016/1043-4666(94)90046-9	29	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134240	10.1371/journal.pone.0134240	http://dx.doi.org/10.1371/journal.pone.0134240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230502	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400091
J	Srivastava, A; Golden, KL; Sanchez, CA; Liu, K; Fong, PY; Li, XH; Cowan, DS; Rabinovitch, PS; Reid, BJ; Blount, PL; Odze, RD				Srivastava, Amitabh; Golden, Kevin L.; Sanchez, Carissa A.; Liu, Karen; Fong, Pui Yee; Li, Xiaohong; Cowan, David S.; Rabinovitch, Peter S.; Reid, Brian J.; Blount, Patricia L.; Odze, Robert D.			High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus	PLOS ONE			English	Article							COLUMNAR EPITHELIUM; INTESTINAL METAPLASIA; GRADE DYSPLASIA; PROGRESSION; CANCER; PREDICTORS; MECHANISMS; DIAGNOSIS; JUNCTION; MUCIN	Purpose Goblet cells may represent a potentially successful adaptive response to acid and bile by producing a thick mucous barrier that protects against cancer development in Barrett's esophagus (BE). The aim of this study was to determine the relationship between goblet cells (GC) and risk of progression to adenocarcinoma, and DNA content flow cytometric abnormalities, in BE patients. Experimental Design Baseline mucosal biopsies (N=2988) from 213 patients, 32 of whom developed cancer during the follow up period, enrolled in a prospective dynamic cohort of BE patients were scored in a blinded fashion, for the total number (#) of GC, mean # of GC/crypt (GC density), # of crypts with >= 1 GC, and the proportion of crypts with >= 1 GC, in both dysplastic and non-dysplastic epithelium separately. The relationship between these four GC parameters and DNA content flow cytometric abnormalities and adenocarcinoma outcome was compared, after adjustment for age, gender, and BE segment length. Results High GC parameters were inversely associated with DNA content flow cytometric abnormalities, such as aneuploidy, ploidy >2.7N, and an elevated 4N fraction >6%, and with risk of adenocarcinoma. However, a Kaplan-Meier analysis showed that the total # of GC and the total # crypts with >= 1 GC were the only significant GC parameters (p<0.001 and 0.003, respectively). Conclusions The results of this study show, for the first time, an inverse relationship between high GC counts and flow cytometric abnormalities and risk of adenocarcinoma in BE. Further studies are needed to determine if GC depleted foci within esophageal columnar mucosa are more prone to neoplastic progression or whether loss of GC occurs secondary to underlying genetic abnormalities.	[Srivastava, Amitabh; Golden, Kevin L.; Odze, Robert D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Sanchez, Carissa A.; Fong, Pui Yee; Li, Xiaohong; Cowan, David S.; Reid, Brian J.; Blount, Patricia L.] Fred Hutchinson Canc Res Ctr, Dept Human Biol, Seattle, WA 98104 USA; [Sanchez, Carissa A.; Li, Xiaohong; Cowan, David S.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, Seattle, WA 98104 USA; [Liu, Karen] Fred Hutchinson Canc Res Ctr, Dept Vaccine, Infect Dis Inst, Seattle, WA 98104 USA; [Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Reid, Brian J.; Blount, Patricia L.] Univ Washington, Dept Med, Seattle, WA USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Odze, RD (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	rodze@partners.org			National Institute of Health [P01 CA91955]; NATIONAL CANCER INSTITUTE [P01CA091955] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health P01 CA91955, BJR.	BANSAL A, 2011, GASTROENTEROLOGY S1, V140, pS306; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Chandrasoma P, 2007, DIS ESOPHAGUS, V20, P36, DOI 10.1111/j.1442-2050.2007.00638.x; Chaves P, 2007, MODERN PATHOL, V20, P788, DOI 10.1038/modpathol.3800787; Dixon J, 2001, AM J GASTROENTEROL, V96, P2575, DOI 10.1111/j.1572-0241.2001.04159.x; Fijneman RJA, 2008, CANCER SCI, V99, P2113, DOI 10.1111/j.1349-7006.2008.00924.x; HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jovov B, 2007, AM J PHYSIOL-GASTR L, V293, pG1106, DOI 10.1152/ajpgi.00158.2007; Kelty CJ, 2007, SCAND J GASTROENTERO, V42, P1271, DOI 10.1080/00365520701420735; Lao-Sirieix P, 2008, DIS ESOPHAGUS, V21, P529, DOI 10.1111/j.1442-2050.2007.00807.x; Leers JM, 2008, GASTROENTEROLOGY, V134, pA380; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; LEVINE DS, 1989, LAB INVEST, V60, P418; LEVINE DS, 1989, GASTROENTEROLOGY, V96, P355, DOI 10.1016/S0016-5085(89)91559-X; Liu W, 2009, AM J GASTROENTEROL, V104, P816, DOI 10.1038/ajg.2009.85; Menke V, 2010, DIS MODEL MECH, V3, P104, DOI 10.1242/dmm.003012; Nancarrow DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022513; Ostrowski J, 2007, J MOL MED, V85, P733, DOI 10.1007/s00109-007-0176-3; PARAF F, 1995, AM J SURG PATHOL, V19, P183, DOI 10.1097/00000478-199502000-00007; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; Reid BJ, 2011, CLIN CANCER RES, V17, P3512, DOI 10.1158/1078-0432.CCR-09-2358; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Riddell RH, 2009, AM J GASTROENTEROL, V104, P2588, DOI 10.1038/ajg.2009.390; Romagnoli S, 2001, LAB INVEST, V81, P241, DOI 10.1038/labinvest.3780232; SHANKEY TV, 1993, CYTOMETRY, V14, P472, DOI 10.1002/cyto.990140503; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; SKINNER DB, 1983, ANN SURG, V198, P554, DOI 10.1097/00000658-198310000-00016; Srivastava A, 2007, AM J GASTROENTEROL, V102, P483, DOI 10.1111/j.1572-0241.2007.01073.x; Takubo K, 2009, HUM PATHOL, V40, P65, DOI 10.1016/j.humpath.2008.06.008; Themeau T, 2013, PACKAGE SURVIVAL; Tobey NA, 2007, AM J PHYSIOL-GASTR L, V293, pG264, DOI 10.1152/ajpgi.00047.2007; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598	38	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133403	10.1371/journal.pone.0133403	http://dx.doi.org/10.1371/journal.pone.0133403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230607	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400037
J	Wang, SZ; Chen, WY; Xiao, WF; Yang, CD; Xin, Y; Qiu, JR; Hu, WM; Ying, W; Fu, YP; Tong, JX; Hu, GC; Chen, ZZ; Fang, XP; Yu, H; Lai, WG; Ruan, SL; Ma, HS				Wang, Shuzhen; Chen, Wenyue; Xiao, Wenfei; Yang, Changdeng; Xin, Ya; Qiu, Jieren; Hu, Weimin; Ying, Wu; Fu, Yaping; Tong, Jianxin; Hu, Guocheng; Chen, Zhongzhong; Fang, Xianping; Yu, Hong; Lai, Wenguo; Ruan, Songlin; Ma, Huasheng			Differential Proteomic Analysis Using iTRAQ Reveals Alterations in Hull Development in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; GRAIN WIDTH; PALEA DEVELOPMENT; MAJOR QTL; GENE; LEMMA; ANNOTATION; WEIGHT; RESOURCE; GENOMICS	Rice hull, the outer cover of the rice grain, determines grain shape and size. Changes in the rice hull proteome in different growth stages may reflect the underlying mechanisms involved in grain development. To better understand these changes, isobaric tags for relative and absolute quantitative (iTRAQ) MS/MS was used to detect statistically significant changes in the rice hull proteome in the booting, flowering, and milk-ripe growth stages. Differentially expressed proteins were analyzed to predict their potential functions during development. Gene ontology (GO) terms and pathways were used to evaluate the biological mechanisms involved in rice hull at the three growth stages. In total, 5,268 proteins were detected and characterized, of which 563 were differentially expressed across the development stages. The results showed that the flowering and milk-ripe stage proteomes were more similar to each other (r=0.61) than either was to the booting stage proteome. A GO enrichment analysis of the differentially expressed proteins was used to predict their roles during rice hull development. The potential functions of 25 significantly differentially expressed proteins were used to evaluate their possible roles at various growth stages. Among these proteins, an unannotated protein (Q7X8A1) was found to be overexpressed especially in the flowering stage, while a putative uncharacterized protein (B8BF94) and an aldehyde dehydrogenase (Q9FPK6) were overexpressed only in the milk-ripe stage. Pathways regulated by differentially expressed proteins were also analyzed. Magnesium-protoporphyrin IX monomethyl ester [ oxidative] cyclase (Q9SDJ2), and two magnesium-chelatase subunits, ChlD (Q6ATS0), and ChlI (Q53RM0), were associated with chlorophyll biosynthesis at different developmental stages. The expression of Q9SDJ2 in the flowering and milk-ripe stages was validated by qRT-PCR. The 25 candidate proteins may be pivotal markers for controlling rice hull development at various growth stages and chlorophyll biosynthesis pathway related proteins, especially magnesium-protoporphyrin IX monomethylester [oxidative] cyclase (Q9SDJ2), may provide new insights into the molecular mechanisms of rice hull development and chlorophyll associated regulation.	[Wang, Shuzhen; Chen, Wenyue; Xiao, Wenfei; Xin, Ya; Qiu, Jieren; Ying, Wu; Tong, Jianxin; Chen, Zhongzhong; Fang, Xianping; Yu, Hong; Lai, Wenguo; Ruan, Songlin; Ma, Huasheng] Hangzhou Acad Agr Sci, Inst Biotechnol, Lab Plant Mol Biol & Prote, Hangzhou 310024, Zhejiang, Peoples R China; [Wang, Shuzhen; Yang, Changdeng; Fu, Yaping; Hu, Guocheng] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Shuzhen; Hu, Weimin] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Hangzhou 310012, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Ruan, SL (corresponding author), Hangzhou Acad Agr Sci, Inst Biotechnol, Lab Plant Mol Biol & Prote, Hangzhou 310024, Zhejiang, Peoples R China.	ruansl1@hotmail.com; hzhsma@163.com		Chen, Zhongzhong/0000-0001-6662-5837	Great Project of Science and Technology of Hangzhou City [20131812A02]; Zhejiang Provincial Natural Science Foundation of China [LR12C13001]; Open Project of State Key Laboratory of Rice Biology [12020313]	Great Project of Science and Technology of Hangzhou City; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Open Project of State Key Laboratory of Rice Biology	This work was supported by the Great Project of Science and Technology of Hangzhou City (Research Grant #20131812A02 to SLR), Zhejiang Provincial Natural Science Foundation of China (Research Grant #LR12C13001 to SLR) and the Open Project of State Key Laboratory of Rice Biology (Research Grant #12020313 to SZW and SLR).	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Deswal R, 2013, PHYSIOL MOL BIOL PLA, V19, P461, DOI 10.1007/s12298-013-0198-y; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber L, 2014, NEW PHYTOLOGIST; Ghosh D, 2013, MOL CELL PROTEOMICS, V12, P1865, DOI 10.1074/mcp.M112.023085; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; Hong LL, 2010, J GENET GENOMICS, V37, P101, DOI 10.1016/S1673-8527(09)60029-1; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-22; Jin Y, 2011, DEV BIOL, V359, P277, DOI 10.1016/j.ydbio.2011.08.023; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latterich M, 2008, EUR J CANCER, V44, P2737, DOI 10.1016/j.ejca.2008.09.007; Li JB, 2009, RICE SCI, V16, P79, DOI 10.1016/S1672-6308(08)60061-X; Li XJ, 2012, PLANT MOL BIOL, V78, P351, DOI 10.1007/s11103-011-9868-8; Liu GT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-110; Lu C, 2013, RICE SCI, V20, P191, DOI 10.1016/S1672-6308(13)60122-5; Luo LL, 2014, RICE SCI, V21, P29, DOI 10.1016/S1672-6308(13)60156-0; Monahan LG, 2014, MBIO, V5, DOI 10.1128/mBio.00935-14; Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023; Mulukutla BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098756; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Poulsen ET, 2014, J PROTEOME RES; Prasad K, 2005, PLANT J, V43, P915, DOI 10.1111/j.1365-313X.2005.02504.x; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaya T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00409; Satoh M, 2013, PLANT PHYSIOLOGY AND; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Wang SS, 2011, THEOR APPL GENET, V122, P1489, DOI 10.1007/s00122-011-1548-1; Wei XJ, 2013, PLANT CELL REP, V32, P1455, DOI 10.1007/s00299-013-1457-7; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wilm M, 2009, PROTEOMICS, V9, P4590, DOI 10.1002/pmic.200900299; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoshida A, 2009, P NATL ACAD SCI USA, V106, P20103, DOI 10.1073/pnas.0907896106; Yu XR, 2014, RICE SCI, V21, P142, DOI 10.1016/S1672-6308(13)60176-6; Zeiger E, 2012, PLANT PHYSIOL, P484; Zhang Quanfang, 2007, Journal of Genetics and Genomics, V34, P519, DOI 10.1016/S1673-8527(07)60057-5; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	49	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133696	10.1371/journal.pone.0133696	http://dx.doi.org/10.1371/journal.pone.0133696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230730	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400050
J	Duprez, W; Bachu, P; Stoermer, MJ; Tay, S; McMahon, RM; Fairlie, DP; Martin, JL				Duprez, Wilko; Bachu, Prabhakar; Stoermer, Martin J.; Tay, Stephanie; McMahon, Roisin M.; Fairlie, David P.; Martin, Jennifer L.			Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; CRYSTAL-STRUCTURE; ANTIMICROBIAL AGENTS; CONFORMER GENERATION; CLINICAL PIPELINE; IN-VIVO; PROTEIN; ANTIBIOTICS; VIRULENCE; MECHANISM	Antibacterial drugs with novel scaffolds and new mechanisms of action are desperately needed to address the growing problem of antibiotic resistance. The periplasmic oxidative folding system in Gram-negative bacteria represents a possible target for anti-virulence antibacterials. By targeting virulence rather than viability, development of resistance and side effects (through killing host native microbiota) might be minimized. Here, we undertook the design of peptidomimetic inhibitors targeting the interaction between the two key enzymes of oxidative folding, DsbA and DsbB, with the ultimate goal of preventing virulence factor assembly. Structures of DsbB - or peptides - complexed with DsbA revealed key interactions with the DsbA active site cysteine, and with a hydrophobic groove adjacent to the active site. The present work aimed to discover peptidomimetics that target the hydrophobic groove to generate non-covalent DsbA inhibitors. The previously reported structure of a Proteus mirabilis DsbA active site cysteine mutant, in a non-covalent complex with the heptapeptide PWATCDS, was used as an in silico template for virtual screening of a peptidomimetic fragment library. The highest scoring fragment compound and nine derivatives were synthesized and evaluated for DsbA binding and inhibition. These experiments discovered peptidomimetic fragments with inhibitory activity at millimolar concentrations. Although only weakly potent relative to larger covalent peptide inhibitors that interact through the active site cysteine, these fragments offer new opportunities as templates to build non-covalent inhibitors. The results suggest that non-covalent peptidomimetics may need to interact with sites beyond the hydrophobic groove in order to produce potent DsbA inhibitors.	[Duprez, Wilko; Bachu, Prabhakar; Stoermer, Martin J.; Tay, Stephanie; McMahon, Roisin M.; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	University of Queensland	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	j.martin@imb.uq.edu.au	McMahon, Roisin/A-9823-2014; Fairlie, David P/F-8865-2014; Stoermer, Martin J/E-2317-2012; Martin, Jennifer L./A-6039-2010	McMahon, Roisin/0000-0001-5437-0355; Fairlie, David P/0000-0002-7856-8566; Stoermer, Martin J/0000-0003-3445-2104; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council Laureate Fellowship [FL0992138]	Australian Research Council Laureate Fellowship(Australian Research Council)	Australian Research Council Laureate Fellowship FL0992138 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; [Anonymous], OMEGA 2 4, V6; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Butler MS, 2012, CURR DRUG TARGETS, V13, P373; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; CASEWELL MW, 1987, J ANTIMICROB CHEMOTH, V19, P1, DOI 10.1093/jac/19.1.1; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Duprez W, 2015, J MED CHEM, V58, P577, DOI 10.1021/jm500955s; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Ford C. W., 2001, Current Drug Targets - Infectious Disorders, V1, P181, DOI 10.2174/1568005014606099; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; Gaisford S, 2006, PHARM ISOTHERMAL CAL; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heras B, 2015, BRIT J CLIN PHARMACO, V79, P208, DOI 10.1111/bcp.12356; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jones D, 2011, NAT REV DRUG DISCOV, V10, P161, DOI 10.1038/nrd3400; Jones D, 2010, NAT REV DRUG DISCOV, V9, P751, DOI 10.1038/nrd3289; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Kurth F, 2014, J BIOL CHEM, V289, P19810, DOI 10.1074/jbc.M114.552380; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Latham PW, 1999, NAT BIOTECHNOL, V17, P755, DOI 10.1038/11686; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Liskamp RMJ, 2011, CHEMBIOCHEM, V12, P1626, DOI 10.1002/cbic.201000717; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Moellering RC, 2011, INT J ANTIMICROB AG, V37, P2, DOI 10.1016/j.ijantimicag.2010.08.018; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; Novak R, 2010, CURR OPIN INVEST DR, V11, P182; Palomino JC, 2013, FUTURE MICROBIOL, V8, P1071, DOI 10.2217/fmb.13.85; PCAST, 2014, REP PRES COMB ANT RE; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Regeimbal J, 2002, J BIOL CHEM, V277, P32706, DOI 10.1074/jbc.M205433200; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Schrodinger LLC, 2010, AXPYMOL MOL GRAPH PL; Schrodinger LLC, 2010, JYMOL MOL GRAPH DEV; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Ung P, 2011, J MED CHEM, V54, P1111, DOI 10.1021/jm1012984; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Venugopal AA, 2012, CLIN INFECT DIS, V54, P568, DOI 10.1093/cid/cir830; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; World Health Organization, 2014, ANT RES GLOB REP SUR	67	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133805	10.1371/journal.pone.0133805	http://dx.doi.org/10.1371/journal.pone.0133805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225423	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700038
J	Goliasch, G; Zotter-Tufaro, C; Aschauer, S; Duca, F; Koell, B; Kammerlander, AA; Ristl, R; Lang, IM; Maurer, G; Mascherbauer, J; Bonderman, D				Goliasch, Georg; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Koell, Benedikt; Kammerlander, Andreas A.; Ristl, Robin; Lang, Irene M.; Maurer, Gerald; Mascherbauer, Julia; Bonderman, Diana			Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance	PLOS ONE			English	Article							SOCIETY-OF-CARDIOLOGY; EUROPEAN-SOCIETY; TASK-FORCE; PULMONARY-HYPERTENSION; MAGNETIC-RESONANCE; SYSTOLIC FUNCTION; ASSOCIATION; DYSFUNCTION; GUIDELINES; ECHOCARDIOGRAPHY	Background Heart failure with preserved ejection fraction (HFpEF) is recognized as a major cause of cardiovascular morbidity and mortality. Thus, a profound understanding of the pathophysiologic changes in HFpEF is needed to identify risk factors and potential treatment targets in this specific patient population. Therefore, we aimed to comprehensively assess the impact of left-and right-ventricular function and hemodynamics on long-term mortality and morbidity in order to improve risk prediction in patients with HFpEF. Methods and Results We prospectively included 142 consecutive patients with HFpEF into our observational, non-interventional registry. Echocardiography, cardiac magnetic resonance imaging and invasive hemodynamic assessments including myocardial biopsy were performed at baseline. We detected significant correlations between left ventricular extracellular matrix and left ventricular end-diastolic diameter (r = -0.64; p = 0.03) and stroke volume (r = -0.53; p = 0.04). Hospitalization for heart failure and/or cardiac death was observed over a median follow up of 10 months. The strongest risk factors were reduced right ventricular function (adj. HR 6.62; 95% CI 3.1214.02; p<0.001), systolic pulmonary arterial pressure (adj. HR per 1-SD 1.55; 95% CI 1.152.09; p = 0.004) and the pulmonary artery wedge pressure (adj. HR per 1-SD 1.51; 95% CI 1.09-2.08; p = 0.012). The area under the ROC curve for right ventricular function was 0.63, for systolic pulmonary arterial pressure 0.75, and for pulmonary artery wedge pressure 0.68. Conclusion The current study emphasizes the importance of right ventricular function and pulmonary pressures on outcome in patients with HFpEF providing pathophysiological insights into the hemodynamic changes in HFpEF.	[Goliasch, Georg; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Koell, Benedikt; Kammerlander, Andreas A.; Lang, Irene M.; Maurer, Gerald; Mascherbauer, Julia; Bonderman, Diana] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Goliasch, G (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria.	georg.goliasch@meduniwien.ac.at; diana.bonderman@meduniwien.ac.at	Kammerlander, Andreas/F-7391-2018	Kammerlander, Andreas/0000-0002-7632-9879; Lang, Irene/0000-0003-0485-2692; Mascherbauer, Julia/0000-0001-7478-1450; Goliasch, Georg/0000-0002-6219-6104; Aschauer, Stefan/0000-0003-2220-9182; Ristl, Robin/0000-0002-4163-9236; Maurer, Gerald/0000-0002-9043-7657	Bayer Healthcare; United Therapeutics; Actelion; AOP; GSK; Pfizer	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); United Therapeutics; Actelion; AOP; GSK(GlaxoSmithKline); Pfizer(Pfizer)	DB and IML have received grants and consulting fees from Bayer Healthcare, United Therapeutics, Actelion, AOP, GSK, and Pfizer.	Andersen MJ, 2015, CIRC-HEART FAIL, V8, P542, DOI 10.1161/CIRCHEARTFAILURE.114.002114; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Funk GC, 2008, CHEST, V133, P1354, DOI 10.1378/chest.07-2685; GARVEY W, 1987, STAIN TECHNOL, V62, P365, DOI 10.3109/10520298709108026; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Kapoor JR, 2010, AM HEART J, V159, P75, DOI 10.1016/j.ahj.2009.10.026; Kass David A., 2000, Cardiology Clinics, V18, P571, DOI 10.1016/S0733-8651(05)70162-4; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lund LH, 2014, EUR J HEART FAIL, V16, P992, DOI 10.1002/ejhf.137; Mascherbauer J, 2013, CIRC-CARDIOVASC IMAG, V6, P1056, DOI 10.1161/CIRCIMAGING.113.000633; McManus DD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005694; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Melenovsky V, 2014, EUROPEAN HEART J; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2014, CIRC-HEART FAIL, V7, P123, DOI 10.1161/CIRCHEARTFAILURE.113.000568; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	27	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134479	10.1371/journal.pone.0134479	http://dx.doi.org/10.1371/journal.pone.0134479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225557	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700099
J	Hanrahan, D; Sexton, P; Hui, K; Teitcher, J; Sugarman, J; London, AJ; Barnes, M; Purpura, J; Klitzman, R				Hanrahan, Donna; Sexton, Patrina; Hui, Katrina; Teitcher, Jennifer; Sugarman, Jeremy; London, Alex John; Barnes, Mark; Purpura, James; Klitzman, Robert			Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies	PLOS ONE			English	Article							RESEARCH ETHICS COMMITTEES; INFORMED-CONSENT; TRIALS	Linguistic and cultural differences can impede comprehension among potential research participants during the informed consent process, but how researchers and IRBs respond to these challenges in practice is unclear. We conducted in-depth interviews with 15 researchers, research ethics committee (REC) chairs and members from 8 different countries with emerging economies, involved in HIV-related research sponsored by HIV Prevention Trials Network (HPTN), regarding the ethical and regulatory challenges they face in this regard. In the interviews, problems with translating study materials often arose as major concerns. Four sets of challenges were identified concerning linguistic and cultural translations of informed consent documents and other study materials, related to the: (1) context, (2) process, (3) content and (4) translation of these documents. Host country contextual issues included low literacy rates, education (e.g., documents may need to be written below 5th grade reading level), and experiences with research, and different views of written documentation. Certain terms and concepts may not exist in other languages, or have additional connotations that back translations do not always reveal. Challenges arise because of not only the content of word-for-word, literal translation, but the linguistic form of the language, such as tone (e.g., appropriate forms of politeness vs. legalese, seen as harsh), syntax, manner of questions posed, and the concept of the consent); and the contexts of use affect meaning. Problems also emerged in bilateral communications - US IRBs may misunderstand local practices, or communicate insufficiently the reasons for their decisions to foreign RECs. In sum, these data highlight several challenges that have received little, if any, attention in past literature on translation of informed consent and study materials, and have crucial implications for improving practice, education, research and policy, suggesting several strategies, including needs for broader open-source multilingual lexicons, and more awareness of the complexities involved.	[Hanrahan, Donna; Sexton, Patrina; Hui, Katrina; Teitcher, Jennifer] Columbia Univ, New York, NY USA; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [London, Alex John] Carnegie Mellon Univ, Ctr Eth & Policy, Pittsburgh, PA 15213 USA; [Barnes, Mark] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Barnes, Mark] Partner Ropes & Gray LLC, Boston, MA USA; [Purpura, James] Columbia Univ, Teachers Coll, Appl Linguist & TESOL Program, New York, NY 10027 USA; [Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA	Columbia University; Johns Hopkins University; Carnegie Mellon University; Harvard University; Columbia University; Columbia University Teachers College; Columbia University	Klitzman, R (corresponding author), Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA.	rlk2@.cumc.columbia.edu		Sugarman, Jeremy/0000-0001-7022-8332; Hui, Katrina/0000-0002-5472-3779; London, Alex/0000-0002-6450-0309	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068619]; National Institute on Drug Abuse (NIDA); Ropes Gray LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ropes Gray LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work on this manuscript was supported by Grant Number U01 AI068619 from the National Institute of Allergy and Infectious Diseases (NIAID), with additional support from the National Institute on Drug Abuse (NIDA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIDA, or the National Institutes of Health. NIAID Website: http://www.niaid.nih.gov/Pages/default.aspx. NIDA Website: http://www.drugabuse.gov/. NIH Website: http://www.nih.gov/. Ropes & Gray LLC provided support in the form of salaries for author [MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Angeles-Llerenas AR, 2009, DEV WORLD BIOETH, V9, P18, DOI 10.1111/j.1471-8847.2007.00208.x; Arda B, 2000, J MED ETHICS, V26, P459, DOI 10.1136/jme.26.6.459; Becker A.L., 1995, TRANSLATION ESSAYS M; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Comrie B, 2009, WORDS MAJOR LANGUAGE; Elsayed Dya Eldin M, 2004, Dev World Bioeth, V4, P154, DOI 10.1111/j.1471-8731.2004.00090.x; Geertz Clifford, 1973, INTERPRETATION CULTU; Hafeez TL, 1972, J CROSS CULTURAL PSY, V3, P41; Hymes D, 2001, LINGUISTIC ANTHR REA, P60; Katz J, 1994, J Contemp Health Law Policy, V10, P69; KAUFERT JM, 1984, SOC SCI MED, V18, P283, DOI 10.1016/0277-9536(84)90092-3; Keymanthri M, 2007, BMC MED ETHICS, V8, P1; Klitzman R, 2008, DEV WORLD BIOETH, V8, P207, DOI 10.1111/j.1471-8847.2007.00189.x; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Mack N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073799; Macpherson C C, 2001, Dev World Bioeth, V1, P57, DOI 10.1111/1471-8847.00008; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Matar A, 2013, J EMPIR RES HUM RES, V8, P32, DOI 10.1525/jer.2013.8.1.32; Meaning PP, 2006, INTRO LANGUAGE LINGU, P137; Nida E., 2006, PLIEGOS YUSTE, V4, P11; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Penn C, 2010, PATIENT EDUC COUNS, V80, P191, DOI 10.1016/j.pec.2009.10.019; Purpura JE, 2004, ASSESSING GRAMMER; Ramirez C., 2013, TOOLKIT DEV BILINGUA; Schaffner C, 2004, J PRAGMATICS, V36, P1253, DOI 10.1016/j.pragma.2003.10.012; Sexton P, 2014, DEV WORLD BIOETH; Stevenson A., 2002, OXFORD ENGLISH DICT; Strauss A., 1990, BASICS QUALITATIVE R; Tsvetaeva M, 1972, NEIZDANNYE PISMA; WAGER E, 1995, BMJ-BRIT MED J, V311, P734, DOI 10.1136/bmj.311.7007.734; Wierzbicka A, 1995, SEMANTICS CULTURE CO	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133394	10.1371/journal.pone.0133394	http://dx.doi.org/10.1371/journal.pone.0133394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225759	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700020
J	Wei, JY; Bai, DD; Yang, LY				Wei, Jinyu; Bai, Dongdong; Yang, Liying			Polymer Photovoltaic Cells with Rhenium Oxide as Anode Interlayer	PLOS ONE			English	Article							SOLAR-CELLS; DEGRADATION; LAYER	The effect of a new transition metal oxide, rhenium oxide (ReO3), on the performance of polymer solar cells based on regioregular poly(3-hexylthiophene) (P3HT) and methanofullerene [6,6]-phenyl C-61-butyric acid methyl ester (PCBM) blend as buffer layer was investigated. The effect of the thickness of ReO3 layer on electrical characteristics of the polymer solar cells was studied. It is found that insertion of ReO3 interfacial layer results in the decreased performance for P3HT: PCBM based solar cells. In order to further explore the mechanism of the decreasing of the open-circuit voltage (V-oc), the X-ray photoelectron spectroscopy (XPS) is used to investigate the ReO3 oxidation states. Kelvin Probe method showed that the work function of the ReO3 is estimated to be 5.13eV after thermal evaporation. The results indicated the fact that a portion of ReO3 decomposed during thermal evaporation process, resulting in the formation of a buffer layer with a lower work function. As a consequence, a higher energy barrier was generated between the ITO and the active layer.	[Wei, Jinyu; Bai, Dongdong] Tianjin Univ Technol, Sch Management, Tianjin, Peoples R China; [Yang, Liying] Tianjin Univ Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Display Mat & Photoelect Devices, Tianjin, Peoples R China	Tianjin University of Technology; Tianjin University of Technology	Yang, LY (corresponding author), Tianjin Univ Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Display Mat & Photoelect Devices, Tianjin, Peoples R China.	liyingyang@tjut.edu.cn			National Science Foundation of China [60976048]; Tianjin Natural Science Council [10ZCKFGX01900]; Tianjin Key Discipline of Material Physics and Chemistry	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Council; Tianjin Key Discipline of Material Physics and Chemistry	This research was partly supported by grants from the National Science Foundation of China (Grant No. 60976048), Tianjin Natural Science Council (Grant No. 10ZCKFGX01900), and the Tianjin Key Discipline of Material Physics and Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen FC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2937202; Chung J, 2008, ORG ELECTRON, V9, P869, DOI 10.1016/j.orgel.2008.06.009; Hains AW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834697; Ikeda H, 2006, SID INT S, V37, P923; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Kawano K, 2006, SOL ENERG MAT SOL C, V90, P3520, DOI 10.1016/j.solmat.2006.06.041; Kemerink M, 2004, J PHYS CHEM B, V108, P18820, DOI 10.1021/jp0464674; Leem DS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2754635; Li G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2212270; Shrotriya V, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174093; WAGNER CD, HDB XRAY PHOTOELECTR; Yan H, 2005, J AM CHEM SOC, V127, P3172, DOI 10.1021/ja044455q	12	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133725	10.1371/journal.pone.0133725	http://dx.doi.org/10.1371/journal.pone.0133725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226439	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700036
J	Adkins-Regan, E				Adkins-Regan, Elizabeth			Hit or Miss: Fertilization Outcomes of Natural Inseminations by Japanese Quail	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; SPERM-STORAGE TUBULES; COTURNIX-JAPONICA; MATING SUCCESS; DOMESTIC-FOWL; TESTES SIZE; BIRDS; FEMALE; SPERMATOZOA; COMPETITION	Variation in fertilization success underlies sexual selection, yet mating does not guarantee fertilization. The relationship between natural inseminations and fertilization success is essential for understanding sexual selection, yet that relationship and its underlying mechanisms are poorly understood in sperm-storing vertebrates such as birds. Here the relationship is analyzed in mating trials using Japanese quail (Coturnix japonica), which show striking variation in the fertilizing success of inseminations. Failures of males' inseminations to fertilize eggs were mainly due to failures prior to sperm-egg contact. Fertilization probabilities on any given day were unrelated to whether the female had laid an egg the previous day, arguing against stimulation of sperm release from sperm storage tubules by the events of the daily egg-laying cycle. Instead, an unfertilized egg laid between two fertilized eggs predicted a longer sperm storage interval. Both sexes gained similar numbers of fertilized eggs by mating with a second partner the next day, but males, unlike females in a previous study, did not gain by having two females to mate with at the same time. Instead, they were both behaviorally and sperm limited, whereas females gain by mating twice in quick succession. Even double inseminations often failed to fertilize any eggs, and multiple matings would be needed for an entire clutch to be fertilized with high certainty. Paradoxically, this low and probabilistic fertilization success co-occurs with other notable characteristics of male quail suggestive of past sexual selection for increased success, including vigorous copulatory behavior, forced copulations, foamy secretion aiding in sperm competition, large testes and unusual sperm morphology.	[Adkins-Regan, Elizabeth] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Adkins-Regan, Elizabeth] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Adkins-Regan, E (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	er12@cornell.edu			NSF grant [IBN 0130986]	NSF grant(National Science Foundation (NSF))	This work was funded by NSF grant IBN 0130986 to EA-R. NSF URL: http://www.nsf.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins EK, 1974, PHYSIOL BEHAV, V13, P75; Adkins-Regan E, 1999, AUK, V116, P184, DOI 10.2307/4089465; Adkins-Regan E, 2014, BEHAV PROCESS, V108, P71, DOI 10.1016/j.beproc.2014.09.027; ADKINSREGAN E, 1995, ANIM BEHAV, V50, P1405, DOI 10.1016/0003-3472(95)80055-7; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Bakst MR, 2011, J ANIM SCI, V89, P1323, DOI 10.2527/jas.2010-3663; BAKST MR, 1994, BIOL REPROD, V50, P987, DOI 10.1095/biolreprod50.5.987; Bakst MR, 1998, J EXP ZOOL, V282, P618, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5&lt;618::AID-JEZ11&gt;3.0.CO;2-M; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P451, DOI 10.1006/anbe.1995.0058; BIRKHEAD TR, 1994, IBIS, V136, P101, DOI 10.1111/j.1474-919X.1994.tb08137.x; BIRKHEAD TR, 1994, J REPROD FERTIL, V101, P353, DOI 10.1530/jrf.0.1010353; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Birkhead TR, 1992, SPERM COMPETITION BI; Birkhead TR, 1998, SPERM COMPETITION SE; BOBR LW, 1964, J REPROD FERTIL, V8, P39, DOI 10.1530/jrf.0.0080039; BURKE WH, 1969, POULTRY SCI, V48, P408, DOI 10.3382/ps.0480408; Collet JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2973; COMPTON MM, 1979, POULTRY SCI, V58, P187, DOI 10.3382/ps.0580187; Domjan M, 2003, J COMP PSYCHOL, V117, P391, DOI 10.1037/0735-7036.117.4.391; Etches R. J., 1996, REPROD POULTRY; Ferree ED, 2014, ANIM BEHAV, V90, P11, DOI 10.1016/j.anbehav.2014.01.009; Finseth FR, 2013, J EVOLUTION BIOL, V26, P1875, DOI 10.1111/jeb.12189; Forstmeier W, 2014, TRENDS ECOL EVOL, V29, P456, DOI 10.1016/j.tree.2014.05.005; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; GOWATY PA, 1984, BEHAV ECOL SOCIOBIOL, V15, P91, DOI 10.1007/BF00299374; Griffith SC, 2007, AM NAT, V169, P274, DOI 10.1086/510601; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; GRIGG GW, 1957, POULTRY SCI, V36, P450, DOI 10.3382/ps.0360450; Hasson O, 2009, BIOL REV, V84, P225, DOI 10.1111/j.1469-185X.2008.00068.x; Ito T, 2011, ENDOCRINOLOGY, V152, P3952, DOI 10.1210/en.2011-0237; West-Eberhard MJ, 2014, NEUROSCI BIOBEHAV R, V46, P501, DOI 10.1016/j.neubiorev.2014.06.015; Jones R.C., 1993, Oxford Reviews of Reproductive Biology, V15, P233; KENNEY AM, 1979, BRAIN BEHAV EVOLUT, V16, P176, DOI 10.1159/000121835; Ketterson Ellen D., 1998, Ornithological Monographs, V49, P81; Korn N, 2000, POULTRY SCI, V79, P407, DOI 10.1093/ps/79.3.407; Krakauer AH, 2008, CONDOR, V110, P1, DOI 10.1525/cond.2008.110.1.1; Madge S., 2002, PHEASANTS PARTRIDGES; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; Morrow EH, 2002, J EVOLUTION BIOL, V15, P702, DOI 10.1046/j.1420-9101.2002.00445.x; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Persaud KN, 2005, J COMP PSYCHOL, V119, P440, DOI 10.1037/0735-7036.119.4.440; Pischedda A, 2012, P NATL ACAD SCI USA, V109, P2049, DOI 10.1073/pnas.1110841109; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Teijeiro JD, 2003, ETHOLOGY, V109, P291, DOI 10.1046/j.1439-0310.2003.00873.x; Sasanami T, 2013, J REPROD DEVELOP, V59, P334, DOI 10.1262/jrd.2013-038; SCHEIN MW, 1972, ANIM BEHAV, V20, P61, DOI 10.1016/S0003-3472(72)80173-8; SITTMANN KURT, 1965, BRIT POULTRY SCI, V6, P245, DOI 10.1080/00071666508415580; Stepinska U, 2007, REPROD BIOL PHYLOGEN, P149; Torok J, 2003, P ROY SOC B-BIOL SCI, V270, P641, DOI 10.1098/rspb.2002.2257; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Williams T., 2012, PHYSL ADAPTATIONS BR; WISHART GJ, 1987, J REPROD FERTIL, V80, P493, DOI 10.1530/jrf.0.0800493; Wishart GJ, 1999, POULTRY SCI, V78, P428, DOI 10.1093/ps/78.3.428; Wolff JO, 2002, BEHAV PROCESS, V58, P105, DOI 10.1016/S0376-6357(02)00022-0; Woolfenden BE, 2002, BEHAV ECOL SOCIOBIOL, V52, P417, DOI 10.1007/s00265-002-0529-4	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131786	10.1371/journal.pone.0131786	http://dx.doi.org/10.1371/journal.pone.0131786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222780	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800019
J	Alexandre, J; Hof, T; Puddu, PE; Rouet, R; Guinamard, R; Manrique, A; Beygui, F; Salle, L; Milliez, P				Alexandre, Joachim; Hof, Thomas; Puddu, Paolo Emilio; Rouet, Rene; Guinamard, Romain; Manrique, Alain; Beygui, Farzin; Salle, Laurent; Milliez, Paul			Rapid and MR-Independent I-K1 Activation by Aldosterone during Ischemia-Reperfusion	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; INWARD RECTIFIER CURRENT; MINERALOCORTICOID RECEPTOR; MYOCARDIAL-INFARCTION; POTASSIUM CURRENT; ATRIAL-FIBRILLATION; PLASMA-ALDOSTERONE; CA2+ CURRENT; K+ CHANNELS; QT SYNDROME	In ST elevation myocardial infarction (STEMI) context, clinical studies have shown the deleterious effect of high aldosterone levels on ventricular arrhythmia occurrence and cardiac mortality. Previous in vitro reports showed that during ischemia-reperfusion, aldosterone modulates K+ currents involved in the holding of the resting membrane potential (RMP). The aim of this study was to assess the electrophysiological impact of aldosterone on I-K1 current during myocardial ischemia-reperfusion. We used an in vitro model of "border zone" using right rabbit ventricle and standard microelectrode technique followed by cell-attached recordings from freshly isolated rabbit ventricular cardiomyocytes. In microelectrode experiments, aldosterone (10 and 100 nmol/L, n=7 respectively) increased the action potential duration (APD) dispersion at 90% between ischemic and normoxic zones (from 95 +/- 4 ms to 116 +/- 6 ms and 127 +/- 5 ms respectively, P<0.05) and reperfusion-induced sustained premature ventricular contractions occurrence (from 2/12 to 5/7 preparations, P<0.05). Conversely, potassium canrenoate 100 nmol/L and RU 28318 1 mu mol/l alone did not affect AP parameters and premature ventricular contractions occurrence (except Vmax which was decreased by potassium canrenoate during simulated-ischemia). Furthermore, aldosterone induced a RMP hyperpolarization, evoking an implication of a K+ current involved in the holding of the RMP. Cell-attached recordings showed that aldosterone 10 nmol/L quickly activated (within 6.2 +/- 0.4 min) a 30 pS K+-selective current, inward rectifier, with pharmacological and biophysical properties consistent with the I-K1 current (NPo = 1.9 +/- 0.4 in control vs NPo=3.0 +/- 0.4, n=10, P<0.05). These deleterious effects persisted in presence of RU 28318, a specific MR antagonist, and were successfully prevented by potassium canrenoate, a non specific MR antagonist, in both microelectrode and patch-clamp recordings, thus indicating a MR-independent I-K1 activation. In this ischemia-reperfusion context, aldosterone induced rapid and MR-independent deleterious effects including an arrhythmia substrate (increased APD(90) dispersion) and triggered activities (increased premature ventricular contractions occurrence on reperfusion) possibly related to direct I-K1 activation.	[Alexandre, Joachim; Beygui, Farzin; Milliez, Paul] CHU Caen, Dept Cardiol, F-14000 Caen, France; [Alexandre, Joachim; Hof, Thomas; Rouet, Rene; Guinamard, Romain; Manrique, Alain; Salle, Laurent; Milliez, Paul] Univ Caen Basse Normandie, EA Signalisat Electrophysiol & Imagerie Lesions I, Caen, France; [Puddu, Paolo Emilio] Univ Roma La Sapienza, Dept Cardiovasc Sci, I-00185 Rome, Italy; [Rouet, Rene; Guinamard, Romain; Manrique, Alain; Beygui, Farzin; Salle, Laurent; Milliez, Paul] Univ Caen Basse Normandie, Sch Med, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Sapienza University Rome; Universite de Caen Normandie; Universite de Franche-Comte	Milliez, P (corresponding author), CHU Caen, Dept Cardiol, F-14000 Caen, France.	milliez-p@chu-caen.fr	Puddu, Paolo Emilio/G-6180-2012; Alexandre, Joachim/ABE-6176-2020; Alexandre, Joachim/ABE-2490-2020	Puddu, Paolo Emilio/0000-0002-6191-7838; Alexandre, Joachim/0000-0002-9197-8404; 	Federation Francaise de Cardiologie	Federation Francaise de Cardiologie	JA was supported by the Federation Francaise de Cardiologie.	Alexandre J, 2015, J CARDIOVASC PHARM T, V20, P313, DOI 10.1177/1074248414557036; Alexandre J, 2014, J CARDIOVASC PHARM, V64, P134, DOI 10.1097/FJC.0000000000000097; Alexandre J, 2014, J CARDIOVASC PHARM, V63, P49, DOI 10.1097/FJC.0000000000000023; Alexandre Joachim, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P52; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Azibani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038197; Barbato JC, 2004, HYPERTENSION, V44, P751, DOI 10.1161/01.HYP.0000144466.11568.7e; Bebarova M, 2014, J PHYSIOL PHARMACOL, V65, P497; Benitah JP, 1999, CIRC RES, V85, P1139; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Beygui F, 2013, INT J CARDIOL, V167, P73, DOI 10.1016/j.ijcard.2011.11.076; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Boixel C, 2006, AM J PHYSIOL-HEART C, V290, pH2257, DOI 10.1152/ajpheart.01060.2005; Brette F, 2013, J MOL CELL CARDIOL, V57, P96, DOI 10.1016/j.yjmcc.2013.01.012; Caballero R, 2003, CIRCULATION, V107, P889, DOI 10.1161/01.CIR.0000048189.58449.F7; Christ M, 1999, VITAM HORM, V57, P325; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; CORABOEUF E, 1974, J PHARMACOL EXP THER, V191, P128; Deo M, 2013, P NATL ACAD SCI USA, V110, P4291, DOI 10.1073/pnas.1218154110; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; ELSHERIF N, 1982, CIRC RES, V51, P152, DOI 10.1161/01.RES.51.2.152; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Ferrario CM, 2015, CIRC RES, V116, P206, DOI 10.1161/CIRCRESAHA.116.302706; Girerd N, 2013, EUR J HEART FAIL, V15, P1228, DOI 10.1093/eurjhf/hft100; KIYOSUE T, 1993, J PHYSIOL-LONDON, V468, P85, DOI 10.1113/jphysiol.1993.sp019761; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; LOMBES M, 1995, CIRCULATION, V92, P175, DOI 10.1161/01.CIR.92.2.175; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Mihailidou AS, 2004, ENDOCRINOLOGY, V145, P773, DOI 10.1210/en.2003-1137; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; MURDOCK DK, 1980, CIRCULATION, V61, P175, DOI 10.1161/01.CIR.61.1.175; Niederer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060323; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Paajanen V, 2004, AM J PHYSIOL-REG I, V286, pR405, DOI 10.1152/ajpregu.00500.2003; Perrier R, 2005, J PHYSIOL-LONDON, V569, P153, DOI 10.1113/jphysiol.2005.092692; Piao L, 2007, BASIC RES CARDIOL, V102, P416, DOI 10.1007/s00395-007-0659-y; Picard S, 1998, J MOL CELL CARDIOL, V30, P2613, DOI 10.1006/jmcc.1998.0819; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2005, J AM COLL CARDIOL, V46, P425, DOI 10.1016/j.jacc.2005.04.038; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Shah NC, 2007, J HYPERTENS, V25, P2345, DOI 10.1097/HJH.0b013e3282e9a72d; Shimizu W, 1998, CIRCULATION, V98, P2314, DOI 10.1161/01.CIR.98.21.2314; Stambler BS, 2009, HEART RHYTHM, V6, P776, DOI 10.1016/j.hrthm.2009.02.005; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomsen MB, 2006, PHARMACOL THERAPEUT, V112, P150, DOI 10.1016/j.pharmthera.2005.04.009; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; Wehling M, 1998, J CLIN ENDOCR METAB, V83, P3517, DOI 10.1210/jc.83.10.3517; WEHLING M, 1992, AM J PHYSIOL, V263, pE974, DOI 10.1152/ajpendo.1992.263.5.E974; Wenzel S, 2010, BASIC RES CARDIOL, V105, P247, DOI 10.1007/s00395-009-0059-6	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132592	10.1371/journal.pone.0132592	http://dx.doi.org/10.1371/journal.pone.0132592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222262	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800025
J	Xi, G; Shen, XC; Wai, C; Vilas, CK; Clemmons, DR				Xi, Gang; Shen, Xinchun; Wai, Christine; Vilas, Caroline K.; Clemmons, David R.			Hyperglycemia stimulates p62/PKC zeta interaction, which mediates NF-kappa B activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle	FASEB JOURNAL			English	Article						PDK1; p65 rel; diabetes; TNF-alpha; IGF-I	PROTEIN-KINASE-C; PKC-ZETA; HIGH GLUCOSE; SRC ACTIVATION; NADPH OXIDASE; DYSFUNCTION; RECEPTOR; BINDING; PHOSPHORYLATION; ASSOCIATION	Hyperglycemia leads to vascular smooth muscle cell (VSMC) dedifferentiation and enhances responses to IGF-I. Prior studies showed that hyperglycemia stimulated NADPH oxidase 4 (Nox4) synthesis, and IGF-I facilitated its recruitment to a signaling complex where it oxidized src, leading to AKT and MAPK activation. To determine the mechanism that led to these changes, we analyzed the roles of p62 (sequestrosome1) and PKC zeta. Hyperglycemia induced a 4.9 +/- 1.0-fold increase in p62/PKC zeta association, and disruption of PKC zeta/p62 using a peptide inhibitor or p62 knockdown reduced PKC zeta activation (786 +/- 6%). 3-Phosphoinoside-dependent protein kinase 1 was also recruited to the p62 complex and directly phosphorylated PKC zeta, leading to its activation (3.1 +/- 0.4-fold). Subsequently, activated PKC zeta phosphorylated p65 rel, which led to increased Nox4 synthesis. Studies in diabetic mice confirmed these findings (6.0 +/- 0.4-fold increase in p62/PKC zeta) and their disruption of attenuated Nox4 synthesis (7669% reduction). PKC zeta/p62 activation stimulated inflammatory cytokine production and enhanced IGF-I-stimulated VSMC proliferation. These results define the molecular mechanism by which PKC zeta is activated in response to hyperglycemia and suggest that this could be a mechanism by which other stimuli such as cytokines or metabolic stress function to stimulate NF-kappa B activation, thereby altering VSMC sensitivity to IGF-I.	[Xi, Gang; Wai, Christine; Vilas, Caroline K.; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu		Vilas, Caroline/0000-0002-8080-3035	U.S. National Institutes of Health [AG-02331]; National Natural Science Foundation of China [31271983]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ms. Laura Lindsey (University of North Carolina, Chapel Hill) for her help in preparing the manuscript. This work was supported by a grant (AG-02331) from the U.S. National Institutes of Health. D.R.C. is a guarantor of this manuscript. X.S. was supported by a grant from the National Natural Science Foundation of China (No. 31271983). G.X. contributed to research design, performed the experiments, and wrote/edited the manuscript. X.S., C.W., and C.K.V. performed the experiments. D.R.C. wrote and edited the manuscript, and contributed to research design and discussion of the results. The authors declare no conflicts of interest.	Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Huang CL, 2014, LAB INVEST, V94, P309, DOI 10.1038/labinvest.2014.2; Huang HC, 2009, MOL CARCINOGEN, V48, P517, DOI 10.1002/mc.20490; Kai M, 2009, FEBS LETT, V583, P3265, DOI 10.1016/j.febslet.2009.09.017; Kim GY, 2012, ARTERIOSCL THROM VAS, V32, P2974, DOI 10.1161/ATVBAHA.112.300054; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/265895; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000476; McManus Stephen, 2012, J Mol Signal, V7, P1, DOI 10.1186/1750-2187-7-1; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Shen XC, 2010, J BIOL CHEM, V285, P29416, DOI 10.1074/jbc.M110.155325; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Sugimoto R, 2010, J CELL MOL MED, V14, P1546, DOI 10.1111/j.1582-4934.2009.00914.x; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Wedgwood S, 2013, ANTIOXID REDOX SIGN, V18, P1765, DOI 10.1089/ars.2012.4766; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433	40	23	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4772	4782		10.1096/fj.15-275453	http://dx.doi.org/10.1096/fj.15-275453			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26231202	Green Published			2022-12-26	WOS:000365523600005
J	Akagi, T; Kuure, S; Uranishi, K; Koide, H; Costantini, F; Yokota, T				Akagi, Tadayuki; Kuure, Satu; Uranishi, Kousuke; Koide, Hiroshi; Costantini, Frank; Yokota, Takashi			ETS-related Transcription Factors ETV4 and ETV5 Are Involved in Proliferation and Induction of Differentiation-associated Genes in Embryonic Stem (ES) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORK; SELF-RENEWAL; SIGNALING PATHWAYS; KIDNEY DEVELOPMENT; PLURIPOTENT CELLS; GROUND-STATE; MOUSE; NANOG; EXPRESSION; TARGET	The pluripotency and self-renewal capacity of embryonic stem (ES) cells is regulated by several transcription factors. Here, we show that the ETS-related transcription factors Etv4 and Etv5 (Etv4/5) are specifically expressed in undifferentiated ES cells, and suppression of Oct3/4 results in down-regulation of Etv4/5. Simultaneous deletion of Etv4 and Etv5( Etv4/5doubleknock-out(dKO)) in ES cells resulted in a flat, epithelial cell-like appearance, whereas the morphology changed into compact colonies in a 2i medium (containing two inhibitors for GSK3 and MEK/ERK). Expression levels of self-renewal marker genes, including Oct3/4 and Nanog, were similar between wild-type and dKO ES cells, whereas proliferation of Etv4/5 dKO ES cells was decreased with overexpression of cyclin-dependent kinase inhibitors (p16/p19, p15, and p57). A differentiation assay revealed that the embryoid bodies derived from Etv4/5 dKO ES cells were smaller than the control, and expression of ectoderm marker genes, including Fgf5, Sox1, and Pax3, was not induced in dKO-derived embryoid bodies. Microarray analysis demonstrated that stem cell-related genes, including Tcf15, Gbx2, Lrh1, Zic3, and Baf60c, were significantly repressed in Etv4/5 dKO ES cells. The artificial expression of Etv4 and/or Etv5 in Etv4/5 dKO ES cells induced re-expression of Tcf15 and Gbx2. These results indicate that Etv4 and Etv5, potentially through regulation of Gbx2 and Tcf15, are involved in the ES cell proliferation and induction of differentiation-associated genes in ES cells.	[Akagi, Tadayuki; Uranishi, Kousuke; Koide, Hiroshi; Yokota, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Kuure, Satu] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland; [Costantini, Frank] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Kanazawa University; University of Helsinki; Columbia University	Akagi, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	tadayuki@staff.kanazawa-u.ac.jp; tyokota@med.kanazawa-u.ac.jp	Yokota, Takashi/J-8483-2015; , shkuure/AAE-2751-2019; Akagi, Tadayuki/E-1078-2011	, shkuure/0000-0002-9076-0622; Akagi, Tadayuki/0000-0002-1733-9452; Koide, Hiroshi/0000-0001-5916-3179	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22370050, 21790268]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid for Scientific Research (B) 22370050 (to T. Y.) and for Young Scientists (B) 21790268 (to T. A.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Takeda Science Foundation (to T. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BLANAR MA, 1995, P NATL ACAD SCI USA, V92, P5870, DOI 10.1073/pnas.92.13.5870; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Davies OR, 2013, CELL REP, V3, P472, DOI 10.1016/j.celrep.2013.01.017; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Eo J, 2011, MOL HUM REPROD, V17, P568, DOI 10.1093/molehr/gar021; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Fujii S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09146; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Jiang JH, 2007, BIOCHEM BIOPH RES CO, V358, P53, DOI 10.1016/j.bbrc.2007.04.043; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Keld R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-313; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kuure S, 2010, DEVELOPMENT, V137, P1975, DOI 10.1242/dev.051656; Laing MA, 2000, MOL CELL BIOL, V20, P9337, DOI 10.1128/MCB.20.24.9337-9345.2000; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun C, 2008, BIOCHEM BIOPH RES CO, V372, P91, DOI 10.1016/j.bbrc.2008.04.154; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Uranishi K, 2013, MOL CELL BIOL, V33, P2056, DOI 10.1128/MCB.01520-12; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	66	31	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22460	22473		10.1074/jbc.M115.675595	http://dx.doi.org/10.1074/jbc.M115.675595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224636	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000361171500014
J	Montoro, AG; Ramirez, SC; Taubas, JV				Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Valdez Taubas, Javier			The Canonical DHHC Motif Is Not Absolutely Required for the Activity of the Yeast S-acyltransferases Swf1 and Pfa4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; SUBSTRATE-SPECIFICITY; IDENTIFICATION; MECHANISM; PALMITOYLTRANSFERASES; ALIGNMENT; FAMILY; ERF2	Protein S-acyltransferases, also known as palmitoyltransferases (PATs), are characterized by the presence of a 50-amino acid domain called the DHHC domain. Within this domain, these four amino acids constitute a highly conserved motif. It has been proposed that the palmitoylation reaction occurs through a palmitoyl-PAT covalent intermediate that involves the conserved cysteine in the DHHC motif. Mutation of this cysteine results in lack of function for several PATs, and DHHA or DHHS mutants are used regularly as catalytically inactive controls. In a genetic screen to isolate loss-of-function mutations in the yeast PAT Swf1, we isolated an allele encoding a Swf1 DHHR mutant. Overexpression of this mutant is able to partially complement a swf1 Delta strain and to acylate the Swf1 substrates Tlg1, Syn8, and Snc1. Overexpression of the palmitoyltransferase Pfa4 DHHA or DHHR mutants also results in palmitoylation of its substrate Chs3. We also investigated the role of the first histidine of the DHHC motif. A Swf1 DQHC mutant is also partially active but a DQHR is not. Finally, we show that Swf1 substrates are differentially modified by both DHHR and DQHC Swf1 mutants. We propose that, in the absence of the canonical mechanism, alternative suboptimal mechanisms take place that are more dependent on the reactivity of the acceptor protein. These results also imply that caution must be exercised when proposing non-canonical roles for PATs on the basis of considering DHHC mutants as catalytically inactive and, more generally, contribute to an understanding of the mechanism of protein palmitoylation	Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, RA-5000 Cordoba, Argentina; Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Taubas, JV (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, CIQUIBIC, Ciudad Univ,X5000HUA Cordoba, RA-5000 Cordoba, Argentina.	jvaldezt@dqb.fcq.unc.edu.ar		Valdez Taubas, Javier/0000-0002-2806-9419	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT [0288]; Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP); Consejo Nacional de Ciencia y Tecnologia de Argentina	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT; Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP); Consejo Nacional de Ciencia y Tecnologia de Argentina	This work was supported by the Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (ANPCyT) Prestamo BID PICT 0288 (to J. V. T.) and Consejo Nacional de Ciencia y Tecnologia de Argentina (PIP 2011). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Consejo Nacional de Ciencia y Tecnologia de Argentina.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BHARADWAJ M, 1995, J NEUROCHEM, V65, P1805; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Montoro AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016969; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeste-Velasco M, 2014, J PATHOL, V232, P566, DOI 10.1002/path.4327	43	16	17	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22448	22459		10.1074/jbc.M115.651356	http://dx.doi.org/10.1074/jbc.M115.651356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26224664	hybrid, Green Published			2022-12-26	WOS:000361171500013
J	Hiroshima, Y; Zhao, M; Zhang, Y; Zhang, N; Maawy, A; Murakami, T; Mii, S; Uehara, F; Yamamoto, M; Miwa, S; Yano, S; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhao, Ming; Zhang, Yong; Zhang, Nan; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice	PLOS ONE			English	Article							HUMAN PANCREATIC-CANCER; LUNG METASTASIS; MOUSE MODEL; EFFICACY; CHEMOTHERAPY; THERAPY; MUTANT; CELLS; CYCLE	A patient-derived nude-mouse model of soft-tissue sarcoma has been established and treated in the following groups: (1) untreated controls; (2) gemcitabine (GEM) (80 mg/kg, ip, weekly, 3 weeks); (3) Pazopanib (100 mg/kg, orally, daily, 3 weeks) and (4) Salmonella typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 3 weeks). The sarcoma was resistant to GEM (p = 0.879). Pazopanib tended to reduce the tumor volume compared to the untreated mice, but there was no significant difference (p = 0.115). S. typhimurium A1-R significantly inhibited tumor growth compared to the untreated mice (p = 0.001). S. typhimurium A1-R was the only effective treatment for the soft-tissue sarcoma nude mouse model among all treatments including a newly approved multiple tyrosine kinase inhibitor; Pazopanib. These results suggest tumor-targeting S. typhimurium A1-R is a promising treatment for chemo-resistant soft-tissue sarcoma.	[Hiroshima, Yukihiko; Zhao, Ming; Zhang, Yong; Zhang, Nan; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020; Zhang, Nan/GXH-0361-2022	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA183280]; JSPS KAKENHI [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R43CA183280] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA183280 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. AntiCancer, Inc., provided support in the form of salaries for authors [MZ, YZ, NZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117417; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Yano S, 2014, CELL CYCLE, V13, P2110, DOI 10.4161/cc.29156; Zhang Y, 2012, ANTICANCER RES, V32, P2501; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667	22	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134324	10.1371/journal.pone.0134324	http://dx.doi.org/10.1371/journal.pone.0134324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237416	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942400021
J	Baptista, I; Ritsema, C; Geissen, V				Baptista, Isaurinda; Ritsema, Coen; Geissen, Violette			Effect of Integrated Water-Nutrient Management Strategies on Soil Erosion Mediated Nutrient Loss and Crop Productivity in Cabo Verde Drylands	PLOS ONE			English	Article							LAND DEGRADATION; CONSERVATION MEASURES; CENTRAL HIGHLANDS; SANTIAGO ISLAND; RAINWATER-USE; RUNOFF; NITROGEN; DESERTIFICATION; MAIZE; LIVELIHOODS	Soil erosion, runoff and related nutrient losses are a big risk for soil fertility in Cabo Verde drylands. In 2012, field trials were conducted in two agro-ecological zones to evaluate the effects of selected techniques of soil-water management combined with organic amendments (T1: compost/manure + soil surfactant; T2: compost/animal or green manure + pigeon-pea hedges + soil surfactant; T3: compost/animal or green manure + mulch + pigeon-pea hedges) on nitrogen (N) and phosphorus (P) losses in eroded soil and runoff and on crop yields. Three treatments and one control (traditional practice) were tested in field plots at three sites with a local maize variety and two types of beans. Runoff and eroded soil were collected after each erosive rain, quantified, and analysed for NO3-N and PO4-P concentrations. In all treatments runoff had higher concentrations of NO3-N (2.20-4.83 mg L-1) than of PO4-P (0.02-0.07 mg L-1), and the eroded soil had higher content of PO4-P (5.27-18.8 mg g(-1)) than of NO3-N (1.30-8.51 mg g(-1)). The control had significantly higher losses of both NO3-N (5.4, 4.4 and 19 kg ha(-1)) and PO4-P (0.2, 0.1 and 0.4 kg ha(-1)) than the other treatments. T3 reduced soil loss, runoff and nutrient losses to nearly a 100% while T1 and T2 reduced those losses from 43 to 88%. The losses of NO3-N and PO4-P were highly correlated with the amounts of runoff and eroded soil. Nutrient losses from the applied amendments were low (5.7% maximum), but the losses in the control could indicate long-term nutrient depletion in the soil (19 and 0.4 kg ha(-1) of NO3-N and PO4-P, respectively). T1-T3 did not consistently increase crop yield or biomass in all three sites, but T1 increased both crop yield and biomass. We conclude that T3 (combining crop-residue mulch with organic amendment and runoff hedges) is the best treatment for steep slope areas but, the pigeon-pea hedges need to be managed for higher maize yield. T1 (combining organic amendment with soil surfactant) could be a better choice for flatter areas with deeper soils.	[Baptista, Isaurinda] INIDA, Inst Nacl Invest & Desenvolvimento Agr, Praia, Cape Verde; [Baptista, Isaurinda; Ritsema, Coen; Geissen, Violette] Wageningen Univ WUR, Soil Phys & Sustainable Land Management Grp SLM, Wageningen, Netherlands; [Geissen, Violette] Univ Bonn, INRES, Bonn, Germany	Wageningen University & Research; University of Bonn	Baptista, I (corresponding author), INIDA, Inst Nacl Invest & Desenvolvimento Agr, Praia, Cape Verde.	ibaptista@inida.gov.cv			Netherlands Universities Foundation for International Cooperation (NUFFIC) [NFP-PhD-10/132]	Netherlands Universities Foundation for International Cooperation (NUFFIC)	The study was funded by the Netherlands Universities Foundation for International Cooperation (NUFFIC) through the NFP-PhD-10/132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi O. A., 2013, International Journal of Agriculture and Forestry, V3, P40; Adimassu Z, 2014, LAND DEGRAD DEV, V25, P554, DOI 10.1002/ldr.2182; Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; Araya A, 2010, AGR WATER MANAGE, V97, P841, DOI 10.1016/j.agwat.2010.01.012; Araya T, 2011, SOIL USE MANAGE, V27, P404, DOI 10.1111/j.1475-2743.2011.00347.x; Baptista I, 2015, GEODERMA, V237, P283, DOI 10.1016/j.geoderma.2014.09.015; Baptista I, 1996, THESIS U GEORGIA ATH, P222; Baptista I, 2000, P WORKSH INTERCRSP P; Baptista I, 2003, TECHNOLOGY ADAPTATIO; Baptista I, 2015, LAND-BASEL, V4, P22, DOI 10.3390/land4010022; Bationo A, 1998, AGR ECOSYST ENVIRON, V71, P19, DOI 10.1016/S0167-8809(98)00129-7; Bhatti A.U, 2007, PAKIS J AGRIC RES, V20, P3; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Bossio D, 2010, AGR WATER MANAGE, V97, P536, DOI 10.1016/j.agwat.2008.12.001; Buerkert A, 2002, EXP AGR, V38, P163, DOI 10.1017/S0014479702000236; Cooper PJM, 2012, AGR ECOSYST ENVIRON, V126, P24; Dass A, 2011, NUTR CYCL AGROECOSYS, V89, P45, DOI 10.1007/s10705-010-9375-3; Drechsel P., 2004, Research Report - International Water Management Institute; FAO, 2014, EV CROP PROD; Han JG, 2010, AGR WATER MANAGE, V97, P757, DOI 10.1016/j.agwat.2010.01.007; Huang MX, 2015, CATENA, V128, P195, DOI 10.1016/j.catena.2015.02.010; INIDA, 1997, MAN FERT SOL FERT CU; INIDA, 2006, AV PROD CULT SEQ; INMG, 2010, DAD AN PLUV REF EST; Jackson ML, 1982, SOIL CHEM ANAL; Khan F., 2014, American Journal of Plant Sciences, V5, P2582; Kogbe J. O. S., 2003, African Journal of Biotechnology, V2, P345; Lal R, 1998, J SUSTAIN AGR, V11, P2; Lal R, 2009, AGRON SUSTAIN DEV, V29, P7, DOI 10.1051/agro:2008060; Liniger Hanspeter, 2007, LAND IS GREEN CAS ST; LOPES VL, 1993, ENVIRON MANAGE, V17, P51, DOI 10.1007/BF02393794; Mando A, 1997, SOIL TECHNOL, V11, P121, DOI 10.1016/S0933-3630(97)00003-2; Mannaerts CM, 1993, THESIS ITC NETHERLAN; MITTAL SP, 1992, AGROFOREST SYST, V19, P207, DOI 10.1007/BF00118778; Modesto V. C., 2014, American Journal of Plant Sciences, V5, P497, DOI 10.4236/ajps.2014.54064; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Novara A, 2013, SOLID EARTH, V4, P255, DOI 10.5194/se-4-255-2013; O'Geen AT, 2006, ANR PUBLICATION, V8194; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; Querido A, 1999, THESIS INT I AEROSPA; Reed MS, 2015, J ENVIRON MANAGE, V151, P472, DOI 10.1016/j.jenvman.2014.11.010; Rockstrom J, 2009, SOIL TILL RES, V103, P23, DOI 10.1016/j.still.2008.09.013; Rockstrom J, 2003, PHYS CHEM EARTH, V28, P869, DOI 10.1016/j.pce.2003.08.009; Rockstrom J, 2010, AGR WATER MANAGE, V97, P543, DOI 10.1016/j.agwat.2009.09.009; Roose E, 2004, B EROSION, V22, P74; Ryan J. G., 2001, FUTURE CHALLENGES OP; Salak J, 2010, SOIL FERTILITY GUIDE; Schwilch G, 2009, LAND DEGRAD DEV, V20, P308, DOI 10.1002/ldr.920; Schwilch G, 2012, DESIRE GREENER LAND; Sharma AR, 2010, NUTR CYCL AGROECOSYS, V86, P39, DOI 10.1007/s10705-009-9272-9; Smolikowski B, 2001, AGR ECOSYST ENVIRON, V87, P67, DOI 10.1016/S0167-8809(00)00292-9; Stroosnijder L, 1996, ECOL MODEL, V92, P79, DOI 10.1016/0304-3800(95)00197-2; Stroosnijder L, 2003, S WORKSH BLOEMF S AF; Stroosnijder L, 2012, CURR OPIN ENV SUST, V4, P1; Tavares J, 2010, THESIS BOURGOGNE U D, P226; Tavares JDP, 2015, CATENA, V128, P214, DOI 10.1016/j.catena.2014.10.005; Tavares JD, 2014, LAND DEGRAD DEV, V25, P45, DOI 10.1002/ldr.2273; Tesfaye A, 2014, LAND DEGRAD DEV, V25, P71, DOI 10.1002/ldr.2187; Tiscareno-Lopez M, 2004, J AM WATER RESOUR AS, V40, P401, DOI 10.1111/j.1752-1688.2004.tb01038.x; Varela AC, 2012, THESIS UNICV PRAIA; Wu W, 2015, SCI TOTAL ENVIRON, V512, P415, DOI 10.1016/j.scitotenv.2014.12.101; Xia LZ, 2013, CATENA, V110, P86, DOI 10.1016/j.catena.2013.05.009; Zhang SL, 2011, NUTR CYCL AGROECOSYS, V89, P427, DOI 10.1007/s10705-010-9406-0; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; ZOBISCH MA, 1995, SOIL TILL RES, V33, P109, DOI 10.1016/0167-1987(94)00441-G; Zougmore R, 2004, NUTR CYCL AGROECOSYS, V70, P261, DOI 10.1007/s10705-004-0533-3; Zougmore R, 2003, SOIL USE MANAGE, V19, P257, DOI 10.1079/SUM2003199; Zougmore R, 2009, ARID LAND RES MANAG, V23, P85, DOI 10.1080/15324980802599142; Zougmoru R., 2014, AGR FOOD SECURITY, V3, P1, DOI [10.1186/2048-7010-3-16, DOI 10.1186/2048-7010-3-16]	71	16	16	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134244	10.1371/journal.pone.0134244	http://dx.doi.org/10.1371/journal.pone.0134244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230549	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400092
J	Crona, J; Ljungstrom, V; Welin, S; Walz, MK; Hellman, P; Bjorklund, P				Crona, Joakim; Ljungstrom, Viktor; Welin, Staffan; Walz, Martin K.; Hellman, Per; Bjorklund, Peyman			Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma	PLOS ONE			English	Article							MUTATIONS; PARAGANGLIOMA; GENE; SUSCEPTIBILITY; EXOME; IDENTIFICATION; SDHB	Background Recent studies have demonstrated equal quality of targeted next generation sequencing (NGS) compared to Sanger Sequencing. Whereas these novel sequencing processes have a validated robust performance, choice of enrichment method and different available bioinformatic software as reliable analysis tool needs to be further investigated in a diagnostic setting. Methods DNA from 21 patients with genetic variants in SDHB, VHL, EPAS1, RET, (n=17) or clinical criteria of NF1 syndrome (n=4) were included. Targeted NGS was performed using Truseq custom amplicon enrichment sequenced on an Illumina MiSEQ instrument. Results were analysed in parallel using three different bioinformatics pipelines; (1) Commercially available MiSEQ Reporter, fully automatized and integrated software, (2) CLC Genomics Workbench, graphical interface based software, also commercially available, and ICP (3) an in-house scripted custom bioinformatic tool. Results A tenfold read coverage was achieved in between 95-98% of targeted bases. All workflows had alignment of reads to SDHA and NF1 pseudogenes. Compared to Sanger sequencing, variant calling revealed a sensitivity ranging from 83 to 100% and a specificity of 99.9-100%. Only MiSEQ reporter identified all pathogenic variants in both sequencing runs. Conclusions We conclude that targeted next generation sequencing have equal quality compared to Sanger sequencing. Enrichment specificity and the bioinformatic performance need to be carefully assessed in a diagnostic setting. As acceptable accuracy was noted for a fully automated bioinformatic workflow, we suggest that processing of NGS data could be performed without expert bioinformatics skills utilizing already existing commercially available bioinformatics tools.	[Crona, Joakim; Hellman, Per; Bjorklund, Peyman] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Ljungstrom, Viktor] Uppsala Univ, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Welin, Staffan] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden; [Walz, Martin K.] Univ Duisburg Essen, Acad Teaching Hosp, Kliniken Essen Mitte, Dept Surg, DE-45136 Essen, Germany; [Walz, Martin K.] Univ Duisburg Essen, Acad Teaching Hosp, Kliniken Essen Mitte, Ctr Minimal Invas Surg, DE-45136 Essen, Germany	Uppsala University; Uppsala University; Uppsala University; Kliniken Essen-Mitte; University of Duisburg Essen; Kliniken Essen-Mitte; University of Duisburg Essen	Crona, J (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	joakim.crona@surgsci.uu.se	Hellman, Per/AAL-9817-2021; Walz, Martin/AHE-7790-2022; Crona, Joakim/D-3474-2013	Hellman, Per/0000-0002-5322-5073; Crona, Joakim/0000-0003-0677-4894	Swedish Cancer Society; Selander Foundation; Lions Cancer Foundation, Uppsala	Swedish Cancer Society(Swedish Cancer Society); Selander Foundation; Lions Cancer Foundation, Uppsala	This work was supported by grants from Swedish Cancer Society (PB), Selander Foundation (PB, PH) and Lions Cancer Foundation, Uppsala (JC, PH). PB is a Swedish Cancer Society Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Burnichon N, 2012, HUM MOL GENET, V6, P6; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Casey R, 2014, J CLIN ENDOCR METAB, V99, pE1392, DOI 10.1210/jc.2013-4536; Chan M, 2012, J MOL DIAGN, V14, P602, DOI 10.1016/j.jmoldx.2012.06.003; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Crona J, 2015, CLIN CANC RES; Crona J, 2013, FAM CANCER, V7, P7; Crona J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086756; Crona J, 2013, J CLIN ENDOCR METAB, V98, pE1266, DOI 10.1210/jc.2012-4257; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Erlic Z, 2009, CLIN CANCER RES, V15, P6378, DOI 10.1158/1078-0432.CCR-09-1237; Feliubadalo L, 2012, EUR J HUM GENET, V19, P27; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garrison E, 2012, 12073907 ARXIV, V1207, P3907; Grossmann V, 2013, J MOL DIAGN, V13, P00057; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Jacob HJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006468; Jafri M, 2013, CLIN ENDOCRINOL, V78, P898, DOI 10.1111/cen.12074; Jafri M, 2012, EUR J ENDOCRINOL, V166, P151, DOI 10.1530/EJE-11-0497; Korf B R, 2001, Curr Neurol Neurosci Rep, V1, P162, DOI 10.1007/s11910-001-0012-z; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Letouze E, 2013, CANCER CELL, V21, P00183; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; Martucci VL, 2014, CURR PROB CANCER, V38, P7, DOI 10.1016/j.currproblcancer.2014.01.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pritchard CC, 2012, J MOL DIAGN, V14, P357, DOI 10.1016/j.jmoldx.2012.03.002; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Rattenberry E, 2013, J CLIN ENDOCR METAB, V10, P10; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Sikkema-Raddatz B, 2013, HUM MUTAT, V8, P2233; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Welander J, 2014, J CLIN ENDOCR METAB, V99, pE1352, DOI 10.1210/jc.2013-4375; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	46	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133210	10.1371/journal.pone.0133210	http://dx.doi.org/10.1371/journal.pone.0133210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230854	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400029
J	Cui, Y; Tian, SS; Qiao, N; Wang, C; Wang, T; Huang, JJ; Sun, CM; Liang, J; Liu, XM				Cui, Yan; Tian, Shuang-Shuang; Qiao, Nan; Wang, Cong; Wang, Tong; Huang, Jian-Jun; Sun, Chen-Ming; Liang, Jie; Liu, Xiao-Meng			Associations of Individual-Related and Job-Related Risk Factors with Nonfatal Occupational Injury in the Coal Workers of Shanxi Province: A Cross-Sectional Study	PLOS ONE			English	Article							LIFE-STYLE; AGE; BURNOUT; QUESTIONNAIRE; FATALITIES; EMPLOYEES; BEHAVIOR; INDUSTRY; STRESS; MINERS	Objectives To assess the relationships between the risk factors and the incidence of nonfatal occupational injury of coal mine workers of Shanxi Province. Methods A cross-sectional study was conducted from July 2013 to December 2013, and 4319 workers were recruited from more than 200,000 coal mine employees who are exposed to continuous potential risk of occupational injuries by using a two-stage stratified cluster sampling method. Trained interviewers having necessary medical knowledge conducted face-to-face interviews with the participants. Univariate and multivariable logistic regression models were used to estimate the odds ratio (OR) and the 95% confidence interval (CI). Results A total number of 3618 effective respondents were got from 4319 participants (83.77%) and the mean age of the participants was 41.5 years with the standard deviation of 8.65. Significant crude odds ratios were observed for all factors considered except for marital status, education, work duration, BMI, EPQ-RSC(P) scale and EPQ-RSC(L) scale. Results from multivariable logistic regression model showed significant adjusted odds ratios for risk factors including gender (female vs male 0.275, 0.094-0.800), age (>= 55 vs <= 25yr 0.169, 0.032-0.900), work type (light physical labor vs heavy physical labor 0.504, 0.328-0.774), workplace (underground auxiliary vs underground front-line 0.595, 0.385-0.919), length of shiftwork experience (0 similar to 5yr vs no shift 2.075, 1.287-3.344 and >= 15yr vs no shift 2.076, 1.230-3.504) and EPQ-RSC(E) score (extraversion vs introversion 0.538, 0.334-0.867). Conclusions Several risk factors of nonfatal occupational injury were identified including male, age, heavy physical labor, underground front-line, length of shiftwork experience and introversion. The coal mining enterprises should pay attention to controlling the hazards associated with frontline physical work. Workers' behaviors, life styles and personality traits should also be considered, so that the enterprises could set achievable targets for workers and lessen the exposed period to the risky underground workstation.	[Cui, Yan; Tian, Shuang-Shuang; Qiao, Nan; Wang, Cong; Wang, Tong; Liang, Jie; Liu, Xiao-Meng] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China; [Tian, Shuang-Shuang] Taiyuan Xinghualing Dist Food & Drug Adm, Dept Hlth Stat, Taiyuan, Peoples R China; [Huang, Jian-Jun] Gen Hosp, Datong Coal Min Grp, Dept Neurosurg, Taiyuan, Peoples R China; [Sun, Chen-Ming] Gen Hosp, Datong Coal Min Grp, Dept Urol, Taiyuan, Peoples R China; [Wang, Tong; Huang, Jian-Jun] Ctr Postgrad Educ Innovat Shanxi Prov, Taiyuan, Peoples R China	Shanxi Medical University	Wang, T (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China.	13835120380@163.com; tmhjj1958@163.com	wang, tong/I-6454-2018	wang, tong/0000-0002-9403-7167; Liang, Jie/0000-0002-0767-3908	National Natural Science Foundation of China [81473073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundation of China (81473073) URLs: (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderaw Z, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/657275; Ahola K, 2013, J OCCUP HEALTH, V55, P450, DOI 10.1539/joh.13-0021-OA; Andersen LP, 2008, SAFETY SCI, V46, P255, DOI 10.1016/j.ssci.2007.06.014; [Anonymous], 2006, REPUBLIC; [Anonymous], 1986, Ministry of Labour and Social Security of the People's Republic of China, P6441, Patent No. 644186; [Anonymous], 2012, INJ EXP SAND GRAV MI; [Anonymous], 2013, NONF OCC INJ ILLN RE; Arlinghaus A, 2012, AM J EPIDEMIOL, V176, P597, DOI 10.1093/aje/kws219; Barling J., 2004, PSYCHOL WORKPLACE SA, P3; Bhattacherjee A, 2011, 34 INT C SAF MIN RES, P481; Bhattacherjee A, 2009, J GEOLOGY MINING RES, V1, P025; Boniface R, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.120.3420; Chau N, 2008, INT ARCH OCC ENV HEA, V81, P379, DOI 10.1007/s00420-007-0223-y; Chau N, 2009, OCCUP MED-OXFORD, V59, P114, DOI 10.1093/occmed/kqp002; Chau N, 2014, AM J IND MED, V57, P172, DOI 10.1002/ajim.22259; CHU JP, 2011, CHINA J HLTH PSYCHOL, V19, P664; COSTA G, 1989, ERGONOMICS, V32, P373, DOI 10.1080/00140138908966104; Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330; Ghosh AK, 2004, J OCCUP HEALTH, V46, P470, DOI 10.1539/joh.46.470; Gorgens-Ekermans G, 2012, J CLIN NURS, V21, P2275, DOI 10.1111/j.1365-2702.2012.04171.x; Gonzalez-Delgado M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121490; Groves WA, 2007, J SAFETY RES, V38, P461, DOI 10.1016/j.jsr.2007.03.011; Horberry T, 2013, ERGONOMICS, V56, P556, DOI 10.1080/00140139.2012.718800; Hutchinson TA, 2014, W INDIAN MED J, V63, P262, DOI 10.7727/wimj.2013.330; Ishtiaq M, 2014, J MED SCI, V22, P21; Khanzode VV, 2012, SAFETY SCI, V50, P1355, DOI 10.1016/j.ssci.2011.12.015; Kipping RR, 2015, EUR J PUBLIC HEALTH, V25, P44, DOI 10.1093/eurpub/cku078; Kouvonen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077178; Kunar BM, 2008, J OCCUP HEALTH, V50, P236, DOI 10.1539/joh.L7054; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; Li XR, 2015, INT J ENV RES PUB HE, V12, P2984, DOI 10.3390/ijerph120302984; Li Y, 2008, CHIN OCCUP MED, V135, P417; Margolis KA, 2010, SAFETY SCI, V48, P417, DOI 10.1016/j.ssci.2009.12.015; Marusic A, 2001, NORD J PSYCHIAT, V55, P157; MITCHELL OS, 1988, MON LABOR REV, V111, P8; Nakata A, 2005, IND HEALTH, V43, P89, DOI 10.2486/indhealth.43.89; Onder M, 2010, IND HEALTH, V48, P872, DOI 10.2486/indhealth.MS1136; Pordanjani RT, 2013, JOHE SUMMER 2013, V2, P93; Salminen S, 2010, J SLEEP RES, V19, P207, DOI 10.1111/j.1365-2869.2009.00780.x; Shao T, 2004, J ENV OCCUP MED, V21, P326; Sun GF, 2012, OCCUPATIONAL HLTH OC; Tucker P, 1998, J Occup Health Psychol, V3, P265, DOI 10.1037/1076-8998.3.3.265; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Xie ZY, 2011, J ADV NURS, V67, P1537, DOI 10.1111/j.1365-2648.2010.05576.x; Yumang-Ross DJ, 2014, WORKPLACE HEALTH SAF, V62, P256, DOI 10.3928/21650799-20140514-07	45	15	15	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134367	10.1371/journal.pone.0134367	http://dx.doi.org/10.1371/journal.pone.0134367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230266	Green Published, gold			2022-12-26	WOS:000358838400110
J	Fehervari, TD; Okazaki, Y; Sawai, H; Yagi, T				Fehervari, Tams David; Okazaki, Yuka; Sawai, Hajime; Yagi, Tetsuya			In Vivo Voltage-Sensitive Dye Study of Lateral Spreading of Cortical Activity in Mouse Primary Visual Cortex Induced by a Current Impulse	PLOS ONE			English	Article							HORIZONTAL CONNECTIONS; SPATIOTEMPORAL DYNAMICS; INTRINSIC CONNECTIONS; RECEPTIVE-FIELDS; SYNAPTIC CONNECTIONS; AXONAL PROJECTIONS; STRIATE CORTEX; NEURONS; EXCITATION; RESPONSES	In the mammalian primary visual cortex (V1), lateral spreading of excitatory potentials is believed to be involved in spatial integrative functions, but the underlying cortical mechanism is not well understood. Visually-evoked population-level responses have been shown to propagate beyond the V1 initial activation site in mouse, similar to higher mammals. Visually- evoked responses are, however, affected by neuronal circuits prior to V1 (retina, LGN), making the separate analysis of V1 difficult. Intracortical stimulation eliminates these initial processing steps. We used in vivo RH1691 voltage-sensitive dye (VSD) imaging and intracortical microstimulation in adult C57BL/6 mice to elucidate the spatiotemporal properties of population-level signal spreading in V1 cortical circuits. The evoked response was qualitatively similar to that measured in single-cell electrophysiological experiments in rodents: a fast transient fluorescence peak followed by a fast and a slow decrease or hyperpolarization, similar to EPSP and fast and slow IPSPs in single cells. The early cortical response expanded at speeds commensurate with long horizontal projections (at 5% of the peak maximum, 0.08-0.15 m/s) however, the bulk of the VSD signal propagated slowly (at half-peak maximum, 0.05-0.08 m/s) suggesting an important role of regenerative multisynaptic transmission through short horizontal connections in V1 spatial integrative functions. We also found a tendency for a widespread and fast cortical response suppression in V1, which was eliminated by GABAA-antagonists gabazine and bicuculline methiodide. Our results help understand the neuronal circuitry involved in lateral spreading in V1.	[Fehervari, Tams David; Okazaki, Yuka; Yagi, Tetsuya] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan; [Okazaki, Yuka] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Sawai, Hajime] Osaka Univ, Grad Sch Med, Div Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Yagi, T (corresponding author), Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan.	yagi@eei.eng.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project "Creating Hybrid Organs of the Future" at Osaka University; MEXT [21700332]; Japan Society for the Promotion of Science [19206041]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project "Creating Hybrid Organs of the Future" at Osaka University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/) project "Creating Hybrid Organs of the Future" at Osaka University, a Grant-in-Aid for Young Scientists (B) (21700332) from MEXT to YO and a Grant-in-Aid for Scientific Research (A) (19206041) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2008, CEREB CORTEX, V18, P2796, DOI 10.1093/cercor/bhn038; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BISHOP PO, 1971, J PHYSIOL-LONDON, V219, P625, DOI 10.1113/jphysiol.1971.sp009681; Bosking WH, 1997, J NEUROSCI, V17, P2112; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; BURKHALTER A, 1990, J COMP NEUROL, V302, P920, DOI 10.1002/cne.903020417; Chavane F, 2000, J PHYSIOL-PARIS, V94, P333, DOI 10.1016/S0928-4257(00)01096-2; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Fehervari T, 2011, PROGRAM NO 37806; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fukuda M, 1998, NEUROSCI RES, V31, P9, DOI 10.1016/S0168-0102(98)00018-2; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Ichinose T, 1996, NEUROSCIENCE, V73, P25, DOI 10.1016/0306-4522(96)00026-7; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MCDONALD CT, 1993, J NEUROSCI, V13, P768; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Muller L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4675; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; MURAKOSHI T, 1995, VISION RES, V35, P25, DOI 10.1016/0042-6989(94)E0056-Q; NELSON DA, 1995, NEURON, V15, P23, DOI 10.1016/0896-6273(95)90061-6; Olivas ND, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00070; ORBACH HS, 1993, EXP BRAIN RES, V94, P371, DOI 10.1007/BF00230197; Osanai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013738; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pisauro MA, 2013, J NEUROSCI, V33, P18343, DOI 10.1523/JNEUROSCI.2130-13.2013; Polack PO, 2012, J NEUROSCI, V32, P11120, DOI 10.1523/JNEUROSCI.6304-11.2012; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; SCHARFMAN HE, 1988, SYNAPSE, V2, P619, DOI 10.1002/syn.890020607; Schuett S, 2002, J NEUROSCI, V22, P6549; Shao ZW, 1996, J NEUROSCI, V16, P7353; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; Sit YF, 2009, NEURON, V64, P943, DOI 10.1016/j.neuron.2009.08.041; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001; Vaiceliunaite A, 2013, J NEUROPHYSIOL, V110, P964, DOI 10.1152/jn.00138.2013; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WELIKY M, 1994, J NEUROSCI, V14, P7291; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; YOSHIMURA Y, 1994, J NEUROPHYSIOL, V71, P1638, DOI 10.1152/jn.1994.71.5.1638; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546	66	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133853	10.1371/journal.pone.0133853	http://dx.doi.org/10.1371/journal.pone.0133853			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230520	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400059
J	Lis, CG; Patel, K; Gupta, D				Lis, Christopher G.; Patel, Kamal; Gupta, Digant			The Relationship between Patient Satisfaction with Service Quality and Survival in Non-Small Cell Lung Cancer - Is Self-Rated Health a Potential Confounder?	PLOS ONE			English	Article							ADVANCED COLORECTAL-CANCER; OF-LIFE PARAMETERS; BREAST-CANCER; PROGNOSTIC-FACTORS; EORTC QLQ-C30; ONCOLOGY; CARE; DETERMINANTS; ASSOCIATION; PREDICTOR	Background/Aims Previously we reported that higher patient satisfaction (PS) with service quality is associated with favorable survival outcomes in a variety of cancers. However, we cautioned the readers that patients with greater satisfaction might be the ones with better self-rated health (SRH), a well-established prognosticator of cancer survival. In other words, SRH could potentially confound the PS and survival relationship. We investigated this hypothesis in non-small cell lung cancer (NSCLC). Methods 778 NSCLC patients (327 males and 451 females; mean age 58.8 years) treated at 4 Cancer Treatment Centers of America hospitals between July 2011 and March 2013. PS was measured on a 7-point scale ranging from "completely dissatisfied" to "completely satisfied". SRH was measured on a 7-point scale ranging from "very poor" to "excellent". Both were dichotomized into 2 categories: top box response (7) versus all others (1-6). Patient survival was the primary end point. Cox regression was used to evaluate the association between PS and survival controlling for covariates. Results 74, 70, 232 and 391 patients had stage I, II, III and IV disease respectively. 631 (81.1%) patients were "completely satisfied". 184 (23.7%) patients had "excellent" SRH. There was a weak but significant correlation between overall PS and SRH (Kendall's tau b = 0.19; p<0.001). On univariate analysis, "completely satisfied" patients had a significantly lower risk of mortality (HR = 0.75; 95% CI: 0.57 to 0.99; p = 0.04). Similarly, patients with "excellent" SRH had a significantly lower risk of mortality (HR = 0.61; 95% CI: 0.46 to 0.81; p = 0.001). On multivariate analysis controlling for stage at diagnosis, treatment history and gender, SRH was found to be a significant predictor of survival (HR = 0.67; 95% CI: 0.50 to 0.89; p = 0.007) while PS was not (HR = 0.86; 95% CI: 0.64 to 1.2; p = 0.32). Among the individual PS items, the only significant independent predictor of survival was "teams communicating with each other concerning your medical condition and treatment" (HR = 0.59; 95% CI: 0.36 to 0.94; p = 0.03). Conclusion SRH appears to confound the PS-survival relationship in NSCLC. SRH should be used as a control/stratification variable in analyses involving PS as a predictor of clinical cancer outcomes.	[Lis, Christopher G.; Patel, Kamal; Gupta, Digant] Canc Treatment Ctr Amer, Schaumburg, IL 60173 USA		Gupta, D (corresponding author), Canc Treatment Ctr Amer, 500 Remington Rd, Schaumburg, IL 60173 USA.	digant.gupta@ctca-hope.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				Akin S, 2010, EUR J ONCOL NURS, V14, P400, DOI 10.1016/j.ejon.2010.01.003; Besley D., 2004, REGRESSION DIAGNOSTI; Bredart A, 2003, PSYCHO-ONCOLOGY, V12, P68, DOI 10.1002/pon.620; Bredart A, 2001, ONCOLOGY-BASEL, V61, P120, DOI 10.1159/000055362; Cleary PD, 1999, QUAL HEALTH CARE, V8, P212, DOI 10.1136/qshc.8.4.212; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; Collette L, 2004, J CLIN ONCOL, V22, P3877, DOI 10.1200/JCO.2004.07.089; Dancey J, 1997, QUAL LIFE RES, V6, P151; Dharma-Wardene M, 2004, QUAL LIFE RES, V13, P1209, DOI 10.1023/B:QURE.0000037481.36604.eb; Efficace F, 2004, J CLIN ONCOL, V22, P3381, DOI 10.1200/JCO.2004.02.060; Fang FM, 2004, INT J RADIAT ONCOL, V58, P1394, DOI 10.1016/j.ijrobp.2003.09.100; Fielding R, 2007, EUR J CANCER, V43, P1723, DOI 10.1016/j.ejca.2007.05.002; Gupta D, 2012, J HEALTHC QUAL, P10; Gupta D, 2013, INT J QUAL HLTH CARE; Gupta D, 2013, SUPPORT CARE CANC; Gupta D, 2007, SUPPORT CARE CANCER, V15, P387, DOI 10.1007/s00520-006-0165-z; Gupta D, 2006, J GASTROINTEST CANC, V37, P65, DOI 10.1007/s12029-007-0001-9; Halyard Michele Y, 2008, J Support Oncol, V6, P221; Arraras JI, 2013, PSYCHO-ONCOLOGY, V22, P2454, DOI 10.1002/pon.3307; Iskandarsyah A, 2013, SUPPORT CARE CANCER, V21, P2999, DOI 10.1007/s00520-013-1877-5; Kleeberg UR, 2005, SUPPORT CARE CANCER, V13, P303, DOI 10.1007/s00520-004-0727-x; Langendijk H, 2000, RADIOTHER ONCOL, V55, P19, DOI 10.1016/S0167-8140(00)00158-4; Lis CG, 2006, SUPPORT CARE CANCER, V14, P1104, DOI 10.1007/s00520-006-0100-3; Lis CG, 2006, J GASTROINTEST CANC, V37, P35, DOI 10.1385/IJGC:37:1:35; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; Lis CG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-190; Loblaw DA, 1999, J CLIN ONCOL, V17, P1931, DOI 10.1200/JCO.1999.17.6.1931; Maisey NR, 2002, EUR J CANCER, V38, P1351, DOI 10.1016/S0959-8049(02)00098-9; Mathieson CM, 1996, CAN FAM PHYSICIAN, V42, P1712; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pita-Fernandez S, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-117; Roychowdhury DF, 2003, J CLIN ONCOL, V21, P673, DOI 10.1200/JCO.2003.04.166; Sixma Herman J., 1998, Health Expect, V1, P82, DOI 10.1046/j.1369-6513.1998.00004.x; Wong WS, 2008, MED CARE, V46, P293, DOI 10.1097/MLR.0b013e31815b9785; Wong WS, 2009, MED CARE, V47, P875, DOI 10.1097/MLR.0b013e3181a393cf	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134617	10.1371/journal.pone.0134617	http://dx.doi.org/10.1371/journal.pone.0134617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230934	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400140
J	Roy, S; Banerjee, V; Das, KP				Roy, Sujit; Banerjee, Victor; Das, Kali Pada			Understanding the Physical and Molecular Basis of Stability of Arabidopsis DNA Pol lambda under UV-B and High NaCl Stress	PLOS ONE			English	Article							POLYMERASE-LAMBDA; ESCHERICHIA-COLI; PROLINE RESIDUES; ATPOL-LAMBDA; X-FAMILY; PROTEINS; REPAIR; SALT; BYPASS; DAMAGE	Here, we have investigated the physical and molecular basis of stability of Arabidopsis DNA Pol lambda, the sole X family DNA polymerase member in plant genome, under UV-B and salinity stress in connection with the function of the N-terminal BRCT (breast cancer-associated C terminus) domain and Ser-Pro rich region in the regulation of the overall structure of this protein. Tryptophan fluorescence studies, fluorescence quenching and Bis-ANS binding experiments using purified recombinant full length Pol lambda and its N-terminal deletion forms have revealed UV-B induced conformational change in BRCT domain deficient Pol lambda. On the other hand, the highly conserved C-terminal catalytic core PolX domain maintained its tertiary folds under similar condition. Circular dichroism (CD) and fourier transform infrared (FT-IR) spectral studies have indicated appreciable change in the secondary structural elements in UV-B exposed BRCT domain deficient Pol lambda. Increased thermodynamic stability of the C-terminal catalytic core domain suggested destabilizing effect of the N-terminal SerPro rich region on the protein structure. Urea-induced equilibrium unfolding studies have revealed increased stability of Pol lambda and its N-terminal deletion mutants at high NaCl concentration. In vivo aggregation studies using transient expression systems in Arabidopsis and tobacco indicated possible aggregation of Pol lambda lacking the BRCT domain. Immunoprecipitation assays revealed interaction of Pol lambda with the eukaryotic molecular chaperone HSP90, suggesting the possibility of regulation of Pol lambda stability by HSP90 in plant cell. Overall, our results have provided one of the first comprehensive information on the biophysical characteristics of Pol lambda and indicated the importance of both BRCT and Ser-Pro rich modules in regulating the stability of this protein under genotoxic stress in plants.	[Roy, Sujit; Banerjee, Victor; Das, Kali Pada] Bose Inst, Dept Chem, Prot Chem Lab, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Roy, S (corresponding author), Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan 713104, W Bengal, India.	sujitroy2006@gmail.com	Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019	Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362	Council of Scientific and Industrial Research (CSIR), Govt. of India [13(8611-A)/2013-Pool)]; Bose Institute; Council of Scientific and Industrial Research, Govt. of India	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the research grant from the Council of Scientific and Industrial Research (CSIR) Pool Scientist's Scheme (Ref. No. 13(8611-A)/2013-Pool), Govt. of India to SR and funding from Bose Institute to KPD. VB was supported by doctoral fellowship from the Council of Scientific and Industrial Research, Govt. of India.	Albani JR, 2004, STRUCTURE AND DYNAMI; Amoroso A, 2011, PLANT CELL, V23, P806, DOI 10.1105/tpc.110.081455; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Choudhury SR, 2012, J BIOL CHEM, V287, P17870, DOI 10.1074/jbc.M112.353219; Crespan E, 2007, NUCLEIC ACIDS RES, V35, P5173, DOI 10.1093/nar/gkm568; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fersht A, 1999, STRUCTURE AND MECHAN; Forsberg J, 1998, PLANT SCI, V131, P65, DOI 10.1016/S0168-9452(97)00242-2; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kunkel TA, 2004, DNA REPAIR AND REPLI; Lakowicz JR, 1991, TOPICS IN FLUORESCEN, V1; Layton JC, 2005, J BACTERIOL, V187, P449, DOI 10.1128/JB.187.2.449-457.2005; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; McIntyre J, 2006, MUTAT RES-FUND MOL M, V593, P153, DOI 10.1016/j.mrfmmm.2005.07.003; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Navratilova B, 2008, PLANT CELL TISS ORG, V94, P313, DOI 10.1007/s11240-008-9416-7; Nelson ED, 1998, P NATL ACAD SCI USA, V95, P10682, DOI 10.1073/pnas.95.18.10682; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; Pozo FM, 2011, MOL CELL BIOL, V31, P3396, DOI 10.1128/MCB.05117-11; Pradeep L, 2002, J MOL BIOL, V324, P331, DOI 10.1016/S0022-2836(02)01068-9; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; Ray S, 2014, PROTEIN J, V33, P143, DOI 10.1007/s10930-014-9546-1; Roy S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00487; Roy S, 2013, PLANT PHYSIOL, V162, P1195, DOI 10.1104/pp.113.219022; Roy S, 2011, PLANT CELL PHYSIOL, V52, P448, DOI 10.1093/pcp/pcr002; Sakurai K, 2001, PROTEIN SCI, V10, P2325, DOI 10.1110/ps.17001; SALVUCCI ME, 1987, PLANT PHYSIOL, V85, P66, DOI 10.1104/pp.85.1.66; Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Uchiyama Y, 2004, EUR J BIOCHEM, V271, P2799, DOI 10.1111/j.1432-1033.2004.04214.x; Wen W-S, 2010, MOL VIS, V16, P2777; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; Xia Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01560; Zucca E, 2013, NUCLEIC ACIDS RES, V41, P229, DOI 10.1093/nar/gks1016	56	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133843	10.1371/journal.pone.0133843	http://dx.doi.org/10.1371/journal.pone.0133843			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230318	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400056
J	Su, Z; Robinson, A; Hu, L; Klein, JD; Hassounah, F; Li, M; Wang, HD; Cai, H; Wang, XNH				Su, Zhen; Robinson, Alayna; Hu, Li; Klein, Janet D.; Hassounah, Faten; Li, Min; Wang, Haidong; Cai, Hui; Wang, Xiaonan H.			Acupuncture plus Low-Frequency Electrical Stimulation (Acu-LFES) Attenuates Diabetic Myopathy by Enhancing Muscle Regeneration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PROTEIN-DEGRADATION; PROTEOLYSIS; ACTIVATION; EXERCISE; PATHWAY; ATROPHY; DYSFUNCTION; EXPRESSION; INHIBITOR	Mortality and morbidity are increased in patients with muscle atrophy resulting from catabolic diseases such as diabetes. At present there is no pharmacological treatment that successfully reverses muscle wasting from catabolic conditions. We hypothesized that acupuncture plus low frequency electric stimulation (Acu-LFES) would mimic the impact of exercise and prevent diabetes-induced muscle loss. Streptozotocin (STZ) was used to induce diabetes in mice. The mice were then treated with Acu-LFES for 15 minutes daily for 14 days. Acupuncture points were selected according to the WHO Standard Acupuncture Nomenclature guide. The needles were connected to an SDZ-II electronic acupuncture device delivering pulses at 20Hz and 1mA. Acu-LFES prevented soleus and EDL muscle weight loss and increased hind-limb muscle grip function in diabetic mice. Muscle regeneration capacity was significantly increased by Acu-LFES. The expression of Pax7, MyoD, myogenin and embryo myosin heavy chain (eMyHC) was significantly decreased in diabetic muscle vs. control muscle. The suppressed levels in diabetic muscle were reversed by Acu-LFES. The IGF-1 signaling pathway was also upregulated by Acu-LFES. Phosphorylation of Akt, mTOR and p70S6K were downregulated by diabetes leading to a decline in muscle mass, however, Acu-LFES countered the diabetes-induced decline. In addition, microRNA-1 and -206 were increased by Acu-LFES after 24 days of treatment. We conclude that Acu-LFES is effective in counteracting diabetes-induced skeletal muscle atrophy by increasing IGF-1 and its stimulation of muscle regeneration.	[Su, Zhen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China; [Hu, Li] Shanghai Univ Tradit Chinese Med, Coll Acumox & Tuina, Acumox & Tuina Res Sect, Shanghai, Peoples R China; [Su, Zhen; Robinson, Alayna; Hu, Li; Klein, Janet D.; Hassounah, Faten; Li, Min; Wang, Haidong; Cai, Hui; Wang, Xiaonan H.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA	Wenzhou Medical University; Shanghai University of Traditional Chinese Medicine; Emory University	Wang, XNH (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.	xwang03@emory.edu			NIAMS [R01 AR060268]; National Natural Science Foundation of China [30871179]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIAMS R01 AR060268 to XW (PI), National Natural Science Foundation of China (30871179) to ZS (PI), and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents to ZS (PI).	Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Butterfield GE, 1997, AM J PHYSIOL-ENDOC M, V272, pE94, DOI 10.1152/ajpendo.1997.272.1.E94; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Chen Y, 2008, KIDNEY INT, V73, P848, DOI 10.1038/sj.ki.5002801; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; D'Souza DM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00379; Eddins MJ, 2011, CELL BIOCHEM BIOPHYS, V60, P113, DOI 10.1007/s12013-011-9175-7; Ernst G, 2003, COMPLEMENT THER MED, V11, P93, DOI 10.1016/S0965-2299(03)00004-9; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4; Hu JP, 2008, ENDOCRINOLOGY, V149, P5384, DOI 10.1210/en.2008-0132; Hu JP, 2010, J AM SOC NEPHROL, V21, P1174, DOI 10.1681/ASN.2009101011; Hu L, 2015, J AM SOC NEPHROL, V26, P626, DOI 10.1681/ASN.2014020144; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x; Jamart C, 2011, MUSCLE NERVE, V43, P708, DOI 10.1002/mus.21949; Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Lim S, 2010, EVID-BASED COMPL ALT, V7, P167, DOI 10.1093/ecam/nep006; Lin RT, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/371475; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Macdonald JH, 2007, NEPHRON CLIN PRACT, V106, P125, DOI 10.1159/000103000; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; Majchrzak KM, 2008, NEPHROL DIAL TRANSPL, V23, P1362, DOI 10.1093/ndt/gfm773; Man KM, 2011, EUR J ANAESTH, V28, P420, DOI 10.1097/EJA.0b013e32833fad52; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Onda A, 2011, BIOCHEM BIOPH RES CO, V410, P434, DOI 10.1016/j.bbrc.2011.05.152; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Takaoka Y, 2007, PHYSIOL GENOMICS, V30, P102, DOI 10.1152/physiolgenomics.00057.2006; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wang XH, 2007, GENE THER, V14, P711, DOI 10.1038/sj.gt.3302927; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2013, INT J BIOCHEM CELL B, V45, P2230, DOI 10.1016/j.biocel.2013.06.027; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; WINDSOR JA, 1988, ANN SURG, V208, P209, DOI 10.1097/00000658-198808000-00013; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	46	31	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134511	10.1371/journal.pone.0134511	http://dx.doi.org/10.1371/journal.pone.0134511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230945	Green Published, gold			2022-12-26	WOS:000358838400129
J	Sun, H; Yang, ZQ; Lin, KQ; Liu, SY; Huang, K; Wang, XY; Chu, JY; Huang, XQ				Sun, Hao; Yang, Zhaoqing; Lin, Keqin; Liu, Shuyuan; Huang, Kai; Wang, Xiuyun; Chu, Jiayou; Huang, Xiaoqin			The Adaptive Change of HLA-DRB1 Allele Frequencies Caused by Natural Selection in a Mongolian Population That Migrated to the South of China	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; MULTILOCUS GENOTYPE DATA; GENETIC DIVERSITY; DNA POLYMORPHISM; INFERENCE; SOFTWARE; MHC; HISTORY; LOCI	Pathogen-driven balancing selection determines the richness of human leukocyte antigen (HLA) alleles. Changes in the pathogen spectrum may cause corresponding changes in HLA loci. Approximately 700 years ago, a Mongolian population moved from the north of China to the Yunnan region in the south of China. The pathogen spectrum in the south of China differs from that in the north. In this study, changes in the HLA genes in the Yunnan Mongolian population, as well as the underlying mechanism, were investigated. A sequence-based typing method (SBT) was used to genotype HLA-DRB1 in 470 individuals from two Mongolian populations and another five ethnic groups. Meanwhile, 10 autosomal short tandem repeats (STRs) were genotyped to assess the influence of genetic background on HLA-DRB1 frequencies. The frequencies of certain alleles changed significantly in the Mongolian population that migrated to Yunnan. For example, DRB1*12:02:01 increased from 6.1% to 35.4%. STR analysis excluded the possibility of a recent bottleneck and indicated that 50% of the genetic consistency between northern and southern Mongolians; Tajima's D value for HLA-DRB1 exon2 and dN/dS analysis showed that the HLA-DRB1 genes in both Mongolian populations were under balancing selection. However, the sites under natural selection changed. We proposed that the dramatically change of HLA frequencies in southern Mongolian was caused by a combination of inter-population gene flow and natural selection. Certain diseases specific to the south of China, such as malaria, may be the driving force behind the enhanced DRB1*12:02:01 frequency.	[Huang, Xiaoqin] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; Peking Union Med Coll, Kunming 650118, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, XQ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.	Huangxiaoqin@imbcams.com.cn			Fundamental Research Funds for the Central Universities [3332013085, 33320140013]; Chinese National High Technology Research and Development Program [2012AA021802]; Chinese National Natural Science Foundation [31371265]; Peking Union Medical College Youth Fund	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Youth Fund	This research was funded by Peking Union Medical College Youth Fund & Fundamental Research Funds for the Central Universities (NO. 3332013085, NO. 33320140013), which was received by HS. It was funded in part with Chinese National High Technology Research and Development Program (NO. 2012AA021802) which was received by ZY, and Chinese National Natural Science Foundation (NO. 31371265) which was received by JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P3842, DOI 10.1111/j.1365-294X.2010.04772.x; Andres AM, 2001, ENCY LIFE SCI; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cornuet JM, 2014, BIOINFORMATICS; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Di D, 2011, AM J PHYS ANTHROPOL, V145, P81, DOI 10.1002/ajpa.21470; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Harris EE, 2006, YEARB PHYS ANTHROPOL, V49, P89, DOI 10.1002/ajpa.20518; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P8; Lu L., 2009, J KUNMING MED U, V8, P17; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Park L, 2011, GENET RES, V93, P105, DOI 10.1017/S0016672310000558; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Sayer D, 2001, TISSUE ANTIGENS, V57, P46, DOI 10.1034/j.1399-0039.2001.057001046.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Sun H, 2013, J HUM GENET, V58, P686, DOI 10.1038/jhg.2013.79; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060822; TAJIMA F, 1989, GENETICS, V123, P585; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134334	10.1371/journal.pone.0134334	http://dx.doi.org/10.1371/journal.pone.0134334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230582	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400103
J	Yue, CJ; Chen, J; Hou, RR; Liu, J; Li, XP; Gao, ZZ; Liu, C; Wang, DY; Lu, Y; Li, HQ; Hu, YL				Yue, Chanjuan; Chen, Jin; Hou, Ranran; Liu, Jie; Li, Xiuping; Gao, Zhenzhen; Liu, Cui; Wang, Deyun; Lu, Yu; Li, Hongquan; Hu, Yuanliang			Effects of Selenylation Modification on Antioxidative Activities of Schisandra chinensis Polysaccharide	PLOS ONE			English	Article							DETOXIFYING ENZYMES; SELENIUM; OPTIMIZATION; GLYCATION; EXTRACT; GLYCOXIDATION; GENOTOXICITY; ACTIVATION; EXPRESSION; ASSAY	The selenylation modification of Schisandra chinensis polysaccharide (SCP) was conducted by the HNO3-Na2SeO3 method respectively under nine conditions according to L-9(3(4)) orthogonal design. Nine selenizing SCPs, sSCP(1)-sSCP(9), were obtained, and their antioxidant activities were compared. In vitro test, the free radical-scavenging rates of nine sSCPs were determined for DPPH center dot, center dot OH and ABTS(+). sSCP(1) presented the most significant effect, and could inhibit the nonenzymatic protein glycation. In vivo test, 14-day-old chickens were injected respectively with sSCP(1) and SCP, the serum contents of CAT, SOD and MDA were determined. The result showed that as compared with the SCP group, the SOD and CAT activities were significantly or numerically raised and MDA content was significantly or numerically lowered in the sSCP(1) group. These results indicate that selenylation modification can significantly enhance the antioxidant and antiglycative activity of SCP in vitro or in vivo. sSCP(1) possesses the best efficacy and its modification conditions can be as optimal modification conditions that were 200 mg of Na2SeO3 for 500 mg of SCP, reaction temperature of 50 degrees C and reaction time of 6 h.	[Yue, Chanjuan; Hou, Ranran; Liu, Jie; Li, Xiuping; Gao, Zhenzhen; Liu, Cui; Wang, Deyun; Hu, Yuanliang] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jin; Lu, Yu] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Li, Hongquan] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Shanxi Agricultural University	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Natural Science Foundation of China [31272596]; Special Fund for Agro-scientific Research in the Public Interest [201403051]; Priority Academic Program Development of Jiangsu Higher Education Institutions [09080900101]; Key Scientific and Technological Grant from Shanxi Province [2010311047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province	The project was supported by National Natural Science Foundation of China (31272596), Special Fund for Agro-scientific Research in the Public Interest (201403051), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (09080900101), and Key Scientific and Technological Grant from Shanxi Province (2010311047). The authors are grateful to all other staff in the Institute of Traditional Chinese Veterinary Medicine of Nanjing Agricultural University for their assistance in the experiments.	Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; BAKER JR, 1994, CLIN CHEM, V40, P1950; Chen L, 2005, WORLD J GASTROENTERO, V11, P5795, DOI 10.3748/wjg.v11.i37.5795; Chen SH, 2013, EUR FOOD RES TECHNOL, V237, P691, DOI 10.1007/s00217-013-2044-4; Chen W. J., 2007, FOOD DRUG, V9, P66; Cheng N, 2013, FOOD CHEM TOXICOL, V55, P234, DOI 10.1016/j.fct.2012.11.022; Cui JJ, 2010, J ETHNOPHARMACOL, V132, P512, DOI 10.1016/j.jep.2010.08.052; Fan YP, 2012, INT J BIOL MACROMOL, V51, P1028, DOI 10.1016/j.ijbiomac.2012.08.025; FU MX, 1994, DIABETES, V43, P676, DOI 10.2337/diabetes.43.5.676; GT Ling, 2004, ANTIOXIDANT FOOD HLT, P295; HALLIWELL B, 1994, NUTR REV, V52, P253; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hancke JL, 1999, FITOTERAPIA, V70, P451, DOI 10.1016/S0367-326X(99)00102-1; Harabawy ASA, 2014, ECOTOX ENVIRON SAFE, V104, P28, DOI 10.1016/j.ecoenv.2014.02.015; Jia SR, 2007, BIOTECHNOL BIOPROC E, V12, P271, DOI 10.1007/BF02931103; Kokubo T, 2011, FOOD CHEM, V129, P92, DOI 10.1016/j.foodchem.2011.04.031; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Lee IK, 2006, BIOORG MED CHEM LETT, V16, P2376, DOI 10.1016/j.bmcl.2006.01.121; Lee MS, 2015, FOOD CHEM, V174, P538, DOI 10.1016/j.foodchem.2014.11.090; Li G, 2001, Chinese Patent, Patent No. [CNn21414C, 21414C]; Li HW, 2010, CHINESE J ANAL CHEM, V38, P1256, DOI 10.3724/SP.J.1096.2010.01256; Li Siwei, 2013, Chinese Journal of Applied and Environmental Biology, V19, P980, DOI 10.3724/SP.J.1145.2013.00980; Olabinri B M, 2010, RES J BIOL SCI, V5, P102; Pareek A, 2013, J ETHNOPHARMACOL, V150, P973, DOI 10.1016/j.jep.2013.09.048; Qin T, 2013, CARBOHYD POLYM, V92, P645, DOI 10.1016/j.carbpol.2012.08.097; Qiu SL, 2014, CARBOHYD POLYM, V103, P148, DOI 10.1016/j.carbpol.2013.12.032; Qiu SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086377; Rahbar S, 1999, BIOCHEM BIOPH RES CO, V262, P651, DOI 10.1006/bbrc.1999.1275; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ren XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087578; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Souza BWS, 2012, FOOD HYDROCOLLOID, V27, P287, DOI 10.1016/j.foodhyd.2011.10.005; Sun ZH, 2012, LIVEST SCI, V149, P232, DOI 10.1016/j.livsci.2012.07.014; Veterinary Pharmacopoeia Commission of the People's Republic of China, 2010, VET PHARM PEOPL RE 1, P72; Wang JL, 2012, INT J BIOL MACROMOL, V51, P987, DOI 10.1016/j.ijbiomac.2012.08.011; Wang L, 2011, CARBOHYD POLYM, V86, P1745, DOI 10.1016/j.carbpol.2011.07.007; Wang X, 2012, FOOD CHEM, V130, P821, DOI 10.1016/j.foodchem.2011.07.064; Wang YP, 2014, CARBOHYD POLYM, V111, P324, DOI 10.1016/j.carbpol.2014.03.083; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Xu FB, 1994, SELENIUM ITS CHEM BI, P66; Zhao BT, 2013, INT J BIOL MACROMOL, V58, P320, DOI 10.1016/j.ijbiomac.2013.04.059; Zhao T, 2014, CARBOHYD POLYM, V105, P26, DOI 10.1016/j.carbpol.2014.01.059; Zhao T, 2014, CARBOHYD POLYM, V103, P488, DOI 10.1016/j.carbpol.2013.12.058	46	30	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134363	10.1371/journal.pone.0134363	http://dx.doi.org/10.1371/journal.pone.0134363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230941	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400107
J	Cabasso, O; Pekar, O; Horowitz, M				Cabasso, Or; Pekar, Olga; Horowitz, Mia			SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; NUCLEAR-PORE COMPLEX; PLASMA-MEMBRANE; FAMILY PROTEINS; MECHANISMS; SPECIFICITY; ENDOSOME; SUMO; INTERACTS; RME-1	Endocytosis defines the entry of molecules or macromolecules through the plasma membrane as well as membrane trafficking in the cell. It depends on a large number of proteins that undergo protein-protein and protein-phospholipid interactions. EH Domain containing (EHDs) proteins formulate a family, whose members participate in different stages of endocytosis. Of the four mammalian EHDs (EHD1-EHD4) EHD1 and EHD3 control traffic to the endocytic recycling compartment (ERC) and from the ERC to the plasma membrane, while EHD2 modulates internalization. Recently, we have shown that EHD2 undergoes SUMOylation, which facilitates its exit from the nucleus, where it serves as a co-repressor. In the present study, we tested whether EHD3 undergoes SUMOylation and what is its role in endocytic recycling. We show, both in-vitro and in cell culture, that EHD3 undergoes SUMOylation. Localization of EHD3 to the tubular structures of the ERC depends on its SUMOylation on lysines 315 and 511. Absence of SUMOylation of EHD3 has no effect on its dimerization, an important factor in membrane localization of EHD3, but has a dominant negative effect on its appearance in tubular ERC structures. Non-SUMOylated EHD3 delays transferrin recycling from the ERC to the cell surface. Our findings indicate that SUMOylation of EHD3 is involved in tubulation of the ERC membranes, which is important for efficient recycling.	[Cabasso, Or; Pekar, Olga; Horowitz, Mia] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel	Tel Aviv University	Horowitz, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	horwitzm@post.tau.ac.il			Jascquline Seroussi Foundation [0604460011]	Jascquline Seroussi Foundation	This work was supported by Jascquline Seroussi Foundation no 0604460011 (Tel Aviv University).	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Balogh P, 2013, PATHOL ONCOL RES, V19, P141, DOI 10.1007/s12253-012-9595-8; Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2014, PLANT MOL BIOL, V84, P509, DOI 10.1007/s11103-013-0148-7; Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; DEFIGUEIREDO P, 1995, MOL BIOL CELL, V6, P871, DOI 10.1091/mbc.6.7.871; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Gupta GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100554; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Ishii K, 2012, J PHARMACOL SCI, V120, P264, DOI 10.1254/jphs.12R12CP; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Ma L, 2014, MOL CELL PROTEOMICS, V13, P1659, DOI 10.1074/mcp.M113.035626; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pekar O, 2012, THESIS; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shah C, 2014, STRUCTURE, V22, P409, DOI 10.1016/j.str.2013.12.015; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wasik U, 2014, BBA-MOL CELL RES, V1843, P2878, DOI 10.1016/j.bbamcr.2014.07.018; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; Wilkinson Kevin A, 2012, Commun Integr Biol, V5, P223, DOI 10.4161/cib.19195; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116	57	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134053	10.1371/journal.pone.0134053	http://dx.doi.org/10.1371/journal.pone.0134053			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226295	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700054
J	Hueging, K; Weller, R; Doepke, M; Vieyres, G; Todt, D; Wolk, B; Vondran, FWR; Geffers, R; Lauber, C; Kaderali, L; Penin, F; Pietschmann, T				Hueging, Kathrin; Weller, Romy; Doepke, Mandy; Vieyres, Gabrielle; Todt, Daniel; Woelk, Benno; Vondran, Florian W. R.; Geffers, Robert; Lauber, Chris; Kaderali, Lars; Penin, Francois; Pietschmann, Thomas			Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LOW-DENSITY LIPOPROTEINS; SCAVENGER RECEPTOR BI; A-I; CHOLESTEROL TRANSPORT; BINDING-SITES; HDL RECEPTOR; LIFE-CYCLE; SR-BI; ASSOCIATION	Apolipoprotein E (ApoE), an exchangeable apolipoprotein, is necessary for production of infectious Hepatitis C virus (HCV) particles. However, ApoE is not the only liver-expressed apolipoprotein and the role of other apolipoproteins for production of infectious HCV progeny is incompletely defined. Therefore, we quantified mRNA expression of human apolipoproteins in primary human hepatocytes. Subsequently, cDNAs encoding apolipoproteins were expressed in 293T/miR-122 cells to explore if they complement HCV virus production in cells that are non-permissive due to limiting endogenous levels of human apolipoproteins. Primary human hepatocytes expressed high mRNA levels of ApoA1, A2, C1, C3, E, and H. ApoA4, A5, B, D, F, J, L1, L2, L3, L4, L6, M, and O were expressed at intermediate levels, and C2, C4, and L5 were not detected. All members of the ApoA and ApoC family of lipoproteins complemented HCV virus production in HCV transfected 293T/miR-122 cells, albeit with significantly lower efficacy compared with ApoE. In contrast, ApoD expression did not support production of infectious HCV. Specific infectivity of released particles complemented with ApoA family members was significantly lower compared with ApoE. Moreover, the ratio of extracellular to intracellular infectious virus was significantly higher for ApoE compared to ApoA2 and ApoC3. Since apolipoproteins complementing HCV virus production share amphipathic alpha helices as common structural features we altered the two alpha helices of ApoC1. Helix breaking mutations in both ApoC1 helices impaired virus assembly highlighting a critical role of alpha helices in apolipoproteins supporting HCV assembly. In summary, various liver expressed apolipoproteins with amphipathic alpha helices complement HCV virus production in human non liver cells. Differences in the efficiency of virus assembly, the specific infectivity of released particles, and the ratio between extracellular and intracellular infectivity point to distinct characteristics of these apolipoproteins that influence HCV assembly and cell entry. This will guide future research to precisely pinpoint how apolipoproteins function during virus assembly and cell entry.	[Hueging, Kathrin; Weller, Romy; Doepke, Mandy; Vieyres, Gabrielle; Todt, Daniel; Pietschmann, Thomas] TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Vondran, Florian W. R.; Pietschmann, Thomas] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany; [Lauber, Chris; Kaderali, Lars] Tech Univ Dresden, Fac Med, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Penin, Francois] Univ Lyon, Inst Biol & Chim Prot Bases Mol & Struct Syst Inf, CNRS, Labex Ecofect,UMR 5086, Lyon, France	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pietschmann, T (corresponding author), TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany.	thomas.pietschmann@twincore.de	Pietschmann, Thomas/E-9241-2015; Todt, Daniel/W-9362-2019	Pietschmann, Thomas/0000-0001-5138-6239; Todt, Daniel/0000-0002-3564-1014; Pietschmann, Thomas/0000-0001-6789-4422; Kaderali, Lars/0000-0002-2359-2294; Hueging, Kathrin/0000-0002-9850-8640	Deutsche Forschungsgemeinschaft [SFB 900]; Helmholtz Association [SO-024];  [ANR-11-BINF-003]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); 	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 900, project A6) and by a grant from the Helmholtz Association (SO-024) to TP. FP is supported by the Mapping project (ANR-11-BINF-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; de Beer MC, 2001, J LIPID RES, V42, P309; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jonas A, 2008, LIPOPROTEIN STRUCTUR, P485; Kleine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101386; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; LI WH, 1988, J LIPID RES, V29, P245; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; SEGREST JP, 1992, J LIPID RES, V33, P141; Smith LE, 2013, J LIPID RES, V54, P1939, DOI 10.1194/jlr.M037903; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thuahnai ST, 2003, J LIPID RES, V44, P1132, DOI 10.1194/jlr.M200429-JLR200; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Xu SZ, 1997, J LIPID RES, V38, P1289; Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134529	10.1371/journal.pone.0134529	http://dx.doi.org/10.1371/journal.pone.0134529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226615	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700107
J	Matsuzaki, J; Suzuki, H; Kobayakawa, M; Inadomi, JM; Takayama, M; Makino, K; Iwao, Y; Sugino, Y; Kanai, T				Matsuzaki, Juntaro; Suzuki, Hidekazu; Kobayakawa, Masao; Inadomi, John M.; Takayama, Michiyo; Makino, Kanako; Iwao, Yasushi; Sugino, Yoshinori; Kanai, Takanori			Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan	PLOS ONE			English	Article							INTERNATIONAL BEACON CONSORTIUM; POOLED ANALYSIS; INCREASED RISK; UNITED-STATES; ADENOCARCINOMA; METAANALYSIS; DIAGNOSIS; OBESITY; DISEASE; TRENDS	Background Central obesity has been suggested as a risk factor for gastroesophageal reflux disease. The aim of this study was to evaluate the association of visceral fat area and other lifestyle factors with reflux esophagitis or Barrett's esophagus in Japanese population. Methods Individuals who received thorough medical examinations including the measurement of visceral fat area by abdominal computed tomography were enrolled. Factors associated with the presence of reflux esophagitis, the severity of reflux esophagitis, or the presence of Barrett's esophagus were determined using multivariable logistic regression models. Results A total of 2608 individuals were eligible for the analyses. Visceral fat area was associated with the presence of reflux esophagitis both in men (odds ratio, 1.21 per 50 cm(2); 95% confident interval, 1.01 to 1.46) and women (odds ratio, 2.31 per 50 cm(2); 95% confident interval, 1.57 to 3.40). Current smoking and serum levels of triglyceride were also associated with the presence of reflux esophagitis in men. However, significant association between visceral fat area and the severity of reflux esophagitis or the presence of Barrett's esophagus was not shown. In men, excessive alcohol consumption on a drinking day, but not the frequency of alcohol drinking, was associated with both the severity of reflux esophagitis (odds ratio, 2.13; 95% confident interval, 1.03 to 4.41) and the presence of Barrett's esophagus (odds ratio, 1.71; 95% confident interval, 1.14 to 2.56). Conclusion Visceral fat area was independently associated with the presence of reflux esophagitis, but not with the presence of Barrett's esophagus. On the other hand, quantity of alcohol consumption could play a role in the development of severe reflux esophagitis and Barrett's esophagus in Japanese population.	[Matsuzaki, Juntaro; Takayama, Michiyo; Makino, Kanako; Iwao, Yasushi; Sugino, Yoshinori] Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan; [Suzuki, Hidekazu; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Kobayakawa, Masao] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Inadomi, John M.] Univ Washington, Sch Med, Dept Internal Med, Div Gastroenterol, Seattle, WA USA	Keio University; Keio University; National Center for Global Health & Medicine - Japan; University of Washington; University of Washington Seattle	Suzuki, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	hsuzuki.a6@keio.jp	Matsuzaki, Juntaro/S-4107-2019; 小早川, 雅男/HII-5007-2022; SUZUKI, HIDEKAZU/S-9376-2019; Sato, Yurie/B-2144-2014; Suzuki, Hidekazu/AAO-6330-2020; Suzuki, Hidekazu/J-4396-2013; Inadomi, John/A-6221-2014	Matsuzaki, Juntaro/0000-0002-3204-5049; Suzuki, Hidekazu/0000-0002-8994-6163; Kanai, Takanori/0000-0002-1466-4532; Inadomi, John/0000-0001-6776-8661	Japan Society for the Promotion of Science (JSPS) [26860527, 25293178, 26670065]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411003]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was funded by a Grant-in-Aid for Young Scientists (B) (26860527, to J.M.), a Grant-in-Aid for Scientific Research B (25293178, to H.S.), and a Grant-in-Aid for challenging Exploratory Research (26670065, to H.S.) from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411003, to H.S.) (http://www.mext.go.jp/english/pressrelease/1317526.htm), and a grant from Takeda Science Foundation (to J.M.) (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-56; Akiyama T, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-58; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Breslow RA, 2008, ALCOHOL CLIN EXP RES, V32, P513, DOI 10.1111/j.1530-0277.2007.00595.x; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; Endlicher E, 2005, ENDOSCOPY, V37, P1131, DOI 10.1055/s-2005-870409; Fernandes ML, 2006, AM J GASTROENTEROL, V101, P1430, DOI 10.1111/j.1572-0241.2006.00570.x; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; GOEDDE HW, 1992, HUM GENET, V88, P344; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Kagemoto K, 2014, GASTROINTEST ENDOSC, V80, P239, DOI 10.1016/j.gie.2014.01.022; Kato M, 2011, J GASTROENTEROL, V46, P1361, DOI 10.1007/s00535-011-0453-3; Kubo A, 2013, GUT, V62, P1684, DOI 10.1136/gutjnl-2012-303753; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Lee HS, 2014, CLIN ENDOSC, V47, P15, DOI 10.5946/ce.2014.47.1.15; Lou ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105612; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Murase K, 2014, SLEEP, V37, P1810, DOI 10.5665/sleep.4176; Nam SY, 2015, J NEUROGASTROENTEROL, V21, P247, DOI 10.5056/jnm14114; Okita K, 2008, J GASTROENTEROL, V43, P928, DOI 10.1007/s00535-008-2261-y; Rubenstein JH, 2014, GUT, V63, P230, DOI 10.1136/gutjnl-2012-304103; Shinkai H, 2014, DIGESTION, V90, P1, DOI 10.1159/000357776; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Thrift AP, 2014, AM J GASTROENTEROL, V109, P1586, DOI 10.1038/ajg.2014.206; Watari J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-143	29	38	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133865	10.1371/journal.pone.0133865	http://dx.doi.org/10.1371/journal.pone.0133865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225858	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700041
J	Moraes, I; Yuan, ZF; Liu, SC; Souza, GM; Garcia, BA; Casas-Mollano, JA				Moraes, Izabel; Yuan, Zuo-Fei; Liu, Shichong; Souza, Glaucia Mendes; Garcia, Benjamin A.; Armando Casas-Mollano, J.			Analysis of Histones H3 and H4 Reveals Novel and Conserved Post-Translational Modifications in Sugarcane	PLOS ONE			English	Article							MASS-SPECTROMETRY ANALYSIS; MODIFICATION PATTERNS; ARABIDOPSIS; CHROMATIN; GENE; ACETYLATION; VARIANTS; GENOME; PHOSPHORYLATION; IDENTIFICATION	Histones are the main structural components of the nucleosome, hence targets of many regulatory proteins that mediate processes involving changes in chromatin. The functional outcome of many pathways is "written" in the histones in the form of post-translational modifications that determine the final gene expression readout. As a result, modifications, alone or in combination, are important determinants of chromatin states. Histone modifications are accomplished by the addition of different chemical groups such as methyl, acetyl and phosphate. Thus, identifying and characterizing these modifications and the proteins related to them is the initial step to understanding the mechanisms of gene regulation and in the future may even provide tools for breeding programs. Several studies over the past years have contributed to increase our knowledge of epigenetic gene regulation in model organisms like Arabidopsis, yet this field remains relatively unexplored in crops. In this study we identified and initially characterized histones H3 and H4 in the monocot crop sugarcane. We discovered a number of histone genes by searching the sugarcane ESTs database. The proteins encoded correspond to canonical histones, and their variants. We also purified bulk histones and used them to map post-translational modifications in the histones H3 and H4 using mass spectrometry. Several modifications conserved in other plants, and also novel modified residues, were identified. In particular, we report O-acetylation of serine, threonine and tyrosine, a recently identified modification conserved in several eukaryotes. Additionally, the sub-nuclear localization of some well-studied modifications (i.e., H3K4me3, H3K9me2, H3K27me3, H3K9ac, H3T3ph) is described and compared to other plant species. To our knowledge, this is the first report of histones H3 and H4 as well as their post-translational modifications in sugarcane, and will provide a starting point for the study of chromatin regulation in this crop.	[Moraes, Izabel; Souza, Glaucia Mendes; Armando Casas-Mollano, J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Yuan, Zuo-Fei; Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA	Universidade de Sao Paulo; University of Pennsylvania; Pennsylvania Medicine	Casas-Mollano, JA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	acasasmollano@gmail.com	Yuan, Zuofei/O-3209-2017; Souza, Glaucia/E-6780-2012; Mollano, Juan Armando Casas/G-4065-2012; Moraes, Izabel/R-8959-2017; Moraes, Izabel/H-7125-2013	Yuan, Zuofei/0000-0003-1252-6766; Souza, Glaucia/0000-0001-6903-9913; Mollano, Juan Armando Casas/0000-0001-7246-7142; Moraes, Izabel/0000-0002-5540-3179; Moraes, Izabel/0000-0003-0019-1620	Sao Paulo Research Foundation [FAPESP 2011/50483-2]; National Science Foundation (NSF) Early Faculty CAREER award; FAPESP Post-doctoral fellowship [2013/01484-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation (NSF) Early Faculty CAREER award(National Science Foundation (NSF)); FAPESP Post-doctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sao Paulo Research Foundation (www.fapesp.br) grant FAPESP 2011/50483-2 to JAC-M. BAG acknowledges funding from the National Science Foundation (NSF) Early Faculty CAREER award. IM is recipient of a FAPESP Post-doctoral fellowship (2013/01484-1).	Alvarez-Venegas Raul, 2010, Arabidopsis Book, V8, pe0128, DOI 10.1199/tab.0128; Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Boeckmann L, 2013, MOL BIOL CELL, V24, P2034, DOI 10.1091/mbc.E12-12-0893; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Britton LMP, 2013, EPIGENETICS-US, V8, P1101, DOI 10.4161/epi.26025; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CHABOUTE ME, 1993, BIOCHIMIE, V75, P523, DOI 10.1016/0300-9084(93)90057-Y; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fu Y, 2004, BIOINFORMATICS, V20, P1948, DOI 10.1093/bioinformatics/bth186; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Garsmeur O, 2011, NEW PHYTOL, V189, P629, DOI 10.1111/j.1469-8137.2010.03497.x; Goutte-Gattat D, 2013, P NATL ACAD SCI USA, V110, P8579, DOI 10.1073/pnas.1302955110; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000982; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Moraes I, 2014, EPIGENETICS IN PLANTS OF AGRONOMIC IMPORTANCE: FUNDAMENTALS AND APPLICATIONS: TRANSCRIPTIONAL REGULATION AND CHROMATIN REMODELLING IN PLANTS, P47, DOI 10.1007/978-3-319-07971-4_4; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r62; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Sui PF, 2013, MOL PLANT, V6, P975, DOI 10.1093/mp/sss152; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Wang LH, 2007, RAPID COMMUN MASS SP, V21, P2985, DOI 10.1002/rcm.3173; Waterborg JH, 2012, BIOCHEM CELL BIOL, V90, P79, DOI [10.1139/O11-036, 10.1139/o11-036]; Waterborg JH, 2011, BBA-GENE REGUL MECH, V1809, P353, DOI 10.1016/j.bbagrm.2011.02.005; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; WATERBORG JH, 1995, PLANT PHYSIOL, V109, P393, DOI 10.1104/pp.109.2.393; Wu T, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-98; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Yuan ZF, 2014, J PROTEOME RES, V13, P4470, DOI 10.1021/pr5008015; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang XL, 2005, PLANT CELL, V17, P572, DOI 10.1105/tpc.104.028522	64	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134586	10.1371/journal.pone.0134586	http://dx.doi.org/10.1371/journal.pone.0134586			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226299	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700114
J	Olsson, M; Tengvall, K; Frankowiack, M; Kierczak, M; Bergvall, K; Axelsson, E; Tintle, L; Marti, E; Roosje, P; Leeb, T; Hedhammar, A; Hammarstrom, L; Lindblad-Toh, K				Olsson, Mia; Tengvall, Katarina; Frankowiack, Marcel; Kierczak, Marcin; Bergvall, Kerstin; Axelsson, Erik; Tintle, Linda; Marti, Eliane; Roosje, Petra; Leeb, Tosso; Hedhammar, Ake; Hammarstrom, Lennart; Lindblad-Toh, Kerstin			Genome-Wide Analyses Suggest Mechanisms Involving Early B-Cell Development in Canine IgA Deficiency	PLOS ONE			English	Article							SERUM IGA; RELATIVE DEFICIENCY; IMMUNOGLOBULIN-A; PROTEIN; SLIT; DOG; POPULATION; GENE; IMMUNODEFICIENCY; ROBO	Immunoglobulin A deficiency (IgAD) is the most common primary immune deficiency disorder in both humans and dogs, characterized by recurrent mucosal tract infections and a predisposition for allergic and other immune mediated diseases. In several dog breeds, low IgA levels have been observed at a high frequency and with a clinical resemblance to human IgAD. In this study, we used genome-wide association studies (GWAS) to identify genomic regions associated with low IgA levels in dogs as a comparative model for human IgAD. We used a novel percentile groups-approach to establish breed-specific cut-offs and to perform analyses in a close to continuous manner. GWAS performed in four breeds prone to low IgA levels (German shepherd, Golden retriever, Labrador retriever and Shar-Pei) identified 35 genomic loci suggestively associated (p < 0.0005) to IgA levels. In German shepherd, three genomic regions (candidate genes include KIRREL3 and SERPINA9) were genome-wide significantly associated (p < 0.0002) with IgA levels. A similar to 20kb long haplotype on CFA28, significantly associated (p = 0.0005) to IgA levels in Shar-Pei, was positioned within the first intron of the gene SLIT1. Both KIRREL3 and SLIT1 are highly expressed in the central nervous system and in bone marrow and are potentially important during B-cell development. SERPINA9 expression is restricted to B-cells and peaks at the time-point when B-cells proliferate into antibody-producing plasma cells. The suggestively associated regions were enriched for genes in Gene Ontology gene sets involving inflammation and early immune cell development.	[Olsson, Mia; Frankowiack, Marcel; Hammarstrom, Lennart] Karolinska Univ Hosp, Karolinska Inst, Div Clin Immunol, Dept Lab Med, Huddinge, Sweden; [Tengvall, Katarina; Kierczak, Marcin; Axelsson, Erik; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Bergvall, Kerstin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Tintle, Linda] Wurtsboro Vet Clin, Wurtsboro, NY USA; [Marti, Eliane] Univ Bern, Vetsuisse Fac, Div Clin Dermatol, Dept Clin Vet Med, Bern, Switzerland; [Marti, Eliane; Roosje, Petra; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland; [Roosje, Petra] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Swedish University of Agricultural Sciences; University of Bern; University of Bern; University of Bern; University of Bern; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tengvall, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	Mia.Olsson@ki.se; Katarina.Tengvall@imbim.uu.se; kersli@broadinstitute.org	Leeb, Tosso/G-3187-2014; Tengvall, Katarina/L-1933-2019	Leeb, Tosso/0000-0003-0553-4880; Hedhammar, Ake/0000-0001-7048-3851; Kierczak, Marcin/0000-0003-2629-5655	Swedish Research Council [521-2012-2826, 521-2011-3515]; Swedish Research Council FORMAS [221-2009-1689]; European Research Council (ERC) [310203]; European Commission, FP7-LUPA [GA-201370]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission, FP7-LUPA(European Commission)	The study has been funded by grants to; KLT the Swedish Research Council, http://www.vr.se/, grant number 521-2012-2826, Swedish Research Council FORMAS, http://www.formas.se/, grant number: 221-2009-1689 and the European Research Council (ERC), http://erc.europa.eu/, starting grant agreement: 310203; LH the Swedish Research Council, http://www.vr.se/, grant number 521-2011-3515; TL the European Commission, http://www.eurolupa.eu/, FP7-LUPA, GA-201370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; CONLEY ME, 1981, NEW ENGL J MED, V305, P495, DOI 10.1056/NEJM198108273050905; DAY MJ, 1988, RES VET SCI, V45, P360, DOI 10.1016/S0034-5288(18)30965-2; Day MJ, 1999, J SMALL ANIM PRACT, V40, P561, DOI 10.1111/j.1748-5827.1999.tb03022.x; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; FELSBURG PJ, 1985, CLIN IMMUNOL IMMUNOP, V36, P297, DOI 10.1016/0090-1229(85)90050-9; Ferreira RC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002476; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Frankowiack M, 2013, DEV COMP IMMUNOL, V40, P180, DOI 10.1016/j.dci.2013.01.005; Frazer JK, 2000, EUR J IMMUNOL, V30, P3039, DOI 10.1002/1521-4141(200010)30:10<3039::AID-IMMU3039>3.0.CO;2-H; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Geutskens SB, 2012, LAB INVEST, V92, P1129, DOI 10.1038/labinvest.2012.81; GLICKMAN LT, 1988, AM J VET RES, V49, P1240; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Griot-Wenk ME, 1999, RES VET SCI, V67, P239, DOI 10.1053/rvsc.1999.0314; Guerin A, 2012, AM J MED GENET A, V158A, P2551, DOI 10.1002/ajmg.a.35621; HAMMARSTROM L, 1985, CLIN EXP IMMUNOL, V60, P661; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; HAMMARSTROM L, 1985, LANCET, V1, P778; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hasegawa K, 2004, HUM GENET, V115, P295, DOI 10.1007/s00439-004-1157-z; Heuser M, 2014, HAEMATOLOGICA, V99, pE165, DOI 10.3324/haematol.2013.101642; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacob CMA, 2008, J CLIN IMMUNOL, V28, pS56, DOI 10.1007/s10875-007-9163-2; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Littler RM, 2006, VET REC, V158, P334, DOI 10.1136/vr.158.10.334; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOROFF SD, 1986, VET IMMUNOL IMMUNOP, V13, P181, DOI 10.1016/0165-2427(86)90071-1; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Olsson M, 2014, VET IMMUNOL IMMUNOP, V160, P255, DOI 10.1016/j.vetimm.2014.05.010; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Prince JEA, 2013, DEVELOPMENT, V140, P2398, DOI 10.1242/dev.087262; Rabenhorst A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0423-y; Raychaudhuri S, 2011, BIOINFORMATICS, V27, P1589, DOI 10.1093/bioinformatics/btr185; RIVAS AL, 1995, CLIN IMMUNOL IMMUNOP, V74, P243, DOI 10.1006/clin.1995.1036; SCHREIBER M, 1992, EUR J CLIN CHEM CLIN, V30, P775; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tengvall K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003475; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Weber-Mzell D, 2004, EUR J CLIN INVEST, V34, P224, DOI 10.1111/j.1365-2362.2004.01311.x; WHITBREAD TJ, 1984, RES VET SCI, V37, P350, DOI 10.1016/S0034-5288(18)31877-0; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; WILLARD MD, 1994, J AM VET MED ASSOC, V204, P1201; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	65	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133844	10.1371/journal.pone.0133844	http://dx.doi.org/10.1371/journal.pone.0133844			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225558	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700039
J	Hoffmann, KQ; McGovern, M; Chiu, CC; de Pablo, JJ				Hoffmann, Kyle Quynn; McGovern, Michael; Chiu, Chi-cheng; de Pablo, Juan J.			Secondary Structure of Rat and Human Amylin across Force Fields	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; PROTEIN-FOLDING SIMULATIONS; ALPHA-HELICAL STATES; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; DIABETES-MELLITUS; FIBRIL FORMATION; IAPP; PEPTIDE; MECHANICS	The aggregation of human amylin has been strongly implicated in the progression of Type II diabetes. This 37-residue peptide forms a variety of secondary structures, including random coils, alpha-helices, and beta-hairpins. The balance between these structures depends on the chemical environment, making amylin an ideal candidate to examine inherent biases in force fields. Rat amylin differs from human amylin by only 6 residues; however, it does not form fibrils. Therefore it provides a useful complement to human amylin in studies of the key events along the aggregation pathway. In this work, the free energy of rat and human amylin was determined as a function of alpha-helix and beta-hairpin content for the Gromos96 53a6, OPLS-AA/L, CHARMM22/CMAP, CHARMM22*, Amberff99sb*-ILDN, and Amberff03w force fields using advanced sampling techniques, specifically bias exchange metadynamics. This work represents a first systematic attempt to evaluate the conformations and the corresponding free energy of a large, clinically relevant disordered peptide in solution across force fields. The NMR chemical shifts of rIAPP were calculated for each of the force fields using their respective free energy maps, allowing us to quantitatively assess their predictions. We show that the predicted distribution of secondary structures is sensitive to the choice of force-field: Gromos53a6 is biased towards beta-hairpins, while CHARMM22/CMAP predicts structures that are overly alpha-helical. OPLS-AA/L favors disordered structures. Amberff99sb*-ILDN, AmberFF03w and CHARMM22* provide the balance between secondary structures that is most consistent with available experimental data. In contrast to previous reports, our findings suggest that the equilibrium conformations of human and rat amylin are remarkably similar, but that subtle differences arise in transient alpha-helical and beta-strand containing structures that the human peptide can more readily adopt. We hypothesize that these transient states enable dynamic pathways that facilitate the formation of aggregates and, eventually, amyloid fibrils.	[Hoffmann, Kyle Quynn; McGovern, Michael; de Pablo, Juan J.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Chiu, Chi-cheng] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan; [de Pablo, Juan J.] Argonne Natl Lab, Argonne, IL 60439 USA	University of Chicago; National Cheng Kung University; United States Department of Energy (DOE); Argonne National Laboratory	de Pablo, JJ (corresponding author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.	depablo@uchicago.edu	de Pablo, Juan/AAJ-9161-2021	Chiu, Chi-cheng/0000-0003-2385-6947	National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems [CBET 1264021]	National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems	This work is supported by the National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems, CBET 1264021. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Baftizadeh F, 2012, J AM CHEM SOC, V134, P3886, DOI 10.1021/ja210826a; BALASUBRAMANIAM A, 1991, PEPTIDES, V12, P919, DOI 10.1016/0196-9781(91)90038-Q; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cino EA, 2012, J CHEM THEORY COMPUT, V8, P2725, DOI 10.1021/ct300323g; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Crespo Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055701; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Garcia AE, 2002, P NATL ACAD SCI USA, V99, P2782, DOI 10.1073/pnas.042496899; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; H&ouml;ppener J, N ENGL J MED, V343, P411; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039; Li DW, 2010, J PHYS CHEM LETT, V1, P246, DOI 10.1021/jz9001345; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Lindorff-Larsen K., 2012, PLOS ONE, V7, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0032131, 10.1371/journal.pone.0032131]; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; McGovern M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818153; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miller C, 2013, J PHYS CHEM B, V117, P16066, DOI 10.1021/jp409755y; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005; Murphy RD, 2012, BIOPHYS CHEM, V167, P1, DOI 10.1016/j.bpc.2012.03.010; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okur A, 2003, J COMPUT CHEM, V24, P21, DOI 10.1002/jcc.10184; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patapati KK, 2011, BIOPHYS J, V101, P1766, DOI 10.1016/j.bpj.2011.08.044; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Qi RX, 2014, BIOMACROMOLECULES, V15, P122, DOI 10.1021/bm401406e; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Reddy AS, 2010, BIOPHYS J, V98, P443, DOI 10.1016/j.bpj.2009.10.029; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Scalisi S, 2010, CHEMBIOCHEM, V11, P1856, DOI 10.1002/cbic.201000090; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Singh S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798460; Singh S, 2012, ANNU REV CHEM BIOMOL, V3, P369, DOI 10.1146/annurev-chembioeng-062011-081032; Singh S, 2011, J STAT PHYS, V145, P932, DOI 10.1007/s10955-011-0301-0; Smit B, 2001, FROM ALGORITHMS TO A; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Todorova N, 2008, J PHYS CHEM B, V112, P11137, DOI 10.1021/jp076825d; Todorova N, 2009, J PHYS CHEM B, V113, P3556, DOI 10.1021/jp809776v; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1987, AM J PATHOL, V127, P414; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Wu C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003211; Yoda T, 2004, CHEM PHYS LETT, V386, P460, DOI 10.1016/j.cplett.2004.01.078; Yonemoto IT, 2008, BIOCHEMISTRY-US, V47, P9900, DOI 10.1021/bi800828u	116	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134091	10.1371/journal.pone.0134091	http://dx.doi.org/10.1371/journal.pone.0134091			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221949	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800102
J	Radev, Z; Hermel, JM; Elipot, Y; Bretaud, S; Arnould, S; Duchateau, P; Ruggiero, F; Joly, JS; Sohm, F				Radev, Zlatko; Hermel, Jean-Michel; Elipot, Yannick; Bretaud, Sandrine; Arnould, Sylvain; Duchateau, Philippe; Ruggiero, Florence; Joly, Jean-Stephane; Sohm, Frederic			A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; COLLAGEN-VI DEFICIENCY; AQUATIC SURFACE RESPIRATION; SKELETAL-MUSCLE; MITOCHONDRIAL DYSFUNCTION; CYCLOPHILIN INHIBITOR; EXTRACELLULAR-MATRIX; GENETIC MODEL; ULLRICH; BEHAVIOR	Presently, human collagen VI-related diseases such as Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) remain incurable, emphasizing the need to unravel their etiology and improve their treatments. In UCMD, symptom onset occurs early, and both diseases aggravate with ageing. In zebrafish fry, morpholinos reproduced early UCMD and BM symptoms but did not allow to study the late phenotype. Here, we produced the first zebrafish line with the human mutation frequently found in collagen VI-related disorders such as UCMD and BM. We used a transcription activator-like effector nuclease (TALEN) to design the col6a1(ama605003)-line with a mutation within an essential splice donor site, in intron 14 of the col6a1 gene, which provoke an in-frame skipping of exon 14 in the processed mRNA. This mutation at a splice donor site is the first example of a template-independent modification of splicing induced in zebrafish using a targetable nuclease. This technique is readily expandable to other organisms and can be instrumental in other disease studies. Histological and ultrastructural analyzes of homozygous and heterozygous mutant fry and 3 months post-fertilization (mpf) fish revealed co-dominantly inherited abnormal myofibers with disorganized myofibrils, enlarged sarcoplasmic reticulum, altered mitochondria and misaligned sarcomeres. Locomotion analyzes showed hypoxia-response behavior in 9 mpf col6a1 mutant unseen in 3 mpf fish. These symptoms worsened with ageing as described in patients with collagen VI deficiency. Thus, the col6a1(ama605003)-line is the first adult zebrafish model of collagen VI-related diseases; it will be instrumental both for basic research and drug discovery assays focusing on this type of disorders.	[Radev, Zlatko; Sohm, Frederic] INRA, AMAGEN, UMS 1374, Jouy En Josas, Domaine De Vilv, France; [Radev, Zlatko; Sohm, Frederic] CNRS, AMAGEN, UMS 3504, Gif Sur Yvette, France; [Hermel, Jean-Michel] CNRS, INRA CASBAH Team, UMR 9197, NEURO Psi, Gif Sur Yvette, France; [Elipot, Yannick; Joly, Jean-Stephane] CNRS, NEURO Psi, DECA Team, UMR 9197, Gif Sur Yvette, France; [Bretaud, Sandrine; Ruggiero, Florence] Univ Lyon 1, CNRS, ENS Lyon, Inst Genom Fonct Lyon,UMR 5242, F-69365 Lyon, France; [Arnould, Sylvain; Duchateau, Philippe] CELLECTIS SA, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Hermel, JM (corresponding author), CNRS, INRA CASBAH Team, UMR 9197, NEURO Psi, Gif Sur Yvette, France.	jmhermel@inaf.cnrs-gif.fr; sohm@inaf.cnrs-gif.fr		BRETAUD, SANDRINE/0000-0002-1430-7359; RUGGIERO, Florence/0000-0003-2915-5359	Cellectis SA; Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA); CELLECTIS SA [13000408]; Animaux Modeles Aquatiques et GENetique (AMAGEN) [439549]; Fondation de la Recherche Medicale (FRM) [ING201401129350]; Conseil General de l'Essonne; French National Research Agency [ANR-10-INSB-04-01]; TEFOR-Investissement d'avenir [ANR-II-INBS-0014]	Cellectis SA(Cellartis); Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA); CELLECTIS SA(Cellartis); Animaux Modeles Aquatiques et GENetique (AMAGEN); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Conseil General de l'Essonne(General Electric); French National Research Agency(French National Research Agency (ANR)); TEFOR-Investissement d'avenir(French National Research Agency (ANR))	Cellectis SA supported the project in the form of a participation to ZR salary and to the running cost of the project and provided research material (i.e. the TALEN). SA and PD participated to the design of the TALEN and the technical choices related to gene targeting and to mutation detection. SA and PD did not participate to the choice of the gene to target nor did they participate to data collection or the analysis made to characterize the isolated mutants. ZR's PhD thesis was financed by Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA; contrat number NA; http://www.phase.inra.fr), CELLECTIS SA (#13000408; http://www.cellectis.com/) and Animaux Modeles Aquatiques et GENetique (AMAGEN, #439549; http://www.inaf.cnrs-gif.fr/neuro-psi/amagen.html); YE was supported by the Fondation de la Recherche Medicale (FRM; #ING201401129350; http://www.frm.org). The electron microscopy facilities of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) is supported by the Conseil General de l'Essonne (http://www.essonne.fr). The authors acknowledge the France-BioImaging infrastructure (http://france-bioimaging.org) supported by the French National Research Agency (ANR-10-INSB-04-01; http://www.agence-nationale-recherche.fr). This work has benefited from the support of TEFOR-Investissement d'avenir (#ANR-II-INBS-0014; http://tefor.net/main/pages/main/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for ZR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah SJ, 2015, J EXP BIOL, V218, P1777, DOI 10.1242/jeb.116343; Ahlborn LB, 2015, FAM CANCER, V14, P129, DOI 10.1007/s10689-014-9747-y; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Bernardi P, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011387; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Bertini Enrico, 2002, Eur J Paediatr Neurol, V6, P193, DOI 10.1053/ejpn.2002.0593; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bushby KMD, 2014, ADV EXP MED BIOL, V802, P185, DOI 10.1007/978-94-007-7893-1_12; CARLSEN F, 1961, J BIOPHYS BIOCHEM CY, V11, P95, DOI 10.1083/jcb.11.1.95; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Charvet Benjamin, 2012, Muscles Ligaments Tendons J, V2, P53; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Deconinck N, 2015, J NEUROL NEUROSUR PS, V86, P1337, DOI 10.1136/jnnp-2013-307245; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Gattazzo F, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00244; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Goody MF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001409; Grobler LA, 2004, BRIT J SPORT MED, V38, P697, DOI 10.1136/bjsm.2003.006502; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Haq RU, 1999, NEUROLOGY, V52, P174, DOI 10.1212/WNL.52.1.174; Hermanns-Le T, 2014, ULTRASTRUCT PATHOL, V38, P164, DOI 10.3109/01913123.2013.829151; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jiang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069089; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; Jonz MG, 2006, RESP PHYSIOL NEUROBI, V154, P139, DOI 10.1016/j.resp.2006.01.004; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kopp MU, 1997, EUR J BIOCHEM, V249, P489, DOI 10.1111/j.1432-1033.1997.00489.x; KRAMER DL, 1983, ENVIRON BIOL FISH, V8, P49, DOI 10.1007/BF00004945; KRAMER DL, 1983, ENVIRON BIOL FISH, V9, P145, DOI 10.1007/BF00690859; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; McNeil DG, 2007, FRESHWATER BIOL, V52, P412, DOI 10.1111/j.1365-2427.2006.01705.x; Merlini L, 2008, NEUROTHERAPEUTICS, V5, P613, DOI 10.1016/j.nurt.2008.08.004; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Nolte H, 2014, J PROTEOME RES, V13, P2162, DOI 10.1021/pr5000335; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Nozu K, 2014, CLIN J AM SOC NEPHRO, V9, P1958, DOI 10.2215/CJN.04140414; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Pan TC, 2014, J BIOL CHEM, V289, P10293, DOI 10.1074/jbc.M114.549311; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Pepe Guglielmina, 2002, Neuromuscul Disord, V12, P296, DOI 10.1016/S0960-8966(01)00275-9; Petrini S, 2007, NEUROMUSCULAR DISORD, V17, P587, DOI 10.1016/j.nmd.2007.04.010; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Quijano-Roy S, 2014, NEUROMUSCULAR DISORD, V24, P125, DOI 10.1016/j.nmd.2013.11.002; Ramanoudjame L, 2012, NEUROMUSCULAR DISORD, V22, P828, DOI 10.1016/j.nmd.2012.06.089; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Rouede D, 2014, BIOMED OPT EXPRESS, V5, P858, DOI 10.1364/BOE.5.000858; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Solares Perez A, 2012, NEUROMUSCULAR DISORD, V22, P827, DOI [10.1016/j.nmd.2012.06.088, DOI 10.1016/J.NMD.2012.06.088]; Tagliavini Francesca, 2013, Muscles Ligaments Tendons J, V3, P281; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Valton J, 2014, METHODS, V69, P151, DOI 10.1016/j.ymeth.2014.06.013; van der Kooi AJ, 2006, ARCH NEUROL-CHICAGO, V63, P1617, DOI 10.1001/archneur.63.11.1617; Yonekawa T, 2015, J NEUROL NEUROSUR PS, V86, P280, DOI 10.1136/jnnp-2013-307052; Zamurs LK, 2015, J BIOL CHEM, V290, P4272, DOI 10.1074/jbc.M114.632208; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7; Zulian A, 2014, HUM MOL GENET, V23, P5353, DOI 10.1093/hmg/ddu254	88	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133986	10.1371/journal.pone.0133986	http://dx.doi.org/10.1371/journal.pone.0133986			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221953	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800092
J	Spiousas, I; Etchemendy, PE; Vergara, RO; Calcagno, ER; Eguia, MC				Spiousas, Ignacio; Etchemendy, Pablo E.; Vergara, Ramiro O.; Calcagno, Esteban R.; Eguia, Manuel C.			An Auditory Illusion of Proximity of the Source Induced by Sonic Crystals	PLOS ONE			English	Article							REVERBERANT ENERGY RATIO; DISTANCE PERCEPTION; LEVEL DISCRIMINATION; NEGATIVE REFRACTION; EGOCENTRIC DISTANCE; BINAURAL LOUDNESS; SOUND-ATTENUATION; RIGID CYLINDERS; ACOUSTIC-WAVES; CUES	In this work we report an illusion of proximity of a sound source created by a sonic crystal placed between the source and a listener. This effect seems, at first, paradoxical to naive listeners since the sonic crystal is an obstacle formed by almost densely packed cylindrical scatterers. Even when the singular acoustical properties of these periodic composite materials have been studied extensively (including band gaps, deaf bands, negative refraction, and birrefringence), the possible perceptual effects remain unexplored. The illusion reported here is studied through acoustical measurements and a psychophysical experiment. The results of the acoustical measurements showed that, for a certain frequency range and region in space where the focusing phenomenon takes place, the sonic crystal induces substantial increases in binaural intensity, direct-to-reverberant energy ratio and interaural cross-correlation values, all cues involved in the auditory perception of distance. Consistently, the results of the psychophysical experiment revealed that the presence of the sonic crystal between the sound source and the listener produces a significant reduction of the perceived relative distance to the sound source.	[Spiousas, Ignacio; Etchemendy, Pablo E.; Vergara, Ramiro O.; Calcagno, Esteban R.; Eguia, Manuel C.] Univ Nacl Quilmes, Lab Acust & Percepc Sonora, Bernal, Buenos Aires, Argentina		Eguia, MC (corresponding author), Univ Nacl Quilmes, Lab Acust & Percepc Sonora, Bernal, Buenos Aires, Argentina.	meguia@unq.edu.ar	Etchemendy, Pablo Esteban/AAE-1387-2019	Etchemendy, Pablo Esteban/0000-0001-9015-4190; Vergara, Ramiro Oscar/0000-0003-0504-0434; Spiousas, Ignacio/0000-0002-0283-4696	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 114-200801-00016]; Universidad Nacional de Quilmes (UNQ) [PUNQ 976/11]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Quilmes (UNQ)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (http://www.conicet.gov.ar/), PIP 114-200801-00016 (MCE, ROV). This work was also supported by Universidad Nacional de Quilmes (UNQ) (http://www.unq.edu.ar), PUNQ 976/11 (MCE, ROV, IS, PEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2008, ACOUSTICS UNDERGROUN, P4167; Akeroyd MA, 2007, J ACOUST SOC AM, V121, P1077, DOI 10.1121/1.2404927; Ando Y, 2000, J SOUND VIB, V232, P101, DOI 10.1006/jsvi.1999.2687; Begault DR, 2001, J AUDIO ENG SOC, V49, P904; Blauert J., 1997, SPATIAL HEARING PSYC; BREMER CD, 1977, AM J PSYCHOL, V90, P645, DOI 10.2307/1421738; Brimijoin WO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083068; Bronkhorst A.W., 2002, MODELING AUDITORY DI; Bronkhorst A.W., 2001, PHYSL PSYCHOL BASES, P184; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; BUUS S, 1990, J ACOUST SOC AM, V87, P2643, DOI 10.1121/1.399057; BUUS S, 1991, J ACOUST SOC AM, V90, P1371, DOI 10.1121/1.401928; Catic J, 2013, J ACOUST SOC AM, V134, P1232, DOI 10.1121/1.4812264; Cervera F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.023902; Chen LS, 2004, APPL PHYS LETT, V85, P1072, DOI 10.1063/1.1781351; Cicek A, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676581; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Dattorro J, 1997, J AUDIO ENG SOC, V45; Declercq NF, 2007, J ACOUST SOC AM, V121, P2011, DOI 10.1121/1.2709842; Farina A, 2000, AUDIO ENG SOC CONV, V108; Feng L, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.014301, 10.1103/PhysrevLett.96.014301]; Fluitt, 2013, AUDITORY PERCEPTION; Gupta BC, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036603; Hartmann WM, 1996, J ACOUST SOC AM, V99, P3678, DOI 10.1121/1.414965; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; HOLM S, 1979, SCAND J STAT, V6, P65; Holway A, P NATL ACAD SCI, P32; Knight David, 2010, THESIS U SOUTHAMPTON; Kolarik A, 2013, J ACOUST SOC AM, V134, P3395, DOI 10.1121/1.4824395; Kopco N, 2011, J ACOUST SOC AM, V130, P1530, DOI 10.1121/1.3613705; Larsen E, 2008, J ACOUST SOC AM, V124, P450, DOI 10.1121/1.2936368; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; LITTLE AD, 1992, PERCEPTION, V21, P405, DOI 10.1068/p210405; Lokki T, 2011, J ACOUST SOC AM, V130, pEL345, DOI 10.1121/1.3647866; Lokki T, 2011, J ACOUST SOC AM, V129, pEL223, DOI 10.1121/1.3579145; Lu MH, 2007, NAT MATER, V6, P744, DOI 10.1038/nmat1987; Lubman D, 2010, J ACOUST SOC AM, V127, P193, DOI [10.1121/1.3384859, DOI 10.1121/1.3384859]; Lubman D, 2013, P MEET ACOUST, V19, DOI [10.1121/1.4800220, DOI 10.1121/1.4800220]; Madison G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008151; MAJERNIK V, 1978, ACUSTICA, V39, P117; MARTINEZSALA R, 1995, NATURE, V378, P241, DOI 10.1038/378241a0; MERSHON DH, 1979, PERCEPTION, V8, P311, DOI 10.1068/p080311; MERSHON DH, 1975, PERCEPT PSYCHOPHYS, V18, P409, DOI 10.3758/BF03204113; Moller H, 1996, J AUDIO ENG SOC, V44, P451; Moore BCJ, 2007, J ACOUST SOC AM, V121, P1604, DOI 10.1121/1.2431331; Nielsen SH, 1992, AUDIO ENG SOC CONV, V92, P3307; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; Raman CV, 1922, P R SOC LOND A-CONTA, V100, P424, DOI 10.1098/rspa.1922.0007; Sanchez-Perez JV, 1998, PHYS REV LETT, V80, P5325, DOI 10.1103/PhysRevLett.80.5325; Shinn-Cunningham BG, 2000, P IEEE PCM, V2000, P227; Sukhovich A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014301; TOOLE FE, 1970, J ACOUST SOC AM, V48, P943, DOI 10.1121/1.1912233; Vassilantonopoulos SL, 2001, ACUSTICA, V87, P604; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2002, J ACOUST SOC AM, V112, P2110, DOI 10.1121/1.1506692; Zhang XD, 2004, APPL PHYS LETT, V85, P341, DOI 10.1063/1.1772854	60	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133271	10.1371/journal.pone.0133271	http://dx.doi.org/10.1371/journal.pone.0133271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222281	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800045
J	Stalder, K; Vaz, PK; Gilkerson, JR; Baker, R; Whiteley, P; Ficorilli, N; Tatarczuch, L; Portas, T; Skogvold, K; Anderson, GA; Devlin, JM				Stalder, Kathryn; Vaz, Paola K.; Gilkerson, James R.; Baker, Rupert; Whiteley, Pam; Ficorilli, Nino; Tatarczuch, Liliana; Portas, Timothy; Skogvold, Kim; Anderson, Garry A.; Devlin, Joanne M.			Prevalence and Clinical Significance of Herpesvirus Infection in Populations of Australian Marsupials	PLOS ONE			English	Article							COMMON WOMBATS; GAMMAHERPESVIRUS; DISEASE; IDENTIFICATION; REACTIVATION; MORTALITIES; MANGE; CATS	Herpesviruses have been reported in several marsupial species, but molecular classification has been limited to four herpesviruses in macropodids, a gammaherpesvirus in two antechinus species (Antechinus flavipes and Antechinus agilis), a gammaherpesvirus in a potoroid, the eastern bettong (Bettongia gaimardi) and two gammaherpesviruses in koalas (Phascolarctos cinereus). In this study we examined a range of Australian marsupials for the presence of herpesviruses using molecular and serological techniques, and also assessed risk factors associated with herpesvirus infection. Our study population included 99 koalas (Phascolarctos cinereus), 96 eastern grey kangaroos (Macropus giganteus), 50 Tasmanian devils (Sarcophilus harrisii) and 33 common wombats (Vombatus ursinius). In total, six novel herpesviruses (one alphaherpesvirus and five gammaherpesviruses) were identified in various host species. The overall prevalence of detection of herpesvirus DNA in our study population was 27.2% (95% confidence interval (CI) of 22.6-32.2%), but this varied between species and reached as high as 45.4% (95% CI 28.1-63.7%) in common wombats. Serum antibodies to two closely related macropodid herpesviruses (macropodid herpesvirus 1 and 2) were detected in 44.3% (95% CI 33.1-55.9%) of animals tested. This also varied between species and was as high as 92% (95% CI 74.0-99.0%) in eastern grey kangaroos. A number of epidemiological variables were identified as positive predictors for the presence of herpesvirus DNA in the marsupial samples evaluated. The most striking association was observed in koalas, where the presence of Chlamydia pecorum DNA was strongly associated with the presence of herpesvirus DNA (Odds Ratio = 60, 95% CI 12.1-297.8). Our results demonstrate the common presence of herpesviruses in Australian marsupials and provide directions for future research.	[Stalder, Kathryn; Vaz, Paola K.; Gilkerson, James R.; Whiteley, Pam; Ficorilli, Nino; Tatarczuch, Liliana; Anderson, Garry A.; Devlin, Joanne M.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [Stalder, Kathryn; Baker, Rupert] Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia; [Portas, Timothy] Tidbinbilla Nat Reserve, Vet & Res Ctr, Paddys River, ACT, Australia; [Skogvold, Kim] Murdoch Univ, Sch Vet & Life Sci, Conservat Med Program, Perth, WA, Australia; [Skogvold, Kim] Perth Zoo, Perth Zoo Vet Dept, S Perth, WA, Australia	University of Melbourne; Murdoch University	Devlin, JM (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia.	devlinj@unimelb.edu.au	Vaz, Paola K./D-8713-2015	Vaz, Paola K./0000-0001-6877-7383; Gilkerson, James/0000-0003-1801-4817; Tatarczuch, Liliana/0000-0001-9556-0753; Devlin, Joanne/0000-0003-0400-9670	Ian Potter Foundation; Vizard Foundation; Australian Research Council	Ian Potter Foundation; Vizard Foundation; Australian Research Council(Australian Research Council)	This work was supported by the Ian Potter Foundation. PW works with Wildlife Health Surveillance Victoria and receives support from The Vizard Foundation. JMD is supported by a fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ACLAND HM, 1981, J WILDLIFE DIS, V17, P471, DOI 10.7589/0090-3558-17.3.471; Amery-Gale J, 2014, J WILDLIFE DIS, V50, P334, DOI 10.7589/2013-07-165; Cai Y, 2002, J VET MED SCI, V64, P215, DOI 10.1292/jvms.64.215; CALLINAN RB, 1981, J WILDLIFE DIS, V17, P311, DOI 10.7589/0090-3558-17.2.311; Chmielewicz B, 2003, XENOTRANSPLANTATION, V10, P349, DOI 10.1034/j.1399-3089.2003.02074.x; DICKSON J, 1980, AUST VET J, V56, P463, DOI 10.1111/j.1751-0813.1980.tb02657.x; FINNIE EP, 1976, AUST VET J, V52, P294, DOI 10.1111/j.1751-0813.1976.tb00123.x; GASKELL RM, 1977, VET REC, V100, P128, DOI 10.1136/vr.100.7.128; Guliani S, 1999, VET MICROBIOL, V68, P59, DOI 10.1016/S0378-1135(99)00061-9; JOHNSON MA, 1985, ARCH VIROL, V85, P313, DOI 10.1007/BF01314240; Jones SM, 2005, AUST J ZOOL, V53, P339, DOI 10.1071/ZO05043; KERR A, 1981, AUST VET J, V57, P347, DOI 10.1111/j.1751-0813.1981.tb05847.x; Kibur M, 2000, SEX TRANSM DIS, V27, P425, DOI 10.1097/00007435-200009000-00001; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martin RW, 1998, AUST VET J, V76, P411, DOI 10.1111/j.1751-0813.1998.tb12391.x; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Meier J, 2005, J CLIN MICROBIOL, V43, P1318, DOI 10.1128/JCM.43.3.1318-1324.2005; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Portas T, 2014, J WILDLIFE DIS, V50, P210, DOI 10.7589/2013-08-202; Roizman B, 2001, FIELDS VIROL, P2381; ROTHWELL JT, 1988, AUST VET J, V65, P360, DOI 10.1111/j.1751-0813.1988.tb14269.x; Shizuma Toru, 2008, Kansenshogaku Zasshi, V82, P451; Skerratt LF, 1999, J WILDLIFE DIS, V35, P633, DOI 10.7589/0090-3558-35.4.633; Skerratt LF, 2004, AUST J ZOOL, V52, P303, DOI 10.1071/ZO02061; Smith JA, 2008, VET MICROBIOL, V129, P236, DOI 10.1016/j.vetmic.2007.11.019; Stalder K, 2013, THESIS U MELBOURNE; Sykes JE, 1999, J VET INTERN MED, V13, P153, DOI 10.1892/0891-6640(1999)013&lt;0153:POFPAF&gt;2.3.CO;2; UREN J, 1966, EXP CELL RES, V43, P677, DOI 10.1016/0014-4827(66)90043-7; Vaz P, 2011, J WILDLIFE DIS, V47, P787, DOI 10.7589/0090-3558-47.3.787; Vaz P, 2012, J WILDLIFE DIS, V48, P226, DOI 10.7589/0090-3558-48.1.226; Vaz PK, 2013, J WILDLIFE DIS, V49, P143, DOI 10.7589/2012-01-027; WEBBER CE, 1978, AUST J EXP BIOL MED, V56, P351, DOI 10.1038/icb.1978.38; Wilcox RS, 2011, AUST VET J, V89, P55, DOI 10.1111/j.1751-0813.2010.00662.x; WILKS CR, 1981, J COMP PATHOL, V91, P461, DOI 10.1016/0021-9975(81)90019-0	35	26	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133807	10.1371/journal.pone.0133807	http://dx.doi.org/10.1371/journal.pone.0133807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222660	gold, Green Published			2022-12-26	WOS:000358836800068
J	Tan, MF; Gao, T; Liu, WQ; Zhang, CY; Yang, X; Zhu, JW; Teng, MY; Li, L; Zhou, R				Tan, Mei-Fang; Gao, Ting; Liu, Wan-Quan; Zhang, Chun-Yan; Yang, Xi; Zhu, Jia-Wen; Teng, Mu-Ye; Li, Lu; Zhou, Rui			MsmK, an ATPase, Contributes to Utilization of Multiple Carbohydrates and Host Colonization of Streptococcus suis	PLOS ONE			English	Article							GLUCAN-DEGRADING ENZYME; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; GLYCOGEN-METABOLISM; ZOONOTIC PATHOGEN; ABC TRANSPORTERS; MOUSE INTESTINE; MUTANS; PNEUMONIAE; IDENTIFICATION	Acquisition and metabolism of carbohydrates are essential for host colonization and pathogenesis of bacterial pathogens. Different bacteria can uptake different lines of carbohydrates via ABC transporters, in which ATPase subunits energize the transport though ATP hydrolysis. Some ABC transporters possess their own ATPases, while some share a common ATPase. Here we identified MsmK, an ATPase from Streptococcus suis, an emerging zoonotic bacterium causing dead infections in pigs and humans. Genetic and biochemistry studies revealed that the MsmK was responsible for the utilization of raffinose, melibiose, maltotetraose, glycogen and maltotriose. In infected mice, the msmK-deletion mutant showed significant defects of survival and colonization when compared with its parental and complementary strains. Taken together, MsmK is an ATPase that contributes to multiple carbohydrates utilization and host colonization of S. suis. This study gives new insight into our understanding of the carbohydrates utilization and its relationship to the pathogenesis of this zoonotic pathogen.	[Tan, Mei-Fang; Gao, Ting; Liu, Wan-Quan; Zhang, Chun-Yan; Yang, Xi; Zhu, Jia-Wen; Teng, Mu-Ye; Li, Lu; Zhou, Rui] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Gao, Ting] Hubei Acad Agr Sci, Inst Anim Husb & Vet, Wuhan 430064, Peoples R China; [Li, Lu; Zhou, Rui] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Zhou, R (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China.	rzhou@mail.hzau.edu.cn			International S & T Cooperation Program of China (ISTCP) [2013DFG32360]; National Basic Research Program of China (973 Program) [2012CB518802]	International S & T Cooperation Program of China (ISTCP); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the International S & T Cooperation Program of China (ISTCP grant no. 2013DFG32360) and the National Basic Research Program of China (973 Program grant no. 2012CB518802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; [Anonymous], 2001, STREPTOCOCCUS SUIS, V46, P140; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dubreuil JD, 1996, MICROBIOL-UK, V142, P837, DOI 10.1099/00221287-142-4-837; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feng YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00710; Ferrando ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089334; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; FRENCH GL, 1989, J MED MICROBIOL, V28, P275, DOI 10.1099/00222615-28-4-275; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gough H, 1996, ARCH ORAL BIOL, V41, P141, DOI 10.1016/0003-9969(95)00121-2; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Grenier D, 2009, VET J, V179, P292, DOI 10.1016/j.tvjl.2007.09.005; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; HOFHERR L, 1979, AM J MED TECHNOL, V45, P127; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Li W, 2009, FEMS MICROBIOL LETT, V292, P123, DOI 10.1111/j.1574-6968.2008.01476.x; Li W, 2011, FEMS MICROBIOL LETT, V316, P115, DOI 10.1111/j.1574-6968.2010.02200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Mccoy JG, 2015, BBA-GEN SUBJECTS, V1850, P577, DOI 10.1016/j.bbagen.2014.03.013; MEURMAN JH, 1987, CARIES RES, V21, P353, DOI 10.1159/000261039; MORMANN JE, 1981, CARIES RES, V15, P166; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Shelburne SA, 2009, MOL MICROBIOL, V74, P159, DOI 10.1111/j.1365-2958.2009.06858.x; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; TARAVEL FR, 1983, EUR J BIOCHEM, V130, P147; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TILLOTSON GS, 1982, J CLIN PATHOL, V35, P468, DOI 10.1136/jcp.35.4.468; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Webb AJ, 2007, J BACTERIOL, V189, P3322, DOI 10.1128/JB.01633-06; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zheng F, 2011, INFECT IMMUN, V79, P1319, DOI 10.1128/IAI.00193-10; Zhu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091971	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130792	10.1371/journal.pone.0130792	http://dx.doi.org/10.1371/journal.pone.0130792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222651	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800008
J	Jayakar, SS; Zhou, XJ; Savechenkov, PY; Chiara, DC; Desai, R; Bruzik, KS; Miller, KW; Cohen, JB				Jayakar, Selwyn S.; Zhou, Xiaojuan; Savechenkov, Pavel Y.; Chiara, David C.; Desai, Rooma; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			Positive and Negative Allosteric Modulation of an alpha 1 beta 3 gamma 2 gamma-Aminobutyric Acid Type A (GABA(A))Receptor by Binding to a Site in the Transmembrane Domain at the gamma(+)-beta(-) Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUBUNIT INTERFACES; ETOMIDATE SITES; GABA RECEPTOR; CONVULSANT; IDENTIFICATION; BARBITURATE; AGONIST; DESENSITIZATION; PURIFICATION	In the process of developing safer general anesthetics, isomers of anesthetic ethers and barbiturates have been discovered that act as convulsants and inhibitors of gamma-aminobutyric acid type A receptors (GABA(A)Rs) rather than potentiators. It is unknown whether these convulsants act as negative allosteric modulators by binding to the intersubunit anesthetic-binding sites in the GABA(A)R transmembrane domain (Chiara, D. C., Jayakar, S. S., Zhou, X., Zhang, X., Savechenkov, P. Y., Bruzik, K. S., Miller, K. W., and Cohen, J. B. (2013) J. Biol. Chem. 288, 19343-19357) or to known convulsant sites in the ion channel or extracellular domains. Here, we show that S-1-methyl-5-propyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (S-mTFD-MPPB), a photoreactive analog of the convulsant barbiturate S-MPPB, inhibits alpha 1 beta 3 gamma 2 but potentiates alpha 1 beta 3 GABA(A)R responses. In the alpha 1 beta 3 gamma 2 GABA(A)R, S-mTFD-MPPB binds in the transmembrane domain with high affinity to the gamma(+)-beta(-) subunit interface site with negative energetic coupling to GABA binding in the extracellular domain at the beta(+)-alpha(-) subunit interfaces. GABA inhibits S-[H-3] mTFD-MPPB photolabeling of gamma 2Ser-280 (gamma M2-15') in this site. In contrast, within the same site GABA enhances photolabeling of beta 3Met-227 in beta M1 by an anesthetic barbiturate, R-[H-3] methyl-5-allyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (mTFD-MPAB), which differs from S-mTFD-MPPB in structure only by chirality and two hydrogens (propyl versus allyl). S-mTFD-MPPB and R-mTFD-MPAB are predicted to bind in different orientations at the gamma(+)-beta(-) site, based upon the distance in GABA(A)R homology models between gamma 2Ser-280 and beta 3Met-227. These results provide an explanation for S-mTFD-MPPB inhibition of alpha 1 beta 3 gamma 2 GABA(A)R function and provide a first demonstration that an intersubunit-binding site in the GABA(A)R transmembrane domain binds negative and positive allosteric modulators.	[Jayakar, Selwyn S.; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Desai, Rooma; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408	National Institutes of Health from USPHS [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 from USPHS. The authors declare that they have no conflicts of interest with the contents of the article.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BUCH HP, 1973, N-S ARCH PHARMACOL, V277, P191, DOI 10.1007/BF00501159; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; Desai R, 2013, FASEB J, V27; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DOWNES H, 1970, J PHARMACOL EXP THER, V175, P692; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; Erkkila BE, 2008, BIOPHYS J, V94, P4299, DOI 10.1529/biophysj.107.118455; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HOLLAND KD, 1990, BRAIN RES, V516, P147, DOI 10.1016/0006-8993(90)90910-4; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kamiya Y, 1999, ANESTHESIOLOGY, V90, P1704, DOI 10.1097/00000542-199906000-00028; KOBLIN DD, 1981, ANESTH ANALG, V60, P464; KRANTZ JC, 1957, J PHARMACOL EXP THER, V121, P362; Krasowski MD, 2000, NEUROPHARMACOLOGY, V39, P1168, DOI 10.1016/S0028-3908(99)00221-X; LEEBLUNDBERG F, 1982, MOL PHARMACOL, V21, P320; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; LING ASC, 1959, J PHARMACOL EXP THER, V126, P366; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Nayak TK, 2013, P NATL ACAD SCI USA, V110, P13654, DOI 10.1073/pnas.1308247110; Patel P.M., 2011, GOODMAN GILMANS PHAR, P527; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; QUAST U, 1983, J NEUROCHEM, V41, P418, DOI 10.1111/j.1471-4159.1983.tb04758.x; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; TICKU MK, 1985, EUR J PHARMACOL, V112, P1, DOI 10.1016/0014-2999(85)90232-8; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	48	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23432	23446		10.1074/jbc.M115.672006	http://dx.doi.org/10.1074/jbc.M115.672006			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229099	Green Published, hybrid			2022-12-26	WOS:000361685500047
J	Abbott, MJ; Roth, TM; Ho, L; Wang, LP; O'Carroll, D; Nissenson, RA				Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.			Negative Skeletal Effects of Locally Produced Adiponectin	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MASS; INSULIN SENSITIVITY; ADIPOSE-TISSUE; PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; CIRCULATING ADIPONECTIN; SUPPRESSING OSTEOCLAST; MARROW FAT	Epidemiological studies show that high circulating levels of adiponectin are associated with low bone mineral density. The effect of adiponectin on skeletal homeostasis, on osteoblasts in particular, remains controversial. We investigated this issue using mice with adipocyte-specific over-expression of adiponectin (AdTg). MicroCT and histomorphometric analysis revealed decreases (15%) in fractional bone volume in AdTg mice at the proximal tibia with no changes at the distal femur. Cortical bone thickness at mid-shafts of the tibia and at the tibiofibular junction was reduced (3-4%) in AdTg mice. Dynamic histomorphometry at the proximal tibia in AdTg mice revealed inhibition of bone formation. AdTg mice had increased numbers of adipocytes in close proximity to trabecular bone in the tibia, associated with increased adiponectin levels in tibial marrow. Treatment of BMSCs with adiponectin after initiation of osteoblastic differentiation resulted in reduced mineralized colony formation and reduced expression of mRNA of osteoblastic genes, osterix (70%), Runx2 (52%), alkaline phosphatase (72%), Col1 (74%), and osteocalcin (81%). Adiponectin treatment of differentiating osteoblasts increased expression of the osteoblast genes PPAR gamma (32%) and C/ebp alpha (55%) and increased adipocyte colony formation. These data suggest a model in which locally produced adiponectin plays a negative role in regulating skeletal homeostasis through inhibition of bone formation and by promoting an adipogenic phenotype.	[Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, VA Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA; [Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Abbott, Marcia J.] Chapman Univ, Crean Coll Hlth & Behav Sci, Dept Hlth Sci & Kinesiol, Orange, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chapman University System; Chapman University	Nissenson, RA (corresponding author), Univ Calif San Francisco, VA Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA.	Robert.Nissenson@ucsf.edu		Ho, Linh/0000-0001-9252-8539	Department of Veterans Affairs (Merit Review grant) [1I01BX001496]	Department of Veterans Affairs (Merit Review grant)(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Merit Review grant 1I01BX001496), to RAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Barbour KE, 2011, J BONE MINER RES, V26, P1568, DOI 10.1002/jbmr.361; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gimble JM, 2012, CLIN BIOCHEM, V45, P874, DOI 10.1016/j.clinbiochem.2012.03.006; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kao R, 2012, ENDOCRINE, V42, P622, DOI 10.1007/s12020-012-9717-9; Kao RS, 2013, BONE, V55, P277, DOI 10.1016/j.bone.2013.04.001; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lin YY, 2014, BONE, V64, P147, DOI 10.1016/j.bone.2014.03.051; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029; Millard SM, 2011, J BONE MINER RES, V26, P822, DOI 10.1002/jbmr.273; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Naot D, 2012, ENDOCRINOLOGY, V153, P2076, DOI 10.1210/en.2011-2004; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Ritchie IRW, 2011, AM J PHYSIOL-REG I, V300, pR492, DOI 10.1152/ajpregu.00602.2010; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Shafiei MS, 2011, AM J PATHOL, V178, P2690, DOI 10.1016/j.ajpath.2011.02.035; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Wang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068497; Wattanachanya L, 2013, ENDOCRINOLOGY, V154, P2069, DOI 10.1210/en.2012-2034; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wren TAL, 2011, J CLIN ENDOCR METAB, V96, P782, DOI 10.1210/jc.2010-1922; Wu YW, 2014, AM J PHYSIOL-ENDOC M, V306, pE1418, DOI 10.1152/ajpendo.00048.2014; Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003; Zaidi M, 2012, ENDOCRINOLOGY, V153, P2070, DOI 10.1210/en.2012-1022	43	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134290	10.1371/journal.pone.0134290	http://dx.doi.org/10.1371/journal.pone.0134290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230337	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400100
J	Koenigs, A; Zipfel, PF; Kraiczy, P				Koenigs, Arno; Zipfel, Peter F.; Kraiczy, Peter			Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein	PLOS ONE			English	Article							FACTOR EF-TU; IMMUNE EVASION; FACTOR-H; PSEUDOMONAS-AERUGINOSA; LEGIONELLA-PNEUMOPHILA; BORRELIA-BURGDORFERI; SURFACE PROTEIN; BACTERIAL; COMPLEMENT; ACTIVATION	Acinetobacter baumannii is an important nosocomial pathogen, causing a variety of opportunistic infections of the skin, soft tissues and wounds, urinary tract infections, secondary meningitis, pneumonia and bacteremia. Over 63% of A. baumannii infections occurring in the United States are caused by multidrug resistant isolates, and pan-resistant isolates have begun to emerge that are resistant to all clinically relevant antibiotics. The complement system represents the first line of defense against invading pathogens. However, many A. baumannii isolates, especially those causing severe bacteremia are resistant to complement- mediated killing, though the underlying mechanisms remain poorly understood. Here we show for the first time that A. baumannii binds host-derived plasminogen and we identify the translation elongation factor Tuf as a moonlighting plasminogen-binding protein that is exposed on the outer surface of A. baumannii. Binding of plasminogen to Tuf is at least partly dependent on lysine residues and ionic interactions. Plasminogen, once bound to Tuf can be converted to active plasmin and proteolytically degrade fibrinogen as well as the key complement component C3b. Thus, Tuf acts as a multifunctional protein that may contribute to virulence of A. baumannii by aiding in dissemination and evasion of the complement system.	[Koenigs, Arno; Kraiczy, Peter] Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de						Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Baensch M, 1998, MICROBIOL-UK, V144, P2241, DOI 10.1099/00221287-144-8-2241; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BHAKDI S, 1991, IMMUNOL TODAY, V12, P318, DOI 10.1016/0167-5699(91)90007-G; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Cateau E, 2014, J HOSP INFECT, V87, P131, DOI 10.1016/j.jhin.2014.05.001; Cateau E, 2011, FEMS MICROBIOL LETT, V319, P19, DOI 10.1111/j.1574-6968.2011.02261.x; CDC U, 2013, ANTIBIOTIC RESISTANC; Chapman MR, 2010, MBIO, V1, DOI [10.1128/mBio.00131-10, DOI 10.1128/MBI0.00131-10]; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10; Dallo SF, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/128705; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Fulde M, 2011, BIOCHEM J, V434, P523, DOI 10.1042/BJ20101121; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Grundy JE, 2007, THROMB HAEMOSTASIS, V97, P38, DOI 10.1160/TH06-08-0476; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Heffron SE, 2006, ACTA CRYSTALLOGR D, V62, P433, DOI 10.1107/S0907444906004021; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; King LB, 2013, J INFECT DIS, V207, P1128, DOI 10.1093/infdis/jis939; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Klos A, 2009, MOL IMMUNOL; Koenigs A, 2013, J BIOL CHEM, V288, P25229, DOI 10.1074/jbc.M112.413872; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LIJNEN HR, 1995, BAILLIERE CLIN HAEM, V8, P277, DOI 10.1016/S0950-3536(05)80268-9; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mohan S, 2014, MOL IMMUNOL, V62, P249, DOI 10.1016/j.molimm.2014.06.029; Muller-Eberhard HJ, 1985, J INVEST DERMATOL S, V85, p47s; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Premkumar L, 2014, J BIOL CHEM, V289, P19869, DOI 10.1074/jbc.M114.571737; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; ULLBERG M, 1989, APMIS, V97, P996, DOI 10.1111/j.1699-0463.1989.tb00508.x; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vranckx L, 2007, MICROBIOL-SGM, V153, P3757, DOI 10.1099/mic.0.2007/010116-0; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WEBER S, 1995, J BACTERIOL, V177, P11, DOI 10.1128/jb.177.1.11-19.1995; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; WU HL, 1990, J BIOL CHEM, V265, P19658; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	69	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134418	10.1371/journal.pone.0134418	http://dx.doi.org/10.1371/journal.pone.0134418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230848	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400117
J	Biros, E; Moran, CS; Norman, PE; Hankey, GJ; Yeap, BB; Almeida, OP; Flicker, L; White, R; Jones, R; Golledge, J				Biros, Erik; Moran, Corey S.; Norman, Paul E.; Hankey, Graeme J.; Yeap, Bu B.; Almeida, Osvaldo P.; Flicker, Leon; White, Richard; Jones, Rhondda; Golledge, Jonathan			Association between the Advanced Glycosylation End Product-Specific Receptor Gene and Cardiovascular Death in Older Men	PLOS ONE			English	Article							INHIBITS MACROPHAGE ACTIVITY; ABDOMINAL AORTIC-ANEURYSM; SPLICE VARIANTS; CAROTID PLAQUE; RAGE GENE; INFLAMMATION; HMGB1; BINDING; HEALTH; ALPHA(V)BETA(3)-INTEGRIN	Advanced glycosylation end product-specific receptor (AGER) signaling has been implicated in atherosclerosis. The aim of this study was to evaluate whether a common genetic variation in the AGER gene is associated with cardiovascular (CV) death. We included 1304 older men who were genotyped for rs1035798: C>T, which is a single nucleotide polymorphism (SNP) mapped to the third intron of AGER. Cox proportional hazard analysis was used to estimate the association of rs1035798: C>T with CV death. In addition we analyzed total RNA extracted from carotid atherosclerosis biopsies of 18 patients that did or did not have recent symptoms of cerebral embolization by quantitative real-time reverse transcription PCR (qRT-PCR). The minor T-allele of rs1035798: C>T was found to be associated with CV death under dominant (HR = 1.43, 95% CI: 1.01-2.02, P = 0.04) and recessive (HR = 2.05, 95% CI: 1.11-3.81, P = 0.02) models of inheritance even after adjustment for traditional cardiovascular risk factors. No association was found between rs1035798: C>T and non-CV death. qRT-PCR results suggested that median relative expression of AGER isoform 1 and isoform 6 transcripts were approximately 6-(P = 0.01) and 2-fold (P = 0.02) greater, respectively, within carotid biopsies of symptomatic compared to asymptomatic patients. These data suggest that the minor (T) allele of rs1035798: C>T represents an independent susceptibility factor for CV death. The expression of AGER isoforms is different in atheroma from patients with recent symptoms. Further studies are needed to investigate if rs1035798: C>T influences the alternative splicing of AGER.	[Biros, Erik; Moran, Corey S.; Jones, Rhondda; Golledge, Jonathan] James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol, Perth, WA, Australia; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia; [White, Richard] Townsville Hosp, Dept Neurol, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia	James Cook University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia	Golledge, J (corresponding author), James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	Flicker, Leon/AAE-1530-2022; Hankey, Graeme J/H-4968-2014; golledge, jonathan/I-2371-2013; Almeida, Osvaldo P./A-4925-2008; Jones, Rhondda/E-4853-2013	Flicker, Leon/0000-0002-3650-0475; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; golledge, jonathan/0000-0002-5779-8848; Jones, Rhondda/0000-0002-1031-2863	Townsville Private Practice Trust Fund, Australia [RG04213]; National Health and Medical Research Council [1022752, 1021416, 1020955, 1003707, 1000967]; National Heart Foundation of Australia; Queensland Government; National Health and Medical Research Council, Australia [1019921]; Health and Medical Research Office, Queensland Government	Townsville Private Practice Trust Fund, Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Queensland Government; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Health and Medical Research Office, Queensland Government	The Townsville Private Practice Trust Fund (http://www.health.qld.gov.au/; RG04213), Australia, The National Health and Medical Research Council (http://www.nhmrc.gov.au/; 1022752, 1021416, 1020955, 1003707 and 1000967), The National Heart Foundation of Australia (http://www.heartfoundation.org.au/), and The Queensland Government supported this work. JG holds a Practitioner Fellowship from the National Health and Medical Research Council, Australia (1019921), and a Senior Clinical Research Fellowship from the Health and Medical Research Office, Queensland Government.	Barr ELM, 2009, INTERN MED J, V39, P49, DOI 10.1111/j.1445-5994.2008.01864.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caillier SJ, 2008, J IMMUNOL, V181, P5473, DOI 10.4049/jimmunol.181.8.5473; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Goiledge J, 2008, EUR J VASC ENDOVASC, V35, P2, DOI 10.1016/j.ejvs.2007.09.004; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Golledge J, 2014, J NUTR HEALTH AGING; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Hunter GC, 1999, J VASC SURG, V30, P36, DOI 10.1016/S0741-5214(99)70174-6; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li SSY, 2003, BIOSTATISTICS, V4, P513, DOI 10.1093/biostatistics/4.4.513; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mendis S., 2011, GLOB ATL CARD DIS PR; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Najafi AH, 2013, DIS MODEL MECH, V6, P323, DOI 10.1242/dmm.009977; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Norton K., 2000, ANTHROPOMETRICA, V2, P27; Olsson S, 2013, EUR J NEUROL, V20, P991, DOI 10.1111/ene.12041; Organization WH, 2016, GLOBAL STATUS REPORT; Pisetsky DS, 2010, AM J PHYSIOL-CELL PH, V299, pC1253, DOI 10.1152/ajpcell.00397.2010; Rossi A, 2006, INT J CARDIOL, V111, P263, DOI 10.1016/j.ijcard.2005.08.030; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Shaikh S, 2012, EUR J VASC ENDOVASC, V44, P491, DOI 10.1016/j.ejvs.2012.08.005; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Tedgui A, 2005, VASC MED, V10, P45, DOI 10.1191/1358863x05vm589ra; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134475	10.1371/journal.pone.0134475	http://dx.doi.org/10.1371/journal.pone.0134475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226616	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358837700097
J	Gonzalez-Tokman, D; Martinez-Garza, C				Gonzalez-Tokman, Daniel; Martinez-Garza, Cristina			Effect of Ecological Restoration on Body Condition of a Predator	PLOS ONE			English	Article							ORB-WEAVING SPIDER; NEPHILA-CLAVIPES; CONSERVATION PHYSIOLOGY; MATING SUCCESS; HABITAT; TERRITORIAL; PREY; SIZE; DRAGONFLIES; NUTRITION	Ecological restoration attempts to recover the structure and function of ecosystems that have been degraded by human activities. A crucial test of ecosystem recovery would be to determine whether individuals in restored environments are as healthy as those in conserved environments. However, the impact of restoration on physiology of terrestrial animals has never been tested. Here, we evaluated the effect of two restoration methods on body condition measured as body size, body mass, lipid and muscle content of the spider Nephila clavipes in a tropical dry forest that has suffered chronic disturbance due to cattle grazing. We used experimental plots that had been excluded from disturbance by cattle grazing during eight years. Plots were either planted with native trees (i.e. maximal intervention), or only excluded from disturbance (i.e. minimal intervention), and were compared with control conserved (remnants of original forest) and disturbed plots (where cattle is allowed to graze). We predicted (1) better body condition in spiders of conserved and restored sites, compared to disturbed sites, and (2) better body condition in plots with maximal intervention than in plots with minimal intervention. The first prediction was not supported in males or females, and the second prediction was only supported in females: body dry mass was higher in planted than in conserved plots for spiders of both sexes and also higher that in disturbed plots for males, suggesting that plantings are providing more resources. We discuss how different life histories and environmental pressures, such as food availability, parasitism, and competition for resources can explain our contrasting findings in male and female spiders. By studying animal physiology in restoration experiments it is possible to understand the mechanistic basis of ecological and evolutionary processes that determine success of ecological restoration.	[Gonzalez-Tokman, Daniel; Martinez-Garza, Cristina] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico; [Gonzalez-Tokman, Daniel] Consejo Nacl Ciencia & Technol, Catedras CONACYT, Mexico City, DF, Mexico	Universidad Autonoma del Estado de Morelos	Gonzalez-Tokman, D (corresponding author), Inst Ecol, AC Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico.	daniel.gt@inecol.mx	Martínez-Garza, Cristina/K-4519-2019; Martínez-Garza, Cristina/H-8956-2019; Gonzalez-Tokman, Daniel/Q-6833-2018	Martínez-Garza, Cristina/0000-0002-9310-564X; Gonzalez-Tokman, Daniel/0000-0001-7251-5773				Adams SM, 2005, HYDROBIOLOGIA, V542, P77, DOI 10.1007/s10750-004-3951-y; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Carrasco-Carballido V., 2011, MEM C COL REST EC 2, P297; CHRISTENSON TE, 1979, BEHAV ECOL SOCIOBIOL, V5, P87, DOI 10.1007/BF00302697; COHN J, 1987, J ARACHNOL, V15, P185; Cooke SJ, 2008, BIOSCIENCE, V58, P957, DOI 10.1641/B581009; Cooke SJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot001; Crawley M.J., 2007, R BOOK; de la O-Toris J, 2012, BOT SCI, V90, P469, DOI 10.17129/botsci.475; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Dorado O, 2005, PROGRAMA CONSERVACIO; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gonzalez-Tokman DM, 2013, FUNCT ECOL, V27, P739, DOI 10.1111/1365-2435.12072; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Heiling AM, 1998, J ARACHNOL, V26, P91; HIGGINS L, 1993, J ARACHNOL, V21, P107; HIGGINS LE, 1992, ANIM BEHAV, V44, P485, DOI 10.1016/0003-3472(92)90058-H; HIGGINS LE, 1987, J ARACHNOL, V15, P401; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; Howe HF, 2014, BOT SCI, V92, P459; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Juan-Baeza I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128583; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lee KP, PHYSL ENTOMOLOGY, V29, P108; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; Martinez-Garza C, 2011, FOREST ECOL MANAG, V262, P2207, DOI 10.1016/j.foreco.2011.08.013; Martinez-Perez A, 2014, EFECTO TRATAMIENTOS; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; McIver J, 2001, FOREST ECOL MANAG, V153, P15, DOI 10.1016/S0378-1127(01)00451-0; MCLACHLAN AD, 1984, ANNU REV BIOPHYS BIO, V13, P167; Meraz LC, 2012, J ETHOL, V30, P93, DOI 10.1007/s10164-011-0300-2; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MOORE CW, 1977, AM MIDL NAT, V98, P95, DOI 10.2307/2424717; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; R Development Core Team, 2014, R LANG ENV STAT COMP; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Razeng E, 2014, J AVIAN BIOL, V45, P1, DOI DOI 10.1111/JAY.00475; Richmond CE, 2005, ECOL MODEL, V188, P279, DOI 10.1016/j.ecolmodel.2005.03.002; Robinson M. H., 1976, SMITHSON CONTRIB ZOO, V218, P1; Shackelford N, 2013, RESTOR ECOL, V21, P297, DOI 10.1111/rec.12012; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1088, DOI 10.1093/icb/icl053; Stockwell Craig A., 2006, P113; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Toft Soren, 2013, P373; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Wilder SM, 2010, OECOLOGIA, V162, P617, DOI 10.1007/s00442-009-1518-3; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zedier I. B., 2006, FDN RESTORATION ECOL; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuur Alain F., 2009, P1	72	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133551	10.1371/journal.pone.0133551	http://dx.doi.org/10.1371/journal.pone.0133551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226363	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700025
J	Heer, K; Kalko, EKV; Albrecht, L; Garcia-Villacorta, R; Staeps, FC; Herre, EA; Dick, CW				Heer, Katrin; Kalko, Elisabeth K. V.; Albrecht, Larissa; Garcia-Villacorta, Roosevelt; Staeps, Felix C.; Allen Herre, Edward; Dick, Christopher W.			Spatial Scales of Genetic Structure in Free-Standing and Strangler Figs (Ficus, Moraceae) Inhabiting Neotropical Forests	PLOS ONE			English	Article							RAIN-FOREST; FRUIT CHARACTERISTICS; TREE; SOFTWARE; BAT; PHYLOGEOGRAPHY; POPULATIONS; DISPERSAL; INSIPIDA; ECOLOGY	Wind-borne pollinating wasps (Agaonidae) can transport fig (Ficus sp., Moraceae) pollen over enormous distances (> 100 km). Because of their extensive breeding areas, Neotropical figs are expected to exhibit weak patterns of genetic structure at local and regional scales. We evaluated genetic structure at the regional to continental scale (Panama, Costa Rica, and Peru) for the free-standing fig species Ficus insipida. Genetic differentiation was detected only at distances > 300 km (Jost's D-est = 0.68 +/- 0.07 & F-ST = 0.30 +/- 0.03 between Mesoamerican and Amazonian sites) and evidence for phylogeographic structure (R-ST>>permuted R-ST) was only significant in comparisons between Central and South America. Further, we assessed local scale spatial genetic structure (SGS, d <= 8 km) in Panama and developed an agent-based model parameterized with data from F. insipida to estimate minimum pollination distances, which determine the contribution of pollen dispersal on SGS. The local scale data for F. insipida was compared to SGS data collected for an additional free-standing fig, F. yoponensis (subgenus Pharmacosycea), and two species of strangler figs, F. citrifolia and F. obtusifolia (subgenus Urostigma) sampled in Panama. All four species displayed significant SGS (mean Sp = 0.014 +/- 0.012). Model simulations indicated that most pollination events likely occur at distances > > 1 km, largely ruling out spatially limited pollen dispersal as the determinant of SGS in F. insipida and, by extension, the other fig species. Our results are consistent with the view that Ficus develops fine-scale SGS primarily as a result of localized seed dispersal and/or clumped seedling establishment despite extensive long-distance pollen dispersal. We discuss several ecological and life history factors that could have species-or subgenus-specific impacts on the genetic structure of Neotropical figs.	[Heer, Katrin] Univ Marburg, Fac Biol, Conservat Biol, D-35043 Marburg, Germany; [Heer, Katrin] Univ Marburg, Fac Biol, Dept Ecol, D-35043 Marburg, Germany; [Heer, Katrin; Kalko, Elisabeth K. V.; Albrecht, Larissa] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Kalko, Elisabeth K. V.; Allen Herre, Edward] Smithsonian Trop Res Inst, Balboa, Panama; [Garcia-Villacorta, Roosevelt] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Dick, Christopher W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Philipps University Marburg; Philipps University Marburg; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh; University of Michigan System; University of Michigan	Heer, K (corresponding author), Univ Marburg, Fac Biol, Conservat Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany.	katrin.heer@uni-marburg.de	Heer, Katrin/C-6725-2018	Heer, Katrin/0000-0002-1036-599X	German National Merit Foundation (Studienstiftung des Deutschen Volkes); NSF [DEB 0640379]	German National Merit Foundation (Studienstiftung des Deutschen Volkes); NSF(National Science Foundation (NSF))	The project was funded by a scholarship from the German National Merit Foundation (Studienstiftung des Deutschen Volkes) to KH and NSF funding (DEB 0640379) to CWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; [Anonymous], 2014, R LANG ENV STAT COMP; Banack SA, 2002, BIOTROPICA, V34, P232, DOI 10.1111/j.1744-7429.2002.tb00534.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BERG CC, 1989, EXPERIENTIA, V45, P605, DOI 10.1007/BF01975677; Born C, 2008, P ROY SOC B-BIOL SCI, V275, P2171, DOI 10.1098/rspb.2008.0446; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Cavers S, 2005, HEREDITY, V95, P281, DOI 10.1038/sj.hdy.6800709; Cavers S, 2013, J BIOGEOGR, V40, P615, DOI 10.1111/jbi.12097; Chen Y, 2011, BIOCHEM SYST ECOL, V39, P441, DOI 10.1016/j.bse.2011.06.006; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; Crozier YC, 2007, MOL ECOL NOTES, V7, P57, DOI 10.1111/j.1471-8286.2006.01523.x; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dev SA, 2011, BIOTROPICA, V43, P309, DOI 10.1111/j.1744-7429.2010.00704.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2008, EVOLUTION, V62, P2760, DOI 10.1111/j.1558-5646.2008.00506.x; Dick CW, 2013, ECOL EVOL, V3, P162, DOI 10.1002/ece3.441; Doyle J. J., 1987, PHYTOCHEM B, P11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Graffelman J, 2009, GUIDE SCATTERPLOT BI; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heer K, 2012, AM J BOT, V99, pE330, DOI 10.3732/ajb.1200032; Heer K, 2010, OECOLOGIA, V163, P425, DOI 10.1007/s00442-010-1600-x; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Coronado ENH, 2014, J BIOGEOGR, V41, P1697, DOI 10.1111/jbi.12326; Jackson AP, 2008, SYMBIOSIS, V45, P57; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jump AS, 2012, HEREDITY, V108, P633, DOI 10.1038/hdy.2012.1; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; LASKA M, 1990, Z SAUGETIERKD, V55, P49; Lemon J., 2006, R R NEWS; Lewin-Koh N.J., 2011, MAPTOOLS TOOLS READI; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MILTON K, 1991, J ECOL, V79, P1, DOI 10.2307/2260781; MILTON K, 1982, ECOLOGY, V63, P752, DOI 10.2307/1936796; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; MORRISON DW, 1978, J MAMMAL, V59, P622, DOI 10.2307/1380242; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Nazareno AG, 2013, ECOL EVOL, V3, P3495, DOI 10.1002/ece3.739; Pardini EA, 2008, MOL ECOL, V17, P2865, DOI 10.1111/j.1365-294X.2008.03807.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pebesma E.J., 2005, R NEWS, V5; Pritchard JK, 2000, GENETICS, V155, P945; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rymer PD, 2013, J BIOGEOGR, V40, P693, DOI 10.1111/j.1365-2699.2012.02727.x; Saeki I, 2011, J BIOGEOGR, V38, P992, DOI 10.1111/j.1365-2699.2010.02462.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Scotti-Saintagne C, 2013, J BIOGEOGR, V40, P707, DOI 10.1111/j.1365-2699.2012.02797.x; Serio-Silva JC, 2002, ORYX, V36, P266, DOI 10.1017/S0030605302000480; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; Thornton IWB, 1996, J BIOGEOGR, V23, P577, DOI 10.1111/j.1365-2699.1996.tb00019.x; VALDEYRON G, 1985, GENETIC DIFFERENTIAT, P383; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanderhoff Elizabeth Natasha, 2009, Biota Neotrop., V9, P419, DOI 10.1590/S1676-06032009000300039; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vignes H, 2006, MOL ECOL NOTES, V6, P792, DOI 10.1111/j.1471-8286.2006.01347.x; Wang R, 2009, POPUL ECOL, V51, P307, DOI 10.1007/s10144-008-0126-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; WINDSOR DM, 1989, EXPERIENTIA, V45, P647, DOI 10.1007/BF01975681; Wright S, 1943, GENETICS, V28, P114; Yu H, 2010, MOL ECOL, V19, P4441, DOI 10.1111/j.1365-294X.2010.04777.x	78	10	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133581	10.1371/journal.pone.0133581	http://dx.doi.org/10.1371/journal.pone.0133581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226482	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700026
J	Jo, DH; Park, SW; Cho, CS; Powner, MB; Kim, JH; Fruttiger, M; Kim, JH				Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Powner, Michael B.; Kim, Jin Hyoung; Fruttiger, Marcus; Kim, Jeong Hun			Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB AVASTIN; ADIPOSE-TISSUE; RETINOPATHY; ANGIOGENESIS; SAFETY; NEOVASCULARIZATION; PHARMACOKINETICS; ENERGY	Anti-vascular endothelial growth factor (VEGF) agents are the mainstay treatment for various angiogenesis-related retinal diseases. Currently, bevacizumab, a recombinant humanized anti-VEGF antibody, is trailed in retinopathy of prematurity, a vasoproliferative retinal disorder in premature infants. However, the risks of systemic complications after intravitreal injection of anti-VEGF antibody in infants are not well understood. In this study, we show that intravitreally injected anti-VEGF antibody is transported into the systemic circulation into the periphery where it reduces brown fat in neonatal C57BL/6 mice. A considerable amount of anti-VEGF antibody was detected in serum after intravitreal injection. Furthermore, in interscapular brown adipose tissue, we found lipid droplet accumulation, decreased VEGF levels, loss of vascular network, and decreased expression of mitochondria-related genes, Ppargc1a and Ucp1, all of which are characteristics of "whitening" of brown fat. With increasing age and body weight, brown fat restored its morphology and vascularity. Our results show that there is a transient, but significant impact of intravitreally administered anti-VEGF antibody on brown adipose tissue in neonatal mice. We suggest that more attention should be focused on the metabolic and developmental significance of brown adipose tissue in bevacizumab treated retinopathy of prematurity infants.	[Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea; [Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Powner, Michael B.; Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of London; University College London; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	steph25@snu.ac.kr	Jo, Dong Hyun/D-5962-2012; Park, Sung Wook/D-5541-2012; Powner, Michael/CAG-7455-2022	Jo, Dong Hyun/0000-0002-6320-6829; Park, Sung Wook/0000-0001-8151-6663; Kim, Jeong Hun/0000-0003-2957-1766; Fruttiger, Marcus/0000-0002-6962-5485; Powner, Michael/0000-0003-4913-1004	Bio-Signal Analysis Technology Innovation Program of NRF [20090090895]; pioneer Research Program of NRF [2012-0009544]; MD-PhD program of KRIBB [700-2015-2018]; Seoul National University Research Grant [800-20140542]; Seoul National University Hospital Research Grant [03-2014-0260]	Bio-Signal Analysis Technology Innovation Program of NRF; pioneer Research Program of NRF; MD-PhD program of KRIBB; Seoul National University Research Grant; Seoul National University Hospital Research Grant	This study was supported by the Bio-Signal Analysis Technology Innovation Program (20090090895) of NRF, the pioneer Research Program (2012-0009544) of NRF, the MD-PhD program of KRIBB (700-2015-2018), the Seoul National University Research Grant (800-20140542) and the Seoul National University Hospital Research Grant (03-2014-0260).	Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Avery RL, 2012, J AAPOS, V16, P2, DOI 10.1016/j.jaapos.2011.11.002; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Hard AL, 2011, ACTA PAEDIATR, V100, P1523, DOI 10.1111/j.1651-2227.2011.02445.x; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Jo DH, 2014, ARCH PHARM RES, V37, P285, DOI 10.1007/s12272-013-0324-y; Kim H, 2009, MOL VIS, V15; Kim JH, 2008, J CELL MOL MED, V12, P2407, DOI 10.1111/j.1582-4934.2008.00243.x; Kim LA, 2012, AM J PATHOL, V181, P376, DOI 10.1016/j.ajpath.2012.06.006; Lee BJ, 2012, EYE, V26, P903, DOI 10.1038/eye.2012.111; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mintz-Hittner HA, 2010, J AAPOS, V14, P2, DOI 10.1016/j.jaapos.2009.12.002; Miyake T, 2010, INVEST OPHTH VIS SCI, V51, P1606, DOI 10.1167/iovs.09-4140; Powner MB, 2014, INVEST OPHTH VIS SCI, V55, P1607, DOI 10.1167/iovs.13-12574; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009	33	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134308	10.1371/journal.pone.0134308	http://dx.doi.org/10.1371/journal.pone.0134308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226015	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358837700072
J	Lovato, TL; Sensibaugh, CA; Swingle, KL; Martinez, MM; Cripps, RM				Lovato, TyAnna L.; Sensibaugh, Cheryl A.; Swingle, Kirstie L.; Martinez, Melody M.; Cripps, Richard M.			The Drosophila Transcription Factors Tinman and Pannier Activate and Collaborate with Myocyte Enhancer Factor-2 to Promote Heart Cell Fate	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; HUMAN FIBROBLASTS; NKX2.5 MUTATIONS; CARDIAL CELLS; RAT HEARTS; LAME DUCK; CARDIOMYOCYTES; DISEASE; TARGET	Expression of the MADS domain transcription factor Myocyte Enhancer Factor 2 (MEF2) is regulated by numerous and overlapping enhancers which tightly control its transcription in the mesoderm. To understand how Mef2 expression is controlled in the heart, we identified a late stage Mef2 cardiac enhancer that is active in all heart cells beginning at stage 14 of embryonic development. This enhancer is regulated by the NK-homeodomain transcription factor Tinman, and the GATA transcription factor Pannier through both direct and indirect interactions with the enhancer. Since Tinman, Pannier and MEF2 are evolutionarily conserved from Drosophila to vertebrates, and since their vertebrate homologs can convert mouse fibroblast cells to cardiomyocytes in different activator cocktails, we tested whether over-expression of these three factors in vivo could ectopically activate known cardiac marker genes. We found that mesodermal over-expression of Tinman and Pannier resulted in approximately 20% of embryos with ectopic Hand and Sulphonylurea receptor (Sur) expression. By adding MEF2 alongside Tinman and Pannier, a dramatic expansion in the expression of Hand and Sur was observed in almost all embryos analyzed. Two additional cardiac markers were also expanded in their expression. Our results demonstrate the ability to initiate ectopic cardiac fate in vivo by the combination of only three members of the conserved Drosophila cardiac transcription network, and provide an opportunity for this genetic model system to be used to dissect the mechanisms of cardiac specification.	[Lovato, TyAnna L.; Sensibaugh, Cheryl A.; Swingle, Kirstie L.; Martinez, Melody M.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu	Avila, Melody/W-7725-2019	Avila, Melody/0000-0001-8416-603X	National Institutes of Health [R01 GM061738, R25 GM060201, P20 GM103452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P30GM110907, R01GM061738, R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM061738 awarded by the National Institutes of Health, RMC R25 GM060201 awarded by the National Institutes of Health, KLS, MMM P20 GM103452 awarded by the National Institutes of Health, provided resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brown S, 2003, DEVELOPMENT, V130, P3077, DOI 10.1242/dev.00535; Busser BW, 2012, P NATL ACAD SCI USA, V109, P20768, DOI 10.1073/pnas.1210415109; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Christianson A., 2006, GLOBAL REPORT BIRTH; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; Duan H, 2001, DEVELOPMENT, V128, P4489; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Gajewski K, 1997, EMBO J, V16, P515, DOI 10.1093/emboj/16.3.515; Gajewski K, 1998, DEV GENES EVOL, V208, P382, DOI 10.1007/s004270050194; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Gutierrez-Roelens Ilse, 2002, Hum Mutat, V20, P75, DOI 10.1002/humu.9041; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hendren JD, 2007, MECH DEVELOP, V124, P416, DOI 10.1016/j.mod.2007.03.002; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ifkovits JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089678; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leal SM, 2009, DEV BIOL, V325, P138, DOI 10.1016/j.ydbio.2008.10.006; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lockwood WK, 2002, MECH DEVELOP, V114, P13, DOI 10.1016/S0925-4773(02)00044-8; Maass M, 2010, EUROPEAN HEART J, V34; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Ponzielli R, 2002, DEVELOPMENT, V129, P4509; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryan KM, 2007, DEV BIOL, V302, P694, DOI 10.1016/j.ydbio.2006.10.025; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shiojima I, 1999, J BIOL CHEM, V274, P8231, DOI 10.1074/jbc.274.12.8231; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Thummel CS, 1992, DROS INF SERV, V71, P150; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977; Zhang SX, 2001, MECH DEVELOP, V101, P35, DOI 10.1016/S0925-4773(00)00549-9	60	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132965	10.1371/journal.pone.0132965	http://dx.doi.org/10.1371/journal.pone.0132965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225919	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700012
J	Carrick, DM; Mehaffey, MG; Sachs, MC; Altekruse, S; Camalier, C; Chuaqui, R; Cozen, W; Das, B; Hernandez, BY; Lih, CJ; Lynch, CF; Makhlouf, H; McGregor, P; McShane, LM; Rohan, JP; Walsh, WD; Williams, PM; Gillanders, EM; Mechanic, LE; Schully, SD				Carrick, Danielle Mercatante; Mehaffey, Michele G.; Sachs, Michael C.; Altekruse, Sean; Camalier, Corinne; Chuaqui, Rodrigo; Cozen, Wendy; Das, Biswajit; Hernandez, Brenda Y.; Lih, Chih-Jian; Lynch, Charles F.; Makhlouf, Hala; McGregor, Paul; McShane, Lisa M.; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.; Gillanders, Elizabeth M.; Mechanic, Leah E.; Schully, Sheri D.			Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue	PLOS ONE			English	Article							FFPE TUMOR-TISSUES; SOMATIC MUTATIONS; CANCER; IDENTIFICATION; CONFIDENCE; CARCINOMA; SAMPLES; FROZEN	Next Generation Sequencing (NGS) technologies are used to detect somatic mutations in tumors and study germ line variation. Most NGS studies use DNA isolated from whole blood or fresh frozen tissue. However, formalin-fixed paraffin-embedded (FFPE) tissues are one of the most widely available clinical specimens. Their potential utility as a source of DNA for NGS would greatly enhance population-based cancer studies. While preliminary studies suggest FFPE tissue may be used for NGS, the feasibility of using archived FFPE specimens in population based studies and the effect of storage time on these specimens needs to be determined. We conducted a study to determine whether DNA in archived FFPE high-grade ovarian serous adenocarcinomas from Surveillance, Epidemiology and End Results (SEER) registries Residual Tissue Repositories (RTR) was present in sufficient quantity and quality for NGS assays. Fifty-nine FFPE tissues, stored from 3 to 32 years, were obtained from three SEER RTR sites. DNA was extracted, quantified, quality assessed, and subjected to whole exome sequencing (WES). Following DNA extraction, 58 of 59 specimens (98%) yielded DNA and moved on to the library generation step followed by WES. Specimens stored for longer periods of time had significantly lower coverage of the target region (6% lower per 10 years, 95% CI: 3-10%) and lower average read depth (40x lower per 10 years, 95% CI: 18-60), although sufficient quality and quantity of WES data was obtained for data mining. Overall, 90% (53/59) of specimens provided usable NGS data regardless of storage time. This feasibility study demonstrates FFPE specimens acquired from SEER registries after varying lengths of storage time and under varying storage conditions are a promising source of DNA for NGS.	[Carrick, Danielle Mercatante; Altekruse, Sean; Gillanders, Elizabeth M.; Mechanic, Leah E.; Schully, Sheri D.] NCI, DCCPS, Rockville, MD 20850 USA; [Mehaffey, Michele G.; Camalier, Corinne; Das, Biswajit; Lih, Chih-Jian; McGregor, Paul; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.] Leidos Biomed Res Inc, Mol Characterizat & Clin Assay Dev Lab, Frederick, MD 21702 USA; [Mehaffey, Michele G.; Camalier, Corinne; Das, Biswajit; Lih, Chih-Jian; McGregor, Paul; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.] Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Sachs, Michael C.; Chuaqui, Rodrigo; Makhlouf, Hala; McShane, Lisa M.] NCI, DCTD, Rockville, MD 20850 USA; [Cozen, Wendy] Univ So Calif, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Hernandez, Brenda Y.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Iowa	Carrick, DM (corresponding author), NCI, DCCPS, 9609 Med Ctr Dr, Rockville, MD 20850 USA.	Danielle.Carrick@nih.gov	McShane, Lisa/GXM-8870-2022	Sachs, Michael/0000-0002-1279-8676	National Cancer Institute [N01-PC-35143, P30CA014089]; Hawaii Tumor Registry [N01-PC-35137]; University of Hawaii Cancer Center Pathology Shared Resource; California Department of Health Services; National Cancer Institute, National Institutes of Health; Department of Health and Human Services [N01-PC-2010-00035]; Centers for Disease Control and Prevention [1U58DP000807-3]; Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE [P30CA086862, P30CA014089, P30CA071789] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hawaii Tumor Registry; University of Hawaii Cancer Center Pathology Shared Resource; California Department of Health Services; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported in part in Iowa by contract N01-PC-35143 from the National Cancer Institute, and by the Hawaii Tumor Registry (N01-PC-35137) and the University of Hawaii Cancer Center Pathology Shared Resource. Collection of data used in this publication was supported in part by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services under Contract No. N01-PC-2010-00035; and grant number 1U58DP000807-3 from the Centers for Disease Control and Prevention, and by award number P30CA014089 from the National Cancer Institute. This study was funded by the National Institutes of Health, National Cancer Institute. NCI and a NCI contract laboratory (Leidos) staff members were involved in the design of this study, lab analyses, statistical analyses, pathology reviews, data interpretation, and writing/reviewing the manuscript. The corresponding author, DMC, had full access to all the data in the study and had final responsibility for the decision to submit for publication. Leidos Biomedical Research Inc. provided support in the form of salaries for authors MM, CC, BD, CJL, PM, JPR, WWand PMW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MD, 2012, MODERN PATHOL, V25, P1599, DOI 10.1038/modpathol.2012.121; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Corless CL, 2012, CANCER DISCOV, V2, P23, DOI 10.1158/2159-8290.CD-11-0319; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Feldman AL, 2011, BLOOD, V117, P915, DOI 10.1182/blood-2010-08-303305; Goodman MT, 2005, HUM PATHOL, V36, P812, DOI 10.1016/j.humpath.2005.03.010; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; KapaBiosystems, 2014, KAPA HUM GEN DNA QUA; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Yost SE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks299	26	71	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0127353	10.1371/journal.pone.0127353	http://dx.doi.org/10.1371/journal.pone.0127353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222067	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800003
J	Chen, CW; Yao, Y; Zhang, L; Xu, MJ; Jiang, JP; Dou, TH; Lin, W; Zhao, GP; Huang, MR; Zhou, Y				Chen, Chengwen; Yao, Ye; Zhang, Liang; Xu, Minjie; Jiang, Jianping; Dou, Tonghai; Lin, Wei; Zhao, Guoping; Huang, Minren; Zhou, Yan			A Comprehensive Analysis of the Transcriptomes of Marssonina brunnea and Infected Poplar Leaves to Capture Vital Events in Host-Pathogen Interactions	PLOS ONE			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; INFERENCE; RECEPTOR; DISEASE; GENOME; MODEL	Background Understanding host-pathogen interaction mechanisms helps to elucidate the entire infection process and focus on important events, and it is a promising approach for improvement of disease control and selection of treatment strategy. Time-course host-pathogen transcriptome analyses and network inference have been applied to unravel the direct or indirect relationships of gene expression alterations. However, time series analyses can suffer from absent time points due to technical problems such as RNA degradation, which limits the application of algorithms that require strict sequential sampling. Here, we introduce an efficient method using independence test to infer an independent network that is exclusively concerned with the frequency of gene expression changes. Results Highly resistant NL895 poplar leaves and weakly resistant NL214 leaves were infected with highly active and weakly active Marssonina brunnea, respectively, and were harvested at different time points. The independent network inference illustrated the top 1,000 vital fungus- poplar relationships, which contained 768 fungal genes and 54 poplar genes. These genes could be classified into three categories: a fungal gene surrounded by many poplar genes; a poplar gene connected to many fungal genes; and other genes (possessing low degrees of connectivity). Notably, the fungal gene M6_ 08342 (a metalloprotease) was connected to 10 poplar genes, particularly including two disease-resistance genes. These core genes, which are surrounded by other genes, may be of particular importance in complicated infection processes and worthy of further investigation. Conclusions We provide a clear framework of the interaction network and identify a number of candidate key effectors in this process, which might assist in functional tests, resistant clone selection, and disease control in the future.	[Chen, Chengwen; Yao, Ye; Xu, Minjie; Jiang, Jianping; Dou, Tonghai; Lin, Wei; Zhou, Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Chen, Chengwen; Zhang, Liang; Xu, Minjie; Jiang, Jianping; Zhao, Guoping; Zhou, Yan] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Chen, Chengwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Yao, Ye; Lin, Wei] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Yao, Ye; Lin, Wei] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Huang, Minren] Nanjing Forestry Univ, Jiangsu Key Lab Poplar Germplasm Enhancement & Va, Nanjing, Jiangsu, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; Nanjing Forestry University	Zhou, Y (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	zhouy@chgc.sh.cn	CHEN, CHEN/HDM-6657-2022; chen, chen wen/GZM-3705-2022; Lin, Wei/C-9640-2011	Lin, Wei/0000-0002-1863-4306; Zhao, Guo-Ping/0000-0002-7621-6620	National High-tech R&D Program (863 Program) [2012AA020409]; National Basic Research Program (973 Program) [2011CB111610]; National S&T Basic Work Program [2009FY120100]; National Natural Science Foundation of China [11322111, 61273014]; Shanghai Postdoctoral Sustentation Fund [13R21420700]; Science and Technology Commission of Shanghai Municipality [11JC1400900, 12ZR1421300]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program (973 Program)(National Basic Research Program of China); National S&T Basic Work Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Postdoctoral Sustentation Fund; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by National High-tech R&D Program (863 Program, Grant No. 2012AA020409), National Basic Research Program (973 Program, Grant No. 2011CB111610), National S&T Basic Work Program (Grant No. 2009FY120100), National Natural Science Foundation of China (Grant No. 11322111 and 61273014), Shanghai Postdoctoral Sustentation Fund (Grant No. 13R21420700), and Science and Technology Commission of Shanghai Municipality Grant No. 11JC1400900 and 12ZR1421300).	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Beare JA, 1999, ENVIRON POLLUT, V105, P409, DOI 10.1016/S0269-7491(99)00034-2; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gallie D.R., 2013, SCIENTIFICA, DOI DOI 10.1155/2013/795964; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gupta SK, 2012, INDIAN J PHARMACOL, V44, P143, DOI 10.4103/0253-7613.91895; Han ZM, 2000, THEOR APPL GENET, V100, P614, DOI 10.1007/s001220050081; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kemppainen M, 2009, ENVIRON MICROBIOL, V11, P1878, DOI 10.1111/j.1462-2920.2009.01912.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Mobini R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-19; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Son YS, 2008, PATTERN RECOGN LETT, V29, P232, DOI 10.1016/j.patrec.2007.09.015; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Usadel B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00048; Wang Z, 2014, EUKARYOT CELL, V13, P154, DOI 10.1128/EC.00248-13; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Ying SH, 2011, BIOL CONTROL, V59, P255, DOI 10.1016/j.biocontrol.2011.07.005; Yonekura-Sakakibara K, 2012, CURRENT OPINION BIOT; Zhou S, 2007, J HUM HYPERTENS, V21, P861, DOI 10.1038/sj.jhh.1002244; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	36	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134246	10.1371/journal.pone.0134246	http://dx.doi.org/10.1371/journal.pone.0134246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222429	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800116
J	Jroundi, F; Gonzalez-Munoz, MT; Sterflinger, K; Pinar, G				Jroundi, Fadwa; Teresa Gonzalez-Munoz, Maria; Sterflinger, Katja; Pinar, Guadalupe			Molecular Tools for Monitoring the Ecological Sustainability of a Stone Bio-Consolidation Treatment at the Royal Chapel, Granada	PLOS ONE			English	Article							ENDOLITHIC BACTERIAL COMMUNITIES; GREEN NONSULFUR BACTERIA; CALCITE PRECIPITATION; MICROBIAL COMMUNITIES; MICROCOLONIAL FUNGI; CULTURAL-HERITAGE; LIMESTONE; MONUMENTS; FRESCOES; BIOMINERALIZATION	Background Biomineralization processes have recently been applied in situ to protect and consolidate decayed ornamental stone of the Royal Chapel in Granada (Spain). While this promising method has demonstrated its efficacy regarding strengthening of the stone, little is known about its ecological sustainability. Methodology/Principal Findings Here, we report molecular monitoring of the stone-autochthonous microbiota before and at 5, 12 and 30 months after the bio-consolidation treatment (medium/long-term monitoring), employing the well-known molecular strategy of DGGE analyses. Before the bio-consolidation treatment, the bacterial diversity showed the exclusive dominance of Actinobacteria (100%), which decreased in the community (44.2%) after 5 months, and Gamma-proteobacteria (30.24%) and Chloroflexi (25.56%) appeared. After 12 months, Gamma-proteobacteriavanished from the community and Cyanobacteria (22.1%) appeared and remained dominant after thirty months, when the microbiota consisted of Actinobacteria (42.2%) and Cyanobacteria (57.8%) only. Fungal diversity showed that the Ascomycota phylum was dominant before treatment (100%), while, after five months, Basidiomycota (6.38%) appeared on the stone, and vanished again after twelve months. Thirty months after the treatment, the fungal population started to stabilize and Ascomycota dominated on the stone (83.33%) once again. Members of green algae (Chlorophyta, Viridiplantae) appeared on the stone at 5, 12 and 30 months after the treatment and accounted for 4.25%, 84.77% and 16.77%, respectively. Conclusions The results clearly show that, although a temporary shift in the bacterial and fungal diversity was observed during the first five months, most probably promoted by the application of the bio-consolidation treatment, the microbiota tends to regain its initial stability in a few months. Thus, the treatment does not seem to have any negative side effects on the stone-autochthonous microbiota over that time. The molecular strategy employed here is suggested as an efficient monitoring tool to assess the impact on the stone-autochthonous microbiota of the application of biomineralization processes as a restoration/conservation procedure.	[Jroundi, Fadwa; Teresa Gonzalez-Munoz, Maria] Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain; [Sterflinger, Katja; Pinar, Guadalupe] Univ Nat Resources & Life Sci, VIBT BOKU, Dept Biotechnol, Vienna, Austria	University of Granada; University of Natural Resources & Life Sciences, Vienna	Jroundi, F (corresponding author), Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain.	fadwa@ugr.es	Pinar, Guadalupe/I-8959-2016; Jroundi, Fadwa/AAN-8363-2021; Jroundi, Fadwa/K-5724-2014	Pinar, Guadalupe/0000-0001-7881-8572; Jroundi, Fadwa/0000-0002-6532-1441; Sterflinger, Katja/0000-0002-0296-6728	European Regional Development Fund (ERDF); Junta de Andalucia (Spain); "Fortalecimiento de la I+D+i" program from the University of Granada; Junta de Andalucia [BIO-103]; Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i); Austrian Science Fund (FWF) [V194-B20];  [RNM-3493]	European Regional Development Fund (ERDF)(European Commission); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); "Fortalecimiento de la I+D+i" program from the University of Granada; Junta de Andalucia(Junta de Andalucia); Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); 	This work was supported by the European Regional Development Fund (ERDF), Junta de Andalucia (Spain) and the "Fortalecimiento de la I+D+i" program from the University of Granada, co-financed by grant RNM-3493 and Research Group BIO-103 from Junta de Andalucia, as well as by the Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i 2008-2011), and by the Austrian Science Fund (FWF) under Grant "Elise-Richter V194-B20". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bang SS, 2001, ENZYME MICROB TECH, V28, P404, DOI 10.1016/S0141-0229(00)00348-3; Batista JF, 2000, BIODEGRADATION, V11, P441, DOI 10.1023/A:1011620023116; Beer M, 2002, FEMS MICROBIOL LETT, V207, P179, DOI 10.1016/S0378-1097(01)00561-4; BIANCHI A, 1980, INT BIODETERIOR, V16, P45; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; Bjornsson L, 2002, MICROBIOL-SGM, V148, P2309, DOI 10.1099/00221287-148-8-2309; Bogomolova EV, 2003, MYCOTAXON, V86, P195; Boomer SM, 2002, APPL ENVIRON MICROB, V68, P346, DOI 10.1128/AEM.68.1.346-355.2002; BOQUET E, 1973, NATURE, V246, P527, DOI 10.1038/246527a0; Bruand A, 1999, SOIL SCI SOC AM J, V63, P164, DOI 10.2136/sssaj1999.03615995006300010023x; Brusetti L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-220; Burford EP, 2006, GEOMICROBIOL J, V23, P599, DOI 10.1080/01490450600964375; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Cappitelli F, 2009, MICROB ECOL, V57, P633, DOI 10.1007/s00248-008-9441-4; Chouaia B, 2012, J BACTERIOL, V194, P2752, DOI 10.1128/JB.00320-12; COLLIER PJ, 1990, J APPL BACTERIOL, V69, P578, DOI 10.1111/j.1365-2672.1990.tb01551.x; Coutinho ML, 2013, INT BIODETER BIODEGR, V84, P322, DOI 10.1016/j.ibiod.2012.05.028; de los Rios A, 2012, INT BIODETER BIODEGR, V67, P64, DOI 10.1016/j.ibiod.2011.10.010; Dick J, 2006, BIODEGRADATION, V17, P357, DOI 10.1007/s10532-005-9006-x; Herrero AD, 2006, AEROBIOLOGIA, V22, P135, DOI 10.1007/s10453-006-9025-z; Docampo S, 2011, SCI TOTAL ENVIRON, V409, P835, DOI 10.1016/j.scitotenv.2010.10.048; Eppard M, 1996, ARCH MICROBIOL, V166, P12, DOI 10.1007/s002030050350; Ettenauer J, 2011, SCI TOTAL ENVIRON, V409, P5337, DOI 10.1016/j.scitotenv.2011.08.063; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Gaylarde CC, 2012, CURR MICROBIOL, V64, P85, DOI 10.1007/s00284-011-0034-y; Gladis F, 2010, BIOFOULING, V26, P89, DOI 10.1080/08927010903278184; Gleeson DB, 2006, MICROB ECOL, V51, P526, DOI 10.1007/s00248-006-9052-x; Gonz?lez-Mu?oz M.T., 2008, COALITION, V15, P12; Gonzalez JM, 2005, INT MICROBIOL, V8, P189; Gonzalez-Mu&ntilde;oz MT, 2008, Spanish patent, Patent No. [WO2008/009771 A1, 2008009771AI]; Gorbushina AA, 2000, INT BIODETER BIODEGR, V46, P277, DOI 10.1016/S0964-8305(00)00103-7; Gtari M, 2012, FEMS MICROBIOL ECOL, V80, P566, DOI 10.1111/j.1574-6941.2012.01320.x; Heuer H, 1999, APPL ENVIRON MICROB, V65, P1045; Horath T, 2009, MICROB ECOL, V58, P290, DOI 10.1007/s00248-008-9483-7; Jimenez-Lopez C, 2007, CHEMOSPHERE, V68, P1929, DOI 10.1016/j.chemosphere.2007.02.044; Jimenez-Lopez C, 2008, INT BIODETER BIODEGR, V62, P352, DOI 10.1016/j.ibiod.2008.03.002; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Jroundi F, 2013, PROCEEDINGS OF THE 8, VIII, P159; Jroundi F, 2014, ACTA BIOMATER, V10, P3844, DOI 10.1016/j.actbio.2014.03.007; Jroundi F, 2012, SCI TOTAL ENVIRON, V425, P89, DOI 10.1016/j.scitotenv.2012.02.059; Jroundi F, 2010, MICROB ECOL, V60, P39, DOI 10.1007/s00248-010-9665-y; Kusumi A, 2013, MICROBES ENVIRON, V28, P422, DOI 10.1264/jsme2.ME13033; Lacey J, 1981, BIOL CONIDIAL FUNGI, V1, P373; Laiz L, 2003, ENVIRON MICROBIOL, V5, P72, DOI 10.1046/j.1462-2920.2003.00381.x; Le Metayer-Levrel G, 1999, SEDIMENT GEOL, V126, P25, DOI 10.1016/S0037-0738(99)00029-9; McNamara CJ, 2006, MICROB ECOL, V51, P51, DOI 10.1007/s00248-005-0200-5; Michaelsen A, 2006, INT BIODETER BIODEGR, V58, P133, DOI 10.1016/j.ibiod.2006.06.019; Monger HC, 1996, SOIL SCI SOC AM J, V60, P519, DOI 10.2136/sssaj1996.03615995006000020026x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Pinar G, 2015, MICROB ECOL, V69, P118, DOI 10.1007/s00248-014-0481-7; Pinar G, 2010, MICROB ECOL, V60, P15, DOI 10.1007/s00248-010-9661-2; Portillo MC, 2009, SCI TOTAL ENVIRON, V407, P4876, DOI 10.1016/j.scitotenv.2009.05.038; Ramachandran SK, 2001, ACI MATER J, V98, P3; Rodriguez-Navarro C, 2003, APPL ENVIRON MICROB, V69, P2182, DOI 10.1128/AEM.69.4.2182-2193.2003; Rodriguez-Navarro C., 2015, RESTOR BUILD MONUMEN, V21, P9, DOI [10.1515/rbm-2015-0002, DOI 10.1515/RBM-2015-0002, DOI 10.1515/rbm-2015-0002]; Rodriguez-Navarro C, 2012, APPL ENVIRON MICROB, V78, P4017, DOI 10.1128/AEM.07044-11; Sambrook J., 1989, MOLECULAR CLONING A; SAMPO S, 1989, INT BIODETERIOR, V25, P343, DOI 10.1016/0265-3036(89)90014-6; Sanmartin P, 2011, BIODEGRADATION, V22, P763, DOI 10.1007/s10532-010-9402-8; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Sert HB, 2007, ANTON LEEUW INT J G, V91, P217, DOI 10.1007/s10482-006-9111-9; SORLINI C, 1987, INT BIODETERIOR, V23, P167, DOI 10.1016/0265-3036(87)90052-2; STALEY JT, 1982, SCIENCE, V215, P1093, DOI 10.1126/science.215.4536.1093; Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809; Sterflinger K, 1997, GEOMICROBIOL J, V14, P219, DOI 10.1080/01490459709378045; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Suihko ML, 2007, SYST APPL MICROBIOL, V30, P494, DOI 10.1016/j.syapm.2007.05.001; Tang Y, 2012, GEOMICROBIOL J, V29, P213, DOI 10.1080/01490451.2011.558560; Tiano P, 1999, J MICROBIOL METH, V36, P139, DOI 10.1016/S0167-7012(99)00019-6; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; Urzi C, 2004, INT J SYST EVOL MICR, V54, P253, DOI 10.1099/ijs.0.02745-0; Urzi C, 1998, INT BIODETER BIODEGR, V42, P45, DOI 10.1016/S0964-8305(98)00045-6; Urzi C., 2001, AEROBIOLOGIA, V17, P11, DOI [DOI 10.1023/A:1007652300354, 10.1023/A:1007652300354]; VERRECCHIA EP, 1993, J SEDIMENT PETROL, V63, P1000; Walker JJ, 2007, APPL ENVIRON MICROB, V73, P3497, DOI 10.1128/AEM.02656-06; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wollenzien U, 1997, ANTON LEEUW INT J G, V71, P281, DOI 10.1023/A:1000157803954; Yan Fei, 2012, Weishengwu Xuebao, V52, P629; Young ME, 2008, ENVIRON GEOL, V56, P631, DOI 10.1007/s00254-008-1455-1; Zanardini E, 2000, INT BIODETER BIODEGR, V45, P35, DOI 10.1016/S0964-8305(00)00043-3	85	9	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132465	10.1371/journal.pone.0132465	http://dx.doi.org/10.1371/journal.pone.0132465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222040	Green Published, gold			2022-12-26	WOS:000358836800023
J	Pimentel, MS; Faleiro, F; Diniz, M; Machado, J; Pousao-Ferreira, P; Peck, MA; Portner, HO; Rosa, R				Pimentel, Marta S.; Faleiro, Filipa; Diniz, Mario; Machado, Jorge; Pousao-Ferreira, Pedro; Peck, Myron A.; Poertner, Hans O.; Rosa, Rui			Oxidative Stress and Digestive Enzyme Activity of Flatfish Larvae in a Changing Ocean	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; EARLY-LIFE STAGES; HSP70 EXPRESSION; SOLEA-SENEGALENSIS; THERMAL TOLERANCE; ACIDIFICATION; HISTORY; FISH; IMPACT; CO2	Until now, it is not known how the antioxidant and digestive enzymatic machinery of fish early life stages will change with the combined effects of future ocean acidification and warming. Here we show that high pCO(2) (similar to 1600 mu atm) significantly decreased metabolic rates (up to 27.4 %) of flatfish larvae, Solea senegalensis, at both present (18 degrees C) and warmer temperatures (+4 degrees C). Moreover, both warming and hypercapnia increased the heat shock response and the activity of antioxidant enzymes, namely catalase (CAT) and glutathione S-transferase (GST), mainly in post-metamorphic larvae (30 dph). The lack of changes in the activity of CAT and GST of pre-metamorphic larvae (10 dph) seems to indicate that earlier stages lack a fully-developed antioxidant defense system. Nevertheless, the heat shock and antioxidant responses of post-metamorphic larvae were not enough to avoid the peroxidative damage, which was greatly increased under future environmental conditions. Digestive enzymatic activity of S. senegalensis larvae was also affected by future predictions. Hypercapnic conditions led to a decrease in the activity of digestive enzymes, both pancreatic (up to 26.1 % for trypsin and 74.5 % for amylase) and intestinal enzymes (up to 36.1 % for alkaline phosphatase) in post-metamorphic larvae. Moreover, the impact of ocean acidification and warming on some of these physiological and biochemical variables (namely, lower OCR and higher HSP and MDA levels) were translated into larvae performance, being significantly correlated with decreased larval growth and survival or increased incidence of skeletal deformities. The increased vulnerability of flatfish early life stages under future ocean conditions is expected to potentially determine recruitment and population dynamics in marine ecosystems.	[Pimentel, Marta S.; Faleiro, Filipa; Rosa, Rui] Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, MARE Marine & Environm Sci Ctr, P-2750374 Cascais, Portugal; [Pimentel, Marta S.; Machado, Jorge] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; [Diniz, Mario] Univ Nova Lisboa, Fac Ciencias & Tecnol, REQUIMTE, Dept Quim,Ctr Quim Fina & Biotecnol, P-2829516 Caparica, Portugal; [Pousao-Ferreira, Pedro] Inst Portugues Mar & Atmosfera, P-8700305 Olhao, Portugal; [Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, D-22767 Hamburg, Germany; [Poertner, Hans O.] Alfred Wegener Inst Polar & Marine Res, Anim Ecophysiol, D-27515 Bremerhaven, Germany	Universidade de Lisboa; Universidade do Porto; Universidade Nova de Lisboa; Instituto Portugues do Mar e da Atmosfera; University of Hamburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Pimentel, MS (corresponding author), Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, MARE Marine & Environm Sci Ctr, Av Nossa Senhora do Cabo 939, P-2750374 Cascais, Portugal.	mcrsilva@fc.ul.pt	/AAL-3738-2021; Faleiro, Filipa/I-8097-2012; Pousão-Ferreira, Pedro/H-3689-2014; Ferreira, Pedro/HDO-1346-2022; Diniz, Mário/C-7849-2013; Rosa, Rui/A-4580-2009; Pimentel, Marta S./I-4844-2012; Peck, Myron A/H-6164-2011; Pimentel, Marta S/H-3229-2014; Pörtner, Hans-O./K-9429-2016; Quality, Aquaculture Seafood/AAD-7718-2019	Faleiro, Filipa/0000-0003-4315-1856; Pousão-Ferreira, Pedro/0000-0001-6746-764X; Diniz, Mário/0000-0003-1571-0366; Rosa, Rui/0000-0003-2801-5178; Peck, Myron A/0000-0001-7423-1854; Pimentel, Marta S/0000-0003-3248-4479; Pörtner, Hans-O./0000-0001-6535-6575; Machado, Jorge/0000-0003-4570-5445	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/81928/2011, SFRH/BPD/79038/2011, PTDC/MAR/0908066/2008, PTDC/AAG-GLO/3342/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology (FCT) supported this study through a doctoral grant to MSP (SFRH/BD/81928/2011), a post-doc grant to FF (SFRH/BPD/79038/2011) and project grants to RR (PTDC/MAR/0908066/2008 and PTDC/AAG-GLO/3342/2012).	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Abele D, 2002, J EXP BIOL, V205, P1831; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguilera J, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P58; AlvarezSalgado XA, 1997, CONT SHELF RES, V17, P1247, DOI 10.1016/S0278-4343(97)00014-9; [Anonymous], 2005, FUNCTIONAL METABOLIS; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bignami S, 2013, GLOBAL CHANGE BIOL, V19, P996, DOI 10.1111/gcb.12133; BISBAL GA, 1995, J FISH BIOL, V47, P277, DOI 10.1006/jfbi.1995.0133; Borges AV, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001385; BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; CAHU CL, 1994, COMP BIOCHEM PHYS A, V109, P213, DOI 10.1016/0300-9629(94)90123-6; COUSIN JCB, 1987, J FISH BIOL, V30, P15, DOI 10.1111/j.1095-8649.1987.tb05728.x; CRANE RK, 1979, BIOCHIM BIOPHYS ACTA, V554, P264, DOI 10.1016/0005-2736(79)90024-5; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Fernandez I, 2008, AQUACULTURE, V283, P102, DOI 10.1016/j.aquaculture.2008.06.037; Fernandez I, 2009, AQUACULTURE, V295, P250, DOI 10.1016/j.aquaculture.2009.06.046; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Guppy M, 2004, COMP BIOCHEM PHYS B, V139, P435, DOI 10.1016/j.cbpc.2004.02.019; HAUSAMEN TU, 1967, CLIN CHIM ACTA, V15, P241, DOI 10.1016/0009-8981(67)90060-5; Henning Susan J., 1994, P571; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HOLM H, 1988, J NUTR, V118, P515, DOI 10.1093/jn/118.4.515; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Lesser MP, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P9; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lopes AR, 2013, DEEP-SEA RES PT I, V82, P10, DOI 10.1016/j.dsr.2013.07.014; Luft JC, 1999, CELL STRESS CHAPERON, V4, P162, DOI 10.1379/1466-1268(1999)004<0162:HEAFDE>2.3.CO;2; Malanga G, 2004, AQUAT TOXICOL, V69, P299, DOI 10.1016/j.aquatox.2004.05.008; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; METAIS P, 1968, ANN BIOL CLIN-PARIS, V26, P133; Metzger R, 2007, J THERM BIOL, V32, P144, DOI 10.1016/j.jtherbio.2007.01.010; Mirkes PE, 1997, MUTAT RES, V396, P63; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Munday PL, 2012, J EXP BIOL, V215, P3865, DOI 10.1242/jeb.074765; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; P&ouml;rtner HO, 2014, OCEAN SYSTEMS CLIMAT; P&ouml;rtner HO, 2012, ANTARCTIC ECOSYSTEMS, P360; Perez FF, 1999, J MARINE SYST, V19, P27, DOI 10.1016/S0924-7963(98)00022-0; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Pimentel MS, 2012, MAR BIOL, V159, P2051, DOI 10.1007/s00227-012-1991-9; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Ramnanan CJ, 2006, J EXP BIOL, V209, P677, DOI 10.1242/jeb.02052; Ribeiro L, 1999, AQUACULTURE, V179, P465, DOI 10.1016/S0044-8486(99)00180-5; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2014, GLOBAL CHANGE BIOL, V20, P3068, DOI 10.1111/gcb.12621; Rosa R, 2014, J EXP BIOL, V217, P518, DOI 10.1242/jeb.096081; Rosa R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1695; Rosa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038282; Sarazin G, 1999, WATER RES, V33, P290, DOI 10.1016/S0043-1354(98)00168-7; Sokolova IM, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P263; Stumpp M, 2013, DIGESTION SEA URCHIN; Takle H, 2005, AQUACULTURE, V249, P515, DOI 10.1016/j.aquaculture.2005.04.043; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P119, DOI 10.1016/j.cbpa.2013.02.005; Viant MR, 2003, FISH PHYSIOL BIOCHEM, V29, P159, DOI 10.1023/B:FISH.0000035938.92027.81; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Zambonino-Infante J.L., 2008, FEEDING DIGESTIVE FU, P281, DOI 10.1201/b10749-8	70	82	84	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134082	10.1371/journal.pone.0134082	http://dx.doi.org/10.1371/journal.pone.0134082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221723	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800101
J	Shanmugam, M; El Abbar, F; Ramasubbu, N				Shanmugam, Mayilvahanan; El Abbar, Faiha; Ramasubbu, Narayanan			Transcriptome Profiling of Wild-Type and pga-Knockout Mutant Strains Reveal the Role of Exopolysaccharide in Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							ACETYLGLUCOSAMINE SURFACE POLYSACCHARIDE; DIFFERENTIAL EXPRESSION ANALYSIS; ESCHERICHIA-COLI; BIOFILM FORMATION; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; GENE-EXPRESSION; DISPERSIN-B; BIOSYNTHESIS; ADHESIN; PGAABCD	Exopolysaccharides have a diverse set of functions in most bacteria including a mechanistic role in protecting bacteria against environmental stresses. Among the many functions attributed to the exopolysaccharides, biofilm formation, antibiotic resistance, immune evasion and colonization have been studied most extensively. The exopolysaccharide produced by many Gram positive as well as Gram negative bacteria including the oral pathogen Aggregatibacter actinomycetemcomitans is the homopolymer of beta(1,6)-linked N-acetylglucosamine. Recently, we reported that the PGA-deficient mutant of A. actinomycetemcomitans failed to colonize or induce bone resorption in a rat model of periodontal disease, and the colonization genes, apiA and aae, were significantly down regulated in the mutant strain. To understand the role of exopolysaccharide and the pga locus in the global expression of A. actinomycetemcomitans, we have used comparative transcriptome profiling to identify differentially expressed genes in the wild-type strain in relation to the PGA-deficient strain. Transcriptome analysis revealed that about 50% of the genes are differently expressed (P < 0.05 and fold change >1.5). Our study demonstrated that the absence of the pga locus affects the genes involved in peptidoglycan recycling, glycogen storage, and virulence. Further, using confocal microscopy and plating assays, we show that the viability of pga mutant strain is significantly reduced during biofilm growth. Thus, this study highlights the importance of pga genes and the exopolysaccharide in the virulence of A. actinomycetemcomitans.	[Shanmugam, Mayilvahanan; El Abbar, Faiha; Ramasubbu, Narayanan] Rutgers State Univ, Sch Dent Med, Dept Oral Biol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Ramasubbu, N (corresponding author), Rutgers State Univ, Sch Dent Med, Dept Oral Biol, Newark, NJ 07102 USA.	ramasun1@sdm.rutgers.edu			United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research [DE022544]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022544] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research DE022544; NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gulez G, 2014, MICROBIOLOGYOPEN, V3, P457, DOI 10.1002/mbo3.180; Isaza MP, 2008, INFECT IMMUN, V76, P3561, DOI 10.1128/IAI.01687-07; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17; Rupani D, 2008, ORAL MICROBIOL IMMUN, V23, P127, DOI 10.1111/j.1399-302X.2007.00399.x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117487; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x	36	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134285	10.1371/journal.pone.0134285	http://dx.doi.org/10.1371/journal.pone.0134285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221956	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800122
J	Shaw, R; Kundu, S				Shaw, Rahul; Kundu, Sudip			Metabolic Plasticity and Inter-Compartmental Interactions in Rice Metabolism: An Analysis from Reaction Deletion Study	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ARABIDOPSIS-THALIANA; CARBON ASSIMILATION; STRESS; MODEL; CHLOROPLASTS; MITOCHONDRIA; REDUNDANCY; NETWORK; LIGHT	More than 20% of the total caloric intake of human population comes from rice. The expression of rice genes and hence, the concentration of enzymatic proteins might vary due to several biotic and abiotic stresses. It in turn, can influence the overall metabolism and survivability of rice plant. Thus, understanding the rice cellular metabolism, its plasticity and potential readjustments under different perturbations can help rice biotechnologists to design efficient rice cultivars. Here, using the flux balance analysis (FBA) method, with the help of in-silico reaction deletion strategy, we study the metabolic plasticity of genome-scale metabolic model of rice leaf. A set of 131 reactions, essential for the production of primary biomass precursors is identified; deletion of any of them can inhibit the overall biomass production. Usability Index (I-U) for the rest of the reactions are estimated and based on this parameter, they are classified into three categories-maximally-favourable, quasi-favourable and unfavourable for the primary biomass production. The lower value of 1 - I-U of a reaction suggests that the cell cannot easily bypass it for biomass production. While some of the alternative paths are energetically equally efficient, others demand for higher photon. The variations in (i) ATP/NADPH ratio, (ii) exchange of metabolites through chloroplastic transporters and (iii) total biomass production are also presented here. Mutual metabolic dependencies of different cellular compartments are also demonstrated.	[Shaw, Rahul; Kundu, Sudip] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, W Bengal, India; [Kundu, Sudip] Univ Calcutta, Ctr Excellence Syst Biol & Biomed Engn, TEQIP, Kolkata 700009, W Bengal, India	University of Calcutta; University of Calcutta	Kundu, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, 92 APC Rd, Kolkata 700009, W Bengal, India.	skbmbg@caluniv.ac.in			Council of Scientific & Industrial Research, Govt. of India; Center of Excellence, TEQIP-II, University of Calcutta [09/028(0922)/2014-EMR-I]	Council of Scientific & Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Center of Excellence, TEQIP-II, University of Calcutta	RS is supported by a research fellowship provided by the Council of Scientific & Industrial Research, Govt. of India. This work is supported by the Center of Excellence, TEQIP-II, University of Calcutta (Sanction No. 09/028(0922)/2014-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Atkin O, 2004, PHOTOSYNTHESIS, P153; Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Brinkmann H, 1996, PLANT MOL BIOL, V30, P65, DOI 10.1007/BF00017803; Bustos DM, 2002, FEBS LETT, V530, P169, DOI 10.1016/S0014-5793(02)03455-5; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; Cheung CYM, 2013, GENOME SCALE METABOL; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fresco L, 2005, J FOOD COMPOS ANAL, V18, P249, DOI 10.1016/j.jfca.2004.09.006; Gardestrom P, 1996, BBA-BIOENERGETICS, V1275, P38, DOI 10.1016/0005-2728(96)00047-3; Guo L, 2012, PLANT CELL, V24, P2200, DOI 10.1105/tpc.111.094946; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; JOHNSON MD, 1994, PLANT PHYSIOL, V105, P1023, DOI 10.1104/pp.105.3.1023; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Padmasree K, 2002, CRIT REV BIOCHEM MOL, V37, P71, DOI 10.1080/10409230290771465; Poolman MG, 2006, IEE P SYST BIOL, V153, P375, DOI 10.1049/ip-syb:20060010; Poolman MG, 2013, PLANT PHYSIOL, V162, P1060, DOI 10.1104/pp.113.216762; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Price ND, 2002, GENOME RES, V12, P760, DOI 10.1101/gr.218002; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Reeves AR, 2012, METHODS MOL BIOL, V834, P153, DOI 10.1007/978-1-61779-483-4_11; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Schwender J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00668; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang CL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S9	33	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133899	10.1371/journal.pone.0133899	http://dx.doi.org/10.1371/journal.pone.0133899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222686	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800079
J	Jurak, E; Patyshakuliyeva, A; de Vries, RP; Gruppen, H; Kabel, MA				Jurak, Edita; Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.; Gruppen, Harry; Kabel, Mirjam A.			Compost Grown Agaricus bisporus Lacks the Ability to Degrade and Consume Highly Substituted Xylan Fragments	PLOS ONE			English	Article							WHEAT-FLOUR ARABINOXYLAN; H-1-NMR SPECTROSCOPY; ASPERGILLUS-AWAMORI; ENZYME-ACTIVITIES; BUTTON MUSHROOM; MODE; OLIGOSACCHARIDES; PURIFICATION	The fungus Agaricus bisporus is commercially grown for the production of edible mushrooms. This cultivation occurs on compost, but not all of this substrate is consumed by the fungus. To determine why certain fractions remain unused, carbohydrate degrading enzymes, water-extracted from mushroom-grown compost at different stages of mycelium growth and fruiting body formation, were analyzed for their ability to degrade a range of polysaccharides. Mainly endo-xylanase, endo-glucanase, beta-xylosidase and beta-glucanase activities were determined in the compost extracts obtained during mushroom growth. Interestingly, arabinofuranosidase activity able to remove arabinosyl residues from doubly substituted xylose residues and a-glucuronidase activity were not detected in the compost enzyme extracts. This correlates with the observed accumulation of arabinosyl and glucuronic acid substituents on the xylan backbone in the compost towards the end of the cultivation. Hence, it was concluded that compost grown A. bisporus lacks the ability to degrade and consume highly substituted xylan fragments.	[Jurak, Edita; Gruppen, Harry; Kabel, Mirjam A.] Wageningen Univ, Food Chem Lab, NL-6708 WG Wageningen, Netherlands; [Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.] Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, NL-3584 CT Utrecht, Netherlands; [Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.] Univ Utrecht, Fungal Mol Physiol, NL-3584 CT Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University	Kabel, MA (corresponding author), Wageningen Univ, Food Chem Lab, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.	mirjam.kabel@wur.nl	de Vries, Ronald P./F-8125-2011; Jurak, Edita/AAM-2163-2020; Kabel, Mirjam/M-1051-2016	de Vries, Ronald P./0000-0002-4363-1123; Kabel, Mirjam/0000-0002-2787-7852; Jurak, Edita/0000-0003-4253-4556	Technology Foundation STW [11108]; applied science division of NWO; technology programme of the Ministry of Economic Affairs (The Netherlands); CNC Grondstoffen B.V.; Walkro International	Technology Foundation STW(Technologiestichting STW); applied science division of NWO(Netherlands Organization for Scientific Research (NWO)); technology programme of the Ministry of Economic Affairs (The Netherlands); CNC Grondstoffen B.V.; Walkro International	This research was supported and approved by the Technology Foundation STW (11108), applied science division of NWO and the technology programme of the Ministry of Economic Affairs (The Netherlands) and by CNC Grondstoffen B.V. and Walkro International. CNC provided the compost samples used in this research.	BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; Broek L. A. M. van den, 2005, Applied Microbiology and Biotechnology, V67, P641, DOI 10.1007/s00253-004-1850-9; CLAYDON N, 1988, T BRIT MYCOL SOC, V90, P85, DOI 10.1016/S0007-1536(88)80183-9; Daas PJH, 1999, CARBOHYD RES, V318, P135, DOI 10.1016/S0008-6215(99)00093-2; de Vries RP, 1999, APPL ENVIRON MICROB, V65, P2453; Gerrits J, 1968, MUSHROOM SCI, V7, P1; GRUPPEN H, 1992, CARBOHYD RES, V233, P45, DOI 10.1016/S0008-6215(00)90919-4; HAYES WA, 1969, ANN APPL BIOL, V64, P177, DOI 10.1111/j.1744-7348.1969.tb02867.x; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538, DOI 10.1128/AEM.60.5.1538-1546.1994; Jurak E, ACCUMULATION R UNPUB; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kabel MA, 2006, BIOTECHNOL BIOENG, V93, P56, DOI 10.1002/bit.20685; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; KORMELINK FJM, 1993, CARBOHYD RES, V249, P369, DOI 10.1016/0008-6215(93)84101-B; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; McCleary BV, 1993, US Patent, Patent No. [US 5250306 A, 5250306]; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Patyshakuliyeva A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-663; PULS J, 1987, ENZYME MICROB TECH, V9, P83, DOI 10.1016/0141-0229(87)90147-5; Savoie JM, 1998, MYCOL RES, V102, P1113, DOI 10.1017/S0953756298006121; Schols HA, CARBOHYDR RES, V206, P117; Singh A, 2003, J CHEM TECHNOL BIOT, V78, P743, DOI 10.1002/jctb.852; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439; WOOD DA, 1977, ARCH MICROBIOL, V114, P161, DOI 10.1007/BF00410778; WOOD DA, 1980, J GEN MICROBIOL, V117, P327	26	15	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134169	10.1371/journal.pone.0134169	http://dx.doi.org/10.1371/journal.pone.0134169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237450	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400016
J	Esteban-Tejeda, L; Prado, C; Cabal, B; Sanz, J; Torrecillas, R; Moya, JS				Esteban-Tejeda, Leticia; Prado, Catuxa; Cabal, Belen; Sanz, Jesus; Torrecillas, Ramon; Moya, Jose Serafin			Antibacterial and Antifungal Activity of ZnO Containing Glasses	PLOS ONE			English	Article							ZINC-OXIDE; IN-VITRO; NANOPARTICLES; TOXICITY; COATINGS; CORROSION; PAINTS; COPPER	A new family of non-toxic biocides based on low melting point (1250 degrees C) transparent glasses with high content of ZnO (15-40wt%) belonging to the miscibility region of the B2O3-SiO2-Na2O-ZnO system has been developed. These glasses have shown an excellent biocide activity (logarithmic reduction > 3) against Gram-(E. coli), Gram+ (S. aureus) and yeast (C. krusei); they are chemically stable in different media (distilled water, sea-like water, LB and DMEN media) as well as biocompatible. The cytotoxicity was evaluated by the Neutral Red Uptake using NIH-3T3 (mouse embryonic fibroblast cells) and the cell viability was >80%. These new glasses can be considered in several and important applications in the field of inorganic non-toxic biocide agents such as medical implants, surgical equipment, protective apparels in hospitals, water purifications systems, food packaging, food storages or textiles.	[Esteban-Tejeda, Leticia; Sanz, Jesus; Moya, Jose Serafin] CSIC, Mat Sci Inst Madrid ICMM, Dept Biomat & Bioinspired Mat, Spanish Natl Res Council, E-28049 Madrid, Spain; [Prado, Catuxa; Cabal, Belen; Torrecillas, Ramon] Univ Oviedo, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, CINN CSIC UNIOVI PA,Principado Asturias, El Entrego 33940, Asturias, Spain; [Torrecillas, Ramon] Moscow State Univ Technol STANKIN, Moscow 101472, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; University of Oviedo; Moscow State Technology University Stankin	Esteban-Tejeda, L (corresponding author), CSIC, Mat Sci Inst Madrid ICMM, Dept Biomat & Bioinspired Mat, Spanish Natl Res Council, Plaza Murillo 2, E-28049 Madrid, Spain.	lesteban@icmm.csic.es	Cabal, Belén/G-2694-2019; Torrecillas, Ramón/G-7851-2011	Cabal, Belén/0000-0002-4102-3810; Torrecillas, Ramón/0000-0003-3856-0217; Prado, Catuxa/0000-0002-6630-4395	Consejo Superior de Investigaciones Cientificas (CSIC) [201360E012]; Spanish Ministry of Science and Innovation [MAT2012-38645]; JAE-Doc program (CSIC)	Consejo Superior de Investigaciones Cientificas (CSIC); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); JAE-Doc program (CSIC)	This study has been supported by Consejo Superior de Investigaciones Cientificas (CSIC) project reference number 201360E012 and by the Spanish Ministry of Science and Innovation MAT2012-38645. C. Prado and B. Cabal acknowledge financial support from JAE-Doc program (CSIC, cofounded by FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, 109935 ISO; [Anonymous], 2004, 20645 ISO; Bai Y, 2014, ENV SCI TECHNOL; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boch P, 2007, CERAMIC MATERIALS: PROCESSES, PROPERTIES AND APPLICATIONS, P1, DOI 10.1002/9780470612415; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5; Cabal B, 2014, NEW BIOCOMPATIBLE AN, V4, DOI [10.1038/srep05440, DOI 10.1038/SREP05440]; Cates S, 2014, ENVIRON SCI TECHNOL, V48; Commission, 2011, TE COMB ANT RES NEWD; Cook J, 1996, BIOL CONTROL, V7, P333, DOI 10.1006/bcon.1996.0102; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; DOE US, 2001, DESIGN CONSTRUCTION; Drewello R, 1997, APPL MICROBIOL BIOT, V47, P337, DOI 10.1007/s002530050937; Ehrt D, 2013, PHYS CHEM GLASSES-B, V54, P65; Engelhardt G, 1987, HIGH RESOLUTION SOLI; ENNAS G, 1990, J NON-CRYST SOLIDS, V125, P181, DOI 10.1016/0022-3093(90)90337-L; Esteban-Tejeda L, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1447-2; Esteban-Tejeda L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033135; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Hanley C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295103; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5; Jantzen CM, 1993, CHARACTERIZATION DEF; Kogel J.E., 2006, IND MINERALS ROCKS C; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Le Y, 2010, MATER CHEM PHYS, V120, P351, DOI 10.1016/j.matchemphys.2009.11.020; LES A, 1984, WATER AIR SOIL POLL, V23, P129, DOI 10.1007/BF00206971; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li JH, 2012, TOXICOL RES-UK, V1, P137, DOI 10.1039/c2tx20016c; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; Lusvardi G, 2002, J PHYS CHEM B, V106, P9753, DOI 10.1021/jp020321s; Materials ASfTa, 1997, C128997 ASTM; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Moya JS, 2011, J AM CERAM SOC, V94, P2067, DOI 10.1111/j.1551-2916.2011.04399.x; Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133; Navarro JMF, 1991, CONSEJO SUPERIOR INV, P144; Nriagu J., 2007, ZINC TOXICITY HUMANS, P1; Owen D, 1981, J AM CERAM SOC; Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rawat J, 2010, MATER SCI FORUM, V657, P75, DOI 10.4028/www.scientific.net/MSF.657.75; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Rogalsky S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40050; Savvova OV, 2012, GLASS CERAM+, V69, P20, DOI 10.1007/s10717-012-9407-3; SCHOLES S, 1975, J NON-CRYST SOLIDS, V19, P167, DOI 10.1016/0022-3093(75)90082-4; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Simoncic B, 2010, TEXT RES J, V80, P1721, DOI 10.1177/0040517510363193; Spencer CG, 2009, ANGLE ORTHOD, V79, P317, DOI 10.2319/011408-19.1; van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p; Wang X, 2009, ADV MATER RES-SWITZ, V79-82, P2091, DOI 10.4028/www.scientific.net/AMR.79-82.2091; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; Yebra DM, 2006, PROG ORG COAT, V56, P327, DOI 10.1016/j.porgcoat.2006.06.007	58	34	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132709	10.1371/journal.pone.0132709	http://dx.doi.org/10.1371/journal.pone.0132709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230940	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400019
J	Gargano, EM; Allegretta, G; Perspicace, E; Carotti, A; Van Koppen, C; Frotscher, M; Marchais-Oberwinkler, S; Hartmann, RW				Gargano, Emanuele M.; Allegretta, Giuseppe; Perspicace, Enrico; Carotti, Angelo; Van Koppen, Chris; Frotscher, Martin; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.			17 beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog	PLOS ONE			English	Article							17-BETA-HYDROXY STEROID DEHYDROGENASE; 4,5-DISUBSTITUTED CIS-PYRROLIDINONES; II 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; BIOLOGICAL EVALUATION; NONSTEROIDAL INHIBITORS; DRUG DISCOVERY; OSTEOPOROSIS; POTENT; DERIVATIVES; IDENTIFICATION	Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparative h17 beta-HSD2 and m17 beta-HSD2 SAR study are described. 17a is the first compound to show strong inhibition of both h17 beta-HSD2 and m17 beta-HSD2, intracellular activity, metabolic stability, selectivity toward h17 beta-HSD1, m17 beta-HSD1 and estrogen receptors a and beta as well as appropriate physicochemical properties for oral bioavailability. These properties make it eligible for pre-clinical animal studies, prior to human studies.	[Gargano, Emanuele M.; Perspicace, Enrico; Frotscher, Martin; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.] Univ Saarland, Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany; [Allegretta, Giuseppe; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.] Helmholtz Inst Pharmaceut Res Saarland, Saarbrucken, Germany; [Carotti, Angelo] Univ Bari, Dipartimento Farmacochim, Bari, Italy; [Van Koppen, Chris] ElexoPharm GmbH, Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; Universita degli Studi di Bari Aldo Moro	Marchais-Oberwinkler, S (corresponding author), Univ Saarland, Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany.	s.marchais@mx.uni-saarland.de; rolf.hartmann@helmoltz-hzi.de		gargano, emanuele/0000-0001-8277-6248	Deutsche Forschungsgemeinschaft (DFG) [HA1315/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge the Deutsche Forschungsgemeinschaft (DFG) for financial support (Grants HA1315/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Elexopharm GmbH had no financial interest in this collaboration.	Bey E, 2008, BIOORGAN MED CHEM, V16, P6423, DOI 10.1016/j.bmc.2008.04.073; Bydal P, 2004, STEROIDS, V69, P325, DOI 10.1016/j.steroids.2004.03.002; Day JM, 2006, MOL CELL ENDOCRINOL, V248, P246, DOI 10.1016/j.mce.2006.01.011; Di L, 2003, J BIOMOL SCREEN, V8, P453, DOI 10.1177/1087057103255988; Dong Y, 1998, J BONE MINER RES, V13, P1539, DOI 10.1359/jbmr.1998.13.10.1539; Gargano EM, 2014, EUR J MED CHEM, V87, P203, DOI 10.1016/j.ejmech.2014.09.061; Gunn D, 2005, BIOORG MED CHEM LETT, V15, P3053, DOI 10.1016/j.bmcl.2005.04.025; Hui JPM, 2012, RAPID COMMUN MASS SP, V26, P345, DOI 10.1002/rcm.5336; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; LIN SX, 1992, J BIOL CHEM, V267, P16182; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Marchais-Oberwinkler S, 2013, J MED CHEM, V56, P167, DOI 10.1021/jm3014053; Marchais-Oberwinkler S, 2011, J MED CHEM, V54, P534, DOI 10.1021/jm1009082; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Moreno-Farre J., 2007, AUSTR ASIAN J CANC, V6, P55; Perspicace E, 2013, EUR J MED CHEM, V69, P201, DOI 10.1016/j.ejmech.2013.08.026; Poirier D, 2001, MOL CELL ENDOCRINOL, V171, P119, DOI 10.1016/S0303-7207(00)00427-5; PURANEN TJ, 1994, BIOCHEM J, V304, P289, DOI 10.1042/bj3040289; Reinwald S, 2008, J BONE MINER RES, V23, P1353, DOI 10.1359/JBMR.080516; Sam K M, 1998, Drug Des Discov, V15, P157; SAM KM, 1995, J MED CHEM, V38, P4518, DOI 10.1021/jm00022a018; Tremblay MR, 2001, STEROIDS, V66, P821, DOI 10.1016/S0039-128X(01)00116-7; Turner A. Simon, 2001, European Cells & Materials, V1, P66; U. S. Environmental Protection Agency, 2015, PROT IN VITR ESTR RE; Vanderschueren D, 2008, CURR OPIN ENDOCRINOL, V15, P250, DOI 10.1097/MED.0b013e3282fe6ca9; Wetzel M, 2012, EUR J MED CHEM, V47, P1, DOI 10.1016/j.ejmech.2011.09.004; Wetzel M, 2011, J MED CHEM, V54, P7547, DOI 10.1021/jm2008453; Wood J, 2006, BIOORG MED CHEM LETT, V16, P4965, DOI 10.1016/j.bmcl.2006.06.041; WU L, 1993, J BIOL CHEM, V268, P12964; Xu KY, 2011, EUR J MED CHEM, V46, P5978, DOI 10.1016/j.ejmech.2011.10.010; Xu KY, 2011, LETT DRUG DES DISCOV, V8, P406, DOI 10.2174/157018011795514230; ZHU DW, 1993, J MOL BIOL, V234, P242, DOI 10.1006/jmbi.1993.1578	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134754	10.1371/journal.pone.0134754	http://dx.doi.org/10.1371/journal.pone.0134754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230928	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400162
J	Gazy, I; Zeevi, DA; Renbaum, P; Zeligson, S; Eini, L; Bashari, D; Smith, Y; Lahad, A; Goldberg, M; Ginsberg, D; Levy-Lahad, E				Gazy, Inbal; Zeevi, David A.; Renbaum, Paul; Zeligson, Sharon; Eini, Lital; Bashari, Dana; Smith, Yoav; Lahad, Amnon; Goldberg, Michal; Ginsberg, Doron; Levy-Lahad, Ephrat			TODRA, a IncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; TRANSCRIPTIONAL REGULATION; NONCODING RNA; C-ABL; EXPRESSION; LONG; BRCA1; E2F	Expression of RAD51, a crucial player in homologous recombination (HR) and DNA double-strand break (DSB) repair, is dysregulated in human tumors, and can contribute to genomic instability and tumor progression. To further understand RAD51 regulation we functionally characterized a long non-coding (lnc) RNA, dubbed TODRA (Transcribed in the Opposite Direction of RAD51), transcribed 69bp upstream to RAD51, in the opposite direction. We demonstrate that TODRA is an expressed transcript and that the RAD51 promoter region is bidirectional, supporting TODRA expression (7-fold higher than RAD51 in this assay, p = 0.003). TODRA overexpression in HeLa cells induced expression of TPIP, a member of the TPTE family which includes PTEN. Similar to PTEN, we found that TPIP co-activates E2F1 induction of RAD51. Analysis of E2F1's effect on the bidirectional promoter showed that E2F1 binding to the same site that promotes RAD51 expression, results in downregulation of TODRA. Moreover, TODRA overexpression induces HR in a RAD51-dependent DSB repair assay, and increases formation of DNA damage-induced RAD51-positive foci. Importantly, gene expression in breast tumors supports our finding that E2F1 oppositely regulates RAD51 and TODRA: increased RAD51 expression, which is associated with an aggressive tumor phenotype (e.g. negative correlation with positive ER (r = -0.22, p = 0.02) and positive PR status (r = -0.27, p<0.001); positive correlation with ki67 status (r = 0.36, p = 0.005) and HER2 amplification (r = 0.41, p = 0.001)), correlates as expected with lower TODRA and higher E2F1 expression. However, although E2F1 induction resulted in TPIP downregulation in cell lines, we find that TPIP expression in tumors is not reduced despite higher E2F1 expression, perhaps contributing to increased RAD51 expression. Our results identify TPIP as a novel E2F1 co-activator, suggest a similar role for other TPTEs, and indicate that the TODRA lncRNA affects RAD51 dysregulation and RAD51-dependent DSB repair in malignancy. Importantly, gene expression in breast tumors supports our finding that E2F1 oppositely regulates RAD51 and TODRA: increased RAD51 expression, which is associated with an aggressive tumor phenotype (e.g. negative correlation with positive ER (r = -0.22, p = 0.02) and positive PR status (r = -0.27, p<0.001); positive correlation with ki67 status (r = 0.36, p = 0.005) and HER2 amplification (r = 0.41, p = 0.001)), correlates as expected with lower TODRA and higher E2F1 expression. However, although E2F1 induction resulted in TPIP downregulation in cell lines, we find that TPIP expression in tumors is not reduced despite higher E2F1 expression, perhaps contributing to increased RAD51 expression. Our results identify TPIP as a novel E2F1 co-activator, suggest a similar role for other TPTEs, and indicate that the TODRA lncRNA affects RAD51 dysregulation and RAD51-dependent DSB repair in malignancy.	[Gazy, Inbal; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, Human Genet, IL-91010 Jerusalem, Israel; [Gazy, Inbal; Zeevi, David A.; Renbaum, Paul; Zeligson, Sharon; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Eini, Lital; Goldberg, Michal] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem, Israel; [Bashari, Dana; Ginsberg, Doron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Smith, Yoav] Hebrew Univ Jerusalem, Sch Med, Genom Data Anal Unit, IL-91010 Jerusalem, Israel; [Lahad, Amnon] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel; [Lahad, Amnon] Clalit Hlth Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Clalit Health Services	Levy-Lahad, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Human Genet, IL-91010 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; ginsberg, doron/0000-0002-1257-4920; Gazy, Inbal/0000-0003-3944-6977; Goldberg, Michal/0000-0001-9397-2383	New York Breast Cancer Research Foundation; Israel Science Foundation [635/06, 648/13]	New York Breast Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the New York Breast Cancer Research Foundation (IG, ELL), the Israel Science Foundation (Grant Number: 635/06 to DG; 648/13 to MG), and a gift of Ellie and David Werber (IG, ELL). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Carninci P, 2009, NATURE, V457, P974, DOI 10.1038/457974b; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Suen TC, 2005, BBA-GENE STRUCT EXPR, V1728, P126, DOI 10.1016/j.bbaexp.2005.01.014; Suen TC, 1999, J BIOL CHEM, V274, P31297, DOI 10.1074/jbc.274.44.31297; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viera A, 2009, J CELL SCI, V122, P2149, DOI 10.1242/jcs.046706; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wickramasinghe VO, 2013, MOL CELL, V51, P737, DOI 10.1016/j.molcel.2013.08.031; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	64	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134120	10.1371/journal.pone.0134120	http://dx.doi.org/10.1371/journal.pone.0134120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230935	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400074
J	Ghosh, T; Basu, U				Ghosh, Trinath; Basu, Utpal			Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5 '-UTR Repress Cap-Dependent Translation	PLOS ONE			English	Article							DYSTROPHIN-RELATED PROTEIN; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE FIBERS; ENCEPHALOMYOCARDITIS VIRUS-RNA; THERAPEUTIC UP-REGULATION; RIBOSOME ENTRY SITE; MDX MICE; RICH ELEMENT; EXPRESSION; ACTIVATION	Utrophin, the autosomal homologue of dystrophin can functionally compensate for dystrophin deficiency. Utrophin upregulation could therefore be a therapeutic strategy in Duchenne Muscular Dystrophy (DMD) that arises from mutation in dystrophin gene. In contrast to its transcriptional regulation, mechanisms operating at post-transcriptional level of utrophin expression have not been well documented. Although utrophin-A 5'-UTR has been reported with internal ribosome entry site (IRES), its inhibitory effect on translation is also evident. In the present study we therefore aimed to compare relative contribution of cap-independent and cap-dependent translation with mouse utrophin-A 5'-UTR through m7G-capped and A-capped mRNA transfection based reporter assay. Our results demonstrate that cap-independent translation with utrophin-A 5'-UTR is not as strong as viral IRES. However, cap-independent mode has significant contribution as cap-dependent translation is severely repressed with utrophin-A 5'-UTR. We further identified two sequence elements and one upstream open reading frame in utrophin-A 5'-UTR responsible for repression. The repressor elements in utrophin-A 5'-UTR may be targeted for utrophin upregulation.	[Ghosh, Trinath; Basu, Utpal] Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India	Kalyani University	Basu, U (corresponding author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.	utpal@klyuniv.ac.in		Basu, Utpal/0000-0002-8063-3777	Department of Science and Technology, Govt. of India [SR/FT/LS-121/2008]; Council for Scientific and Indistrial Research [09/106(0122)/2010-EMR-I]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Council for Scientific and Indistrial Research	Department of Science and Technology, Govt. of India sanction no. SR/FT/LS-121/2008 Dt. 7 Sept, 2009 to UB. Council for Scientific and Indistrial Research sanction no. 09/106(0122)/2010-EMR-I to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirouche A, 2014, NUCLEIC ACIDS RES, V42, P3982, DOI 10.1093/nar/gkt1350; Amirouche A, 2013, HUM MOL GENET, V22, P3093, DOI 10.1093/hmg/ddt165; Andreev DE, 2012, FEBS LETT, V586, P4139, DOI 10.1016/j.febslet.2012.10.010; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Basu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029376; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; EVSTAFIEVA AG, 1991, NUCLEIC ACIDS RES, V19, P665, DOI 10.1093/nar/19.3.665; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2013, COLD SPRING HARBOR P, V5; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kolupaeva VG, 1998, J BIOL CHEM, V273, P18599, DOI 10.1074/jbc.273.29.18599; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134809	10.1371/journal.pone.0134809	http://dx.doi.org/10.1371/journal.pone.0134809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230628	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400170
J	Liu, CJ; Wu, YW; Ko, KY; Chen, YC; Cheng, MF; Yen, RF; Tzen, KY				Liu, Chia-Ju; Wu, Yen-Wen; Ko, Kuan-Yin; Chen, Yi-Chieh; Cheng, Mei-Fang; Yen, Ruoh-Fang; Tzen, Kai-Yuan			Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging	PLOS ONE			English	Article							TRANSIENT ISCHEMIC DILATION; HEART-RATE RECOVERY; VENTRICULAR EJECTION FRACTION; PROGNOSTIC VALUE; TREADMILL EXERCISE; NORMAL LIMITS; COMPUTED-TOMOGRAPHY; NUCLEAR CARDIOLOGY; PULMONARY UPTAKE; CAVITY DILATION	Purpose Myocardial perfusion imaging (MPI) using gated single-photon emission tomography (gSPECT) may underestimate the severity of coronary artery disease (CAD). This study aimed to evaluate the significance of combined parameters derived from gSPECT, as well as treadmill stress test parameters, in the detection of severe CAD. Methods A total of 211 consecutive patients referred for exercise MPI between June 2011 and June 2013 (who received invasive coronary angiography within six months after MPI) were retrospectively reviewed. Exercise MPI was performed with Bruce protocol and Tl-201 injected at peak exercise. Gated SPECT was performed using a cadmium-zinc-telluride camera and processed by QPS/QGS software. Perfusion defect abnormalities such as sum stress score (SSS); sum difference score, algorithm-derived total perfusion deficits, transient ischemic dilatation ratios of end-diastolic volumes and end-systolic volumes, post-stress changes in ejection fraction, and lung/heart ratio (LHR) were calculated. Treadmill parameters, including ST depression (STD) at the 1st and 3rd minutes of recovery stage (1'STD and 3'STD), maximal STD corrected by heart rate increment (ST/HR), heart rate decline in 1st and 3rd minutes of recovery stage, recovery heart rate ratio (HR ratio), systolic and mean blood pressure ratios (SBP ratio and MAP ratio) during recovery phase were recorded. Diagnostic performances of these parameters were analyzed with receiver operating characteristic (ROC) analysis and logistic regression for detection of left main (>= 50%) or 3-vessel disease (all >= 70% luminal stenosis) on invasive angiography. Results Among various MPI and treadmill parameters used for detection of severe CAD, SSS and ST/HR had the highest AUC (0.78, 0.73, p = NS) and best cut-off values (SSS > 6, ST/HR > 17.39 10(-2)mV/bpm), respectively. By univariate logistic regression, all parameters except 1'HRR, 3'HRR, SBP and MAP ratios increased the odds ratio of severe CAD. Only increased L/H ratio, 3'STD, and HR ratio remained significant after multivariate regression. The predicted values of combined MPI and treadmill parameters (LHR, 3'STD, and HR ratio) gave the best ROC (AUC: 0.91) than any individual parameter or parameter combination. Conclusions Of all treadmill and gSPECT parameters, the combination of MPI and treadmill parameters can offer better diagnostic performance for severe CAD.	[Liu, Chia-Ju; Wu, Yen-Wen; Ko, Kuan-Yin; Chen, Yi-Chieh; Cheng, Mei-Fang; Yen, Ruoh-Fang; Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Wu, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan.	wuyw0502@gmail.com	CHENG, MEIFANG/AAV-8665-2021; Liu, Chia-Ju/AAX-8643-2021	CHENG, MEIFANG/0000-0002-9359-0606; Liu, Chia-Ju/0000-0003-1641-5617; YEN, RUOH-FANG/0000-0003-1648-6482; WU, YEN-WEN/0000-0003-1520-1166; TZEN, KAI-YUAN/0000-0002-5657-8579	Ministry of Science and Technology of Taiwan [MOST 100-2314-B-002-158, 101-2314-B-418-012-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	YWW. Grants MOST 100-2314-B-002-158 and 101-2314-B-418-012-MY3 from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh AA, 2000, J NUCL CARDIOL, V7, P661, DOI 10.1067/mnc.2000.109861; Abidov A, 2004, J NUCL MED, V45, P1999; Abidov A, 2003, J AM COLL CARDIOL, V42, P1818, DOI 10.1016/j.jacc.2003.07.010; Afonso L, 2009, CLIN CARDIOL, V32, P658, DOI [10.1002/clc.20534, 10.1002/clc.20659]; Allison TG, 1999, AM J CARDIOL, V83, P371, DOI 10.1016/S0002-9149(98)00871-6; Borges-Neto S, 2000, RADIOLOGY, V215, P529, DOI 10.1148/radiology.215.2.r00ma13529; Buechel RR, 2010, EUR J NUCL MED MOL I, V37, P773, DOI 10.1007/s00259-009-1375-7; Cheng VY, 2011, CIRCULATION, V124, P2424, DOI 10.1161/CIRCULATIONAHA.111.039255; Chien CL, 2011, OBESITY FACTS, V4, P372, DOI 10.1159/000333439; Chowdhury FU, 2014, EUR HEART J-CARD IMG, V15, P275, DOI 10.1093/ehjci/jet149; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; De Winter O, 2005, J NUCL CARDIOL, V12, P662, DOI 10.1016/j.nuclcard.2005.08.002; Dona M, 2011, EUR J NUCL MED MOL I, V38, P485, DOI 10.1007/s00259-010-1643-6; Emmett L, 2005, J NUCL MED, V46, P1596; Germano G, 2007, J NUCL CARDIOL, V14, P433, DOI 10.1016/j.nuclcard.2007.06.008; GILL JB, 1987, NEW ENGL J MED, V317, P1485, DOI 10.1056/NEJM198712103172401; Hamasaki S, 1998, AM J CARDIOL, V81, P1100, DOI 10.1016/S0002-9149(98)00124-6; Hansen CL, 1999, J AM COLL CARDIOL, V33, P1323, DOI 10.1016/S0735-1097(98)00699-8; Hansen CL, 2002, J NUCL CARDIOL, V9, P47, DOI 10.1067/mnc.2002.118695; HASHIMOTO M, 1993, J AM COLL CARDIOL, V22, P659, DOI 10.1016/0735-1097(93)90173-X; Heston TF, 2005, J NUCL MED, V46, P1990; Higgins JP, 2007, EUR J NUCL MED MOL I, V34, P584, DOI 10.1007/s00259-006-0293-1; Hsu BL, 2014, EUR J NUCL MED MOL I, V41, P2294, DOI 10.1007/s00259-014-2881-9; Hsu JC, 2007, INT J CARDIOL, V119, P274, DOI 10.1016/j.ijcard.2006.07.160; Hsu PY, 2015, ACTA CARDIO IN PRESS; Kaminek M, 2002, CLIN NUCL MED, V27, P255, DOI 10.1097/00003072-200204000-00004; Kinoshita N, 2002, CLIN NUCL MED, V27, P34, DOI 10.1097/00003072-200201000-00008; Ko CL, 2015, J NUCL CARDIOL, V22, P308, DOI 10.1007/s12350-014-9963-8; Liu CJ, 2015, ANN NUCL MED; Mang CL, 2008, AM J CARDIOL, V102, P518, DOI 10.1016/j.amjcard.2008.04.027; Mazzanti M, 1996, J AM COLL CARDIOL, V27, P1612, DOI 10.1016/0735-1097(96)00052-6; McHam SA, 1999, J AM COLL CARDIOL, V34, P754, DOI 10.1016/S0735-1097(99)00269-7; Nakajima K, 2007, EUR J NUCL MED MOL I, V34, P1088, DOI 10.1007/s00259-006-0321-1; Nakajima K, 2010, ANN NUCL MED, V24, P125, DOI 10.1007/s12149-009-0337-2; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Petretta M, 2013, J NUCL CARDIOL, V20, P45, DOI 10.1007/s12350-012-9642-6; Romanens M, 2001, EUR J NUCL MED, V28, P907, DOI 10.1007/s002590100532; Ronan G, 2014, J NUCL CARDIOL, V21, P192, DOI 10.1007/s12350-013-9841-9; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; Schindler TH, 2014, SEMIN NUCL MED, V44, P274, DOI 10.1053/j.semnuclmed.2014.04.002; Schultz MG, 2013, AM J HYPERTENS, V26, P357, DOI 10.1093/ajh/hps053; Sharir T, 1999, CIRCULATION, V100, P1035, DOI 10.1161/01.CIR.100.10.1035; Songy B, 2011, CLIN NUCL MED, V36, P776, DOI 10.1097/RLU.0b013e31821a294e; Takahashi Y, 2013, ANN NUCL MED, V27, P11, DOI 10.1007/s12149-012-0653-9; Tanaka H, 2013, CIRC J, V77, P1009, DOI 10.1253/circj.CJ-12-1093; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Wang SY, 2011, NUCL MED COMMUN, V32, P113, DOI 10.1097/MNM.0b013e3283422838; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; WEISS AT, 1987, J AM COLL CARDIOL, V9, P752; Wu YW, 2010, J NUCL MED, V51, P906, DOI 10.2967/jnumed.109.073833; Xu Y, 2012, J NUCL CARDIOL, V19, P465, DOI 10.1007/s12350-012-9527-8; Zaman MU, 2011, ANN NUCL MED, V25, P566, DOI 10.1007/s12149-011-0500-4; Zimarino M, 2013, INT J CARDIOL, V168, P1274, DOI 10.1016/j.ijcard.2012.12.007	54	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134485	10.1371/journal.pone.0134485	http://dx.doi.org/10.1371/journal.pone.0134485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230651	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400126
J	Obokata, M; Negishi, K; Ohyama, Y; Okada, H; Imai, K; Kurabayashi, M				Obokata, Masaru; Negishi, Kazuaki; Ohyama, Yoshiaki; Okada, Haruka; Imai, Kunihiko; Kurabayashi, Masahiko			A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts	PLOS ONE			English	Article							CARDIOVASCULAR RISK; US ADULTS; URIC-ACID; HEALTH; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; DIAGNOSIS; CRITERIA	Background Although many risk factors for Metabolic syndrome (MetS) have been reported, there is no clinical score that predicts its incidence. The purposes of this study were to create and validate a risk score for predicting both incidence and recovery from MetS in a large cohort. Methods Subjects without MetS at enrollment (n = 13,634) were randomly divided into 2 groups and followed to record incidence of MetS. We also examined recovery from it in rest 2,743 individuals with prevalent MetS. Results During median follow-up of 3.0 years, 878 subjects in the derivation and 757 in validation cohorts developed MetS. Multiple logistic regression analysis identified 12 independent variables from the derivation cohort and initial score for subsequent MetS was created, which showed good discrimination both in the derivation (c-statistics 0.82) and validation cohorts (0.83). The predictability of the initial score for recovery from MetS was tested in the 2,743 MetS population (906 subjects recovered from MetS), where nine variables (including age, sex, gamma-glutamyl transpeptidase, uric acid and five MetS diagnostic criteria constituents.) remained significant. Then, the final score was created using the nine variables. This score significantly predicted both the recovery from MetS (c-statistics 0.70, p<0.001, 78% sensitivity and 54% specificity) and incident MetS (c-statistics 0.80) with an incremental discriminative ability over the model derived from five factors used in the diagnosis of MetS (continuous net reclassification improvement: 0.35, p < 0.001 and integrated discrimination improvement: 0.01, p<0.001). Conclusions We identified four additional independent risk factors associated with subsequent MetS, developed and validated a risk score to predict both incident and recovery from MetS.	[Obokata, Masaru; Negishi, Kazuaki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan; [Ohyama, Yoshiaki] Gunma Univ, Grad Sch Med, Clin Invest & Res Unit, Maebashi, Gunma, Japan; [Okada, Haruka; Imai, Kunihiko] Gunma Chuo Hosp, Japan Community Healthcare Org, Maebashi, Gunma, Japan; [Negishi, Kazuaki] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Gunma University; Gunma University; University of Tasmania; Menzies Institute for Medical Research	Negishi, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan.	kazz.negishi@nifty.com	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565; Obokata, Masaru/0000-0002-5473-0688	Select Foundation	Select Foundation	The authors received no specific funding for this work. Kazuaki Negishi, MD, PhD, is supported by an award from the Select Foundation, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Boudreau DM, 2009, METAB SYNDR RELAT D, V7, P305, DOI 10.1089/met.2008.0070; Carnethon MR, 2004, DIABETES CARE, V27, P2707, DOI 10.2337/diacare.27.11.2707; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi Y, 2009, STROKE, V40, P1187, DOI 10.1161/STROKEAHA.108.531319; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kim MK, 2013, ENDOCR J, V60, P321, DOI 10.1507/endocrj.EJ12-0331; Koskinen J, 2010, CIRCULATION, V121, P392, DOI 10.1161/CIRCULATIONAHA.109.894584; Kunutsor SK, 2015, INT J CLIN PRACT, V69, P136, DOI 10.1111/ijcp.12507; Lewis SJ, 2008, INT J CLIN PRACT, V62, P1168, DOI 10.1111/j.1742-1241.2008.01770.x; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Magnussen CG, 2012, J AM COLL CARDIOL, V60, P1631, DOI 10.1016/j.jacc.2012.05.056; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Oda E, 2013, INTERNAL MED, V52, P2707, DOI 10.2169/internalmedicine.52.0696; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Population Reference Bureau, 2013, WORLD POPULATION DAT; Pradhan AD, 2014, CLIN CHEM, V60, P44, DOI 10.1373/clinchem.2013.202549; Ryu S, 2007, ANN EPIDEMIOL, V17, P245, DOI 10.1016/j.annepidem.2006.10.001; Sheu WHH, 2006, DIABETES RES CLIN PR, V74, P162, DOI 10.1016/j.diabres.2006.03.011; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; World Health Organization, 1997, PREVENTING MANAGING; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133884	10.1371/journal.pone.0133884	http://dx.doi.org/10.1371/journal.pone.0133884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230621	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400060
J	de Hair, MJH; Leclerc, P; Newsum, EC; Maijer, KI; van de Sande, MGH; Ramwadhdoebe, TH; van Schaardenburg, D; van Baarsen, LGM; Korotkova, M; Gerlag, DM; Tak, PP; Jakobsson, PJ				de Hair, Maria J. H.; Leclerc, Patrick; Newsum, Elize C.; Maijer, Karen I.; van de Sande, Marleen G. H.; Ramwadhdoebe, Tamara H.; van Schaardenburg, Dirkjan; van Baarsen, Lisa G. M.; Korotkova, Marina; Gerlag, Danielle M.; Tak, Paul-Peter; Jakobsson, Per-Johan			Expression of Prostaglandin E-2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients	PLOS ONE			English	Article							E SYNTHASE; PROINFLAMMATORY CYTOKINES; CELL INFILTRATE; IMAGE-ANALYSIS; TISSUE; PAIN; CYCLOOXYGENASE-2; JOINT; QUANTIFICATION; GENERATION	Objective Arthralgia may precede the development of synovial inflammation in autoantibody-positive individuals at risk of developing rheumatoid arthritis (RA). A major pathway involved in pain is the prostaglandin (PG) E-2 pathway. We investigated this pathway in the synovium of individuals with RA-specific autoantibodies and in early arthritis patients. Methods Nineteen autoantibody-positive individuals (IgM-rheumatoid factor and/or anti-cyclic citrullinated peptide antibodies) with arthralgia (n=15) and/or a positive family history of RA (n=8), who had been prospectively followed for at least 2 years, were included. In addition, we included early arthritis patients (disease-modifying antirheumatic drug naive) who after 2 years follow up fulfilled classification criteria for RA (n=63), spondyloarthritis (SpA; n=14), or had unclassified arthritis (UA; n=27). In all subjects we assessed pain and performed synovial biopsy sampling by mini-arthroscopy at baseline. Tissue sections were examined by immunohistochemistry to detect and quantify PGE(2) pathway enzymes expression levels (mPGES-1; COX-1 and -2; 15-PGDH). Results In both study groups synovial expression of PGE(2) enzymes was not clearly related to pain sensation. Expression levels at baseline were not associated with the development of arthritis after follow up (6 out of 19 autoantibody-positive individuals). However, in early SpA patients the expression levels of mPGES-1 and COX-1 were significantly increased compared to RA and UA patients. Conclusion Pain in autoantibody-positive individuals without synovial inflammation who are at risk of developing RA and in early arthritis patients may be regulated by pathways other than the PGE(2) pathway or originate at sites other than the synovium. In contrast, in SpA, the PGE2 pathway may be inherently linked to the pathophysiology/etiology of the disease.	[de Hair, Maria J. H.; Newsum, Elize C.; Maijer, Karen I.; van de Sande, Marleen G. H.; Ramwadhdoebe, Tamara H.; van Baarsen, Lisa G. M.; Gerlag, Danielle M.; Tak, Paul-Peter] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Leclerc, Patrick; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Inst, Dept Med, Rheumatol Res Unit, Stockholm, Sweden; [Ramwadhdoebe, Tamara H.; van Baarsen, Lisa G. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Reade, Dept Rheumatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam	Tak, PP (corresponding author), GlaxoSmithKline, Stevenage, Herts, England.	paul-peter.x.tak@gsk.com	van Baarsen, Lisa G/N-3646-2015; Jakobsson, Per-Johan/ABC-5594-2021	van Baarsen, Lisa G/0000-0003-3346-8921; 	Dutch Arthritis Foundation [6-1-303]; Swedish Research Council; Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Karolinska Institutet Foundation; Marianne and Marcus Wallenberg foundation	Dutch Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Karolinska Institutet Foundation(Karolinska Institutet); Marianne and Marcus Wallenberg foundation	This study was financially supported by the Dutch Arthritis Foundation (grant 6-1-303), the Swedish Research Council; the Swedish Rheumatism Association; the King Gustaf V 80 years Foundation; the Karolinska Institutet Foundation and the Marianne and Marcus Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1991, J RHEUMATOL, V18, P1282; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; de Hair MJH, 2014, ARTHRITIS RHEUMATOL, V66, P513, DOI 10.1002/art.38273; de Hair MJH, 2011, J RHEUMATOL, V38, P2068, DOI 10.3899/jrheum.110426; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P324; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Gerlag DM, 2009, BEST PRACT RES CL RH, V23, P221, DOI 10.1016/j.berh.2009.01.006; Gheorghe KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016378; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Korotkova M, 2014, NAT REV RHEUMATOL, V10, P229, DOI 10.1038/nrrheum.2014.1; Kraan MC, 2000, RHEUMATOLOGY, V39, P43, DOI 10.1093/rheumatology/39.1.43; MAPP PI, 1995, ANN RHEUM DIS, V54, P398, DOI 10.1136/ard.54.5.398; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Myers LK, 2000, ARTHRITIS RHEUM-US, V43, P2687, DOI 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pulichino AM, 2006, J PHARMACOL EXP THER, V319, P1043, DOI 10.1124/jpet.106.110387; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Schaible HG, 2004, LANGENBECK ARCH SURG, V389, P237, DOI 10.1007/s00423-004-0468-9; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van de Sande MGH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036668; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; van der Hall Pascal O., 2007, V135, P121; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133669	10.1371/journal.pone.0133669	http://dx.doi.org/10.1371/journal.pone.0133669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225917	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700032
J	Jiang, Y; Wan, LP; Qin, YW; Wang, XR; Yan, SK; Xie, KC; Wang, C				Jiang, Ying; Wan, Liping; Qin, Youwen; Wang, Xiaorui; Yan, Shike; Xie, Kuangcheng; Wang, Chun			Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MYELOGENOUS LEUKEMIA; PEDIATRIC-PATIENTS; ENGRAFTMENT; KINETICS; MALIGNANCIES; SURVIVAL; MARROW	In this study we investigated the correlation between donor chimerism status and disease relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The chimerism of Fluorescence-activated cell sorter (FACS) sorted CD3+T lymphocytes of 153 cases, CD56+CD16+NK lymphocytes of 153 cases and CD19+B lymphocytes of 31 cases with acute B lymphoblastic leukemia (B-ALL) was analyzed post-transplant utilizing polymerase chain reaction amplification of short tandem repeats (PCR-STR). A total of 33 patients (33/153, 21.6%) had recurrent disease. The positive predictive values of declining donor chimerism for hematologic and isolated extramedullary relapse were 58.8% and 10% (P=0.018, Chi-Square). The positive predictive values of declining donor chimerism in BMB, BMT, BMNK and PBB for hematologic relapse were 11.6%, 0%, 0% and 0% under close monitoring in patients with B-ALL. Only the donor chimerism in BMB significantly decreased in the group with hematologic relapse as compared with the group without hematologic relapse (P=0.00, Independent-samples T test) in patients with B-ALL. The median drop of donor chimerism in PBT, BMT, PBNK and BMNK were 0%, 0%, 5.9% and 2.8% one or two weeks prior to hematologic relapse in patients with non-B-ALL. The donor chimerism in PBNK significantly decreased prior to hematologic relapse in the group with hematologic relapse as compared with the group without hematologic relapse (P=0.022, Independent-samples T test). These data suggest donor chimerism of BMB can be used to predict the occurrence of hematologic relapse in patients with B-ALL. Donor chimerism decrease in PBNK was associated with a somewhat increased risk of hematologic relapse in patients with non-B-ALL. Therefore, our results reveal a more effective path to individually predict for hematologic relapse by dynamic monitoring different cell lineages in different disease.	[Jiang, Ying; Wan, Liping; Qin, Youwen; Wang, Xiaorui; Yan, Shike; Wang, Chun] Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China; [Xie, Kuangcheng] Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China.	wangchun2@medmail.com.cn		Wan, Liping/0000-0001-6868-0258	Shanghai Science and Technology Committee Grant [044119632]	Shanghai Science and Technology Committee Grant	This study supported by Shanghai Science and Technology Committee Grant (rant numbers 044119632; http://www.stcsm.gov.cn/) (to CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin JH, 2001, BIOL BLOOD MARROW TR, V7, P473, DOI 10.1053/bbmt.2001.v7.pm11669214; Bader P, 2000, BRIT J HAEMATOL, V108, P761, DOI 10.1046/j.1365-2141.2000.01927.x; Bader P, 2004, J CLIN ONCOL, V22, P1696, DOI 10.1200/JCO.2004.05.198; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Bornhauser M, 2009, HAEMATOL-HEMATOL J, V94, P1613, DOI 10.3324/haematol.2009.007765; Chiorean EG, 2004, BIOL BLOOD MARROW TR, V10, P171, DOI 10.1016/j.bbmt.2003.10.004; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Czekalska Sylwia, 2010, Przegl Lek, V67, P1282; Dubovsky J, 1999, LEUKEMIA, V13, P2060, DOI 10.1038/sj.leu.2401603; George Nahas, 2013, BLOOD, V122, P4545; Horky O, 2011, INT J LAB HEMATOL, V33, P57, DOI 10.1111/j.1751-553X.2010.01249.x; Jiang Ying, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P667; Kristt D, 2007, BONE MARROW TRANSPL, V39, P255, DOI 10.1038/sj.bmt.1705576; Kumar L, 2007, NATL MED J INDIA, V20, P128; Lange T, 2011, LEUKEMIA, V25, P498, DOI 10.1038/leu.2010.283; Lion T, 2001, LEUKEMIA, V15, P307, DOI 10.1038/sj.leu.2402017; Lion Thomas, 2007, Methods Mol Med, V134, P197; Machaczka M, 2012, LEUKEMIA LYMPHOMA, V53, P1699, DOI 10.3109/10428194.2012.666661; Maeng H, 2004, YONSEI MED J, V45, P330, DOI 10.3349/ymj.2004.45.2.330; Maris MB, 2003, BLOOD, V102, P2021, DOI 10.1182/blood-2003-02-0482; Mollet I, 2012, PATHOL BIOL, V60, P106, DOI 10.1016/j.patbio.2010.07.001; Nikolousis E, 2013, LEUKEMIA RES, V37, P561, DOI 10.1016/j.leukres.2013.01.010; Nollet F, 2001, BONE MARROW TRANSPL, V28, P511, DOI 10.1038/sj.bmt.1703162; Ohashi H, 2005, AM J HEMATOL, V79, P142, DOI 10.1002/ajh.20333; Oran B, 2011, CURR OPIN HEMATOL, V18, P388, DOI 10.1097/MOH.0b013e32834b6158; Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Peterlin P, 2015, BIOL BLOOD MARROW TR, V21, P180, DOI 10.1016/j.bbmt.2014.08.018; Qin XY, 2012, CHINESE MED J-PEKING, V125, P1952, DOI 10.3760/cma.j.issn.0366-6999.2012.11.021; Rauwerdink CA, 2012, EXP MOL PATHOL, V93, P339, DOI 10.1016/j.yexmp.2012.07.003; Reshef R, 2014, BIOL BLOOD MARROW TR, V20, P1758, DOI 10.1016/j.bbmt.2014.07.003; Sufliarska S, 2007, NEOPLASMA, V54, P424; Wan Li-ping, 2006, Zhonghua Nei Ke Za Zhi, V45, P485	32	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133671	10.1371/journal.pone.0133671	http://dx.doi.org/10.1371/journal.pone.0133671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226104	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700033
J	Lal, S; Kersch, C; Beeson, KA; Wu, YJ; Muldoon, LL; Neuwelt, EA				Lal, Sangeet; Kersch, Cymon; Beeson, Kathleen A.; Wu, Y. Jeffrey; Muldoon, Leslie L.; Neuwelt, Edward A.			Interactions between alpha v-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROSTATE-CANCER; PHASE-II; METASTASIS; GROWTH; INTETUMUMAB; ACTIVATION; SURVIVAL; KINASE; ALPHA-V-BETA-3	Background We tested the hypothesis that alpha v-integrin and the human epidermal growth factor receptor type 2 (HER2) interact with each other in brain trophic metastatic breast cancer cells and influence their invasive phenotype. Methods Clones of MDA-MB231BR human breast cancer cells with stable knock down of av-integrin in combination with high or low levels of HER2 were created. The interactions of these two proteins and their combined effect on cell migration and invasion were investigated in vitro and in vivo. Results Knockdown of alpha v-integrin in MDA-MB231BR clones altered the actin cytoskeleton and cell morphology. HER2 co-precipitated with alpha v-integrin in three breast cancer cell lines in vitro, suggesting they complex in cells. Knockdown of alpha v-integrin altered HER2 localization from its normal membrane position to a predominantly lysosomal localization. When alpha v-integrin expression was decreased by 69-93% in HER2-expressing cells, cellular motility was significantly reduced. Deficiency of both alpha v-integrin and HER2 decreased cellular migration and invasion by almost 90% compared to cells expressing both proteins (P<0.01). After intracerebral inoculation, cells expressing high levels of both alpha v-integrin and HER2 showed a diffusely infiltrative tumor phenotype, while cells deficient in alpha v-integrin and/or HER2 showed a compact tumor growth phenotype. In the alpha v-integrin positive/HER2 positive tumors, infiltrative growth was 57.2 +/- 19% of tumor volume, compared to only 5.8 +/- 6.1% infiltration in the double deficient tumor cells. Conclusions alpha v-integrin interacts with HER2 in breast cancer cells and may regulate HER2 localization. The combined impacts of alpha v-integrin and HER2 influence the invasive phenotype of breast cancer cells. Targeting alpha v-integrin in HER2-positive breast cancer may slow growth and decrease infiltration in the normal brain.	[Lal, Sangeet; Kersch, Cymon; Beeson, Kathleen A.; Wu, Y. Jeffrey; Muldoon, Leslie L.; Neuwelt, Edward A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Muldoon, Leslie L.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Neuwelt, Edward A.] Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; [Neuwelt, Edward A.] Vet Adm Med Ctr EAN, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Neuwelt, EA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	neuwelte@ohsu.edu	Davis, William E/P-1888-2016		National Institutes of Health National Cancer Institute grant [CA137488]; National Institute of Neurological Diseases and Stroke grant [NS44687]; Veterans Administration Merit Review grant; Department of Defense grant [W81XWH]; Walter S. and Lucienne Driskill Foundation;  [PS0NSO61800]; NATIONAL CANCER INSTITUTE [R01CA137488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044687, R37NS044687] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Diseases and Stroke grant; Veterans Administration Merit Review grant(US Department of Veterans Affairs); Department of Defense grant(United States Department of Defense); Walter S. and Lucienne Driskill Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health National Cancer Institute grant CA137488; National Institute of Neurological Diseases and Stroke grant NS44687; a Veterans Administration Merit Review grant; a Department of Defense grant W81XWH; and the Walter S. and Lucienne Driskill Foundation, all to Edward A. Neuwelt. Immunofluorescence was performed at the OHSU Neuroscience Imaging Center core, supported by grant PS0NSO61800 (PI: Sue Aicher).	Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Beasley KD, 2011, NEUROSURG CLIN N AM, V22, P7, DOI 10.1016/j.nec.2010.08.009; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Brufsky AM, 2011, CLIN CANCER RES, V17, P4834, DOI 10.1158/1078-0432.CCR-10-2962; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dittrich A, 2014, J MAMMARY GLAND BIOL, P1; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta P, 2014, ONCOTARGET, V5, P1812, DOI 10.18632/oncotarget.1743; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Kim KB, 2012, MELANOMA RES, V22, P294, DOI 10.1097/CMR.0b013e32835312e4; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Moore KM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju169; Ning SC, 2010, CANCER RES, V70, P7591, DOI 10.1158/0008-5472.CAN-10-1639; Novitskaya V, 2014, ONCOGENE, V33, P2779, DOI 10.1038/onc.2013.231; O'Day S, 2011, BRIT J CANCER, V105, P346, DOI 10.1038/bjc.2011.183; Owonikoko TK, 2014, NAT REV CLIN ONCOL, V11, P203, DOI 10.1038/nrclinonc.2014.25; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Patil A, 2015, CANCER LETT, V358, P93, DOI 10.1016/j.canlet.2014.12.026; Puhalla S, 2015, NEURO-ONCOLOGY, V17, P639, DOI 10.1093/neuonc/nov023; Sato T, 2003, HEPATO-GASTROENTEROL, V50, P27; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; van den Hoogen C, 2011, AM J PATHOL, V179, P2559, DOI 10.1016/j.ajpath.2011.07.011; Vogetseder A, 2013, INT J CANCER, V133, P2362, DOI 10.1002/ijc.28267; von Schlippe M, 2000, J CELL SCI, V113, P425; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0	37	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131842	10.1371/journal.pone.0131842	http://dx.doi.org/10.1371/journal.pone.0131842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222911	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800020
J	Song, CG; Huang, JJ; Li, YJ; Xia, Y; Wang, Y; Bi, XW; Jiang, WQ; Huang, HQ; Lin, TY; Li, ZM				Song, Chen-Ge; Huang, Jia-Jia; Li, Ya-Jun; Xia, Yi; Wang, Yu; Bi, Xi-Wen; Jiang, Wen-Qi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Zhi-Ming			Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis	PLOS ONE			English	Article							LYMPHOPROLIFERATIVE DISORDERS; RITUXIMAB-CHOP; OPEN-LABEL; DLBCL; LENALIDOMIDE; CHEMOTHERAPY; COMBINATION; INHIBITOR; IBRUTINIB; THERAPY	Background Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) in the elderly has rarely been reported. This study aimed to explore the clinical characteristics and prognosis of this entity. Methods In situ hybridization (ISH) analysis of Epstein-Barr virus (EBV) and immunohistochemistry was performed in 230 tumor specimens from consecutive de novo DLBCL patients over 50 years old. A matched-case control analysis (1:3) was utilized to compare EBV-positive and EBV-negative DLBCL in the elderly. Results A total of 16 patients (7.0%) were diagnosed with EBV-positive DLBCL. Of these 16 cases, the median age was 62 years, with a male to female ratio of 11:5. Elderly EBV-positive DLBCL patients had a higher incidence of non-germinal center B-cell (non-GCB) subtypes (87.5%) and high Ki67 (75%) and CD30 expression (93.8%). For EBV-positive patients undergoing initial chemotherapy, 7 of 16 (43.8%) had complete remission, 2 (12.5%) had partial remission, 2 (12.5%) had stable disease, and 5 (31.3%) had progressive disease. The median overall survival was 9 months for the EBV-positive patients. A matched-case control analysis suggested that EBV-positive patients had inferior survival outcomes compared with EBV-negative patients (3-year progression-free survival [PFS]: 25% vs. 76.7%, respectively; 3-year overall survival [OS]: 25% vs. 77.4%, respectively; P<0.001). Conclusion EBV-positive DLBCL of the elderly is associated with an inferior clinical course and inferior survival outcomes. The role of EBV in this disease and the optimal management of this subgroup warrants further investigation.	[Song, Chen-Ge; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Bi, Xi-Wen; Jiang, Wen-Qi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Zhi-Ming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Li, Ya-Jun] Tumor Hosp Hunan Prov, Changsha, Hunan, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Li, ZM (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	lzmsysu@hotmail.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81472759, 81301903]; Guangdong Natural Science Foundation [S2013010016331]; Science and Technology Planning Project of Guangdong Province, China [2014J4100163]; Science and Technology Planning Project of Guangzhou, China [2013B021800142]; Fundamental Research Funds for the Central Universities [10ykpy36]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Planning Project of Guangzhou, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by the National Natural Science Foundation of China (project number: 81472759, 81301903), Guangdong Natural Science Foundation (project number: S2013010016331), Science and Technology Planning Project of Guangdong Province, China (project number: 2014J4100163), Science and Technology Planning Project of Guangzhou, China (project number: 2013B021800142), Fundamental Research Funds for the Central Universities (project number: 10ykpy36), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center.	Bellas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098169; Chang ST, 2014, J CLIN PATHOL, V67, P326, DOI 10.1136/jclinpath-2013-201905; Cohen M, 2014, INT J CANCER, V135, P2816, DOI 10.1002/ijc.28942; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dasmahapatra G, 2013, BRIT J HAEMATOL, V161, P43, DOI 10.1111/bjh.12206; Davids MS, 2014, FUTURE ONCOL, V10, P957, DOI 10.2217/fon.14.51; Desai M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-55; Elstrom RL, 2012, LEUKEMIA LYMPHOMA, V53, P1469, DOI 10.3109/10428194.2012.656629; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064158; Li YJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-84; Michallet AS, 2012, CURR OPIN ONCOL, V24, P461, DOI 10.1097/CCO.0b013e3283562036; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Murawski N, 2014, ANN ONCOL, V25, P1800, DOI 10.1093/annonc/mdu208; Nikiforow S, 2014, J CLIN ONCOL, V32, P830, DOI 10.1200/JCO.2013.53.2994; Nowakowski GS, 2015, J CLIN ONCOL, V33, P251, DOI 10.1200/JCO.2014.55.5714; Ogura M, 2014, CANCER SCI, V105, P840, DOI 10.1111/cas.12435; Ok CY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.82; Ok CY, 2014, CLIN CANCER RES, V20, P2338, DOI 10.1158/1078-0432.CCR-13-3157; Ok CY, 2013, BLOOD, V122, P328, DOI 10.1182/blood-2013-03-489708; Oki Y, 2014, BRIT J HAEMATOL, V166, P891, DOI 10.1111/bjh.12982; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Shimoyama Y, 2008, CANCER SCI, V99, P1085, DOI 10.1111/j.1349-7006.2008.00813.x; Vitolo U, 2014, LANCET ONCOL, V15, P730, DOI 10.1016/S1470-2045(14)70191-3; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0	31	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133973	10.1371/journal.pone.0133973	http://dx.doi.org/10.1371/journal.pone.0133973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222726	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800089
J	Chakroun, I; Yang, DB; Girgis, J; Gunasekharan, A; Phenix, H; Kaern, M; Blais, A				Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Phenix, Hilary; Kaern, Mads; Blais, Alexandre			Genome-wide association between Six4, MyoD, and the histone demethylase Utx during myogenesis	FASEB JOURNAL			English	Article						adult muscle regeneration; transcriptional regulation; histone methylation	MUSCLE FIBER-TYPE; 6 FAMILY GENES; SKELETAL-MUSCLE; SATELLITE CELLS; TRANSCRIPTION FACTOR; ADULT MUSCLE; EXPRESSION; MEF2; ACTIVATION; PROTEIN	Adult skeletalmuscles can regenerate after injury, due to the presence of satellite cells, a quiescent population of myogenic progenitor cells. Once activated, satellite cells repair the muscle damage by undergoing myogenic differentiation. The myogenic regulatory factors (MRFs) coordinate the process of progenitor differentiation in cooperation with other families of transcription factors (TFs). The Six1 and Six4 homeodomain TFs are expressed in developing and adult muscle and Six1 is critical for embryonic and adult myogenesis. However, the lack of a muscle developmental phenotype in Six4-null mice, which has been attributed to compensation by other Six family members, has discouraged further assessment of the role of Six4 during adult muscle regeneration. By employing genome-wide approaches to address the function of Six4 during adult skeletal myogenesis, we have identified a core set of muscle genes coordinately regulated in adult muscle precursors by Six4 and the MRF MyoD. Throughout the genome of differentiating adult myoblasts, the cooperation between Six4 and MyoD is associated with chromatin repressive mark removal by Utx, a demethylase of histone H3 trimethylated at lysine 27. Among the genes coordinately regulated by Six4 and MyoD are several genes critical for proper in vivo muscle regeneration, implicating a role of Six4 in this process. Using in vivo RNA interference of Six4, we expose an uncompensated function of this TF during muscle regeneration. Together, our results reveal a role for Six4 during adult muscle regeneration and suggest a widespread mechanism of cooperation between Six4 and MyoD.	[Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Phenix, Hilary; Kaern, Mads; Blais, Alexandre] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Chakroun, Imane; Yang, Dabo; Girgis, John; Gunasekharan, Atchayaa; Blais, Alexandre] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Phenix, Hilary] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Blais, A (corresponding author), Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	alexandre.blais@uottawa.ca	Kaern, Mads/GVU-6867-2022; Phenix, Hilary/AAE-9326-2019	Kaern, Mads/0000-0002-9371-666X; Blais, Alexandre/0000-0003-2446-1883; Girgis, John/0000-0003-2563-6905	Canadian Institutes of Health Research [MOP 119458]; Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada	The authors thank Jeffrey Dilworth for discussions and reagents, Uzma Islam for help with cloning, Emeka Enwere for help with primary myoblast isolation and culture, and John Lunde for advice and technical help with muscle injury. The authors also thank Yubing Liu and Ellias Horner for helpful discussions, technical help, and editing the manuscript. This work was supported by a research grant from the Canadian Institutes of Health Research (MOP 119458 to A.B.), a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada (to I.C.), and by an Alexander Graham Bell Doctoral Scholarship from Natural Sciences and Engineering Research Council of Canada (to H.P.). I.C. and A.B. designed the experiments, performed bioinformatic analyses, and wrote the manuscript; I.C., D.Y., and J.G. implemented the animal work; D.Y. performed embryonic myosin heavy-chain immunostaining on tissues; D.Y. and J.G. performed hematoxylin and eosin staining; A.B., D.Y., and J.G. analyzed images of embryonic myosin heavy chain and hematoxylin and eosin staining; I.C. and A.G. performed luciferase assays; H.P. and M.K. analyzed luciferase data; and all other experiments, including gene expression profiling, chromatin immunoprecipitation, and chromatin immunoprecipitation followed by sequencing, were performed by I.C. The authors declare no conflicts of interest.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Benhaddou A, 2012, CELL DEATH DIFFER, V19, P220, DOI 10.1038/cdd.2011.87; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bharathy Narendra, 2013, Subcell Biochem, V61, P139, DOI 10.1007/978-94-007-4525-4_7; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blais A, 2015, J MOL BIOL, V427, P2023, DOI 10.1016/j.jmb.2015.02.009; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; Enwere EK, 2013, HUM MOL GENET, V22, P867, DOI 10.1093/hmg/dds493; Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644; Giordani J, 2007, P NATL ACAD SCI USA, V104, P11310, DOI 10.1073/pnas.0611299104; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Gunther S, 2013, CELL STEM CELL, V13, P590, DOI 10.1016/j.stem.2013.07.016; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Le Grand F, 2012, J CELL BIOL, V198, P815, DOI 10.1083/jcb.201201050; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067762; Liu YB, 2012, NUCLEIC ACIDS RES, V40, P8227, DOI 10.1093/nar/gks587; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Mueller AC, 2015, MOL CELL BIOL, V35, P498, DOI 10.1128/MCB.01079-14; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Niro C, 2010, DEV BIOL, V338, P168, DOI 10.1016/j.ydbio.2009.11.031; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ohto H, 1999, MOL CELL BIOL, V19, P6815; OLIVER G, 1995, DEVELOPMENT, V121, P693; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Ozaki H, 2001, MOL CELL BIOL, V21, P3343, DOI 10.1128/MCB.21.10.3343-3350.2001; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Rocha-Viegas L, 2014, MOL CELL BIOL, V34, P3765, DOI 10.1128/MCB.00839-14; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; SHAFIQ SA, 1968, J ANAT, V103, P135; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Takanashi T, 1997, J NEUROL SCI, V145, P41, DOI 10.1016/S0022-510X(96)00237-7; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang AHJ, 2013, EMBO J, V32, P1075, DOI 10.1038/emboj.2013.54; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yajima H, 2010, EXP CELL RES, V316, P2932, DOI 10.1016/j.yexcr.2010.08.001; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	85	25	25	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4738	4755		10.1096/fj.15-277053	http://dx.doi.org/10.1096/fj.15-277053			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26229056				2022-12-26	WOS:000364514700029
J	Fazakerley, DJ; Naghiloo, S; Chaudhuri, R; Koumanov, F; Burchfield, JG; Thomas, KC; Krycer, JR; Prior, MJ; Parker, BL; Murrow, BA; Stockli, J; Meoli, CC; Holman, GD; James, DE				Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Koumanov, Francoise; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; Prior, Matthew J.; Parker, Ben L.; Murrow, Beverley A.; Stoeckli, Jacqueline; Meoli, Christopher C.; Holman, Geoffrey D.; James, David E.			Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; CELL-SURFACE GLUT4; RAT ADIPOSE-CELLS; STIMULATED TRANSLOCATION; PROTEIN; TISSUE; BINDING; SUFFICIENT; METFORMIN; INCREASES	Insulin signaling augments glucose transport by regulating glucose transporter 4 (GLUT4) trafficking from specialized intracellular compartments, termed GLUT4 storage vesicles (GSVs), to the plasma membrane. Proteomic analysis of GSVs by mass spectrometry revealed enrichment of 59 proteins in these vesicles. We measured reduced abundance of 23 of these proteins following insulin stimulation and assigned these as high confidence GSV proteins. These included established GSV proteins such as GLUT4 and insulin-responsive aminopeptidase, as well as six proteins not previously reported to be localized to GSVs. Tumor suppressor candidate 5 (TUSC5) was shown to be a novel GSV protein that underwent a 3.7-fold increase in abundance at the plasma membrane in response to insulin. siRNA-mediated knockdown of TUSC5 decreased insulin-stimulated glucose uptake, although overexpression of TUSC5 had the opposite effect, implicating TUSC5 as a positive regulator of insulin-stimulated glucose transport in adipocytes. Incubation of adipocytes with TNF alpha caused insulin resistance and a concomitant reduction in TUSC5. Consistent with previous studies, peroxisome proliferator-activated receptor (PPAR) gamma agonism reversed TNF alpha-induced insulin resistance. TUSC5 expression was necessary but insufficient for PPAR gamma-mediated reversal of insulin resistance. These findings functionally link TUSC5 to GLUT4 trafficking, insulin action, insulin resistance, and PPAR gamma action in the adipocyte. Further studies are required to establish the exact role of TUSC5 in adipocytes.	[Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Burchfield, James G.; Thomas, Kristen C.; Krycer, James R.; Parker, Ben L.; Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Fazakerley, Daniel J.; Naghiloo, Sheyda; Chaudhuri, Rima; Burchfield, James G.; Krycer, James R.; Prior, Matthew J.; Parker, Ben L.; Murrow, Beverley A.; Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Koumanov, Francoise; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Bath	James, DE (corresponding author), Univ Sydney, Sch Med, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au	Stoeckli, Jacqueline/Z-4443-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Burchfield, James/C-1779-2019; Koumanov, Francoise/AAV-7654-2020	Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Burchfield, James/0000-0002-6609-6151; Koumanov, Francoise/0000-0002-9029-3390; James, David/0000-0001-5946-5257; Holman, Geoffrey/0000-0001-7045-1358; Krycer, James/0000-0003-1536-7270; Cooke, Kristen/0000-0002-3534-1660	National Health and Medical Research Council of Australia [1052782]; Medical Research Council UK; Diabetes UK; National Health and Medical Research Council of Australia Early Career Fellowships; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [G9225018, MR/J003417/1, G0300415] Funding Source: researchfish; MRC [MR/J003417/1, G0300415, G9225018] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); National Health and Medical Research Council of Australia Early Career Fellowships(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1052782 (to D.J.F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Medical Research Council UK and Diabetes UK.; Supported by National Health and Medical Research Council of Australia Early Career Fellowships.	Ahuja HS, 2001, MOL PHARMACOL, V59, P765, DOI 10.1124/mol.59.4.765; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Chen Y., 2013, COMMUN INTEGRATIVE B, V6, P545; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HOFMANN C, 1991, ENDOCRINOLOGY, V129, P1915, DOI 10.1210/endo-129-4-1915; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; IWAMOTO Y, 1991, DIABETES CARE, V14, P1083, DOI 10.2337/diacare.14.11.1083; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2005, DIABETES, V54, P1459, DOI 10.2337/diabetes.54.5.1459; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; Kim KY, 2007, MOL PHARMACOL, V71, P1554, DOI 10.1124/mol.106.031948; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Knotts T. A., 2010, PPAR RES; Konishi H, 2003, ONCOGENE, V22, P1892, DOI 10.1038/sj.onc.1206304; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Malide D, 2001, MOL BIOL CELL, V12, P101, DOI 10.1091/mbc.12.1.101; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ohiro Y, 2002, FEBS LETT, V524, P163, DOI 10.1016/S0014-5793(02)03049-1; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; R Core Team, 2021, R LANGUAGE ENV STAT; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shibata T, 2007, MOL CELL ENDOCRINOL, V263, P38, DOI 10.1016/j.mce.2006.08.007; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sommer C., 2011, IEEE 8 INT S BIOM IM; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Yamakuni T, 2002, FEBS LETT, V530, P94, DOI 10.1016/S0014-5793(02)03431-2; Yang P., 2015, DIRECT ANAL PATHWAYS; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YOUNG PW, 1995, DIABETES, V44, P1087, DOI 10.2337/diabetes.44.9.1087	72	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23528	23542		10.1074/jbc.M115.657361	http://dx.doi.org/10.1074/jbc.M115.657361			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240143	Green Published, hybrid			2022-12-26	WOS:000361816500006
J	Otsubo, C; Bharathi, S; Uppala, R; Ilkayeva, OR; Wang, D; McHugh, K; Zou, Y; Wang, J; Alcorn, JF; Zuo, YY; Hirschey, MD; Goetzman, ES				Otsubo, Chikara; Bharathi, Sivakama; Uppala, Radha; Ilkayeva, Olga R.; Wang, Dongning; McHugh, Kevin; Zou, Ye; Wang, Jieru; Alcorn, John F.; Zuo, Yi Y.; Hirschey, Matthew D.; Goetzman, Eric S.			Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-DEFICIENCY; BETA-OXIDATION; L-CARNITINE; MILDRONATE; PLASMA; DRUG; PALMITOYLCARNITINE; ENHANCEMENT; MEMBRANE; MUTATION	The role of mitochondrial energy metabolism in maintaining lung function is not understood. We previously observed reduced lung function in mice lacking the fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase (LCAD). Here, we demonstrate that long-chain acylcarnitines, a class of lipids secreted by mitochondria when metabolism is inhibited, accumulate at the air-fluid interface in LCAD(-/-) lungs. Acylcarnitine accumulation is exacerbated by stress such as influenza infection or by dietary supplementation with L-carnitine. Long-chain acylcarnitines co-localize with pulmonary surfactant, a unique film of phospholipids and proteins that reduces surface tension and prevents alveolar collapse during breathing. In vitro, the long-chain species palmitoylcarnitine directly inhibits the surface adsorption of pulmonary surfactant as well as its ability to reduce surface tension. Treatment of LCAD(-/-) mice with mildronate, a drug that inhibits carnitine synthesis, eliminates acylcarnitines and improves lung function. Finally, acylcarnitines are detectable in normal human lavage fluid. Thus, long-chain acylcarnitines may represent a risk factor for lung injury in humans with dysfunctional fatty acid oxidation.	[Otsubo, Chikara; Bharathi, Sivakama; Uppala, Radha; McHugh, Kevin; Wang, Jieru; Alcorn, John F.; Goetzman, Eric S.] Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA; [Ilkayeva, Olga R.; Wang, Dongning; Hirschey, Matthew D.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Durham, NC 27701 USA; [Zou, Ye; Zuo, Yi Y.] Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University of Hawaii System; University of Hawaii Manoa	Goetzman, ES (corresponding author), Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA.	Eric.goetzman@chp.edu	Zou, Ye/AAY-1073-2021; Zuo, Yi Y./B-3177-2013	Zuo, Yi Y./0000-0002-3992-3238; Hirschey, Matthew/0000-0003-4541-5376; Zou, Ye/0000-0002-3145-9661	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000371] Funding Source: Medline; NHLBI NIH HHS [R01 HL113655] Funding Source: Medline; NIMHD NIH HHS [U54 MD007584] Funding Source: Medline; Div Of Chem, Bioeng, Env, & Transp Sys [1254795] Funding Source: National Science Foundation	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bakermans AJ, 2013, J INHERIT METAB DIS, V36, P973, DOI 10.1007/s10545-013-9604-4; BRACIALE TJ, 1977, CELL IMMUNOL, V33, P423, DOI 10.1016/0008-8749(77)90170-8; DATORRE SD, 1991, J MOL CELL CARDIOL, V23, P11, DOI 10.1016/0022-2828(91)90019-I; Doi N, 2011, DRUG METAB PHARMACOK, V26, P162, DOI 10.2133/dmpk.DMPK-10-RG-071; Duan YL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-4; Duizer E, 1998, J PHARMACOL EXP THER, V287, P395; Dzerve V, 2011, MEDICINA-LITHUANIA, V47, P544; Gentili A, 2008, MINERVA ANESTESIOL, V74, P207; Goetzman ES, 2014, J BIOL CHEM, V289, P10668, DOI 10.1074/jbc.M113.540260; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Hayashi M, 1999, J CONTROL RELEASE, V62, P141, DOI 10.1016/S0168-3659(99)00031-0; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kao HJ, 2006, HUM MOL GENET, V15, P3569, DOI 10.1093/hmg/ddl433; KURTH L, 1994, BBA-GEN SUBJECTS, V1201, P321, DOI 10.1016/0304-4165(94)90057-4; Liepinsh E, 2011, J PHARM PHARMACOL, V63, P1195, DOI 10.1111/j.2042-7158.2011.01325.x; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lopez-Rodriguez E., 2014, BIOCH BIOPHYS ACTA; Lundy CT, 2003, J INHERIT METAB DIS, V26, P537, DOI 10.1023/A:1025995813914; Madala SK, 2011, PULM MED, V2011, DOI 10.1155/2011/653524; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Miller ML, 1995, TISSUE CELL, V27, P613, DOI 10.1016/S0040-8166(05)80017-5; Millington DS, 2011, METHODS MOL BIOL, V708, P55, DOI 10.1007/978-1-61737-985-7_3; Nasser M., 2012, COCHRANE DB SYST REV, V2, P1; Onofrj M, 2013, EXPERT REV NEUROTHER, V13, P925, DOI 10.1586/14737175.2013.814930; REQUERO MA, 1995, BIOCHEMISTRY-US, V34, P10400, DOI 10.1021/bi00033a011; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Sjakste N, 2005, CNS DRUG REV, V11, P151; Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500; Tyni T, 1997, J PEDIATR-US, V130, P67, DOI 10.1016/S0022-3476(97)70312-3; Ussher JR, 2014, J PHARMACOL EXP THER, V349, P487, DOI 10.1124/jpet.114.214197; Valle R. P., 2014, ACS SUSTAIN CHEM ENG, V2, P6; Veiga MP, 1996, MOL MEMBR BIOL, V13, P165, DOI 10.3109/09687689609160593; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Zhu Y, 2013, CLIN DRUG INVEST, V33, P755, DOI 10.1007/s40261-013-0121-x; Zuo YY, 2004, BBA-GEN SUBJECTS, V1675, P12, DOI 10.1016/j.bbagen.2004.08.003	43	36	36	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23897	23904		10.1074/jbc.M115.655837	http://dx.doi.org/10.1074/jbc.M115.655837			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240137	hybrid, Green Published			2022-12-26	WOS:000361816500035
J	Li, H; Liu, Q; Wang, Z; Fang, RP; Shen, Y; Cai, XL; Gao, Y; Li, YH; Zhang, XD; Ye, LH				Li, Hang; Liu, Qian; Wang, Zhen; Fang, Runping; Shen, Yu; Cai, Xiaoli; Gao, Yuen; Li, Yinghui; Zhang, Xiaodong; Ye, Lihong			The Oncoprotein HBXIP Modulates the Feedback Loop of MDM2/p53 to Enhance the Growth of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTE PROLIFERATION; CENTROSOME DYNAMICS; CELL-PROLIFERATION; PROTEIN PROMOTES; UP-REGULATION; P53 FUNCTION; TRANSCRIPTION; EXPRESSION; TARGET; P300	MDM2 and p53 form a negative feedback loop, in which p53 as a transcription factor positively regulates MDM2 and MDM2 negatively regulates tumor suppressor p53 through promoting its degradation. However, the mechanism of the feedback loop is poorly understood in cancers. We had reported previously that the oncoprotein hepatitis B X-interacting protein (HBXIP) is a key oncoprotein in the development of cancer. Thus, we supposed that HBXIP might be involved in the event. Here, we observed that the expression levels of HBXIP were positively correlated to those of MDM2 in clinical breast cancer tissues. Interestingly, HBXIP was able to up-regulate MDM2 at the levels of mRNA and protein in MCF-7 breast cancer cells. Mechanically, HBXIP increased the promoter activities of MDM2 through directly binding to p53 in the P2 promoter of MDM2. Strikingly, we identified that the acetyltransferase p300 was recruited by HBXIP to p53 in the promoter of MDM2. Moreover, we validated that HBXIP enhanced the p53 degradation mediated by MDM2. Functionally, the knockdown of HBXIP or/and p300 inhibited the proliferation of breast cancer cells in vitro, and the depletion of MDM2 or overexpression of p53 significantly blocked the HBXIP-promoted growth of breast cancer in vitro and in vivo. Thus, we concluded that highly expressed HBXIP accelerates the MDM2-mediated degradation of p53 in breast cancer through modulating the feedback loop of MDM2/p53, resulting in the fast growth of breast cancer cells. Our findings provide new insights into the mechanism of the acceleration of the MDM2/p53 feedback loop in the development of cancer.	[Li, Hang; Liu, Qian; Wang, Zhen; Fang, Runping; Shen, Yu; Cai, Xiaoli; Li, Yinghui; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [Gao, Yuen; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Fang, Runping/AAF-6835-2020; Gao, Yuen/AAM-7541-2021	Gao, Yuen/0000-0002-2807-2976	National Basic Research Program of China (973 Program) [2015CB553905]; National Natural Science Foundation of China [81372186, 81272217, 81272218]; Project for Prevention and Treatment of Key Infectious Diseases [2014ZX0002002-005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Prevention and Treatment of Key Infectious Diseases	This work was supported by Grant 2015CB553905 from the National Basic Research Program of China (973 Program), Grants 81372186, 81272217, and 81272218 from the National Natural Science Foundation of China, and Grant 2014ZX0002002-005 from the Project for Prevention and Treatment of Key Infectious Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Amaral JD, 2007, J BIOL CHEM, V282, P34250, DOI 10.1074/jbc.M704075200; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chen HL, 2012, BIOMED PHARMACOTHER, V66, P334, DOI 10.1016/j.biopha.2011.12.005; D'Arcy P, 2009, CANCER LETT, V275, P285, DOI 10.1016/j.canlet.2008.10.030; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Debes JD, 2002, CANCER RES, V62, P5632; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jenkins LMM, 2015, BIOCHEMISTRY-US, V54, P2001, DOI 10.1021/acs.biochem.5b00044; JUVEN T, 1993, ONCOGENE, V8, P3411; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li SD, 2008, MOL THER, V16, P942, DOI 10.1038/mt.2008.51; Li Song, 2003, FASEB Journal, V17, P97; Li YH, 2014, CANCER LETT, V355, P288, DOI 10.1016/j.canlet.2014.09.047; Liu FB, 2014, CARCINOGENESIS, V35, P1144, DOI 10.1093/carcin/bgu021; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Maglic D, 2013, ONCOGENE, V32, P4120, DOI 10.1038/onc.2012.423; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miyajima K, 2001, CANCER LETT, V164, P177, DOI 10.1016/S0304-3835(00)00607-8; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Okita N, 2014, BIOCHEM BIOPH RES CO, V446, P91, DOI 10.1016/j.bbrc.2014.02.059; Onel K, 2004, MOL CANCER RES, V2, P1; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phelps M, 2003, CANCER RES, V63, P2616; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Turbin DA, 2006, MODERN PATHOL, V19, P69, DOI 10.1038/modpathol.3800484; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu FQ, 2014, INT J ONCOL, V45, P255, DOI 10.3892/ijo.2014.2411; Xu FQ, 2013, CANCER LETT, V333, P124, DOI 10.1016/j.canlet.2013.01.029; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang X, 2012, J BIOL CHEM, V287, P30468, DOI 10.1074/jbc.M112.373738; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhang YY, 2013, BIOCHEM BIOPH RES CO, V434, P305, DOI 10.1016/j.bbrc.2013.02.123; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	59	21	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22649	22661		10.1074/jbc.M115.658468	http://dx.doi.org/10.1074/jbc.M115.658468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26229107	Green Published, hybrid			2022-12-26	WOS:000361171500030
J	Gremmel, T; Frelinger, AL; Michelson, AD				Gremmel, Thomas; Frelinger, Andrew L., III; Michelson, Alan D.			Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PLATELET ACTIVATION; PLASMA-LEVELS; P-SELECTIN; CLOPIDOGREL; RISK; EVENTS	Plasma soluble CD40 ligand (sCD40L) is mainly generated by cleavage of CD40L from the surface of activated platelets, and therefore considered a platelet activation marker. Although the predictive value of sCD40L for ischemic events has been demonstrated in patients with acute coronary syndromes (ACS), studies on the association of sCD40L with cardiovascular outcomes in lower risk populations yielded heterogeneous results. We therefore sought to investigate factors influencing sCD40L levels, and the predictive value of sCD40L for long-term ischemic events in unselected, aspirin-treated patients undergoing cardiac catheterization. sCD40L was determined by a commercially available enzyme-linked immunosorbent assay in 682 consecutive patients undergoing cardiac catheterization. Two-year follow-up data were obtained from 562 patients. Dual antiplatelet therapy with aspirin and clopidogrel was associated with significantly lower levels of sCD40L and lower platelet surface expressions of P-selectin and activated GPIIb/IIIa compared to aspirin monotherapy (all p <= 0.01). Hypertension was linked to lower plasma concentrations of sCD40L, whereas female sex, increasing high-sensitivity C-reactive protein, and hematocrit were associated with higher sCD40L concentrations (all p<0.05). sCD40L levels were similar in patients without and with the primary endpoint in the overall study population (p = 0.4). Likewise, sCD40L levels did not differ significantly between patients without and with the secondary endpoints (both p >= 0.4). Similar results were obtained when only patients with angiographically-proven coronary artery disease (n = 459), stent implantation (n = 205) or ACS (n = 125) were analyzed. The adjustment for differences in patient characteristics by multivariate regression analyses did not change the results. ROC curve analyses did not reveal cut-off values for sCD40L for the prediction of the primary or secondary endpoints. In conclusion, plasma sCD40L levels are reduced by antiplatelet therapy with clopidogrel, but not associated with long-term ischemic outcomes in unselected consecutive aspirin-treated patients undergoing cardiac catheterization.	[Gremmel, Thomas; Frelinger, Andrew L., III; Michelson, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol,Boston, Boston, MA 02115 USA; [Gremmel, Thomas] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Medical University of Vienna	Gremmel, T (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol,Boston, 44 Binney St, Boston, MA 02115 USA.	thomas.gremmel@childrens.harvard.edu	Michelson, Alan/ABE-8487-2021	Michelson, Alan/0000-0002-1746-4819; Gremmel, Thomas/0000-0001-9554-7292	Bristol-Myers Squibb; GLSynthesis; Lilly/Daiichi Sankyo; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); GLSynthesis; Lilly/Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Pfizer(Pfizer)	Alan D. Michelson has received grant support from Bristol-Myers Squibb, GLSynthesis, Lilly/Daiichi Sankyo and Pfizer, and served on data monitoring committees of Lilly/Daiichi Sankyo clinical trials. Andrew L. Frelinger has received grant support from Bristol-Myers Squibb, GLSynthesis, Lilly/Daiichi Sankyo and Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Azar RR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.021; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P578, DOI 10.1160/TH04-09-0586; de Lemos JA, 2005, ARTERIOSCL THROM VAS, V25, P2192, DOI 10.1161/01.ATV.0000182904.08513.60; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; Furman MI, 2005, J THROMB HAEMOST, V3, P312, DOI 10.1111/j.1538-7836.2005.01124.x; Furman MI, 2004, J AM COLL CARDIOL, V43, P2319, DOI 10.1016/j.jacc.2003.12.055; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Gremmel T, 2014, ATHEROSCLEROSIS, V237, P692, DOI 10.1016/j.atherosclerosis.2014.10.095; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hristov M, 2010, CIRCULATION, V121, P315, DOI 10.1161/CIRCULATIONAHA.109.862771; Jefferis BJ, 2011, J THROMB HAEMOST, V9, P1452, DOI 10.1111/j.1538-7836.2011.04415.x; Lim HS, 2004, CIRCULATION, V109, P2524, DOI 10.1161/01.CIR.0000129773.70647.94; Linden MD, 2007, J THROMB HAEMOST, V5, P761, DOI 10.1111/j.1538-7836.2007.02462.x; Ludwiczek O, 2003, INT J COLORECTAL DIS, V18, P142, DOI 10.1007/s00384-002-0425-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Morrow DA, 2008, EUR HEART J, V29, P1096, DOI 10.1093/eurheartj/ehn071; Nannizzi-Alaimo L, 2002, CIRCULATION, V105, P2849, DOI 10.1161/01.CIR.0000019068.32280.B3; Pusuroglu H, 2014, CORONARY ARTERY DIS, V25, P558, DOI 10.1097/MCA.0000000000000142; Rondina MT, 2008, CARDIOLOGY, V109, P196, DOI 10.1159/000106683; Rosiak M, 2013, CARDIOL J, V20, P545, DOI 10.5603/CJ.2013.0045; Rosin C, 2006, PLATELETS, V17, P61, DOI 10.1080/09537100500227021; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Santilli F, 2009, J AM COLL CARDIOL, V53, P667, DOI 10.1016/j.jacc.2008.10.047; Schernthaner GH, 2006, EUR J CLIN INVEST, V36, P395, DOI 10.1111/j.1365-2362.2006.01649.x; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; Tanne D, 2006, INT J CARDIOL, V107, P322, DOI 10.1016/j.ijcard.2005.03.051; Undas A, 2009, KARDIOL POL, V67, P591; Valdes V, 2015, J THROMB THROMBOLYS, V40, P83, DOI 10.1007/s11239-015-1179-5; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Varo N, 2003, CIRCULATION, V107, P2664, DOI 10.1161/01.CIR.0000074043.46437.44; Varo N, 2006, CLIN SCI, V111, P341, DOI 10.1042/CS20060047; Wenzel F, 2008, CLIN HEMORHEOL MICRO, V39, P417, DOI 10.3233/CH-2008-1112; Wiley JA, 1997, J IMMUNOL, V158, P2932; Wykrzykowska JJ, 2009, J THROMB THROMBOLYS, V28, P410, DOI 10.1007/s11239-009-0354-y; Yip HK, 2006, AM J CARDIOL, V97, P192, DOI 10.1016/j.amjcard.2005.08.023	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134599	10.1371/journal.pone.0134599	http://dx.doi.org/10.1371/journal.pone.0134599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237513	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400030
J	Diedrichsen, J; Zotow, E				Diedrichsen, Joern; Zotow, Ewa			Surface-Based Display of Volume-Averaged Cerebellar Imaging Data	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; HUMAN CONNECTOME PROJECT; HUMAN CEREBRAL-CORTEX; CORTICAL SURFACE; ORGANIZATION; ATLAS; FMRI; REGISTRATION; SEGMENTATION; LOCALIZATION	The paper presents a flat representation of the human cerebellum, useful for visualizing functional imaging data after volume-based normalization and averaging across subjects. Instead of reconstructing individual cerebellar surfaces, the method uses a white-and grey-matter surface defined on volume-averaged anatomical data. Functional data can be projected along the lines of corresponding vertices on the two surfaces. The flat representation is optimized to yield a roughly proportional relationship between the surface area of the 2D-representation and the volume of the underlying cerebellar grey matter. The map allows users to visualize the activation state of the complete cerebellar grey matter in one concise view, equally revealing both the anterior-posterior (lobular) and medial-lateral organization. As examples, published data on resting-state networks and task-related activity are presented on the flatmap. The software and maps are freely available and compatible with most major neuroimaging packages.	[Diedrichsen, Joern; Zotow, Ewa] UCL, Inst Cognit Neurosci, London, England	University of London; University College London	Diedrichsen, J (corresponding author), UCL, Inst Cognit Neurosci, London, England.	j.diedrichsen@ucl.ac.uk	Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532	Wellcome Trust [094874/Z/10/Z]; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded by the Wellcome Trust (094874/Z/10/Z) and by a Understanding Human Cognition Scholar award from the James S. McDonnell Foundation (see: https://www.jsmf.org/programs/uhc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; Andersson JL, 2008, FNIRT FMRIBS NONLINE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BRAITENBERG V, 1958, J COMP NEUROL, V109, P1, DOI 10.1002/cne.901090102; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2015, CEREBELLAR TOOLBOX S, DOI DOI 10.6084/M9.FIGSHARE.1485637; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Friston K, 1999, J STAT PARAMETER MAP; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glickstein M, 2011, CORTEX, V47, P59, DOI 10.1016/j.cortex.2009.09.001; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Jansen J, 1972, HUMAN CEREBEL LUM CE; KH E, 2014, HUM BRAIN MAPP, V35, P593, DOI [10.1002/hbm.22194, DOI 10.1002/HBM.22194]; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; LARSELL O, 1958, Arch Sci Biol (Bologna), V42, P90; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Pelphrey KA, 2014, NEURAL CORRELATES AN, DOI [10.1093/cercor/bhu146, DOI 10.1093/CERC0R/BHU146]; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Sereno MI, 2014, ANN M SOC NEUROSCIEN; Shaikh AG, 2011, J NEUROPHYSIOL, V105, P3034, DOI 10.1152/jn.00721.2010; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sultan Fahad, 1993, Journal fuer Hirnforschung, V34, P79; Timmann D, 2009, NEUROSCIENCE, V162, P836, DOI 10.1016/j.neuroscience.2009.01.040; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; Tukey JW, 1977, EXPLORATORY DATA ANA; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Voogd J., 2004, HUMAN NERVOUS SYSTEM, P321, DOI [10.1016/B978-012547626-3/50012-0, DOI 10.1016/B978-012547626-3/50012-0]; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011; WORSLEY KJ, 1996, HUM BRAIN MAPP, V12, P900, DOI DOI 10.1038/JCBFM.1992.127; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	55	128	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133402	10.1371/journal.pone.0133402	http://dx.doi.org/10.1371/journal.pone.0133402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230510	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400036
J	Heim, O; Treitler, JT; Tschapka, M; Knornschild, M; Jung, K				Heim, Olga; Treitler, Julia T.; Tschapka, Marco; Knoernschild, Mirjam; Jung, Kirsten			The Importance of Landscape Elements for Bat Activity and Species Richness in Agricultural Areas	PLOS ONE			English	Article							FORAGING HABITAT; SCATTERED TREES; BIODIVERSITY; INTENSIFICATION; ECHOLOCATION; CONSEQUENCES; INSECT; IDENTIFICATION; CONNECTIVITY; VARIABILITY	Landscape heterogeneity is regarded as a key factor for maintaining biodiversity and ecosystem function in production landscapes. We investigated whether grassland sites at close vicinity to forested areas are more frequently used by bats. Considering that bats are important consumers of herbivorous insects, including agricultural pest, this is important for sustainable land management. Bat activity and species richness were assessed using repeated monitoring from May to September in 2010 with acoustic monitoring surveys on 50 grassland sites in the Biosphere Reserve Schorfheide-Chorin (North-East Germany). Using spatial analysis (GIS), we measured the closest distance of each grassland site to potentially connecting landscape elements (e.g., trees, linear vegetation, groves, running and standing water). In addition, we assessed the distance to and the percent land cover of forest remnants and urban areas in a 200 m buffer around the recording sites to address differences in the local landscape setting. Species richness and bat activity increased significantly with higher forest land cover in the 200 m buffer and at smaller distance to forested areas. Moreover, species richness increased in proximity to tree groves. Larger amount of forest land cover and smaller distance to forest also resulted in a higher activity of bats on grassland sites in the beginning of the year during May, June and July. Landscape elements near grassland sites also influenced species composition of bats and species richness of functional groups (open, edge and narrow space foragers). Our results highlight the importance of forested areas, and suggest that agricultural grasslands that are closer to forest remnants might be better buffered against outbreaks of agricultural pest insects due to higher species richness and higher bat activity. Furthermore, our data reveals that even for highly mobile species such as bats, a very dense network of connecting elements within the landscape is beneficial to promote activity in open areas and thus assure vital ecosystem function in agricultural landscapes.	[Heim, Olga; Treitler, Julia T.; Tschapka, Marco; Knoernschild, Mirjam; Jung, Kirsten] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Tschapka, Marco; Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Jung, K (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany.	kirsten.jung@uni-ulm.de	Heim, Olga/T-9756-2019	Heim, Olga/0000-0002-6664-7793; Knornschild, Mirjam/0000-0003-0448-9600	German Science Foundation [KA 1241/19-1]	German Science Foundation(German Research Foundation (DFG))	This work has been funded by the German Science Foundation (http://www.dfg.de), Priority Program 1374 (KA 1241/19-1) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barto EK, 2010, SOIL BIOL BIOCHEM, V42, P2316, DOI 10.1016/j.soilbio.2010.09.008; Bates D, 2003, R LANG ENV STAT COMP; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Boughey KL, 2011, BIOL CONSERV, V144, P1790, DOI 10.1016/j.biocon.2011.02.017; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ellenberg H, 1996, VEGETATION MITTELEUR; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ewers RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058093; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fischer M, 2010, LONG-TERM ECOLOGICAL RESEARCH: BETWEEN THEORY AND APPLICATION, P429, DOI 10.1007/978-90-481-8782-9_29; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FORMAN RTT, 1984, ENVIRON MANAGE, V8, P495, DOI 10.1007/BF01871575; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Kalda O, 2015, AGR ECOSYST ENVIRON, V199, P105, DOI 10.1016/j.agee.2014.08.028; Kalda R, 2015, BIODIVERS CONSERV, V24, P337, DOI 10.1007/s10531-014-0811-6; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; MILLER LA, 1981, J COMP PHYSIOL, V142, P67, DOI 10.1007/BF00605477; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Obrist MK, 2004, MAMMALIA, V68, P307, DOI 10.1515/mamm.2004.030; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Parsons S, 2000, J EXP BIOL, V203, P2641; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Rich TCG, 1996, BIOL CONSERV, V75, P217, DOI 10.1016/0006-3207(95)00077-1; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; RYDELL J, 1990, ETHOLOGY, V85, P103; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Skiba R, 2003, EUROPAISCHE FLEDERMA, V1; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8	56	47	49	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134443	10.1371/journal.pone.0134443	http://dx.doi.org/10.1371/journal.pone.0134443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231029	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400119
J	Hu, HJ; Park, SG; Jang, HB; Choi, MG; Park, KH; Kang, JH; Park, SI; Lee, HJ; Cho, SH				Hu, Hae-Jin; Park, Sin-Gi; Jang, Han Byul; Choi, Min-Gyu; Park, Kyung-Hee; Kang, Jae Heon; Park, Sang Ick; Lee, Hye-Ja; Cho, Seung-Hak			Obesity Alters the Microbial Community Profile in Korean Adolescents	PLOS ONE			English	Article							GUT MICROBIOME; DNA EXTRACTION; CHILDREN; BACTERIAL; IMPACT; AGE	Obesity is an increasing public health concern worldwide. According to the latest Organization for Economic Co-operation and Development (OECD) report (2014), the incidence of child obesity in Korea has exceeded the OECD average. To better understand and control this condition, the present study examined the composition of the gut microbial community in normal and obese adolescents. Fecal samples were collected from 67 obese (body mass index [BMI] >= 30 kg/m(2), or >= 99th BMI percentile) and 67 normal (BMI < 25 kg/m(2) or < 85th BMI percentile) Korean adolescents aged 13-16 years and subjected to 16S rRNA gene sequencing. Analysis of bacterial composition according to taxonomic rank (genus, family, and phylum) revealed marked differences in the Bacteroides and Prevotella populations in normal and obese samples (p < 0.005) at the genus and family levels; however, there was no difference in the Firmicutes-to-Bacteroidetes (F/B) ratio between normal and obese adolescents samples at the phylum level (F/B normal = 0.50 +/- 0.53; F/B obese = 0.56 +/- 0.86; p = 0.384). Statistical analysis revealed a significant association between the compositions of several bacterial taxa and child obesity. Among these, Bacteroides and Prevotella showed the most significant association with BMI (p < 0.0001 and 0.0001, respectively). We also found that the composition of Bacteroides was negatively associated with triglycerides (TG), total cholesterol, and high-sensitive C-reactive protein (hs-crp) (p = 0.0049, 0.0023, and 0.0038, respectively) levels, whereas that of Prevotella was positively associated with TG and hs-crp levels (p = 0.0394 and 0.0150, respectively). We then applied the association rule mining algorithm to generate "rules" to identify the association between the populations of multiple bacterial taxa and obesity; these rules were able to discriminate obese from normal states. Therefore, the present study describes a systemic approach to identify the association between bacterial populations in the gut and childhood obesity.	[Cho, Seung-Hak] Korea Natl Inst Hlth, Div Enter Dis, Cheongju, Chungcheongbuk, South Korea; [Jang, Han Byul; Park, Sang Ick; Lee, Hye-Ja] Korea Natl Inst Hlth, Ctr Biomed Sci, Cheongju, Chungcheongbuk, South Korea; [Hu, Hae-Jin; Park, Sin-Gi] TheragenEtex Bio Inst Inc, Suwon, South Korea; [Choi, Min-Gyu] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Seoul, South Korea; [Park, Kyung-Hee] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Anyang, Gyeonggi Do, South Korea; [Kang, Jae Heon] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Family Med,Obes Res Inst, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Hallym University; Hallym University; Inje University	Lee, HJ (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Cheongju, Chungcheongbuk, South Korea.	hyejalee@yahoo.co.kr; skcho38@korea.kr	Park, Kyung Hee/AAU-7867-2020	Park, Kyung Hee/0000-0001-9806-0076	Korea National Institute of Health [KNIH4800-4845-300, KNIH4800-4845-302]; Korean Children & Adolescent Study [KoCAS2013-64001-00]; TheragenEtex Bio Institute Inc	Korea National Institute of Health; Korean Children & Adolescent Study; TheragenEtex Bio Institute Inc	This study was funded by the following grants: KNIH4800-4845-300, http://www.nih.go.kr/NIH/eng/main.jsp, Korea National Institute of Health, SHC KNIH4800-4845-302, http://www.nih.go.kr/NIH/eng/main.jsp, Korea National Institute of Health, HJL KoCAS2013-64001-00, Korean Children & Adolescent Study, SIP. Bioinformatics analyses were performed by TheragenEtex Bio Institute Inc. Additionally, TheragenEtex Bio Institute Inc provided support in the form of salaries for authors Hae-Jin Hu and Sin-Gi Park, but did not have any additional role in the study design, data collection and analysis (other than already disclosed), decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Durban A., 2013, METAGENOMICS, V2, P235722, DOI [10.4303/mg/235722, DOI 10.4303/MG/235722]; Ferrer M, 2013, ENVIRON MICROBIOL, V15, P211, DOI 10.1111/j.1462-2920.2012.02845.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lim MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07348; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marti A, 2008, P NUTR SOC, V67, P1, DOI 10.1017/S002966510800596X; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin XX, 2003, SIAM PROC S, P331; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	41	75	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134333	10.1371/journal.pone.0134333	http://dx.doi.org/10.1371/journal.pone.0134333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230509	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400102
J	Ivers, KM; Sredar, N; Patel, NB; Rajagopalan, L; Queener, HM; Twa, MD; Harwerth, RS; Porter, J				Ivers, Kevin M.; Sredar, Nripun; Patel, Nimesh B.; Rajagopalan, Lakshmi; Queener, Hope M.; Twa, Michael D.; Harwerth, Ronald S.; Porter, Jason			In Vivo Changes in Lamina Cribrosa Microarchitecture and Optic Nerve Head Structure in Early Experimental Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; OPEN-ANGLE GLAUCOMA; SCANNING LASER OPHTHALMOSCOPY; AXONAL-TRANSPORT BLOCKADE; FIBER LAYER THICKNESS; COHERENCE TOMOGRAPHY; CONNECTIVE-TISSUE; MONKEY EYES; DAMAGE; DEFORMATION	The lamina cribrosa likely plays an important role in retinal ganglion cell axon injury in glaucoma. We sought to (1) better understand optic nerve head (ONH) structure and anterior lamina cribrosa surface (ALCS) microarchitecture between fellow eyes of living, normal non-human primates and (2) characterize the time-course of in vivo structural changes in the ONH, ALCS microarchitecture, and retinal nerve fiber layer thickness (RNFLT) in non-human primate eyes with early experimental glaucoma (EG). Spectral domain optical coherence tomography (SDOCT) images of the ONH were acquired cross-sectionally in six bilaterally normal rhesus monkeys, and before and approximately every two weeks after inducing unilateral EG in seven rhesus monkeys. ONH parameters and RNFLT were quantified from segmented SDOCT images. Mean ALCS pore area, elongation and nearest neighbor distance (NND) were quantified globally, in sectors and regionally from adaptive optics scanning laser ophthalmoscope images. In bilaterally normal monkeys, ONH parameters were similar between fellow eyes with few inter-eye differences in ALCS pore parameters. In EG monkeys, an increase in mean ALCS Depth (ALCSD) was the first structural change measured in 6 of 7 EG eyes. A decrease in mean minimum rim width (MRW) simultaneously accompanied this early change in 4 of 6 EG eyes and was the first structural change in the 7th EG eye. Mean ALCS pore parameters were among the first or second changes measured in 4 EG eyes. Mean ALCS pore area and NND increased in superotemporal and temporal sectors and in central and peripheral regions at the first time-point of change in ALCS pore geometry. RNFLT and/or mean ALCS radius of curvature were typically the last parameters to initially change. Survival analyses found mean ALCSD was the only parameter to significantly show an initial change prior to the first measured loss in RNFLT across EG eyes.	[Ivers, Kevin M.; Patel, Nimesh B.; Rajagopalan, Lakshmi; Queener, Hope M.; Harwerth, Ronald S.; Porter, Jason] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Sredar, Nripun] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Twa, Michael D.] Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Alabama System; University of Alabama Birmingham	Porter, J (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77204 USA.	jporter@central.uh.edu	Twa, Michael/I-3131-2019; Sredar, Nripun/Q-3714-2019	Twa, Michael/0000-0003-4544-5153; Sredar, Nripun/0000-0002-9567-9815; Patel, Nimesh/0000-0002-1772-2611	National Institutes of Health [R01 EY021783, R01 EY001139, K23 EY021761, P30 EY007551]; NATIONAL EYE INSTITUTE [R01EY001139, R01EY022362, R01EY021783, K23EY021761, P30EY007551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health R01 EY021783 (JP); National Institutes of Health R01 EY001139 (RH); National Institutes of Health K23 EY021761 (NP); National Institutes of Health P30 EY007551 (Laura Frishman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2012, INVEST OPHTH VIS SCI, V53, P4111, DOI 10.1167/iovs.11-7536; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Downs JC, 2001, INVEST OPHTH VIS SCI, V42, P3202; Fontana L, 1998, CURR EYE RES, V17, P363, DOI 10.1080/02713689808951216; Fortune B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077831; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; GAASTERLAND D, 1974, INVEST OPHTH VISUAL, V13, P455; Harwerth RS, 1997, J GLAUCOMA, V6, P390; He L, 2014, INVEST OPHTH VIS SCI, V55, P574, DOI 10.1167/iovs.13-13245; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Ivers KM, 2011, INVEST OPHTH VIS SCI, V52, P5473, DOI 10.1167/iovs.11-7347; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Li CH, 2010, OPT EXPRESS, V18, P16671, DOI 10.1364/OE.18.016671; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14191; PEDERSON JE, 1984, ARCH OPHTHALMOL-CHIC, V102, P1689, DOI 10.1001/archopht.1984.01040031373030; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P295, DOI 10.1167/iovs.09-4016; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sredar N, 2013, BIOMED OPT EXPRESS, V4, P1153, DOI 10.1364/BOE.4.001153; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; Vilupuru AS, 2007, J OPT SOC AM A, V24, P1417, DOI 10.1364/JOSAA.24.001417; Wang B, 2013, INVEST OPHTH VIS SCI, V54, P8270, DOI 10.1167/iovs.13-13109; Yang H, 2011, INVEST OPHTH VIS SCI, V53, P394; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	51	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134223	10.1371/journal.pone.0134223	http://dx.doi.org/10.1371/journal.pone.0134223			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230993	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400086
J	Lin, ZJ; Zhao, ZH; Xu, HH; Zhang, X; Wang, TT; Kan, HD; Norback, D				Lin, Zhijing; Zhao, Zhuohui; Xu, Huihui; Zhang, Xin; Wang, Tingting; Kan, Haidong; Norback, Dan			Home Dampness Signs in Association with Asthma and Allergic Diseases in 4618 Preschool Children in Urumqi, China-The Influence of Ventilation/Cleaning Habits	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; HOUSING CHARACTERISTICS; ENVIRONMENTAL-FACTORS; CHILDHOOD ASTHMA; EARLY-LIFE; HEALTH; PREVALENCE; BUILDINGS; MOLDS; SCHOOLCHILDREN	There is an increasing prevalence of childhood asthma and allergic diseases in mainland of China. Few studies investigated the indoor dampness, ventilation and cleaning habits and their interrelationship with childhood asthma and allergic diseases. A large-scale cross-sectional study was performed in preschool children in Urumqi, China. Questionnaire was used to collect information on children's health, home dampness and ventilation/cleaning (V/C) habits. Multiple logistic regressions were applied to analyze the associations between childhood asthma/allergic diseases and each sign of home dampness, dampness levels, each V/C habit and total V/C scores. The associations between dampness and health were further performed by strata analyses in two groups with low and high V/C scores. Totally 4618 (81.7%) of 5650 children returned the questionnaire. Reports on home dampness were most common for water condensation on windows (20.8%) followed by damp beddings (18.0%). The most common ventilation measure was the use of exhaust fan in bathroom (59.3%), followed by daily home cleaning (48.3%), frequently putting beddings to sunshine (29.9%) and frequently opening windows in winter (8.4%). There were positive associations between the 6 signs of home dampness and children's health particularly the symptoms last 12 months. By comparing with the reference dampness level (dampness scored 0), both the low dampness (scored 1 similar to 2) level and the high dampness level (scored 3 similar to 6) showed significantly increasing associations with childhood symptoms. There were crude negative associations between V/C habits and childhood health but not significant adjusting for home dampness levels. The risks of home dampness on children's health were lower in the group with higher V/C score but the differences were not statistically significant. Home dampness is a potential risk factor for childhood asthma and allergic symptoms in preschool children in Urumqi, China. No significant effects were observed for ordinary home ventilation and cleaning habits in reducing the risks of home dampness on childhood asthma and allergic diseases in Urumqi, China.	[Lin, Zhijing; Zhao, Zhuohui; Kan, Haidong] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200032, Peoples R China; [Xu, Huihui] Shanghai Municipal Ctr Dis Control & Prevent, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Zhang, Xin] Shanxi Univ, Inst Environm Sci, Taiyuan 030006, Peoples R China; [Wang, Tingting] Xinjiang Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Urumqi, Peoples R China; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, SE-751 Uppsala, Sweden	Fudan University; Shanghai Center for Disease Control & Prevention; Shanxi University; Xinjiang Medical University; Uppsala University	Zhao, ZH (corresponding author), Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200032, Peoples R China.	zhzhao@fudan.edu.cn	wang, tingting/AAK-2640-2020; Kan, Haidong/AGU-0328-2022	Norback, Dan/0000-0002-5174-6668				Aberg N, 1996, ALLERGY, V51, P232, DOI 10.1111/j.1398-9995.1996.tb04598.x; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; [Anonymous], 2009, WHO GUID IND AIR QUA; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2001, INDOOR AIR, V11, P72; Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x; Braun FC, 2004, EUR J RESP, V23, P407; BRUNEKREEF B, 1989, AM REV RESPIR DIS, V140, P1363, DOI 10.1164/ajrccm/140.5.1363; Butler Sarnia, 2003, N Z Med J, V116, pU494; Chang P, 1954, COLLECTED SCI PAPERS, P273; Chen Yu-zhi, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P112; Claeson AS, 2007, J ENVIRON MONITOR, V9, P240, DOI 10.1039/b614766f; DALES RE, 1991, AM J EPIDEMIOL, V134, P196, DOI 10.1093/oxfordjournals.aje.a116072; Dong GH, 2008, RESPIRATION, V76, P82, DOI 10.1159/000121370; Dong GH, 2008, INT J ENVIRON HEAL R, V18, P267, DOI 10.1080/09603120701842864; Dong GH, 2008, REV EPIDEMIOL SANTE, V56, P97, DOI 10.1016/j.respe.2007.12.002; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Gunnbjornsdottir MI, 2006, THORAX, V61, P221, DOI 10.1136/thx.2005.057430; Hsu NY, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/158248; Hu Y, 2014, INDOOR AIR, V24, P450, DOI 10.1111/ina.12104; Karvonen AM, 2009, PEDIATRICS, V124, pE329, DOI 10.1542/peds.2008-1590; Lee IS, 2003, YONSEI MED J, V44, P313, DOI 10.3349/ymj.2003.44.2.313; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Leung R, 1997, EUR RESPIR J, V10, P354, DOI 10.1183/09031936.97.10020354; Li XF, 2013, HV AC, V43, P46; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; National Bureau of Statistics-People's Republic of China, 2011, CHIN STAT YB 2010 20; National Cooperative Group on Childhood Asthma, 2013, Zhonghua Er Ke Za Zhi, V51, P729; Naydenov K, 2008, PEDIAT ALLERG IMM-UK, V19, P702, DOI 10.1111/j.1399-3038.2008.00721.x; Pirhonen I, 1996, EUR RESPIR J, V9, P2618, DOI 10.1183/09031936.96.09122618; PLATT SD, 1989, BRIT MED J, V298, P1673, DOI 10.1136/bmj.298.6689.1673; Sauni R, 2013, EVID BASED CHILD HLT, V8, P994; Sun Y, 2011, INDOOR AIR, V21, P277, DOI 10.1111/j.1600-0668.2010.00699.x; Sun YX, 2011, SCI TOTAL ENVIRON, V409, P4229, DOI 10.1016/j.scitotenv.2011.07.011; Tham KW, 2007, PEDIAT ALLERG IMM-UK, V18, P418, DOI 10.1111/j.1399-3038.2007.00544.x; VERHOEFF AP, 1995, AM J EPIDEMIOL, V141, P103, DOI 10.1093/oxfordjournals.aje.a117398; Wang H, 2013, CHINESE SCI BULL, V58, P4259, DOI 10.1007/s11434-013-5774-6; Wang Hong-yu, 2006, Zhonghua Er Ke Za Zhi, V44, P41; Wang TT, 2013, CHINESE SCI BULL, V58, P4237, DOI 10.1007/s11434-013-5727-0; Yang CY, 1997, PEDIATR PULM, V24, P73, DOI 10.1002/(SICI)1099-0496(199708)24:2<73::AID-PPUL1>3.0.CO;2-J; Zhang M, 2013, CHINESE SCI BULL, V58, P4223, DOI 10.1007/s11434-013-5687-4; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983; Zhao ZH, 2013, CHINESE SCI BULL, V58, P4245, DOI 10.1007/s11434-013-5705-6	47	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134359	10.1371/journal.pone.0134359	http://dx.doi.org/10.1371/journal.pone.0134359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230849	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400106
J	Loffler, A; Luck, T; Then, FS; Sikorski, C; Kovacs, P; Bottcher, Y; Breitfeld, J; Tonjes, A; Horstmann, A; Loffler, M; Engel, C; Thiery, J; Villringer, A; Stumvoll, M; Riedel-Heller, SG				Loeffler, Antje; Luck, Tobias; Then, Francisca S.; Sikorski, Claudia; Kovacs, Peter; Boettcher, Yvonne; Breitfeld, Jana; Toenjes, Anke; Horstmann, Annette; Loeffler, Markus; Engel, Christoph; Thiery, Joachim; Villringer, Arno; Stumvoll, Michael; Riedel-Heller, Steffi G.			Eating Behaviour in the General Population: An Analysis of the Factor Structure of the German Version of the Three-Factor-Eating-Questionnaire (TFEQ) and Its Association with the Body Mass Index	PLOS ONE			English	Article							DIETARY RESTRAINT; QUESTIONNAIRE	The Three-Factor-Eating-Questionnaire (TFEQ) is an established instrument to assess eating behaviour. Analysis of the TFEQ-factor structure was based on selected, convenient and clinical samples so far. Aims of this study were (I) to analyse the factor structure of the German version of the TFEQ and (II)-based on the refined factor structure-to examine the association between eating behaviour and the body mass index (BMI) in a general population sample of 3,144 middle-aged and older participants (40-79 years) of the ongoing population based cohort study of the Leipzig Research Center for Civilization Diseases (LIFE Health Study). The factor structure was examined in a split-half analysis with both explorative and confirmatory factor analysis. Associations between TFEQ-scores and BMI values were tested with multiple regression analyses controlled for age, gender, and education. We found a three factor solution for the TFEQ with an 'uncontrolled eating', a 'cognitive restraint' and an 'emotional eating' domain including 29 of the original 51 TFEQ-items. Scores of the 'uncontrolled eating domain' showed the strongest correlation with BMI values (partial r = 0.26). Subjects with scores above the median in both 'uncontrolled eating' and 'emotional eating' showed the highest BMI values (mean = 29.41 kg/m(2)), subjects with scores below the median in all three domains showed the lowest BMI values (mean = 25.68 kg/m(2); F = 72.074, p<0.001). Our findings suggest that the TFEQ is suitable to identify subjects with specific patterns of eating behaviour that are associated with higher BMI values. Such information may help health care professionals to develop and implement more tailored interventions for overweight and obese individuals.	[Loeffler, Antje; Luck, Tobias; Then, Francisca S.; Sikorski, Claudia; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany; [Loeffler, Antje; Luck, Tobias; Then, Francisca S.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Sikorski, Claudia; Kovacs, Peter; Boettcher, Yvonne; Breitfeld, Jana; Horstmann, Annette; Stumvoll, Michael] Univ Leipzig, IFB AdiposityDis, Med Ctr, D-04109 Leipzig, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany; [Horstmann, Annette; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Loeffler, Markus; Engel, Christoph] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Villringer, Arno] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society; Leipzig University; Leipzig University; Leipzig University	Loffler, A (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany.	antje.loeffler@medizin.uni-leipzig.de	Horstmann, Annette/C-9083-2011; Rodriguez, Francisca/AAD-6803-2019; Riedel-Heller, Steffi/ABG-1537-2021; Rodriguez, Francisca S./N-4360-2018; Stumvoll, Michael/ABE-1121-2021	Horstmann, Annette/0000-0001-6184-8484; Rodriguez, Francisca/0000-0003-2919-5510; Rodriguez, Francisca S./0000-0003-2919-5510; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Luck, Tobias/0000-0001-7551-4397; Engel, Christoph/0000-0002-7247-282X; Villringer, Arno/0000-0003-2604-2404	LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany) [FKZ: 01EO1001]; European Union; European Regional Development Fund (ERDF); Free State of Saxony; German Research Council [DFG - SFB 1052, SPP 1629 TO 718/2-1]; German Diabetes Association	LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; German Research Council(German Research Foundation (DFG)); German Diabetes Association	This publication was supported by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, and the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany, FKZ: 01EO1001). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of the excellence initiative. A. T. was supported by grants from the German Research Council (DFG - SFB 1052 "Obesity mechanisms"; and SPP 1629 TO 718/2-1) and from the German Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dietrich A, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.00079, 10.3389/fpsyg.2014.01073]; Effertz T, 2013, KOSTEN ADIPOSITAS DE; French SA, 2012, APPETITE, V59, P541, DOI 10.1016/j.appet.2012.07.001; GANLEY RM, 1988, INT J EAT DISORDER, V7, P635, DOI 10.1002/1098-108X(198809)7:5<635::AID-EAT2260070507>3.0.CO;2-K; Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9; Hautzinger M, 2012, ALLGEMEINE DEPRESSIO, V2nd; Horstmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074362; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HYLAND ME, 1989, CURR PSYCHOL RES REV, V8, P228, DOI 10.1007/BF02686751; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Koenders PG, 2011, J OCCUP ENVIRON MED, V53, P1287, DOI 10.1097/JOM.0b013e31823078a2; Mazzeo SE, 2003, INT J EAT DISORDER, V34, P255, DOI 10.1002/eat.10180; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; Stein J, 2014, PSYCHIAT PRAX, V41, P135, DOI 10.1055/s-0033-1343176; Stewart TM, 2002, APPETITE, V38, P39, DOI 10.1006/appe.2001.0445; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Timko C Alix, 2005, Eat Behav, V6, P119, DOI 10.1016/j.eatbeh.2004.09.002; Westenh&ouml;fer J, 1989, VERL FUR PSYCHOLOGIE; Westenhoefer J, 1999, INT J EAT DISORDER, V26, P53, DOI 10.1002/(SICI)1098-108X(199907)26:1&lt;53::AID-EAT7&gt;3.0.CO;2-N	25	46	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133977	10.1371/journal.pone.0133977	http://dx.doi.org/10.1371/journal.pone.0133977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230264	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400066
J	Schupbach, J; Niederhauser, C; Yerly, S; Regenass, S; Gorgievski, M; Aubert, V; Ciardo, D; Klimkait, T; Dollenmaier, G; Andreutti, C; Martinetti, G; Brandenberger, M; Gebhardt, MD				Schuepbach, Joerg; Niederhauser, Christoph; Yerly, Sabine; Regenass, Stephan; Gorgievski, Meri; Aubert, Vincent; Ciardo, Diana; Klimkait, Thomas; Dollenmaier, Guenter; Andreutti, Corinne; Martinetti, Gladys; Brandenberger, Marcel; Gebhardt, Martin D.			Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms	PLOS ONE			English	Article							UNITED-STATES; SPECIFICITY; ANTIBODIES; ASSAYS; GAG; PERFORMANCE; HEMOPHILIA; DIVERSITY; DYNAMICS; MARKER	Background HIV surveillance requires monitoring of new HIV diagnoses and differentiation of incident and older infections. In 2008, Switzerland implemented a system for monitoring incident HIV infections based on the results of a line immunoassay (Inno-Lia) mandatorily conducted for HIV confirmation and type differentiation (HIV-1, HIV-2) of all newly diagnosed patients. Based on this system, we assessed the proportion of incident HIV infection among newly diagnosed cases in Switzerland during 2008-2013. Methods and Results Inno-Lia antibody reaction patterns recorded in anonymous HIV notifications to the federal health authority were classified by 10 published algorithms into incident (up to 12 months) or older infections. Utilizing these data, annual incident infection estimates were obtained in two ways, (i) based on the diagnostic performance of the algorithms and utilizing the relationship 'incident = true incident + false incident', (ii) based on the window-periods of the algorithms and utilizing the relationship 'Prevalence = Incidence x Duration'. From 20082013, 3'851 HIV notifications were received. Adult HIV-1 infections amounted to 3'809 cases, and 3'636 of them (95.5%) contained Inno-Lia data. Incident infection totals calculated were similar for the performance-and window-based methods, amounting on average to 1'755 (95% confidence interval, 1588-1923) and 1'790 cases (95% CI, 1679-1900),respectively. More than half of these were among men who had sex with men. Both methods showed a continuous decline of annual incident infections 2008-2013, totaling -59.5% and -50.2%, respectively. The decline of incident infections continued even in 2012, when a 15% increase in HIV notifications had been observed. This increase was entirely due to older infections. Overall declines 2008-2013 were of similar extent among the major transmission groups. Conclusions Inno-Lia based incident HIV-1 infection surveillance proved useful and reliable. It represents a free, additional public health benefit of the use of this relatively costly test for HIV confirmation and type differentiation.	[Schuepbach, Joerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, CH-8057 Zurich, Switzerland; [Niederhauser, Christoph] Swiss Red Cross Berne, Blood Transfus Serv, Bern, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, CH-14 Geneva, Switzerland; [Regenass, Stephan] Univ Hosp, Clin Immunol, Zurich, Switzerland; [Gorgievski, Meri] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Aubert, Vincent] Univ Hosp Ctr, Univ Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Ciardo, Diana] Inst Dr Viollier AG, Basel, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Basel, Switzerland; [Dollenmaier, Guenter] Zentrum Labormed St Gallen, St Gallen, Switzerland; [Andreutti, Corinne] Clin Source, Lab, Lausanne, Switzerland; [Martinetti, Gladys] Ente Osped Cantonale, Microbiol Serv, Bellinzona, Switzerland; [Brandenberger, Marcel] Lab Synlab Luzern, Luzern, Switzerland; [Gebhardt, Martin D.] Swiss Fed Off Publ Hlth, CH-3003 Bern, Switzerland	University of Zurich; University of Geneva; University of Zurich; University Zurich Hospital; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Schupbach, J (corresponding author), Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	schupbach.jorg@virology.uzh.ch	Schüpbach, Jörg/G-4209-2016	Schüpbach, Jörg/0000-0002-8074-5891; Klimkait, Thomas/0000-0003-4945-6511	Swiss Federal Office of Public Health (SFOPH) [07.005822, 09.001294, 10.001983, 11.005726]; Labor Synlab Luzern; Institut Dr. Viollier AG; Clinique de la Source	Swiss Federal Office of Public Health (SFOPH); Labor Synlab Luzern; Institut Dr. Viollier AG; Clinique de la Source	This study was financed by contracts 07.005822, 09.001294, 10.001983 and 11.005726 with the Swiss Federal Office of Public Health (SFOPH); see: http://www.bag.admin.ch/org/index.html?lang = en. Even though one of the authors (MDG) is an employee of the SFOPH, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Institut Dr. Viollier AG, Clinique de la Source, and Labor Synlab Luzern provided support in the form of salaries for authors DC, CA & MB respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghaizu A, 2014, EUROSURVEILLANCE, V19; [Anonymous], 2013, MONITORING RECENTLY; [Anonymous], 2013, SHCS REPORT; [Anonymous], 2010, NATL PROGRAMME HIV S; [Anonymous], 2014, SERVICES DOHAH; [Anonymous], 2006, SCHWEIZERISCHE HIV T, P1022; [Anonymous], 2014, BAG B, P351; [Anonymous], 2014, HIV AIDS ESTIMATES 2; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; CHARGELEGUE D, 1993, CLIN EXP IMMUNOL, V93, P331, DOI 10.1111/j.1365-2249.1993.tb08181.x; CHARGELEGUE D, 1993, AIDS, V7, pS87, DOI 10.1097/00002030-199311002-00017; Chavez P, 2011, J CLIN VIROL, V52, pS51, DOI 10.1016/j.jcv.2011.09.010; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077765; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hladik W, 2012, AIDS RES HUM RETROV, V28, P95, DOI [10.1089/aid.2010.0347, 10.1089/AID.2010.0347]; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P1177, DOI 10.1089/aid.2011.0341; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; LANGE JMA, 1988, ANN MED INTERNE, V139, P80; Le Vu S, 2008, EURO SURVEILL, P13; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Malm K, 2009, TRANSFUSION MED, V19, P78, DOI 10.1111/j.1365-3148.2009.00907.x; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Miller WC, 2013, LANCET INFECT DIS, V13, P459, DOI 10.1016/S1473-3099(12)70314-6; Ministerial Council on Education Employment Training and Youth Affairs, 2009, MCEETYA 4 YEAR PLAN; Murphy G, 2008, EURO SURVEILL, V13; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; POLLET DE, 1991, CLIN CHEM, V37, P1700; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Schupbach J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071662; Schupbach J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-88; Schupbach J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-254; SCHUPBACH J, 1985, NEW ENGL J MED, V312, P265, DOI 10.1056/NEJM198501313120502; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, USE ASS REC INF EST, P1; WALTHER L, 1995, CLIN DIAGN VIROL, V4, P67, DOI 10.1016/0928-0197(94)00057-2; Welte A, 2010, EUROSURVEILLANCE, V15, P18	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131828	10.1371/journal.pone.0131828	http://dx.doi.org/10.1371/journal.pone.0131828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230082	gold, Green Published, Green Accepted			2022-12-26	WOS:000358838400010
J	Silvy, F; Bertin, D; Bardin, N; Auger, I; Guzian, MC; Mattei, JP; Guis, S; Roudier, J; Balandraud, N				Silvy, Florent; Bertin, Daniel; Bardin, Nathalie; Auger, Isabelle; Guzian, Marie-Caroline; Mattei, Jean-Pierre; Guis, Sandrine; Roudier, Jean; Balandraud, Nathalie			Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; RHEUMATOID-ARTHRITIS; CLASSIFICATION CRITERIA; AUTOANTIBODY INDUCTION; CASPAR CRITERIA; INFLIXIMAB; SPONDYLOARTHRITIS; AUTOIMMUNITY	Background With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis. Objective To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis (PsA), we evaluated the prevalence of ANA in biologic-naive PsA patients and in healthy blood donors. Methods 232 patients from the Rheumatology department, St Marguerite's Hospital, Marseilles, who fulfilled the CASPAR criteria for PsA, underwent clinical and laboratory investigations. Antinuclear antibodies (ANA), anti-extractable nuclear antigen antibodies (ENA), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) were assayed. Ninety-one healthy blood donors were also tested. Results Detection of ANA by indirect immunofluorescence was significantly more frequent in sera from PsA patients than those from controls at serum dilution of 1: 100 (57% compared with 40%, Odds Ratio (OR) 1.98 (1.2-3.4) p<0.02) and 1: 160 (52% compared with 24%, OR 3,7 (1.9-7.2) p<0.001). No patients had lupus specific autoantibodies, 15% had RF (34/232), and 1.7% had ACPA (4/232). Conclusions Detection of ANA was more frequent in sera from PsA patients than in those from healthy controls. This suggests that ANA could be a diagnosis orientation tool in PsA. Nevertheless, the specificity of these antibodies still remains to be investigated.	[Silvy, Florent; Guzian, Marie-Caroline; Mattei, Jean-Pierre; Guis, Sandrine; Roudier, Jean; Balandraud, Nathalie] AP HM, IML, Rheumatol 1, F-13009 Marseille, France; [Bertin, Daniel; Bardin, Nathalie] Hop Conception, AP HM, Immunol Lab, Pole Biol, F-13005 Marseille, France; [Bardin, Nathalie] Aix Marseille Univ, INSERM UMRs 1076, UFR Pharm, F-13005 Marseille, France; [Auger, Isabelle; Roudier, Jean; Balandraud, Nathalie] Aix Marseille Univ, INSERM UMRs 1097, Immunogenet Lab, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Balandraud, N (corresponding author), AP HM, IML, Rheumatol 1, 270 Blvd St Marguerite, F-13009 Marseille, France.	nathalie.balandraud@ap-hm.fr	AUGER, ISABELLE/P-6294-2016; Balandraud, Nathalie/ABD-6012-2020; Bardin, Nathalie/AAL-3663-2020; roudier, jean/A-8654-2011	AUGER, ISABELLE/0000-0002-1414-8095; Balandraud, Nathalie/0000-0002-3839-0185; Bardin, Nathalie/0000-0003-3680-082X; roudier, jean/0000-0001-5435-8567				Bacquet-Deschryver H, 2008, J CLIN IMMUNOL, V28, P445, DOI 10.1007/s10875-008-9214-3; Bogliolo L, 2005, J RHEUMATOL, V32, P511; Brito FD, 2014, REV BRAS REUMATOL, V54, P13, DOI [10.1016/j.rbre.2014.02.001, 10.1016/j.rbr.2014.01.002]; Candia L, 2006, JCR-J CLIN RHEUMATOL, V12, P226, DOI 10.1097/rhu.0000242779.73390.51; Caspi D, 2006, ARTHRIT RHEUM-ARTHR, V55, P53, DOI 10.1002/art.21691; Chandran V, 2012, NAT REV RHEUMATOL, V8, P503, DOI 10.1038/nrrheum.2012.121; Chimenti MS, 2014, DRUG DEVELOP RES, V75, pS61, DOI 10.1002/ddr.21198; Dalmady S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/474028; Feletar M, 2004, ANN RHEUM DIS, V63, P156, DOI 10.1136/ard.2003.006775; Hoffmann JHO, 2011, BRIT J DERMATOL, V165, P1355, DOI 10.1111/j.1365-2133.2011.10555.x; Inanc N, 2007, CLIN RHEUMATOL, V26, P17, DOI 10.1007/s10067-006-0214-5; Johnson SR, 2005, ANN RHEUM DIS, V64, P770, DOI 10.1136/ard.2004.031286; Li QZ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3271; Lora V, 2013, IMMUNOL RES, V56, P382, DOI 10.1007/s12026-013-8410-2; Maejima H, 2010, J DERMATOL, V37, P339, DOI 10.1111/j.1346-8138.2010.00814.x; Marchesoni A, 2006, J RHEUMATOL, V33, P435; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Ouedraogo DD, 2007, CLIN EXP RHEUMATOL, V25, P930; Poulalhon N, 2007, BRIT J DERMATOL, V156, P329, DOI 10.1111/j.1365-2133.2006.07639.x; Saraceno R, 2013, J AM ACAD DERMATOL, V69, P314, DOI 10.1016/j.jaad.2013.03.020; Saraceno R, 2012, J AM ACAD DERMATOL, V66, pE180, DOI 10.1016/j.jaad.2011.06.008; Sellam J, 2005, JOINT BONE SPINE, V72, P48, DOI 10.1016/j.jbspin.2004.03.003; Shibata S, 2009, J DERMATOL SCI, V53, P34, DOI 10.1016/j.jdermsci.2008.06.008; Sonnichsen N, 1966, Dtsch Gesundheitsw, V21, P973; Tillett W, 2012, J RHEUMATOL, V39, P154, DOI 10.3899/jrheum.110845; Alonso JCT, 2010, REUMATOL CLIN, V6, P18, DOI 10.1016/j.reuma.2009.12.002; Vander Cruyssen B, 2005, ANN RHEUM DIS, V64, P1145, DOI 10.1136/ard.2004.032177; Viana VST, 2010, REV BRAS REUMATOL, V50, P230, DOI 10.1590/S0482-50042010000300003; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	29	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134218	10.1371/journal.pone.0134218	http://dx.doi.org/10.1371/journal.pone.0134218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230924	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400085
J	Song, YC; Sanganahalli, BG; Hyder, F; Lin, WC; Riera, JJ				Song, Yinchen; Sanganahalli, Basavaraju G.; Hyder, Fahmeed; Lin, Wei-Chiang; Riera, Jorge J.			Distributions of Irritative Zones Are Related to Individual Alterations of Resting-State Networks in Focal Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; TONIC-CLONIC SEIZURES; CORTICAL DYSPLASIA; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; BOLD-FMRI; EEG-FMRI; RAT MODEL; DISCHARGES; SPIKE	Alterations in the connectivity patterns of the fMRI-based resting-state networks (RSNs) have been reported in several types of epilepsies. Evidence pointed out these alterations might be associated with the genesis and propagation of interictal epileptiform discharges (IEDs). IEDs also evoke blood-oxygen-level dependent (BOLD) responses, which have been used to delineate irritative zones during preoperative work-up. Therefore, one may expect a relationship between the topology of the IED-evoked BOLD response network and the altered spatial patterns of the RSNs. In this study, we used EEG recordings and fMRI data obtained simultaneously from a chronic model of focal epilepsy in Wistar rats to verify our hypothesis. We found that IED-evoked BOLD response networks comprise both cortical and subcortical structures with a rat-dependent topology. In all rats, IEDs evoke both activation and deactivation types of BOLD responses. Using a Granger causality method, we found that in many cases areas with BOLD deactivation have directed influences on areas with activation (p<0.05). We were able to predict topological properties (i.e., focal/diffused, unilateral/bilateral) of the IED-evoked BOLD response network by performing hierarchical clustering analysis on major spatial features of the RSNs. All these results suggest that IEDs and disruptions in the RSNs found previously in humans may be different manifestations of the same transient events, probably reflecting altered consciousness. In our opinion, the shutdown of specific nodes of the default mode network may cause uncontrollable excitability in other functionally connected brain areas. We conclude that IED-evoked BOLD responses (i.e., activation and deactivation) and alterations of RSNs are intrinsically related, and speculate that an understanding of their interplay is necessary to discriminate focal epileptogenesis and network propagation phenomena across different brain modules via hub-based connectivity.	[Song, Yinchen; Lin, Wei-Chiang; Riera, Jorge J.] Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA; [Sanganahalli, Basavaraju G.; Hyder, Fahmeed] Yale Univ, Magnet Resonance Res Ctr, New Haven, CT USA	State University System of Florida; Florida International University; Yale University	Riera, JJ (corresponding author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA.	jrieradi@fiu.edu	Riera, J/ABB-8551-2020; Song, Yinchen/K-5874-2019; Sanganahalli, Basavaraju G/C-3296-2008	Riera, J/0000-0001-8530-8431; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Song, Yinchen/0000-0001-5820-0353	Florida International University start-up package	Florida International University start-up package	This work was supported by Florida International University start-up package to JJR.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Airaksinen AM, 2012, EPILEPSIA, V53, P1245, DOI 10.1111/j.1528-1167.2012.03539.x; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Alonso-Nanclares L, 2005, BRAIN, V128, P158, DOI 10.1093/brain/awh331; Bae J, 2015, JOVE-J VIS EXP, DOI 10.3791/52700; Battaglia G, 2013, EPILEPSIA, V54, P33, DOI 10.1111/epi.12272; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Caballero-Gaudes C, 2013, NEUROIMAGE, V68, P248, DOI 10.1016/j.neuroimage.2012.12.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cepeda C, 2003, J NEUROSCI RES, V72, P472, DOI 10.1002/jnr.10604; Charara A, 2013, 29 SO BIOM ENG C; Chowdhury FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110136; Colacitti C, 1999, J NEUROPATH EXP NEUR, V58, P92, DOI 10.1097/00005072-199901000-00010; Colciaghi F, 2011, BRAIN, V134, P2828, DOI 10.1093/brain/awr045; Colombo N, 2003, AM J NEURORADIOL, V24, P724; Cui ZG, 2011, J CLIN NEUROSCI, V18, P404, DOI 10.1016/j.jocn.2010.05.035; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Englot DJ, 2009, J NEUROSCI, V29, P13006, DOI 10.1523/JNEUROSCI.3846-09.2009; Fahoum F, 2012, EPILEPSIA, V53, P1618, DOI 10.1111/j.1528-1167.2012.03533.x; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Grouiller F, 2011, BRAIN, V134, P2867, DOI 10.1093/brain/awr156; Hamandi K, 2008, NEUROIMAGE, V39, P608, DOI 10.1016/j.neuroimage.2007.07.009; Jacobs J, 2007, EPILEPSIA, V48, P2068, DOI 10.1111/j.1528-1167.2007.01192.x; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kabat J, 2012, POL J RADIOL, V77, P35, DOI 10.12659/PJR.882968; Keogh BP, 2005, EPILEPSY RES, V66, P75, DOI 10.1016/j.eplepsyres.2005.07.008; Kobayashi E, 2006, EPILEPSIA, V47, P343, DOI 10.1111/j.1528-1167.2006.00427.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Luo Q, 2013, NEUROIMAGE, V79, P241, DOI 10.1016/j.neuroimage.2013.04.091; Marin-Padilla M, 2003, J NEUROPATH EXP NEUR, V62, P1129, DOI 10.1093/jnen/62.11.1129; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Moeller F, 2013, EPILEPSIA, V54, pE103, DOI 10.1111/epi.12243; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pedreira C, 2014, NEUROIMAGE, V99, P461, DOI 10.1016/j.neuroimage.2014.05.009; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Schmidt H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003947; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Song J, 2015, BRAIN CONNECT, V5, P276, DOI 10.1089/brain.2014.0308; Song Y, 2015, IEEE T BIOMEDICAL EN; Spreafico R, 2010, ACTA NEUROPATHOL, V120, P359, DOI 10.1007/s00401-010-0714-x; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Szaflarski JP, 2010, EPILEPSY BEHAV, V18, P404, DOI 10.1016/j.yebeh.2010.05.009; Tenney JR, 2004, EPILEPSIA, V45, P576, DOI 10.1111/j.0013-9580.2004.39303.x; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Thornton R, 2011, ANN NEUROL, V70, P822, DOI 10.1002/ana.22535; Valdes-Hernandez PA, 2011, FRONTIERS NEUROINFOR, V5; van den Heuvel MP, 2016, BRAIN STRUCT FUNCT, V221, P1719, DOI 10.1007/s00429-015-0999-6; van Diessen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114606; van Luijtelaar G, 2013, NEUROBIOL DIS, V60, P126, DOI 10.1016/j.nbd.2013.08.013; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; Vulliemoz S, 2009, NEUROIMAGE, V46, P834, DOI 10.1016/j.neuroimage.2009.01.070; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	84	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134352	10.1371/journal.pone.0134352	http://dx.doi.org/10.1371/journal.pone.0134352			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226628	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700077
J	Trombetta, B; D'Atanasio, E; Massaia, A; Myres, NM; Scozzari, R; Cruciani, F; Novelletto, A				Trombetta, Beniamino; D'Atanasio, Eugenia; Massaia, Andrea; Myres, Natalie M.; Scozzari, Rosaria; Cruciani, Fulvio; Novelletto, Andrea			Regional Differences in the Accumulation of SNPs on the Male-Specific Portion of the Human Y Chromosome Replicate Autosomal Patterns: Implications for Genetic Dating	PLOS ONE			English	Article							MUTATION-RATE; SEQUENCE; CONVERSION; HISTORY; RATES; TIME; AGE	Factors affecting the rate and pattern of the mutational process are being identified for human autosomes, but the same relationships for the male specific portion of the Y chromosome (MSY) are not established. We considered 3,390 mutations occurring in 19 sequence bins identified by sequencing 1.5 Mb of the MSY from each of 104 present-day chromosomes. The occurrence of mutations was not proportional to the amount of sequenced bases in each bin, with a 2-fold variation. The regression of the number of mutations per unit sequence against a number of indicators of the genomic features of each bin, revealed the same fundamental patterns as in the autosomes. By considering the sequences of the same region from two precisely dated ancient specimens, we obtained a calibrated region-specific substitution rate of 0.716 x 10(-9)/site/year. Despite its lack of recombination and other peculiar features, the MSY then resembles the autosomes in displaying a marked regional heterogeneity of the mutation rate. An immediate implication is that a given figure for the substitution rate only makes sense if bound to a specific DNA region. By strictly applying this principle we obtained an unbiased estimate of the antiquity of lineages relevant to the genetic history of the human Y chromosome. In particular, the two deepest nodes of the tree highlight the survival, in Central-Western Africa, of lineages whose coalescence (291 ky, 95% C.I. 253-343) predates the emergence of anatomically modern features in the fossil record.	[Trombetta, Beniamino; D'Atanasio, Eugenia; Massaia, Andrea; Scozzari, Rosaria; Cruciani, Fulvio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Myres, Natalie M.] AncestryDNA, Provo, UT USA; [Cruciani, Fulvio] CNR, Ist Biol & Patol Mol, Rome, Italy; [Novelletto, Andrea] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Rome Tor Vergata	Cruciani, F (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fulvio.cruciani@uniroma1.it; novelletto@bio.uniroma2.it	D'ATANASIO, EUGENIA/AAX-8157-2020	D'ATANASIO, EUGENIA/0000-0002-4965-246X; Trombetta, Beniamino/0000-0001-8245-9437; Novelletto, Andrea/0000-0002-1146-7680; Cruciani, Fulvio/0000-0002-6900-024X	Italian Ministry of Education [2012JA4BTY_004, 2012JA4BTY_003]; Sapienza University of Rome [C26A13S9AR]; AncestryDNA	Italian Ministry of Education; Sapienza University of Rome; AncestryDNA	This work was supported by the Italian Ministry of Education (http://www.istruzione.it), Progetti PRIN (grant numbers 2012JA4BTY_004 to F.C. and 2012JA4BTY_003 to A. N.) and by Sapienza University of Rome (http://www.uniroma1.it) (grant number C26A13S9AR to F.C). AncestryDNA provided support in the form of salaries for author N.M.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Cruciani F, 2010, AM J HUM GENET, V86, P495, DOI 10.1016/j.ajhg.2010.01.033; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elhaik E, 2014, EUR J HUM GENET, V1-6; Elhaik E, 2015, EUR J HUM GENET, V23, P567, DOI 10.1038/ejhg.2014.227; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Francioli LC, 2015, NAT GENET; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Helgason A, 2015, NAT GENET; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Mendez FL, 2014, EUR J HUM GENET; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Niederstatter H, 2013, FORENSIC SCI INT-GEN, V7, P593, DOI 10.1016/j.fsigen.2013.05.010; O'Fallon B, 2013, GENETICS, V194, P485, DOI 10.1534/genetics.113.152074; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Sayres MAW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004064; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trombetta B, 2015, GENOME BIOL EVOL; Trombetta B, 2014, MOL BIOL EVOL, V31, P2108, DOI 10.1093/molbev/msu155; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Wang CC, 2015, INVESTIG GENET, V6, DOI [10.1186/s13323-015-0025-z, 10.1186/2041-2223-5-12]; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	65	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134646	10.1371/journal.pone.0134646	http://dx.doi.org/10.1371/journal.pone.0134646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226630	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700127
J	Zhang, P; Ha, T; Larouche, M; Swanson, D; Goldowitz, D				Zhang, Peter; Ha, Thomas; Larouche, Matt; Swanson, Douglas; Goldowitz, Dan			Kruppel-Like Factor 4 Regulates Granule Cell Pax6 Expression and Cell Proliferation in Early Cerebellar Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GOBLET CELLS; KLF4; TRANSCRIPTION; CANCER; MOUSE; GENE; ROLES; MATH1; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (Klf4) is a transcription factor that regulates many important cellular processes in stem cell biology, cancer, and development. We used histological and molecular methods to study the expression of Klf4 in embryonic development of the normal and Klf4 knockout cerebellum. We find that Klf4 is expressed strongly in early granule cell progenitor development but tails-off considerably by the end of embryonic development. Klf4 is also co-expressed with Pax6 in these cells. In the Klf4-null mouse, which is perinatal lethal, Klf4 positively regulates Pax6 expression and regulates the proliferation of neuronal progenitors in the rhombic lip, external granular layer and the neuroepithelium. This paper is the first to describe a role for Klf4 in the cerebellum and provides insight into this gene's function in neuronal development.	[Zhang, Peter; Ha, Thomas; Larouche, Matt; Swanson, Douglas; Goldowitz, Dan] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia	Goldowitz, D (corresponding author), Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	dang@cmmt.ubc.ca		Goldowitz, Daniel/0000-0003-4756-4017	National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; NeuroDevNet; University of British Columbia	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NeuroDevNet; University of British Columbia	We thank A. Poon, J. Yeung, J. Cairns, S. Tremblay, J. Wilking for support and suggestions on experimental design and manuscript preparation. We thank F. Lucero Villegas for animal management. We thank D. Rains and J. Boyle for technical support. We thank National Institutes of Health, Natural Sciences and Engineering Research Council of Canada, NeuroDevNet and University of British Columbia for funding.	Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Ha T, 2015, DEV BIOL, V397, P18, DOI 10.1016/j.ydbio.2014.09.032; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Katz JP, 2002, DEVELOPMENT, V129, P2619; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nakahara Y, NEOPLASIA NEW YORK N, V12, P20; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Seto Y, 2014, NATURE COMMUNICATION, V5; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swanson DJ, 2005, DEV BRAIN RES, V160, P176, DOI 10.1016/j.devbrainres.2005.09.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134390	10.1371/journal.pone.0134390	http://dx.doi.org/10.1371/journal.pone.0134390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226504	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700086
J	Rukhlenko, OS; Dudchenko, OA; Zlobina, KE; Guria, GT				Rukhlenko, Oleksii S.; Dudchenko, Olga A.; Zlobina, Ksenia E.; Guria, Georgy Th.			Mathematical Modeling of Intravascular Blood Coagulation under Wall Shear Stress	PLOS ONE			English	Article							SPATIAL-ASPECTS; THROMBUS FORMATION; CLOTTING DYNAMICS; PLATELET-ADHESION; ENDOTHELIUM; MECHANISMS; INFLAMMATION; AGGREGATION; FIBRINOGEN; RUPTURE	Increased shear stress such as observed at local stenosis may cause drastic changes in the permeability of the vessel wall to procoagulants and thus initiate intravascular blood coagulation. In this paper we suggest a mathematical model to investigate how shear stress-induced permeability influences the thrombogenic potential of atherosclerotic plaques. Numerical analysis of the model reveals the existence of two hydrodynamic thresholds for activation of blood coagulation in the system and unveils typical scenarios of thrombus formation. The dependence of blood coagulation development on the intensity of blood flow, as well as on geometrical parameters of atherosclerotic plaque is described. Relevant parametric diagrams are drawn. The results suggest a previously unrecognized role of relatively small plaques (resulting in less than 50% of the lumen area reduction) in atherothrombosis and have important implications for the existing stenting guidelines.	[Rukhlenko, Oleksii S.; Zlobina, Ksenia E.; Guria, Georgy Th.] Natl Res Ctr Hematol, Moscow, Russia; [Rukhlenko, Oleksii S.; Dudchenko, Olga A.; Guria, Georgy Th.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Rukhlenko, Oleksii S.] Cherkasy Natl Univ, Cherkassy, Ukraine	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Moscow Institute of Physics & Technology	Guria, GT (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.	guria@blood.ru	Guria, Georgy/L-6873-2013; Rukhlenko, Oleksii S/G-6893-2014; Zlobina, Ksenia/G-6767-2014	Guria, Georgy/0000-0002-5579-9820; Rukhlenko, Oleksii S/0000-0003-1863-4987; Zlobina, Ksenia/0000-0001-6592-0965	Russian Scientific Foundation [14-14-00990]	Russian Scientific Foundation(Russian Science Foundation (RSF))	GTh had won Russian Scientific Foundation (http://rscf.ru/) grant (grant no. 14-14-00990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; ALEVRIADOU BR, 1993, BLOOD, V81, P1263; Anand M, 2005, PATHOPHYSIOL HAEMO T, V34, P109, DOI 10.1159/000089931; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; ATAULLAKHANOV FI, 1994, BIOFIZIKA+, V39, P89; ATAULLAKHANOV FI, 1994, BIOFIZIKA+, V39, P97; BACHMANN L, 1975, MAKROMOL CHEM, V176, P2603; Badimon L, 2011, THROMB HAEMOSTASIS, V105, pS34, DOI 10.1160/THS10-11-0717; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Chulichkov AL, 2000, MATH MODELING, V12, P76; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Davies MT, 1994, CIRCULATION, V90, P2013; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dirksen MT, 1998, CIRCULATION, V98, P2000, DOI 10.1161/01.CIR.98.19.2000; Doi M., 1988, THEORY POLYM DYNAMIC; Echeverri LF, 2015, B MATH BIOL, V77, P156, DOI 10.1007/s11538-014-0055-3; Eeckhout E, 1999, EUR HEART J, V20, P1014, DOI 10.1053/euhj.1998.1395; Favaloro EJ, 2011, THROMB RES, V127, pS13, DOI 10.1016/S0049-3848(10)70148-1; Friedlander S. K., 2000, SMOKE DUST HAZE FUND; GERTZ SD, 1990, AM J CARDIOL, V66, P1368, DOI 10.1016/0002-9149(90)91170-B; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Guria GT, 2010, J ENG MATH, V66, P293, DOI 10.1007/s10665-009-9340-9; Guria G.T., 2000, MATEMATICHESKOE MODE, V12, P39; Guria GT, 2009, DISCRETE CONT DYN-A, V25, P175, DOI 10.3934/dcds.2009.25.175; Guria K, 2015, THROMB RES, V135, P423, DOI 10.1016/j.thromres.2014.12.014; Guy RD, 2007, MATH MED BIOL, V24, P111, DOI 10.1093/imammb/dql022; Hemker HC, 2012, J THROMB HAEMOST, V10, P1470, DOI 10.1111/j.1538-7836.2012.04802.x; Henderson A, 2007, PARAVIEW GUIDE PARAL; Herrero MA, 2005, PROG NONLIN, V63, P309; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hirsch C, 2007, NUMERICAL COMPUTATION OF INTERNAL AND EXTERNAL FLOWS, VOL 1: FUNDAMENTALS OF COMPUTATIONAL FLUID DYNAMICS, 2ND EDITION, P1; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Jasak H., 1996, THESIS U LONDON LOND; Lee KW, 2003, BLOOD COAGUL FIBRIN, V14, P605, DOI 10.1097/00001721-200310000-00001; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Lobanov AI, 2005, PATHOPHYSIOL HAEMO T, V34, P121, DOI 10.1159/000089932; Lobanov AI, 1997, PHYSTECH J, V3, P96; LOBANOV AI, 1997, MAT MODELIROVANIE, V9, P83; Makris GC, 2010, BRIT J RADIOL, V83, P729, DOI 10.1259/bjr/49957752; Melkumyants A. M., 2012, Uspekhi Fiziologicheskikh Nauk, V43, P45; Nayfeh A H, 2008, PERTURBATION METHODS; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; Nield D.A., 2006, CONVECTION POROUS ME, V24; OpenFOAM, 2009, OP SOURC CFD TOOLB U; Oran E.S., 2001, NUMERICAL SIMULATION; Patankar S.V., 2018, NUMERICAL HEAT TRANS; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; REININGER AJ, 1994, THROMB RES, V74, P629, DOI 10.1016/0049-3848(94)90219-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119; [Рухленко Алексей Сергеевич Rukhlenko A.S.], 2012, [Труды Московского физико-технического института, Trudy Moskovskogo fiziko-tekhnicheskogo instituta], V4, P192; [Рухленко Алексей Сергеевич Rukhlenko A.S.], 2012, [Компьютерные исследования и моделирование, Computer Research and Modeling, Komp'yuternye issledovaniya i modelirovanie], V4, P155; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Sadat U, 2010, EXPERT REV CARDIOVAS, V8, P1469, DOI [10.1586/erc.10.130, 10.1586/ERC.10.130]; Schmelzer JWP, 2005, NUCLEATION THEORY AND APPLICATIONS, P1, DOI 10.1002/3527604790; Schmidt RF, 1989, HUMAN PHYSL; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Shirinskii VP, 2006, CARDIOLOGICHESKY VES, V1, P39; Shirinsky V. P., 2011, Uspekhi Fiziologicheskikh Nauk, V42, P18; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P456, DOI 10.1038/ncpcardio0298; Slezov VV., 2009, KINETICS 1 ORDER PHA; Strobl G., 2007, PHYS POLYM CONCEPTS; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Uzlova SG, 2009, THESIS NATL RES CTR; Uzlova SG, 2008, B BAKOULEV SCI CTR C, P55; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Virchow R., 1856, PHLEBOSE THROMBOSE G; Volkenstein M., 1977, MOL BIOPHYSICS; Wagenvoord R, 2006, J THROMB HAEMOST, V4, P1331, DOI 10.1111/j.1538-7836.2006.01967.x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wu KK, 1996, ANNU REV MED, V47, P315	73	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134028	10.1371/journal.pone.0134028	http://dx.doi.org/10.1371/journal.pone.0134028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222505	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800097
J	Lu, W; Fang, WQ; Li, J; Zhang, B; Yang, Q; Yan, XY; Peng, L; Ai, H; Wang, JJ; Liu, X; Luo, JH; Yang, W				Lu, Wen; Fang, Weiqing; Li, Jian; Zhang, Bin; Yang, Qian; Yan, Xunyi; Peng, Lin; Ai, Heng; Wang, Jie-jie; Liu, Xiao; Luo, Jianhong; Yang, Wei			Phosphorylation of Tyrosine 1070 at the GluN2B Subunit Is Regulated by Synaptic Activity and Critical for Surface Expression of N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; NR2B SUBUNIT; PROTEIN; SRC; FYN; TRAFFICKING; CONTRIBUTES; KINASES; COMPLEX; ACTIVATION	The number and subunit composition of synaptic N-methyl-D-aspartate receptors (NMDARs) play critical roles in synaptic plasticity, learning, and memory and are implicated in neurological disorders. Tyrosine phosphorylation provides a powerful means of regulating NMDAR function, but the underling mechanism remains elusive. In this study we identified a tyrosine site on the GluN2B subunit, Tyr-1070, which was phosphorylated by a proto-oncogene tyrosine-protein (Fyn) kinase and critical for the surface expression of GluN2B-containing NMDARs. The phosphorylation of GluN2B at Tyr-1070 was required for binding of Fyn kinase to GluN2B, which up-regulated the phosphorylation of GluN2B at Tyr-1472. Moreover, our results revealed that the phosphorylation change of GluN2B at Tyr-1070 accompanied the Tyr-1472 phosphorylation and Fyn associated with GluN2B in synaptic plasticity induced by both chemical and contextual fear learning. Taken together, our findings provide a new mechanism for regulating the surface expression of NMDARs with implications for synaptic plasticity.	[Lu, Wen; Fang, Weiqing; Li, Jian; Zhang, Bin; Yang, Qian; Yan, Xunyi; Peng, Lin; Wang, Jie-jie; Liu, Xiao; Luo, Jianhong; Yang, Wei] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Collabora, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Jian] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Ai, Heng] Zhejiang Med Coll, Dept Physiol, Hangzhou 310053, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn; yangwei@zju.edu.cn	Luo, jian/HGE-7331-2022; Lu, Wen/AAL-8524-2020	Wang, Jiejie/0000-0001-7585-0585; Yang, Qian/0000-0001-9861-2790	National Basic Research Program of China [2010CB912002, 2014CB910300, 2013CB910204]; Natural Science Foundation of China [91232303, 81221003, 30900418, 81371302]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2010CB912002 and 2014CB910300 (to J. Luo) and 2013CB910204 (to W. Y.) and Natural Science Foundation of China Grants 91232303 and 81221003 (to J. Luo) and 30900418 and 81371302 (to W. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Ai H, 2011, NEUROSCI LETT, V497, P94, DOI 10.1016/j.neulet.2011.04.038; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Barki-Harrington L, 2009, J NEUROSCI, V29, P9219, DOI 10.1523/JNEUROSCI.5667-08.2009; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Knox R, 2014, STROKE, V45, P3040, DOI 10.1161/STROKEAHA.114.006170; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lu W, 2015, EXP NEUROL, V271, P251, DOI 10.1016/j.expneurol.2015.06.016; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Qiu S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003778; Salter MW, 2012, FEBS J, V279, P2, DOI 10.1111/j.1742-4658.2011.08390.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YB, 2012, J NEUROSCI, V32, P11919, DOI 10.1523/JNEUROSCI.3852-11.2012; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253	45	29	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22945	22954		10.1074/jbc.M115.663450	http://dx.doi.org/10.1074/jbc.M115.663450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229100	hybrid, Green Published			2022-12-26	WOS:000361685500008
J	Panwar, P; Lamour, G; Mackenzie, NCW; Yang, H; Ko, F; Li, HB; Bromme, D				Panwar, Preety; Lamour, Guillaume; Mackenzie, Neil C. W.; Yang, Heejae; Ko, Frank; Li, Hongbin; Broemme, Dieter			Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; CATHEPSIN-K ACTIVITY; MATRIX METALLOPROTEINASES; VASCULAR CALCIFICATION; CROSS-LINKING; NANOMECHANICAL PROPERTIES; ARTICULAR-CARTILAGE; CYSTEINE PROTEASES; BONE; AGE	During aging, changes occur in the collagen network that contribute to various pathological phenotypes in the skeletal, vascular, and pulmonary systems. The aim of this study was to investigate the consequences of age-related modifications on the mechanical stability and in vitro proteolytic degradation of type I collagen. Analyzing mouse tail and bovine bone collagen, we found that collagen at both fibril and fiber levels varies in rigidity and Young's modulus due to different physiological changes, which correlate with changes in cathepsin K (CatK)-mediated degradation. A decreased susceptibility to CatK-mediated hydrolysis of fibrillar collagen was observed following mineralization and advanced glycation end product-associated modification. However, aging of bone increased CatK-mediated osteoclastic resorption by similar to 27%, and negligible resorption was observed when osteoclasts were cultured on mineral-deficient bone. We observed significant differences in the excavations generated by osteoclasts and C-terminal telopeptide release during bone resorption under distinct conditions. Our data indicate that modification of collagen compromises its bio-mechanical integrity and affects CatK-mediated degradation both in bone and tissue, thus contributing to our understanding of extracellular matrix aging.	[Panwar, Preety; Mackenzie, Neil C. W.; Broemme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC 6T 1Z3, Canada; [Panwar, Preety; Mackenzie, Neil C. W.; Broemme, Dieter] Univ British Columbia, Fac Med, Ctr Blood Res, Vancouver, BC 6T 1Z3, Canada; [Yang, Heejae; Ko, Frank] Univ British Columbia, Fac Med, Dept Mech Engn, Vancouver, BC 6T 1Z3, Canada; [Broemme, Dieter] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC 6T 1Z3, Canada; [Lamour, Guillaume; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Bromme, D (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC 6T 1Z3, Canada.	dbromme@dentistry.ubc.ca	Lamour, Guillaume/D-6758-2015; Li, Hongbin/G-2949-2012	Lamour, Guillaume/0000-0002-9331-5532; Li, Hongbin/0000-0001-7813-1332	Canadian Institutes of Health Research [MOP-8994, MOP-125866]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MOP-8994 and MOP-125866. The authors declare that they have no conflicts of interest with the contents of this article.	Aguda AH, 2014, P NATL ACAD SCI USA, V111, P17474, DOI 10.1073/pnas.1414126111; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; Cheng XW, 2013, ATHEROSCLEROSIS, V228, P211, DOI 10.1016/j.atherosclerosis.2013.01.004; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Duong L. T., 2013, IBMS BONEKEY, DOI [10.1038/bonekey.2013.130, DOI 10.1038/BONEKEY.2013.130]; Ebenstein DM, 2009, J BIOMED MATER RES A, V91A, P1028, DOI 10.1002/jbm.a.32321; Ebrahimi Ali P, 2009, J Vasc Interv Neurol, V2, P155; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Garnero Patrick, 2012, Bonekey Rep, V1, P182, DOI 10.1038/bonekey.2012.182; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Gineyts E, 2000, BIOCHEM J, V345, P481, DOI 10.1042/0264-6021:3450481; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; Huebschmann AG, 2006, DIABETES CARE, V29, P1420, DOI 10.2337/dc05-2096; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lamour G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-16; Lamour G, 2014, ACS NANO, V8, P3851, DOI 10.1021/nn5007013; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Noordzij MJ, 2008, J REN CARE, V34, P207, DOI 10.1111/j.1755-6686.2008.00038.x; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olsson LF, 2001, AM J KIDNEY DIS, V38, P377, DOI 10.1053/ajkd.2001.26104; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rodriguez KJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-29; Rolewska P, 2013, EXP GERONTOL, V48, P29, DOI 10.1016/j.exger.2012.04.012; SCHMID K, 1980, ATHEROSCLEROSIS, V37, P199, DOI 10.1016/0021-9150(80)90005-2; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; Paiva KBS, 2014, ARCH BIOCHEM BIOPHYS, V561, P74, DOI 10.1016/j.abb.2014.07.034; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021; Tang SY, 2011, J BIOMECH, V44, P330, DOI 10.1016/j.jbiomech.2010.10.016; Thiam S, 2004, J ENVIRON SCI HEAL A, V39, P1497, DOI 10.1081/ESE-120037849; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	75	63	64	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23291	23306		10.1074/jbc.M115.644310	http://dx.doi.org/10.1074/jbc.M115.644310			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224630	Green Published, hybrid			2022-12-26	WOS:000361685500037
J	Holm, LS; Thulstrup, PW; Kasimova, MR; van de Weert, M				Holm, Louise Stenstrup; Thulstrup, Peter W.; Kasimova, Marina R.; van de Weert, Marco			Preferential Interactions and the Effect of Protein PEGylation	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ULTRAVIOLET CIRCULAR-DICHROISM; INCREASED THERMAL-STABILITY; GUANIDINE HYDROCHLORIDE; POLYETHYLENE-GLYCOL; THERAPEUTIC PROTEINS; SECONDARY-STRUCTURE; PHYSICAL STABILITY; NATIVE-STATE; HEN LYSOZYME	Background PEGylation is a strategy used by the pharmaceutical industry to prolong systemic circulation of protein drugs, whereas formulation excipients are used for stabilization of proteins during storage. Here we investigate the role of PEGylation in protein stabilization by formulation excipients that preferentially interact with the protein. Methodology/Principal Findings The model protein hen egg white lysozyme was doubly PEGylated on two lysines with 5 kDa linear PEGs (mPEG-succinimidyl valerate, MW 5000) and studied in the absence and presence of preferentially excluded sucrose and preferentially bound guanine hydrochloride. Structural characterization by far-and near-UV circular dichroism spectroscopy was supplemented by investigation of protein thermal stability with the use of differential scanning calorimetry, far and near-UV circular dichroism and fluorescence spectroscopy. It was found that PEGylated lysozyme was stabilized by the preferentially excluded excipient and destabilized by the preferentially bound excipient in a similar manner as lysozyme. However, compared to lysozyme in all cases the melting transition was lower by up to a few degrees and the calorimetric melting enthalpy was decreased to half the value for PEGylated lysozyme. The ratio between calorimetric and van't Hoff enthalpy suggests that our PEGylated lysozyme is a dimer. Conclusion/Significance The PEGylated model protein displayed similar stability responses to the addition of preferentially active excipients. This suggests that formulation principles using preferentially interacting excipients are similar for PEGylated and non-PEGylated proteins.	[Holm, Louise Stenstrup; Kasimova, Marina R.; van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Thulstrup, Peter W.] Univ Copenhagen, Dept Chem, Dept Chem, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Holm, LS (corresponding author), Novo Nordisk AS, CMC Supply, Biopharm Formulat Dev, DK-2820 Gentofte, Denmark.	LouiseSHolm@gmail.com	Thulstrup, Peter Waaben/C-5598-2013; Thulstrup, Peter Waaben/V-6371-2019; van de Weert, Marco/AGR-7726-2022	Thulstrup, Peter Waaben/0000-0002-9241-4352; Thulstrup, Peter Waaben/0000-0002-9241-4352; van de Weert, Marco/0000-0002-8530-6441	Advanced Technology Foundation; Ministry of Science, Technology and Innovation; Apotekerfonden; Drug Research Academy; Danish Agency for Science, Technology and Innovation	Advanced Technology Foundation; Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Apotekerfonden; Drug Research Academy; Danish Agency for Science, Technology and Innovation	Funding was kindly provided by the Advanced Technology Foundation and the Ministry of Science, Technology and Innovation for the NanoDSC instrument, by Apotekerfonden af 1991 for the Fluorolog, by the Drug Research Academy for the purchase of the NanoDrop 2000c and the Danish Agency for Science, Technology and Innovation for a PhD mobility stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author MRK is currently employed by Symphogen A/S, however, the work performed in connection with the article itself commenced prior to MRK's employment with Symphogen A/S and was then completed outside of her regular working hours at Symphogen A/S. MRK asked and received permission from Symphogen A/S to work on this paper. Symphogen A/S did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1982, J BIOL CHEM, V257, P2935; AHMAD F, 1992, BIOCHEM J, V287, P481, DOI 10.1042/bj2870481; Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Arakawa T, 2001, BIOSCI BIOTECH BIOCH, V65, P1321, DOI 10.1271/bbb.65.1321; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005; AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4579, DOI 10.1021/bi00839a052; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Blumlein A, 2013, BBA-PROTEINS PROTEOM, V1834, P2064, DOI 10.1016/j.bbapap.2013.06.001; Cueto M, 2003, INT J PHARM, V252, P159, DOI 10.1016/S0378-5173(02)00627-0; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Ferreira M, 1997, J THERM ANAL, V48, P683, DOI 10.1007/bf01979514; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; FORMOSO C, 1975, J BIOL CHEM, V250, P3738; Furness EL, 1998, BIOMATERIALS, V19, P1361, DOI 10.1016/S0142-9612(98)00007-6; GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330; GOUX WJ, 1980, BIOPOLYMERS, V19, P2191, DOI 10.1002/bip.1980.360191205; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GRIKO YV, 1995, J MOL BIOL, V252, P447, DOI 10.1006/jmbi.1995.0510; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hawe A, 2012, J PHARM SCI-US, V101, P895, DOI 10.1002/jps.22812; Heller MC, 1999, J PHARM SCI, V88, P58, DOI 10.1021/js980257j; Hinds K, 2000, BIOCONJUGATE CHEM, V11, P195, DOI 10.1021/bc9901189; Holm LS, 2014, J PHARM SCI-US, V103, P3043, DOI 10.1002/jps.24094; IMOTO T, 1972, P NATL ACAD SCI USA, V69, P1151, DOI 10.1073/pnas.69.5.1151; ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026; Ivens IA, 2013, HAEMOPHILIA, V19, P11, DOI 10.1111/j.1365-2516.2012.02931.x; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kendrick BS, 1997, P NATL ACAD SCI USA, V94, P11917, DOI 10.1073/pnas.94.22.11917; Kim YS, 2003, PROTEIN SCI, V12, P1252, DOI 10.1110/ps.0242603; Kurtin WE, 2002, BIOCHEM MOL BIOL EDU, V30, P244, DOI 10.1002/bmb.2002.494030040083; Laurents DV, 1997, BIOCHEMISTRY-US, V36, P1496, DOI 10.1021/bi962198z; Lee H, 2003, J PHARM SCI-US, V92, P97, DOI 10.1002/jps.10270; LEE JC, 1981, J BIOL CHEM, V256, P7193; LEE JC, 1981, J BIOL CHEM, V256, P625; Liu W, 2005, BIOTECHNOL BIOENG, V90, P482, DOI 10.1002/bit.20442; Liu YF, 1996, BIOCHEMISTRY-US, V35, P3059, DOI 10.1021/bi952198j; MAKHATADZE GI, 1992, J MOL BIOL, V226, P491, DOI 10.1016/0022-2836(92)90963-K; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Matsuo K, 2009, PROTEINS, V77, P191, DOI 10.1002/prot.22430; Mosharraf M, 2007, INT J PHARMACEUT, V336, P215, DOI 10.1016/j.ijpharm.2006.11.064; Nodake Y, 2000, BIOSCI BIOTECH BIOCH, V64, P767, DOI 10.1271/bbb.64.767; Nozaki Y, 1972, Methods Enzymol, V26, P43; Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Palm T, 2011, PHARM DEV TECHNOL, V16, P441, DOI 10.3109/10837450.2010.535830; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008; Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pfister D, 2014, J CONTROL RELEASE, V180, P134, DOI 10.1016/j.jconrel.2014.02.002; Pinholt C, 2011, EUR J PHARM BIOPHARM, V77, P139, DOI 10.1016/j.ejpb.2010.11.001; Plesner B, 2011, EUR J PHARM BIOPHARM, V79, P399, DOI 10.1016/j.ejpb.2011.05.003; PRIVALOV G, 1995, ANAL BIOCHEM, V232, P79, DOI 10.1006/abio.1995.9957; Rajan RS, 2006, PROTEIN SCI, V15, P1063, DOI 10.1110/ps.052004006; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Schwalbe H, 2001, PROTEIN SCI, V10, P677, DOI 10.1110/ps.43301; Stigsnaes P, 2007, INT J PHARMACEUT, V330, P89, DOI 10.1016/j.ijpharm.2006.09.002; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; TANFORD C, 1970, BIOCHEMISTRY-US, V9, P206, DOI 10.1021/bi00804a003; TANFORD C, 1973, J MOL BIOL, V73, P185, DOI 10.1016/0022-2836(73)90322-7; TANFORD C, 1966, J MOL BIOL, V15, P489, DOI 10.1016/S0022-2836(66)80123-7; Tattini V, 2005, INT J PHARMACEUT, V304, P124, DOI 10.1016/j.ijpharm.2005.08.006; Tuesca AD, 2009, PHARM RES-DORDR, V26, P727, DOI 10.1007/s11095-008-9816-8; van de Weert M, 2004, PHARM RES-DORDR, V21, P2354, DOI 10.1007/s11095-004-7689-z; Wei W, 1999, INT J PHARMACEUT, V185, P129, DOI 10.1016/S0378-5173(99)00152-0; Wu FG, 2011, PHYS CHEM CHEM PHYS, V13, P3429, DOI 10.1039/c0cp01184c; YUNUS WMB, 1988, APPL OPTICS, V27, P3341, DOI 10.1364/AO.27.003341; Zielenkiewicz W, 2006, J THERM ANAL CALORIM, V83, P587, DOI 10.1007/s10973-005-7417-x	71	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133584	10.1371/journal.pone.0133584	http://dx.doi.org/10.1371/journal.pone.0133584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230338	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400045
J	Protogerou, AD; Fransen, J; Zampeli, E; Argyris, AA; Aissopou, E; Arida, A; Konstantonis, GD; Tentolouris, N; Makrilakis, K; Psichogiou, M; Daikos, G; Kitas, GD; Sfikakis, PP				Protogerou, Athanasios D.; Fransen, Jaap; Zampeli, Evangelia; Argyris, Antonis A.; Aissopou, Evagelia; Arida, Aikaterini; Konstantonis, George D.; Tentolouris, Nikos; Makrilakis, Konstantinos; Psichogiou, Mina; Daikos, George; Kitas, George D.; Sfikakis, Petros P.			The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS; FOLLOW-UP; HIV-INFECTION; ARTERIES; PLAQUES; ASSOCIATION; EVENTS; RECOMMENDATIONS	Background Presence of femoral atheromatic plaques, an emerging cardiovascular disease (CVD) biomarker additional to carotid plaques, is poorly investigated in conditions associating with accelerated atherosclerosis such as Rheumatoid Arthritis (RA), Human Immunodeficiency Virus (HIV) infection and Type 2 Diabetes Mellitus (T2DM). Objective/Methods To assess the frequency of femoral/carotid subclinical atheromatosis phenotypes in RA, HIV and T2DM and search for each disease-specific probability of either femoral and/or carotid subclinical atheromatosis, we examined by ultrasound a single-center cohort of CVD-free individuals comprised of consecutive non-diabetic patients with RA (n=226) and HIV (n=133), T2DM patients (n=109) and non-diabetic individuals with suspected/known hypertension (n=494) who served as reference group. Results Subclinical atheromatosis -defined as local plaque presence in at least on arterial bed was diagnosed in 50% of the overall population. Among them, femoral plaques only were found in 25% of either RA or HIV patients, as well as in 16% of T2DM patients and 35% of reference subjects. After adjusting for all classical CVD risk factors, RA and HIV patients had comparable probability to reference group of having femoral plaques, but higher probability (1.75; 1.17-2.63 (odds ratio; 95% confidence intervals), 2.04; 1.14-3.64, respectively) of having carotid plaques, whereas T2DM patients had higher probability to have femoral and carotid plaques, albeit, due to their pronounced dyslipidemic profile. Conclusion RA and HIV accelerate predominantly carotid than femoral. A "two windows" carotid/femoral, rather than carotid alone ultrasound, screening improves substantially subclinical atheromatosis detection in patients at high CVD risk.	[Protogerou, Athanasios D.; Zampeli, Evangelia; Argyris, Antonis A.; Aissopou, Evagelia; Arida, Aikaterini; Konstantonis, George D.; Tentolouris, Nikos; Makrilakis, Konstantinos; Psichogiou, Mina; Daikos, George; Sfikakis, Petros P.] Laikon Gen Hosp, Dept Propaedeut & Internal Med 1, Athens, Greece; [Protogerou, Athanasios D.; Zampeli, Evangelia; Arida, Aikaterini; Konstantonis, George D.; Sfikakis, Petros P.] Natl & Kapodistrian Univ Athens, Sch Med, Joint Acad Rheumatol Program, Athens 11528, Greece; [Fransen, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; [Kitas, George D.] Dudley Grp NHS Fdn Trust, Dept Rheumatol, Dudley, England; [Kitas, George D.] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England	Laiko General Hospital; Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen; University of Manchester	Protogerou, AD (corresponding author), Laikon Gen Hosp, Dept Propaedeut & Internal Med 1, Athens, Greece.	aprotog@med.uoa.gr	Daikos, George L./ABD-8378-2021; Fransen, J./L-4310-2015; Makrilakis, Konstantinos/AAG-4487-2020; Sfikakis, Petros/AAD-7289-2019; Kitas, George/AAO-6396-2020; Protogerou, Athanassios/AAD-7210-2019; Argyris, Antonios/ABI-8234-2020; TENTOLOURIS, NIKOLAOS/AAH-6231-2019	Makrilakis, Konstantinos/0000-0002-4160-0577; Argyris, Antonios/0000-0002-8906-6959; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Protogerou, Athanase/0000-0002-3825-532X; KITAS, GEORGE/0000-0002-0828-6176; Zampeli, Evangelia/0000-0002-3668-4454	ELKE grant, Athens University Medical School [097]	ELKE grant, Athens University Medical School	Supported by ELKE grant 097, Athens University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other source of funding exists.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Belcaro G, 2001, ATHEROSCLEROSIS, V156, P379, DOI 10.1016/S0021-9150(00)00665-1; Bianda N, 2012, EUR HEART J, V33, P230, DOI 10.1093/eurheartj/ehr332; Currier JS, 2014, ANN INTERN MED, V160, P509, DOI 10.7326/M14-0378; Dalager S, 2008, J VASC SURG, V47, P296, DOI 10.1016/j.jvs.2007.10.037; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; Depairon M, 2001, AIDS, V15, P329, DOI 10.1097/00002030-200102160-00005; European Centre for Diseases Prevention and Control, 2010, EVIDENCE SYNTHESIS F; Evans MR, 2011, ARTHRITIS RHEUM-US, V63, P1211, DOI 10.1002/art.30265; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Frerix M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4489; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Fukudome Y, 1997, Hypertens Res, V20, P175, DOI 10.1291/hypres.20.175; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Griffin M, 2009, VASC MED, V14, P227, DOI 10.1177/1358863X08101542; Held C, 2001, EUR HEART J, V22, P62, DOI 10.1053/euhj.1999.2006; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Hulsen E, 2009, HEART, V95, P1826, DOI [10.1136/hrt.2009.177774, DOI 10.1136/HRT.2009.177774]; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kawai VK1, 2014, ARTHRITIS RHEUMATOL; Khoury Z, 1997, AM J CARDIOL, V80, P1429, DOI 10.1016/S0002-9149(97)00701-7; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kranjec I, 2011, J CARDIOVASC MED, V12, P297, DOI 10.2459/JCM.0b013e328343e962; Lamina C, 2006, EUR HEART J, V27, P2580, DOI 10.1093/eurheartj/ehl228; Langlois MR, 2008, ARTERIOSCL THROM VAS, V28, P1563, DOI 10.1161/ATVBAHA.108.167346; Maeno T, 2002, DIABETES, V51, P1523, DOI 10.2337/diabetes.51.5.1523; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Nolting PRWD, 2003, ARCH INTERN MED, V163, P1837, DOI 10.1001/archinte.163.15.1837; Panayiotou AG, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-44; Pasterkamp G, 1999, ARTERIOSCL THROM VAS, V19, P54, DOI 10.1161/01.ATV.19.1.54; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Protogerou AD, 2014, J AM COLL CARDIOL, V63, P1748, DOI 10.1016/j.jacc.2014.01.044; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Roman MJ, 2006, VASC MED, V11, P201, DOI 10.1177/1358863x06070511; Roman MJ, 2012, HYPERTENSION, V59, P29, DOI 10.1161/HYPERTENSIONAHA.111.181925; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Ryd&eacute;n L, 2014, EUR HEART J; Safar ME, 2006, HDB HYPERTENSION, V23; SALONEN JT, 1994, J INTERN MED, V236, P561, DOI 10.1111/j.1365-2796.1994.tb00846.x; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Sass C, 1998, J HYPERTENS, V16, P1593, DOI 10.1097/00004872-199816110-00005; Schmidt C, 2005, ATHEROSCLEROSIS, V181, P125, DOI 10.1016/j.atherosclerosis.2004.12.034; Scuteri A, 2009, NUTR METAB CARDIOVAS, V19, P532, DOI 10.1016/j.numecd.2008.11.004; Shaikh S, 2012, EUR J VASC ENDOVASC, V44, P491, DOI 10.1016/j.ejvs.2012.08.005; Stamatelopoulos KS, 2010, ATHEROSCLEROSIS, V212, P305, DOI 10.1016/j.atherosclerosis.2010.05.007; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Tyrrell PN, 2010, ARTERIOSCL THROM VAS, V30, P1014, DOI 10.1161/ATVBAHA.109.198424; van Sloten TT, 2014, J AM COLL CARDIOL, V63, P1739, DOI 10.1016/j.jacc.2013.12.041; Weir-McCall JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099190; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Zannad F, 2012, EUR J PREV CARDIOL, V19, P1454, DOI 10.1177/1741826711424873	59	21	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132307	10.1371/journal.pone.0132307	http://dx.doi.org/10.1371/journal.pone.0132307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230728	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400017
J	Schai-Braun, SC; Reichlin, TS; Ruf, T; Klansek, E; Tataruch, F; Arnold, W; Hacklander, K				Schai-Braun, Stephanie C.; Reichlin, Thomas S.; Ruf, Thomas; Klansek, Erich; Tataruch, Frieda; Arnold, Walter; Hacklaender, Klaus			The European Hare (Lepus europaeus): A Picky Herbivore Searching for Plant Parts Rich in Fat	PLOS ONE			English	Article							ACID-COMPOSITION; BROWN HARES; HABITAT SELECTION; FARMLAND; ADAPTATION; DEMOGRAPHY; ABUNDANCE; QUALITY; PALLAS; IMPACT	European hares of both sexes rely on fat reserves, particularly during the reproduc-tive season. Therefore, hares should select dietary plants rich in fat and energy. However, hares also require essential polyunsaturated fatty acids (PUFA) such as linoleic acid (LA) and alpha-linolenic acid (ALA) to reproduce and survive. Although hares are able to absorb PUFA selectively in their gastrointestinal tract, it is unknown whether this mechanism is sufficient to guarantee PUFA supply. Thus, diet selection may involve a trade-off between a preference for energy versus a preference for crucial nutrients, namely PUFA. We compared plant and nutrient availability and use by hares in an arable landscape in Austria over three years. We found that European hares selected their diet for high energy content (crude fat and crude protein), and avoided crude fibre. There was no evidence of a preference for plants rich in LA and ALA. We conclude that fat is the limiting resource for this herbivorous mammal, whereas levels of LA and ALA in forage are sufficiently high to meet daily requirements, especially since their uptake is enhanced by physiological mechanisms. Animals selected several plant taxa all year round, and preferences did not simply correlate with crude fat content. Hence, European hares might not only select for plant taxa rich in fat, but also for high-fat parts of preferred plant taxa. As hares preferred weeds/grasses and various crop types while avoiding cereals, we suggest that promoting heterogeneous habitats with high crop diversity and set-asides may help stop the decline of European hares throughout Europe.	[Schai-Braun, Stephanie C.; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Reichlin, Thomas S.] Univ Bern, Vetsuisse Fac, Div Anim Welf, Bern, Switzerland; [Ruf, Thomas; Klansek, Erich; Tataruch, Frieda; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Bern; University of Veterinary Medicine Vienna	Schai-Braun, SC (corresponding author), Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria.	stephanie.schai-braun@boku.ac.at	Schai-Braun, Stéphanie/Z-2789-2019; Schai-Braun, Stéphanie/AAW-4182-2020; Arnold, Walter/C-3394-2013; Hackländer, Klaus/ABC-4327-2020	Schai-Braun, Stéphanie/0000-0001-8124-9139; Arnold, Walter/0000-0001-6785-5685; Hacklander, Klaus/0000-0002-6774-435X; Ruf, Thomas/0000-0002-9235-7079	Deutsche Wildtier Stiftung; Hunting Societies of Austria; Verein Grunes Keuz	Deutsche Wildtier Stiftung; Hunting Societies of Austria; Verein Grunes Keuz	The study was funded by the Deutsche Wildtier Stiftung, the Hunting Societies of Austria, and the Verein Grunes Keuz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2000, AM J PHYSIOL-ENDOC M, V279, pE744, DOI 10.1152/ajpendo.2000.279.4.E744; [Anonymous], 1993, INTRO BOOTSTRAP; Ayre KJ, 1996, J APPL PHYSIOL, V80, P464, DOI 10.1152/jappl.1996.80.2.464; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barton K., 2013, MUMIN MULTIMODEL INF; Bro E, 2004, J APPL ECOL, V41, P846, DOI 10.1111/j.0021-8901.2004.00939.x; Chapuis JL, 1990, MAMM BIOL, V55, P176; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Chiari M, 2014, EUR J WILDLIFE RES, V60, P891, DOI 10.1007/s10344-014-0856-6; Clapham WM, 2005, J AGR FOOD CHEM, V53, P10068, DOI 10.1021/jf0517039; Dixon Philip M., 1993, P290; Faraway J.J., 2016, EXTENDING LINEAR MOD, DOI [10.1201/9781315382722, DOI 10.1201/9781315382722]; Flux J, 1976, NZ J SCI, V102, P357; Fromm M, 2012, EUR FOOD RES TECHNOL, V234, P1033, DOI 10.1007/s00217-012-1709-8; FRYLESTAM B, 1986, MAMMAL REV, V16, P157, DOI 10.1111/j.1365-2907.1986.tb00037.x; Gorski J, 1999, EUR J APPL PHYSIOL O, V79, P421, DOI 10.1007/s004210050532; Hacklander K, 2011, MAMM BIOL, V76, P662, DOI 10.1016/j.mambio.2011.05.001; Hacklander K, 2002, J COMP PHYSIOL B, V172, P183, DOI 10.1007/s00360-001-0243-y; Hacklander K, 2002, PHYSIOL BIOCHEM ZOOL, V75, P19, DOI 10.1086/324770; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; HOMOLKA M, 1987, FOLIA ZOOL, V36, P103; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jennings N, 2006, WILDLIFE BIOL, V12, P179, DOI 10.2981/0909-6396(2006)12[179:VIDCAD]2.0.CO;2; Krebs CJ., 1989, ECOLOGICAL METHODOLO, P392; Kronfeld N, 1996, J MAMMAL, V77, P171, DOI 10.2307/1382718; Langbein J, 1999, MAMMAL REV, V29, P93, DOI 10.1046/j.1365-2907.1999.00040.x; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; Meichtry-Stier KS, 2014, AGR ECOSYST ENVIRON, V189, P101, DOI 10.1016/j.agee.2014.02.038; Mir PS, 2006, CAN J ANIM SCI, V86, P279, DOI 10.4141/A05-050; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; PALMQUIST DL, 1980, J DAIRY SCI, V63, P1, DOI 10.3168/jds.S0022-0302(80)82881-5; Petrovan SO, 2013, ANIM CONSERV, V16, P344, DOI 10.1111/acv.12002; Pierce BJ, 2014, INTEGR COMP BIOL, V54, P903, DOI 10.1093/icb/icu098; Popescu FD, 2011, J COMP PHYSIOL B, V181, P681, DOI 10.1007/s00360-011-0559-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Raczynski J., 1964, Acta Theriologica, V9, P305; Reichlin T, 2006, EUR J WILDLIFE RES, V52, P109, DOI 10.1007/s10344-005-0013-3; Ruf T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000065; Sahoo A, 2010, GRASSL SCI, V56, P116, DOI 10.1111/j.1744-697X.2010.00183.x; Schai-Braun SC, 2014, ACTA THERIOL, V59, P277, DOI 10.1007/s13364-013-0162-9; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smith RK, 2005, ACTA THERIOL, V50, P391, DOI 10.1007/BF03192634; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; SUCHENTRUNK F, 1991, Z SAUGETIERKD, V56, P365; TAPPER SC, 1986, J APPL ECOL, V23, P39, DOI 10.2307/2403079; Tufarelli V, 2010, ANIMAL, V4, P763, DOI 10.1017/S1751731109991741; Valencak TG, 2009, J EXP BIOL, V212, P231, DOI 10.1242/jeb.022640; Valencak TG, 2009, J COMP PHYSIOL B, V179, P933, DOI 10.1007/s00360-009-0376-y; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4; Z&ouml;rner E, 1996, DER FELDHASE	52	48	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134278	10.1371/journal.pone.0134278	http://dx.doi.org/10.1371/journal.pone.0134278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230115	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400098
J	Su, CY; Liu, YP; Yang, CJ; Lin, YF; Chiou, J; Chi, LH; Lee, JJ; Wu, ATH; Lu, PJ; Huang, MS; Hsiao, M				Su, Chia-Yi; Liu, Yu-Peng; Yang, Chih-Jen; Lin, Yuan-Feng; Chiou, Jean; Chi, Li-Hsing; Lee, Jih-Jong; Wu, Alex T. H.; Lu, Pei-Jung; Huang, Ming-Shyan; Hsiao, Michael			Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							UROKINASE RECEPTOR; MATRIX METALLOPROTEINASES; EXPRESSION; METASTASIS; SERPINB2; MARKER; SYSTEM; TYPE-1; FIBROBLASTS; SURVIVAL	Background In lung cancer, uPA, its receptor (uPAR), and the inhibitors PAI-1 and PAI-2 of the plasminogen activator family interact with MMP-2 and MMP-9 of the MMP family to promote cancer progression. However, it remains undetermined which of these markers plays the most important role and may be the most useful indicator to stratify the patients by risk. Methods We determined the individual prognostic value of these 6 markers by analyzing a derivation cohort with 98 non-small cell lung cancer patients by immunohistochemical staining. The correlation between the IHC expression levels of these markers and disease prognosis was investigated, and an immunohistochemical panel for prognostic prediction was subsequently generated through prognostic model analysis. The value of the immunohistochemical panel was then verified by a validation cohort with 91 lung cancer patients. Results In derivation cohort, PAI-2 is the most powerful prognostic factor (HR = 2.30; P = 0.001), followed by MMP-9 (HR = 2.09; P = 0.019) according to multivariate analysis. When combining PAI-2 and MMP-9, the most unfavorable prognostic group (low PAI-2 and high MMP-9 IHC expression levels) showed a 6.40-fold increased risk of a poor prognosis compared to the most favorable prognostic group (high PAI-2 and low MMP-9 IHC expression levels). PAI-2 and MMP-9 IHC panel could more precisely identify high risk patients in both derivation and validation cohort. Conclusions We revealed PAI-2 as the most powerful prognostic marker among PA and MMP protease family even after considering their close relationships with each other. By utilizing a combination of PAI-2 and MMP-9, more precise prognostic information than merely using pathological stage alone can be obtained for lung cancer patients.	[Su, Chia-Yi; Chiou, Jean; Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Dept Genome Med, Kaohsiung, Taiwan; [Yang, Chih-Jen; Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yuan-Feng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chiou, Jean] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chiou, Jean; Chi, Li-Hsing; Wu, Alex T. H.] Acad Sinica, Taichung, Taiwan; [Chi, Li-Hsing; Wu, Alex T. H.] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan; [Lee, Jih-Jong] Natl Taiwan Univ, Sch Vet Med, Inst Vet Clin Sci, Taipei 10764, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan	Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; China Medical University Taiwan; Academia Sinica - Taiwan; Taipei Medical University; National Taiwan University; National Cheng Kung University	Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	shyang@kmu.edu.tw; mhsiao@gate.sinica.edu.tw	Su, Chia-Yi/L-5378-2016; Hsiao, Michael/U-6238-2019; Chiou, Jean/G-8255-2014; Chi, Tex/I-9129-2012	Su, Chia-Yi/0000-0002-9483-4510; Hsiao, Michael/0000-0001-8529-9213; Chiou, Jean/0000-0001-6926-0159; Chi, Tex/0000-0002-4476-2600; LEE, JIH-JONG/0000-0002-4424-730X				Ali HR, 2012, BRIT J CANCER, V106, P1798, DOI 10.1038/bjc.2012.167; Allen BJ, 2003, BRIT J CANCER, V88, P944, DOI 10.1038/sj.bjc.6600838; Annabi B, 2005, CLIN EXP METASTAS, V22, P429, DOI 10.1007/s10585-005-2669-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chambers SK, 1997, INT J CANCER, V74, P571, DOI 10.1002/(SICI)1097-0215(19971219)74:6<571::AID-IJC2>3.3.CO;2-Z; Cochran BJ, 2011, J BIOL CHEM, V286, P24467, DOI 10.1074/jbc.M111.225706; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cox G, 2001, THORAX, V56, P561, DOI 10.1136/thorax.56.7.561; Cox G, 1999, THORAX, V54, P169, DOI 10.1136/thx.54.2.169; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Di Y, 2010, FEBS LETT, V584, P3469, DOI 10.1016/j.febslet.2010.07.005; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Duggan C, 1997, BRIT J CANCER, V76, P622, DOI 10.1038/bjc.1997.435; GANESH S, 1994, CANCER RES, V54, P4065; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higgins KA, 2012, J THORAC ONCOL, V7, P1141, DOI 10.1097/JTO.0b013e3182519a42; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; MUELLER BM, 1995, P NATL ACAD SCI USA, V92, P205, DOI 10.1073/pnas.92.1.205; Nordengren J, 2002, INT J CANCER, V97, P379, DOI 10.1002/ijc.1611; Offersen BV, 2007, LUNG CANCER, V56, P43, DOI 10.1016/j.lungcan.2006.11.018; OKA T, 1991, CANCER RES, V51, P3522; Pavey S J, 1996, Boll Soc Ital Biol Sper, V72, P331; PEDERSEN H, 1994, CANCER RES, V54, P120; PEDERSEN H, 1994, CANCER RES, V54, P4671; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Praus M, 1999, GENE THER, V6, P227, DOI 10.1038/sj.gt.3300802; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Robbie LA, 2000, BRIT J HAEMATOL, V109, P342, DOI 10.1046/j.1365-2141.2000.02057.x; Robert C, 1999, CLIN CANCER RES, V5, P2094; Salden M, 2000, ANN ONCOL, V11, P327, DOI 10.1023/A:1008312801800; SCHERRER A, 1991, LEUKEMIA, V5, P479; Schroder WA, 2014, CANCER MED-US, V3, P500, DOI 10.1002/cam4.229; Shao WL, 2011, J SURG ONCOL, V104, P841, DOI 10.1002/jso.22001; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart CE, 2013, LUNG, V191, P215, DOI 10.1007/s00408-013-9450-z; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Volm M, 1999, ONCOL REP, V6, P611; Werle B, 2004, ANTICANCER RES, V24, P4147; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yoshino H, 1998, BRIT J CANCER, V78, P833, DOI 10.1038/bjc.1998.588	46	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133411	10.1371/journal.pone.0133411	http://dx.doi.org/10.1371/journal.pone.0133411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230665	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400038
J	Garcia-Cobos, S; Kock, R; Mellmann, A; Frenzel, J; Friedrich, AW; Rossen, JWA				Garcia-Cobos, Silvia; Koeck, Robin; Mellmann, Alexander; Frenzel, Julia; Friedrich, Alexander W.; Rossen, John W. A.			Molecular Typing of Enterobacteriaceae from Pig Holdings in North-Western Germany Reveals Extended-Spectrum and AmpC beta-Lactamases Producing but no Carbapenem Resistant Ones	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; RETAIL CHICKEN MEAT; ESCHERICHIA-COLI; PUBLIC-HEALTH; COMPANION ANIMALS; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; CTX-M; PLASMIDS; HUMANS	The increase of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in humans and in food-producing animals is of public health concern. The latter could contribute to spreading of these bacteria or their resistance genes to humans. Several studies have reported the isolation of third generation cephalosporin resistant bacteria in livestock animals. However, the number of samples and the methodology used differ considerably between studies limiting comparability and prevalence assessment. In the present study, a total of 564 manure and dust samples were collected from 47 pig farms in Northern Germany and analysed to determine the prevalence of ESBL-E. Molecular typing and characterization of resistance genes was performed for all ESBL-E isolates. ESBL-E isolates were found in 55.3% of the farms. ESBL-Escherichia coli was found in 18.8% of the samples, ESBL-Klebsiella pneumoniae in 0.35%. The most prevalent ESBL genes among E. coli were CTX-M-1 like (68.9%), CTX-M-15 like (16%) and CTX-M-9 group (14.2%). In 20% of the latter two, also the OXA-1 like gene was found resulting in a combination of genes typical for isolates from humans. Genetic relation was found between isolates not only from the same, but also from different farms, with multilocus sequence type (ST) 10 being predominant among the E. coli isolates. In conclusion, we showed possible spread of ESBL-E between farms and the presence of resistance genes and STs previously shown to be associated with human isolates. Follow-up studies are required to monitor the extent and pathways of ESBL-E transmission between farms, animals and humans.	[Garcia-Cobos, Silvia; Frenzel, Julia; Friedrich, Alexander W.; Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Koeck, Robin] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany	University of Groningen; University of Munster; University of Munster	Rossen, JWA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	j.rossen@umcg.nl	Köck, Robin/AAC-1552-2019; Rossen, John W/G-7564-2011; GARCÍA-COBOS, SILVIA/A-7087-2017; Friedrich, Alex/ABG-9823-2020	Rossen, John W/0000-0002-7167-8623; GARCÍA-COBOS, SILVIA/0000-0002-1417-5691; Mellmann, Alexander/0000-0002-0649-5185	European Union [III-2-03_025, III-1-02_073]	European Union(European Commission)	This work was supported by the SafeGuard (grant III-2-03_025) and EurSafety Health-net (grant III-1-02_073) projects within the INTERREG IVa program of the European Union.	Bae IK, 2014, DIAGN MICR INFEC DIS, V79, P373, DOI 10.1016/j.diagmicrobio.2014.03.007; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bolton DJ, 2013, INT J FOOD MICROBIOL, V160, P298, DOI 10.1016/j.ijfoodmicro.2012.11.001; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Escudero E, 2010, RES VET SCI, V88, P83, DOI 10.1016/j.rvsc.2009.05.021; EUCAST, CLIN BREAKP TABL V 5; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Goering RV, 2013, EURO SURVEILL, V18; Goncalves A, 2010, FOODBORNE PATHOG DIS, V7, P1569, DOI 10.1089/fpd.2010.0598; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, DOI [10.1128/JCM.01251-15, DOI 10.1128/JCM.01251-15]; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Literak I, 2013, MICROB DRUG RESIST, V19, P57, DOI 10.1089/mdr.2012.0124; Machado E, 2008, J ANTIMICROB CHEMOTH, V62, P296, DOI 10.1093/jac/dkn179; Meyer E, 2012, INFECTION, V40, P685, DOI 10.1007/s15010-012-0324-8; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Ojer-Usoz E, 2013, MEAT SCI, V93, P316, DOI 10.1016/j.meatsci.2012.09.009; Ortega A, 2012, ANTIMICROB AGENTS CH, V56, P3576, DOI 10.1128/AAC.06393-11; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Randall LP, 2014, J ANTIMICROB CHEMOTH, V69, P2947, DOI 10.1093/jac/dku258; Rayamajhi N, 2008, INT J FOOD MICROBIOL, V124, P183, DOI 10.1016/j.ijfoodmicro.2008.03.009; Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7; Rodrigues C, 2013, J ANTIMICROB CHEMOTH, V68, P2245, DOI 10.1093/jac/dkt187; Schink AK, 2013, J ANTIMICROB CHEMOTH, V68, P1741, DOI 10.1093/jac/dkt123; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Strauss LM, 2015, J ANTIMICROB CHEMOTH, V70, P710, DOI 10.1093/jac/dku450; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Thai TH, 2012, J FOOD PROTECT, V75, P1709, DOI 10.4315/0362-028X.12-101; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Wang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00188; Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392	52	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134533	10.1371/journal.pone.0134533	http://dx.doi.org/10.1371/journal.pone.0134533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225428	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700108
J	Lahmann, C; Kramer, HB; Ashcroft, FM				Lahmann, Carolina; Kramer, Holger B.; Ashcroft, Frances M.			Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents	PLOS ONE			English	Article							K-ATP CHANNEL; DRUG-METABOLIZING-ENZYMES; CANCER RESISTANCE PROTEIN; PANCREATIC BETA-CELLS; DEND SYNDROME; ACTIVATING MUTATIONS; DEVELOPMENTAL DELAY; ORAL SULFONYLUREAS; SUBUNIT KIR6.2; P-GLYCOPROTEIN	Activating mutations in the Kir6.2 (KCNJ11) subunit of the ATP-sensitive potassium channel cause neonatal diabetes (ND). Patients with severe mutations also suffer from neurological complications. Glibenclamide blocks the open KATP channels and is the treatment of choice for ND. However, although glibenclamide successfully restores normoglycaemia, it has a far more limited effect on the neurological problems. To assess the extent to which glibenclamide crosses the blood-brain barrier (BBB) in vivo, we quantified glibenclamide concentrations in plasma, cerebrospinal fluid (CSF), and brain tissue of rats, control mice, and mice expressing a human neonatal diabetes mutation (Kir6.2-V59M) selectively in neurones (nV59M mice). As only small sample volumes can be obtained from rodents, we developed a highly sensitive method of analysis, using liquid chromatography tandem mass spectrometry acquisition with pseudo-selected reaction monitoring, achieving a quantification limit of 10ng/ml (20nM) glibenclamide in a 30 mu l sample. Glibenclamide was not detectable in the CSF or brain of rats after implantation with subcutaneous glibenclamide pellets, despite high plasma concentrations. Further, one hour after a suprapharmacological glibenclamide dose was administered directly into the lateral ventricle of the brain, the plasma concentration was twice that of the CSF. This suggests the drug is rapidly exported from the CSF. Elacridar, an inhibitor of P-glycoprotein and breast cancer resistance protein (major multidrug resistance transporters at the BBB), did not affect glibenclamide levels in CSF and brain tissue. We also identified a reduced sensitivity to volatile anaesthetics in nV59M mice and showed this was not reversed by systemic delivery of glibenclamide. Our results therefore suggest that little glibenclamide reaches the central nervous system when given systemically, that glibenclamide is rapidly removed across the BBB when given intracranioventricularly, and that any glibenclamide that does enter (and is below our detection limit) is insufficient to influence neuronal function as assessed by anaesthesia sensitivity.	[Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; Univ Oxford, OXION, Oxford, England	University of Oxford; University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk	Kramer, Holger/AAL-4433-2020	Kramer, Holger/0000-0002-6400-0945	Wellcome Trust [084655/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust grant to OXION (084655/Z/08/Z) to CL HBK FMA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Battaglia D, 2012, PEDIATR DIABETES, V13, P656, DOI 10.1111/j.1399-5448.2012.00874.x; Bauer M, 2013, J NUCL MED, V54, P1181, DOI 10.2967/jnumed.112.118232; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Clark RH, 2010, SCIENCE, V329, P458, DOI 10.1126/science.1186146; Della Manna T, 2008, ARQ BRAS ENDOCRINOL, V52, P1350, DOI 10.1590/S0004-27302008000800024; Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Fendler W, 2013, DIABETES CARE, V36, P2311, DOI 10.2337/dc12-2166; Gedeon C, 2006, PLACENTA, V27, P1096, DOI 10.1016/j.placenta.2005.11.012; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gurgel LC, 2007, DIABETES CARE, V30, P108, DOI DOI 10.2337/DC07-1196; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HENQUIN JC, 1992, DIABETOLOGIA, V35, P907, DOI 10.1007/BF00401417; Hopfgartner G, 2003, MASS SPECTROM REV, V22, P195, DOI 10.1002/mas.10050; Itoh S, 2013, J PEDIATR ENDOCR MET, V26, P143, DOI 10.1515/jpem-2012-0236; Karibe T, 2015, PHARM RES-DORDR, V32, P1634, DOI 10.1007/s11095-014-1563-4; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Masia R, 2007, DIABETES, V56, P328, DOI 10.2337/db06-1275; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; MOURRE C, 1990, BRAIN RES, V519, P29, DOI 10.1016/0006-8993(90)90057-I; Myngheer N, 2014, DIABETES CARE, V37, P3333, DOI 10.2337/dc14-1247; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; PEARSON JG, 1985, AM J MED, V79, P67, DOI 10.1016/S0002-9343(85)80010-3; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Remedi MS, 2008, PLOS MED, V5, P1473, DOI 10.1371/journal.pmed.0050206; Sapunar Damir, 2012, J Pain Res, V5, P31, DOI 10.2147/JPR.S26603; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shimomura K, 2007, NEUROLOGY, V69, P1342, DOI 10.1212/01.wnl.0000268488.51776.53; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Takanaga H, 1998, J PHARM PHARMACOL, V50, P1027, DOI 10.1111/j.2042-7158.1998.tb06918.x; Tournier N, 2013, AAPS J, V15, P1082, DOI 10.1208/s12248-013-9514-2; Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Yao XQ, 1996, J CLIN INVEST, V97, P2525, DOI 10.1172/JCI118700; Zwaveling-Soonawala N, 2011, DIABETOLOGIA, V54, P469, DOI 10.1007/s00125-010-1981-8	44	53	54	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134476	10.1371/journal.pone.0134476	http://dx.doi.org/10.1371/journal.pone.0134476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225433	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700098
J	Li, Q; Yang, F; Liu, R; Luo, L; Yang, YL; Zhang, L; Liu, H; Zhang, W; Fan, ZX; Yang, ZQ; Cui, LW; He, YS				Li, Qing; Yang, Fang; Liu, Rong; Luo, Lan; Yang, Yuling; Zhang, Lu; Liu, Huaie; Zhang, Wen; Fan, Zhixiang; Yang, Zhaoqing; Cui, Liwang; He, Yongshu			Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border	PLOS ONE			English	Article							G6PD DEFICIENCY; PLASMODIUM-FALCIPARUM; CAMBODIAN POPULATION; COMMON VARIANT; ORANG ASLI; MUTATIONS; MALARIA; THAILAND; SPREAD; 871G-GREATER-THAN-A	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary disease that predisposes red blood cells to oxidative damage. G6PD deficiency is particularly prevalent in historically malaria-endemic areas. Use of primaquine for malaria treatment may result in severe hemolysis in G6PD deficient patients. In this study, we systematically evaluated the prevalence of G6PD deficiency in the Kachin (Jingpo) ethnic group along the China-Myanmar border and determined the underlying G6PD genotypes. We surveyed G6PD deficiency in 1770 adult individuals (671 males and 1099 females) of the Kachin ethnicity using a G6PD fluorescent spot test. The overall prevalence of G6PD deficiency in the study population was 29.6% (523/1770), among which 27.9% and 30.6% were males and females, respectively. From these G6PD deficient samples, 198 unrelated individuals (147 females and 51 males) were selected for genotyping at 11 known G6PD single nucleotide polymorphisms (SNPs) in Southeast Asia (ten in exons and one in intron 11) using a multiplex SNaPshot assay. Mutations with known association to a deficient phenotype were detected in 43.9% (87/198) of cases, intronic and synonymous mutations were detected alone in 34.8% (69/198) cases and no mutation were found in 21.2% (42/198) cases. Five non-synonymous mutations, Mahidol 487G>A, Kaiping 1388G>A, Canton 1376G>T, Chinese 4 392G>T, and Viangchan 871G>A were detected. Of the 87 cases with known deficient mutations, the Mahidol variant was the most common (89.7%; 78/87), followed by the Kaiping (8.0%; 7/87) and the Viangchan (2.2%; 2/87) variants. The Canton and Chinese 4 variants were found in 1.1% of these 87 cases. Among them, two females carried the Mahidol/Viangchan and Mahidol/Kaiping double mutations, respectively. Interestingly, the silent SNPs 1311C>T and IVS11nt93T>C both occurred in the same 95 subjects with frequencies at 56.4% and 23.5% in tested females and males, respectively (P<0.05). It is noteworthy that 24 subjects carrying the Mahidol mutation and two carrying the Kaiping mutation also carried the 1311C>T/IVS11nt93T>C SNPs. Further studies are needed to determine the enzyme levels of the G6PD deficient people and presence of additional G6PD mutations in the study population.	[Li, Qing; Yang, Fang; Luo, Lan; Yang, Yuling; Zhang, Lu; Zhang, Wen; Fan, Zhixiang; He, Yongshu] Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan, Peoples R China; [Liu, Rong; Liu, Huaie] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Yunnan, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Kunming Medical University; Kunming Medical University; Kunming Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu; yongshuhe@hotmail.com			National Natural Science Foundation of China [31260264]; High Talents introduction project of Yunnan province [2013HA026]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [NIH U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Talents introduction project of Yunnan province; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China (# 31260264), High Talents introduction project of Yunnan province (# 2013HA026), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH U19AI089672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVING A S, 1960, Bull World Health Organ, V22, P621; Amini F, 2011, INTERN MED J, V41, P351, DOI 10.1111/j.1445-5994.2011.02456.x; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Bancone G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116063; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; Charoenkwan P, 2014, SE ASIAN J TROP MED, V45, P187; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; Gomez-Manzo S, 2014, INT J MOL SCI, V15, P21179, DOI 10.3390/ijms151121179; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Laosombat V, 2005, BLOOD CELL MOL DIS, V34, P191, DOI 10.1016/j.bcmd.2004.11.001; Li NN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-361; Lin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123991; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Moiz B, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-41; Monteiro WM, 2014, MEM I OSWALDO CRUZ, V109, P553, DOI 10.1590/0074-0276140123; Nantakomol D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-289; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Tanphaichitr V S, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P137; Taylor W, 2012, SE ASIAN J TROP MED, V44, P231; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Wang JC, 2008, ACTA MED OKAYAMA, V62, P327; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; Yang YF, 2007, SCI CHINA SER C, V50, P479, DOI 10.1007/s11427-007-0072-7; Yang Z, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P259; Yu Guo-long, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P448; Yu Guo-long, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P610; Zhang L, 2015, INT J LAB H IN PRESS	47	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134593	10.1371/journal.pone.0134593	http://dx.doi.org/10.1371/journal.pone.0134593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226515	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700116
J	Miftahussurur, M; Sharma, RP; Shrestha, PK; Suzuki, R; Uchida, T; Yamaoka, Y				Miftahussurur, Muhammad; Sharma, Rabi Prakash; Shrestha, Pradeep Krishna; Suzuki, Rumiko; Uchida, Tomohisa; Yamaoka, Yoshio			Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root	PLOS ONE			English	Article							CYTOTOXIN PRODUCTION; VIRULENCE FACTORS; CAGA; PREVALENCE; GENOTYPES; VACA; ASSOCIATION; MECHANISMS; DIVERSITY; DISEASE	Prevalence of Helicobacter pylori infection in Nepal, a low-risk country for gastric cancer, is debatable. To our knowledge, no studies have examined H. pylori virulence factors in Nepal. We determined the prevalence of H. pylori infection by using three different tests, and the genotypes of virulence factors were determined by PCR followed by sequencing. Multilocus sequence typing was used to analyze the population structure of the Nepalese strains. The prevalence of H. pylori infection in dyspeptic patients was 38.4% (56/146), and was significantly related with source of drinking water. In total, 51 strains were isolated and all were cagA-positive. Western-type-cagA (94.1%), cagA pre-EPIYA type with no deletion (92.2%), vacA s1a (74.5%), and m1c (54.9%) were the predominant genotypes. Antral mucosal atrophy levels were significantly higher in patients infected with vacA s1 than in those infected with s2 genotypes (P = 0.03). Several Nepalese strains were H. pylori recombinants with genetic features of South Asian and East Asian genotypes. These included all East-Asian-type-cagA strains, with significantly lesser activity and inflammation in the corpus than the strains of the specific South Asian genotype (P = 0.03 and P = 0.005, respectively). Although the population structure confirmed that most Nepalese strains belonged to the hpAsia2 population, some strains shared hpEurope- and Nepalese-specific components. Nepalese patients infected with strains belonging to hpEurope showed higher inflammation in the antrum than strains from the Nepalese specific population (P = 0.05). These results support that ancestor roots of Kathmandu's people not only connected with India alone.	[Miftahussurur, Muhammad; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu City, Oita, Japan; [Miftahussurur, Muhammad] Airlangga Univ, Fac Med, Dept Internal Med, Gastroenterohepatol Div, Surabaya, Indonesia; [Miftahussurur, Muhammad] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Sharma, Rabi Prakash; Shrestha, Pradeep Krishna] Tribhuvan Univ Teaching Hosp, Dept Gastroenterol, Kathmandu, Nepal; [Uchida, Tomohisa] Oita Univ, Dept Mol Pathol, Fac Med, Yufu City, Oita, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA	Oita University; Airlangga University; Airlangga University; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu City, Oita, Japan.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021	Miftahussurur, Muhammad/0000-0003-1415-6033; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); Japanese Government (Monbukagakusho: MEXT) Scholarship Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26440198] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); Japanese Government (Monbukagakusho: MEXT) Scholarship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the National Institutes of Health (DK62813) and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan (24406015, 24659200, 25293104, 26640114 and 15H02657) (YY). It was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY), the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY). MM is a PhD student supported by The Japanese Government (Monbukagakusho: MEXT) Scholarship Program for 2012.	ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Chomvarin C, 2008, INT J INFECT DIS, V12, P30, DOI 10.1016/j.ijid.2007.03.012; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dhakhwa R, 2012, J Nepal Health Res Counc, V10, P57; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dube C., 2009, Reviews on Environmental Health, V24, P1; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gayden T, 2013, AM J PHYS ANTHROPOL, V151, P169, DOI 10.1002/ajpa.22240; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kraft C, 2005, INT J MED MICROBIOL, V295, P299, DOI 10.1016/j.ijmm.2005.06.002; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee YY, 2012, HELICOBACTER, V17, P54, DOI 10.1111/j.1523-5378.2011.00917.x; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Makaju R K, 2005, Kathmandu Univ Med J (KUMJ), V3, P355; Matsuhisa T, 2007, Kathmandu Univ Med J (KUMJ), V5, P295; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Saribasak H, 2004, J CLIN MICROBIOL, V42, P1648, DOI 10.1128/JCM.42.4.1648-1651.2004; Sherpa Tshering W, 2012, N Z Med J, V125, P30; Shrestha Roshana, 2014, J Family Med Prim Care, V3, P154, DOI 10.4103/2249-4863.137663; Shrestha S, 2012, Nepal Med Coll J, V14, P229; Sodhi JS, 2013, J GASTROEN HEPATOL, V28, P808, DOI 10.1111/jgh.12178; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 1999, TRENDS MICROBIOL, V7, P182, DOI 10.1016/S0966-842X(99)01505-X; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Thapa R, 2013, J NEPAL MED ASSOC, V52, P354; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005	48	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134216	10.1371/journal.pone.0134216	http://dx.doi.org/10.1371/journal.pone.0134216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226153	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358837700063
J	Bateson, M; Emmerson, M; Ergun, G; Monaghan, P; Nettle, D				Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Monaghan, Pat; Nettle, Daniel			Opposite Effects of Early-Life Competition and Developmental Telomere Attrition on Cognitive Biases in Juvenile European Starlings	PLOS ONE			English	Article							CHILDHOOD ADVERSITIES; ANIMAL EMOTION; LENGTH; DYNAMICS; MORTALITY; MANIPULATION; PERFORMANCE; HUSBANDRY; PESSIMISM; BEHAVIOR	Moods are enduring affective states that we hypothesise should be affected by an individual's developmental experience and its current somatic state. We tested whether early-life adversity, induced by manipulating brood size, subsequently altered juvenile European starlings' (Sturnus vulgaris) decisions in a judgment bias task designed to provide a cognitive measure of mood. We predicted that starlings from larger broods, specifically those that had experienced more nest competitors larger than themselves would exhibit reduced expectation of reward, indicative of a 'pessimistic', depression-like mood. We used a go/no-go task, in which 30 starlings were trained to probe a grey card disc associated with a palatable mealworm hidden underneath and avoid a different shade of grey card disc associated with a noxious quinine-injected mealworm hidden underneath. Birds' response latencies to the trained stimuli and also to novel, ambiguous stimuli intermediate between these were subsequently tested. Birds that had experienced greater competition in the nest were faster to probe trained stimuli, and it was therefore necessary to control statistically for this difference in subsequent analyses of the birds' responses to the ambiguous stimuli. As predicted, birds with more, larger nest competitors showed relatively longer latencies to probe ambiguous stimuli, suggesting reduced expectation of reward and a 'pessimistic', depression-likemood. However, birds with greater developmental telomere attrition-a measure of cellular aging associated with increased morbidity and reduced life-expectancy that we argue could be used as a measure of somatic state -showed shorter latencies to probe ambiguous stimuli. This would usually be interpreted as evidence for a more positive or 'optimistic' affective state. Thus, increased competition in the nest and poor current somatic state appear to have opposite effects on cognitive biases. Our results lead us to question whether increased expectation of reward when presented with ambiguous stimuli always indicates a more positive affective state. We discuss the possibility that birds in poor current somatic state may adopt a 'hungry' cognitive phenotype that could drive behaviour commonly interpreted as 'optimism' in food-rewarded cognitive bias tasks.	[Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Monaghan, Pat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of Glasgow	Bateson, M (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	melissa.bateson@ncl.ac.uk	Bateson, Melissa/AAE-7075-2022; Bateson, Melissa/B-1874-2008; Monaghan, Pat/E-6810-2015	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	Newcastle University; BBSRC [NC/K000802/1, BB/J016446/1, BB/J015091/1]; ERC [ERC AdG 268926]; Biotechnology and Biological Sciences Research Council [BB/J015091/1, BB/J016446/1] Funding Source: researchfish	Newcastle University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Newcastle University (Bateson/Nettle), the BBSRC under grant numbers NC/K000802/1 (Bateson), BB/J016446/1 (Bateson/Nettle) and BB/J015091/1 (Monaghan), and the ERC under grant number ERC AdG 268926 (Monaghan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Baciadonna L, 2015, ANIM WELFARE, V24, P81, DOI 10.7120/09627286.24.1.081; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barnett CA, 2012, BEHAV ECOL, V23, P418, DOI 10.1093/beheco/arr206; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bateson M, 2007, ANIM WELFARE, V16, P33; Bateson M, 2015, PEERJ, V3, DOI 10.7717/peerj.998; Bateson M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2140; Bateson M, 2011, CAN J PSYCHIAT, V56, P707, DOI 10.1177/070674371105601202; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Bloxham L, 2014, ANIM BEHAV, V91, P33, DOI 10.1016/j.anbehav.2014.02.025; Bonaparte KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023775; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Brust V, 2014, BEHAV PROCESS, V103, P320, DOI 10.1016/j.beproc.2014.01.019; Brydges NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048143; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chaby LE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00328; Feenders G, 2013, ANIM BEHAV, V86, P127, DOI 10.1016/j.anbehav.2013.05.002; Field A, 2013, DISCOVERING STAT USI; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; Green DM, 1966, SIGNAL DETECTION THE; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Needham BL, 2015, MOL PSYCHIATR, V20, P520, DOI 10.1038/mp.2014.89; Nesse RM, 2009, AM PSYCHOL, V64, P129, DOI 10.1037/a0013503; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Nettle D, 2012, CURR BIOL, V22, pR712, DOI 10.1016/j.cub.2012.06.020; Nettle D, 2009, J THEOR BIOL, V257, P100, DOI 10.1016/j.jtbi.2008.10.033; Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Revelle W., 2015, PSYCH PROCEDURES PER; Starling MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107794; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Verhulst S, 2013, EUR J EPIDEMIOL, V28, P859, DOI 10.1007/s10654-013-9845-4; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	58	24	24	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132602	10.1371/journal.pone.0132602	http://dx.doi.org/10.1371/journal.pone.0132602			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222390	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358836800026
J	Chit, A; Roiz, J; Aballea, S				Chit, Ayman; Roiz, Julie; Aballea, Samuel			An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-STATES; EFFICACY; ADULTS; IMMUNIZATION; METAANALYSIS; VACCINATION; CHILDREN; NETWORK	Ontario, Canada, immunizes against influenza using a trivalent inactivated influenza vaccine (IIV3) under a Universal Influenza Immunization Program (UIIP). The UIIP offers IIV3 free-of-charge to all Ontarians over 6 months of age. A newly approved quadrivalent inactivated influenza vaccine (IIV4) offers wider protection against influenza B disease. We explored the expected cost-utility and budget impact of replacing IIV3 with IIV4, within the context of Ontario's UIIP, using a probabilistic and static cost-utility model. Wherever possible, epidemiological and cost data were obtained from Ontario sources. Canadian or U.S. sources were used when Ontario data were not available. Vaccine efficacy for IIV3 was obtained from the literature. IIV4 efficacy was derived from meta-analysis of strain-specific vaccine efficacy. Conservatively, herd protection was not considered. In the base case, we used IIV3 and IIV4 prices of $5.5/dose and $7/dose, respectively. We conducted a sensitivity analysis on the price of IIV4, as well as standard univariate and multivariate statistical uncertainty analyses. Over a typical influenza season, relative to IIV3, IIV4 is expected to avert an additional 2,516 influenza cases, 1,683 influenza-associated medical visits, 27 influenza-associated hospitalizations, and 5 influenza-associated deaths. From a societal perspective, IIV4 would generate 76 more Quality Adjusted Life Years (QALYs) and a net societal budget impact of $4,784,112. The incremental cost effectiveness ratio for this comparison was $63,773/QALY. IIV4 remains cost-effective up to a 53% price premium over IIV3. A probabilistic sensitivity analysis showed that IIV4 was cost-effective with a probability of 65% for a threshold of $100,000/QALY gained. IIV4 is expected to achieve reductions in influenza-related morbidity and mortality compared to IIV3. Despite not accounting for herd protection, IIV4 is still expected to be a cost-effective alternative to IIV3 up to a price premium of 53%. Our conclusions were robust in the face of sensitivity analyses.	[Chit, Ayman] Sanofi Pasteur, Hlth Outcomes & Econ North Amer, Toronto, ON, Canada; [Chit, Ayman] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Roiz, Julie] Creat Ceut Ltd, London, England; [Aballea, Samuel] Creat Ceut SARL, Paris, France	Sanofi-Aventis; University of Toronto	Chit, A (corresponding author), Sanofi Pasteur, Hlth Outcomes & Econ North Amer, Toronto, ON, Canada.	Ayman.chit@sanofipasteur.com			Sanofi Pasteur	Sanofi Pasteur	The study was funded by Sanofi Pasteur. The study was funded by Sanofi Pasteur through the provision of author salaries and research material. The authors of the study had full control of study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2015, CAN CONS PRIC IND; [Anonymous], 2003, JOINT CANADA US SURV; [Anonymous], 2015, CAN HOURL LAB COSTS; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Canadian Agency for Drugs and Technology in Health, 2015, PAN CAN ONC DRUG REV; Clements KM, 2014, HUM VACC IMMUNOTHER, V10, P1171, DOI 10.4161/hv.28221; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; GlaxoSmithKline, 2014, FLULAVAL TETR PROD M; Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074; Heinonen S, 2011, LANCET INFECT DIS, V11, P23, DOI 10.1016/S1473-3099(10)70255-3; Janjua NZ, 2012, J INFECT DIS, V205, P1858, DOI 10.1093/infdis/jis283; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Langley JM, 2014, EXPERT REV VACCINES, V13, P1291, DOI 10.1586/14760584.2014.939637; Lee BY, 2012, VACCINE, V30, P7443, DOI 10.1016/j.vaccine.2012.10.025; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Organisation for Economic Co-operation and Development. StatExtracts, 2013, STATEXTRACTS UNIT LA; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Pogany L, 2006, QUAL LIFE RES, V15, P143, DOI 10.1007/s11136-005-0198-7; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Sanofi Pasteur, 2014, FLUZ QUADR PROD MON; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Statistics Canada, 2013, POP LIF EXP EST; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; You JHS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0618-9; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	39	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133606	10.1371/journal.pone.0133606	http://dx.doi.org/10.1371/journal.pone.0133606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222538	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800057
J	Regan, T; Levesque, JV; Lambert, SD; Kelly, B				Regan, Tim; Levesque, Janelle V.; Lambert, Sylvie D.; Kelly, Brian			A Qualitative Investigation of Health Care Professionals', Patients' and Partners' Views on Psychosocial Issues and Related Interventions for Couples Coping with Cancer	PLOS ONE			English	Article							COMMUNICATION-SKILLS; PROSTATE-CANCER; BREAST-CANCER; OF-LIFE; PSYCHOLOGICAL DISTRESS; INFORMAL CARERS; ONCOLOGY; NEEDS; PERCEPTIONS; WOMEN	Introduction There is growing evidence that cancer affects couples as an interdependent system and that couple-based psychosocial interventions are efficacious in reducing distress and improving coping skills. However, adoption of a couples-focused approach into cancer care is limited. Previous research has shown that patients and partners hold differing views from health care professionals (HCPs) regarding their psychosocial needs, and HCPs from different disciplines also hold divergent views regarding couples' psychosocial needs. This study aimed to explore the perspectives of HCPs and couples on the provision of couple-focused psychosocial care in routine cancer services. Methods A qualitative study using semi-structured interviews was undertaken with 20 HCPs (medical oncologists, nurses, psycho-oncology professionals) and 20 couples where one member had been diagnosed with cancer (breast, prostate, head/neck, bowel, multiple myeloma). Interviews were analysed using the framework approach. Results Three core themes were identified: "How Do Couples Cope with Cancer?" emphasised the positive and negative coping strategies used by couples, and highlighted that partners perceived a lack of engagement by HCPs. "What Is Couple-focused Psychosocial Care for People with Cancer?" described varying perspectives regarding the value of couple-focused psychosocial care and variation in the types of support couples need among HCPs and couples. Whereas most couples did not perceive a need for specialist couple-focused support and interventions, most HCPs felt couple-focused psychosocial care was necessary. "How Can Couple-Focused Psychosocial Care be Improved?" described couples' view of a need for better provision of information, and the importance of their relationship with oncology clinicians. HCPs identified a lack of confidence in responding to the emotional needs of couples, and barriers to providing psychosocial care, including challenges identifying distress (through screening) and referring distressed individuals/couples for specialist assessment. Conclusions The three core themes revealed discrepancies about couple-focused psychosocial care between HCPs and couples, and HCPs from different professional backgrounds, and several barriers to the provision of psychosocial care for couples. Despite HCPs and couples acknowledging that a couple-focused approach to psycho-social support was potentially beneficial, the majority of couples did not feel they needed specific couple-focused interventions. These issues and recommendations for future research are discussed.	[Regan, Tim] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Hlth Behav Res Grp, Newcastle, NSW 2300, Australia; [Levesque, Janelle V.] Univ New S Wales, Ingham Inst Appl Med Res, South Western Sydney Clin Sch,UNSW Med, Ctr Oncol Educ & Res Translat CONCERT Psychooncol, Sydney, NSW, Australia; [Lambert, Sylvie D.] McGill Univ, Ingram Sch Nursing, Montreal, PQ, Canada; [Regan, Tim; Kelly, Brian] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia	University of Newcastle; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; McGill University; University of Newcastle	Regan, T (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Hlth Behav Res Grp, Newcastle, NSW 2300, Australia.	timothy.regan@newcastle.edu.au	Lambert, Sylvie/AAB-2890-2019; Kelly, Brian/G-7755-2013	Lambert, Sylvie/0000-0002-9202-9251; Kelly, Brian/0000-0003-4460-1134	Department of Innovation, Industry, Science, and Research from the Australian government	Department of Innovation, Industry, Science, and Research from the Australian government	Acknowledgement is extended to the Department of Innovation, Industry, Science, and Research from the Australian government for funding Tim Regan's Australian Postgraduate Award (APA) scholarship.	Adams E, 2012, SUPPORT CARE CANCER, V20, P2785, DOI 10.1007/s00520-012-1400-4; Arno PS, 1999, HLTH AFFAIRS, V18; Badr H, 2013, PSYCHO-ONCOLOGY, V22, P1688, DOI 10.1002/pon.3200; Baravelli C, 2009, J CANCER SURVIV, V3, P99, DOI 10.1007/s11764-009-0086-1; Barth J, 2011, ANN ONCOL, V22, P1030, DOI 10.1093/annonc/mdq441; Botti M, 2006, CANCER NURS, V29, P309, DOI 10.1097/00002820-200607000-00010; Broom A, 2009, HEALTH, V13, P317, DOI 10.1177/1363459308101806; Bultz BD, 2011, PSYCHO-ONCOLOGY, V20, P463, DOI 10.1002/pon.1932; Bylund CL, 2010, PSYCHO-ONCOLOGY, V19, P583, DOI 10.1002/pon.1585; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Carnevale Franco A, 2002, Can J Nurs Res, V34, P121; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Christensen A, 1988, PERSPECTIVES MARITAL, P30; Couper J, 2006, PSYCHO-ONCOLOGY, V15; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; COYNE JC, 1991, J PERS SOC PSYCHOL, V61, P404, DOI 10.1037/0022-3514.61.3.404; Dilworth S, 2014, PSYCHO ONCOLGY; Dumont S, 2006, J PALLIAT MED, V9, P912, DOI 10.1089/jpm.2006.9.912; Dzidowska M, 2010, ASIA-PAC J CLIN ONCO, V6, P165, DOI 10.1111/j.1743-7563.2010.01318.x; Evertsen JM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-19; Faller H, 2013, J CLIN ONCOL, V31, P782, DOI 10.1200/JCO.2011.40.8922; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 1998, J CLIN ONCOL, V16, P1961, DOI 10.1200/JCO.1998.16.5.1961; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; Feltwell AK, 2004, PATIENT EDUC COUNS, V54, P179, DOI 10.1016/S0738-3991(03)00212-X; Forsythe LP, 2012, J CLIN ONCOL, V30, P2897, DOI 10.1200/JCO.2011.39.9832; Forsythe LP, 2013, J CLIN ONCOLOGY, V31; Given B, 2009, FAMILY CARE DURING C; Holland JC, 2013, J NATL COMPR CANC NE, V11, P190, DOI 10.6004/jnccn.2013.0027; Hopkinson JB, 2012, J PAIN SYMPTOM MANAG, V43, P111, DOI 10.1016/j.jpainsymman.2011.03.013; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008, CANC CARE WHOLE PATI; Ito T, 2011, PSYCHO-ONCOLOGY, V20, P647, DOI 10.1002/pon.1945; Jacobs JR, 2002, J CANCER EDUC, V17, P33; Johnston BM, 2012, SUPPORT CARE CANCER, V20, P1619, DOI 10.1007/s00520-011-1252-3; Kissane DW, 2012, J CLIN ONCOL, V30, P1242, DOI 10.1200/JCO.2011.39.6184; Lambert SD, 2013, SUPPORT CARE CANCER, V21, P3451, DOI 10.1007/s00520-013-1914-4; Lambert SD, 2012, BMJ SUPPORT PALLIAT, V2, P224, DOI 10.1136/bmjspcare-2012-000226; Lambert SD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-119; Lambert SD, 2013, SUPPORT CARE CANCER, V21, P75, DOI 10.1007/s00520-012-1495-7; LERMAN C, 1993, CANCER, V72, P2612, DOI 10.1002/1097-0142(19931101)72:9<2612::AID-CNCR2820720916>3.0.CO;2-F; Lethborg CE, 2003, SOC WORK HEALTH CARE, V37, P63, DOI 10.1300/J010v37n01_04; Lindau ST, 2011, PSYCHO-ONCOLOGY, V20, P179, DOI 10.1002/pon.1787; Mackenzie L.J., 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001265, DOI 10.1136/BMJ0PEN-2012-001265]; Manne SL, 2006, PSYCHO-ONCOL, V15, P234, DOI 10.1002/pon.941; Manne SL, 2005, J CONSULT CLIN PSYCH, V73, P634, DOI 10.1037/0022-006X.73.4.634; McIlfatrick S, 2007, J ADV NURS, V57, P77, DOI 10.1111/j.1365-2648.2006.04062.x; Merluzzi TV, 1997, PSYCHO-ONCOLOGY, V6, P197, DOI 10.1002/(SICI)1099-1611(199709)6:3<197::AID-PON270>3.0.CO;2-S; MEYER TJ, 1995, HEALTH PSYCHOL, V14, P101, DOI 10.1037/0278-6133.14.2.101; Mitchell A, 2008, PSYCHO-ONCOL, V17, P226, DOI 10.1002/pon.1228; Morrison-Beedy D, 2001, APPL NURS RES, V14, P48, DOI 10.1053/apnr.2001.21081; Mystakidou K, 2007, CANCER NURS, V30, P412, DOI 10.1097/01.NCC.0000290807.84076.73; National Comprehensive Cancer Network, 2010, DISTRESS MANAGEMENT, V10; NBC Centre, 2003, CLINICAL PRACTICE GU; Northouse LL, 2013, PSYCHO-ONCOLOGY, V22, P555, DOI 10.1002/pon.3036; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Pincus HA, 2009, J CLIN ONCOL, V27, P661, DOI 10.1200/JCO.2008.19.7780; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031; Regan T, 2013, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3342, DOI 10.1002/P0N.3342]; Regan TW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-279; Regan TW, 2014, PATIENT ED COUNSELIN; Riege AM, 2003, INT J-TORONTO, V6, P75, DOI [10.1108/13522750310470055, DOI 10.1108/13522750310470055]; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Royak-Schaler R, 2006, ONCOL NURS FORUM, V33, P753, DOI 10.1188/06.ONF.753-760; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Savarkar V.D, 2007, ESSENTIALS HINDUTVA; Segrin C, 2007, PSYCHO-ONCOLOGY, V16, P634, DOI 10.1002/pon.1111; Segrin C, 2012, HEALTH PSYCHOL, V31, P70, DOI 10.1037/a0025394; Sheard T, 1999, BRIT J CANCER, V80, P1770, DOI 10.1038/sj.bjc.6690596; Sinfield P, 2008, PATIENT EDUC COUNS, V73, P91, DOI 10.1016/j.pec.2008.05.001; Steginga SK, 2008, PSYCHO-ONCOLOGY, V17, P997, DOI 10.1002/pon.1317; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Streubert Speziale H., 2003, QUALITATIVE RES NURS, V3rd; Surbone A, 2010, SUPPORT CARE CANCER, V18, P255, DOI 10.1007/s00520-009-0693-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Traa MJ, 2014, SUPPORT CARE CANCER, V22, P763, DOI 10.1007/s00520-013-2032-z; Turner J, 2007, PSYCHO-ONCOL, V16, P149, DOI 10.1002/pon.1106; Uitterhoeve RJ, 2010, EUR J CANCER CARE, V19, P442, DOI 10.1111/j.1365-2354.2009.01082.x; Ussher JM, 2009, HEALTH PSYCHOL REV, V3, P85, DOI 10.1080/17437190903033401; van der Meulen N, 2008, PSYCHO-ONCOLOGY, V17, P857, DOI 10.1002/pon.1290; Wessels H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-198; Western Australia Department of Health, 2008, PSYCHO ONCOLOGY MODE; Zeliadt SB, 2011, BJU INT, V108, P851, DOI [10.1111/j.1464-410X.2010.09945,10540.x, 10.1111/j.1464-410X.2010.09945.x]; Zwahlen D, 2011, PSYCHO-ONCOLOGY, V20, P394, DOI 10.1002/pon.1744	87	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133837	10.1371/journal.pone.0133837	http://dx.doi.org/10.1371/journal.pone.0133837			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222890	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800070
J	Schafer, MJ; Dolgalev, I; Alldred, MJ; Heguy, A; Ginsberg, SD				Schafer, Marissa J.; Dolgalev, Igor; Alldred, Melissa J.; Heguy, Adriana; Ginsberg, Stephen D.			Calorie Restriction Suppresses Age-Dependent Hippocampal Transcriptional Signatures	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GENE-EXPRESSION; NEUROTROPHIN EXPRESSION; MOUSE MODEL; MICE; PROFILE; MEMORY; LTP; NEURODEGENERATION; PLASTICITY	Calorie restriction (CR) enhances longevity and mitigates aging phenotypes in numerous species. Physiological responses to CR are cell-type specific and variable throughout the lifespan. However, the mosaic of molecular changes responsible for CR benefits remains unclear, particularly in brain regions susceptible to deterioration during aging. We examined the influence of long-term CR on the CA1 hippocampal region, a key learning and memory brain area that is vulnerable to age-related pathologies, such as Alzheimer's disease (AD). Through mRNA sequencing and NanoString nCounter analysis, we demonstrate that one year of CR feeding suppresses age-dependent signatures of 882 genes functionally associated with synaptic transmission-related pathways, including calcium signaling, long-term potentiation (LTP), and Creb signaling in wild-type mice. By comparing the influence of CR on hippocampal CA1 region transcriptional profiles at younger-adult (5 months, 2.5 months of feeding) and older-adult (15 months, 12.5 months of feeding) timepoints, we identify conserved upregulation of proteome quality control and calcium buffering genes, including heat shock 70 kDa protein 1b (Hspa1b) and heat shock 70 kDa protein 5 (Hspa5), protein disulfide isomerase family A member 4 (Pdia4) and protein disulfide isomerase family A member 6 (Pdia6), and calreticulin (Calr). Expression levels of putative neuroprotective factors, klotho (Kl) and transthyretin (Ttr), are also elevated by CR in adulthood, although the global CR-specific expression profiles at younger and older timepoints are highly divergent. At a previously unachieved resolution, our results demonstrate conserved activation of neuroprotective gene signatures and broad CR-suppression of age-dependent hippocampal CA1 region expression changes, indicating that CR functionally maintains a more youthful transcriptional state within the hippocampal CA1 sector.	[Schafer, Marissa J.; Ginsberg, Stephen D.] NYU, Cell & Mol Biol Program, Langone Med Ctr, New York, NY 11201 USA; [Schafer, Marissa J.; Alldred, Melissa J.; Ginsberg, Stephen D.] Nathan S Kline Inst Psychiat Res, Ctr Dementa Res, Orangeburg, NY USA; [Dolgalev, Igor; Heguy, Adriana] NYU, Genome Technol Ctr, Langone Med Ctr, New York, NY USA; [Alldred, Melissa J.; Ginsberg, Stephen D.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Heguy, Adriana] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Ginsberg, Stephen D.] NYU, Dept Neurosci & Physiol, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Ginsberg, SD (corresponding author), NYU, Cell & Mol Biol Program, Langone Med Ctr, New York, NY 11201 USA.	ginsberg@nki.rfmh.org	, SDG/AAB-3329-2022; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022	Dolgalev, Igor/0000-0003-4451-126X; Ginsberg, Stephen/0000-0002-1797-4288	National Institutes of Health [AG043375, AG014449, AG017617, GM007238, RR029893, TR000038]; Alzheimer's Association [IIRG-12-237253]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617, P01AG014449, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health grants AG043375, AG014449, AG017617, GM007238, RR029893, TR000038, and the Alzheimer's Association (IIRG-12-237253).	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Alldred MJ, 2015, BRAIN STRUC IN PRESS, DOI [10.1007/s00429-014-0839-0, DOI 10.1007/S00429-014-0839-C]; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Dong HX, 2012, J ALZHEIMERS DIS, V28, P579, DOI 10.3233/JAD-2011-111328; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Eckles-Smith K, 2000, MOL BRAIN RES, V78, P154, DOI 10.1016/S0169-328X(00)00088-7; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hemond P, 2005, NEUROSCIENCE, V135, P413, DOI 10.1016/j.neuroscience.2005.05.044; HORI N, 1992, NEUROREPORT, V3, P1085, DOI 10.1097/00001756-199212000-00013; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MOROIFETTERS SE, 1989, NEUROBIOL AGING, V10, P317, DOI 10.1016/0197-4580(89)90042-0; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oh MM, 2013, J NEUROSCI, V33, P7905, DOI 10.1523/JNEUROSCI.5457-12.2013; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Pawlowski TL, 2009, BRAIN RES, V1256, P101, DOI 10.1016/j.brainres.2008.12.039; PELLEGRINIGIAMPIETRO DE, 1994, NEUROSCIENCE, V61, P41, DOI 10.1016/0306-4522(94)90058-2; Prins D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004069; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Schafer MJ, 2015, NEUROBIOL AGING, V36, P1293, DOI 10.1016/j.neurobiolaging.2014.10.043; Schroeder JE, 2010, BBA-MOL BASIS DIS, V1802, P840, DOI 10.1016/j.bbadis.2010.04.007; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; Wang J., 2005, FASEB J, V18, P1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Ye X, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.004; Zeier Z, 2011, MECH AGEING DEV, V132, P8, DOI 10.1016/j.mad.2010.10.006	50	43	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133923	10.1371/journal.pone.0133923	http://dx.doi.org/10.1371/journal.pone.0133923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221964	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800082
J	Yang, L; Xu, L; Schoepf, UJ; Wichmann, JL; Fox, MA; Yan, J; Fan, ZM; Zhang, ZQ				Yang, Lin; Xu, Lei; Schoepf, U. Joseph; Wichmann, Julian L.; Fox, Mary A.; Yan, Jing; Fan, Zhanming; Zhang, Zhaoqi			Prospectively ECG-Triggered Sequential Dual-Source Coronary CT Angiography in Patients with Atrial Fibrillation: Influence of Heart Rate on Image Quality and Evaluation of Diagnostic Accuracy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ARTERY-DISEASE; RADIATION-EXPOSURE; GATED 16-MDCT; MOTION	Objectives To evaluate the effects of mean heart rate (HR) and heart rate variation (HRV) on image quality and diagnostic accuracy of prospectively ECG-triggered sequential dual-source coronary CT angiography (CCTA) in patients with atrial fibrillation (AF). Methods Eighty-five patients (49 women, 36 men; mean age 62.1 +/- 9.5 years) with persistent AF underwent prospectively ECG-triggered sequential second-generation dual-source CCTA. Tube current and voltage were adjusted according to body mass index (BMI) and iterative reconstruction was used. Image quality of coronary segments (four-point scale) and presence of significant stenosis (>50%) were evaluated. Diagnostic accuracy was analyzed in 30 of the 85 patients who underwent additional invasive coronary angiography (ICA). Results Only 8 of 1102 (0.7%) segments demonstrated poor image quality. No significant impact on image quality was found for mean HR (94.9 +/- 21.8 bpm; r = 0.034, p = 0.758; F = 0.413, p = 0.663) or HRV (67.5 +/- 22.8 bpm; r = 0.097, p = 0.377; F = 0.111, p = 0.895). On per-segment analysis, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 89.7% (26/29), 99.4% (355/357), 92.9% (26/28), and 99.2% (355/358), respectively, with excellent correlation (kappa = 0.91) with ICA. Mean effective dose was 3.3 +/- 1.0 mSv. Conclusions Prospectively ECG-triggered sequential dual-source CCTA provides diagnostic image quality and good diagnostic accuracy for detection of coronary stenosis in AF patients without significant influence by HR or HRV.	[Yang, Lin; Xu, Lei; Fan, Zhanming; Zhang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Schoepf, U. Joseph; Wichmann, Julian L.; Fox, Mary A.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Yan, Jing] Siemens Healthcare China, Shanghai, Peoples R China	Capital Medical University; Medical University of South Carolina; Siemens AG	Xu, L (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.	leixu2001@hotmail.com			Excellent Talents from Beijing City [2011D003034000030]; High Levels of Health Technical Personnel in Beijing City Health System [2013-3-011]	Excellent Talents from Beijing City; High Levels of Health Technical Personnel in Beijing City Health System	This work has been supported by a grant for Excellent Talents from Beijing City (2011D003034000030), and grant for High Levels of Health Technical Personnel in Beijing City Health System (2013-3-011). Jing Yan, is employed by a commercial company: Siemens Healthcare China. This funder only provided support in the form of salaries for author Jing Yan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatap G, 2002, DRUG AGING, V19, P819, DOI 10.2165/00002512-200219110-00002; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hausleiter J, 2012, JACC-CARDIOVASC IMAG, V5, P484, DOI 10.1016/j.jcmg.2011.12.017; Heuschmid M, 2005, AM J ROENTGENOL, V184, P1413, DOI 10.2214/ajr.184.5.01841413; Hoffmann MHK, 2005, RADIOLOGY, V234, P86, DOI 10.1148/radiol.2341031408; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Klass O, 2009, EUR RADIOL, V19, P829, DOI 10.1007/s00330-008-1222-4; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Lee AM, 2012, J CARDIOVASC COMPUT, V6, P172, DOI 10.1016/j.jcct.2012.04.003; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Lu B, 2001, INVEST RADIOL, V36, P250, DOI 10.1097/00004424-200105000-00002; Mao SS, 2000, J COMPUT ASSIST TOMO, V24, P253, DOI 10.1097/00004728-200003000-00012; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Mayurasakorn Sureeporn, 2008, Journal of the Medical Association of Thailand, V91, P1076; Nieman K, 2002, HEART, V88, P470, DOI 10.1136/heart.88.5.470; Oncel D, 2007, RADIOLOGY, V245, P703, DOI 10.1148/radiol.2453070094; Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Rist C, 2009, INVEST RADIOL, V44, P159, DOI 10.1097/RLI.0b013e3181948b05; Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2; Schoenhagen P, 2004, RADIOLOGY, V232, P7, DOI 10.1148/radiol.2321021803; Schoepf UJ, 2004, RADIOLOGY, V232, P18, DOI 10.1148/radiol.2321030636; Shim SS, 2005, AM J ROENTGENOL, V184, P649, DOI 10.2214/ajr.184.2.01840649; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Srichai MB, 2013, J CARDIOVASC COMPUT, V7, P102, DOI 10.1016/j.jcct.2013.02.002; Stolzmann P, 2008, RADIOLOGY, V249, P71, DOI 10.1148/radiol.2483072032; Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009; Uehara M, 2011, INT J CARDIOL, V150, P65, DOI 10.1016/j.ijcard.2010.02.032; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Vembar M, 2003, MED PHYS, V30, P1683, DOI 10.1118/1.1582812; Vorre MM, 2013, RADIOLOGY, V267, P376, DOI 10.1148/radiol.13121224; Wang YN, 2008, EUR J RADIOL, V68, P434, DOI 10.1016/j.ejrad.2008.09.011; Weustink AC, 2008, RADIOLOGY, V248, P792, DOI 10.1148/radiol.2483072098; Xu L, 2013, EUR RADIOL, V23, P1822, DOI 10.1007/s00330-013-2793-2; Xu L, 2010, INT J CARDIOVAS IMAG, V26, P17, DOI 10.1007/s10554-009-9576-5; Yang L, 2009, AM J ROENTGENOL, V193, P795, DOI 10.2214/AJR.08.2012	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134194	10.1371/journal.pone.0134194	http://dx.doi.org/10.1371/journal.pone.0134194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221952	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800112
J	Yoshitake, H; Hashii, N; Kawasaki, N; Endo, S; Takamori, K; Hasegawa, A; Fujiwara, H; Araki, Y				Yoshitake, Hiroshi; Hashii, Noritaka; Kawasaki, Nana; Endo, Shuichiro; Takamori, Kenji; Hasegawa, Akiko; Fujiwara, Hiroshi; Araki, Yoshihiko			Chemical Characterization of N-Linked Oligosaccharide As the Antigen Epitope Recognized by an Anti-Sperm Auto-Monoclonal Antibody, Ts4	PLOS ONE			English	Article							CELL-SPECIFIC ANTIGEN; EPIDERMAL-GROWTH-FACTOR; BISECTING GLCNAC; MOUSE TESTIS; MOLECULAR CHARACTERIZATION; STRUCTURAL ASSESSMENT; STEM-CELLS; TEX101; GLYCOPROTEIN; GLYCANS	Ts4, an anti-sperm auto-monoclonal antibody, possesses immunoreactivity to the acrosomal region of mouse epididymal spermatozoa. In addition, the mAb shows specific immunoreactivity to reproduction-related regions such as testicular germ cells and early embryo. Our qualitative study previously showed that the antigen epitope for Ts4 contained a N-linked common oligosaccharide (OS) chain on testicular glycoproteins as determined by Western blotting for testicular glycoproteins after treatment with several glycohydrolases. Since the distribution of the Ts4-epitope is unique, the OS chain in Ts4-epitope may have role(s) in the reproductive process. The aim of this study was to clarify the molecular structure of the Ts4-epitope, particularly its OS moiety. Using Ts4 immunoprecipitation combined with liquid chromatography and multiple-stage mass spectrometry, the candidate carbohydrate structure in the Ts4-epitope is proposed to be N-linked fucosylated agalacto-biantennary with bisecting N-acetylglucosamine (GlcNAc) or with N-acetylgalactosamine-GlcNAc motif. Further binding analyses using various lectins against the mouse testicular Ts4-immunoprecipitants revealed that Phaseolus vulgaris erythroagglutinin and Pisum sativum agglutinin showed positive staining of the bands corresponding to Ts4 reactive proteins. Moreover, the immunoreactivity of Ts4 against the testicular extract was completely abrogated after digestion with beta-N-acetylglucosaminidase. These results show that the Ts4-epitope contains agalacto-biantennary N-glycan with bisecting GlcNAc carrying fucose residues.	[Yoshitake, Hiroshi; Endo, Shuichiro; Takamori, Kenji; Araki, Yoshihiko] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan; [Endo, Shuichiro; Araki, Yoshihiko] Juntendo Univ, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Akiko] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Fujiwara, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa, Japan	Juntendo University; National Institute of Health Sciences - Japan; Juntendo University; Hyogo College of Medicine; Kanazawa University	Araki, Y (corresponding author), Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba, Japan.	yaraki@juntendo.ac.jp	FUJIWARA, Hiroshi/J-8401-2015	FUJIWARA, Hiroshi/0000-0003-3098-9406	JSPS KAKENHI [21592111, 25462575, 23390389, 24592609]; "High-Tech Research Center" Project for Private Universities: matching fund from the Minister of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [26293358] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "High-Tech Research Center" Project for Private Universities: matching fund from the Minister of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI, Grants-in Aid for General Scientific Research, Grant Numbers 21592111, 25462575 (YA), 23390389 (HF), 24592609 (HY) and "High-Tech Research Center" Project for Private Universities: matching fund subsidy from the Minister of Education, Culture, Sports, Science, and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; ARAKI Y, 1987, J REPROD IMMUNOL, V11, P193, DOI 10.1016/0165-0378(87)90057-X; Araki Yoshihiko, 1998, Journal of Reproduction and Development, V44, P215, DOI 10.1262/jrd.44.215; BIERHUIZEN MFA, 1989, GLYCOCONJUGATE J, V6, P195, DOI 10.1007/BF01050648; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; CHIEN SM, 1974, IMMUNOCHEMISTRY, V11, P501, DOI 10.1016/0019-2791(74)90122-0; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; EYLAR EH, 1962, J BIOL CHEM, V237, P1021; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Haab BB, 2012, PROTEOM CLIN APPL, V6, P346, DOI 10.1002/prca.201200014; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; ISOJIMA S, 1989, HUM REPROD, V4, P605, DOI 10.1093/oxfordjournals.humrep.a136951; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Jin H, 2006, ZYGOTE, V14, P201, DOI 10.1017/S0967199406003753; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Kimura Y, 1999, EUR J BIOCHEM, V264, P168, DOI 10.1046/j.1432-1327.1999.00598.x; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kurita A, 2001, BIOL REPROD, V64, P935, DOI 10.1095/biolreprod64.3.935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE N, 1990, J BIOL CHEM, V265, P20476; MILLERPODRAZA H, 1982, BIOCHEMISTRY-US, V21, P3265, DOI 10.1021/bi00257a003; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; NARASIMHAN S, 1986, CARBOHYD RES, V149, P65, DOI 10.1016/S0008-6215(00)90370-7; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nash R, 2007, STEM CELLS, V25, P974, DOI 10.1634/stemcells.2006-0224; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; OSAWA T, 1987, ANNU REV BIOCHEM, V56, P21, DOI 10.1146/annurev.biochem.56.1.21; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shirai Y, 2009, J REPROD DEVELOP, V55, P240, DOI 10.1262/jrd.20156; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Tsukamoto H, 2006, BIOCHEM BIOPH RES CO, V345, P229, DOI 10.1016/j.bbrc.2006.04.070; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Yoshitake H, 2009, BIOL REPROD, V81, P326; Yoshitake H, 2008, J REPROD IMMUNOL, V79, P1, DOI 10.1016/j.jri.2008.05.001; Yoshitake H, 2011, J REPROD IMMUNOL, V90, P202, DOI 10.1016/j.jri.2011.04.010	44	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133784	10.1371/journal.pone.0133784	http://dx.doi.org/10.1371/journal.pone.0133784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222427	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800066
J	Cai, YT; Teo, BHD; Yeo, JG; Lu, JH				Cai, Yitian; Teo, Boon Heng Dennis; Yeo, Joo Guan; Lu, Jinhua			C1q Protein Binds to the Apoptotic Nucleolus and Causes C1 Protease Degradation of Nucleolar Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMACYTOID DENDRITIC CELLS; COMPLEMENT DEFICIENCY; ALPHA PRODUCTION; 1ST COMPONENT; IFN-ALPHA; ACTIN; INTERFERON; ANTIGENS; IMMUNOLOGY; HEREDITARY	In infection, complement C1q recognizes pathogen-congregated antibodies and elicits complement activation. Among endogenous ligands, C1q binds to DNA and apoptotic cells, but whether C1q binds to nuclear DNA in apoptotic cells remains to be investigated. With UV irradiation-induced apoptosis, C1q initially bound to peripheral cellular regions in early apoptotic cells. By 6 h, binding concentrated in the nuclei to the nucleolus but not the chromatins. When nucleoli were isolated from non-apoptotic cells, C1q also bound to these structures. In vivo, C1q exists as the C1 complex (C1qC1r(2)C1s(2)), and C1q binding to ligands activates the C1r/C1s proteases. Incubation of nucleoli with C1 caused degradation of the nucleolar proteins nucleolin and nucleophosmin 1. This was inhibited by the C1 inhibitor. The nucleoli are abundant with autoantigens. C1q binding and C1r/C1s degradation of nucleolar antigens during cell apoptosis potentially reduces autoimmunity. These findings help us to understand why genetic C1q and C1r/C1s deficiencies cause systemic lupus erythematosus.	[Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Lu, Jinhua] Natl Univ Singapore, Program Immunol, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Lu, JH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore.	miclujh@nus.edu.sg	Yeo, Joo Guan/GRR-5310-2022	Teo, Boon Heng Dennis/0000-0003-4696-9813; Lu, Jinhua/0000-0002-3699-9894; Yeo, Joo Guan/0000-0001-8981-5000	Singapore National University Health System Seed Fund [R-182-000-229-750]; Singapore Ministry of Education [MOE2012-T2-2-122]; NGS scholarship	Singapore National University Health System Seed Fund; Singapore Ministry of Education(Ministry of Education, Singapore); NGS scholarship	This project was supported by Singapore National University Health System Seed Fund R-182-000-229-750 and Singapore Ministry of Education Tier 2 Grant MOE2012-T2-2-122). The authors declare that they have no conflict of interests with the contents of this article.; Supported by an NGS scholarship.	AGNELLO V, 1970, IMMUNOLOGY, V19, P909; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bordet J., 1906, ANN I PASTEUR PARIS, V20, P467; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Brown GD, 2012, NATURE, V485, P589, DOI 10.1038/485589a; Busby WH, 2000, J BIOL CHEM, V275, P37638, DOI 10.1074/jbc.M006107200; Caminschi I, 2012, TRENDS IMMUNOL, V33, P71, DOI 10.1016/j.it.2011.10.007; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Cicardi M, 2012, ACTA HAEMATOL-BASEL, V127, P208, DOI 10.1159/000336590; Clarke EV, 2015, J LEUKOCYTE BIOL, V97, P147, DOI 10.1189/jlb.3A0614-278R; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Elkon KB, 2012, CURR OPIN IMMUNOL, V24, P665, DOI 10.1016/j.coi.2012.08.004; ERIKSSON H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P209, DOI 10.1016/0167-4838(90)90169-G; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Geijtenbeek TBH, 2012, IMMUNITY, V36, P557, DOI 10.1016/j.immuni.2012.04.004; JIANG HX, 1992, J BIOL CHEM, V267, P25597; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; Korb LC, 1997, J IMMUNOL, V158, P4525; LEPOW IH, 1963, J EXP MED, V117, P983, DOI 10.1084/jem.117.6.983; Lewis MJ, 2006, AUTOIMMUNITY, V39, P367, DOI 10.1080/08916930600739233; Lipsker D, 2010, LUPUS, V19, P1096, DOI 10.1177/0961203310373370; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; MAMRACK MD, 1977, BIOCHEM BIOPH RES CO, V76, P150, DOI 10.1016/0006-291X(77)91680-1; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; NISHIOKA M, 1982, BIOCHEM BIOPH RES CO, V108, P1307, DOI 10.1016/0006-291X(82)92142-8; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Tan EM, 2012, J CLIN INVEST, V122, P3835, DOI 10.1172/JCI66510; Teh BK, 2011, MOL IMMUNOL, V48, P1128, DOI 10.1016/j.molimm.2011.02.006; Triggianese P, 2015, AUTOIMMUN REV, V14, P665, DOI 10.1016/j.autrev.2015.03.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Welting TJM, 2003, AUTOIMMUN REV, V2, P313, DOI 10.1016/S1568-9972(03)00029-6; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	47	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22570	22580		10.1074/jbc.M115.670661	http://dx.doi.org/10.1074/jbc.M115.670661			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26231209	Green Published, hybrid			2022-12-26	WOS:000361171500023
J	Corradi, V; Vergani, P; Tieleman, DP				Corradi, Valentina; Vergani, Paola; Tieleman, D. Peter			Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) CLOSED AND OPEN STATE CHANNEL MODELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER MSBA; CHLORIDE CHANNEL; ATP-BINDING; CASSETTE TRANSPORTER; MOLECULAR-DYNAMICS; ANION SELECTIVITY; P-GLYCOPROTEIN; ION-CHANNEL; CONFORMATIONAL-CHANGES	The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette (ABC) transporter superfamily. CFTR controls the flow of anions through the apical membrane of epithelia. Dysfunctional CFTR causes the common lethal genetic disease cystic fibrosis. Transitions between open and closed states of CFTR are regulated by ATP binding and hydrolysis on the cytosolic nucleotide binding domains, which are coupled with the transmembrane (TM) domains forming the pathway for anion permeation. Lack of structural data hampers a global understanding of CFTR and thus the development of "rational" approaches directly targeting defective CFTR. In this work, we explored possible conformational states of the CFTR gating cycle by means of homology modeling. As templates, we used structures of homologous ABC transporters, namely TM(287-288), ABC-B10, McjD, and Sav1866. In the light of published experimental results, structural analysis of the transmembrane cavity suggests that the TM(287-288)-based CFTR model could correspond to a commonly occupied closed state, whereas the McjD-based model could represent an open state. The models capture the important role played by Phe-337 as a filter/gating residue and provide structural information on the conformational transition from closed to open channel.	[Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Vergani, Paola] UCL, Res Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Calgary; University of Calgary; University of London; University College London	Vergani, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6B6, England.	p.vergani@ucl.ac.uk; tieleman@ucalgary.ca	Corradi, Valentina/G-3937-2017; Tieleman, D. Peter/A-4790-2011; Vergani, Paola/C-2019-2008	Tieleman, D. Peter/0000-0001-5507-0688; Vergani, Paola/0000-0002-5422-4662	Canadian Institutes for Health Research; Alberta Innovates Technology Futures; Medical Research Council [G0501200] Funding Source: researchfish; Cystic Fibrosis Trust [RS31] Funding Source: researchfish; MRC [G0501200] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cystic Fibrosis Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Canadian Institutes for Health Research and Alberta Innovates Technology Futures. The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Becker JP, 2010, J PHYS CHEM B, V114, P15948, DOI 10.1021/jp1038392; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Chaves LAP, 2015, J GEN PHYSIOL, V145, P261, DOI 10.1085/jgp.201411347; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Corradi V, 2012, J BIOL CHEM, V287, P28099, DOI 10.1074/jbc.M112.381251; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2014, J GEN PHYSIOL, V143, P269, DOI 10.1085/jgp.201311089; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Damas JM, 2011, PROTEIN SCI, V20, P1220, DOI 10.1002/pro.650; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2014, BIOCHEM CELL BIOL, V92, P481, DOI 10.1139/bcb-2014-0038; El Hiani Y, 2014, J BIOL CHEM, V289, P28149, DOI 10.1074/jbc.M114.593103; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; FEREC C, 1993, HUM MOL GENET, V2, P1557, DOI 10.1093/hmg/2.10.1557; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Guo ZY, 2013, J MOL MODEL, V19, P2901, DOI 10.1007/s00894-013-1819-7; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Hyde BB, 2012, CELL DEATH DIFFER, V19, P1117, DOI 10.1038/cdd.2011.195; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 2001, J PHYSIOL-LONDON, V531, P51, DOI 10.1111/j.1469-7793.2001.0051j.x; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaedel C, 1998, CLIN GENET, V53, P383; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Solymosi EA, 2013, P NATL ACAD SCI USA, V110, pE2308, DOI 10.1073/pnas.1216382110; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2015, BIOCHEMISTRY-US, V54, P2828, DOI 10.1021/acs.biochem.5b00219; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2014, J BIOL CHEM, V289, P30364, DOI 10.1074/jbc.M114.595710; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Wang XH, 2009, J GEN PHYSIOL, V133, P69, DOI 10.1085/jgp.200810049; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Xu J, 2015, ONCOL REP, V33, P2227, DOI 10.3892/or.2015.3829; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	112	41	41	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22891	22906		10.1074/jbc.M115.665125	http://dx.doi.org/10.1074/jbc.M115.665125			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229102	Green Published, hybrid			2022-12-26	WOS:000361685500003
J	Piguet, V; D'Incau, S; Besson, M; Desmeules, J; Cedraschi, C				Piguet, Valerie; D'Incau, Stephanie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine			Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH-CARE; DRUG SUBSTITUTION; SATURATION; MEDICINES; PHARMACY; POLICIES; VIEWS; NEED	Objective Parallel to an ever stronger advocacy for the use of generics, various sources of information report concerns regarding substitution. The literature indicates that information regarding substitution is not univocal. The aim of this qualitative study was to explore patients' representations regarding generics in patients suffering from non-specific disabling chronic musculoskeletal pain, as these patients are confronted with the issue of the prescription and/or substitution of original formulations with generics. Methods Qualitative methods were selected because the aim was to access the range of patients' representations and to consider their conceptions. Standardized face-to-face semi-structured interviews were used, and transcripts were submitted to content analysis. Results Patients' representations suggest that they might be confident in taking a generic medication: when he/she has an understanding of generics as resulting from a development process that has become part of the public domain; the generic medication is prescribed by the physician; each prescription is discussed, i.e., the patient is prescribed the generic version of a given medication and not a generic medication. Discussion Economic arguments are not sufficient to justify substitution, and may even raise issues calling upon cognitive dissonance. Even in non-life-threatening diseases, negative cues require attention and need be de-emphasized - in particular lower price as an indication of lower quality, and generic status as contradictory with advocating individualization of medication.	[Piguet, Valerie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine] Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Piguet, Valerie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [D'Incau, Stephanie] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Piguet, V (corresponding author), Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Clin Pharmacol & Toxicol, Geneva, Switzerland.	Valerie.Piguet@hcuge.ch	Besson, Marie/AAG-3253-2019					Al Ameri MN, 2011, TRANSPL INT, V24, P770, DOI 10.1111/j.1432-2277.2011.01268.x; Andersson K, 2005, PHARMACOEPIDEM DR S, V14, P341, DOI 10.1002/pds.1055; Babar ZUD, 2014, HEALTH POLICY, V117, P285, DOI 10.1016/j.healthpol.2014.06.004; Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Daubresse M, 2013, MED CARE, V51, P870, DOI 10.1097/MLR.0b013e3182a95d86; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; Ess SM, 2003, PHARMACOECONOMICS, V21, P89, DOI 10.2165/00019053-200321020-00002; Fairman KA, 2008, J MANAGE CARE PHARM, V14, P387, DOI 10.18553/jmcp.2008.14.4.387; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gaskell G., 2000, QUALITATIVE RES TEXT, P38, DOI DOI 10.4135/9781849209731; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser B, 1996, DISCOVERY GROUNDED T; Guba E., 2005, SAGE HDB QUALITATIVE, V3rd, P191; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hakonsen H, 2009, CURR MED RES OPIN, V25, P2515, DOI 10.1185/03007990903192223; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Heikkila Reeta, 2011, BMC Clin Pharmacol, V11, P20, DOI 10.1186/1472-6904-11-20; Himmel W, 2005, INT J CLIN PHARM TH, V43, P472; Kaplan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074399; Kjoenniksen I, 2006, PHARM WORLD SCI, V28, P284, DOI 10.1007/s11096-006-9043-5; KUZEL AJ, 1992, RES METH PR, V3, P31; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; Leventhal H., 2003, SELF REGULATION HLTH, P138; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lionberger R, 2013, CLIN PHARMACOL THER, V94, P438, DOI 10.1038/clpt.2013.104; Mays N, 1996, QUALITATIVE RES HLTH; Mody GM, 2012, BEST PRACT RES CL RH, V26, P237, DOI 10.1016/j.berh.2012.03.002; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sander JW, 2010, EXPERT REV NEUROTHER, V10, P1887, DOI [10.1586/ern.10.163, 10.1586/ERN.10.163]; Sarradon-Eck A, 2007, REV EPIDEMIOL SANTE, V55, P179, DOI 10.1016/j.respe.2007.01.026; Schwartz N., 1992, CONTEXT EFFECTS SOCI; Shah RR, 2012, BRIT J CLIN PHARMACO, V74, P698, DOI 10.1111/j.1365-2125.2012.04328.x; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Simoens Steven, 2008, Expert Rev Clin Pharmacol, V1, P497, DOI 10.1586/17512433.1.4.497; Stone J, 2010, FRONT SOC PSYCHOL, P313; Strauss A., 1990, BASICS QUALITATIVE R; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wicklund R.A., 2013, PERSPECTIVES COGNITI; Yu Y, 2013, CLIN PHARMACOL THER, V94, P519, DOI 10.1038/clpt.2013.108	53	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134661	10.1371/journal.pone.0134661	http://dx.doi.org/10.1371/journal.pone.0134661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237036	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400031
J	Rajasingh, S; Thangavel, J; Czirok, A; Samanta, S; Roby, KF; Dawn, B; Rajasingh, J				Rajasingh, Sheeja; Thangavel, Jayakumar; Czirok, Andras; Samanta, Saheli; Roby, Katherine F.; Dawn, Buddhadeb; Rajasingh, Johnson			Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; CONVECTIVE TISSUE MOVEMENTS; PROGENITOR CELLS; DIRECTED DIFFERENTIATION; THERAPY; DISEASE; TRANSPLANTATION; REGENERATION; INDUCTION	Human induced pluripotent stem cells (iPSCs) derived cardiomyocytes (iCMCs) would provide an unlimited cell source for regenerative medicine and drug discoveries. The objective of our study is to generate functional cardiomyocytes from human iPSCs and to develop a novel method of measuring contractility of CMCs. In a series of experiments, adult human skin fibroblasts (HSF) and human umbilical vein endothelial cells (HUVECs) were treated with a combination of pluripotent gene DNA and mRNA under specific conditions. The iPSC colonies were identified and differentiated into various cell lineages, including CMCs. The contractile activity of CMCs was measured by a novel method of frame-by-frame cross correlation (particle image velocimetry-PIV) analysis. Our treatment regimen transformed 4% of HSFs into iPSC colonies at passage 0, a significantly improved efficiency compared with use of either DNA or mRNA alone. The iPSCs were capable of differentiating both in vitro and in vivo into endodermal, ectodermal and mesodermal cells, including CMCs with >88% of cells being positive for troponin T (CTT) and Gata4 by flow cytometry. We report a highly efficient combination of DNA and mRNA to generate iPSCs and functional iCMCs from adult human cells. We also report a novel approach to measure contractility of iCMCs.	[Rajasingh, Sheeja; Thangavel, Jayakumar; Samanta, Saheli; Dawn, Buddhadeb; Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst,Div Cardiovasc Dis, Kansas City, KS 66103 USA; [Czirok, Andras; Roby, Katherine F.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rajasingh, J (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst,Div Cardiovasc Dis, Kansas City, KS 66103 USA.	rjohnson9@kumc.edu	Rajasingh, Johnson/AAT-1985-2021	Rajasingh, Johnson/0000-0002-6172-4083	American Heart Association Grant - Jon Holden DeHaan Foundation [10SDG2630181]; National Institutes of Health [R21HL97349, R01GM102801, R01HL117730]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097349, R01HL117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326, R01GM102801] Funding Source: NIH RePORTER	American Heart Association Grant - Jon Holden DeHaan Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by American Heart Association Grant - Jon Holden DeHaan Foundation 10SDG2630181 and National Institutes of Health grants R21HL97349 (to JR), R01GM102801 (to AC) and R01HL117730 (to BD).	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Aleksandrova A, 2012, DEV BIOL, V363, P348, DOI 10.1016/j.ydbio.2011.12.036; [Anonymous], 2011, GUIDE FOR THE CARE A; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Frati C, 2011, CURR PHARM DESIGN, V17, P3252; Hussein SMI, 2012, CURR OPIN GENET DEV, V22, P435, DOI 10.1016/j.gde.2012.08.007; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Losordo DW, 2012, CIRC CARDIOVASC INTE; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Narsinh K, 2011, CIRC RES, V108, P1146, DOI 10.1161/CIRCRESAHA.111.240374; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pal D., 2012, NAT MED; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Rajasingh J, 2012, PROG MOL BIOL TRANSL, V111, P51, DOI [10.1016/B978-0-12-398459-3.00003-4, 10.1016/B978-0-12-358459-3.00003-4]; Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Thangavel J, 2014, AM J PATHOL, V184, P2237, DOI 10.1016/j.ajpath.2014.05.008; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	47	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134093	10.1371/journal.pone.0134093	http://dx.doi.org/10.1371/journal.pone.0134093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237415	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400014
J	Adhikari, D; Tiwary, R; Barik, SK				Adhikari, Dibyendu; Tiwary, Raghuvar; Barik, Saroj Kanta			Modelling Hotspots for Invasive Alien Plants in India	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; POTENTIAL DISTRIBUTION; BIODIVERSITY HOTSPOTS; BIOLOGICAL INVASIONS; NATURAL-SELECTION; RAPID EVOLUTION; HOT-SPOTS; DIVERSITY; RANGE	Identification of invasion hotspots that support multiple invasive alien species (IAS) is a prerequisite for control and management of invasion. However, till recently it remained a methodological challenge to precisely determine such invasive hotspots. We identified the hotspots of alien species invasion in India through Ecological Niche Modelling (ENM) using species occurrence data from the Global Biodiversity Information Facility (GBIF). The predicted area of invasion for selected species were classified into 4 categories based on number of model agreements for a region i.e. high, medium, low and very low. About 49% of the total geographical area of India was predicted to be prone to invasion at moderate to high levels of climatic suitability. The intersection of anthropogenic biomes and ecoregions with the regions of 'high' climatic suitability was classified as hotspot of alien plant invasion. Nineteen of 47 ecoregions of India, harboured such hotspots. Most ecologically sensitive regions of India, including the 'biodiversity hotspots' and coastal regions coincide with invasion hotspots, indicating their vulnerability to alien plant invasion. Besides demonstrating the usefulness of ENM and open source data for IAS management, the present study provides a knowledge base for guiding the formulation of an effective policy and management strategy for controlling the invasive alien species.	[Adhikari, Dibyendu; Tiwary, Raghuvar; Barik, Saroj Kanta] North Eastern Hill Univ, Dept Bot, Shillong 793022, Meghalaya, India	North Eastern Hill University	Barik, SK (corresponding author), North Eastern Hill Univ, Dept Bot, Shillong 793022, Meghalaya, India.	sarojkbarik@gmail.com	Adhikari, Dibyendu/GPW-8128-2022; BARIK, SAROJ KANTA/ADR-1820-2022	Adhikari, Dibyendu/0000-0002-5057-0541; BARIK, SAROJ KANTA/0000-0002-1795-9539				Adhikari D, 2012, ECOL ENG, V40, P37, DOI 10.1016/j.ecoleng.2011.12.004; Ali Rauf, 2006, Journal of the Bombay Natural History Society, V103, P349; Allouche O, 2008, J APPL ECOL, V45, P599, DOI 10.1111/j.1365-2664.2007.01445.x; Annapurna C, 2003, WEED RES, V43, P190, DOI 10.1046/j.1365-3180.2003.00332.x; [Anonymous], 2011, INDIA STATE OF FORES; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Barik SK, 2012, CABI INVASIVE SER, P77, DOI 10.1079/9781845939076.0077; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Bhatt J, 2011, INVASIVE ALIEN PLANT, V1; Biswas SR, 2007, FOREST ECOL MANAG, V245, P1, DOI 10.1016/j.foreco.2007.02.011; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Dullinger S, 2009, BIOL INVASIONS, V11, P2401, DOI 10.1007/s10530-009-9424-5; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellis E. C., 2008, ANTHROPOGENIC BIOMES; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; GOPINATHAN MC, 1982, NEW PHYTOL, V91, P531, DOI 10.1111/j.1469-8137.1982.tb03331.x; GRACE J, 1987, NEW PHYTOL, V106, P113; Gravuer K, 2008, P NATL ACAD SCI USA, V105, P6344, DOI 10.1073/pnas.0712026105; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hijmans R.J., 2001, MANUAL; Hooker JD, 1882, THE FLORA OF BRITISH, VIII; Hooker JD, 1872, THE FLORA OF BRITISH, VI; Hooker JD, 1885, THE FLORA OF BRITISH, VIV; Hooker JD, 1885, THE FLORA OF BRITISH, VV; Hooker JD, 1879, THE FLORA OF BRITISH, VII; Hooker JD, 1894, THE FLORA OF BRITISH, VVI; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Hulme Philip E., 2007, V25, P56; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jaryan V, 2013, NATL ACAD SCI LETT, V36, P85, DOI 10.1007/s40009-012-0103-1; Jha CS, 2000, CURR SCI INDIA, V79, P231; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Khuroo AA, 2012, BIOL INVASIONS, V14, P99, DOI 10.1007/s10530-011-9981-2; Khuroo AA, 2007, BIOL INVASIONS, V9, P269, DOI 10.1007/s10530-006-9032-6; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Lekevicius Edmundas, 2009, Ekologija, V55, P165; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; MAHESHWA.JK, 1965, NATURE, V206, P1270, DOI 10.1038/2061270a0; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; McNeely JA, 2001, THE GREAT RESHUFFLIN; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negi PS, 2007, CURR SCI INDIA, V92, P968; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PANETTA FD, 1991, WEED RES, V31, P273, DOI 10.1111/j.1365-3180.1991.tb01767.x; Parepa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2632; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Peterson A. T, 2011, ECOLOGICAL NICHES GE, DOI 10.23943/princeton/9780691136868.001.0001; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pysek P, 2003, CONSERV BIOL, V17, P1414, DOI 10.1046/j.1523-1739.2003.02248.x; Rasingam L, 2009, BIODIVERS CONSERV, V18, P1045, DOI 10.1007/s10531-008-9496-z; Reddy CS, 2009, BANGL J PLANT TAXON, V16, P29; Reddy CS, 2008, LIFE SCI J, V5, P84; Reshi Z. A., 2012, Proceedings of the National Academy of Sciences India. Section B, Biological Sciences, V82, P305; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Sekar K. C., 2012, American Journal of Plant Sciences, V3, P177, DOI 10.4236/ajps.2012.32021; Shah MA, 2012, J PLANT ECOL-UK, V5, P167, DOI 10.1093/jpe/rtr021; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Stadler J, 2000, ECOGRAPHY, V23, P169, DOI 10.1111/j.1600-0587.2000.tb00272.x; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Strauss SY, 2014, OIKOS, V123, P257, DOI 10.1111/j.1600-0706.2013.01093.x; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller Wilfried, 2007, V193, P197; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Vandepitte K, 2014, MOL ECOL, V23, P2157, DOI 10.1111/mec.12683; Vicente J, 2010, ECOGRAPHY, V33, P1081, DOI 10.1111/j.1600-0587.2010.6380.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Woodward FI, 1987, CLIMATE AND PLANT DI; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Zenni RD, 2014, ECOL LETT, V17, P727, DOI 10.1111/ele.12278	113	60	63	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134665	10.1371/journal.pone.0134665	http://dx.doi.org/10.1371/journal.pone.0134665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230513	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400146
J	Agudelo-Gomez, D; Pineda-Sierra, S; Ceron-Munoz, MF				Agudelo-Gomez, Divier; Pineda-Sierra, Sebastian; Fernando Ceron-Munoz, Mario			Genetic Evaluation of Dual-Purpose Buffaloes (Bubalus bubalis) in Colombia Using Principal Component Analysis	PLOS ONE			English	Article							FACTOR-ANALYTIC MODELS; DAY MILK-YIELD; BREEDING VALUES; GROWTH TRAITS; PARAMETERS	Genealogy and productive information of 48621 dual-purpose buffaloes born in Colombia between years 1996 and 2014 was used. The following traits were assessed using one-trait models: milk yield at 270 days (MY270), age at first calving (AFC), weaning weight (WW), and weights at the following ages: first year (W12), 18 months (W18), and 2 years (W24). Direct additive genetic and residual random effects were included in all the traits. Maternal permanent environmental and maternal additive genetic effects were included for WW and W12. The fixed effects were: contemporary group (for all traits), sex (for WW, W12, W18, and W24), parity (for WW, W12, and MY270). Age was included as covariate for WW, W12, W18 and W24. Principal component analysis (PCA) was conducted using the genetic values of 133 breeding males whose breeding-value reliability was higher than 50% for all the traits in order to define the number of principal components (PC) which would explain most of the variation. The highest heritabilities were for W18 and MY270, and the lowest for AFC; with 0.53, 0.23, and 0.17, respectively. The first three PCs represented 66% of the total variance. Correlation of the first PC with meat production traits was higher than 0.73, and it was -0.38 with AFC. Correlations of the second PC with maternal genetic component traits for WW and W12 were above 0.75. The third PC had 0.84 correlation with MY270. PCA is an alternative approach for analyzing traits in dual-purpose buffaloes and reduces the dimension of the traits.	[Agudelo-Gomez, Divier] Corp Univ Lasallista, Fac Ciencias Adm & Agr, Grp Invest Sobre Prod Desarrollo & Transformac Ag, Caldas Antioquia, Colombia; [Agudelo-Gomez, Divier; Pineda-Sierra, Sebastian; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Colombia	Universidad de Antioquia	Agudelo-Gomez, D (corresponding author), Corp Univ Lasallista, Fac Ciencias Adm & Agr, Grp Invest Sobre Prod Desarrollo & Transformac Ag, Caldas Antioquia, Colombia.	diagudelo@lasallistadocentes.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020; Agudelo Gomez, Divier Antonio/O-9733-2016	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625; Agudelo Gomez, Divier Antonio/0000-0001-6184-335X	Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia	Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia	The authors received funding for this work from Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia.	[Anonymous], 2014, R LANG ENV STAT COMP; Aspilcueta-Borquis RR, 2010, GENET MOL RES, V9, P1636, DOI 10.4238/vol9-3gmr846; Bignardi AB, 2014, LIVEST SCI, V162, P50, DOI 10.1016/j.livsci.2014.01.031; Bignardi AB, 2012, J DAIRY SCI, V95, P2157, DOI 10.3168/jds.2011-4494; Boldman K.G., 1995, MANUAL USE MTDFREML; Boligon AA, 2013, LIVEST SCI, V152, P135, DOI 10.1016/j.livsci.2013.01.005; Bolívar Vergara Diana María, 2010, Rev. Fac. Nac. Agron. Medellín, V63, P5587; Vergara DMB, 2012, REV COLOMB CIENC PEC, V25, P202; Buzanskas ME, 2013, REPROD FERT DEVELOP, V25, P775, DOI 10.1071/RD12132; de Albuquerque LG, 2001, J ANIM BREED GENET, V118, P83, DOI 10.1046/j.1439-0388.2001.00279.x; Dias LT, 2004, REV BRAS ZOOTECN, V33, P97, DOI 10.1590/S1516-35982004000100013; FEDEGAN, 2006, PLAN ESTR GAN COL 20, P296; Holdridge L, 1996, SKELETAL NUCL MED, P225; Hurtado-Lugo N., 2006, Livestock Research for Rural Development, V18, P39; Husson F., 2014, R PACKAGE VERSION, V1, P102; ICAR, 2012, INT AGR REC REC PRAC, P580; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kirkpatrick M, 2004, GENETICS, V168, P2295, DOI 10.1534/genetics.104.029181; Malhado CHM, 2007, ITAL J ANIM SCI, V6, P325; Malhado CHM, 2013, REV BRAS ZOOTECN, V42, P565, DOI 10.1590/S1516-35982013000800005; Meyer K, 2007, J ANIM BREED GENET, V124, P50, DOI 10.1111/j.1439-0388.2007.00637.x; Meyer K, 2005, ANIM SCI, V81, P337, DOI 10.1079/ASC50850337; Oliveira DP, 2014, 10 WORLD C GEN APPL, P3; Rencher AC, 2002, METHODS MULTIVARIATE, DOI [10.1002/0471271357, DOI 10.1002/0471271357]; Rosati A, 2002, LIVEST PROD SCI, V74, P185, DOI 10.1016/S0301-6226(01)00293-7; Savegnago RP, 2011, POULTRY SCI, V90, P2174, DOI 10.3382/ps.2011-01474; Seno LO, 2010, LIVEST RES RURAL DEV, P22; Tonhati H, 2008, GENET MOL BIOL, V31, P674, DOI 10.1590/S1415-47572008000400012; Val JE, 2008, ARQ BRAS MED VET ZOO, V60, P705, DOI 10.1590/S0102-09352008000300027; Wichern DW, 1992, APPL MULTIVARIATE ST, P442; WILLHAM RL, 1972, J ANIM SCI, V35, P1288	31	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132811	10.1371/journal.pone.0132811	http://dx.doi.org/10.1371/journal.pone.0132811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230093	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400021
J	Zhang, JJ; Tian, JJ; Wei, SS; Duan, SB; Wang, HM; Chen, YZ; Ding, SH; Zhang, C; Meng, QL; Li, Y				Zhang, Jin-ju; Tian, Jing-jing; Wei, Shuang-shi; Duan, Sheng-bao; Wang, Hong-mei; Chen, Ye-zhou; Ding, Shao-hua; Zhang, Chun; Meng, Qing-lin; Li, Yong			An Internal Reference Control Duplex Real-Time Polymerase Chain Reaction Assay for Detecting Bacterial Contamination in Blood Products	PLOS ONE			English	Article							PCR ASSAY; PLATELET; TRANSFUSION; COMPONENTS	Real-time polymerase chain reaction (RT-PCR) enables effective and sensitive screening for infectious risk in the field of blood safety. However, when using RT-PCR to detect bacterial contamination, several intractable points must be considered, one of which is the lack of appropriate quality control. In this study, we developed a simplified RT-PCR assay in which the same primer set and two distinct probes were used to detect both, an internal reference control and the target in a reaction. The copy number of the internal reference control represents the positive detection limit of the assay; therefore, when the threshold-cycle value of the target is less than or equal to that of the internal reference control, the result obtained for the target can be considered to be a true positive. When human gDNA was spiked with Escherichia coli gDNA and the detection limit for the internal reference control was set to five copies, the measured detection limit for E. coli gDNA was two copies. The internal reference control duplex RT-PCR assay showed high efficiency (0.91-1.02), high linearity (R-2 > 0.99), and good reproducibility in intra-and inter-assay comparisons. Lastly, when human platelet-rich plasma samples were spiked with E. coli or other bacterial species, all species were detected efficiently, and the results of a two-sample pooled t test showed that the limit of detection for E. coli was 1 cfu/mL. Here, we present a synthetic internal reference control molecule and a new statistical method for improving the reliability of RT-PCR assays when screening for bacterial contamination in blood products.	[Zhang, Jin-ju; Tian, Jing-jing; Wei, Shuang-shi; Duan, Sheng-bao; Wang, Hong-mei; Chen, Ye-zhou; Ding, Shao-hua; Zhang, Chun; Meng, Qing-lin; Li, Yong] Chinese Acad Sci, Key Lab Biomed Diagnost, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Meng, QL (corresponding author), Chinese Acad Sci, Key Lab Biomed Diagnost, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China.	mengql@sibet.ac.cn		Meng, Qinglin/0000-0002-1885-1183	Suzhou Municipal Science and Technology Project research fund [ZXY201422]; Natural Science Foundation for Young Scientists of Jiangsu Province [BK20130343]	Suzhou Municipal Science and Technology Project research fund; Natural Science Foundation for Young Scientists of Jiangsu Province	This work was supported by the Suzhou Municipal Science and Technology Project research fund (grant ZXY201422) (http://kjxm.szkj.gov.cn/) and the Natural Science Foundation for Young Scientists of Jiangsu Province (Grant BK20130343) (http://www.jskjjh.gov.cn/13kjskj2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2005, FEMS IMMUNOL MED MIC, V44, P177, DOI 10.1016/j.femsim.2004.12.004; Benjamin RJ, 2007, TRANSFUSION, V47, P1381, DOI 10.1111/j.1537-2995.2007.01326.x; Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Dreier J, 2004, J CLIN MICROBIOL, V42, P4759, DOI 10.1128/JCM.42.10.4759-4764.2004; Dreier J, 2007, TRANSFUS MED REV, V21, P237, DOI 10.1016/j.tmrv.2007.03.006; Dunbar NM, 2013, TRANSFUSION, V53, P2307, DOI 10.1111/trf.12083; Jenkins C, 2011, TRANSFUSION, V51, P2555, DOI 10.1111/j.1537-2995.2011.03187.x; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Mohammadi T, 2005, TRANSFUSION, V45, P731, DOI 10.1111/j.1537-2995.2005.04258.x; Patel P, 2012, TRANSFUSION, V52, P1423, DOI 10.1111/j.1537-2995.2011.03484.x; Pietersz RNI, 2007, VOX SANG, V93, P260, DOI 10.1111/j.1423-0410.2007.00967.x; Rood IGH, 2008, J MICROBIOL METH, V75, P64, DOI 10.1016/j.mimet.2008.05.007; Rood IGH, 2011, TRANSFUSION, V51, P2006, DOI 10.1111/j.1537-2995.2011.03090.x; Rood IGH, 2010, TRANSFUSION, V50, P1352, DOI 10.1111/j.1537-2995.2009.02580.x; Roth WK, 2000, VOX SANG, V78, P257; [Standards Program Committee American Association of Blood Banks], 2004, STANDARDS BLOOD BANK; Stocher M, 2004, J CLIN VIROL, V29, P171, DOI 10.1016/S1386-6532(03)00121-5; Stormer M, 2007, CLIN CHEM, V53, P104, DOI 10.1373/clinchem.2006.070987	19	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134743	10.1371/journal.pone.0134743	http://dx.doi.org/10.1371/journal.pone.0134743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230627	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400159
J	Chen, P; Hu, YF; Wang, L; Xiao, WF; Bao, XY; Pan, C; Yi, HS; Chen, XY; Pan, MH; Lu, C				Chen, Peng; Hu, Yan-Fen; Wang, La; Xiao, Wen-Fu; Bao, Xi-Yan; Pan, Chun; Yi, Hua-Shan; Chen, Xiang-Yun; Pan, Min-Hui; Lu, Cheng			Mitochondrial Apoptotic Pathway Is Activated by H2O2-Mediated Oxidative Stress in BmN-SWU1 Cells from Bombyx mori Ovary	PLOS ONE			English	Article							CYTOCHROME-C; ENDONUCLEASE-G; OXYGEN; SILKWORM; RELEASE; AUTOPHAGY	Apoptosis is a known regulator of morphogenetic events. In mammals, the critical role of oxidative stress-induced apoptosis has been well-studied; however, in insects the role of oxidative stress in apoptosis is not clear. In a previous study, we showed that apoptosis-related genes are present in the silkworm Bombyx mori, an important lepidopteran insect model. In this study, we evaluated the effect of H2O2-induced oxidative stress on apoptosis, reactive oxygen species (ROS) levels, mitochondrial response, cytochrome c release and apoptosis-related gene expression in the BmN-SWU1 cell line from B. mori ovaries. Our results showed that BmN-SWU1 cells exposed to H2O2 showed cell protuberances, cytoplasmic condensation, apoptotic bodies, DNA ladder formation and caspase activities indicating apoptosis. H2O2-induced apoptosis also increased intracellular ROS level, changed mitochondrial distribution, reduced mitochondrial membrane potential and increased the release of cytochrome c from mitochondria. Furthermore, western blot analysis revealed a significant increase in p53 and cytochrome c expression, and a decrease in Bcl-2 expression compared to the controls. Moreover, quantitative real-time PCR (qRT-PCR) showed an increase in the transcript levels of BmICE, Bmapaf-1 and BmEndoG by 439.5%, 423.9% and 42.2%, respectively, after treatment with 1 mu M H2O2 for 24 h. However, the transcript levels of Bmbuffy declined by 41.4% after 24 h of exposure to 1 mu M H2O2. These results show that H2O2 treatment induced apoptosis in BmN-SWU1 cells via the mitochondrial apoptotic pathway. Further, it appears that oxidative stress induced by H2O2 activates both caspase-dependent and caspase-independent mitochondrial apoptotic pathways in silkworm cells. Taken together, these findings improve our knowledge of apoptosis in silkworm and the apoptotic pathways in insects.	[Chen, Peng; Hu, Yan-Fen; Wang, La; Xiao, Wen-Fu; Bao, Xi-Yan; Pan, Chun; Yi, Hua-Shan; Chen, Xiang-Yun; Pan, Min-Hui; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Chen, Peng; Pan, Min-Hui; Lu, Cheng] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Pan, MH (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	pmh047@126.com; lucheng@swu.edu.cn	Huashan, Yi/ABD-6113-2021		Hi-Tech Research and Development 863 Program of China [2013AA102507]; National Natural Science Foundation of China [31172269, 31272505, 31472152]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Hi-Tech Research and Development 863 Program of China (No. 2013AA102507) and National Natural Science Foundation of China (Nos. 31172269, 31272505, and 31472152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KM, 1999, MED HYPOTHESES, V52, P451, DOI 10.1054/mehy.1997.0521; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bryant B, 2009, INSECT MOL BIOL, V18, P341, DOI 10.1111/j.1365-2583.2009.00878.x; Casares C, 2012, EUR ARCH OTO-RHINO-L, V269, P2455, DOI 10.1007/s00405-012-2029-0; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li QR, 2010, CAN J ZOOL, V88, P1169, DOI 10.1139/Z10-083; Liu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040877; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pan C, 2014, BIOCHEM BIOPH RES CO, V447, P237, DOI 10.1016/j.bbrc.2014.03.093; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Suganuma I, 2011, INSECT BIOCHEM MOLEC, V41, P909, DOI 10.1016/j.ibmb.2011.08.005; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611; Zhou DH, 2014, ADV CANCER RES, V122, P1, DOI 10.1016/B978-0-12-420117-0.00001-3; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	42	27	30	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134694	10.1371/journal.pone.0134694	http://dx.doi.org/10.1371/journal.pone.0134694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225758	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700130
J	Li, XJ; Wu, J; Han, J; Hu, YF; Mi, KX				Li, Xiaojing; Wu, Jun; Han, Jiao; Hu, Yongfei; Mi, Kaixia			Distinct Responses of Mycobacterium smegmatis to Exposure to Low and High Levels of Hydrogen Peroxide	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; REACTIVE OXYGEN; STATIONARY-PHASE; SIGMA-FACTOR; DNA-DAMAGE; TUBERCULOSIS; ADAPTATION; RESISTANCE; MUTAGENESIS	Hydrogen peroxide (H2O2) is a natural oxidant produced by aerobic organisms and gives rise to oxidative damage, including DNA mutations, protein inactivation and lipid damage. The genus Mycobacterium utilizes redox sensors and H2O2 scavenging enzymes for the detoxification of H2O2. To date, the precise response to oxidative stress has not been fully elucidated. Here, we compared the effects of different levels of H2O2 on transcription in M. smegmatis using RNA-sequencing. A 0.2 mM H2O2 treatment had little effect on the growth and viability of M. smegmatis whereas 7 mM H2O2 was lethal. Analysis of global transcription showed that 0.2 mM H2O2 induced relatively few changes in gene expression, whereas a large proportion of the mycobacterial genome was found to be differentially expressed after treatment with 7 mM H2O2. Genes differentially expressed following treatment with 0.2 mM H2O2 included those coding for proteins involved in glycolysis-gluconeogenesis and fatty acid metabolism pathways, and expression of most genes encoding ribosomal proteins was lower following treatment with 7 mM H2O2. Our analysis shows that M. smegmatis utilizes the sigma factor MSMEG_5214 in response to 0.2 mM H2O2, and the RpoE1 sigma factors MSMEG_0573 and MSMEG_0574 in response to 7 mM H2O2. In addition, different transcriptional regulators responded to different levels of H2O2: MSMEG_1919 was induced by 0.2 mM H2O2, while high-level induction of DevR occurred in response to 7 mM H2O2. We detected the induction of different detoxifying enzymes, including genes encoding KatG, AhpD, TrxB and Trx, at different levels of H2O2 and the detoxifying enzymes were expressed at different levels of H2O2. In conclusion, our study reveals the changes in transcription that are induced in response to different levels of H2O2 in M. smegmatis.	[Li, Xiaojing; Wu, Jun; Han, Jiao; Hu, Yongfei; Mi, Kaixia] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Li, Xiaojing; Wu, Jun; Hu, Yongfei; Mi, Kaixia] Beijing Key Lab Microbial Drug Resistance & Resis, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Mi, KX (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	mik@im.ac.cn		hu, yong fei/0000-0002-2158-6018	National Basic Research Program of China [2012CB518700, 2014CB744400]; Key Program of the Chinese Academy of Sciences [KJZD-EW-L02]	National Basic Research Program of China(National Basic Research Program of China); Key Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2012CB518700 and 2014CB744400) and the Key Program of the Chinese Academy of Sciences (KJZD-EW-L02).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Durbach SI, 1997, MOL MICROBIOL, V26, P643, DOI 10.1046/j.1365-2958.1997.5731934.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grant CM, 2011, ANTIOXID REDOX SIGN, V15, P191, DOI 10.1089/ars.2010.3699; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Hu YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005150; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; KNOX R, 1956, AM REV TUBERC PULM, V73, P726; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XJ, 2014, PROTEIN CELL, V5, P182, DOI 10.1007/s13238-014-0024-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhotra V, 2012, J BACTERIOL, V194, P4184, DOI 10.1128/JB.00585-12; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warner DF, 2010, P NATL ACAD SCI USA, V107, P13093, DOI 10.1073/pnas.1002614107; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	43	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134595	10.1371/journal.pone.0134595	http://dx.doi.org/10.1371/journal.pone.0134595			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225431	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700118
J	Wijtzes, AI; Jansen, W; Jaddoe, VWV; Franco, OH; Hofman, A; van Lenthe, FJ; Raat, H				Wijtzes, Anne I.; Jansen, Wilma; Jaddoe, Vincent W. V.; Franco, Oscar H.; Hofman, Albert; van Lenthe, Frank J.; Raat, Hein			Social Inequalities in Young Children's Meal Skipping Behaviors: The Generation R Study	PLOS ONE			English	Article							BODY-MASS INDEX; BREAKFAST CONSUMPTION; WEIGHT STATUS; SOCIOECONOMIC POSITION; RISK-FACTORS; ADOLESCENTS; OVERWEIGHT; PATTERNS; HEALTH; INCOME	Background Regular meal consumption is considered an important aspect of a healthy diet. While ample evidence shows social inequalities in breakfast skipping among adolescents, little is known about social inequalities in breakfast skipping and skipping of other meals among young school-aged children. Such information is crucial in targeting interventions aimed to promote a healthy diet in children. Methods We examined data from 4704 ethnically diverse children participating in the Generation R Study, a population-based prospective cohort study in Rotterdam, the Netherlands. Information on family socioeconomic position (SEP), ethnic background, and meal skipping behaviors was assessed by parent-reported questionnaire when the child was 6 years old. Multiple logistic regression analyses were performed to assess the associations of family SEP (educational level, household income, employment status, family composition) and ethnic background with meal skipping behaviors, using high SEP children and native Dutch children as reference groups. Results Meal skipping prevalence ranged from 3% (dinner) to 11% (lunch). The prevalence of meal skipping was higher among low SEP children and ethnic minority children. Maternal educational level was independently associated with breakfast skipping ([low maternal educational level] OR: 2.21; 95% CI: 1.24,3.94). Paternal educational level was independently associated with lunch skipping ([low paternal educational level] OR: 1.53; 95% CI: 1.06,2.20) and dinner skipping ([mid-high paternal educational level] OR: 0.39; 95% CI: 0.20,0.76). Household income was independently associated with breakfast skipping ([low income] OR: 2.43, 95% CI: 1.40,4.22) and dinner skipping ([low income] OR: 2.44; 95% CI: 1.22,4.91). In general, ethnicminority children were more likely to skip breakfast, lunch, and dinner compared with native Dutch children. Adjustment for family SEP attenuated the associations of ethnicminority background with meal skipping behaviors considerably. Conclusion Low SEP children and ethnic minority children are at an increased risk of breakfast, lunch, and dinner skipping compared with high SEP children and native Dutch children, respectively. Given these inequalities, interventions aimed to promote regular meal consumption, breakfast consumption in particular, should target children from low socioeconomic groups and ethnic minority children. More qualitative research to investigate the pathways underlying social inequalities in children's meal skipping behaviors is warranted.	[Wijtzes, Anne I.; Jaddoe, Vincent W. V.; Hofman, Albert] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Wijtzes, Anne I.; Jansen, Wilma; van Lenthe, Frank J.; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Jansen, Wilma] Dept Social Dev, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Franco, Oscar H.; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wijtzes, AI (corresponding author), Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands.	a.wijtzes@erasmusmc.nl	Jansen, Wilma/ABD-5066-2020; Franco, Óscar H/ABE-2305-2020	Jansen, Wilma/0000-0002-4453-9054; Franco, Óscar H/0000-0002-4606-4929	Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); ZonMw [102047]; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; Erasmus University Rotterdam	Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); ZonMw(Netherlands Organization for Health Research and Development); Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; Erasmus University Rotterdam	The Generation R Study is made possible by financial support from Erasmus Medical Center, Rotterdam, Erasmus University Rotterdam, and the Netherlands Organization for Health Research and Development (ZonMw). The present study was supported by an additional grant from ZonMw (grant No 102047). O.H. Franco works in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. These funding sources had no involvement in study design; collection, analysis, and interpretation of data; writing of the report; and in the decision to submit this article for publication.	Albertson AM, 2007, OBESITY, V15, P2282, DOI 10.1038/oby.2007.271; Bjelland M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-793; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brugman E, 1998, EUR J PUBLIC HEALTH, V8, P325, DOI 10.1093/eurpub/8.4.325; Brussaard J H, 2001, Public Health Nutr, V4, P659; Crawford PB, 2004, J AM DIET ASSOC, V104, P387, DOI 10.1016/j.jada.2003.12.018; Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023; Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894; Dubois L, 2006, PUBLIC HEALTH NUTR, V9, P436, DOI 10.1079/PHN2005867; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Koletzko B, 2010, CRIT REV FOOD SCI, V50, P100, DOI 10.1080/10408390903467431; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Lehto R, 2011, PUBLIC HEALTH NUTR, V14, P1245, DOI 10.1017/S1368980010003034; Levin KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-228; Levin KA, 2012, APPETITE, V59, P63, DOI 10.1016/j.appet.2012.03.016; Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550; Manios Y, 2015, PUBLIC HEALTH NUTR, V18, P774, DOI 10.1017/S1368980014001219; Matthys C, 2003, EUR J CLIN NUTR, V57, P366, DOI 10.1038/sj.ejcn.1601533; Merten MJ, 2009, J AM DIET ASSOC, V109, P1384, DOI 10.1016/j.jada.2009.05.008; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Nielsen A, 2014, APPETITE, V78, P122, DOI 10.1016/j.appet.2014.03.018; Pearson N, 2012, BRIT J NUTR, V108, P932, DOI 10.1017/S000711451100612X; Pearson N, 2011, PREV MED, V53, P268, DOI 10.1016/j.ypmed.2011.07.014; Pearson N, 2009, APPETITE, V52, P1, DOI 10.1016/j.appet.2008.08.006; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Sausenthaler S, 2007, PUBLIC HEALTH NUTR, V10, P24, DOI 10.1017/S1368980007193940; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Slusser W, 2011, PUBLIC HEALTH NUTR, V14, P1833, DOI 10.1017/S1368980011000620; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Statistics Netherlands, 2004, STAND OND 2003; Statistics Netherlands, 2010, JAARR INT 2010; Stea TH, 2014, PUBLIC HEALTH NUTR, P1; Stronks K, 1997, INT J EPIDEMIOL, V26, P592, DOI 10.1093/ije/26.3.592; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Thibault H, 2013, PUBLIC HEALTH NUTR, V16, P193, DOI 10.1017/S136898001200359X; Thivel D, 2015, J DEV BEHAV PEDIATR, V36, P158, DOI 10.1097/DBP.0000000000000131; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Utter J, 2007, J AM DIET ASSOC, V107, P570, DOI 10.1016/j.jada.2007.01.010; Veldhuis L, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-74; Vik FN, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-58; Vossenaar M, 2009, PUBLIC HEALTH NUTR, V12, P1330, DOI 10.1017/S136898000800400X; Zarnowiecki D, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-44	46	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134487	10.1371/journal.pone.0134487	http://dx.doi.org/10.1371/journal.pone.0134487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225757	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700100
J	Zhen, XM; Wu, BL; Wang, J; Lu, CL; Gao, HF; Qiao, J				Zhen, Xiumei; Wu, Bailin; Wang, Jian; Lu, Cuiling; Gao, Huafang; Qiao, Jie			Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency	PLOS ONE			English	Article							IN-VITRO; DYSFUNCTION; REPRODUCTION; MECHANISMS; INHIBITOR; SEQUENCES; FAILURE; STRESS; POOL	Primary ovarian insufficiency (POI), also known as premature ovarian failure (POF), is defined as more than six months of cessation of menses before the age of 40 years, with two serum follicle stimulating hormone (FSH) levels (at least 1 month apart) falling in the menopause range. The cause of POI remains undetermined in the majority of cases, although some studies have reported increased levels of reactive oxygen species (ROS) in idiopathic POF. The role of mitochondrial DNA in the pathogenesis of POI has not been studied extensively. This aim of this study was to uncover underlying mitochondrial genetic defects in patients with POI. The entire region of the mitochondrial genome was amplified in subjects with idiopathic POI (n=63) and age-matched healthy female controls (n=63) using nine pair sets of primers, followed by screening of the mitochondrial genome using an Illumina MiSeq. We identified a total of 96 non-synonymous mitochondrial variations in POI patients and 93 non-synonymous variations in control subjects. Of these, 21 (9 in POI and 12 in control) non-synonymous variations had not been reported previously. Eight mitochondrial cytochrome coxidase 1 (MT-CO1) missense variants were identified in POI patients, whereas only four missense mutations were observed in controls. A high incidence of MT-CO1 missense variants were identified in POI patients compared with controls, and the difference between the groups was statistically significant (13/63 vs. 5/63, p=0.042). Our results show that patients with primary ovarian insufficiency exhibit an increased incidence of mitochondrial cytochrome c oxidase 1 gene mutations, suggesting that MT-CO1 gene mutation may be causal in POI.	[Zhen, Xiumei; Lu, Cuiling; Qiao, Jie] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100191, Peoples R China; [Zhen, Xiumei; Wu, Bailin; Wang, Jian; Gao, Huafang] Harvard Univ, Sch Med, Boston Childrens Hosp, Genet Diag Lab Med, Boston, MA 02115 USA; [Gao, Huafang] Natl Res Inst Hlth & Family Planning, Human Genet Resource Ctr, Beijing 100081, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China	Peking University; Harvard University; Boston Children's Hospital; Harvard Medical School; Shanghai Jiao Tong University	Gao, HF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Genet Diag Lab Med, Boston, MA 02115 USA.	2548621608@qq.com; jie.qiao@263.net	Lu, Cuiling/C-2347-2015	Lu, Cuiling/0000-0001-6944-9760; Qiao, Jie/0000-0003-2126-1376	Scientific Research Foundation for the returned overseas, Peking University Third Hospital [Y-70538-02]; National Natural Science Foundation of China [81300456]	Scientific Research Foundation for the returned overseas, Peking University Third Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Project sponsored by the Scientific Research Foundation for the returned overseas, Peking University Third Hospital (Y-70538-02) and National Natural Science Foundation of China (81300456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bentov Y, 2013, FERTIL STERIL, V99, P18, DOI 10.1016/j.fertnstert.2012.11.031; Bentov Y, 2011, J ASSIST REPROD GEN, V28, P773, DOI 10.1007/s10815-011-9588-7; Bentov Y, 2010, FERTIL STERIL, V93, P272, DOI 10.1016/j.fertnstert.2009.07.988; Chen Z, 2015, J BIOL CHEM; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; May-Panloup P, 2004, M S-MED SCI, V20, P779, DOI 10.1051/medsci/2004208-9779; Novin Marefat Ghaffari, 2015, Iranian Biomedical Journal, V19, P23, DOI 10.6091/ibj.1400.2015; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rzheshevsky AV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1056, DOI 10.1134/S0006297914100071; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; Slotkin EK, 2015, MOL CANCER THER, V14, P395, DOI 10.1158/1535-7163.MCT-14-0711; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Venkatesh S, 2010, ARCH GYNECOL OBSTET, V282, P313, DOI 10.1007/s00404-010-1444-y; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Zhang HY, 2015, APOPTOSIS, V20, P50, DOI 10.1007/s10495-014-1066-0	27	16	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132610	10.1371/journal.pone.0132610	http://dx.doi.org/10.1371/journal.pone.0132610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225554	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700009
J	Liu, L; Tan, QH; Hu, B; Wu, H; Wang, CH; Liu, R; Tang, CW				Liu, Ling; Tan, Qinghua; Hu, Bin; Wu, Hao; Wang, Chunhui; Liu, Rui; Tang, Chengwei			Somatostatin Improved B Cells Mature in Macaques during Intestinal Ischemia-Reperfusion	PLOS ONE			English	Article							INJURY; LIPOPOLYSACCHARIDE; GUT; INFLAMMATION; CYTOKINE; ANTIBODY; IMMUNITY; PATHWAY; ROLES	Aims Intestinal ischemia-reperfusion has been taken as an important pathophysiological process for multiple organ dysfunctions in critical patients. Recent studies reported that dual expression programs of the B cells receptors and Toll-like receptors on B-lymphocytes permit these ubiquitous cells to integrate both adaptive and innate immune functions. Our previous studies found that somatostatin inhibited the intestinal inflammatory injury after ischemia-reperfusion in macaques. However, the changes of B cells and the effects of somatostatin on B cells after intestinal ischemia-reperfusion were unclear. Methods 15 macaques were divided into control, intestinal ischemia-reperfusion and somatostatin pretreatment groups. Immunohistochemistry was performed to identify the distributions of adaptive and innate immunity markers in the iliac mucosa. Hmy2.cir B lymphoblastoid cell line was cultured in vitro study. Enzyme-linked immunosorbent assay was used to measure IgM, IL-6 and SIgA, and the expressions of B cells transcription factors, PAX-5 and BLIMP-1, were detected by Western blotting. Results B2 lymphocytes in normal Peyer's patches were presented the phenotype of PAX-5(+)CD20(+)CD5(-). Ischemia-reperfusion increased the numbers and sizes of Peyer's patches but with PAX-5(+)CD20(-)CD5(-) B cells, an unmatured set of B cells. Somatostatin partly kept the phenotype of mature B cells during ischemia-reperfusion. The innate immunity of B cells was inhibited whereas the adaptive immunity was increased in the intestinal mucosa in the somatostatin group, compared to the ischemia-reperfusion group. In vitro, somatostatin significantly inhibited IL-6 and promoted IgM by increasing the expression of both PAX-5 and BLIMP-1 in the proinflammatory condition. Conclusion Intestinal ischemia-reperfusion resulted in the proliferation of unmatured B cells which were involved in the augmentation of innate immunity. Somatostatin, with a bi-directional regulation function on innate as well as adaptive immunity of B cells, greatly improved B cells mature in macaques during ischemia-reperfusion. Preventive supplements of somatostatin may greatly limit intestinal injury and bacterial translocation during ischemia-reperfusion.	[Liu, Ling; Tan, Qinghua; Hu, Bin; Wu, Hao; Wang, Chunhui; Tang, Chengwei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China; [Liu, Rui] Sichuan Univ, West China Hosp, Div Peptides Related Human Dis, Key Lab Biotherapy Human Dis,Minist Educ, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Tang, CW (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China.	shcqcdmed@163.com		Liu, Ling/0000-0001-6413-708X	Natural Science Fund of China [30330270]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	Key Grant 30330270 of Natural Science Fund of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2014, MICROSC MICROANAL, V20, P198, DOI 10.1017/S1431927613013640; AMERICAN GASTROENTEROLOGICAL ASSOCIATION MEDICAL POSITION STATEMENT, 2000, GASTROENTEROLOGY, V118, P951, DOI DOI 10.1016/S0016-5085(00)70182-X; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Desouki MM, 2010, CLIN MED RES, V8, P84, DOI 10.3121/cmr.2010.891; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Guo Mei-Mei, 2005, Shengli Xuebao, V57, P719; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Lichtenauer-Kaligis EGR, 2004, EUR J ENDOCRINOL, V150, P565, DOI 10.1530/eje.0.1500565; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Liu BS, 2014, EUR J IMMUNOL, V44, P2121, DOI 10.1002/eji.201344341; Liu L, 2014, DIGEST DIS SCI, V59, P2423, DOI 10.1007/s10620-014-3177-4; Mann MK, 2012, AUTOIMMUNITY, V45, P388, DOI 10.3109/08916934.2012.665523; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Raman VS, 2000, J IMMUNOL, V165, P6809, DOI 10.4049/jimmunol.165.12.6809; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosskopf D, 2003, AM J PHYSIOL-CELL PH, V284, pC179, DOI 10.1152/ajpcell.00160.2001; Rotstein O D, 2000, Surg Infect (Larchmt), V1, P217, DOI 10.1089/109629600750018141; SCICCHITANO R, 1987, Brain Behavior and Immunity, V1, P173, DOI 10.1016/0889-1591(87)90019-5; STANISZ AM, 1986, J IMMUNOL, V136, P152; TARLINTON D, 1994, IMMUNOL REV, V137, P203, DOI 10.1111/j.1600-065X.1994.tb00666.x; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vadasz Z, 2013, FEBS LETT, V587, P2074, DOI 10.1016/j.febslet.2013.05.023; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wu H, 2009, J GASTROINTEST SURG, V13, P983, DOI 10.1007/s11605-009-0816-8; Xu H, 2008, IMMUNOLOGY, V125, P218, DOI 10.1111/j.1365-2567.2008.02832.x; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang H, 2013, NEUROPEPTIDES, V47, P237, DOI 10.1016/j.npep.2013.04.003; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	36	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133692	10.1371/journal.pone.0133692	http://dx.doi.org/10.1371/journal.pone.0133692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222793	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800060
J	Virk, N; Li, DY; Tian, LM; Huang, L; Hong, YB; Li, XH; Zhang, YF; Liu, B; Zhang, HJ; Song, FM				Virk, Nasar; Li, Dayong; Tian, Limei; Huang, Lei; Hong, Yongbo; Li, Xiaohui; Zhang, Yafen; Liu, Bo; Zhang, Huijuan; Song, Fengming			Arabidopsis Raf-Like Mitogen-Activated Protein Kinase Kinase Kinase Gene Raf43 Is Required for Tolerance to Multiple Abiotic Stresses	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INNATE IMMUNITY; ABSCISIC-ACID; MAPKK KINASE; STOMATAL DEVELOPMENT; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; POSITIVE REGULATOR; DROUGHT RESISTANCE; SIGNALING NETWORKS	Mitogen-activated protein kinase (MAPK) cascades are critical signaling modules that mediate the transduction of extracellular stimuli into intracellular response. A relatively large number of MAPKKKs have been identified in a variety of plant genomes but only a few of them have been studied for their biological function. In the present study, we identified an Arabidopsis Raf-like MAPKKK gene Raf43 and studied its function in biotic and abiotic stress response using a T-DNA insertion mutant raf43-1 and two Raf43-overexpressing lines Raf43-OE#1 and Raf43-OE#13. Expression of Raf43 was induced by multiple abiotic and biotic stresses including treatments with drought, mannitol and oxidative stress or defense signaling molecule salicylic acid and infection with necrotrophic fungal pathogen Botrytis cinerea. Seed germination and seedling root growth of raf43-1 were significantly inhibited on MS medium containing mannitol, NaCl, H2O2 or methyl viologen (MV) while seed germination and seedling root growth of the Raf43-OE#1 and Raf43-OE#13 lines was similar to wild type Col-0 under the above stress conditions. Soil-grown raf43-1 plants exhibited reduced tolerance to MV, drought and salt stress. Abscisic acid inhibited significantly seed germination and seedling root growth of the raf43-1 line but had no effect on the two Raf43-overexpressing lines. Expression of stress-responsive RD17 and DREB2A genes was significantly down-regulated in raf43-1 plants. However, the raf43-1 and Raf43-overexpressing plants showed similar disease phenotype to the wild type plants after infection with B. cinerea or Pseudomonas syringae pv. tomato DC3000. Our results demonstrate that Raf43, encoding for a Raf-like MAPKKK, is required for tolerance to multiple abiotic stresses in Arabidopsis.	[Virk, Nasar; Li, Dayong; Tian, Limei; Huang, Lei; Hong, Yongbo; Li, Xiaohui; Zhang, Yafen; Liu, Bo; Zhang, Huijuan; Song, Fengming] Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, HJ (corresponding author), Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China.	zhanghj82@zju.edu.cn			National High-Tech R D Program [2012AA101505]; National Transgenic Major Project of China [2011ZX08009-003-001]; National Natural Science Foundation [31272028]; Research Fund for the Doctoral Program of Higher Education of China [20120101110070]	National High-Tech R D Program(National High Technology Research and Development Program of China); National Transgenic Major Project of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National High-Tech R & D Program (No. 2012AA101505), the National Transgenic Major Project of China (No. 2011ZX08009-003-001), the National Natural Science Foundation (No. 31272028) and the Research Fund for the Doctoral Program of Higher Education of China (20120101110070).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Brunaud V, 2002, EMBO REP, V3, P1152, DOI 10.1093/embo-reports/kvf237; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Faulkner C, 2012, CURR OPIN PLANT BIOL, V15, P699, DOI 10.1016/j.pbi.2012.08.009; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Furuya T, 2013, J PLANT RES, V126, P833, DOI 10.1007/s10265-013-0576-0; Gao L, 2008, PLANT MOL BIOL, V67, P125, DOI 10.1007/s11103-008-9306-8; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Huang YD, 2014, PLANT J, V77, P577, DOI 10.1111/tpj.12404; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Li XH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-166; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Mehrotra R, 2014, J PLANT PHYSIOL, V171, P486, DOI 10.1016/j.jplph.2013.12.007; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Nakagami H, 2004, J BIOL CHEM, V279, P26959, DOI 10.1074/jbc.M312662200; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Sasayama D, 2011, PLANT BIOTECHNOL-NAR, V28, P463, DOI 10.5511/plantbiotechnology.11.1027a; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shitamichi N, 2013, PLANT BIOTECHNOL-NAR, V30, P111, DOI 10.5511/plantbiotechnology.13.0108a; Shou HX, 2004, J EXP BOT, V55, P1013, DOI 10.1093/jxb/erh129; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Sun Y, 2014, J EXP BOT, V65, P2171, DOI 10.1093/jxb/eru092; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tang DZ, 2002, PLANT J, V32, P975, DOI 10.1046/j.1365-313X.2002.01482.x; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103032; Yin ZJ, 2013, INT J MOL SCI, V14, P18740, DOI 10.3390/ijms140918740; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zhao CZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004389	68	20	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133975	10.1371/journal.pone.0133975	http://dx.doi.org/10.1371/journal.pone.0133975			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222830	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800090
J	Sayadi, A; Jeyakani, J; Seet, SH; Wei, CL; Bourque, G; Bard, FA; Jenkins, NA; Copeland, NG; Bard-Chapeau, EA				Sayadi, A.; Jeyakani, J.; Seet, S. H.; Wei, C-L; Bourque, G.; Bard, F. A.; Jenkins, N. A.; Copeland, N. G.; Bard-Chapeau, E. A.			Functional features of EVI1 and EVI1 Delta 324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity	ONCOGENE			English	Article							HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; MYELOID-LEUKEMIA; INTEGRATION SITE; BINDING-SITES; STEM-CELLS; OVARIAN; EXPRESSION; CHROMATIN; MOUSE	The MDS1 and ecotropic viral integration site 1 (EVI1) complex locus (MECOM) gene encodes several transcription factor variants including MDS1-EVI1, EVI1 and EVI1 Delta 324. Although MDS1-EVI1 has been associated with tumor-suppressing activity, EVI1 is a known oncogene in various cancers, whose expression is associated with poor patient survival. Although EVI1 Delta 324 is co-transcribed with EVI1, its activity in cancer cells is not fully understood. Previous reports described that unlike EVI1, EVI1 Delta 324 protein cannot transform fibroblasts because of its disrupted N-terminal zinc finger (ZNF) domain. To better understand EVI1 Delta 324 biology and function, we obtained genome-wide binding occupancies and expression data in ovarian cancer cells. We characterized its DNA-binding sites, binding motif and target genes. Comparative analyses with previous study show that EVI1 and EVI1 Delta 324 share similar transcriptional activities linked to their common C-terminus ZNF domain. They bind to an E-twenty-six family (ETS)-like motif, target to a large extent the same genes and cooperate with AP1 transcription factor. EVI1 Delta 324-occupied genes were 70.7% similar to EVI1-bound genes. More strikingly, EVI1 and EVI1 Delta 324 differentially expressed genes were 99.87% identical, indicating comparable transcriptional regulatory functions. Consistently with gene ontologies linked to these target genes, EVI1 Delta 324 expression in HeLa cells could enhance anchorage-independent growth, such as EVI1, showing that EVI1 Delta 324 expression also lead to pro-oncogenic effects. The main specific feature of EVI1 variant is its N-terminus ZNF domain that binds DNA through GATA-like motif. We found that most GATA-like EVI1 chromatin immunoprecipitation sequencing peaks are far from genes and are not involved in transcriptional regulation. These genomic regions were enriched in simple sequence repeats and displayed high meiotic recombination rates. Overall, our genomics analyses uncovered common and specific features of two major MECOM isoforms. Their influence on transcription and downstream cell proliferation was comparable. However, EVI1-specific GATA-like binding sites, from its N-terminus ZNF domain, associated with high recombination rates, suggesting possible additional oncogenic potential for EVI1 in modulating genomic stability.	[Sayadi, A.; Seet, S. H.; Bard, F. A.; Jenkins, N. A.; Copeland, N. G.; Bard-Chapeau, E. A.] Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore; [Jeyakani, J.; Wei, C-L; Bourque, G.] Genome Inst Singapore, Singapore, Singapore; [Bard-Chapeau, E. A.] Novartis Inst Biomed Res, WKL 125-1-05A, CH-4002 Basel, Switzerland; [Jenkins, N. A.; Copeland, N. G.] Methodist Hosp Res Inst, Houston, TX USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Novartis; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Bard-Chapeau, EA (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.; Bard-Chapeau, EA (corresponding author), Novartis Inst Biomed Res, WKL 125-1-05A, CH-4002 Basel, Switzerland.	emilie.chapeau@novartis.com	Bourque, Guillaume/AFR-2927-2022; Bard, Frederic Andre Jean/G-9914-2011	Bourque, Guillaume/0000-0002-3933-9656; Bard, Frederic Andre Jean/0000-0002-3783-4805	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (Singapore). We thank Archibald Perkins, University of Rochester, for sharing his mouse Evi1 antibodies.	Aytekin M, 2005, GENE, V356, P160, DOI 10.1016/j.gene.2005.04.032; Bard-Chapeau EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089397; Bard-Chapeau EA, 2013, P NATL ACAD SCI USA, V110, pE2885, DOI 10.1073/pnas.1309310110; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; BORDEREAUX D, 1990, ONCOGENE, V5, P925; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Goyama S, 2009, CANCER SCI, V100, P990, DOI 10.1111/j.1349-7006.2009.01152.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hirai H, 2001, CANCER CHEMOTH PHARM, V48, pS35, DOI 10.1007/s002800100303; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Janz C, 2002, ONCOGENE, V21, P5929, DOI 10.1038/sj.onc.1205757; Jazaeri AA, 2010, GYNECOL ONCOL, V118, P189, DOI 10.1016/j.ygyno.2010.04.007; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karakaya K, 2012, CELL CYCLE, V11, P3492, DOI 10.4161/cc.21801; Kilbey A, 1998, ONCOGENE, V16, P2287, DOI 10.1038/sj.onc.1201732; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Medina-Rivera A, 2011, NUCLEIC ACIDS RES, V39, P808, DOI 10.1093/nar/gkq710; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Mitani K, 2004, ONCOGENE, V23, P4263, DOI 10.1038/sj.onc.1207777; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; MORISHITA K, 1990, ONCOGENE, V5, P963; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Nucifora G, 2006, GENE, V368, P1, DOI 10.1016/j.gene.2005.09.020; Ogawa S, 1996, LEUKEMIA, V10, P788; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Tan FJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002633; TANAKA T, 1995, MOL CELL BIOL, V15, P2383; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xia WL, 2007, J ENDOCRINOL, V192, P563, DOI 10.1677/JOE-06-0158; Yanowitz J, 2010, CURR OPIN CELL BIOL, V22, P744, DOI 10.1016/j.ceb.2010.08.016; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Yoshimi A, 2011, ONCOTARGET, V2, P575, DOI 10.18632/oncotarget.304; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zaprazna K, 2012, MOL CELL BIOL, V32, P1542, DOI 10.1128/MCB.05989-11; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680; Zhou LY, 2014, EXP THER MED, V8, P85, DOI 10.3892/etm.2014.1716	71	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2311	2321		10.1038/onc.2015.286	http://dx.doi.org/10.1038/onc.2015.286			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26234679	Bronze			2022-12-26	WOS:000376165000004
J	Macari, F; El-houfi, Y; Boldina, G; Xu, H; Khoury-Hanna, S; Ollier, J; Yazdani, L; Zheng, G; Bieche, I; Legrand, N; Paulet, D; Durrieu, S; Bystrom, A; Delbecq, S; Lapeyre, B; Bauchet, L; Pannequin, J; Hollande, F; Pan, T; Teichmann, M; Vagner, S; David, A; Choquet, A; Joubert, D				Macari, F.; El-houfi, Y.; Boldina, G.; Xu, H.; Khoury-Hanna, S.; Ollier, J.; Yazdani, L.; Zheng, G.; Bieche, I.; Legrand, N.; Paulet, D.; Durrieu, S.; Bystrom, A.; Delbecq, S.; Lapeyre, B.; Bauchet, L.; Pannequin, J.; Hollande, F.; Pan, T.; Teichmann, M.; Vagner, S.; David, A.; Choquet, A.; Joubert, D.			TRM6/61 connects PKC alpha with translational control through tRNA(i)(Met) stabilization: impact on tumorigenesis	ONCOGENE			English	Article							PROTEIN-KINASE-C; MULTIDRUG-RESISTANCE; INITIATOR TRNA(MET); GENE-EXPRESSION; CELL-LINES; CANCER; PHOSPHORYLATION; IDENTIFICATION; PROLIFERATION; ACTIVATION	Accumulating evidence suggests that changes of the protein synthesis machinery alter translation of specific mRNAs and participate in malignant transformation. Here we show that protein kinase C alpha (PKC alpha) interacts with TRM61, the catalytic subunit of the TRM6/61 tRNA methyltransferase. The TRM6/61 complex is known to methylate the adenosine 58 of the initiator methionine tRNA (tRNA(i)(Met)), a nuclear post-transcriptional modification associated with the stabilization of this crucial component of the translation-initiation process. Depletion of TRM6/61 reduced proliferation and increased death of C6 glioma cells, effects that can be partially rescued by overexpression of tRNA(i)(Met). In contrast, elevated TRM6/61 expression regulated the translation of a subset of mRNAs encoding proteins involved in the tumorigenic process and increased the ability of C6 cells to form colonies in soft agar or spheres when grown in suspension. In TRM6/61/tRNA(i)(Met)-overexpressing cells, PKC alpha overexpression decreased tRNA(i)(Met) expression and both colony-and sphere-forming potentials. A concomitant increase in TRM6/TRM61 mRNA and tRNA(i)(Met) expression with decreased expression of PKC alpha mRNA was detected in highly aggressive glioblastoma multiforme as compared with Grade II/III glioblastomas, highlighting the clinical relevance of our findings. Altogether, we suggest that PKC alpha tightly controls TRM6/61 activity to prevent translation deregulation that would favor neoplastic development.	[Macari, F.; El-houfi, Y.; Khoury-Hanna, S.; Ollier, J.; Yazdani, L.; Legrand, N.; Pannequin, J.; Hollande, F.; David, A.; Choquet, A.; Joubert, D.] CNRS, UMR 5203, Dept Oncol, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier, France; [Macari, F.; El-houfi, Y.; Khoury-Hanna, S.; Ollier, J.; Yazdani, L.; Legrand, N.; Pannequin, J.; Hollande, F.; David, A.; Choquet, A.; Joubert, D.] INSERM, U1191, Montpellier, France; [Macari, F.; El-houfi, Y.; Khoury-Hanna, S.; Ollier, J.; Yazdani, L.; Legrand, N.; Pannequin, J.; Hollande, F.; David, A.; Choquet, A.; Joubert, D.] Univ Montpellier, Montpellier, France; [Boldina, G.; Vagner, S.] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Boldina, G.; Vagner, S.] CNRS, UMR3348, F-91405 Orsay, France; [Boldina, G.; Vagner, S.] Univ Paris 11, Orsay, France; [Boldina, G.; Vagner, S.] PSL Res Univ, Paris, France; [Xu, H.; Bystrom, A.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Zheng, G.; Pan, T.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Bieche, I.] Hop Rene Huguenin, Inst Curie, Lab Oncogenet, St Cloud, France; [Paulet, D.] Lab Informat Robot & Microelect Montpellier, Montpellier, France; [Durrieu, S.; Teichmann, M.] Univ Bordeaux, Inst Europeen Chim & Biol, ARNA Lab, Pessac, France; [Delbecq, S.] Univ Montpellier I, Lab Biol Cellulaire & Mol, Montpellier, France; [Lapeyre, B.] CNRS UPHE UPVD, CRIOBE, USR 3278, Moorea, France; [Lapeyre, B.] CNRS, UMR5237, Ctr Rech Biochim Macromol, F-34094 Montpellier, France; [Bauchet, L.] Hop Gui de Chauliac, Dept Neurosurg, Montpellier, France; [Hollande, F.] Univ Melbourne, Dept Pathol, Mol Mech Tumor Progress Lab, Melbourne, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Umea University; University of Chicago; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Montpellier; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Melbourne	David, A; Choquet, A (corresponding author), CNRS, UMR 5203, Dept Oncol, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier, France.	alexandre.david@igf.cnrs.fr; armelle.choquet@igf.cnrs.fr	Wegglin, Reto/AAV-4341-2021; macari, francoise/E-9941-2014; David, Alexandre/B-2447-2013; Hollande, Frederic/GLS-4120-2022; Vagner, Stephan/G-3664-2013; David, Alexandre/AAL-2758-2021; Bièche, Ivan/O-7399-2017; Teichmann, Martin/M-7407-2014	macari, francoise/0000-0001-8942-1845; David, Alexandre/0000-0003-3365-1339; Hollande, Frederic/0000-0002-7046-8392; David, Alexandre/0000-0003-3365-1339; Bièche, Ivan/0000-0002-2430-5429; Delbecq, Stephane/0000-0002-2813-1219; Teichmann, Martin/0000-0002-5257-0510; Choquet, armelle/0000-0002-6959-9387; Bystrom, Anders/0000-0003-1281-3888; vagner, stephan/0000-0003-1452-7164; pannequin, julie/0000-0002-9956-373X	Swedish Cancer Foundation [13 0301]; Swedish Research Council [621-2012-3576]; Karin and Harald Silvanders Foundation [223-2808-12]; Institut National du Cancer (INCa); Fondation ARC	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karin and Harald Silvanders Foundation; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation ARC	This work was generously supported by the Institut National du Cancer (INCa) and the Fondation ARC. We thank Martial Seveno, Serge Urbach and Edith Demettre from the 'Plate-forme de Proteomique Fonctionnelle' (FPP) for their work on proteomic analysis of cell samples. We thank the Gustave Roussy Genomic Core Facility (Noemie Pata-Merci) and the Gustave Roussy Bioinformatic Core Facility (Guillaume Meurice). ASB is supported by grants from the Swedish Cancer Foundation (13 0301), Swedish Research Council (621-2012-3576) and Karin and Harald Silvanders Foundation (223-2808-12).	AHMAD S, 1994, NEUROSURGERY, V35, P904, DOI 10.1227/00006123-199411000-00015; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Andaya A, 2011, J PROTEOME RES, V10, P4613, DOI 10.1021/pr200429y; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; BENZIL DL, 1992, CANCER RES, V52, P2951; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Budworth J, 1997, BRIT J CANCER, V75, P1330, DOI 10.1038/bjc.1997.225; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Diouf B, 2009, J BIOL CHEM, V284, P18808, DOI 10.1074/jbc.M109.004614; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; GRAVITT KR, 1994, BIOCHEM PHARMACOL, V48, P375, DOI 10.1016/0006-2952(94)90110-4; GRUBER JR, 1995, EXP CELL RES, V221, P377, DOI 10.1006/excr.1995.1388; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hou JQ, 2012, ONCOTARGET, V3, P118; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Koromilas A.-E., 2014, BIOCH BIOPHYS ACTA B, V1849, P871, DOI DOI 10.1016/J.BBAGRM.2014.12.007; Lee SK, 2012, MOL CELLS, V34, P61, DOI 10.1007/s10059-012-0087-1; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mandil R, 2001, CANCER RES, V61, P4612; Marques JM, 2013, J NEUROSCI, V33, P18298, DOI 10.1523/JNEUROSCI.3136-13.2013; MISRAPRESS A, 1992, GLIA, V6, P188, DOI 10.1002/glia.440060306; Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605; Ozanick SG, 2009, NUCLEIC ACIDS RES, V37, P298, DOI 10.1093/nar/gkn925; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Quittau-Prevostel C, 2004, J CELL SCI, V117, P63, DOI 10.1242/jcs.00832; Reme T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066574; Ron D, 2007, ELF2ALPHA PHOSPHORYL; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thakor N, 2012, NUCLEIC ACIDS RES, V40, P541, DOI 10.1093/nar/gkr701; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; WELSH GI, 1994, BIOCHEM BIOPH RES CO, V201, P1279, DOI 10.1006/bbrc.1994.1843; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; Zellner A, 1998, CLIN CANCER RES, V4, P1797; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420	49	30	31	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1785	1796		10.1038/onc.2015.244	http://dx.doi.org/10.1038/onc.2015.244			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26234676				2022-12-26	WOS:000373610400005
J	Pushpakumar, S; Kundu, S; Narayanan, N; Sen, U				Pushpakumar, Sathnur; Kundu, Sourav; Narayanan, Nithya; Sen, Utpal			DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney	FASEB JOURNAL			English	Article						epigenetics; renal fibrosis; 5-aza-2'-deoxycytidine; matrix metalloproteinase	CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; DIFFERENTIAL REGULATION; TISSUE INHIBITOR; DIETARY-FOLATE; HOMOCYSTEINE; METHYLATION; METALLOPROTEINASES; HYPERTENSION; EPIGENETICS	Hyperhomocysteinemia (HHcy) is prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Emerging studies suggest that epigenetic mechanisms contribute to the development and progression of fibrosis in CKD. HHcy and its intermediates are known to alter the DNA methylation pattern, which is a critical regulator of epigenetic information. In this study, we hypothesized that HHcy causes renovascular remodeling by DNA hypermethylation, leading to glomerulosclerosis. We also evaluated whether the DNA methylation inhibitor, 5-aza-2'-deoxycytidine (5-Aza) could modulate extracellular matrix (ECM) metabolism and reduce renovascular fibrosis. C57BL/6J (wild-type) and cystathionine-beta-synthase (CBS+/-) mice, treated without or with 5-Aza (0.5 mg/kg body weight, i.p.), were used. CBS+/- mice showed high plasma Hcy levels, hypertension, and significant glomerular and arteriolar injury. 5-Aza treatment normalized blood pressureandreversed renal injury. CBS+/- mice showed global hypermethylation and up-regulation of DNAmethyltransferase-1 and -3a. Methylation-specific PCR showed an imbalance between matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 and also increased collagen and galectin-3 expression. 5-Aza reduced abnormal DNA methylation and restored the MMP-9/TIMP-1, -2 balance. In conclusion, our data suggest that during HHcy, abnormal DNA methylation and an imbalance between MMP-9 and TIMP-1 and -2 lead to ECM remodeling and renal fibrosis.	[Pushpakumar, Sathnur; Kundu, Sourav; Narayanan, Nithya; Sen, Utpal] Univ Louisville, Dept Physiol & Biophys, Sch Med, Louisville, KY 40292 USA	University of Louisville	Pushpakumar, S (corresponding author), 500 South Preston St,HSC-A,1115, Louisville, KY 40292 USA.	sbpush01@louisville.edu; u0sen001@louisville.edu	Kundu, Sourav/J-1531-2015	KUNDU, SOURAV/0000-0001-9027-5734; Narayanan, Nithya/0000-0001-9110-0311	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-104103]; American Heart Association Scientist Development [15SDG25840013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104103] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL-104103 (to U.S.); and American Heart Association Scientist Development Grant 15SDG25840013 (to S.P.). S.P. designed the experiment, acquired data, and wrote the manuscript. S.K. researched data and contributed to methods. N.N. contributed to treatment and data collection. U.S. contributed to research design and discussion. The authors declare no conflicts of interest.	Ahmed AK, 2007, KIDNEY INT, V71, P755, DOI 10.1038/sj.ki.5002108; Amarnath K, 2003, TALANTA, V60, P1229, DOI 10.1016/S0039-9140(03)00232-7; Atamer A, 2008, J NEPHROL, V21, P924; BADER R, 1980, PATHOL RES PRACT, V167, P204, DOI 10.1016/S0344-0338(80)80051-3; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beckerman P, 2014, NEPHROL DIAL TRANSPL, V29, P1821, DOI 10.1093/ndt/gfu026; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chaturvedi P, 2014, PHYSIOL GENOMICS, V46, P245, DOI 10.1152/physiolgenomics.00168.2013; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dang ZX, 2012, TRANSPLANTATION, V93, P477, DOI 10.1097/TP.0b013e318242f40a; Davis CD, 2003, J NUTR, V133, P2907, DOI 10.1093/jn/133.9.2907; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Dong Z, 2001, INT J CANCER, V93, P507, DOI 10.1002/ijc.1358; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Gonzalez-Avila G, 1998, PATHOBIOLOGY, V66, P196, DOI 10.1159/000028023; Higgins DF, 2014, J AM SOC NEPHROL, V25, P865, DOI 10.1681/ASN.2014010006; Huang YC, 2011, TOXICOL LETT, V201, P62, DOI 10.1016/j.toxlet.2010.12.006; Ingrosso D, 2009, BBA-GEN SUBJECTS, V1790, P892, DOI 10.1016/j.bbagen.2008.11.010; Jadavji NM, 2014, BIOCHEM J, V461, P205, DOI 10.1042/BJ20131568; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Kumagai H, 2002, KIDNEY INT, V62, P1219, DOI 10.1046/j.1523-1755.2002.00558.x; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li NJ, 2002, HYPERTENSION, V39, P443, DOI 10.1161/hy02t2.102992; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; MAI M, 1993, HYPERTENSION, V22, P754, DOI 10.1161/01.HYP.22.5.754; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Marti F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-733; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Narayanan N, 2014, FASEB J, V28, P3411, DOI 10.1096/fj.14-250183; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pushpakumar S., 2013, J HYPERTENS, V31, P2281; Pushpakumar S, 2013, J HYPERTENS, V31, P2270, DOI 10.1097/HJH.0b013e3283649b33; Pushpakumar SB, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.63; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sen U, 2008, AM J PHYSIOL-ENDOC M, V295, pE1205, DOI 10.1152/ajpendo.90534.2008; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Shastry S, 2007, KIDNEY INT, V71, P304, DOI 10.1038/sj.ki.5002031; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Tbahriti Hadja Fatima, 2013, World J Nephrol, V2, P31, DOI 10.5527/wjn.v2.i2.31; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; van Guldener C, 2005, CLIN CHEM LAB MED, V43, P1026, DOI 10.1515/CCLM.2005.180; van Guldener C, 2006, NEPHROL DIAL TRANSPL, V21, P1161, DOI 10.1093/ndt/gfl044; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Zhang DH, 2015, ARTERIOSCL THROM VAS, V35, P71, DOI 10.1161/ATVBAHA.114.303899; Zhou SY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-134	70	32	34	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4713	4725		10.1096/fj.15-272443	http://dx.doi.org/10.1096/fj.15-272443			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26224753	Green Published			2022-12-26	WOS:000364514700027
J	Richard-Greenblat, M; Bach, H; Adamson, J; Pena-Diaz, S; Li, W; Steyn, AJC; Av-Gay, Y				Richard-Greenblat, Melissa; Bach, Horacio; Adamson, John; Pena-Diaz, Sandra; Li, Wu; Steyn, Adrie J. C.; Av-Gay, Yossef			Regulation of Ergothioneine Biosynthesis and Its Effect on Mycobacterium tuberculosis Growth and Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; SER/THR PROTEIN-KINASE; MYCOTHIOL BIOSYNTHESIS; SMEGMATIS MUTANTS; CONIDIAL SURVIVAL; NEUROSPORA-CRASSA; PHOSPHORYLATION; GENE; TRANSPORTER; STARVATION	Ergothioneine (EGT) is synthesized in mycobacteria, but limited knowledge exists regarding its synthesis, physiological role, and regulation. We have identified Rv3701c from Mycobacterium tuberculosis to encode for EgtD, a required histidine methyltransferase that catalyzes first biosynthesis step in EGT biosynthesis. EgtD was found to be phosphorylated by the serine/ threonine protein kinase PknD. PknD phosphorylates EgtD both in vitro and in a cell-based system on Thr(213). The phosphomimetic (T213E) but not the phosphoablative (T213A) mutant of EgtD failed to restore EGT synthesis in a Delta egtD mutant. The findings together with observed elevated levels ofEGTin a pknD transposon mutant during in vitro growth suggests that EgtD phosphorylation by PknD negatively regulates EGT biosynthesis. We further showed that EGT is required in a nutrient-starved model of persistence and is needed for long term infection of murine macrophages.	[Richard-Greenblat, Melissa; Bach, Horacio; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V6H 3Z6, Canada; [Pena-Diaz, Sandra] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6H 3Z6, Canada; [Adamson, John; Steyn, Adrie J. C.] Kwazulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa; [Li, Wu] Southwest Univ, Sch Life Sci, Inst Modern Biopharmaceut, Chongqing 400715, Peoples R China; [Steyn, Adrie J. C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA; [Steyn, Adrie J. C.] Univ Alabama Birmingham, Ctr AIDS Res & Free Radical Biol, Birmingham, AL 35233 USA	University of British Columbia; University of British Columbia; Southwest University - China; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Av-Gay, Y (corresponding author), Jack Bell Res Ctr, 350-2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	yossi@mail.ubc.ca	Av-Gay, Yossef/H-5128-2019; Li, Wu/K-3792-2019	Av-Gay, Yossef/0000-0002-9547-0237; Steyn, Adrie JC/0000-0001-9177-8827; Li, Wu/0000-0002-0336-1843; Richard-Greenblatt, Melissa/0000-0001-6717-8856	British Columbia Lung Association; University of British Columbia; Friedman Scholars Program	British Columbia Lung Association; University of British Columbia; Friedman Scholars Program	This work was supported by grants from the British Columbia Lung Association (to Y. A.-G.), University of British Columbia's four-year doctoral fellowship (to M. R.-G.), and the Friedman Scholars Program (to M. R.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Bello MH, 2014, FUNGAL GENET BIOL, V73, P120, DOI 10.1016/j.fgb.2014.10.007; Bello MH, 2012, FUNGAL GENET BIOL, V49, P160, DOI 10.1016/j.fgb.2011.12.007; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Calvin M., 1954, GLUTATHIONE, P3; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Emani CS, 2013, ANTIMICROB AGENTS CH, V57, P3202, DOI 10.1128/AAC.02572-12; Fu P, 2015, ORG LETT, V17, P3046, DOI 10.1021/acs.orglett.5b01328; GENGHOF DS, 1964, J BACTERIOL, V87, P852, DOI 10.1128/JB.87.4.852-862.1964; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; Gomez-Velasco A, 2013, MICROBIOL-SGM, V159, P726, DOI 10.1099/mic.0.062067-0; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Luo DY, 2005, J PHARM SCI-US, V94, P304, DOI 10.1002/jps.20253; MELVILLE DB, 1956, J BIOL CHEM, V223, P9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller CC, 2007, ANTIMICROB AGENTS CH, V51, P3364, DOI 10.1128/AAC.00347-07; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Pfeiffer C, 2011, FOOD CHEM, V129, P1766, DOI 10.1016/j.foodchem.2011.06.047; Pluskal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097774; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rawat M, 2004, J BACTERIOL, V186, P6050, DOI 10.1128/jb.186.18.6050-6058.2004; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rawat M, 2007, BIOCHEM BIOPH RES CO, V363, P71, DOI 10.1016/j.bbrc.2007.08.142; Reinhold VN, 1970, J BACTERIOL, V101, P881, DOI 10.1128/JB.101.3.881-884.1970; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rodriguez JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058378; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Ung KSE, 2006, FEBS LETT, V580, P2712, DOI 10.1016/j.febslet.2006.04.026; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Vit A, 2015, CHEMBIOCHEM, V16, P119, DOI 10.1002/cbic.201402522; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhao QF, 2015, NATURE, V518, P115, DOI 10.1038/nature14137; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	58	35	38	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23064	23076		10.1074/jbc.M115.648642	http://dx.doi.org/10.1074/jbc.M115.648642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229105	Green Published, hybrid			2022-12-26	WOS:000361685500020
J	OuYang, FQ; Mao, JF; Wang, JH; Zhang, SG; Li, Y				OuYang, Fangqun; Mao, Jian-Feng; Wang, Junhui; Zhang, Shougong; Li, Yue			Transcriptome Analysis Reveals that Red and Blue Light Regulate Growth and Phytohormone Metabolism in Norway Spruce [Picea abies (L.) Karst.]	PLOS ONE			English	Article							APICAL BUD FORMATION; GENE-EXPRESSION; PHOTOPERIODIC CONTROL; ABSCISIC-ACID; PHYTOCHROME-B; FAR-RED; ARABIDOPSIS; QUALITY; AUXIN; DORMANCY	The mechanisms by which different light spectra regulate plant shoot elongation vary, and phytohormones respond differently to such spectrum-associated regulatory effects. Light supplementation can effectively control seedling growth in Norway spruce. However, knowledge of the effective spectrum for promoting growth and phytohormone metabolism in this species is lacking. In this study, 3-year-old Norway spruce clones were illuminated for 12 h after sunset under blue or red light-emitting diode (LED) light for 90 d, and stem increments and other growth traits were determined. Endogenous hormone levels and transcriptome differences in the current needles were assessed to identify genes related to the red and blue light regulatory responses. The results showed that the stem increment and gibberellin (GA) levels of the seedlings illuminated by red light were 8.6% and 29.0% higher, respectively, than those of the seedlings illuminated by blue light. The indoleacetic acid (IAA) level of the seedlings illuminated by red light was 54.6% lower than that of the seedlings illuminated by blue light, and there were no significant differences in abscisic acid (ABA) or zeatin riboside [ZR] between the two groups of seedlings. The transcriptome results revealed 58,736,166 and 60,555,192 clean reads for the blue-light-and red-light-illuminated samples, respectively. Illumina sequencing revealed 21,923 unigenes, and 2744 (approximately 93.8%) out of 2926 differentially expressed genes (DEGs) were found to be upregulated under blue light. The main KEGG classifications of the DEGs were metabolic pathway (29%), biosynthesis of secondary metabolites (20.49%) and hormone signal transduction (8.39%). With regard to hormone signal transduction, AUXIN-RESISTANT1 (AUX1), AUX/IAA genes, auxin-inducible genes, and early auxin-responsive genes [(auxin response factor (ARF) and small auxin-up RNA (SAUR)] were all upregulated under blue light compared with red light, which might have yielded the higher IAA level. DELLA and phytochrome-interacting factor 3 (PIF3), involved in negative GA signaling, were also upregulated under blue light, which may be related to the lower GA level. Light quality also affects endogenous hormones by influencing secondary metabolism. Blue light promoted phenylpropanoid biosynthesis, phenylalanine metabolism, flavonoid biosynthesis and flavone and flavonol biosynthesis, accompanied by upregulation of most of the genes in their pathways. In conclusion, red light may promote stem growth by regulating biosynthesis of GAs, and blue light may promote flavonoid, lignin, phenylpropanoid and some hormones (such as jasmonic acid) which were related to plant defense in Norway spruce, which might reduce the primary metabolites available for plant growth.	[OuYang, Fangqun; Wang, Junhui; Zhang, Shougong] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China; [OuYang, Fangqun; Mao, Jian-Feng; Li, Yue] Beijing Forestry Univ, Coll Biol Sci & Technol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Forest Tree Breeding,Minist Educ, Beijing 100083, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China.	wangjh808@sina.com; liyue@bjfu.edu.cn	Mao, Jian-Feng/V-9251-2019	Mao, Jian-Feng/0000-0001-9735-8516	Twelfth Five-Year Plan for Science & Technology Support of China [2012BAD01B01]	Twelfth Five-Year Plan for Science & Technology Support of China	This study was supported by a grant from Twelfth Five-Year Plan for Science & Technology Support of China (2012BAD01B01).	AKSENOVA NP, 1994, J PLANT GROWTH REGUL, V13, P143, DOI 10.1007/BF00196378; Awada MA, 2001, SCI HORTIC-AMSTERDAM, V88, P289, DOI 10.1016/S0304-4238(00)00215-6; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; BEHRINGER FJ, 1992, PLANTA, V188, P85, DOI [10.1007/BF01160716, 10.1007/BF00198943]; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CLINE MG, 1994, PHYSIOL PLANTARUM, V90, P230, DOI 10.1034/j.1399-3054.1994.900133.x; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; COSGROVE DJ, 1981, PLANT PHYSIOL, V67, P584, DOI 10.1104/pp.67.3.584; de Lucas M, 2014, NEW PHYTOL, V202, P1126, DOI 10.1111/nph.12725; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; El Kayal W, 2011, PLANT CELL ENVIRON, V34, P480, DOI 10.1111/j.1365-3040.2010.02257.x; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; FERNBACH E, 1990, PLANTA, V180, P212, DOI 10.1007/BF00193998; Gaba V, 1983, THE CONTROL OF CELL, P358; Gebauer R, 2012, TREES-STRUCT FUNCT, V26, P1079, DOI 10.1007/s00468-012-0684-9; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Jenkins GI, 2001, NEW PHYTOL, V151, P121, DOI 10.1046/j.1469-8137.2001.00151.x; JUNTTILA O, 1988, PHYSIOL PLANTARUM, V74, P371, DOI 10.1111/j.1399-3054.1988.tb00645.x; Kasahara M, 2004, PLANT PHYSIOL, V135, P1388, DOI 10.1104/pp.104.042705; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kurepin LV, 2007, PLANT CELL ENVIRON, V30, P147, DOI 10.1111/j.1365-3040.2006.01612.x; Kurepin LV, 2012, BOTANY, V90, P237, DOI [10.1139/B11-108, 10.1139/b11-108]; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Lu Na, 2012, Environmental Control in Biology, V50, P63; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Molmann JA, 2006, PLANT CELL ENVIRON, V29, P166, DOI 10.1111/j.1365-3040.2005.01408.x; Mortensen L. M., 1988, New Forests, V2, P281; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Olsen JE, 1997, PLANT J, V12, P1339, DOI 10.1046/j.1365-313x.1997.12061339.x; Olsen JE, 1997, PLANT CELL PHYSIOL, V38, P536, DOI 10.1093/oxfordjournals.pcp.a029202; Olsen JE, 2010, PLANT MOL BIOL, V73, P37, DOI 10.1007/s11103-010-9620-9; Pierik R, 2009, PLANT SIGNAL BEHAV, V4, P755, DOI [10.4161/psb.4.8.9179, 10.1104/pp.108.13349]; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Reddy SK, 2014, PLANT PHYSIOL, V164, P1542, DOI 10.1104/pp.113.234021; Reddy SK, 2013, PLANT PHYSIOL, V163, P1047, DOI 10.1104/pp.113.221895; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Sellin A, 2011, PLANT CELL ENVIRON, V34, P1079, DOI 10.1111/j.1365-3040.2011.02306.x; Seo J-K, 2014, SCI REPORTS, P4; Son KH, 2013, HORTSCIENCE, V48, P988; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; Tanaka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P462, DOI 10.1271/bbb.68.462; Wang WJ, 2013, PLANTA, V237, P1123, DOI 10.1007/s00425-012-1831-7; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yakovlev IA, 2006, TREE GENET GENOMES, V2, P39, DOI 10.1007/s11295-005-0031-z; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yu SM, 2013, J APPL MICROBIOL, V115, P509, DOI 10.1111/jam.12252; Zhang ZL, 2014, MOL PLANT, V7, P1429, DOI 10.1093/mp/ssu058; Zhong SW, 2012, CURR BIOL, V22, P1530, DOI 10.1016/j.cub.2012.06.039; Zhou XY, 2013, MOL PLANT, V6, P887, DOI 10.1093/mp/sss123	61	57	57	4	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0127896	10.1371/journal.pone.0127896	http://dx.doi.org/10.1371/journal.pone.0127896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237749	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400002
J	Birlanga, V; Villanova, J; Cano, A; Cano, EA; Acosta, M; Perez-Perez, JM				Birlanga, Virginia; Villanova, Joan; Cano, Antonio; Cano, Emilio A.; Acosta, Manuel; Manuel Perez-Perez, Jose			Quantitative Analysis of Adventitious Root Growth Phenotypes in Carnation Stem Cuttings	PLOS ONE			English	Article							COLD-STORAGE PERIOD; WATER-USE; TRAITS; TRANSPORT; RESPONSES; DROUGHT; REGIONS; LEVEL; LEAF	Carnation is one of the most important species on the worldwide market of cut flowers. Commercial carnation cultivars are vegetatively propagated from terminal stem cuttings that undergo a rooting and acclimation process. For some of the new cultivars that are being developed by ornamental breeders, poor adventitious root (AR) formation limits its commercial scaling-up, due to a significant increase in the production costs. We have initiated a genetical-genomics approach to determine the molecular basis of the differences found between carnation cultivars during adventitious rooting. The detailed characterization of AR formation in several carnation cultivars differing in their rooting losses has been performed (i) during commercial production at a breeders' rooting station and (ii) on a defined media in a controlled environment. Our study reveals the phenotypic signatures that distinguishes the bad-rooting cultivars and provides the appropriate set-up for the molecular identification of the genes involved in AR development in this species.	[Birlanga, Virginia; Villanova, Joan; Manuel Perez-Perez, Jose] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Cano, Antonio; Acosta, Manuel] Univ Murcia, Dept Biol Vegetal Fisiol Vegetal, Murcia, Spain; [Cano, Emilio A.] Barberet & Blanc SA, Dept Res & Dev, Puerto Lumbreras, Spain	Universidad Miguel Hernandez de Elche; University of Murcia	Perez-Perez, JM (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Elche, Spain.	jmperez@umh.es	Cano, Antonio/B-8723-2008; Acosta, Manuel/A-2127-2008; Perez-Perez, Jose Manuel/B-4247-2011	Cano, Antonio/0000-0001-8555-5053; Acosta, Manuel/0000-0003-0611-6672; Perez-Perez, Jose Manuel/0000-0003-2848-4919	Ministerio de Economia y Competitividad (MINECO) of Spain [AGL2012-33610]; Center for the Development of Industrial Technology [CARNOMICS E! 6384]	Ministerio de Economia y Competitividad (MINECO) of Spain; Center for the Development of Industrial Technology	Funding was provided by Ministerio de Economia y Competitividad (MINECO) of Spain (http://www.mineco.gob.es/), grant no. AGL2012-33610; Center for the Development of Industrial Technology (https://www.cdti.es/), grant no. CARNOMICS E! 6384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agull&oacute;-Ant&oacute;n MA, 2011, WHAT MAKES DIFFERENC; Ahkami AH, 2013, PLANTA, V238, P499, DOI 10.1007/s00425-013-1907-z; Agullo-Anton MA, 2013, PLANT SCI, V201, P1, DOI 10.1016/j.plantsci.2012.11.006; Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; Bai CH, 2013, J EXP BOT, V64, P1745, DOI 10.1093/jxb/ert041; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Garrido G, 2003, BIOL PLANTARUM, V47, P481, DOI 10.1023/B:BIOP.0000041050.41513.da; Garrido G, 1996, SCI HORTIC-AMSTERDAM, V65, P73, DOI 10.1016/0304-4238(95)00860-8; Garrido G, 1998, SCI HORTIC-AMSTERDAM, V74, P219, DOI 10.1016/S0304-4238(98)00078-8; Garrido G, 2002, PHYSIOL PLANTARUM, V114, P303, DOI 10.1034/j.1399-3054.2002.1140217.x; Guerrero JR, 1999, J PLANT GROWTH REGUL, V18, P183, DOI 10.1007/PL00007068; Kirkegaard JA, 2007, AUST J AGR RES, V58, P303, DOI 10.1071/AR06285; Lampinen BD, 2004, J HORTIC SCI BIOTECH, V79, P638, DOI 10.1080/14620316.2004.11511819; Lopez-Iglesias B, 2014, ACTA OECOL, V56, P10, DOI 10.1016/j.actao.2014.01.003; Lynch JP, 2015, J EXP BOT, V66, P2199, DOI 10.1093/jxb/eru508; Perez-Perez JM, 2011, PLANT CELL ENVIRON, V34, P2200, DOI 10.1111/j.1365-3040.2011.02415.x; Massey F. J., 1951, J AM STAT ASS, V46; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheela V, 2008, FLOWERS TRADE; Topp CN, 2013, P NATL ACAD SCI USA, V110, pE1695, DOI 10.1073/pnas.1304354110; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; Vegh KR, 2013, BIOLOGIA, V68, P1123, DOI 10.2478/s11756-013-0258-3; Villacorta C, 2015, GENE EXPRESSION PROF; Wojciechowski K, 2015, PHYS CHEM CHEM PHYS, V17, P1106, DOI 10.1039/c4cp03835e; Zurek PR, 2015, PLANT PHYSIOL, V167, P1487, DOI 10.1104/pp.114.251751	30	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133123	10.1371/journal.pone.0133123	http://dx.doi.org/10.1371/journal.pone.0133123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230608	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400026
J	Gomes, TN; Hedeker, D; dos Santos, FK; Pereira, S; Katzmarzyk, PT; Maia, JAR				Gomes, Thayse Natacha; Hedeker, Donald; dos Santos, Fernanda Karina; Pereira, Sara; Katzmarzyk, Peter T.; Maia, Jose A. R.			Why Are Children Different in Their Daily Sedentariness? An Approach Based on the Mixed-Effects Location Scale Model	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PRESCHOOL-CHILDREN; SEX-DIFFERENCES; BEHAVIOR; ADOLESCENTS; TIME; PATTERNS; YOUTH; SCHOOL; MATURATION	This study aimed to investigate the between-and within-individual variability in sedentary time over seven days, using a mixed-effects location scale model. The sample comprised 686 Portuguese children (381 girls) aged 9-11 years, from 23 schools. Sedentary time was estimated by the Actigraph GT3X+ accelerometer, which was used 24 hours/day for 7 consecutive days; height, sitting height, and weight were measured, BMI was computed (WHO cut-points were used to classify subjects as normal weight or overweight/obese), and maturity offset was estimated. Information regarding the home environment was obtained by questionnaire. Results revealed that (i) children were more sedentary on Friday, but less so on Saturday and Sunday (compared to Monday), with significant variation between-and within-subjects (between-subject variance=0.800, within-subject variance=1.793, intra-subject correlation=0.308); (ii) there is a sex effect on sedentariness, with boys being less sedentary than girls (p<0.001), and the between-subject variance was 1.48 times larger for boys than girls; (iii) in terms of the within-subject variance, or erraticism, Tuesday, Wednesday and Friday have similar erraticism levels as Monday (Thursday has less, while Saturday and Sunday have more); in addition, girls (variance ratio=0.632, p<0.001), overweight/obese children (variance ratio=0.861, p=0.019), and those later mature (variance ratio=0.849, p=0.013) have less erraticism than their counterparts; (iv) the within-subject variance varied significantly across subjects (scale std dev=0.342 +/- 0.037, p<0.001); and (v) in the fixed part of the model, only biological maturation was positively related to sedentariness. This study demonstrated that there is significant between-and within-subject variability in sedentariness across a whole week. This implies that a focus on intra-individual variability, instead of only on mean values, would provide relevant information towards a more complete map of children's sedentary behaviour, which can be helpful when developing more efficient strategies to reduce sedentariness.	[Gomes, Thayse Natacha; Pereira, Sara; Maia, Jose A. R.] Univ Porto, Fac Sport, Kinanthropometry Lab, Ctr Res Educ Innovat & Intervent Sport CIFI2D, P-4100 Oporto, Portugal; [Hedeker, Donald] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [dos Santos, Fernanda Karina] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, Pernambuco, Brazil; [Katzmarzyk, Peter T.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Universidade do Porto; University of Chicago; Universidade Federal de Pernambuco; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gomes, TN (corresponding author), Univ Porto, Fac Sport, Kinanthropometry Lab, Ctr Res Educ Innovat & Intervent Sport CIFI2D, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	thayse_natacha@hotmail.com	Katzmarzyk, Peter T/N-1974-2017; Hedeker, Donald/R-7055-2019; Pereira, Sara/V-1516-2019; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020	Katzmarzyk, Peter T/0000-0002-9280-6022; Pereira, Sara/0000-0002-4661-3879; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238	Coca-Cola Company	Coca-Cola Company	ISCOLE was funded by The Coca-Cola Company. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	Atkin AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067627; Barreira TV, 2014, MED SCI SPO IN PRESS; Biddle S., 2010, SEDENTARY BEHAV OBES; Biddle SJH, 2009, PREV MED, V48, P151, DOI 10.1016/j.ypmed.2008.10.025; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; Brodersen NH, 2005, ANN BEHAV MED, V29, P2, DOI 10.1207/s15324796abm2901_2; Carson V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-173; Cumming SP, 2008, J ADOLESCENT HEALTH, V42, P480, DOI 10.1016/j.jadohealth.2007.10.005; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; EPSTEIN S, 1979, J PERS SOC PSYCHOL, V37, P1097, DOI 10.1037/0022-3514.37.7.1097; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Funda&ccedil;&atilde;o Francisco Manuel dos Santos, 2013, PORDATA; Gomes TN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-890; Gomes TN, 2014, J SCHOOL HEALTH, V84, P668, DOI 10.1111/josh.12193; Gorely T, 2007, J BEHAV MED, V30, P521, DOI 10.1007/s10865-007-9126-3; Hamaker EL, 2014, HDB RES ETHODS STUDY, P43; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; Hedeker D, 2012, STAT MED, V31, P3328, DOI 10.1002/sim.5338; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hertzog C, 2003, PSYCHOL AGING, V18, P639, DOI 10.1037/0882-7974.18.4.639; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Katzmarzyk PT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-900; Leatherdale ST, 2010, PREV CHRONIC DIS, V7; Rodrigues AMM, 2010, PEDIATR EXERC SCI, V22, P442, DOI 10.1123/pes.22.3.442; Marques A, 2014, AM J HUM BIOL; Marshall SJ, 2002, PEDIATR EXERC SCI, V14, P401, DOI 10.1123/pes.14.4.401; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Nilsson A, 2009, SCAND J MED SCI SPOR, V19, P10, DOI 10.1111/j.1600-0838.2007.00762.x; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Reis HT, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P1; Ridgers ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056838; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sardinha LB, 2011, INT J PEDIATR OBES, V6, pE124, DOI 10.3109/17477166.2010.490263; Sherar LB, 2007, MED SCI SPORT EXER, V39, P830, DOI 10.1249/mss.0b013e3180335c3c; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Telford RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-81; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Tudor-Locke Catrine, 2014, Appl Physiol Nutr Metab, V39, P53, DOI 10.1139/apnm-2013-0173; Uijtdewilligen L, 2011, BRIT J SPORT MED, V45, P896, DOI 10.1136/bjsports-2011-090197; Van Cauwenberghe E, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-138; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Zabinski MF, 2007, HEALTH PSYCHOL, V26, P113, DOI 10.1037/0278-6133.26.1.113	48	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132192	10.1371/journal.pone.0132192	http://dx.doi.org/10.1371/journal.pone.0132192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230652	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400016
J	Kim, S; Yoon, Y; Choi, KH				Kim, Sejeong; Yoon, Yohan; Choi, Kyoung-Hee			Pseudomonas aeruginosa DesB Promotes Staphylococcus aureus Growth Inhibition in Coculture by Controlling the Synthesis of HAQs	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; GENE; EXPRESSION; RESISTANCE; MEXT; REGULATOR; BIOSYNTHESIS; VIRULENCE; PATHWAYS; PROTEASE	Pseudomonas aeruginosa is a pathogen that can cause serious infections and usually coexists with other pathogens, such as Staphylococcus aureus. Virulence factors are important for maintaining a presence of the organisms in these multispecies environments, and DesB plays an important role in P. aeruginosa virulence. Therefore, we investigated the effect of DesB on S. aureus reduction under competitive situation. Liquid cultures of P. aeruginosa wild type (WT) and its desB mutant were spotted on agar plates containing S. aureus, and the size of the clear zones was compared. In addition, interbacterial competition between P. aeruginosa and S. aureus was observed over time during planktonic coculture. The transcriptional profiles of the WT and desB mutant were compared by qRT-PCR and microarray to determine the role of DesB in S. aureus reduction at the molecular level. As a result, the clear zone was smaller for the desB mutant than for P. aeruginosa PAO1 (WT), and in planktonic coculture, the number of S. aureus cells was reduced in the desB mutant. qRT-PCR and microarray revealed that the expression of MvfR-controlled pqsA-E and phnAB operons was significantly decreased, but the mexEF-oprN operon was highly expressed. The results indicate that intracellular levels of 4-hydroxy-2-heptylquinoline (HHQ), a ligand of MvfR, are reduced due to MexEF-OprN-mediated efflux in desB mutant, resulting in the decrease of MvfR binding to pqsA-E promoter and the reduction of 4-hydroxy-2-alkylquinolines (HAQs) synthesis. Overexpression of mexEF-oprN operon in desB mutant was phenotypically confirmed by observing significantly increased resistance to chloramphenicol. In conclusion, these results suggest that DesB plays a role in the inhibition of S. aureus growth by controlling HAQ synthesis.	[Kim, Sejeong; Yoon, Yohan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choi, Kyoung-Hee] Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, South Korea	Sookmyung Women's University; Wonkwang University	Yoon, Y (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	yyoon@sookmyung.ac.kr; kheechoi@wku.ac.kr		Kim, Sejeong/0000-0001-9741-8056	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A3051383]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A3051383).	Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Barequet IS, 2004, ANTIMICROB AGENTS CH, V48, P1681, DOI 10.1128/AAC.48.5.1681-1687.2004; Beaume M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00321; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; BRITO N, 1989, RES MICROBIOL, V140, P125, DOI 10.1016/0923-2508(89)90046-6; BYNG GS, 1979, J BACTERIOL, V138, P846, DOI 10.1128/JB.138.3.846-852.1979; Chen AI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004480; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fargier E, 2012, J BACTERIOL, V194, P3502, DOI 10.1128/JB.06632-11; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; FUKUDA H, 1990, ANTIMICROB AGENTS CH, V34, P1757, DOI 10.1128/AAC.34.9.1757; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Haba E, 2003, BIOTECHNOL BIOENG, V81, P316, DOI 10.1002/bit.10474; HAYS EE, 1945, J BIOL CHEM, V159, P725; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lamarche MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024310; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; MORSE SA, 1980, ANTIMICROB AGENTS CH, V18, P416, DOI 10.1128/AAC.18.3.416; Nair N, 2014, INFECT IMMUN, V82, P2162, DOI 10.1128/IAI.00059-14; Olivares J, 2012, ENVIRON MICROBIOL, V14, P1968, DOI 10.1111/j.1462-2920.2012.02727.x; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rosenbluth DB, 2004, CHEST, V126, P412, DOI 10.1378/chest.126.2.412; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sage AE, 1997, J BACTERIOL, V179, P4874, DOI 10.1128/jb.179.15.4874-4881.1997; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schweizer HP, 2011, ARCH MICROBIOL, V193, P227, DOI 10.1007/s00203-010-0665-6; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134624	10.1371/journal.pone.0134624	http://dx.doi.org/10.1371/journal.pone.0134624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230088	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400142
J	Leber, A; Viladomiu, M; Hontecillas, R; Abedi, V; Philipson, C; Hoops, S; Howard, B; Bassaganya-Riera, J				Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Howard, Brad; Bassaganya-Riera, Josep			Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection	PLOS ONE			English	Article							TOXIN-A; CELLS; INFLAMMATION; COLITIS	Clostridium difficile infections are associated with the use of broad-spectrum antibiotics and result in an exuberant inflammatory response, leading to nosocomial diarrhea, colitis and even death. To better understand the dynamics of mucosal immunity during C. difficile infection from initiation through expansion to resolution, we built a computational model of the mucosal immune response to the bacterium. The model was calibrated using data from a mouse model of C. difficile infection. The model demonstrates a crucial role of T helper 17 (Th17) effector responses in the colonic lamina propria and luminal commensal bacteria populations in the clearance of C. difficile and colonic pathology, whereas regulatory T (Treg) cells responses are associated with the recovery phase. In addition, the production of anti-microbial peptides by inflamed epithelial cells and activated neutrophils in response to C. difficile infection inhibit the re-growth of beneficial commensal bacterial species. Computational simulations suggest that the removal of neutrophil and epithelial cell derived anti-microbial inhibitions, separately and together, on commensal bacterial regrowth promote recovery and minimize colonic inflammatory pathology. Simulation results predict a decrease in colonic inflammatory markers, such as neutrophilic influx and Th17 cells in the colonic lamina propria, and length of infection with accelerated commensal bacteria regrowth through altered anti-microbial inhibition. Computational modeling provides novel insights on the therapeutic value of repopulating the colonic microbiome and inducing regulatory mucosal immune responses during C. difficile infection. Thus, modeling mucosal immunity-gut microbiota interactions has the potential to guide the development of targeted fecal transplantation therapies in the context of precision medicine interventions.	[Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Bassaganya-Riera, Josep] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Howard, Brad; Bassaganya-Riera, Josep] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Www Nimml Org, Blacksburg, VA USA; [Howard, Brad] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Viladomiu, Monica/GNM-6447-2022; Philipson, Casandra/AAY-5746-2021	Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Beard DA, 2014, PLOS COMPUTATIONAL B, V10, DOI [10.1371/journal.pcbi.1003509, DOI 10.1371/J0URNAL.PCBI.1003509]; Blake KM, 2004, CLIN EXP IMMUNOL, V136, P262, DOI 10.1111/j.1365-2249.2004.02429.x; Bobak DA, 2010, CURRENT INFECTIOUS D, V13, P21; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Gasch M, 2014, MEDIATORS OF INFLAMM, V2014, P1; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Iapichino G, 2008, J MED MICROBIOL, V57, P1007, DOI 10.1099/jmm.0.47387-0; Ishida Y, 2004, J IMMUNOL, V172, P3018, DOI 10.4049/jimmunol.172.5.3018; Jafari NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069846; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Kasendra M, 2014, J INFECT DIS, V209, P1095, DOI 10.1093/infdis/jit617; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Mahida YR, 1996, GUT, V38, P337, DOI 10.1136/gut.38.3.337; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; Mathew S, 2014, J THEOR BIOL, V358, P132, DOI 10.1016/j.jtbi.2014.05.036; McDermott AJ, 2015, IMMUNOLOGY, V144, P704, DOI 10.1111/imm.12425; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; Rao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058265; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Schlackow I, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001279; Scott KP, 2015, MICROBIAL ECOLOGY IN, V26; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Shapira Y, 2010, J AUTOIMMUN, V34, pJ168, DOI 10.1016/j.jaut.2009.11.018; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Swale A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106118; Terrier MCZ, 2014, WORLD J GASTROENTERO, V20, P7416, DOI 10.3748/wjg.v20.i23.7416; Viladomiu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047525; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027	59	20	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134849	10.1371/journal.pone.0134849	http://dx.doi.org/10.1371/journal.pone.0134849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230099	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400175
J	Lutzenberger, M; Burwinkel, M; Riemer, C; Bode, V; Baier, M				Lutzenberger, Manuel; Burwinkel, Michael; Riemer, Constanze; Bode, Victoria; Baier, Michael			Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; GENE-EXPRESSION; AMYLOID PLAQUES; IN-VITRO; A-BETA; ACTIVATION; ASTROCYTES; INFLAMMATION; NEURODEGENERATION; QUANTIFICATION	Alzheimer's disease (AD) and prion diseases carry a significant inflammatory component. The astrocytic overexpression of CCAAT/enhancer-binding protein delta (C/EBPD) in prion-and AD-affected brain tissue prompted us to study the role of this transcription factor in murine model systems of these diseases. Ablation of C/EBPD had neither in the AD model (APP/PS1 double transgenic mice) nor in the prion model (scrapie-infected C57BL/6 mice) an influence on overt clinical symptoms. Moreover, the absence of C/EBPD did not affect the extent of the disease-related gliosis. However, C/EBPD-deficient APP/PS1 double transgenic mice displayed significantly increased amyloid beta (Abeta) plaque burdens while amyloid precursor protein (APP) expression and expression of genes involved in beta amyloid transport and turnover remained unchanged. Gene expression analysis in mixed glia cultures demonstrated a strong dependency of complement component C3 on the presence of C/EBPD. Accordingly, C3 mRNA levels were significantly lower in brain tissue of C/EBPD-deficient mice. Vice versa, C3 expression in U-373 MG cells increased upon transfection with a C/EBPD expression vector. Taken together, our data indicate that a C/EBPD-deficiency leads to increased Abeta plaque burden in AD model mice. Furthermore, as shown in vivo and in vitro, C/EBPD is an important driver of the expression of acute phase response genes like C3 in the amyloid-affected CNS.	[Lutzenberger, Manuel; Burwinkel, Michael; Riemer, Constanze; Bode, Victoria; Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, Berlin, Germany	Robert Koch Institute	Burwinkel, M (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, Berlin, Germany.	burwinkelm@rki.de		Burwinkel, Michael/0000-0003-4811-7323	Germany Federal Ministry of Health [IIA5-2512NIK004//321-4471-02]; Robert Koch-Institut	Germany Federal Ministry of Health; Robert Koch-Institut	This work was funded in part by the Germany Federal Ministry of Health (grant IIA5-2512NIK004//321-4471-02) and Robert Koch-Institut.	Arguello AA, 2013, J NEUROSCI, V33, P3646, DOI 10.1523/JNEUROSCI.1635-12.2013; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Burwinkel M, 2004, EMBO REP, V5, P527, DOI 10.1038/sj.embor.7400125; Cardinaux JR, 1996, J NEUROSCI, V16, P919; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Chang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045378; Chauhan NB, 2004, J NEUROSCI RES, V78, P732, DOI 10.1002/jnr.20298; Chen XQ, 2012, J IMMUNOL, V189, P347, DOI 10.4049/jimmunol.1103715; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Eikelenboom P, 1996, NEUROBIOL AGING, V17, P673; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hasebe R, 2012, VIROLOGY, V423, P205, DOI 10.1016/j.virol.2011.11.017; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Ko CY, 2015, NEUROBIOL AGING, V36, P1356, DOI 10.1016/j.neurobiolaging.2014.11.020; Ko CY, 2014, NEUROBIOL AGING, V35, P24, DOI 10.1016/j.neurobiolaging.2013.07.021; Ko CY, 2012, NEUROBIOL AGING, V33, DOI [10.1016/j.neurobiolaging.2010.09.017, DOI 10.1016/J.NEUR0BI0LAGING.2010.09.017]; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YW, 2007, CELL MOL LIFE SCI, V64, P3282, DOI 10.1007/s00018-007-7375-5; Lv Y, 2015, MOL NEUROBIOL, V52, P1165, DOI 10.1007/s12035-014-8915-2; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Maranto J, 2011, J CELL BIOCHEM, V112, P1168, DOI 10.1002/jcb.23032; Michel B, 2013, INT IMMUNOL, V25, P697, DOI 10.1093/intimm/dxt034; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Morrison JP, 2009, TOXICOL PATHOL, V37, P502, DOI 10.1177/0192623309335631; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sedo A, 2001, EUR J HISTOCHEM, V45, P57; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Sun Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-76; Svotelis A, 2005, BIOCHEM BIOPH RES CO, V328, P461, DOI 10.1016/j.bbrc.2005.01.002; Valente T, 2013, NEUROBIOL AGING, V34, P2110, DOI 10.1016/j.neurobiolaging.2013.02.007; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134228	10.1371/journal.pone.0134228	http://dx.doi.org/10.1371/journal.pone.0134228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230261	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400088
J	Martinez, AA; Zaldivar, Y; Arteaga, G; de Castillo, Z; Ortiz, A; Mendoza, Y; Castillero, O; Castillo, JA; Cristina, J; Pascale, JM				Martinez, Alexander A.; Zaldivar, Yamitzel; Arteaga, Griselda; de Castillo, Zoila; Ortiz, Alma; Mendoza, Yaxelis; Castillero, Omar; Castillo, Juan A.; Cristina, Juan; Pascale, Juan M.			Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCES; INFECTION; MUTATIONS; TIME	The Hepatitis B Virus (HBV) can cause acute or chronic infection it is also associated with the development of liver cancer, thousands of new infections occur on a yearly basis, and many of these cases are located in certain areas of the Caribbean and Latin America. In these areas, the HBV prevalence is still high which makes this virus a serious public health concern to the entire region. Studies performed in Panama suggest a complex pattern in the distribution of HBV among the country's different risk groups. We use phylogenetic analysis in order to determine which HBV genotypes were circulating in these specific groups; for this we used a fragment of the PreS2/2 region of the HBV genome. Subsequently whole HBV genome sequences were used for Bayesian analysis of phylodynamics and phylogeography. Two main genotypes were found: genotype A (54.5%) and genotype F (45.5%). There was a difference in the distribution of genotypes according to risk groups: 72.9% of high risk groups were associated to genotype A, and 55.0% of samples of genotype F were associated to the low risk group (p<0.002). The Bayesian analysis of phylogeny-traits association revealed a statistically significant geographical association (p<0.0001) with both genotypes and different regions of the country. The Bayesian time of most recent common ancestor analysis (tMRCA) revealed a recent tMRCA for genotype A2 circulating in Panama (1997, 95% HPD: 1986-2005), when it is compared with Panamanian genotype F1c sequences (1930, 95% HPD: 1810 - 2005). These results suggest a possible change in the distribution of HBV genotypes in Panama and Latin America as a whole. They also serve to encourage the implementation of vaccination programs in high-risk groups, in order to prevent an increase in the number of new HBV cases in Latin America and worldwide.	[Martinez, Alexander A.; Zaldivar, Yamitzel; Arteaga, Griselda; Ortiz, Alma; Mendoza, Yaxelis; Castillero, Omar; Castillo, Juan A.; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama; [Martinez, Alexander A.; Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Martinez, Alexander A.; Mendoza, Yaxelis] INDICASAT AIP, City of Knowledge, Panama; [de Castillo, Zoila] Complejo Hosp Dr Arnulfo Arias Madrid, Caja de Seguro Social, Nucle Acid Test Unit, Panama City, Panama; [Arteaga, Griselda; Pascale, Juan M.] Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama; [Cristina, Juan] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidad de Panama; Universidad de la Republica, Uruguay	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama.	jpascale@gorgas.gob.pa	Martínez, Alexander/HHC-2101-2022; Martinez Caballero, Alexander Augusto/F-9601-2012	Martinez Caballero, Alexander Augusto/0000-0002-7816-3040	Secretaria Nacional de Ciencia y Tecnologia (SENACYT) [FID09-050]	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)	This study was supported by GRANT FID09-050, Secretaria Nacional de Ciencia y Tecnologia (SENACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Alvarado-Esquivel C, 2006, WORLD J GASTROENTERO, V12, P6540, DOI 10.3748/wjg.v12.i40.6540; Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; ArauzRuiz P, 1997, J INFECT DIS, V176, P851, DOI 10.1086/516507; ArauzRuiz P, 1997, J MED VIROL, V51, P305, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;305::AID-JMV8&gt;3.0.CO;2-9; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Bouckaert R, 2013, ANTIVIR THER, V18, P497, DOI 10.3851/IMP2656; Campos RH, 2006, J CLIN VIROL SUPPL 2, V34, pS8; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chow EPF, PLOS ONE, V9, DOI [10.1371/journal.pone.0089959, DOI 10.1371/J0URNAL.P0NE.0089959]; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Ghany MG, 2015, CLIN GASTROENTEROL H, V13, P183, DOI 10.1016/j.cgh.2014.06.028; Grabarczyk P, 2010, J VIRAL HEPATITIS, V17, P444, DOI 10.1111/j.1365-2893.2009.01192.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUNTHER S, 1995, J VIROL, V69, P5437; Hakre S, J URBAN HEAL SPRINGE, V91, P793; Hakre S, 2013, SEX TRANSM INFECT, V89, P156, DOI 10.1136/sextrans-2012-050557; HOLMES EC, 1995, J INFECT DIS, V171, P45, DOI 10.1093/infdis/171.1.45; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koibuchi T, 2001, J MED VIROL, V64, P435, DOI 10.1002/jmv.1069; Kojima Y, 2013, EPIDEMIOL INFECT, V141, P2410, DOI 10.1017/S0950268812003123; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Garcia-Montalvo BM, 2011, ANN HEPATOL, V10, P133; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinez AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103545; McCullough D., PATH BETWEEN THE SEA, P1870; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Paraskevis D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-57; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pollack H, 2006, MMWR-MORBID MORTAL W, V55, P505; Price H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049314; Ramachandran S, 2014, J VIROL, V88, P13971, DOI 10.1128/JVI.01594-14; Roman S, 2010, J MED VIROL, V82, P1527, DOI 10.1002/jmv.21846; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sakurai M, 2004, WORLD J GASTROENTERO, V10, P2218; Sanchez LV, 2007, INTERVIROLOGY, V50, P9, DOI 10.1159/000096307; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; van der Kuyl AC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-540; van Houdt R, 2012, J HEPATOL, V57, P529, DOI 10.1016/j.jhep.2012.04.030; Venegas M, 2011, J MED VIROL, V83, P1530, DOI 10.1002/jmv.22129	56	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134850	10.1371/journal.pone.0134850	http://dx.doi.org/10.1371/journal.pone.0134850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230260	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400176
J	Mullette-Gillman, OA; Leong, RLF; Kurnianingsih, YA				Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.; Kurnianingsih, Yoanna A.			Cognitive Fatigue Destabilizes Economic Decision Making Preferences and Strategies	PLOS ONE			English	Article							MENTAL FATIGUE; SLEEP-DEPRIVATION; WORKING-MEMORY; ATTENTION; RISK; SELF; UNCERTAINTY; PERFORMANCE; AVERSION; JUDGMENT	Objective It is common for individuals to engage in taxing cognitive activity for prolonged periods of time, resulting in cognitive fatigue that has the potential to produce significant effects in behaviour and decision making. We sought to examine whether cognitive fatigue modulates economic decision making. Methods We employed a between-subject manipulation design, inducing fatigue through 60 to 90 minutes of taxing cognitive engagement against a control group that watched relaxing videos for a matched period of time. Both before and after the manipulation, participants engaged in two economic decision making tasks (one for gains and one for losses). The analyses focused on two areas of economic decision making-preferences and choice strategies. Uncertainty preferences (risk and ambiguity) were quantified as premium values, defined as the degree and direction in which participants alter the valuation of the gamble in comparison to the certain option. The strategies that each participant engaged in were quantified through a choice strategy metric, which contrasts the degree to which choice behaviour relies upon available satisficing or maximizing information. We separately examined these metrics for alterations within both the gains and losses domains, through the two choice tasks. Results The fatigue manipulation resulted in significantly greater levels of reported subjective fatigue, with correspondingly higher levels of reported effort during the cognitively taxing activity. Cognitive fatigue did not alter uncertainty preferences (risk or ambiguity) or informational strategies, in either the gains or losses domains. Rather, cognitive fatigue resulted in greater test-retest variability across most of our economic measures. These results indicate that cognitive fatigue destabilizes economic decision making, resulting in inconsistent preferences and informational strategies that may significantly reduce decision quality.	[Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.; Kurnianingsih, Yoanna A.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Ctr Cognit Neurosci, Singapore, Singapore; [Mullette-Gillman, O'Dhaniel A.] SINAPSE Inst Cognit Sci & Neurotechnol, Singapore, Singapore	National University of Singapore; National University of Singapore	Mullette-Gillman, OA (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	odubik@gmail.com	Mullette-Gillman, O'Dhaniel/B-8707-2012; Kurnianingsih, Yoanna/GQZ-3248-2022; Leong, Ruth/AGW-5987-2022	Mullette-Gillman, O'Dhaniel/0000-0002-5585-2978; Kurnianingsih, Yoanna/0000-0002-3610-2522; 	National University of Singapore [R-581-000-123-133, R-581-000-133-112]	National University of Singapore(National University of Singapore)	This project was funded National University of Singapore grants R-581-000-123-133 and R-581-000-133-112.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Bartlett FC, 1943, PROC R SOC SER B-BIO, V131, P247, DOI 10.1098/rspb.1943.0006; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; BOWMAN EH, 1963, MANAGE SCI, V9, P310, DOI 10.1287/mnsc.9.2.310; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Carod-Artal F. J., 2013, BURNOUT SYNDROME INT, P15; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Henri-Bhargava A, 2012, NEUROPSYCHOLOGIA, V50, P1536, DOI 10.1016/j.neuropsychologia.2012.03.006; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Hockey GRJ, 2000, COGNITION EMOTION, V14, P823, DOI 10.1080/02699930050156654; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; HOGARTH RM, 1981, MANAGE SCI, V27, P93, DOI 10.1287/mnsc.27.1.93; Holding D, 1983, STRESS FATIGUE HUMAN; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Job V, 2013, P NATL ACAD SCI USA, V110, P14837, DOI 10.1073/pnas.1313475110; Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404; Kleiner M, 2007, PERCEPTION, V36, P14; Knight Frank H, 1921, RISK UNCERTAINTY AND; Kurnianingsih YA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00280; Levy DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053978; Lim J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009087; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Massar SA, 2010, PSYCHOPHYSIOLOGY, V47, P1119, DOI 10.1111/j.1469-8986.2010.01028.x; Meijman T, 2000, ERGONOMICS AND SAFETY FOR GLOBAL BUSINESS QUALITY AND PRODUCTIVITY, P45; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Shigihara Y., 2013, NEUROL PSYCHIAT BRAI, V19, P5, DOI [10.1016/j.npbr.2012.07.002, DOI 10.1016/J.NPBR.2012.07.002]; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; van der Linden D, 2006, PSYCHOL RES-PSYCH FO, V70, P395, DOI 10.1007/s00426-005-0228-7; Xu XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109950; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	49	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132022	10.1371/journal.pone.0132022	http://dx.doi.org/10.1371/journal.pone.0132022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230404	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400013
J	Nishikawa, Y; Okuzaki, D; Fukushima, K; Mukai, S; Ohno, S; Ozaki, Y; Yabuta, N; Nojima, H				Nishikawa, Yukihiro; Okuzaki, Daisuke; Fukushima, Kohshiro; Mukai, Satomi; Ohno, Shouichi; Ozaki, Yuki; Yabuta, Norikazu; Nojima, Hiroshi			Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells	PLOS ONE			English	Article							STEM-LIKE CELLS; DOWN-REGULATION; STEROIDAL LACTONE; INDUCED APOPTOSIS; GROWTH ARREST; C-FOS; AUTOPHAGY; ENRICHMENT; CULTURE; AGENT	Withaferin A (WA), a major bioactive component of the Indian herb Withania somnifera, induces cell death (apoptosis/necrosis) in multiple types of tumor cells, but the molecular mechanism underlying this cytotoxicity remains elusive. We report here that 2 mu M WA induced cell death selectively in androgen-insensitive PC-3 and DU-145 prostate adenocarcinoma cells, whereas its toxicity was less severe in androgen-sensitive LNCaP prostate adenocarcinoma cells and normal human fibroblasts (TIG-1 and KD). WA also killed PC-3 cells in spheroid-forming medium. DNA microarray analysis revealed that WA significantly increased mRNA levels of c-Fos and 11 heat-shock proteins (HSPs) in PC-3 and DU-145, but not in LNCaP and TIG-1. Western analysis revealed increased expression of c-Fos and reduced expression of the anti-apoptotic protein c-FLIP(L). Expression of HSPs such as HSPA6 and Hsp70 was conspicuously elevated; however, because siRNA-mediated depletion of HSF-1, an HSP-inducing transcription factor, reduced PC-3 cell viability, it is likely that these heat-shock genes were involved in protecting against cell death. Moreover, WA induced generation of reactive oxygen species (ROS) in PC-3 and DU-145, but not in normal fibroblasts. Immunocytochemistry and immuno-electron microscopy revealed that WA disrupted the vimentin cytoskeleton, possibly inducing the ROS generation, c-Fos expression and c-FLIP(L) suppression. These observations suggest that multiple events followed by disruption of the vimentin cytoskeleton play pivotal roles in WA-mediated cell death.	[Nishikawa, Yukihiro; Okuzaki, Daisuke; Fukushima, Kohshiro; Mukai, Satomi; Ohno, Shouichi; Ozaki, Yuki; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15101006, 20370081, 23370086, 21651085, 22570185]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081 and 23370086) and Exploratory Research (No. 21651085) to H.N. and Scientific Research C (No. 22570185) to N.Y. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/).	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; [Anonymous], MOL CELL BIOL, V16, P211; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063881; Cereda V, 2014, EXPERT OPIN INV DRUG, V23, P469, DOI 10.1517/13543784.2014.885950; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; French LE, 1999, NAT MED, V5, P146, DOI 10.1038/5505; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Geary LA, 2014, MOL CANCER RES, V12, P607, DOI 10.1158/1541-7786.MCR-13-0469; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Hahm ER, 2013, CURR CANCER DRUG TAR, V13, P640, DOI 10.2174/15680096113139990039; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050547; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Lee J., 2013, MOL CARCINOG; Liu BQ, 2013, AUTOPHAGY, V9, P905, DOI 10.4161/auto.24292; Luo Y, 2014, ONCOL REP, V31, P874, DOI 10.3892/or.2013.2905; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Nagalingam A, 2014, CANCER RES, V74, P2617, DOI 10.1158/0008-5472.CAN-13-2081; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Ozorowski G, 2012, BIOL CHEM, V393, P1151, DOI 10.1515/hsz-2012-0184; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Sheng X, 2013, ONCOL LETT, V5, P787, DOI 10.3892/ol.2012.1090; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Silginer M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.543; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Wang L, 2013, INT J BIOL SCI, V9, P472, DOI 10.7150/ijbs.5855; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhang K, 2014, PROSTATE, V74, P381, DOI 10.1002/pros.22759; Zhang XP, 2007, CANCER RES, V67, P9425, DOI 10.1158/0008-5472.CAN-07-1310; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84	43	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134137	10.1371/journal.pone.0134137	http://dx.doi.org/10.1371/journal.pone.0134137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230090	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400076
J	Nuccitelli, R; Berridge, JC; Mallon, Z; Kreis, M; Athos, B; Nuccitelli, P				Nuccitelli, Richard; Berridge, Jon Casey; Mallon, Zachary; Kreis, Mark; Athos, Brian; Nuccitelli, Pamela			Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth	PLOS ONE			English	Article							PULSED ELECTRIC-FIELDS; IMMUNOGENIC CELL-DEATH; HEPATOCELLULAR-CARCINOMA; CALRETICULIN EXPOSURE; IMMUNE-RESPONSE; THERAPY; ABLATION; STIMULATION; CLEARANCE; MELANOMAS	We have used both a rat orthotopic hepatocellular carcinoma model and a mouse allograft tumor model to study liver tumor ablation with nanosecond pulsed electric fields (nsPEF). We confirm that nsPEF treatment triggers apoptosis in rat liver tumor cells as indicated by the appearance of cleaved caspase 3 and 9 within two hours after treatment. Furthermore we provide evidence that nsPEF treatment leads to the translocation of calreticulin (CRT) to the cell surface which is considered a damage-associated molecular pattern indicative of immunogenic cell death. We provide direct evidence that nanoelectroablation triggers a CD8-dependent inhibition of secondary tumor growth by comparing the growth rate of secondary orthotopic liver tumors in nsPEF-treated rats with that in nsPEF-treated rats depleted of CD8(+) cytotoxic T-cells. The growth of these secondary tumors was severely inhibited as compared to tumor growth in CD8-depleated rats, with their average size only 3% of the primary tumor size after the same one-week growth period. In contrast, when we depleted CD8(+) T-cells the second tumor grew more robustly, reaching 54% of the size of the first tumor. In addition, we demonstrate with immunohistochemistry that CD8(+) T-cells are highly enriched in the secondary tumors exhibiting slow growth. We also showed that vaccinating mice with nsPEF-treated isogenic tumor cells stimulates an immune response that inhibits the growth of secondary tumors in a CD8(+)-dependent manner. We conclude that nanoelectroablation triggers the production of CD8(+) cytotoxic T-cells resulting in the inhibition of secondary tumor growth.	[Nuccitelli, Richard; Berridge, Jon Casey; Mallon, Zachary; Kreis, Mark; Athos, Brian; Nuccitelli, Pamela] BioElectroMed Corp, Burlingame, CA 94010 USA		Nuccitelli, R (corresponding author), BioElectroMed Corp, Burlingame, CA 94010 USA.	rich@bioelectromed.com			NIH [R44CA150484]; BioElectroMed Corp; NATIONAL CANCER INSTITUTE [R44CA150484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioElectroMed Corp; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was sponsored by the NIH grant No:R44CA150484. BioElectroMed Corp provided support in the form of salaries for authors RM, JCB, ZM, MK, BA, and PN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Calvet CY, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28131; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086421; Fitzmorris P, 2014, J CANC RES CLIN ONCO; GABRIEL B, 1994, EUR J BIOCHEM, V223, P25, DOI 10.1111/j.1432-1033.1994.tb18962.x; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28518; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kudo M, 2011, ONCOLOGY-BASEL, V81, P1, DOI 10.1159/000333252; Fernandez ML, 2012, BIOCHEM BIOPH RES CO, V423, P325, DOI 10.1016/j.bbrc.2012.05.122; Long G, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2113183; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2013, BIOCHEM BIOPH RES CO, V435, P580, DOI 10.1016/j.bbrc.2013.05.014; Nuccitelli R, 2013, INT J CANCER, V132, P1933, DOI 10.1002/ijc.27860; Nuccitelli R, 2012, PIGM CELL MELANOMA R, V25, P618, DOI 10.1111/j.1755-148X.2012.01027.x; Nuccitelli R, 2012, BIOCHEM BIOPH RES CO, V424, P446, DOI 10.1016/j.bbrc.2012.06.129; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pakhomova ON, 2012, ARCH BIOCHEM BIOPHYS, V527, P55, DOI 10.1016/j.abb.2012.08.004; Panzarini E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105778; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Schoenbach KH., 2010, ADV ELECTROPORATION, P19; Son RS, 2014, J MEMBR BIOL; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Wu S, 2013, CANC LETT, V10; Yin SY, 2014, CANCER LETT, V346, P285, DOI 10.1016/j.canlet.2014.01.009; Yu Z, 2014, ONCOTARGET, V5, P6526, DOI 10.18632/oncotarget.2310	31	59	64	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134364	10.1371/journal.pone.0134364	http://dx.doi.org/10.1371/journal.pone.0134364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231031	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400108
J	Omondi, D; Masiga, DK; Ajamma, YU; Fielding, BC; Njoroge, L; Villinger, J				Omondi, David; Masiga, Daniel K.; Ajamma, Yvonne Ukamaka; Fielding, Burtram C.; Njoroge, Laban; Villinger, Jandouwe			Unraveling Host-Vector-Arbovirus Interactions by Two-Gene High Resolution Melting Mosquito Bloodmeal Analysis in a Kenyan Wildlife-Livestock Interface	PLOS ONE			English	Article							WEST NILE VIRUS; MALARIA VECTOR; CULEX-QUINQUEFASCIATUS; FEEDING-BEHAVIOR; MEAL SOURCES; IDENTIFICATION; TRANSMISSION; DIPTERA; FLAVIVIRUSES; ALPHAVIRUSES	The blood-feeding patterns of mosquitoes are directly linked to the spread of pathogens that they transmit. Efficient identification of arthropod vector bloodmeal hosts can identify the diversity of vertebrate species potentially involved in disease transmission cycles. While molecular bloodmeal analyses rely on sequencing of cytochrome b (cyt b) or cytochrome oxidase 1 gene PCR products, recently developed bloodmeal host identification based on high resolution melting (HRM) analyses of cyt b PCR products is more cost-effective. To resolve the diverse vertebrate hosts that mosquitoes may potentially feed on in sub-Saharan Africa, we utilized HRM profiles of both cyt b and 16S ribosomal RNA genes. Among 445 blood-fed Aedeomyia, Aedes, Anopheles, Culex, Mansonia, and Mimomyia mosquitoes from Kenya's Lake Victoria and Lake Baringo regions where many mosquito-transmitted pathogens are endemic, we identified 33 bloodmeal hosts including humans, eight domestic animal species, six peridomestic animal species and 18 wildlife species. This resolution of vertebrate host species was only possible by comparing profiles of both cyt b and 16S markers, as melting profiles of some pairs of species were similar for either marker but not both. We identified mixed bloodmeals in a Culex pipiens from Mbita that had fed on a goat and a human and in two Mansonia africana mosquitoes from Baringo that each had fed on a rodent (Arvicanthis niloticus) in addition to a human or baboon. We further detected Sindbis and Bunyamwera viruses in blood-fed mosquito homogenates by Vero cell culture and RTPCR in Culex, Aedeomyia, Anopheles and Mansonia mosquitoes from Baringo that had fed on humans and livestock. The observed mosquito feeding on both arbovirus amplifying hosts (including sheep and goats) and possible arbovirus reservoirs (birds, porcupine, baboons, rodents) informs arbovirus disease epidemiology and vector control strategies.	[Omondi, David; Masiga, Daniel K.; Ajamma, Yvonne Ukamaka; Villinger, Jandouwe] Int Ctr Insect Physiol & Ecol, Martin Luscher Emerging Infect Dis ML EID, Nairobi, Kenya; [Omondi, David; Fielding, Burtram C.] Univ Western Cape, Dept Med Biosci, Mol Biol & Virol Lab, ZA-7535 Bellville, South Africa; [Omondi, David] Egerton Univ, Biochem & Mol Biol Dept, Egerton 20115, Kenya; [Njoroge, Laban] Natl Museums Kenya, Dept Zool, Invertebrates Zool Sect, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); University of the Western Cape; Egerton University	Villinger, J (corresponding author), Int Ctr Insect Physiol & Ecol, Martin Luscher Emerging Infect Dis ML EID, POB 30772-00100, Nairobi, Kenya.	jandouwe@icipe.org	Villinger, Jandouwe/ABH-2172-2020; Fielding, Burtram/S-3240-2019; Omondi, David/ABA-9172-2020	Villinger, Jandouwe/0000-0002-5097-6605; Fielding, Burtram/0000-0002-1873-3363; Ajamma, Yvonne/0000-0002-2523-4992; Omondi, David/0000-0002-8735-5255; Masiga, Daniel/0000-0001-7513-0887	Swedish International Development Cooperation Agency (SIDA) from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]	Swedish International Development Cooperation Agency (SIDA) from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust	This study was mainly funded by the Swedish International Development Cooperation Agency (SIDA) (awarded to JV, DKM, and DOO) supplemented by funds from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa (grant number 087540) funded by Wellcome Trust (awarded to JV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P207; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; Conlon JM, 2014, PHARMACEUTICALS, V7, P58, DOI 10.3390/ph7010058; Crabtree M, 2009, J MED ENTOMOL, V46, P961, DOI 10.1603/033.046.0431; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Edwards FW, 1941, MOSQUITOES ETHIOPIAN; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Fornadel CM, 2011, VECTOR-BORNE ZOONOT, V11, P1173, DOI 10.1089/vbz.2010.0082; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Greenberg JA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.7501; Greenberg JA, 2012, J VECTOR ECOL, V37, P83, DOI 10.1111/j.1948-7134.2012.00203.x; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kipanga PN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-429; KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535; LaBeaud AD, 2011, EMERG INFECT DIS, V17, P233, DOI 10.3201/eid1702.091666; Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09; Lewis A., 1989, BIRD ATLAS KENYA; Lutomiah J, 2014, VECTOR-BORNE ZOONOT, V14, P656, DOI 10.1089/vbz.2013.1564; Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Mala AO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-121; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Mukabana WR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-9; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Nichol ST, 2001, BUNYAVIRUSES, P24; O'Guinn ML, 2002, J MED ENTOMOL, V39, P806, DOI 10.1603/0022-2585-39.5.806; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; Odhiambo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105446; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Opiyo P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-48; Pena VH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001530; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; Tabue RN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-262; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Williams CR, 2006, BIOL LETT-UK, V2, P242, DOI 10.1098/rsbl.2006.0448; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11	48	32	33	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134375	10.1371/journal.pone.0134375	http://dx.doi.org/10.1371/journal.pone.0134375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230507	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400113
J	Inshaw, J; Leen, C; Fisher, M; Gilson, R; Hawkins, D; Collins, S; Fox, J; McLean, K; Fidler, S; Phillips, A; Lattimore, S; Babiker, A; Porter, K				Inshaw, Jamie; Leen, Clifford; Fisher, Martin; Gilson, Richard; Hawkins, David; Collins, Simon; Fox, Julie; McLean, Ken; Fidler, Sarah; Phillips, Andrew; Lattimore, Sam; Babiker, Abdel; Porter, Kholoud		UK HIV Seroconverters Cohort	The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; COINFECTION; EPIDEMIOLOGY; INDIVIDUALS; PREVALENCE; ACCELERATE; OUTCOMES; ENGLAND	Introduction The effect of HCV infection on HIV disease progression remains unclear; the effect of HCV infection duration on HIV disease progression is unknown. Methods We used data from a cohort of HIV seroconverters to investigate the effect of HCV infection duration on time from HIV seroconversion to CD4 <350cells/mm(3), AIDS or death, censoring at the earlier of cART initiation or last clinic visit, adjusting for confounders and splitting data into follow up periods from HIV seroconversion (<2, 2-4 and >4 years). We additionally compared CD4 cell decline following HCV infection to that of mono-infected individuals with similar HIV infection duration by fitting a random effects model. In a separate analysis, we used linear mixed models to we examine the effect of HCV infection and its duration on CD4 increase over 48 weeks following cART. Results Of 1655 individuals, 97 (5.9%) were HCV co-infected. HCV<1 year was associated with a higher risk of endpoint in each follow-up period from HIV seroconversion (HR [95% CI] 2.58 [1.51, 4.41], p = 0.001; 3.80 [1.20, 12.03], p = 0.023; 2.03 [0.88, 4.71], p = 0.098 for <2, 2-4 and >4 years respectively), compared to mono-infected individuals. However, we found no evidence of an association for those with HCV>2 years (all p>0.89). Individuals experienced a somewhat greater decrease in CD4 count following HCV infection lasting 13 months, relative to individuals with HIV alone, (estimate = -3.33, 95% CI [-7.29, 0.63] cells/mm(3) per month, p = 0.099). Of 1502 initiating cART, 106 (7.1%) were HCV co-infected, with no evidence of HCV duration at cART being associated with immunological response (p = 0.45). Conclusions The impact of HCV co-infection on HIV disease progression appears to be restricted to the first year after HCV infection.	[Inshaw, Jamie; Babiker, Abdel; Porter, Kholoud] UCL, MRC, Clin Trials Unit, London, England; [Leen, Clifford] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Fisher, Martin] Brighton & Sussex Univ NHS Trust, Brighton, E Sussex, England; [Gilson, Richard; Phillips, Andrew] UCL, Dept Infect & Populat Hlth, London, England; [Hawkins, David] Chelsea & Westminster Hosp, London, England; [Collins, Simon] HIV I Base, London, England; [Fox, Julie] Kings Coll London, Guys & St Thomas NHS Trust, London WC2R 2LS, England; [McLean, Ken] Charing Cross Hosp, London, England; [Fidler, Sarah] Imperial Coll NHS Trust, London, England; [Lattimore, Sam] Publ Hlth England, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; University of Edinburgh; University of London; University College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; Public Health England	Inshaw, J (corresponding author), UCL, MRC, Clin Trials Unit, London, England.	j.inshaw@ucl.ac.uk	Collins, Simon/AAB-5123-2022; Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Fidler, Sarah/0000-0003-1676-7583; fox, Julie/0000-0002-0583-8019; Inshaw, Jamie/0000-0002-7003-8966; delpech, valerie/0000-0002-9952-8109; Collins, Simon/0000-0002-3537-2432; Porter, Kholoud/0000-0002-9226-6206; Leen, Clifford/0000-0001-8439-7719	UK Medical Research Council; Medical Research Council [MC_UU_12023/15, MR/L00528X/1, MC_UU_12023/23, MC_U122886352, MC_UU_12023/16] Funding Source: researchfish; MRC [MC_UU_12023/15, MC_UU_12023/16, MC_U122886352, MR/L00528X/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2003, BRIT HIV ASS BHIVA G; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; Brant LJ, 2007, EPIDEMIOL INFECT, V135, P417, DOI 10.1017/S0950268806006832; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; FEENEY C, 1995, CRIT CARE MED, V23, P1680, DOI 10.1097/00003246-199510000-00012; GORHAM ED, 1993, ARCH INTERN MED, V153, P869, DOI 10.1001/archinte.153.7.869; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Hung CC, 2005, INT J STD AIDS, V16, P42, DOI 10.1258/0956462052932629; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Klein MB, 2003, JAIDS-J ACQ IMM DEF, V33, P365, DOI 10.1097/00126334-200307010-00011; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2006, SCAND J INFECT DIS, V38, P1092, DOI 10.1080/00365540600786515; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Raunch A, 2005, J ACQ IMMUN DEF SYND, V38, P238; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Slavenburg S, 2009, ANTIVIR THER, V14, P1139, DOI 10.3851/IMP1464; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Sulkowski M, 2002, J AM MED ASS, V288; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Sullivan PS, 2006, AIDS, V20, P1171, DOI 10.1097/01.aids.0000226958.87471.48; Turner J, 2010, J VIRAL HEPATITIS, V17, P569, DOI 10.1111/j.1365-2893.2009.01215.x; van de Laar T., 2009, GASTROENTEROLOGY, V136, P1609, DOI DOI 10.1053/J.GASTR0.2009.02.006; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; VENTO S, 1993, LANCET, V341, P958, DOI 10.1016/0140-6736(93)91248-K	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132772	10.1371/journal.pone.0132772	http://dx.doi.org/10.1371/journal.pone.0132772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225723	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700010
J	Jiang, WX; Wei, WJ; Gaertig, MA; Li, SH; Li, XJ				Jiang, Wenxiao; Wei, Wenjie; Gaertig, Marta A.; Li, Shihua; Li, Xiao-Jiang			Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model	PLOS ONE			English	Article							RAT MODEL; COPTIDIS-RHIZOMA; CELL-DEATH; PROTEIN; PATHOGENESIS; EXPRESSION; CANCER; NEUROPROTECTION; ACCUMULATION; IMPAIRMENT	Huntington disease (HD) represents a family of neurodegenerative diseases that are caused by misfolded proteins. The misfolded proteins accumulate in the affected brain regions in an age-dependent manner to cause late-onset neurodegeneration. Transgenic mouse models expressing the HD protein, huntingtin, have been widely used to identify therapeutics that may retard disease progression. Here we report that Berberine (BBR), an organic small molecule isolated from plants, has protective effects on transgenic HD (N171-82Q) mice. We found that BBR can reduce the accumulation of mutant huntingtin in cultured cells. More importantly, when given orally, BBR could effectively alleviate motor dysfunction and prolong the survival of transgenic N171-82Q HD mice. We found that BBR could promote the degradation of mutant huntingtin by enhancing autophagic function. Since BBR is an orally-taken drug that has been safely used to treat a number of diseases, our findings suggest that BBR can be tested on different HD animal models and HD patients to further evaluate its therapeutic effects.	[Jiang, Wenxiao; Wei, Wenjie; Gaertig, Marta A.; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; [Wei, Wenjie] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430032, Peoples R China; [Jiang, Wenxiao] Emory Univ, Grad Program Microbiol & Mol Genet, Atlanta, GA 30322 USA	Emory University; Huazhong University of Science & Technology; Emory University	Li, XJ (corresponding author), Emory Univ, Dept Human Genet, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu			National Institutes of Health [NS036232, NS041669, AG019206]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS036232, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NS036232, NS041669 and AG019206).	Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Chen JH, 2012, INT IMMUNOPHARMACOL, V12, P94, DOI 10.1016/j.intimp.2011.10.019; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dong H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591654; Dragunow M, 2004, FRONT BIOSCI, V9, P100, DOI 10.2741/1197; Dudek NL, 2010, BRAIN PATHOL, V20, P176, DOI 10.1111/j.1750-3639.2008.00258.x; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim M, 2014, INT NEUROUROL J, V18, P115, DOI 10.5213/inj.2014.18.3.115; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KURTH JH, 1993, ANN NEUROL, V33, P368, DOI 10.1002/ana.410330406; Kwon IH, 2010, NEUROSCI LETT, V486, P29, DOI 10.1016/j.neulet.2010.09.038; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lu SS, 2009, J ENDOCRINOL, V200, P159, DOI 10.1677/JOE-08-0419; Margolis RL, 2014, J HUNTINGTONS DIS, V3, P137, DOI 10.3233/JHD-140107; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Panahi N, 2013, ARCH MED SCI, V9, P146, DOI 10.5114/aoms.2013.33354; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Poon LH, 2010, ANN PHARMACOTHER, V44, P1080, DOI 10.1345/aph.1M582; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shin KS, 2013, ARCH PHARM RES, V36, P759, DOI 10.1007/s12272-013-0051-4; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Squitieri F, 2006, MECH AGEING DEV, V127, P208, DOI 10.1016/j.mad.2005.09.012; Takase Hideki, 1993, Folia Pharmacologica Japonica, V102, P101; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yang L, 2002, NEUROSCI RES, V42, P261, DOI 10.1016/S0168-0102(02)00005-6; Yu YL, 2010, BIOCHEM PHARMACOL, V79, P1000, DOI 10.1016/j.bcp.2009.11.017; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	51	102	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134142	10.1371/journal.pone.0134142	http://dx.doi.org/10.1371/journal.pone.0134142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225560	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700059
J	Tomlin, D				Tomlin, Damon			Rational Constraints and the Evolution of Fairness in the Ultimatum Game	PLOS ONE			English	Article							STAKES; EXPECTATIONS; PREFERENCES; INFORMATION; PUNISHMENT; ANONYMITY	Behavior in the Ultimatum Game has been well-studied experimentally, and provides a marked contrast between the theoretical model of a self-interested economic agent and that of an actual human concerned with social norms such as fairness. How did such norms evolve, when punishing unfair behavior can be costly to the punishing agent? The work described here simulated a series of Ultimatum Games, in which populations of agents earned resources based on their preferences for proposing and accepting (or rejecting) offers of various sizes. Two different systems governing the acceptance or rejection of offers were implemented. Under one system, the probability that an agent accepted an offer of a given size was independent of the probabilities of accepting the other possible offers. Under the other system, a simple, ordinal constraint was placed on the acceptance probabilities such that a given offer was at least as likely to be accepted as a smaller offer. For simulations under either system, agents' preferences and their corresponding behavior evolved over multiple generations. Populations without the ordinal constraint came to emulate maximizing economic agents, while populations with the constraint came to resemble the behavior of human players.	Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA	University of Colorado System; University of Colorado at Colorado Springs	Tomlin, D (corresponding author), Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA.	dtomlin@uccs.edu						Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Camerer C, 2003, BEHAV GAME THEORY; Camerer C., 2004, FDN HUMAN SOCIALITY, P55, DOI DOI 10.1093/0199262055.003.0003; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Croson RTA, 1996, J ECON BEHAV ORGAN, V30, P197, DOI 10.1016/S0167-2681(96)00857-8; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Ewens W.J., 2004, MATH POPULATION GENE; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2009, J ECON BEHAV ORGAN, V72, P527, DOI 10.1016/j.jebo.2009.05.021; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harrison GW, 1996, INT J GAME THEORY, V25, P303, DOI 10.1007/BF02425260; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hoffman E, 1996, INT J GAME THEORY, V25, P289, DOI 10.1007/BF02425259; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Huck S, 1999, GAME ECON BEHAV, V28, P13, DOI 10.1006/game.1998.0691; Iranzo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043781; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kagel JH, 1996, GAME ECON BEHAV, V13, P100, DOI 10.1006/game.1996.0026; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kravitz D.A., 1992, J SOCIO-ECON, V21, P65, DOI DOI 10.1016/1053-5357(92)90026-4; Larrick RP, 1997, J PERS SOC PSYCHOL, V72, P810, DOI 10.1037/0022-3514.72.4.810; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; OCHS J, 1989, AM ECON REV, V79, P355; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2001, J THEOR BIOL, V209, P173, DOI 10.1006/jtbi.2000.2251; PRASNIKAR V, 1992, Q J ECON, V107, P865, DOI 10.2307/2118366; RABIN M, 1993, AM ECON REV, V83, P1281; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; ROTH AE, 1991, AM ECON REV, V81, P1068; Sanfey A.G., 2009, MIND SOC, V8, P93, DOI [10.1007/s11299-009-0053-6, DOI 10.1007/S11299-009-0053-6]; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schotter A, 1996, J ECON BEHAV ORGAN, V31, P37, DOI 10.1016/S0167-2681(96)00863-3; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; WEG E, 1993, J ECON PSYCHOL, V14, P17, DOI 10.1016/0167-4870(93)90038-M	43	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134636	10.1371/journal.pone.0134636	http://dx.doi.org/10.1371/journal.pone.0134636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226512	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700126
J	Bibby, BAS; Reynolds, JV; Maher, SG				Bibby, Becky A. S.; Reynolds, John V.; Maher, Stephen G.			MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; CANCER CELLS; SURGERY; CHEMORADIATION; CHEMOTHERAPY; RADIATION; THERAPY; MIRNAS; TIME	Oesophageal adenocarcinoma (OAC) is the sixth most common cause of cancer deaths worldwide, and the 5-year survival rate for patients diagnosed with the disease is approximately 17%. The standard of care for locally advanced disease is neoadjuvant chemotherapy or, more commonly, combined neoadjuvant chemoradiation therapy (neo-CRT) prior to surgery. Unfortunately, similar to 60-70% of patients will fail to respond to neo-CRT. Therefore, the identification of biomarkers indicative of patient response to treatment has significant clinical implications in the stratification of patient treatment. Furthermore, understanding the molecular mechanisms underpinning tumour response and resistance to neo-CRT will contribute towards the identification of novel therapeutic targets for enhancing OAC sensitivity to CRT. MicroRNAs (miRNA/miR) function to regulate gene and protein expression and play a causal role in cancer development and progression. MiRNAs have also been identified as modulators of key cellular pathways associated with resistance to CRT. Here, to identify miRNAs associated with resistance to CRT, pre-treatment diagnostic biopsy specimens from patients with OAC were analysed using miRNA-profiling arrays. In pre-treatment biopsies miR-330-5p was the most downregulated miRNA in patients who subsequently failed to respond to neo-CRT. The role of miR-330 as a potential modulator of tumour response and sensitivity to CRT in OAC was further investigated in vitro. Through vector-based overexpression the E2F1/p-AKT survival pathway, as previously described, was confirmed as a target of miR-330 regulation. However, miR-330-mediated alterations to the E2F1/p-AKT pathway were insufficient to significantly alter cellular sensitivity to chemotherapy (cisplatin and 5-flurouracil). In contrast, silencing of miR-330-5p enhanced, albeit subtly, cellular resistance to clinically relevant doses of radiation. This study highlights the need for further investigation into the potential of miR-330-5p as a predictive biomarker of patient sensitivity to neo-CRT and as a novel therapeutic target for manipulating cellular sensitivity to neo-CRT in patients with OAC.	[Bibby, Becky A. S.; Maher, Stephen G.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England; [Reynolds, John V.; Maher, Stephen G.] St James Hosp, Trin Coll Dublin, Inst Mol Med, Dept Surg, Dublin 8, Ireland	University of Hull; Trinity College Dublin	Maher, SG (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England.	s.maher@hull.ac.uk	Maher, Stephen/HHM-9099-2022	Reynolds, John V/0000-0002-5501-9521; Maher, Stephen/0000-0003-0126-7906	Cancer and Polio Research Fund; Irish Cancer Society [CRF10MAH]; University of Hull PhD scholarship	Cancer and Polio Research Fund; Irish Cancer Society; University of Hull PhD scholarship	This work was supported by the Cancer and Polio Research Fund (www.cprf.org.uk) awarded to SGM and the Irish Cancer Society (www.cancer.ie) CRF10MAH awarded to SGM. BASB is supported by a University of Hull PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Amin M, 2015, EXP MOL PATHOL, V98, P411, DOI 10.1016/j.yexmp.2015.03.002; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GIRLING DJ, 1992, EUR J CANCER, V28A, P1003, DOI 10.1016/0959-8049(92)90170-7; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gwynne S, 2014, CLIN ONCOL-UK, V26, P522, DOI 10.1016/j.clon.2014.05.015; Gwynne S, 2013, CLIN ONCOL-UK, V25, P368, DOI 10.1016/j.clon.2013.01.006; Hotte GJ, 2012, RADIAT RES, V177, P272, DOI 10.1667/RR2776.1; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kelsen DP, 2000, CANCER J, V6, pS177; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Lynam-Lennon N, 2010, RADIAT RES, V174, P703, DOI 10.1667/RR2295.1; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Mukherjee S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1062-y; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Qu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046010; Reynolds JV, 2007, ANN SURG, V245, P707, DOI 10.1097/01.sla.0000254367.15810.38; Sakai NS, 2013, SEMIN CANCER BIOL, V23, P512, DOI 10.1016/j.semcancer.2013.08.005; Shapiro J, 2014, ANN SURG, V260, P807, DOI 10.1097/SLA.0000000000000966; Skinner HD, 2014, CANCER-AM CANCER SOC, V120, P3635, DOI 10.1002/cncr.28911; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095060; Yoo JK, 2014, EXP GERONTOL, V58, P139, DOI 10.1016/j.exger.2014.07.020	40	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134180	10.1371/journal.pone.0134180	http://dx.doi.org/10.1371/journal.pone.0134180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221725	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800111
J	Han, LJ; Li, J; Chen, YT; Zhang, MJ; Qian, L; Chen, Y; Wu, ZZ; Xu, Y; Li, JW				Han, Lijuan; Li, Jie; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei			Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke	PLOS ONE			English	Article							HUMAN TISSUE KALLIKREIN; ISCHEMIC-STROKE; INHIBITING APOPTOSIS; IMMUNOCYTOCHEMICAL LOCALIZATION; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; LIMB ISCHEMIA; BRAIN-INJURY; APELIN; INFLAMMATION	Angiogenesisis a key restorative mechanism in response to ischemia, and pro-angiogenic therapy could be beneficial in stroke. Accumulating experimental and clinical evidence suggest that human urinary kallidinogenase (HUK) improves stroke outcome, but the underlying mechanisms are not clear. The aim of current study was to verify roles of HUK in post-ischemic angiogenesis and identify relevant mediators. In rat middle cerebral artery occlusion (MCAO) model, we confirmed that HUK treatment could improve stroke outcome, indicated by reduced infarct size and improved neurological function. Notably, the F-18-FDG micro-PET scan indicated that HUK enhanced cerebral perfusion in rats after MCAO treatment. In addition, HUK promotespost-ischemic angiogenesis, with increased vessel density as well as up-regulated VEGF andapelin/APJ expression in HUK-treated MCAO mice. In endothelial cell cultures, induction of VEGF and apelin/APJ expression, and ERK1/2 phosphorylation by HUK was further confirmed. These changes were abrogated by U0126, a selective ERK1/2 inhibitor. Moreover, F13A, a competitive antagonist of APJ receptor, significantly suppressed HUK-induced VEGF expression. Furthermore, angiogenic functions of HUK were inhibited in the presence of selective bradykinin B1 or B2 receptor antagonist both in vitro and in vivo. Our findings indicate that HUK treatment promotes post-ischemic angiogenesis and cerebral perfusion via activation of bradykinin B1 and B2 receptors, which is potentially due to enhancement expression of VEGF and apelin/APJ in ERK1/2 dependent way.	[Han, Lijuan; Li, Jie; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Han, Lijuan; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Nanjing Neuropsychiat Clin Med Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Jie] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Neurol, Yixing, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Jiangsu University	Xu, Y (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; ljw323@yeah.net		Schirmer, Claire/0000-0002-7994-1190	National Natural Science Foundation of China [81171085, 81230026, 81200896, 81400971]; Outstanding Researcher Program of Jiangsu Province [LJ 201101]; Natural Science Foundation of Jiangsu Province [BK 2009037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Researcher Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China, https://isisn.nsfc.gov.cn/egrantweb/, grant numbers: 81171085, 81230026 (YX), 81200896 (JL), 81400971 (YC); Outstanding Researcher Program of Jiangsu Province, http://www.jswst.gov.cn/index.html, grant number: LJ 201101 (YX); the Natural Science Foundation of Jiangsu Province, https://isisn.nsfc.gov.cn/egrantweb/, grant number: BK 2009037 (YX).	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chen ZB, 2010, J CEREBR BLOOD F MET, V30, P1356, DOI 10.1038/jcbfm.2010.19; Crafts TD, 2015, CYTOKINE, V71, P385, DOI 10.1016/j.cyto.2014.08.005; Emanueli C, 2004, ARCH MAL COEUR VAISS, V97, P679; Emanueli C, 2003, CURR PHARM DESIGN, V9, P589, DOI 10.2174/1381612033391315; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Liu L, 2009, J NEUROSCI RES, V87, P3576, DOI 10.1002/jnr.22151; Liu L, 2009, EXP NEUROL, V219, P453, DOI 10.1016/j.expneurol.2009.06.021; Lu RY, 2012, CNS NEUROSCI THER, V18, P395, DOI 10.1111/j.1755-5949.2012.00305.x; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Pizard A, 2008, BIOL CHEM, V389, P701, DOI 10.1515/BC.2008.081; Pons S, 2008, EUR J HEART FAIL, V10, P343, DOI 10.1016/j.ejheart.2008.02.002; Porcu P, 2002, CIRCULATION, V105, P67, DOI 10.1161/hc0102.101360; Smith RS, 2008, BIOL CHEM, V389, P725, DOI 10.1515/BC.2008.084; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Zhang Canfei, 2012, J Evid Based Med, V5, P31, DOI 10.1111/j.1756-5391.2012.01167.x; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	35	40	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134543	10.1371/journal.pone.0134543	http://dx.doi.org/10.1371/journal.pone.0134543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222055	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800153
J	Kan, CW; Au, CH				Kan, Chi-wai; Au, Chui-ha			In-Vitro Analysis of the Effect of Constructional Parameters and Dye Class on the UV Protection Property of Cotton Knitted Fabrics	PLOS ONE			English	Article							RING-SPUN YARNS; ULTRAVIOLET PROTECTION; WOVEN FABRICS; UNCONVENTIONAL SYSTEMS; SUMMER FABRICS; SKIN-CANCER; FIBER-TYPE; RADIATION; TRANSMISSION; COLOR	Cotton knitted fabrics were manufactured with different yarn types (conventional ring spun yarn and torque-free ring spun yarn) with different fibre types (combed cotton and combed Supima cotton) and yarn fineness (Ne30 and Ne40). These fabrics were then dyed with three types of dye (reactive, direct and sulphur dye) with three dye concentrations (0.1%, 1.0% and 5.0% on-weight of fabric (owf)) in three colours (red, yellow and blue). This study examined the impact of constructional parameters and dyeing on ultraviolet (UV) protection properties of cotton knitted fabric. In-vitro test with spectrophotometer was used for evaluating the UV protection property of dyed cotton knitted fabrics. Among the six parameters investigated, fineness of yarn and dye concentration were the most significant factors affecting UPF while the color effect is the least significant. Experimental results revealed that the UPF value of dyed fabrics made from combed cotton is generally higher than the combed Supima cotton since combed cotton is composed of shorter fibres which facilitate the blocking or absorption of UV radiation. Second, fabrics made with twist yarn (i.e. ring spun yarn) have higher UPF value than the corresponding ESTex one (i.e. torque-free yarn) in general since fabrics made with ring spun yarn tend to shrink during wet processing and so it is more compact. Third, the UPF value of fabrics made with 30Ne yarn was higher than the 40Ne one since it is thicker and has lower fabric porosity. Fourth, fabrics dyed with lower concentration of dye gave the lowest UPF. Fifth, the sulphur dyed samples performed worse than the reactive and direct dyed samples in terms of UV protection property. Sixth, there is no significant difference in UPF for red, yellow and blue coloured fabrics. Seventh, this study also demonstrated that lightness of fabric is negatively related to UV protection property.	[Kan, Chi-wai; Au, Chui-ha] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Kan, CW (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.	tccwk@polyu.edu.hk		Kan, Chi-wai/0000-0002-7668-2410	Hong Kong Polytechnic University	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	The authors received financial support from the Hong Kong Polytechnic University for this work.	Algaba I, 2004, AATCC REV, V4, P26; Algaba I, 2007, TEXT RES J, V77, P826, DOI 10.1177/0040517507080670; Algaba IM, 2008, FIBRES TEXT EAST EUR, V16, P85; Bajaj P, 2000, INDIAN J FIBRE TEXT, V25, P315; Capjack L., 1994, FAM CONSUM SCI RES J, V23, P198; Crews P.C., 1999, TEXT CHEM COLOR, V31, P17, DOI DOI 10.3403/00776353; Davis S, 1997, INT J DERMATOL, V36, P374, DOI 10.1046/j.1365-4362.1997.00046.x; Dimitrovski K, 2010, TEXT RES J, V80, P1027, DOI 10.1177/0040517509352527; Dubrovski PD, 2009, TEXT RES J, V79, P351, DOI 10.1177/0040517508090490; Gambichler T, 2002, PHOTODERMATOL PHOTO, V18, P29, DOI 10.1034/j.1600-0781.2002.180105.x; Hoffmann K, 2000, J AM ACAD DERMATOL, V43, P1009, DOI 10.1067/mjd.2000.107959; Hoffmann K, 2001, ARCH DERMATOL, V137, P1089; Kan CW, 2014, SCI WORLD J, DOI 10.1155/2014/506049; Kan CW, 2014, CARBOHYD POLYM, V101, P451, DOI 10.1016/j.carbpol.2013.09.044; Kan CW, 2013, MATERIALS, V6, P4985, DOI 10.3390/ma6114985; Kursun S, 2010, TEXT RES J, V80, P1811, DOI 10.1177/0040517510369401; Lau YM, 1997, TEXT RES J, V67, P815, DOI 10.1177/004051759706701106; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Paul R, 2010, TEXT RES J, V80, P454, DOI 10.1177/0040517509342316; Riva A, 2006, J TEXT I, V97, P349, DOI 10.1533/joti.2005.0162; Saladi RN, 2005, DRUG TODAY, V41, P37, DOI 10.1358/dot.2005.41.1.875777; Sarkar AK, 2007, PHOTODERMATOL PHOTO, V23, P191, DOI 10.1111/j.1600-0781.2007.00306.x; Srinivasan M, 2000, TEXT CHEM COLOR AM D, V32, P36; Stankovic SB, 2009, TEXT RES J, V79, P1034, DOI 10.1177/0040517508102016; Takuya T, 2010, RES J TEXTILE APPARE, V14, P9, DOI DOI 10.1108/RJTA-14-02-2010-B002; Tao XM, 1997, TEXT RES J, V67, P739, DOI 10.1177/004051759706701006; Urbas R, 2011, TEXT RES J, V81, P1916, DOI 10.1177/0040517511413326; Wan ML, 2010, COLOR TECHNOL, V126, P18, DOI 10.1111/j.1478-4408.2010.00222.x; Wilson CA, 2006, TEXT RES J, V76, P216, DOI 10.1177/0040517506060907; Wilson CA, 2008, TEXT RES J, V78, P95, DOI 10.1177/0040517508089660; World Health Organization, ULTR RAD HLTH; Xin JH, 2004, TEXT RES J, V74, P97, DOI 10.1177/004051750407400202; Yang K, 2007, TEXT RES J, V77, P675, DOI 10.1177/0040517507080545; Zhang YH, 2015, J TEXT I, V106, P648, DOI 10.1080/00405000.2014.933514; Zhou Y, 1998, TEXT CHEM COLOR, V30, P19	35	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133416	10.1371/journal.pone.0133416	http://dx.doi.org/10.1371/journal.pone.0133416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222792	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800050
J	Chennu, A; Volkenborn, N; de Beer, D; Wethey, DS; Woodin, SA; Polerecky, L				Chennu, Arjun; Volkenborn, Nils; de Beer, Dirk; Wethey, David S.; Woodin, Sarah A.; Polerecky, Lubos			Effects of Bioadvection by Arenicola marina on Microphytobenthos in Permeable Sediments	PLOS ONE			English	Article							PORE-WATER EXCHANGE; ORGANIC-MATTER; ANAEROBIC DECOMPOSITION; MICROSCALE DISTRIBUTION; INTERTIDAL SEDIMENTS; HYDRAULIC ACTIVITIES; BURROW VENTILATION; SANDY SEDIMENTS; ECOLOGICAL ROLE; SECRET GARDEN	We used hyperspectral imaging to study short-term effects of bioturbation by lugworms (Arenicola marina) on the surficial biomass of microphytobenthos (MPB) in permeable marine sediments. Within days to weeks after the addition of a lugworm to a homogenized and recomposed sediment, the average surficial MPB biomass and its spatial heterogeneity were, respectively, 150-250% and 280% higher than in sediments without lugworms. The surficial sediment area impacted by a single medium-sized lugworm (similar to 4 g wet weight) over this time-scale was at least 340 cm(2). While sediment reworking was the primary cause of the increased spatial heterogeneity, experiments with lugworm-mimics together with modeling showed that bioadvective porewater transport from depth to the sediment surface, as induced by the lugworm ventilating its burrow, was the main cause of the increased surficial MPB biomass. Although direct measurements of nutrient fluxes are lacking, our present data show that enhanced advective supply of nutrients from deeper sediment layers induced by faunal ventilation is an important mechanism that fuels high primary productivity at the surface of permeable sediments even though these systems are generally characterized by low standing stocks of nutrients and organic material.	[Chennu, Arjun; de Beer, Dirk; Polerecky, Lubos] Max Planck Inst Marine Microbiol, Bremen, Germany; [Volkenborn, Nils; Wethey, David S.; Woodin, Sarah A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Max Planck Society; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chennu, A (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	achennu@mpi-bremen.de	Chennu, Arjun/AAV-8003-2021; de Beer, Dirk/L-4840-2013; Wethey, David S/K-8063-2014; Woodin, Sarah A/K-8481-2014; Polerecky, Lubos/E-1134-2014	Chennu, Arjun/0000-0002-0389-5589; de Beer, Dirk/0000-0001-5274-1781; Wethey, David S/0000-0002-2549-1606; Woodin, Sarah A/0000-0001-5615-2212; Polerecky, Lubos/0000-0003-4425-585X	Marie Curie Initial Training Network "SENSEnet" [237868]; National Science Foundation [OCE0928002, OCE1129401]; NASA [NNX11AP77G]; Max Planck Society of Germany; Directorate For Geosciences [1129401] Funding Source: National Science Foundation	Marie Curie Initial Training Network "SENSEnet"; National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Max Planck Society of Germany(Max Planck Society); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this work was provided by the Marie Curie Initial Training Network "SENSEnet" (grant number: 237868), the National Science Foundation (OCE0928002, OCE1129401), NASA (NNX11AP77G) and the Max Planck Society of Germany.	Andresen M, 2002, OPHELIA, V56, P179, DOI 10.1080/00785236.2002.10409498; Banta GT, 1999, AQUAT MICROB ECOL, V19, P189, DOI 10.3354/ame019189; Berner R.A., 1980, EARLY DIAGENESIS THE; BEUKEMA JJ, 1979, NETH J SEA RES, V13, P331, DOI 10.1016/0077-7579(79)90010-3; BLACKBURN TH, 1983, LIMNOL OCEANOGR, V28, P477, DOI 10.4319/lo.1983.28.3.0477; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; Brito A, 2009, ESTUAR COAST SHELF S, V83, P67, DOI 10.1016/j.ecss.2009.03.023; BROTAS V, 1995, HYDROBIOLOGIA, V300, P93, DOI 10.1007/BF00024451; Cahoon LB, 1999, OCEANOGR MAR BIOL, V37, P47; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; de Beer D, 2005, LIMNOL OCEANOGR, V50, P113, DOI 10.4319/lo.2005.50.1.0113; de Beer D, 2002, ACS SYM SER, P227; Donadi S, 2013, ECOSYSTEMS, V16, P1325, DOI 10.1007/s10021-013-9686-8; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hulthe G, 1998, GEOCHIM COSMOCHIM AC, V62, P1319, DOI 10.1016/S0016-7037(98)00044-1; HYLLEBERG J, 1975, Ophelia, V14, P113; Koh CH, 2007, ESTUAR COAST SHELF S, V72, P42, DOI 10.1016/j.ecss.2006.10.005; KRAGER CD, 1993, LIMNOL OCEANOGR, V38, P509; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; KRISTENSEN E, 1985, J COASTAL RES, V1, P109; Kristensen E, 1995, LIMNOL OCEANOGR, V40, P1430, DOI 10.4319/lo.1995.40.8.1430; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; Lorenzen J, 1998, APPL ENVIRON MICROB, V64, P3264; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Malcolm S. J., 1997, BIOGEOCHEMISTRY INTE, P84, DOI [10.1017/CBO9780511524905.006, DOI 10.1017/CBO9780511524905.006]; Matsui GY, 2011, LIMNOL OCEANOGR-METH, V9, P84, DOI 10.4319/lom.2011.9.84; Meysman FJR, 2005, MAR ECOL PROG SER, V303, P195, DOI 10.3354/meps303195; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; Na T, 2008, J MAR RES, V66, P691, DOI 10.1357/002224008787536826; Precht E, 2004, LIMNOL OCEANOGR, V49, P693, DOI 10.4319/lo.2004.49.3.0693; Precht E, 2003, LIMNOL OCEANOGR, V48, P1674, DOI 10.4319/lo.2003.48.4.1674; Rao AMF, 2014, ESTUAR COAST SHELF S, V148, P36, DOI 10.1016/j.ecss.2014.06.006; Reise K., 1985, TIDAL FLAT ECOLOGY E; Riisgard HU, 1998, VIE MILIEU, V48, P243; Riisgard HU, 1996, MAR ECOL PROG SER, V138, P149, DOI 10.3354/meps138149; Stal LJ, 2010, ECOL ENG, V36, P236, DOI 10.1016/j.ecoleng.2008.12.032; SUN MY, 1993, GEOCHIM COSMOCHIM AC, V57, P147; Thornton DCO, 1999, MAR ECOL PROG SER, V184, P11, DOI 10.3354/meps184011; Timmermann K, 2003, VIE MILIEU, V53, P187; Timmermann K, 2006, J MAR RES, V64, P915, DOI 10.1357/002224006779698378; Volkenborn N, 2007, LIMNOL OCEANOGR, V52, P1898, DOI 10.4319/lo.2007.52.5.1898; Volkenborn N, 2007, ESTUAR COAST SHELF S, V74, P331, DOI 10.1016/j.ecss.2007.05.001; Volkenborn N, 2006, J EXP MAR BIOL ECOL, V330, P169, DOI 10.1016/j.jembe.2005.12.025; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; Wells G, 1966, J SEA RES, V3, P294; Wethey DS, 2008, J MAR RES, V66, P255, DOI 10.1357/002224008785837121; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031	48	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134236	10.1371/journal.pone.0134236	http://dx.doi.org/10.1371/journal.pone.0134236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230398	Green Published, gold			2022-12-26	WOS:000358838400090
J	Ennequin, G; Boisseau, N; Caillaud, K; Chavanelle, V; Etienne, M; Li, XY; Sirvent, P				Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Li, Xinyan; Sirvent, Pascal			Neuregulin 1 Improves Glucose Tolerance in db/db Mice	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; INSULIN ACTION; MUSCLE-CELLS; CARDIAC DEVELOPMENT; SKELETAL-MUSCLE; GENE-EXPRESSION; FACTOR FKHR; HEREGULIN; ERBB3; LIVER	In vitro experiments using rodent skeletal muscle cells suggest that neuregulin 1 (NRG1) is involved in glucose metabolism regulation, although no study has evaluated the role of NRG1 in systemic glucose homeostasis. The purpose of this study was to investigate the effect of chronic and acute NRG1 treatment on glucose homeostasis in db/db mice. To this aim, glucose tolerance tests were performed in 8-week-old male db/db mice after treatment with NRG1 (50 mu g.kg(-1)) or saline 3 times per week for 8 weeks. In other experiments, glucose tolerance and pyruvate tolerance tests were performed in db/db mice 15 minutes after a single NRG1 (50 mu g.kg(-1)) or saline injection. Liver, adipose tissue, hypothalamus and skeletal muscle were also collected 30 minutes after acute NRG1 (50 mu g.kg(-1)) or saline treatment, and the phosphorylation status of the ERBB receptors, AKT (on Ser473) and FOXO1 (on Ser256) was assessed by western blotting. Chronic treatment (8 weeks) with NRG1 improved glucose tolerance in db/db mice. Acute treatment also lowered glycemia and insulinemia during glucose or pyruvate tolerance tests. NRG1 acute injection induced activation of ERBB3 receptors and phosphorylation of AKT and FOXO1 only in liver. Altogether, this study shows that acute and chronic NRG1 treatments improve glucose tolerance in db/db mice. This effect could be mediated through inhibition of hepatic gluconeogenesis.	[Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Sirvent, Pascal] Univ Clermont Ferrand, Univ Clermont Auvergne, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, F-63171 Aubiere, France; [Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Sirvent, Pascal] CRNH Auvergne, F-63001 Clermont Ferrand, France; [Li, Xinyan] Zensun Sci & Tech Ltd, Shanghai, Peoples R China	Universite Clermont Auvergne (UCA)	Sirvent, P (corresponding author), Univ Clermont Ferrand, Univ Clermont Auvergne, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-63171 Aubiere, France.	pascal.sirvent@univ-bpclermont.fr		CAILLAUD, Kevin/0000-0003-3139-9475	Zensun Sci Tech Ltd.	Zensun Sci Tech Ltd.	The authors received no specific funding for this work. Zensun Sci & Tech Ltd. provided support in the form of salary for author (XL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Barnett AH, 2013, CURR MED RES OPIN, V29, P1503, DOI 10.1185/03007995.2013.834250; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Camprecios G, 2011, J CELL PHYSIOL, V226, P450, DOI 10.1002/jcp.22354; Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Canto C, 2007, DIABETES, V56, P2185, DOI 10.2337/db06-1726; Canto C, 2006, J BIOL CHEM, V281, P21690, DOI 10.1074/jbc.M600475200; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Carver RS, 1996, J BIOL CHEM, V271, P13491, DOI 10.1074/jbc.271.23.13491; Carver RS, 2002, GASTROENTEROLOGY, V123, P2017, DOI 10.1053/gast.2002.37060; Carver RS, 1997, ENDOCRINOLOGY, V138, P5195, DOI 10.1210/en.138.12.5195; Cherrington AD, 2007, BIOCHEM SOC T, V35, P1171, DOI 10.1042/BST0351171; Cote GM, 2005, EXP CELL RES, V311, P135, DOI 10.1016/j.yexcr.2005.08.017; Ennequin G, 2015, DIABETES METAB, V41, P168, DOI 10.1016/j.diabet.2014.12.002; Ennequin G, 2015, J PHYSIOL-LONDON, V593, P2665, DOI 10.1113/JP270026; Erickson SL, 1997, DEVELOPMENT, V124, P4999; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Guma A, 2010, AM J PHYSIOL-ENDOC M, V298, pE742, DOI 10.1152/ajpendo.00541.2009; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miller TA, 2009, BIOCHEM BIOPH RES CO, V379, P32, DOI 10.1016/j.bbrc.2008.11.150; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; SHERWIN RS, 1980, DIABETES CARE, V3, P261, DOI 10.2337/diacare.3.2.261; South JCM, 2013, ENDOCRINOLOGY, V154, P2385, DOI 10.1210/en.2012-2133; Suarez E, 2001, J BIOL CHEM, V276, P18257, DOI 10.1074/jbc.M008100200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tappy L, 2001, CURR OPIN CLIN NUTR, V4, P273, DOI 10.1097/00075197-200107000-00005; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319; Wallia A, 2014, JAMA-J AM MED ASSOC, V311, P2315, DOI 10.1001/jama.2014.5951; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yanai H, 2015, WORLD J DIABETES, V6, P30, DOI 10.4239/wjd.v6.i1.30; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	51	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130568	10.1371/journal.pone.0130568	http://dx.doi.org/10.1371/journal.pone.0130568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230680	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400006
J	Hatt, L; Aagaard, MM; Graakjaer, J; Bach, C; Sommer, S; Agerholm, IE; Kolvraa, S; Bojesen, A				Hatt, Lotte; Aagaard, Mads M.; Graakjaer, Jesper; Bach, Cathrine; Sommer, Steffen; Agerholm, Inge E.; Kolvraa, Steen; Bojesen, Anders			Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA - Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis	PLOS ONE			English	Article							CIRCULATION; TRISOMY-21	Epigenetic markers for cell free fetal DNA in the maternal blood circulation are highly interesting in the field of non-invasive prenatal testing since such markers will offer a possibility to quantify the amount of fetal DNA derived from different chromosomes in a maternal blood sample. The aim of the present study was to define new fetal specific epigenetic markers present in placental DNA that can be utilized in non-invasive prenatal diagnosis. We have conducted a high-resolution methylation specific beadchip microarray study assessing more than 450.000 CpG sites. We have analyzed the DNA methylation profiles of 10 maternal blood samples and compared them to 12 1st trimesters chorionic samples from normal placentas, identifying a number of CpG sites that are differentially methylated in maternal blood cells compared to chorionic tissue. To strengthen the utility of these differentially methylated CpG sites to be used with methyl-sensitive restriction enzymes (MSRE) in PCR-based NIPD, we furthermore refined the list of selected sites, containing a restriction sites for one of 16 different methylation-sensitive restriction enzymes. We present a list of markers on chromosomes 13, 18 and 21 with a potential for aneuploidy testing as well as a list of markers for regions harboring sub-microscopic deletion- or duplication syndromes.	[Hatt, Lotte; Aagaard, Mads M.; Graakjaer, Jesper; Kolvraa, Steen; Bojesen, Anders] Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark; [Hatt, Lotte; Bach, Cathrine; Sommer, Steffen; Agerholm, Inge E.] Horsens Hosp, Dept Gynecol & Obstet, DK-8700 Horsens, Denmark; [Hatt, Lotte; Kolvraa, Steen; Bojesen, Anders] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark	University of Southern Denmark; Lillebaelt Hospital; Aarhus University; University of Southern Denmark	Hatt, L (corresponding author), Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark.	lotte@hatt.nu		Bojesen, Anders Miki/0000-0003-4030-0019	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond	Funding was provided by the University of Southern Denmark(LH), Jorgen Werner Schous Fond (AB), Det Videnskabelige Fond ved Horsens Sygehus(SS), Familien Hede-Nielsens Fond(LH), and Aase og Ejner Danielsens Fond(LH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PHEATMAP PRETTY HEAT; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Bunce K, 2012, PRENATAL DIAG, V32, P542, DOI 10.1002/pd.3853; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Hatt L, 2014, FETAL DIAGN THER, V35, P218, DOI 10.1159/000356073; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Lapaire O, 2007, PLACENTA, V28, P1, DOI 10.1016/j.placenta.2006.02.004; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Mersy E, 2013, HUM REPROD UPDATE, V19, P318, DOI 10.1093/humupd/dmt001; Ou XL, 2014, TRANSFUSION, V54, P2523, DOI 10.1111/trf.12659; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Petersen OB, 2014, ULTRASOUND OBST GYN, V43, P265, DOI 10.1002/uog.13270; R Core Team, 2013, LANG ENV STAT COMP; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsaliki E, 2012, PRENATAL DIAG, V32, P996, DOI 10.1002/pd.3947; Xiang YQ, 2014, MOL HUM REPROD, V20, P875, DOI 10.1093/molehr/gau048	20	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0128918	10.1371/journal.pone.0128918	http://dx.doi.org/10.1371/journal.pone.0128918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230497	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400003
J	Rapacz, M; Sasal, M; Kalaji, HM; Cielniak, JK				Rapacz, Marcin; Sasal, Monika; Kalaji, Hazem M.; Cielniak, Janusz Ko			Is the OJIP Test a Reliable Indicator of Winter Hardiness and Freezing Tolerance of Common Wheat and Triticale under Variable Winter Environments?	PLOS ONE			English	Article							VIVO CHLOROPHYLL FLUORESCENCE; LOW-TEMPERATURE; COLD-ACCLIMATION; FROST TOLERANCE; PHOTOSYSTEM-II; SURVIVAL; STRESS; EFFICIENCY; PLANTS; PHOTOINHIBITION	OJIP analysis, which explores changes in photosystem II (PSII) photochemical performance, has been used as a measure of plant susceptibility to stress. However, in the case of freezing tolerance and winter hardiness, which are highly environmentally variable, the use of this method can give ambiguous results depending on the species as well as the sampling year and time. To clarify this issue, we performed chlorophyll fluorescence measurements over three subsequent winters (2010/11, 2011/12 and 2012/13) on 220 accessions of common winter wheat and 139 accessions of winter triticale. After freezing, leaves were collected from cold-acclimated plants in the laboratory and field-grown plants. Observations of field survival in seven locations across Poland and measurements of freezing tolerance of the studied plants were also recorded. Our results confirm that the OJIP test is a reliable indicator of winter hardiness and freezing tolerance of common wheat and triticale under unstable winter environments. Regardless of species, the testing conditions giving the most reliable results were identical, and the reliability of the test could be easily checked by analysis of some relationships between OJIP-test parameters. We also found that triticale is more winter hardy and freezing tolerant than wheat. In addition, the two species were characterized by different patterns of photosynthetic apparatus acclimation to cold.	[Rapacz, Marcin; Sasal, Monika; Cielniak, Janusz Ko] Agr Univ Krakow, Fac Agr & Econ, Dept Plant Physiol, Krakow, Poland; [Kalaji, Hazem M.] Warsaw Univ Life Sci, Dept Plant Physiol, Fac Agr & Biol, Warsaw, Poland	Agricultural University Krakow; Warsaw University of Life Sciences	Rapacz, M (corresponding author), Agr Univ Krakow, Fac Agr & Econ, Dept Plant Physiol, Krakow, Poland.	rrrapacz@cyf-kr.edu.pl	Rapacz, Marcin/T-8263-2017; Kalaji, Mohamed Hazem/E-8086-2012	Rapacz, Marcin/0000-0003-1071-1159; Kalaji, Mohamed Hazem/0000-0002-3833-4917	Ministry of Agriculture and Rural Development (Poland) [HOR hn 801-19/11, HOR hn 801-21/11, HOR hn 801-18/12, HOR hn 801-19/12, HOR hn 801-7/13, HOR hn 801-8/13, HOR hn 801-10/14]; University of Agriculture in Poland [DS 3113]	Ministry of Agriculture and Rural Development (Poland); University of Agriculture in Poland	This work was supported by Ministry of Agriculture and Rural Development (Poland) - Grant No. HOR hn 801-19/11, 21/11, 18/12, 19/12, 7/13, 8/13, 10/14. http://www.minrol.gov.pl/eng; and University of Agriculture in Poland (DS 3113). http://www.ur.krakow.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Badeck FW, 2015, AGRONOMY-BASEL, V5, P71, DOI 10.3390/agronomy5010071; Borawska-Jarmulowicz B, 2014, PLANT SOIL ENVIRON, V60, P177, DOI 10.17221/57/2014-PSE; Borawska-Jarmulowicz B, 2014, RUSS J PLANT PHYSL+, V61, P281, DOI 10.1134/S1021443714030029; CHERNEV P, 2006, ECOL ENG ENV PROTECT, V5, P19; Crosatti C, 2013, PHYSIOL PLANTARUM, V147, P55, DOI 10.1111/j.1399-3054.2012.01689.x; Gusta LV, 2013, PHYSIOL PLANTARUM, V147, P4, DOI 10.1111/j.1399-3054.2012.01611.x; Gusta LV, 2001, CAN J PLANT SCI, V81, P241, DOI 10.4141/P00-068; HOMMO LM, 1994, PLANT BREEDING, V112, P285, DOI 10.1111/j.1439-0523.1994.tb00686.x; Huner NPA, 2013, BOTANY, V91, P127, DOI 10.1139/cjb-2012-0174; Humphreys MW, 2007, EUPHYTICA, V158, P337, DOI 10.1007/s10681-006-9240-2; HUNER NPA, 1993, PHOTOSYNTH RES, V37, P19, DOI 10.1007/BF02185436; Kalaji HM, 2014, PLANT PHYSIOL BIOCH, V81, P16, DOI 10.1016/j.plaphy.2014.03.029; Kalaji HM, 2012, J PHOTOCH PHOTOBIO B, V112, P1, DOI 10.1016/j.jphotobiol.2012.03.009; Kalaji HM, 2011, OMICS, V15, P925, DOI 10.1089/omi.2011.0070; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; LIMIN AE, 1985, CAN J PLANT SCI, V65, P487, DOI 10.4141/cjps85-070; Mishra A, 2011, PLANT SIGNAL BEHAV, V6, P301, DOI 10.4161/psb.6.2.15278; Neuner G, 1999, J APPL BOT-ANGEW BOT, V73, P50; Prasil IT, 2007, FIELD CROP RES, V102, P1, DOI 10.1016/j.fcr.2006.12.012; Rapacz M, 2008, J AGRON CROP SCI, V194, P61, DOI 10.1111/j.1439-037X.2007.00292.x; Rapacz M, 2007, PHOTOSYNTHETICA, V45, P409, DOI 10.1007/s11099-007-0069-2; Rapacz M, 2004, NEW PHYTOL, V162, P105, DOI 10.1111/j.1469-8137.2004.01024.x; Rapacz M, 2011, J AGRON CROP SCI, V197, P378, DOI 10.1111/j.1439-037X.2011.00472.x; Rapacz M, 2010, J AGRON CROP SCI, V196, P9, DOI 10.1111/j.1439-037X.2009.00389.x; Rapacz M, 2009, PLANT BREEDING, V128, P227, DOI 10.1111/j.1439-0523.2008.01566.x; Rapacz M, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1907-7; Rapacz M, 2014, PLANT SCI, V225, P34, DOI 10.1016/j.plantsci.2014.05.009; Rizza F, 2001, PLANT BREEDING, V120, P389, DOI 10.1046/j.1439-0523.2001.00635.x; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Soja G, 1998, PHYSIOL PLANTARUM, V104, P639, DOI 10.1034/j.1399-3054.1998.1040417.x; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Taulavuori K, 2000, J PLANT PHYSIOL, V157, P227, DOI 10.1016/S0176-1617(00)80195-9; Yan K, 2013, IND CROP PROD, V50, P809, DOI 10.1016/j.indcrop.2013.08.012; Yan K, 2013, ACTA PHYSIOL PLANT, V35, P2867, DOI 10.1007/s11738-013-1325-7; Yan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062100; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475	40	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134820	10.1371/journal.pone.0134820	http://dx.doi.org/10.1371/journal.pone.0134820			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230839	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400172
J	Romsang, A; Duang-nkern, J; Wirathorn, W; Vattanaviboon, P; Mongkolsuk, S				Romsang, Adisak; Duang-nkern, Jintana; Wirathorn, Wilaiwan; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Pseudomonas aeruginosa IscR-Regulated Ferredoxin NADP(+) Reductase Gene (fprB) Functions in Iron-Sulfur Cluster Biogenesis and Multiple Stress Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEPENDENT REGULATION; OXIDATIVE STRESS; SUCCINATE-DEHYDROGENASE; SUPEROXIDE STRESS; SOXRS RESPONSE; EXPRESSION; BINDING; 4FE-4S; SUSCEPTIBILITY	P. aeruginosa (PAO1) has two putative genes encoding ferredoxin NADP(+) reductases, denoted fprA and fprB. Here, the regulation of fprB expression and the protein's physiological roles in [4Fe-4S] cluster biogenesis and stress protection are characterized. The fprB mutant has defects in [4Fe-4S] cluster biogenesis, as shown by reduced activities of [4Fe-4S] cluster-containing enzymes. Inactivation of the gene resulted in increased sensitivity to oxidative, thiol, osmotic and metal stresses compared with the PAO1 wild type. The increased sensitivity could be partially or completely suppressed by high expression of genes from the isc operon, which are involved in [Fe-S] cluster biogenesis, indicating that stress sensitivity in the fprB mutant is partially caused by a reduction in levels of [4Fe-4S] clusters. The pattern and regulation of fprB expression are in agreement with the gene physiological roles; fprB expression was highly induced by redox cycling drugs and diamide and was moderately induced by peroxides, an iron chelator and salt stress. The stress-induced expression of fprB was abolished by a deletion of the iscR gene. An IscR DNA-binding site close to fprB promoter elements was identified and confirmed by specific binding of purified IscR. Analysis of the regulation of fprB expression supports the role of IscR in directly regulating fprB transcription as a transcription activator. The combination of IscRr-egulated expression of fprB and the fprB roles in response to multiple stressors emphasizes the importance of [Fe-S] cluster homeostasis in both gene regulation and stress protection.	[Romsang, Adisak; Wirathorn, Wilaiwan; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Ctr Excellence Emerging Bacterial Infect, Bangkok 10400, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Mongkolsuk, Skorn] Minist Educ, Ctr Excellence Environm Hlth & Toxicol EHT, Bangkok, Thailand	Mahidol University; Chulabhorn Research Institute; Mahidol University; Chulabhorn Graduate Institute	Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	skorn.mon@mahidol.ac.th	Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/K-2630-2019; Romsang, Adisak/H-7142-2014	Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Program from Thailand Research Fund [PHD/0294/2550]; Royal Golden Jubilee Ph.D. Program from Mahidol University [PHD/0294/2550]	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Program from Thailand Research Fund; Royal Golden Jubilee Ph.D. Program from Mahidol University	This work was supported by grants from the Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand (http://www.etm.sc.mahidol.ac.th/index.asp), the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php) and by the Royal Golden Jubilee Ph.D. Program (PHD/0294/2550) from the joint funding of Thailand Research Fund and Mahidol University (http://rgj.trf.or.th/eng/rgje11.asp). Parts of this work are from A.R. dissertation submitted for a Ph.D. degree from Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Daung-nkern J, 2010, J ANTIMICROB CHEMOTH, V65, P1831, DOI 10.1093/jac/dkq194; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; EnosBerlage JL, 1997, J BACTERIOL, V179, P3989, DOI 10.1128/jb.179.12.3989-3996.1997; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; JOHNSON MK, 1985, J BIOL CHEM, V260, P7368; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tondo ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027124; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; Lewis TA, 2013, J BACTERIOL, V195, P3876, DOI 10.1128/JB.00528-13; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11; Medina M, 2008, PROTEINS, V72, P848, DOI 10.1002/prot.21979; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Prasad GS, 1998, PROTEIN SCI, V7, P2541, DOI 10.1002/pro.5560071207; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Shin M, 2004, PHOTOSYNTH RES, V80, P307, DOI 10.1023/B:PRES.0000030456.96329.f9; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Thorgersen MP, 2009, MICROBIOL-SGM, V155, P295, DOI 10.1099/mic.0.020727-0; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0	60	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134374	10.1371/journal.pone.0134374	http://dx.doi.org/10.1371/journal.pone.0134374			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230408	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400112
J	Butler, BE; Hall, AJ; Lomber, SG				Butler, Blake E.; Hall, Amee J.; Lomber, Stephen G.			High-Field Functional Imaging of Pitch Processing in Auditory Cortex of the Cat	PLOS ONE			English	Article							BOLD SIGNAL CHANGES; SOUND LOCALIZATION; POSTERIOR FIELD; TONOTOPIC MAPS; REPRESENTATION; ORGANIZATION; PERIODICITY; PERCEPTION; RESPONSES; NOISE	The perception of pitch is a widely studied and hotly debated topic in human hearing. Many of these studies combine functional imaging techniques with stimuli designed to disambiguate the percept of pitch from frequency information present in the stimulus. While useful in identifying potential "pitch centres" in cortex, the existence of truly pitch-responsive neurons requires single neuron-level measures that can only be undertaken in animal models. While a number of animals have been shown to be sensitive to pitch, few studies have addressed the location of cortical generators of pitch percepts in non-human models. The current study uses high-field functional magnetic resonance imaging (fMRI) of the feline brain in an attempt to identify regions of cortex that show increased activity in response to pitch-evoking stimuli. Cats were presented with iterated rippled noise (IRN) stimuli, narrowband noise stimuli with the same spectral profile but no perceivable pitch, and a processed IRN stimulus in which phase components were randomized to preserve slowly changing modulations in the absence of pitch (IRNo). Pitch-related activity was not observed to occur in either primary auditory cortex (A1) or the anterior auditory field (AAF) which comprise the core auditory cortex in cats. Rather, cortical areas surrounding the posterior ectosylvian sulcus responded preferentially to the IRN stimulus when compared to narrowband noise, with group analyses revealing bilateral activity centred in the posterior auditory field (PAF). This study demonstrates that fMRI is useful for identifying pitch-related processing in cat cortex, and identifies cortical areas that warrant further investigation. Moreover, we have taken the first steps in identifying a useful animal model for the study of pitch perception.	[Butler, Blake E.; Lomber, Stephen G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Butler, Blake E.; Lomber, Stephen G.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Hall, Amee J.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Butler, BE (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	bbutler9@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909	Natural Sciences and Engineering Research Council; Canadian Institutes for Health Research; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Funding for this project was provided by the Natural Sciences and Engineering Research Council, the Canadian Institutes for Health Research, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 2012, CEREB CORTEX, V22, P745, DOI 10.1093/cercor/bhr065; Barker D, 2011, NEUROREPORT, V22, P111, DOI 10.1097/WNR.0b013e328342ba30; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Brown TA, 2013, NEUROIMAGE, V64, P458, DOI 10.1016/j.neuroimage.2012.09.034; Butler BE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00180; CHUNG DY, 1976, PERCEPT PSYCHOPHYS, V20, P433, DOI 10.3758/BF03208278; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; DYSON DH, 1988, CAN J VET RES, V52, P419; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Hall AJ, 2014, J NEUROSCI METH, V224, P96, DOI 10.1016/j.jneumeth.2013.12.012; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Hall DA, 2007, NEUROREPORT, V18, P323, DOI 10.1097/WNR.0b013e32802b70ce; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; Harrington IA, 2008, HEARING RES, V240, P22, DOI 10.1016/j.heares.2008.02.004; HEFFNER H, 1976, J ACOUST SOC AM, V59, P915, DOI 10.1121/1.380951; Heil P, 1998, CEREB CORTEX, V8, P125, DOI 10.1093/cercor/8.2.125; HU XP, 1994, MAGN RESON MED, V31, P495, DOI 10.1002/mrm.1910310505; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Langers D, 2014, INT C AUD CORT MAGD; Langner G, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.027.2009; Lee CC, 2011, HEARING RES, V274, P85, DOI 10.1016/j.heares.2010.05.008; Loftus WC, 2001, J NEUROPHYSIOL, V86, P475, DOI 10.1152/jn.2001.86.1.475; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Oxenham AJ, 2012, J NEUROSCI, V32, P13335, DOI 10.1523/JNEUROSCI.3815-12.2012; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PHILLIPS DP, 1984, J NEUROPHYSIOL, V51, P147, DOI 10.1152/jn.1984.51.1.147; Puschmann S, 2010, NEUROIMAGE, V49, P1641, DOI 10.1016/j.neuroimage.2009.09.045; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Schafer K, 2012, NEUROIMAGE, V59, P3119, DOI 10.1016/j.neuroimage.2011.11.085; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134362	10.1371/journal.pone.0134362	http://dx.doi.org/10.1371/journal.pone.0134362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225563	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700079
J	Chen, C; Cai, JJ; Zhang, S; Gan, L; Dong, YL; Zhu, T; Ma, G; Li, T; Zhang, XY; Li, Q; Cheng, X; Wu, CM; Yang, J; Zuo, YX; Liu, J				Chen, Chan; Cai, Jingjing; Zhang, Shu; Gan, Lu; Dong, Yuanlin; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin			Protective Effect of RNase on Unilateral Nephrectomy-Induced Postoperative Cognitive Dysfunction in Aged Mice	PLOS ONE			English	Article							EXTRACELLULAR RNA; SURGERY; DECLINE; RESPONSES; DELIRIUM; BRAIN; DRUGS	Postoperative cognitive dysfunction (POCD) is a common complication after surgery, especially for elderly patients. Administration of RNase has been reported to exhibit neuroprotective effects in acute stroke. However, the potential role of RNase on POCD is unknown. Therefore, we sought to investigate whether RNase treatment could mitigate unilateral nephrectomy induced-cognitive deficit in aged mice. In the present study, twelve-month-old mice were administered RNase or an equal amount of normal saline perioperatively. All mice underwent Morris Water Maze (MWM) training 3 times per day for 7 days to acclimatize them to the water maze before surgical operation, and testing on days 1, 3 and 7 after surgery. We found that perioperative administration of RNase: 1) attenuated unilateral nephrectomy-induced cognitive impairment at day 3 after surgery; 2) reduced the hippocampal cytokines mRNA production and serum cytokines protein production at day 1 and day 7 (for MCP-1) after surgery, and; 3) inhibited hippocampal apoptosis as indicated by cleaved caspase-3 western blot and TUNEL staining at day 1 after surgery. In addition, a trend decrease of total serum RNA levels was detected in the RNase treated group after surgery compared with the untreated group. Further, our protocol of RNase administration had no impact on the arterial blood gas analysis right after surgery, kidney function and mortality rate at the observed days postoperatively. In conclusion, perioperative RNase treatment attenuated unilateral nephrectomy-induced cognitive impairment in aged mice.	[Chen, Chan; Cai, Jingjing; Gan, Lu; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Sichuan, Peoples R China; [Chen, Chan; Cai, Jingjing; Gan, Lu; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Shu] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu 610064, Sichuan, Peoples R China; [Dong, Yuanlin] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Boston, MA 02114 USA; [Dong, Yuanlin] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Sichuan University; Sichuan University; Sichuan University; Harvard University; Massachusetts General Hospital; Harvard University	Li, T (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Sichuan, Peoples R China.	xwtao_zhu@yahoo.com	Li, Tao/ADA-1377-2022	Dong, Yuanlin/0000-0002-4760-0519; Chen, Chan/0000-0001-5823-8247; Liu, Jin/0000-0002-2026-2513	China Medical Board [0082827601157]; Science and Technology Pillar Program of Sichuan Province Research Grant [2014sz0056]	China Medical Board; Science and Technology Pillar Program of Sichuan Province Research Grant	This work was financially supported by Distinguished Professorships Awards (no. 0082827601157, to JL) from the China Medical Board (URLs: http://www.chinamedicalboard.org/active_grants), and the Science and Technology Pillar Program of Sichuan Province Research Grant (no. 2014sz0056, to CC) (URLs: http://xmgl.scst.gov.cn/index.html).	Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; BAYNES JW, 1976, J BIOL CHEM, V251, P6016; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Kong FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061385; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Li YC, 2012, ACTA ANAESTH SCAND, V56, P595, DOI 10.1111/j.1399-6576.2011.02616.x; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Rudolph JL, 2008, J GERONTOL A-BIOL, V63, P184, DOI 10.1093/gerona/63.2.184; Rybak SM, 2009, CURR PHARM DESIGN, V15, P2665, DOI 10.2174/138161209788923921; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Simsekyilmaz S, 2014, CIRCULATION, V129, P598, DOI 10.1161/CIRCULATIONAHA.113.002562; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Vizcaychipi MP, 2014, ANN SURG, V259, P1235, DOI 10.1097/SLA.0000000000000257; Vlisides P, 2014, J ANESTH PERIOPER ME, V1, P60; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb	28	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134307	10.1371/journal.pone.0134307	http://dx.doi.org/10.1371/journal.pone.0134307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225860	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700071
J	Hu, ZL; Holzschuh, J; Driever, W				Hu, Zhilian; Holzschuh, Jochen; Driever, Wolfgang			Loss of DDB1 Leads to Transcriptional p53 Pathway Activation in Proliferating Cells, Cell Cycle Deregulation, and Apoptosis in Zebrafish Embryos	PLOS ONE			English	Article							DNA-BINDING PROTEIN-1; NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; DAMAGED DNA; GENOME STABILITY; S-PHASE; XERODERMA-PIGMENTOSUM; DANIO-RERIO; GENES DDB1; DEGRADATION	DNA damage-binding protein 1 (DDB1) is a large subunit of the heterodimeric DDB complex that recognizes DNA lesions and initiates the nucleotide excision repair process. DDB1 is also a component of the CUL4 E3 ligase complex involved in a broad spectrum of cellular processes by targeted ubiquitination of key regulators. Functions of DDB1 in development have been addressed in several model organisms, however, are not fully understood so far. Here we report an ENU induced mutant ddb1 allele (ddb1(m863)) identified in zebrafish (Danio rerio), and analyze its effects on development. Zebrafish ddb1 is expressed broadly, both maternally and zygotically, with enhanced expression in proliferation zones. The (ddb1(m863) mutant allele affects the splice acceptor site of exon 20, causing a splicing defect that results in truncation of the 1140 amino acid protein after residue 800, lacking part of the beta-propeller domain BPC and the C-terminal helical domain CTD. ddb1(m863) zygotic mutant embryos have a pleiotropic phenotype, including smaller and abnormally shaped brain, head skeleton, eyes, jaw, and branchial arches, as well as reduced dopaminergic neuron groups. However, early forming tissues develop normally in zygotic ddb1(m863) mutant embryos, which may be due to maternal rescue. In ddb1(m863) mutant embryos, pcna-expressing proliferating cell populations were reduced, concurrent with increased apoptosis. We also observed a concomitant strong up-regulation of transcripts of the tumor suppressor p53 (tp53) and the cell cycle inhibitor cdkn1a (p21a/b(CIP1/WAF1)) in proliferating tissues. In addition, transcription of cyclin genes ccna2 and ccnd1 was deregulated in ddb1(m863) mutants. Reduction of p53 activity by anti-sense morpholinos alleviated the apoptotic phenotype in ddb1(m863) mutants. These results imply that Ddb1 may be involved in maintaining proper cell cycle progression and viability of dividing cells during development through transcriptional mechanisms regulating genes involved in cell cycle control and cell survival.	[Hu, Zhilian; Holzschuh, Jochen; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Dev Biol, Fac Biol, D-79104 Freiburg, Germany; [Hu, Zhilian] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Driever, Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Michigan System; University of Michigan; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Dev Biol, Fac Biol, Hauptstr 1, D-79104 Freiburg, Germany.	driever@biologie.uni-freiburg.de	HU, ZHILIANN/AIF-3594-2022	Driever, Wolfgang/0000-0002-9551-9141; HU, ZHILIAN/0000-0002-1632-6318	LGFG (State of Baden-Wurttemberg); EC; Excellence Initiative of the German Federal Government [DFG BIOSS - EXC 294]; German Research Foundation (DFG); Albert Ludwigs University Freiburg; Excellence Initiative of the German State Government [DFG BIOSS - EXC 294]	LGFG (State of Baden-Wurttemberg); EC(European CommissionEuropean Commission Joint Research Centre); Excellence Initiative of the German Federal Government; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; Excellence Initiative of the German State Government	This work was supported by a fellowship of the LGFG (State of Baden-Wurttemberg; www.mwk.baden-wuerttemberg.de) (ZH), by the EC programs EU-FP6 IP ZF-MODELS and EU-FP7 IP ZF-HEALTH (www.http://ec.europa.eu/research/), and the Excellence Initiative of the German Federal and State Governments (DFG BIOSS - EXC 294; www.dfg.de). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Bernhardt A, 2010, PLANTA, V232, P555, DOI 10.1007/s00425-010-1195-9; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bevilacqua MA, 2005, J BIOL CHEM, V280, P31809, DOI 10.1074/jbc.M414677200; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cheng R, 1997, MOL MAR BIOL BIOTECH, V6, P88; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Cid E, 2002, CELL TISSUE RES, V308, P47, DOI 10.1007/s00441-002-0529-8; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Desdouets C, 1996, FEBS LETT, V385, P34, DOI 10.1016/0014-5793(96)00330-4; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo ZY, 2009, BBA-GENE REGUL MECH, V1789, P758, DOI 10.1016/j.bbagrm.2009.09.011; Harashima H, 2013, TRENDS CELL BIOL, V23, P345, DOI 10.1016/j.tcb.2013.03.002; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hauptmann G, 2000, METH MOL B, V137, P139; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Hyun DH, 2010, NEUROSCI LETT, V477, P115, DOI 10.1016/j.neulet.2010.04.045; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Iovine B, 2011, BIOCHIMIE, V93, P867, DOI 10.1016/j.biochi.2010.12.017; Iovine B, 2009, BIOCHIMIE, V91, P364, DOI 10.1016/j.biochi.2008.10.017; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin SK, 2001, J CELL SCI, V114, P4139; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee Kyu-Sung, 1992, Yonsei Medical Journal, V33, P265; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lv XB, 2010, J BIOL CHEM, V285, P18234, DOI 10.1074/jbc.M109.094144; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimanouchi K, 2006, J BIOCHEM, V139, P51, DOI 10.1093/jb/mvj006; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Takata K, 2004, BIOCHEM BIOPH RES CO, V323, P1024, DOI 10.1016/j.bbrc.2004.08.182; Takata K, 2002, NUCLEIC ACIDS RES, V30, P3795, DOI 10.1093/nar/gkf490; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Vejrup-Hansen R, 2014, J CELL SCI, V127, P2460, DOI 10.1242/jcs.139816; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakasugi M, 2007, BIOCHEM BIOPH RES CO, V364, P771, DOI 10.1016/j.bbrc.2007.10.063; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; ZHANG Y, 2008, EURASIP J ADV SIG PR, V2008, P1, DOI DOI 10.1155/2008/529480; Zhao XH, 2015, HUM MOL GENET, V24, P853, DOI 10.1093/hmg/ddu503; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zolezzi F, 2002, J BIOL CHEM, V277, P41183, DOI 10.1074/jbc.M207890200	92	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134299	10.1371/journal.pone.0134299	http://dx.doi.org/10.1371/journal.pone.0134299			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225764	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700070
J	Antonelli, R; Viera, AJ				Antonelli, Ray; Viera, Anthony J.			Potential Effect of Physical Activity Calorie Equivalent (PACE) Labeling on Adult Fast Food Ordering and Exercise	PLOS ONE			English	Article							OBESITY; CHOICES	Introduction Numeric calorie content labels show limited efficacy in reducing the number of calories ordered from fast food meals. Physical activity calorie equivalent (PACE) labels are an alternative that may reduce the number of calories ordered in fast food meals while encouraging patrons to exercise. Methods A total of 1000 adults from 47 US states were randomly assigned via internet survey to one of four generic fast food menus: no label, calories only, calories + minutes, or calories + miles necessary to walk to burn off the calories. After completing hypothetical orders participants were asked to rate the likelihood of calorie-only and PACE labels to influence (1) food choice and (2) physical activity. Results Respondents (n = 823) ordered a median of 1580 calories from the no-label menu, 1200 from the calories-only menu, 1140 from the calories + minutes menu, and 1210 from the calories + miles menu (p = 0.0001). 40% of respondents reported that PACE labels were "very likely" to influence food item choice vs. 28% for calorie-only labels (p<0.0001). 64% of participants reported that PACE labels were "somewhat likely" or "very likely" to influence their level of physical activity vs. 49% for calorie-only labels (p<0.0001). Conclusions PACE labels may be helpful in reducing the number of calories ordered in fast food meals and may have the added benefit of encouraging exercise.	[Antonelli, Ray] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Viera, Anthony J.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Viera, AJ (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA.	anthony_viera@med.unc.edu			National Institutes of Health [T35-DK007386]; MD '06 Distinguished Professorship of Family Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD '06 Distinguished Professorship of Family Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the endowed Charles B Wilkerson, MD '06 Distinguished Professorship of Family Medicine and by grant number T35-DK007386 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NCHS DATA BRIEF; BLAIR SN, 2001, ACTIVE LIVING EVERY; Block JP, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2907; Dowray S, 2013, APPETITE, V62, P173, DOI 10.1016/j.appet.2012.11.013; Elbel B, 2013, OBESITY, V21, P2172, DOI 10.1002/oby.20550; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Platkin Charles, 2014, BMC Obes, V1, P21, DOI 10.1186/s40608-014-0021-5; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Sinclair SE, 2014, J ACAD NUTR DIET, DOI S2212-2672(14)00599-1[pii]; Swartz JJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-72; Swartz JJ, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-135; Temple NJ, 2014, NUTRITION, V30, P257, DOI 10.1016/j.nut.2013.06.012; United States Census Bureau Geography Division, 2014, CENS REG DIV US; US Food and Drug Administration, 2011, FOOD LAB NUTR LAB ST, V76; Varlyam J. H., 2005, ERR4 EC RES, P28; Viera AJ, 2015, PEDIATRICS, V135, pE376, DOI 10.1542/peds.2014-2902; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; ZARKIN GA, 1993, AM J PUBLIC HEALTH, V83, P717, DOI 10.2105/AJPH.83.5.717	21	15	16	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134289	10.1371/journal.pone.0134289	http://dx.doi.org/10.1371/journal.pone.0134289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222056	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800123
J	Muneer, S; Jeong, BR				Muneer, Sowbiya; Jeong, Byoung Ryong			Proteomic Analysis Provides New Insights in Phosphorus Homeostasis Subjected to Pi (Inorganic Phosphate) Starvation in Tomato Plants (Solanum lycopersicum L.)	PLOS ONE			English	Article							TRANSLATION INITIATION; OXIDATIVE STRESS; USE EFFICIENCY; ARABIDOPSIS; DEFICIENCY; TOLERANCE; RESPONSES; RICE; TRANSPORTERS; ACQUISITION	Phosphorus is a major nutrient acquired by plants via high-affinity inorganic phosphate (Pi) transporters. To determine the adaptation and homeostasis strategy to Pi starvation, we compared the proteome analysis of tomato leaves that were treated with and without Pi (as KH2PO4) for 10 days. Among 600 reproducible proteins on 2-DE gels 46 of them were differentially expressed. These proteins were involved in major metabolic pathways, including photosynthesis, transcriptional/translational regulations, carbohydrate/energy metabolism, protein synthesis, defense response, and other secondary metabolism. The results also showed that the reduction in photosynthetic pigments lowered P content under -Pi treatments. Furthermore, high-affinity Pi transporters (lePT1 and lePT2) expressed in higher amounts under -Pi treatments. Also, the accumulation of Pi transporters was observed highly in the epidermis and palisade parenchyma under +Pi treatments compared to -Pi treatments. Our data suggested that tomato plants developed reactive oxygen species (ROS) scavenging mechanisms to cope with low Pi content, including the up-regulation of proteins mostly involved in important metabolic pathways. Moreover, Pi-starved tomato plants increased their internal Pi utilization efficiency by increasing the Pi transporter genes and their rational localization. These results thus provide imperative information about how tomato plants respond to Pi starvation and its homeostasis.	[Muneer, Sowbiya; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21 Plus, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21 Plus, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Jeong, Byoung Ryong/D-7667-2014; Muneer, Sowbiya/S-5382-2019	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea	BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea	This study was supported from the grants of BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea. Authors would like to thank Mr. Prabhakaran Soundarajan, Division of Applied Life Science, Gyeongsang National University, for assistance in section cutting under microtome.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Chen ZJ, 2011, PROTEOMICS, V11, P4648, DOI 10.1002/pmic.201100231; Cubero B, 2009, MOL PLANT, V2, P535, DOI 10.1093/mp/ssp013; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Echevarria-Zomeno S, 2013, INT J MOL SCI, V14, P4670, DOI 10.3390/ijms14034670; FOYER C, 1986, PLANTA, V167, P369, DOI 10.1007/BF00391341; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Hammond JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024606; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; JACOB J, 1992, PLANT PHYSIOL, V98, P801, DOI 10.1104/pp.98.3.801; Jennings MD, 2013, GENE DEV, V27, P2696, DOI 10.1101/gad.231514.113; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Kim SG, 2011, J KOREAN SOC APPL BI, V54, P667, DOI 10.3839/jksabc.2011.102; Lee BR, 2007, J EXP BOT, V58, P1271, DOI 10.1093/jxb/erl280; Li KP, 2008, PLANT J, V55, P927, DOI 10.1111/j.1365-313X.2008.03561.x; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-18; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Morita S, 1999, PLANT CELL PHYSIOL, V40, P417, DOI 10.1093/oxfordjournals.pcp.a029557; Mostek A, 2015, J PLANT PHYSIOL, V174, P166, DOI 10.1016/j.jplph.2014.08.020; Muneer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120899; Muneer S, 2014, INT J MOL SCI, V15, P21803, DOI 10.3390/ijms151221803; Muneer S, 2012, PLANT OMICS, V5, P167; Paolacci AR, 2014, J INTEGR PLANT BIOL, V56, P88, DOI 10.1111/jipb.12110; POIRIER Y, ARABIDOPSIS BOOK; PREISS J, 1984, TRENDS BIOCHEM SCI, V9, P24, DOI 10.1016/0968-0004(84)90043-4; Qureshi MI, 2010, ADV BOT RES, V56, P1, DOI 10.1016/S0065-2296(10)56001-4; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rolfe BG, 2003, COMP FUNCT GENOM, V4, P225, DOI 10.1002/cfg.263; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Torabi S, 2009, PROTEOMICS, V9, P159, DOI 10.1002/pmic.200800350; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Tyburski J, 2009, PLANT GROWTH REGUL, V59, P27, DOI 10.1007/s10725-009-9385-9; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang Z, 2005, FEBS LETT, V579, P1683, DOI 10.1016/j.febslet.2005.02.024; Wissuwa M, 2005, PLANT SOIL, V269, P57, DOI 10.1007/s11104-004-2026-1; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Zhang HW, 2009, PLANT SOIL, V320, P91, DOI 10.1007/s11104-008-9873-0; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zimmerli C, 2012, PLANT J, V72, P199, DOI 10.1111/j.1365-313X.2012.05058.x	60	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134103	10.1371/journal.pone.0134103	http://dx.doi.org/10.1371/journal.pone.0134103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222137	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800104
J	Wang, Y; Deng, O; Feng, Z; Du, Z; Xiong, X; Lai, J; Yang, X; Xu, M; Wang, H; Taylor, D; Yan, C; Chen, C; Difeo, A; Ma, Z; Zhang, J				Wang, Y.; Deng, O.; Feng, Z.; Du, Z.; Xiong, X.; Lai, J.; Yang, X.; Xu, M.; Wang, H.; Taylor, D.; Yan, C.; Chen, C.; Difeo, A.; Ma, Z.; Zhang, J.			RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression	ONCOGENE			English	Article							SPORADIC BREAST-CANCER; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; OVARIAN-CANCER; DIFFERENTIAL REGULATION; REPLICATION ARREST; GENE-EXPRESSION; MESSENGER-RNA; FREQUENT LOSS; E2F1	RNF126 is an E3 ubiquitin ligase. The deletion of RNF126 gene was observed in a wide range of human cancers and is correlated with improved disease-free and overall survival. These data highlight the clinical relevance of RNF126 in tumorigenesis and cancer therapy. However, the specific functions of RNF126 remain largely unknown. Homologous recombination (HR)-mediated DNA double-strand break repair is important for tumor suppression and cancer therapy resistance. Here, we demonstrate that RNF126 facilitates HR by promoting the expression of BRCA1, in a manner independent of its E3 ligase activity but depending on E2F1, a well-known transcription factor of BRCA1 promoter. In support of this result, RNF126 promotes transactivation of BRCA1 promoter by directly binding to E2F1. Most importantly, an RNF126 mutant lacking 11 amino acids that is responsible for the interaction with E2F1 has a dominant-negative effect on BRCA1 expression and HR by suppressing E2F1-mediated transactivation of BRCA1 promoter and blocking the enrichment of E2F1 on BRCA1 promoter. Lastly, RNF126 depletion leads to the increased sensitivity to ionizing radiation and poly (ADP-ribose) polymerase inhibition. Collectively, our results suggest a novel role of RNF126 in promoting HR-mediated repair through positive regulation on BRCA1 expression by direct interaction with E2F1. This study not only offers novel insights into our current understanding of the biological functions of RNF126 but also provides a potential therapeutic target for cancer treatment.	[Wang, Y.; Deng, O.; Feng, Z.; Du, Z.; Xiong, X.; Lai, J.; Zhang, J.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, 10900 Euclid Ave,BRB 323, Cleveland, OH 44106 USA; [Deng, O.; Yang, X.; Ma, Z.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Lai, J.] Fujian Med Univ, Affiliated Hosp 2, Quanzhou, Fujian, Peoples R China; [Xu, M.; Taylor, D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, H.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Yan, C.] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA USA; [Chen, C.] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Difeo, A.] Case Western Reserve Univ, Gen Med Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Sun Yat Sen University; Fujian Medical University; Case Western Reserve University; University System of Maryland; University of Maryland Baltimore; University System of Georgia; Augusta University; Chinese Academy of Sciences; Kunming Institute of Zoology; Case Western Reserve University	Zhang, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, 10900 Euclid Ave,BRB 323, Cleveland, OH 44106 USA.; Ma, Z (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	mazhefu@mail.sysu.edu.cn; Junran.zhang@case.edu	Du, Zhanwen/H-9903-2016	Deng, Ou/0000-0002-9933-1832; Yan, Chunhong/0000-0002-3974-7991; DiFeo, Analisa/0000-0001-8319-6763	National Cancer Institute [R01C A154625]; Department of Radiation Oncology, Case Western Reserve University School of Medicine; National Natural Science Foundation of China [31271503]; Guangdong Provincial Natural Science Foundation of China [S2012010008368]; Sun Yat-sen University; Radiation Resources Core Facility; Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [DP2CA186571, R01CA139107, R01CA154625, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107058] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Radiation Oncology, Case Western Reserve University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Sun Yat-sen University; Radiation Resources Core Facility; Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant (R01C A154625) from the National Cancer Institute and a startup fund from the Department of Radiation Oncology, Case Western Reserve University School of Medicine to JZ; National Natural Science Foundation of China grant (31271503), Guangdong Provincial Natural Science Foundation of China grant (S2012010008368) and a startup fund from Sun Yat-sen University to ZM. This research was also supported by Radiation Resources Core Facility and Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). We thank Daniel Li and Mehdi Haider for the technical support.	AMFO K, 1995, ONCOGENE, V11, P351; Andreassen PR, 2006, CARCINOGENESIS, V27, P883, DOI 10.1093/carcin/bgi319; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Biswas AK, 2014, CANCER RES, V74, P3369, DOI 10.1158/0008-5472.CAN-13-3216; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; De Siervi A, 2010, CANCER RES, V70, P532, DOI 10.1158/0008-5472.CAN-09-1477; Delker RK, 2013, P NATL ACAD SCI USA, V110, P1029, DOI 10.1073/pnas.1214538110; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2012, NUCLEIC ACIDS RES, V40, P726, DOI 10.1093/nar/gkr748; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Johnson DG, 2006, CURR MOL MED, V6, P731; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Smith CJ, 2013, J CELL SCI, V126, P1366, DOI 10.1242/jcs.116129; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Yanaihara N, 2003, INT J ONCOL, V23, P567; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yang TL, 2004, GENE CHROMOSOME CANC, V41, P250, DOI 10.1002/gcc.20080; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhang JR, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-11; Zheng WX, 2000, GYNECOL ONCOL, V76, P294, DOI 10.1006/gyno.1999.5664; Zhi X, 2013, CANCER RES, V73, P385, DOI 10.1158/0008-5472.CAN-12-0562; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	49	26	26	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1363	1372		10.1038/onc.2015.198	http://dx.doi.org/10.1038/onc.2015.198			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26234677	Green Accepted			2022-12-26	WOS:000372196400003
J	Lin, L; Gopal, S; Sharda, A; Passam, F; Bowley, SR; Stopa, J; Xue, GP; Yuan, C; Furie, BC; Flaumenhaft, R; Huang, MD; Furie, B				Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Xue, Guangpu; Yuan, Cai; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce			Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b ' x Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; THROMBUS FORMATION; PLATELET; FIBRIN; HEMOSTASIS; MOUSE	Quercetin-3-rutinoside inhibits thrombus formation in a mouse model by inhibiting extracellular protein disulfide isomerase (PDI), an enzyme required for platelet thrombus formation and fibrin generation. Prior studies have identified PDI as a potential target for novel antithrombotic agents. Using a fluorescence enhancement-based assay and isothermal calorimetry, we show that quercetin-3-rutinoside directly binds to the b'domain of PDI with a 1: 1 stoichiometry. The binding of quercetin-3-rutinoside to PDI induces a more compact conformation and restricts the conformational flexibility of PDI, as revealed by small angle x-ray scattering. The binding sites of quercetin-3-rutinoside to PDI were determined by studying its interaction with isolated fragments of PDI. Quercetin-3-rutinoside binds to the b'x domain of PDI. The infusion of the b'x fragment of PDI rescued thrombus formation that was inhibited by quercetin-3-rutinoside in a mouse thrombosis model. This b'x fragment does not possess reductase activity and, in the absence of quercetin-3-rutinoside, does not affect thrombus formation in vivo. The isolated b'domain of PDI has potential as an antidote to reverse the antithrombotic effect of quercetin-3-rutinoside by binding and neutralizing quercetin-3-rutinoside.	[Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02115 USA; [Lin, Lin; Gopal, Srila; Sharda, Anish; Passam, Freda; Bowley, Sheryl R.; Stopa, Jack; Furie, Barbara C.; Flaumenhaft, Robert; Huang, Mingdong; Furie, Bruce] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Xue, Guangpu; Yuan, Cai] Chinese Acad Sci, Fujian Inst Res Struct Matter, Fuzhou 350002, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Life Sci, Dept Med, Div Hemostasis Thrombosis, 3 Blackfan Circle, Boston, MA 02215 USA.	bfurie@bidmc.harvard.edu	Passam, Freda/AAC-2005-2019; Huang, Mingdong/J-4278-2017	Passam, Freda/0000-0003-4584-2044; Huang, Mingdong/0000-0003-0085-9141; Gopal, Srila/0000-0003-2732-3216	Department of Energy Office of Biological and Environmental Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007917, U54HL112302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SAXS experiments were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by the Department of Energy Office of Biological and Environmental Research.	Bellido-Martin L, 2011, THROMB HAEMOSTASIS, V105, P776, DOI 10.1160/TH10-12-0771; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Cho J, 2013, J THROMB HAEMOST, V11, P2084, DOI 10.1111/jth.12413; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; Dubois C, 2007, PLATELETS, 2ND EDITION, P611, DOI 10.1016/B978-012369367-9/50796-5; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Flaumenhaft R, 2015, ARTERIOSCL THROM VAS, V35, P16, DOI 10.1161/ATVBAHA.114.303410; Furie B, 2014, CIRC RES, V114, P1162, DOI 10.1161/CIRCRESAHA.114.301808; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Wu Y, 2012, BLOOD, V119, P1737, DOI 10.1182/blood-2011-06-360685	27	60	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23543	23552		10.1074/jbc.M115.666180	http://dx.doi.org/10.1074/jbc.M115.666180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240139	Green Published, hybrid			2022-12-26	WOS:000361816500007
J	Meekins, DA; Raththagala, M; Auger, KD; Turner, BD; Santelia, D; Kotting, O; Gentry, MS; Kooi, CWV				Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Santelia, Diana; Koetting, Oliver; Gentry, Matthew S.; Kooi, Craig W. Vander			Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SPECIFICITY PROTEIN PHOSPHATASE; CARBOHYDRATE-BINDING DOMAIN; LAFORA-DISEASE; WATER DIKINASE; STARCH DEGRADATION; ARABIDOPSIS LEAVES; TYROSINE PHOSPHATASES; CORPORA-AMYLACEA; R1 PROTEIN	Glucan phosphatases are central to the regulation of starch and glycogen metabolism. Plants contain two known glucan phosphatases, Starch EXcess4 (SEX4) and Like Sex Four2 (LSF2), which dephosphorylate starch. Starch is water-insoluble and reversible phosphorylation solubilizes its outer surface allowing processive degradation. Vertebrates contain a single known glucan phosphatase, laforin, that dephosphorylates glycogen. In the absence of laforin, water-soluble glycogen becomes insoluble, leading to the neurodegenerative disorder Lafora Disease. Because of their essential role in starch and glycogen metabolism glucan phosphatases are of significant interest, yet a comparative analysis of their activities against diverse glucan substrates has not been established. We identify active site residues required for specific glucan dephosphorylation, defining a glucan phosphatase signature motif (C zeta AG Psi GR) in the active site loop. We further explore the basis for phosphate position-specific activity of these enzymes and determine that their diverse phosphate position-specific activity is governed by the phosphatase domain. In addition, we find key differences in glucan phosphatase activity toward soluble and insoluble polyglucan substrates, resulting from the participation of ancillary glucan-binding domains. Together, these data provide fundamental insights into the specific activity of glucan phosphatases against diverse polyglucan substrates.	[Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Gentry, Matthew S.; Kooi, Craig W. Vander] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Meekins, David A.; Raththagala, Madushi; Auger, Kyle D.; Turner, Benjamin D.; Gentry, Matthew S.; Kooi, Craig W. Vander] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Santelia, Diana] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Koetting, Oliver] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland	University of Kentucky; University of Kentucky; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gentry, MS (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone Ave, Lexington, KY 40536 USA.	matthew.gentry@uky.edu; craig.vanderkooi@uky.edu	Santelia, Diana/AAQ-3967-2020; Regan, Clinton/E-6250-2012; Kötting, Oliver/L-5325-2013; Raththagala, Madushi/AAU-5254-2020	Kötting, Oliver/0000-0002-8977-5907; Raththagala, Madushi/0000-0001-6227-6203	National Institutes of Health [R01NS070899, P20GM103486]; KSEF [KSEF-2268RDE-014, KSEF-2971-RDE-017]; Mitzutani Foundation for Glycoscience Award; NSF [IIA-1355438, MCB-1252345]; ETH-Eurich; Swiss-South African Joint Research Program [IZ LS X3122916]; Swiss National Science Foundation SNSF [31003A_147074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSEF; Mitzutani Foundation for Glycoscience Award; NSF(National Science Foundation (NSF)); ETH-Eurich; Swiss-South African Joint Research Program; Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS070899 (to M. S. G), P20GM103486 (to M. S. G. and C. W. V. K.); KSEF grants KSEF-2268RDE-014 and KSEF-2971-RDE-017 (to M. S. G.); Mitzutani Foundation for Glycoscience Award (to M. S. G.); NSF Grants IIA-1355438 (to M. S. G.) and MCB-1252345 (to M. S. G.); the ETH-Eurich (to O. K.), and Swiss-South African Joint Research Program Grant IZ LS X3122916 (to O. K.); Swiss National Science Foundation SNSF-Grant 31003A_147074 (to D. S.). M. S. G. and C. W. V. K. are founders of Opti-Mol Enzymes LLC.	Alonso A, 2003, DUAL SPECIFIC PROTEI; Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Fordham-Skelton AP, 2002, PLANT J, V29, P705, DOI 10.1046/j.1365-313X.2002.01250.x; Gallant DJ, 1997, CARBOHYD POLYM, V32, P177, DOI 10.1016/S0144-8617(97)00008-8; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2002, HUM MOL GENET, V11, P1263, DOI 10.1093/hmg/11.11.1263; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hejazi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28892; Hejazi M, 2010, PLANT PHYSIOL, V152, P711, DOI 10.1104/pp.109.149914; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lafora G. R., 1911, ARCH F, P205; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Mahlow S, 2014, NEW PHYTOL, V203, P495, DOI 10.1111/nph.12801; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Meekins DA, 2013, PLANT CELL, V25, P2302, DOI 10.1105/tpc.113.112706; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; MUHRBECK P, 1991, J SCI FOOD AGR, V55, P13, DOI 10.1002/jsfa.2740550103; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Raththagala M, 2015, MOL CELL, V57, P261, DOI 10.1016/j.molcel.2014.11.020; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Skeffington AW, 2014, PLANT PHYSIOL, V165, P866, DOI 10.1104/pp.114.237016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Takeda Y., 1981, CARBOHYD RES, V39, P151; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	74	20	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23361	23370		10.1074/jbc.M115.658203	http://dx.doi.org/10.1074/jbc.M115.658203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26231210	Green Published, hybrid			2022-12-26	WOS:000361685500042
J	Li, WS; Wang, Y; Zhang, Q; Tang, LL; Liu, XP; Dai, YH; Xiao, L; Huang, SG; Chen, L; Guo, ZM; Lu, J; Yuan, K				Li, Wanshuai; Wang, Yong; Zhang, Qi; Tang, Lili; Liu, Xiaoping; Dai, Yunhua; Xiao, Liang; Huang, Shuguang; Chen, Lu; Guo, Zhongmin; Lu, Jim; Yuan, Kai			MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DOWN-REGULATION; MIR-150; SERUM; PROLIFERATION; EXPRESSIONS; STATISTICS; PLASMA	Background Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is essential for improvements of prognosis and survival of the patients. Currently, there is no effective biomarker available in clinical settings for early detection of lung cancer. Altered expressions in many cancer types including NSCLC and stable existence in plasma make microRNAs (miRNAs) a group of potentially useful biomarkers for clinical assessments of patients with NSCLC. Objectives To evaluate the potential values of miRNAs as blood-based biomarkers for early diagnosis and prognosis in NSCLC patients. Methods Peripheral blood samples from healthy volunteers and early-staged NSCLC patients before and after surgery were collected, and plasma was separated. Expression of ten miRNAs in the plasma and tumor sections of the patients was detected by quantitative real-time polymerase chain reaction. Results MiRNA (miR)-486 and miR-150 were found to significantly distinguish lung cancer patients from healthy volunteers. Area under curve of miR-486 and miR-150 were 0.926 (sensitivity, 0.909; specificity, 0.818) and 0.752 (sensitivity, 0.818; specificity, 0.818), respectively. In response to therapy, patients with down-regulated miR-486 expression showed prolonged recurrence-free survival than those with un-reduced miR-486 expression (median, unreached vs. 19 months; hazard ratio, 0.1053; 95% confidence interval, 0.01045 to 1.060; P=0.056). Conclusions The results suggest that miR-486 and miR-150 could be potential blood-based biomarkers for early diagnosis of NSCLC. Monitoring change of miR-486 expression in plasma might be an effective and non-invasive method for recurrence prediction of early-staged NSCLC patients.	[Wang, Yong; Yuan, Kai] 2 Peoples Hosp Changzhou, Dept Cardiothorac Surg, Changzhou 213004, Jiangsu, Peoples R China; [Li, Wanshuai; Zhang, Qi; Tang, Lili; Liu, Xiaoping; Dai, Yunhua; Xiao, Liang; Huang, Shuguang; Chen, Lu; Guo, Zhongmin; Lu, Jim] Changzhou GoPath Diagnost Lab Co Ltd, Changzhou 213164, Jiangsu, Peoples R China; [Lu, Jim] GoPath Labs LLC, Buffalo Grove, IL 60089 USA		Lu, J (corresponding author), Changzhou GoPath Diagnost Lab Co Ltd, 801 Changwuzhong Rd, Changzhou 213164, Jiangsu, Peoples R China.	JLu@gopathlabs.com; yuankai1978@163.com	Li, Wanshuai/F-6092-2014	Li, Wanshuai/0000-0002-5361-4319	Changzhou Science and Technology Support Program [CE20125002]	Changzhou Science and Technology Support Program	This work was supported by Changzhou Science and Technology Support Program (No. CE20125002).	Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Ebrahimi F, 2014, EXP MOL PATHOL, V96, P98, DOI 10.1016/j.yexmp.2013.12.004; Gu XY, 2014, TUMOR BIOL, V35, P5287, DOI 10.1007/s13277-014-1688-4; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jiang M, 2013, MOL CELL BIOCHEM, V383, P67, DOI 10.1007/s11010-013-1755-y; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee HY, 2015, MOL MED REP, V11, P2034, DOI 10.3892/mmr.2014.2890; Li ZH, 2013, J INT MED RES, V41, P1437, DOI 10.1177/0300060513497560; Mozzoni P, 2013, BIOMARKERS, V18, P679, DOI 10.3109/1354750X.2013.845610; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Shao YJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/626185; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solomides CC, 2012, ACTA CYTOL, V56, P645, DOI 10.1159/000343473; Song HT, 2014, J PSYCHIATR RES, V54, P134, DOI 10.1016/j.jpsychires.2014.03.008; Tafsiri E, 2015, TUMOR BIOL, V36, P1603, DOI 10.1007/s13277-014-2755-6; Tio TL, 1996, GASTROINTEST ENDOSC, V43, pS19; Wang DT, 2013, ONCOL REP, V30, P492, DOI 10.3892/or.2013.2453; Wang J, 2014, ONCOGENE, V33, P1181, DOI 10.1038/onc.2013.42; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Wink KCJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00292; Zeng XL, 2013, CHINESE MED J-PEKING, V126, P4510, DOI 10.3760/cma.j.issn.0366-6999.20122931; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059	25	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134220	10.1371/journal.pone.0134220	http://dx.doi.org/10.1371/journal.pone.0134220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237047	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400017
J	Carias, C; Reed, C; Kim, IK; Foppa, IM; Biggerstaff, M; Meltzer, MI; Finelli, L; Swerdlow, DL				Carias, Cristina; Reed, Carrie; Kim, Inkyu K.; Foppa, Ivo M.; Biggerstaff, Matthew; Meltzer, Martin I.; Finelli, Lyn; Swerdlow, David L.			Net Costs Due to Seasonal Influenza Vaccination - United States, 2005-2009	PLOS ONE			English	Article							HEALTHY WORKING ADULTS; PANDEMIC INFLUENZA; HOSPITALIZATION; IMPACT; AGE; IMMUNIZATION; CHILDREN; DISEASE; BURDEN; RISK	Background Seasonal influenza causes considerable morbidity and mortality across all age groups, and influenza vaccination was recommended in 2010 for all persons aged 6 months and above. We estimated the averted costs due to influenza vaccination, taking into account the seasonal economic burden of the disease. Methods We used recently published values for averted outcomes due to influenza vaccination for influenza seasons 2005-06, 2006-07, 2007-08, and 2008-09, and age cohorts 6 months-4 years, 5-19 years, 20-64 years, and 65 years and above. Costs were calculated according to a payer and societal perspective (in 2009 US$), and took into account medical costs and productivity losses. Results When taking into account direct medical costs (payer perspective), influenza vaccination was cost saving only for the older age group (65 >=) in seasons 2005-06 and 2007-08. Using the same perspective, influenza vaccination resulted in total costs of $US 1.7 billion (95% CI: $US 0.3-4.0 billion) in 2006-07 and $US 1.8 billion (95% CI: $US 0.1-4.1 billion) in 2008-09. When taking into account a societal perspective (and including the averted lost earnings due to premature death) averted deaths in the older age group influenced the results, resulting in cost savings for all ages combined in season 07-08. Discussion Influenza vaccination was cost saving in the older age group (65 >=) when taking into account productivity losses and, in some seasons, when taking into account medical costs only. Averted costs vary significantly per season; however, in seasons where the averted burden of deaths is high in the older age group, averted productivity losses due to premature death tilt overall seasonal results towards savings. Indirect vaccination effects and the possibility of diminished case severity due to influenza vaccination were not considered, thus the averted burden due to influenza vaccine may be even greater than reported.	[Carias, Cristina; Swerdlow, David L.] Ctr Dis Control & Prevent, Off Sci & Integrated Programs, Atlanta, GA 30322 USA; [Carias, Cristina] IHRC INC, Atlanta, GA USA; [Reed, Carrie; Kim, Inkyu K.; Foppa, Ivo M.; Biggerstaff, Matthew; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kim, Inkyu K.; Foppa, Ivo M.] Battelle Mem Inst, Atlanta, GA USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Carias, C (corresponding author), Ctr Dis Control & Prevent, Off Sci & Integrated Programs, Atlanta, GA 30322 USA.	vnn9@cdc.gov	Foppa, Ivo/I-8694-2016; Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Foppa, Ivo/0000-0002-3933-8565; Meltzer, Martin/0000-0002-7250-0472; Biggerstaff, Matthew/0000-0001-5108-8311	IHRC.INC; Battelle Memorial Institute	IHRC.INC; Battelle Memorial Institute	IHRC.INC provided support in the form of salaries for authors CC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Battelle Memorial Institute provided support in the form of salaries for authors IKK and IMF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; [Bureau of Labor Statistics United States Department of Labor], 2014, LAB FORC STAT CURR P; [Bureau of Labor Statistics United States Department of Labor], OCC LAB STAT MAY 200; [Bureau of Labor Statistics United States Department of Labor], 2013, AM TIME USE SURVEY; Centers for Disease Control and Prevention, FLU VACC COV HIGH RI; Coleman MS, 2005, VACCINE, V23, P915, DOI 10.1016/j.vaccine.2004.07.028; Fairbrother G, 2010, VACCINE, V28, P4913, DOI 10.1016/j.vaccine.2010.05.036; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Foppa IM, 2015, VACCINE INPRESS; Haddix AC, 2003, PREVENTION EFFECTIVE; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Kennedy Erin D., 2011, Morbidity and Mortality Weekly Report, V60, P781; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; McLean HQ, 2014, VACCINE, V32, P453, DOI 10.1016/j.vaccine.2013.11.060; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Newall AT, 2009, PHARMACOECONOMICS, V27, P439, DOI 10.2165/00019053-200927060-00001; Nichol KL, 1996, ARCH INTERN MED, V156, P1546, DOI 10.1001/archinte.156.14.1546; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Postma MJ, 2002, DRUGS, V62, P1013, DOI 10.2165/00003495-200262070-00003; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Thompson M. G., 2010, MMWR-MORBID MORTAL W, V59, P1057; Zimmerman RK, 2010, VACCINE, V28, P6470, DOI 10.1016/j.vaccine.2010.07.037	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132922	10.1371/journal.pone.0132922	http://dx.doi.org/10.1371/journal.pone.0132922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230271	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400022
J	Edwards, AE; Fitzgerald, SM; Parrish, JK; Klavitter, JL; Romano, MD				Edwards, Ann E.; Fitzgerald, Shannon M.; Parrish, Julia K.; Klavitter, John L.; Romano, Marc D.			Foraging Strategies of Laysan Albatross Inferred from Stable Isotopes: Implications for Association with Fisheries	PLOS ONE			English	Article							BLACK-BROWED ALBATROSS; NORTH PACIFIC-OCEAN; TROPHIC RELATIONSHIPS; SOUTHERN-OCEAN; ENVIRONMENTAL VARIABILITY; PROVISIONING BEHAVIOR; COMMERCIAL FISHERIES; BREEDING PERFORMANCE; LONGLINE FISHERIES; ANTHROPOGENIC CO2	Fatal entanglement in fishing gear is the leading cause of population decline for albatross globally, a consequence of attraction to bait and fishery discards of commercial fishing operations. We investigated foraging strategies of Laysan albatross (Phoebastria immutabilis), as inferred from nitrogen and carbon isotope values of primary feathers, to determine breeding-related, seasonal, and historic factors that may affect the likelihood of association with Alaskan or Hawaiian longline fisheries. Feather samples were collected from live birds monitored for breeding status and breeding success on Midway Atoll in the northwestern Hawaiian Islands, birds salvaged as fisheries-bycatch, and birds added to museum collections before 1924. During the chick-rearing season (sampled April-May), means and variances of stable isotope values of birds with the highest, most consistent reproductive success were distinct from less productive conspecifics and completely different from birds caught in Hawaiian or Alaskan longline fisheries, suggesting birds with higher multi-annual reproductive success were less likely to associate with these fisheries. Contemporary birds with the highest reproductive success had mean values most similar to historic birds. Values of colony-bound, courting prebreeders were similar to active breeders but distinct from prebreeders caught in Alaskan longline fisheries. During the breeding season, delta N-15 values were highly variable for both contemporary and historic birds. Although some historic birds exhibited extremely low d15N values unmatched by contemporary birds (< 11.2%), others had values as high as the highest fishery-associated contemporary birds. During the non-breeding season (sampled July-September), isotopic variability coalesced into a more narrow set of values for both contemporary and historic birds. Our results suggest that foraging strategies of Laysan albatross are a complex function of season, breeding status, and multi-annual breeding success, factors that likely affect the probability of association with fisheries.	[Edwards, Ann E.; Fitzgerald, Shannon M.] Alaska Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Seattle, WA 98195 USA; [Edwards, Ann E.; Parrish, Julia K.] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA; [Klavitter, John L.] US Fish & Wildlife Serv, Midway Atoll Natl Wildlife Refuge, Papah Naumoku Kea Marine Natl Monument, Falls Church, VA USA; [Romano, Marc D.] US Fish & Wildlife Serv, Migratory Birds & Habitat Programs, Portland, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Edwards, AE (corresponding author), Alaska Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Seattle, WA 98195 USA.	aee@uw.edu			NOAA National Seabird Grant	NOAA National Seabird Grant	This research was initiated while AEE held a National Research Council Postdoctoral Fellowship Award at NOAA's Alaska Fisheries Science Center. Funding for feather shipment and stable isotope analysis came from an NOAA National Seabird Grant to SMF and AEE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented are those of the authors, and do not necessarily represent those of the funders.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Arata JA, 2009, US GEOLOGICAL SURVEY; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Becker BH, 2006, CONSERV BIOL, V20, P470, DOI 10.1111/j.1523-1739.2006.00379.x; Bisson JR, 2008, THESIS U HAWAII; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Bond AL, 2010, WATERBIRDS, V33, P50, DOI 10.1675/063.033.0106; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Bunce A, 2005, J ZOOL, V266, P163, DOI 10.1017/S0952836905006734; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Chouvelon T, 2012, PROG OCEANOGR, V101, P92, DOI 10.1016/j.pocean.2012.01.004; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dietrich KS, 2009, BIOL CONSERV, V142, P2642, DOI 10.1016/j.biocon.2009.06.013; Edwards AE, 2005, CONDOR, V107, P835, DOI 10.1650/7533.1; Edwards AE, 2008, J AVIAN BIOL, V39, P144, DOI 10.1111/j.2007.0908-8857.04139.x; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fischer KN, 2009, BIOL CONSERV, V142, P751, DOI 10.1016/j.biocon.2008.12.007; FISHER HI, 1967, IBIS, V109, P373, DOI 10.1111/j.1474-919X.1967.tb04011.x; FISHER HI, 1976, WILSON BULL, V88, P121; Fisher HI, 1969, MICRONESICA, V5, P173; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Furness RW, 2006, ARDEA, V94, P631; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Gould P, 2000, WATERBIRDS, V23, P165; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Hilton GM, 2006, GLOBAL CHANGE BIOL, V12, P611, DOI 10.1111/j.1365-2486.2006.01130.x; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Huang HW, 2011, ANIM CONSERV, V14, P562, DOI 10.1111/j.1469-1795.2011.00462.x; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; Ichii T, 2004, FISH OCEANOGR, V13, P295, DOI 10.1111/j.1365-2419.2004.00293.x; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; LANGSTON NE, 1995, CONDOR, V97, P1, DOI 10.2307/1368978; Larson KW, 2009, J ORNITHOL, V150, P709, DOI 10.1007/s10336-009-0408-0; Mariano-Jelicich R, 2014, MAR BIOL, V161, P119, DOI 10.1007/s00227-013-2320-7; McNeil BI, 2001, GLOBAL BIOGEOCHEM CY, V15, P597, DOI 10.1029/2000GB001352; Morrison KW, 2014, MAR BIOL, V161, P2243, DOI 10.1007/s00227-014-2502-y; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Naughton MB, 2007, CONSERVATION ACTION; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Oppel S, 2008, MAR ECOL PROG SER, V373, P149, DOI 10.3354/meps07744; Patrick SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087269; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pitman Robert L., 2004, Marine Ornithology, V32, P159; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; PRINCE PA, 1993, IBIS, V135, P121, DOI 10.1111/j.1474-919X.1993.tb02823.x; Quay P, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001817; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; Quillfeldt P, 2008, MAR ECOL PROG SER, V373, P137, DOI 10.3354/meps07751; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rohwer S, 2011, CONDOR, V113, P61, DOI 10.1525/cond.2011.100092; Rohwer Sievert, 2006, Western Birds, V37, P245; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Suryan RM, 2007, BIOL CONSERV, V137, P450, DOI 10.1016/j.biocon.2007.03.015; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Tanaka H, 2008, MAR BIOL, V154, P557, DOI 10.1007/s00227-008-0949-4; USFWS, 2012, BIOL OP US FISH WILD; WARHAM J, 1990, PETRELS THEIR ECOLOG; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wu JP, 1997, DEEP-SEA RES PT I, V44, P287, DOI 10.1016/S0967-0637(96)00099-4; Xavier JC, 2007, J ZOOL, V271, P408, DOI 10.1111/j.1469-7998.2006.00224.x; Young LC, 2010, J ZOOL, V281, P232, DOI 10.1111/j.1469-7998.2010.00698.x; Young LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007623	90	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133471	10.1371/journal.pone.0133471	http://dx.doi.org/10.1371/journal.pone.0133471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230731	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400039
J	Peng, J; Wheeler, K; Shi, JX; Groner, JI; Haley, KJ; Xiang, HY				Peng, Jin; Wheeler, Krista; Shi, Junxin; Groner, Jonathan Ira; Haley, Kathryn Jo; Xiang, Huiyun			Trauma with Injury Severity Score of 75: Are These Unsurvivable Injuries?	PLOS ONE			English	Article							MORTALITY; TRIAGE; CARE	Trauma patients with an ISS=75 have been deliberately excluded from some trauma studies because they were assumed to have "unsurvivable injuries." This study aimed to assess the true mortality among patients with an ISS=75, and to examine the characteristics and primary diagnoses of these patients. Retrospective review of the 2006-2010 U.S. Nationwide Emergency Department Sample (NEDS) generated 2,815 patients with an ISS=75 for analysis, representing an estimated 13,569 patients in the country. Dispositions from the emergency department and hospital for these patients were tabulated by trauma center level. Survivors and non-survivors were compared using Pearson's chi-square test. Primary diagnosis codes of these patients were tabulated by mortality status. Overall, about 48.6% of patients with an ISS=75 were discharged alive, 25.8% died and 25.6% had unknown mortality status. The mortality risks of these patients did not vary significantly across different levels of trauma centers (15.6% vs. 13.0%, P = 0.16). Non-survivors were more likely than survivors to: be male (81.2% vs. 74.4%, P < 0.0001), be over 65 years (20.3% vs. 10.2%, P < 0.0001), be uninsured (33.8% vs. 19.1%), have at least one chronic condition (58.0% vs. 43.7%, P < 0.0001), sustain life-threatening injuries (79.2% vs. 49.4%, P<0.0001), sustain penetrating injuries (42.0% vs. 25.9%, P<0.0001), and have injuries caused by motor vehicle crashes (32.9% vs. 21.1%, P<0.0001) or firearms (21.9% vs. 4.4%, P<0.0001). The most frequent diagnosis code was 862.8 (injury to multiple and unspecified intrathoracic organs, without mention of open wound into cavity). Our results revealed that at least half of patients with an ISS=75 survived, demonstrating that the rationale for excluding patients with an ISS=75 from analysis is not always justified. To avoid bias and inaccurate results, trauma researchers should examine the mortality status of patients with an ISS= 75 before exclusion, and explicitly describe their method of generating ISS scores.	[Peng, Jin; Wheeler, Krista; Shi, Junxin; Groner, Jonathan Ira; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43205 USA; [Peng, Jin; Xiang, Huiyun] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Groner, Jonathan Ira; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Groner, Jonathan Ira; Haley, Kathryn Jo] Nationwide Childrens Hosp, Trauma Program, Dept Pediat Surg, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Xiang, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43205 USA.	huiyun.xiang@nationwidechildrens.org	Groner, Jonathan/E-3156-2011		Agency for Healthcare Research and Quality [1R03-HS022277]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS022277] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by a research grant from the Agency for Healthcare Research and Quality (http://www.ahrq.gov/ PI: Dr. Huiyun Xiang, Grant # 1R03-HS022277). The views expressed here are solely the responsibility of the authors and do not necessarily reflect the official views of the funding agencies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Charles A, 2007, AM SURGEON, V73, P1; Clark D, 2010, STAT SOFTWARE COMPON; Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17; Greene NH, 2015, INJ PREV; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; MacLeod JBA., 2003, EUR J TRAUMA, V29, P392, DOI [10.1007/s00068-003-1277-5, DOI 10.1007/s00068-003-1277-5]; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Miller Matthew L, 2008, Ann Adv Automot Med, V52, P101; Mohan D, 2014, MED DECIS MAKING, V34, P242, DOI 10.1177/0272989X13508007; Mohan D, 2011, ARCH SURG-CHICAGO, V146, P786, DOI 10.1001/archsurg.2011.43; Murad MK, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-13; Murad MK, 2010, PREHOSP DISASTER MED, V25, P533, DOI 10.1017/S1049023X00008724; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Petrucelli E, 1981, ACCID ANALPREV, V12, P29; Pruitt Z, 2013, AM J MANAG CARE, V19, P917; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Thomas A, 2008, ABBREVIATED INJURY S; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038	19	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134821	10.1371/journal.pone.0134821	http://dx.doi.org/10.1371/journal.pone.0134821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230931	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400173
J	Waechter, S; Sutterlin, B; Siegrist, M				Waechter, Signe; Suetterlin, Bernadette; Siegrist, Michael			Desired and Undesired Effects of Energy Labels-An Eye-Tracking Study	PLOS ONE			English	Article							CARBON EMISSIONS; DECISION-MAKING; NUTRITION LABEL; ECO-LABELS; CONSUMPTION; INFORMATION; EFFICIENCY; MOVEMENTS; CHOICE; POLICY	Saving energy is an important pillar for the mitigation of climate change. Electric devices (e.g., freezer and television) are an important player in the residential sector in the final demand for energy. Consumers' purchase decisions are therefore crucial to successfully reach the energy-efficiency goals. Putting energy labels on products is often considered an adequate way of empowering consumers to make informed purchase decisions. Consequently, this approach should contribute to reducing overall energy consumption. The effectiveness of its measurement depends on consumers' use and interpretation of the information provided. Despite advances in energy efficiency and a mandatory labeling policy, final energy consumption per capita is in many countries still increasing. This paper provides a systematic analysis of consumers' reactions to one of the most widely used ecolabels, the European Union (EU) energy label, by using eye-tracking methodology as an objective measurement. The study's results partially support the EU's mandatory policy, showing that the energy label triggers attention toward energy information in general. However, the energy label's effect on consumers' actual product choices seems to be rather low. The study's results show that the currently used presentation format on the label is insufficient. The findings suggest that it does not facilitate the integration of energy-related information. Furthermore, the current format can attract consumers to focus more on energy-efficiency information, leading them to disregard information about actual energy consumption. As a result, the final energy consumption may increase because excellent ratings on energy efficiency (e.g., A(++)) do not automatically imply little consumption. Finally, implications for policymakers and suggestions for further research are discussed.	[Waechter, Signe; Suetterlin, Bernadette; Siegrist, Michael] ETH, IED, Consumer Behav, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Waechter, S (corresponding author), ETH, IED, Consumer Behav, Zurich, Switzerland.	siwaechter@ethz.ch	Sütterlin, Bernadette/S-3265-2016; Siegrist, Michael/A-1032-2008	Sütterlin, Bernadette/0000-0001-9749-6660; Siegrist, Michael/0000-0002-6139-7190	Swiss Federal Office of Energy; Energy-Economy-Society research project	Swiss Federal Office of Energy; Energy-Economy-Society research project	This work was funded by the Swiss Federal Office of Energy and it is part of the Energy-Economy-Society research project (http://www.bfe.admin.ch/forschungewg/index.html?lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[AFD OECD/IEA], 2008, PROM EN EFF INV CAS; Allcott H, 2013, ENERGY EFFICIENCY: TOWARDS THE END OF DEMAND GROWTH, P133, DOI 10.1016/B978-0-12-397879-0.00005-0; ANDERSON CD, 1982, J CONSUM RES, V9, P163, DOI 10.1086/208909; [Anonymous], 1992, OFFIC J EUR COMMUNIT; [Anonymous], 2012, OFFIC J EUR UNION; [Anonymous], 2010, OFFIC J EUR UNION; Ares G, 2013, J SENS STUD, V28, P138, DOI 10.1111/joss.12031; Ashby NJS, 2015, JUDGM DECIS MAK, V10, P172; Ashby NJS, 2012, JUDGM DECIS MAK, V7, P254; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Ball D.A., 1992, J CONSUM PSYCHOL, V1, P155, DOI [10.1016/S1057-7408(08)80055-1, DOI 10.1016/S1057-7408(08)80055-1]; BFE, 2013, SWISS EN STAT 2012; Boardman B, 2004, ENVIRON SCI POLICY, V7, P165, DOI 10.1016/j.envsci.2004.03.002; Bradu C, 2014, J BUS ETHICS, V124, P283, DOI 10.1007/s10551-013-1872-2; Buckley R, 2014, J CLEAN PROD, DOI [http://dx.doi.org/10.1016/j.jclepro.2014.08.067, DOI 10.1016/J.JCLEPR0.2014.08.067]; Davis LW, 2008, RAND J ECON, V39, P530, DOI 10.1111/j.0741-6261.2008.00026.x; de Almeida A, 2011, ENERG BUILDINGS, V43, P1884, DOI 10.1016/j.enbuild.2011.03.027; Dendler L, 2014, J CLEAN PROD, V63, P74, DOI 10.1016/j.jclepro.2013.04.037; Djamasbi S, 2012, 18 AM C INF SYST AMC; Duchowski A, 2007, VISUAL ATTENTION EYE, P3; Duchowski A, 2007, EYE TRACKING METHODO, P137, DOI [10.1007/978-1-84628-609-4_12, DOI 10.1007/978-1-84628-609-4_12]; Egan C, 2000, INTERIM FINDINGS EVA; Eidgen&ouml;ssisches Departement f&uuml;r Umwelt V Energie und Kommunikation (UVEK), 2013, EN STRAT 2050; Eurostat, 2012, EN TRANSP ENV IND; Field A., 2013, DISCOVERING STAT USI; Galarraga Gallastegui I., 2002, European Environment, V12, P316, DOI 10.1002/eet.304; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gillingham K., 2013, BRIDGING ENERGY EFFI; Glockner A, 2011, J BEHAV DECIS MAKING, V24, P71, DOI 10.1002/bdm.684; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Graham DJ, 2012, FOOD POLICY, V37, P378, DOI 10.1016/j.foodpol.2012.03.004; Heinzle S, 2009, CONSUMER SURVEY NEW; Heinzle SL, 2012, J CONSUM POLICY, V35, P43, DOI 10.1007/s10603-012-9189-6; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Herring H, 2006, ENERGY, V31, P10, DOI 10.1016/j.energy.2004.04.055; Holmqvist K., 2011, EYE TRACKING COMPREH; Horstmann N, 2009, JUDGM DECIS MAK, V4, P335; IEA, 2009, GADG GIG; IEA & OECD, 2003, COOL APPL POL STRAT; International Risk Governance Council, 2013, REB EFF IMPL CONS BE; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kahneman D., 2011, THINKING FAST SLOW; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Le Meur O, 2009, IM PROC ICIP 2009 16; MCNEILL DL, 1979, J CONSUM RES, V6, P1, DOI 10.1086/208743; Merritt AC, 2010, SOC PERSONAL PSYCHOL, V4, P344, DOI 10.1111/j.1751-9004.2010.00263.x; Molenbroek E, 2013, EVALUATION ENERGY LA; Molenbroek E, 2014, ENERC32012523 EC; OECD/IEA, 2013, EN POL HIGHL; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Otto S, 2014, EUR PSYCHOL, V19, P96, DOI 10.1027/1016-9040/a000182; Pedersen E.R., 2006, BUSINESS STRATEGY EN, V15, P15, DOI DOI 10.1002/BSE.434; Pieters RGM, 1996, ADV CONSUM RES, V23, P242; Poole A, 2005, BCS CONF SERIES, P363, DOI 10.1007/1-84628-062-1_23; Prognos, 2012, EN SWITZ UNT 2050; Sammer K., 2006, BUSINESS STRATEGY EN, V15, P185, DOI [10.1002/bse.522, DOI 10.1002/BSE.522]; Schulte-Mecklenbeck M, 2013, APPETITE, V71, P242, DOI 10.1016/j.appet.2013.08.008; Shen J, 2009, J ENVIRON MANAGE, V90, P3561, DOI 10.1016/j.jenvman.2009.06.010; Shi SW, 2013, MANAGE SCI, V59, P1009, DOI 10.1287/mnsc.1120.1625; SHIPPEE G, 1980, ENVIRON MANAGE, V4, P297, DOI 10.1007/BF01869423; Siegrist M, 2015, FOOD QUAL PREFER, V39, P183, DOI 10.1016/j.foodqual.2014.07.010; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Soytas U, 2007, ECOL ECON, V62, P482, DOI 10.1016/j.ecolecon.2006.07.009; Stawreberg L, 2011, J CLEAN PROD, V19, P1300, DOI 10.1016/j.jclepro.2011.03.016; Stuttgen P, 2012, MARKET SCI, V31, P878, DOI 10.1287/mksc.1120.0732; Sutterlin B, 2014, J ENVIRON PSYCHOL, V40, P259, DOI 10.1016/j.jenvp.2014.07.005; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; Teisl MF, 2008, J ECON PSYCHOL, V29, P140, DOI 10.1016/j.joep.2007.04.002; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Thogersen J, 2003, J ENVIRON PSYCHOL, V23, P225, DOI 10.1016/S0272-4944(03)00018-5; Tiefenbeck V, 2013, ENERG POLICY, V57, P160, DOI 10.1016/j.enpol.2013.01.021; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; UNEMA P, 1990, VISUAL SEARCH, P193; van Amstel M, 2008, J CLEAN PROD, V16, P263, DOI 10.1016/j.jclepro.2006.07.039; Velichkovsky B.M., 2002, TRANSPORT RES F, V5, P145, DOI [10.1016/S1369-8478(02)00013-X, DOI 10.1016/S1369-8478(02)00013-X]; Waechter S, 2015, J CLEAN PROD, V93, P193, DOI 10.1016/j.jclepro.2015.01.011; Walton KC, 2014, ENRGY PROCED, V57, P826, DOI 10.1016/j.egypro.2014.10.291; Ward DO, 2011, ENERG POLICY, V39, P1450, DOI 10.1016/j.enpol.2010.12.017; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Wiel S, 2003, ENERG POLICY, V31, P1403, DOI 10.1016/S0301-4215(02)00199-4; Wiel S, 2000, ENVIRON SCI POLICY, V3, P7, DOI [http://dx.doi.org/10.1016/S1462-9011(00)00014-9, DOI 10.1016/S1462-9011(00)00014-9]; Wilson C, 2007, ANNU REV ENV RESOUR, V32, P169, DOI 10.1146/annurev.energy.32.053006.141137; Zhang XP, 2009, ECOL ECON, V68, P2706, DOI 10.1016/j.ecolecon.2009.05.011	87	32	33	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134132	10.1371/journal.pone.0134132	http://dx.doi.org/10.1371/journal.pone.0134132			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26231028	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400075
J	Wright, NE; Strong, JA; Gilbart, ER; Shollenbarger, SG; Lisdahl, KM				Wright, Natasha E.; Strong, Judith A.; Gilbart, Erika R.; Shollenbarger, Skyler G.; Lisdahl, Krista M.			5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MDMA ECSTASY; CANNABIS USE; NEUROPSYCHOLOGICAL EVIDENCE; HIPPOCAMPAL DYSFUNCTION; COGNITIVE FUNCTION; POSITRON EMISSION; POLYMORPHISMS; MOOD; ASSOCIATION	Objective Ecstasy use is associated with memory deficits. Serotonin transporter gene (5-HTTLPR) polymorphisms have been linked with memory function in healthy samples. The present pilot study investigated the influence of 5-HTTLPR polymorphisms on memory performance in ecstasy users, marijuana-using controls, and non-drug-using controls, after a minimum of 7 days of abstinence. Method Data were collected from 116 young adults (18-25 years-old), including 45 controls, 42 marijuana users, and 29 ecstasy users, and were balanced for 5-HTTLPR genotype. Participants were abstinent seven days prior to completing memory testing. Three MANCOVAs and one ANCOVA were run to examine whether drug group, 5-HTTLPR genotype, and their interactions predicted verbal and visual memory after controlling for gender, past year alcohol use, other drug use, and nicotine cotinine levels. Results MANCOVA and ANCOVA analysis revealed a significant interaction between drug group and genotype (p = .03) such that ecstasy users with the L/L genotype performed significantly worse on CVLT-2 total recall (p = .05), short (p = .008) and long delay free recall (p = .01), and recognition (p = .006), with the reverse pattern found in controls. Ecstasy did not significantly predict visual memory. 5-HTTLPR genotype significantly predicted memory for faces (p = .02); short allele carriers performed better than those with L/L genotype. Conclusions 5-HTTLPR genotype moderated the effects of ecstasy on verbal memory, with L/L carriers performing worse compared to controls. Future research should continue to examine individual differences in ecstasy's impact on neurocognitive performance as well as relationships with neuronal structure. Additional screening and prevention efforts focused on adolescents and emerging adults are necessary to prevent ecstasy consumption.	[Wright, Natasha E.; Gilbart, Erika R.; Shollenbarger, Skyler G.; Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Strong, Judith A.] Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH USA	University of Wisconsin System; University of Wisconsin Milwaukee; University System of Ohio; University of Cincinnati	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335; Strong, Judith/0000-0001-9363-0551; Wade, Natasha/0000-0002-9629-2305	National Institute on Drug Abuse [R03 DA027457]; University of Cincinnati Center for Environmental Genetics Pilot Program [P30 ES06096]; National Institute of Drug Abuse [R01 DA030354]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354, R03DA027457] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of Cincinnati Center for Environmental Genetics Pilot Program; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (R03 DA027457; PI: KML) and the University of Cincinnati Center for Environmental Genetics Pilot Program (P30 ES06096; PI: KML). KML was also funded by the National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Ando RD, 2010, BEHAV BRAIN RES, V207, P280, DOI 10.1016/j.bbr.2009.10.011; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Lopez-Rodriguez AB, 2014, BRIT J PHARMACOL, V171, P1435, DOI 10.1111/bph.12519; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Buchert R, 2004, AM J PSYCHIAT, V161, P1181, DOI 10.1176/appi.ajp.161.7.1181; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; Curran HV, 1997, ADDICTION, V92, P821, DOI 10.1111/j.1360-0443.1997.tb02951.x; Cuyas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027206; De Pradier M, 2010, EUR PSYCHIAT, V25, P323, DOI 10.1016/j.eurpsy.2009.10.002; Delis DC, 2000, MANUAL CALIFORNIA VE; Fagundo AB, 2010, J PSYCHOPHARMACOL, V24, P1381, DOI 10.1177/0269881109354926; FISCHER C, 1995, J NEUROSCI, V15, P5476; Fox HC, 2002, PSYCHOPHARMACOLOGY, V162, P203, DOI 10.1007/s00213-002-1071-9; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Gilbertson R, 2011, J CLIN EXP NEUROPSYC, V33, P609, DOI 10.1080/13803395.2010.543887; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonzalez R, 2012, J CLIN EXP NEUROPSYC, V34, P962, DOI 10.1080/13803395.2012.703642; Goodwin RS, 2008, J ANAL TOXICOL, V32, P562, DOI 10.1093/jat/32.8.562; Gouzoulis-Mayfrank E, 2003, PROG NEURO-PSYCHOPH, V27, P819, DOI 10.1016/S0278-5846(03)00114-3; Haenisch B, 2013, J AFFECT DISORDERS, V146, P438, DOI 10.1016/j.jad.2012.08.001; Hall MH, 2010, HARVARD REV PSYCHIAT, V18, P67, DOI 10.3109/10673220903523532; Halpern JH, 2011, ADDICTION, V106, P777, DOI 10.1111/j.1360-0443.2010.03252.x; Hanson KL, 2010, J CLIN EXP NEUROPSYC, V32, P337, DOI 10.1080/13803390903042361; Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245; Harvey MA, 2007, DRUG ALCOHOL REV, V26, P309, DOI 10.1080/09595230701247772; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Jacobsen LK, 2004, PSYCHOPHARMACOLOGY, V173, P383, DOI 10.1007/s00213-003-1679-4; Jager G, 2007, PSYCHOPHARMACOLOGY, V193, P403, DOI 10.1007/s00213-007-0792-1; Johnston L. D., 2012, MONITORING FUTURE NA, VI; Kaiser R, 2002, CLIN BIOCHEM, V35, P49, DOI 10.1016/S0009-9120(02)00273-4; Kalechstein AD, 2007, PSYCHOPHARMACOLOGY, V189, P531, DOI 10.1007/s00213-006-0601-2; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Lamers CTJ, 2006, J PSYCHOPHARMACOL, V20, P302, DOI 10.1177/0269881106059495; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lisdahl KL, 2012, J INT NEUROPSYCH SOC, V18, P876; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martin-Santos R, 2010, ADDICT BIOL, V15, P15, DOI 10.1111/j.1369-1600.2009.00180.x; Martins SS, 2005, EXP CLIN PSYCHOPHARM, V13, P244, DOI 10.1037/1064-1297.13.3.244; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Medina KL, 2005, J INT NEUROPSYCH SOC, V11, P753, DOI 10.1017/S1355617705050915; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Meyers J. E., 1995, REY COMPLEX FIGURE T; Morgan MJ, 2002, PSYCHOPHARMACOLOGY, V159, P294, DOI 10.1007/s002130100907; Noskova T, 2008, PRONEUROPSYCHOPHARMA, V32, P1745; Pardo-Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047599; Parrott AC, 2001, HUM PSYCHOPHARM CLIN, V16, P557, DOI 10.1002/hup.351; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; Parrott AC, 2004, PSYCHOPHARMACOLOGY, V173, P234, DOI 10.1007/s00213-003-1712-7; Perrine SA, 2010, NEUROTOXICOLOGY, V31, P654, DOI 10.1016/j.neuro.2010.08.005; Price JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115645; Price JS, 2013, BEHAV BRAIN RES, V242, P158, DOI 10.1016/j.bbr.2012.11.013; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Reneman L, 2000, PSYCHOPHARMACOLOGY, V148, P322, DOI 10.1007/s002130050057; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Rodgers J, 2003, J PSYCHOPHARMACOL, V17, P389, DOI 10.1177/0269881103174016; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Semple DM, 1999, BRIT J PSYCHIAT, V175, P63, DOI 10.1192/bjp.175.1.63; SHARKEY J, 1991, PSYCHOPHARMACOLOGY, V105, P113, DOI 10.1007/BF02316872; Sobell L. C, 1992, MEASURING ALCOHOL CO; Sprague JE, 1993, PHYSIOL BEHAV, V79, P1281; Starr LR, 2014, DEV PSYCHOPATHOL, V26, P1241, DOI 10.1017/S0954579414000996; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Tait RJ, 2011, ADDICTION, V106, P2195, DOI 10.1111/j.1360-0443.2011.03574.x; Takagi M, 2011, DRUG ALCOHOL REV, V30, P629, DOI 10.1111/j.1465-3362.2010.00256.x; Tanner-Smith EE, 2006, DRUG ALCOHOL DEPEN, V83, P247, DOI 10.1016/j.drugalcdep.2005.11.016; Taurah L, 2014, PSYCHOPHARMACOLOGY, V231, P737, DOI 10.1007/s00213-013-3288-1; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Thompson RD, 2010, ALCOHOL, V44, P401, DOI 10.1016/j.alcohol.2010.05.008; Urban NBL, 2012, NEUROPSYCHOPHARMACOL, V37, P1465, DOI 10.1038/npp.2011.332; Verbaten MN, 2003, HUM PSYCHOPHARM, V167, P85; Verdejo-Garcia A, 2013, NEUROPSYCHOPHARMACOL, V38, P1598, DOI 10.1038/npp.2013.59; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P784, DOI 10.1017/S1355617714000666; Wu P, 2010, DRUG ALCOHOL DEPEN, V112, P33, DOI 10.1016/j.drugalcdep.2010.05.006; Yubero-Lahoz S, 2014, EUROPEAN J PHARM, V674, P337; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873; Zhang XL, 2015, EXP THER MED, V9, P245, DOI 10.3892/etm.2014.2043	86	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134708	10.1371/journal.pone.0134708	http://dx.doi.org/10.1371/journal.pone.0134708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231032	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400152
J	Yong, HS; Song, SL; Eamsobhana, P; Goh, SY; Lim, PE; Chow, WL; Chan, KG; Abrahams-Sandi, E				Yong, Hoi-Sen; Song, Sze-Looi; Eamsobhana, Praphathip; Goh, Share-Yuan; Lim, Phaik-Eem; Chow, Wan-Loo; Chan, Kok-Gan; Abrahams-Sandi, Elizabeth			Mitochondrial Genome Supports Sibling Species of Angiostrongylus costaricensis (Nematoda: Angiostrongylidae)	PLOS ONE			English	Article							PHYLOGEOGRAPHY; REDESCRIPTION; ENVIRONMENT; CONGENERS; VASORUM; MODEL	Angiostrongylus costaricensis is a zoonotic parasitic nematode that causes abdominal or intestinal angiostrongyliasis in humans. It is endemic to the Americas. Although the mitochondrial genome of the Brazil taxon has been published, there is no available mitochondrial genome data on the Costa Rica taxon. We report here the complete mitochondrial genome of the Costa Rica taxon and its genetic differentiation from the Brazil taxon. The whole mitochondrial genome was obtained from next-generation sequencing of genomic DNA. It had a total length of 13,652 bp, comprising 36 genes (12 protein-coding genes-PCGs, 2 rRNA and 22 tRNA genes) and a control region (A + T rich non-coding region). It is longer than that of the Brazil taxon (13,585 bp). The larger mitogenome size of the Costa Rica taxon is due to the size of the control region as the Brazil taxon has a shorter length (265 bp) than the Costa Rica taxon (318 bp). The size of 6 PCGs and the start codon for ATP6, CYTB and NAD5 genes are different between the Costa Rica and Brazil taxa. Additionally, the two taxa differ in the stop codon of 6 PCGs. Molecular phylogeny based on 12 PCGs was concordant with two rRNA, 22 tRNA and 36 mitochondrial genes. The two taxa have a genetic distance of p = 16.2% based on 12 PCGs, p = 15.3% based on 36 mitochondrial genes, p = 13.1% based on 2 rRNA genes and p = 10.7% based on 22 tRNA genes, indicating status of sibling species. The Costa Rica and Brazil taxa of A. costaricensis are proposed to be accorded specific status as members of a species complex.	[Yong, Hoi-Sen; Goh, Share-Yuan; Lim, Phaik-Eem; Chan, Kok-Gan] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yong, Hoi-Sen; Song, Sze-Looi; Goh, Share-Yuan] Univ Malaya, Chancellery High Impact Res, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Chow, Wan-Loo] Sci Vis Sdn Bhd, Shah Alam 40170, Selangor Darul, Malaysia; [Abrahams-Sandi, Elizabeth] Univ Costa Rica, Dept Parasitol, San Pedro, Costa Rica	Universiti Malaya; Universiti Malaya; Mahidol University; Universiti Malaya; Universidad Costa Rica	Yong, HS (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	yong@um.edu.my; praphathip.eam@mahidol.ac.th; phaikeem@um.edu.my	Song, Sze-Looi/E-7939-2015; LIM, Phaik Eem/B-5331-2010; Yong, Hoi Sen/C-1548-2010; Chan, Kok Gan/B-8347-2010; song, sl/GRS-1884-2022; Eamsobhana, Praphathip/H-3343-2012	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Chan, Kok Gan/0000-0002-1883-1115; 	MoHE-HIR Grant [H-50001-00-A000025]; University of Malaya [H-5620009]	MoHE-HIR Grant; University of Malaya(Universiti Malaya)	This study was funded in part by MoHE-HIR Grant (H-50001-00-A000025) and the University of Malaya (H-5620009).	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Andrews S., 2010, FASTQC QUALITY CONTR; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Eamsobhana P, 2010, EXP PARASITOL, V126, P564, DOI 10.1016/j.exppara.2010.06.001; Eamsobhna P., 2010, ANGIOSTRONGYLUS ANGI, P41; Gasser RB, 2012, INFECT GENET EVOL, V12, P1884, DOI 10.1016/j.meegid.2012.07.022; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Hyman BC, 2011, GENETICA, V139, P611, DOI 10.1007/s10709-010-9531-3; Jabbar A, 2013, GENE, V516, P294, DOI 10.1016/j.gene.2012.10.072; Jefferies R, 2009, PARASITOLOGY, V136, P107, DOI 10.1017/S0031182008005258; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kramer MH, 1998, CLIN INFECT DIS, V26, P365, DOI 10.1086/516325; Lagisz M, 2013, J EVOLUTION BIOL, V26, P683, DOI 10.1111/jeb.12068; Lv Shan, 2014, Zhongguo Xuexichongbing Fangzhi Zazhi, V26, P175; Lv S, 2012, PARASITOL RES, V111, P115, DOI 10.1007/s00436-011-2807-4; Maldonado A, 2012, ZOONOSIS, P303, DOI DOI 10.5572/2125; McNulty SN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-145; MORERA P., 1971, Revista de Biologia Tropicale, V18, P173; MORERA P, 1973, AM J TROP MED HYG, V22, P613, DOI 10.4269/ajtmh.1973.22.613; Mota EM, 2005, MEM I OSWALDO CRUZ, V100, P407, DOI 10.1590/S0074-02762005000400012; Mota EM, 1995, MEM I OSWALDO CRUZ, V90, P707, DOI 10.1590/S0074-02761995000600010; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-392; Rambaut A, FIGTREE VERSION 1 4; RODRIGUEZ Rubens, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P55, DOI 10.1590/S0036-46652002000100010; Romero-Alegria A., 2014, ADV INFECT DIS, V04, P36, DOI [10.4236/aid.2014.41007, DOI 10.4236/AID.2014.41007]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spratt DM, 2015, INT J PARASITOL-PAR, V4, P178, DOI 10.1016/j.ijppaw.2015.02.006; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yong HS, 2015, ACTA TROP, V148, P66, DOI 10.1016/j.actatropica.2015.04.020	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134581	10.1371/journal.pone.0134581	http://dx.doi.org/10.1371/journal.pone.0134581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230642	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400137
J	Mentek, M; Truffer, F; Chiquet, C; Godin-Ribuot, D; Amoos, S; Loeuillet, C; Bernabei, M; Geiser, M				Mentek, Marielle; Truffer, Frederic; Chiquet, Christophe; Godin-Ribuot, Diane; Amoos, Serge; Loeuillet, Corinne; Bernabei, Mario; Geiser, Martial			Compact Laser Doppler Flowmeter (LDF) Fundus Camera for the Assessment of Retinal Blood Perfusion in Small Animals	PLOS ONE			English	Article							OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; RAT RETINA; FLOW; MICROVASCULATURE; CAT; ISCHEMIA; GRADIENT; VELOCITY; VOLUME	Purpose Noninvasive techniques for ocular blood perfusion assessment are of crucial importance for exploring microvascular alterations related to systemic and ocular diseases. However, few techniques adapted to rodents are available and most are invasive or not specifically focused on the optic nerve head (ONH), choroid or retinal circulation. Here we present the results obtained with a new rodent-adapted compact fundus camera based on laser Doppler flowmetry (LDF). Methods A confocal miniature flowmeter was fixed to a specially designed 3D rotating mechanical arm and adjusted on a rodent stereotaxic table in order to accurately point the laser beam at the retinal region of interest. The linearity of the LDF measurements was assessed using a rotating Teflon wheel and a flow of microspheres in a glass capillary. In vivo reproducibility was assessed in Wistar rats with repeated measurements (inter-session and inter-day) of retinal arteries and ONH blood velocity in six and ten rats, respectively. These parameters were also recorded during an acute intraocular pressure increase to 150 mmHg and after heart arrest (n = 5 rats). Results The perfusion measurements showed perfect linearity between LDF velocity and Teflon wheel or microsphere speed. Intraclass correlation coefficients for retinal arteries and ONH velocity (0.82 and 0.86, respectively) indicated strong inter-session repeatability and stability. Inter-day reproducibility was good (0.79 and 0.7, respectively). Upon ocular blood flow cessation, the retinal artery velocity signal substantially decreased, whereas the ONH signal did not significantly vary, suggesting that it could mostly be attributed to tissue light scattering. Conclusion We have demonstrated that, while not adapted for ONH blood perfusion assessment, this device allows pertinent, stable and repeatable measurements of retinal blood perfusion in rats.	[Mentek, Marielle; Chiquet, Christophe; Godin-Ribuot, Diane; Loeuillet, Corinne] Grenoble Alpes Univ, Lab HP2, F-38000 Grenoble, France; [Mentek, Marielle; Chiquet, Christophe; Godin-Ribuot, Diane; Loeuillet, Corinne] INSERM, Lab U1042, F-38000 Grenoble, France; [Truffer, Frederic; Amoos, Serge; Bernabei, Mario; Geiser, Martial] Univ Appl Sci & Arts Western Switzerland, Inst Syst Engn, Sion, Switzerland; [Chiquet, Christophe] Grenoble Alpes Univ, Grenoble Univ Hosp, Dept Ophthalmol, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Geiser, M (corresponding author), Univ Appl Sci & Arts Western Switzerland, Inst Syst Engn, Sion, Switzerland.	martial.geiser@hevs.ch	Godin-Ribuot, Diane/B-6945-2014; Chiquet, Christophe/M-7426-2014; loeuillet, corinne/M-6504-2014	Godin-Ribuot, Diane/0000-0001-7589-932X; Chiquet, Christophe/0000-0002-7601-4885; Geiser, Martial Henri/0000-0002-1017-2872; loeuillet, corinne/0000-0001-6474-4453	Retina France; Fondation de France, bourse Berthe Fouassier; PHC Germaine de Stael [26419NE, 777772H]	Retina France; Fondation de France, bourse Berthe Fouassier; PHC Germaine de Stael	Funding provided by Retina France 2012 (CC) http://www.retina.fr/retinaDrupal/content/projets-et-bourses-finances-en-2012, Fondation de France, bourse Berthe Fouassier (MM) http://www.fondationdefrance.org/La-Fondation-de-France/Fonds-et-fondations-sous-egide/Toutes-lesfondations/Berthe-Fouassier and PHC Germaine de Stael 2012, projet no 26419NE (CC, MHG), PHC Germaine de Stael 2013, projet no 777772H (CC, MHG) http://www.campusfrance.org/fr/stael. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHUTTO IA, 1995, OPHTHALMIC RES, V27, P249, DOI 10.1159/000267734; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; CAMPBELL MCW, 1981, VISION RES, V21, P1129, DOI 10.1016/0042-6989(81)90016-X; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Chiquet C, 2014, INVEST OPHTH VIS SCI, V55, P485, DOI 10.1167/iovs.13-12975; Choi W, 2012, BIOMED OPT EXPRESS, V3, P1047, DOI 10.1364/BOE.3.001047; FITZGERALD MEC, 1990, INVEST OPHTH VIS SCI, V31, P2483; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; GEIJER C, 1979, INVEST OPHTH VIS SCI, V18, P1030; Geiser MH, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127001; Geiser MH, 1999, J BIOMED OPT, V4, P459, DOI 10.1117/1.429960; HEIKE M, 1991, INVEST OPHTH VIS SCI, V32, P73; Hetu S, 2013, CURR EYE RES, V38, P158, DOI 10.3109/02713683.2012.723296; KIEL JW, 1992, INVEST OPHTH VIS SCI, V33, P2399; Li YX, 2008, NEUROIMAGE, V39, P1744, DOI 10.1016/j.neuroimage.2007.10.030; Lorentz K, 2008, ADV EXP MED BIOL, V614, P253, DOI 10.1007/978-0-387-74911-2_29; Mohammed AA, 2012, ANIM SCI PAP REP, V30, P285; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Ninomiya H, 2001, VET OPHTHALMOL, V4, P55, DOI 10.1046/j.1463-5224.2001.00143.x; OBrien C, 1997, BRIT J OPHTHALMOL, V81, P68, DOI 10.1136/bjo.81.1.68; Pannarale L, 1996, J ANAT, V188, P693; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Pouliot M, 2009, EXP EYE RES, V89, P960, DOI 10.1016/j.exer.2009.08.005; R Core Team, 2021, R LANGUAGE ENV STAT; RAPP LM, 1990, INVEST OPHTH VIS SCI, V31, P1186; Reiner A, 2010, EXP EYE RES, V90, P734, DOI 10.1016/j.exer.2010.03.006; RIVA C, 1972, INVEST OPHTH VISUAL, V11, P936; Riva CE, 1996, MICROVASC RES, V52, P258, DOI 10.1006/mvre.1996.0063; RIVA CE, 1990, MICROVASC RES, V40, P36, DOI 10.1016/0026-2862(90)90005-C; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P608; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; SHONAT RD, 1992, INVEST OPHTH VIS SCI, V33, P3174; SOSSI N, 1983, ARCH OPHTHALMOL-CHIC, V101, P98, DOI 10.1001/archopht.1983.01040010100018; Strohmaier C, 2011, EXP EYE RES, V92, P545, DOI 10.1016/j.exer.2011.03.014; Sugiyama K, 1999, INVEST OPHTH VIS SCI, V40, P3084; Tsujikawa A, 2000, JPN J OPHTHALMOL, V44, P257, DOI 10.1016/S0021-5155(99)00226-9; Wang L, 2007, EXP EYE RES, V84, P108, DOI 10.1016/j.exer.2006.09.005; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	40	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134378	10.1371/journal.pone.0134378	http://dx.doi.org/10.1371/journal.pone.0134378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226150	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700083
J	Jiang, ZX; Hennein, L; Tao, YL; Tao, LM				Jiang, Zhengxuan; Hennein, Lauren; Tao, Yulin; Tao, Liming			Interleukin-23 Receptor Gene Polymorphism May Enhance Expression of the IL-23 Receptor, IL-17, TNF-alpha and IL-6 in Behcet's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IL23R-IL12RB2; UVEITIS; IL10; DIFFERENTIATION; SUSCEPTIBILITY; HLA-B51	Purpose Recent studies identified an association between Behcet's disease (BD) and the IL-23R gene polymorphism (rs17375018) in different populations. This study examined whether this IL-23R gene polymorphism is associated with enhanced inflammatory responses. Methods We recruited 27 BD patients and 32 controls with three genotypes. Peripheral blood mononuclear cells (PBMCs) were seeded with or without anti-CD3 and CD28. Cells were incubated for 24 hours, and then supernatants were collected and stored at -20 degrees C until analyzed. Levels of interferon (IFN)-gamma, tissue necrosis factor (TNF)-alpha, interleukin (IL)-17 and IL-6 were detected by ELISA. IL-23R expression was assessed by quantitative real-time polymerase chain reaction (RT-PCR). Results The expression of IL-23R was significantly higher in both BD patients and healthy controls with the GG genotype compared to the AG and AA genotype with anti-CD3 and CD28 stimulation (all P-value < 0.05). Among the PBMCs cultured with anti-CD3 and CD28 stimulation, there was an elevated secretion of TNF-alpha, IL-6 and IL-17 in BD patients and healthy controls with the GG genotype. However, there was no significant change in secretion of IFN-gamma in BD patients and healthy controls among the genotype of this IL-23R gene polymorphism. Conclusions The results suggest that the GG genotype of the rs17375018 variant in the IL-23R gene enhances pro-inflammatory cytokine responses.	[Jiang, Zhengxuan; Tao, Yulin; Tao, Liming] Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China; [Hennein, Lauren] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Hennein, Lauren] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Anhui Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jiang, ZX (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China.	jzx1287@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation Project of China [81300755]; Natural Science Foundation of the Higher Educational Bureau of Anhui Province [KJ2013A147]; Second Affiliated Hospital of Anhui Medical University [2014BKJ047]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Higher Educational Bureau of Anhui Province; Second Affiliated Hospital of Anhui Medical University	This work was supported by the National Natural Science Foundation Project of China (81300755), the key project of the Natural Science Foundation of the Higher Educational Bureau of Anhui Province (KJ2013A147), and the Grant of Second Affiliated Hospital of Anhui Medical University (2014BKJ047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Bhakta BB, 1999, RHEUMATOLOGY, V38, P728, DOI 10.1093/rheumatology/38.8.728; Cavus F, 2014, IMMUNOL LETT, V160, P96, DOI 10.1016/j.imlet.2014.01.001; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Criteria for diagnosis of Behcet's disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-6736(90)92643-V; Gheita TA, 2015, JOINT BONE SPINE, V82, P213, DOI 10.1016/j.jbspin.2014.10.008; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Na SY, 2013, CLIN EXP RHEUMATOL, V31, pS32; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; TAKENO M, 1995, ARTHRITIS RHEUM, V38, P426, DOI 10.1002/art.1780380321; Touzot M, 2014, AUTOIMMUN REV; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Yu RY, 2015, J IMMUNOL, V194, P1062, DOI 10.4049/jimmunol.1401850; Zhou ZY, 2012, AUTOIMMUN REV, V11, P699, DOI 10.1016/j.autrev.2011.12.005	20	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134632	10.1371/journal.pone.0134632	http://dx.doi.org/10.1371/journal.pone.0134632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222305	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800155
J	Khurana, H; Meena, VK; Prakash, S; Chuttani, K; Chadha, N; Jaswal, A; Dhawan, DK; Mishra, AK; Hazari, PP				Khurana, Harleen; Meena, Virendra Kumar; Prakash, Surbhi; Chuttani, Krishna; Chadha, Nidhi; Jaswal, Ambika; Dhawan, Devinder Kumar; Mishra, Anil Kumar; Hazari, Puja Panwar			Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT (GSHMe)(2) to Detect Gamma Glutamyl Transferase Over Expressing Tumors	PLOS ONE			English	Article							HUMAN LYMPHOID-CELLS; CANCER-CELLS; TRANSPEPTIDASE; GLUTATHIONE; GROWTH; RADIOPROTECTION; METABOLISM; RESISTANCE; INCREASES	Gamma Glutamyl Transferase (GGT) is an important biomarker in malignant cancers. The redox processes ensuing from GGT-mediated metabolism of extracellular GSH are implicated in critical aspects of tumor cell biology. Reportedly, Glutathione monoethyl ester (GSHMe) is a substrate of GGT, which has been used for its rapid transport over glutathione. Exploring GGT to be an important target, a homobivalent peptide system, DT (GSHMe)(2) was designed to target GGT-over expressing tumors for diagnostic purposes. DT(GSHMe)(2) was synthesized, characterized and preclinically evaluated in vitro using toxicity, cell binding assays and time dependent experiments. Stable and defined radiochemistry with Tc-99m and Ga-68 was optimized for high radiochemical yield. In vivo biodistribution studies were conducted for different time points along with scintigraphic studies of radiolabeled DT(GSHMe)(2) on xenografted tumor models. For further validation, in silico docking studies were performed on GGT (hGGT1, P19440). Preclinical in vitro evaluations on cell lines suggested minimal toxicity of DT(GSHMe)(2) at 100 mu M concentration. Kinetic analysis revealed transport of Tc-99m-DT(GSHMe)(2) occurs via a saturable high-affinity carrier with Michaelis constant (Km) of 2.25 mu M and maximal transport rate velocity (Vmax) of 0.478 mu M/min. Quantitative estimation of GGT expression from western blot experiments showed substantial expression with 41.6 +/- 7.07 % IDV for tumor. Small animal micro PET (Positron Emission Tomography)/CT(Computed Tomography) coregistered images depicted significantly high uptake of DT(GSHMe)(2) at the BMG-1 tumor site. ROI analysis showed high tumor to contra lateral muscle ratio of 9.33 in PET imaging studies. Avid accumulation of radiotracer was observed at tumor versus inflammation site at 2 h post i.v. injection in an Ehrlich Ascites tumor (EAT) mice model, showing evident specificity for tumor. We propose DT(GSHMe)(2) to be an excellent candidate for prognostication and tumor imaging using PET/SPECT.	[Khurana, Harleen; Meena, Virendra Kumar; Prakash, Surbhi; Chuttani, Krishna; Chadha, Nidhi; Jaswal, Ambika; Mishra, Anil Kumar; Hazari, Puja Panwar] Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Delhi, India; [Khurana, Harleen; Dhawan, Devinder Kumar] Panjab Univ, Dept Biophys, Chandigarh 160014, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Panjab University	Mishra, AK (corresponding author), Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Delhi, India.	akmishra63@gmail.com; puja.hazari@gmail.com	Meena, Dr. Virendra Kumar/ABA-7698-2021	Meena, Dr. Virendra Kumar/0000-0002-2083-7188	INMAS DRDO project [INM311 (3.1)]; Council of scientific and Industrial Research (CSIR)	INMAS DRDO project; Council of scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by INMAS DRDO project INM311 (3.1), and the research fellowship was provided by Council of scientific and Industrial Research (CSIR).	Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; Campbell EB, 1992, United States patent No, Patent No. [US 5093458, 5093458]; Corti A, 2010, ANTICANCER RES, V30, P1169; Dilworth JR, 1998, CHEM SOC REV, V27, P43; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Fani M, 2012, THERANOSTICS, V2, P481, DOI 10.7150/thno.4024; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Hanada K, 1997, J INVEST DERMATOL, V108, P727, DOI 10.1111/1523-1747.ep12292108; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hanigan MH, 1999, BRIT J CANCER, V81, P75, DOI 10.1038/sj.bjc.6690653; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Hazari PP, 2014, CURR CANCER DRUG TAR, V14, P817; Hazari PP, 2010, BIOCONJUGATE CHEM, V21, P229, DOI 10.1021/bc900197n; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; JENSEN GL, 1983, P NATL ACAD SCI-BIOL, V80, P4714, DOI 10.1073/pnas.80.15.4714; JHA B, 1992, INT J RADIAT BIOL, V62, P409, DOI 10.1080/09553009214552291; Jong M, 2003, EUR J NUCL MED MOL I, V30, P463, DOI 10.1007/s00259-002-1107-8; Laverman P, 2012, EUR J NUCL MED MOL I, V39, P78, DOI 10.1007/s00259-011-2014-7; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006; Maecke HR, 2005, J NUCL MED, V46, p172S; Mansi L, 2011, EUR J NUCL MED MOL I, V38, P605, DOI 10.1007/s00259-011-1762-8; NY SL, 2014, PROTEIN PREPWIZARD L; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Roomi MW, 2006, EXP MOL PATHOL, V81, P8, DOI 10.1016/j.yexmp.2006.02.006; Van Dort ME, 2008, CURR COMPUT-AID DRUG, V4, P46, DOI 10.2174/157340908783769265; Wang W, 1998, PHARMACOL REV, V50, P335; WELLNER VP, 1984, P NATL ACAD SCI-BIOL, V81, P4732, DOI 10.1073/pnas.81.15.4732; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	35	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134281	10.1371/journal.pone.0134281	http://dx.doi.org/10.1371/journal.pone.0134281			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221728	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800121
J	Musser, JMB; Heatley, JJ; Koinis, AV; Suchodolski, PF; Guo, JH; Escandon, P; Tizard, IR				Musser, Jeffrey M. B.; Heatley, J. Jill; Koinis, Anastasia V.; Suchodolski, Paulette F.; Guo, Jianhua; Escandon, Paulina; Tizard, Ian R.			Ribavirin Inhibits Parrot Bornavirus 4 Replication in Cell Culture	PLOS ONE			English	Article							PROVENTRICULAR DILATATION DISEASE; COCKATIELS NYMPHICUS-HOLLANDICUS; AVIAN BORNAVIRUS; ANTIVIRAL ACTIVITY; VIRUS-REPLICATION; PSITTACINE BIRDS; MECHANISM; INFECTION; IDENTIFICATION; INTERFERON	Parrot bornavirus 4 is an etiological agent of proventricular dilatation disease, a fatal neurologic and gastrointestinal disease of psittacines and other birds. We tested the ability of ribavirin, an antiviral nucleoside analog with antiviral activity against a range of RNA and DNA viruses, to inhibit parrot bornavirus 4 replication in duck embryonic fibroblast cells. Two analytical methods that evaluate different products of viral replication, indirect immunocytochemistry for viral specific nucleoprotein and qRT-PCR for viral specific phosphoprotein gene mRNA, were used. Ribavirin at concentrations between 2.5 and 25 mu g/mL inhibited parrot bornavirus 4 replication, decreasing viral mRNA and viral protein load, in infected duck embryonic fibroblast cells. The addition of guanosine diminished the antiviral activity of ribavirin suggesting that one possible mechanism of action against parrot bornavirus 4 may likely be through inosine monophosphate dehydrogenase inhibition. This study demonstrates parrot bornavirus 4 susceptibility to ribavirin in cell culture.	[Musser, Jeffrey M. B.; Heatley, J. Jill; Suchodolski, Paulette F.; Guo, Jianhua; Tizard, Ian R.] Texas A&M Univ, Coll Vet Med, Schubot Exot Bird Hlth Ctr, College Stn, TX 77843 USA; [Musser, Jeffrey M. B.; Guo, Jianhua; Escandon, Paulina; Tizard, Ian R.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Heatley, J. Jill] Texas A&M Univ, Coll Vet Med, Dept Small Anim Clin Sci, Zool Med, College Stn, TX 77843 USA; [Koinis, Anastasia V.] Texas A&M Univ, Coll Vet Med, Morris Anim Fdn Vet Student Scholar, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Musser, JMB (corresponding author), Texas A&M Univ, Coll Vet Med, Schubot Exot Bird Hlth Ctr, College Stn, TX 77843 USA.	jmusser@cvm.tamu.edu	Heatley, J Jill/AAI-1838-2020	Heatley, J Jill/0000-0001-7715-7784	Schubot Exotic Bird Health Center; Morris Animal Foundation Veterinary Student Scholar	Schubot Exotic Bird Health Center; Morris Animal Foundation Veterinary Student Scholar	This work was supported by Schubot Exotic Bird Health Center (JMBM, JJH) and Morris Animal Foundation Veterinary Student Scholar (AVK).	BAYLOR NW, 1992, J INFECT DIS, V165, P433, DOI 10.1093/infdis/165.3.433; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; CARBONE KM, 1993, J VIROL, V67, P1453, DOI 10.1128/JVI.67.3.1453-1460.1993; Charlier CM, 2013, J VIROL, V87, P12339, DOI 10.1128/JVI.01127-13; Chen LL, 2011, ANTIVIR RES, V91, P314, DOI 10.1016/j.antiviral.2011.07.008; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; DAHLHAUSEN R, 2002, P ANN C ASS AV VET, P9; DELATORRE JC, 1987, J VIROL, V61, P233, DOI 10.1128/JVI.61.1.233-235.1987; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; Dou J, 2011, ARCH VIROL, V156, P793, DOI 10.1007/s00705-011-0917-z; Evers DL, 2005, ANTIVIR RES, V68, P124, DOI 10.1016/j.antiviral.2005.08.002; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; GonzalezDunia D, 1997, J VIROL, V71, P3208, DOI 10.1128/JVI.71.4.3208-3218.1997; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Guo J, 2012, VET MED-RES REP, V3, P49, DOI 10.2147/VMRR.S33353; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Hoppes S, 2013, J EXOT PET MED, V22, P275, DOI 10.1053/j.jepm.2013.08.014; Hoppes Sharman M., 2013, Veterinary Clinics of North America Exotic Animal Practice, V16, P339, DOI 10.1016/j.cvex.2013.01.004; Hui CK, 2003, J INFECT DIS, V187, P1071, DOI 10.1086/368217; Jordan I, 1999, J VIROL, V73, P7903, DOI 10.1128/JVI.73.9.7903-7906.1999; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; KNIGHT V, 1981, ANTIMICROB AGENTS CH, V20, P477, DOI 10.1128/AAC.20.4.477; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marroqui L, 2007, VET MICROBIOL, V122, P52, DOI 10.1016/j.vetmic.2007.01.002; Martin P, 2008, J GASTROEN HEPATOL, V23, P844, DOI 10.1111/j.1440-1746.2008.05398.x; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; Mirhosseini N, 2011, J AVIAN MED SURG, V25, P199, DOI 10.1647/2010-030.1; Mizutani T, 1998, ARCH VIROL, V143, P2039, DOI 10.1007/s007050050440; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; MULLER WEG, 1977, BIOCHEM PHARMACOL, V26, P1071, DOI 10.1016/0006-2952(77)90246-5; Nedorost N, 2012, AVIAN DIS, V56, P414, DOI 10.1637/10026-112911-ResNote.1; Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006; Ouyang N, 2009, AVIAN PATHOL, V38, P393, DOI 10.1080/03079450903191036; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; POVEY RC, 1978, AM J VET RES, V39, P175; Reuter A, 2010, VIRUSES-BASEL, V2, P927, DOI 10.3390/v2040927; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Rotman Y, 2014, GUT, V63, P161, DOI 10.1136/gutjnl-2012-303852; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Stitz L, 2002, FRONT BIOSCI, V7, pD541, DOI 10.2741/stitz; Thomas Emmanuel, 2012, Antiviral Chemistry & Chemotherapy, V23, P1, DOI 10.3851/IMP2125; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134080	10.1371/journal.pone.0134080	http://dx.doi.org/10.1371/journal.pone.0134080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222794	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800100
J	Shao, MW; Lu, YH; Miao, S; Zhang, Y; Chen, TT; Zhang, YL				Shao, Ming-Wei; Lu, Yi-Hui; Miao, Shuang; Zhang, Yun; Chen, Ting-Ting; Zhang, Ying-Lao			Diversity, Bacterial Symbionts and Antibacterial Potential of Gut-Associated Fungi Isolated from the Pantala flavescens Larvae in China	PLOS ONE			English	Article							METABOLITES	The diversity of fungi associated with the gut of Pantala flavescens larvae was investigated using a culture-dependent method and molecular identification based on an analysis of the internally transcribed spacer sequence. In total, 48 fungal isolates were obtained from P. flavescens larvae. Based on phylogenetic analyses, the fungal isolates were grouped in 5 classes and 12 different genera. Fourteen bacterial 16S rDNA sequences derived from total genomic DNA extractions of fungal mycelia were obtained. The majority of the sequences were associated with Proteobacteria (13/14), and one Bacillaceae (1/14) was included. Leclercia sp., Oceanobacillus oncorhynchi and Methylobacterium extorquens, were reported for the first time as bacterial endosymbionts in fungi. High-performance liquid chromatography (HPLC) analysis indicated that bacterial symbionts produced specific metabolites and also exerted an inhibitory effect on fungal metabolites. The biological activity of the fungal culture extracts against the pathogenic bacteria Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633) and Escherichia coli (ATCC 8739) was investigated, and 20 extracts (42%) exhibited antibacterial activity against at least one of the tested bacterial strains. This study is the first report on the diversity and antibacterial activity of symbiotic fungi residing in the gut of P. flavescens larvae, and the results show that these fungi are highly diverse and could be exploited as a potential source of bioactive compounds.	[Shao, Ming-Wei; Lu, Yi-Hui; Miao, Shuang; Zhang, Yun; Chen, Ting-Ting; Zhang, Ying-Lao] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China; [Zhang, Ying-Lao] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Zhejiang Normal University; Nanjing University	Zhang, YL (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China.	ylzhang@zjnu.cn	Zhang, Yinglao/AAR-9281-2021		National Natural Science Foundation of China (NSFC) [21002092, 21272215]; State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University [01KF-201104]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University	This work was co-financed by the National Natural Science Foundation of China (NSFC) (21002092 and 21272215), and Open Project of State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University (01KF-201104).	Angela ED, 2015, ANNU REV ENTOMOL, V60, P17, DOI [10.1146/annurev-ento-010814-020822, DOI 10.1146/ANNUREV-ENT0-010814-020822]; Bhadury P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026445; Camara MPS, 2001, MYCOL RES, V105, P41, DOI 10.1017/S0953756200003233; Cazemier AE, 1997, MICROB ECOL, V33, P189, DOI 10.1007/s002489900021; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; Hollister EB, 2010, SOIL BIOL BIOCHEM, V42, P1816, DOI 10.1016/j.soilbio.2010.06.022; HUGHES GM, 1958, J EXP BIOL, V35, P567; Judith K, 2007, TERMITES CURR BIOL, V17, P995; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Lackner G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002096; Leone MR, 2010, ANGEW CHEM, V122, P7638; Li S, 2014, J AGR FOOD CHEM, V62, P8997, DOI 10.1021/jf502484n; Lin ZJ, 2014, J ANTIBIOT, V67, P121, DOI 10.1038/ja.2013.115; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; McFrederick QS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2653; Minerdi D, 2008, ENVIRON MICROBIOL, V10, P1725, DOI 10.1111/j.1462-2920.2008.01594.x; Mueller UG, 2012, CURR OPIN MICROBIOL, V15, P269, DOI 10.1016/j.mib.2012.03.001; Nancy AM, 2006, SYMBIOSIS CURR BIOL, V16, P866; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Salvioli A., ENV MICROB, V12, P2083; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schaaf O, 1997, MICROBIOL RES, V152, P57; Scherlach K, 2012, ANGEW CHEM, V124, P9753, DOI DOI 10.1002/ANGE.201204540; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Steinhaus EA, 1941, J BACTERIOL, V42, P757, DOI 10.1128/JB.42.6.757-790.1941; Sulemankhil I, 2012, ANTIMICROB AGENTS CH, V56, P6095, DOI 10.1128/AAC.01173-12; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wagenaar MM, 2001, J NAT PROD, V64, P1006, DOI 10.1021/np010020u; White MM, 2004, MYCOLOGIA, V96, P891, DOI 10.2307/3762122; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhang Y., 2008, ANGEW CHEM, V120, P5907, DOI DOI 10.1002/ANGE.200801284; Zhang YL, 2011, J AM CHEM SOC, V133, P5931, DOI 10.1021/ja110932p; Zhang YL, 2008, CHEM BIODIVERS, V5, P2402, DOI 10.1002/cbdv.200890204; Zhang YL, 2011, BIORESOURCE TECHNOL, V102, P3575, DOI 10.1016/j.biortech.2010.10.028	38	16	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134542	10.1371/journal.pone.0134542	http://dx.doi.org/10.1371/journal.pone.0134542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221957	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800152
J	Yeo, JHC; Skinner, JPJ; Bird, MJ; Formosa, LE; Zhang, JG; Kluck, RM; Belz, GT; Chong, MMW				Yeo, Janet H. C.; Skinner, Jarrod P. J.; Bird, Matthew J.; Formosa, Luke E.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.; Chong, Mark M. W.			A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; MOLECULAR DIAGNOSIS; RNA-POLYMERASE; LARGE SUBUNIT; TRANSLATION; RIBOSOME; MUTATIONS; GENOME; DISORDERS; SPECTRUM	We identified Mrpl44 in a search for mammalian proteins that contain RNase III domains. This protein was previously found in association with the mitochondrial ribosome of bovine liver extracts. However, the precise Mrpl44 localization had been unclear. Here, we show by immunofluorescence microscopy and subcellular fractionation that Mrpl44 is localized to the matrix of the mitochondria. We found that it can form multimers, and confirm that it is part of the large subunit of the mitochondrial ribosome. By manipulating its expression, we show that Mrpl44 may be important for regulating the expression of mtDNA-encoded genes. This was at the level of RNA expression and protein translation. This ultimately impacted ATP synthesis capability and respiratory capacity of cells. These findings indicate that Mrpl44 plays an important role in the regulation of the mitochondrial OXPHOS capacity.	[Yeo, Janet H. C.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Yeo, Janet H. C.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Yeo, Janet H. C.; Skinner, Jarrod P. J.; Chong, Mark M. W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Bird, Matthew J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bird, Matthew J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Formosa, Luke E.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Chong, Mark M. W.] Univ Melbourne, Dept Med St Vincents, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; St. Vincent's Institute of Medical Research; Murdoch Children's Research Institute; University of Melbourne; La Trobe University; University of Melbourne	Chong, MMW (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	mchong@svi.edu.au	Kluck, Ruth M/C-8413-2013; Belz, Gabrielle T/C-9350-2013; Chong, Mark/H-6684-2016	Kluck, Ruth M/0000-0002-7101-1925; Belz, Gabrielle T/0000-0002-9660-9587; Chong, Mark/0000-0002-3701-7397; Formosa, Luke/0000-0002-7740-6151; Bird, Matthew/0000-0003-3185-0780	National Health and Medical Research Council, Australia [1004541, 1042211, 1042582, 1016647]; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	This work was funded by grants from the National Health and Medical Research Council, Australia (#1004541 and #1042211 to MMWC; #1042582 to GTB; #1016647 to JGZ), MMWC is an Australian Research Council QEII Fellow, GTB is an Australian Research Council Future Fellow, JHCY was supported by the Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. This work was made possible through Victorian State Government Operational Infrastructure Support, Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme and the Australian Mitochondrial Disease Foundation.	Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Calin-Jageman I, 2003, NUCLEIC ACIDS RES, V31, P2381, DOI 10.1093/nar/gkg329; Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144; Dames S, 2013, J MOL DIAGN, V15, P526, DOI 10.1016/j.jmoldx.2013.03.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Greber BJ, 2014, NATURE; Hahn SH, 2012, GENOME MED, V4, DOI 10.1186/gm321; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Macias S, 2013, BIOCHEM SOC T, V41, P838, DOI 10.1042/BST20130011; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wanschers BFJ, 2012, NUCLEIC ACIDS RES, V40, P4040, DOI 10.1093/nar/gkr1271; Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001; Yeo JHC, 2011, IUBMB LIFE, V63, P972, DOI 10.1002/iub.524; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134326	10.1371/journal.pone.0134326	http://dx.doi.org/10.1371/journal.pone.0134326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221731	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800131
J	O'Hurley, G; Busch, C; Fagerberg, L; Hallstrom, BM; Stadler, C; Tolf, A; Lundberg, E; Schwenk, JM; Jirstrom, K; Bjartell, A; Gallagher, WM; Uhlen, M; Ponten, F				O'Hurley, Gillian; Busch, Christer; Fagerberg, Linn; Hallstrom, Bjorn M.; Stadler, Charlotte; Tolf, Anna; Lundberg, Emma; Schwenk, Jochen M.; Jirstrom, Karin; Bjartell, Anders; Gallagher, William M.; Uhlen, Mathias; Ponten, Fredrik			Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer	PLOS ONE			English	Article							BIOMARKER DISCOVERY; EXPRESSION; ANTIGEN; ATLAS; LOCALIZATION; KALLIKREINS; ROLES	To better understand prostate function and disease, it is important to define and explore the molecular constituents that signify the prostate gland. The aim of this study was to define the prostate specific transcriptome and proteome, in comparison to 26 other human tissues. Deep sequencing of mRNA (RNA-seq) and immunohistochemistry-based protein profiling were combined to identify prostate specific gene expression patterns and to explore tissue biomarkers for potential clinical use in prostate cancer diagnostics. We identified 203 genes with elevated expression in the prostate, 22 of which showed more than five-fold higher expression levels compared to all other tissue types. In addition to previously well-known proteins we identified two poorly characterized proteins, TMEM79 and ACOXL, with potential to differentiate between benign and cancerous prostatic glands in tissue biopsies. In conclusion, we have applied a genome-wide analysis to identify the prostate specific proteome using transcriptomics and antibody-based protein profiling to identify genes with elevated expression in the prostate. Our data provides a starting point for further functional studies to explore the molecular repertoire of normal and diseased prostate including potential prostate cancer markers such as TMEM79 and ACOXL.	[O'Hurley, Gillian; Busch, Christer; Tolf, Anna; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [O'Hurley, Gillian; Gallagher, William M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [O'Hurley, Gillian] OncoMark Ltd, NovaUCD, Dublin 4, Ireland; [Fagerberg, Linn; Hallstrom, Bjorn M.; Stadler, Charlotte; Schwenk, Jochen M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund Oncol & Pathol, Lund, Sweden; [Bjartell, Anders] Lund Univ, Dept Clin Sci, Div Urol Canc, Skane Univ Hosp Malmo, Malmo, Sweden	Uppsala University; University College Dublin; Royal Institute of Technology; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Ponten, F (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	fredrik.ponten@igp.uu.se	Uhlen, Mathias/B-3262-2016; Schwenk, Jochen/AAS-4164-2021; Schwenk, Jochen M/F-1730-2010; Uhlen, Mathias/AAV-8746-2021; Lundberg, Emma S K/F-3891-2010	Uhlen, Mathias/0000-0002-4858-8056; Schwenk, Jochen/0000-0001-8141-8449; Schwenk, Jochen M/0000-0001-8141-8449; Kaller Lundberg, Emma/0000-0001-7034-0850; Fagerberg, Linn/0000-0003-0198-7137; Gallagher, William/0000-0002-4307-5999	Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation; Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH [285910]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation; Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH	Funding was provided by the Knut and Alice Wallenberg Foundation and the Swedish Cancer Foundation and by the Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH (No. 285910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OncoMark Ltd provided support in the form of salaries for author GOH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bangma CH, 2012, CRIT REV ONCOL HEMAT, V83, P235, DOI 10.1016/j.critrevonc.2011.10.003; Borgono CA, 2004, MOL CANCER RES, V2, P257; Brawer MK, 1998, UROLOGY, V52, P372, DOI 10.1016/S0090-4295(98)00241-6; Carter HB, 2011, BJU INT, V108, P1684, DOI [10.1111/j.1464-410X.2011.10489.x, 10.1111/j.1464-410X.2010.10489.x]; Carter HB, 2004, JNCI-J NATL CANCER I, V96, P557, DOI 10.1093/jnci/djh111; Danielsson F, 2013, P NATL ACAD SCI USA, V110, P6853, DOI 10.1073/pnas.1216436110; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gunia S, 2009, VIRCHOWS ARCH, V454, P573, DOI 10.1007/s00428-009-0759-1; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; HENTTU P, 1994, ANN MED, V26, P157, DOI 10.3109/07853899409147884; Hong MG, 2013, HUM MUTAT, V34, P515, DOI 10.1002/humu.22267; Issaq HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/elps.201000588; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kong HY, 2013, BIOMOL THER, V21, P10, DOI 10.4062/biomolther.2012.095; Kristiansen G, 2012, HISTOPATHOLOGY, V60, P125, DOI 10.1111/j.1365-2559.2011.04083.x; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; RCoreTeam, 2013, R A LANGUAGE AND ENV; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stadler C, 2012, J PROTEOMICS, V75, P2236, DOI 10.1016/j.jprot.2012.01.030; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Tassidis H, 2013, TUMOR BIOL, V34, P637, DOI 10.1007/s13277-012-0590-1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069744	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133449	10.1371/journal.pone.0133449	http://dx.doi.org/10.1371/journal.pone.0133449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237329	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942400012
J	Badria, FA; Ibrahim, AS; Badria, AF; Elmarakby, AA				Badria, Farid A.; Ibrahim, Ahmed S.; Badria, Adel F.; Elmarakby, Ahmed A.			Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats	PLOS ONE			English	Article							LIPID-PEROXIDATION; TOXICITY; SUPPLEMENTATION; CHELATION; ACID	Objectives Iron overload is now recognized as a health problem in industrialized countries, as excessive iron is highly toxic for liver and spleen. The potential use of curcumin as an iron chelator has not been clearly identified experimentally in iron overload condition. Here, we evaluate the efficacy of curcumin to alleviate iron overload-induced hepatic and splenic abnormalities and to gain insight into the underlying mechanisms. Design and Methods Three groups of male adult rats were treated as follows: control rats, rats treated with iron in a drinking water for 2 months followed by either vehicle or curcumin treatment for 2 more months. Thereafter, we studied the effects of curcumin on iron overload-induced lipid peroxidation and anti-oxidant depletion. Results Treatment of iron-overloaded rats with curcumin resulted in marked decreases in iron accumulation within liver and spleen. Iron-overloaded rats had significant increases in malonyl-dialdehyde (MDA), a marker of lipid peroxidation and nitric oxide (NO) in liver and spleen when compared to control group. The effects of iron overload on lipid peroxidation and NO levels were significantly reduced by the intervention treatment with curcumin (P < 0.05). Furthermore, the endogenous anti-oxidant activities/levels in liver and spleen were also significantly decreased in chronic iron overload and administration of curcumin restored the decrease in the hepatic and splenic antioxidant activities/levels. Conclusion Our study suggests that curcumin may represent a new horizon in managing iron overload-induced toxicity as well as in pathological diseases characterized by hepatic iron accumulation such as thalassemia, sickle cell anemia, and myelodysplastic syndromes possibly via iron chelation, reduced oxidative stress derived lipid peroxidation and improving the body endogenous antioxidant defense mechanism.	[Badria, Farid A.] Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt; [Ibrahim, Ahmed S.] Mansoura Univ, Fac Pharm, Dept Biochem & Clin Biochem, Mansoura 35516, Egypt; [Badria, Adel F.] Univ Alexandria, Med Technol Ctr, Alexandria 21526, Egypt; [Badria, Adel F.] Univ Patras, Dept Mech & Aeronaut Engn, Patras 26500, Greece; [Elmarakby, Ahmed A.] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Patras; University System of Georgia; Augusta University	Badria, FA (corresponding author), Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt.	faridbadria@yahoo.com	Elmarakby, Ahmed/ABF-5055-2021; Badria, Adel/AFS-8650-2022; Ibrahim, Ahmed/D-5241-2017; Badria, Adel/C-6488-2018	Badria, Adel/0000-0003-4686-603X; Ibrahim, Ahmed/0000-0001-8480-6252; Badria, Adel/0000-0003-4686-603X				Abou-Seif M, 2004, ARAB J LAB MED, V30, P193; Aebi H, 1984, Methods Enzymol, V105, P121; Badria F, 2007, J ENVIRON SCI, V33, P25; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barbagallo I, 2013, ANTIOXID REDOX SIGN, V18, P507, DOI 10.1089/ars.2011.4360; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Bernabe-Pineda M, 2004, SPECTROCHIM ACTA A, V60, P1105, DOI 10.1016/S1386-1425(03)00344-5; Beutler E, 1984, MANUAL BIOCH METHODS; BOYETT JD, 1976, CLIN CHIM ACTA, V69, P233, DOI 10.1016/0009-8981(76)90501-5; Burgos-Moron E, 2011, INT J CANCER, V128, P245, DOI 10.1002/ijc.25291; Burgos-Moron E, 2010, INT J CANCER, V126, P1771, DOI 10.1002/ijc.24967; Calabrese V, 2008, MOL NUTR FOOD RES, V52, P1062, DOI 10.1002/mnfr.200700316; CALLENDER ST, 1980, LANCET, V2, P689; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Cohen AR, 2003, BLOOD, V102, P1583, DOI 10.1182/blood-2002-10-3280; COOK JD, 1990, AM J CLIN NUTR, V51, P301, DOI 10.1093/ajcn/51.2.301; Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Erdincler DS, 1997, CLIN CHIM ACTA, V265, P77, DOI 10.1016/S0009-8981(97)00106-X; Fleenor BS, 2012, EXP GERONTOL; Galleano M, 1997, TOXICOLOGY, V124, P73, DOI 10.1016/S0300-483X(97)00135-2; GORDEUK VR, 1987, ANNU REV NUTR, V7, P485, DOI 10.1146/annurev.nu.07.070187.002413; HERSHKO C, 1988, CRC CR REV CL LAB SC, V26, P303, DOI 10.3109/10408368809105894; HORTELANO S, 1995, HEPATOLOGY, V21, P776; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Kohli K., 2005, Indian Journal of Pharmacology, V37, P141; Lefevre G, 1998, ANN BIOL CLIN-PARIS, V56, P305; LEGGETT BA, 1990, CLIN CHEM, V36, P1350; Mancuso C, 2009, CURR DRUG METAB, V10, P579, DOI 10.2174/138920009789375405; Mancuso C, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00086; Mancuso C, 2009, TRENDS PHARMACOL SCI, V30, P333, DOI 10.1016/j.tips.2009.04.004; Martins JM, 2013, REV BRAS HEMATOL HEM, V34, P459; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; Miriyala S, 2007, ADV EXP MED BIOL, V595, P359; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Pearse AGE, 1985, THEORETICL APPL ANAL, P183; Qian Jing-jing, 2012, Zhonghua Yi Xue Za Zhi, V92, P1997; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; Richardson, 1999, Expert Opin Investig Drugs, V8, P2141, DOI 10.1517/13543784.8.12.2141; Rivera-Espinoza Y, 2009, LIVER INT, V29, P1457, DOI 10.1111/j.1478-3231.2009.02086.x; Soetikno V, 2012, MOL NUTR FOOD RES; SUMMERS MR, 1979, BRIT J HAEMATOL, V42, P547, DOI 10.1111/j.1365-2141.1979.tb01167.x; Swamy AV, 2012, INDIAN J PHARMACOL, V44, P73, DOI 10.4103/0253-7613.91871; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang Z, 2015, DRUG DEV IND PHARM, V41, P613, DOI 10.3109/03639045.2014.886697; ZEBROWSKI EJ, 1979, PHARMACOL RES COMMUN, V11, P95, DOI 10.1016/S0031-6989(79)80063-6; Zhang JF, 2014, FOOD CHEM, V145, P57, DOI 10.1016/j.foodchem.2013.08.025; Zhao YL, 2005, EUR J PHARMACOL, V509, P195, DOI 10.1016/j.ejphar.2004.11.060	50	78	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134156	10.1371/journal.pone.0134156	http://dx.doi.org/10.1371/journal.pone.0134156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230491	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400080
J	Chen, SC; Hsiao, PJ; Huang, JC; Lin, KD; Hsu, WH; Lee, YL; Lee, MY; Chang, JM; Shin, SJ				Chen, Szu-Chia; Hsiao, Pi-Jung; Huang, Jiun-Chi; Lin, Kun-Der; Hsu, Wei-Hao; Lee, Yu-Li; Lee, Mei-Yueh; Chang, Jer-Ming; Shin, Shyi-Jang			Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; BLOOD-PRESSURE INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; MORTALITY; ATHEROSCLEROSIS; HEART; CREATININE; MARKERS	Although some studies have reported that low ankle-brachial index (ABI) is associated with diabetic retinopathy (DR) in diabetic patients, it remains controversial as to which stage of DR. The aim of this study is to assess whether peripheral artery disease (PAD), indicated by abnormally low or high ABI, is associated with different stages of DR in patients with type 2 diabetes mellitus (DM), and further evaluate the risk factors. A total of 2001 (858 men and 1143 women) patients with type 2 DM who underwent ABI measurement in an outpatient clinic were enrolled. PAD was defined as ABI < 0.9 or >= 1.3 in either leg. DR was classified as non-DR, nonproliferative DR and proliferative DR stages. The clinical data were analyzed and the risk factors for abnormal ABI were determined by multivariate logistic regression analysis. The prevalence of ABI < 0.9 or >= 1.3 was 3.0%. Multivariate forward logistic regression analysis identified proliferative DR (vs. non-DR) was associated with abnormal ABI (odds ratio, 1.718; 95% confidence interval, 1.152 to 2.562; p = 0.008), but nonproliferative DR was not. Furthermore, the presence of coronary artery disease, cerebrovascular disease, declining renal function and patients without diuretics use were associated with abnormal ABI in patients with proliferative DR. Our study in patients of type 2 DM demonstrated that PAD was associated with proliferative DR. We emphasize the recommendation of performing the ABI test in this population at risk.	[Chen, Szu-Chia; Huang, Jiun-Chi; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Hsiao, Pi-Jung; Lin, Kun-Der; Hsu, Wei-Hao; Lee, Yu-Li; Lee, Mei-Yueh; Shin, Shyi-Jang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Hsu, Wei-Hao; Lee, Mei-Yueh; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Yu-Li] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Lee, Mei-Yueh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Med Univ, Coll Med, Renal Care, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Lee, MY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan.	lovellelee@hotmail.com	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860; Hsiao, Pi-Jung/0000-0001-5024-9371				Abbott JD, 2012, AM HEART J, V164, P585, DOI 10.1016/j.ahj.2012.06.017; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bundo M, 2010, ANN VASC SURG, V24, P985, DOI 10.1016/j.avsg.2010.06.001; Chatziralli Irini P, 2010, BMC Res Notes, V3, P153, DOI 10.1186/1756-0500-3-153; Chen Ai-Hua, 2013, Rev Diabet Stud, V10, P101, DOI 10.1900/RDS.2013.10.101; Chen YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122022; de Kreutzenberg SV, 2011, NUTR METAB CARDIOVAS, V21, P286, DOI 10.1016/j.numecd.2009.10.003; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; FOWKES FGR, 1992, AM J EPIDEMIOL, V135, P331; Georgieva AM, 2004, ATHEROSCLEROSIS, V175, P345, DOI 10.1016/j.atherosclerosis.2004.04.006; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; Juutilainen A, 2007, DIABETES CARE, V30, P292, DOI 10.2337/dc06-1747; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Koba S, 2002, ATHEROSCLEROSIS, V160, P249, DOI 10.1016/S0021-9150(01)00580-9; Kuswardhani R A Tuty, 2010, Acta Med Indones, V42, P94; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2001, AM J KIDNEY DIS, V38, P1398, DOI 10.1053/ajkd.2001.29275; Li X, 2012, J DIABETES, V4, P140, DOI 10.1111/j.1753-0407.2011.00171.x; Li Xiang, 2012, Zhonghua Yi Xue Za Zhi, V92, P236; MacGregor AS, 1999, DIABETES CARE, V22, P453, DOI 10.2337/diacare.22.3.453; Nathan DM, 2007, DIABETIC MED, V24, P137; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Sodhi H S, 2007, Kathmandu Univ Med J (KUMJ), V5, P12; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Tseng Chin-Hsiao, 1994, Journal of the Formosan Medical Association, V93, P842; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Watkins PJ, 2003, BRIT MED J, V326, P924, DOI 10.1136/bmj.326.7395.924; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Yu JH, 2011, DIABETES METAB J, V35, P543, DOI 10.4093/dmj.2011.35.5.543; Yun Yong Woon, 2011, J Prev Med Public Health, V44, P260, DOI 10.3961/jpmph.2011.44.6.260	43	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134718	10.1371/journal.pone.0134718	http://dx.doi.org/10.1371/journal.pone.0134718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230390	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400156
J	Chen, Y; Du, YW; Li, Y; Wang, XQ; Gao, P; Yang, G; Fang, Y; Meng, Y; Zhao, XJ				Chen, Yan; Du, Yanwei; Li, Yang; Wang, Xiaoqin; Gao, Pin; Yang, Guang; Fang, Yuan; Meng, Yan; Zhao, Xuejian			Panaxadiol Saponin and Dexamethasone Improve Renal Function in Lipopolysaccharide-Induced Mouse Model of Acute Kidney Injury	PLOS ONE			English	Article							NITRIC-OXIDE; SEPSIS; THERAPY	Background Acute kidney injury (AKI) is a serious complication of systemic inflammatory response syndrome (SIRS), which has a high mortality rate. Previous studies showed that panaxadiol saponin (PDS) and Dexamethasone have similar anti-inflammatory properties and protect cardiopulmonary function in lipopolysaccharide (LPS)-induced septic shock rats. In the present study, we investigated whether PDS or Dexamethasone has a similar role in improving kidney function in LPS-induced AKI mice. Methods and Results Mice subjected to LPS (10 mg/kg) treatment exhibited AKI demonstrated by markedly increased blood urea nitrogen and creatinine levels compared with controls (P<0.01). However, PDS and Dexamethasone induce similar reverse effects on renal function, such as reduced serum creatinine and blood urea nitrogen levels compared with the LPS group (P<0.05). PDS decreased the production and release of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 by inhibiting the NF-kappa B signaling pathway, down-regulating inducible nitric oxide synthase protein expression levels and inhibiting oxidative stress. In most anti-AKI mechanisms, PDS and dexamethasone were similar, but PDS are better at inhibition of TNF production, promote SOD activity and inhibition of IKB phosphorylation. In addition, nuclear glucocorticoid receptor expression was markedly enhanced in PDS and Dexamethasone treatment groups. Further research is required to determine whether PDS can combine with the glucocorticoid receptor to enter the nucleus. Conclusion This study demonstrated that PDS and dexamethasone have similar reverse amelioration for renal functions, and have potential application prospects in the treatment of sepsis-induced AKI.	[Chen, Yan; Du, Yanwei; Li, Yang; Wang, Xiaoqin; Gao, Pin; Yang, Guang; Fang, Yuan; Meng, Yan; Zhao, Xuejian] Jilin Univ, Coll Basic Med, Dept Pathophysiol, Changchun 130023, Peoples R China; [Chen, Yan] Jilin Univ, Hosp 1, Dept Nephropathy, Changchun 130023, Peoples R China	Jilin University; Jilin University	Meng, Y (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathophysiol, Changchun 130023, Peoples R China.	mengyan2@yahoo.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Natural Science Foundation of China [30900518, 81170304, 81370240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Nos. 30900518, 81170304, 30900518 and 81370240).	Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Choi HM, 2013, BIOCHEM BIOPH RES CO, V435, P678, DOI 10.1016/j.bbrc.2013.05.042; Chvojka J, 2010, PHYSIOL RES, V59, P859, DOI 10.33549/physiolres.931936; Dixon WG, 2012, ANN RHEUM DIS, V71, P1761, DOI 10.1136/annrheumdis-2012-202021; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Holthoff JH, 2010, BIOCHEM PHARMACOL, V80, P1260, DOI 10.1016/j.bcp.2010.06.027; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hsing CH, 2011, NEPHROL DIAL TRANSPL, V26, P1162, DOI 10.1093/ndt/gfq572; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; [李璐 Li Lu], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P231; Mayeux PR, 2012, PHARMACOL THERAPEUT, V134, P139, DOI 10.1016/j.pharmthera.2012.01.004; Naito M, 2008, J AM SOC NEPHROL, V19, P1321, DOI 10.1681/ASN.2007121368; NOIRI E, 1994, AM J PATHOL, V144, P1159; Sadr-Azodi O, 2013, JAMA INTERN MED, V173, P444, DOI 10.1001/jamainternmed.2013.2737; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Venkatachalam MA, 2012, KIDNEY INT, V81, P338, DOI 10.1038/ki.2011.401; Wang W, 2003, AM J PHYSIOL-RENAL, V284, pF532, DOI 10.1152/ajprenal.00323.2002; Wu LP, 2007, J AM SOC NEPHROL, V18, P1807, DOI 10.1681/ASN.2006121402; Wu LP, 2007, J PHARMACOL EXP THER, V320, P1061, DOI 10.1124/jpet.106117184; Xu L, 1990, CHINESE J PATHOPYSIO, V6, P69	24	35	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134653	10.1371/journal.pone.0134653	http://dx.doi.org/10.1371/journal.pone.0134653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230340	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400144
J	Montuelle, SJ; Williams, SH				Montuelle, Stephane J.; Williams, Susan H.			In Vivo Measurement of Mesokinesis in Gekko gecko: The Role of Cranial Kinesis during Gape Display, Feeding and Biting	PLOS ONE			English	Article							PREY TRANSPORT KINEMATICS; BITE FORCE; VARANUS-EXANTHEMATICUS; LACERTID LIZARDS; FINITE-ELEMENT; SKULL; PERFORMANCE; EVOLUTION; BIRDS; BIOMECHANICS	Cranial kinesis refers to movements of skeletal sub-units relative to one another at mobile sutures within the skull. The presence and functional significance of cranial kinesis has been investigated in various vertebrates, with much of our understanding coming from comparative studies and manipulation of ligamentous specimens. Drawing on these studies, cranial kinesis in lizards has been modeled as a four-bar linkage system involving streptostyly (rotation of the quadrate), hypokinesis (dorsoventral flexion and extension of the palatomaxillary sub-unit), mesokinesis (dorsoventral flexion and extension of the snout at the fronto-parietal suture) and metakinesis (sliding movements between parietal and supraocciptal bones). In vivo studies, although limited, suggest that cranial kinesis serves an important role during routine behaviors such as feeding. Here, we use X-ray Reconstruction Of Moving Morphology to further quantify mesokinesis in vivo in Gekko gecko during three routine behaviors: gape display, biting and post-ingestion feeding. During gape display, the snout rotates dorsally above rest position, with mesokinesis accounting for a 10% increase in maximum gape over that achieved solely by the depression of the lower jaw. During defensive biting, the snout rotates ventrally below rest position to participate in gape closure. Finally, ventroflexion of the snout also occurs during post-ingestion feeding, accounting for 42% of gape closure during intra-oral transport, 86% during puncture-crushing, and 61% during pharyngeal packing. Mesokinesis thus appears to facilitate prey puncturing by allowing the snout to rotate ventrally so that the upper teeth pierce the prey item, thus limiting the need for large movements of the lower jaw. This is suggested to maintain a firm grip on the prey and reduce the possibility of prey escape. More generally, this study demonstrates that mesokinesis is a key component of defensive biting and gape display behaviors, as well as post-ingestion feeding, all of which are linked to organismal fitness.	[Montuelle, Stephane J.; Williams, Susan H.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Montuelle, SJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Irvine Hall 228, Athens, OH 45701 USA.	montuell@ohio.edu		Montuelle, Stephane/0000-0002-8638-9779; Williams, Susan/0000-0003-4167-678X	National Science Foundation [MRI DBI-0922988]; Ohio Board of Regents; Ohio University Office of the Vice President for Research; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee	National Science Foundation(National Science Foundation (NSF)); Ohio Board of Regents; Ohio University Office of the Vice President for Research; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee	Funding for this project was provided by the National Science Foundation (MRI DBI-0922988), the Ohio Board of Regents, the Ohio University Office of the Vice President for Research and the Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee (to SHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2010, J MORPHOL, V271, P990, DOI 10.1002/jmor.10850; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Aowphol A, 2006, AMPHIBIA-REPTILIA, V27, P491, DOI 10.1163/156853806778877121; Baier DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063982; Bout RG, 2001, COMP BIOCHEM PHYS A, V131, P197, DOI 10.1016/S1095-6433(01)00470-6; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Chai N, 2009, POINT VET, V40, P25; CONDON K, 1987, EXP BIOL, V47, P73; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cox MJ, 1998, SNAKES OTHER REPTILE; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Curtis N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0442; Dawson MM, 2011, J EXP BIOL, V214, P2036, DOI 10.1242/jeb.047159; Daza JD, 2009, BIOL J LINN SOC, V97, P677, DOI 10.1111/j.1095-8312.2009.01242.x; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Elias JA, 2000, J EXP BIOL, V203, P791; Estrella SM, 2007, J EXP BIOL, V210, P3757, DOI 10.1242/jeb.007690; Frazzetta T., 1983, P222; FRAZZETTA TH, 1962, J MORPHOL, V111, P287, DOI 10.1002/jmor.1051110306; Gidmark NJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1181; Gussekloo SWS, 2005, J EXP BIOL, V208, P3409, DOI 10.1242/jeb.01768; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Herrel A, 2000, J EXP BIOL, V203, P1415; Herrel A, 1999, J EXP BIOL, V202, P3687; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 1999, J EXP BIOL, V202, P1127; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; Holliday CM, 2010, ANAT REC, V293, P1350, DOI 10.1002/ar.21180; Iordansky NN, 2011, BIOL BULL+, V38, P868, DOI 10.1134/S1062359011090032; KARDONG K V, 1974, Forma et Functio, V7, P327; Kleinteich T, 2012, J EXP BIOL, V215, P833, DOI 10.1242/jeb.065979; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; Lujan NK, 2012, J MORPHOL, V273, P24, DOI 10.1002/jmor.11003; McBrayer LD, 2002, CAN J ZOOL, V80, P882, DOI 10.1139/Z02-068; McBrayer LD, 2002, ZOOLOGY, V105, P71, DOI 10.1078/0944-2006-00047; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Mezzasalma M, 2014, ANAT REC, V297, P463, DOI 10.1002/ar.22827; Mitchell M.A., 2009, MANUAL EXOTIC PET PR; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moazen M, 2013, ANAT REC, V296, P198, DOI 10.1002/ar.22629; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Montuelle SJ, 2009, J EXP BIOL, V212, P2501, DOI 10.1242/jeb.026336; O'Reilly James C., 2000, P149, DOI 10.1016/B978-012632590-4/50007-1; PATCHELL FC, 1986, J HERPETOL, V20, P59, DOI 10.2307/1564125; Payne SL, 2011, ANAT REC, V294, P399, DOI 10.1002/ar.21329; RIEPPEL O, 1981, ZOOL J LINN SOC-LOND, V72, P203, DOI 10.1111/j.1096-3642.1981.tb01570.x; Schaerlaeken V, 2008, J EXP BIOL, V211, P3908, DOI 10.1242/jeb.021345; Schwenk Kurt, 2000, P175, DOI 10.1016/B978-012632590-4/50009-5; SMITH KK, 1985, J EXP BIOL, V114, P53; SMITH KK, 1982, J MORPHOL, V173, P137, DOI 10.1002/jmor.1051730203; THROCKMORTON GS, 1981, J EXP ZOOL, V216, P25, DOI 10.1002/jez.1402160105; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Wainwright PC, 2008, J EXP BIOL, V211, P3523, DOI 10.1242/jeb.007187; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761	56	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134710	10.1371/journal.pone.0134710	http://dx.doi.org/10.1371/journal.pone.0134710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230087	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400153
J	Ugorji, CO; Samson, RS; Liechti, MD; Panicker, JN; Miller, DH; Wheeler-Kingshott, CAM; Yiannakas, MC				Ugorji, Chinyere O.; Samson, Rebecca S.; Liechti, Martina D.; Panicker, Jalesh N.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.; Yiannakas, Marios C.			Grey and White Matter Magnetisation Transfer Ratio Measurements in the Lumbosacral Enlargement: A Pilot In Vivo Study at 3T	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; BLADDER DYSFUNCTION; MRI; SEGMENTATION; REFLEXES; IMPACT; TISSUE; BRAIN	Magnetisation transfer (MT) imaging of the central nervous system has provided further insight into the pathophysiology of neurological disease. However, the use of this method to study the lower spinal cord has been technically challenging, despite the important role of this region, not only for motor control of the lower limbs, but also for the neural control of lower urinary tract, sexual and bowel functions. In this study, the feasibility of obtaining reliable grey matter (GM) and white matter (WM) magnetisation transfer ratio (MTR) measurements within the lumbosacral enlargement (LSE) was investigated in ten healthy volunteers using a clinical 3T MRI system. The mean cross-sectional area of the LSE (LSE-CSA) and the mean GM area (LSE-GM-CSA) were first obtained by means of image segmentation and tissue-specific (i.e. WM and GM) MTR measurements within the LSE were subsequently obtained. The reproducibility of the segmentation method and MTR measurements was assessed from repeated measurements and their % coefficient of variation (%COV). Mean (+/- SD) LSE-CSA across 10 healthy subjects was 59.3 (+/- 8.4) mm(2) and LSE-GM-CSA was 17.0 (+/- 3.1) mm(2). The mean intra-and inter-rater % COV for measuring the LSE-CSA were 0.8% and 2.3%, respectively and for the LSE-GM-CSA were 3.8% and 5.4%, respectively. Mean (+/- SD) WM-MTR was 43.2 (+/- 4.4) and GM-MTR was 40.9 (+/- 4.3). The mean scan-rescan % COV for measuring WM-MTR was 4.6% and for GM-MTR was 3.8%. Using a paired t-test, a statistically significant difference was identified between WM-MTR and GM-MTR in the LSE (p<0.0001). This pilot study has shown that it is possible to obtain reliable tissue-specific MTR measurements within the LSE using a clinical MR system at 3T. The MTR acquisition and analysis protocol presented in this study can be used in future investigations of intrinsic spinal cord diseases that affect the LSE.	[Ugorji, Chinyere O.; Samson, Rebecca S.; Liechti, Martina D.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.; Yiannakas, Marios C.] UCL Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, NMR Res Unit, London, England; [Liechti, Martina D.; Panicker, Jalesh N.] Natl Hosp Neurol & Neurosurg, Dept Uroneurol, London WC1N 3BG, England; [Liechti, Martina D.; Panicker, Jalesh N.] UCL Inst Neurol, London, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Ugorji, CO (corresponding author), UCL Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, NMR Res Unit, London, England.	c.ugorji@ucl.ac.uk	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Liechti, Martina/0000-0002-3024-0975; Samson, Rebecca/0000-0002-0197-702X	Multiple Sclerosis Society of Great Britain and Northern Ireland; Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	Multiple Sclerosis Society of Great Britain and Northern Ireland; Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work and the NMR Research Unit are supported by the Multiple Sclerosis Society of Great Britain and Northern Ireland (http://www.mssociety.org.uk/). This work was supported by the Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Craggs MD, 2006, AUTON NEUROSCI-BASIC, V126, P355, DOI 10.1016/j.autneu.2006.03.010; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUBOULAY GH, 1966, BRIT J RADIOL, V39, P255, DOI 10.1259/0007-1285-39-460-255; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Fernandez O, 2002, J NEUROL, V249, P1, DOI 10.1007/PL00007835; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; FRALIX TA, 1991, MAGN RESON MED, V18, P214, DOI 10.1002/mrm.1910180122; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gilmore CP, 2006, BRAIN PATHOL, V16, P202, DOI 10.1111/j.1750-3639.2006.00018.x; GLOVER GH, 1992, MAGNET RESON MED, V28, P275, DOI 10.1002/mrm.1910280209; Gringel T, 2009, J MAGN RESON IMAGING, V29, P1285, DOI 10.1002/jmri.21756; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hess MJ, 2012, J SPINAL CORD MED, V35, P211, DOI 10.1179/2045772312Y.0000000025; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; KONNO H, 1986, J NEUROL SCI, V73, P193, DOI 10.1016/0022-510X(86)90130-9; Labauge P, 2009, Int MS J, V16, P47; LANE B, 1974, RADIOLOGY, V110, P579, DOI 10.1148/110.3.579; Malas MA, 2000, SURG RADIOL ANAT, V22, P163, DOI 10.1007/s00276-000-0163-7; McCombe PA, 2009, EXPERT REV NEUROTHER, V9, P331, DOI 10.1586/14737175.9.3.331; MEHTA RC, 1995, AM J NEURORADIOL, V16, P2085; Nout YS, 2006, PROG BRAIN RES, V152, P359, DOI 10.1016/S0079-6123(05)52024-7; Oh J, 2013, MULT SCLER J, V19, P427, DOI 10.1177/1352458512456614; Oh J, 2013, NEUROLOGY, V80, P540, DOI 10.1212/WNL.0b013e31828154c5; Reitz A, 2004, INT J IMPOT RES, V16, P167, DOI 10.1038/sj.ijir.3901193; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; SAKAKIBARA R, 1993, JPN J PSYCHIAT NEUR, V47, P591; Samson RS, 2013, NMR BIOMED, V26, P1823, DOI 10.1002/nbm.3022; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Sled JG, 2004, MAGNET RESON MED, V51, P299, DOI 10.1002/mrm.10701; TSUKAGOSHI H, 1979, J NEUROL SCI, V41, P287, DOI 10.1016/0022-510X(79)90089-3; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Wu Y, 2010, P INT MAG REASON MED, V18, P4444; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134495	10.1371/journal.pone.0134495	http://dx.doi.org/10.1371/journal.pone.0134495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230729	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400127
J	van Diest, M; Stegenga, J; Wortche, HJ; Roerdink, JBTM; Verkerke, GJ; Lamoth, CJC				van Diest, Mike; Stegenga, Jan; Wortche, Heinrich J.; Roerdink, Jos B. T. M.; Verkerke, Gijsbertus J.; Lamoth, Claudine J. C.			Quantifying Postural Control during Exergaming Using Multivariate Whole-Body Movement Data: A Self-Organizing Maps Approach	PLOS ONE			English	Article							NONLINEAR DYNAMICS; LATERAL STABILITY; MICROSOFT KINECT; BALANCE CONTROL; FALL RISK; VARIABILITY; REHABILITATION; PREDICTORS; ACCURACY; VALIDITY	Background Exergames are becoming an increasingly popular tool for training balance ability, thereby preventing falls in older adults. Automatic, real time, assessment of the user's balance control offers opportunities in terms of providing targeted feedback and dynamically adjusting the gameplay to the individual user, yet algorithms for quantification of balance control remain to be developed. The aim of the present study was to identify movement patterns, and variability therein, of young and older adults playing a custom-made weight-shifting (ice-skating) exergame. Methods Twenty older adults and twenty young adults played a weight-shifting exergame under five conditions of varying complexity, while multi-segmental whole-body movement data were captured using Kinect. Movement coordination patterns expressed during gameplay were identified using Self Organizing Maps (SOM), an artificial neural network, and variability in these patterns was quantified by computing Total Trajectory Variability (TTvar). Additionally a k Nearest Neighbor (kNN) classifier was trained to discriminate between young and older adults based on the SOM features. Results Results showed that TTvar was significantly higher in older adults than in young adults, when playing the exergame under complex task conditions. The kNN classifier showed a classification accuracy of 65.8%. Conclusions Older adults display more variable sway behavior than young adults, when playing the exergame under complex task conditions. The SOM features characterizing movement patterns expressed during exergaming allow for discriminating between young and older adults with limited accuracy. Our findings contribute to the development of algorithms for quantification of balance ability during home-based exergaming for balance training.	[van Diest, Mike; Stegenga, Jan; Wortche, Heinrich J.] INCAS3, Assen, Netherlands; [van Diest, Mike; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Twente, Dept Biomech Engn, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Twente	van Diest, M (corresponding author), INCAS3, Assen, Netherlands.	mikevandiest@incas3.eu	Roerdink, Jos B.T.M/B-3631-2008; Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823; Verkerke, Bart/0000-0003-3533-2446	INCAS3; research center SPRINT; Province of Drenthe; Municipality of Assen; European Fund for Regional Development; Ministry of Economic Affairs, Peaks in the Delta; Northern Netherlands Provinces Alliance, Course for the North	INCAS3; research center SPRINT; Province of Drenthe; Municipality of Assen; European Fund for Regional Development(European Commission); Ministry of Economic Affairs, Peaks in the Delta; Northern Netherlands Provinces Alliance, Course for the North	This work was supported by INCAS<SUP>3</SUP> and research center SPRINT. INCAS<SUP>3</SUP> is supported by the Province of Drenthe, the Municipality of Assen, the European Fund for Regional Development and the Ministry of Economic Affairs, Peaks in the Delta. This project is financially supported by the Northern Netherlands Provinces Alliance, Course for the North. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baranowski MT, 2013, GAMES HLTH J, V2; Barzilay O, 2013, J ELECTROMYOGR KINES, V23, P182, DOI 10.1016/j.jelekin.2012.09.004; Bauer HU, 1997, NEURAL PROCESS LETT, V5, P193, DOI 10.1023/A:1009646811510; Beauchet O, 2009, GERONTOLOGY, V55, P702, DOI 10.1159/000235905; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; de Vries EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098494; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Demura S, 2008, GERIATR GERONTOL INT, V8, P188, DOI 10.1111/j.1447-0594.2008.00469.x; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Fitzgerald D, 2010, J ORTHOP SPORT PHYS, V40, P11, DOI 10.2519/jospt.2010.3121; Fix E., 1951, JOSEPH; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Haykin S, 1999, P842; Hernandez ME, 2012, HUM MOVEMENT SCI, V31, P1213, DOI 10.1016/j.humov.2011.11.002; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Khoshelham K, 2012, SENSORS-BASEL, V12, P1437, DOI 10.3390/s120201437; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lakany HM, 2000, NEUROCOMPUTING, V35, P27, DOI 10.1016/S0925-2312(00)00316-7; Lamb PF, 2013, HUM MOVEMENT SCI, V33, P54, DOI [10.1016/j.humov.2013.08.005, DOI 10.1016/J.HUM0V.2013.08.005]; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Maillot P, 2012, PSYCHOL AGING, V27, P589, DOI 10.1037/a0026268; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Nishihori T, 2012, AGING CLIN EXP RES, V24, P162, DOI 10.3275/7626; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Sloot LH, 2011, ANN BIOMED ENG, V39, P1563, DOI 10.1007/s10439-010-0240-y; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; van Diest M, 2014, J BIOMECH, V47, P2925, DOI 10.1016/j.jbiomech.2014.07.017; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937	48	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134350	10.1371/journal.pone.0134350	http://dx.doi.org/10.1371/journal.pone.0134350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230655	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400104
J	Vongrad, V; Imig, J; Mohammadi, P; Kishore, S; Jaskiewicz, L; Hall, J; Guenthard, HF; Beerenwinkel, N; Metzner, KJ				Vongrad, Valentina; Imig, Jochen; Mohammadi, Pejman; Kishore, Shivendra; Jaskiewicz, Lukasz; Hall, Jonathan; Guenthard, Huldrych F.; Beerenwinkel, Niko; Metzner, Karin J.			HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages	PLOS ONE			English	Article							SMALL NONCODING RNAS; ENCODED MICRORNAS; MONONUCLEAR PHAGOCYTES; HIV-1-INFECTED CELLS; WIDE IDENTIFICATION; SECONDARY STRUCTURE; GENE-EXPRESSION; INFECTED-CELLS; BINDING-SITES; TAR ELEMENT	Background MiRNAs and other small noncoding RNAs (sncRNAs) are key players in post-transcriptional gene regulation. HIV-1 derived small noncoding RNAs (sncRNAs) have been described in HIV-1 infected cells, but their biological functions still remain to be elucidated. Here, we approached the question whether viral sncRNAs may play a role in the RNA interference (RNAi) pathway or whether viral mRNAs are targeted by cellular miRNAs in human monocyte derived macrophages (MDM). Methods The incorporation of viral sncRNAs and/or their target RNAs into RNA-induced silencing complex was investigated using photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) as well as high-throughput sequencing of RNA isolated by cross-linking immunoprecipitation (HITS-CLIP), which capture Argonaute2-bound miRNAs and their target RNAs. HIV-1 infected monocyte-derived macrophages (MDM) were chosen as target cells, as they have previously been shown to express HIV-1 sncRNAs. In addition, we applied small RNA deep sequencing to study differential cellular miRNA expression in HIV-1 infected versus non-infected MDMs. Results and Conclusion PAR-CLIP and HITS-CLIP data demonstrated the absence of HIV-1 RNAs in Ago2-RISC, although the presence of a multitude of HIV-1 sncRNAs in HIV-1 infected MDMs was confirmed by small RNA sequencing. Small RNA sequencing revealed that 1.4% of all sncRNAs were of HIV-1 origin. However, neither HIV-1 derived sncRNAs nor putative HIV-1 target sequences incorporated into Ago2-RISC were identified suggesting that HIV-1 sncRNAs are not involved in the canonical RNAi pathway nor is HIV-1 targeted by this pathway in HIV-1 infected macrophages.	[Vongrad, Valentina; Guenthard, Huldrych F.; Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Vongrad, Valentina; Guenthard, Huldrych F.; Metzner, Karin J.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Imig, Jochen; Hall, Jonathan] ETH, Inst Pharmaceut Sci, Zurich, Switzerland; [Mohammadi, Pejman; Beerenwinkel, Niko] ETH, Dept Biosyst Sci & Engn, Basel, Switzerland; [Mohammadi, Pejman; Beerenwinkel, Niko] Swiss Inst Bioinformat, Basel, Switzerland; [Kishore, Shivendra; Jaskiewicz, Lukasz] Univ Basel, Computat & Syst Biol, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Basel	Vongrad, V (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	valentina.vongrad@usz.ch	gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011; mohammadi, pejman/AAX-6002-2020	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; mohammadi, pejman/0000-0003-4457-8552; Hall, Jonathan/0000-0003-4160-7135; Imig, Jochen/0000-0003-0385-1081	Swiss National Science Foundation [31003A_112670, 310030_141067]; University of Zurich's clinical research priority program: viral infectious diseases - ZPHI; Swiss National Science Foundation by a joint Sinergia grant [CRSII3_127454]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich's clinical research priority program: viral infectious diseases - ZPHI; Swiss National Science Foundation by a joint Sinergia grant(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (grant no. 31003A_112670 and 310030_141067 to KJM and HFG). This project was further supported by the University of Zurich's clinical research priority program: viral infectious diseases - ZPHI (to KJM and HFG). JI was supported by the Swiss National Science Foundation (in part) by a joint Sinergia grant (CRSII3_127454) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Imig J, 2015, NAT CHEM BIOL, V11, P107, DOI [10.1038/NCHEMBIO.1713, 10.1038/nchembio.1713]; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaul D, 2006, P INDIAN NATL SCI AC, V72; Kaul D, 2009, MOL CELL BIOCHEM, V323, P143, DOI 10.1007/s11010-008-9973-4; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rusert P, 2005, J VIROL, V79, P8454, DOI 10.1128/JVI.79.13.8454-8469.2005; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tan J, 2013, TRENDS MICROBIOL, V21, P405, DOI 10.1016/j.tim.2013.05.001; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang LF, 2012, CELL MOL IMMUNOL, V9, P103, DOI 10.1038/cmi.2011.43; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Xing L, 2007, J VIROL, V81, P9967, DOI 10.1128/JVI.02244-06; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	58	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132127	10.1371/journal.pone.0132127	http://dx.doi.org/10.1371/journal.pone.0132127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226348	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358837700005
J	Bartels, S; Schipper, E; Kreipe, HH; Lehmann, U				Bartels, Stephan; Schipper, Elisa; Kreipe, Hans Heinrich; Lehmann, Ulrich			Comprehensive Molecular Profiling of Archival Bone Marrow Trephines Using a Commercially Available Leukemia Panel and Semiconductor-Based Targeted Resequencing	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; SEQUENCE ARTIFACTS; MUTATIONS; ASXL1; DNA; APPLICABILITY; FEASIBILITY; DIAGNOSTICS; SPECIMENS; GENE	Comprehensive mutation profiling becomes more and more important in hematopathology complementing morphological and immunohistochemical evaluation of fixed, decalcified and embedded bone marrow biopsies for diagnostic, prognostic and also predictive purposes. However, the number and the size of relevant genes leave conventional Sanger sequencing impracticable in terms of costs, required input DNA, and turnaround time. Since most published protocols and commercially available reagents for targeted resequencing of gene panels are established and validated for the analysis of fresh bone marrow aspirate or peripheral blood it remains to be proven whether the available technology can be transferred to the analysis of archival trephines. Therefore, the performance of the recently available Ion AmpliSeq AML Research panel (LifeTechnologies) was evaluated for the analysis of fragmented DNA extracted from archival bone marrow trephines. Taking fresh aspirate as gold standard all clinically relevant mutations (n = 17) as well as 25 well-annotated SNPs could be identified reliably with high quality in the corresponding archival trephines of the training set (n = 10). Pre-treatment of the extracted DNA with Uracil-DNA-Glycosylase reduced the number of low level artificial sequence variants by more than 60%, vastly reducing time required for proper evaluation of the sequencing results. Subsequently, randomly picked FFPE samples (n = 41) were analyzed to evaluate sequencing performance under routine conditions. Thereby all known mutations (n = 43) could be verified and 36 additional mutations in genes not yet covered by the routine work-up (e.g., TET2, ASXL1, DNMT3A), demonstrating the feasibility of this approach and the gain of diagnostically relevant information. The dramatically reduced amount of input DNA, the increase in sensitivity as well as calculated cost-effectiveness, low hands on, and turn-around-time, necessary for the analysis of 237 amplicons strongly argue for replacing Sanger sequencing by this semiconductor-based targeted resequencing approach.	[Bartels, Stephan; Schipper, Elisa; Kreipe, Hans Heinrich; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School	Lehmann, U (corresponding author), Hannover Med Sch, Inst Pathol, Hannover, Germany.	Lehmann.Ulrich@MH-Hannover.de		Bartels, Stephan/0000-0002-8903-2345	Deutsche Krebshilfe [1097154]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (grant number 1097154, TP A,D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2013, J CLIN PATHOL, V66, P803, DOI 10.1136/jclinpath-2013-201549; Bernard V, 2014, INT J CLIN EXP PATHO, V7, P1667; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hasemeier B, 2013, HAEMATOLOGICA, V98, pE115, DOI 10.3324/haematol.2013.091652; JACKSON DP, 1990, J CLIN PATHOL, V43, P499, DOI 10.1136/jcp.43.6.499; Kohlmann A, 2013, BRIT J HAEMATOL, V160, P736, DOI 10.1111/bjh.12194; Luthra R, 2014, HAEMATOLOGICA, V99, P465, DOI 10.3324/haematol.2013.093765; Malapelle U, 2015, J CLIN PATHOL, V68, P64, DOI 10.1136/jclinpath-2014-202691; Malcovati L, 2014, BLOOD, V124, P1513, DOI 10.1182/blood-2014-03-560227; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Patnaik MM, 2014, LEUKEMIA, V28, P2206, DOI 10.1038/leu.2014.125; Schnittger S, 2013, LEUKEMIA, V27, P82, DOI 10.1038/leu.2012.262; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Zhang LX, 2014, ONCOLOGIST, V19, P336, DOI 10.1634/theoncologist.2013-0180	20	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133930	10.1371/journal.pone.0133930	http://dx.doi.org/10.1371/journal.pone.0133930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222071	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800083
J	Guillotte, M; Juillerat, A; Igonet, S; Hessel, A; Petres, S; Crublet, E; Le Scanf, C; Lewit-Bentley, A; Bentley, GA; Vigan-Womas, I; Mercereau-Puijalon, O				Guillotte, Micheline; Juillerat, Alexandre; Igonet, Sebastien; Hessel, Audrey; Petres, Stephane; Crublet, Elodie; Le Scanf, Cecile; Lewit-Bentley, Anita; Bentley, Graham A.; Vigan-Womas, Ines; Mercereau-Puijalon, Odile			Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN-SULFATE-A; PLACENTAL MALARIA; INHIBITORY ANTIBODIES; BLOCKING ANTIBODIES; VAR GENES; IN-VITRO; VAR2CSA; DOMAIN; VARIANT	Adhesion of Plasmodium falciparum-infected red blood cells (iRBC) to human erythrocytes (i.e. rosetting) is associated with severe malaria. Rosetting results from interactions between a subset of variant PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1) adhesins and specific erythrocyte receptors. Interfering with such interactions is considered a promising intervention against severe malaria. To evaluate the feasibility of a vaccine strategy targetting rosetting, we have used here the Palo Alto 89F5 VarO rosetting model. PfEMP1-VarO consists of five Duffy-Binding Like domains (DBL1-5) and one Cysteine-rich Interdomain Region (CIDR1). The binding domain has been mapped to DBL1 and the ABO blood group was identified as the erythrocyte receptor. Here, we study the immunogenicity of all six recombinant PfEMP1-VarO domains and the DBL1-CIDR1 Head domain in BALB/c and outbred OF1 mice. Five readouts of antibody responses are explored: ELISA titres on the recombinant antigen, VarO-iRBC immunoblot reactivity, VarO-iRBC surface-reactivity, capacity to disrupt VarO rosettes and the capacity to prevent VarO rosette formation. For three domains, we explore influence of the expression system on antigenicity and immunogenicity. We show that correctly folded PfEMP1 domains elicit high antibody titres and induce a homogeneous response in outbred and BALB/c mice after three injections. High levels of rosette-disrupting and rosette-preventing antibodies are induced by DBL1 and the Head domain. Reduced-alkylated or denatured proteins fail to induce surface-reacting and rosette-disrupting antibodies, indicating that surface epitopes are conformational. We also report limited cross-reactivity between some PfEMP1 VarO domains. These results highlight the high immunogenicity of the individual domains in outbred animals and provide a strong basis for a rational vaccination strategy targeting rosetting.	[Guillotte, Micheline; Hessel, Audrey; Vigan-Womas, Ines; Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Guillotte, Micheline; Vigan-Womas, Ines; Mercereau-Puijalon, Odile] CNRS, Unite Rech Associee 2581, Paris, France; [Juillerat, Alexandre; Igonet, Sebastien; Hessel, Audrey; Lewit-Bentley, Anita; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Paris, France; [Juillerat, Alexandre; Igonet, Sebastien; Lewit-Bentley, Anita; Bentley, Graham A.] CNRS, Unite Rech Associee 2185, Paris, France; [Petres, Stephane; Crublet, Elodie] Inst Pasteur, PFPR, Paris, France; [Le Scanf, Cecile] CHU Bordeaux, Grp Hosp Pellegrin, Bordeaux Biotheques Sante, Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Bordeaux	Mercereau-Puijalon, O (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, Paris, France.	odile.puijalon@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; Ines, VIGAN-WOMAS/I-8604-2012; Ines, VIGAN-WOMAS/A-7846-2017	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Ines, VIGAN-WOMAS/0000-0001-7848-9297; petres, stephane/0000-0002-4716-565X	French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes) [ANR-07-MIME-021-0]; European Community's Seventh Framework Programme (FP7) [Evimalar 242095]	French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes)(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7)	This work was supported by the French National Research Agency (www.agence-nationale-recherche.fr/) (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes, grant ANR-07-MIME-021-0, Project Rosettes, PIs OMP and GAB), which supported a fellowship to A. J. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No Evimalar 242095. OMP is a member of the Evimalar Network of Excellence (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Y, 2014, INFECT IMMUN, V82, P949, DOI 10.1128/IAI.01233-13; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Barragan A, 1999, EXP PARASITOL, V91, P133, DOI 10.1006/expr.1998.4349; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Guillotte M, 2013, BIOPROTOCOLS, V3; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; leScanf C, 1997, EXP PARASITOL, V85, P135, DOI 10.1006/expr.1996.4121; Mercereau-Puijalon O, 2008, TRANSFUS CLIN BIOL, V15, P62, DOI 10.1016/j.tracli.2008.04.003; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Obiakor H, 2013, CLIN VACCINE IMMUNOL, V20, P433, DOI 10.1128/CVI.00638-12; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Pinto VV, 2012, VACCINE, V30, P572, DOI 10.1016/j.vaccine.2011.11.068; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Saveria T, 2013, INFECT IMMUN, V81, P1031, DOI 10.1128/IAI.00978-12; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Smith JD, 2014, MOL BIOCHEM PARASIT, V195, P82, DOI 10.1016/j.molbiopara.2014.07.006; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2013, BIOPROTOCOLS, V3; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vigan-Womas I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-267	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134292	10.1371/journal.pone.0134292	http://dx.doi.org/10.1371/journal.pone.0134292			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222304	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800125
J	Tasoff, J; Mee, MT; Wang, HH				Tasoff, Joshua; Mee, Michael T.; Wang, Harris H.			An Economic Framework of Microbial Trade	PLOS ONE			English	Article							ESCHERICHIA-COLI; COMPARATIVE-ADVANTAGE; EVOLUTION; DYNAMICS; COOPERATION; MODEL; POPULATIONS; MICROORGANISMS; COMMUNITIES; METABOLISM	A large fraction of microbial life on earth exists in complex communities where metabolic exchange is vital. Microbes trade essential resources to promote their own growth in an analogous way to countries that exchange goods in modern economic markets. Inspired by these similarities, we developed a framework based on general equilibrium theory (GET) from economics to predict the population dynamics of trading microbial communities. Our biotic GET (BGET) model provides an a priori theory of the growth benefits of microbial trade, yielding several novel insights relevant to understanding microbial ecology and engineering synthetic communities. We find that the economic concept of comparative advantage is a necessary condition for mutualistic trade. Our model suggests that microbial communities can grow faster when species are unable to produce essential resources that are obtained through trade, thereby promoting metabolic specialization and increased intercellular exchange. Furthermore, we find that species engaged in trade exhibit a fundamental tradeoff between growth rate and relative population abundance, and that different environments that put greater pressure on group selection versus individual selection will promote varying strategies along this growth-abundance spectrum. We experimentally tested this tradeoff using a synthetic consortium of Escherichia coli cells and found the results match the predictions of the model. This framework provides a foundation to study natural and engineered microbial communities through a new lens based on economic theories developed over the past century.	[Tasoff, Joshua] Claremont Grad Univ, Dept Econ, Claremont, CA 91711 USA; [Mee, Michael T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wang, Harris H.] Columbia Univ, Dept Syst Biol, New York, NY USA	Claremont Colleges; Claremont Graduate School; Boston University; Columbia University	Tasoff, J (corresponding author), Claremont Grad Univ, Dept Econ, Claremont, CA 91711 USA.	joshua.tasoff@cgu.edu; hw2429@columbia.edu			National Institute of Health Director's Early Independence Award [7DP5OD009172-03]; Canadian Institutes of Health Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	National Institute of Health Director's Early Independence Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by HHW received a National Institute of Health Director's Early Independence Award (7DP5OD009172-03) [http://www.nih.gov/]. MTM received a Doctoral Study Award from the Canadian Institutes of Health Research [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein HC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210017; Boucher DH, 1985, THE BIOLOGY OF MUTUA, px; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; D'Souza G, 2014, EVOLUTION, V68, P2559, DOI 10.1111/evo.12468; Doebeli M, 2002, POPUL ECOL, V44, P59, DOI 10.1007/s101440200008; Doroshenko V, 2007, FEMS MICROBIOL LETT, V275, P312, DOI 10.1111/j.1574-6968.2007.00894.x; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; Enyeart PJ, 2015, J THEOR BIOL, V364, P326, DOI 10.1016/j.jtbi.2014.09.030; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Gartner B, 2007, UNDERSTANDING AND US, pviii; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hammerstein P, 2003, GENETIC AND CULTURAL, pxiv; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Henson MA, 2014, IET SYST BIOL, V8, P214, DOI 10.1049/iet-syb.2013.0021; Hoeksema JD, 2003, P ROY SOC B-BIOL SCI, V270, P913, DOI 10.1098/rspb.2002.2312; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Mas-Colell A, 1995, MICROECONOMIC THEORY, pxvii; McInerney MJ, 2008, ANN NY ACAD SCI, V1125, P58, DOI 10.1196/annals.1419.005; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Mee MT, 2012, MOL BIOSYST, V8, P2470, DOI 10.1039/c2mb25133g; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Ricardo D, 1821, ON THE PRINCIPLES OF, pxii; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.1890/0012-9658(1998)079[1029:SARTBM]2.0.CO;2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Waite AJ, 2012, P NATL ACAD SCI USA, V109, P19079, DOI 10.1073/pnas.1210190109; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Werner GDA, 2014, P NATL ACAD SCI USA, V111, P1237, DOI 10.1073/pnas.1315980111; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yu TC, 2012, CURR OPIN BIOTECH, V23, P791, DOI 10.1016/j.copbio.2012.01.006; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108297	45	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132907	10.1371/journal.pone.0132907	http://dx.doi.org/10.1371/journal.pone.0132907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222307	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800035
J	Nguyen, TMD; Seigneurin, F; Froment, P; Combarnous, Y; Blesbois, E				Thi Mong Diep Nguyen; Seigneurin, Francois; Froment, Pascal; Combarnous, Yves; Blesbois, Elisabeth			The 5 '-AMP-Activated Protein Kinase (AMPK) Is Involved in the Augmentation of Antioxidant Defenses in Cryopreserved Chicken Sperm	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; SEMEN CRYOPRESERVATION; LIQUID-NITROGEN; FREE-RADICALS; FOWL SEMEN; METFORMIN; ACTIVATION	Semen cryopreservation is a unique tool for the management of animal genetic diversity. However, the freeze-thaw process causes biochemical and physical alterations which make difficult the restoration of sperm energy-dependent functions needed for fertilization. 5'-AMP activated protein kinase (AMPK) is a key sensor and regulator of intracellular energy metabolism. Mitochondria functions are known to be severely affected during sperm cryopreservation with deleterious oxidative and peroxidative effects leading to cell integrity and functions damages. The aim of this study was thus to examine the role of AMPK on the peroxidation/antioxidant enzymes defense system in frozen-thawed sperm and its consequences on sperm functions. Chicken semen was diluted in media supplemented with or without AMPK activators (AICAR or Metformin [MET]) or inhibitor (Compound C [CC]) and then cryopreserved. AMPK alpha phosphorylation, antioxidant enzymes activities, mitochondrial potential, ATP, citrate, viability, acrosome reaction ability (AR) and various motility parameters were negatively affected by the freeze-thaw process while reactive oxygen species (ROS) production, lipid peroxidation (LPO) and lactate concentration were dramatically increased. AICAR partially restored superoxide dismutase (SOD), Glutathione Peroxidase (GPx) and Glutathione Reductase (GR), increased ATP, citrate, and lactate concentration and subsequently decreased the ROS and LPO (malondialdehyde) in frozen-thawed semen. Motility parameters were increased (i.e., +23% for motility, +34% for rapid sperm) as well as AR (+100%). MET had similar effects as AICAR except that catalase activity was restored and that ATP and mitochondrial potential were further decreased. CC showed effects opposite to AICAR on SOD, ROS, LPO and AR and motility parameters. Taken together, our results strongly suggest that, upon freeze-thaw process, AMPK stimulated intracellular anti-oxidative defense enzymes through ATP regulation, thus reducing ROS and lipid peroxidation, and consequently partially restoring several essential sperm functions and leading to a better quality of cryopreserved sperm.	[Thi Mong Diep Nguyen; Froment, Pascal; Combarnous, Yves; Blesbois, Elisabeth] INRA CNRS, Unite Mixte Rech Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen] Univ Tours, Tours, France; [Seigneurin, Francois] SYSAAF, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universite de Tours	Blesbois, E (corresponding author), INRA CNRS, Unite Mixte Rech Physiol Reprod & Comportements, F-37380 Nouzilly, France.	Elisabeth.Blesbois@tours.inra.fr	Nguyen, Thi Mong Diep/AAB-3939-2020; Combarnous, Yves/K-4161-2019	Nguyen, Thi Mong Diep/0000-0001-6534-9041; Combarnous, Yves/0000-0002-0574-2025	French Agence Nationale de la Recherche; French National Science Infrastructure CRB-Anim; Vietnam Education Ministry; non-profit SYSAAF	French Agence Nationale de la Recherche(French National Research Agency (ANR)); French National Science Infrastructure CRB-Anim; Vietnam Education Ministry; non-profit SYSAAF	This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), and the French National Science Infrastructure CRB-Anim. Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). Francois Seigneurin received funding in the form of salary from the non-profit SYSAAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1996, FREE RADICAL BIO MED, V21, P495, DOI 10.1016/0891-5849(96)00119-0; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bertoldo MJ, 2014, CRYOBIOLOGY, V68, P262, DOI 10.1016/j.cryobiol.2014.02.006; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Blesbois E, 2007, ANIMAL, V1, P1472, DOI 10.1017/S175173110700081X; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E., 2003, PHOSPHOLIPIDS MALE F, P73; Blesbois E, 2012, J POULT SCI, V49, P141, DOI 10.2141/jpsa.011120; Blesbois E, 2011, AVIAN BIOL RES, V4, P52, DOI 10.3184/175815511X13069413108523; Buldak L, 2014, PHARMACOL REP, V66, P418, DOI 10.1016/j.pharep.2013.11.008; Burk RF, 1976, BIOCHEM BIOPH RES CO, V425, P503; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalah T, 1998, THERIOGENOLOGY, V50, P487, DOI 10.1016/S0093-691X(98)00155-1; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Cordova A, 2014, CRYOBIOLOGY, V69, P473, DOI 10.1016/j.cryobiol.2014.10.008; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dai J, 2014, CHEM-BIOL INTERACT, V216, P34, DOI 10.1016/j.cbi.2014.03.013; Dandekar S P, 2002, J Postgrad Med, V48, P186; DELAMIRANDE E, 1993, INT J ANDROL, V16, P21; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esfandiari N, 2003, J ANDROL, V24, P862; Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006; Froman DP, 2011, J ANIM SCI, V89, P1330, DOI 10.2527/jas.2010-3367; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; Gaskin FS, 2009, MICROCIRCULATION, V16, P167, DOI 10.1080/10739680802355897; Goth L, 1986, CLINICACHIMICAACTA, V196, P143; GRIVEAU JF, 1995, J REPROD FERTIL, V103, P17; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; Horrocks AJ, 2000, BIOCHEM BIOPH RES CO, V278, P84, DOI 10.1006/bbrc.2000.3766; Hu L, 2014, INT J CLIN EXP PATHO, V7, P7378; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; LAKE PE, 1978, BRIT POULTRY SCI, V19, P187, DOI 10.1080/00071667808416462; LAKE PE, 1981, BRIT POULTRY SCI, V22, P71, DOI 10.1080/00071688108447865; Lake PE, 1968, INTREPRODANIMINSEMAR, V2, P1633; LASSO JL, 1994, J ANDROL, V15, P255; Lemoine M, 2008, REPRODUCTION, V136, P391, DOI 10.1530/REP-08-0094; Lemoine M, 2009, BIOL REPROD, V81, P657, DOI 10.1095/biolreprod.108.072660; Long JA, 2006, POULTRY SCI, V85, P232, DOI 10.1093/ps/85.2.232; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin-Hidalgo D, 2013, THERIOGENOLOGY, V80, P285, DOI 10.1016/j.theriogenology.2013.02.015; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moce E, 2010, ANIM REPROD SCI, V122, P359, DOI 10.1016/j.anireprosci.2010.10.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ouslimani N, 2005, METABOLISM, V54, P829, DOI 10.1016/j.metabol.2005.01.029; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Partyka A, 2012, THERIOGENOLOGY, V77, P1497, DOI 10.1016/j.theriogenology.2011.11.006; Partyka A, 2010, THERIOGENOLOGY, V74, P1019, DOI 10.1016/j.theriogenology.2010.04.032; Peron A, 2006, POULTRY SCI, V85, P462, DOI 10.1093/ps/85.3.462; PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109; Piwkowska A, 2010, BIOCHEM BIOPH RES CO, V393, P268, DOI 10.1016/j.bbrc.2010.01.119; Richardson MC, 2009, J CLIN ENDOCR METAB, V94, P670, DOI 10.1210/jc.2008-2025; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; SEIGNEURIN F, 1995, THERIOGENOLOGY, V43, P1351, DOI 10.1016/0093-691X(95)00119-S; SEXTON TJ, 1977, POULTRY SCI, V56, P1443, DOI 10.3382/ps.0561443; Surai PF, 1998, COMP BIOCHEM PHYS B, V120, P527, DOI 10.1016/S0305-0491(98)10039-1; Surai PF, 1998, POULT AVIAN BIOL REV, V9, P11; Surai PF, 2001, ASIAN AUSTRAL J ANIM, V14, P1024, DOI 10.5713/ajas.2001.1024; Tchir J, 2010, CRYOBIOLOGY, V61, P100, DOI 10.1016/j.cryobiol.2010.05.007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Weber G, 1966, Adv Enzyme Regul, V4, P59, DOI 10.1016/0065-2571(66)90007-0; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017	72	57	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134420	10.1371/journal.pone.0134420	http://dx.doi.org/10.1371/journal.pone.0134420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222070	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800143
J	Zhao, YG; Ma, CA; Wu, LM; Iwai, K; Ashwell, JD; Oltz, EM; Ballard, DW; Jain, A				Zhao, Yongge; Ma, Chi A.; Wu, Liming; Iwai, Kazuhiro; Ashwell, Jonathan D.; Oltz, Eugene M.; Ballard, Dean W.; Jain, Ashish			CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ECTODERMAL DYSPLASIA; POLYUBIQUITINATION; INFLAMMATION; ACTIVATION; APOPTOSIS; MICE	NF-kappa B essential modulator (NEMO) and cylindromatosis protein (CYLD) are intracellular proteins that regulate the NF-kappa B signaling pathway. Although mice with either CYLD deficiency or an alteration in the zinc finger domain of NEMO (K392R) are born healthy, we found that the combination of these two gene defects in double mutant (DM) mice is early embryonic lethal but can be rescued by the absence of TNF receptor 1 (TNFR1). Notably, NEMO was not recruited into the TNFR1 complex of DM cells, and consequently NF-kappa B induction by TNF was severely impaired and DM cells were sensitized to TNF-induced cell death. Interestingly, the TNF signaling defects can be fully rescued by reconstitution of DM cells with CYLD lacking ubiquitin hydrolase activity but not with CYLD mutated in TNF receptor-associated factor 2 (TRAF2) or NEMO binding sites. Therefore, our data demonstrate an unexpected non-catalytic function for CYLD as an adapter protein between TRAF2 and the NEMO zinc finger that is important for TNF-induced NF-kappa B signaling during embryogenesis.	[Zhao, Yongge; Ma, Chi A.; Wu, Liming; Jain, Ashish] NIAID, Lab Host Defenses, NIH, Bethesda, MD 20892 USA; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto 6068501, Japan; [Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ballard, Dean W.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Vanderbilt University	Zhao, YG (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Clin Res Ctr, Rm 5-W-5832,9000 Rockville Pike, Bethesda, MD 20892 USA.	yongge.zhao@nih.gov; ashish.jain1@merck.com	Wu, liming/AAH-5415-2019; IWAI, KAZUHIRO/GSN-7385-2022; Regan, Clinton/E-6250-2012	Iwai, Kazuhiro/0000-0001-5620-5951	Intramural Research Program of the National Institutes of Health, NIAID; National Institutes of Health [CA082556, AI052379]; NATIONAL CANCER INSTITUTE [R01CA082556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052379] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIAID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIAID, and National Institutes of Health Grants CA082556 and AI052379 (to D. W. B). The authors declare that they have no conflicts of interest with the contents of this article.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cao Z, 1999, COLD SPRING HARB SYM, V64, P473, DOI 10.1101/sqb.1999.64.473; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Ma CA, 2011, HUM MUTAT, V32, P318, DOI 10.1002/humu.21439; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ni CY, 2008, J IMMUNOL, V180, P7107, DOI 10.4049/jimmunol.180.11.7107; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Temmerman ST, 2006, BLOOD, V108, P2324, DOI 10.1182/blood-2006-04-017210; Temmerman ST, 2012, J CLIN INVEST, V122, P315, DOI 10.1172/JCI42534; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhao YG, 2011, J BIOL CHEM, V286, P40520, DOI 10.1074/jbc.M111.292961	24	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22076	22084		10.1074/jbc.M115.658096	http://dx.doi.org/10.1074/jbc.M115.658096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26224629	hybrid, Green Published			2022-12-26	WOS:000360968500026
J	Li, MY; Ko, TY; Li, SS				Li, Mingyang; Ko, Tengyu; Li, Shisheng			High-resolution Digital Mapping of N-Methylpurines in Human Cells Reveals Modulation of Their Induction and Repair by Nearest-neighbor Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; SEQUENCE CONTEXT; DNA GLYCOSYLASE; DAMAGE; TRANSCRIPTION; MITOCHONDRIA; 8-OXOGUANINE; MECHANISM; AGENTS; SITES	N-Methylpurines (NMPs), including N-7-methylguanine (7MeG) and N-3-methyladenine (3MeA), can be induced by environmental methylating agents, chemotherapeutics, and natural cellular methyl donors. In human cells, NMPs are repaired by the multi-step base excision repair pathway initiated by human alkyladenine glycosylase. Repair of NMPs has been shown to be affected by DNA sequence contexts. However, the nature of the sequence contexts has been poorly understood. We developed a sensitive method, LAF-Seq (Lesion-Adjoining Fragment Sequencing), which allows nucleotide-resolution digital mapping of DNA damage and repair in multiple genomic fragments of interest in human cells. We also developed a strategy that allows accurate measurement of the excision kinetics of NMP bases in vitro. We demonstrate that 3MeAs are induced to a much lower level by the SN2 methylating agent dimethyl sulfate and repaired much faster than 7MeGs in human fibroblasts. Induction of 7MeGs by dimethyl sulfate is affected by nearest-neighbor nucleotides, being enhanced at sites neighbored by aG orTon the 3' side, but impaired at sites neighbored by a Gon the 5' side. Repair of 7MeGs is also affected by nearest-neighbor nucleotides, being slow if the lesions are between purines, especially Gs, and fast if the lesions are between pyrimidines, especially Ts. Excision of 7MeG bases from the DNA backbone by human alkyladenine glycosylase in vitro is similarly affected by nearest-neighbor nucleotides, suggesting that the effect of nearest-neighbor nucleotides on repair of 7MeGs in the cells is primarily achieved by modulating the initial step of the base excision repair process.	[Li, Mingyang; Ko, Tengyu; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@lsu.edu	Li, Mingyang/GXG-9833-2022		National Institute of Health [R15CA164862]; National Science Foundation [MCB-1244019]; NATIONAL CANCER INSTITUTE [R15CA164862] Funding Source: NIH RePORTER; Direct For Biological Sciences [1244019] Funding Source: National Science Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Health Grant R15CA164862 (to S. L.) and National Science Foundation Grant MCB-1244019 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; Besaratinia Ahmad, 2012, Methods Mol Biol, V920, P189, DOI 10.1007/978-1-61779-998-3_14; Blondal T, 2005, NUCLEIC ACIDS RES, V33, P135, DOI 10.1093/nar/gki149; Cloutier JF, 1999, CHEM RES TOXICOL, V12, P840, DOI 10.1021/tx990025f; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Donigan KA, 2009, MOL CARCINOGEN, V48, P362, DOI 10.1002/mc.20497; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Henderson D. S., 2005, DNA REPAIR PROTOCOLS; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Li SS, 2011, DNA REPAIR, V10, P65, DOI 10.1016/j.dnarep.2010.09.020; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 1999, J BIOL CHEM, V274, P12201, DOI 10.1074/jbc.274.18.12201; Luke April M, 2012, Methods Mol Biol, V920, P307, DOI 10.1007/978-1-61779-998-3_21; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Prakash A, 2012, PROG MOL BIOL TRANSL, V110, P71, DOI 10.1016/B978-0-12-387665-2.00004-3; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; ROSA S, 1991, NUCLEIC ACIDS RES, V19, P5569, DOI 10.1093/nar/19.20.5569; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; van Loon B, 2013, DNA REPAIR, V12, P177, DOI 10.1016/j.dnarep.2012.11.009; Vaughan P., 2000, DNA REPAIR PROTOCOLS; WEINER PK, 1982, P NATL ACAD SCI-BIOL, V79, P3754, DOI 10.1073/pnas.79.12.3754; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Ye N, 1998, J MOL BIOL, V284, P269, DOI 10.1006/jmbi.1998.2138	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23148	23161		10.1074/jbc.M115.676296	http://dx.doi.org/10.1074/jbc.M115.676296			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240148	Green Published, hybrid			2022-12-26	WOS:000361685500026
J	Haurogne, K; Pavlovic, M; Rogniaux, H; Bach, JM; Lieubeau, B				Haurogne, Karine; Pavlovic, Marija; Rogniaux, Helene; Bach, Jean-Marie; Lieubeau, Blandine			Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+T Lymphocytes	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR1; IL-8 RECEPTOR; INTERLEUKIN-8 RECEPTORS; T-CELLS; DEFICIENCY; PROTEIN; LOCI; BETA; PYELONEPHRITIS; SUSCEPTIBILITY	In humans, CXCR1 and CXCR2 are two homologous proteins that bind ELR+ chemokines. Both receptors play fundamental roles in neutrophil functions such as migration and reactive oxygen species production. Mouse Cxcr1 and Cxcr2 genes are located in an insulin-dependent diabetes genetic susceptibility locus. The non obese diabetic (NOD) mouse is a spontaneous well-described animal model for insulin-dependent type 1 diabetes. In this disease, insulin deficiency results from the destruction of insulin-producing beta cells by auto-reactive T lymphocytes. This slow-progressing disease is dependent on both environmental and genetic factors. Here, we report descriptive data about the Cxcr1 gene in NOD mice. We demonstrate decreased expression of mRNA for Cxcr1 in neutrophils and CD4+ lymphocytes isolated from NOD mice compared to other strains, related to reduced NOD Cxcr1 gene promoter activity. Looking for Cxcr1 protein, we next analyze the membrane proteome of murine neutrophils by mass spectrometry. Although Cxcr2 protein is clearly found in murine neutrophils, we did not find evidence of Cxcr1 peptides using this method. Nevertheless, in view of recently-published experimental data obtained in NOD mice, we argue for possible Cxcr1 involvement in type 1 diabetes pathogenesis.	[Haurogne, Karine; Bach, Jean-Marie; Lieubeau, Blandine] INRA, USC1383, IECM, F-44026 Nantes, France; [Haurogne, Karine; Bach, Jean-Marie; Lieubeau, Blandine] LUNAM Univ, EA4644, Oniris, Nantes, France; [Pavlovic, Marija; Rogniaux, Helene] INRA, UR1268, BIA, BIBS, F-44026 Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Lieubeau, B (corresponding author), INRA, USC1383, IECM, F-44026 Nantes, France.	blandine.lieubeau@oniris-nantes.fr	Bach, Jean-Marie/AAR-1086-2020	Bach, Jean-Marie/0000-0002-5265-8854; Lieubeau, Blandine/0000-0002-1434-1506				Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; [Anonymous], 2009, Q810W6 CXCR1 MOUSE; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Beech JS, 2007, J NEUROIMMUNOL, V184, P198, DOI 10.1016/j.jneuroim.2006.12.015; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bishayi B, 2015, INFLAMMATION, V38, P812, DOI 10.1007/s10753-014-9991-1; Bleijerved OB, 2012, J PROTEOME RES, V11, P5235, DOI 10.1021/pr3004375; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Citro A, 2015, DIABETES, V64, P1329, DOI 10.2337/db14-0443; Clarke C, 2011, HEPATOLOGY, V53, P261, DOI 10.1002/hep.24028; Cooke A, 2004, TRENDS PARASITOL, V20, P316, DOI 10.1016/j.pt.2004.04.010; Diana J, 2014, EMBO MOL MED, V6, P1090, DOI 10.15252/emmm.201404144; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Eikawa S, 2010, J IMMUNOL, V185, P6734, DOI 10.4049/jimmunol.1000225; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hosking MP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000648; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, P6338, DOI 10.1093/nar/gkm715; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; LEE J, 1995, J IMMUNOL, V155, P2158; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Liu LP, 2013, GENESIS, V51, P587, DOI 10.1002/dvg.22401; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Ludwig A, 1997, BLOOD, V90, P4588; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Raine C, 2007, J NEUROIMMUNOL, V186, P199, DOI 10.1016/j.jneuroim.2007.03.018; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; SPRENGER H, 1994, J IMMUNOL, V153, P2524; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Stemmler S, 2005, GENES IMMUN, V6, P225, DOI 10.1038/sj.gene.6364181; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Sturm A, 2005, CYTOKINE, V29, P42, DOI 10.1016/j.cyto.2004.09.007; Svensson M, 2011, KIDNEY INT, V80, P1064, DOI 10.1038/ki.2011.257; Takata H, 2004, J IMMUNOL, V173, P2231, DOI 10.4049/jimmunol.173.4.2231; Takata H, 2012, BLOOD, V119, P1390, DOI 10.1182/blood-2011-03-343251; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Tomazella GG, 2010, J PROTEOME RES, V9, P2030, DOI 10.1021/pr1000253; Tomazella GG, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-32; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Uriarte SM, 2008, J IMMUNOL, V180, P5575, DOI 10.4049/jimmunol.180.8.5575; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wilkinson NC, 1999, J BIOL CHEM, V274, P438, DOI 10.1074/jbc.274.1.438; Williams EJ, 2000, J PATHOL, V192, P533; Zaccone P, 2011, SEMIN IMMUNOL, V23, P122, DOI 10.1016/j.smim.2011.01.013; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	72	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134365	10.1371/journal.pone.0134365	http://dx.doi.org/10.1371/journal.pone.0134365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230114	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400109
J	Zhang, XB; Du, YP; Wang, LH; Zhou, Q; Huang, XH; Sun, ZG				Zhang, Xuanbo; Du, Yuping; Wang, Lihong; Zhou, Qing; Huang, Xiaohua; Sun, Zhaoguo			Combined Effects of Lanthanum (III) and Acid Rain on Antioxidant Enzyme System in Soybean Roots	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; ULTRAVIOLET-B RADIATION; STORED POTATO-TUBERS; LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; SEED-GERMINATION; OXIDATIVE STRESS; SEEDLINGS; RESPONSES; GROWTH	Rare earth element pollution (REEs) and acid rain (AR) pollution simultaneously occur in many regions, which resulted in a new environmental issue, the combined pollution of REEs and AR. The effects of the combined pollution on the antioxidant enzyme system of plant roots have not been reported. Here, the combined effects of lanthanum ion (La3+), one type of REE, and AR on the antioxidant enzyme system of soybean roots were investigated. In the combined treatment of La3+ (0.08 mM) and AR, the cell membrane permeability and the peroxidation of cell membrane lipid of soybean roots increased, and the superoxide dismutase, catalase, peroxidase and reduced ascorbic acid served as scavengers of reactive oxygen species. In other combined treatments of La3+ (0.40 mM, 1.20 mM) and AR, the membrane permeability, malonyldialdehyde content, superoxide dismutase activity, peroxidase activity and reduced ascorbic acid content increased, while the catalase activity decreased. The increased superoxide dismutase activity, peroxidase activity and reduced ascorbic acid content were inadequate to scavenge the excess hydrogen peroxide and superoxide, leading to the damage of the cell membrane, which was aggravated with the increase in the concentration of La3+ and the level of AR. The deleterious effects of the combined treatment of La3+ and AR were stronger than those of the single treatment of La3+ or AR. Moreover, the activity of antioxidant enzyme system in the combined treatment group was affected directly and indirectly by mineral element content in soybean plants.	[Zhang, Xuanbo; Du, Yuping; Wang, Lihong; Zhou, Qing; Sun, Zhaoguo] Jiangnan Univ, Jiangsu Coorperat Innovat Ctr Water Treatment Tec, State Key Lab Food Sci & Technol, Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China; [Huang, Xiaohua] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Nanjing Normal University	Zhou, Q (corresponding author), Jiangnan Univ, Jiangsu Coorperat Innovat Ctr Water Treatment Tec, State Key Lab Food Sci & Technol, Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China.	qingzhou510@yahoo.com; huangxiaohuanjnu@yahoo.com		Huang, Xiaohua/0000-0003-4150-0477	Natural Science Foundation of China [31170477]; Jiangsu Province [BK2011160]; Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province [CXZZ12 0760]; Fundamental Research Funds for the Central Universities [JUDCF 12024]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported through the Natural Science Foundation of China (31170477), Jiangsu Province (BK2011160), the Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province (CXZZ12 0760) and the Fundamental Research Funds for the Central Universities (JUDCF12024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERS RF, 1952, J BIOL CHEM, V195, P133; Benedet JA, 2008, FOOD CHEM, V107, P165, DOI 10.1016/j.foodchem.2007.07.076; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; CAMPBELL WJ, 1990, J EXP BOT, V41, P427, DOI 10.1093/jxb/41.4.427; Chen J, 2013, PLANT PHYSIOL BIOCH, V64, P41, DOI 10.1016/j.plaphy.2012.12.012; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gu ZM, 2001, CHEMOSPHERE, V44, P545, DOI 10.1016/S0045-6535(00)00484-7; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Huang GR, 2013, BIOL TRACE ELEM RES, V151, P105, DOI 10.1007/s12011-012-9528-0; Huang XH, 2006, J RARE EARTH, V24, P248, DOI 10.1016/S1002-0721(06)60103-8; Ippolito MP, 2011, PLANT BIOSYST, V145, P248, DOI 10.1080/11263504.2010.509937; Ippolito MP, 2010, ARCH ENVIRON CON TOX, V58, P42, DOI 10.1007/s00244-009-9340-9; Kobayashi Y, 2007, FUNCT PLANT BIOL, V34, P984, DOI 10.1071/FP07133; [孔然 Kong Ran], 2012, [城市环境与城市生态, Urban Environment and Urban Ecology], V25, P22; Koricheva J, 1997, ENVIRON POLLUT, V95, P249, DOI 10.1016/S0269-7491(96)00071-1; Kovacik J, 2011, ECOTOXICOLOGY, V20, P348, DOI 10.1007/s10646-010-0585-x; KUMAR GNM, 1993, PLANT PHYSIOL, V102, P115, DOI 10.1104/pp.102.1.115; Liu DW, 2012, ENVIRON SCI POLLUT R, V19, P3282, DOI 10.1007/s11356-012-0844-x; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Noto LL, 2013, J LUMIN, V140, P14, DOI 10.1016/j.jlumin.2013.02.051; Olmos E, 1996, PLANT SCI, V120, P37, DOI 10.1016/S0168-9452(96)04483-4; Pang X, 2002, CHEMOSPHERE, V47, P1033, DOI 10.1016/S0045-6535(02)00022-X; Peng Q, 2009, BIOL TRACE ELEM RES, V127, P69, DOI 10.1007/s12011-008-8218-4; Rodewald UC, 2007, J SOLID STATE CHEM, V180, P1720, DOI 10.1016/j.jssc.2007.03.007; SHAW RH, 1967, AGRON J, V59, P155, DOI 10.2134/agronj1967.00021962005900020009x; Shi P, 2005, RUSS J PLANT PHYSL+, V52, P294, DOI 10.1007/s11183-005-0044-3; Shi SY, 2005, NITRIC OXIDE-BIOL CH, V13, P1, DOI 10.1016/j.niox.2005.04.006; Singh A, 2008, J ENVIRON BIOL, V29, P15; Smirnoff N, 2005, BIOL SCI SER, P1, DOI 10.1002/9780470988565; SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1207, DOI 10.1104/pp.94.3.1207; SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1214, DOI 10.1104/pp.94.3.1214; Sulaiman SF, 2011, J FOOD COMPOS ANAL, V24, P1, DOI 10.1016/j.jfca.2010.04.005; Sun ZG, 2013, CHEMOSPHERE, V93, P344, DOI 10.1016/j.chemosphere.2013.04.089; Sun ZG, 2012, ECOTOX ENVIRON SAFE, V79, P62, DOI 10.1016/j.ecoenv.2011.12.004; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wang LH, 2008, CHEMOSPHERE, V73, P314, DOI 10.1016/j.chemosphere.2008.06.004; Wang LH, 2009, BIOL TRACE ELEM RES, V128, P82, DOI 10.1007/s12011-008-8250-4; Wang XQ, 2013, TREES-STRUCT FUNCT, V27, P297, DOI 10.1007/s00468-012-0799-z; Wei ZG, 2001, ENVIRON POLLUT, V114, P345, DOI 10.1016/S0269-7491(00)00240-2; Wen KJ, 2011, CHEMOSPHERE, V84, P601, DOI 10.1016/j.chemosphere.2011.03.054; Wen XJ, 2013, ENVIRON EARTH SCI, V69, P843, DOI 10.1007/s12665-012-1969-4; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Xie S.Y., 2012, ENV MONITOR FOREWARN, V4, P33; Xu QM, 2011, ECOTOX ENVIRON SAFE, V74, P1693, DOI 10.1016/j.ecoenv.2011.04.005; Yao D, 2013, INT J METALCAST, V7, P49, DOI 10.1007/BF03355544; Yu JQ, 2002, PHOTOSYNTHETICA, V40, P331, DOI 10.1023/A:1022658504882; Zheng HL, 2000, BIOMETALS, V13, P157, DOI 10.1023/A:1009232821175	54	14	16	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134546	10.1371/journal.pone.0134546	http://dx.doi.org/10.1371/journal.pone.0134546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230263	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400132
J	Benhalevy, D; Bochkareva, ES; Biran, I; Bibi, E				Benhalevy, Daniel; Bochkareva, Elena S.; Biran, Ido; Bibi, Eitan			Model Uracil-Rich RNAs and Membrane Protein mRNAs Interact Specifically with Cold Shock Proteins in Escherichia coli	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CSPA FAMILY; GENE; EXPRESSION; PHASE	Are integral membrane protein-encoding mRNAs (MPRs) different from other mRNAs such as those encoding cytosolic mRNAs (CPRs)? This is implied from the emerging concept that MPRs are specifically recognized and delivered to membrane-bound ribosomes in a translation-independent manner. MPRs might be recognized through uracil-rich segments that encode hydrophobic transmembrane helices. To investigate this hypothesis, we designed DNA sequences encoding model untranslatable transcripts that mimic MPRs or CPRs. By utilizing in vitro-synthesized biotinylated RNAs mixed with Escherichia coli extracts, we identified a highly specific interaction that takes place between transcripts that mimic MPRs and the cold shock proteins CspE and CspC, which are normally expressed under physiological conditions. Co-purification studies with E. coli expressing 6His-tagged CspE or CspC confirmed that the specific interaction occurs in vivo not only with the model uracil-rich untranslatable transcripts but also with endogenous MPRs. Our results suggest that the evolutionarily conserved cold shock proteins may have a role, possibly as promiscuous chaperons, in the biogenesis of MPRs.	[Benhalevy, Daniel; Bochkareva, Elena S.; Biran, Ido; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Benhalevy, Daniel/AGG-5321-2022	Benhalevy, Daniel/0000-0001-6998-1933; Bibi, Eitan/0000-0003-3700-2707	Israel Science Foundation First Award; Minerva Foundation; Federal German Ministry for Education and Research	Israel Science Foundation First Award; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Israel Science Foundation First Award and by the Minerva Foundation with funding from the Federal German Ministry for Education and Research. E.B. holds the Jerome A., Freda, and Edward M. Siegel professorial Chair.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae WH, 1999, MOL MICROBIOL, V31, P1429, DOI 10.1046/j.1365-2958.1999.01284.x; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jagannathan S, 2014, J BIOL CHEM, V289, P25907, DOI 10.1074/jbc.M114.580688; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jiang WN, 1996, J BACTERIOL, V178, P4919, DOI 10.1128/jb.178.16.4919-4925.1996; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kraut-Cohen J, 2010, TRENDS BIOCH SCI; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Lenz G, 2014, J MOL BIOL, V426, P460, DOI 10.1016/j.jmb.2013.10.018; Lipfert J, 2014, ANNU REV BIOCHEM, V83, P813, DOI 10.1146/annurev-biochem-060409-092720; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Rath D, 2006, J BACTERIOL, V188, P6780, DOI 10.1128/JB.00471-06; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Serganov A, 2008, CURR OPIN STRUC BIOL, V18, P120, DOI 10.1016/j.sbi.2007.12.006; Shenhar Y, 2012, ENV MICROBIOL REP, V4, P532, DOI 10.1111/j.1758-2229.2012.00358.x; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; TABOR S, 1990, J BIOL CHEM, V265, P8322; Uppal S, 2008, FEMS MICROBIOL LETT, V279, P83, DOI 10.1111/j.1574-6968.2007.01009.x; Xia B, 2002, J BIOL CHEM, V277, P6005, DOI 10.1074/jbc.M109700200; Yamanaka K, 1997, J BACTERIOL, V179, P5126, DOI 10.1128/jb.179.16.5126-5130.1997; Yamanaka K, 2001, MOL MICROBIOL, V39, P1572, DOI 10.1046/j.1365-2958.2001.02345.x; Yosef I, 2010, MBIO, V1, DOI 10.1128/mBio.00020-10; Yosef I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009130	45	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134413	10.1371/journal.pone.0134413	http://dx.doi.org/10.1371/journal.pone.0134413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225847	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700091
J	Covington, MF; Sherman, S; Lewis, D; Lei, H; Krupinski, E; Kuo, PH				Covington, Matthew F.; Sherman, Scott; Lewis, Denise; Lei, Hong; Krupinski, Elizabeth; Kuo, Phillip H.			Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging	PLOS ONE			English	Article							PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; I-123-FP-CIT SPECT; COST-EFFECTIVENESS; FOLLOW-UP; I-123-IOFLUPANE; MANAGEMENT	Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.	[Covington, Matthew F.; Lewis, Denise; Krupinski, Elizabeth] Univ Arizona, Coll Med, Dept Med Imaging, Tucson, AZ USA; [Sherman, Scott; Lei, Hong] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA; [Kuo, Phillip H.] Univ Arizona, Coll Med, Dept Med Imaging Med & Biomed Engn, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Kuo, PH (corresponding author), Univ Arizona, Coll Med, Dept Med Imaging Med & Biomed Engn, Tucson, AZ 85721 USA.	pkuo@radiology.arizona.edu			General Electric Healthcare	General Electric Healthcare(General ElectricGE Healthcare)	Funding for this project was received from General Electric Healthcare. The funder provided support in the form of salaries for authors [PHK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antonini A, 2008, MOVEMENT DISORD, V23, P2202, DOI 10.1002/mds.22278; Bega D, 2015, NEURODEGENER DIS, V15, P81, DOI 10.1159/000370116; Booij J, 2001, EUR J NUCL MED, V28, P266, DOI 10.1007/s002590000460; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Dodel RC, 2003, MOVEMENT DISORD, V18, pS52, DOI 10.1002/mds.10580; Hauser RA, 2012, J NEUROIMAGING, V22, P225, DOI 10.1111/j.1552-6569.2011.00583.x; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; Kuo PH, 2013, J NUCL MED TECHNOL, V41, P26, DOI 10.2967/jnmt.112.114827; Kupsch A, 2013, NEURODEGENER DIS, V11, P22, DOI 10.1159/000337351; Kupsch AR, 2012, J NEUROL NEUROSUR PS, V83, P620, DOI 10.1136/jnnp-2011-301695; Marshall VL, 2009, MOVEMENT DISORD, V24, P500, DOI 10.1002/mds.22108; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Seifert Kimberly D, 2013, Am J Neurodegener Dis, V2, P29; Tolosa E, 2007, MOVEMENT DISORD, V22, P2346, DOI 10.1002/mds.21710; Van Laere K, 2008, EUR J NUCL MED MOL I, V35, P1367, DOI 10.1007/s00259-008-0777-2; Vlaar AM, 2007, BMC NEURO, V1, P7; Vlaar AMM, 2008, EUR NEUROL, V59, P258, DOI 10.1159/000115640	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134457	10.1371/journal.pone.0134457	http://dx.doi.org/10.1371/journal.pone.0134457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226362	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700095
J	Hargreaves, SK; Williams, RJ; Hofmockel, KS				Hargreaves, Sarah K.; Williams, Ryan J.; Hofmockel, Kirsten S.			Environmental Filtering of Microbial Communities in Agricultural Soil Shifts with Crop Growth	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; NITROGEN DEPOSITION; ENZYME-ACTIVITY; DIVERSITY; FERTILIZATION; PRODUCTIVITY; BIOGEOGRAPHY; ECOSYSTEMS; LINKAGES	Plant and soil properties cooperatively structure soil microbial communities, with implications for ecosystem functioning. However, the extent to which each factor contributes to community structuring is not fully understood. To quantify the influence of plants and soil properties on microbial diversity and composition in an agricultural context, we conducted an experiment within a corn-based annual cropping system and a perennial switchgrass cropping system across three topographic positions. We sequenced barcoded 16S ribosomal RNA genes from whole soil three times throughout a single growing season and across two years in July. To target the belowground effects of plants, we also sampled rhizosphere soil in July. We hypothesized that microbial community alpha-diversity and composition (beta-diversity) would be more sensitive to cropping system effects (annual vs. perennial inputs) than edaphic differences among topographic positions, with greater differences occurring in the rhizosphere compared to whole soil. We found that microbial community composition consistently varied with topographic position, and cropping system and the rhizosphere influenced alpha-diversity. In July, cropping system and rhizosphere structured a small but specific group of microbes implying a subset of microbial taxa, rather than broad shifts in community composition, may explain previously observed differences in resource cycling between treatments. Using rank abundance analysis, we detected enrichment of Saprospirales and Actinomycetales, including cellulose and chitin degraders, in the rhizosphere soil and enrichment of Nitrospirales, Syntrophobacterales, and MND1 in the whole soil. Overall, these findings support environmental filtering for the soil microbial community first by soil and second by the rhizosphere. Across cropping systems, plants selected for a general rhizosphere community with evidence for plant-specific effects related to time of sampling.	[Hargreaves, Sarah K.; Williams, Ryan J.; Hofmockel, Kirsten S.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Iowa State University	Hofmockel, KS (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	khof@iastate.edu		Hofmockel, Kirsten/0000-0003-1586-2167	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-85101-20471]; National Science Foundation Doctoral Dissertation Improve Grant [DEB-1210742]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; National Science Foundation Doctoral Dissertation Improve Grant	Funding for this research was provided by the Agriculture and Food Research Initiative Competitive Grant No. 2010-85101-20471 from the USDA National Institute of Food and Agriculture (http://www.nifa.usda.gov/) to KSH and a National Science Foundation (http://www.nsf.gov/) Doctoral Dissertation Improve Grant (DEB-1210742) to SKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson-Teixeira K. J., 2013, Ecosystems, V16, P508, DOI 10.1007/s10021-012-9628-x; Aronesty E., 2013, OPEN BIOINFORMATICS; Bell CW, 2015, SOIL BIOL BIOCHEM, V85, P170, DOI 10.1016/j.soilbio.2015.03.006; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; de Vries FT, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00265; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enwall K, 2007, SOIL BIOL BIOCHEM, V39, P106, DOI 10.1016/j.soilbio.2006.06.015; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franco-Correa M, 2010, APPL SOIL ECOL, V45, P209, DOI 10.1016/j.apsoil.2010.04.007; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Hargreaves SK, 2014, BIOGEOCHEMISTRY, V117, P67, DOI 10.1007/s10533-013-9893-6; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Hurlbert AH, 2014, ECOL LETT, V17, P401, DOI 10.1111/ele.12240; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Ladygina N, 2010, SOIL BIOL BIOCHEM, V42, P162, DOI 10.1016/j.soilbio.2009.10.009; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Mao YJ, 2013, ENVIRON MICROBIOL, V15, P928, DOI 10.1111/j.1462-2920.2012.02844.x; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martinez A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00340; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ofek M, 2014, ENVIRON MICROBIOL, V16, P2157, DOI 10.1111/1462-2920.12228; Ontl TA, 2013, NEW PHYTOL, V199, P727, DOI 10.1111/nph.12302; Palaniyandi SA, 2013, APPL MICROBIOL BIOT, V97, P9621, DOI 10.1007/s00253-013-5206-1; PARKIN TB, 1987, SOIL SCI SOC AM J, V51, P1194, DOI 10.2136/sssaj1987.03615995005100050019x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rosenzweig N, 2013, CAN J MICROBIOL, V59, P494, DOI 10.1139/cjm-2012-0661; Salles JF, 2004, APPL ENVIRON MICROB, V70, P4012, DOI 10.1128/AEM.70.7.4012-4020.2004; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Team RC, LANG ENV STAT COMP; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; Turner TR, 2013, ISME J, V7, P2248, DOI 10.1038/ismej.2013.119; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Wilson DM, 2014, BIOENERG RES, V7, P885, DOI 10.1007/s12155-014-9409-9; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085301; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Ziegler M, 2013, J MICROBIOL METH, V94, P30, DOI 10.1016/j.mimet.2013.04.003	60	45	45	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134345	10.1371/journal.pone.0134345	http://dx.doi.org/10.1371/journal.pone.0134345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226508	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700076
J	Kudo, N; Yokokawa, H; Fukuda, H; Sanada, H; Miwa, Y; Hisaoka, T; Isonuma, H				Kudo, Nagako; Yokokawa, Hirohide; Fukuda, Hiroshi; Sanada, Hironobu; Miwa, Yuichi; Hisaoka, Teruhiko; Isonuma, Hiroshi			Achievement of Target Blood Pressure Levels among Japanese Workers with Hypertension and Healthy Lifestyle Characteristics Associated with Therapeutic Failure	PLOS ONE			English	Article							BODY-MASS INDEX; PRIMARY-CARE PHYSICIANS; US ADULTS; ALCOHOL; SLEEP; HOME	Background Few studies have examined Japanese with regard to the achievement rates for target blood pressure levels, or the relationship between these rates and healthy lifestyle characteristics in patients with hypertension as defined by the newly established hypertension management guidelines (JSH2014). The aim of this study was to elucidate achievement rates and examine healthy lifestyle characteristics associated with achievement status among Japanese. Methods This cross-sectional study, conducted in January-December 2012, examined blood pressure control and healthy lifestyle characteristics in 8,001 Japanese workers with hypertension (mean age, 57.0 years; 78.8% were men) who participated in a workplace health checkup. Data were collected from workplace medical checkup records and participants' self-administered questionnaires. We divided into 5 groups [G1; young, middle-aged, and early-phase elderly patients (65-74 years old) without diabetes mellitus or chronic kidney disease (CKD) (< 140/90 mmHg), G2; late-phase elderly patients (>= 75 years old) without diabetes mellitus or CKD (< 150/90 mmHg), G3; diabetic patients (< 130/80 mmHg), G4; patients with CKD (< 130/80 mmHg), and G5; patients with cerebrovascular and/or coronary artery diseases (< 140/90 mmHg)] according to JSH2014. And then, achievement rates were calculated in each group. Multivariate analysis identified healthy lifestyle characteristics associated with "therapeutic failure" of target blood pressure. Results Target blood pressures were achieved by 60.2% of young, middle-aged, and early-phase elderly patients (G1), 71.4% of late-phase elderly patients (G2), 30.5% of diabetic patients (G3), 33.4% of those with chronic kidney disease (G4), and 66.0% of those with cerebrovascular and/or coronary artery diseases (G5). A body mass index of 18.5-24.9 and non-daily alcohol consumption were protective factors, and adequate sleep was found to contribute to therapeutic success. Discussion We found low achievement rates for treatment goals among patients with chronic kidney disease and diabetes mellitus. Maintaining an ideal body weight and adequate alcohol consumption may help with blood pressure control. Lifestyle modification may be necessary for better management of hypertension.	[Kudo, Nagako; Yokokawa, Hirohide; Fukuda, Hiroshi; Hisaoka, Teruhiko; Isonuma, Hiroshi] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 113, Japan; [Kudo, Nagako] Tokorozawa Med Clin, Tokorozawa, Saitama, Japan; [Sanada, Hironobu] Fukushima Welf Federat Agr Cooperat, Div Hlth Sci Res, Aizubange Town, Fukushima, Japan; [Sanada, Hironobu] Fukushima Med Univ, Sch Med, Dept Tumor & Host Biosci, Fukushima, Japan; [Miwa, Yuichi] Tokyo Hlth Serv Assoc, Dept Hlth Screening, Tokyo, Japan	Juntendo University; Fukushima Medical University	Yokokawa, H (corresponding author), Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 113, Japan.	hyokoka@juntendo.ac.jp						[Anonymous], ATL HEART STROK RISK; [Anonymous], CARD DIS; Belloc N B, 1972, Prev Med, V1, P409, DOI 10.1016/0091-7435(72)90014-X; Chirinos JA, 2009, ARCH INTERN MED, V169, P580, DOI 10.1001/archinternmed.2008.611; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Droyvold WB, 2005, INT J OBESITY, V29, P650, DOI 10.1038/sj.ijo.0802944; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jee SH, 2001, AM J HEALTH PROMOT, V15, P244, DOI 10.4278/0890-1171-15.4.244; Johansson JK, 2011, J HYPERTENS, V29, P1897, DOI 10.1097/HJH.0b013e32834abccd; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ministry of Health Labour and Welfare & Ministry of Education Culture Sports Science and Technology, 2013, ETH GUID EP STUD; Muntner P, 2007, CIRCULATION, V116, P39; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; Nakamura K, 2014, WORLD J CARDIOL, V6, P531, DOI 10.4330/wjc.v6.i7.531; Nakamura K, 2013, J HYPERTENS, V31, P1032, DOI 10.1097/HJH.0b013e32835f5747; Navar-Boggan AM, 2014, JAMA-J AM MED ASSOC, V311, P1424, DOI 10.1001/jama.2014.2531; Obara T, 2006, DIABETES RES CLIN PR, V73, P276, DOI 10.1016/j.diabres.2006.01.015; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Sforza E, 2014, J CLIN SLEEP MED, V10, P965, DOI 10.5664/jcsm.4026; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tseng CH, 2007, CIRC J, V71, P1749, DOI 10.1253/circj.71.1749; WARNICK GR, 1990, CLIN CHEM, V36, P15; Wolf AM, 2007, J AM DIET ASSOC, V107, P1365, DOI 10.1016/j.jada.2007.05.015; World Health Organization, GLOB HLTH OBS RAIS B; Yokokawa H, 2011, INTERNAL MED, V50, P1149, DOI 10.2169/internalmedicine.50.4969; Yoshita K, 2005, J HYPERTENS, V23, P1485, DOI 10.1097/01.hjh.0000173394.39197.4e	31	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133641	10.1371/journal.pone.0133641	http://dx.doi.org/10.1371/journal.pone.0133641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225722	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700030
J	Mondesert, O; Frongia, C; Clayton, O; Boizeau, ML; Lobjois, V; Ducommun, B				Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard			Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model	PLOS ONE			English	Article							CELL-CYCLE; ATM KINASE; P53; MDM2; PROLIFERATION; INHIBITION; CHECKPOINT; EXPRESSION; PROTEINS; DYNAMICS	Monitoring the DNA-Damage Response (DDR) activated pathway in multicellular tumor spheroid models is an important challenge as these 3D models have demonstrated their major relevance in pharmacological evaluation. Herein we present DDR-Act-FP, a fluorescent biosensor that allows detection of DDR activation through monitoring of the p21 promoter p53-dependent activation. We show that cells expressing the DDR-Act-FP biosensor efficiently report activation of the DDR pathway after DNA damage and its pharmacological manipulation using ATM kinase inhibitors. We also report the successful use of this assay to screen a small compound library in order to identify activators of the DDR response. Finally, using multicellular spheroids expressing the DDR-Act-FP we demonstrate that DDR activation and its pharmacological manipulation with inhibitory and activatory compounds can be efficiently monitored in live 3D spheroid model. This study paves the way for the development of innovative screening and preclinical evaluation assays.	[Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard] Univ Toulouse, ITAV USR3505, F-31106 Toulouse, France; [Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard] CNRS, ITAV USR3505, F-31106 Toulouse, France; [Ducommun, Bernard] CHU Toulouse, F-31059 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU de Toulouse	Lobjois, V (corresponding author), Univ Toulouse, ITAV USR3505, F-31106 Toulouse, France.	valerie.lobjois@itav.fr; bernard.ducommun@itav.fr		Lobjois, Valerie/0000-0003-2428-2084; DUCOMMUN, Bernard/0000-0002-7126-8368	ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences Health); Fondation pour la Recherche Medicale; Agence Nationale de la Recherche ANR [12-BSV5-0008-01]; Region Midi-Pyrenees	ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences Health); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This work was financially supported by the Region Midi-Pyrenees, ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan, Fondation pour la Recherche Medicale (Equipe labellisee 2011), and Agence Nationale de la Recherche ANR (12-BSV5-0008-01).	Chehab NH, 2000, GENE DEV, V14, P278; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Curtin NJ, 2013, BRIT J PHARMACOL, V169, P1745, DOI 10.1111/bph.12244; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fedrigo CA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-156; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jeandupeux E, 2015, BIOCHEM BIOPH RES CO, V463, P1141, DOI 10.1016/j.bbrc.2015.06.072; Johnson SA, 2007, DNA REPAIR, V6, P1277, DOI 10.1016/j.dnarep.2007.02.025; Jorand R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035795; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Lobjois V, 2009, EUR J CANCER, V45, P2402, DOI 10.1016/j.ejca.2009.05.026; Lorenzo C, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-22; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Miwa S, 2013, J CELL BIOCHEM, V114, P2493, DOI 10.1002/jcb.24599; Miwa S, 2013, ANTICANCER RES, V33, P1373; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nadkarni A, 2012, J NEURO-ONCOL, V110, P349, DOI 10.1007/s11060-012-0979-0; Olive PL, 2004, CANCER RES, V64, P5363, DOI 10.1158/0008-5472.CAN-04-0729; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Tomas M, 2013, J BIOPHOTONICS, V6, P645, DOI 10.1002/jbio.201200170; Uehara F, 2014, J CELL BIOCHEM, V115, P1724, DOI 10.1002/jcb.24837; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134411	10.1371/journal.pone.0134411	http://dx.doi.org/10.1371/journal.pone.0134411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225756	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700090
J	Namachivayam, K; MohanKumar, K; Arbach, D; Jagadeeswaran, R; Jain, SK; Natarajan, V; Mehta, D; Jankov, RP; Maheshwari, A				Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Arbach, Dima; Jagadeeswaran, Ramasamy; Jain, Sunil K.; Natarajan, Viswanathan; Mehta, Dolly; Jankov, Robert P.; Maheshwari, Akhil			All-Trans Retinoic Acid Induces TGF-beta(2) in Intestinal Epithelial Cells via RhoA-and p38 alpha MAPK-Mediated Activation of the Transcription Factor ATF2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; VITAMIN-A SUPPLEMENTATION; RAR DOUBLE MUTANTS; TRANSFORMING GROWTH-FACTOR-BETA-2; NECROTIZING ENTEROCOLITIS; HUMAN-MILK; TGF-BETA; PANCREATIC ORGANOGENESIS; NEGATIVE FEEDBACK; RESPONSE ELEMENTS	Objective We have shown previously that preterm infants are at risk of necrotizing enterocolitis (NEC), an inflammatory bowel necrosis typically seen in infants born prior to 32 weeks' gestation, because of the developmental deficiency of transforming growth factor (TGF)beta(2) in the intestine. The present study was designed to investigate all-trans retinoic acid (atRA) as an inducer of TGF-beta(2) in intestinal epithelial cells (IECs) and to elucidate the involved signaling mechanisms. Methods AtRA effects on intestinal epithelium were investigated using IEC6 cells. TGF-beta(2) expression was measured using reverse transcriptase-quantitative polymerase chain reaction (RTqPCR) and Western blots. Signaling pathways were investigated using Western blots, transiently- transfected/transduced cells, kinase arrays, chromatin immunoprecipitation, and selective small molecule inhibitors. Results AtRA-treatment of IEC6 cells selectively increased TGF-beta(2) mRNA and protein expression in a time-and dose-dependent fashion, and increased the activity of the TGF-beta(2) promoter. AtRA effects were mediated via RhoA GTPase, Rho-associated, coiled-coil-containing protein kinase 1 (ROCK1), p38 alpha MAPK, and activating transcription factor (ATF)-2. AtRA increased phospho-ATF2 binding to the TGF-beta(2) promoter and increased histone H2B acetylation in the TGF-beta(2) nucleosome, which is typically associated with transcriptional activation. Conclusions AtRA induces TGF-beta(2) expression in IECs via RhoA-and p38 alpha MAPK-mediated activation of the transcription factor ATF2. Further studies are needed to investigate the role of atRA as a protective/therapeutic agent in gut mucosal inflammation.	[Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Arbach, Dima; Jagadeeswaran, Ramasamy; Maheshwari, Akhil] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Maheshwari, Akhil] Univ S Florida, Dept Pediat, Morsani Coll Med, Tampa, FL 33620 USA; [Jain, Sunil K.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Natarajan, Viswanathan; Mehta, Dolly; Maheshwari, Akhil] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Jankov, Robert P.] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Jankov, Robert P.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Jankov, Robert P.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Maheshwari, Akhil] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Maheshwari, Akhil] Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, Tampa, FL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of South Florida; University of Texas System; University of Texas Medical Branch Galveston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Maheshwari, A (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	akhilm@health.usf.edu		Ramasamy, Jagadeesh/0000-0002-7906-4239; Namachivayam, Kopperuncholan/0000-0003-3556-8870	National Institutes of Health [R01HD059142]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health award R01HD059142 (to A.M.).	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Colakoglu N, 2004, J MOL HISTOL, V35, P823, DOI 10.1007/s10735-004-1683-y; Colakoglu N, 2005, J MOL HISTOL, V36, P413, DOI 10.1007/s10735-005-9013-6; Fernandez-Calotti P, 2010, J BIOL CHEM, V285, P13589, DOI 10.1074/jbc.M109.055673; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Frost BL, 2014, PEDIAT RES; Ghatpande SK, 2010, DEV GROWTH DIFFER, V52, P433, DOI 10.1111/j.1440-169X.2010.01183.x; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Han GR, 1997, J BIOL CHEM, V272, P13711, DOI 10.1074/jbc.272.21.13711; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hawkes JS, 1999, PEDIATR RES, V46, P194, DOI 10.1203/00006450-199908000-00012; Jakowlew SB, 2000, PEPTIDES, V21, P1831, DOI 10.1016/S0196-9781(00)00344-2; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kadison A, 2001, J PEDIATR SURG, V36, P1150, DOI 10.1053/jpsu.2001.25734; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kurien BT, 2006, METHODS, V38, P283, DOI 10.1016/j.ymeth.2005.11.007; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Lebman DA, 1999, MICROBES INFECT, V1, P1297, DOI 10.1016/S1286-4579(99)00254-3; Lee HY, 1999, MOL CELL BIOL, V19, P1973; Lee MY, 2002, DIABETES, V51, P3400; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li H, 2001, ARCH BIOCHEM BIOPHYS, V394, P1, DOI 10.1006/abbi.2001.2518; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LOHNES D, 1994, DEVELOPMENT, V120, P2723; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Moreira A, 2012, J MATERN-FETAL NEO M, V25, P84, DOI 10.3109/14767058.2011.561893; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nafday SM, 2002, J PERINAT MED, V30, P121, DOI 10.1515/JPM.2002.014; Namachivayam K, 2012, RETINOIC ACID PROTEC; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG1055, DOI 10.1152/ajpgi.00039.2013; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG167, DOI 10.1152/ajpgi.00141.2012; Natarajan V, 2001, AM J PHYSIOL-LUNG C, V281, pL435, DOI 10.1152/ajplung.2001.281.2.L435; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen LK, 2012, J R SOC INTERFACE, V9, P1998, DOI 10.1098/rsif.2012.0028; Ozdemir R, 2013, NEONATOLOGY, V104, P22, DOI 10.1159/000350510; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Plateroti M, 1997, J CELL SCI, V110, P1227; Priyamvada S, 2015, J BIOL CHEM; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rautava S, 2012, J PEDIATR GASTR NUTR, V54, P630, DOI 10.1097/MPG.0b013e31823e7c29; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; Reeves AA, 2013, BREASTFEED MED, V8, P496, DOI 10.1089/bfm.2013.0017; Rodriguez-Ubreva J, 2014, METHODS MOL BIOL, V1094, P309, DOI 10.1007/978-1-62703-706-8_24; RUDERT F, 1993, J STEROID BIOCHEM, V46, P121, DOI 10.1016/0960-0760(93)90287-7; Sakabe M, 2012, DEVELOPMENT, V139, P385, DOI 10.1242/dev.067058; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Wardle SP, 2001, ARCH DIS CHILD-FETAL, V84, pF9, DOI 10.1136/fn.84.1.F9; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; Xiao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104589; Yen A, 1998, CANCER RES, V58, P3163; Yuen DE, 2004, PEDIATR RES, V55, P935, DOI 10.1203/01.pdr.0000127023.22960.85	69	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134003	10.1371/journal.pone.0134003	http://dx.doi.org/10.1371/journal.pone.0134003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225425	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700048
J	Schmidt, A; John, K; Arida, G; Auge, H; Brandl, R; Horgan, FG; Hotes, S; Marquez, L; Radermacher, N; Settele, J; Wolters, V; Schadler, M				Schmidt, Anja; John, Katharina; Arida, Gertrudo; Auge, Harald; Brandl, Roland; Horgan, Finbarr G.; Hotes, Stefan; Marquez, Leonardo; Radermacher, Nico; Settele, Josef; Wolters, Volkmar; Schaedler, Martin			Effects of Residue Management on Decomposition in Irrigated Rice Fields Are Not Related to Changes in the Decomposer Community	PLOS ONE			English	Article							CONTRASTING CHEMICAL-COMPOSITIONS; LEAF-LITTER DECOMPOSITION; HUMID TROPICAL CONDITIONS; PLANT RESIDUES; STRAW INCORPORATION; STREAM DETRITIVORE; SOIL FAUNA; NITROGEN; INVERTEBRATES; DYNAMICS	Decomposers provide an essential ecosystem service that contributes to sustainable production in rice ecosystems by driving the release of nutrients from organic crop residues. During a single rice crop cycle we examined the effects of four different crop residue management practices (rice straw or ash of burned straw scattered on the soil surface or incorporated into the soil) on rice straw decomposition and on the abundance of aquatic and soild-welling invertebrates. Mass loss of rice straw in litterbags of two different mesh sizes that either prevented or allowed access of meso-and macro-invertebrates was used as a proxy for decomposition rates. Invertebrates significantly increased total loss of litter mass by up to 30%. Initially, the contribution of invertebrates to decomposition was significantly smaller in plots with rice straw scattered on the soil surface; however, this effect disappeared later in the season. We found no significant responses in microbial decomposition rates to management practices. The abundance of aquatic fauna was higher in fields with rice straw amendment, whereas the abundance of soil fauna fluctuated considerably. There was a clear separation between the overall invertebrate community structure in response to the ash and straw treatments. However, we found no correlation between litter mass loss and abundances of various lineages of invertebrates. Our results indicate that invertebrates can contribute to soil fertility in irrigated paddy fields by decomposing rice straw, and that their abundance as well as efficiency in decomposition may be promoted by crop residue management practices.	[Schmidt, Anja; Auge, Harald; Settele, Josef; Schaedler, Martin] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [John, Katharina; Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, D-35390 Giessen, Germany; [Arida, Gertrudo; Marquez, Leonardo] Philippine Rice Res Inst, Crop Protect Div, Munoz, Nueva Ecija, Philippines; [Auge, Harald; Settele, Josef; Schaedler, Martin] iDiv German Ctr Integrat Biodivers Res Halle Jena, Leipzig, Germany; [Brandl, Roland; Hotes, Stefan] Univ Marburg, Dept Ecol, Fac Biol, Marburg, Germany; [Horgan, Finbarr G.] Int Rice Res Inst, Manila 1099, Philippines; [Radermacher, Nico] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Justus Liebig University Giessen; Philippine Rice Research Institute; Philipps University Marburg; CGIAR; International Rice Research Institute (IRRI); University of Gottingen	Schmidt, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	a.schmidt@ufz.de	Schädler, Martin/H-3176-2011; Auge, Harald/D-4802-2015; Settele, Josef/A-6371-2009; Wolters, Volkmar/B-4635-2010; Schmidt, Anja/V-3289-2017; John, Katharina/AAQ-9248-2021	Schädler, Martin/0000-0001-9700-0311; Auge, Harald/0000-0001-7432-8453; Settele, Josef/0000-0002-8624-4983; Wolters, Volkmar/0000-0002-7556-4578; Schmidt, Anja/0000-0001-5339-219X; John, Katharina/0000-0002-7611-822X; Horgan, Finbarr/0000-0003-3796-667X	German Federal Ministry of Education and Research (BMBF) [01LL0917A, 01LL0917L]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study is part of the international project "LEGATO" (Land-use intensity and Ecological Engineering - Assessment Tools for risks and Opportunities in irrigated rice based production systems - www.legato-project.net), funded by the German Federal Ministry of Education and Research (BMBF, 01LL0917A, 01LL0917L), within the BMBF-Funding Measure "Sustainable Land Management" (http://nachhaltiges-landmanagement.de/en/). The study was carried out in cooperation with the "ICON" project (Introducing Non-Flooded Crops in Rice-Dominated Landscapes: Impact on Carbon, Nitrogen and Water Cycles), sub-project 3 (Influence of soil animals on C and N turnover in rice-based cropping systems) within the DFG-Research Unit FOR 1701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1977, Introduction to soil microbiology.; ANDERSON JM, 1988, BIOL FERT SOILS, V6, P216, DOI 10.1007/BF00260818; ANDERSON JM, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P267; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Bambaradeniya CNB, 2004, 63 INT WAT MAN I; Beare MH, 1997, APPL SOIL ECOL, V6, P87, DOI 10.1016/S0929-1393(96)00150-3; Bijay-Singh, 2001, NUTR CYCL AGROECOSYS, V59, P227, DOI 10.1023/A:1014410203975; Bird JA, 2001, SOIL SCI SOC AM J, V65, P1143, DOI 10.2136/sssaj2001.6541143x; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V58, P147, DOI 10.1016/j.soilbio.2012.12.001; BOLLEN WB, 1953, J AGR FOOD CHEM, V1, P379, DOI 10.1021/jf60005a004; CANHOTO C, 1995, FRESHWATER BIOL, V34, P209, DOI 10.1111/j.1365-2427.1995.tb00881.x; Chaudhury M, 2005, COMMUN SOIL SCI PLAN, V36, P1141, DOI 10.1081/CSS-200056885; CHRISTENSEN BT, 1985, SOIL BIOL BIOCHEM, V17, P691, DOI 10.1016/0038-0717(85)90047-1; Cobb N.A., 1918, ESTIMATING NEMA POPU; COGLE AL, 1987, AUST J SOIL RES, V25, P481, DOI 10.1071/SR9870481; Cucu MA, 2014, BIOL FERT SOILS, V50, P755, DOI 10.1007/s00374-013-0893-4; da Fonseca JPC, 1998, APPL SOIL ECOL, V9, P105, DOI 10.1016/S0929-1393(98)00062-6; de Vries Franciska T, 2013, Proc Natl Acad Sci U S A, V110, P14296, DOI 10.1073/pnas.1305198110; Dobermann A., 2002, Better Crops International, V16, P7; Dormann C.F., 2011, ANGEW STATISTIK BIOL; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Eagle AJ, 2001, AGRON J, V93, P1346, DOI 10.2134/agronj2001.1346; Eisenhauer N, 2011, OECOLOGIA, V165, P403, DOI 10.1007/s00442-010-1784-0; Fairhurst T., 2007, RICE PRACTICAL GUIDE; Fernando CH, 1980, RICEFIELD ECOSYSTEMS; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; FRIEBE B, 1991, Zeitschrift fuer Kulturtechnik und Landentwicklung, V32, P121; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Hagen EM, 2012, OIKOS, V121, P1507, DOI 10.1111/j.1600-0706.2011.19666.x; Heal O. W., 1997, P3; Khandaker AH, 2004, COMMUN SOIL SCI PLAN, V35, P1469, DOI 10.1081/css-120037558; Klotzbucher T, 2015, BASIC APPL ECOLOGY; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; KOWALENKO CG, 1978, SOIL BIOL BIOCHEM, V10, P417, DOI 10.1016/0038-0717(78)90068-8; Lavelle P., 1994, The biological management of tropical soil fertility., P137; LEKHA A, 1989, P INDIAN AS-ANIM SCI, V98, P275, DOI 10.1007/BF03179409; Leps J., 2003, MULTIVARIATE ANAL EC; Levine JS, 1996, BIOMASS BURNING GLOB; Leyer I., 2007, MULTIVARIATE STAT OK; [李孝勇 Li Xiaoyong], 2003, [安徽农业科学, Journal of anhui agricultural sciences], V31, P870; Liang WJ, 2005, APPL SOIL ECOL, V29, P185, DOI 10.1016/j.apsoil.2004.10.004; Lu YH, 2003, SOIL BIOL BIOCHEM, V35, P1223, DOI 10.1016/S0038-0717(03)00184-6; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Martinez A, 2014, FEMS MICROBIOL ECOL, V87, P257, DOI 10.1111/1574-6941.12221; Miller, 2000, ACRES US, V30, P20; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Oksanen J., 2007, COMMUN ECOL PACK, P631; Perez J, 2014, MICROB ECOL, V67, P245, DOI 10.1007/s00248-013-0306-0; Powell JR, 2014, PEDOBIOLOGIA, V57, P1, DOI 10.1016/j.pedobi.2014.01.001; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; REDDY MV, 1994, BIOL FERT SOILS, V17, P45, DOI 10.1007/BF00418671; Riutta T, 2012, SOIL BIOL BIOCHEM, V49, P124, DOI 10.1016/j.soilbio.2012.02.028; Saha P.K., 2009, BANGLADESH J AGR RES, V34, P633, DOI [10.3329/bjar.v34i4.5839, DOI 10.3329/BJAR.V34I4.5839]; Samra JS, 2003, ASA SPEC PUBL, V65; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; Schmidt A, 2015, BASIC APPL ECOL, V16, P674, DOI 10.1016/j.baae.2015.01.006; Schneider K, 2011, ECOLOGY, V92, P765, DOI 10.1890/10-0157.1; Schulze ED, 1993, BIOL DIVERSITY ECOSY; Settele J, 2015, BASIC APPL IN PRESS; Singh Y, 2005, ADV AGRON, P85; Swan CM, 2006, OECOLOGIA, V147, P469, DOI 10.1007/s00442-005-0297-8; Thuy NH, 2008, SOIL SCI SOC AM J, V72, P514, DOI 10.2136/sssaj2006.0403; TIAN G, 1995, APPL SOIL ECOL, V2, P25, DOI 10.1016/0929-1393(94)00033-4; TIAN G, 1993, SOIL BIOL BIOCHEM, V25, P731, DOI 10.1016/0038-0717(93)90114-Q; TIAN G, 1992, SOIL BIOL BIOCHEM, V24, P1051, DOI 10.1016/0038-0717(92)90035-V; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Villegas-Pangga G, 2000, PLANT SOIL, V223, P1, DOI 10.1023/A:1004777911428; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Widyastuti R, 2002, ECOLOGY DEV SERIES, V3; Witkamp M, 1976, ROLE TERRESTRIAL AQU, P375; WOLTERS V, 1991, Z PFLANZ BODENKUNDE, V154, P389, DOI 10.1002/jpln.19911540602; Xu YZ, 2010, FIELD CROP RES, V115, P79, DOI 10.1016/j.fcr.2009.10.005; Yadvinder-Singh, 2010, NUTR CYCL AGROECOSYS, V88, P471, DOI 10.1007/s10705-010-9370-8; YEATES GW, 1993, J NEMATOL, V25, P315	74	15	15	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134402	10.1371/journal.pone.0134402	http://dx.doi.org/10.1371/journal.pone.0134402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225556	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700089
J	Flinner, N; Schleiff, E				Flinner, Nadine; Schleiff, Enrico			Dynamics of the Glycophorin A Dimer in Membranes of Native-Like Composition Uncovered by Coarse-Grained Molecular Dynamics Simulations	PLOS ONE			English	Article							TRANSMEMBRANE HELICES; PREFERENTIAL INTERACTION; HYDROPHOBIC MISMATCH; LIPID RAFTS; MODEL; CHOLESTEROL; DOMAINS; BILAYER; NMR; PHOSPHOLIPIDS	Membranes are central for cells as borders to the environment or intracellular organelle definition. They are composed of and harbor different molecules like various lipid species and sterols, and they are generally crowded with proteins. The membrane system is very dynamic and components show lateral, rotational and translational diffusion. The consequence of the latter is that phase separation can occur in membranes in vivo and in vitro. It was documented that molecular dynamics simulations of an idealized plasma membrane model result in formation of membrane areas where either saturated lipids and cholesterol (liquid-ordered character, L-o) or unsaturated lipids (liquid-disordered character, L-d) were enriched. Furthermore, current discussions favor the idea that proteins are sorted into the liquid-disordered phase of model membranes, but experimental support for the behavior of isolated proteins in native membranes is sparse. To gain insight into the protein behavior we built a model of the red blood cell membrane with integrated glycophorin A dimer. The sorting and the dynamics of the dimer were subsequently explored by coarse-grained molecular dynamics simulations. In addition, we inspected the impact of lipid head groups and the presence of cholesterol within the membrane on the dynamics of the dimer within the membrane. We observed that cholesterol is important for the formation of membrane areas with L-o and L-d character. Moreover, it is an important factor for the reproduction of the dynamic behavior of the protein found in its native environment. The protein dimer was exclusively sorted into the domain of L-d character in the model red blood cell plasma membrane. Therefore, we present structural information on the glycophorin A dimer distribution in the plasma membrane in the absence of other factors like e.g. lipid anchors in a coarse grain resolution.	[Flinner, Nadine; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60438 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60438 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Flinner, Nadine/AAZ-5668-2020; Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489	Cluster of Excellence Frankfurt "Macromolecular Complexes"; graduate program TRAM; Deutsche Forschungsgemeinschaft;  [SFB 807 P17]	Cluster of Excellence Frankfurt "Macromolecular Complexes"; graduate program TRAM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This project was funded by the Cluster of Excellence Frankfurt "Macromolecular Complexes" (ES), the SFB 807 P17 (ES), the graduate program TRAM (NF), and the Deutsche Forschungsgemeinschaft (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; BRULET P, 1976, BIOCHEM BIOPH RES CO, V68, P363, DOI 10.1016/0006-291X(76)91153-0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; de Jong DH, 2013, FARADAY DISCUSS, V161, P347, DOI 10.1039/c2fd20086d; de Planque MRR, 1998, BIOCHEMISTRY-US, V37, P9333, DOI 10.1021/bi980233r; Domanski J, 2012, BBA-BIOMEMBRANES, V1818, P984, DOI 10.1016/j.bbamem.2011.08.021; Duque D, 2002, J CHEM PHYS, V116, P10478, DOI 10.1063/1.1477927; EDIDIN M, 1974, ANNU REV BIOPHYS BIO, V3, P179, DOI 10.1146/annurev.bb.03.060174.001143; Efremov RG, 2006, J COMPUT AID MOL DES, V20, P27, DOI 10.1007/s10822-006-9034-6; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FATTAL DR, 1993, BIOPHYS J, V65, P1795, DOI 10.1016/S0006-3495(93)81249-9; Flinner N, 2014, INT J MOL SCI, V15, P14247, DOI 10.3390/ijms150814247; GRANT CWM, 1974, P NATL ACAD SCI USA, V71, P4653, DOI 10.1073/pnas.71.12.4653; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; MCCAUGHAN L, 1980, SCIENCE, V207, P1481, DOI 10.1126/science.7361101; Mineev KS, 2011, ACTA NATURAE, V3, P90, DOI 10.32607/20758251-2011-3-2-90-98; MULLER P, 1993, BIOCHIM BIOPHYS ACTA, V1151, P7, DOI 10.1016/0005-2736(93)90064-7; ONG RL, 1984, J MEMBRANE BIOL, V78, P1, DOI 10.1007/BF01872526; ONG RL, 1982, BIOCHIM BIOPHYS ACTA, V692, P252, DOI 10.1016/0005-2736(82)90529-6; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pan JJ, 2012, J PHYS CHEM B, V116, P14829, DOI 10.1021/jp310345j; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Poole J, 2000, BLOOD REV, V14, P31, DOI 10.1054/blre.1999.0124; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; SHAN X, 1994, BBA-BIOMEMBRANES, V1193, P127, DOI 10.1016/0005-2736(94)90341-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smondyrev AM, 1999, BIOPHYS J, V77, P2075, DOI 10.1016/S0006-3495(99)77049-9; Sparr E, 2005, J BIOL CHEM, V280, P39324, DOI 10.1074/jbc.M502810200; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; TAMPE R, 1991, BIOCHEMISTRY-US, V30, P4909, DOI 10.1021/bi00234a011; TAMPE R, 1989, BIOCHIM BIOPHYS ACTA, V982, P41, DOI 10.1016/0005-2736(89)90171-5; TANNER MJA, 1993, BAILLIERE CLIN HAEM, V6, P333, DOI 10.1016/S0950-3536(05)80149-0; VANZOELEN EJJ, 1977, BIOCHIM BIOPHYS ACTA, V464, P482, DOI 10.1016/0005-2736(77)90024-4; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; ZACHOWSKI A, 1990, EXPERIENTIA, V46, P644, DOI 10.1007/BF01939703	54	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133999	10.1371/journal.pone.0133999	http://dx.doi.org/10.1371/journal.pone.0133999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222139	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800094
J	Franciscovich, A; Vaidya, D; Doyle, J; Bolinger, J; Capdevila, M; Rice, M; Hancock, L; Mahr, T; Mogul, DB				Franciscovich, Amy; Vaidya, Dhananjay; Doyle, Joe; Bolinger, Josh; Capdevila, Montserrat; Rice, Marcus; Hancock, Leslie; Mahr, Tanya; Mogul, Douglas B.			PoopMD, a Mobile Health Application, Accurately Identifies Infant Acholic Stools	PLOS ONE			English	Article							BILIARY ATRESIA; COLOR CARD	Biliary atresia (BA) is the leading cause of pediatric end-stage liver disease in the United States. Education of parents in the perinatal period with stool cards depicting acholic and normal stools has been associated with improved time-to-diagnosis and survival in BA. PoopMD is a mobile application that utilizes a smartphone's camera and color recognition software to analyze an infant's stool and determine if additional follow-up is indicated. PoopMD was developed using custom HTML5/CSS3 and wrapped to work on iOS and Android platforms. In order to define the gold standard regarding stool color, seven pediatricians were asked to review 45 photographs of infant stool and rate them as acholic, normal, or indeterminate. Samples for which 6+ pediatricians demonstrated agreement defined the gold standard, and only these samples were included in the analysis. Accuracy of PoopMD was assessed using an iPhone 5s with incandescent lighting. Variability in analysis of stool photographs as acholic versus normal with intermediate rating weighted as 50% agreement (kappa) was compared between three laypeople and one expert user. Variability in output was also assessed between an iPhone 5s and a Samsung Galaxy S4, as well as between incandescent lighting and compact fluorescent lighting. Six-plus pediatricians agreed on 27 normal and 7 acholic photographs; no photographs were defined as indeterminate. The sensitivity was 7/7 (100%). The specificity was 24/27 (89%) with 3/27 labeled as indeterminate; no photos of normal stool were labeled as acholic. The Laplace-smoothed positive likelihood ratio was 6.44 (95% CI 2.52 to 16.48) and the negative likelihood ratio was 0.13 (95% CI 0.02 to 0.83). kappa(user) was 0.68, kappa(phone) was 0.88, and kappa(light) was 0.81. Therefore, in this pilot study, PoopMD accurately differentiates acholic from normal color with substantial agreement across users, and almost perfect agreement across two popular smartphones and ambient light settings. PoopMD may be a valuable tool to help parents identify acholic stools in the perinatal period, and provide guidance as to whether additional evaluation with their pediatrician is indicated. PoopMD may improve outcomes for children with BA.	[Franciscovich, Amy; Mogul, Douglas B.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Vaidya, Dhananjay] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Doyle, Joe; Bolinger, Josh; Rice, Marcus; Hancock, Leslie; Mahr, Tanya] HCB Hlth, Austin, TX USA; [Capdevila, Montserrat] Johns Hopkins Univ, Off Technol Transfer, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mogul, DB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	dmogul1@jhmi.edu	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601	HCB Health	HCB Health	There were no grants or external funding for this study. HCB Health performed this work "pro bono." HCB Health provided support in the form of salaries for authors JD, JB, MR, LH, TM and had a role in the preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], SMARTPHONE OWNERSHIP; [Anonymous], 2015, INTEGRATED PUBLIC AL; Bakshi B, 2012, ARCH DIS CHILD-FETAL, V97, pF385, DOI 10.1136/fetalneonatal-2010-209700; Chen SM, 2006, PEDIATRICS, V117, P1147, DOI 10.1542/peds.2005-1267; de Vries W, 2012, J PEDIATR-US, V160, P638, DOI 10.1016/j.jpeds.2011.09.061; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fox S and Duggan M. Mobile health, 2012, MOBILE HEALTH 2012; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Hung PY, 2006, J PEDIATR GASTR NUTR, V42, P190, DOI 10.1097/01.mpg.0000189339.92891.64; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Mogul D, 2015, J PEDIATR GASTR NUTR, V60, P91, DOI 10.1097/MPG.0000000000000569; Pringle Beverly, 2012, NCHS Data Brief, P1; Schreiber RA, 2014, J MED SCREEN, V21, P126, DOI 10.1177/0969141314542115; Schwarz KB, 2013, HEPATOLOGY, V58, P1724, DOI 10.1002/hep.26512; Sokol RJ, 2003, J PEDIATR GASTR NUTR, V37, P4, DOI 10.1097/00005176-200307000-00003; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Tiao MM, 2008, J GASTROEN HEPATOL, V23, P62, DOI 10.1111/j.1440-1746.2007.05114.x; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376	19	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132270	10.1371/journal.pone.0132270	http://dx.doi.org/10.1371/journal.pone.0132270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221719	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800021
J	Hahn, P; Oezdemir, S; Komp, M; Giannakopoulos, A; Heikenfeld, R; Kasch, R; Merk, H; Godolias, G; Ruetten, S				Hahn, Patrick; Oezdemir, Semih; Komp, Martin; Giannakopoulos, Athanasios; Heikenfeld, Roderich; Kasch, Richard; Merk, Harry; Godolias, Georgios; Ruetten, Sebastian			A New Electromagnetic Navigation System for Pedicle Screws Placement: A Human Cadaver Study at the Lumbar Spine	PLOS ONE			English	Article							COMPLICATIONS	Introduction Technical developments for improving the safety and accuracy of pedicle screw placement play an increasingly important role in spine surgery. In addition to the standard techniques of free-hand placement and fluoroscopic navigation, the rate of complications is reduced by 3D fluoroscopy, cone-beam CT, intraoperative CT/MRI, and various other navigation techniques. Another important aspect that should be emphasized is the reduction of intraoperative radiation exposure for personnel and patient. The aim of this study was to investigate the accuracy of a new navigation system for the spine based on an electromagnetic field. Material and Method Twenty pedicle screws were placed in the lumbar spine of human cadavers using EMF navigation. Navigation was based on data from a preoperative thin-slice CT scan. The cadavers were positioned on a special field generator and the system was matched using a patient tracker on the spinous process. Navigation was conducted using especially developed instruments that can be tracked in the electromagnetic field. Another thin-slice CT scan was made postoperatively to assess the result. The evaluation included the position of the screws in the direction of trajectory and any injury to the surrounding cortical bone. The results were classified in 5 groups: grade 1: ideal screw position in the center of the pedicle with no cortical bone injury; grade 2: acceptable screw position, cortical bone injury with cortical penetration <= 2 mm; grade 3: cortical bone injury with cortical penetration 2,1-4 mm, grad 4: cortical bone injury with cortical penetration 4,1-6 mm, grade 5: cortical bone injury with cortical penetration > 6 mm. Results The initial evaluation of the system showed good accuracy for the lumbar spine (65% grade 1, 20% grade 2, 15% grade 3, 0% grade 4, 0% grade 5). A comparison of the initial results with other navigation techniques in literature (CT navigation, 2D fluoroscopic navigation) shows that the accuracy of this system is comparable. Conclusion EMF navigation offers a high accuracy in Pedicle screw placement with additional advantages compared to other techniques. The short set-up time and easy handling of EMF navigation should be emphasized. Additional advantages are the absence of intraoperative radiation exposure for the operator and surgical team in the current set-up and the operator's free mobility without interfering with navigation. Further studies with navigation at higher levels of the spine, larger numbers of cases and studies with control group are planned.	[Hahn, Patrick; Oezdemir, Semih; Komp, Martin; Giannakopoulos, Athanasios; Ruetten, Sebastian] Univ Hosp, Marien Hosp Witten,Ctr Spine Surg & Pain Theraphy, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr,St El, Herne, Germany; [Kasch, Richard; Merk, Harry] Univ Med Greifswald, Clin Orthopaed & Orthopaed Surg, Greifswald, Germany; [Heikenfeld, Roderich; Godolias, Georgios] Univ Hosp, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr, Marien Hosp,St Elisabeth Grp, Herne, Germany	Ruhr University Bochum; Saint Anna Hospital; St. Marien Hospital; Greifswald Medical School; Ruhr University Bochum; Saint Anna Hospital; St. Marien Hospital	Hahn, P (corresponding author), Univ Hosp, Marien Hosp Witten,Ctr Spine Surg & Pain Theraphy, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr,St El, Herne, Germany.	Patrick-hahn@gmx.de						Acosta Frank L Jr, 2005, Spine J, V5, P339, DOI 10.1016/j.spinee.2004.09.012; Amiot LP, 2000, SPINE, V25, P606, DOI 10.1097/00007632-200003010-00012; Ammirati M, 2013, NEUROSURG REV, V36, P157, DOI 10.1007/s10143-012-0421-2; Bandela JR, 2013, WORLD NEUROSURG, V79, P390, DOI 10.1016/j.wneu.2011.05.019; Barber JW, 1998, J SPINAL DISORD, V11, P215; Brown CA, 1998, SPINE, V23, P1566, DOI 10.1097/00007632-199807150-00012; Bruners P, 2009, EUR RADIOL, V19, P990, DOI 10.1007/s00330-008-1227-z; Costa F, 2011, SPINE, V36, P2094, DOI 10.1097/BRS.0b013e318201129d; Fu TS, 2008, INT ORTHOP, V32, P517, DOI 10.1007/s00264-007-0358-1; Gebhard F, 2000, UNFALLCHIRURG, V103, P696, DOI 10.1007/s001130050605; Gebhard F, 2003, UNFALLCHIRURG, V106, P492, DOI 10.1007/s00113-003-0606-9; Gebhard FT, 2006, SPINE, V31, P2024, DOI 10.1097/01.brs.0000229250.69369.ac; Geerling J, 2008, COMPUT AIDED SURG, V13, P157, DOI 10.3109/10929080802102110; Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3; Hamill CL, 1996, SPINE, V21, P1241, DOI 10.1097/00007632-199605150-00020; HARRINGTON PR, 1969, SOUTH MED J, V62, P1, DOI 10.1097/00007611-196901000-00001; Hayhurst C, 2009, J NEUROSURG, V111, P1179, DOI 10.3171/2008.12.JNS08628; Hojo Y, 2014, EUR SPINE J, V22; Holly LT, 2007, ORTHOP CLIN N AM, V38, P451, DOI 10.1016/j.ocl.2007.04.001; Komp M, 2014, SURG INNOV, V21, P605, DOI 10.1177/1553350614525668; Komp M, 2011, J SPINAL DISORD TECH, V24, P281, DOI 10.1097/BSD.0b013e3181f9f55e; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; Kraus MD, 2012, ARCH ORTHOP TRAUM SU, V132, P741, DOI 10.1007/s00402-012-1471-1; Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003; Mezger U, 2013, LANGENBECK ARCH SURG, V398, P501, DOI 10.1007/s00423-013-1059-4; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Ringel Florian, 2014, Adv Tech Stand Neurosurg, V41, P3, DOI 10.1007/978-3-319-01830-0_1; Roser F, 1227, NEUROSURGERY, V1, P12; Sagi HC, 2003, SPINE, V28, P2013, DOI 10.1097/01.BRS.0000087851.51547.00; Sagi HC, 2003, SPINE, V28, pE351, DOI 10.1097/01.BRS.0000086822.76638.76; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Schnake KJ, 2004, UNFALLCHIRURG, V107, P104, DOI 10.1007/s00113-003-0720-8; Tabaraee E, 2013, SPINE, V38, P1953, DOI 10.1097/BRS.0b013e3182a51d1e; Tang J, J BIOMED RES, V28, P228; Tian NF, 2009, INT ORTHOP, V33, P895, DOI 10.1007/s00264-009-0792-3	35	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133708	10.1371/journal.pone.0133708	http://dx.doi.org/10.1371/journal.pone.0133708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221733	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800061
J	Vergara, M; Basto, MP; Madeira, MJ; Gomez-Moliner, BJ; Santos-Reis, M; Fernandes, C; Ruiz-Gonzalez, A				Vergara, Maria; Basto, Mafalda P.; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Santos-Reis, Margarida; Fernandes, Carlos; Ruiz-Gonzalez, Aritz			Inferring Population Genetic Structure in Widely and Continuously Distributed Carnivores: The Stone Marten (Martes foina) as a Case Study	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MINK MUSTELA-VISON; MICROSATELLITE LOCI; COMPUTER-PROGRAM; SOFTWARE; BARRIERS; INFERENCE; MARKERS; FLOW; DIFFERENTIATION	The stone marten is a widely distributed mustelid in the Palaearctic region that exhibits variable habitat preferences in different parts of its range. The species is a Holocene immigrant from southwest Asia which, according to fossil remains, followed the expansion of the Neolithic farming cultures into Europe and possibly colonized the Iberian Peninsula during the Early Neolithic (ca. 7,000 years BP). However, the population genetic structure and historical biogeography of this generalist carnivore remains essentially unknown. In this study we have combined mitochondrial DNA (mtDNA) sequencing (621 bp) and microsatellite genotyping (23 polymorphic markers) to infer the population genetic structure of the stone marten within the Iberian Peninsula. The mtDNA data revealed low haplotype and nucleotide diversities and a lack of phylogeographic structure, most likely due to a recent colonization of the Iberian Peninsula by a few mtDNA lineages during the Early Neolithic. The microsatellite data set was analysed with a) spatial and non-spatial Bayesian individual-based clustering (IBC) approaches (STRUCTURE, TESS, BAPS and GENELAND), and b) multivariate methods [discriminant analysis of principal components (DAPC) and spatial principal component analysis (sPCA)]. Additionally, because isolation by distance (IBD) is a common spatial genetic pattern in mobile and continuously distributed species and it may represent a challenge to the performance of the above methods, the microsatellite data set was tested for its presence. Overall, the genetic structure of the stone marten in the Iberian Peninsula was characterized by a NE-SW spatial pattern of IBD, and this may explain the observed disagreement between clustering solutions obtained by the different IBC methods. However, there was significant indication for contemporary genetic structuring, albeit weak, into at least three different subpopulations. The detected subdivision could be attributed to the influence of the rivers Ebro, Tagus and Guadiana, suggesting that main watercourses in the Iberian Peninsula may act as semi-permeable barriers to gene flow in stone martens. To our knowledge, this is the first phylogeographic and population genetic study of the species at a broad regional scale. We also wanted to make the case for the importance and benefits of using and comparing multiple different clustering and multivariate methods in spatial genetic analyses of mobile and continuously distributed species.	[Vergara, Maria; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Zool Lab, Dept Zool & Anim Cell Biol, Vitoria, Spain; [Vergara, Maria; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Lascaray Res Ctr, Systemat Biogeog & Populat Dynam Res Grp, Vitoria, Spain; [Basto, Mafalda P.; Santos-Reis, Margarida; Fernandes, Carlos] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Lisbon, Portugal	University of Basque Country; University of Basque Country; Universidade de Lisboa	Vergara, M (corresponding author), Univ Basque Country UPV EHU, Zool Lab, Dept Zool & Anim Cell Biol, Vitoria, Spain.	maria.vergara@ehu.es	Fernandes, Carlos/AAB-5256-2019; Gomez, Benjamin/AAA-4119-2019; MADEIRA, MARÍA JOSÉ/L-7556-2014; Fernandes, Carlos/J-3045-2013; Ruiz-Gonzalez, Aritz/A-1613-2013; GONZALEZ, ARITZ RUIZ/P-3384-2019; Santos-Reis, Margarida/H-4064-2011	Fernandes, Carlos/0000-0002-1386-8103; MADEIRA, MARÍA JOSÉ/0000-0002-7357-7228; Fernandes, Carlos/0000-0002-1386-8103; GONZALEZ, ARITZ RUIZ/0000-0001-7409-4634; Santos-Reis, Margarida/0000-0002-0337-963X; GOMEZ MOLINER, BENJAMIN JUAN/0000-0002-3054-8806	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' [IT317-10, GIC10/76, IT575-13]; Dept. of Education, Universities and Research of the Basque Government [RBFI-2012-446, DKR-2012-64]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/38410/2007];  [C2007-UL-342-CBA1];  [PTDC/BIA-BEC/101511/2008]	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics''; Dept. of Education, Universities and Research of the Basque Government; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This study has been partially funded by the Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' (Ref. IT317-10; GIC10/76; IT575-13). MV (Ref: RBFI-2012-446) and ARG (Ref: DKR-2012-64) were supported by a PhD and post-doctoral fellowships awarded by the Dept. of Education, Universities and Research of the Basque Government. MPB and CF acknowledge financial support from Fundacao para a Ciencia e Tecnologia through the PhD fellowship SFRH/BD/38410/2007, the Ciencia 2007 contract C2007-UL-342-CBA1, and the research project PTDC/BIA-BEC/101511/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E., 1970, Acta Zoologica Fennica, VNo.130,1970, P1; Aurelle D, 2013, CONSERV GENET, V14, P705, DOI 10.1007/s10592-013-0464-0; Balestrieri A, 2008, HYSTRIX, V19, P77; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basto MP, 2010, CONSERV GENET RESOUR, V2, P317, DOI 10.1007/s12686-010-9217-2; Basto MP, 2014, THESIS U LISBON PORT; Belkhir K, 2000, GENETIX V 4 02 LOGIC; Bijlsma R, 2000, MOL ECOL, V9, P2216; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Cabria MT, 2007, MOL ECOL NOTES, V7, P1185, DOI 10.1111/j.1471-8286.2007.01825.x; Cercueil A, 2007, THEOR POPUL BIOL, V71, P332, DOI 10.1016/j.tpb.2007.01.007; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Dallas JF, 1998, MOL ECOL, V7, P1248; Dallas JF, 2003, MOL ECOL, V12, P275, DOI 10.1046/j.1365-294X.2003.01712.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Delibes M., 1983, Acta Zoologica Fennica, P229; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Fu YX, 1997, GENETICS, V147, P915; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hapeman P, 2011, J HERED, V102, P251, DOI 10.1093/jhered/esr001; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartmann SA, 2013, CONSERV GENET, V14, P413, DOI 10.1007/s10592-013-0468-9; Herr J, 2008, THESIS U SUSSEX ENGL, P226; Hobbs GI, 2011, J APPL ECOL, V48, P1206, DOI 10.1111/j.1365-2664.2011.02028.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jordan MJ, 2007, MOL ECOL NOTES, V7, P797, DOI 10.1111/j.1471-8286.2007.01708.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Kyle CJ, 2003, CONSERV GENET, V4, P179, DOI 10.1023/A:1023334521996; Landguth EL, 2012, MOL ECOL RESOUR, V12, P363, DOI 10.1111/j.1755-0998.2011.03075.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2014, CONSERV GENET, V15, P981, DOI 10.1007/s10592-014-0593-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latch EK, 2014, MOL ECOL, V23, P3171, DOI 10.1111/mec.12803; Li B, 2014, MOL PHYLOGENET EVOL, V80, P156, DOI 10.1016/j.ympev.2014.08.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llorente L, 2011, ACT 31 RENC INT ARCH, P189; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mucci N, 2010, CONSERV GENET, V11, P583, DOI 10.1007/s10592-010-0054-3; Nagai T, 2012, MAMM STUDY, V37, P353, DOI 10.3106/041.037.0410; Nei M., 1987, MOL EVOLUTIONARY GEN; OConnell M, 1996, MOL ECOL, V5, P311, DOI 10.1111/j.1365-294X.1996.tb00320.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Reig S, 2002, ATLAS MAMIFEROS TERR, P270; Reig S, 2007, ATLAS LIBRO ROJO MAM, P305; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruiz-Gonzalez A, 2013, BIOL J LINN SOC, V109, P1, DOI 10.1111/bij.12046; Rutledge LY, 2010, HEREDITY, V105, P520, DOI 10.1038/hdy.2010.6; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; Schwartz M, 2012, BIOL CONSERVATION MA; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Sommer R, 2004, MAMMAL REV, V34, P249, DOI 10.1111/j.1365-2907.2004.00043.x; TAJIMA F, 1989, GENETICS, V123, P585; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tikhonov A, 2008, IUCN RED LIST THREAT; Tucker JM, 2014, CONSERV GENET, V15, P123, DOI 10.1007/s10592-013-0525-4; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Virgos E, 2012, BIOL CONSERVATION MA, P255; Virgos E, 2010, ANIM BIOL, V60, P423, DOI 10.1163/157075610X523297; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1946, GENETICS, V31, P39	103	27	27	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134257	10.1371/journal.pone.0134257	http://dx.doi.org/10.1371/journal.pone.0134257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222680	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800118
J	Zhang, G; He, LS; Wong, YH; Xu, Y; Zhang, Y; Qian, PY				Zhang, Gen; He, Li-sheng; Wong, Yue-Him; Xu, Ying; Zhang, Yu; Qian, Pei-yuan			Chemical Component and Proteomic Study of the Amphibalanus (= Balanus) amphitrite Shell	PLOS ONE			English	Article							PROTEIN COMPLEX SIPC; C-TYPE-LECTIN; WHEY ACIDIC PROTEIN; BARNACLE CEMENT; ACORN BARNACLE; CARBONIC-ANHYDRASE; MATRIX PROTEIN; PURIFICATION; INVOLVEMENT; CLONING	As typical biofoulers, barnacles possess hard shells and cause serious biofouling problems. In this study, we analyzed the protein component of the barnacle Amphibalanus (= Balanus) amphitrite shell using gel-based proteomics. The results revealed 52 proteins in the A. Amphitrite shell. Among them, 40 proteins were categorized into 11 functional groups based on KOG database, and the remaining 12 proteins were unknown. Besides the known proteins in barnacle shell (SIPC, carbonic anhydrase and acidic acid matrix protein), we also identified chorion peroxidase, C-type lectin-like domains, serine proteases and proteinase inhibitor proteins in the A. Amphitrite shell. The sequences of these proteins were characterized and their potential functions were discussed. Histology and DAPI staining revealed living cells in the shell, which might secrete the shell proteins identified in this study.	[Zhang, Gen; Wong, Yue-Him; Qian, Pei-yuan] Hong Kong Univ Sci & Technol, Sch Sci, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China; [Zhang, Gen; Wong, Yue-Him; Qian, Pei-yuan] Hong Kong Univ Sci & Technol, Sch Sci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [He, Li-sheng] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya City 572000, Hainan Province, Peoples R China; [Xu, Ying; Zhang, Yu] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen 518060, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Shenzhen University	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Sch Sci, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Xu, Ying/E-2072-2018; Zhang, Yu/K-4912-2012; Zhang/L-6428-2017	Xu, Ying/0000-0003-4658-3283; Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [GRF661611, GRF662413]; National Natural Science Foundation of China [31460092]	China Ocean Mineral Resources Research and Development Association; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (DY125-15-T-02) from the China Ocean Mineral Resources Research and Development Association, an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) and grants (GRF661611, GRF662413) from the Research Grants Council of the Hong Kong Special Administrative Region to PYQ as well as a grant from the National Natural Science Foundation of China (31460092) to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018; BOURGET E, 1974, MAR BIOL, V28, P27; Chen ZF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094493, 10.1371/journal.pone.0088744]; CRISP DJ, 1985, ADV MAR BIOL, V22, P199, DOI 10.1016/S0065-2881(08)60052-8; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; Fernandez MS, 2002, MATER RES SOC SYMP P, V724, P3; FUKUZAWA H, 1990, P NATL ACAD SCI USA, V87, P4383, DOI 10.1073/pnas.87.11.4383; Glazer L, 2012, INVERTEBR REPROD DEV, V56, P57, DOI 10.1080/07924259.2011.588010; Gohad NV, 2009, J EXP MAR BIOL ECOL, V380, P88, DOI 10.1016/j.jembe.2009.09.008; GORDON CM, 1970, LIMNOL OCEANOGR, V15, P461, DOI 10.4319/lo.1970.15.3.0461; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Han Q, 2000, ARCH BIOCHEM BIOPHYS, V378, P107, DOI 10.1006/abbi.2000.1821; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033; Kamiya H, 2002, MAR BIOL, V140, P1235, DOI 10.1007/s00227-002-0789-6; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khalifa GM, 2011, CRYST GROWTH DES, V11, P5122, DOI 10.1021/cg2010216; Khandeparker L, 2011, J ZOOL, V284, P206, DOI 10.1111/j.1469-7998.2011.00794.x; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Li M, 2014, DEV COMP IMMUNOL, V46, P231, DOI 10.1016/j.dci.2014.04.014; Liu XF, 2014, J PROTEOME RES, V13, P1223, DOI 10.1021/pr400669d; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marie B, 2011, MAR BIOTECHNOL, V13, P955, DOI 10.1007/s10126-010-9357-0; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Matsubara H, 2008, FISHERIES SCI, V74, P418, DOI 10.1111/j.1444-2906.2008.01539.x; Matsumura K, 1998, P ROY SOC B-BIOL SCI, V265, P1825, DOI 10.1098/rspb.1998.0508; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; Robinson CM, 2013, MBIO, V4, DOI 10.1128/mBio.00595-12; Rodde RH, 2008, CARBOHYD POLYM, V71, P388, DOI 10.1016/j.carbpol.2007.06.006; Shafer TH, 2006, INTEGR COMP BIOL, V46, P978, DOI 10.1093/icb/icl022; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; Wade N, 2005, COMP BIOCHEM PHYS B, V141, P307, DOI 10.1016/j.cbpc.2005.04.004; Wu CL, 2013, IMMUNOBIOLOGY, V218, P159, DOI 10.1016/j.imbio.2012.02.011; Yoon GL, 2003, WASTE MANAGE, V23, P825, DOI 10.1016/S0956-053X(02)00159-9; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384	53	14	14	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133866	10.1371/journal.pone.0133866	http://dx.doi.org/10.1371/journal.pone.0133866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222041	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800073
J	Allegue, C; Coll, M; Mates, J; Campuzano, O; Iglesias, A; Sobrino, B; Brion, M; Amigo, J; Carracedo, A; Brugada, P; Brugada, J; Brugada, R				Allegue, Catarina; Coll, Monica; Mates, Jesus; Campuzano, Oscar; Iglesias, Anna; Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel; Brugada, Pedro; Brugada, Josep; Brugada, Ramon			Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; SUDDEN CARDIAC DEATH; LONG-QT SYNDROME; COMMON POLYMORPHISM; ANKYRIN-G; MUTATIONS; COMPOUND; PHENOTYPE; NA(V)1.5; NOISE	Background The use of next-generation sequencing enables a rapid analysis of many genes associated with sudden cardiac death in diseases like Brugada Syndrome. Genetic variation is identified and associated with 30-35% of cases of Brugada Syndrome, with nearly 20-25% attributable to variants in SCN5A, meaning many cases remain undiagnosed genetically. To evaluate the role of genetic variants in arrhythmogenic diseases and the utility of next-generation sequencing, we applied this technology to resequence 28 main genes associated with arrhythmogenic disorders. Materials and Methods A cohort of 45 clinically diagnosed Brugada Syndrome patients classified as SCN5A-negative was analyzed using next generation sequencing. Twenty-eight genes were resequenced: AKAP9, ANK2, CACNA1C, CACNB2, CASQ2, CAV3, DSC2, DSG2, DSP, GPD1L, HCN4, JUP, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, NOS1AP, PKP2, RYR2, SCN1B, SCN3B, SCN4B, SCN5A, SNTA1, and TMEM43. A total of 85 clinically evaluated relatives were also genetically analyzed to ascertain familial segregation. Results and Discussion Twenty-two patients carried 30 rare genetic variants in 12 genes, only 4 of which were previously associated with Brugada Syndrome. Neither insertion/deletion nor copy number variation were detected. We identified genetic variants in novel candidate genes potentially associated to Brugada Syndrome. These include: 4 genetic variations in AKAP9 including a de novo genetic variation in 3 positive cases; 5 genetic variations in ANK2 detected in 4 cases; variations in KCNJ2 together with CASQ2 in 1 case; genetic variations in RYR2, including a de novo genetic variation and desmosomal proteins encoding genes including DSG2, DSP and JUP, detected in 3 of the cases. Larger gene panels or whole exome sequencing should be considered to identify novel genes associated to Brugada Syndrome. However, application of approaches such as whole exome sequencing would difficult the interpretation for clinical purposes due to the large amount of data generated. The identification of these genetic variants opens new perspectives on the implications of genetic background in the arrhythmogenic substrate for research purposes. Conclusions As a paradigm for other arrhythmogenic diseases and for unexplained sudden death, our data show that clinical genetic diagnosis is justified in a family perspective for confirmation of genetic causality. In the era of personalized medicine using high-throughput tools, clinical decision-making is increasingly complex.	[Allegue, Catarina; Coll, Monica; Mates, Jesus; Campuzano, Oscar; Iglesias, Anna; Brugada, Ramon] IdIBGi Univ Girona, Cardiovasc Genet Ctr, Girona, Spain; [Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel] Grp Med Xenom, Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel] SERGAS, Fundac Publ Galega Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Brugada, Pedro] UZ Brussel VUB, Heart Rhythm Management Ctr, Brussels, Belgium; [Brugada, Josep] Univ Barcelona, Hosp Clin, Cardiol Unit, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universidade de Santiago de Compostela; King Abdulaziz University; Vrije Universiteit Brussel; University of Barcelona; Hospital Clinic de Barcelona	Brugada, R (corresponding author), IdIBGi Univ Girona, Cardiovasc Genet Ctr, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Amigo Lechuga, Jorge/A-4892-2010; Brion, Maria/J-8059-2014; Rey, Beatriz Sobrino/ABB-8518-2020; Carracedo, Angel/D-4257-2012	campuzano, oscar/0000-0001-5298-5276; Amigo Lechuga, Jorge/0000-0002-1362-2605; Brion, Maria/0000-0001-7463-2148; Carracedo, Angel/0000-0003-1085-8986; Sobrino Rey, Beatriz/0000-0002-6605-9377; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159	Instituto de Salud Carlos III [FIS-PI11/01826]; Fundacio La Caixa; Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacio La Caixa(La Caixa FoundationEuropean Commission); Centro Nacional de Investigaciones Cardiovasculares	This work was supported by CA: Instituto de Salud Carlos III (FIS-PI11/01826); RB: Fundacio La Caixa; and RB: Centro Nacional de Investigaciones Cardiovasculares (CNIC-03-2008).	Agullo-Pascual E, 2014, FEBS LETT, V588, P1322, DOI 10.1016/j.febslet.2014.02.008; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Brugada R., 1993, GENEREVIEWS; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Campuzano O, 2015, SCI REPORTS IN PRESS, DOI 10.1038; Campuzano O, 2014, INT J LEGAL MED, V128, P599, DOI 10.1007/s00414-014-0966-4; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Cordeiro JM, 2006, CIRCULATION, V114, P2026, DOI 10.1161/CIRCULATIONAHA.106.627489; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Giudicessi JR, 2013, CURR OPIN CARDIOL, V28, P63, DOI 10.1097/HCO.0b013e32835b0a41; Gollob MH, 2011, CAN J CARDIOL, V27, P232, DOI 10.1016/j.cjca.2010.12.078; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hwang HW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027995; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Kauferstein S, 2011, INT J CARDIOL, V146, P249, DOI 10.1016/j.ijcard.2010.10.062; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kharche S, 2008, PROG BIOPHYS MOL BIO, V98, P186, DOI 10.1016/j.pbiomolbio.2008.10.010; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Ohno S, 2013, CIRC J, V77, P1534, DOI 10.1253/circj.CJ-12-1446; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; The 1000 Genomes Project Consortium, 2010, NATURE, V467, P1061, DOI [10.1038/nature09534, DOI 10.1038/NATURE09534]; Vernooy K, 2006, HEART RHYTHM, V3, P131, DOI 10.1016/j.hrthm.2005.11.005; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020	33	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133037	10.1371/journal.pone.0133037	http://dx.doi.org/10.1371/journal.pone.0133037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230511	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400025
J	Chen, WC; Tseng, CK; Chen, YH; Lin, CK; Hsu, S; Wang, SN; Lee, JC				Chen, Wei-Chun; Tseng, Chin-Kai; Chen, Yen-Hsu; Lin, Chun-Kuang; Hsu, Shihhsien; Wang, Shen-Nien; Lee, Jin-Ching			HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; GENE-EXPRESSION; PROSTAGLANDIN E-2; RNA REPLICATION; VIRAL-INFECTION; LIVER-CANCER; INTERLEUKIN-8; CYCLOOXYGENASE-2	Chronic hepatitis C virus (HCV) infection leads to intrahepatic inflammation and liver cell injury, which are considered a risk factor for virus-associated hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. Inflammatory cytokines are critical components of the immune system and influence cellular signaling, and genetic imbalances. In this study, we found that cyclooxygenase-2 (COX-2) and interleukin-8 (IL-8) were significantly induced by HCV infection and HCV NS5A expression, and induction of COX-2 correlated with HCV-induced IL-8 production. We also found that the ERK and JNK signaling pathways were involved in the regulation of IL-8-mediated COX-2 induction in response to HCV infection. Using a promoter-linked reporter assay, we identified that the C/EBP regulatory element within the COX-2 promoter was the dominant factor responsible for the induction of COX-2 by HCV. Silencing C/EBP attenuated HCV-induced COX-2 expression. Our results revealed that HCV-induced inflammation promotes viral replication, providing new insights into the involvement of IL-8-mediated COX-2 induction in HCV replication.	[Chen, Wei-Chun; Hsu, Shihhsien] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Sepsis Res Ctr, Sch Med,Grad Inst Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Wang, Shen-Nien] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan; [Wang, Shen-Nien] Kaohsiung Med Univ Hosp, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lee, JC (corresponding author), Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan.	jclee@kmu.edu.tw		Lee, Jin-Ching/0000-0003-0729-9589; Chen, Yen-hsu/0000-0002-8667-4844	Ministry of Science and Techonology of Taiwan [MOST 103-2622-B-037-007-CC3, MOST 103-2314-B-037 -039 -MY3, NSC 101-2311-B-037-002-MY3, NSC 100-2314-B-037 -001 -MY3]; Kaohsiung Medical University [KMU-TP103H12]	Ministry of Science and Techonology of Taiwan; Kaohsiung Medical University	This work was funded by grants from Ministry of Science and Techonology of Taiwan (http://www.most.gov.tw/mp.aspx) (MOST 103-2622-B-037-007-CC3, MOST 103-2314-B-037 -039 -MY3, NSC 101-2311-B-037-002-MY3, and NSC 100-2314-B-037 -001 -MY3) and Kaohsiung Medical University (http://www2.kmu.edu.tw/index.phtml) (KMU-TP103H12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Aghemo A, 2013, SEMIN IMMUNOPATHOL, V35, P111, DOI 10.1007/s00281-012-0330-z; Akiba J, 2001, INT J ONCOL, V18, P257; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; Buck M, 2007, J CLIN GASTROENTEROL, V41, pS295, DOI 10.1097/MCG.0b013e31814927d5; Dessouki O, 2010, BIOCHEM BIOPH RES CO, V393, P331, DOI 10.1016/j.bbrc.2010.02.008; Emmanouil Kochlios PFaPM, 2012, JOURNAL OF MOLECULAR, V1, P40; Gales Dominique, 2013, ISRN Oncol, V2013, P859154, DOI 10.1155/2013/859154; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hashem Ahmed Murad, 2010, INTERNATIONAL JOURNA, V1, P9; Jahan S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-155; Kato Takanobu, 2005, Uirusu, V55, P287, DOI 10.2222/jsv.55.287; Kumar KJS, 2009, PLANTA MED, V75, P494, DOI 10.1055/s-0029-1185309; Lee CM, 2011, ANTIVIR THER, V16, P825, DOI 10.3851/IMP1868; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lu LL, 2008, VIROLOGY, V371, P61, DOI 10.1016/j.virol.2007.09.025; Lu XL, 2012, MOL MED REP, V5, P637, DOI 10.3892/mmr.2011.702; Markaverich BM, 2007, ENVIRON HEALTH PERSP, V115, P1727, DOI 10.1289/ehp.10659; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Mukaida N, 2000, INT J HEMATOL, V72, P391; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Pollicino T, 2013, VIROLOGY, V444, P317, DOI 10.1016/j.virol.2013.06.028; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Qadri I, 2012, J BIOL CHEM, V287, P37340, DOI 10.1074/jbc.M112.384743; Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sertic J, 2007, CLIN CHEM LAB MED, V45, P1347, DOI 10.1515/CCLM.2007.321; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tveteraas IH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-72; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005; Wu XZ, 2008, NEOPLASMA, V55, P472; Xi Liang Y-NH, 2010, SIGNIFICANCE OF COX, V18, P3040; Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	48	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133264	10.1371/journal.pone.0133264	http://dx.doi.org/10.1371/journal.pone.0133264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231035	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400031
J	Zhang, SM; Jejcic, A; Tam, JP; Vahlne, A				Zhang, Si Min; Jejcic, Alenka; Tam, James P.; Vahlne, Anders			Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; SECONDARY STRUCTURE ANALYSES; NEUTRALIZING ANTIBODIES; ATOMIC-STRUCTURE; MEDIATED FUSION; LIPID RAFTS; DOMAIN; ENTRY; GAG	The membrane proximal external region (MPER) is a highly conserved membrane-active region located at the juxtamembrane positions within class I viral fusion glycoproteins and essential for membrane fusion events during viral entry. The MPER in the human immunodeficiency virus type I (HIV-1) envelope protein (Env) interacts with the lipid bilayers through a cluster of tryptophan (Trp) residues and a C-terminal cholesterol-interacting motif. The inclusion of the MPER N-terminal sequence contributes to the membrane reactivity and anti-viral efficacy of the first two anti-HIV peptidyl fusion inhibitors T20 and T1249. As a type I transmembrane protein, Env also interacts with the cellular membranes during its biosynthesis and trafficking. Here we investigated the roles of MPER membrane-active sequences during both viral entry and assembly, specifically, their roles in the design of peptidyl fusion inhibitors and the biosynthesis of viral structural proteins. We found that elimination of the membrane-active elements in MPER peptides, namely, penta Trp -> alanine (Ala) substitutions and the disruption of the C-terminal cholesterol-interacting motif through deletion inhibited the anti-viral effect against the pseudotyped HIV-1. Furthermore, as compared to C-terminal dimerization, N-terminal dimerization of MPER peptides and N-terminal extension with five helix-forming residues enhanced their anti-viral efficacy substantially. The secondary structure study revealed that the penta-Trp -> Ala substitutions also increased the helical content in the MPER sequence, which prompted us to study the biological relevance of such mutations in pre-fusion Env. We observed that Ala mutations of Trp664, Trp668 and Trp670 in MPER moderately lowered the intracellular and intraviral contents of Env while significantly elevating the content of another viral structural protein, p55/Gag and its derivative p24/capsid. The data suggest a role of the gp41 MPER in the membrane-reactive events during both viral entry and budding, and provide insights into the future development of anti-viral therapeutics.	[Zhang, Si Min; Vahlne, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, SE-14186 Stockholm, Sweden; [Zhang, Si Min; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Jejcic, Alenka] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; KU Leuven	Vahlne, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, SE-14186 Stockholm, Sweden.	anders.vahlne@ki.se	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Zhang, Si Min/0000-0001-7763-603X	National Research Foundation in Singapore [NRF-CRP8-2011-05]	National Research Foundation in Singapore(National Research Foundation, Singapore)	This work was supported by the Competitive Research Grant by the National Research Foundation in Singapore (NRF-CRP8-2011-05), available at http://www.nrf.gov.sg/about-nrf/programmes/competitive-research-programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Borrego P, 2013, AIDS, V27, P1081, DOI 10.1097/QAD.0b013e32835edc1d; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Celigoy J, 2011, PROTEIN SCI, V20, P2125, DOI 10.1002/pro.736; Chan WE, 2006, VIROLOGY, V348, P418, DOI 10.1016/j.virol.2006.01.010; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Devito C, 2000, J IMMUNOL METHODS, V238, P69, DOI 10.1016/S0022-1759(00)00141-1; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jejcic A, 2009, J VIROL, V83, P10075, DOI 10.1128/JVI.01700-08; Gomara MJ, 2014, CURR MED CHEM, V21, P1188, DOI 10.2174/15672050113109990204; KLATZMANN D, 1986, CR ACAD SCI III-VIE, V303, P343; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; Liao Y, 2015, BIOCHEMISTRY-US, V54, P1819, DOI 10.1021/bi501352u; Ling YB, 2013, BIOORG MED CHEM LETT, V23, P4770, DOI 10.1016/j.bmcl.2013.07.012; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lopez CS, 2014, VIROLOGY, V462, P126, DOI 10.1016/j.virol.2014.05.019; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Noah E, 2008, BIOCHEMISTRY-US, V47, P6782, DOI 10.1021/bi7023139; Nomura W, 2013, BIOORGAN MED CHEM, V21, P4452, DOI 10.1016/j.bmc.2013.05.060; Nomura W, 2012, CHEMMEDCHEM, V7, P205, DOI 10.1002/cmdc.201100542; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; Shnaper S, 2004, J BIOL CHEM, V279, P18526, DOI 10.1074/jbc.M304950200; Song HC, 2004, J VIROL, V78, P10328, DOI 10.1128/JVI.78.19.10328-10335.2004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tam JP, 2002, ORG LETT, V4, P4167, DOI 10.1021/ol026932k; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Walmsley S, 2003, J INFECT DIS, V188, P1827, DOI 10.1086/379810; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xiao JP, 2013, BIOORG MED CHEM LETT, V23, P6046, DOI 10.1016/j.bmcl.2013.09.034; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhang LS, 2013, J PEPT SCI, V19, P491, DOI 10.1002/psc.2526; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	81	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134851	10.1371/journal.pone.0134851	http://dx.doi.org/10.1371/journal.pone.0134851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230322	gold, Green Published, Green Accepted			2022-12-26	WOS:000358838400177
J	Aouida, M; Eid, A; Ali, Z; Cradick, T; Lee, C; Deshmukh, H; Atef, A; AbuSamra, D; Gadhoum, SZ; Merzaban, J; Bao, G; Mahfouz, M				Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Atef, Ahmed; AbuSamra, Dina; Gadhoum, Samah Zeineb; Merzaban, Jasmeen; Bao, Gang; Mahfouz, Magdy			Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering	PLOS ONE			English	Article							NUCLEASE-INDUCED MUTATIONS; DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; OFF-TARGET ACTIVITY; CRISPR-CAS SYSTEMS; TAL EFFECTORS; SACCHAROMYCES-CEREVISIAE; SURROGATE REPORTERS; GENE MODIFICATION; HUMAN-CELLS	The Cas9 endonuclease is used for genome editing applications in diverse eukaryotic species. A high frequency of off-target activity has been reported in many cell types, limiting its applications to genome engineering, especially in genomic medicine. Here, we generated a synthetic chimeric protein between the catalytic domain of the FokI endonuclease and the catalytically inactive Cas9 protein (fdCas9). A pair of guide RNAs (gRNAs) that bind to sense and antisense strands with a defined spacer sequence range can be used to form a catalytically active dimeric fdCas9 protein and generate double-strand breaks (DSBs) within the spacer sequence. Our data demonstrate an improved catalytic activity of the fdCas9 endonuclease, with a spacer range of 15-39 nucleotides, on surrogate reporters and genomic targets. Furthermore, we observed no detectable fdCas9 activity at known Cas9 off-target sites. Taken together, our data suggest that the fdCas9 endonuclease variant is a superior platform for genome editing applications in eukaryotic systems including mammalian cells.	[Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia; [Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia; [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Emory Univ, Atlanta, GA 30332 USA; [AbuSamra, Dina; Gadhoum, Samah Zeineb; Merzaban, Jasmeen] King Abdullah Univ Sci & Technol, Lab Cell Signaling & Migrat, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; University System of Georgia; Georgia Institute of Technology; Emory University; King Abdullah University of Science & Technology	Mahfouz, M (corresponding author), 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia.	Magdy.mahfouz@kaust.edu.sa	MAHFOUZ, MAGDY/O-1550-2016; Deshmukh, Harshavardhan/AAD-3213-2022; Lee, Ciaran Michael/AAV-4690-2020; atef, ahmed/B-7842-2013; Eid, Ayman Yehia/K-8509-2019; Merzaban, Jasmeen/V-3147-2018; Aouida, Mustapha/AEJ-4513-2022; Cradick, Thomas/ABC-3775-2021	Lee, Ciaran Michael/0000-0002-0789-9149; Eid, Ayman Yehia/0000-0002-9120-9680; Merzaban, Jasmeen/0000-0002-7276-2907; Aouida, Mustapha/0000-0001-7945-5320; Cradick, Thomas/0000-0002-8489-8318; Mahfouz, Magdy M/0000-0002-0616-6365; Ali, Zahir/0000-0002-7814-8908; Atef, Ahmed/0000-0001-7530-2060	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	King Abdullah University of Science and Technology funded this study.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Aouida M, 2015, J BIOSCI BIOENG, V120, P364, DOI 10.1016/j.jbiosc.2015.02.017; Aouida M, 2014, CURR GENET, V60, P61, DOI 10.1007/s00294-013-0412-z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099314; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li LX, 2013, MOL PLANT, V6, P1318, DOI 10.1093/mp/sst006; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Mahfouz Magdy M, 2011, GM Crops, V2, P99, DOI 10.4161/gmcr.2.2.17254; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	50	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133373	10.1371/journal.pone.0133373	http://dx.doi.org/10.1371/journal.pone.0133373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225561	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700019
J	Atray, I; Bentur, JS; Nair, S				Atray, Isha; Bentur, Jagadish Sanmallappa; Nair, Suresh			The Asian Rice Gall Midge (Orseolia oryzae) Mitogenome Has Evolved Novel Gene Boundaries and Tandem Repeats That Distinguish Its Biotypes	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; WOOD-MASON; DNA; EVOLUTION; SEQUENCE; REARRANGEMENTS; REVEALS; INSECTA; REGIONS; MODEL	The complete mitochondrial genome of the Asian rice gall midge, Orseolia oryzae (Diptera; Cecidomyiidae) was sequenced, annotated and analysed in the present study. The circular genome is 15,286 bp with 13 protein-coding genes, 22 tRNAs and 2 ribosomal RNA genes, and a 578 bp non-coding control region. All protein coding genes used conventional start codons and terminated with a complete stop codon. The genome presented many unusual features: (1) rearrangement in the order of tRNAs as well as protein coding genes; (2) truncation and unusual secondary structures of tRNAs; (3) presence of two different repeat elements in separate non-coding regions; (4) presence of one pseudo-tRNA gene; (5) inversion of the rRNA genes; (6) higher percentage of non-coding regions when compared with other insect mitogenomes. Rearrangements of the tRNAs and protein coding genes are explained on the basis of tandem duplication and random loss model and why intramito-chondrial recombination is a better model for explaining rearrangements in the O. oryzae mitochondrial genome is discussed. Furthermore, we evaluated the number of iterations of the tandem repeat elements found in the mitogenome. This led to the identification of genetic markers capable of differentiating rice gall midge biotypes and the two Orseolia species investigated.	[Atray, Isha; Nair, Suresh] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India; [Bentur, Jagadish Sanmallappa] Directorate Rice Res, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Nair, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India.	suresh@icgeb.res.in			ICGEB; Department of Biotechnology (DBT); Indian Council of Agricultural Research (ICAR), Government of India; DBT; ICAR; University Grants Commission (UGC), Government of India	ICGEB(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Agricultural Research (ICAR), Government of India(Indian Council of Agricultural Research (ICAR)); DBT(Department of Biotechnology (DBT) India); ICAR(Indian Council of Agricultural Research (ICAR)); University Grants Commission (UGC), Government of India(University Grants Commission, India)	Research on rice gall midge and gall midge-rice interaction in SN's laboratory is partially supported by core grants from ICGEB and extramural funding from the Department of Biotechnology (DBT) and the Indian Council of Agricultural Research (ICAR), Government of India. JSB wishes to acknowledge extramural funding from DBT and ICAR. IA thanks the University Grants Commission (UGC), Government of India, for a Senior Research Fellowship.	Agarrwal R, 2014, J INTEGR PLANT BIOL, V56, P837, DOI 10.1111/jipb.12244; Andow DA, 2010, ENTOMOL EXP APPL, V135, P18, DOI 10.1111/j.1570-7458.2010.00973.x; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2000, MOL GEN GENET, V263, P328, DOI 10.1007/s004380051175; Behura SK, 1999, INSECT MOL BIOL, V8, P391, DOI 10.1046/j.1365-2583.1999.83126.x; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentur J. S., 2004, New approaches to gall midge resistance in rice, Proceedings of the International Workshop, Hyderabad, India, 22-24 November, 1998, P23; Bentur JS, 2011, INT J MOL SCI, V12, P755, DOI 10.3390/ijms12010755; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; BOYCE TM, 1989, GENETICS, V123, P825; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Carapelli A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-315; CROZIER RH, 1993, GENETICS, V133, P97; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Dowton M, 1999, MOL PHYLOGENET EVOL, V11, P283, DOI 10.1006/mpev.1998.0580; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Keane B, 1999, AM J BOT, V86, P1226, DOI 10.2307/2656770; Khush GS, 1995, HOST PLANT RESISTANC, P240; Komoto N, 2012, GENOME, V55, P222, DOI [10.1139/g2012-007, 10.1139/G2012-007]; Lakshmi P. Vijaya, 2006, International Journal of Tropical Insect Science, V26, P207, DOI 10.1079/IJT2006114; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Rawat N, 2013, PLANT PHYSIOL BIOCH, V63, P122, DOI 10.1016/j.plaphy.2012.11.021; Rawat N, 2012, FUNCT INTEGR GENOMIC, V12, P249, DOI 10.1007/s10142-012-0275-2; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shao RF, 2001, MOL BIOL EVOL, V18, P1828, DOI 10.1093/oxfordjournals.molbev.a003970; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Sperisen C, 2001, MOL ECOL, V10, P257, DOI 10.1046/j.1365-294X.2001.01180.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04089; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134625	10.1371/journal.pone.0134625	http://dx.doi.org/10.1371/journal.pone.0134625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226163	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700123
J	Capone, F; Guerriero, E; Colonna, G; Maio, P; Mangia, A; Marfella, R; Paolisso, G; Izzo, F; Potenza, N; Tomeo, L; Castello, G; Costantini, S				Capone, Francesca; Guerriero, Eliana; Colonna, Giovanni; Maio, Patrizia; Mangia, Alessandra; Marfella, Raffaele; Paolisso, Giuseppe; Izzo, Francesco; Potenza, Nicoletta; Tomeo, Luigi; Castello, Giuseppe; Costantini, Susan			The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; HIGH EXPRESSION; DOWN-REGULATION; ADIPOSE-TISSUE; CANCER-CELLS; LIVER; P53; GENE	Understanding the dynamics of the complex interaction network of cytokines, defined as "cytokinome'', can be useful to follow progression and evolution of hepatocellular carcinoma (HCC) from its early stages as well as to define therapeutic strategies. Recently we have evaluated the cytokinome profile in patients with type 2 diabetes (T2D) and/or chronic hepatitis C (CHC) infection and/or cirrhosis suggesting specific markers for the different stages of the diseases. Since T2D has been identified as one of the contributory cause of HCC, in this paper we examined the serum levels of cytokines, growth factors, chemokines, as well as of other cancer and diabetes biomarkers in a discovery cohort of patients with T2D, chronic hepatitis C (CHC) and/or CHC-related HCC comparing them with a healthy control group to define a profile of proteins able to characterize these patients, and to recognize the association between diabetes and HCC. The results have evidenced that the serum levels of some proteins are significantly and differently up-regulated in all the patients but they increased still more when HCC develops on the background of T2D. Our results were verified also using a separate validation cohort. Furthermore, significant correlations between clinical and laboratory data characterizing the various stages of this complex disease, have been found. In overall, our results highlighted that a large and simple omics approach, such as that of the cytokinome analysis, supplemented by common biochemical and clinical data, can give a complete picture able to improve the prognosis of the various stages of the disease progression. We have also demonstrated by means of interactomic analysis that our experimental results correlate positively with the general metabolic picture that is emerging in the literature for this complex multifactorial disease.	[Capone, Francesca; Guerriero, Eliana; Castello, Giuseppe; Costantini, Susan] Fdn G Pascale IRCCS, Ist Nazl Tumori, CROM, Naples, Italy; [Colonna, Giovanni] Univ Naples 2, Ctr Med Informat, SIM AOU, Naples, Italy; [Maio, Patrizia] Azienda Osped Rilievo Nazl San Giuseppe Moscati, Unita Operat Malattie Infett, Avellino, Italy; [Mangia, Alessandra] IRCCS Casa Sollievo Sofferenza, Liver Unit, San Giovanni Rotondo, Italy; [Marfella, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy; [Izzo, Francesco] Fdn G Pascale IRCCS, Ist Nazl Tumori, Naples, Italy; [Potenza, Nicoletta] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Tomeo, Luigi] Lab Borriello SAS, Avellino, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital; IRCCS Casa Sollievo Della Sofferenza; Universita della Campania Vanvitelli; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	Costantini, S (corresponding author), Fdn G Pascale IRCCS, Ist Nazl Tumori, CROM, Naples, Italy.	s.costantini@istitutotumori.na.it	Colonna, Giovanni/AAY-3568-2021; paolisso, giuseppe/AAP-8516-2020; Costantini, Susan/J-9914-2018; Mangia, A/AAL-5357-2020; Marfella, Raffaele/AAH-2595-2019; Capone, Francesca/AAS-7458-2021; Izzo, Francesco/K-5261-2016	paolisso, giuseppe/0000-0002-2137-455X; Mangia, A/0000-0002-2600-3555; Marfella, Raffaele/0000-0003-3960-9270; Costantini, Susan/0000-0002-7538-4657; Potenza, Nicoletta/0000-0002-9736-792X; Colonna, Giovanni/0000-0002-0473-1455; Capone, Francesca/0000-0002-5402-6228; Izzo, Francesco/0000-0003-3093-5408				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baffy G, 2012, AM J GASTROENTEROL, V107, P53, DOI 10.1038/ajg.2011.390; Botella LM, 2000, J IMMUNOL, V164, P1372, DOI 10.4049/jimmunol.164.3.1372; Capone F, 2014, WORLD J GASTROENTERO, V20, P9261, DOI 10.3748/wjg.v20.i28.9261; Capone F, 2010, EUR CYTOKINE NETW, V21, P99, DOI 10.1684/ecn.2010.0192; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Classen JB, 2011, J PEDIATR ENDOCR MET, V24, P455, DOI 10.1515/JPEM.2011.023; Costantini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039486; Costantini S, 2010, BIOINFORMATION, V5, P166, DOI 10.6026/97320630005166; Costantini S, 2010, EUR CYTOKINE NETW, V21, P251, DOI 10.1684/ecn.2010.0214; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Duszka K, 2013, MOL ENDOCRINOL, V27, P135, DOI 10.1210/me.2012-1248; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Garcia-Tello A, 2014, ACTAS UROL ESP, V38, P506, DOI 10.1016/j.acuro.2014.02.015; Guerriero E, 2013, CYTOKINE, V64, P584, DOI 10.1016/j.cyto.2013.09.002; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230; Kavandi L, 2012, J CELL BIOCHEM, V113, P3143, DOI 10.1002/jcb.24191; Kojima K, 2011, BLOOD, V118, P4431, DOI 10.1182/blood-2011-02-334136; Li M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-5; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Liu Y, 2011, J HUAZHONG U SCI-MED, V31, P365, DOI 10.1007/s11596-011-0382-7; Macis D, 2014, INT J EPIDEMIOL, V43, P1226, DOI 10.1093/ije/dyu088; Manfroid I, 2001, MOL ENDOCRINOL, V15, P625, DOI 10.1210/me.15.4.625; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; McCormick ME, 2011, ARTERIOSCL THROM VAS, V31, P643, DOI 10.1161/ATVBAHA.110.216200; Meng X, 2014, CANC RES; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Montella M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.12725; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Otte C, 2004, EXP CLIN ENDOCR DIAB, V112, P10, DOI 10.1055/s-2004-815720; Parasole R, 2001, CLIN CANCER RES, V7, P3504; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Robinson SM, 2010, CLIN SCI, V118, P691, DOI 10.1042/CS20090549; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Tan DY, 2013, CHINESE J PHYSIOL, V56, P282, DOI 10.4077/CJP.2013.BAB139; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030; Zhang P, 2012, J INT MED RES, V40, P1654, DOI 10.1177/030006051204000504; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729	54	15	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134594	10.1371/journal.pone.0134594	http://dx.doi.org/10.1371/journal.pone.0134594			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226632	Green Submitted, gold, Green Published			2022-12-26	WOS:000358837700117
J	Ding, SM; Li, XK; Wang, N; Cameron, SL; Mao, M; Wang, YY; Xi, YQ; Yang, D				Ding, Shuangmei; Li, Xuankun; Wang, Ning; Cameron, Stephen L.; Mao, Meng; Wang, Yuyu; Xi, Yuqiang; Yang, Ding			The Phylogeny and Evolutionary Timescale of Muscoidea (Diptera: Brachycera: Calyptratae) Inferred from Mitochondrial Genomes	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; DROSOPHILA-YAKUBA; DNA; FLY; ORGANIZATION; POPULATION; FLIES; SYSTEMATICS; SCHIZOPHORA; NUCLEAR	Muscoidea is a significant dipteran clade that includes house flies (Family Muscidae), latrine flies (F. Fannidae), dung flies (F. Scathophagidae) and root maggot flies (F. Anthomyiidae). It is comprised of approximately 7000 described species. The monophyly of the Muscoidea and the precise relationships of muscoids to the closest superfamily the Oestroidea (blow flies, flesh flies etc) are both unresolved. Until now mitochondrial (mt) genomes were available for only two of the four muscoid families precluding a thorough test of phylogenetic relationships using this data source. Here we present the first two mt genomes for the families Fanniidae (Euryomma sp.) (family Fanniidae) and Anthomyiidae (Delia platura (Meigen, 1826)). We also conducted phylogenetic analyses containing of these newly sequenced mt genomes plus 15 other species representative of dipteran diversity to address the internal relationship of Muscoidea and its systematic position. Both maximum-likelihood and Bayesian analyses suggested that Muscoidea was not a monophyletic group with the relationship: (Fanniidae + Muscidae) + ((Anthomyiidae + Scathophagidae) + (Calliphoridae + Sarcophagidae)), supported by the majority of analysed datasets. This also infers that Oestroidea was paraphyletic in the majority of analyses. Divergence time estimation suggested that the earliest split within the Calyptratae, separating (Tachinidae + Oestridae) from the remaining families, occurred in the Early Eocene. The main divergence within the paraphyletic muscoidea grade was between Fanniidae + Muscidae and the lineage ((Anthomyiidae + Scathophagidae) + (Calliphoridae + Sarcophagidae)) which occurred in the Late Eocene.	[Ding, Shuangmei; Li, Xuankun; Wang, Ning; Wang, Yuyu; Xi, Yuqiang; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wang, Ning] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Cameron, Stephen L.] Queensland Univ Technol, Fac Sci & Engn, Earth Environm & Biol Sci Sch, Brisbane, Qld 4001, Australia; [Mao, Meng] Univ Wollongong, Sch Biol Sci, Ctr Med Biosci, Wollongong, NSW 2522, Australia	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Queensland University of Technology (QUT); University of Wollongong	Xi, YQ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	yuqiangxi2012@126.com; dyangcau@126.com	Cameron, Stephen L/A-3742-2008; Wang, Yuyu/J-3117-2019; Mao, Meng/AAP-9930-2021	Cameron, Stephen L/0000-0002-6694-4130; 	National Natural Science Foundation of China [31320103902]; National "Twelfth Five-Year" Plan for Science and Technology Support [2012BAD19B00]; Australian Research Council Future Fellowship [FT120100746]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology Support; Australian Research Council Future Fellowship(Australian Research Council)	DY was funded by the National Natural Science Foundation of China (31320103902) and the National "Twelfth Five-Year" Plan for Science and Technology Support (2012BAD19B00). SLC was funded by an Australian Research Council Future Fellowship (FT120100746) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; AVISE J, 1994, NATURAL HIST EVOLUTI; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Bernasconi MV, 2000, INSECT MOL BIOL, V9, P67, DOI 10.1046/j.1365-2583.2000.00158.x; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Caravas J, 2013, SYST ENTOMOL, V38, P93, DOI 10.1111/j.1365-3113.2012.00657.x; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMING JM, 1995, ENTOMOL SCAND, V26, P121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; GRIFFITHS GD, 1972, PHYLOGENETIC CLASSIF; Grimaldi David, 2005, pi; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hennig W., 1965, Stuttgarter Beitraege zur Naturkunde, VNr. 141, P1; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hillis DM., 1996, MOL SYSTEMATICS, V2nd; Igawa T, 2008, GENE, V407, P116, DOI 10.1016/j.gene.2007.10.001; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Kutty SN, 2008, SYST ENTOMOL, V35, P614; Kutty SN, 2010, MOL PHYLOGENET EVOL, V49, P639; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li XK, 2014, MITOCHONDRIAL DNA; Li XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123594; Llopart A, 2014, MOL ECOL, V23, P1124, DOI 10.1111/mec.12678; McAlpine J.F., 1989, Agriculture Canada Monograph, P1397; MICHELSEN V, 1991, SYST ENTOMOL, V16, P85, DOI 10.1111/j.1365-3113.1991.tb00574.x; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Quicke Donald L.J., 1993, PRINCIPLES TECHNIQUE; Rambaut A, 2007, TREE ANNOTATORY1 4 8; Rambaut A., 2007, TRACER V1 4; Richard VJ, 2010, MANUAL CENTRAL AM DI, V2, P1267; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; von Tschirnhaus Michael, 2009, Denisia, P171; WADA S, 1991, J NAT HIST, V25, P1531, DOI 10.1080/00222939100770971; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zatwarnicki T., 1996, GENUS, V3, P103; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]	72	30	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134170	10.1371/journal.pone.0134170	http://dx.doi.org/10.1371/journal.pone.0134170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225760	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700060
J	Jennings, S; Collingridge, K				Jennings, Simon; Collingridge, Kate			Predicting Consumer Biomass, Size-Structure, Production, Catch Potential, Responses to Fishing and Associated Uncertainties in the World's Marine Ecosystems	PLOS ONE			English	Article							FOOD-WEB; SPECIES ABUNDANCE; CLIMATE-CHANGE; ENERGY-FLOW; FISHERIES; COMMUNITY; MODEL; SCALE; OCEAN; CONSTRAINTS	Existing estimates of fish and consumer biomass in the world's oceans are disparate. This creates uncertainty about the roles of fish and other consumers in biogeochemical cycles and ecosystem processes, the extent of human and environmental impacts and fishery potential. We develop and use a size-based macroecological model to assess the effects of parameter uncertainty on predicted consumer biomass, production and distribution. Resulting uncertainty is large (e.g. median global biomass 4.9 billion tonnes for consumers weighing 1 g to 1000 kg; 50% uncertainty intervals of 2 to 10.4 billion tonnes; 90% uncertainty intervals of 0.3 to 26.1 billion tonnes) and driven primarily by uncertainty in trophic transfer efficiency and its relationship with predator-prey body mass ratios. Even the upper uncertainty intervals for global predictions of consumer biomass demonstrate the remarkable scarcity of marine consumers, with less than one part in 30 million by volume of the global oceans comprising tissue of macroscopic animals. Thus the apparently high densities of marine life seen in surface and coastal waters and frequently visited abundance hotspots will likely give many in society a false impression of the abundance of marine animals. Unexploited baseline biomass predictions from the simple macroecological model were used to calibrate a more complex size-and trait-based model to estimate fisheries yield and impacts. Yields are highly dependent on baseline biomass and fisheries selectivity. Predicted global sustainable fisheries yield increases approximate to 4 fold when smaller individuals (< 20 cm from species of maximum mass < 1kg) are targeted in all oceans, but the predicted yields would rarely be accessible in practice and this fishing strategy leads to the collapse of larger species if fishing mortality rates on different size classes cannot be decoupled. Our analyses show that models with minimal parameter demands that are based on a few established ecological principles can support equitable analysis and comparison of diverse ecosystems. The analyses provide insights into the effects of parameter uncertainty on global biomass and production estimates, which have yet to be achieved with complex models, and will therefore help to highlight priorities for future research and data collection. However, the focus on simple model structures and global processes means that non-phytoplankton primary production and several groups, structures and processes of ecological and conservation interest are not represented. Consequently, our simple models become increasingly less useful than more complex alternatives when addressing questions about food web structure and function, biodiversity, resilience and human impacts at smaller scales and for areas closer to coasts.	[Jennings, Simon; Collingridge, Kate] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Jennings, S (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England.	simon.jennings@cefas.co.uk	Jennings, Simon/F-5085-2012	Jennings, Simon/0000-0002-2390-7225	Centre for Environment, Fisheries and Aquaculture Science "Feeding people and conserving biodiversity: options, tradeoffs and consequences" [DP275-2010]; Department of Environment, Food and Rural Affairs "Developing the evidence base to support the integration of fisheries and environmental management" [MF1225]	Centre for Environment, Fisheries and Aquaculture Science "Feeding people and conserving biodiversity: options, tradeoffs and consequences"; Department of Environment, Food and Rural Affairs "Developing the evidence base to support the integration of fisheries and environmental management"	This research was supported by the Centre for Environment, Fisheries and Aquaculture Science DP275-2010 "Feeding people and conserving biodiversity: options, tradeoffs and consequences" and the Department of Environment, Food and Rural Affairs MF1225 "Developing the evidence base to support the integration of fisheries and environmental management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Andersen KH, 2006, AM NAT, V168, P54, DOI 10.1086/504849; Andersen KH, 2008, P ROYAL SOC B, V276, P109; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barnes C, 2008, ECOLOGY, V89; Barnes C, 2011, J PLANKTON RES, V33, P13, DOI 10.1093/plankt/fbq088; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Blanchard JL, 2014, J APPL ECOL, V51, P612, DOI 10.1111/1365-2664.12238; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; BODC, 2008, GEBCO DIG ATL; BORGMANN U, 1987, CAN J FISH AQUAT SCI, V44, P136, DOI 10.1139/f87-316; BOUDREAU PR, 1992, CAN J FISH AQUAT SCI, V49, P1528, DOI 10.1139/f92-169; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Chassot E, 2007, MAR ECOL PROG SER, V343, P45, DOI 10.3354/meps06919; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christensen V, 2015, GLOBAL ECOL BIOGEOGR, V24, P507, DOI 10.1111/geb.12281; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Cushing DH, 1975, MARINE ECOLOGY FISHE; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; Eakins B. W., 2010, VOLUMES WORLDS OCEAN; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Espinoza P, 2008, PROG OCEANOGR, V79, P215, DOI 10.1016/j.pocean.2008.10.022; FAO, 2013, FAO MAJ FISH AR; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gjosaeter J., 1980, REV WORLD RESOURCES; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hartvig M, 2011, J THEOR BIOL, V272, P113, DOI 10.1016/j.jtbi.2010.12.006; Heymans JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095845; Hill SL, 2007, FISH FISH, V8, P315, DOI 10.1111/j.1467-2979.2007.00257.x; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Jennings S, 2007, J ANIM ECOL, V76, P72, DOI 10.1111/j.1365-2656.2006.01180.x; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kelleher K., 2005, FAO FISH TECH PAP, P152, DOI DOI 10.1136/EBMED-2011-0012; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Link JS, 2012, PROG OCEANOGR, V102, P102, DOI 10.1016/j.pocean.2012.03.008; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Maury O, 2007, PROG OCEANOGR, V74, P500, DOI 10.1016/j.pocean.2007.05.001; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; Moreno AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107690; Pope JG, 2006, ICES J MAR SCI, V63, P1029, DOI 10.1016/j.icesjms.2006.04.015; R Core Team, 2021, R LANGUAGE ENV STAT; Reum J, 2015, J ANIMAL EC IN PRESS; Reuman DC, 2014, J ANIM ECOL, V83, P963, DOI 10.1111/1365-2656.12194; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rosenberg A.A., 2014, 1086 FAO, P175; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; SCHAEFER MB, 1965, T AM FISH SOC, V94, P123, DOI 10.1577/1548-8659(1965)94[123:TPHOTS]2.0.CO;2; Schmidtko S, 2013, J GEOPHYS RES-OCEANS, V118, P1658, DOI 10.1002/jgrc.20122; Scott F, 2014, MIZER MULTISPECIES S; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Travers-Trolet M, 2014, AFR J MAR SCI, V36, P11, DOI 10.2989/1814232X.2014.883326; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Tremblay-Boyer L, 2011, MAR ECOL PROG SER, V442, P169, DOI 10.3354/meps09375; University of Rhode Island/NOAA, 2013, LME POL BOUND; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Venables WN., 2002, MODERN APPL STAT S 4; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WIEBE PH, 1975, FISH B-NOAA, V73, P777; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	80	69	70	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133794	10.1371/journal.pone.0133794	http://dx.doi.org/10.1371/journal.pone.0133794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226590	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358837700037
J	Nielsen, TJ; Vestergaard, M; Fenger-Gron, M; Christensen, B; Larsen, KK				Nielsen, Tine Jepsen; Vestergaard, Mogens; Fenger-Gron, Morten; Christensen, Bo; Larsen, Karen Kjaer			Healthcare Contacts after Myocardial Infarction According to Mental Health and Socioeconomic Position: A Population-Based Cohort Study	PLOS ONE			English	Article							CARDIAC REHABILITATION; DEPRESSION SCALE; HOSPITAL ANXIETY; CARDIOVASCULAR EVENTS; COLLABORATIVE CARE; RISK-FACTOR; MORTALITY; ADHERENCE; ATTENDANCE; SURVIVORS	Objective To examine the long-term use of healthcare contacts to general practice (GP) and hospital after a first-time myocardial infarction (MI) according to mental health and socioeconomic position. Methods Population-based cohort study of all patients discharged with first-time MI in the Central Denmark Region in 2009 (n=908) using questionnaires and nationwide registers. We estimated adjusted incidence rates and incidence rate ratios (IRR) for GP and hospital contacts according to depressive and anxiety symptoms, educational level and cohabitation status. Results During the 24-month period after the MI, patients with anxiety symptoms had 24% more GP contacts (adjusted IRR 1.24, 95% confidence interval (CI) 1.12-1.36) than patients with no anxiety symptoms. In contrast, patients with depressive symptoms (1.05, 0.94-1.16) and with short and medium education (<10 years: 0.96, 0.84-1.08; 10-12 years: 0.91, 0.80-1.03) and patients living alone (0.95, 0.87-1.04) had the same number of GP contacts as their counterparts (patients with no depressive symptoms, with long education [> 12 years] and patients living with a partner). During the first 6 months after the MI, patients living alone had 13% fewer hospital contacts (0.87, 0.77-0.99), patients with short education had 16% fewer hospital contacts (< 10 years: 0.84, 0.72-0.98) and patients with anxiety symptoms had 27% fewer hospital contacts (0.73, 0.62-0.86) than their counterparts. In contrast, patients with depressive symptoms (0.92, 0.77-1.10) and medium education (10-12 years: 1.05, 0.91-1.22) had the same number of hospital contacts as their counterparts. Conclusions This study indicates that patients with depressive symptoms, short and medium education and patients living alone have a lower long-term use of healthcare contacts following MI than patients without these risk factors. Patients with depressive symptoms and low socioeconomic position would be expected to have a higher need of healthcare after MI as they have a poorer prognosis.	[Nielsen, Tine Jepsen; Vestergaard, Mogens; Fenger-Gron, Morten; Larsen, Karen Kjaer] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Mental Hlth Primary Care MEPRICA, Aarhus, Denmark; [Vestergaard, Mogens; Christensen, Bo; Larsen, Karen Kjaer] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, TJ (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Mental Hlth Primary Care MEPRICA, Aarhus, Denmark.	tjn@ph.au.dk	Vestergaard, Mogens/M-9333-2014	Vestergaard, Mogens/0000-0001-8830-2174; Fenger-Gron, Morten/0000-0002-6354-5871	Lundbeck Foundation [R155-2012-11280]	Lundbeck Foundation(Lundbeckfonden)	This study has been supported by an unrestricted grant from the Lundbeck Foundation (grant number: R155-2012-11280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Doyle F, 2012, PSYCHOSOM MED, V74, P711, DOI 10.1097/PSY.0b013e318268978e; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Frasure-Smith N, 2003, ARCH GEN PSYCHIAT, V60, P627, DOI 10.1001/archpsyc.60.6.627; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Glazer Kelly M, 2002, J Cardiopulm Rehabil, V22, P40, DOI 10.1097/00008483-200201000-00006; Grace SL, 2002, GEN HOSP PSYCHIAT, V24, P127, DOI 10.1016/S0163-8343(02)00179-2; Green P, 2013, AM J CARDIOL, V111, P1264, DOI 10.1016/j.amjcard.2013.01.272; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Huffman JC, 2010, NEUROPSYCH DIS TREAT, V6, P123; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kim HK, 2010, PSYCHOSOM MED, V72, P80, DOI 10.1097/PSY.0b013e3181c4e3e9; Larsen KK, 2014, PSYCHOSOM MED, V76, P739, DOI 10.1097/PSY.0000000000000115; Larsen KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074393; Larsen KK, 2011, SCAND J PRIM HEALTH, V29, P210, DOI 10.3109/02813432.2011.629147; Larsen KK, 2012, EUR J PREV CARD 0410; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; Mayer O, 2004, J EPIDEMIOL COMMUN H, V58, P47, DOI 10.1136/jech.58.1.47; McKee MM, 2012, J AM BOARD FAM MED, V25, P416, DOI 10.3122/jabfm.2012.04.110282; Meijer A, 2013, BRIT J PSYCHIAT, V203, P90, DOI 10.1192/bjp.bp.112.111195; Meillier LK, 2012, SCAND J PUBLIC HEALT, V40, P286, DOI 10.1177/1403494812443600; Murphy BM, 2013, EUR J PREV CARDIOL, V20, P995, DOI 10.1177/2047487312449593; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nielsen KM, 2008, EUR J PUBLIC HEALTH, V18, P479, DOI 10.1093/eurpub/ckn060; Nielsen KM, 2013, DAN MED J, V60; Nielsen TJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003045; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Statistics Denmark, 1991, IDA INT DAT LAB MARK; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thombs BD, 2006, J GEN INTERNAL MED, V21; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Vestbo J, 1988, AM REV RESP DIS, V137; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134557	10.1371/journal.pone.0134557	http://dx.doi.org/10.1371/journal.pone.0134557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225864	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700111
J	Alonso, TO; Santos, JM; Teran, LO; Hernandez, MB; Broto, JP; de Erausquin, GA				Ortiz Alonso, Tomas; Matias Santos, Juan; Teran, Laura Ortiz; Borrego Hernandez, Mayelin; Poch Broto, Joaquin; de Erausquin, Gabriel Alejandro			Differences in Early Stages of Tactile ERP Temporal Sequence (P100) in Cortical Organization during Passive Tactile Stimulation in Children with Blindness and Controls	PLOS ONE			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; CROSS-MODAL PLASTICITY; MEDIAN NERVE-STIMULATION; SIGHTED INDIVIDUALS; MENTAL-IMAGERY; CORTEX; SHAPE; ATTENTION; RESPONSES; HUMANS	Compared to their seeing counterparts, people with blindness have a greater tactile capacity. Differences in the physiology of object recognition between people with blindness and seeing people have been well documented, but not when tactile stimuli require semantic processing. We used a passive vibrotactile device to focus on the differences in spatial brain processing evaluated with event related potentials (ERP) in children with blindness (n = 12) vs. normally seeing children (n = 12), when learning a simple spatial task (lines with different orientations) or a task involving recognition of letters, to describe the early stages of its temporal sequence (from 80 to 220 msec) and to search for evidence of multi-modal cortical organization. We analysed the P100 of the ERP. Children with blindness showed earlier latencies for cognitive (perceptual) event related potentials, shorter reaction times, and (paradoxically) worse ability to identify the spatial direction of the stimulus. On the other hand, they are equally proficient in recognizing stimuli with semantic content (letters). The last observation is consistent with the role of P100 on somatosensory-based recognition of complex forms. The cortical differences between seeing control and blind groups, during spatial tactile discrimination, are associated with activation in visual pathway (occipital) and task-related association (temporal and frontal) areas. The present results show that early processing of tactile stimulation conveying cross modal information differs in children with blindness or with normal vision.	[Ortiz Alonso, Tomas] Univ Complutense Madrid, Fac Med, Dept Psychiat, Madrid, Spain; [Matias Santos, Juan] Univ Atacama, Dept Psychol, Copiapo, Chile; [Matias Santos, Juan] Fdn J Robert Cade, CONICET, Cordoba, Argentina; [Teran, Laura Ortiz] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr, Boston, MA 02115 USA; [Borrego Hernandez, Mayelin] Ctr Neurociencias Cuba, Havana, Cuba; [Poch Broto, Joaquin] Univ Complutense Madrid, Hosp Clin Univ San Carlos, Dept Ear Nose & Throat ENT, Madrid, Spain; [de Erausquin, Gabriel Alejandro] Univ S Florida, Ctr Neuromodulat, Tampa, FL 33620 USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Roskamp Lab Brain Dev Modulat & Repair, Dept Psychiat, Tampa, FL USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Dept Neurosurg, Tampa, FL USA	Complutense University of Madrid; Universidad de Atacama; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Harvard University; Massachusetts General Hospital; Complutense University of Madrid; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	de Erausquin, GA (corresponding author), Univ S Florida, Ctr Neuromodulat, Tampa, FL 33620 USA.	gdeeraus@health.usf.edu	de Erausquin, Gabriel A./Z-1952-2019	de Erausquin, Gabriel A./0000-0001-6423-4461; ORTIZ ALONSO, TOMAS/0000-0002-0527-5869	Comunidad Autonoma de Madrid/Madrid Regional Government [CAM-4131308]; Fundacion Mutua Madrilena [MM-4131220]; NIMH [7K08MH077220]; Roskamp Endowment at USF; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH077220] Funding Source: NIH RePORTER	Comunidad Autonoma de Madrid/Madrid Regional Government; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Roskamp Endowment at USF; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been made possible through grants from the Comunidad Autonoma de Madrid/Madrid Regional Government (grant #CAM-4131308) and the Fundacion Mutua Madrilena (grants #MM-4131220). GdE was funded in part by NIMH 7K08MH077220 and the Roskamp Endowment at USF. GdE is a Stephen and Constance Lieber Investigator and Sidney R. Baer Jr. Investigator. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLISON T, 1992, ELECTROEN CLIN NEURO, V84, P301, DOI 10.1016/0168-5597(92)90082-M; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bjoertomt O, 2009, J NEUROPSYCHOL, V3, P31, DOI 10.1348/174866408X394604; Bolognini N, 2012, CEREB CORTEX, V22, P2055, DOI 10.1093/cercor/bhr283; Bolton DAE, 2011, NEUROPSYCHOLOGIA, V49, P1928, DOI 10.1016/j.neuropsychologia.2011.03.020; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2010, HUM BRAIN MAPP, V31, P1686, DOI 10.1002/hbm.20966; Carbonell F, 2004, NEUROIMAGE, V22, P268, DOI 10.1016/j.neuroimage.2004.01.020; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Champoux F, 2011, PSYCHOL SCI, V22, P19, DOI 10.1177/0956797610391099; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Collignon O, 2006, BRAIN RES, V1075, P175, DOI 10.1016/j.brainres.2005.12.079; Collignon O, 2009, BRAIN TOPOGR, V21, P232, DOI 10.1007/s10548-009-0075-8; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Cooke SF, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0284; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; DESMEDT JE, 1983, ELECTROEN CLIN NEURO, V56, P272, DOI 10.1016/0013-4694(83)90252-3; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gordon KA., 2011, COCHLEAR IMPLANTS S2, V12, pS8, DOI DOI 10.1179/146701011X13074645127199; Hegner YL, 2010, J NEUROPHYSIOL, V103, P3115, DOI 10.1152/jn.00940.2009; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Kanno A, 2003, NEUROIMAGE, V18, P169, DOI 10.1006/nimg.2002.1283; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; Legon W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051177; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Lucan JN, 2010, HUMAN BRAIN MAPPING; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; MORRONGIELLO BA, 1994, PERCEPTION, V23, P833, DOI 10.1068/p230833; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Ortiz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023264; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sehatpour P, 2008, P NATL ACAD SCI USA, V105, P4399, DOI 10.1073/pnas.0708418105; SHIMIZU Y, 1995, PERCEPT MOTOR SKILL, V80, P1069, DOI 10.2466/pms.1995.80.3c.1069; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wimmer VC, 2010, J COMP NEUROL, V518, P4629, DOI 10.1002/cne.22483; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	53	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0124527	10.1371/journal.pone.0124527	http://dx.doi.org/10.1371/journal.pone.0124527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225827	gold, Green Submitted, Green Published			2022-12-26	WOS:000358837700001
J	Fischer, DL; Collier, TJ; Cole-Strauss, A; Wohlgenant, SL; Lipton, JW; Steece-Collier, K; Manfredsson, FP; Kemp, CJ; Sortwell, CE				Fischer, D. Luke; Collier, Timothy J.; Cole-Strauss, Allyson; Wohlgenant, Susan L.; Lipton, Jack W.; Steece-Collier, Kathy; Manfredsson, Fredric P.; Kemp, Christopher J.; Sortwell, Caryl E.			High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; NIGRA PARS RETICULATA; STAGE PARKINSONS-DISEASE; REACTION-TIME-TASK; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; SUBSTANTIA-NIGRA; GLOBUS-PALLIDUS; NIGROSTRIATAL SYSTEM; ELECTRICAL-STIMULATION	Deep brain stimulation (DBS) is the most common neurosurgical treatment for Parkinson's disease (PD). Whereas the globus pallidus interna (GPi) has been less commonly targeted than the subthalamic nucleus (STN), a recent clinical trial suggests that GPi DBS may provide better outcomes for patients with psychiatric comorbidities. Several laboratories have demonstrated that DBS of the STN provides neuroprotection of substantia nigra pars compacta (SNpc) dopamine neurons in preclinical neurotoxin models of PD and increases brain-derived neurotrophic factor (BDNF). However, whether DBS of the entopeduncular nucleus (EP), the homologous structure to the GPi in the rat, has similar neuroprotective potential in preclinical models has not been investigated. We investigated the impact of EP DBS on forelimb use asymmetry and SNpc degeneration induced by 6-hydroxydopamine (6-OHDA) and on BDNF levels. EP DBS in male rats received unilateral, intrastriatal 6-OHDA and ACTIVE or INACTIVE stimulation continuously for two weeks. Outcome measures included quantification of contralateral forelimb use, stereological assessment of SNpc neurons and BDNF levels. EP DBS 1) did not ameliorate forelimb impairments induced by 6-OHDA, 2) did not provide neuroprotection for SNpc neurons and 3) did not significantly increase BDNF levels in any of the structures examined. These results are in sharp contrast to the functional improvement, neuroprotection and BDNF-enhancing effects of STN DBS under identical experimental parameters in the rat. The lack of functional response to EP DBS suggests that stimulation of the rat EP may not represent an accurate model of clinical GPi stimulation.	[Fischer, D. Luke; Collier, Timothy J.; Cole-Strauss, Allyson; Wohlgenant, Susan L.; Lipton, Jack W.; Steece-Collier, Kathy; Manfredsson, Fredric P.; Kemp, Christopher J.; Sortwell, Caryl E.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA; [Fischer, D. Luke] Michigan State Univ, Coll Human Med, MD PhD Program, Grand Rapids, MI USA; [Fischer, D. Luke] Michigan State Univ, Coll Human Med, Neurosci Grad Program, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Sortwell, CE (corresponding author), Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	caryl.sortwell@hc.msu.edu	Fischer, David/AAH-1934-2019; Lipton, Jack/L-3631-2019; Manfredsson, Fredric/GMI-5876-2022	Fischer, David/0000-0002-5245-3832; Lipton, Jack/0000-0003-0991-8275; Manfredsson, Fredric/0000-0001-5802-5487	Spectrum Health; Mercy Health Saint Mary's; Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University [NS058830]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS058830] Funding Source: NIH RePORTER	Spectrum Health; Mercy Health Saint Mary's; Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support provided by Spectrum Health (DLF), Mercy Health Saint Mary's (FPM) and the Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University NS058830 (CES, TJC, KSC, CJK, JWL, ACS, SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2010, BRAIN RES, V1306, P159, DOI 10.1016/j.brainres.2009.09.040; Aminoff MJ, 2001, NEUROL CLIN, V19, P119, DOI 10.1016/S0733-8619(05)70008-6; Andrade P, 2009, J CLIN NEUROSCI, V16, P877, DOI 10.1016/j.jocn.2008.11.006; ARBUTHNOTT GW, 1975, EXP NEUROL, V47, P162, DOI 10.1016/0014-4886(75)90244-7; Benhamou L, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00007; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; CARPENTER MB, 1976, J COMP NEUROL, V165, P401, DOI 10.1002/cne.901650402; Chang JY, 2003, BRAIN RES, V983, P174, DOI 10.1016/S0006-8993(03)03053-1; Charles D, 2014, PARKINSONISM RELAT D, V20, P731, DOI 10.1016/j.parkreldis.2014.03.019; Charles PD, 2012, PARKINSONISM RELAT D, V18, P268, DOI 10.1016/j.parkreldis.2011.11.001; Charles PD, 2008, NAT CLIN PRACT NEURO, V4, P424, DOI 10.1038/ncpneuro0848; Charles PDea, SAFETY TOLERABILITY; Collier TJ, 1999, DRUG AGING, V14, P261, DOI 10.2165/00002512-199914040-00003; Creed MC, 2013, BRAIN STIMUL, V6, P506, DOI 10.1016/j.brs.2012.09.012; Daniels C, 2010, MOVEMENT DISORD, V25, P1583, DOI 10.1002/mds.23078; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; Fang X, 2006, BRAIN RES, V1120, P202, DOI 10.1016/j.brainres.2006.08.073; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; FRANCOIS C, 1984, NEUROSCIENCE, V13, P61, DOI 10.1016/0306-4522(84)90259-8; Gill CE, 2011, NEUROMODULATION, V14, P515, DOI 10.1111/j.1525-1403.2011.00391.x; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gombash SE, 2014, GENE THERAP IN PRESS; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Gulcebi MI, 2012, BRAIN RES BULL, V87, P312, DOI 10.1016/j.brainresbull.2011.11.005; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; Harnack D, 2010, NEUROMODULATION, V13, P160, DOI 10.1111/j.1525-1403.2010.00282.x; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kahn E, 2012, J NEUROL NEUROSUR PS, V83, P164, DOI 10.1136/jnnp-2011-300008; Kha HT, 2000, J COMP NEUROL, V426, P366; KINCAID AE, 1991, NEUROSCI LETT, V128, P121, DOI 10.1016/0304-3940(91)90774-N; KINCAID AE, 1992, NEUROSCIENCE, V51, P705, DOI 10.1016/0306-4522(92)90309-P; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; KITA H, 1983, J COMP NEUROL, V215, P245, DOI 10.1002/cne.902150302; Kita H, 2006, THE BASAL GANGLIA, P357; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kondziolka D, 2004, STEREOT FUNCT NEUROS, V82, P127, DOI 10.1159/000079844; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Li XH, 2010, J NEUROSCI RES, V88, P1510, DOI 10.1002/jnr.22313; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; MINK JW, 1991, J NEUROPHYSIOL, V65, P273, DOI 10.1152/jn.1991.65.2.273; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Oertel W H, 1984, Adv Neurol, V40, P91; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Olds ME, 2001, SYNAPSE, V40, P215, DOI 10.1002/syn.1044; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penney J B Jr, 1986, Mov Disord, V1, P3, DOI 10.1002/mds.870010102; RAJAKUMAR N, 1994, J COMP NEUROL, V350, P324, DOI 10.1002/cne.903500214; RAJAKUMAR N, 1994, J COMP NEUROL, V346, P337, DOI 10.1002/cne.903460303; Sato F, 2000, J COMP NEUROL, V424, P142, DOI 10.1002/1096-9861(20000814)424:1<142::AID-CNE10>3.0.CO;2-8; Schallert T, 2000, CONT NEUROS, P131; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Shi LH, 2006, SYNAPSE, V59, P445, DOI 10.1002/syn.20261; Shi LH, 2004, BRAIN RES, V1013, P98, DOI 10.1016/j.brainres.2004.03.053; SHINK E, 1995, J COMP NEUROL, V358, P119, DOI 10.1002/cne.903580108; SMITH Y, 1994, J COMP NEUROL, V343, P297, DOI 10.1002/cne.903430209; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; SPANN BM, 1991, J COMP NEUROL, V311, P375, DOI 10.1002/cne.903110308; Spieles-Engemann AL, 2010, EUR J NEUROSCI, V32, P1092, DOI 10.1111/j.1460-9568.2010.07416.x; Spieles-Engemann AL, 2010, NEUROBIOL DIS, V39, P105, DOI 10.1016/j.nbd.2010.03.009; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; STEININGER TL, 1992, J COMP NEUROL, V321, P515, DOI 10.1002/cne.903210403; Summerson SR, 2014, IEEE T NEUR SYS REH, V22, P1218, DOI 10.1109/TNSRE.2014.2330515; Summerson SR, 2013, IEEE ENG MED BIO, P783, DOI 10.1109/EMBC.2013.6609617; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Sutton AC, 2013, J NEUROPHYSIOL, V109, P363, DOI 10.1152/jn.00311.2012; Tachibana Y, 2008, EUR J NEUROSCI, V27, P238, DOI 10.1111/j.1460-9568.2007.05990.x; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; VANDERKOOY D, 1981, BRAIN RES, V211, P15, DOI 10.1016/0006-8993(81)90064-0; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; WATANABE H, 1983, FOLIA PHARMACOL JPN, V82, P247, DOI 10.1254/fpj.82.247; Yurek DM, 2001, BRAIN RES, V891, P228, DOI 10.1016/S0006-8993(00)03217-0; Zhang XQ, 2006, BRAIN RES, V1095, P207, DOI 10.1016/j.brainres.2006.04.019; Zhou FM, 2011, NEUROSCIENCE, V198, P69, DOI 10.1016/j.neuroscience.2011.07.061	89	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133957	10.1371/journal.pone.0133957	http://dx.doi.org/10.1371/journal.pone.0133957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222442	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800086
J	Lan, T; Kisseleva, T; Brenner, DA				Lan, Tian; Kisseleva, Tatiana; Brenner, David A.			Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation	PLOS ONE			English	Article							NADPH OXIDASE; OXIDATIVE STRESS; HEPATOCYTE APOPTOSIS; SIGNALING PATHWAYS; HEDGEHOG PATHWAY; NAD(P)H OXIDASES; TRANSFORMATION; PROLIFERATION; INVOLVEMENT; EXPRESSION	Reactive oxygen species (ROS) produced by nicotinamide adenine dinucleotide phosphate oxidase (NOX) play a key role in liver injury and fibrosis. Previous studies demonstrated that GKT137831, a dual NOX1/4 inhibitor, attenuated liver fibrosis in mice as well as pro-fibrotic genes in hepatic stellate cells (HSCs) as well as hepatocyte apoptosis. The effect of NOX1 and NOX4 deficiency in liver fibrosis is unclear, and has never been directly compared. HSCs are the primary myofibroblasts in the pathogenesis of liver fibrosis. Therefore, we aimed to determine the role of NOX1 and NOX4 in liver fibrosis, and investigated whether NOX1 and NOX4 signaling mediates liver fibrosis by regulating HSC activation. Mice were treated with carbon tetrachloride (CCl4) to induce liver fibrosis. Deficiency of either NOX1 or NOX4 attenuates liver injury, inflammation, and fibrosis after CCl4 compared to wild-type mice. NOX1 or NOX4 deficiency reduced lipid peroxidation and ROS production in mice with liver fibrosis. NOX1 and NOX4 deficiency are approximately equally effective in preventing liver injury in the mice. The NOX1/4 dual inhibitor GKT137831 suppressed ROS production as well as inflammatory and proliferative genes induced by lipopolysaccharide (LPS), platelet-derived growth factor (PDGF), or sonic hedgehog (Shh) in primary mouse HSCs. Furthermore, the mRNAs of proliferative and pro-fibrotic genes were downregulated in NOX1 and NOX4 knock-out activated HSCs (cultured on plastic for 5 days). Finally, NOX1 and NOX4 protein levels were increased in human livers with cirrhosis compared with normal controls. Thus, NOX1 and NOX4 signaling mediates the pathogenesis of liver fibrosis, including the direct activation of HSC.	[Lan, Tian; Kisseleva, Tatiana; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lan, Tian] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Diego; Guangdong Pharmaceutical University	Brenner, DA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dbrenner@ucsd.edu		Brenner, David/0000-0003-2573-525X	Natural Science Foundation of China [81200308]; Zhujiang Technology New Star of Guangzhou City [2013J2200025]; National Institutes of Health [R01 GM041804-26, P50 AA011999-16, P42 ES010337-13, U01 AA021856-02, R01 DK101737-01A1, U01 AA022614-01A1, R01 DK099205-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099205, R01DK101737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, U01AA021856, U01AA022614] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhujiang Technology New Star of Guangzhou City; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Natural Science Foundation of China (No. 81200308) and the Zhujiang Technology New Star of Guangzhou City (2013J2200025) (to Tian Lan), and by the National Institutes of Health (R01 GM041804-26, P50 AA011999-16, P42 ES010337-13, U01 AA021856-02, R01 DK101737-01A1, U01 AA022614-01A1, R01 DK099205-01A1).	Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bai T, 2013, INT IMMUNOPHARMACOL, V15, P275, DOI 10.1016/j.intimp.2012.12.020; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Burt AD, 1999, J GASTROENTEROL, V34, P299, DOI 10.1007/s005350050264; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; De Bleser PJ, 1999, J BIOL CHEM, V274, P33881, DOI 10.1074/jbc.274.48.33881; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040; Li T, 2014, HEPATOLOGY, V59, P2383, DOI 10.1002/hep.27049; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Nieto N, 2002, J BIOL CHEM, V277, P9853, DOI 10.1074/jbc.M110506200; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369	41	130	132	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0129743	10.1371/journal.pone.0129743	http://dx.doi.org/10.1371/journal.pone.0129743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222337	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800005
J	Schoeni, A; Roser, K; Roosli, M				Schoeni, Anna; Roser, Katharina; Roeoesli, Martin			Symptoms and Cognitive Functions in Adolescents in Relation to Mobile Phone Use during Night	PLOS ONE			English	Article							SLEEP-DEPRIVATION; JAPANESE ADOLESCENTS; PROSPECTIVE COHORT; PERFORMANCE; ATTENTION; DURATION; MEMORY; WELL; DISTURBANCES; ASSOCIATION	Many adolescents tend to leave their mobile phones turned on during night, accepting that they may be awakened by an incoming text message or call. Using self-reported and objective operator recorded mobile phone use data, we thus aimed to analyze how being awakened during night by mobile phone affects adolescents' perceived health and cognitive functions. In this cross-sectional study, 439 adolescents completed questionnaires about their mobile phone use during night, health related quality of life and possible confounding factors. Standardized computerized cognitive tests were performed to assess memory and concentration capacity. Objective operator recorded mobile phone use data was further collected for 233 study participants. Data were analyzed by multivariable regression models adjusted for relevant confounders including amount of mobile phone use. For adolescents reporting to be awakened by a mobile phone during night at least once a month the odds ratio for daytime tiredness and rapid exhaustibility were 1.86 (95% CI: 1.02-3.39) and 2.28 (95% CI: 0.97-5.34), respectively. Similar results were found when analyzing objective operator recorded mobile phone use data (tiredness: 1.63, 95% CI: 0.94-2.82 and rapid exhaustibility: 2.32, 95% CI: 1.01-5.36). The cognitive tests on memory and concentration capacity were not related to mobile phone use during night. Overall, being awakened during night by mobile phone was associated with an increase in health symptom reports such as tiredness, rapid exhaustibility, headache and physical ill-being, but not with memory and concentration capacity. Prevention strategies should focus on helping adolescents set limits for their accessibility by mobile phone, especially during night.	[Schoeni, Anna; Roser, Katharina; Roeoesli, Martin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schoeni, Anna; Roser, Katharina; Roeoesli, Martin] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Roosli, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.roosli@unibas.ch	Röösli, Martin/A-2658-2008; Roser, Katharina/AAI-1429-2020	Röösli, Martin/0000-0002-7475-1531; Roser, Katharina/0000-0001-5253-3333; Schoeni, Anna/0000-0002-2421-5925	Swiss National Science Foundation [138190]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (Project Number 138190, www.snf.ch); MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson MJ, 2009, BIOELECTROMAGNETICS, V30, P678, DOI 10.1002/bem.20534; Aydin D, 2011, PROG BIOPHYS MOL BIO, V107, P356, DOI 10.1016/j.pbiomolbio.2011.08.013; Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Byun Yoon-Hwan, 2013, Environ Health Toxicol, V28, pe2013018, DOI 10.5620/eht.2013.28.e2013018; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chiu C.T., 2014, J FORMOS MED ASS; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dinges DF, 1997, SLEEP, V20, P267; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; FAKT II, 2007, FRANKFURTER ADAPTIVE; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Harvard School of Public Health, CAUS INF BOOK; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Iber C, 2005, NEUROL CLIN, V23, P1045, DOI 10.1016/j.ncl.2005.08.001; Ikeda K, 2014, ENVIRON HEALTH PREV, V19, P187, DOI 10.1007/s12199-013-0373-3; Inyang I, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-36; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kalak N, 2014, NEUROPSYCH DIS TREAT, V10, P1199, DOI 10.2147/NDT.S62533; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Liepmann D., 2006, I S T 2000R; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Nuutinen T, 2014, INT J PUBLIC HEALTH, V59, P619, DOI 10.1007/s00038-014-0561-y; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Punamaki RL, 2007, J ADOLESCENCE, V30, P569, DOI 10.1016/j.adolescence.2006.07.004; Rains JC, 2008, CURR NEUROL NEUROSCI, V8, P167, DOI 10.1007/s11910-008-0027-9; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Redmayne M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-90; The Kidscreen Group Europe, 2006, HDB KIDSCREEN QUEST; Thomas S, 2010, OCCUP ENVIRON MED, V67, P861, DOI 10.1136/oem.2009.054080; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Van den Bulck J, 2003, J SLEEP RES, V12, P263, DOI 10.1046/j.1365-2869.2003.00362.x; Van den Bulck J, 2007, SLEEP, V30, P1220, DOI 10.1093/sleep/30.9.1220; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Vrijheid M, 2009, J EXPO SCI ENV EPID, V19, P369, DOI 10.1038/jes.2008.27	39	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133528	10.1371/journal.pone.0133528	http://dx.doi.org/10.1371/journal.pone.0133528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222312	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800055
J	Yu, XY; Liang, XY; Liu, KX; Dong, WX; Wang, JX; Zhou, MG				Yu, Xiaoyue; Liang, Xiaoyu; Liu, Kexue; Dong, Wenxia; Wang, Jianxin; Zhou, Ming-guo			The thiG Gene Is Required for Full Virulence of Xanthomonas oryzae pv. oryzae by Preventing Cell Aggregation	PLOS ONE			English	Article							THIAMIN BIOSYNTHESIS; OXIDATIVE STRESS; RESISTANCE; DEFICIENT; VECTORS; MUTANTS; DNA	Bacterial blight of rice is an important serious bacterial diseases of rice in many rice-growing regions, caused by Xanthomonas oryzae pv. oryzae (Xoo). The thiG gene from Xoo strain ZJ173, which is involved with thiazole moiety production in the thiamine biosynthesis pathway, is highly conserved among the members of Xanthomonas. The thiG deletion mutant displayed impaired virulence and growth in thiamine-free medium but maintained its normal growth rate in the rice tissues, indicating that the thiG gene is involved in Xoo virulence. Compared to the wild type strain, the formation of cell-cell aggregates was affected in thiG deletion mutants. Although biofilm formation was promoted, motility and migration in rice leaves were repressed in the thiG mutants, and therefore limited the expansion of pathogen infection in rice. Quorum sensing and extracellular substance are two key factors that contribute to the formation of cell-cell aggregates. Our study found that in the thiG mutant the expression of two genes, rpfC and rpfG, which form a two-component regulatory signal system involved in the regulation of biofilm formation by a second messenger cyclic di-GMP is down-regulated. In addition, our study showed that xanthan production was not affected but the expression of some genes associated with xanthan biosynthesis, like gumD, gumE, gumH and gumM, were up-regulated in thiG mutants. Taken together, these findings are the first to demonstrate the role of the thiazole biosynthsis gene, thiG, in virulence and the formation of aggregates in Xanthomonas oryzae pv. oryzae.	[Yu, Xiaoyue; Liang, Xiaoyu; Liu, Kexue; Dong, Wenxia; Wang, Jianxin; Zhou, Ming-guo] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	mgzhou@njau.edu.cn			National Science and Technology Support Program [2012BAD19B01]	National Science and Technology Support Program	This work was supported by the National Science and Technology Support Program (2012BAD19B01) to MZ. The funders had the role in the study design and data analysis, decision to publish.	Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bradbury JF, 1984, BERGEYS MANUAL SYSTE, V1; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Jenkinson HF, 1997, CRIT REV ORAL BIOL M, V8, P175, DOI 10.1177/10454411970080020601; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Kauffman H, 1973, PLANT DIS REPORTER; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ou S.H., 1985, RICE DIS IRRI; Qian GL, 2013, MOL PLANT PATHOL, V14, P145, DOI 10.1111/j.1364-3703.2012.00838.x; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Ruiz-Roldan C, 2008, FUNGAL GENET BIOL, V45, P6, DOI 10.1016/j.fgb.2007.09.003; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schauer K, 2009, J BACTERIOL, V191, P2218, DOI 10.1128/JB.01636-08; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Yuan ZH, 2013, J GENET GENOMICS, V40, P473, DOI 10.1016/j.jgg.2013.05.003; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao YC, 2011, MICROB PATHOGENESIS, V50, P48, DOI 10.1016/j.micpath.2010.09.002; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	42	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134237	10.1371/journal.pone.0134237	http://dx.doi.org/10.1371/journal.pone.0134237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222282	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800115
J	Calabretta, S; Bielli, P; Passacantilli, I; Pilozzi, E; Fendrich, V; Capurso, G; Delle Fave, G; Sette, C				Calabretta, S.; Bielli, P.; Passacantilli, I.; Pilozzi, E.; Fendrich, V.; Capurso, G.; Delle Fave, G.; Sette, C.			Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells	ONCOGENE			English	Article							PYRUVATE-KINASE; EMERGING ROLE; RNA; APOPTOSIS; M2; TRANSCRIPTION; ACTIVATION; PATHWAYS; REVEALS; ISOFORM	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and incurable disease. Poor prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the first-line chemotherapeutic approach. Thus, there is a strong need for novel therapies, targeting more directly the molecular aberrations of this disease. We found that chronic exposure of PDAC cells to gemcitabine selected a subpopulation of cells that are drug-resistant (DR-PDAC cells). Importantly, alternative splicing (AS) of the pyruvate kinase gene (PKM) was differentially modulated in DR-PDAC cells, resulting in promotion of the cancer-related PKM2 isoform, whose high expression also correlated with shorter recurrence-free survival in PDAC patients. Switching PKM splicing by antisense oligonucleotides to favor the alternative PKM1 variant rescued sensitivity of DR-PDAC cells to gemcitabine and cisplatin, suggesting that PKM2 expression is required to withstand drug-induced genotoxic stress. Mechanistically, upregulation of the polypyrimidine-tract binding protein (PTBP1), a key modulator of PKM splicing, correlated with PKM2 expression in DR-PDAC cell lines. PTBP1 was recruited more efficiently to PKM pre-mRNA in DR-than in parental PDAC cells. Accordingly, knockdown of PTBP1 in DR-PDAC cells reduced its recruitment to the PKM pre-mRNA, promoted splicing of the PKM1 variant and abolished drug resistance. Thus, chronic exposure to gemcitabine leads to upregulation of PTBP1 and modulation of PKM AS in PDAC cells, conferring resistance to the drug. These findings point to PKM2 and PTBP1 as new potential therapeutic targets to improve response of PDAC to chemotherapy.	[Calabretta, S.; Passacantilli, I.; Sette, C.] Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy; [Calabretta, S.; Passacantilli, I.; Capurso, G.; Delle Fave, G.] Univ Roma La Sapienza, Dept Sci Med Chirurg & Translat Med, Via Grottarossa, I-00189 Rome, Italy; [Bielli, P.; Sette, C.] Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy; [Pilozzi, E.] Univ Roma La Sapienza, Dept Clin & Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Fendrich, V.] Univ Marburg, Dept Surg, Marburg, Germany	University of Rome Tor Vergata; Sapienza University Rome; IRCCS Santa Lucia; Sapienza University Rome; Philipps University Marburg	Sette, C (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.; Delle Fave, G (corresponding author), Univ Roma La Sapienza, Dept Sci Med Chirurg & Translat Med, Via Grottarossa, I-00189 Rome, Italy.	gianfranco.dellefave@uniroma1.it; claudio.sette@uniroma2.it	PILOZZI, Emanuela/AAC-1854-2022; Capurso, Gabriele/AAB-1389-2019; Sette, Claudio/S-4307-2019; Bielli, Pamela/K-1208-2018	PILOZZI, Emanuela/0000-0002-7110-9172; Capurso, Gabriele/0000-0002-0019-8753; Sette, Claudio/0000-0003-2864-8266; Bielli, Pamela/0000-0003-3347-8345	Association for International Cancer Research (AICR) [12-0150]; Associazione Italiana Ricerca sul Cancro (AIRC) [14581]; Fondazione Santa Lucia Ricerca Corrente; Worldwide Cancer Research [12-0150] Funding Source: researchfish	Association for International Cancer Research (AICR); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Santa Lucia Ricerca Corrente; Worldwide Cancer Research	We thank Andrea D'Ascenzo and Enrico Duranti for help with immunohistochemistry; Dr Chiara Naro for helpful suggestions throughout the study; and Dr Vittoria Pagliarini for critical reading of the manuscript. This work was supported by Association for International Cancer Research (AICR) (grant 12-0150), Associazione Italiana Ricerca sul Cancro (AIRC) (grant 14581) and Fondazione Santa Lucia Ricerca Corrente.	Adesso L, 2013, ONCOGENE, V32, P2848, DOI 10.1038/onc.2012.306; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bielli P, 2014, NUCLEIC ACIDS RES, V42, P12070, DOI 10.1093/nar/gku922; Bielli P, 2014, EMBO REP, V15, P419, DOI 10.1002/embr.201338241; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bonomi Serena, 2013, Int J Cell Biol, V2013, P962038, DOI 10.1155/2013/962038; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Cerwenka H, 1999, ANTICANCER RES, V19, P849; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Costello BA, 2014, INVEST NEW DRUG, V32, P710, DOI 10.1007/s10637-014-0096-3; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Droin N, 2001, ONCOGENE, V20, P260, DOI 10.1038/sj.onc.1204066; Dutertre M, 2011, RNA BIOL, V8, P740, DOI 10.4161/rna.8.5.16016; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Maimon A, 2014, CELL REP, V7, P501, DOI 10.1016/j.celrep.2014.03.041; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; Naro Chiara, 2013, Int J Cell Biol, V2013, P151839, DOI 10.1155/2013/151839; Omenn GS, 2010, DIS MARKERS, V28, P241, DOI [10.1155/2010/705847, 10.3233/DMA-2010-0702]; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Proussakova OV, 2003, J BIOL CHEM, V278, P36236, DOI 10.1074/jbc.M305896200; Sawa H, 1998, ONCOGENE, V16, P1701, DOI 10.1038/sj.onc.1201691; Sette Claudio, 2013, Int J Cell Biol, V2013, P421606, DOI 10.1155/2013/421606; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Tang SC, 2014, WORLD J GASTROENTERO, V20, P10825, DOI 10.3748/wjg.v20.i31.10825; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ZX, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120133; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zhou XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5581	50	134	135	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2031	2039		10.1038/onc.2015.270	http://dx.doi.org/10.1038/onc.2015.270			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26234680	Green Accepted, Green Published			2022-12-26	WOS:000374505600003
J	Kadyrova, LY; Dahal, BK; Kadyrov, FA				Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.			Evidence That the DNA Mismatch Repair System Removes 1-Nucleotide Okazaki Fragment Flaps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; SIMPLE REPETITIVE DNA; SACCHAROMYCES-CEREVISIAE; MUTL-ALPHA; MUTATION AVOIDANCE; REPLICATION FORK; POLYMERASES DELTA; PROTEIN MUTS; TUMOR-CELLS; IN-VITRO	The DNA mismatch repair (MMR) system plays a major role in promoting genome stability and suppressing carcinogenesis. In this work, we investigated whether the MMR system is involved in Okazaki fragment maturation. We found that in the yeast Saccharomyces cerevisiae, the MMR system and the flap endonuclease Rad27 act in overlapping pathways that protect the nuclear genome from 1-bp insertions. In addition, we determined that purified yeast and human MutS alpha proteins recognize 1-nucleotide DNA and RNA flaps. In reconstituted human systems, MutS alpha, proliferating cell nuclear antigen, and replication factor C activate MutL alpha endonuclease to remove the flaps. ATPase and endonuclease mutants of MutL alpha are defective in the flap removal. These results suggest that the MMR system contributes to the removal of 1-nucleotide Okazaki fragment flaps.	[Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Kadyrov, FA (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			National Institutes of Health from NIGMS [R01GM095758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095758] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM095758 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Greene CN, 2001, GENETICS, V159, P65; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003899; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kuhn H, 2002, ELECTROPHORESIS, V23, P2384, DOI 10.1002/1522-2683(200208)23:15<2384::AID-ELPS2384>3.0.CO;2-O; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MODRICH P, 1995, PHILOS T ROY SOC B, V347, P89, DOI 10.1098/rstb.1995.0014; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200	74	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24051	24065		10.1074/jbc.M115.660357	http://dx.doi.org/10.1074/jbc.M115.660357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26224637	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000362218900002
J	Chung, C; Wu, WH; Chen, BS				Chung, Connie; Wu, Wei-Hua; Chen, Bo-Shiun			Identification of Novel 14-3-3 Residues That Are Critical for Isoform-specific Interaction with GluN2C to Regulate N-Methyl-D-aspartate (NMDA) Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-SPECIFIC REGULATION; NR2C SUBUNIT; STRUCTURAL BASIS; RAT-BRAIN; MEMBRANE-PROTEINS; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; SURFACE EXPRESSION; SPLICE VARIANTS	The 14-3-3 family of proteins is widely distributed in the CNS where they are major regulators of essential neuronal functions. There are seven known mammalian 14-3-3 isoforms (zeta,gamma, tau, epsilon, eta, beta, and sigma), which generally function as adaptor proteins. Previously, we have demonstrated that 14-3-3 epsilon isoform dynamically regulates forward trafficking of GluN2C-containing NMDA receptors (NMDARs) in cerebellar granule neurons, that when expressed on the surface, promotes neuronal survival following NMDA-induced excitotoxicity. Here, we report 14-3-3 isoform-specific binding and functional regulation of GluN2C. In particular, we show that GluN2C C-terminal domain (CTD) binds to all 14-3-3 isoforms except 14-3-3 sigma, and binding is dependent on GluN2C serine 1096 phosphorylation. Co-expression of 14-3-3 (zeta and epsilon) and GluN1/ GluN2C promotes the forward delivery of receptors to the cell surface. We further identify novel residues serine 145, tyrosine 178, and cysteine 189 on alpha-helices 6, 7, and 8, respectively, within zeta-isoform as part of the GluN2C binding motif and independent of the canonical peptide binding groove. Mutation of these conserved residues abolishes GluN2C binding and has no functional effect on GluN2C trafficking. Reciprocal mutation of alanine 145, histidine 180, and isoleucine 191 on 14-3-3 sigma isoform promotes GluN2C binding and surface expression. Moreover, inhibiting endogenous 14-3-3 using a high-affinity peptide inhibitor, difopein, greatly diminishes GluN2C surface expression. Together, these findings highlight the isoform-specific structural and functional differences within the 14-3-3 family of proteins, which determine GluN2C binding and its essential role in targeting the receptor to the cell surface to facilitate glutamatergic neurotransmission.	[Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, BS (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, CA 3008,1120 15th St, Augusta, GA 30912 USA.	bochen@gru.edu		Chung, Connie/0000-0002-3065-7498	National Institutes of Health NINDS [R00NS057266]; NCI [1K22CA122453]; NATIONAL CANCER INSTITUTE [K22CA122453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS057266] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Career Transition Award R00NS057266 (to B.-S. C.) and an NCI Career Transition Award 1K22CA122453 (to W.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Binshtok AM, 2006, J NEUROSCI, V26, P708, DOI 10.1523/JNEUROSCI.4409-05.2006; Brennan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054491; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dalal SN, 2004, CELL CYCLE, V3, P672; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Kaniakova M, 2012, J BIOL CHEM, V287, P26423, DOI 10.1074/jbc.M112.339085; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Kumar SS, 2003, J NEUROSCI, V23, P10074; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lichnerova K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00375; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; PEREZVELAZQUEZ JL, 1994, J NEUROCHEM, V63, P1171; POLLARD H, 1993, NEUROREPORT, V4, P411, DOI 10.1097/00001756-199304000-00018; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roque PJ, 2011, METHODS MOL BIOL, V758, P361, DOI 10.1007/978-1-61779-170-3_25; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Umahara T, 2009, BRAIN RES, V1253, P15, DOI 10.1016/j.brainres.2008.11.065; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Wei Z, 2015, J BIOL CHEM, V290, P5105, DOI 10.1074/jbc.M114.599969; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2	49	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23188	23200		10.1074/jbc.M115.648436	http://dx.doi.org/10.1074/jbc.M115.648436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229101	hybrid, Green Published			2022-12-26	WOS:000361685500029
J	An, DG; Zheng, Q; Luo, QL; Ma, PT; Zhang, HX; Li, LH; Han, FP; Xu, HX; Xu, YF; Zhang, XT; Zhou, YL				An, Diaoguo; Zheng, Qi; Luo, Qiaoling; Ma, Pengtao; Zhang, Hongxia; Li, Lihui; Han, Fangpu; Xu, Hongxing; Xu, Yunfeng; Zhang, Xiaotian; Zhou, Yilin			Molecular Cytogenetic Identification of a New Wheat-Rye 6R Chromosome Disomic Addition Line with Powdery Mildew Resistance	PLOS ONE			English	Article							TRITICUM-AESTIVUM-L.; SECALE-CEREALE; HEXAPLOID WHEAT; GENE; TRANSLOCATIONS; LOCATION; INTROGRESSION; HYBRIDIZATION; SUBSTITUTION; IMPROVEMENT	Rye (Secale cereale L.) possesses many valuable genes that can be used for improving disease resistance, yield and environment adaptation of wheat (Triticum aestivum L.). However, the documented resistance stocks derived from rye is faced severe challenge due to the variation of virulent isolates in the pathogen populations. Therefore, it is necessary to develop desirable germplasm and search for novel resistance gene sources against constantly accumulated variation of the virulent isolates. In the present study, a new wheat-rye line designated as WR49-1 was produced through distant hybridization and chromosome engineering protocols between common wheat cultivar Xiaoyan 6 and rye cultivar German White. Using sequential GISH (genomic in situ hybridization), mc-FISH (multicolor fluorescence in situ hybridization), mc-GISH (multicolor GISH) and EST (expressed sequence tag)-based marker analysis, WR49-1 was proved to be a new wheat-rye 6R disomic addition line. As expected, WR49-1 showed high levels of resistance to wheat powdery mildew (Blumeria graminis f. sp. tritici, Bgt) pathogens prevalent in China at the adult growth stage and 19 of 23 Bgt isolates tested at the seedling stage. According to its reaction pattern to different Bgt isolates, WR49-1 may possess new resistance gene(s) for powdery mildew, which differed from the documented powdery mildew gene, including Pm20 on chromosome arm 6RL of rye. Additionally, WR49-1 was cytologically stable, had improved agronomic characteristics and therefore could serve as an important bridge for wheat breeding and chromosome engineering.	[An, Diaoguo; Luo, Qiaoling; Ma, Pengtao; Zhang, Hongxia; Xu, Hongxing; Xu, Yunfeng; Zhang, Xiaotian] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China; [Zheng, Qi; Han, Fangpu] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China; [Li, Lihui] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Zhou, Yilin] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	An, DG (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China.	dgan@sjziam.ac.cn		Xu, Yunfeng/0000-0001-6669-4349	National Natural Science Foundation of China [(31171550]; National High-Tech Research and Development Program of China [2011AA1001]; National Scientific and Technological Supporting Program of China [2013BAD01B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Scientific and Technological Supporting Program of China	This work was supported by the National Natural Science Foundation of China (31171550) (http://www.nsfc.gov.cn/) to DGA, National High-Tech Research and Development Program of China (2011AA1001) (http://www.863.gov.cn/) to DGA, and National Scientific and Technological Supporting Program of China (2013BAD01B02) (http://www.most.gov.cn/) to DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; An DG, 2003, ACTA AGRO SIN, V6, P955; An DG, 2006, J INTEGR PLANT BIOL, V48, P838, DOI 10.1111/j.1744-7909.2006.00275.x; An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Cui Lei, 2012, Acta Agronomica Sinica, V38, P1009, DOI 10.3724/SP.J.1006.2012.01009; CURTIS CA, 1993, PLANT BREEDING, V111, P106, DOI 10.1111/j.1439-0523.1993.tb00615.x; Dundas IS, 2001, CROP SCI, V41, P1771, DOI 10.2135/cropsci2001.1771; Endo TR, 2007, CHROMOSOME RES, V15, P67, DOI 10.1007/s10577-006-1100-3; Falke KC, 2009, THEOR APPL GENET, V118, P1225, DOI 10.1007/s00122-009-0976-7; Farshadfar E., 2013, Australian Journal of Crop Science, V7, P130; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; FRIEBE B, 1991, THEOR APPL GENET, V83, P33, DOI 10.1007/BF00229223; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; Gallego FJ, 1997, THEOR APPL GENET, V95, P393, DOI 10.1007/s001220050575; He ZhongHu, 2011, Scientia Agricultura Sinica, V44, P2193; HEUN M, 1990, PHYTOPATHOLOGY, V80, P1129, DOI 10.1094/Phyto-80-1129; HEUN M, 1990, PHYTOPATHOLOGY, V80, P242, DOI 10.1094/Phyto-80-242; Hsam SLK, 1997, PLANT BREEDING, V116, P119, DOI 10.1111/j.1439-0523.1997.tb02164.x; Hu H, 1990, PLANT CELL ENG BREED; Huang J, 2012, MOL BREEDING, V30, P1737, DOI 10.1007/s11032-012-9757-0; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Lee TG, 2009, THEOR APPL GENET, V119, P663, DOI 10.1007/s00122-009-1077-3; Li HongJie, 2011, Acta Agronomica Sinica, V37, P943, DOI 10.3724/SP.J.1006.2011.00943; Li ZS, 2008, J GENET GENOMICS, V35, P451, DOI 10.1016/S1673-8527(08)60062-4; Lind V., 1982, Tagungsbericht, Akademie der Landwirtschaftswissenschaften der Deutschen Demokratischen Republik, P509; Lukaszewski A. J., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P363; Ma PT, 2015, THEOR APPL GENET, V128, P613, DOI 10.1007/s00122-015-2457-5; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; MILLER TE, 1984, CAN J GENET CYTOL, V26, P578, DOI 10.1139/g84-091; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Sheng BQ, 1991, BEIJING AGR SCI, V1, P38; Si Q.M., 1992, ACTA PHYTOPATHOL SIN, V22, P349, DOI [10.13926/j.cnki.apps.1992.04.021, DOI 10.13926/J.CNKI.APPS.1992.04.021]; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Taylor C, 1998, THEOR APPL GENET, V97, P1000, DOI 10.1007/s001220050984; Wan P, 2007, EUPHYTICA, V155, P125, DOI 10.1007/s10681-006-9313-2; Wang CM, 2009, CEREAL RES COMMUN, V37, P13, DOI 10.1556/CRC.37.2009.1.2; Wang CM, 2009, PLANT DIS, V93, P124, DOI 10.1094/PDIS-93-2-0124; Wang D, 2010, EUPHYTICA, V176, P157, DOI 10.1007/s10681-010-0199-7; Xu H, 2012, CYTOGENET GENOME RES, V136, P220, DOI 10.1159/000336478; Zheng Q, 2006, EUPHYTICA, V152, P51, DOI 10.1007/s10681-006-9176-6; Zhong G. C., 2002, WHEAT DISTANT HYBRID; Zhuang QS., 2003, CHINESE WHEAT IMPROV	46	36	36	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134534	10.1371/journal.pone.0134534	http://dx.doi.org/10.1371/journal.pone.0134534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237413	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400028
J	Evans-Marin, HL; Cao, AT; Yao, SX; Chen, FD; He, C; Liu, H; Wu, W; Gonzalez, MG; Dann, SM; Cong, YZ				Evans-Marin, Heather L.; Cao, Anthony T.; Yao, Suxia; Chen, Feidi; He, Chong; Liu, Han; Wu, Wei; Gonzalez, Maria G.; Dann, Sara M.; Cong, Yingzi			Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR; INTESTINAL INFLAMMATION; EXPERIMENTAL COLITIS; CXCL12 SDF-1-ALPHA; CROHNS-DISEASE; INDUCTION; STIMULATION; MECHANISMS	T cells reactive to microbiota regulate the pathogenesis of inflammatory bowel disease (IBD). As T cell trafficking to intestines is regulated through interactions between highly specific chemokine-chemokine receptors, efforts have been made to develop intestine-specific immunosuppression based on blocking these key processes. CCR9, a gut-trophic chemokine receptor expressed by lymphocytes and dendritic cells, has been implicated in the regulation of IBD through mediating recruitment of T cells to inflamed sites. However, the role of CCR9 in inducing and sustaining inflammation in the context of IBD is poorly understood. In this study, we demonstrate that CCR9 deficiency in effector T cells and Tregs does not affect the development of colitis in a microbiota antigen-specific, T cell-mediated model. However, Treg cells express higher levels of CCR9 compared to those in effector T cells. Interestingly, CCR9 inhibits Treg cell development, in that CCR9(-/)-mice demonstrate a high level of Foxp3(+) Tregs, and ligation of CCR9 by its ligand CCL25 inhibits Treg cell differentiation in vitro. Collectively, our data indicate that in addition to acting as a gut-homing molecule, CCR9 signaling shapes immune responses by inhibiting Treg cell development.	[Evans-Marin, Heather L.; Cao, Anthony T.; Yao, Suxia; He, Chong; Liu, Han; Wu, Wei; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Chen, Feidi; Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [He, Chong; Wu, Wei] Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Liu, Han] Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Gonzalez, Maria G.] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Dann, Sara M.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Tongji University; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cong, YZ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	yicong@utmb.edu	Liu, Han/GVT-8296-2022	Dann, Sara/0000-0002-6893-2838; Cong, Yingzi/0000-0003-4167-7395	National Institutes of Health [DK079918, DK098370]; J.W. McLaughlin Predoctoral Fellowship, UTMB; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R01DK098370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.W. McLaughlin Predoctoral Fellowship, UTMB; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by DK079918 National Institutes of Health (www.nih.gov) and DK098370 National Institutes of Health (www.nih.gov) to YC. HLE is a recipient of the J.W. McLaughlin Predoctoral Fellowship, UTMB.	Baumgart DC, 2009, DTSCH ARZTEBL INT, V106, P123, DOI 10.3238/arztebl.2009.0123; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cong Y, GUT MICROBES, V3, P332; Danese S, 2014, GASTROENTEROLOGY, V147, P981, DOI 10.1053/j.gastro.2014.08.044; Eberhardson M, 2013, CLIN IMMUNOL, V149, P73, DOI 10.1016/j.clim.2013.05.021; Evans-Marin Heather L., 2014, Inflammation & Allergy Drug Targets, V13, P65; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Johnson EL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-15; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Karlsson F, 2013, INFLAMM BOWEL DIS, V19, P2282, DOI 10.1097/MIB.0b013e31829c32dd; Keshav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060094; Linton L, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.23; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Sapir Y, 2010, J IMMUNOL, V185, P2589, DOI 10.4049/jimmunol.1000666; Saruta M, 2007, J IMMUNOL, V178, P3293, DOI 10.4049/jimmunol.178.5.3293; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shachar I, 2013, J LEUKOCYTE BIOL, V93, P51, DOI 10.1189/jlb.0612293; Shale M, 2013, IMMUNOL REV, V252, P164, DOI 10.1111/imr.12039; Sharma PK, 2010, INT J CANCER, V127, P2020, DOI 10.1002/ijc.25219; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Wurbel MA, 2014, INFLAMM BOWEL DIS, V20, P1165, DOI 10.1097/MIB.0000000000000059; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	36	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134100	10.1371/journal.pone.0134100	http://dx.doi.org/10.1371/journal.pone.0134100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230654	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400071
J	Martinez-Cuenca, MR; Martinez-Alcantara, B; Quinones, A; Ruiz, M; Iglesias, DJ; Primo-Millo, E; Forner-Giner, MA				Martinez-Cuenca, Mary-Rus; Martinez-Alcantara, Belen; Quiones, Ana; Ruiz, Marta; Iglesias, Domingo J.; Primo-Millo, Eduardo; Angeles Forner-Giner, M.			Physiological and Molecular Responses to Excess Boron in Citrus macrophylla W	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; OXIDATIVE STRESS; MESSENGER-RNA; BORIC-ACID; RT-PCR; TOLERANCE; TRANSPORTER; EXPRESSION; TOXICITY; PLANTS	This work provides insight into several mechanisms involved in boron (B) regulation pathway in response to high B conditions in Citrus. The study was carried out in Citrus macrophylla W. (Cm) seedlings cultured "in vitro" in media with 50 or 400 mu M H3BO3 (control, Ct, and B-excess, +B, plants, respectively). Growth parameters, B concentration, leaf chlorophyll (Chl) concentration, the expression of the main putative genes involved in B transport and distribution, and leaf and root proline and malonaldehyde (MDA) concentrations, were assessed. Excess B led to high B concentration in +B plants (3.8- and 1.4-fold in leaves and roots, respectively) when compared with Ct ones. However, a minor effect was recorded in the plant (incipient visual symptoms, less than 27% reduction in root growth and 26% decrease in Chl b concentration). B toxicity down-regulated by half the expression level of putative B transporter genes NIP5 and PIP1. CmBOR1 gene was not repressed in +B plants and B accumulated in the shoots. High B level increased the transcripts of putative gene TIP5, involved in B transport across the tonoplast, by 3.3- and 2.4-fold in leaves and roots, respectively. The activity of V-PPiase proton pump, related with the electrochemical gradient in the vacuole, was also enhanced in +B organs. B toxicity up-regulated putative BOR4 gene (2.1- and 2.7-fold in roots and leaves, respectively), which codifies for an active efflux B transporter. Accordingly, B was located in +B plants preferently in an insoluble form on cell walls. Finally, excess B caused a significant rise in proline concentration (51% and 34% in roots and leaves, respectively), while the MDA level did not exceed 20%. In conclusion, Cm tolerance to a high B level is likely based on the synergism of several specific mechanisms against B toxicity, including: 1/ down-regulation of NIP5 and PIP1 boron transporters; 2/ activation of B efflux from cells due to the up-regulation of putative BOR4 gene; 3/ compartmentation of B in the vacuole through TIP5 transporter activation and the acidification of the organelle; 4/ insolubilisation of B and deposition in cell walls preventing from cytoplasm damage; and, 5/ induction of an efficient antioxidant system through proline accumulation.	[Martinez-Cuenca, Mary-Rus; Martinez-Alcantara, Belen; Quiones, Ana; Iglesias, Domingo J.; Primo-Millo, Eduardo; Angeles Forner-Giner, M.] Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Valencia, Spain; [Ruiz, Marta] Valencian Inst Agrarian Res, Dept Vegetal Protect & Biotechnol, Valencia, Spain		Martinez-Cuenca, MR (corresponding author), Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Valencia, Spain.	martinez_mru@gva.es	Iglesias, Domingo J./C-9000-2014; Forner-Giner, Angeles/D-5306-2014; Primo-Millo, Eduardo/D-8584-2014; Quinones, Ana/E-6229-2014; Martinez-Cuenca, Mary-Rus/K-7710-2015	Forner-Giner, Angeles/0000-0003-3237-0893; Primo-Millo, Eduardo/0000-0002-2146-0175; Quinones, Ana/0000-0002-6096-734X; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951; MARTINEZ ALCANTARA, BELEN/0000-0002-7816-4115; Ruiz, Marta/0000-0002-7818-4327	National Institute of Research and Agrarian and Food Technology [RTA2011-00127]; Valencian Generalitat; FEDER funds	National Institute of Research and Agrarian and Food Technology; Valencian Generalitat; FEDER funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2011-00127), Valencian Generalitat and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JC, 2012, SCI HORTIC-AMSTERDAM, V142, P149, DOI 10.1016/j.scienta.2012.05.013; Atik AE, 2011, TURK J BOT, V35, P379, DOI 10.3906/bot-1007-29; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Canon P, 2013, PHYSIOL PLANTARUM, V149, P329, DOI 10.1111/ppl.12037; Cervilla LM, 2007, ANN BOT-LONDON, V100, P747, DOI 10.1093/aob/mcm156; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Embleton TW, 1973, CITRUS IND, V3, P145; Eraslan F, 2007, J PLANT NUTR, V30, P981, DOI 10.1080/15226510701373221; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; Gimeno V, 2012, TREES-STRUCT FUNCT, V26, P1513, DOI 10.1007/s00468-012-0724-5; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gunes A, 2006, SCI HORTIC-AMSTERDAM, V110, P279, DOI 10.1016/j.scienta.2006.07.014; Hajiboland R, 2013, ACTA PHYSIOL PLANT, V35, P2373, DOI 10.1007/s11738-013-1272-3; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hanitzsch M, 2007, MOL MEMBR BIOL, V24, P507, DOI 10.1080/09687680701447393; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kaur S, 2006, FUNCT PLANT BIOL, V33, P973, DOI 10.1071/FP06111; Keles Y, 2004, PLANT SOIL, V265, P345, DOI 10.1007/s11104-005-0646-8; Legua P, 2014, SCI HORTIC-AMSTERDAM, V174, P60, DOI 10.1016/j.scienta.2014.05.004; Liu GD, 2013, PLANT SOIL, V370, P555, DOI 10.1007/s11104-013-1659-3; MAKKEE M, 1985, RECL TRAV CHIM PAY B, V104, P230; Martinez-Alcantara B, 2015, ENVIRON EXP BOT, V111, P52, DOI 10.1016/j.envexpbot.2014.11.002; Martinez-Ballesta MD, 2008, PHYSIOL PLANTARUM, V132, P479, DOI 10.1111/j.1399-3054.2007.01045.x; Mei L, 2011, SCI HORTIC-AMSTERDAM, V129, P426, DOI 10.1016/j.scienta.2011.04.012; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Pandey N, 2013, ACTA PHYSIOL PLANT, V35, P697, DOI 10.1007/s11738-012-1110-z; Pang YQ, 2010, J GENET GENOMICS, V37, P389, DOI 10.1016/S1673-8527(09)60057-6; Papadakis IE, 2004, PLANT SCI, V166, P539, DOI 10.1016/j.plantsci.2003.10.027; Perez-Castro R, 2012, PLANT CELL PHYSIOL, V53, P485, DOI 10.1093/pcp/pcs001; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Reid R, 2007, PLANT CELL PHYSIOL, V48, P1673, DOI 10.1093/pcp/pcm159; Rodriguez-Gamir J, 2011, PLANT PHYSIOL BIOCH, V49, P636, DOI 10.1016/j.plaphy.2011.03.003; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Silva P, 2009, PLANT SIGNAL BEHAV, V4, P718, DOI 10.4161/psb.4.8.9236; Stiles AR, 2010, ENVIRON SCI TECHNOL, V44, P7089, DOI 10.1021/es1016334; Sun JH, 2012, MOL BIOL REP, V39, P1963, DOI 10.1007/s11033-011-0930-z; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2011, PLANT CELL, V23, P3547, DOI 10.1105/tpc.111.088351; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang LT, 2012, MOL BIOL REP, V39, P6353, DOI 10.1007/s11033-012-1457-7; Zekri M, 2002, CITRUS IND, V83, P17	57	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134372	10.1371/journal.pone.0134372	http://dx.doi.org/10.1371/journal.pone.0134372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225859	Green Published, gold			2022-12-26	WOS:000358837700081
J	Saavedra-Garcia, L; Bernabe-Ortiz, A; Gilman, RH; Diez-Canseco, F; Cardenas, MK; Sacksteder, KA; Miranda, JJ				Saavedra-Garcia, Lorena; Bernabe-Ortiz, Antonio; Gilman, Robert H.; Diez-Canseco, Francisco; Kathia Cardenas, Maria; Sacksteder, Katherine A.; Jaime Miranda, J.			Applying the Triangle Taste Test to Assess Differences between Low Sodium Salts and Common Salt: Evidence from Peru	PLOS ONE			English	Article							BLOOD-PRESSURE; POTASSIUM-CHLORIDE; RANDOMIZED-TRIALS; MORTALITY; REDUCTION; METAANALYSIS; MAGNESIUM; DISEASE; FLAVOR; ADULTS	Background In resourced-constrained settings, daily cooking practices are still the norm. Replacing sodium in regular salt to produce potassium-enriched salts are potential alternative routes to reduce sodium intake, paired with the benefit associated with potassium intake. This change would likely have effects on palatability and taste of prepared foods, yet a threshold to discriminate sensorial changes can be determined. The main goal of this study was to assess if the use of potassium-enriched salt substitutes lead to perceived differences in taste utilizing a sensory discrimination test. Methods and Results A triangle taste test was conducted and participants were offered samples of cooked rice prepared with different salts. The only ingredient that differed in the preparation was the salt used: 100% NaCl (regular salt) and salts where sodium was replaced by 50%, 33% or 25% KCl (potassium-enriched salt). Comparisons were carried out according to the minimum number of correct judgments. A total of 156 subjects, 49% males, mean age 41.0 years (SD +/- 15.5) years, participated in the study. Samples using 25% potassium-enrichment were indistinguishable in terms of taste from regular salt, whereas samples with 33% and 50% potassium-enrichment were distinguishable. Results were consistent when stratified by sex and age. Less than 10% of participants attributed the differences to bitterness or metallic flavor. Conclusions The 25% potassium-enriched salt is indistinguishable from regular salt. These findings suggest a potential to achieve sodium intake reduction strategies in cooking practices by substituting regular salt with potassium-enriched salt without affecting palatability.	[Saavedra-Garcia, Lorena; Bernabe-Ortiz, Antonio; Diez-Canseco, Francisco; Kathia Cardenas, Maria; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Gilman, Robert H.; Sacksteder, Katherine A.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] Asociac Benef PRISMA, Area Invest & Desarrollo, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Dept Med, Sch Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Saavedra-Garcia, Lorena/AAC-4956-2021	Saavedra-Garcia, Lorena/0000-0003-1524-780X; Diez-Canseco, Francisco/0000-0002-7611-8190; CARDENAS, MARIA KATHIA/0000-0002-3173-9284; Miranda, J. Jaime/0000-0002-4738-5468; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America under the Global Alliance for Chronic Diseases programme [1 U01 HL114180-01]; National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases [268200900033C-1-0-1]; Medical Research Council [MR/K007467/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114180] Funding Source: NIH RePORTER; MRC [MR/K007467/1] Funding Source: UKRI	National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America under the Global Alliance for Chronic Diseases programme; National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is supported by a grant from the National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America (Project 1 U01 HL114180-01) under the Global Alliance for Chronic Diseases programme. All authors and the CRONICAS Center of Excellence in Chronic Diseases are supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases (Project Number 268200900033C-1-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Armenteros M, 2012, MEAT SCI, V90, P361, DOI 10.1016/j.meatsci.2011.07.023; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bernabe-Ortiz A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-93; Bi J, 2006, SENSORY DISCRIMINATION TESTS AND MEASUREMENTS: STATISTICAL PRINCIPLES, PROCEDURES AND TABLES, P1; Bobowski N, 2015, CHEMOSENS PERCEPT, V8, P112, DOI 10.1007/s12078-015-9179-6; Braschi A, 2009, INT J FOOD SCI NUTR, V60, P507, DOI 10.1080/09637480701782118; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; DeSimone JA, 2013, NUTR REV, V71, P52, DOI 10.1111/nure.12006; Dickinson HO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004641.pub2; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Geleijnse JM, 2007, EUR J EPIDEMIOL, V22, P763, DOI 10.1007/s10654-007-9186-2; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Grummer J, 2013, J DAIRY SCI, V96, P1401, DOI 10.3168/jds.2012-6057; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Hetherington MM, 1996, NEUROSCI BIOBEHAV R, V20, P113, DOI 10.1016/0149-7634(95)00048-J; Hooper L, 2004, COCHRANE DATABASE SY; Li N, 2009, BRIT J NUTR, V101, P1088, DOI 10.1017/S0007114508042360; Liem DG, 2011, NUTRIENTS, V3, P694, DOI 10.3390/nu3060694; Meilgaard M. C., 2007, SENSORY EVAL TECHN, V4th; Organization WH, 2016, GLOBAL STATUS REPORT; Pretell EA, 2004, THYROID, V14, P590, DOI 10.1089/1050725041692909; Saavedra-Garcia L, 2015, PUBLIC HEALTH NUTR, V19, P1; SALOVAARA H, 1982, CEREAL CHEM, V59, P427; Sarkkinen ES, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-88; Sinopoli DA, 2012, J FOOD SCI, V77, pS319, DOI 10.1111/j.1750-3841.2012.02862.x; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organisation, 2012, GUID SOD INT AD CHIL GUID SOD INT AD CHIL; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Zhou B, 2013, J HUM HYPERTENS, V27, P427, DOI 10.1038/jhh.2012.63	35	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134700	10.1371/journal.pone.0134700	http://dx.doi.org/10.1371/journal.pone.0134700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225848	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700131
J	Catarino, R; Vassilakos, P; Scaringella, S; Undurraga-Malinverno, M; Meyer-Hamme, U; Ricard-Gauthier, D; Matute, JC; Petignat, P				Catarino, Rosa; Vassilakos, Pierre; Scaringella, Stefano; Undurraga-Malinverno, Manuela; Meyer-Hamme, Ulrike; Ricard-Gauthier, Dominique; Matute, Juan Carlos; Petignat, Patrick			Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; POOLED ANALYSIS; KNOWLEDGE; AFRICA	Background Visual inspection of the cervix after application of 5% acetic acid (VIA) is a screening technique for cervical cancer used widely in low and middle-income countries (LMIC). To improve VIA screening performance, digital images after acid acetic application (D-VIA) are taken. The aim of this study was to evaluate the use of a smartphone for on- and off-site D-VIA diagnosis. Materials and Methods Women aged 30-65 years, living in the city of Ambanja, Madagascar, were recruited through a cervical cancer screening campaign. Each performed a human papillomavirus (HPV) self-sample as a primary screen. Women testing positive for HPV were referred for VIA followed by D-VIA, cervical biopsy and endocervical curettage according to routine protocol. In addition, the same day, the D-VIA was emailed to a tertiary care center for immediate assessment. Results were scored as either D-VIA normal or D-VIA abnormal, requiring immediate therapy or referral to a tertiary center. Each of the three off-site physicians were blinded to the result reported by the one on-site physician and each gave their individual assessment followed by a consensus diagnosis. Statistical analyses were conducted using STATA software. Results Of the 332 women recruited, 137 (41.2%) were HPV-positive and recalled for VIA triage; compliance with this invitation was 69.3% (n = 95). Cervical intraepithelial neoplasia was detected in 17.7% and 21.7% of digital images by on-site and off-site physicians, respectively. The on-site physician had a sensitivity of 66.7% (95% CI: 30.0-90.3) and a specificity of 85.7% (95% CI: 76.7-91.6); the off-site physician consensus sensitivity was 66.7% (95% CI: 30.0-90.3) with a specificity of 82.3%(95% CI: 72.4-89.1). Conclusion This pilot study supports the use of telemedicine for off-site diagnosis of cervical intraepithelial neoplasia, with diagnostic performance similar to those achieved on-site. Further studies need to determine if smartphones can improve cervical cancer screening efficiency in LMIC.	[Catarino, Rosa; Undurraga-Malinverno, Manuela; Meyer-Hamme, Ulrike; Ricard-Gauthier, Dominique; Matute, Juan Carlos; Petignat, Patrick] Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland; [Scaringella, Stefano] St Damien Hlth Care Ctr, Ambanja, Madagascar	University of Geneva	Catarino, R (corresponding author), Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland.	rosapintocatarino@gmail.com		Ricard-Gauthier, Dominique/0000-0002-7796-9587; Catarino, Rosa/0000-0002-5317-7710; Petignat, Patrick/0000-0002-6835-533X	Action Madagascar Foundation; University Hospitals of Geneva, Switzerland	Action Madagascar Foundation; University Hospitals of Geneva, Switzerland	This study was supported by the Action Madagascar Foundation and the University Hospitals of Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bediang G, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00180; Bigoni J, 2015, INT J CANCER, V137, P127, DOI 10.1002/ijc.29353; Blumenthal PD, 2005, INT J GYNECOL OBSTET, V89, pS30, DOI 10.1016/j.ijgo.2005.01.012; Bruni L, ICO INFORM CTR HPV C; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Ebu NI, 2015, INT J WOMENS HEALTH, V7, P31, DOI 10.2147/IJWH.S71797; Ferris DG, 2002, OBSTET GYNECOL, V99, P248, DOI 10.1016/S0029-7844(01)01671-4; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Hitt WC, 2013, TELEMED E-HEALTH, V19, P403, DOI 10.1089/tmj.2012.0148; Makwe CC, 2012, J EPIDEMIOL GLOB HEA, V2, P199, DOI 10.1016/j.jegh.2012.11.001; Mwaka AD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-84; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Pinco J, 2009, ARCH PATHOL LAB MED, V133, P57, DOI 10.1043/1543-2165-133.1.57; Quinley KE, 2011, J TELEMED TELECARE, V17, P203, DOI 10.1258/jtt.2011.101008; Rosser JI, 2015, PATIENT EDUC COUNS, V98, P884, DOI 10.1016/j.pec.2015.03.017; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Schadel D, 2005, J TELEMED TELECARE, V11, P103, DOI 10.1258/1357633053499831; WHO, 2013, WHO GUID SCREEN TREA; WHO Library Cataloguing-in-Publication Data, 2002, WHO LIB CAT IN PUBL; Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571	21	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134309	10.1371/journal.pone.0134309	http://dx.doi.org/10.1371/journal.pone.0134309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222772	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800129
J	Kandori, I; Tsuchihara, K; Suzuki, TA; Yokoi, T; Papaj, DR				Kandori, Ikuo; Tsuchihara, Kazuko; Suzuki, Taichi A.; Yokoi, Tomoyuki; Papaj, Daniel R.			Long Frontal Projections Help Battus philenor (Lepidoptera: Papilionidae) Larvae Find Host Plants	PLOS ONE			English	Article							PIPEVINE SWALLOWTAIL; SEXUAL SELECTION; PHENOTYPIC PLASTICITY; FORAGING BEHAVIOR; PREDATORY WASPS; CATERPILLARS; ALLOMETRY; EVOLUTION; BEETLE; PATTERNS	Animals sometimes develop conspicuous projections on or near their heads as, e.g., weaponry, burrowing or digging tools, and probes to search for resources. The frontal projections that insects generally use to locate and assess resources are segmented appendages, including antennae, maxillary palps, and labial palps. There is no evidence to date that arthropods, including insects, use projections other than true segmental appendages to locate food. In this regard, it is noteworthy that some butterfly larvae possess a pair of long antenna-like projections on or near their heads. To date, the function of these projections has not been established. Larvae of pipevine swallowtail butterflies Battus philenor (Papilionidae) have a pair of long frontal fleshy projections that, like insect antennae generally, can be actively moved. In this study, we evaluated the possible function of this pair of long moveable frontal projections. In laboratory assays, both frontal projections and lateral ocelli were shown to increase the frequency with which search larvae found plants. The frontal projections increased finding of host and non-host plants equally, suggesting that frontal projections do not detect host-specific chemical cues. Detailed SEM study showed that putative mechanosensillae are distributed all around the frontal as well as other projections. Taken together, our findings suggest that the frontal projections and associated mechanosensillae act as vertical object detectors to obtain tactile information that, together with visual information from lateral ocelli and presumably chemical information from antennae and mouthparts, help larvae to find host plants. Field observations indicate that host plants are small and scattered in southern Arizona locations. Larvae must therefore find multiple host plants to complete development and face significant challenges in doing so. The frontal projections may thus be an adaptation for finding a scarce resource before starving to death. This is the first evidence that arthropods use projections other than true segmental appendages such as antennae, mouthparts and legs, to locate food resources.	[Kandori, Ikuo] Kinki Univ, Fac Agr, Entomol Lab, Nara 631, Japan; [Tsuchihara, Kazuko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Suzuki, Taichi A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Yokoi, Tomoyuki] Univ Tsukuba, Fac Life & Environm Sci, Lab Conservat Ecol, Tsukuba, Ibaraki, Japan; [Papaj, Daniel R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Kindai University (Kinki University); Forestry & Forest Products Research Institute - Japan; University of California System; University of California Berkeley; University of Tsukuba; University of Arizona	Kandori, I (corresponding author), Kinki Univ, Fac Agr, Entomol Lab, Nara 631, Japan.	kandori@nara.kindai.ac.jp						Baker RH, 2001, EVOLUTION, V55, P1373; Bennett VA, 2003, CRYOLETTERS, V24, P191; Bergmann PJ, 2012, EVOL BIOL, V39, P311, DOI 10.1007/s11692-011-9147-2; Bierzychudek P, 2009, ECOL ENTOMOL, V34, P632, DOI 10.1111/j.1365-2311.2009.01112.x; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Cain ML, 1983, ECOL ENTOMOL, V10, P1; Crespo JG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.6201; Cunningham JP, 1998, ANIM BEHAV, V55, P227, DOI 10.1006/anbe.1997.0600; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Dethier VG, 1937, BIOL BULL-US, V72, P7, DOI 10.2307/1537535; DETHIER VG, 1989, ECOL ENTOMOL, V14, P375, DOI 10.1111/j.1365-2311.1989.tb00939.x; Dweck HKM, 2009, MICRON, V40, P769, DOI 10.1016/j.micron.2009.07.012; Emlen DJ, 2005, EVOLUTION, V59, P1060; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Fordyce JA, 2003, EVOLUTION, V57, P1089, DOI 10.1111/j.0014-3820.2003.tb00318.x; Fox H, 1999, HYDROBIOLOGIA, V403, P153, DOI 10.1023/A:1003778125517; GABEL B, 1992, J CHEM ECOL, V18, P693, DOI 10.1007/BF00994607; Gripenberg S, 2007, J ANIM ECOL, V76, P854, DOI 10.1111/j.1365-2656.2007.01261.x; Hashimoto K, 2012, ENTOMOL SCI, V15, P274, DOI 10.1111/j.1479-8298.2012.00517.x; Honda K, 2001, PHYSIOL ENTOMOL, V26, P6, DOI 10.1046/j.1365-3032.2001.00208.x; Honda K, 2011, J CHEM ECOL, V37, P575, DOI 10.1007/s10886-011-9965-9; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; IBM SPSS, 2013, IBM SPSS STAT 22; Juma G, 2008, ENTOMOL EXP APPL, V128, P93, DOI 10.1111/j.1570-7458.2008.00673.x; Kalkowski K, 1958, FOLIA BIOL, V6, P79; Layne JR, 1999, AM MIDL NAT, V141, P293, DOI 10.1674/0003-0031(1999)141[0293:CHOTWB]2.0.CO;2; Lincoln G.A., 1994, P131; Liu Z, 2011, MICRON, V42, P478, DOI 10.1016/j.micron.2011.01.006; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; Mason PA, 2014, J EXP BIOL, V217, P2250, DOI 10.1242/jeb.093716; McCullough EL, 2012, BEHAV ECOL, V23, P1042, DOI 10.1093/beheco/ars069; Murphy SM, 2010, BEHAV ECOL, V21, P153, DOI 10.1093/beheco/arp166; Nice CC, 2006, OECOLOGIA, V146, P541, DOI 10.1007/s00442-005-0229-7; Nielsen ME, 2014, OECOLOGIA; OHSUGI T, 1991, APPL ENTOMOL ZOOL, V26, P29, DOI 10.1303/aez.26.29; Okada K, 2004, ANN ENTOMOL SOC AM, V97, P1342, DOI 10.1603/0013-8746(2004)097[1342:SDIMAM]2.0.CO;2; Papaj DR, 2007, OECOLOGIA, V152, P365, DOI 10.1007/s00442-007-0658-6; Papaj DR, 2005, P ROY SOC B-BIOL SCI, V272, P2519, DOI 10.1098/rspb.2005.3186; Plard F, 2011, OIKOS, V120, P601, DOI 10.1111/j.1600-0706.2010.18934.x; Plepys D, 2002, OIKOS, V99, P75, DOI 10.1034/j.1600-0706.2002.990108.x; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; Pratt GF, 2010, J INSECT CONSERV, V14, P107, DOI 10.1007/s10841-009-9229-y; SAXENA KN, 1977, J INSECT PHYSIOL, V23, P1421, DOI 10.1016/0022-1910(77)90167-6; SAXENA KN, 1977, EXPERIENTIA, V33, P1312, DOI 10.1007/BF01920152; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; STAMP NE, 1992, OECOLOGIA, V92, P596, DOI 10.1007/BF00317854; Stamp NE, 1997, OIKOS, V79, P147, DOI 10.2307/3546099; STAMP NE, 1993, OECOLOGIA, V95, P376, DOI 10.1007/BF00320992; STAMP NE, 1988, OECOLOGIA, V75, P619, DOI 10.1007/BF00776428; Stankowich T, 2012, ADAPT BEHAV, V20, P32, DOI 10.1177/1059712311426798; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stoffolano JG, 2013, CAN ENTOMOL, V145, P265, DOI 10.4039/tce.2012.103; Tamura M, 1966, P KANTO TOSAN PLAN T, V13, P118; Warren AD, 2014, BUTTERFLIES AM	57	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131596	10.1371/journal.pone.0131596	http://dx.doi.org/10.1371/journal.pone.0131596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222554	Green Published, gold			2022-12-26	WOS:000358836800017
J	Khaw, MW; Grab, DA; Livermore, MA; Vossler, CA; Glimcher, PW				Khaw, Mel W.; Grab, Denise A.; Livermore, Michael A.; Vossler, Christian A.; Glimcher, Paul W.			The Measurement of Subjective Value and Its Relation to Contingent Valuation and Environmental Public Goods	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; ORBITOFRONTAL CORTEX; NEURAL RESPONSES; CHOICE; PREFERENCES; REPRESENTATION; ACTIVATION; MECHANISMS; VALIDITY	Environmental public goods-including national parks, clean air/water, and ecosystem services-provide substantial benefits on a global scale. These goods have unique characteristics in that they are typically "nonmarket" goods, with values from both use and passive use that accrue to a large number of individuals both in current and future generations. In this study, we test the hypothesis that neural signals in areas correlated with subjective valuations for essentially all other previously studied categories of goods (ventromedial prefrontal cortex and ventral striatum) also correlate with environmental valuations. We use contingent valuation (CV) as our behavioral tool for measuring valuations of environmental public goods. CV is a standard stated preference approach that presents survey respondents with information on an issue and asks questions that help policymakers determine how much citizens are willing to pay for a public good or policy. We scanned human subjects while they viewed environmental proposals, along with three other classes of goods. The presentation of all four classes of goods yielded robust and similar patterns of temporally synchronized brain activation within attentionalnetworks. The activations associated with the traditional classes of goods replicate previous correlations between neural activity in valuation areas and behavioral preferences. In contrast, CV-elicited values for environmental proposals did not correlate with brain activity at either the individual or population level. For a sub-population of participants, CV-elicited values were correlated with activity within the dorsomedial prefrontal cortex, a region associated with cognitive control and shifting decision strategies. The results show that neural activity associated with the subjective valuation of environmental proposals differs profoundly from the neural activity associated with previously examined goods and preference measures.	[Khaw, Mel W.; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Grab, Denise A.] NYU, Sch Law, Inst Policy Integr, New York, NY 10003 USA; [Livermore, Michael A.] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Vossler, Christian A.] Univ Tennessee, Dept Econ, Knoxville, TN USA; [Vossler, Christian A.] Univ Tennessee, Howard H Baker Jr Ctr Publ Policy, Knoxville, TN USA	New York University; New York University; University of Virginia; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Khaw, MW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	mwk247@nyu.edu	Vossler, Christian A/A-5453-2010	Khaw, Mel Win/0000-0002-6601-3715	National Institutes of Health [5R01AG033406]; NATIONAL INSTITUTE ON AGING [R01AG033406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grants from the National Institutes of Health (no. 5R01AG033406), http://grants.nih.gov/grants/oer.htm, received by PWG.	Adamowicz W, 1998, AM J AGR ECON, V80, P64, DOI 10.2307/3180269; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Carson RT, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.4.27; Carson RT, 2001, ENVIRON RESOUR ECON, V19, P173, DOI 10.1023/A:1011128332243; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Cooper JC, 2010, NEURON, V67, P511, DOI 10.1016/j.neuron.2010.06.030; Corso PS, 2001, J RISK UNCERTAINTY, V23, P165, DOI 10.1023/A:1011184119153; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fehr E, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.4.3; Gross J, 2014, J NEUROSCI, V34, P7580, DOI 10.1523/JNEUROSCI.5082-13.2014; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hausman J, 2012, J ECON PERSPECT, V26, P43, DOI 10.1257/jep.26.4.43; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Kling CL, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.4.3; Krajbich I, 2009, SCIENCE, V326, P596, DOI 10.1126/science.1177302; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Vossler CA, 2006, ENVIRON RESOUR ECON, V35, P137, DOI 10.1007/s10640-006-9011-5; Vossler CA, 2013, J ECON BEHAV ORGAN, V86, P137, DOI 10.1016/j.jebo.2012.12.007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	33	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132842	10.1371/journal.pone.0132842	http://dx.doi.org/10.1371/journal.pone.0132842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26221734	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800031
J	Voorwald, FA; Marchi, FA; Villacis, RAR; Alves, CEF; Toniollo, GH; Amorim, RL; Drigo, SA; Rogatto, SR				Voorwald, Fabiana Azevedo; Marchi, Fabio Albuquerque; Rios Villacis, Rolando Andre; Fonseca Alves, Carlos Eduardo; Toniollo, Gilson Helio; Amorim, Renee Laufer; Drigo, Sandra Aparecida; Rogatto, Silvia Regina			Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; HYPERPLASIA-PYOMETRA COMPLEX; DOGS; BITCH; INFECTION; MUCOMETRA; MARKERS; TRACT	Cystic endometrial hyperplasia (CEH), mucometra, and pyometra are common uterine diseases in intact dogs, with pyometra being a life threatening disease. This study aimed to determine the gene expression profile of these lesions and potential biomarkers for closed-cervix pyometra, the most severe condition. Total RNA was extracted from 69 fresh endometrium samples collected from 21 healthy female dogs during diestrus, 16 CEH, 15 mucometra and 17 pyometra (eight open and nine closed-cervixes). Global gene expression was detected using the Affymetrix Canine Gene 1.0 ST Array. Unsupervised analysis revealed two clusters, one mainly composed of diestrus and CEH samples and the other by 12/15 mucometra and all pyometra samples. When comparing pyometra with other groups, 189 differentially expressed genes were detected. SLPI, PTGS2/COX2, MMP1, S100A8, S100A9 and IL8 were among the top up-regulated genes detected in pyometra, further confirmed by external expression data. Notably, a particular molecular profile in pyometra from animals previously treated with exogenous progesterone compounds was observed in comparison with pyometra from untreated dogs as well as with other groups irrespective of exogenous hormone treatment status. In addition to S100A8 and S100A9 genes, overexpression of the inflammatory cytokines IL1B, TNF and IL6 as well as LTF were detected in the pyometra from treated animals. Interestingly, closed pyometra was more frequently detected in treated dogs (64% versus 33%), with IL1B, TNF, LBP and CXCL10 among the most relevant overexpressed genes. This molecular signature associated with potential biomarkers and therapeutic targets, such as CXCL10 and COX2, should guide future clinical studies. Based on the gene expression profile we suggested that pyometra from progesterone treated dogs is a distinct molecular entity.	[Voorwald, Fabiana Azevedo; Toniollo, Gilson Helio] Sao Paulo State Univ UNESP, Vet Clin, Jaboticabal, SP, Brazil; [Voorwald, Fabiana Azevedo; Toniollo, Gilson Helio] Sao Paulo State Univ UNESP, Dept Surg, Jaboticabal, SP, Brazil; [Marchi, Fabio Albuquerque; Rios Villacis, Rolando Andre; Rogatto, Silvia Regina] AC Camargo Canc Ctr, Int Res Ctr CIPE, Sao Paulo, Brazil; [Fonseca Alves, Carlos Eduardo; Amorim, Renee Laufer] Sao Paulo State Univ UNESP, Vet Clin Dept, Botucatu, SP, Brazil; [Drigo, Sandra Aparecida; Rogatto, Silvia Regina] Sao Paulo State Univ UNESP, Fac Med, Dept Urol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade Estadual Paulista; Universidade Estadual Paulista	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Int Res Ctr CIPE, Sao Paulo, Brazil.	rogatto@fmb.unesp.br	Drigo, Sandra A/I-6514-2012; Voorwald, Fabiana A/G-6893-2013; Fonseca-Alves, Carlos Eduardo/G-7554-2012; Marchi, Fabio A/N-9288-2018; Rogatto, Silvia R/E-6535-2012; LINDE, SANDRA/S-3128-2019; AMORIM, RENEE LAUFER/AAV-2951-2020	Drigo, Sandra A/0000-0001-6747-6642; Fonseca-Alves, Carlos Eduardo/0000-0002-6702-6139; Marchi, Fabio A/0000-0001-5815-8423; LINDE, SANDRA/0000-0001-6747-6642; AMORIM, RENEE LAUFER/0000-0002-8653-7938; Rogatto, Silvia/0000-0003-4637-5687; Villacis, Rolando/0000-0003-3851-2696	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); FAPESP [2011/51976-2]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). SRR received research grants from FAPESP (2011/51976-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branescu C, 2012, J Med Life, V5, P342; De Bosschere H, 2001, THERIOGENOLOGY, V55, P1509, DOI 10.1016/S0093-691X(01)00498-8; Egenvall A, 2001, J VET INTERN MED, V15, P530, DOI 10.1892/0891-6640(2001)015&lt;0530:BROPII&gt;2.3.CO;2; Drago-Serrano ME, 2012, INT IMMUNOPHARMACOL, V12, P1, DOI 10.1016/j.intimp.2011.11.002; Fieni F, 2014, REPROD DOMEST ANIM, V49, P28, DOI 10.1111/rda.12302; Floras ANK, 2014, J VET INTERN MED, V28, P1447, DOI 10.1111/jvim.12409; Hagman R, 2014, REPROD DOMEST ANIM, V49, P16, DOI 10.1111/rda.12331; Hagman R, 2012, REPROD DOMEST ANIM, V47, P323, DOI 10.1111/rda.12031; Hagman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008039; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Harvey MJA, 1997, J SMALL ANIM PRACT, V38, P336, DOI 10.1111/j.1748-5827.1997.tb03480.x; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Johnston SD, 2001, CANINE FELINE THERIO, P206; Karlsson I, 2012, REPROD DOMEST ANIM, V47, P337, DOI 10.1111/rda.12034; Kida K, 2006, THERIOGENOLOGY, V66, P1325, DOI 10.1016/j.theriogenology.2006.04.028; Pretzer SD, 2008, THERIOGENOLOGY, V70, P359, DOI 10.1016/j.theriogenology.2008.04.028; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Serrano M, 2013, ATHEROSCLEROSIS, V230, P223, DOI 10.1016/j.atherosclerosis.2013.07.004; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Smith FO, 2006, THERIOGENOLOGY, V66, P610, DOI 10.1016/j.theriogenology.2006.04.023; Sorribas CE, 2006, ATLAS REPROD CANINA; Tahir MZ, 2013, DOMEST ANIM ENDOCRIN, V45, P141, DOI 10.1016/j.domaniend.2013.07.002; Tsalkidou EA, 2013, PEDIATR NEPHROL, V28, P1091, DOI 10.1007/s00467-013-2432-9; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Verstegen J, 2008, THERIOGENOLOGY, V70, P364, DOI 10.1016/j.theriogenology.2008.04.036	28	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133894	10.1371/journal.pone.0133894	http://dx.doi.org/10.1371/journal.pone.0133894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222498	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800077
J	Dodd, RD; Sachdeva, M; Mito, JK; Eward, WC; Brigman, BE; Ma, Y; Dodd, L; Kim, Y; Lev, D; Kirsch, DG				Dodd, R. D.; Sachdeva, M.; Mito, J. K.; Eward, W. C.; Brigman, B. E.; Ma, Y.; Dodd, L.; Kim, Y.; Lev, D.; Kirsch, D. G.			Myogenic transcription factors regulate pro-metastatic miR-182	ONCOGENE			English	Article							MOUSE MODEL; SARCOMA; PAX7; NETWORKS; DISTINCT; GENES	Approximately 30% of patients with soft-tissue sarcoma die from pulmonary metastases. The mechanisms that drive sarcoma metastasis are not well understood. Recently, we identified miR-182 as a driver of sarcoma metastasis in a primary mouse model of soft-tissue sarcoma. We also observed elevated miR-182 in a subset of primary human sarcomas that metastasized to the lungs. Here, we show that myogenic differentiation factors regulate miR-182 levels to contribute to metastasis in mouse models. We find that MyoD directly binds the miR-182 promoter to increase miR-182 expression. Furthermore, mechanistic studies revealed that Pax7 can promote sarcoma metastasis in vivo through MyoD-dependent regulation of pro-metastatic miR-182. Taken together, these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression.	[Dodd, R. D.; Sachdeva, M.; Ma, Y.; Kirsch, D. G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Box 91006, Durham, NC 27708 USA; [Mito, J. K.; Kirsch, D. G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Eward, W. C.; Brigman, B. E.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA; [Dodd, L.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Kim, Y.] Seoul Natl Univ, Coll Vet Med, Dept Clin Pathol, Seoul, South Korea; [Lev, D.] Univ Texas MD Anderson Canc Ctr, Sarcoma Res Ctr, Houston, TX 77030 USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center	Kirsch, DG (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Box 91006, Durham, NC 27708 USA.	david.kirsch@duke.edu		Dodd, Rebecca/0000-0001-7295-1882	American Cancer Society/Canary Foundation; Children's Tumor Foundation; QuadW/AACR; SARC SPORE pilot project [5U54 CA 168512-02];  [RO1 CA 138265]; NATIONAL CANCER INSTITUTE [R01CA138265] Funding Source: NIH RePORTER	American Cancer Society/Canary Foundation(American Cancer Society); Children's Tumor Foundation; QuadW/AACR; SARC SPORE pilot project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ron Dephino (MD Anderson) for providing the Ink4a/Arf flox mice, Tyler Jacks (MIT) for the LSL-Kras mice, and Anton Berns (Netherlands Cancer Institute) for the p53 flox mice. We thank Michael Rudnicki for the Pax7-FLAG tagged vectors. We thank Laura Jeffords, Rafaela Rodrigues, and Loretta Woodleif for assistance with mouse work. RDD is supported by postdoctoral fellowships from the American Cancer Society/Canary Foundation and the Children's Tumor Foundation. MS is supported by a postdoctoral fellowship from the QuadW/AACR. This work is supported by RO1 CA 138265 (DGK) and a SARC SPORE pilot project 5U54 CA 168512-02 (DKG and RDD).	Blum JM, 2013, CELL REP, V5, P933, DOI 10.1016/j.celrep.2013.10.020; Borden EC, 2003, CLIN CANCER RES, V9, P1941; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Canter RJ, 2007, CANCER, V110, P2050, DOI 10.1002/cncr.23023; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Dodd RD, 2010, DIS MODEL MECH, V3, P557, DOI 10.1242/dmm.005223; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mito JK, 2013, J PATHOL, V229, P132, DOI 10.1002/path.4099; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	29	16	16	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1868	1875		10.1038/onc.2015.252	http://dx.doi.org/10.1038/onc.2015.252			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26234681	Green Accepted, Green Submitted			2022-12-26	WOS:000373610400012
J	Liu, QG; Wang, ZC; Xu, XM; Zhang, HZ; Li, CH				Liu, Quangang; Wang, Zhanchao; Xu, Xuemei; Zhang, Haizhen; Li, Chenghao			Genome-Wide Analysis of C2H2 Zinc-Finger Family Transcription Factors and Their Responses to Abiotic Stresses in Poplar (Populus trichocarpa)	PLOS ONE			English	Article							PROTEIN GENE; SALT TOLERANCE; COMPREHENSIVE ANALYSIS; SALINITY STRESS; ARABIDOPSIS; DROUGHT; EXPRESSION; RICE; EXPANSION; COLD	Background C2H2 zinc-finger (C2H2-ZF) proteins are a large gene family in plants that participate in various aspects of normal plant growth and development, as well as in biotic and abiotic stress responses. To date, no overall analysis incorporating evolutionary history and expression profiling of the C2H2-ZF gene family in model tree species poplar (Populus trichocarpa) has been reported. Principal Findings Here, we identified 109 full-length C2H2-ZF genes in P. trichocarpa, and classified them into four groups, based on phylogenetic analysis. The 109 C2H2-ZF genes were distributed unequally on 19 P. trichocarpa linkage groups (LGs), with 39 segmental duplication events, indicating that segmental duplication has been important in the expansion of the C2H2-ZF gene family. Promoter cis-element analysis indicated that most of the C2H2-ZF genes contain phytohormone or abiotic stress-related cis-elements. The expression patterns of C2H2-ZF genes, based on heatmap analysis, suggested that C2H2-ZF genes are involved in tissue and organ development, especially root and floral development. Expression analysis based on quantitative real-time reverse transcription polymerase chain reaction indicated that C2H2-ZF genes are significantly involved in drought, heat and salt response, possibly via different mechanisms. Conclusions This study provides a thorough overview of the P. trichocarpa C2H2-ZF gene family and presents a new perspective on the evolution of this gene family. In particular, some C2H2ZF genes may be involved in environmental stress tolerance regulation. PtrZFP2, 19 and 95 showed high expression levels in leaves and/or roots under environmental stresses. Additionally, this study provided a solid foundation for studying the biological roles of C2H2-ZF genes in Populus growth and development. These results form the basis for further investigation of the roles of these candidate genes and for future genetic engineering and gene functional studies in Populus.	[Liu, Quangang; Wang, Zhanchao; Zhang, Haizhen; Li, Chenghao] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China; [Xu, Xuemei] Lib Northeast Forestry Univ, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Li, CH (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China.	chli0@163.com						Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bi HQ, 2014, AGR FOREST METEOROL, V197, P188, DOI 10.1016/j.agrformet.2014.06.006; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Caldeira CF, 2014, PLANT PHYSIOL, V164, P1718, DOI 10.1104/pp.113.228379; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Dinneny JR, 2006, DEVELOPMENT, V133, P2285, DOI 10.1242/dev.02416; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gourcilleau D, 2011, DNA RES, V18, P77, DOI 10.1093/dnares/dsr001; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu B, 2014, BIOINFORMATICS; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Huang F, 2006, MOL BIOL REP, V33, P279, DOI 10.1007/s11033-006-9012-z; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; Joseph MP, 2014, PLANT PHYSIOL, V165, P1203, DOI 10.1104/pp.113.234294; Kam J, 2008, PLANT MOL BIOL, V67, P305, DOI 10.1007/s11103-008-9319-3; Kim SH, 2004, PLANT MOL BIOL, V55, P883, DOI 10.1007/s11103-005-2151-0; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li CL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-131; Li SJ, 2010, MOL CELLS, V29, P475, DOI 10.1007/s10059-010-0059-2; Liu QG, 2015, PLANT MOL BIOL REP, V33, P1740, DOI 10.1007/s11105-015-0870-1; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Luo X, 2012, PLANTA, V235, P1141, DOI 10.1007/s00425-011-1563-0; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Moore Michael, 2003, Briefings in Functional Genomics & Proteomics, V1, P342, DOI 10.1093/bfgp/1.4.342; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Song YP, 2014, PLANT MOL BIOL, V86, P139, DOI 10.1007/s11103-014-0218-5; Street NR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-589; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; Syvertsen JP, 2014, ENVIRON EXP BOT, V103, P128, DOI 10.1016/j.envexpbot.2013.09.015; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian ZD, 2010, PLANT BIOLOGY, V12, P689, DOI 10.1111/j.1438-8677.2009.00276.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang Z, 2013, GASTROENT RES PRACT, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0055471; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211	87	69	76	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134753	10.1371/journal.pone.0134753	http://dx.doi.org/10.1371/journal.pone.0134753			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237514	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400037
J	Norstrom, M; Kristoffersen, AB; Gorlach, FS; Nygard, K; Hopp, P				Norstrom, Madelaine; Kristoffersen, Anja Brathen; Gorlach, Franziska Sophie; Nygard, Karin; Hopp, Petter			An Adjusted Likelihood Ratio Approach Analysing Distribution of Food Products to Assist the Investigation of Foodborne Outbreaks	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI; SAFETY	In order to facilitate foodborne outbreak investigations there is a need to improve the methods for identifying the food products that should be sampled for laboratory analysis. The aim of this study was to examine the applicability of a likelihood ratio approach previously developed on simulated data, to real outbreak data. We used human case and food product distribution data from the Norwegian enterohaemorrhagic Escherichia coli outbreak in 2006. The approach was adjusted to include time, space smoothing and to handle missing or misclassified information. The performance of the adjusted likelihood ratio approach on the data originating from the HUS outbreak and control data indicates that the adjusted approach is promising and indicates that the adjusted approach could be a useful tool to assist and facilitate the investigation of food borne outbreaks in the future if good traceability are available and implemented in the distribution chain. However, the approach needs to be further validated on other outbreak data and also including other food products than meat products in order to make a more general conclusion of the applicability of the developed approach.	[Norstrom, Madelaine; Kristoffersen, Anja Brathen; Gorlach, Franziska Sophie; Hopp, Petter] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway; [Gorlach, Franziska Sophie] Tech Univ Munich, D-80290 Munich, Germany; [Nygard, Karin] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	Norwegian Veterinary Institute; Technical University of Munich; Norwegian Institute of Public Health (NIPH)	Norstrom, M (corresponding author), Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway.	madelaine.norstrom@vetinst.no		Hopp, Petter/0000-0002-8695-0378				[Anonymous], 2006, E COLI O103 UTBRUDDE; Aung MM, 2014, FOOD CONTROL, V39, P172, DOI 10.1016/j.foodcont.2013.11.007; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Beni LH, 2012, SPAT SPATIO-TEMPORAL, V3, P215, DOI 10.1016/j.sste.2012.02.009; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Doerr D., 2012, P ACM 1 ACM SIGSPATI, P44, DOI [10.1145/2452516.2452525, DOI 10.1145/2452516.2452525]; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; HUFF DL, 1963, LAND ECON, V39, P81, DOI 10.2307/3144521; Kaferstein F, 1999, B WORLD HEALTH ORGAN, V77, P347; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Kaufman J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003692; KELLO D, 1990, FOOD ADDIT CONTAM, V7, pS5, DOI 10.1080/02652039009373835; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Norstrom M, 2012, ISVEE 13 INT S VET E, P114; R Core Team, 2012, R LANG ENV STAT COMP; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Sekse C, 2009, INT J FOOD MICROBIOL, V133, P259, DOI 10.1016/j.ijfoodmicro.2009.05.026; Stewart G.F., 1982, INTRO FOOD SCI TECHN; Tirado C, 2001, J INFECTION, V43, P80, DOI 10.1053/jinf.2001.0861; Werber D, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-11; World Health Organization (WHO), 2008, FOODB DIS OUTBR GUID	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134344	10.1371/journal.pone.0134344	http://dx.doi.org/10.1371/journal.pone.0134344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237468	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942400023
J	Roybal, KT; Mace, EM; Mantell, JM; Verkade, P; Orange, JS; Wulfing, C				Roybal, Kole T.; Mace, Emily M.; Mantell, Judith M.; Verkade, Paul; Orange, Jordan S.; Wuelfing, Christoph			Early Signaling in Primary T Cells Activated by Antigen Presenting Cells Is Associated with a Deep and Transient Lamellal Actin Network	PLOS ONE			English	Article							KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; SPATIOTEMPORAL ORGANIZATION; RECEPTOR MICROCLUSTERS; RETROGRADE FLOW; STEM-CELLS; F-ACTIN; CYTOSKELETON; MOLECULES; DYNAMICS	Cellular signaling transduction critically depends on molecular interactions that are in turn governed by dynamic subcellular distributions of the signaling system components. Comprehensive insight into signal transduction requires an understanding of such distributions and cellular structures driving them. To investigate the activation of primary murine T cells by antigen presenting cells (APC) we have imaged more than 60 signaling intermediates during T cell stimulation with microscopy across resolution limits. A substantial number of signaling intermediates associated with a transient, wide, and actin-associated lamellum extending from an interdigitated T cell: APC interface several micrometers into the T cell, as characterized in detail here. By mapping the more than 60 signaling intermediates onto the spatiotemporal features of cell biological structures, the lamellum and other ones previously described, we also define distinct spatial and temporal characteristics of T cell signal initiation, amplification, and core signaling in the activation of primary T cells by APCs. These characteristics differ substantially from ones seen when T cells are activated using common reductionist approaches.	[Roybal, Kole T.; Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Mace, Emily M.; Orange, Jordan S.] Univ Penn, Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Mantell, Judith M.; Verkade, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA; [Wuelfing, Christoph] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bristol; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bristol	Wulfing, C (corresponding author), UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.	Christoph.Wuelfing@bristol.co.uk	Verkade, Paul/N-7240-2014	Verkade, Paul/0000-0002-2497-1026; orange, jordan/0000-0001-7117-7725; Wuelfing, Christoph/0000-0002-6156-9861; Mace, Emily/0000-0003-0226-7393	NIH Ruth L. Kirschstein research service award [2T32AI005284-32]; NIH [A1-97981]; NSF [1121793]; Marie Sklodowska-Curie [321554]; BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER	NIH Ruth L. Kirschstein research service award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Marie Sklodowska-Curie; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH Ruth L. Kirschstein research service award (2T32AI005284-32) to K.R. and NIH (A1-97981), NSF (1121793), and Marie Sklodowska-Curie (321554) funding to C.W.	Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nelson CM, 2012, ANNU REV BIOMED ENG, V14, P129, DOI [10.1146/annurev-bioeng-071811-150043, 10.1146/annurev.bioeng-071811-150043]; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rangamani P, 2013, CELL, V154, P1356, DOI 10.1016/j.cell.2013.08.026; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Sage PT, 2012, J IMMUNOL, V188, P3686, DOI 10.4049/jimmunol.1102594; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Smoligovets AA, 2012, J CELL SCI, V125, P735, DOI 10.1242/jcs.092825; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	40	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133299	10.1371/journal.pone.0133299	http://dx.doi.org/10.1371/journal.pone.0133299			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237050	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942400010
J	Bettembourg, C; Diot, C; Dameron, O				Bettembourg, Charles; Diot, Christian; Dameron, Olivier			Optimal Threshold Determination for Interpreting Semantic Similarity and Particularity: Application to the Comparison of Gene Sets and Metabolic Pathways Using GO and ChEBI	PLOS ONE			English	Article							ONTOLOGY ANNOTATIONS; DATABASE; EXPRESSION	Background The analysis of gene annotations referencing back to Gene Ontology plays an important role in the interpretation of high-throughput experiments results. This analysis typically involves semantic similarity and particularity measures that quantify the importance of the Gene Ontology annotations. However, there is currently no sound method supporting the interpretation of the similarity and particularity values in order to determine whether two genes are similar or whether one gene has some significant particular function. Interpretation is frequently based either on an implicit threshold, or an arbitrary one (typically 0.5). Here we investigate a method for determining thresholds supporting the interpretation of the results of a semantic comparison. Results We propose a method for determining the optimal similarity threshold by minimizing the proportions of false-positive and false-negative similarity matches. We compared the distributions of the similarity values of pairs of similar genes and pairs of non-similar genes. These comparisons were performed separately for all three branches of the Gene Ontology. In all situations, we found overlap between the similar and the non-similar distributions, indicating that some similar genes had a similarity value lower than the similarity value of some non-similar genes. We then extend this method to the semantic particularity measure and to a similarity measure applied to the ChEBI ontology. Thresholds were evaluated over the whole HomoloGene database. For each group of homologous genes, we computed all the similarity and particularity values between pairs of genes. Finally, we focused on the PPAR multigene family to show that the similarity and particularity patterns obtained with our thresholds were better at discriminating orthologs and paralogs than those obtained using default thresholds. Conclusion We developed a method for determining optimal semantic similarity and particularity thresholds. We applied this method on the GO and ChEBI ontologies. Qualitative analysis using the thresholds on the PPAR multigene family yielded biologically-relevant patterns.	[Bettembourg, Charles; Dameron, Olivier] Univ Rennes 1, Rennes, France; [Bettembourg, Charles; Diot, Christian] INRA, UMR PEGASE 1348, St Gilles, France; [Bettembourg, Charles; Diot, Christian] Agrocampus OUEST, UMR PEGASE 1348, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] IRISA, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] INRIA, Rennes, France	Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Inria	Bettembourg, C (corresponding author), Univ Rennes 1, Rennes, France.	charles.bettembourg@irisa.fr	Diot, Christian/AAE-2514-2020	Diot, Christian/0000-0001-9525-6401; Dameron, Olivier/0000-0001-8959-7189	French ministry of research	French ministry of research(Ministry of Research, FranceEuropean Commission)	CB was supported by a fellowship from the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MA, 2011, J BIOINF COMPUT BIOL, V9, P681, DOI 10.1142/S0219720011005641; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, PREDICTIVE INTEGRATI; Barriot R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-332; Bettembourg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086525; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chen Gang, 2013, Int J Bioinform Res Appl, V9, P173, DOI 10.1504/IJBRA.2013.052448; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; Couto FM, 2010, PLOS COMPUT BIOL, V6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dameron O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075993; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diaz-Diaz N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-360; Gan MX, 2013, SCI WORLD J, DOI 10.1155/2013/793091; Gentleman R., 2014, VISUALIZING AND DIST; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang J, 1997, PROCEEDINGS OF THE I; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057809, 10.1371/journal.pone.0066745]; Lin D, 1998, P INT C MACH LEARN; Lord P W, 2003, Pac Symp Biocomput, P601; Mazandu Gaston K., 2012, Advances in Bioinformatics, V2012, P975783, DOI 10.1155/2012/975783; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Michalik L, 2002, INT J DEV BIOL, V46, P105; Miller George, 1998, WORDNET ELECT LEXICA; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Pesquita C, 2007, P 10 ANN BIOONT M; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Staab S, 2002, COLING; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	46	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133579	10.1371/journal.pone.0133579	http://dx.doi.org/10.1371/journal.pone.0133579			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230274	gold, Green Submitted, Green Published			2022-12-26	WOS:000358838400044
J	Hofmann, WP; Mauss, S; Lutz, T; Schober, A; Boker, K; Moog, G; Baumgarten, A; Pfeiffer-Vornkahl, H; Alshuth, U; Huppe, D; Wedemeyer, H; Manns, MP; Schott, E				Hofmann, Wolf Peter; Mauss, Stefan; Lutz, Thomas; Schober, Andreas; Boeker, Klaus; Moog, Gero; Baumgarten, Axel; Pfeiffer-Vornkahl, Heike; Alshuth, Ulrich; Hueppe, Dietrich; Wedemeyer, Heiner; Manns, Michael P.; Schott, Eckart			Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN; HCV GENOTYPE-2; PEGYLATED-INTERFERON; TREATMENT DURATION; THERAPY; INFECTION; CIRRHOSIS; TYPE-1	Background and Aims Individualization of treatment with peginterferon alfa and ribavirin in patients with chronic hepatitis C showed benefit in controlled trials and was implemented in treatment guidelines to increase response rates and to reduce side effects and costs. However, it is unknown whether individualization was adopted in routine daily practice and whether it translated into improved outcomes. Methods From a large noninterventional cohort study, clinical and virologic response data of 10,262 HCV patients who received peginterferon alfa-2a and ribavirin between 2003-2007 and 2008-2011 were analyzed. To account for treatment individualization, a matched-pair analysis (2,997 matched pairs) was performed. Variation in treatment duration and dosing of ribavirin were analyzed as indicators for individualization. Results Sustained virological response (SVR) rates were similar between 2003-2007 and 20082011 (62.0% vs. 63.7%). Patients with comorbidities were more abundant in the later period, (44.3% vs. 57.1%). The subsequent matched-pair analysis demonstrated higher SVR rates in the 2008-2011 period (64.3%) than in the 2003-2007 period (61.2%, p=0.008). More patients received abbreviated or extended treatment regimens in the later than the earlier period as an indicator of treatment individualization. To the same end, ribavirin doses were higher in the later period ( 12.6 versus 11.6 mg/kg/day). Factors independently associated with SVR included HCV genotype, low baseline viral load, younger age, route of infection, absence of concomitant diseases, lower APRI score, normal gamma-GT, higher ribavirin doses, no substitution for drug abuse, treatment duration, and treatment in the 2008-2011 period. Conclusions Treatment individualization with peginterferon alfa and ribavirin was implemented in daily routine between 2003-2007 and 2008-2011, SVR rates improved in the same period. These findings may be most relevant in resource-limited settings.	[Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Lutz, Thomas] Infektiologikum, Frankfurt, Germany; [Baumgarten, Axel] Ctr Infect Dis, Berlin, Germany; [Pfeiffer-Vornkahl, Heike] Inst Clin Res & Stat, Offenbach, Germany; [Alshuth, Ulrich] Roche Pharma AG, Virol, Grenzach Wyhlen, Germany; [Hueppe, Dietrich] Ctr Gastroenterol, Herne, Germany; [Wedemeyer, Heiner; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30623 Hannover, Germany; [Schott, Eckart] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schott, E (corresponding author), Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	eckart.schott@charite.de			Roche Pharma AG	Roche Pharma AG(Roche Holding)	This noninterventional study was funded in full according to GPP (Good Pharmacoepidemiology Practice) guideline definition of a sponsor by Roche Pharma AG, Grenzach-Wyhlen, Germany (Pharmacoepidemiology and Drug Safety 2008; 17: 200-208). Roche Pharma AG provided support in the form of salary for author Ulrich Alshuth. The specific roles of this author are articulated in the 'author contributions' section. According to GPP responsibility for scientific integrity is shared by the collaborating institutions in that case the sponsor Roche Pharma AG, the Association of German gastroenterologists in office based practices (bng, Bundesverband niedergelassener Gastroenterologen e. V.) and lead author Prof. Niederau. Analysis of data, decision to publish, and preparation of the manuscript were in the responsiblity of the authors.	Berg T, 2006, GASTROENTEROLOGY, V130, P1086, DOI 10.1053/j.gastro.2006.02.015; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Ferenci P, 2010, GASTROENTEROLOGY, V138, P503, DOI 10.1053/j.gastro.2009.10.058; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gellad ZF, 2012, VALUE HEALTH, V15, P876, DOI 10.1016/j.jval.2012.06.010; Hofmann WP, 2012, DTSCH ARZTEBL INT, V109, P352, DOI 10.3238/arztebl.2012.0352; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Hofmann WP, 2006, Z GASTROENTEROL, V44, P25, DOI 10.1055/s-2005-858960; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobson IM, 2007, HEPATOLOGY, V46, P982, DOI 10.1002/hep.21670; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2014, LIVER INT, V34, pE217, DOI 10.1111/liv.12352; Mangia A, 2010, J HEPATOL, V53, P1000, DOI 10.1016/j.jhep.2010.04.042; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Sanchez-Tapias JM, 2006, GASTROENTEROLOGY, V131, P451, DOI 10.1053/j.gastro.2006.05.016; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]; Zeuzem S, 2010, CURR MED RES OPIN, V26, P1733, DOI 10.1185/03007995.2010.487038	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134839	10.1371/journal.pone.0134839	http://dx.doi.org/10.1371/journal.pone.0134839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230998	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400174
J	Lewinson, RT; Wiley, JP; Humble, RN; Worobets, JT; Stefanyshyn, DJ				Lewinson, Ryan T.; Wiley, J. Preston; Humble, R. Neil; Worobets, Jay T.; Stefanyshyn, Darren J.			Altering Knee Abduction Angular Impulse Using Wedged Insoles for Treatment of Patellofemoral Pain in Runners: A Six-Week Randomized Controlled Trial	PLOS ONE			English	Article							VISUAL ANALOG SCALE; JOINT COORDINATE SYSTEM; FOOT-ORTHOSES; ADDUCTION MOMENT; OSTEOARTHRITIS; KINEMATICS; INJURIES; KINETICS; ORTHOTICS; SEVERITY	Objective Determine if a change in internal knee abduction angular impulse (KAAI) is related to pain reduction for runners with patellofemoral pain (PFP) by comparing lateral and medial wedge insole interventions, and increased KAAI and decreased KAAI groups. Design Randomized controlled clinical trial (ClinicalTrials. gov ID# NCT01332110). Setting Biomechanics laboratory and community. Patients Thirty-six runners with physician-diagnosed PFP enrolled in the trial, and 27 were analyzed. Interventions Runners with PFP were randomly assigned to either an experimental 3 mm lateral wedge or control 6 mm medial wedge group. Participants completed a biomechanical gait analysis to quantify KAAIs with their assigned insole, and then used their assigned insole for six-weeks during their regular runs. Usual pain during running was measured at baseline and at six-week follow-up using a visual analog scale. Statistical tests were performed to identify differences between wedge types, differences between biomechanical response types (i.e. increase or decrease KAAI), as well as predictors of pain reduction. Main Outcome Measures Percent change in KAAI relative to neutral, and % change in pain over six weeks. Results Clinically meaningful reductions in pain (>33%) were measured for both footwear groups; however, no significant differences between footwear groups were found (p = 0.697). When participants were regrouped based on KAAI change (i.e., increase or decrease), again, no significant differences in pain reduction were noted (p = 0.146). Interestingly, when evaluating absolute change in KAAI, a significant relationship between absolute% change in KAAI and % pain reduction was observed (R-2 = 0.21; p = 0.030), after adjusting for baseline pain levels. Conclusion The greater the absolute % change in KAAI during running, the greater the % reduction in pain over six weeks, regardless of wedge type, and whether KAAIs increased or decreased. Lateral and medial wedge insoles were similar in effectiveness for treatment of PFP.	[Lewinson, Ryan T.; Wiley, J. Preston; Worobets, Jay T.; Stefanyshyn, Darren J.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Lewinson, Ryan T.; Stefanyshyn, Darren J.] Univ Calgary, Schulich Sch Engn, Biomed Engn Program, Calgary, AB, Canada; [Lewinson, Ryan T.; Wiley, J. Preston; Humble, R. Neil] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Wiley, J. Preston] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Lewinson, RT (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	lewinson@ucalgary.ca		Stefanyshyn, Darren/0000-0001-7180-360X	Canadian Institutes of Health Research; Natural Sciences & Engineering Research Council of Canada CREATE program; Alberta Innovates [201300001] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada CREATE program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This study was funded by graduate student awards for RTL from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Sciences & Engineering Research Council of Canada CREATE program (http://www.nserc-crsng.gc.ca/index_eng.asp). The funding agencies played no role in study design or analysis.	Barton CJ, 2010, SPORTS MED, V40, P377, DOI 10.2165/11530780-000000000-00000; Barton CJ, 2009, GAIT POSTURE, V30, P405, DOI 10.1016/j.gaitpost.2009.07.109; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Boldt AR, 2013, J APPL BIOMECH, V29, P68, DOI 10.1123/jab.29.1.68; Brechter JH, 2002, MED SCI SPORT EXER, V34, P1582, DOI 10.1249/01.MSS.0000035990.28354.c6; Chapman GJ, OSTEOARTHRI IN PRESS; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; Clement D B, 1981, Phys Sportsmed, V9, P47, DOI 10.1080/00913847.1981.11711077; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Dempster WT., 1955, 55159 WADC WRIGHT PA; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; Fisher DS, 2007, J ORTHOP RES, V25, P540, DOI 10.1002/jor.20157; Fukuchi C, 2012, FOOTWEAR SCI, V4, P207, DOI 10.1080/19424280.2012.683044; Fulkerson JP, 2002, AM J SPORT MED, V30, P447, DOI 10.1177/03635465020300032501; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Herzog W, 2003, ARTHRIT RHEUM-ARTHR, V49, P239, DOI 10.1002/art.11004; Hinman RS, 2008, ARTHRIT RHEUM-ARTHR, V59, P408, DOI 10.1002/art.23326; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Lenhart RL, 2014, MED SCI SPORT EXER, V46, P557, DOI 10.1249/MSS.0b013e3182a78c3a; Lewinson RT, 2013, CLIN J SPORT MED, V23, P392, DOI 10.1097/JSM.0b013e31828b0848; Lewinson RT, 2013, P I MECH ENG H, V227, P811, DOI 10.1177/0954411913483431; Lewinson RT, 2013, CLIN J SPORT MED, V23, P208, DOI 10.1097/JSM.0b013e31826b7c83; Lun VMY, 2005, CLIN J SPORT MED, V15, P233; MacLean CL, 2008, CLIN J SPORT MED, V18, P338, DOI 10.1097/MJT.0b013e31815fa75a; MATHESON GO, 1989, MED SCI SPORT EXER, V21, P379; Mundermann A, 2003, CLIN BIOMECH, V18, P254, DOI 10.1016/S0268-0033(02)00186-9; Mundermann A, 2003, MED SCI SPORT EXER, V35, P1710, DOI 10.1249/01.MSS.0000089352.47259.CA; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Nimon G, 1998, J PEDIATR ORTHOPED, V18, P118, DOI 10.1097/00004694-199801000-00021; Park SK, 2011, CLIN BIOMECH, V26, P392, DOI 10.1016/j.clinbiomech.2010.11.015; Radzimski AO, 2012, KNEE, V19, P163, DOI 10.1016/j.knee.2011.05.013; Reeves ND, 2011, NAT REV RHEUMATOL, V7, P113, DOI 10.1038/nrrheum.2010.212; Robertson GE., 2004, RES METHODS BIOMECHA; Sawatsky A, 2012, CLIN BIOMECH, V27, P595, DOI 10.1016/j.clinbiomech.2011.12.011; Schmalz T, 2006, CLIN BIOMECH, V21, P631, DOI 10.1016/j.clinbiomech.2006.02.004; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Stefanyshyn DJ, 2006, AM J SPORT MED, V34, P1844, DOI 10.1177/0363546506288753; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Thomee R, 1997, PHYS THER, V77, P1690, DOI 10.1093/ptj/77.12.1690; Utting MR, 2005, KNEE, V12, P362, DOI 10.1016/j.knee.2004.12.006; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; van Linschoten R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4074; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	45	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134461	10.1371/journal.pone.0134461	http://dx.doi.org/10.1371/journal.pone.0134461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230399	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400123
J	Ostermann, JK; Reinhold, T; Witt, CM				Ostermann, Julia K.; Reinhold, Thomas; Witt, Claudia M.			Can Additional Homeopathic Treatment Save Costs? A Retrospective Cost-Analysis Based on 44500 Insured Persons	PLOS ONE			English	Article							COHORT	Objectives The aim of this study was to compare the health care costs for patients using additional homeopathic treatment (homeopathy group) with the costs for those receiving usual care (control group). Methods Cost data provided by a large German statutory health insurance company were retrospectively analysed from the societal perspective (primary outcome) and from the statutory health insurance perspective. Patients in both groups were matched using a propensity score matching procedure based on socio-demographic variables as well as costs, number of hospital stays and sick leave days in the previous 12 months. Total cumulative costs over 18 months were compared between the groups with an analysis of covariance (adjusted for baseline costs) across diagnoses and for six specific diagnoses (depression, migraine, allergic rhinitis, asthma, atopic dermatitis, and headache). Results Data from 44,550 patients (67.3% females) were available for analysis. From the societal perspective, total costs after 18 months were higher in the homeopathy group (adj. mean: EUR 7,207.72 [95% CI 7,001.14-7,414.29]) than in the control group (EUR 5,857.56 [5,650.98-6,064.13]; p<0.0001) with the largest differences between groups for productivity loss (homeopathy EUR 3,698.00 [3,586.48-3,809.53] vs. control EUR 3,092.84 [2,981.31-3,204.37]) and outpatient care costs (homeopathy EUR 1,088.25 [1,073.90-1,102.59] vs. control EUR 867.87 [853.52-882.21]). Group differences decreased over time. For all diagnoses, costs were higher in the homeopathy group than in the control group, although this difference was not always statistically significant. Conclusion Compared with usual care, additional homeopathic treatment was associated with significantly higher costs. These analyses did not confirm previously observed cost savings resulting from the use of homeopathy in the health care system.	[Ostermann, Julia K.; Reinhold, Thomas; Witt, Claudia M.] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10117 Berlin, Germany; [Witt, Claudia M.] Univ Zurich, Inst Complementary & Integrat Med, Zurich, Switzerland; [Witt, Claudia M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University of Zurich; University Zurich Hospital; University System of Maryland; University of Maryland Baltimore	Ostermann, JK (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10117 Berlin, Germany.	julia.ostermann@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Reinhold, Thomas/0000-0001-5169-7029; Ostermann, Julia/0000-0002-0180-8752	statutory health insurance company Techniker Krankenkasse	statutory health insurance company Techniker Krankenkasse	This is an investigator initiated trial that is co-sponsored by the statutory health insurance company Techniker Krankenkasse. The co-sponsor provided data, but was not involved in the main data analysis, data interpretation, writing, or decision to submit the manuscript. All authors had full access to the data and are responsible for the veracity and completeness of the data reported. All authors had full access to the data in the study and take final responsibility to submit for publication.	[Anonymous], 2014, R LANG ENV STAT COMP; AVERILL RF, 1992, HEALTH SERV RES, V27, P587; AVINA RL, 1978, WESTERN J MED, V128, P366; Baars EW, 2014, BMJ OPEN, V4, DOI DOI 10.1136/BMJ0PEN-2014-005332; DZVh&Auml;, 2012, SEL KLASS HOM BET KR; Ernst E, 2002, BRIT J CLIN PHARMACO, V54, P577, DOI 10.1046/j.1365-2125.2002.01699.x; Gesundheitsberichterstattung des Bundes, 2015, ARZT ARZT ZUS WEIT; Institut f&uuml;r Demoskopie, 2014, HOM ARZN 2014 BEK VE; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; Kliems H, 2011, J ALTERN COMPLEM MED, V17, P265, DOI 10.1089/acm.2010.0158; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; Marian F, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-52; Moebus S, 2002, FEDERAL HLTH REPORT; Reinhold T, 2010, J PUBLIC HEALTH-HEID, V18, P327, DOI 10.1007/s10389-010-0315-0; Roll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054973; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Smith K, 2012, BIOETHICS, V26, P398, DOI 10.1111/j.1467-8519.2010.01876.x; Statistisches Bundesamt, 2014, JAHR ARB; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Viksveen P, 2014, EUR J HEALTH ECON, V15, P157, DOI 10.1007/s10198-013-0462-7; Witt C, 2005, COMPLEMENT THER MED, V13, P79, DOI 10.1016/j.ctim.2005.03.005; Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854; Witt CM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2158-5-115	24	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134657	10.1371/journal.pone.0134657	http://dx.doi.org/10.1371/journal.pone.0134657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230412	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400145
J	Slattery, ML; Pellatt, DF; Mullany, LE; Wolff, RK				Slattery, Martha L.; Pellatt, Daniel F.; Mullany, Lila E.; Wolff, Roger K.			Differential Gene Expression in Colon Tissue Associated With Diet, Lifestyle, and Related Oxidative Stress	PLOS ONE			English	Article							ALPHA-7 NICOTINIC RECEPTOR; MEDIATED TOBACCO TOXICITY; CIGARETTE-SMOKING; COLORECTAL ADENOMA; ANTIOXIDANT EXPOSURES; CANCER; RISK; ALCOHOL; BALANCE	Several diet and lifestyle factors may impact health by influencing oxidative stress levels. We hypothesize that level of cigarette smoking, alcohol, anti-inflammatory drugs, and diet alter gene expression. We analyzed RNA-seq data from 144 colon cancer patients who had information on recent cigarette smoking, recent alcohol consumption, diet, and recent aspirin/non-steroidal anti-inflammatory use. Using a false discovery rate of 0.1, we evaluated gene differential expression between high and low levels of exposure using DESeq2. Ingenuity Pathway Analysis (IPA) was used to determine networks associated with de-regulated genes in our data. We identified 46 deregulated genes associated with recent cigarette use; these genes enriched causal networks regulated by TEK and MAP2K3. Different differentially expressed genes were associated with type of alcohol intake; five genes were associated with total alcohol, six were associated with beer intake, six were associated with wine intake, and four were associated with liquor consumption. Recent use of aspirin and/or ibuprofen was associated with differential expression of TMC06, ST8SIA4, and STEAP3 while a summary oxidative balance score (OBS) was associated with SYCP3, HDX, and NRG4 (all up-regulated with greater oxidative balance). Of the dietary antioxidants and carotenoids evaluated only intake of beta carotene (1 gene), Lutein/Zeaxanthine (5 genes), and Vitamin E (4 genes) were associated with differential gene expression. There were similarities in biological function of de-regulated genes associated with various dietary and lifestyle factors. Our data support the hypothesis that diet and lifestyle factors associated with oxidative stress can alter gene expression. However genes altered were unique to type of alcohol and type of antioxidant. Because of potential differences in associations observed between platforms these findings need replication in other populations.	[Slattery, Martha L.; Pellatt, Daniel F.; Mullany, Lila E.; Wolff, Roger K.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.	Marty.Slattery@hsc.utah.edu			National Cancer Institute (NCI) [CA48998]; NATIONAL CANCER INSTITUTE [U01CA048998, R01CA048998, R01CA163683] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by National Cancer Institute (NCI) grants CA48998.	Arredondo J, 2008, FASEB J, V22, P1356, DOI 10.1096/fj.07-9965.com; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chavez Jennifier, 2007, Am J Ther, V14, P189; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; EDWARDS S, 1994, AM J EPIDEMIOL, V140, P1020, DOI 10.1093/oxfordjournals.aje.a117192; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; Goodman M, 2008, CANCER CAUSE CONTROL, V19, P1051, DOI 10.1007/s10552-008-9169-y; Goodman M, 2010, ANN EPIDEMIOL, V20, P955, DOI 10.1016/j.annepidem.2010.08.011; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; He BM, 2013, MOL MED REP, V8, P1683, DOI 10.3892/mmr.2013.1724; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Llinas L, 2011, PULM PHARMACOL THER, V24, P32, DOI 10.1016/j.pupt.2010.10.010; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nagamma T, 2012, ASIAN PAC J CANCER P, V13, P3513, DOI 10.7314/APJCP.2012.13.7.3513; Nielsen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006210; Ornish D, 2008, P NATL ACAD SCI USA, V105, P8369, DOI 10.1073/pnas.0803080105; Oyesanmi Olu, 2010, Evid Rep Technol Assess (Full Rep), P1; Petersen DR, 2005, ALCOHOL, V35, P243, DOI 10.1016/j.alcohol.2005.03.013; Rafi MM, 2014, J MED FOOD; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Slattery ML, 2012, MUTAT RES-FUND MOL M, V734, P30, DOI 10.1016/j.mrfmmm.2012.04.002; Slattery ML, 1998, CANCER EPIDEM BIOMAR, V7, P1079; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 1998, NUTR CANCER, V30, P201, DOI 10.1080/01635589809514664; Slattery ML, 2000, AM J CLIN NUTR, V71, P575; Slattery ML, 2000, MUTAT RES-GENOMICS, V432, P7, DOI 10.1016/S1383-5726(99)00010-2; Stone WL, 1997, JNCI-J NATL CANCER I, V89, P1006, DOI 10.1093/jnci/89.14.1006; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010	40	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134406	10.1371/journal.pone.0134406	http://dx.doi.org/10.1371/journal.pone.0134406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230583	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400114
J	Tamminen, K; Balboa, D; Toivonen, S; Pakarinen, MP; Wiener, Z; Alitalo, K; Otonkoski, T				Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Pakarinen, Mikko P.; Wiener, Zoltan; Alitalo, Kari; Otonkoski, Timo			Intestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1	PLOS ONE			English	Article							EFFICIENT DIFFERENTIATION; IN-VITRO; WNT; EXPRESSION; SIGNALS; COLON; SPECIFICATION; TRANSCRIPTION; INDUCTION; EXPANSION	Wnt/beta-catenin signaling plays a central role in guiding the differentiation of the posterior parts of the primitive gut tube into intestinal structures in vivo and some studies suggest that FGF4 is another crucial factor for intestinal development. The aim of this study was to define the effects of Wnt and FGF4 on intestinal commitment in vitro by establishing conditions for differentiation of human pluripotent stem cells (hPSC) into posterior endoderm (hindgut) and further to self-renewing intestinal-like organoids. The most prominent induction of the well-established intestinal marker gene CDX2 was achieved when hPSC-derived definitive endoderm cells were treated with Wnt agonist molecule CHIR99021 during differentiation to hindgut. FGF4 was found to be dispensable during intestinal commitment, but it had an early role in repressing development towards the hepatic lineage. When hindgut stage cells were further cultured in 3D, they formed self-renewing organoid structures containing all major intestinal cell types even without exogenous R-spondin1 (RSPO1), a crucial factor for the culture of epithelial organoids derived from adult intestine. This may be explained by the presence of a mesenchymal compartment in the hPSC-derived organoids. Addition of WNT3A increased the expression of the Paneth cell marker Lysozyme in hPSC-derived organoid cultures, whereas FGF4 inhibited both the formation and maturation of intestinal-like organoids. Similar hindgut and organoid cultures were established from human induced pluripotent stem cells, implying that this approach can be used to create patient-specific intestinal tissue models for disease modeling in vitro.	[Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Otonkoski, Timo] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland; [Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Otonkoski, Timo] Univ Helsinki, Biomedicum, Stem Cell Ctr, Helsinki, Finland; [Pakarinen, Mikko P.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Pakarinen, Mikko P.; Otonkoski, Timo] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Biomedicum Helsinki, Translat Canc Biol Program, Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Biomedicum Helsinki, Wihuri Res Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Wihuri Research Institute	Otonkoski, T (corresponding author), Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.	timo.otonkoski@helsinki.fi	Alitalo, Kari K/J-5013-2014; Pakarinen, Mikko/AAD-8834-2019	Alitalo, Kari K/0000-0002-7331-0902; Balboa, Diego/0000-0002-4784-5452	Sigrid Juselius Foundation; Academy of Finland [257157]; Novo Nordisk Foundation [10719]; Helsinki University Central Hospital research funds; Novo Nordisk Fonden [NNF13OC0005565, NNF14OC0010719] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Helsinki University Central Hospital research funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/), the Academy of Finland (Grant number: 257157 http://www.aka.fi/en-GB/A/), The Novo Nordisk Foundation (Grant number: 10719, http://www.novonordiskfonden.dk/en) and the Helsinki University Central Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Illig R, 2013, DEV DYNAM, V242, P53, DOI 10.1002/dvdy.23893; Iwao T, 2014, DRUG METAB PHARMACOK, V29, P44, DOI 10.2133/dmpk.DMPK-13-RG-005; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Mikkola M, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0365; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ogaki S, 2013, STEM CELLS, V31, P1086, DOI 10.1002/stem.1344; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shibamoto S, 1998, GENES CELLS, V3, P659; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Watson CL, 2014, NATURE MED; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	50	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134551	10.1371/journal.pone.0134551	http://dx.doi.org/10.1371/journal.pone.0134551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230325	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400133
J	Zinellu, A; Sotgia, S; Scanu, B; Forteschi, M; Giordo, R; Cossu, A; Posadino, AM; Carru, C; Pintus, G				Zinellu, Angelo; Sotgia, Salvatore; Scanu, Bastianina; Forteschi, Mauro; Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Carru, Ciriaco; Pintus, Gianfranco			Human Serum Albumin Increases the Stability of Green Tea Catechins in Aqueous Physiological Conditions	PLOS ONE			English	Article							(-)-EPIGALLOCATECHIN GALLATE; DRUG-BINDING; POLYPHENOLS; RESVERATROL; METABOLITES; MECHANISMS; FLAVONOIDS; INGESTION; EPIMERS; BSA	Epicatechin (EC), epigallocatechin (EGC), epicatechingallate (ECG) and epigallocatechingallate (EGCG) are antioxidants present in the green tea, a widely used beverage whose health benefits are largely recognized. Nevertheless, major physicochemical limitations, such as the high instability of catechins, pose important questions concerning their potential pharmacological use. Recent studies indicate that binding of catechins with plasmatic proteins may modulate their plasma concentration, tissue delivery and biological activity. After 5 minutes of incubation with HSA both ECG and EGCG were fully bound to HSA, while after 48h incubation only 41% of EC and 70% of EGC resulted linked. HSA had a strong stabilizing effect on all catechins, which could be found in solution between 29 and 85% even after 48h of incubation. In the absence of HSA, EGC and EGCG disappeared in less than 24h, while ECG and EC were found after 48h at 5 and 50%, respectively. The stabilizing effect of HSA toward EGCG, obtained in aqueous physiological conditions, resulted stronger in comparison to cysteine and HCl, previously reported to stabilize this polyphenol. Because of the multitude of contradictory data concerning in vivo and in vitro antioxidant-based experimentations, we believe our work may shed some light on this debated field of research.	[Zinellu, Angelo; Sotgia, Salvatore; Scanu, Bastianina; Forteschi, Mauro; Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Carru, Ciriaco; Pintus, Gianfranco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Pintus, Gianfranco] Univ Sassari, Lab Cell Signaling & Redox Biol, I-07100 Sassari, Italy; [Carru, Ciriaco] Hosp Univ Sassari AOU, Qual Control Unit, Sassari, Italy	University of Sassari; University of Sassari	Zinellu, A (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	azinellu@uniss.it; gpintus@uniss.it	Pintus, Gianfranco/C-2975-2009; Carru, Ciriaco/AAI-9996-2021; Sotgia, Salvatore/T-6598-2019	Pintus, Gianfranco/0000-0002-3031-7733; Carru, Ciriaco/0000-0002-6985-4907; Posadino, Anna Maria/0000-0002-6155-159X; forteschi, mauro/0000-0002-3958-6788; Zinellu, Angelo/0000-0002-8396-0968; Sotgia, Salvatore/0000-0002-3717-3437	Sardinia Region [7-2007, CPR-25920]; Bank of Sardinia Foundation; Sardinia Region P.O.R. SARDEGNA, F.S.E. Human Capital Objective-Line of Activity 1.3.1	Sardinia Region(Regione Sardegna); Bank of Sardinia Foundation; Sardinia Region P.O.R. SARDEGNA, F.S.E. Human Capital Objective-Line of Activity 1.3.1	This research was supported by the Sardinia Region within the framework of the L.R. no 7-2007, call 2010, grant no CPR-25920 (GP) and the Bank of Sardinia Foundation (GP, CC, AZ). RG is a research fellow supported by the Sardinia Region P.O.R. SARDEGNA, F.S.E. 2007-2013-Human Capital Objective-Line of Activity 1.3.1, while AC is supported by fellowships within the L.R. no 7-2007, call 2010, grant no CPR-25920 GP).	Bae MJ, 2009, MOL NUTR FOOD RES, V53, P709, DOI 10.1002/mnfr.200800274; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Cao H, 2013, CURR DRUG METAB, V14, P446, DOI 10.2174/1389200211314040007; Cha MK, 1996, BIOCHEM BIOPH RES CO, V222, P619, DOI 10.1006/bbrc.1996.0793; Chakraborty B, 2009, J LUMIN, V129, P34, DOI 10.1016/j.jlumin.2008.07.012; Chen ML, 2013, J NUTR BIOCHEM, V24, P1823, DOI 10.1016/j.jnutbio.2013.04.003; Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Henning SM, 2008, J NUTR, V138, P1529; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Kusuda M, 2006, BIOSCI BIOTECH BIOCH, V70, P152, DOI 10.1271/bbb.70.152; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Li CA, 2001, CHEM RES TOXICOL, V14, P702, DOI 10.1021/tx0002536; Li N, 2012, J AGR FOOD CHEM, V60, P12531, DOI 10.1021/jf304116s; Liu EH, 2010, MOLECULES, V15, P9092, DOI 10.3390/molecules15129092; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Nakayama T, 2002, FOOD SCI TECHNOL RES, V8, P261, DOI 10.3136/fstr.8.261; Narumi K, 2014, J CHROMATOGR B, V945, P147, DOI 10.1016/j.jchromb.2013.11.007; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; Pal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043321; Pantusa M, 2014, J AGR FOOD CHEM, V62, P4384, DOI 10.1021/jf405584a; PETERS T, 1995, ALL ALBUMIN BIOCHEM; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Su YL, 2003, FOOD CHEM, V83, P189, DOI 10.1016/S0308-8146(03)00062-1; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Unno T, 2000, J SCI FOOD AGR, V80, P601, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;601::AID-JSFA581&gt;3.0.CO;2-O; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zinellu A, 2014, J CHROMATOGR A, V1367, P167, DOI 10.1016/j.chroma.2014.09.053	37	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134690	10.1371/journal.pone.0134690	http://dx.doi.org/10.1371/journal.pone.0134690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230943	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400151
J	Crona, M; Hofer, A; Astorga-Wells, J; Sjoberg, BM; Tholander, F				Crona, Mikael; Hofer, Anders; Astorga-Wells, Juan; Sjoberg, Britt-Marie; Tholander, Fredrik			Biochemical Characterization of the Split Class II Ribonucleotide Reductase from Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYSTEINE RESIDUES; IN-VITRO; PROTEINS; HYDROXYUREA; PREDICTION; INHIBITION; EXPRESSION; TASSER; VIVO	The opportunistic pathogen Pseudomonas aeruginosa can grow under both aerobic and anaerobic conditions. Its flexibility with respect to oxygen load is reflected by the fact that its genome encodes all three existing classes of ribonucleotides reductase (RNR): the oxygen-dependent class I RNR, the oxygen-indifferent class II RNR, and the oxygen-sensitive class III RNR. The P. aeruginosa class II RNR is expressed as two separate polypeptides (NrdJa and NrdJb), a unique example of a split RNR enzyme in a free-living organism. A split class II RNR is also found in a few closely related gamma-Proteobacteria. We have characterized the P. aeruginosa class II RNR and show that both subunits are required for formation of a biologically functional enzyme that can sustain vitamin B12-dependent growth. Binding of the B12 coenzyme as well as substrate and allosteric effectors resides in the NrdJa subunit, whereas the NrdJb subunit mediates efficient reductive dithiol exchange during catalysis. A combination of activity assays and activity-independent methods like surface plasmon resonance and gas phase electrophoretic macromolecule analysis suggests that the enzymatically active form of the enzyme is a (NrdJa-NrdJb) 2 homodimer of heterodimers, and a combination of hydrogen-deuterium exchange experiments and molecular modeling suggests a plausible region in NrdJa that interacts with NrdJb. Our detailed characterization of the split NrdJ from P. aeruginosa provides insight into the biochemical function of a unique enzyme known to have central roles in biofilm formation and anaerobic growth.	[Crona, Mikael; Astorga-Wells, Juan; Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Karolinska Institutet; Umea University; Stockholm University	Tholander, F (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	fredrik.tholander@ki.se		Crona, Mikael/0000-0002-6420-6097; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Research Council [VR-NT 2012-5262, VR-M 2012-1932, VR-M 2013-2918]; Royal Swedish Academy of Sciences (the Hierta-Retzius foundation); Magnus Bergvall foundation; Carl Trygger foundation; Swedish Cancer Foundation [CAN 2013/643]; NIH [P30DK089507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences (the Hierta-Retzius foundation); Magnus Bergvall foundation; Carl Trygger foundation; Swedish Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Swedish Research Council to FT, AH and BMS (VR-NT 2012-5262 to FT, VR-M 2012-1932 to AH and VR-M 2013-2918 to BMS), the Royal Swedish Academy of Sciences (the Hierta-Retzius foundation) to FT, the Magnus Bergvall foundation to FT, the Carl Trygger foundation to AH and the Swedish Cancer Foundation (CAN 2013/643) to BMS. The authors also acknowledge the NIH grant P30DK089507 for funding the P. aeruginosa PAO1 transposon mutant library, from which strains used in this work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG A, 1989, J BIOL CHEM, V264, P12249; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Comuzzi C, 2003, TALANTA, V59, P67, DOI 10.1016/S0039-9140(02)00457-5; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Crona M, 2010, PROTEIN ENG DES SEL, V23, P633, DOI 10.1093/protein/gzq035; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Fylstra D, 1998, INTERFACES, V28, P29, DOI 10.1287/inte.28.5.29; Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Licht SS, 1999, J AM CHEM SOC, V121, P7463, DOI 10.1021/ja9913840; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mathews CK, 2014, FASEB J, V28, P3832, DOI 10.1096/fj.14-251249; Mera PE, 2010, APPL MICROBIOL BIOT, V88, P41, DOI 10.1007/s00253-010-2773-2; Perez F, 2014, CLIN INFECT DIS, V59, pS335, DOI 10.1093/cid/ciu612; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; ROSENKRANZ HS, 1967, J BACTERIOL, V94, P1025, DOI 10.1128/JB.94.4.1025-1033.1967; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; TEIPEL J, 1969, BIOCHEMISTRY-US, V8, P4656, DOI 10.1021/bi00839a064; Thelander L, 1978, Methods Enzymol, V51, P227; Tholander F, 2012, P NATL ACAD SCI USA, V109, P9798, DOI 10.1073/pnas.1113051109; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134293	10.1371/journal.pone.0134293	http://dx.doi.org/10.1371/journal.pone.0134293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225432	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700068
J	Farshbaf, M; Lindberg, MJ; Truong, A; Bevens, Z; Chambers, E; Pournara, A; Wallberg, AE; White, JB				Farshbaf, Mozhgan; Lindberg, Mikael J.; Anh Truong; Bevens, Zachery; Chambers, Elaina; Pournara, Angeliki; Wallberg, Annika E.; White, J. Brandon			Mastermind-Like 1 Is Ubiquitinated: Functional Consequences for Notch Signaling	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MAMMALIAN NOTCH; MAML1; ACTIVATION; ACETYLATION; PROTEOLYSIS; RECEPTORS; REGULATOR; TURNOVER; HOMOLOG	Early studies demonstrated the involvement of ubiquitination of the Notch intracellular domain for rapid turnover of the transcriptional complex at Notch target genes. It was shown that this ubiquitination was promoted by the co-activator Mastermind like 1 (MAML1). MAML1 also contains numerous lysine residues that may also be ubiquitinated and necessary for protein regulation. In this study, we show that over-expressed MAML1 is ubiquitinated and identify eight conserved lysine residues which are required for ubiquitination. We also show that p300 stimulates ubiquitination and that Notch inhibits ubiquitination. Furthermore, we show that a mutant MAML1 that has decreased ubiquitination shows increased output from a HES1 reporter gene assay. Therefore, we speculate that ubiquitination of MAML1 might be a mechanism to maintain low levels of the protein until needed for transcriptional activation. In summary, this study identifies that MAML1 is ubiquitinated in the absence of Notch signaling to maintain low levels of MAML1 in the cell. Our data supports the notion that a precise and tight regulation of the Notch pathway is required for this signaling pathway.	[Farshbaf, Mozhgan; Anh Truong; Bevens, Zachery; Chambers, Elaina; White, J. Brandon] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Lindberg, Mikael J.; Pournara, Angeliki; Wallberg, Annika E.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	California State University System; San Jose State University; Karolinska Institutet	Wallberg, AE (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	Annika.Wallberg@ki.se; Brandon.White@sjsu.edu		Lindberg, Mikael/0000-0001-8595-8901; Truong, Anh/0000-0003-1033-1666; White, Joseph/0000-0001-7854-4444	National Science Foundation [1052039, 0923573]; Swedish Research Council; Direct For Biological Sciences [1052039] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants 1052039 and 0923573 to J.B.W. and by grants from the Swedish Research Council to A.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kopan R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011213; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2011, ONCOGENE, V30, P4350, DOI 10.1038/onc.2011.151; Lindberg MJ, 2010, FASEB J, V24, P2396, DOI 10.1096/fj.09-149401; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Popko-Scibor AE, 2011, BIOCHEM BIOPH RES CO, V416, P300, DOI 10.1016/j.bbrc.2011.11.030; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribeiro MSJ, 2009, CURR PROTEIN PEPT SC, V10, P570; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134013	10.1371/journal.pone.0134013	http://dx.doi.org/10.1371/journal.pone.0134013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225565	Green Published, gold			2022-12-26	WOS:000358837700049
J	Fiser, Z; Altermatt, F; Zaksek, V; Knapic, T; Fiser, C				Fiser, Ziga; Altermatt, Florian; Zaksek, Valerija; Knapic, Tea; Fiser, Cene			Morphologically Cryptic Amphipod Species Are "Ecological Clones" at Regional but Not at Local Scale: A Case Study of Four Niphargus Species	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; NICHE CONSERVATISM; DIVERSITY; COEXISTENCE; WATER; SIMILARITY; CRUSTACEA; HABITAT; DISTRIBUTIONS; PERSPECTIVES	Recent studies indicate that morphologically cryptic species may be ecologically more different than would be predicted from their morphological similarity and phylogenetic relatedness. However, in biodiversity research it often remains unclear whether cryptic species should be treated as ecologically equivalent, or whether detected differences have ecological significance. In this study, we assessed the ecological equivalence of four morphologically cryptic species of the amphipod genus Niphargus. All species live in a small, isolated area on the Istrian Peninsula in the NW Balkans. The distributional ranges of the species are partially overlapping and all species are living in springs. We reconstructed their ecological niches using morphological traits related to feeding, bioclimatic niche envelope and species' preference for epi-hypogean habitats. The ecological meaning of differences in niches was evaluated using distributional data and co-occurrence frequencies. We show that the species comprise two pairs of sister species. All species differ from each other and the degree of differentiation is not related to phylogenetic relatedness. Moreover, low co-occurrence frequencies in sympatric zones imply present or past interspecific competition. This pattern suggests that species are not differentiated enough to reduce interspecific competition, nor ecologically equivalent to co-exist via neutral dynamics. We tentatively conclude that the question of ecological equivalence relates to the scale of the study: at a fine scale, species' differences may influence dynamics in a local community, whereas at the regional level these species likely play roughly similar ecological roles.	[Fiser, Ziga; Zaksek, Valerija; Fiser, Cene] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Knapic, Tea] Slovenian Museum Nat Hist, Ljubljana, Slovenia	University of Ljubljana; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zurich	Fiser, Z (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	fiser.ziga@gmail.com		Altermatt, Florian/0000-0002-4831-6958; Fiser, Ziga/0000-0003-4576-5173	Slovenian Research Agency [P1-0184]; Swiss National Science Foundation [31003A_135622, PP00P3_150698]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was funded by Slovenian Research Agency, program P1-0184 (to ZF, VK and CF), and by the Swiss National Science Foundation, grants nr. 31003A_135622 and PP00P3_150698 (to FA).	Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cothran RD, 2015, OECOLOGIA, V178, P819, DOI 10.1007/s00442-015-3262-1; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Esselstyn JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021885; Fiser C, 2006, ZOOL ANZ, V245, P77, DOI 10.1016/j.jcz.2006.05.003; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2009, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Freckler A, 2014, SCI TOTAL ENVIRON, V439, P158; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heibl C, 2013, PHYLOCLIM INTEGRATIN; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Karaman G, 1984, GLAS PRIR MUZ BEOG B, V39, P85; Karaman G.S., 1989, Bioloski Vestnik, V37, P19; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Knox MA, 2012, MOL ECOL, V21, P4885, DOI 10.1111/j.1365-294X.2012.05729.x; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lustrik R, 2011, CONTRIB ZOOL, V80, P133, DOI 10.1163/18759866-08002003; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Meleg IN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076760; Menzel U, 2013, EMT EXACT MULTINOMIA; Mermillod-Blondin F, 2013, J EXP BIOL, V216, P1683, DOI 10.1242/jeb.081232; Nygren A, 2014, ZOOL SCR, V43, P172, DOI 10.1111/zsc.12044; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pfenninger M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002157; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pipan T, 2011, J NAT HIST, V45, P253, DOI 10.1080/00222933.2010.523797; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Soucek DJ, 2013, ECOTOXICOLOGY, V22, P1359, DOI 10.1007/s10646-013-1122-5; Steen DA, 2014, J ANIM ECOL, V83, P286, DOI 10.1111/1365-2656.12121; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Westram AM, 2011, INFECT GENET EVOL, V11, P1083, DOI 10.1016/j.meegid.2011.03.024; Wiens JJ, 2008, ECOL LETT, V11, P1004, DOI 10.1111/j.1461-0248.2008.01238.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x	67	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134384	10.1371/journal.pone.0134384	http://dx.doi.org/10.1371/journal.pone.0134384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226375	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358837700085
J	Ho, SMY; Mak, CWY; Yeung, DN; Duan, WJ; Tang, S; Yeung, JC; Ching, RT				Ho, Samuel M. Y.; Mak, Christine W. Y.; Yeung, Dannii; Duan, Wenjie; Tang, Sandy; Yeung, June C.; Ching, Rita			Emotional Valence, Arousal, and Threat Ratings of 160 Chinese Words among Adolescents	PLOS ONE			English	Article							GENERALIZED SOCIAL PHOBIA; AFFECTIVE NORMS; ATTENTIONAL BIAS; ENGLISH; ADAPTATION; ANEW; INTERFERENCE; INDIVIDUALS; DIMENSIONS; DOMINANCE	This study was conducted to provide ratings of valence/pleasantness, arousal/excitement, and threat/potential harm for 160 Chinese words. The emotional valence classification (positive, negative, or neutral) of all of the words corresponded to that of the equivalent English language words. More than 90% of the participants, junior high school students aged between 12 and 17 years, understood the words. The participants were from both mainland China and Hong Kong, thus the words can be applied to adolescents familiar with either simplified (e.g. in mainland China) or traditional Chinese (e.g. in Hong Kong) with a junior secondary school education or higher. We also established eight words with negative valence, high threat, and high arousal ratings to facilitate future research, especially on attentional and memory biases among individuals prone to anxiety. Thus, the new emotional word list provides a useful source of information for affective research in the Chinese language.	[Ho, Samuel M. Y.; Mak, Christine W. Y.; Yeung, Dannii; Duan, Wenjie; Tang, Sandy; Yeung, June C.] City Univ Hong Kong, Dept Appl Social Sci, Psychol Labs, Hong Kong, Hong Kong, Peoples R China; [Ching, Rita] Womens Fdn, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong	Ho, SMY (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Psychol Labs, Hong Kong, Hong Kong, Peoples R China.	munyinho@cityu.edu.hk	Duan, Wenjie/C-8722-2016; Yeung, June/M-4688-2015; Yeung, Dannii Y./K-4183-2012; Ho, Samuel M.Y./D-2454-2014	Duan, Wenjie/0000-0002-1251-3685; Yeung, June/0000-0003-1293-8576; Yeung, Dannii Y./0000-0002-0548-0328; Ho, Samuel M.Y./0000-0001-7803-1657	Women's Foundation [CityU, 9231137]	Women's Foundation	This work was supported by The Women's Foundation (http://twfhk.org/) Grant Number: CityU, Project Number: 9231137.	Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; ASMUNDSON GJG, 1994, J ANXIETY DISORD, V8, P107, DOI 10.1016/0887-6185(94)90009-4; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bertels J, 2009, PSYCHOL BELG, V49, P19, DOI 10.5334/pb-49-1-19; Bjork R.A., 1972, CODING PROCESS HUM, P217; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosan L, 2011, J BEHAV THER EXP PSY, V42, P258, DOI 10.1016/j.jbtep.2010.12.006; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duan W, 2012, HONG KONG J MENT HLT, V38, P24; Duan WJ, 2013, RES SOCIAL WORK PRAC, V23, P336, DOI 10.1177/1049731513477214; Duan WJ, 2012, RES SOCIAL WORK PRAC, V22, P680, DOI 10.1177/1049731512450074; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; Ho S.M.Y., 2010, POSTTRAUMATIC GROWTH, P147; Ho SMY, 2014, ROUTL STUD ETH MORAL, V28, P215; Ho SMY, PSYCHOL ASS IN PRESS; Jones DC, 2005, J YOUTH ADOLESCENCE, V34, P629, DOI 10.1007/s10964-005-8951-3; Kanske P, 2011, BEHAV RES METHODS, V43, P409, DOI 10.3758/s13428-010-0048-6; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C., 1991, HDB BEHAV THERAPY PS, V16, P116; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; McAdoo HP, 1994, ACTIVITIES ADAPTATIO, V19, P27; McCabe RE, 1999, COGNITIVE THER RES, V23, P21, DOI 10.1023/A:1018706607051; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McNally R. J., 1989, COGNITION EMOTION, V3, P27, DOI DOI 10.1080/026999389084; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Onraedt T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090632; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P32, DOI 10.1027/1015-5759.23.1.32; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Reff RC, 2005, J SOC CLIN PSYCHOL, V24, P638, DOI 10.1521/jscp.2005.24.5.638; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; RUSSELL JA, 1978, J PERS SOC PSYCHOL, V36, P1152, DOI 10.1037/0022-3514.36.10.1152; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Siakaluk PD, 2014, COGNITIVE SCI, V38, P1698, DOI 10.1111/cogs.12137; Siegle GJ, 2002, COGNITIVE THER RES, V26, P73, DOI 10.1023/A:1013893705009; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Stewart SH, 1998, COGNITION EMOTION, V12, P105, DOI 10.1080/026999398379808; VASEY MW, 1995, J ABNORM CHILD PSYCH, V23, P267, DOI 10.1007/BF01447092; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Wei WL, 2011, LECT NOTES COMPUT SC, V6975, P121, DOI 10.1007/978-3-642-24571-8_13; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172	50	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132294	10.1371/journal.pone.0132294	http://dx.doi.org/10.1371/journal.pone.0132294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226604	gold, Green Published, Green Submitted			2022-12-26	WOS:000358837700007
J	Vymetalkova, V; Soucek, P; Kunicka, T; Jiraskova, K; Brynychova, V; Pardini, B; Novosadova, V; Polivkova, Z; Kubackova, K; Kozevnikovova, R; Ambrus, M; Vodickova, L; Naccarati, A; Vodicka, P				Vymetalkova, Veronika; Soucek, Pavel; Kunicka, Tereza; Jiraskova, Katerina; Brynychova, Veronika; Pardini, Barbara; Novosadova, Vendula; Polivkova, Zdena; Kubackova, Katerina; Kozevnikovova, Renata; Ambrus, Miloslav; Vodickova, Ludmila; Naccarati, Alessio; Vodicka, Pavel			Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; REPAIR PATHWAY GENES; COLORECTAL-CANCER; ADJUVANT THERAPY; ARGININE ALLELE; CELL-LINES; P53; MUTATIONS; SUSCEPTIBILITY; CHEMOTHERAPY	Variations in the TP53 gene have been suggested to play a role in many cancers, including breast. We previously observed an association between TP53 haplotypes based on four polymorphisms (rs17878362, rs1042522, rs12947788, and rs17884306) and the risk of colorectal and pancreatic cancer. Based on these results, in the present study, we have investigated the same polymorphisms and their haplotypes in 705 breast cancer cases and 611 healthy controls in relation to the disease risk, histopathological features of the tumor and clinical outcomes. In comparison to the most common haplotype A(1)-G-C-G, all the other identified haplotypes were globally associated with a significantly decreased breast cancer risk (P = 0.006). In particular, the A(2)-G-C-G haplotype was associated with a marked decreased risk of breast cancer when compared with the common haplotype (P = 0.0001). Moreover, rs1042522 in patients carrying the GC genotype and receiving only the anthracycline-based chemotherapy was associated with both overall and disease-free survival (recessive model for overall survival HR = 0.30 95% CI 0.11-0.80, P = 0.02 and for diseasefree survival HR = 0.42 95% CI 0.21-0.84, P = 0.01). Present results suggest common genetic features in the susceptibility to breast and gastrointestinal cancers in respect to TP53 variations. In fact, similar haplotype distributions were observed for breast, colorectal, and pancreatic patients in associations with cancer risk. Rs1042522 polymorphism (even after applying the Dunn-Bonferroni correction for multiple testing) appears to be an independent prognostic marker in breast cancer patients.	[Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Naccarati, Alessio; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Soucek, Pavel; Kunicka, Tereza; Brynychova, Veronika] Natl Inst Publ Hlth, Toxicogen Unit, Prague, Czech Republic; [Pardini, Barbara; Naccarati, Alessio] Human Genet Fdn, Turin, Italy; [Novosadova, Vendula] Acad Sci Czech Republ, Inst Biotechnol, Prague, Czech Republic; [Kubackova, Katerina] Univ Hosp Motol, Dept Oncol, Prague, Czech Republic; [Kozevnikovova, Renata] MEDICON, Dept Oncosurg, Prague, Czech Republic; [Ambrus, Miloslav] Charles Univ Prague, Fac Med 3, Dept Radiotherapy & Oncol, Prague, Czech Republic; [Polivkova, Zdena] Charles Univ Prague, Fac Med 3, Dept Gen Biol & Genet, Prague, Czech Republic; [Kunicka, Tereza; Brynychova, Veronika] Charles Univ Prague, Fac Med 3, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Motol University Hospital; Charles University Prague; Charles University Prague; Charles University Prague	Vymetalkova, V (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic.	vpolakova@biomed.cas.cz	Pardini, Barbara/K-9451-2016; Novosadova, Vendula/AAJ-1449-2021; Jiraskova, Katerina/C-8232-2017; Vymetalkova, Veronika/H-3167-2014; Soucek, Pavel/H-8018-2019; Pardini, Barbara/ABI-2295-2020	Pardini, Barbara/0000-0001-9571-4257; Jiraskova, Katerina/0000-0001-8462-6358; Vymetalkova, Veronika/0000-0001-6870-6788; Soucek, Pavel/0000-0002-4294-6799; Pardini, Barbara/0000-0001-9571-4257; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Brynychova, Veronika/0000-0001-7206-8942	Grant agency of the Czech Republic (GACR) [CZ:GACR:P304/12/1585]; Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic) [Prvouk-P27/LF1/1]; Internal Grant Agency Ministry of Health [NT 13424, NT 14055-3]	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic); Internal Grant Agency Ministry of Health	This work was supported by Grant agency of the Czech Republic (GACR) [CZ:GACR: P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient) and by Internal Grant Agency Ministry of Health: NT 13424 and NT 14055-3.	Allen-Brady K, 2006, CANCER EPIDEM BIOMAR, V15, P1306, DOI 10.1158/1055-9965.EPI-05-0959; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beggs AD, 2009, EUR J HUM GENET, V17, P855, DOI 10.1038/ejhg.2008.235; Bewick MA, 2006, J CLIN ONCOL, V24, P5645, DOI 10.1200/JCO.2006.05.9923; Bisof V, 2012, MED ONCOL, V29, P472, DOI 10.1007/s12032-011-9875-2; Bisof V, 2010, EUR J GYNAECOL ONCOL, V31, P539; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; Budach W, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-267; Cheng HT, 2012, MOL BIOL REP, V39, P9265, DOI 10.1007/s11033-012-1800-z; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Dahabreh IJ, 2013, AM J EPIDEMIOL, V177, P1317, DOI 10.1093/aje/kws394; Di Leo A, 2007, ANN ONCOL, V18, P997, DOI 10.1093/annonc/mdm075; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fernandez-Cuesta L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3179; Gao YX, 2011, HUM PATHOL, V42, P1693, DOI 10.1016/j.humpath.2010.12.027; Geisler S, 2001, CANCER RES, V61, P2505; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Hubackova M, 2012, INT J CANCER, V130, P338, DOI 10.1002/ijc.26006; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kunicka T, 2014, DRUG METAB REV; Lajin B, 2013, BREAST CANCER RES TR, V138, P611, DOI 10.1007/s10549-013-2467-4; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Mangoni M, 2011, INT J RADIAT ONCOL, V81, P52, DOI 10.1016/j.ijrobp.2010.04.023; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Naccarati A, 2012, CARCINOGENESIS, V33, P1346, DOI 10.1093/carcin/bgs172; OConnor PM, 1997, CANCER RES, V57, P4285; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Pardini B, 2011, MUTAT RES-GEN TOX EN, V721, P74, DOI 10.1016/j.mrgentox.2010.12.008; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Pooley KA, 2008, CANCER EPIDEM BIOMAR, V17, P3482, DOI 10.1158/1055-9965.EPI-08-0594; Rodrigues P, 2013, MOL CELL BIOCHEM, V379, P181, DOI 10.1007/s11010-013-1640-8; Sagne C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.24; Sapkota Y, 2014, CYTOGENET GENOME RES, V144, P77, DOI 10.1159/000369045; Schneider-Stock R, 2004, NEOPLASIA, V6, P529, DOI 10.1593/neo.04178; Sehl ME, 2009, CLIN CANCER RES, V15, P2192, DOI 10.1158/1078-0432.CCR-08-1417; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Szkandera J, 2012, MOL GENET GENOMICS, V287, P755, DOI 10.1007/s00438-012-0715-7; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Trifa F, 2010, CANCER EPIDEMIOL, V34, P184, DOI 10.1016/j.canep.2010.02.007; Vaclavikova R, 2012, CLIN CHEM LAB MED, V50, P1999, DOI 10.1515/cclm-2012-0103; Vymetalkova V, 2014, MUTAGENESIS, V29, P259, DOI 10.1093/mutage/geu014; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061662; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507	62	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134463	10.1371/journal.pone.0134463	http://dx.doi.org/10.1371/journal.pone.0134463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226484	gold, Green Published			2022-12-26	WOS:000358837700096
J	Wu, MH; Lee, WJ; Hua, KT; Kuo, ML; Lin, MT				Wu, Ming-Hsun; Lee, Wei-Jiunn; Hua, Kuo-Tai; Kuo, Min-Liang; Lin, Ming-Tsan			Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the beta-Catenin Pathway	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; REGULATES EXPRESSION; NECROSIS-FACTOR; CELL-MIGRATION; PROGRESSION; INVASION; SURVIVAL; METALLOPROTEINASE; TUMORIGENESIS; METASTASIS	Background Despite evidence that activated macrophages act in an inflammatory microenvironment to promote gastric tumorigenesis via beta-catenin signaling, the effects of beta-catenin signaling on gastric cancer cell metastasis and the relationship of these cells with surrounding tumor associated macrophages have not been directly studied. Methods Immunohistochemical staining was employed to analyze 103 patients. An invasion assay was used to evaluate the relationship between macrophages and gastric cancer cells. beta-catenin gain-of-function and loss-of-function approaches were performed. To assess the beta-catenin regulation mechanism in gastric cancer cells, Western blotting and reverse-transcription polymerase chain reaction were used. Results Increased density of macrophages was associated with advanced stage and poor survival. Gastric cancer cell lines co-cultured with macrophages conditioned medium showed increased nuclear accumulation of beta-catenin and increased invading ability. AKT but not ERK regulated beta-catenin translocation. MMP7 and CD44, both beta-catenin downstream genes, were involved in macrophage-activated gastric cancer cell invasion. Conclusion(s) Collectively, the clinical data suggest that macrophage infiltration is correlated with increased grade and poor prognosis for gastric cancer patients who underwent radical resection. Macrophages may induce invasiveness by activating the beta-catenin pathway.	[Wu, Ming-Hsun; Lin, Ming-Tsan] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Wei-Jiunn] Taipei Med Univ, Wan Fang Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Hua, Kuo-Tai; Kuo, Min-Liang] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan; [Lin, Ming-Tsan] Natl Taiwan Univ, Coll Med, Dept Med Educ & Bioeth, Grad Inst Med Educ & Bioeth, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University	Lin, MT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	larrywu@hotmail.com	wu, larry/AAV-5282-2021	wu, larry/0000-0002-8811-9203; LIN, MING-TSAN/0000-0001-7313-7057; Hua, Kuo-Tai/0000-0002-8468-4977; KUO, MIN-LIANG/0000-0002-7139-0144	National Science Council, Taiwan [NSC 98-2314-B-002-055-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan (NSC 98-2314-B-002-055-MY2).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Correa P, 2003, CANCER EPIDEM BIOMAR, V12, p238S; Crumley ABC, 2011, ANN SURG ONCOL, V18, P2604, DOI 10.1245/s10434-011-1658-7; Dvory-Sobol H, 2007, CANCER-AM CANCER SOC, V109, P188, DOI 10.1002/cncr.22416; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Fernando HC, 2011, EUR J CARDIO-THORAC, V40, P1177, DOI 10.1016/j.ejcts.2011.02.062; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Julkunen K, 2003, ANTICANCER RES, V23, P5043; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Ohno S, 2003, ANTICANCER RES, V23, P5015; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsukamoto T, 2003, CANCER SCI, V94, P1046, DOI 10.1111/j.1349-7006.2003.tb01399.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wu MH, 2012, J NUTR BIOCHEM, V23, P1434, DOI 10.1016/j.jnutbio.2011.09.004; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134122	10.1371/journal.pone.0134122	http://dx.doi.org/10.1371/journal.pone.0134122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226629	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700057
J	Sehgal, M; Gupta, R; Moussa, A; Singh, TR				Sehgal, Manika; Gupta, Rajinder; Moussa, Ahmed; Singh, Tiratha Raj			An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in Colorectal Cancer	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; COLON-CANCER; TOOL; PATHWAYS; DISEASE; EXPLORATION; MICROARRAYS; RESOURCE; DATABASE; COMPLEX	For examining the intricate biological processes concerned with colorectal cancer (CRC), a systems biology approach integrating several biological components and other influencing factors is essential to understand. We performed a comprehensive system level analysis for CRC which assisted in unravelling crucial network components and many regulatory elements through a coordinated view. Using this integrative approach, the perceptive of complexity hidden in a biological phenomenon is extensively simplified. The microarray analyses facilitated differential expression of 631 significant genes employed in the progression of disease and supplied interesting associated up and down regulated genes like jun, fos and mapk1. The transcriptional regulation of these genes was deliberated widely by examining transcription factors such as hnf4, nr2f1, znf219 and dr1 which directly influence the expression. Further, interactions of these genes/proteins were evaluated and crucial network motifs were detected to associate with the pathophysiology of CRC. The available standard statistical parameters such as z-score, p-value and significance profile were explored for the identification of key signatures from CRC pathway whereas a few novel parameters representing over-represented structures were also designed in the study. The applied approach revealed 5 key genes i.e. kras, araf, pik3r5, ralgds and akt3 via our novel designed parameters illustrating high statistical significance. These novel parameters can assist in scrutinizing candidate markers for diseases having known biological pathways. Further, investigating and targeting these proposed genes for experimental validations, instead being spellbound by the complicated pathway will certainly endow valuable insight in a well-timed systematic understanding of CRC.	[Sehgal, Manika; Gupta, Rajinder; Singh, Tiratha Raj] JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India; [Moussa, Ahmed] Abdelmalek Essaadi Univ, ENSA, LabTIC Lab, Tangier, Morocco	Jaypee University of Information Technology; Abdelmalek Essaadi University of Tetouan	Singh, TR (corresponding author), JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.	tiratharaj@gmail.com	Gupta, Rajinder/ABC-8188-2020; Moussa, Ahmed/AAI-1351-2020; Singh, Tiratha Raj/AAL-4256-2020	Gupta, Rajinder/0000-0003-3342-2122; of Information Technology, Jaypee University/0000-0003-4907-3764; Moussa, Ahmed/0000-0003-1628-8179; SEHGAL, MANIKA/0000-0003-0255-7219	Science and Engineering Research Board, Department of Science and Technology (DST), India [SR/FT/LS-026/2009]	Science and Engineering Research Board, Department of Science and Technology (DST), India(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology (DST), India, grant number SR/FT/LS-026/2009.	American Cancer Society, 2013, CANCER FACTS FIGURES; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Baglioni S, 2004, AM J MED GENET C, V129C, P35, DOI 10.1002/ajmg.c.30023; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Covell DG, 2003, MOL CANCER THER, V2, P317; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Ferlay J, 2013, GLOBOCAN 2012; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Hegde P, 2001, CANCER RES, V61, P7792; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi-Tope G, 2003, COLD SPRING HARB SYM, V68, P237, DOI 10.1101/sqb.2003.68.237; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Lee JW, 2005, APMIS, V113, P54, DOI 10.1111/j.1600-0463.2005.apm1130108.x; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Panigrahi PP, 2013, J THEOR BIOL, V334, P109, DOI 10.1016/j.jtbi.2013.06.013; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Pratap A, 2014, J BIOL SYST, V22, P89, DOI 10.1142/S0218339014500053; Pulido EG, 2011, THE CHALLENGE OF COL; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Sehgal M, 2014, DNA REPAIR, V16, P97, DOI 10.1016/j.dnarep.2014.01.004; Sehgal Manika, 2012, J Nat Sci Biol Med, V3, P139, DOI 10.4103/0976-9668.101887; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tan WY, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-26; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zang SZ, 2007, J BIOMED INFORM, V40, P552, DOI 10.1016/j.jbi.2007.01.002; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zou TT, 2002, ONCOGENE, V21, P4855, DOI 10.1038/sj.onc.1205613	55	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133901	10.1371/journal.pone.0133901	http://dx.doi.org/10.1371/journal.pone.0133901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222778	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800080
J	Zhu, L; McDavid, S; Currie, KPM				Zhu, Lei; McDavid, Sarah; Currie, Kevin P. M.			"Slow" Voltage-Dependent Inactivation of CaV2.2 Calcium Channels Is Modulated by the PKC Activator Phorbol 12-Myristate 13-Acetate (PMA)	PLOS ONE			English	Article							PROTEIN-KINASE-C; GATED CA2+ CHANNELS; ADRENAL CHROMAFFIN CELLS; METABOTROPIC GLUTAMATE RECEPTORS; RAT SYMPATHETIC NEURONS; N-TYPE; MOLECULAR DETERMINANTS; BETA-SUBUNITS; CUMULATIVE INACTIVATION; CA(V)2.2 CHANNELS	Ca(V)2.2 (N-type) voltage-gated calcium channels (Ca2+ channels) play key roles in neurons and neuroendocrine cells including the control of cellular excitability, neurotransmitter / hormone secretion, and gene expression. Calcium entry is precisely controlled by channel gating properties including multiple forms of inactivation. "Fast" voltage-dependent inactivation is relatively well-characterized and occurs over the tens-to- hundreds of milliseconds timeframe. Superimposed on this is the molecularly distinct, but poorly understood process of "slow" voltage-dependent inactivation, which develops / recovers over seconds-to-minutes. Protein kinases can modulate "slow" inactivation of sodium channels, but little is known about if/how second messengers control "slow" inactivation of Ca2+ channels. We investigated this using recombinant Ca(V)2.2 channels expressed in HEK293 cells and native Ca(V)2 channels endogenously expressed in adrenal chromaffin cells. The PKC activator phorbol 12-myristate 13-acetate (PMA) dramatically prolonged recovery from "slow" inactivation, but an inactive control (4 alpha-PMA) had no effect. This effect of PMA was prevented by calphostin C, which targets the C1-domain on PKC, but only partially reduced by inhibitors that target the catalytic domain of PKC. The subtype of the channel beta-subunit altered the kinetics of inactivation but not the magnitude of slowing produced by PMA. Intracellular GDP-beta-S reduced the effect of PMA suggesting a role for G proteins in modulating "slow" inactivation. We postulate that the kinetics of recovery from "slow" inactivation could provide a molecular memory of recent cellular activity and help control Ca(V)2 channel availability, electrical excitability, and neurotransmission in the seconds-to-minutes timeframe.	[Zhu, Lei; McDavid, Sarah; Currie, Kevin P. M.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37235 USA; [Currie, Kevin P. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Currie, Kevin P. M.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Currie, KPM (corresponding author), Vanderbilt Univ, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	kevin.currie@vanderbilt.edu	Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X	National Institutes of Health [R01 NS052446, R21 NS081492]; Vanderbilt University Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081492, R01NS052446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health [Grant R01 NS052446 and Grant R21 NS081492] to KC and by a Discovery grant from Vanderbilt University Medical Center to KC. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CF, 2000, J GEN PHYSIOL, V115, P277, DOI 10.1085/jgp.115.3.277; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blair NT, 2003, J NEUROSCI, V23, P10338; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Cahill AL, 2000, J NEUROSCI, V20, P1685; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2013, J BIOL CHEM, V288, P10742, DOI 10.1074/jbc.R112.411645; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Degtiar VE, 2000, J NEUROSCI, V20, P4355, DOI 10.1523/JNEUROSCI.20-12-04355.2000; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Diaz-Cardenas AF, 2008, ARCH BIOCHEM BIOPHYS, V473, P1, DOI 10.1016/j.abb.2008.01.030; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Fang HY, 2006, J BIOL CHEM, V281, P20011, DOI 10.1074/jbc.M601776200; Gandini MA, 2014, PFLUG ARCH EUR J PHY, V466, P2113, DOI 10.1007/s00424-014-1476-4; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jewell M.L., 2013, MODULATION PRESYNAPT, P01; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; Kanda VA, 2011, HEART RHYTHM, V8, P1641, DOI 10.1016/j.hrthm.2011.04.034; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; McCool BA, 1996, MOL PHARMACOL, V50, P912; McCool BA, 1998, J NEUROPHYSIOL, V79, P379, DOI 10.1152/jn.1998.79.1.379; McDavid S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109203; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Mykoniatis A, 2010, AM J PHYSIOL-CELL PH, V298, pC85, DOI 10.1152/ajpcell.00118.2009; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Perez-Burgos A, 2008, NEUROSCIENCE, V155, P1079, DOI 10.1016/j.neuroscience.2008.06.047; Rajagopal S, 2014, NEUROSCIENCE, V280, P1, DOI 10.1016/j.neuroscience.2014.08.049; Rajagopal S, 2009, NEUROSCIENCE, V159, P618, DOI 10.1016/j.neuroscience.2008.12.047; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Sculptoreanu A, 2003, J NEUROPHYSIOL, V90, P21, DOI 10.1152/jn.00108.2003; Silva Jonathan, 2014, Handb Exp Pharmacol, V221, P33, DOI 10.1007/978-3-642-41588-3_3; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Stephens GJ, 2009, TRENDS PHARMACOL SCI, V30, P421, DOI 10.1016/j.tips.2009.05.008; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Todd RD, 2012, ANESTHESIOLOGY, V116, P1013, DOI 10.1097/ALN.0b013e31825153ea; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Wykes RCE, 2007, J NEUROSCI, V27, P5236, DOI 10.1523/JNEUROSCI.3545-06.2007; Yan JL, 2003, ANAL CHEM, V75, P5406, DOI 10.1021/ac034017m; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; ZHU Y, 1994, J NEUROPHYSIOL, V72, P1549, DOI 10.1152/jn.1994.72.4.1549	68	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134117	10.1371/journal.pone.0134117	http://dx.doi.org/10.1371/journal.pone.0134117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222492	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800107
J	Ahn, JS; Li, J; Chen, E; Kent, DG; Park, HJ; Green, AR				Ahn, J. S.; Li, J.; Chen, E.; Kent, D. G.; Park, H. J.; Green, A. R.			JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; FORKHEAD TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM-CELLS; ABL-EXPRESSING CELLS; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; GENE-EXPRESSION; CANCER-CELLS; JAK2	The JAK2V617F mutation is found in most patients with a myeloproliferative neoplasm (MPN). This gain-of-function mutation dysregulates cytokine signaling and is associated with increased accumulation of DNA damage, a process likely to drive disease evolution. JAK2V617F inhibits NHE-1 upregulation in response to DNA damage and consequently represses Bcl-xL deamidation and apoptosis, thus giving rise to inappropriate cell survival. However, the mechanism whereby NHE-1 expression is inhibited by JAK2V617F is unknown. In this study, we demonstrate that the accumulation of reactive oxygen species (ROS) in cells expressing JAK2V617F compromises the NHE-1/Bcl-xL deamidation pathway by repressing NHE-1 upregulation in response to DNA damage. In JAK2V617F-positive cells, increased ROS levels results from aberrant PI3K signaling, which decreases nuclear localization of FOXO3A and decreases catalase expression. Furthermore, when compared with autologous control erythroblasts, clonally derived JAK2V617F-positive erythroblasts from MPN patients displayed increased ROS levels and reduced nuclear FOXO3A. However, in hematopoietic stem cells (HSCs), FOXO3A is largely localized within the nuclei despite the presence of JAK2V617F mutation, suggesting that JAK2-FOXO signaling has a different effect on progenitors compared with stem cells. Inactivation of FOXO proteins and elevation of intracellular ROS are characteristics common to many cancers, and hence these findings are likely to be of relevance beyond the MPN field.	[Ahn, J. S.; Li, J.; Chen, E.; Kent, D. G.; Park, H. J.; Green, A. R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Ahn, J. S.; Li, J.; Chen, E.; Kent, D. G.; Park, H. J.; Green, A. R.] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge, England; [Ahn, J. S.; Li, J.; Chen, E.; Kent, D. G.; Park, H. J.; Green, A. R.] Univ Cambridge, Dept Haematol, Cambridge, England; [Green, A. R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 0XY, England.	arg1000@cam.ac.uk	Kent, David/AAZ-4916-2021	Kent, David/0000-0001-7871-8811; Green, Anthony/0000-0002-9795-0218	Leukemia and Lymphoma Research, Cancer Research UK; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America; Canadian Institutes of Health Research (Ottawa, ON); Lady Tata Memorial Trust International Award for Research in Leukaemia (London, UK); Human Frontier Science Program; Cancer Research UK [12765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10079] Funding Source: researchfish	Leukemia and Lymphoma Research, Cancer Research UK; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Canadian Institutes of Health Research (Ottawa, ON)(Canadian Institutes of Health Research (CIHR)); Lady Tata Memorial Trust International Award for Research in Leukaemia (London, UK); Human Frontier Science Program(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank patients and staff of the Addenbrookes MPN clinic who have contributed samples to this study; Yvonne Silber for technical assistance; Philip Beer, Anna Godfrey, Christina Ortmann and Joanna Baxter (Translational Research Laboratory, University of Cambridge) for help with acquiring clinical samples; Peter Campbell (Sanger Institute) for helpful discussions; and Michael Murphy (MRC MBU) for supplying MitoQ. Work in the Green lab is supported by Leukemia and Lymphoma Research, Cancer Research UK, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre and the Leukemia & Lymphoma Society of America. DGK was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (Ottawa, ON), and a Lady Tata Memorial Trust International Award for Research in Leukaemia (London, UK). HJP was supported by a postdoctoral fellowship from the Human Frontier Science Program.	Akram S, 2006, CELL DEATH DIFFER, V13, P628, DOI 10.1038/sj.cdd.4401775; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen E, 2014, P NATL ACAD SCI USA, V111, P15190, DOI 10.1073/pnas.1401873111; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fernandes MS, 2009, BLOOD, V114, P1813, DOI 10.1182/blood-2008-07-172148; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Huang Y, 1998, BIOCHEM BIOPH RES CO, V249, P307, DOI 10.1006/bbrc.1998.9139; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jhumka Z, 2009, INT J BIOCHEM CELL B, V41, P945, DOI 10.1016/j.biocel.2008.09.028; Kagoya Y, 2014, BLOOD, V124, P2996, DOI 10.1182/blood-2014-04-570572; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kumar AP, 2007, CELL DEATH DIFFER, V14, P1733, DOI 10.1038/sj.cdd.4402176; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Li J, 2014, BLOOD, V123, P3139, DOI 10.1182/blood-2013-06-510222; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Lin B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07041; Marty C, 2013, LEUKEMIA, V27, P2187, DOI 10.1038/leu.2013.102; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Pellicano F, 2014, STEM CELLS, V32, P2324, DOI 10.1002/stem.1748; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Pourova J, ACTA PHYSL OXF, V198, P15; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rakshit S, 2009, APOPTOSIS, V14, P298, DOI 10.1007/s10495-008-0305-7; Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005; Sikora MJ, 2008, CANCER BIOL THER, V7, P767, DOI 10.4161/cbt.7.5.5767; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsai SY, 2007, CANCER SCI, V98, P1206, DOI 10.1111/j.1349-7006.2007.00513.x; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Weinberg F, P NATL ACAD SCI US, V107, P8788; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	58	19	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2235	2246		10.1038/onc.2015.285	http://dx.doi.org/10.1038/onc.2015.285			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26234675	Green Accepted			2022-12-26	WOS:000374986000009
J	Calattini, S; Fusil, F; Mancip, J; Thi, VLD; Granier, C; Gadot, N; Scoazec, JY; Zeisel, MB; Baumert, TF; Lavillette, D; Dreux, M; Cosset, FL				Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Gadot, Nicolas; Scoazec, Jean-Yves; Zeisel, Mirjam B.; Baumert, Thomas F.; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic			Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR-BI; SURFACE HEPARAN-SULFATE; HUMAN HEPATOCYTES; SR-BI; NEUTRALIZING ANTIBODIES; CHOLESTERYL ESTER; CELL-CULTURE; ENTRY FACTOR	Lipoprotein components are crucial factors for hepatitis C virus (HCV) assembly and entry. As hepatoma cells producing cell culture-derived HCV (HCVcc) particles are impaired in some aspects of lipoprotein metabolism, it is of upmost interest to biochemically and functionally characterize the in vivo produced viral particles, particularly regarding how lipoprotein components modulate HCV entry by lipid transfer receptors such as scavenger receptor BI (SR-BI). Sera from HCVcc-infected liver humanized FRG mice were separated by density gradients. Viral subpopulations, termed HCVfrg particles, were characterized for their physical properties, apolipoprotein association, and infectivity. We demonstrate that, in contrast to the widely spread distribution of apolipoproteins across the different HCVcc subpopulations, the most infectious HCVfrg particles are highly enriched in apoE, suggesting that such apolipoprotein enrichment plays a role for entry of in vivo derived infectious particles likely via usage of apolipoprotein receptors. Consistent with this salient feature, we further reveal previously undefined functionalities of SR-BI in promoting entry of in vivo produced HCV. First, unlike HCVcc, SR-BI is a particularly limiting factor for entry of HCVfrg subpopulations of very low density. Second, HCVfrg entry involves SR-BI lipid transfer activity but not its capacity to bind to the viral glycoprotein E2. In conclusion, we demonstrate that composition and biophysical properties of the different subpopulations of in vivo produced HCVfrg particles modulate their levels of infectivity and receptor usage, hereby featuring divergences with in vitro produced HCVcc particles and highlighting the powerfulness of this in vivo model for the functional study of the interplay between HCV and liver components.	[Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, CIRI Int Ctr Infectiol Res, Team EVIR Enveloped Viruses Vectors & Innate Resp, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] INSERM, U1111, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon 1, Ctr Int Rech Infectiol, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] CNRS, UMR5308, F-69007 Lyon, France; [Calattini, Sara; Fusil, Floriane; Mancip, Jimmy; Viet Loan Dao Thi; Granier, Christelle; Lavillette, Dimitri; Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, LabEx Ecofect, F-69007 Lyon, France; [Gadot, Nicolas; Scoazec, Jean-Yves] CNRS, ANIPATH Ctr Histopathol Petit Anim Lab, SFR Lyon Est, UMS3453 INSERM US7, F-69372 Lyon, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, Inst Malad Virales & Hepat, U1110, F-67000 Strasbourg, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Inst Hosp Univ, Pole Hepatodigestif, F-67000 Strasbourg, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cosset, FL (corresponding author), Univ Lyon, CIRI Int Ctr Infectiol Res, Team EVIR, F-69007 Lyon, France.	flcosset@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Dreux, Marlene/M-7295-2014; Baumert, Thomas/ABF-4718-2020; Zeisel, Mirjam B/E-9205-2016	Cosset, François-Loïc/0000-0001-8842-3726; Dreux, Marlene/0000-0002-6607-4796; Baumert, Thomas/0000-0002-8864-2168; Zeisel, Mirjam B/0000-0003-1606-0131; Lavillette, Dimitri/0000-0002-4706-1519; Christelle, GRANIER/0000-0001-8987-0632; FUSIL, Floriane/0000-0002-1619-7333; Dao Thi, Viet Loan/0000-0003-2293-3592	French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS); ANRS consortium on humanized mouse models for viral hepatitis; FINOVI foundation; European Research Council [ERC-2008-AdG-233130-HEPCENT]; LabEx Ecofect Grant [ANR-11-LABX-0048]; ANRS	French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS)(French National Research Agency (ANR)); ANRS consortium on humanized mouse models for viral hepatitis(French National Research Agency (ANR)); FINOVI foundation; European Research Council(European Research Council (ERC)European Commission); LabEx Ecofect Grant; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported in part by the French "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS), "ANRS consortium on humanized mouse models for viral hepatitis," the FINOVI foundation, European Research Council Grant ERC-2008-AdG-233130-HEPCENT, and LabEx Ecofect Grant ANR-11-LABX-0048. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the ANRS.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Ellis ECS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078550; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067982; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Lefevre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095550; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loison C, 2002, BRIT J NUTR, V87, P199, DOI [10.1079/BJNBJN2002521, 10.1079/BJN2002521]; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Spady DK, 1999, J LIPID RES, V40, P1384; SPARKS DL, 1995, J BIOL CHEM, V270, P26910, DOI 10.1074/jbc.270.45.26910; Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Xu Y, 2015, J VIROL, V89, P3846, DOI 10.1128/JVI.03647-14; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097	64	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23173	23187		10.1074/jbc.M115.662999	http://dx.doi.org/10.1074/jbc.M115.662999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26224633	Green Published, hybrid			2022-12-26	WOS:000361685500028
J	Saez-Jimenez, V; Baratto, MC; Pogni, R; Rencoret, J; Gutierrez, A; Santos, JI; Martinez, AT; Ruiz-Duenas, FJ				Saez-Jimenez, Veronica; Baratto, Maria Camilla; Pogni, Rebecca; Rencoret, Jorge; Gutierrez, Ana; Ignacio Santos, Jose; Martinez, Angel T.; Javier Ruiz-Duenas, Francisco			Demonstration of Lignin-to-Peroxidase Direct Electron Transfer A TRANSIENT-STATE KINETICS, DIRECTED MUTAGENESIS, EPR, AND NMR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYNGII VERSATILE PEROXIDASE; PLEUROTUS-ERYNGII; MICROBIAL-DEGRADATION; VERATRYL ALCOHOL; OXIDATION SITES; LACCASE; IDENTIFICATION; EXPRESSION; RESONANCE; ENZYMES	Versatile peroxidase (VP) is a high redox-potential peroxidase of biotechnological interest that is able to oxidize phenolic and non-phenolic aromatics, Mn2+, and different dyes. The ability of VP from Pleurotus eryngii to oxidize water-soluble lignins (softwood and hardwood lignosulfonates) is demonstrated here by a combination of directed mutagenesis and spectroscopic techniques, among others. In addition, direct electron transfer between the peroxidase and the lignin macromolecule was kinetically characterized using stopped-flow spectrophotometry. VP variants were used to show that this reaction strongly depends on the presence of a solvent-exposed tryptophan residue (Trp-164). Moreover, the tryptophanyl radical detected by EPR spectroscopy of H2O2-activated VP (being absent from the W164S variant) was identified as catalytically active because it was reduced during lignosulfonate oxidation, resulting in the appearance of a lignin radical. The decrease of lignin fluorescence (excitation at 355 nm/emission at 400 nm) during VP treatment under steady-state conditions was accompanied by a decrease of the lignin (aromatic nuclei and side chains) signals in one-dimensional and two-dimensional NMR spectra, confirming the ligninolytic capabilities of the enzyme. Simultaneously, size-exclusion chromatography showed an increase of the molecular mass of the modified residual lignin, especially for the (low molecular mass) hardwood lignosulfonate, revealing that the oxidation products tend to recondense during the VP treatment. Finally, mutagenesis of selected residues neighboring Trp-164 resulted in improved apparent second-order rate constants for lignosulfonate reactions, revealing that changes in its protein environment (modifying the net negative charge and/or substrate accessibility/binding) can modulate the reactivity of the catalytic tryptophan.	[Martinez, Angel T.; Javier Ruiz-Duenas, Francisco] CSIC, CIB, E-28040 Madrid, Spain; [Baratto, Maria Camilla; Pogni, Rebecca] Univ Siena, Dept Biotechnol Chem & Pharm, I-53100 Siena, Italy; [Rencoret, Jorge; Gutierrez, Ana] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain; [Ignacio Santos, Jose] Univ Basque Country, UPV EHU Donostia, SGIKER, NMR Facil, Leioa 48940, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Basque Country	Martinez, AT (corresponding author), CSIC, CIB, Ramiro Maeztu 9, E-28040 Madrid, Spain.	ATMartinez@cib.csic.es; fjruiz@cib.csic.es	RENCORET, JORGE/E-1747-2013; Martínez, Angel T/G-7284-2017; Santos, Jose I/C-9546-2016; Ruiz-Dueñas, Francisco J/L-9837-2015; Gutiérrez, Ana/ABG-9861-2020; RENCORET, JORGE/ABE-4139-2020; Santos, José I./AAH-1969-2019	RENCORET, JORGE/0000-0003-2728-7331; Martínez, Angel T/0000-0002-1584-2863; Santos, Jose I/0000-0002-5199-2332; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Gutiérrez, Ana/0000-0002-8823-9029; RENCORET, JORGE/0000-0003-2728-7331; Santos, José I./0000-0002-5199-2332; Saez-Jimenez, Veronica/0000-0001-7043-5622	European Union [KBBE-2013-613549]; Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2011-26694, BIO2014-56388-R, AGL2014-53730-R]; FEDER funds; Italian Ministry of Education, Universities and Research (MIUR) [PRIN 2009-STNWX3]; Spanish MINECO; CSIC [201440E097]; Ramon y Cajal contract of the Spanish MINECO	European Union(European Commission); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); FEDER funds(European Commission); Italian Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Spanish MINECO(Spanish Government); CSIC; Ramon y Cajal contract of the Spanish MINECO	This work was supported by the INDOX (KBBE-2013-613549) European Union project, the HIPOP (BIO2011-26694), NOESIS (BIO2014-56388-R), and BIORENZYMERY (AGL2014-53730-R) projects of the Spanish Ministry of Economy and Competitiveness (MINECO) co-financed by FEDER funds, and the PRIN 2009-STNWX3 project of the Italian Ministry of Education, Universities and Research (MIUR).; Supported by an FPI Fellowship of the Spanish MINECO.; Supported by a contract of the CSIC project 201440E097.; Supported by a Ramon y Cajal contract of the Spanish MINECO. To whom correspondence may be addressed: CIB, CSIC, Ramiro de Maeztu 9, E-28040 Madrid, Spain. Tel.: 34-918373112; Fax: 34-915360432; E-mail: fjruiz@cib.csic.es.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Albinsson B, 1999, J MOL STRUCT, V508, P19, DOI 10.1016/S0022-2860(98)00913-2; Areskogh D, 2011, THESIS KTH STOCKHOLM; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Felby C, 1997, APPL MICROBIOL BIOT, V48, P459, DOI 10.1007/s002530051080; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Floudas D, 2015, FUNGAL GENET BIOL, V76, P78, DOI 10.1016/j.fgb.2015.02.002; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Glennie D.W., 1971, LIGNINS OCCURRENCE F, P597; Gronqvist S, 2005, APPL MICROBIOL BIOT, V67, P489, DOI 10.1007/s00253-004-1800-6; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Lebo SE, 2008, CHARACTERIZATION LIG, P189; Lu FC, 2011, J BIOBASED MATER BIO, V5, P169, DOI 10.1166/jbmb.2011.1131; Lutnaes BF, 2008, MAGN RESON CHEM, V46, P299, DOI 10.1002/mrc.2184; Magina S, 2015, HOLZFORSCHUNG, V69, P513, DOI 10.1515/hf-2014-0218; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2005, INT MICROBIOL, V8, P195; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Prasetyo EN, 2010, BIORESOURCE TECHNOL, V101, P5054, DOI 10.1016/j.biortech.2010.01.048; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ralph J., 1999, PROGR LIGNOCELLULOSI, P55; Rencoret J, 2009, HOLZFORSCHUNG, V63, P691, DOI 10.1515/HF.2009.070; Rico A, 2015, BIOENERG RES, V8, P211, DOI 10.1007/s12155-014-9505-x; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200; Schmidt JA., 2010, LIGNIN LIGNANS ADV C, P49, DOI 10.1201/EBK1574444865-c3; Shin Kwang-Soo, 1995, Mycoscience, V36, P31, DOI 10.1007/BF02268570; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Taboada-Puig R, 2013, APPL BIOCHEM BIOTECH, V169, P1262, DOI 10.1007/s12010-012-0023-z; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661	46	29	29	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23201	23213		10.1074/jbc.M115.665919	http://dx.doi.org/10.1074/jbc.M115.665919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240145	Green Published, hybrid			2022-12-26	WOS:000361685500030
J	Williamson, DM; Elferich, J; Shinde, U				Williamson, Danielle M.; Elferich, Johannes; Shinde, Ujwal			Mechanism of Fine-tuning pH Sensors in Proprotein Convertases IDENTIFICATION OF A pH-SENSING HISTIDINE PAIR IN THE PROPEPTIDE OF PROPROTEIN CONVERTASE 1/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; INTRAMOLECULAR CHAPERONE; CIS/TRANS ISOMERIZATION; ENZYME ACTIVATION; PRO-DOMAIN; FURIN; OBESITY; CLEAVAGE; PC1/3; DEFICIENCY	The propeptides of proprotein convertases (PCs) regulate activation of cognate protease domains by sensing pH of their organellar compartments as they transit the secretory pathway. Earlier experimental work identified a conserved histidine-encoded pH sensor within the propeptide of the canonical PC, furin. To date, whether protonation of this conserved histidine is solely responsible for PC activation has remained unclear because of the observation that various PC paralogues are activated at different organellar pH values. To ascertain additional determinants of PC activation, we analyzed PC1/3, a paralogue of furin that is activated at a pH of similar to 5.4. Using biophysical, biochemical, and cell-based methods, we mimicked the protonation status of various histidines within the propeptide of PC1/3 and examined how such alterations can modulate pH-dependent protease activation. Our results indicate that whereas the conserved histidine plays a crucial role in pH sensing and activation of this protease an additional histidine acts as a "gatekeeper" that fine-tunes the sensitivity of the PC1/3 propeptide to facilitate the release inhibition at higher proton concentrations when compared with furin. Coupled with earlier analyses that highlighted the enrichment of the amino acid histidine within propeptides of secreted eukaryotic proteases, our work elucidates how secreted proteases have evolved to exploit the pH of the secretory pathway by altering the spatial juxtaposition of titratable groups to regulate their activity in a spatiotemporal fashion.	[Williamson, Danielle M.; Elferich, Johannes; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Shinde, U (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	shindeu@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health Ruth L. Kirschstein National Research Service [5F30DK096752]; National Science Foundation [MCB0746589]; American Heart Association [12PRE11470005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award 5F30DK096752 (to D. M. W.). This work was also supported by National Science Foundation Grant MCB0746589 (to U. S.) and American Heart Association Predoctoral Training Grant 12PRE11470005 (to J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Arsenault D, 2012, J CELL PHYSIOL, V227, P789, DOI 10.1002/jcp.22792; Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Blanco EH, 2014, ENDOCRINOLOGY, V155, P3434, DOI 10.1210/en.2013-2151; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; de Cicco RL, 2005, CANCER RES, V65, P4162, DOI 10.1158/0008-5472.CAN-04-2820; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; Elferich J., 2012, P 6 INT C BIOINF BIO; Elferich J, 2015, ANAL CHEM, V87, P7909, DOI 10.1021/acs.analchem.5b01721; Elferich J, 2013, FASEB J, V27, P2939, DOI 10.1096/fj.12-226886; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu J, 2012, NEOPLASIA, V14, P271, DOI 10.1593/neo.12166; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martin MG, 2013, GASTROENTEROLOGY, V145, P138, DOI 10.1053/j.gastro.2013.03.048; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pasquato A, 2013, ANTIVIR RES, V99, P49, DOI 10.1016/j.antiviral.2013.04.013; Pickett LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055065; Prabhu Y, 2014, ENDOCRINOLOGY, V155, P2391, DOI 10.1210/en.2013-1985; Rashid S, 2014, CIRCULATION, V130, P431, DOI 10.1161/CIRCULATIONAHA.113.006720; Reimer U, 1997, BIOCHEMISTRY-US, V36, P13802, DOI 10.1021/bi9713916; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Scamuffa N, 2014, CARCINOGENESIS, V35, P528, DOI 10.1093/carcin/bgt345; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Stijnen P, 2014, AM J EPIDEMIOL, V180, P1051, DOI 10.1093/aje/kwu237; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Subbian E., 2015, ADV BIOSCI BIOTECHNO, V06, P73; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; TANFORD C, 1961, J BIOL CHEM, V236, P1711; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tangrea MA, 2001, BIOCHEMISTRY-US, V40, P5488, DOI 10.1021/bi0026472; TEXTER FL, 1992, BIOCHEMISTRY-US, V31, P5687, DOI 10.1021/bi00140a001; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Williamson DM, 2013, J BIOL CHEM, V288, P19154, DOI 10.1074/jbc.M112.442681; Yabuta Y, 2003, J BIOL CHEM, V278, P15246, DOI 10.1074/jbc.M212003200; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x; Zandberg WF, 2011, GLYCOBIOLOGY, V21, P1290, DOI 10.1093/glycob/cwr060; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	59	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23214	23225		10.1074/jbc.M115.665430	http://dx.doi.org/10.1074/jbc.M115.665430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26229104	Green Published, hybrid			2022-12-26	WOS:000361685500031
J	Austin, KG; Price, LL; McGraw, SM; Lieberman, HR				Austin, Krista G.; Price, Lori Lyn; McGraw, Susan M.; Lieberman, Harris R.			Predictors of Dietary Supplement Use by US Coast Guard Personnel	PLOS ONE			English	Article								Background Personnel in Armed Forces entities such as the US Coast Guard (USCG) engage in strenuous tasks requiring high levels of physiological and psychological fitness. Previous reports have found increased prevalence of dietary supplement (DS) use by military personnel to meet the demands of their occupation. Objective This study assessed DS prevalence and patterns of use in USCG personnel and compared these findings to reports from other Armed Forces personnel. Design Use of DS by USCG personnel (n = 1059) was assessed by survey at USCG installations. Data were weighted by age, sex, and rank to be representative of total USCG demographics. Results Seventy percent of USCG personnel reported using a DS at least 1 time/wk. Thirty-three percent used 1-2 DS >= 1 time/wk, 18% 3-4 DS >= 1 time/wk, and almost 19% >= 5 DS >= 1 time/wk. Average expenditure on DSs by UCSG personnel was $40/mo. More than 47% of USCG personnel used a multivitamin and mineral, 33% consumed protein supplements, 22% used individual vitamins and minerals, 23% reported taking combination products, and 9% consumed herbal supplements. Increased use of DS use was associated with high intensity operational occupations, participating in high volumes of aerobic exercise and strength training. Use of DS was not associated with age, education or body mass index. Conclusion Occupation is an important determinate of DS use. Prevalence of DS use by USCG personnel is greater than reported for other Armed Forces personnel and reflects high levels of participation in aerobic and strength training activities.	[Austin, Krista G.; McGraw, Susan M.; Lieberman, Harris R.] US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA; [Austin, Krista G.] Oak Ridge Inst Sci & Educ, Belcamp, MD 21017 USA; [Price, Lori Lyn] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Tufts Medical Center	Lieberman, HR (corresponding author), US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA.	harris.r.lieberman.civ@mail.mil			United States Army Medical Research and Material Command (USAMRMC); Department of Defense Center Alliance for Dietary Supplement Research	United States Army Medical Research and Material Command (USAMRMC); Department of Defense Center Alliance for Dietary Supplement Research	This work was supported by the United States Army Medical Research and Material Command (USAMRMC) and the Department of Defense Center Alliance for Dietary Supplement Research.	Austin KG, 2013, INT J SPORT NUTR EXE, V23, P322, DOI 10.1123/ijsnem.23.4.322; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Barlas FM, 2013, 2011 SURVEY HLTH REL; Bray RM, 2006, 2005 SURVEY HLTH REL; Deuster PA, 2003, MIL MED, V168, P57; Dickinson A, 2014, J AM COLL NUTR, V33, P176, DOI 10.1080/07315724.2013.875423; Dickinson A, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-14; Erdman KA, 2006, MED SCI SPORT EXER, V38, P349, DOI 10.1249/01.mss.0000187332.92169.e0; Gahche Jamie, 2011, NCHS Data Brief, P1; Goston JL, 2010, NUTRITION, V26, P604, DOI 10.1016/j.nut.2009.06.021; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Human Performance Resource Center, OPER SUPPL; Jacobson IG, 2012, ANN EPIDEMIOL, V22, P318, DOI 10.1016/j.annepidem.2012.02.017; Knapik JJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-143; Lieberman HR, 2010, AM J CLIN NUTR, V92, P985, DOI 10.3945/ajcn.2010.29274; Lyle BJ, 1998, J NUTR, V128, P2355, DOI 10.1093/jn/128.12.2355; Marcus DM, 2012, ARCH INTERN MED, V172, P1035, DOI 10.1001/archinternmed.2012.2687; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Maughan RJ, 2013, J NUTR, V143, P1843, DOI 10.3945/jn.113.176651; Morrison LJ, 2004, INT J SPORT NUTR EXE, V14, P481, DOI 10.1123/ijsnem.14.4.481; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Stoltzfus RJ, 1998, GUIDELINES USE IRON; Tsitsimpikou C, 2011, INT J SPORT NUTR EXE, V21, P377, DOI 10.1123/ijsnem.21.5.377; U. S. Coast Guard, 2012, COAST GUARD AVIAT ME; U.S. Food and Drug Administration (FDA), STIM POT DANG HLTH; United States Coast Guard, 2014, MISS READ TOD PREP T; United States Coast Guard, 2013, COAST GUARD HLTH PRO; United States Coast Guard, 2012, COAST GUARD WEIGHT B	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133006	10.1371/journal.pone.0133006	http://dx.doi.org/10.1371/journal.pone.0133006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230407	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400024
J	Gervasini, G; Garcia-Cerrada, M; Coto, E; Vergara, E; Garcia-Pino, G; Alvarado, R; Fernandez-Cavada, MJ; Suarez-Alvarez, B; Barroso, S; Doblare, E; Diaz-Corte, C; Lopez-Larrea, C; Cubero, JJ				Gervasini, Guillermo; Garcia-Cerrada, Montserrat; Coto, Eliecer; Vergara, Esther; Garcia-Pino, Guadalupe; Alvarado, Raul; Jesus Fernandez-Cavada, Maria; Suarez-Alvarez, Beatriz; Barroso, Sergio; Doblare, Emilio; Diaz-Corte, Carmen; Lopez-Larrea, Carlos; Jose Cubero, Juan			A 3 '-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; ARACHIDONIC-ACID; PHARMACOKINETICS; PHARMACODYNAMICS; CYTOCHROME-P450; METABOLITES; DYSFUNCTION; EXPRESSION	Background and Purpose Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that play a protective role against damaging processes that may occur after re-oxygenation of the graft. We aimed to investigate whether the presence of functional polymorphisms in the gene encoding soluble epoxy hydrolase (EPHX2), which metabolizes EETs to less active compounds, may play a role in the outcome of renal transplantation. Methods In a group of 259 Caucasian renal transplant recipients and 183 deceased donors, we determined the presence of three common EPHX2 SNPs, namely rs41507953 (K55R), rs751141 (R287Q) and rs1042032 A/G. Associations with parameters of graft function and the incidence of acute rejection were retrospectively investigated throughout the first year after grafting by logistic regression adjusting for clinical and demographic variables. Results Carriers of the rs1042032 GG genotype displayed significantly lower estimated glomerular filtration rate (eGFR) (38.15 +/- 15.57 vs. 45.99 +/- 16.05; p = 0.04) and higher serum creatinine values (1.57 +/- 0.58 vs. 1.30 +/- 0.47 g/dL; p = 0.02) one year after grafting, compared to patients carrying the wildtype A-allele. The same GG genotype was also associated to increased risk of acute rejection. Interestingly, this association was observed for the genotype of both recipients [OR = 6.34 (1.35-29.90); p = 0.015] and donors [OR = 5.53 (1.10-27.80); p=0.042]. A statistical model including both genotypes along with other meaningful demographic and clinical variables resulted in an increased significance for the association with the recipients' genotype [OR=8.28 (1.21-74.27); p=0.031]. Conclusions Our results suggest that genetic variability in the EETs-metabolizing gene, EPHX2, may have a significant impact on the outcome of deceased-donor renal transplantation.	[Gervasini, Guillermo; Garcia-Cerrada, Montserrat] Univ Extremadura, Sch Med, Dept Med & Surg Therapeut, Div Pharmacol, Badajoz, Spain; [Coto, Eliecer] HUCA, Lab Med, Mol Genet, Oviedo, Spain; [Vergara, Esther; Jesus Fernandez-Cavada, Maria; Doblare, Emilio] Infanta Cristina Univ Hosp, Serv Immunol, Badajoz, Spain; [Garcia-Pino, Guadalupe; Alvarado, Raul; Barroso, Sergio; Jose Cubero, Juan] Infanta Cristina Univ Hosp, Serv Nephrol, Badajoz, Spain; [Suarez-Alvarez, Beatriz] Univ Autonoma Madrid, Hlth Res Inst F Jimenez Diaz, Lab Mol Biol Renal Dis, E-28049 Madrid, Spain; [Diaz-Corte, Carmen] HUCA, Serv Nephrol, Oviedo, Spain; [Lopez-Larrea, Carlos] HUCA, Serv Immunol, Oviedo, Spain; [Coto, Eliecer; Diaz-Corte, Carmen; Lopez-Larrea, Carlos] Inst Salud Carlos III, Red Invest Renal, Madrid, Spain	Universidad de Extremadura; Central University Hospital Asturias; Autonomous University of Madrid; Central University Hospital Asturias; Central University Hospital Asturias; Instituto de Salud Carlos III	Gervasini, G (corresponding author), Univ Extremadura, Sch Med, Dept Med & Surg Therapeut, Div Pharmacol, Badajoz, Spain.	ggervasi@unex.es	Gervasini, Guillermo/N-2198-2014; CASTELLANO, EMILIO DOBLARÉ/R-1342-2019	Gervasini, Guillermo/0000-0002-0524-9767; CASTELLANO, EMILIO DOBLARÉ/0000-0002-8330-8566; , Montse/0000-0002-3867-1630; Barroso Hernandez, sergio/0000-0002-0588-2415; Lopez-Larrea, Carlos/0000-0001-9988-1730	Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain; Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain [GR10022]; RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds)	Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain; Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain; RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds)	This work has been supported in part by the Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain, and by grant GR10022 from Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain. Authors EC, CD-C and CL-L are supported by RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds).	Alkayed NJ, 2002, STROKE, V33, P1677, DOI 10.1161/01.STR.0000016332.37292.59; Chen D, 2012, J CLIN PHARMACOL, V52, P319, DOI 10.1177/0091270010397049; Fisslthaler B, 2001, HYPERTENSION, V38, P1427, DOI 10.1161/hy1201.096532; Fornage M, 2005, HUM MOL GENET, V14, P2829, DOI 10.1093/hmg/ddi315; Garcia M, 2013, EUR J CLIN PHARMACOL, V69, P385, DOI 10.1007/s00228-012-1355-x; Gervasini G, 2013, J CLIN PHARMACOL, V53, P427, DOI 10.1002/jcph.15; Gervasini G, 2012, TRANSPL INT, V25, P471, DOI 10.1111/j.1432-2277.2012.01446.x; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Lebranchu Y, 2014, TRANSPL INT, V27, P129, DOI 10.1111/tri.12205; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lee JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037075; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Macphee IAM, 2002, TRANSPLANTATION, V74, P1486, DOI 10.1097/00007890-200212150-00002; Morris STW, 2000, KIDNEY INT, V57, P1100, DOI 10.1046/j.1523-1755.2000.00937.x; Naderi GH, 2009, TRANSPL P, V41, P2772, DOI 10.1016/j.transproceed.2009.07.041; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; Podolin PL, 2013, PROSTAG OTH LIPID M, V104, P25, DOI 10.1016/j.prostaglandins.2013.02.001; Poge U, 2005, AM J TRANSPLANT, V5, P1306, DOI 10.1111/j.1600-6143.2005.00861.x; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Sharma M, 2009, PROSTAG OTH LIPID M, V89, P43, DOI 10.1016/j.prostaglandins.2009.04.004; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Thervet E, 2003, TRANSPLANTATION, V76, P1233, DOI 10.1097/01.TP.0000090753.99170.89; Yang L, 2015, BRIT J CLIN PHARMACO, V80, P28, DOI 10.1111/bcp.12603; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133563	10.1371/journal.pone.0133563	http://dx.doi.org/10.1371/journal.pone.0133563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230946	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400041
J	Ismael-Badarneh, R; Guetta, J; Klorin, G; Berger, G; Abu-Saleh, N; Abassi, Z; Azzam, ZS				Ismael-Badarneh, Reem; Guetta, Julia; Klorin, Geula; Berger, Gidon; Abu-saleh, Niroz; Abassi, Zaid; Azzam, Zaher S.			The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CELLS; EXPRESSION; CLEARANCE; MEMBRANE; LIQUID; LUNG; NA,K-ATPASE	Active alveolar fluid clearance is important in keeping airspaces free of edema. Angiotensin II plays a role in the pathogenesis of hypertension, heart failure and others. However, little is known about its contribution to alveolar fluid clearance. Angiotensin II effects are mediated by two specific receptors; AT1 and AT2. The localization of these two receptors in the lung, specifically in alveolar epithelial cells type II, was recently reported. We hypothesize that Angiotensin II may have a role in the regulation of alveolar fluid clearance. We investigated the effect of Angiotensin II on alveolar fluid clearance in rats using the isolated perfused lung model and isolated rat alveolar epithelial cells. The rate of alveolar fluid clearance in control rats was 8.6% +/- 0.1 clearance of the initial volume and decreased by 22.5%, 28.6%, 41.6%, 48.7% and 39% in rats treated with 10(-10) M, 10(-9) M, 10(-8) M, 10(-7) M or 10(-6) M of Ang II respectively (P < 0.003). The inhibitory effect of Angiotensin II was restored in losartan, an AT1 specific antagonist, pretreated rats, indicating an AT1 mediated effect of Ang II on alveolar fluid clearance. The expression of Na, K-ATPase proteins and cAMP levels in alveolar epithelial cells were down-regulated following the administration of Angiotensin II; suggesting that cAMP may be involved in AngII-induced reduced Na, K-ATPase expression, though the contribution of additional factors could not be excluded. We herein suggest a novel mechanism of clinical relevance by which angiotensin adversely impairs the ability of the lungs to clear edema.	[Guetta, Julia; Klorin, Geula; Berger, Gidon; Azzam, Zaher S.] Rambam Human Hlth Care Campus, Internal Med B, Haifa, Israel; [Ismael-Badarneh, Reem; Berger, Gidon; Abu-saleh, Niroz; Abassi, Zaid; Azzam, Zaher S.] Technion Israel Inst Technol, Dept Physiol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Azzam, Zaher S.] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Azzam, ZS (corresponding author), Rambam Human Hlth Care Campus, Internal Med B, Haifa, Israel.	z_azzam@rambam.health.gov.il	Abu-Saleh, Niroz/AAQ-6396-2021	Abu-Saleh, Niroz/0000-0001-9253-2773; Abassi, Zaid/0000-0002-7272-197X	Israel Foundation (ISF) [625/08]; Office of Chief Scientist [6267-1]; Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science; Technion, The Israel Institute of Technology; Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa	Israel Foundation (ISF); Office of Chief Scientist; Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science; Technion, The Israel Institute of Technology; Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa	This work was supported by Israel Foundation (ISF), Grant No. 625/08; The Office of Chief Scientist (Grant No. 6267-1); Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science, Technion, The Israel Institute of Technology and The Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashry O, 2014, RESP PHYSIOL NEUROBI, V195, P37, DOI 10.1016/j.resp.2014.02.001; BERTHIAUME Y, 1988, J APPL PHYSIOL, V65, P585, DOI 10.1152/jappl.1988.65.2.585; Bertorello AM, 1999, AM J PHYSIOL-LUNG C, V276, pL20, DOI 10.1152/ajplung.1999.276.1.L20; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; DZAU VJ, 1987, KIDNEY INT, V31, P1402, DOI 10.1038/ki.1987.156; FRANCIS GS, 1984, ANN INTERN MED, V101, P370, DOI 10.7326/0003-4819-101-3-370; HELWIG J Jr, 1956, Annu Rev Med, V7, P141; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Klorin G, 2003, ANAL QUANT CYTOL, V25, P297; PACKER M, 1992, LANCET, V340, P92, DOI 10.1016/0140-6736(92)90406-S; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Papp M, 2002, AM J PHYSIOL-LUNG C, V282, pL713, DOI 10.1152/ajplung.00103.2001; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; RUTSCHMAN DH, 1993, J APPL PHYSIOL, V75, P1574, DOI 10.1152/jappl.1993.75.4.1574; Saldias FJ, 2001, AM J PHYSIOL-LUNG C, V281, pL591, DOI 10.1152/ajplung.2001.281.3.L591; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; TAYLOR AE, 1965, CIRC RES, V16, P353, DOI 10.1161/01.RES.16.4.353; Yamamoto T, 2001, KIDNEY INT, V60, P364, DOI 10.1046/j.1523-1755.2001.00808.x; Yun AJ, 2006, MED HYPOTHESES, V66, P776, DOI 10.1016/j.mehy.2005.10.019	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134175	10.1371/journal.pone.0134175	http://dx.doi.org/10.1371/journal.pone.0134175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230832	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400084
J	Juuhl-Langseth, M; Hartberg, CB; Holmen, A; Thormodsen, R; Groote, IR; Rimol, LM; Emblem, KE; Agartz, I; Rund, BR				Juuhl-Langseth, Monica; Hartberg, Cecilie B.; Holmen, Aina; Thormodsen, Rune; Groote, Inge R.; Rimol, Lars M.; Emblem, Kyrre E.; Agartz, Ingrid; Rund, Bjorn R.			Impaired Verbal Learning Is Associated with Larger Caudate Volumes in Early Onset Schizophrenia Spectrum Disorders	PLOS ONE			English	Article							CONSENSUS COGNITIVE BATTERY; SUBCORTICAL BRAIN VOLUMES; BASAL GANGLIA; NEUROCOGNITION; MODEL; ANTIPSYCHOTICS; ABNORMALITIES; SEGMENTATION; MORPHOLOGY; SELECTION	Background Both brain structural abnormalities and neurocognitive impairments are core features of schizophrenia. We have previously reported enlargements in subcortical brain structure volumes and impairment of neurocognitive functioning as measured by the MATRICS Cognitive Consensus Battery (MCCB) in early onset schizophrenia spectrum disorders (EOS). To our knowledge, no previous study has investigated whether neurocognitive performance and volumetric abnormalities in subcortical brain structures are related in EOS. Methods Twenty-four patients with EOS and 33 healthy controls (HC) were included in the study. Relationships between the caudate nucleus, the lateral and fourth ventricles volumes and neurocognitive performance were investigated with multivariate linear regression analyses. Intracranial volume, age, antipsychotic medication and IQ were included as independent predictor-variables. Results The caudate volume was negatively correlated with verbal learning performance uniquely in the EOS group (r=-.454, p=.034). There were comparable positive correlations between the lateral ventricular volume and the processing speed, attention and reasoning and problem solving domains for both the EOS patients and the healthy controls. Antipsychotic medication was related to ventricular enlargements, but did not affect the brain structure-function relationship. Conclusion Enlargement of the caudate volume was related to poorer verbal learning performance in patients with EOS. Despite a 32% enlargement of the lateral ventricles in the EOS group, associations to processing speed, attention and reasoning and problem solving were similar for both the EOS and the HC groups.	[Juuhl-Langseth, Monica] Oslo Univ Hosp, Res Unit Child & Adolescent Mental Hlth, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, NORMENT, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Juuhl-Langseth, Monica; Holmen, Aina; Groote, Inge R.; Rund, Bjorn R.] Univ Oslo, Dept Psychol, Oslo, Norway; [Holmen, Aina] Akershus Univ Hosp, Mental Hlth Serv, Lorenskog, Norway; [Thormodsen, Rune; Rund, Bjorn R.] Vestre Viken Hosp Trust, Drammen, Norway; [Rimol, Lars M.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Emblem, Kyrre E.] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; Diakonhjemmet Hospital	Juuhl-Langseth, M (corresponding author), Oslo Univ Hosp, Res Unit Child & Adolescent Mental Hlth, Oslo, Norway.	monica.juuhl-langseth@psykologi.uio.no	Emblem, Kyrre E/H-6691-2012	Emblem, Kyrre E/0000-0002-6580-9519; Agartz, Ingrid/0000-0002-9839-5391	South-Eastern Norway Regional Health Authority [2004-259, 2006-186, 2008011, 2009037]; Oslo University Hospital; Research Council of Norway [190311/V50, 167153/V50]	South-Eastern Norway Regional Health Authority; Oslo University Hospital; Research Council of Norway(Research Council of Norway)	South-Eastern Norway Regional Health Authority provided the main financial support to the study to BRR (Grant # 2004-259, 2006-186). In addition, the study was supported by Oslo University Hospital and by grants to IA (Research Council of Norway: Grants # 190311/V50 and 167153/V50 and the South-Eastern Norway Regional Health Authority: Grants # 2008011 and 2009037). http://www.uio.no, http://www.helse-sorost.no, http://www.forskningsradet.no/no/Forsiden/1173185591033. The funder had no involvement in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev YG, 1998, BEHAV BRAIN RES, V97, P159, DOI 10.1016/S0166-4328(98)00037-0; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amminger GP, 2011, SCHIZOPHR RES, V131, P112, DOI 10.1016/j.schres.2011.06.009; Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Armenteros JL, 2006, EUR CHILD ADOLES PSY, V15, P141, DOI 10.1007/s00787-005-0515-2; Aron A.R., 2009, COGNITION BASAL GANG; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Brandt GN, 2008, WIEN MED WOCHENSCHR, V158, P84, DOI 10.1007/s10354-007-0478-7; Brent BK, 2013, CHILD ADOL PSYCH CL, V22, P689, DOI 10.1016/j.chc.2013.06.003; Brodal P, 2010, THE CENTRAL NERVOUS; Burgaleta M, 2014, HUM BRAIN MAPP, V35, P1957, DOI 10.1002/hbm.22305; Cannon M, 1999, ARCH GEN PSYCHIAT, V56, P457, DOI 10.1001/archpsyc.56.5.457; Crespo-Facorro B, 2007, INT REV PSYCHIATR, V19, P325, DOI 10.1080/09540260701486647; Crespo-Facorro B, 2007, SCHIZOPHR RES, V91, P87, DOI 10.1016/j.schres.2006.12.015; DELISI LE, 1991, BIOL PSYCHIAT, V29, P159, DOI 10.1016/0006-3223(91)90044-M; DEQUARDO JR, 1994, BIOL PSYCHIAT, V35, P517, DOI 10.1016/0006-3223(94)90098-1; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Driver DI, 2013, CHILD ADOL PSYCH CL, V22, P539, DOI 10.1016/j.chc.2013.04.001; Duffau H, 2014, BRAIN LANG, V131, P1, DOI 10.1016/j.bandl.2013.05.011; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Frangou S, 2013, CHILD ADOL PSYCH CL, V22, P715, DOI 10.1016/j.chc.2013.04.007; Gogtay N, 2008, SCHIZOPHRENIA BULL, V34, P30, DOI 10.1093/schbul/sbm103; Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green Michael F, 2014, Schizophr Res Cogn, V1, pe1; Hartberg CB, 2011, PROG NEURO-PSYCHOPH, V35, P1122, DOI 10.1016/j.pnpbp.2011.03.014; Hollis C, 2003, BRIT J PSYCHIAT, V182, P37, DOI 10.1192/bjp.182.1.37; Holmen A, 2012, SCHIZOPHR RES, V142, P177, DOI 10.1016/j.schres.2012.10.006; Holmen A, 2010, SCHIZOPHRENIA BULL, V36, P852, DOI 10.1093/schbul/sbn174; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Juuhl-Langseth M, 2014, SCHIZOPHR RES, V156, P241, DOI 10.1016/j.schres.2014.04.014; Juuhl-Langseth M, 2012, PSYCHIAT RES-NEUROIM, V203, P14, DOI 10.1016/j.pscychresns.2011.10.005; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2013, SCHIZOPHRENIA BULL, V39, P417, DOI 10.1093/schbul/sbr153; Keefe RSE, 2011, SCHIZOPHR RES, V125, P161, DOI 10.1016/j.schres.2010.09.015; Koziol L. F., 2009, SUBCORTICAL STRUCTUR; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kumra S, 2008, SCHIZOPHRENIA BULL, V34, P15, DOI 10.1093/schbul/sbm123; Kyriakopoulos M, 2007, INT REV PSYCHIATR, V19, P315, DOI 10.1080/09540260701486258; Lawyer G, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-31; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; MacDonald PA, 2014, BRAIN IMAGING BEHAV, V8, P52, DOI 10.1007/s11682-013-9242-3; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; McClure RK, 2008, SCHIZOPHR RES, V98, P29, DOI 10.1016/j.schres.2007.05.012; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Nesvag R, 2012, SCHIZOPHR RES, V142, P209, DOI 10.1016/j.schres.2012.10.004; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pedersen G, 2007, COMPR PSYCHIAT, V48, P88, DOI 10.1016/j.comppsych.2006.03.008; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Robles SG, 2005, J NEUROL NEUROSUR PS, V76, P940, DOI 10.1136/jnnp.2004.045948; Rund BR, 2009, NORD J PSYCHIAT, V63, P196, DOI 10.1080/08039480902767286; Sandman CA, 2014, NEUROIMAGE, V99, P93, DOI 10.1016/j.neuroimage.2014.05.020; Scherk H, 2006, CURR OPIN PSYCHIATR, V19, P145, DOI 10.1097/01.yco.0000214339.06507.d8; Schobel SA, 2009, SCHIZOPHR RES, V114, P110, DOI 10.1016/j.schres.2009.07.016; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Thormodsen R, 2013, PSYCHIAT RES-NEUROIM, V214, P190, DOI 10.1016/j.pscychresns.2013.07.003; Tost H, 2010, NEUROSCI BIOBEHAV R, V34, P689, DOI 10.1016/j.neubiorev.2009.06.005; WASI. Wechsler Abbreviated Scale of Intelligence (WASI), 2007, NORWEGIAN MANUAL SUP; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Zipursky RB, 2013, SCHIZOPHRENIA BULL, V39, P1363, DOI 10.1093/schbul/sbs135	73	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130435	10.1371/journal.pone.0130435	http://dx.doi.org/10.1371/journal.pone.0130435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230626	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400005
J	Li, AHT; McArthur, E; Maclean, J; Isenor, C; Prakash, V; Kim, SJ; Knoll, G; Shah, B; Garg, AX				Li, Alvin Ho-ting; McArthur, Eric; Maclean, Janet; Isenor, Cynthia; Prakash, Versha; Kim, S. Joseph; Knoll, Greg; Shah, Baiju; Garg, Amit X.			Deceased Organ Donation Registration and Familial Consent among Chinese and South Asians in Ontario, Canada	PLOS ONE			English	Article							POPULATION-BASED COHORT; RACIAL-DIFFERENCES; TRANSPLANT DONORS; BRITISH-COLUMBIA; ATTITUDES; CALIFORNIA; RECIPIENTS; KNOWLEDGE; RATES	Objective For various reasons, people of Chinese (China, Hong Kong or Taiwan) and South Asian (Indian subcontinent) ancestry (the two largest ethnic minority groups in Ontario, Canada) may be less likely to register for deceased organ donation than the general public, and their families may be less likely to consent for deceased organ donation at the time of death. Methods We conducted two population-based studies: (1) a cross-sectional study of deceased organ donor registration as of May 2013, and (2) a cohort study of the steps in proceeding with deceased organ donation for patients who died in hospital from October 2008 to December 2012. Results A total of 49 938 of 559 714 Chinese individuals (8.9%) and 47 774 of 374 291 South Asians (12.8%) were registered for deceased organ donation, proportions lower than the general public (2 676 260 of 10 548 249 (25.4%). Among the 168 703 Ontarians who died in a hospital, the families of 33 of 81 Chinese (40.1%; 95% CI: 30.7%-51.6%) and 39 of 72 South Asian individuals (54.2%; 95% CI: 42.7-65.2%) consented for deceased organ donation, proportions lower than the general public (68.3%; 95% CI: 66.4%-70.0%). Conclusions In Ontario, Canada Chinese and South Asian individuals are less likely to register and their families are less likely to consent to deceased organ donation compared to the remaining general public. There is an opportunity to build support for organ and tissue donation in these two large ethnic communities in Canada.	[Li, Alvin Ho-ting; Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [McArthur, Eric; Kim, S. Joseph; Shah, Baiju; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Maclean, Janet; Isenor, Cynthia; Prakash, Versha] Trillium Gift Life Network, Toronto, ON, Canada; [Kim, S. Joseph] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada; [Knoll, Greg] Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada; [Knoll, Greg] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Knoll, Greg] Univ Ottawa, Ottawa, ON, Canada; [Shah, Baiju] Univ Toronto, Dept Med, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto	Li, AHT (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.	Alvin.li@lhsc.on.ca	Garg, Amit X/G-3295-2011	Knoll, Greg/0000-0001-5442-9310; Isenor, Cynthia/0000-0002-4030-0126	Ontario Ministry of Health and Longterm Care; Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute; Canadian Institutes of Health Research; Kidney Foundation of Canada	Ontario Ministry of Health and Longterm Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	This Institute for Clinical Evaluative Sciences (ICES) project was conducted by the Kidney, Dialysis and Transplantation program at the ICES Western site. ICES is funded by an annual grant from the Ontario Ministry of Health and Longterm Care. Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario, the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute. The ICES Kidney, Dialysis and Transplantation receives programmatic operating grant support from the Canadian Institutes of Health Research. Mr. Li was supported by a doctoral scholarship from the Kidney Foundation of Canada and the Canadian Institutes of Health Research. The opinions, results and conclusions are those of the authors and are independent from the funding sources. No endorsement by these organizations is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsahafi M, 2013, TRANSPLANTATION, V95, pE70, DOI 10.1097/TP.0b013e3182928261; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Brown CVR, 2010, J TRAUMA, V68, P447, DOI 10.1097/TA.0b013e3181caab8f; Chon WJ, 2014, AM J TRANSPLANT, V14, P172, DOI 10.1111/ajt.12519; (CIHI) CI for HI, 2014, 2014 CORR REP TREAT; Deedat S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003453; Goldberg DS, 2013, CRIT CARE MED, V41, P496, DOI 10.1097/CCM.0b013e318271198c; Government of Canada SC, 2011, NAT HOUS SURV PROF P; Irving MJ, 2012, NEPHROL DIAL TRANSPL, V27, P2526, DOI 10.1093/ndt/gfr683; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Lee E, 2010, CLIN TRANSPLANT, V24, pE223, DOI 10.1111/j.1399-0012.2010.01260.x; Li AHT, 2014, JAMA-J AM MED ASSOC, V312, P291, DOI 10.1001/jama.2014.2934; Li AHT, 2013, PEDIATR TRANSPLANT, V17, P119, DOI 10.1111/petr.12045; Molzahn AE, 2005, QUAL HEALTH RES, V15, P82, DOI 10.1177/1049732304270653; Molzahn AE, 2005, PROG TRANSPLANT ALIS, V15, P233; Morgan M, 2013, ETHNIC HEALTH, V18, P367, DOI 10.1080/13557858.2012.752073; Morgan SE, 2008, HEALTH COMMUN, V23, P23, DOI 10.1080/10410230701805158; Mukerji G, 2013, J MATERN-FETAL NEO M, V26, P279, DOI 10.3109/14767058.2012.735996; Redelmeier DA, 2013, CAN MED ASSOC J, V185, pE337, DOI 10.1503/cmaj.122047; Rosenblum AM, 2012, TRANSPL INT, V25, P801, DOI 10.1111/j.1432-2277.2012.01472.x; Salim A, 2014, JAMA SURG, V149, P899, DOI 10.1001/jamasurg.2014.1014; Salim A, 2014, JAMA SURG, V149, P71, DOI 10.1001/jamasurg.2013.3967; Salim A, 2010, J AM COLL SURGEONS, V211, P596, DOI 10.1016/j.jamcollsurg.2010.06.390; Saub EJ, 1998, J COMMUN HEALTH, V23, P407, DOI 10.1023/A:1018754023705; Shah BR, 2013, DIABETES CARE, V36, P2670, DOI 10.2337/dc12-2105; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Wilkins R, 2007, STAT CAN; Yeung DF, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-114; Yoshida EM, 1999, TRANSPLANTATION, V67, P1324, DOI 10.1097/00007890-199905270-00006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0124321	10.1371/journal.pone.0124321	http://dx.doi.org/10.1371/journal.pone.0124321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230320	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400001
J	Li, CY; Gao, BL; Liu, XW; Fan, QY; Zhang, XJ; Liu, GC; Yang, HQ; Feng, PY; Wang, Y; Song, P				Li, Cai-Ying; Gao, Bu-Lang; Liu, Xiao-Wei; Fan, Qiong-Ying; Zhang, Xue-Jing; Liu, Guo-Chao; Yang, Hai-Qing; Feng, Ping-Yong; Wang, Yong; Song, Peng			Quantitative Evaluation of the Substantially Variable Morphology and Function of the Left Atrial Appendage and Its Relation with Adjacent Structures	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; STROKE PREVENTION; CATHETER ABLATION; FIBRILLATION; RISK; ANATOMY; CLOSURE; EPIDEMIOLOGY; OBLITERATION; PREVALENCE	Objective To investigate quantitatively the morphology, anatomy and function of the left atrial appendage (LAA) and its relation with adjacent structures. Materials and Methods A total of 860 patients (533 men, 62.0%, age 55.9 +/- 10.4 year) who had cardiac multidetector computed tomography angiography from May to October 2012 were enrolled for analysis. Results Seven types and 6 subtypes of LAA morphology were found with Type 2 being the most prevalent. Type 5 was more significantly (P<0.05) present in women (8.0%) than in men (4.2%). LAA orifice was oval in 81.5%, triangular in 7.3%, semicircular in 4%, water drop-like in 3.2%, round in 2.4% and foot-like in 1.6%. The LAA orifice had a significantly greater (P<0.01) major axis in men (24.79 +/- 3.81) than in women (22.68 +/- 4.07). The LAA orifice long axis was significantly (P<0.05) positively correlated with the height, weight and surface area of the patient. The LAA morphology parameters displayed strong positive correlation with the left atrium volume, aortic cross area long axis or LSPV long axis but poor correlation with the height, weight, surface area and vertebral body height of the patients. Four types of LAA ridge were identified: AI, AII, B and C with the distribution of 17.6%, 69.9%, 5.9% and 6.6%, respectively. The LAA had a significantly (P<0.05) greater distance from its orifice to the mitral ring in women than in men. The LAA had two filling and two emptying processes with the greatest volume at 45% phase but the least volume at 5% phase. The LAA maximal, minimal and emptying volumes were all significantly (P<0.05) positively correlated with the body height, weight and surface area, whereas the LAA ejection fraction had an inverse correlation with the LAA minimal volume but no correlation with the maximal volume. Conclusion The LAA has substantially variable morphologies and relation with the adjacent structures, which may be helpful in guiding the LAA trans-catheter occlusion or catheter ablation procedures.	[Li, Cai-Ying; Liu, Xiao-Wei; Yang, Hai-Qing; Feng, Ping-Yong; Wang, Yong; Song, Peng] Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei Province, Peoples R China; [Gao, Bu-Lang; Fan, Qiong-Ying; Zhang, Xue-Jing; Liu, Guo-Chao] Hebei Med Univ, Shijiazhuang Hosp 1, Dept Med Res, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University	Li, CY (corresponding author), Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei Province, Peoples R China.	licaying63@163.com; browngao@163.com						Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Budge LP, 2008, J INTERV CARD ELECTR, V23, P87, DOI 10.1007/s10840-008-9281-7; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chang SH, 2007, J CARDIOVASC ELECTR, V18, P47, DOI 10.1111/j.1540-8167.2006.00655.x; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Garcia-Fernandez MA, 2003, J AM COLL CARDIOL, V42, P1253, DOI 10.1016/S0735-1097(03)00954-9; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gottlieb I, 2008, J CARDIOVASC ELECTR, V19, P247, DOI 10.1111/j.1540-8167.2007.01043.x; GRIMM RA, 1993, J AM COLL CARDIOL, V22, P1359, DOI 10.1016/0735-1097(93)90543-A; Guo Y, 2014, CHEST; Healey JS, 2005, AM HEART J, V150, P288, DOI 10.1016/j.ahj.2004.09.054; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; HONDO T, 1995, JPN HEART J, V36, P225; Jue J, 1993, J Am Soc Echocardiogr, V6, P237; Kamalesh M, 2000, ECHOCARDIOGR-J CARD, V17, P313, DOI 10.1111/j.1540-8175.2000.tb01142.x; Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8; Kerut EK, 2008, ECHOCARDIOGR-J CARD, V25, P669, DOI 10.1111/j.1540-8175.2008.00637.x; Koplay M, 2012, EUR J RADIOL, V81, P1575, DOI 10.1016/j.ejrad.2011.04.060; Lacomis JM, 2007, EUROPACE, V9, P1134, DOI 10.1093/europace/eum227; Leal S, 2012, CURR CARDIOL REV, V8, P37, DOI 10.2174/157340312801215827; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Nguyen-Do Phong, 2004, Ann Thorac Surg, V78, pe26, DOI 10.1016/j.athoracsur.2003.10.117; Odell JA, 1996, ANN THORAC SURG, V61, P565, DOI 10.1016/0003-4975(95)00885-3; Palios John, 2014, Thrombosis, V2014, P832752, DOI 10.1155/2014/832752; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Pollick C, 2000, CHEST, V117, P297, DOI 10.1378/chest.117.2.297; Qamruddin Salima, 2010, Expert Rev Cardiovasc Ther, V8, P65, DOI 10.1586/erc.09.161; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; Su P, 2008, HEART, V94, P1166, DOI 10.1136/hrt.2006.111989; Syed TM, 2007, NAT CLIN PRACT CARD, V4, P428, DOI 10.1038/ncpcardio0933; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; Vivas D, 2011, CIRC J, V75, P1314, DOI 10.1253/circj.CJ-11-0402; Walker AM, 2008, HEART RHYTHM, V5, P1365, DOI 10.1016/j.hrthm.2008.07.014; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wongcharoen W, 2006, J CARDIOVASC ELECTR, V17, P951, DOI 10.1111/j.1540-8167.2006.00549.x; Wu YW, 2008, INT J CARDIOL, V128, P69, DOI 10.1016/j.ijcard.2007.06.017; Zhou ZQ, 2008, J EPIDEMIOL, V18, P209, DOI 10.2188/jea.JE2008021	45	12	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0126818	10.1371/journal.pone.0126818	http://dx.doi.org/10.1371/journal.pone.0126818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230395	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400002
J	Makdissy, N; Haddad, K; Mouawad, C; Popa, I; Younsi, M; Valet, P; Brunaud, L; Ziegler, O; Quilliot, D				Makdissy, Nehman; Haddad, Katia; Mouawad, Charbel; Popa, Iuliana; Younsi, Mohamed; Valet, Philippe; Brunaud, Laurent; Ziegler, Olivier; Quilliot, Didier			Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; PPAR-GAMMA; ADIPOSE-TISSUE; NEUTRAL SPHINGOMYELINASE; INSULIN-RESISTANCE; PLASMA-MEMBRANE; IN-VITRO; PHOSPHOLIPID-COMPOSITION; CHOLESTEROL-SYNTHESIS; GENE-EXPRESSION	Sterol response element binding protein (SREBP) is a key transcription factor in insulin and glucose metabolism. We previously demonstrated that elevated levels of membrane sphingomyelin (SM) were related to peroxisome proliferator-activated receptor-gamma (PPAR gamma), which is a known target gene of SREBP-1 in adipocytes. However, the role of SM in SREBP expression in adipocytes remains unknown. In human abdominal adipose tissue from obese women with various concentrations of fasting plasma insulin, SREBP-1 proteins decreased in parallel with increases in membrane SM levels. An inverse correlation was found between the membrane SM content and the levels of SREBP-1c/ERK/Ras/PPAR gamma/CREB proteins. For the first time, we demonstrate the effects of SM and its signaling pathway in 3T3-F442A adipocytes. These cells were enriched or unenriched with SM in a range of concentrations similar to those observed in obese subjects by adding exogenous natural SMs (having different acyl chain lengths) or by inhibiting neutral sphingomyelinase. SM accumulated in caveolae of the plasma membrane within 24 h and then in the intracellular space. SM enrichment decreased SREBP-1 through the inhibition of extracellular signal-regulated protein kinase (ERK) but not JNK or p38 mitogen-activated protein kinase (MAPK). Ras/Raf-1/MEK1/2 and KSR proteins, which are upstream mediators of ERK, were down-regulated, whereas SREBP-2/caveolin and cholesterol were up-regulated. In SM-unmodulated adipocytes treated with DL-1-Phenyl-2-Palmitoylamino-3-morpholino-1-propanol (PPMP), where the ceramide level increased, the expression levels of SREBPs and ERK were modulated in an opposite direction relative to the SM-enriched cells. SM inhibited the insulin-induced expression of SREBP-1. Rosiglitazone, which is an anti-diabetic agent and potent activator of PPAR gamma, reversed the effects of SM on SREBP-1, PPAR gamma and CREB. Taken together, these findings provide novel insights indicating that excess membrane SM might be critical for regulating SREBPs in adipocytes via a MAPK-dependent pathway.	[Makdissy, Nehman; Haddad, Katia; Mouawad, Charbel] Lebanese Univ, Fac Sci 3, Middle East Inst Hlth, Reviva Regenerat Med Ctr, Bsalim, Lebanon; [Makdissy, Nehman; Younsi, Mohamed; Ziegler, Olivier; Quilliot, Didier] Univ Nancy 1, Lab Nutr & Metab Dis, Vandoeuvre Les Nancy, France; [Popa, Iuliana] Univ Lyon 1, Lab Dermatol Res, EA 4169, F-69365 Lyon, France; [Valet, Philippe] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [Brunaud, Laurent; Ziegler, Olivier; Quilliot, Didier] CHU Nancy, Serv Diabetol Nutr, Nancy, France; [Brunaud, Laurent; Quilliot, Didier] Univ Nancy 1, Fac Med, INSERM 954, Nancy, France	Universite de Lorraine; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Makdissy, N (corresponding author), Lebanese Univ, Fac Sci 3, Middle East Inst Hlth, Reviva Regenerat Med Ctr, Bsalim, Lebanon.	n.makdissy@revivamedical.com	Brunaud, Laurent/AAW-9384-2020; Quillot, Didier/ABB-5326-2021; Valet, Philippe/N-7472-2017	Brunaud, Laurent/0000-0001-5182-6660; Valet, Philippe/0000-0001-6520-7393				Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Al-Makdissy N, 2001, FEBS LETT, V493, P75, DOI 10.1016/S0014-5793(01)02278-5; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bodennec J, 2000, J LIPID RES, V41, P1524; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fruhbeck G, 2007, TRENDS ENDOCRIN MET, V18, P177, DOI 10.1016/j.tem.2007.04.001; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Grigsby RJ, 2001, BIOCHEM BIOPH RES CO, V287, P1121, DOI 10.1006/bbrc.2001.5694; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; KEAN EL, 1966, J LIPID RES, V7, P449; KEMPEN HJM, 1991, ARTERIOSCLER THROMB, V11, P146, DOI 10.1161/01.ATV.11.1.146; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kotzka J, 2000, J LIPID RES, V41, P99; Kummerow FA, 2001, J NUTR BIOCHEM, V12, P602, DOI 10.1016/S0955-2863(01)00181-4; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leon NM, 2002, REV INVEST CLIN, V54, P145; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Mendez-Gimenez L, 2014, MOL CELL ENDOCRINOL, V397, P78, DOI 10.1016/j.mce.2014.06.017; Muller-Wieland D, 2002, ANN NY ACAD SCI, V967, P19; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; NAOI M, 1974, ANAL BIOCHEM, V58, P571, DOI 10.1016/0003-2697(74)90226-7; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pham NA, 2005, J INHERIT METAB DIS, V28, P991, DOI 10.1007/s10545-005-0117-7; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Popa I, 2010, ARCH DERMATOL RES, V302, P639, DOI 10.1007/s00403-010-1049-0; Prattes S, 2000, J CELL SCI, V113, P2977; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RESH MD, 1982, J BIOL CHEM, V257, P6978; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; ROSE HG, 1965, J LIPID RES, V6, P428; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Subbaiah PV, 2001, MED HYPOTHESES, V57, P135, DOI 10.1054/mehy.2001.1336; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Zeghari N, 2000, AM J PHYSIOL-ENDOC M, V279, pE736, DOI 10.1152/ajpendo.2000.279.4.E736; Zeghari N, 2000, INT J OBESITY, V24, P1600, DOI 10.1038/sj.ijo.0801459; Zhang H, 2013, BIOCHEM SOC T, V41, P1078, DOI 10.1042/BST20130042; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; ZLATKIS A, 1969, ANAL BIOCHEM, V29, P143, DOI 10.1016/0003-2697(69)90017-7	78	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133181	10.1371/journal.pone.0133181	http://dx.doi.org/10.1371/journal.pone.0133181			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230734	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400028
J	Mordecai, EA; Hindenlang, M; Mitchell, CE				Mordecai, Erin A.; Hindenlang, Madeleine; Mitchell, Charles E.			Differential Impacts of Virus Diversity on Biomass Production of a Native and an Exotic Grass Host	PLOS ONE			English	Article							PLANT-VIRUS; COINFECTION; BARLEY; INFECTION; APHID; DISEASE	Pathogens are common and diverse in natural communities and have been implicated in the success of host invasions. Yet few studies have experimentally measured how pathogens impact native versus exotic hosts, particularly when individual hosts are simultaneously coinfected by diverse pathogens. To estimate effects of interactions among multiple pathogens within host individuals on both transmission of pathogens and fitness consequences for hosts, we conducted a greenhouse experiment using California grassland species: the native perennial grass Nassella (Stipa) pulchra, the exotic annual grass Bromus hordeaceus, and three virus species, Barley yellow dwarf virus-PAV, Barley yellow dwarf virus-MAV, and Cereal yellow dwarf virus-RPV. In terms of virus transmission, the native host was less susceptible than the exotic host to MAV. Coinfection of PAV and MAV did not occur in any of the 157 co-inoculated native host plants. In the exotic host, PAV infection most strongly reduced root and shoot biomass, and coinfections that included PAV severely reduced biomass. Infection with single or multiple viruses did not affect biomass in the native host. However, in this species the most potentially pathogenic coinfections (PAV + MAV and PAV + MAV + RPV) did not occur. Together, these results suggest that interactions among multiple pathogens can have important consequences for host health, which may not be predictable from interactions between hosts and individual pathogens. This work addresses a key empirical gap in understanding the impact of multiple generalist pathogens on competing host species, with potential implications for population and community dynamics of native and exotic species. It also demonstrates how pathogens with relatively mild impacts independently can more substantially reduce host performance in coinfection.	[Mordecai, Erin A.; Hindenlang, Madeleine; Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	emordeca@stanford.edu	Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993; Mordecai, Erin/0000-0002-4402-5547	National Science Foundation Postdoctoral Research Fellowship in Biology [DBI-1202892]; NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases [DEB-1015909]; Direct For Biological Sciences [1015909] Funding Source: National Science Foundation; Division Of Environmental Biology [1015825] Funding Source: National Science Foundation	National Science Foundation Postdoctoral Research Fellowship in Biology; NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	E.A.M. was supported by a National Science Foundation Postdoctoral Research Fellowship in Biology (DBI-1202892; nsf.gov) and C.E.M. was supported by the NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases (DEB-1015909; nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOLA AIE, 1971, VIROLOGY, V46, P127, DOI 10.1016/0042-6822(71)90012-2; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Comas J, 1995, J PHYTOPATHOL, V143, P609, DOI 10.1111/j.1439-0434.1995.tb00209.x; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Copeland R, 1998, METH MOL B, V81, P455; Cronin JP, 2014, AM NAT, V184, P172, DOI 10.1086/676854; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; DINOOR A, 1984, ANNU REV PHYTOPATHOL, V22, P443; Esch GW, 2001, PARASITOLOGY, V123, pS57, DOI 10.1017/S0031182001007697; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fitt BDL, 2006, ANNU REV PHYTOPATHOL, V44, P163, DOI 10.1146/annurev.phyto.44.070505.143417; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1995, APHID TRANSMISSION B, P259; Hersh MH, 2012, ECOLOGY, V93, P511, DOI 10.1890/11-0598.1; JAROSZ AM, 1995, NEW PHYTOL, V129, P371, DOI 10.1111/j.1469-8137.1995.tb04308.x; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2011, ECOLOGY, V92, P535, DOI 10.1890/10-0570.1; Lacroix C, 2014, NEW PHYTOL, V204, P424, DOI 10.1111/nph.12909; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Meentemeyer R, 2004, FOREST ECOL MANAG, V200, P195, DOI 10.1016/j.foreco.2004.06.021; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144; R Core Team, 2021, R LANGUAGE ENV STAT; ROCHOW WF, 1983, PHYTOPATHOLOGY, V73, P919, DOI 10.1094/Phyto-73-919; ROCHOW WF, 1971, VIROLOGY, V46, P117, DOI 10.1016/0042-6822(71)90011-0; Rua MA, 2013, J ECOL, V101, P1007, DOI 10.1111/1365-2745.12106; Rua MA, 2013, NEW PHYTOL, V199, P541, DOI 10.1111/nph.12273; Seabloom EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055675; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791	37	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134355	10.1371/journal.pone.0134355	http://dx.doi.org/10.1371/journal.pone.0134355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230720	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400105
J	Morita, H; Arae, K; Unno, H; Toyama, S; Motomura, K; Matsuda, A; Suto, H; Okumura, K; Sudo, K; Takahashi, T; Saito, H; Matsumoto, K; Nakae, S				Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Toyama, Sumika; Motomura, Kenichiro; Matsuda, Akio; Suto, Hajime; Okumura, Ko; Sudo, Katsuko; Takahashi, Takao; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu			IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T(H)2 CYTOKINE PRODUCTION; CELL-DERIVED TNF; CD4(+) T-CELLS; ALLERGIC SENSITIZATION; BARRIER DYSFUNCTION; ATOPIC-DERMATITIS; ASTHMATIC AIRWAYS; EXPRESSION; RESPONSES	Background IL-25, IL-33 and TSLP are produced predominantly by epithelial cells and are known to induce Th2-type cytokines. Th2-type cytokines are involved not only in host defense against nematodes, but also in the development of Th2-type allergic diseases. TSLP was reported to be crucial for development of allergic airway inflammation in mice after inhalation of allergens to which they had been sensitized epicutaneously (EC) beforehand. However, the roles of IL-25 and IL-33 in the setting remain unclear. Methods Mice deficient in IL-25 and IL-33 were sensitized EC with ovalbumin (OVA) and then challenged intranasally with OVA. Airway inflammation, the number of inflammatory cells in bronchoalveolar lavage fluids (BALFs) and airway hyperresponsiveness (AHR) in the mice were determined, respectively, by histological analysis, with a hemocytometer, and by using plethysmograph chambers with a ventilator. Expression of mRNA in the skin and lungs was determined by quantitative PCR, while the BALF levels of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) and the serum levels of IgE were determined by ELISA. Results Normal OVA-specific Th2- and Th17-cell responses of lymph nodes and spleens were observed in IL-25-deficient (IL-25(-/-)) and IL-33(-/-) mice after EC sensitization with OVA. Nevertheless, the number of eosinophils, but not neutrophils, in the BALFs, and the levels of Th2 cytokines, but not Th17 cytokines, in the lungs were significantly decreased in the IL-25(-/-) and IL-33(-/-) mice pre-sensitized EC with OVA, followed by inhalation of OVA, whereas their levels of AHR and OVA-specific serum IgE were normal. Conclusions Both IL-25 and IL-33 are critical for induction of Th2-type cytokine-mediated allergic airway eosinophilia, but not Th17-type cytokine-mediated airway neutrophilia, at the local sites of lungs in the challenge phase of mice sensitized EC with OVA. They do not affect OVA-specific T-cell induction in the sensitization phase.	[Morita, Hideaki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Toyama, Sumika; Motomura, Kenichiro; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo 1578535, Japan; [Unno, Hirotoshi] Jikei Univ, Dept Pediat, Sch Med, Tokyo 1058461, Japan; [Arae, Ken] Kyorin Univ, Dept Immunol, Fac Hlth Sci, Tokyo 1928508, Japan; [Suto, Hajime; Okumura, Ko; Nakae, Susumu] Juntendo Univ, Atopy Res Ctr, Sch Med, Tokyo 1138412, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo 1608402, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo 1088639, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan	Keio University; National Center for Child Health & Development - Japan; Jikei University; Kyorin University; Juntendo University; Tokyo Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakae, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo 1578535, Japan.	snakae@ims.u-tokyo.ac.jp	Morita, Hideaki/ADL-2008-2022; Morita, Hideaki/S-2214-2016	Morita, Hideaki/0000-0003-0928-8322; Saito, Hirohisa/0000-0002-6630-8337	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST); Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan; Banyu Life Science Foundation International; Grants-in-Aid for Scientific Research [15H04866] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Banyu Life Science Foundation International(Banyu Life Science Foundation International); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (H.M. and K.A.), a Grant-in-Aid for Scientific Research (B) (H. Saito and K. Matsumoto), Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST) (S.N.) and the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (H. Saito, S.N. and K. Matsumoto), and a grant from Banyu Life Science Foundation International (H.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kodama M, 2010, INT ARCH ALLERGY IMM, V152, P67, DOI 10.1159/000312128; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; Morita H, 2012, ALLERGOL INT, V61, P265, DOI 10.2332/allergolint.11-OA-0379; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Suzuki Yusuke, 2011, Allergology International, V60, P11, DOI 10.2332/allergolint.10-RAI-0281; Talabot-Ayer D, 2014, CYTOKINE, V69, P68, DOI 10.1016/j.cyto.2014.05.007; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	40	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134226	10.1371/journal.pone.0134226	http://dx.doi.org/10.1371/journal.pone.0134226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230091	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400087
J	Nurwulan, NR; Jiang, BC; Iridiastadi, H				Nurwulan, Nurul Retno; Jiang, Bernard C.; Iridiastadi, Hardianto			Posture and Texting: Effect on Balance in Young Adults	PLOS ONE			English	Article							MULTIVARIATE MULTISCALE ENTROPY; ATTENTIONAL DEMANDS; PRESSURE SIGNALS; DISTRACTION; PHONE	Using a mobile phone while doing another activity is a common dual-task activity in our daily lives. This study examined the effect of texting on the postural stability of young adults. Twenty college students were asked to perform static and dynamic postural stability tasks. Traditional COP and multivariate multiscale entropy (MMSE) were used to assess the static postural stability and the Star Excursion Balance Test (SEBT) was used to assess the dynamic postural stability. Results showed that (1) texting impaired postural stability, (2) the complexity index did not change much although the task conditions changed, and (3) performing texting is perceived to be more difficult.	[Nurwulan, Nurul Retno; Jiang, Bernard C.] Natl Taiwan Univ & Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan; [Iridiastadi, Hardianto] Inst Teknol Bandung, Fac Ind Technol, Dept Ind Engn, Bandung, Indonesia	National Taiwan University of Science & Technology; Institute Technology of Bandung	Nurwulan, NR (corresponding author), Natl Taiwan Univ & Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan.	nurul.retno@gmail.com	Nurwulan, Nurul Retno/AAE-5713-2020; Nussbaum, Maury A/A-9655-2008	Nurwulan, Nurul Retno/0000-0002-6308-6249; Nussbaum, Maury A/0000-0002-1887-8431	National Science Council (NSC) of Taiwan [NSC 102-2221-E-155-026-MY3]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by the National Science Council (NSC) of Taiwan (NSC 102-2221-E-155-026-MY3).	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; [Anonymous], 2011, MATLAB VERS 7 13 0 5; Bungum TJ, 2005, J COMMUN HEALTH, V30, P269, DOI 10.1007/s10900-005-3705-4; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Costa M, 2005, PHYS REV LETT, V89; Forgays DK, 2014, COMPUT HUM BEHAV, V31, P314, DOI 10.1016/j.chb.2013.10.053; Gonzales AL, 2014, COMPUT HUM BEHAV, V39, P197, DOI 10.1016/j.chb.2014.07.026; GRANAT MH, 1990, MED BIOL ENG COMPUT, V28, P601, DOI 10.1007/BF02442615; Gribble, 2003, MEAS PHYS ED EXERC S, V7, P89, DOI [10.1207/S15327841MPEE0702_3, DOI 10.1207/S15327841MPEE0702_3]; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Huang CW, 2013, SENSORS-BASEL, V13, P10151, DOI 10.3390/s130810151; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; Jiang BC, 2013, THEOR ISS ERGON SCI, V14, P227, DOI 10.1080/1463922X.2011.617109; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Neider MB, 2010, ACCIDENT ANAL PREV, V42, P589, DOI 10.1016/j.aap.2009.10.004; Parasuraman R, 1977, VIGILANCE THEORY OPE; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Skierkowski D, 2012, COMPUT HUM BEHAV, V28, P744, DOI 10.1016/j.chb.2011.11.023; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Wei Q, 2012, ENTROPY-SWITZ, V14, P2157, DOI 10.3390/e14112157; Yang WH, 2010, THESIS YUAN ZE U CHU	29	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134230	10.1371/journal.pone.0134230	http://dx.doi.org/10.1371/journal.pone.0134230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230323	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400089
J	Yamaguchi, M; Okamoto, K; Kusano, T; Matsuda, Y; Suzuki, G; Fuse, A; Yokota, H				Yamaguchi, Masahiro; Okamoto, Ken; Kusano, Teruo; Matsuda, Yoko; Suzuki, Go; Fuse, Akira; Yokota, Hiroyuki			The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice	PLOS ONE			English	Article							NF-KAPPA-B; FOCAL CEREBRAL-ISCHEMIA; OXIDASE INHIBITOR; FREE-RADICALS; MOUSE MODEL; ALLOPURINOL; FEBUXOSTAT; EXPRESSION; OXYPURINOL; SCAVENGER	We demonstrated that 3-nitrotyrosine and 4-hydroxy-2-nonenal levels in mouse brain were elevated from 1 h until 8 h after global brain ischemia for 14 min induced with the 3-vessel occlusion model; this result indicates that ischemia reperfusion injury generated oxidative stress. Reactive oxygen species production was observed not only in the hippocampal region, but also in the cortical region. We further evaluated the neuroprotective effect of xanthine oxidoreductase inhibitors in the mouse 3-vessel occlusion model by analyzing changes in the expression of genes regulated by the transcription factor nuclear factor-kappa B (including pro-inflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-9 and intercellular adhesion molecules-1). Administration of allopurinol resulted in a statistically significant decrease in IL-1 beta and TNF-alpha mRNA expression, whereas febuxostat had no significant effect on expression of these genes; nevertheless, both inhibitors effectively reduced serum uric acid concentration. It is suggested that the neuroprotective effect of allopurinol is derived not from inhibition of reactive oxygen species production by xanthine oxidoreductase, but rather from a direct free-radical-scavenging effect.	[Yamaguchi, Masahiro; Suzuki, Go; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Emergency & Crit Care Med, Tokyo 113, Japan; [Okamoto, Ken; Kusano, Teruo] Nippon Med Sch, Biochem & Mol Biol, Tokyo 113, Japan; [Matsuda, Yoko] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Matsuda, Yoko] Inst Gerontol, Dept Pathol, Tokyo, Japan	Nippon Medical School; Nippon Medical School; Tokyo Metropolitan Institute of Gerontology	Okamoto, K (corresponding author), Nippon Med Sch, Biochem & Mol Biol, 1-1-5 Sendagi, Tokyo 113, Japan.	okamoto@nms.ac.jp	Okamoto, Ken/AAC-8604-2020		JSPS KAKENHI Grant [24590393, 15H04702, 23570198]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24590393, 15H04702 and 23570198. KO received these grants.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Arai T, 1998, LIFE SCI, V63, pPL107, DOI 10.1016/S0024-3205(98)00312-9; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Belboul A, 2001, PERFUSION-UK, V16, P59, DOI 10.1177/026765910101600109; BETZ AL, 1991, AM J PHYSIOL, V260, pH563, DOI 10.1152/ajpheart.1991.260.2.H563; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Cuzzocrea S, 2000, BRAIN RES, V875, P96, DOI 10.1016/S0006-8993(00)02582-8; DAS DK, 1987, BIOCHEM BIOPH RES CO, V148, P314, DOI 10.1016/0006-291X(87)91112-0; ELION GB, 1966, BIOCHEM PHARMACOL, V15, P863, DOI 10.1016/0006-2952(66)90163-8; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Guan T, 2013, EUR J PHARMACOL, V714, P303, DOI 10.1016/j.ejphar.2013.07.036; Hashiguchi A, 2003, NEUROSCIENCE, V121, P379, DOI 10.1016/S0306-4522(03)00490-1; HOPSON SB, 1995, J NATL MED ASSOC, V87, P480; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kristian T, 2013, TRANSL STROKE RES, V4, P343, DOI 10.1007/s12975-012-0236-z; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Linder N, 1999, LAB INVEST, V79, P967; LINDSAY S, 1991, AM J PHYSIOL, V261, pH2051, DOI 10.1152/ajpheart.1991.261.6.H2051; MALKIEL S, 1993, FREE RADICAL RES COM, V18, P7, DOI 10.3109/10715769309149909; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mohiuddin I, 2006, J SURG RES, V133, P143, DOI 10.1016/j.jss.2005.10.008; MOORHOUSE PC, 1987, FEBS LETT, V213, P23, DOI 10.1016/0014-5793(87)81458-8; Nishino T, 1997, BIOCHEM SOC T, V25, P783, DOI 10.1042/bst0250783; Niwa M, 2001, NEUROL MED-CHIR, V41, P63, DOI 10.2176/nmc.41.63; Nomura J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04554; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; Saban-Ruiz Jose, 2013, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V12, P94; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Soletsky B, 2012, HYPERTENSION, V60, P1148, DOI 10.1161/HYPERTENSIONAHA.112.196980; Suzuki G, 2015, NEUROL MED-CHIR, V55, P77, DOI 10.2176/nmc.oa.2013-0307; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017; Yonekura I, 2004, J CEREBR BLOOD F MET, V24, P151, DOI 10.1097/01.WCB.0000096063.84070.C1; Zhu DY, 2002, LIFE SCI, V71, P1985, DOI 10.1016/S0024-3205(02)01970-7	38	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133980	10.1371/journal.pone.0133980	http://dx.doi.org/10.1371/journal.pone.0133980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230326	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400067
J	Zandkarimi, H; Ebadi, A; Salami, SA; Alizade, H; Baisakh, N				Zandkarimi, Hana; Ebadi, Ali; Salami, Seyed Alireza; Alizade, Houshang; Baisakh, Niranjan			Analyzing the Expression Profile of AREB/ABF and DREB/CBF Genes under Drought and Salinity Stresses in Grape (Vitis vinifera L.)	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; SIGNAL-TRANSDUCTION PATHWAY; ABSCISIC-ACID; LOW-TEMPERATURE; MOLECULAR RESPONSES; SALT STRESS; TOLERANCE; COLD; DEHYDRATION; ARABIDOPSIS	Expression patterns of four candidate AREB/ABF genes and four DREB/CBF genes were evaluated in leaf and root tissues of five grape varieties ('Qalati', 'Kaj Angoor', 'Sabz Angoor', 'Siahe Zarghan', 'Bidane Safid') with differential response to drought stress. Among the AREB/ABF genes, AREB1 and ABF2 showed up-regulation in response to drought stress in leaf and root tissues of all varieties while AREB2 and ABF1 showed down-regulation in both leaf and root tissues of the sensitive variety 'Bidane Sefid' in response to drought and salt stress. Among the DREB/CBF genes, CBF4 was the most responsive to drought stress in both leaf and root tissues. CBF2 and CBF3 showed up-regulation in all varieties in response to drought stress in leaf except in 'Bidane Sefid'. Under salinity stress, AREB2 and ABF2 showed up-regulation in response to the increasing level of salinity in the leaf tissues but in the root tissues ABF2 was up-regulated in response to increasing NaCl concentration while AREB2 was down-regulated. Therefore, it seems AREB2 has tissue-specific response to salinity stress. All CBF genes were up-regulated in response to salinity stress in the leaf and root tissues. Expression data suggested that CBF2 is more responsive to NaCl stress. Among all four promising and stress tolerant varieties 'Siah Zarghan' and 'Kaj Angoor' were more tolerant than 'Qalati' and 'Sabz Angoor' to drought and salinity.	[Zandkarimi, Hana; Ebadi, Ali; Salami, Seyed Alireza; Alizade, Houshang] Univ Tehran, Dept Hort, Fac Agr, Karaj 31587, Iran; [Zandkarimi, Hana; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	University of Tehran; Louisiana State University System; Louisiana State University	Ebadi, A (corresponding author), Univ Tehran, Dept Hort, Fac Agr, Karaj 31587, Iran.	aebadi@ut.ac.ir; nbaisakh@agcenter.lsu.edu						Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; Bartels D, 2003, TOP CURR GENET, V4, P9; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Boneh U, 2012, PLANT SCI, V187, P89, DOI 10.1016/j.plantsci.2012.01.015; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Ghaderi N, 2011, J AGR SCI TECH-IRAN, V13, P601; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haddadinejad M, 2012, IRANIAN JOURNAL OF H, V44, P193; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McGovern PE, 2007, ANCIENT WINE THE SEA; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vanjildorj E, 2005, PLANT CELL TISS ORG, V83, P41, DOI 10.1007/s11240-005-3800-3; Vanjildorj E, 2006, PLANT CELL TISS ORG, V87, P109, DOI 10.1007/s11240-006-9143-x; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao T, 2014, MOL BIOL REP, V41, P1577, DOI 10.1007/s11033-013-3004-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	55	41	49	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134288	10.1371/journal.pone.0134288	http://dx.doi.org/10.1371/journal.pone.0134288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230273	Green Submitted, gold, Green Published			2022-12-26	WOS:000358838400099
J	Ohsawa, Y; Takayama, K; Nishimatsu, S; Okada, T; Fujino, M; Fukai, Y; Murakami, T; Hagiwara, H; Itoh, F; Tsuchida, K; Hayashi, Y; Sunada, Y				Ohsawa, Yutaka; Takayama, Kentaro; Nishimatsu, Shin-ichiro; Okada, Tadashi; Fujino, Masahiro; Fukai, Yuta; Murakami, Tatsufumi; Hagiwara, Hiroki; Itoh, Fumiko; Tsuchida, Kunihiro; Hayashi, Yoshio; Sunada, Yoshihide			The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVIN; IDENTIFICATION; GENE; MICE; RECOGNITION; EXPRESSION; PROPEPTIDE; REVEALS; GDF-8	Myostatin, a muscle-specific transforming growth factor-beta (TGF-beta), negatively regulates skeletal muscle mass. The N-terminal prodomain of myostatin noncovalently binds to and suppresses the C-terminal mature domain (ligand) as an inactive circulating complex. However, which region of the myostatin prodomain is required to inhibit the biological activity of myostatin has remained unknown. We identified a 29-amino acid region that inhibited myostatin-induced transcriptional activity by 79% compared with the full-length prodomain. This inhibitory core resides near the N-terminus of the prodomain and includes an a-helix that is evolutionarily conserved among other TGF-beta family members, but suppresses activation of myostatin and growth and differentiation factor 11 (GDF11) that share identical membrane receptors. Interestingly, the inhibitory core co-localized and co-immunoprecipitated with not only the ligand, but also its type I and type II membrane receptors. Deletion of the inhibitory core in the full-length prodomain removed all capacity for suppression of myostatin. A synthetic peptide corresponding to the inhibitory core (p29) ameliorates impaired myoblast differentiation induced by myostatin and GDF11, but not activin or TGF-beta 1. Moreover, intramuscular injection of p29 alleviated muscle atrophy and decreased the absolute force in caveolin 3-deficient limb-girdle muscular dystrophy 1C model mice. The injection suppressed activation of myostatin signaling and restored the decreased numbers of muscle precursor cells caused by caveolin 3 deficiency. Our findings indicate a novel concept for this newly identified inhibitory core of the prodomain of myostatin: that it not only suppresses the ligand, but also prevents two distinct membrane receptors from binding to the ligand. This study provides a strong rationale for the use of p29 in the amelioration of skeletal muscle atrophy in various clinical settings.	[Ohsawa, Yutaka; Okada, Tadashi; Fujino, Masahiro; Fukai, Yuta; Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan; [Takayama, Kentaro; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Dept Med Chem, Hachioji, Tokyo 1920392, Japan; [Nishimatsu, Shin-ichiro] Kawasaki Med Sch, Dept Mol & Dev Biol, Kurashiki, Okayama 7010192, Japan; [Okada, Tadashi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Fujino, Masahiro] Kawasaki Univ Med Welf, Fac Med Profess, Dept Hlth & Sports Sci, Kurashiki, Okayama 7010193, Japan; [Hagiwara, Hiroki] Teikyo Univ Sci, Dept Med Sci, Uenohara, Yamanashi 4090193, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan; [Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi 4701192, Japan	Kawasaki Medical School; Tokyo University of Pharmacy & Life Sciences; Kawasaki Medical School; Obihiro University of Agriculture & Veterinary Medicine; Tokyo University of Pharmacy & Life Sciences; Fujita Health University	Ohsawa, Y (corresponding author), Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.	yosawa@med.kawasaki-m.ac.jp; ysunada@med.kawasaki-m.ac.jp	Tsuchida, Kunihiro/A-4501-2012	Tsuchida, Kunihiro/0000-0002-3983-5756; Murakami, Tatsufumi/0000-0001-7851-6822; Itoh, Fumiko/0000-0002-6134-5331	Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [20B-13, 23-5, 26-8]; Ministry of Health, Labour, and Welfare of Japan [H20-018]; Japan Society for the Promotion of Science [C-20591013, C-21591101, C-23591261, C-24590363, C-24591281, C-26461285]; Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency [AS2421276Q]; Kawasaki Medical School [23-T1, 26-T1]	Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency; Kawasaki Medical School	This work was supported by research grants for Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (20B-13, 23-5, 26-8); by grants for Comprehensive Research on Disability, Health, and Welfare from the Ministry of Health, Labour, and Welfare of Japan (H20-018); by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C-20591013, C-21591101, C-23591261, C-24590363, C-24591281, C-26461285); by the Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency (AS2421276Q); and by research project grants from Kawasaki Medical School (23-T1, 26-T1). The sponsors played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moustakas A, 2001, J CELL SCI, V114, P4359; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Ohsawa Y, 2012, LAB INVEST, V92, P1100, DOI 10.1038/labinvest.2012.78; Partridge T A, 1997, Methods Mol Biol, V75, P131; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Takayama K, 2015, J MED CHEM, V58, P1544, DOI 10.1021/jm501170d; Thies RS, 2001, GROWTH FACTORS, V18, P251; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	33	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133713	10.1371/journal.pone.0133713	http://dx.doi.org/10.1371/journal.pone.0133713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226340	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700035
J	Chung, MG; Kang, H; Choi, SU				Chung, Min Gon; Kang, Hojeong; Choi, Sung-Uk			Assessment of Coastal Ecosystem Services for Conservation Strategies in South Korea	PLOS ONE			English	Article							COUPLED HUMAN; TRADEOFFS; IMPACTS	Despite the fact that scientific and political consideration for ecosystem services has dramatically increased over the past decade, few studies have focused on marine and coastal ecosystem services for conservation strategies. We used an ecosystem services approach to assess spatial distributions of habitat risks and four ecosystem services (coastal protection, carbon storage, recreation, and aesthetic quality), and explored the tradeoffs among them in coastal areas of South Korea. Additionally, we analyzed how the social and ecological characteristics in coastal areas interact with conservation and development policies by using this approach. We found strong negative associations between the habitat risks and ecosystem services (aquaculture, carbon storage, recreation, and aesthetic quality) across the coastal counties. Our results showed that the intensity of the habitat risks and the provision of ecosystem services were significantly different between reclamation-dominated and conservation-dominated counties, except for coastal vulnerability. A generalized linear model suggested that reclamation projects were dependent on economic efficiency, whereas demographic pressures and habitat conditions influenced the designation of protected areas at a county level. The ecosystem services approach provided guidelines to achieve both sustainable development and environment conservation. By using the approach, we can select the priority areas for developments while we can minimize the degradation of biodiversity and ecosystem services. As cultural ecosystem services are evenly distributed throughout coastal areas of South Korea, decision makers may employ them to improve the conditions of coastal wetlands outside of protected areas.	[Chung, Min Gon; Kang, Hojeong; Choi, Sung-Uk] Yonsei Univ, Sch Civil & Environm Engn, Seoul 120749, South Korea	Yonsei University	Kang, H (corresponding author), Yonsei Univ, Sch Civil & Environm Engn, Seoul 120749, South Korea.	hj_kang@yonsei.ac.kr	Kang, Hojeong/C-7208-2011; Chung, Min Gon/AAF-7277-2021	Chung, Min Gon/0000-0002-7177-7189; Choi, Sung-Uk/0000-0002-0802-7705	National Research Foundation [2011-0030040]	National Research Foundation	This work was supported by National Research Foundation 2011-0030040 (http://www.nrf.re.kr) to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SW, 2005, J CONTEMP ASIA, V35, P485, DOI 10.1080/00472330580000281; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Cochard R, 2008, PERSPECT PLANT ECOL, V10, P3, DOI 10.1016/j.ppees.2007.11.001; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dhakal S, 2010, WIREL TELECOMM SYMP; Dudley N., 2008, GUIDELINES FOR APPLY; Dudley N., 2011, SOLUTIONS, V2, P87; Eggleston S., 2006, IPCC GUIDELINES FOR; ESRI, 2012, ARCGIS DESKTOP RELEA; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Garcia-Nieto AP, 2013, ECOSYST SERV, V4, P126, DOI 10.1016/j.ecoser.2013.03.003; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gornitz V., 1990, J COASTAL RES, V9, P201, DOI DOI 10.1007/S10661-017-6282-Y; Guerry Anne D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P107, DOI 10.1080/21513732.2011.647835; Hong SK, 2010, ENVIRON MANAGE, V45, P1014, DOI 10.1007/s00267-006-0164-3; Hong SY, 2010, DIGITAL SOIL MAPPING; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Hwang SI, 2010, LOW CARBON LAND USE; Ingram J, 2012, APPLYING ECOSYSTEM S, V5; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; KHOA, 2013, CALCULATING DEVATION; Kim J., 2007, ECO, V11, P285; KMA, 2011, ANNUAL CLIMATOLOGICA; Koh CH, 2009, COMP STUDY POLICY MA; Korea Statistics, 2010, CENSUS OF AGRICULTUR; Korea Statistics, 2014, KOREAN STATISTICAL I; Korea Statistics, 2010, UNDERSTANDING STATIS; Korea Statistics, 2013, KOREA STATISTICAL YE; Korea Statistics, 2014, STATISTICAL GEOGRAPH; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035420; Liverman D, 1998, PEOPLE AND PIXELS LI; MA, 2005, ECOSYSTEMS AND HUMAN; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; McLeod K., 2009, ECOSYSTEM BASED MANA; Ministry of Environment, 2014, ENVIRONMENT GEOGRAPH; MLTM, 2013, NATIONAL SPATIAL INF; MLTM, 2011, THE SECOND INTEGRATE; MLTM, 2008, THE MANAGEMENT OF CO; MOF, 2014, THE NATIONAL SURVEY; MOF, 2014, COASTAL MANAGEMENT I; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Petter M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05260-180131; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Potschin M, 2013, COMMON INTERNATIONAL; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R Core Team, 2021, R LANGUAGE ENV STAT; Rees SE, 2013, FISH RES, V146, P51, DOI 10.1016/j.fishres.2013.04.003; Sachedina H., 2012, INTEGRATING ECOLOGY, DOI [10.1007/978-1-4614-0186-5_12, DOI 10.1007/978-1-4614-0186-5_12]; Sander HA, 2009, LAND USE POLICY, V26, P837, DOI 10.1016/j.landusepol.2008.10.009; SAS Institute Inc, 2008, SAS STAT 9 2 USERS G; Schroth G, 2011, ENVIRON MANAGE, V48, P229, DOI 10.1007/s00267-011-9708-2; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sharp R, 2014, INVEST USERS GUIDE T; Tallis HT, 2013, THE NATURAL CAPITAL; Tallis HT, 2011, THE NATURAL CAPITAL; TEEB, 2010, THE ECONOMICS OF ECO; UNEP, 2006, MARINE AND COASTAL E; Wang X, 2010, ECOL ECON, V69, P2549, DOI 10.1016/j.ecolecon.2010.07.031; Willemen L, 2013, ECOSYST SERV, V4, P95, DOI 10.1016/j.ecoser.2013.02.004; Yackulic CB, 2011, ECOL SOC, V16, DOI 10.5751/ES-04275-160315; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	73	27	27	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133856	10.1371/journal.pone.0133856	http://dx.doi.org/10.1371/journal.pone.0133856			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221950	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800072
J	Gimenez-Dejoz, J; Kolar, MH; Ruiz, FX; Crespo, I; Cousido-Siah, A; Podjarny, A; Barski, OA; Fanfrlik, J; Pares, X; Farres, J; Porte, S				Gimenez-Dejoz, Joan; Kolar, Michal H.; Ruiz, Francesc X.; Crespo, Isidro; Cousido-Siah, Alexandra; Podjarny, Alberto; Barski, Oleg A.; Fanfrlik, Jindrich; Pares, Xavier; Farres, Jaume; Porte, Sergio			Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase	PLOS ONE			English	Article							RETINOIC ACID BIOSYNTHESIS; SCORING FUNCTION; AKR1B10; BINDING; SITE; DEHYDROGENASE; PROTEINS; SUPERFAMILY; FLEXIBILITY; METABOLISM	Human aldo-keto reductase 1B15 (AKR1B15) is a newly discovered enzyme which shares 92% amino acid sequence identity with AKR1B10. While AKR1B10 is a well characterized enzyme with high retinaldehyde reductase activity, involved in the development of several cancer types, the enzymatic activity and physiological role of AKR1B15 are still poorly known. Here, the purified recombinant enzyme has been subjected to substrate specificity characterization, kinetic analysis and inhibitor screening, combined with structural modeling. AKR1B15 is active towards a variety of carbonyl substrates, including retinoids, with lower k(cat) and K-m values than AKR1B10. In contrast to AKR1B10, which strongly prefers all-trans-retinaldehyde, AKR1B15 exhibits superior catalytic efficiency with 9-cis-retinaldehyde, the best substrate found for this enzyme. With ketone and dicarbonyl substrates, AKR1B15 also shows higher catalytic activity than AKR1B10. Several typical AKR inhibitors do not significantly affect AKR1B15 activity. Amino acid substitutions clustered in loops A and C result in a smaller, more hydrophobic and more rigid active site in AKR1B15 compared with the AKR1B10 pocket, consistent with distinct substrate specificity and narrower inhibitor selectivity for AKR1B15.	[Gimenez-Dejoz, Joan; Crespo, Isidro; Pares, Xavier; Farres, Jaume; Porte, Sergio] Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Kolar, Michal H.; Fanfrlik, Jindrich] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Kolar, Michal H.] Forschungszentrum Julich, INM 9, D-52425 Julich, Germany; [Kolar, Michal H.] Forschungszentrum Julich, IAS 5, D-52425 Julich, Germany; [Ruiz, Francesc X.; Cousido-Siah, Alexandra; Podjarny, Alberto] UdS, INSERM, CNRS, Dept Integrat Struct Biol,Inst Genet & Biol Mol &, Illkirch Graffenstaden, France; [Barski, Oleg A.] Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40292 USA	Autonomous University of Barcelona; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Louisville	Farres, J (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain.	jaume.farres@uab.cat; sergio.porte@gmail.com	Ruiz, Francesc Xavier/AAA-1324-2020; Giménez Dejoz, Joan/C-7434-2017; Farrés, Jaume/F-8648-2016; Kolář, Michal H./AFP-3197-2022; Kolar, Michal H/H-3721-2011; Pares, Xavier/K-8228-2017	Ruiz, Francesc Xavier/0000-0002-0457-0030; Giménez Dejoz, Joan/0000-0002-3839-950X; Farrés, Jaume/0000-0001-9069-3987; Kolář, Michal H./0000-0003-0841-944X; Podjarny, Alberto/0000-0002-7685-1077; Pares, Xavier/0000-0002-5071-9465; Fanfrlik, Jindrich/0000-0002-1257-1201; Cousido-Siah, Alexandra/0000-0002-3051-1560; Crespo, Isidro/0000-0001-7698-1720	Spanish Ministerio de Economia y Competitividad [BFU2011-24176]; Generalitat de Catalunya [2009 SGR 795]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite de Strasbourg; Region Alsace; Hopital Civil de Strasbourg; l Instruct part of the European Strategy Forum of Research Infrastructures; ESFRI; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Fondation pour la Recherche Medicale [SPF20121226275]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Hopital Civil de Strasbourg; l Instruct part of the European Strategy Forum of Research Infrastructures; ESFRI; French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	JGD, IC, XP, JF and SP received support from Spanish Ministerio de Economia y Competitividad [BFU2011-24176] (http://www.mineco.gob.es) and Generalitat de Catalunya [2009 SGR 795] (http://www.gencat.cat/agaur). FXR, ACS and AP received support from Centre National de la Recherche Scientifique (http://www.cnrs.fr); Institut National de la Sante et de la Recherche Medicale (http://www.inserm.fr); Universite de Strasbourg (https://www.unistra.fr); Region Alsace (http://www.region.alsace); Hopital Civil de Strasbourg (http://www.chru-strasbourg.fr/Hopital-civi); l Instruct (part of the European Strategy Forum of Research Infrastructures; ESFRI) (https://www.structuralbiology.eu); and French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01] (http://frisbi.eu). FXR received support from Fondation pour la Recherche Medicale [SPF20121226275] (http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Calam E, 2013, CHEM-BIOL INTERACT, V202, P195, DOI 10.1016/j.cbi.2012.12.006; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chatzopoulou M, 2012, EXPERT OPIN THER PAT, V22, P1303, DOI 10.1517/13543776.2012.726615; Constantinescu S, 2014, CHEM RES TOXICOL, V27, P377, DOI 10.1021/tx400427t; Cousido-Siah A, 2014, ACTA CRYSTALLOGR D, V70, P889, DOI 10.1107/S1399004713033452; Crosas B, 2001, J BIOL CHEM, V276, P19132, DOI 10.1074/jbc.M010478200; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Echtay KS, 2007, REDOX REP, V12, P26, DOI 10.1179/135100007X162158; EHRIG T, 1994, BIOCHEMISTRY-US, V33, P7157, DOI 10.1021/bi00189a019; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Endo S, 2010, BIOL PHARM BULL, V33, P886, DOI 10.1248/bpb.33.886; Endo S, 2010, BIOORGAN MED CHEM, V18, P2485, DOI 10.1016/j.bmc.2010.02.050; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; Fanfrlik J, 2013, ACS CHEM BIOL, V8, P2484, DOI 10.1021/cb400526n; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kimble-Hill AC, 2014, J MED CHEM, V57, P714, DOI 10.1021/jm401377v; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kokkinidis M, 2012, ADV PROTEIN CHEM STR, V87, P181, DOI 10.1016/B978-0-12-398312-1.00007-X; KUBISESKI TJ, 1995, J BIOL CHEM, V270, P16911, DOI 10.1074/jbc.270.28.16911; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepsik M, 2013, CHEMPLUSCHEM, V78, P921, DOI 10.1002/cplu.201300199; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Ma J., 2012, CLIN DEV IMMUNOL, V2012, P1, DOI DOI 10.1109/PESGM.2012.6345243; Matsunaga T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00005; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Palczewski G, 2014, FASEB J, P1, DOI [10.1096/fj.14-0101LTE, DOI 10.1096/FJ.14-0101LTE]; Pastel E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00148; Pathania S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061327; Porte S, 2013, CHEM-BIOL INTERACT, V202, P186, DOI 10.1016/j.cbi.2012.11.014; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Ruiz FX, 2011, BIOCHEM J, V440, P335, DOI 10.1042/BJ20111286; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Salabei JK, 2011, CHEM-BIOL INTERACT, V191, P177, DOI 10.1016/j.cbi.2011.01.020; Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Soda M, 2012, EUR J MED CHEM, V48, P321, DOI 10.1016/j.ejmech.2011.12.034; Sundaram K, 2011, BIOORG MED CHEM LETT, V21, P801, DOI 10.1016/j.bmcl.2010.11.086; Tammali R, 2011, CARCINOGENESIS, V32, P1259, DOI 10.1093/carcin/bgr102; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Verma M, 2008, EUR J PHARMACOL, V584, P213, DOI 10.1016/j.ejphar.2008.01.036; Weber S, 2015, J BIOL CHEM, V290, P6531, DOI 10.1074/jbc.M114.610121; Ruiz FX, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00058; Ruiz FX, 2011, CHEM-BIOL INTERACT, V191, P199, DOI 10.1016/j.cbi.2011.02.007; Ruiz FX, 2013, CHEM-BIOL INTERACT, V202, P178, DOI 10.1016/j.cbi.2012.12.013; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zhang LP, 2014, CHEMMEDCHEM, V9, P706, DOI 10.1002/cmdc.201300455; Zhang LP, 2013, FEBS LETT, V587, P3681, DOI 10.1016/j.febslet.2013.09.031; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	71	14	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134506	10.1371/journal.pone.0134506	http://dx.doi.org/10.1371/journal.pone.0134506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222439	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800146
J	Liu, JL; Wang, TS				Liu, Ji-Long; Wang, Tong-Song			Systematic Analysis of the Molecular Mechanism Underlying Decidualization Using a Text Mining Approach	PLOS ONE			English	Article							ENDOMETRIAL STROMAL CELLS; PROGESTERONE-RECEPTOR; BIOLOGICAL NETWORKS; EMBRYO IMPLANTATION; DEFINED FACTORS; GENE; FIBROBLASTS; EXPRESSION; PROTEINS; DATABASE	Decidualization is a crucial process for successful embryo implantation and pregnancy in humans. Defects in decidualization during early pregnancy are associated with several pregnancy complications, such as pre-eclampsia, intrauterine growth restriction and recurrent pregnancy loss. However, the mechanism underlying decidualization remains poorly understood. In the present study, we performed a systematic analysis of decidualization- related genes using text mining. We identified 286 genes for humans and 287 genes for mice respectively, with an overlap of 111 genes shared by both species. Through enrichment test, we demonstrated that although divergence was observed, the majority of enriched gene ontology terms and pathways were shared by both species, suggesting that functional categories were more conserved than individual genes. We further constructed a decidualization-related protein-protein interaction network consisted of 344 nodes connected via 1,541 edges. We prioritized genes in this network and identified 12 genes that may be key regulators of decidualization. These findings would provide some clues for further research on the mechanism underlying decidualization.	[Liu, Ji-Long] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Tong-Song] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Shantou University	Liu, JL (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	jilongliu@scau.edu.cn		Liu, Ji-Long/0000-0002-6948-2576	National Natural Science Foundation of China [31271602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant (31271602 to JLL) (http://www.nsfc.gov.cn/).	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrientos G, 2014, HUM REPROD UPDATE, V20, P175, DOI 10.1093/humupd/dmt040; Blois SM, 2011, J REPROD IMMUNOL, V88, P86, DOI 10.1016/j.jri.2010.11.002; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Christian Mark, 2002, Reprod Biomed Online, V4 Suppl 3, P24; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Garrido-Gomez T, 2011, J CLIN ENDOCR METAB, V96, P706, DOI 10.1210/jc.2010-1825; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IRWIN JC, 1989, FERTIL STERIL, V52, P761; Kashiwagi A, 2007, ENDOCRINOLOGY, V148, P4173, DOI 10.1210/en.2007-0268; KREHBIEL ROBERT H[ENRY], 1937, PHYSIOL ZOOL, V10, P212; Large MJ, 2012, MOL CELL ENDOCRINOL, V358, P155, DOI 10.1016/j.mce.2011.07.027; LEDFORD BE, 1976, BIOL REPROD, V15, P529, DOI 10.1095/biolreprod15.4.529; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Paule SG, 2010, J PROTEOME RES, V9, P5739, DOI 10.1021/pr100525a; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Tierney EP, 2003, PHYSIOL GENOMICS, V16, P47, DOI 10.1152/physiolgenomics.00066.2003; VELARDO JT, 1953, AM J ANAT, V93, P273, DOI 10.1002/aja.1000930205; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134585	10.1371/journal.pone.0134585	http://dx.doi.org/10.1371/journal.pone.0134585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222155	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800154
J	Singha, UK; Hamilton, V; Chaudhuri, M				Singha, Ujjal K.; Hamilton, VaNae; Chaudhuri, Minu			Tim62, a Novel Mitochondrial Protein in Trypanosoma brucei, Is Essential for Assembly and Stability of the TbTim17 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; IMPORT; INSERTION; TIM23; KINETOPLAST; CRITHIDIA; CHANNEL; TIM50	Trypanosoma brucei, the causative agent of human African trypanosomiasis, possesses non-canonical mitochondrial protein import machinery. Previously, we characterized the essential translocase of the mitochondrial inner membrane (TIM) consisting of Tim17 in T. brucei. TbTim17 is associated with TbTim62. Here we show that TbTim62, a novel protein, is localized in the mitochondrial inner membrane, and its import into mitochondria depends on TbTim17. Knockdown (KD) of TbTim62 decreased the steady-state levels of TbTim17 post-transcriptionally. Further analysis showed that import of TbTim17 into mitochondria was not inhibited, but its half-life was reduced >4-fold due to TbTim62 KD. Blue-native gel electrophoresis revealed that TbTim62 is present primarily in similar to 150-kDa and also in similar to 1100-kDa protein complexes, whereas TbTim17 is present in multiple complexes within the range of similar to 300 to similar to 1100 kDa. TbTim62 KD reduced the levels of both TbTim62 as well as TbTim17 protein complexes. Interestingly, TbTim17 was accumulated as lower molecular mass complexes in TbTim62 KD mitochondria. Furthermore, depletion of TbTim62 hampered the assembly of the ectopically expressed TbTim17-2X-myc into TbTim17 protein complex. Co-immunoprecipitation analysis revealed that association of TbTim17 with mHSP70 was markedly reduced in Tb Tim62 KD mitochondria. All together our results demonstrate that TbTim62, a unique mitochondrial protein in T. brucei, is required for the formation of a stable TbTim17 protein complex. TbTim62 KD destabilizes this complex, and unassembled TbTim17 degrades. Therefore, TbTim62 acts as a novel regulatory factor to maintain the levels of TIM in T. brucei mitochondria.	[Singha, Ujjal K.; Hamilton, VaNae; Chaudhuri, Minu] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Meharry Medical College	Chaudhuri, M (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, West Basic Sci Bldg,Rm 4105, Nashville, TN 37208 USA.	mchaudhuri@mmc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [2SC1GM081146, T32HL007727, U54RR026140, U54MDO7593, G12RR003032]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM081146] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 2SC1GM081146, T32HL007727, U54RR026140, U54MDO7593, and G12RR003032. The authors declare that they have no conflicts of interest with the contents of this article.	Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Beschin A, 2014, TRENDS PARASITOL, V30, P538, DOI 10.1016/j.pt.2014.08.006; Brennand Ana, 2012, Cells, V1, P346, DOI 10.3390/cells1030346; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; de Macedo JP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004875; Duncan MR, 2013, J BIOL CHEM, V288, P3184, DOI 10.1074/jbc.M112.436378; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; EFFRON PN, 1993, MOL BIOCHEM PARASIT, V59, P191, DOI 10.1016/0166-6851(93)90217-L; Esseiva AC, 2004, EMBO REP, V5, P268, DOI 10.1038/sj.embor.7400095; Ferramosca A, 2013, BBA-MOL CELL RES, V1833, P494, DOI 10.1016/j.bbamcr.2012.11.014; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Hamilton V, 2014, EUKARYOT CELL, V13, P539, DOI 10.1128/EC.00312-13; Hasne MP, 2000, MOL BIOCHEM PARASIT, V111, P299, DOI 10.1016/S0166-6851(00)00321-2; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Hewitt VL, 2014, BBA-GEN SUBJECTS, V1840, P1246, DOI 10.1016/j.bbagen.2013.08.013; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Melin J, 2014, MOL CELL BIOL, V34, P3473, DOI 10.1128/MCB.00433-14; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; Motta MCM, 2008, CURR PHARM DESIGN, V14, P847, DOI 10.2174/138161208784041051; Murcha MW, 2014, BBA-GEN SUBJECTS, V1840, P1233, DOI 10.1016/j.bbagen.2013.09.026; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni XQ, 2013, BIOMED REP, V1, P674, DOI 10.3892/br.2013.120; Povelones ML, 2014, MOL BIOCHEM PARASIT, V196, P53, DOI 10.1016/j.molbiopara.2014.03.008; PRIEST JW, 1994, MOL BIOCHEM PARASIT, V65, P291, DOI 10.1016/0166-6851(94)90080-9; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Rezende AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1175; Rodrigues Juliany Cola Fernandes, 2014, Subcell Biochem, V74, P1, DOI 10.1007/978-94-007-7305-9_1; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Singha UK, 2012, J BIOL CHEM, V287, P14480, DOI 10.1074/jbc.M111.322925; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Volpato H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130652; Weems E, 2015, EUKARYOT CELL, V14, P286, DOI 10.1128/EC.00203-14; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618	64	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23226	23239		10.1074/jbc.M115.663492	http://dx.doi.org/10.1074/jbc.M115.663492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240144	Green Published, hybrid			2022-12-26	WOS:000361685500032
J	Ray, P; Chapman, SC				Ray, Poulomi; Chapman, Susan C.			Cytoskeletal Reorganization Drives Mesenchymal Condensation and Regulates Downstream Molecular Signaling	PLOS ONE			English	Article							CELL-SHAPE CHANGES; RHO-KINASE; EXTRACELLULAR-MATRIX; CARTILAGE FORMATION; ACTIN ORGANIZATION; FOCAL ADHESIONS; TENSILE FORCES; GROWTH-FACTOR; CHICK LIMB; STEM-CELLS	Skeletal condensation occurs when specified mesenchyme cells self-organize over several days to form a distinctive cartilage template. Here, we determine how and when specified mesenchyme cells integrate mechanical and molecular information from their environment, forming cartilage condensations in the pharyngeal arches of chick embryos. By disrupting cytoskeletal reorganization, we demonstrate that dynamic cell shape changes drive condensation and modulate the response of the condensing cells to Fibroblast Growth Factor (FGF), Bone Morphogenetic Protein (BMP) and Transforming Growth Factor beta (TGF-beta) signaling pathways. Rho Kinase (ROCK)-driven actomyosin contractions and Myosin II-generated differential cell cortex tension regulate these cell shape changes. Disruption of the condensation process inhibits the differentiation of the mesenchyme cells into chondrocytes, demonstrating that condensation regulates the fate of the mesenchyme cells. We also find that dorsal and ventral condensations undergo distinct cell shape changes. BMP signaling is instructive for dorsal condensation-specific cell shape changes. Moreover, condensations exhibit ventral characteristics in the absence of BMP signaling, suggesting that in the pharyngeal arches ventral morphology is the ground pattern. Overall, this study characterizes the interplay between cytoskeletal dynamics and molecular signaling in a self-organizing system during tissue morphogenesis.	[Ray, Poulomi; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Chapman, SC (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	schapm2@clemson.edu	Chapman, Susan C/J-2688-2013	Chapman, Susan C/0000-0002-4314-9193	National Institute on Deafness and other Communication Disorders of the National Institutes of Health [R01DC009236]; NIFA (National Institute of Food and Agriculture)/USDA [SC-1700374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIFA (National Institute of Food and Agriculture)/USDA; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by National Institute on Deafness (http://www.nidcd.nih.gov/) and other Communication Disorders of the National Institutes of Health under award number R01DC009236 to SCC. Technical Contribution No. 6248 of the Clemson University Experiment Station. This material is based upon work supported by the NIFA (National Institute of Food and Agriculture)/USDA, under project number SC-1700374 to SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; COULY GF, 1993, DEVELOPMENT, V117, P409; DANIELS K, 1991, J CELL SCI, V100, P249; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Goldmann WH, 2012, CELL BIOL INT, V36, P649, DOI 10.1042/CBI20120184; HALL BK, 1992, ANAT EMBRYOL, V186, P107; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanein D, 2012, CURR OPIN CELL BIOL, V24, P134, DOI 10.1016/j.ceb.2011.12.001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim D, 2009, J CELL BIOCHEM, V107, P622, DOI 10.1002/jcb.22191; Kim MJ, 2012, BIOCHEM BIOPH RES CO, V418, P500, DOI 10.1016/j.bbrc.2012.01.053; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kumar M, 2012, DEV DYNAM, V241, P1091, DOI 10.1002/dvdy.23768; Lecuit T, 2008, HFSP J, V2, P72, DOI 10.2976/1.2896332; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; Merrill AE, 2008, DEVELOPMENT, V135, P1223, DOI 10.1242/dev.015933; Meyer TN, 2006, DIFFERENTIATION, V74, P638, DOI 10.1111/j.1432-0436.2006.00102.x; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Miyajima D, 2012, J BIOL CHEM, V287, P33545, DOI 10.1074/jbc.M111.329938; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Staines KA, 2012, CELL BIOCHEM FUNCT, V30, P633, DOI 10.1002/cbf.2852; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Watanabe T, 2010, CURR OPIN GENET DEV, V20, P443, DOI 10.1016/j.gde.2010.05.004; Wood JL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-16; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yan YL, 2002, DEVELOPMENT, V129, P5065; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	61	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134702	10.1371/journal.pone.0134702	http://dx.doi.org/10.1371/journal.pone.0134702			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237312	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942400033
J	Brittin, J; Sorensen, D; Trowbridge, M; Lee, KK; Breithecker, D; Frerichs, L; Huang, T				Brittin, Jeri; Sorensen, Dina; Trowbridge, Matthew; Lee, Karen K.; Breithecker, Dieter; Frerichs, Leah; Huang, Terry			Physical Activity Design Guidelines for School Architecture	PLOS ONE			English	Article							BODY-MASS INDEX; ELEMENTARY-SCHOOL; BUILT ENVIRONMENT; ACTIVITY THERMOGENESIS; CHILDHOOD OBESITY; NON-EXERCISE; ACTIVITY INTERVENTIONS; PLAYGROUND MARKINGS; COMMUNITY DESIGN; STAIR USE	Increasing children's physical activity at school is a national focus in the U.S. to address childhood obesity. While research has demonstrated associations between aspects of school environments and students' physical activity, the literature currently lacks a synthesis of evidence to serve as a practical, spatially-organized resource for school designers and decision-makers, as well as to point to pertinent research opportunities. This paper describes the development of a new practical tool: Physical Activity Design Guidelines for School Architecture. Its aims are to provide architects and designers, as well as school planners, educators, and public health professionals, with strategies for making K-12 school environments conducive to healthy physical activity, and to engage scientists in transdisciplinary perspectives toward improved knowledge of the school environment's impact. We used a qualitative review process to develop evidence-based and theory-driven school design guidelines that promote increased physical activity among students. The design guidelines include specific strategies in 10 school design domains. Implementation of the guidelines is expected to enable students to adopt healthier physical activity behaviors. The tool bridges a translational gap between research and environmental design practice, and may contribute to setting new industry and education standards.	[Brittin, Jeri; Frerichs, Leah; Huang, Terry] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Hlth Promot Social & Behav Hlth, Omaha, NE 68182 USA; [Sorensen, Dina] VMDO Architects, Charlottesville, VA USA; [Trowbridge, Matthew] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA; [Lee, Karen K.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Breithecker, Dieter] Fed Inst Posture & Mobilisat Support, Wiesbaden, Germany; [Frerichs, Leah] Univ N Carolina, Ctr Hlth Equ, Chapel Hill, NC USA; [Huang, Terry] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Nebraska System; University of Nebraska Medical Center; University of Virginia; New York City Department of Health & Mental Hygiene; University of North Carolina; University of North Carolina Chapel Hill; City University of New York (CUNY) System	Brittin, J (corresponding author), Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Hlth Promot Social & Behav Hlth, Omaha, NE 68182 USA.	jeri.brittin@unmc.edu	Brittin, Jeri/P-3780-2019; Lee, Karen/GVT-9602-2022	Brittin, Jeri/0000-0002-1316-6451; Trowbridge, Matthew/0000-0002-8012-1966; Huang, Terry/0000-0001-5544-5187	YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development; VMDO Architects	YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development; VMDO Architects	This work was supported by funding from YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development (MT and TH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VMDO Architects provided support in the form of a salary for author DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unrelated to this project, authors TS and JB have been consultants to VMDO Architects. The specific roles of the authors are articulated in the 'author contributions' section.	Amedeo D.M., 2003, GEOGRAPHY AM DAWN 21, P133; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Anthamatten P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-27; Ashe M, 2011, PUBLIC HEALTH, V125, P889, DOI 10.1016/j.puhe.2011.04.010; Ashe M, 2007, J LAW MED ETHICS, V35, P138, DOI 10.1111/j.1748-720X.2007.00118.x; Babey SH, 2009, J PUBLIC HEALTH POL, V30, pS203, DOI 10.1057/jphp.2008.61; Bandura A., 1986, SOCIAL FDN THOUGHT A; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Barrett P, 2012, BUILD ENVIRON, V59, P678; Barrett P, 2010, INTELL BUILD INT, V2, P218, DOI 10.3763/inbi.2010.0042; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bell, 2007, CHILDRENS GEOGRAPHIE, V5, P463, DOI DOI 10.1080/14733280701631965; Benden M.E., 2012, J EXERC PHYSL ONLINE, V15, P9; Benden ME, 2011, AM J PUBLIC HEALTH, V101, P1433, DOI 10.2105/AJPH.2010.300072; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P514, DOI 10.1177/003335491012500402; Binns HJ, 2009, PEDIATRICS, V123, P1591, DOI 10.1542/peds.2009-0750; Blake JJ, 2012, J PUBLIC HEALTH MAN, V18, P412, DOI 10.1097/PHH.0b013e3182215048; Boarnet MG, 2005, AM J PREV MED, V28, P134, DOI 10.1016/j.amepre.2004.10.026; Boehmer TK, 2008, AM J PREV MED, V34, P333, DOI 10.1016/j.amepre.2008.01.003; Boldemann C, 2006, PREV MED, V42, P301, DOI 10.1016/j.ypmed.2005.12.006; Boutelle KN, 2001, AM J PUBLIC HEALTH, V91, P2004, DOI 10.2105/AJPH.91.12.2004; Braza M, 2004, AM J HEALTH PROMOT, V19, P128, DOI 10.4278/0890-1171-19.2.128; Breithecker D, OPPORTUNITIES IMPROV; Breithecker D, 2008, HALTUNG BEWEGUNG, V3, P5; Breithecker D, 2003, HALTUNG BEWEGUNG, V2, P5; Brink LA, 2010, AM J PUBLIC HEALTH, V100, P1672, DOI 10.2105/AJPH.2009.178939; Buck C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-65; Budgen Pip, 2007, Health Promot J Austr, V18, P77; Buliung RN, 2009, PREV MED, V48, P507, DOI 10.1016/j.ypmed.2009.03.001; Burke NM, 2009, AM J PREV MED, V37, pS386, DOI 10.1016/j.amepre.2009.09.010; Canter D, 1997, ADV ENV BEH, V4, P109; Cardon G, 2004, PATIENT EDUC COUNS, V54, P133, DOI 10.1016/S0738-3991(03)00215-5; Cardon G, 2009, PREV MED, V48, P335, DOI 10.1016/j.ypmed.2009.02.013; Cardon GM, 2012, HEALTH EDUC RES, V27, P470, DOI 10.1093/her/cys043; Carpet and Rug Institute, 2010, ARCHIT REC, V198, P123; City of New York, 2010, ACT DES GUID PROM PH; Cohen D, 2008, J PHYS ACT HEALTH, V5, P719, DOI 10.1123/jpah.5.5.719; Cohen Deborah A, 2006, J Phys Act Health, V3, pS129, DOI 10.1123/jpah.3.s1.s129; Colabianchi N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-32; Colabianchi N, 2009, PREV MED, V48, P140, DOI 10.1016/j.ypmed.2008.11.005; [Committee on Physical Activity and Physical Education in the School Environment Institute of Medicine (US)], 2013, ED STUD BODY TAK PHY; Community Preventive Services Task Force, 2018, PHYS ACT ACT TRAV SC; Cradock AL, 2007, AM J PREV MED, V33, P106, DOI 10.1016/j.amepre.2007.04.009; D'Haese S, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-88; Dobbins M, 2013, COCHRANE DATABASE SY, P2; Doggett F, 2010, J ACOUST SOC AM, V127, P1860; Duderstadt KG, 2009, J PEDIATR HEALTH CAR, V23, P269, DOI 10.1016/j.pedhc.2009.04.009; Durant N, 2009, J SCHOOL HEALTH, V79, P153, DOI 10.1111/j.1746-1561.2008.00384.x; Dyment JE, 2008, HEALTH EDUC RES, V23, P952, DOI 10.1093/her/cym059; Egger J., 2009, NYC VITAL SIGNS, V8, P1; Eves FF, 2009, J ENVIRON PSYCHOL, V29, P300, DOI 10.1016/j.jenvp.2008.10.002; Eyler AA, 2008, HEALTH EDUC RES, V23, P963, DOI 10.1093/her/cym061; Farley TA, 2007, AM J PUBLIC HEALTH, V97, P1625, DOI 10.2105/AJPH.2006.092692; Fein AJ, 2004, INT J BEHAV MED, V11, P135, DOI 10.1207/s15327558ijbm1103_2; Fenton M, 2012, CHILD OBES, V8, P44, DOI 10.1089/chi.2011.0122; Fernandes M, 2010, PREV MED, V50, pS30, DOI 10.1016/j.ypmed.2009.09.022; Fitzhugh EC, 2010, AM J PREV MED, V39, P259, DOI 10.1016/j.amepre.2010.05.010; Fjortoft I, 2010, SCAND J PUBLIC HEALT, V38, P28, DOI 10.1177/1403494810384909; Ford MA, 2008, J AM COLL HEALTH, V57, P242, DOI 10.3200/JACH.57.2.242-244; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Frerichs L, 2012, CURR NUTR REP, V1, P228; Frerichs L, 2015, AM J PUBLIC HEALTH, V105, pE46, DOI 10.2105/AJPH.2014.302453; Garcia JM, 2014, MED SCI SPORT EXER, V46, P513, DOI 10.1249/01.mss.0000495005.45665.db; Geraghty AB, 2009, AM J PREV MED, V37, pS420, DOI 10.1016/j.amepre.2009.09.009; Giddens A., 1979, CENTRAL PROBLEMS SOC; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Giles-Corti B, 2011, HEALTH PLACE, V17, P545, DOI 10.1016/j.healthplace.2010.12.011; Glickman D, 2012, ACC PROGR OB PREV SO, P333; Gomez-Feliciano L, 2009, AM J PREV MED, V37, pS361, DOI 10.1016/j.amepre.2009.09.003; Gorman N, 2007, OBESITY, V15, P2521, DOI 10.1038/oby.2007.300; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P87, DOI 10.1001/jama.297.1.87; Gouvali MK, 2006, APPL ERGON, V37, P765, DOI 10.1016/j.apergo.2005.11.009; Grantmakers in Health, 2007, REV OB EP POL STRAT; Guerra PH, 2013, CLINICS, V68, P1263, DOI 10.6061/clinics/2013(09)14; Gump P. V., 1987, HDB ENV PSYCHOL, P691; Hagle M, 2013, ARCH DESIGN REV HOUS, V92, P20; Hall Edward T, 1992, HIDDEN DIMENSION; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hanks AS, 2013, J PEDIATR-US, V162, P867, DOI 10.1016/j.jpeds.2012.12.031; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Harrison F, 2012, HEALTH PLACE, V18, P639, DOI 10.1016/j.healthplace.2011.12.009; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Heelan KA, 2005, CHILD CARE HLTH DEV, V31, P341, DOI 10.1111/j.1365-2214.2005.00513.x; Heinrich Katie M, 2011, Hawaii Med J, V70, P21; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hillier B., 1989, SOCIAL LOGIC SPACE; Hobin E, 2012, INT J PUBLIC HEALTH, V57, P699, DOI 10.1007/s00038-012-0336-2; Hooper PL, 2013, J PHYS ACT HEALTH, V10, P792, DOI 10.1123/jpah.10.6.792; Huang TT, 2009, PREV CHRONIC DIS, V6; Huang TTK, 2007, J LAW MED ETHICS, V35, P148, DOI 10.1111/j.1748-720X.2007.00119.x; Huang TTK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120084; Huberty JL, 2011, J PHYS ACT HEALTH, V8, pS249, DOI 10.1123/jpah.8.s2.s249; Huberty JL, 2009, AM J PREV MED, V37, pS428, DOI 10.1016/j.amepre.2009.09.024; Ittelson W.H., 1973, ENV COGNITION, P141; Jones NR, 2010, HEALTH PLACE, V16, P776, DOI 10.1016/j.healthplace.2010.04.002; Kayser B, 2008, PREV MED, V46, P8, DOI 10.1016/j.ypmed.2007.08.016; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Kim S, 2010, PREV MED, V50, pS80, DOI 10.1016/j.ypmed.2009.07.025; King AC, 1995, HEALTH EDUC QUART, V22, P499, DOI 10.1177/109019819502200407; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; KLESGES RC, 1990, HEALTH PSYCHOL, V9, P435, DOI 10.1037/0278-6133.9.4.435; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kumanyika S, 2006, FUTURE CHILD, V16, P187, DOI 10.1353/foc.2006.0005; Lackney JA, 1994, CTR ARCHITECTURE URB, pR94; Lanningham-Foster L, 2008, OBESITY, V16, P1849, DOI 10.1038/oby.2008.282; Lee KK, 2012, AM J PREV MED, V42, P136, DOI 10.1016/j.amepre.2011.10.005; Lee KK, 2012, HEALTH PLACE, V18, P5, DOI 10.1016/j.healthplace.2011.09.009; Lee KK, 2014, DEV ACTIVE DESIGN IN; Lee SM, 2008, HEALTH PROMOT PRACT, V9, P246, DOI 10.1177/1524839907301403; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1111/j.1753-4887.2004.tb00094.x; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lewis A, 2012, BRIT J HEALTH PSYCH, V17, P631, DOI 10.1111/j.2044-8287.2011.02060.x; Loucaides CA, 2009, J PHYS ACT HEALTH, V6, P722, DOI 10.1123/jpah.6.6.722; Martin JJ, 2008, J SPORT EXERCISE PSY, V30, P378, DOI 10.1123/jsep.30.4.378; Martin K, 2012, AUST NZ J PUBL HEAL, V36, P469, DOI 10.1111/j.1753-6405.2012.00914.x; Martin SH, 2002, J ENVIRON PSYCHOL, V22, P139, DOI 10.1006/jevp.2001.0239; Martinez Maldonado Roberto, 2012, Intelligent Tutoring Systems. Proceedings 11th International Conference (ITS 2012), P482, DOI 10.1007/978-3-642-30950-2_62; Maxwell LE, 2003, ENVIRON BEHAV, V35, P566, DOI 10.1177/0013916503035004007; McAlister A.L., 2008, HLTH BEHAV HLTH ED T; Millstein RA, 2011, PEDIATR EXERC SCI, V23, P487, DOI 10.1123/pes.23.4.487; Mitra R, 2010, HEALTH PLACE, V16, P646, DOI 10.1016/j.healthplace.2010.01.009; Nelson KM, 2008, J PUBLIC HEALTH MAN, V14, P266, DOI 10.1097/01.PHH.0000316485.49888.f6; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Nicaise V, 2012, PEDIATR EXERC SCI, V24, P507, DOI 10.1123/pes.24.4.507; Nichols A, 2013, EVALUATION OF COMMUN; Nicoll GA, 2013, ACTIVE DESIGN AFFORD; Nicoll G, 2007, AM J HEALTH PROMOT, V21, P346, DOI 10.4278/0890-1171-21.4s.346; Nielsen G, 2010, J PHYS ACT HEALTH, V7, P490, DOI 10.1123/jpah.7.4.490; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; [NYC Department of Health and Mental Hygiene Society for Public Health Education Johns Hopkins Center for Injury Research and Policy], 2013, ACT DES SUPPL PROM S; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ozer EJ, 2007, HEALTH EDUC BEHAV, V34, P846, DOI 10.1177/1090198106289002; Panter JR, 2010, J EPIDEMIOL COMMUN H, V64, P41, DOI 10.1136/jech.2009.086918; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; *PHYS ACT GUID ADV, 2008, PHYS ACT GUID ADV CO, P1; Poole ES, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P395; Professional Glidden, 2013, ARCHIT REC, V201, P262; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Ridgers ND, 2007, PREV MED, V44, P393, DOI 10.1016/j.ypmed.2007.01.009; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ruff RR, 2014, PREV MED, V60, P60, DOI 10.1016/j.ypmed.2013.12.006; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Sallis JF, 2008, HLTH BEHAV HLTH ED T, DOI DOI 10.1111/J.1442-9993.2008.01952.X; Salmon J, 2007, AM J HEALTH PROMOT, V22, P107, DOI 10.4278/0890-1171-22.2.107; Schasberger MG, 2009, AM J PREV MED, V37, pS336, DOI 10.1016/j.amepre.2009.09.012; School Planning and Management, 2014, ANN SCH CONTR REP; Schroder I, 1997, COLLEGIUM ANTROPOL, V21, P397; Scott MM, 2007, PREV MED, V44, P398, DOI 10.1016/j.ypmed.2006.12.010; Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1; Silva KS, 2011, J PHYS ACT HEALTH, V8, P750, DOI 10.1123/jpah.8.6.750; Sirard JR, 2008, J NUTR EDUC BEHAV, V40, P324, DOI 10.1016/j.jneb.2007.12.002; Sirard JR, 2008, AM J LIFESTYLE MED, V2, P372, DOI 10.1177/1559827608320127; Sirard JR, 2005, MED SCI SPORT EXER, V37, P2062, DOI 10.1249/01.mss.0000179102.17183.6b; Skala KA, 2012, J PHYS ACT HEALTH, V9, P481, DOI 10.1123/jpah.9.4.481; Smith TJ, 2013, WORK, V44, pS39, DOI 10.3233/WOR-121493; Stone MR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-5; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tanner CK, 2009, J EDUC ADMIN, V47, P381, DOI 10.1108/09578230910955809; Teske JA, 2008, NEUROENDOCRINOLOGY, V87, P71, DOI 10.1159/000110802; The Third Teacher, 2010, 3 TEACHER OWP P CANN; Thompson D, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3074; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Toftager M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-777; Trilk JL, 2011, HEALTH PLACE, V17, P651, DOI 10.1016/j.healthplace.2011.01.005; Trowbridge MJ, 2013, AM J PREV MED, V44, P489, DOI 10.1016/j.amepre.2013.01.010; U. S. Green Building Council, LEED DES ACT OCC; Dyck D, 2009, PREV MED, V48, P516, DOI 10.1016/j.ypmed.2009.03.005; Van Sluijs EMF, 2011, INT J PEDIATR OBES, V6, pE574, DOI 10.3109/17477166.2010.518239; Verstraete SJM, 2006, EUR J PUBLIC HEALTH, V16, P415, DOI 10.1093/eurpub/ckl008; Voorhees CC, 2010, MED SCI SPORT EXER, V42, P1253, DOI 10.1249/MSS.0b013e3181cd5dfd; Watson Margaret, 2008, Prev Chronic Dis, V5, pA90; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; WEINSTEIN CS, 1979, REV EDUC RES, V49, P577, DOI 10.3102/00346543049004577; Wells NM, 2014, PREV MED, V69, pS27, DOI 10.1016/j.ypmed.2014.10.012; Wendel AM, 2009, PREV MED, V48, P513, DOI 10.1016/j.ypmed.2009.05.010; Willenberg LJ, 2010, J SCI MED SPORT, V13, P210, DOI 10.1016/j.jsams.2009.02.011; Williams AJ, 2012, HEALTH PLACE, V18, P504, DOI 10.1016/j.healthplace.2012.02.004; Zhu XM, 2008, AM J PREV MED, V34, P282, DOI 10.1016/j.amepre.2008.01.024; Zhu XM, 2009, J PUBLIC HEALTH POL, V30, pS177, DOI 10.1057/jphp.2008.51; Zimring C, 2005, AM J PREV MED, V28, P186, DOI 10.1016/j.amepre.2004.10.025	188	26	27	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132597	10.1371/journal.pone.0132597	http://dx.doi.org/10.1371/journal.pone.0132597			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230850	Green Published, gold			2022-12-26	WOS:000358838400018
J	Dukers-Muijrers, NHTM; Theunissen, KATM; Wolffs, PT; Kok, G; Hoebe, CJPA				Dukers-Muijrers, Nicole H. T. M.; Theunissen, Kevin A. T. M.; Wolffs, Petra T.; Kok, Gerjo; Hoebe, Christian J. P. A.			Acceptance of Home-Based Chlamydia Genital and Anorectal Testing Using Short Message Service (SMS) in Previously Tested Young People and Their Social and Sexual Networks	PLOS ONE			English	Article							TAKEN VAGINAL SWABS; OF-THE-LITERATURE; NEISSERIA-GONORRHOEAE; TRANSMITTED-DISEASES; UROGENITAL CHLAMYDIA; SCREENING-PROGRAM; TRACHOMATIS; WOMEN; ACCEPTABILITY; RISK	Background Control strategies for Chlamydia trachomatis (CT) are most effective when targeting people at highest risk. We assessed test acceptance of home-collection test kits offered by short messaging services (SMS) texts, in high-risk young people, i.e. those who had previously tested CT positive (positive indices), or negative reporting more than 3 sex partners (negative indices), and their sexual and social networks. Methods Young (16 to 25 years old) heterosexuals who previously tested positive (n=536) or negative (n=536) in our STI clinic received, 3 to 20 months after their initial screening, an SMS inviting them to re-test. They were offered a free home-collection test kit including a genital (men and women) and anorectal (women only) test, and a test kit to pass on to a friend or sex partner (peer). SMS reminders were sent in case of non-response. We assessed proportions of tests requested and returned, peers tested, and positivity. Associations with the individual's initial screening result and other factors were explored using logistic regression. Results Of 1072 people invited to retest, 34.4% (n=369) requested a test. Of these, 55.8% (n=206) retested. Overall, retest participation was higher in positive (22%) than in negative indices (16%) (p<0.001); it was also higher in women and in those aged >22 years. Positivity was 13% and 7% in positive and negative indices, respectively. One in 3 retesters also had a peer tested. Of tested peers (n=87), 84% were friends, 31% were first-time testers, and 7% tested positive. Conclusion Acceptance of a relatively low-cost strategy for genital and anorectal testing, i.e. using SMS and home-collection test kits, was highest in individuals who previously tested CT positive suggesting that implementation for this group may be considered. By further including a peer-led testing component, undetected CT positives can be identified in the social networks surrounding a high-risk individual.	[Dukers-Muijrers, Nicole H. T. M.; Theunissen, Kevin A. T. M.; Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Wolffs, Petra T.; Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Kok, Gerjo] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands	Maastricht University; Maastricht University	Dukers-Muijrers, NHTM (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	nicole.dukers@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014	Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Wolffs, Petra/0000-0002-5326-3985				Balfe M, 2010, SOCIOL HEALTH ILL, V32, P1041, DOI 10.1111/j.1467-9566.2010.01281.x; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Blake DR, 2003, ARCH PEDIAT ADOL MED, V157, P523, DOI 10.1001/archpedi.157.6.523; Burton J, 2014, SEX TRANSM INFECT, V90, P11, DOI 10.1136/sextrans-2013-051228; Busse P, 2010, COMMUN RES, V37, P239, DOI 10.1177/0093650209356393; Centers for Disease Control and Prevention, SUMM REV LIT PROG PR; Cunningham SD, 2009, PERSPECT SEX REPRO H, V41, P225, DOI 10.1363/4122509; Desai M, 2015, SEX TRANSM INFECT, V91, P314, DOI 10.1136/sextrans-2014-051930; Dokkum NFB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-176; Doshi JS, 2008, INT J STD AIDS, V19, P507, DOI 10.1258/ijsa.2008.008056; Downing SG, 2013, SEX TRANSM INFECT, V89, P16, DOI 10.1136/sextrans-2011-050454; Dukers-Muijrers NHTM, 2013, SEX TRANSM INFECT, V89, P25, DOI 10.1136/sextrans-2011-050467; European Centre for Disease Prevention and Control, 2014, CHLAM CONTR EUR LIT; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Gotz HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-239; Gotz HM, 2005, SEX TRANSM DIS, V32, P557, DOI 10.1097/01.olq.0000175416.15905.db; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Guy R, 2013, SEX TRANSM INFECT, V89, P11, DOI 10.1136/sextrans-2011-050370; Guy R, 2012, SEX TRANSM DIS, V39, P136, DOI 10.1097/OLQ.0b013e31823ed4ec; Guy R, 2011, SEX HEALTH, V8, P242, DOI 10.1071/SH10086; Hoebe CJPA, 2006, SEX TRANSM DIS, V33, P491, DOI 10.1097/01.olq.0000204619.87066.28; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Jamil MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-189; Kegg S, 2004, COMMUNICATION, V15; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Loaring J, 2013, J FAM PLAN REPROD H, V39, P21, DOI 10.1136/jfprhc-2011-100151; Lunny C, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-7; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Newby KV, 2012, BRIT J HEALTH PSYCH, V17, P144, DOI 10.1111/j.2044-8287.2011.02027.x; Odesanmi TY, 2013, SEX HEALTH, V10, P559, DOI 10.1071/SH13029; Ostergaard L, 2003, SEX TRANSM INFECT, V79, P358, DOI 10.1136/sti.79.5.358; Pavlin NL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-221; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; Rose SB, 2010, AUST NZ J PUBL HEAL, V34, P517, DOI 10.1111/j.1753-6405.2010.00600.x; Senior K, 2012, LANCET INFECT DIS, V12, P517, DOI 10.1016/S1473-3099(12)70161-5; Smith KS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-223; Theunissen KATM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-996; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; Trebach JD, 2015, SEX TRANSM DIS, V42, P233, DOI 10.1097/OLQ.0000000000000248; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-274; Youm Y, 2002, SEX TRANSM DIS, V29, P689, DOI 10.1097/00007435-200211000-00012	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133575	10.1371/journal.pone.0133575	http://dx.doi.org/10.1371/journal.pone.0133575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230085	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400043
J	Winder, EM; Bonheyo, GT				Winder, Eric M.; Bonheyo, George T.			DNA Persistence in a Sink Drain Environment	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PCR; MICROCOSMS; BIOFILMS; MATRIX; TISSUE	Biofilms are organized structures composed mainly of cells and extracellular polymeric substances produced by the constituent microorganisms. Ubiquitous in nature, biofilms have an innate ability to capture and retain passing material and may therefore act as natural collectors of contaminants or signatures of upstream activities. To determine the persistence and detectability of DNA passing through a sink drain environment, Bacillus anthracis strain Ames35 was cultured (6.35 x 10(7) CFU/mL), sterilized, and disposed of by addition to a sink drain apparatus with an established biofilm. The sink drain apparatus was sampled before and for several days after the addition of the sterilized B. anthracis culture to detect the presence of B. anthracis DNA. Multiple PCR primer pairs were used to screen for chromosomal and plasmid DNA with primers targeting shorter sequences showing greater amplification efficiency and success. PCR amplification and detection of target sequences indicate persistence of chromosomal DNA and plasmid DNA in the biofilm for 5 or more and 14 or more days, respectively.	[Winder, Eric M.; Bonheyo, George T.] Pacific NW Natl Lab, Sequim, WA 98382 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Winder, EM (corresponding author), Pacific NW Natl Lab, Sequim, WA 98382 USA.	eric.winder@pnnl.gov	Bonheyo, George/AAU-6018-2020	Bonheyo, George/0000-0001-8853-5744; Winder, Eric/0000-0003-3707-7549	Intelligence Community Postdoctoral Research Fellowship Program	Intelligence Community Postdoctoral Research Fellowship Program	This project was supported by a grant from the Intelligence Community Postdoctoral Research Fellowship Program. All statements of fact, opinion, or analysis expressed are those of the author and do not reflect the official positions or views of the Intelligence Community or any other United States Government agency. Nothing in the contents should be construed as asserting or implying United States Government authentication of information or Intelligence Community endorsement of the author's views.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Butler JM, 2003, DEV REDUCED SIZE STR, V48, P11; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cheun HI, 2001, J APPL MICROBIOL, V91, P421, DOI 10.1046/j.1365-2672.2001.01395.x; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Geigl EM, 2002, ARCHAEOMETRY, V44, P337, DOI 10.1111/1475-4754.t01-1-00066; Jackson PJ, 1998, P NATL ACAD SCI USA, V95, P1224, DOI 10.1073/pnas.95.3.1224; Jaeger K-E, 2003, ENCY ENV MICROBIOLOG; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P5433, DOI 10.1128/AEM.69.9.5433-5442.2003; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P177, DOI 10.1128/AEM.69.1.177-185.2003; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Simmon KE, 2004, J MICROBIOL METH, V56, P143, DOI 10.1016/j.mimet.2003.10.003; Straub T, 2013, J MICROBIOL METH, V92, P9, DOI 10.1016/j.mimet.2012.10.013; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Volokhov D, 2004, DIAGN MICR INFEC DIS, V49, P163, DOI 10.1016/j.diagmicrobio.2004.03.015; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	20	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134798	10.1371/journal.pone.0134798	http://dx.doi.org/10.1371/journal.pone.0134798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230525	Green Published, gold, Green Submitted			2022-12-26	WOS:000358838400169
J	Yang, GL; Xu, ZP; Lu, W; Li, X; Sun, CW; Guo, J; Xue, P; Guan, F				Yang, Ganglong; Xu, Zhipeng; Lu, Wei; Li, Xiang; Sun, Chengwen; Guo, Jia; Xue, Peng; Guan, Feng			Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ICAM-1 EXPRESSION; URINARY-BLADDER; CARCINOMA; IDENTIFICATION; BIOMARKERS; TISSUES; OVARIAN; CULTURE	The best way to increase patient survival rate is to identify patients who are likely to progress to muscle-invasive or metastatic disease upfront and treat them more aggressively. The human cell lines HCV29 (normal bladder epithelia), KK47 (low grade nonmuscle invasive bladder cancer, NMIBC), and YTS1 (metastatic bladder cancer) have been widely used in studies of molecular mechanisms and cell signaling during bladder cancer (BC) progression. However, little attention has been paid to global quantitative proteome analysis of these three cell lines. We labeled HCV29, KK47, and YTS1 cells by the SILAC method using three stable isotopes each of arginine and lysine. Labeled proteins were analyzed by 2D ultrahigh-resolution liquid chromatography LTQ Orbitrap mass spectrometry. Among 3721 unique identified and annotated proteins in KK47 and YTS1 cells, 36 were significantly upregulated and 74 were significantly downregulated with >95% confidence. Differential expression of these proteins was confirmed by western blotting, quantitative RT-PCR, and cell staining with specific antibodies. Gene ontology (GO) term and pathway analysis indicated that the differentially regulated proteins were involved in DNA replication and molecular transport, cell growth and proliferation, cellular movement, immune cell trafficking, and cell death and survival. These proteins and the advanced proteome techniques described here will be useful for further elucidation of molecular mechanisms in BC and other types of cancer.	[Yang, Ganglong; Lu, Wei; Guo, Jia; Guan, Feng] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Xu, Zhipeng] Shaanxi Prov Peoples Hosp, Xian, Peoples R China; [Li, Xiang] Jiangnan Univ, Wuxi Med Sch, Wuxi, Peoples R China; [Sun, Chengwen] Jiangnan Univ, Affiliated Hosp, Dept Urol, Wuxi, Peoples R China; [Xue, Peng] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China	Jiangnan University; Xi'an Medical University; Jiangnan University; Jiangnan University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xue, P (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China.	xuepeng@moon.ibp.ac.cn; fengguan@jiangnan.edu.cn	Yang, Ganglong/GPP-4135-2022		National Science Foundation for Young Scientists of China [81402115, 81201572]; Natural Science Foundation of Jiangsu Province, China [BK20140172]; 111 Project of China [111-2-06]	National Science Foundation for Young Scientists of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Science Foundation for Young Scientists of China (No. 81402115, 81201572), the Natural Science Foundation of Jiangsu Province, China (No. BK20140172) and the 111 Project of China (No. 111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2014, TRENDS CELL BIOL, V24, P257, DOI 10.1016/j.tcb.2013.10.010; Arnold JM, 2001, BRIT J CANCER, V85, P1351, DOI 10.1054/bjoc.2001.2075; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Berard AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051939; Buitrago D, 2012, ANN SURG ONCOL, V19, P973, DOI 10.1245/s10434-011-2029-0; Caceres NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058285; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen JS, 2010, FEBS J, V277, P3028, DOI 10.1111/j.1742-4658.2010.07712.x; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Despierre E, 2013, GYNECOL ONCOL, V130, P192, DOI 10.1016/j.ygyno.2013.03.024; Goodison S, 2013, MOL DIAGN THER, V17, P71, DOI 10.1007/s40291-013-0023-x; Goodison S, 2009, EXPERT REV PROTEOMIC, V6, P507, DOI 10.1586/EPR.09.70; HISAZUMI H, 1979, JPN J UROL, V70, P485, DOI 10.5980/jpnjurol1928.70.5_485; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kakizaki H, 1986, Nihon Hinyokika Gakkai Zasshi, V77, P1790; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Khaled H, 2013, J ADV RES, V4, P461, DOI 10.1016/j.jare.2013.06.007; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lawlor K, 2009, J PROTEOME RES, V8, P1489, DOI 10.1021/pr8008572; Lei T, 2013, CLIN GENITOURIN CANC, V11, P56, DOI 10.1016/j.clgc.2012.06.003; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruo Y, 2002, INT J CANCER, V100, P486, DOI 10.1002/ijc.10514; MASTERS JRW, 1986, CANCER RES, V46, P3630; Matic I, 2011, J PROTEOME RES, V10, P4869, DOI 10.1021/pr2004715; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Quan H, 2011, CELL PHYSIOL BIOCHEM, V27, P91, DOI 10.1159/000325209; Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Takakura D, 2014, PROTEOMICS, V14, P196, DOI 10.1002/pmic.201300332; Tian Y, 2011, ANAL CHEM, V83, P7013, DOI 10.1021/ac200815q; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang P, 2014, UROLOGY, V84, P1351, DOI 10.1016/j.urology.2014.07.029; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang GL, 2015, J PROTEOME RES, V14, P639, DOI 10.1021/pr5006026; Yang GL, 2013, PROTEOMICS, V13, P1481, DOI 10.1002/pmic.201200259; Yang GL, 2013, PROTEOMICS, V13, P878, DOI 10.1002/pmic.201200018	49	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134727	10.1371/journal.pone.0134727	http://dx.doi.org/10.1371/journal.pone.0134727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230496	Green Submitted, Green Published, gold			2022-12-26	WOS:000358838400157
J	Fraessdorf, J; Hollmann, MW; Hanschmann, I; Heinen, A; Weber, NC; Preckel, B; Huhn, R				Fraessdorf, Jan; Hollmann, Markus W.; Hanschmann, Iris; Heinen, Andre; Weber, Nina C.; Preckel, Benedikt; Huhn, Ragnar			Role of Endogenous Opioid System in Ischemic-Induced Late Preconditioning	PLOS ONE			English	Article							INDUCED DELAYED CARDIOPROTECTION; INTACT RAT-HEART; IN-VIVO; GENE-EXPRESSION; MET-ENKEPHALIN; LATE-PHASE; RECEPTOR; INJURY; INVOLVEMENT; CYCLOOXYGENASE-2	Background Opioid receptors (OR) are involved in myocardial late preconditioning (LPC) induced by morphine and delta 1-opioid receptor (delta 1-OR) agonists. The role of OR in ischemic-induced LPC is unknown. We investigated whether 1) OR are involved in the trigger and/or mediation phase of LPC and 2) a time course effect on the expression of different opioid receptors and their endogenous ligands exists. Methods Male Wistar rats were randomly allocated to four groups (each group n = 8). Awake animals were ischemic preconditioned by a 5 minutes coronary occlusion. 24 hours later, anesthetized animals underwent 25 minutes coronary occlusion followed by 2 hours of reperfusion. The role of OR was investigated by treatment with intraperitoneal naloxone (Nal) 10 minutes prior to LPC (Nal-LPC; trigger phase) or 10 min prior to sustained ischemia (LPC-Nal; mediation phase). Results LPC reduced infarct size from 61 +/- 10% in controls to 25 +/- 9% (P<0.001). Naloxone during trigger or mediation phase completely abolished LPC-induced cardioprotection (59 +/- 9% and 62 +/- 9%; P<0.001 vs. LPC). 8, 12 and 24 hours after the ischemic stimulus, expression of delta-OR in the heart was increased, whereas mu-opioid receptor (mu-OR) and kappa-opioid receptor (kappa-OR) were not. Plasma concentrations of beta-endorphin and leu-enkephalin but not dynorphin were increased by LPC. Conclusion Ischemic LPC is triggererd and mediated by OR. Expression of delta-OR and plasma levels of endogenous opioid peptides are increased after ischemic LPC.	[Fraessdorf, Jan; Hanschmann, Iris; Huhn, Ragnar] Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, Germany; [Fraessdorf, Jan; Hollmann, Markus W.; Weber, Nina C.; Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Heinen, Andre] Univ Dusseldorf, Dept Cardiovasacular Physiol, Dusseldorf, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Heinrich Heine University Dusseldorf	Hollmann, MW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	M.W.Hollmann@amc.uva.nl	Weber, Nina/CAH-0231-2022	Weber, Nina/0000-0003-1111-9042; Preckel, Benedikt/0000-0003-4412-9183	Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany [FoKo 9772215]	Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany	This work was supported by a Research Fund (FoKo 9772215) from the Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany.	Bao N, 2007, CIRC J, V71, P1622, DOI 10.1253/circj.71.1622; Baxter GF, 1997, BASIC RES CARDIOL, V92, P159; Bell SP, 2000, J AM COLL CARDIOL, V36, P2296, DOI 10.1016/S0735-1097(00)01011-1; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; CLEMENTJONES V, 1980, NATURE, V283, P295, DOI 10.1038/283295a0; Frassdorf J, 2005, ANESTH ANALG, V101, P934, DOI 10.1213/01.ane.0000172130.70274.84; Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141; Fryer RM, 1999, CIRC RES, V84, P846; Gao CJ, 2012, NEUROSCIENCE, V202, P352, DOI 10.1016/j.neuroscience.2011.11.060; Guo Y, 2005, AM J PHYSIOL-HEART C, V289, pH2251, DOI 10.1152/ajpheart.00341.2005; Guo Y, 2000, BASIC RES CARDIOL, V95, P479, DOI 10.1007/s003950070024; HOWLETT TA, 1984, BRIT MED J, V288, P1950, DOI 10.1136/bmj.288.6435.1950; Huhn R, 2009, BRIT J ANAESTH, V102, P614, DOI 10.1093/bja/aep042; Jackson KE, 2001, AUTON NEUROSCI-BASIC, V94, P84, DOI 10.1016/S1566-0702(01)00351-4; Jiang XJ, 2006, LIFE SCI, V78, P2543, DOI 10.1016/j.lfs.2005.10.032; Jiang XJ, 2005, J AM COLL CARDIOL, V45, P1707, DOI 10.1016/j.jacc.2005.02.046; Jiang XJ, 2004, ANESTHESIOLOGY, V101, P82, DOI 10.1097/00000542-200407000-00014; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; McLaughlin PJ, 1998, DEV DYNAM, V211, P153, DOI 10.1002/(SICI)1097-0177(199802)211:2<153::AID-AJA4>3.3.CO;2-O; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PARADIS P, 1992, BIOCHEM CELL BIOL, V70, P593, DOI 10.1139/o92-090; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P2187, DOI 10.1006/jmcc.1997.0454; Ventura C, 1998, J BIOL CHEM, V273, P13383, DOI 10.1074/jbc.273.22.13383; VENTURA C, 1994, J BIOL CHEM, V269, P5384; Weber NC, 2005, BRIT J PHARMACOL, V146, P445, DOI 10.1038/sj.bjp.0706324; Weber NC, 2008, ANESTH ANALG, V107, P1807, DOI 10.1213/ane.Ob013e31818874bf; Wu S, 1999, CIRC RES, V84, P1388; Zhang Y, 2004, ANESTHESIOLOGY, V101, P918, DOI 10.1097/00000542-200410000-00017	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134283	10.1371/journal.pone.0134283	http://dx.doi.org/10.1371/journal.pone.0134283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226627	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700067
J	Lador, F; Herve, P; Bringard, A; Gunther, S; Garcia, G; Savale, L; Ferretti, G; Soccal, PM; Chemla, D; Humbert, M; Simonneau, G; Sitbon, O				Lador, Frederic; Herve, Philippe; Bringard, Aurellen; Guenther, Sven; Garcia, Gilles; Savale, Laurent; Ferretti, Guido; Soccal, Paola M.; Chemla, Denis; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier			Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension	PLOS ONE			English	Article							PULSE PRESSURE PROFILES; ARTERIAL-HYPERTENSION; STRESS ECHOCARDIOGRAPHY; EXERCISE; CIRCULATION; FLOW; HEMODYNAMICS; MODELFLOW(R); RESISTANCE; CONTOUR	Background Cardiac output (CO) is a major diagnostic and prognostic factor in pre-capillary pulmonary hypertension (PH). Reference methods for CO determination, like thermodilution (TD), require invasive procedures and allow only steady-state measurements. The Modelflow (MF) method is an appealing technique for this purpose as it allows non-invasive and beat-by-beat determination of CO. Methods We aimed to compare CO values obtained simultaneously from non-invasive pulse wave analysis by MF (COMF) and by TD (COTD) to determine its precision and accuracy in precapillary PH. The study was performed on 50 patients with pulmonary arterial hypertension (PAH) or chronic thrombo-embolic PH (CTEPH). CO was determined at rest in all patients (n = 50) and during nitric oxide vasoreactivity test, fluid challenge or exercise (n = 48). Results Baseline COMF and COTD were 6.18 +/- 1.95 and 5.46 +/- 1.95 L.min(-1), respectively. Accuracy and precision were 0.72 and 1.04 L.min-1, respectively. Limits of agreement (LoA) ranged from -1.32 to 2.76 L.min-1. Percentage error (PE) was +/- 35.7%. Overall sensitivity and specificity of COMF for directional change were 95.2% and 82.4%, (n = 48) and 93.3% and 100% for directional changes during exercise (n = 16), respectively. After application of a correction factor (1.17 +/- 0.25), neither proportional nor fixed bias was found for subsequent CO determination (n = 48). Accuracy was -0.03 L.min(-1) and precision 0.61 L.min(-1). LoA ranged from -1.23 to 1.17 L.min(-1) and PE was +/- 19.8%. Conclusions After correction against a reference method, MF is precise and accurate enough to determine absolute values and beat-by-beat relative changes of CO in pre-capillary PH.	[Lador, Frederic; Soccal, Paola M.] Hop Univ Geneve, Programme Hypertens Pulm, Serv Pneumol, Geneva, Switzerland; [Herve, Philippe; Guenther, Sven; Garcia, Gilles; Savale, Laurent; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier] Hop Bicetre, AP HP, Ctr Reference Hypertens Pulm Severe,Serv Pneumol, Dept Hosp Univ DHU Thorax Innovat TORINO, Le Kremlin Bicetre, France; [Herve, Philippe] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [Bringard, Aurellen] Univ Geneva, Dept Neurosci Fondamentales, Ctr Med Univ, Geneva, Switzerland; [Guenther, Sven; Garcia, Gilles; Savale, Laurent; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Ferretti, Guido] Univ Brescia, Dipartimento Sci Clin & Sperimentali, Brescia, Italy; [Chemla, Denis] Univ Paris 11, Fac Med, Dept Physiol, EA4533,APHP, Le Kremlin Bicetre, France	University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Lador, F (corresponding author), Hop Univ Geneve, Programme Hypertens Pulm, Serv Pneumol, Geneva, Switzerland.	Frederic.lador@hcuge.ch	Günther, Sven/P-4177-2017; GÜNTHER, Sven/W-7090-2019; Savale, Laurent/AAJ-9781-2020; Humbert, Marc/ABD-5112-2021; Humbert, Marc/AAC-8459-2019; Simonneau, Gerald/ABE-6614-2020; Sitbon, Olivier/I-3623-2019	Günther, Sven/0000-0001-8388-6131; GÜNTHER, Sven/0000-0001-8388-6131; Humbert, Marc/0000-0003-0703-2892; Sitbon, Olivier/0000-0002-1942-1951; CHEMLA, Denis/0000-0001-7479-9896	European Respiratory Society (RESPIRE postdoctoral fellowship program - European Commission Seventh Framework Program (FP7)-Marie Curie Actions) [MC-1630-2010]	European Respiratory Society (RESPIRE postdoctoral fellowship program - European Commission Seventh Framework Program (FP7)-Marie Curie Actions)	This study was supported by an educational grant from the European Respiratory Society (RESPIRE postdoctoral fellowship program-Co-funded by the European Commission Seventh Framework Program (FP7)-Marie Curie Actions; MC-1630-2010) to Frederic Lador.	Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129; Chaouat A, 2014, EUR RESPIR J, V44, P704, DOI 10.1183/09031936.00153613; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; de Wilde RBP, 2009, ANAESTHESIA, V64, P762, DOI 10.1111/j.1365-2044.2009.05934.x; Garcia-Alvarez A, 2011, EUR HEART J, V32, P2438, DOI 10.1093/eurheartj/ehr173; Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938; Hedelin P, 2011, CLIN PHYSIOL FUNCT I, V31, P39, DOI [10.1111/j.1475-097X.2010.00977.x, DOI 10.1111/J.1475-097X.2010.00977.X]; Herve P, 2015, EUR RESP J; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hoeper MM, 1999, AM J RESP CRIT CARE, V160, P535, DOI 10.1164/ajrccm.160.2.9811062; Houtman S, 1999, CLIN PHYSIOL, V19, P230, DOI 10.1046/j.1365-2281.1999.00166.x; Jakovljevic DG, 2014, BEST PRACT RES-CLIN, V28, P381, DOI 10.1016/j.bpa.2014.09.003; Kenfack MA, 2004, CLIN SCI, V106, P365, DOI 10.1042/CS20030303; Lador F, 2013, SEMIN RESP CRIT CARE, V34, P654, DOI 10.1055/s-0033-1356549; Lau EMT, 2014, CHEST, V146, P959, DOI 10.1378/chest.13-2300; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Provencher S, 2008, EUR RESPIR J, V32, P393, DOI 10.1183/09031936.00009008; Reeves JT, 2005, AM J PHYSIOL-LUNG C, V288, pL419, DOI 10.1152/ajplung.00162.2004; Remmen JJ, 2002, CLIN SCI, V103, P143, DOI 10.1042/CS20010357; Rich JD, 2013, EUR RESPIR J, V42, P125, DOI 10.1183/09031936.00102212; Saggar R, 2010, ARTHRITIS RHEUM-US, V62, P3741, DOI 10.1002/art.27695; Schloglhofer T, 2014, CAN J ANESTH, V61, P452, DOI 10.1007/s12630-014-0135-8; Swift AJ, 2013, JACC-CARDIOVASC IMAG, V6, P1036, DOI 10.1016/j.jcmg.2013.01.013; Tam E, 2004, CLIN SCI, V106, P371, DOI 10.1042/CS20030302; van Lieshout JJ, 2003, EUR J APPL PHYSIOL, V90, P131, DOI 10.1007/s00421-003-0901-8; van Lieshout JJ, 2003, CLIN SCI, V104, P239; Warburton DER, 1999, SPORTS MED, V27, P23, DOI 10.2165/00007256-199927010-00003; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; York D, 2004, AM J PHYS, V72, P367, DOI 10.1119/1.1632486	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134221	10.1371/journal.pone.0134221	http://dx.doi.org/10.1371/journal.pone.0134221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226280	Green Published, Green Submitted, gold			2022-12-26	WOS:000358837700064
J	So, NN; Franks, B; Lim, S; Curley, JP				So, Nina; Franks, Becca; Lim, Sean; Curley, James P.			A Social Network Approach Reveals Associations between Mouse Social Dominance and Brain Gene Expression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AGGRESSIVE-BEHAVIOR; MEDIAL AMYGDALA; ANIMAL-MODELS; MALE-MICE; AGONISTIC ENCOUNTERS; CENTRAL NUCLEUS; HOUSE MICE; STRESS; SYSTEM	Modelling complex social behavior in the laboratory is challenging and requires analyses of dyadic interactions occurring over time in a physically and socially complex environment. In the current study, we approached the analyses of complex social interactions in group-housed male CD1 mice living in a large vivarium. Intensive observations of social interactions during a 3-week period indicated that male mice form a highly linear and steep dominance hierarchy that is maintained by fighting and chasing behaviors. Individual animals were classified as dominant, sub-dominant or subordinate according to their David's Scores and I& SI ranking. Using a novel dynamic temporal Glicko rating method, we ascertained that the dominance hierarchy was stable across time. Using social network analyses, we characterized the behavior of individuals within 66 unique relationships in the social group. We identified two individual network metrics, Kleinberg's Hub Centrality and Bonacich's Power Centrality, as accurate predictors of individual dominance and power. Comparing across behaviors, we establish that agonistic, grooming and sniffing social networks possess their own distinctive characteristics in terms of density, average path length, reciprocity out-degree centralization and out-closeness centralization. Though grooming ties between individuals were largely independent of other social networks, sniffing relationships were highly predictive of the directionality of agonistic relationships. Individual variation in dominance status was associated with brain gene expression, with more dominant individuals having higher levels of corticotropin releasing factor mRNA in the medial and central nuclei of the amygdala and the medial preoptic area of the hypothalamus, as well as higher levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor mRNA. This study demonstrates the potential and significance of combining complex social housing and intensive behavioral characterization of group-living animals with the utilization of novel statistical methods to further our understanding of the neurobiological basis of social behavior at the individual, relationship and group levels.	[So, Nina; Franks, Becca; Lim, Sean; Curley, James P.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [So, Nina] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10025 USA; [Franks, Becca] UBC Anim Welf Program, Vancouver, BC V6T 1Z4, Canada	Columbia University; Columbia University	Curley, JP (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	jc3181@columbia.edu		Curley, James/0000-0001-5546-007X	Psychology Department, Columbia University	Psychology Department, Columbia University	This research was supported by the Psychology Department, Columbia University.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; [Anonymous], 2014, R LANG ENV STAT COMP; APPLEBY MC, 1983, ANIM BEHAV, V31, P600, DOI 10.1016/S0003-3472(83)80084-0; Arakawa H, 2007, BEHAV BRAIN RES, V176, P27, DOI 10.1016/j.bbr.2006.07.027; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bauman MD, 2004, J COGNITIVE NEUROSCI, V16, P1388, DOI 10.1162/0898929042304741; BENTON D, 1980, ANIM BEHAV, V28, P1274, DOI 10.1016/S0003-3472(80)80115-1; BERRY R J, 1970, Field Studies, V3, P219; Bickart KC, 2014, NEUROPSYCHOLOGIA, V63, P235, DOI 10.1016/j.neuropsychologia.2014.08.013; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Boden B, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), DOI 10.1145/2505515.2508200; BOLHUIS JJ, 1984, PHYSIOL BEHAV, V32, P575, DOI 10.1016/0031-9384(84)90311-1; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; BRONSON FH, 1973, PHYSIOL BEHAV, V10, P947, DOI 10.1016/0031-9384(73)90065-6; Butts C.T., 2014, SNA TOOLS SOCIAL NET; Butts CT, 2011, SOCIOL METHODOL, V41, P299, DOI 10.1111/j.1467-9531.2011.01246.x; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Carpenter RE, 2009, NEUROSCIENCE, V158, P412, DOI 10.1016/j.neuroscience.2008.10.014; Carpenter RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096632; Cooper MA, 2010, PHYSIOL BEHAV, V101, P527, DOI 10.1016/j.physbeh.2010.08.003; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Crowcroft P, 1955, J MAMMAL, P299; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cumbo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105001; Curley J, 2015, COMPETE ANAL COMPETI; David H.A., 1988, METHOD PAIRED COMP; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Donaldson ZR, 2015, BIOL PSYCHIAT, V77, P15, DOI 10.1016/j.biopsych.2014.02.004; ELKABIR DR, 1990, REGUL PEPTIDES, V28, P199, DOI 10.1016/0167-0115(90)90018-R; Elo A. E., 1978, RATING CHESSPLAYERS; ELY DL, 1978, HORM BEHAV, V10, P156, DOI 10.1016/0018-506X(78)90005-3; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; Fiore M, 2003, EUR J NEUROSCI, V17, P1455, DOI 10.1046/j.1460-9568.2003.02573.x; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Gray SJ, 2000, ANIM BEHAV, V60, P765, DOI 10.1006/anbe.2000.1527; HAEMISCH A, 1994, PHYSIOL BEHAV, V56, P1041, DOI 10.1016/0031-9384(94)90341-7; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; HAYASHI S, 1993, J ETHOL, V11, P77, DOI 10.1007/BF02350040; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Heinrichs SC, 2003, BRAIN RES, V994, P107, DOI 10.1016/j.brainres.2003.09.028; HILAKIVICLARKE LA, 1992, J COMP PSYCHOL, V106, P184, DOI 10.1037/0735-7036.106.2.184; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Hostetler CM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00092; Huang SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103733; HURST JL, 1993, ANIM BEHAV, V45, P997, DOI 10.1006/anbe.1993.1117; Husson F, 2015, FACTOMINER MULTIVARI; Insel TR, 1998, BIOL PSYCHIAT, V44, P207, DOI 10.1016/S0006-3223(98)00094-8; JONES RB, 1973, ANIM BEHAV, V21, P707, DOI 10.1016/S0003-3472(73)80095-8; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1125, DOI 10.1007/s00213-013-3268-5; Kasahara M, 2011, BEHAV BRAIN RES, V218, P357, DOI 10.1016/j.bbr.2010.12.029; Kleinberg J., 1998, P 9 ACM SIAM S DISCR; KRACKHARDT D, 1987, SOC NETWORKS, V9, P171, DOI 10.1016/0378-8733(87)90012-8; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lehmann J, 2011, AM J PRIMATOL, V73, P775, DOI 10.1002/ajp.20967; Leiva D., 2011, STEEPNESS TESTING ST; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; LUITEN PGM, 1985, BRAIN RES, V332, P283, DOI 10.1016/0006-8993(85)90597-9; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; MACKINTO.JH, 1970, ANIM BEHAV, V18, P177, DOI 10.1016/0003-3472(70)90088-6; Markham CM, 2008, LEARN MEMORY, V15, P6, DOI 10.1101/lm.768208; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Mashoodh R, 2012, P NATL ACAD SCI USA, V109, P17232, DOI 10.1073/pnas.1121083109; MONDRAGON R, 1987, BEHAV NEURAL BIOL, V47, P384, DOI 10.1016/S0163-1047(87)90500-0; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Noonan MP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001940; Ohayon S, 2013, J NEUROSCI METH, V219, P10, DOI 10.1016/j.jneumeth.2013.05.013; Pan YL, 2010, HORM BEHAV, V58, P478, DOI 10.1016/j.yhbeh.2010.05.001; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Paxinos G, 2012, PAXINOS FRANKLINS MO; Perony N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002786; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; POOLE TB, 1973, ANIM BEHAV, V21, P788, DOI 10.1016/S0003-3472(73)80105-8; Poole TB, 1976, ANIM BEHAV, V23, P470; POSHIVALOV VP, 1980, BRIT J PHARMACOL, V70, P367, DOI 10.1111/j.1476-5381.1980.tb08712.x; Robison CL, 2004, ANN NY ACAD SCI, V1032, P324, DOI 10.1196/annals.1314.052; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; ROSEN JB, 1991, BEHAV NEUROSCI, V105, P817, DOI 10.1037/0735-7044.105.6.817; ROSVOLD HE, 1954, J COMP PHYSIOL PSYCH, V47, P173, DOI 10.1037/h0058870; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Shizuka D, 2012, ANIM BEHAV, V83, P925, DOI 10.1016/j.anbehav.2012.01.011; Stephenson A., 2014, PLAYERRATINGS DYNAMI; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Taylor SL, 2011, BEHAV NEUROSCI, V125, P911, DOI 10.1037/a0026172; Timmer M, 2011, NEUROPSYCHOPHARMACOL, V36, P2349, DOI 10.1038/npp.2011.125; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uhrich J, 1938, J COMP PSYCHOL, V25, P373, DOI 10.1037/h0056350; Usunoff KG, 2009, CELLS TISSUES ORGANS, V190, P256, DOI 10.1159/000209233; van Hoof J.A.R.A.M., 1987, Perspectives in Vertebrate Science, V4, P219; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; VOCHTELOO JD, 1987, PHYSIOL BEHAV, V41, P99, DOI 10.1016/0031-9384(87)90137-5; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	116	75	75	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134509	10.1371/journal.pone.0134509	http://dx.doi.org/10.1371/journal.pone.0134509			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226265	Green Published, gold, Green Submitted			2022-12-26	WOS:000358837700104
J	Antonissen, G; Devreese, M; De Baere, S; Hellebuyck, T; Van de Maele, I; Rouffaer, L; Stemkens, HJJ; De Backer, P; Martel, A; Croubels, S				Antonissen, Gunther; Devreese, Mathias; De Baere, Siegrid; Hellebuyck, Tom; Van de Maele, Isabel; Rouffaer, Lieze; Stemkens, Hendrickus J. J.; De Backer, Patrick; Martel, An; Croubels, Siska			Comparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian Species	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GLOMERULAR-FILTRATION; PLASMA; TUMOR; CLEARANCE; CISPLATIN; TOXICITY; DRUGS	The use of chemotherapeutics as a possible treatment strategy in avian oncology is steadily increasing over the last years. Despite this, literature reports regarding dosing strategies and pharmacokinetic behaviour of chemotherapeutics in avian species are lacking. The aim of the present study was to investigate the pharmacokinetics of carboplatin in a representative species of the order of Galliformes, Anseriformes, Columbiformes and Psittaciformes. Eight chickens, ducks and pigeons and twenty-eight parakeets were administered carboplatin intravenously (5 mg/kg body weight). A specific and sensitive liquid chromatographytandem mass spectrometry method was developed and validated for quantification of the free carboplatin in plasma of the four birds species (limit of quantification: 20 ng/mL for chicken and duck, 50 ng/mL for pigeon and 100 ng/mL for parakeets). Non-compartmental pharmacokinetic analysis and allometric scaling demonstrated a significant correlation (R-2 = 0.9769) between body weight (BW) and elimination half-life (T-1/2el). T-1/2el ranged from 0.41 h in parakeets (BW: 61 +/- 8 g) to 1.16 h chickens (BW: 1909 +/- 619 g). T-1/2el is a good parameter for dose optimization of carboplatin in other avian species, since also the previously reported T-1/2el in cockatoos (average BW: 769 +/- 68 g) of 1.00 h corresponds to the results obtained in the present study.	[Antonissen, Gunther; Devreese, Mathias; De Baere, Siegrid; De Backer, Patrick; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Antonissen, Gunther; Hellebuyck, Tom; Rouffaer, Lieze; Stemkens, Hendrickus J. J.; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van de Maele, Isabel] Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.	Gunther.Antonissen@UGent.be		Devreese, Mathias/0000-0003-2512-4176; Antonissen, Gunther/0000-0001-8832-1498; Croubels, Siska/0000-0001-6357-3517				ADOLPH EF, 1949, SCIENCE, V109, P579, DOI 10.1126/science.109.2841.579; [Anonymous], 2015, STUD EV MET RES KIN; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; Bailey DB, 2004, AM J VET RES, V65, P1502, DOI 10.2460/ajvr.2004.65.1502; Bradford C, 2009, J AVIAN MED SURG, V23, P214, DOI 10.1647/2008-015.1; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; Childs-Sanford SE, 2006, VET COMP ONCOL, V4, P51, DOI 10.1111/j.1476-5810.2006.00087.x; Citac Eurachem, 2000, J EUR UNION, VL221, P8; DALEYYATES PT, 1985, BIOCHEM PHARMACOL, V34, P1423, DOI 10.1016/0006-2952(85)90679-3; De Baere S, 2011, J CHROMATOGR B, V879, P2403, DOI 10.1016/j.jchromb.2011.06.036; Desjardins C, 2008, J CHROMATOGR B, V875, P373, DOI 10.1016/j.jchromb.2008.09.013; Filippich L, 2004, AUST VET J, V82, P366, DOI 10.1111/j.1751-0813.2004.tb11106.x; Filippich LJ, 2004, SEMIN AVIAN EXOT PET, V13, P25, DOI 10.1053/S1055-937X(03)00055-0; Flammer K, 2005, J AVIAN MED SURG, V19, P216, DOI 10.1647/2004-007.1; GAVER RC, 1988, CANCER CHEMOTH PHARM, V21, P197; Graham Jennifer E, 2004, Vet Clin North Am Exot Anim Pract, V7, P757, DOI 10.1016/j.cvex.2004.04.004; Guo P, 2003, J CHROMATOGR B, V783, P43, DOI 10.1016/S1570-0232(02)00489-0; HARLAND SJ, 1984, CANCER RES, V44, P1693; Heitzman R. J, 1994, 14126EN; Ito H, 2013, J CHROMATOGR B, V917, P18, DOI 10.1016/j.jchromb.2012.11.024; Jiang HL, 2011, J CHROMATOGR B, V879, P2162, DOI 10.1016/j.jchromb.2011.05.057; Kent Michael S, 2004, Vet Clin North Am Exot Anim Pract, V7, P807, DOI 10.1016/j.cvex.2004.04.006; Kloft C, 2002, J CLIN PHARMACOL, V42, P762, DOI 10.1177/009127002401102704; Macwhirter P., 2002, Exotic DVM, V4, P11; Mahmood I, 1999, J PHARM SCI-US, V88, P1101, DOI 10.1021/js9902163; Mete A, 2013, AVIAN DIS, V57, P311, DOI 10.1637/10382-092312-Case.1; Mo JX, 2014, ANAL BIOANAL CHEM, V406, P2659, DOI 10.1007/s00216-014-7684-0; PAGE RL, 1993, J VET INTERN MED, V7, P235, DOI 10.1111/j.1939-1676.1993.tb01013.x; Reavill Drury R, 2004, Vet Clin North Am Exot Anim Pract, V7, P537, DOI 10.1016/j.cvex.2004.04.008; REID HAC, 1993, AVIAN DIS, V37, P1158, DOI 10.2307/1591930; Riviere JE, 1997, J VET PHARMACOL THER, V20, P453, DOI 10.1046/j.1365-2885.1997.00095.x; Screnci D, 2000, BRIT J CANCER, V82, P966, DOI 10.1054/bjoc.1999.1026; Shimonohara N, 2013, AVIAN DIS, V57, P133, DOI 10.1637/10244-051012-Case.1; SIDDIK ZH, 1987, BIOCHEM PHARMACOL, V36, P1925, DOI 10.1016/0006-2952(87)90490-4; Sooriyaarachchi M, 2011, METALLOMICS, V3, P49, DOI 10.1039/c0mt00058b; SORENSEN BT, 1992, CANCER CHEMOTH PHARM, V30, P317, DOI 10.1007/BF00686302; Speer BL, 2001, P EUR C AV MED SURG, P20; VANDERVIJGH WJF, 1991, CLIN PHARMACOKINET, V21, P242, DOI 10.2165/00003088-199121040-00002; YOKOTA SD, 1985, RENAL PHYSIOL BIOCH, V8, P193; Zehnder AM, 2011, P 32 ANN ASS AV VET, P27	40	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134177	10.1371/journal.pone.0134177	http://dx.doi.org/10.1371/journal.pone.0134177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222777	gold, Green Published, Green Submitted			2022-12-26	WOS:000358836800110
J	Mobley, BC; Kwon, M; Kraemer, BR; Hickman, FE; Qiao, JB; Chung, DH; Carter, BD				Mobley, Bret C.; Kwon, Minjae; Kraemer, Bradley R.; Hickman, F. Edward; Qiao, Jingbo; Chung, Dai H.; Carter, Bruce D.			Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis	PLOS ONE			English	Article							CREST STEM-CELLS; N-MYC; IN-VIVO; NEURONAL DIFFERENTIATION; AMPLIFIED NEUROBLASTOMA; SYMPATHETIC NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; PROMOTES; DNA	Neuroblastoma is a pediatric malignancy of the sympathetic ganglia and adrenal glands, hypothesized to originate from progenitors of the developing sympathetic nervous system. Amplification of the MYCN oncogene is a genetic marker of risk in this disease. Understanding the impact of oncogene expression on sympathoadrenal progenitor development may improve our knowledge of neuroblastoma initiation and progression. We isolated sympathoadrenal progenitor cells from the postnatal murine adrenal gland by sphere culture and found them to be multipotent, generating differentiated colonies of neurons, Schwann cells, and myofibroblasts. MYCN overexpression in spheres promoted commitment to the neural lineage, evidenced by an increased frequency of neuron-containing colonies. MYCN promoted proliferation of both sympathoadrenal progenitor spheres and differentiated neurons derived from these spheres, but there was also an increase in apoptosis. The proliferation, apoptosis, and neural lineage commitment induced by MYCN are tumor-like characteristics and thereby support the hypothesis that multipotent adrenal medullary progenitor cells are cells of origin for neuroblastoma. We find, however, that MYCN overexpression is not sufficient for these cells to form tumors in nude mice, suggesting that additional transforming mutations are necessary for tumorigenesis.	[Mobley, Bret C.; Kwon, Minjae] Vanderbilt Univ, Med Ctr, Div Neuropathol, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA; [Kraemer, Bradley R.; Hickman, F. Edward; Carter, Bruce D.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA; [Kraemer, Bradley R.; Hickman, F. Edward; Carter, Bruce D.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [Qiao, Jingbo; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Mobley, BC (corresponding author), Vanderbilt Univ, Med Ctr, Div Neuropathol, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA.	bret.mobley@vanderbilt.edu; bruce.carter@vanderbilt.edu		Mobley, Bret/0000-0002-8138-5330	American Cancer Society Institutional Research Grant [IRG-58-009-52]; National Institutes of Health [R01 NS038220, R01 DK061470]; NIH [CA68485, DK20593, DK58404, DK59637, EY08126]; NCI/NIH Cancer Center Support Grant [2P30 CA068485-14]; Vanderbilt Mouse Metabolic Phenotyping Center Grant [5U24DK059637-13]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P30DK058404, P30DK020593, P60DK020593, R01DK061470, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH Cancer Center Support Grant; Vanderbilt Mouse Metabolic Phenotyping Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Cancer Society Institutional Research Grant #IRG-58-009-52 (BCM) and from the National Institutes of Health R01 NS038220 (B.D.C.) and R01 DK061470 (D.H.C.). The VUMC Cell Imaging Shared Resource is supported by NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126. The Translational Pathology Shared Resource is supported by NCI/NIH Cancer Center Support Grant 2P30 CA068485-14 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant 5U24DK059637-13.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Cohen LE, 2014, BONE MARROW TRANSPL, V49, P502, DOI 10.1038/bmt.2013.218; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; DELELLIS RA, 2004, STERNBERGS DIAGNOSTI, P622; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; Escobar MA, 2006, J PEDIATR SURG, V41, P377, DOI 10.1016/j.jpedsurg.2005.11.032; Gonsalvez DG, 2013, J NEUROSCI, V33, P5969, DOI 10.1523/JNEUROSCI.4350-12.2013; Guglielmi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.42; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Gutierrez JC, 2007, PEDIATR SURG INT, V23, P637, DOI 10.1007/s00383-007-1933-7; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Henriksen JR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-1; Hoehner JC, 1998, LAB INVEST, V78, P29; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kubota M, 2010, J PEDIATR SURG, V45, P673, DOI 10.1016/j.jpedsurg.2009.09.002; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nara K, 2007, INT J ONCOL, V30, P1189; NEGRONI A, 1991, CELL GROWTH DIFFER, V2, P511; Nishino J, 2010, J NEUROSCI, V30, P15228, DOI 10.1523/JNEUROSCI.2286-10.2010; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; ROHRER H, 1987, J NEUROSCI, V7, P3739; Santana MM, 2012, STEM CELL TRANSL MED, V1, P783, DOI 10.5966/sctm.2012-0022; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Saxena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064454; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Straub JA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-10; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Watt F, 2007, CANCER GENE THER, V14, P287, DOI 10.1038/sj.cgt.7701012; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wolf E, 1999, J NEUROBIOL, V40, P366, DOI 10.1002/(SICI)1097-4695(19990905)40:3<366::AID-NEU8>3.0.CO;2-B; Yazawa T, 2002, AM J PATHOL, V161, P291, DOI 10.1016/S0002-9440(10)64181-8; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	57	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133897	10.1371/journal.pone.0133897	http://dx.doi.org/10.1371/journal.pone.0133897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222553	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800078
J	Yi, JZ; Warunek, D; Craft, D				Yi, Jizu; Warunek, David; Craft, David			Degradation and Stabilization of Peptide Hormones in Human Blood Specimens	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; HUMAN PLASMA; MASS-SPECTROMETRY; PROFILING EXPERIMENTS; DIABETES-MELLITUS; FOOD-INTAKE; HUMAN SERUM; LC-MS/MS; GLUCAGON; GLP-1	Plasma hormone peptides, including GLP-1, GIP, Glucagon, and OXM, possess multiple physiological roles and potential therapeutic and diagnostic utility as biomarkers in the research of metabolic disorders. These peptides are subject to proteolytic degradation causing preanalytical variations. Stabilization for accurate quantitation of these active peptides in ex vivo blood specimens is essential for drug and biomarker development. We investigated the protease-driven instability of these peptides in conventional serum, plasma, anticoagulated whole blood, as well as whole blood and plasma stabilized with protease inhibitors. The peptide was monitored by both time-course Matrix-Assisted Laser Desorption Ionization Time-to-Flight Mass Spectrometry (MALDI -TOF MS) and Ab-based assay (ELISA or RIA). MS enabled the identification of proteolytic fragments. In non-stabilized blood samples, the results clearly indicated that dipeptidyl peptidase-IV (DPP-IV) removed the N-terminal two amino acid residues from GLP-1, GIP and OXM(1-37) and not-yet identified peptidase(s) cleave(s) the full-length OXM(1-37) and its fragments. DPP-IV also continued to remove two additional N-terminal residues of processed OXM(3-37) to yield OXM(5-37). Importantly, both DPP-IV and other peptidase(s) activities were inhibited efficiently by the protease inhibitors included in the BD P800* tube. There was preservation of GLP-1, GIP, OXM and glucagon in the P800 plasma samples with half-lives > 96, 96, 72, and 45 hours at room temperature (RT), respectively. In the BD P700* plasma samples, the stabilization of GLP-1 was also achieved with half-life > 96 hours at RT. The stabilization of these variable peptides increased their utility in drug and/or biomarker development. While stability results of GLP-1 obtained with Ab-based assay were consistent with those obtained by MS analysis, the Ab-based results of GIP, Glucagon, and OXM did not reflect the time-dependent degradations revealed by MS analysis. Therefore, we recommended characterizing the degradation of the peptide using the MS-based method when investigating the stability of a specific peptide.	[Yi, Jizu; Warunek, David; Craft, David] BD Diagnost, Franklin Lakes, NJ 07417 USA		Yi, JZ (corresponding author), BD Diagnost, One Becton Dr, Franklin Lakes, NJ 07417 USA.	Jizu_Yi@bd.com; David_Craft@BD.com			BD Diagnostics	BD Diagnostics	The authors received no specific funding for this work. BD Diagnostics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bhat VK, 2013, BIOCHEM PHARMACOL, V85, P1655, DOI 10.1016/j.bcp.2013.03.009; BLACHE P, 1988, ANAL BIOCHEM, V173, P151, DOI 10.1016/0003-2697(88)90172-8; Bystrom CE, 2010, CLIN CHEM, V56, P1561, DOI 10.1373/clinchem.2010.146449; CarlesBonnet C, 1996, PEPTIDES, V17, P557, DOI 10.1016/0196-9781(96)00001-0; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Craft D, 2009, ANAL LETT, V42, P1398, DOI 10.1080/00032710902961073; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Findeisen P, 2005, CLIN CHEM, V51, P2409, DOI 10.1373/clinchem.2005.054585; Garber Alan J, 2011, Rev Diabet Stud, V8, P307, DOI 10.1900/RDS.2011.8.307; Gautier JF, 2005, DIABETES METAB, V31, P233, DOI 10.1016/S1262-3636(07)70190-8; Greco V, 2014, PROTEOMICS, V14, P1954, DOI 10.1002/pmic.201300565; Halquist MS, 2012, J CHROMATOGR B, V903, P102, DOI 10.1016/j.jchromb.2012.06.047; Hewage CM, 2013, CHEMMEDCHEM, V8, P560, DOI 10.1002/cmdc.201200445; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Hoist JJ, 1994, GUT PEPTIDES BIOCH P, P305; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Karsan A, 2005, CLIN CHEM, V51, P1525, DOI 10.1373/clinchem.2005.050708; KERVRAN A, 1990, REGUL PEPTIDES, V31, P41, DOI 10.1016/0167-0115(90)90194-2; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kolb A, 2009, CANCER BIOL THER, V8, P1527, DOI 10.4161/cbt.8.16.9006; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Li YX, 2012, BIOANALYSIS, V4, P685, DOI [10.4155/BIO.12.12, 10.4155/bio.12.12]; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; McDonald TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042084; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Mentlein R, 2009, BEST PRACT RES CL EN, V23, P443, DOI 10.1016/j.beem.2009.03.005; Miyachi A, 2013, J PROTEOME RES, V12, P2690, DOI 10.1021/pr400069f; Nauck M, 2009, BEST PRACT RES CL EN, V23, P513, DOI 10.1016/j.beem.2009.03.002; Percy AJ, 2013, BIOANALYSIS, V5, P2837, DOI 10.4155/bio.13.245; Pieragostino D, 2010, J PROTEOMICS, V73, P579, DOI 10.1016/j.jprot.2009.07.014; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rai AJ, 2006, EXPERT REV PROTEOMIC, V3, P409, DOI 10.1586/14789450.3.4.409; Razavi M, 2012, J PROTEOME RES, V11, P5642, DOI 10.1021/pr300652v; Rogatsky E, 2006, J SEP SCI, V29, P538, DOI 10.1002/jssc.200500474; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; Sharma R, 2013, DRUG METAB DISPOS, V41, P2148, DOI 10.1124/dmd.113.054254; Siskos AP, 2009, J PROTEOME RES, V8, P3487, DOI 10.1021/pr900155h; Skibicka KP, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00181; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; THIM L, 1981, REGUL PEPTIDES, V2, P139, DOI 10.1016/0167-0115(81)90007-0; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Troutt JS, 2011, CLIN CHEM, V57, P849, DOI 10.1373/clinchem.2010.159954; van den Broek I, 2013, J CHROMATOGR B, V929, P161, DOI 10.1016/j.jchromb.2013.04.030; Wettergren A, 1998, REGUL PEPTIDES, V77, P83, DOI 10.1016/S0167-0115(98)00044-5; White CM, 1999, J CLIN PHARMACOL, V39, P442; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2011, METHODS MOL BIOL, V728, P161, DOI 10.1007/978-1-61779-068-3_10; Yi JZ, 2011, METHODS MOL BIOL, V728, P137, DOI 10.1007/978-1-61779-068-3_8; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c; Zhang HW, 2011, RAPID COMMUN MASS SP, V25, P3427, DOI 10.1002/rcm.5241; Zhu L, 2003, J BIOL CHEM, V278, P22418, DOI 10.1074/jbc.M212355200	57	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134427	10.1371/journal.pone.0134427	http://dx.doi.org/10.1371/journal.pone.0134427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222180	gold, Green Submitted, Green Published			2022-12-26	WOS:000358836800144
J	Calpena, E; Palau, F; Espinos, C; Galindo, MI				Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo			Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; METHYLTRANSFERASE; PROTEIN; DOMAIN; SET; EXPRESSION; NEOFUNCTIONALIZATION; SUBFUNCTIONALIZATION; IDENTIFICATION; TRANSCRIPTION	The Smyd gene family code for proteins containing a conserved core consisting of a SET domain interrupted by a MYND zinc finger. Smyd proteins are important in epigenetic control of development and carcinogenesis, through posttranslational modifications in histones and other proteins. Previous reports indicated that the Smyd family is quite variable in metazoans, so a rigorous phylogenetic reconstruction of this complex gene family is of central importance to understand its evolutionary history and functional diversification or conservation. We have performed a phylogenetic analysis of Smyd protein sequences, and our results show that the extant metazoan Smyd genes can be classified in three main classes, Smyd3 (which includes chordate-specific Smyd1 and Smyd2 genes), Smyd4 and Smyd5. In addition, there is an arthropod-specific class, SmydA. While the evolutionary history of the Smyd3 and Smyd5 classes is relatively simple, the Smyd4 class has suffered several events of gene loss, gene duplication and lineage-specific expansions in the animal phyla included in our analysis. A more specific study of the four Smyd4 genes in Drosophila melanogaster shows that they are not redundant, since their patterns of expression are different and knock-down of individual genes can have dramatic phenotypes despite the presence of the other family members.	[Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo] CIPF, Program Rare & Genet Dis, Valencia, Spain; [Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo] Inst Salud Carlos III, CIBERER, Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Galindo, MI (corresponding author), CIPF, Program Rare & Genet Dis, Valencia, Spain.	igalindo@cipf.es	Espinós, Carmen/A-9369-2014; Calpena, Eduardo/HCI-9261-2022; Galindo, Máximo Ibo/A-5299-2010; Palau, Francesc/A-9391-2014	Espinós, Carmen/0000-0003-4435-1809; Calpena, Eduardo/0000-0001-6399-6528; Galindo, Máximo Ibo/0000-0001-8448-9760; Palau, Francesc/0000-0002-8635-5421	Ministerio de Economia y Competitividad [AP2009-0642]; International Rare Diseases Research Consortium; Instituto de Salud Carlos III [IR11/TREAT-CMT]; FEDER funds [PI12/00453]; Centro de Investigacion Principe Felipe [CPII14/00002]; Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R01DK098370] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); International Rare Diseases Research Consortium; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Centro de Investigacion Principe Felipe; Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EC has a FPU studentship funded by the Ministerio de Economia y Competitividad (AP2009-0642), http://www.idi.mineco.gob.es. FP, CE and MIG are supported a collaborative grant from International Rare Diseases Research Consortium and Instituto de Salud Carlos III (IR11/TREAT-CMT), http://www.treat-cmt.es/index.php/en. CE has a project grant from the National R+D+I Plan, co-funded with FEDER funds (PI12/00453), http://www.eng.isciii.es/ISCIII/es/general/index.shtml. CE has a "Miguel Servet" contract funded by the Instituto de Salud Carlos III and Centro de Investigacion Principe Felipe (CPII14/00002), http://www.eng.isciii.es/ISCIII/es/general/index.shtml; http://www.cipf.es. FP is supported by funding from Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER), http://www.ciberer.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Du SJ, 2014, ANAT REC, V297, P1650, DOI 10.1002/ar.22972; Force A, 1999, GENETICS, V151, P1531; Fujii T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023491; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Green EM, 2012, NUCLEUS-PHILA, V3, P335, DOI 10.4161/nucl.20695; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Del Amo VL, 2015, HUM MOL GENET, V24, P21, DOI 10.1093/hmg/ddu416; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Minguillon C, 2002, GENE, V287, P121, DOI 10.1016/S0378-1119(01)00828-9; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Veerappan CS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-190; Vibranovski MD, 2005, J MOL EVOL, V61, P341, DOI 10.1007/s00239-004-0318-y; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Woods S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003330; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang LS, 2012, NEW PHYTOL, V195, P248, DOI 10.1111/j.1469-8137.2012.04143.x; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	57	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134106	10.1371/journal.pone.0134106	http://dx.doi.org/10.1371/journal.pone.0134106			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230726	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400072
J	Cronin, DT; Woloszynek, S; Morra, WA; Honarvar, S; Linder, JM; Gonder, MK; O'Connor, MP; Hearn, GW				Cronin, Drew T.; Woloszynek, Stephen; Morra, Wayne A.; Honarvar, Shaya; Linder, Joshua M.; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.			Long-Term Urban Market Dynamics Reveal Increased Bushmeat Carcass Volume despite Economic Growth and Proactive Environmental Legislation on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							HUNTING SUSTAINABILITY; WILDLIFE CONSUMPTION; CONSERVATION; WEST; IMPACT; TRADE; EXPLOITATION; BIODIVERSITY; FOREST; REGRESSION	Bushmeat hunting is extensive in west and central Africa as both a means for subsistence and for commercial gain. Commercial hunting represents one of the primary threats to wildlife in the region, and confounding factors have made it challenging to examine how external factors influence the commercial bushmeat trade. Bioko Island, Equatorial Guinea is a small island with large tracts of intact forest that support sizeable populations of commercially valuable vertebrates, especially endemic primates. The island also has a low human population and has experienced dramatic economic growth and rapid development since the mid-1990's. From October 1997 - September 2010, we monitored the largest bushmeat market on Bioko in Malabo, recording over 197,000 carcasses for sale. We used these data to analyze the dynamics of the market in relation to political events, environmental legislation, and rapid economic growth. Our findings suggest that bushmeat hunting and availability increased in parallel with the growth of Equatorial Guinea's GDP and disposable income of its citizens. During this 13-year study, the predominant mode of capture shifted from trapping to shotguns. Consequently, carcass volume and rates of taxa typically captured with shotguns increased significantly, most notably including intensified hunting of Bioko's unique and endangered monkey fauna. Attempts to limit bushmeat sales, including a 2007 ban on primate hunting and trade, were only transiently effective. The hunting ban was not enforced, and was quickly followed by a marked increase in bushmeat hunting compared to hunting rates prior to the ban. Our results emphasize the negative impact that rapid development and unenforced legislation have had on Bioko's wildlife, and demonstrate the need for strong governmental support if conservation strategies are to be successful at preventing extinctions of tropical wildlife.	[Cronin, Drew T.; Woloszynek, Stephen; Honarvar, Shaya; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Cronin, Drew T.; O'Connor, Michael P.; Hearn, Gail W.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Cronin, Drew T.; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.] Bioko Biodivers Protect Program, Malabo, Bioko Norte, Equat Guinea; [Woloszynek, Stephen] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Morra, Wayne A.] Arcadia Univ, Sch Global Business, Glenside, PA USA; [Honarvar, Shaya] Purdue Univ, Indiana Univ, Dept Biol, Ft Wayne, IN USA; [Linder, Joshua M.] James Madison Univ, Dept Sociol & Anthropol, Harrisonburg, VA 22807 USA	Drexel University; Drexel University; Drexel University; Purdue University System; Indiana University Purdue University Fort Wayne; James Madison University	Cronin, DT (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	dtc33@drexel.edu			ExxonMobil Foundation; Mobil Equatorial Guinea, Inc.; Margot Marsh Biodiversity Foundation; Conservation International; Los Angeles Zoo; National Geographic Conservation Trust; Phoebe Haas Charitable Trust B; Sally Hunter Challenge Fund; Office Of Internatl Science &Engineering [1243524] Funding Source: National Science Foundation	ExxonMobil Foundation(Exxon Mobil Corporation); Mobil Equatorial Guinea, Inc.(Exxon Mobil Corporation); Margot Marsh Biodiversity Foundation; Conservation International; Los Angeles Zoo; National Geographic Conservation Trust(National Geographic Society); Phoebe Haas Charitable Trust B; Sally Hunter Challenge Fund; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the ExxonMobil Foundation, Mobil Equatorial Guinea, Inc., the Margot Marsh Biodiversity Foundation, Conservation International, the Los Angeles Zoo, the National Geographic Conservation Trust, the Phoebe Haas Charitable Trust B, and the Sally Hunter Challenge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0303; Albrechtsen L, 2007, ENVIRON SCI POLICY, V10, P654, DOI 10.1016/j.envsci.2007.04.007; Albrechtsen L, 2005, ENVIRON CONSERV, V32, P340, DOI 10.1017/S0376892906002694; Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], 2007, PUB L; [Anonymous], 2013, EQ GUIN; Astaras C., 2009, ECOLOGY STATUS DRILL; Barnes JI, 1996, ECOL ECON, V18, P215, DOI 10.1016/0921-8009(96)00035-3; Bennett EL, 2007, CONSERV BIOL, V21, P884, DOI 10.1111/j.1523-1739.2006.00595.x; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Biggs D, 2013, SCIENCE, V339, P1038, DOI 10.1126/science.1229998; Bowen-Jones E, 2003, AREA, V35, P390, DOI 10.1111/j.0004-0894.2003.00189.x; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Box GEP, 2008, TIME SERIS ANAL FORC; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brooks EGE, 2010, BIOL CONSERV, V143, P2808, DOI 10.1016/j.biocon.2010.07.030; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burton M, 1999, ECOL ECON, V30, P93, DOI 10.1016/S0921-8009(98)00102-5; Butynski Thomas M., 2009, Primate Conservation, V24, P99; BUTYNSKI TM, 1994, BIODIVERS CONSERV, V3, P893, DOI 10.1007/BF00129665; Chan KS, 2012, TIME SERIES ANAL; Chapman CA, 2006, AFR J ECOL, V44, P116, DOI 10.1111/j.1365-2028.2006.00636.x; CIA, 2013, WORLD FACT BOOK 2013; Cleveland R.B., 1990, J OFF STAT, V6, P3; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COLELL M, 1994, BIODIVERS CONSERV, V3, P939, DOI 10.1007/BF00129668; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Cronin D. T., 2014, PRIMATES PERIL WORLD, P17; Cronin D. T., 2010, OPPORTUNITIES LOST R; Cronin D. T., 2013, AFRICAN PRIMATES, V8, P1; Cronin D. T., 2013, THESIS DREXEL U PHIL; Cronin DT, 2015, S FUT BIOD GRAN CLAD; Crookes DJ, 2005, ENVIRON CONSERV, V32, P333, DOI 10.1017/S037689290500250X; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Drury Rebecca, 2011, Conservation & Society, V9, P247, DOI 10.4103/0972-4923.86995; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Environmental Regulation Law in the Republic of Equatorial Guinea, 2003, PUB L; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2002, HUM ECOL, V30, P397, DOI 10.1023/A:1016524703607; Fa JE, 2000, BIOL RESOURCE MANAGE, P168; Fa JE, 2000, CONSERV BIOL, V14, P1602, DOI [10.1111/j.1523-1739.2000.99067.x, 10.1046/j.1523-1739.2000.99067.x]; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2006, BIOL CONSERV, V129, P497, DOI 10.1016/j.biocon.2005.11.031; Fa JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep08168; Fa JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112367; Gill DJC, 2012, CONSERV BIOL, V26, P1052, DOI 10.1111/j.1523-1739.2012.01876.x; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Vega MG, 2013, CONSERV BIOL, V27, P576, DOI 10.1111/cobi.12067; Groves CP, 2007, J ANTHROPOL SCI, V85, P7; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hearn G, 2006, MONKEYS TROUBLE RAPI; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; IUCN, 2013, IUCN RED LIST THREAT; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kumpel NF, 2009, ANIM CONSERV, V12, P531, DOI 10.1111/j.1469-1795.2009.00279.x; Kumpel N. F., 2006, THESIS U LONDON LOND; Kumpel NF, 2008, INT J PRIMATOL, V29, P1065, DOI [10.1007/s10764-008-9254-9, 10.1007/s10764-008-9277-2]; Lahm SA, 1993, THESIS NEW YORK U NE; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Ley de &Aacute;reas Protegidas, 2000, PUB L; Macdonald DW, 2012, BIOL CONSERV, V147, P107, DOI 10.1016/j.biocon.2011.12.018; Maisels F, 2001, ORYX, V35, P322, DOI 10.1017/S0030605300032087; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; MATLAB, 2013, MATLAB VERSION 8 1 0; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Miron JA, 1998, J DRUG ISSUES, V28, P741, DOI 10.1177/002204269802800310; Morra W, 2009, ECOL ECON, V68, P2619, DOI 10.1016/j.ecolecon.2009.04.015; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nasi R., 2008, CBD Technical Series, V33, P1; Nosti J., 1947, NOTAS GEOGRAFICAS FI; Oates J.F., 2005, ADV APPL BIODIVERS S, P1; Oates J. F., 1999, MYTH REALITY RAIN FO; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Rao P.V., 1998, STAT RES METHODS LIF; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reid J., 2005, EC MONKEY TRADE BIOK; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; Robinson JG, 2002, ORYX, V36, P332, DOI 10.1017/S0030605302000662; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; Rowcliffe JM, 2003, J APPL ECOL, V40, P872, DOI 10.1046/j.1365-2664.2003.00841.x; Schaaf CD, 1990, DRILL MANDRILLUS LEU; Schulte-Herbruggen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072807; Struhsaker TT, 2005, INT J PRIMATOL, V26, P525, DOI 10.1007/s10764-005-4364-0; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; U. S. Census Bureau, X 12 ARIMA; Warchol GL, 2004, CRIM JUSTICE STUD CR, V1, P57, DOI DOI 10.1080/08884310420001679334; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Willcox AS, 2007, BIOL CONSERV, V134, P251, DOI 10.1016/j.biocon.2006.08.016; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Zafra-Calvo N, 2010, BIOL CONSERV, V143, P787, DOI 10.1016/j.biocon.2009.12.022; Zuur Alain F., 2009, P1	104	23	24	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134464	10.1371/journal.pone.0134464	http://dx.doi.org/10.1371/journal.pone.0134464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230504	gold, Green Published, Green Submitted			2022-12-26	WOS:000358838400124
J	Gilbert, M; Conchedda, G; Van Boeckel, TP; Cinardi, G; Linard, C; Nicolas, G; Thanapongtharm, W; D'Aietti, L; Wint, W; Newman, SH; Robinson, TP				Gilbert, Marius; Conchedda, Giulia; Van Boeckel, Thomas P.; Cinardi, Giuseppina; Linard, Catherine; Nicolas, Gaelle; Thanapongtharm, Weerapong; D'Aietti, Laura; Wint, William; Newman, Scott H.; Robinson, Timothy P.			Income Disparities and the Global Distribution of Intensively Farmed Chicken and Pigs	PLOS ONE			English	Article							INFLUENZA-VIRUS; ASIA; ANTIBIOTICS; DUCKS	The rapid transformation of the livestock sector in recent decades brought concerns on its impact on greenhouse gas emissions, disruptions to nitrogen and phosphorous cycles and on land use change, particularly deforestation for production of feed crops. Animal and human health are increasingly interlinked through emerging infectious diseases, zoonoses, and antimicrobial resistance. In many developing countries, the rapidity of change has also had social impacts with increased risk of marginalisation of smallholder farmers. However, both the impacts and benefits of livestock farming often differ between extensive (backyard farming mostly for home-consumption) and intensive, commercial production systems (larger herd or flock size, higher investments in inputs, a tendency towards market-orientation). A density of 10,000 chickens per km(2) has different environmental, epidemiological and societal implications if these birds are raised by 1,000 individual households or in a single industrial unit. Here, we introduce a novel relationship that links the national proportion of extensively raised animals to the gross domestic product (GDP) per capita (in purchasing power parity). This relationship is modelled and used together with the global distribution of rural population to disaggregate existing 10 km resolution global maps of chicken and pig distributions into extensive and intensive systems. Our results highlight countries and regions where extensive and intensive chicken and pig production systems are most important. We discuss the sources of uncertainties, the modelling assumptions and ways in which this approach could be developed to forecast future trajectories of intensification.	[Gilbert, Marius; Linard, Catherine; Nicolas, Gaelle; Thanapongtharm, Weerapong] Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium; [Gilbert, Marius; Linard, Catherine] Fonds Natl Rech Sci, Brussels, Belgium; [Conchedda, Giulia; Cinardi, Giuseppina; D'Aietti, Laura] Food & Agr Org United Nations FAO, Anim Prod & Hlth Div AGA, Rome, Italy; [Van Boeckel, Thomas P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Thanapongtharm, Weerapong] Dept Livestock Dev, Bangkok, Thailand; [Wint, William] Environm Res Grp Oxford, Dept Zool, Oxford, England; [Newman, Scott H.] Food & Agr Org United Nations FAO, Emergency Ctr Control Transboundary Anim Dis ECTA, Hanoi, Vietnam; [Robinson, Timothy P.] ILRI, LSE, Nairobi, Kenya	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; Food & Agriculture Organization of the United Nations (FAO); Princeton University; Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Livestock Research Institute (ILRI)	Gilbert, M (corresponding author), Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium.	mgilbert@ulb.ac.be	Linard, Catherine/AAF-1670-2021		Fonds National de la Recherche Scientifique; CGIAR Research Programmes on the Humidtropics; Climate Change, Agriculture and Food Security (CCAFS); Agriculture for Nutrition and Health (A4NH); Fulbright Belgium program; Science and Technology Directorate, Department of Homeland Security [HSHQDC-12-C-00058]; NIH NIAID grant [1R01AI101028-01A1]; United States Agency for International Development's Emerging Pandemic Threat (EPT+) program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101028] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); CGIAR Research Programmes on the Humidtropics(CGIAR); Climate Change, Agriculture and Food Security (CCAFS); Agriculture for Nutrition and Health (A4NH); Fulbright Belgium program(CGIAR); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); NIH NIAID grant(CGIAR); United States Agency for International Development's Emerging Pandemic Threat (EPT+) program(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MG is funded by the "Fonds National de la Recherche Scientifique". TR is funded by the CGIAR Research Programmes on the Humidtropics; Climate Change, Agriculture and Food Security (CCAFS) and Agriculture for Nutrition and Health (A4NH). TPVB is supported by the Fulbright Belgium program and the Science and Technology Directorate, Department of Homeland Security contract HSHQDC-12-C-00058. Part of the work was funded through the NIH NIAID grant (1R01AI101028-01A1) and the United States Agency for International Development's Emerging Pandemic Threat (EPT+) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, WORLD AGR 2030 2050; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Boeckel TPV, 2015, PNAS, DOI [10.1073/pnas.1503141112, DOI 10.1073/PNAS.1503141112]; Delgado CL, 1999, INTL FOOD POLICY RES; DeSA U, 2013, WORLD POP PROSP 2012; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Dolman MA, 2012, LIVEST SCI, V149, P143, DOI 10.1016/j.livsci.2012.07.008; FAO, 2009, FAO STAT DAT; FAO, 2014, AV FLU FARM SYST INT; Fowler CW, 2003, P ROY SOC B-BIOL SCI, V270, P2579, DOI 10.1098/rspb.2003.2553; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; MacPherson DW, 2009, EMERGING INFECT DIS; McLeod A, 2009, WORLD POULTRY SCI J, V65, P191, DOI 10.1017/S0043933909000129; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Monne I, 2014, J VIROL, V88, P4375, DOI 10.1128/JVI.03181-13; NBS GDP DATA, REV CHIN GDP 2004 20; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Robinson T.P., 2011, GLOBAL LIVESTOCK PRO; Robinson T.P., 2011, MAPPING SUPPLY DEMAN; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Steinfeld H, 2004, VET PARASITOL, V125, P19, DOI 10.1016/j.vetpar.2004.05.003; Steinfeld H., 2013, LIVESTOCK CHANGING L, V1; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Willer H, 2011, WORLD ORGANIC AGR 20; Wint W., 2007, GRIDDED LIVESTOCK WO; World Bank, 2014, DAT WORLD BANK; Zimmerman D.R., 1986, J ANIM SCI, V62, P6, DOI [10.2527/1986.62Supplement_36s, DOI 10.2527/1986.62SUPPLEMENT_36S]	40	53	54	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133381	10.1371/journal.pone.0133381	http://dx.doi.org/10.1371/journal.pone.0133381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230336	Green Published, Green Submitted, gold			2022-12-26	WOS:000358838400034
J	Fleming, JC; Schmehl, DR; Ellis, JD				Fleming, James C.; Schmehl, Daniel R.; Ellis, James D.			Characterizing the Impact of Commercial Pollen Substitute Diets on the Level of Nosema spp. in Honey Bees (Apis mellifera L.)	PLOS ONE			English	Article							PESTICIDES; HYMENOPTERA; INFECTION; EXPOSURE; CERANAE; APIDAE; RESPONSIVENESS; FLUVALINATE; NUTRITION; SUCROSE	Western honey bee (Apis mellifera L.) populations face declines commonly attributed to pesticide, pathogen, and parasite stress. One way beekeepers combat these stressors is by providing supplemental protein diets to honey bee colonies to ensure adequate colony nutrition. However Nosema spp., a microsporidian parasite of the honey bee, is thought to be associated closely with a colony's nutritional intake, thus possibly negating any benefit the bees otherwise would have received from a nutritional supplement. Through three objectives, we examined how adult bees' consumption of wildflower pollen or commercial pollen substitute diets affected Nosema levels in the bees' midguts. For our first objective, we investigated how method of inoculation with Nosema affects infection levels in inoculated bees. Bees were infected with spores of Nosema four days after emergence. On day 15, bees were collected from the cages and Nosema spores were quantified. We found that inoculation through the pollen diet resulted in the highest Nosema levels in inoculated bees. In our second and third objectives, we provided the test diets to caged, newly emerged bees for a period of 15 days. Bees consuming pollen and a sucrose solution had more Nosema in their midguts than did bees consuming the sucrose solution alone (control). The overall volume of diet consumed by the bees did not correlate with the level of Nosema in their midguts. The level of Nosema was higher in bees fed certain commercial pollen substitute diets than in bees fed wildflower pollen. Our study illustrates how providing nutritional supplements to adult honey bees can impact the intensity of Nosema in their midguts.	[Fleming, James C.; Schmehl, Daniel R.; Ellis, James D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Schmehl, DR (corresponding author), Bayer CropSci, 2 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	daniel.schmehl@bayer.com	Ellis, James/L-7985-2013	Ellis, James/0000-0003-0318-8646; Schmehl, Daniel/0000-0003-1591-8722				Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; CANTWELL G E, 1970, American Bee Journal, V110, P222; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Frost EH, 2013, J EXP BIOL, V216, P2931, DOI 10.1242/jeb.086538; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Malone LA, 1998, J INVERTEBR PATHOL, V71, P169, DOI 10.1006/jipa.1997.4715; Matheson A, 1996, BEE WORLD, V77, P45, DOI 10.1080/0005772X.1996.11099281; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; OLSEN PE, 1986, J INVERTEBR PATHOL, V47, P65, DOI 10.1016/0022-2011(86)90164-3; PICKARD RS, 1989, J APICULT RES, V28, P93; Porrini MP, 2011, J APICULT RES, V50, P35, DOI 10.3896/IBRA.1.50.1.04; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Standifer L.N., 1977, ANN ENTOMOL SOC AM, V70, P691; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	44	35	37	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132014	10.1371/journal.pone.0132014	http://dx.doi.org/10.1371/journal.pone.0132014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226229	Green Submitted, Green Published, gold			2022-12-26	WOS:000358837700004
J	Allen, K; Corre, MD; Tjoa, A; Veldkamp, E				Allen, Kara; Corre, Marife D.; Tjoa, Aiyen; Veldkamp, Edzo			Soil Nitrogen-Cycling Responses to Conversion of Lowland Forests to Oil Palm and Rubber Plantations in Sumatra, Indonesia	PLOS ONE			English	Article							MICROBIAL BIOMASS NITROGEN; OLD-GROWTH LOWLAND; LAND-USE SYSTEMS; CENTRAL SULAWESI; RETENTION PROCESSES; DIRECT EXTRACTION; PRODUCTIVITY; EMISSIONS; AMAZONIA; DYNAMICS	Rapid deforestation in Sumatra, Indonesia is presently occurring due to the expansion of palm oil and rubber production, fueled by an increasing global demand. Our study aimed to assess changes in soil-N cycling rates with conversion of forest to oil palm (Elaeis guineensis) and rubber (Hevea brasiliensis) plantations. In Jambi Province, Sumatra, Indonesia, we selected two soil landscapes - loam and clay Acrisol soils - each with four land-use types: lowland forest and forest with regenerating rubber (hereafter, "jungle rubber") as reference land uses, and rubber and oil palm as converted land uses. Gross soil-N cycling rates were measured using the N-15 pool dilution technique with in-situ incubation of soil cores. In the loam Acrisol soil, where fertility was low, microbial biomass, gross N mineralization and NH4+ immobilization were also low and no significant changes were detected with land-use conversion. The clay Acrisol soil which had higher initial fertility based on the reference land uses (i.e. higher pH, organic C, total N, effective cation exchange capacity (ECEC) and base saturation) (P <= 0.05-0.09) had larger microbial biomass and NH4+ transformation rates (P <= 0.05) compared to the loam Acrisol soil. Conversion of forest and jungle rubber to rubber and oil palm in the clay Acrisol soil decreased soil fertility which, in turn, reduced microbial biomass and consequently decreased NH4+ transformation rates (P <= 0.05-0.09). This was further attested by the correlation of gross N mineralization and microbial biomass N with ECEC, organic C, total N (R=0.51-0.76; P <= 0.05) and C: N ratio (R=-0.71 - -0.75, P <= 0.05). Our findings suggest that the larger the initial soil fertility and N availability, the larger the reductions upon land-use conversion. Because soil N availability was dependent on microbial biomass, management practices in converted oil palm and rubber plantations should focus on enriching microbial biomass.	[Allen, Kara; Corre, Marife D.; Veldkamp, Edzo] Univ Gottingen, Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany; [Tjoa, Aiyen] Univ Tadulako, Fak Pertanian, Agroforestry Ctr, Palu, Sulawesi, Indonesia	University of Gottingen; Universitas Tadulako	Allen, K (corresponding author), Univ Gottingen, Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany.	Kara.Allen@forst.uni-goettingen.de	Veldkamp, Edzo/A-6660-2008; Tjoa, A Min/AAL-5676-2020	Veldkamp, Edzo/0000-0002-8318-8349; Tjoa, A Min/0000-0002-8295-9252	Deutsche Forschungsgemeinschaft (DFG), German-Indonesian Collaborative Research Center [990]	Deutsche Forschungsgemeinschaft (DFG), German-Indonesian Collaborative Research Center(German Research Foundation (DFG))	The study was financed by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de) as part of the project A05 in the framework of the German-Indonesian Collaborative Research Center 990 entitled "Ecological and Socioeconomic Function of Tropical Lowland Rainforest Transformation Systems" (EEFForTs) (https://www.uni-goettingen.de/en/310995.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Arnold J, 2009, FOREST ECOL MANAG, V257, P2079, DOI 10.1016/j.foreco.2009.02.014; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Carlson KM, 2012, NAT CLIM CHANG; Corre MD, 2007, GLOBAL CHANGE BIOL, V13, P1509, DOI 10.1111/j.1365-2486.2007.01371.x; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Corre MD, 2006, SOIL SCI SOC AM J, V70, P359, DOI 10.2136/sssaj2005.0061; Corre MD, 2003, ECOL APPL, V13, P287, DOI 10.1890/1051-0761(2003)013[0287:SNCIHN]2.0.CO;2; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; DAVIDSON EA, 1989, SOIL BIOL BIOCHEM, V21, P773, DOI 10.1016/0038-0717(89)90169-7; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Dechert G, 2005, NUTR CYCL AGROECOSYS, V72, P201, DOI 10.1007/s10705-005-1546-2; Dechert G, 2004, PLANT SOIL, V265, P197, DOI 10.1007/s11104-005-0885-8; FAO/IIASA/ISRIC/ISSCAS/JRC, HARM WORLD SOIL DAT; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; GOUYON A, 1993, AGROFOREST SYST, V22, P181, DOI 10.1007/BF00705233; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Jarvis A., HOLE FILLED SRTM GLO; Klinge R, 2004, BIOGEOCHEMISTRY, V69, P63, DOI 10.1023/B:BIOG.0000031040.38388.9b; Kotowska MM, 2015, GLOBAL CHANGE BIOL, V21, P3620, DOI 10.1111/gcb.12979; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Margono BA, 2014, NAT CLIM CHANG; Markewitz D, 2001, NATURE, V410, P802, DOI 10.1038/35071052; Ngoze S, 2008, GLOBAL CHANGE BIOL, V14, P2810, DOI 10.1111/j.1365-2486.2008.01698.x; R Core Team, R LANG ENV STAT COMP; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Silver WL, 2001, ECOLOGY, V82, P2410, DOI 10.1890/0012-9658(2001)082[2410:DNRTAI]2.0.CO;2; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; Silver WL, 2005, ECOL APPL, V15, P1604, DOI 10.1890/04-1322; Sotta ED, 2008, SOIL BIOL BIOCHEM, V40, P740, DOI 10.1016/j.soilbio.2007.10.009; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Templer PH, 2008, ECOLOGY, V89, P3030, DOI 10.1890/07-1631.1; VANBREEMEN N, 1983, PLANT SOIL, V75, P283, DOI 10.1007/BF02369968; Veldkamp E, 2008, J GEOPHYS RES; Wang YF, 2007, GLOBAL CHANGE BIOL, V13, P2270, DOI 10.1111/j.1365-2486.2007.01441.x; WHITE CS, 1991, BIOGEOCHEMISTRY, V12, P43, DOI 10.1007/BF00002625	42	84	88	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133325	10.1371/journal.pone.0133325	http://dx.doi.org/10.1371/journal.pone.0133325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222690	Green Submitted, gold, Green Published			2022-12-26	WOS:000358836800049
J	Heinze, J; Buschinger, A; Poettinger, T; Suefuji, M				Heinze, Juegen; Buschinger, Alfred; Poettinger, Theo; Suefuji, Masaki			Multiple Convergent Origins of Workerlessness and Inbreeding in the Socially Parasitic Ant Genus Myrmoxenus	PLOS ONE			English	Article							SYMPATRIC SPECIATION; EPIMYRMA HYMENOPTERA; EVOLUTION; MORPHOLOGY; RAVOUXI	The socially parasitic ant genus Myrmoxenus varies strongly in fundamental life history traits, such as queen-worker ratio, the timing of sexual production, and mating behavior. Myrmoxenus queens generally take over nests of Temnothorax ants, kill the resident queen by throttling, and force the workers to take care of the social parasite's brood. Young queens of M. ravouxi and other species produce large numbers of workers, which during "slaveraids" pillage host pupae from neighboring Temnothorax colonies to increase the workforce in their own nests. Other species, such as M. corsicus, have lost caste polyphenism and rear only male and female sexual offspring. Using sequences of the genes CO I / CO II and wingless we reconstruct the phylogeny of Myrmoxenus and document that the worker caste was lost convergently at least three times. Furthermore, mating in the nest and inbreeding obviously also evolved in parallel from ancestors whose sexuals presumably mated during nuptial flights. Myrmoxenus might thus provide a suitable model to investigate caste differentiation and the plasticity of mating behavior in Hymenoptera.	[Heinze, Juegen; Poettinger, Theo; Suefuji, Masaki] Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany; [Buschinger, Alfred] Tech Univ Darmstadt, Reinheim, Germany	University of Regensburg; Technical University of Darmstadt	Heinze, J (corresponding author), Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany.	juergen.heinze@ur.de	Poettinger, Theodor/A-8141-2015	Poettinger, Theodor/0000-0001-7274-615X	 [15623/24]		Funding was provided by He 15623/24, www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beibl J, 2007, INSECT SOC, V54, P174, DOI 10.1007/s00040-007-0929-6; Beibl J, 2005, INSECT SOC, V52, P291, DOI 10.1007/s00040-005-0808-y; Bolton B., 1994, IDENTIFICATION GUIDE; BOURKE AFG, 1991, BIOL J LINN SOC, V43, P157, DOI 10.1111/j.1095-8312.1991.tb00591.x; Buschinger A., 1983, Psyche (Cambridge), V90, P335, DOI 10.1155/1983/48717; BUSCHINGER A, 1986, Psyche (Cambridge), V93, P253, DOI 10.1155/1986/43540; BUSCHINGER A, 1989, Psyche (Cambridge), V96, P69, DOI 10.1155/1989/19504; BUSCHINGER A, 1985, ENTOMOL GEN, V10, P65; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; BUSCHINGER A, 1983, ENTOMOL GEN, V8, P251; BUSCHINGER A, 1989, J EVOLUTION BIOL, V2, P265, DOI 10.1046/j.1420-9101.1989.2040265.x; BUSCHINGER A, 1990, Z ZOOL SYST EVOL, V28, P241; Buschinger Alfred, 2001, Myrmecologische Nachrichten, V4, P25; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Cardoso DC, 2014, MOL PHYLOGENET EVOL, V70, P378, DOI 10.1016/j.ympev.2013.10.012; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOUWES P, 1988, ENTOMOL SCAND, V19, P239; Gratiashvili N, 2014, ORG DIVERS EVOL, V14, P259, DOI 10.1007/s13127-014-0174-6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heinze J, 2000, TRENDS ECOL EVOL, V15, P508, DOI 10.1016/S0169-5347(00)01995-9; Horandl E, 2010, TAXON, V59, P1641, DOI 10.1002/tax.596001; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; JESSEN K, 1990, INSECT SOC, V37, P273, DOI 10.1007/BF02225993; Oster G.F., 1978, Monographs in Population Biology, pi; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; PEETERS C, 1991, BIOL J LINN SOC, V44, P141, DOI 10.1111/j.1095-8312.1991.tb00612.x; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 2001, MOL CLONING; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schulz Andreas, 2002, Entomofauna, V23, P157; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; SEIFERT B, 2007, AMEISEN MITTEL NORDE; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suefuji M, 2015, INTEGR ZOOL, V10, P182, DOI 10.1111/1749-4877.12120; Suefuji M, 2014, CONSERV GENET, V15, P201, DOI 10.1007/s10592-013-0531-6; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Ward PS, 2015, SYST ENTOMOL, V40, P61, DOI 10.1111/syen.12090; WHEELER WILLIAM MORTON, 1931, BULL MUS COMP ZOOL HARVARD COLLEGE, V72, P1; Wheeler WM, 1913, B MUS COMP ZOOL HARV, V54, P477; WILSON EO, 1963, EVOLUTION, V17, P249, DOI 10.2307/2406469	44	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131023	10.1371/journal.pone.0131023	http://dx.doi.org/10.1371/journal.pone.0131023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221735	Green Submitted, Green Published, gold			2022-12-26	WOS:000358836800011
J	Igawa, T; Watanabe, A; Suzuki, A; Kashiwagi, A; Kashiwagi, K; Noble, A; Guille, M; Simpson, DE; Horb, ME; Fujii, T; Sumida, M				Igawa, Takeshi; Watanabe, Ai; Suzuki, Atsushi; Kashiwagi, Akihiko; Kashiwagi, Keiko; Noble, Anna; Guille, Matt; Simpson, David E.; Horb, Marko E.; Fujii, Tamotsu; Sumida, Masayuki			Inbreeding Ratio and Genetic Relationships among Strains of the Western Clawed Frog, Xenopus tropicalis	PLOS ONE			English	Article							GENOME; ACCURACY; MUTANTS; LAEVIS; TREES; TOOL; MAP	The Western clawed frog, Xenopus tropicalis, is a highly promising model amphibian, especially in developmental and physiological research, and as a tool for understanding disease. It was originally found in the West African rainforest belt, and was introduced to the research community in the 1990s. The major strains thus far known include the Nigerian and Ivory Coast strains. However, due to its short history as an experimental animal, the genetic relationship among the various strains has not yet been clarified, and establishment of inbred strains has not yet been achieved. Since 2003 the Institute for Amphibian Biology (IAB), Hiroshima University has maintained stocks of multiple X. tropicalis strains and conducted consecutive breeding as part of the National BioResource Project. In the present study we investigated the inbreeding ratio and genetic relationship of four inbred strains at IAB, as well as stocks from other institutions, using highly polymorphic microsatellite markers and mitochondrial haplotypes. Our results show successive reduction of heterozygosity in the genome of the IAB inbred strains. The Ivory Coast strains clearly differed from the Nigerian strains genetically, and three subgroups were identified within both the Nigerian and Ivory Coast strains. It is noteworthy that the Ivory Coast strains have an evolutionary divergent genetic background. Our results serve as a guide for the most effective use of X. tropicalis strains, and the long-term maintenance of multiple strains will contribute to further research efforts.	[Igawa, Takeshi; Watanabe, Ai; Suzuki, Atsushi; Kashiwagi, Akihiko; Kashiwagi, Keiko; Sumida, Masayuki] Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Higashihiroshima, Hiroshima 724, Japan; [Noble, Anna; Guille, Matt] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Portsmouth, Hants, England; [Simpson, David E.] Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England; [Horb, Marko E.] Marine Biol Lab, Bell Ctr Regenerat Biol & Tissue Engn, Woods Hole, MA 02543 USA; [Horb, Marko E.] Marine Biol Lab, Natl Xenopus Resource, Woods Hole, MA 02543 USA; [Fujii, Tamotsu] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Dept Hlth Sci, Hiroshima, Japan	Hiroshima University; University of Portsmouth; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole	Igawa, T (corresponding author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Div Dev Sci, Higashihiroshima, Hiroshima 724, Japan.	tigawa@hiroshima-u.ac.jp	Igawa, Takeshi/E-2881-2014	Igawa, Takeshi/0000-0001-6880-6180; Horb, Marko/0000-0002-5067-0518; Guille, Matthew/0000-0001-6865-4519	Wellcome Trust [101480/Z/13/Z]; Biotechnology and Biological Sciences Research Council [BB/K019988/1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23710282, 20510216]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010997] Funding Source: NIH RePORTER; BBSRC [BB/K019988/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (101480/Z/13/Z, http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_publishing_group/documents/web_document/wts058331.pdf) and Biotechnology and Biological Sciences Research Council (BB/K019988/1, http://www.bbsrc.ac.uk/pa/grants/AwardDetails.aspx? FundingReference=BB/K019988/1) to the European Xenopus Resource Centre. This work was also supported by a Grant-in-Aid for Young Scientists (B) (No. 23710282, http://kaken.nii.ac.jp/d/p/23710282.en.html) to TI from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a Grant-in-Aid for Scientific Research (B) (No. 20510216, http://kaken.nii.ac.jp/d/p/24310173.en.html) to MS from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Castresana J, 2002, GBLOCKS SELECTION OF; Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gao Z, 2014, EVOLUTION NY, V62, P431, DOI [10.1111/evo.12567, DOI 10.1111/EV0.12567]; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grainger Robert M, 2012, Methods Mol Biol, V917, P3, DOI 10.1007/978-1-61779-992-1_1; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; Johnson SL, 1999, METHOD CELL BIOL, V60, P357; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; KROTOSKI DM, 1985, J EXP ZOOL, V233, P443, DOI 10.1002/jez.1402330313; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Milligan BG, 2003, GENETICS, V163, P1153; Nakajima K, 2012, DEV GROWTH DIFFER, V54, P777, DOI 10.1111/dgd.12006; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nowell RW, 2011, GENET RES, V93, P255, DOI 10.1017/S0016672311000206; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Sater AK, 2012, GENOME MAPPING GENOM, P183, DOI 10.1007/978-3-642-31316-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seifertova E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-357; Showell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022392; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMPKINS R, 1991, METHOD CELL BIOL, V36, P35; TYMOWSKA J, 1973, CHROMOSOMA, V44, P335, DOI 10.1007/BF00291027; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; van Oppen MJH, 2000, MOL BIOL EVOL, V17, P489, DOI 10.1093/oxfordjournals.molbev.a026329; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wells DE, 2011, DEV BIOL, V354, P1, DOI 10.1016/j.ydbio.2011.03.022; Xu ZK, 2008, BIOINFORM BIOL INSIG, V2, P157; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	42	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133963	10.1371/journal.pone.0133963	http://dx.doi.org/10.1371/journal.pone.0133963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222540	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800087
J	Lange, N; Unger, FT; Schoppler, M; Pursche, K; Juhl, H; David, KA				Lange, Nicole; Unger, Florian T.; Schoeppler, Monika; Pursche, Katja; Juhl, Hartmut; David, Kerstin A.			Identification and Validation of a Potential Marker of Tissue Quality Using Gene Expression Analysis of Human Colorectal Tissue	PLOS ONE			English	Article							REAL-TIME PCR; CELL CARCINOMA; ISCHEMIA; PROTEIN; IMPACT; TUMOR; MODEL	Correlative studies have identified numerous biomarkers that are individualizing therapy across many medical specialties, including oncology. Accurate interpretation of these studies requires the collection of tissue samples of sufficient quality. Tissue quality can be measured by changes in levels of gene expression and can be influenced by many factors including pre-analytical conditions, ischemic effects and the surgical collection procedure itself. However, as yet there are no reliable biomarkers of tissue quality at researchers' disposal. The aim of the current study was to identify genes with expression patterns that fluctuated reproducibly in response to typical post-surgical stress (ischemia) in order to identify a specific marker of tissue quality. All tissue samples were obtained from patients with primary colorectal carcinoma (CRC) (N = 40) either via colonoscopy prior to surgery, or by surgical resection. Surgically resected tissue samples were divided into three groups and subjected to cold ischemia for 10, 20 or 45 minutes. Normal colorectal tissue and CRC tissue was analyzed using microarray and quantitative real-time PCR (qPCR). Comparing changes in gene expression between pre-and post-surgical tissue using microarray analysis identified a list of potential tissue quality biomarkers and this list was validated using qPCR. Results revealed that postoperative ischemia significantly alters gene expression in normal and CRC tissue samples. Both microarray analysis and qPCR revealed regulator of G-protein signaling 1 (RGS1) as a potential marker of CRC tissue quality and eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) as a potential reference gene of post-operative tissue quality. Larger studies with additional time points and endpoints will be needed to confirm these results.	[Lange, Nicole; Unger, Florian T.; Schoeppler, Monika; Pursche, Katja; Juhl, Hartmut; David, Kerstin A.] Indivumed GmbH, Hamburg, Germany		David, KA (corresponding author), Indivumed GmbH, Hamburg, Germany.	David@indivumed.com			Indivumed GmbH; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Indivumed GmbH; Federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part by Indivumed GmbH and with Federal funds from the National Cancer Institute, National Institutes of Health (http://www.cancer.gov/), under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. National Cancer Institute, National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Indivumed GmbH provided support in the form of salaries for all authors (Nicole Lange, Florian T. Unger, Monika Schoppler, Katja Pursche, Hartmut Juhl and Kerstin A. David), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cervia D, 2008, J NEUROCHEM, V106, P2224, DOI 10.1111/j.1471-4159.2008.05556.x; David KA, 2014, ONCOTARGET, V5, P11017, DOI 10.18632/oncotarget.2669; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gourdin M, 2013, IMPACT ISCHEMIA CELL; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Liu NW, 2013, CLIN CANCER RES, V19, P42, DOI 10.1158/1078-0432.CCR-12-2606; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Piepoli A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-11; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Piovan E, 2007, CANCER RES, V67, P8605, DOI 10.1158/0008-5472.CAN-06-4722; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Sinicropi D, 2007, BIOMEMS BIOMEDICAL N, VII, P23, DOI DOI 10.1007/B136238/PAGE/1]; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Yamagishi A, 2014, ONCOL REP, V31, P1531, DOI 10.3892/or.2014.3053; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153	23	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133987	10.1371/journal.pone.0133987	http://dx.doi.org/10.1371/journal.pone.0133987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222051	Green Published, Green Submitted, gold			2022-12-26	WOS:000358836800093
J	Rueckert, IM; Baumert, J; Schunk, M; Holle, R; Schipf, S; Voelzke, H; Kluttig, A; Greiser, KH; Tamayo, T; Rathmann, W; Meisinger, C				Ruckert, Ina-Maria; Baumert, Jens; Schunk, Michaela; Holle, Rolf; Schipf, Sabine; Volzke, Henry; Kluttig, Alexander; Greiser, Karin-Halina; Tamayo, Teresa; Rathmann, Wolfgang; Meisinger, Christa			Blood Pressure Control Has Improved in People with and without Type 2 Diabetes but Remains Suboptimal: A Longitudinal Study Based on the German DIAB-CORE Consortium	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PULSE PRESSURE; HYPERTENSION; RISK; POPULATION; PREVALENCE; MANAGEMENT; HEALTH; IMPACT	Background Hypertension is a very common comorbidity and major risk factor for cardiovascular complications, especially in people with Type 2 Diabetes (T2D). Nevertheless, studies in the past have shown that blood pressure is often insufficiently controlled in medical practice. For the DIAB-CARE study, we used longitudinal data based on the German DIAB-CORE Consortium to assess whether health care regarding hypertension has improved during the last decade in our participants. Methods Data of the three regional population-based studies CARLA (baseline 2002-2006 and follow-up 2007-2010), KORA (baseline 1999-2001 and follow-up 2006-2008) and SHIP (baseline 1997-2001 and follow-up 2002-2006) were pooled. Stratified by T2D status we analysed changes in frequencies, degrees of awareness, treatment and control. Linear mixed models were conducted to assess the influence of sex, age, study, and T2D status on changes of systolic blood pressure between the baseline and follow-up examinations (mean observation time 5.7 years). We included 4,683 participants aged 45 to 74 years with complete data and accounted for 1,256 participants who were lost to follow-up by inverse probability weighting. Results Mean systolic blood pressure decreased in all groups from baseline to follow-up (e. g. -8.5 mmHg in those with incident T2D). Pulse pressure (PP) was markedly higher in persons with T2D than in persons without T2D (64.14 mmHg in prevalent T2D compared to 52.87 mmHg in non-T2D at baseline) and did not change much between the two examinations. Awareness, treatment and control increased considerably in all subgroups however, the percentage of those with insufficiently controlled hypertension remained high (at about 50% of those with hypertension) especially in prevalent T2D. Particularly elderly people with T2D often had both, high blood pressure >= 140/90 mmHg and a PP of >= 60 mmHg. Blood pressure in men had improved more than in women at follow-up, however, men still had higher mean SBP than women at follow-up. Conclusion Blood pressure management has developed positively during past years in Germany. While hypertension prevalence, awareness and treatment were substantially higher in participants with T2D than in those without T2D at follow-up, hypertension control was achieved only in about half the number of people in each T2D group leaving much room for further improvement.	[Ruckert, Ina-Maria; Baumert, Jens; Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Ruckert, Ina-Maria; Baumert, Jens; Schunk, Michaela; Holle, Rolf; Meisinger, Christa] German Ctr Diabet Res DZD EV, D-85764 Neuherberg, Germany; [Schunk, Michaela; Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Schipf, Sabine; Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Volzke, Henry] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Kluttig, Alexander; Greiser, Karin-Halina] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany; [Greiser, Karin-Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; German Centre for Cardiovascular Research; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Rueckert, IM (corresponding author), Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany.	ina-maria.rueckert@helmholtz-muenchen.de	Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014	Holle, Rolf/0000-0001-5395-2695; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' - Federal Ministry of Education and Research [FKZ 01GI0814-0816/-0855-0858]; Deutsche Forschungsgemeinschaft [Collaborative Research Center 598]; Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [01ZZ0403]; Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania	'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' - Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office; Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania	This work was supported by 'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' funded by the Federal Ministry of Education and Research (FKZ 01GI0814-0816/-0855-0858). The CARLA study was funded by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt and by the Federal Employment Office. The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. SHIP is part of the Community Medicine Research net (http://www.community-medicine.de) at the University of Greifswald, Germany. Funding was provided by grants from the German Federal Ministry of Education and Research (BMBF, grant 01ZZ0403), the Ministry for Education, Research and Cultural Affairs and the Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anthony H, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-24; Assmann G, 2005, EUR HEART J, V26, P2120, DOI 10.1093/eurheartj/ehi467; Avanzini F, 2006, J HYPERTENS, V24, P2377, DOI 10.1097/01.hjh.0000251897.40002.bf; Bundesarztek&auml;mmer, 2002, NATIONALES PROGRAMM; Bundesarztekammer. Programm fur Nationale Versorgungsleitlinien, 2013, PROGRAMM FUR NATIONA; Dao HH, 2005, CARDIOVASC RES, V66, P307, DOI 10.1016/j.cardiores.2005.01.012; de Burgos-Lunar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086713; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Furthauer J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-47; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greving JP, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-25; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Janhsen K, 2008, HYPERTONIE; Kengne AP, 2009, HYPERTENSION, V54, P399, DOI 10.1161/HYPERTENSIONAHA.109.133041; Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023; Labeit AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052229; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; MARMOT MG, 1984, BRIT MED BULL, V40, P380, DOI 10.1093/oxfordjournals.bmb.a072008; Neuhauser HK, 2015, J HUM HYPERTENS, V29, P247, DOI 10.1038/jhh.2014.82; Niiranen TJ, 2006, J HYPERTENS, V24, P463, DOI 10.1097/01.hjh.0000209982.21112.bc; Nilsson PM, 2009, DIABETES METAB, V35, P439, DOI 10.1016/j.diabet.2009.04.010; Ott P, 2009, DEUT MED WOCHENSCHR, V134, P291, DOI 10.1055/s-0028-1123994; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; Prugger C, 2006, HERZ, V31, P287, DOI 10.1007/s00059-006-2818-6; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-120; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-50; Schunk M, 2011, BUNDESGESUNDHEITSBLA, V54, P1187, DOI 10.1007/s00103-011-1364-4; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Strandberg TE, 2003, CURR OPIN NEPHROL HY, V12, P293, DOI 10.1097/00041552-200305000-00011; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Williams B, 2008, DIABETIC MED, V25, P13, DOI 10.1111/j.1464-5491.2008.02506.x; Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133493	10.1371/journal.pone.0133493	http://dx.doi.org/10.1371/journal.pone.0133493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221962	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800052
J	Wong, ESY; Shekar, S; Chan, CHT; Hong, LZ; Poon, SY; Silla, T; Lin, C; Kumar, V; Davila, S; Voorhoeve, M; Thike, AA; Ho, GH; Yap, YS; Tan, PH; Tan, MH; Ang, P; Lee, ASG				Wong, Edward S. Y.; Shekar, Sandhya; Chan, Claire H. T.; Hong, Lewis Z.; Poon, Suk-Yean; Silla, Toomas; Lin, Clarabelle; Kumar, Vikrant; Davila, Sonia; Voorhoeve, Mathijs; Thike, Aye Aye; Ho, Gay Hui; Yap, Yoon Sim; Tan, Puay Hoon; Tan, Min-Han; Ang, Peter; Lee, Ann S. G.			Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; ESTROGEN-RECEPTOR STATUS; GERMLINE MUTATIONS; OVARIAN-CANCER; WOMEN; GRADE; PREVALENCE; CARCINOMA; PLATFORM; RISK	Purpose The National Comprehensive Cancer Network (NCCN) has proposed guidelines for the genetic testing of the BRCA1 and BRCA2 genes, based on studies in western populations. This current study assessed potential predictive factors for BRCA mutation probability, in an Asian population. Methods A total of 359 breast cancer patients, who presented with either a family history (FH) of breast and/or ovarian cancer or early onset breast cancer, were accrued at the National Cancer Center Singapore (NCCS). The relationships between clinico-pathological features and mutational status were calculated using the Chi-squared test and binary logistic regression analysis. Results Of 359 patients, 45 (12.5%) had deleterious or damaging missense mutations in BRCA1 and/or BRCA2. BRCA1 mutations were more likely to be found in ER-negative than ER-positive breast cancer patients (P=0.01). Moreover, ER-negative patients with BRCA mutations were diagnosed at an earlier age (40 vs. 48 years, P=0.008). Similarly, triple-negative breast cancer (TNBC) patients were more likely to have BRCA1 mutations (P=0.001) and that these patients were diagnosed at a relatively younger age than non-TNBC patients (38 vs. 46 years, P=0.028). Our analysis has confirmed that ER-negative status, TNBC status and a FH of hereditary breast and ovarian cancer (HBOC) are strong factors predicting the likelihood of having BRCA mutations. Conclusions Our study provides evidence that TNBC or ER-negative patients may benefit from BRCA genetic testing, particularly younger patients (<40 years) or those with a strong FH of HBOC, in Asian patients.	[Wong, Edward S. Y.; Shekar, Sandhya; Chan, Claire H. T.; Lee, Ann S. G.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Hong, Lewis Z.; Poon, Suk-Yean] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Silla, Toomas; Voorhoeve, Mathijs] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Lin, Clarabelle; Kumar, Vikrant; Davila, Sonia] Genome Inst Singapore, Human Genet, Singapore, Singapore; [Thike, Aye Aye; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ho, Gay Hui] Natl Canc Ctr, Dept Surg Oncol, Singapore, Singapore; [Yap, Yoon Sim; Tan, Min-Han; Ang, Peter] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Ang, Peter] Mt Elizabeth Novena Specialist Ctr, OncoCare Canc Ctr, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Yoo Lin Sch Med, Dept Physiol, Singapore 117548, Singapore; [Lee, Ann S. G.] Duke NUS Grad Med Sch, Off Clin & Acad Fac Affairs, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore General Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	Lin, Clarabelle/AAK-4409-2020; Tan, Min/GQQ-2702-2022	Ang, Peter/0000-0002-0482-3069; Yap, Yoon-Sim/0000-0002-0347-5066	National Medical Research Council of Singapore [NMRC/CBRG/0034/2013]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by the National Medical Research Council of Singapore (NMRC/CBRG/0034/2013).	Ahmed SS, 2011, J CLIN PATHOL, V64, P120, DOI 10.1136/jcp.2010.085423; Ang P, 2007, CANCER EPIDEM BIOMAR, V16, P2276, DOI 10.1158/1055-9965.EPI-07-0403; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Castera L, 2014, NEXT GENERATION SEQU; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan M, 2012, J MOL DIAGN, V14, P602, DOI 10.1016/j.jmoldx.2012.06.003; Claes K, 1999, Hum Mutat, V13, P256, DOI 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M; Comen E, 2011, BREAST CANCER RES TR, V129, P185, DOI 10.1007/s10549-011-1433-2; Eisinger F, 1996, CANCER RES, V56, P471; Evans DG, 2011, J MED GENET, V48, P520, DOI 10.1136/jmedgenet-2011-100006; Feliubadalo L, 2013, EUR J HUM GENET, V21, P864, DOI 10.1038/ejhg.2012.270; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Iqbal J, 2012, HISTOPATHOLOGY, V61, P652, DOI 10.1111/j.1365-2559.2012.04255.x; Janavicius R, 2010, EPMA J, V1, P397, DOI 10.1007/s13167-010-0037-y; Kang PCE, 2014, BREAST CANCER RES TR, V144, P635, DOI 10.1007/s10549-014-2894-x; Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Loman N, 1998, CANCER, V83, P310, DOI 10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038361, DOI 10.1371/J0URNAL.P0NE.0038361]; National Comprehensive Cancer Network I, 2014, NCCN GUID GEN FAM HI; Peshkin Beth N, 2010, Breast Dis, V32, P25, DOI 10.3233/BD-2010-0306; Phuah SY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3347; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Seong MW, 2014, BREAST CANCER RES TR, V146, P63, DOI 10.1007/s10549-014-3006-7; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Yeo ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-516	35	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134408	10.1371/journal.pone.0134408	http://dx.doi.org/10.1371/journal.pone.0134408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221963	Green Published, gold, Green Submitted			2022-12-26	WOS:000358836800142
